<SEC-DOCUMENT>0001178913-22-001304.txt : 20220330
<SEC-HEADER>0001178913-22-001304.hdr.sgml : 20220330
<ACCEPTANCE-DATETIME>20220330163823
ACCESSION NUMBER:		0001178913-22-001304
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		97
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220330
DATE AS OF CHANGE:		20220330

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		22787037

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>zk2227534.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:i="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:cmmb="http://anchiano.com/20211231" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:iso4217="http://www.xbrl.org/2003/iso4217">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <head>
    <title>CHEMOMAB THERAPEUTICS LTD.</title>
    <meta content="text/html" http-equiv="Content-Type"/>
  </head>
  <body style=" font-family:Times New Roman, Times, serif; font-size:10pt;"><div style="font-size: 10pt;"><div style="font-size: 10pt;"><div style="font-size: 10pt;"><div style="font-size: 10pt;">
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2021-01-01to2021-12-31" id="Fact_0000000000489">0001534248</ix:nonNumeric>
          <ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="From2021-01-01to2021-12-31" id="Fact_0000000000490">FY</ix:nonNumeric>
          <ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2021-01-01to2021-12-31" id="Fact_0000000000491">false</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="From2021-01-01to2021-12-31" id="Fact_0000000000492">CHEMOMAB THERAPEUTICS LTD.</ix:nonNumeric>
          <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="As_Of_12_31_2020" unitRef="usd" id="Fact_0000000000493" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2021-12-31" unitRef="usd" id="Fact_0000000000494" xsi:nil="true"></ix:nonFraction>
          <ix:nonNumeric name="us-gaap:LeaseExpirationDate1" contextRef="From2020-05-01to2020-05-31" id="Fact_0000000000271">2023-05-31</ix:nonNumeric>
          <ix:nonNumeric name="us-gaap:LeaseExpirationDate1" contextRef="From2021-10-01to2021-10-24" id="Fact_0000000000276">2024-10-31</ix:nonNumeric>
        </ix:hidden>
        <ix:references>
          <xbrll:schemaRef xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="cmmb-20211231.xsd" xlink:type="simple"></xbrll:schemaRef>
        </ix:references>
        <ix:resources>
          <i:context id="Duration_1_1_2020_To_12_31_2020">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:unit id="usd">
            <i:measure>iso4217:USD</i:measure>
          </i:unit>
          <i:context id="From2021-01-01to2021-12-31">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-03-14to2021-03-16_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-03-14</i:startDate>
              <i:endDate>2021-03-16</i:endDate>
            </i:period>
          </i:context>
          <i:unit id="Share">
            <i:measure>i:shares</i:measure>
          </i:unit>
          <i:context id="From2020-12-13to2020-12-14_custom_FormerChemomabSecurityHoldersMember_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cmmb:FormerChemomabSecurityHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-12-13</i:startDate>
              <i:endDate>2020-12-14</i:endDate>
            </i:period>
          </i:context>
          <i:unit id="Pure">
            <i:measure>i:pure</i:measure>
          </i:unit>
          <i:context id="From2020-12-13to2020-12-14_custom_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cmmb:SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-12-13</i:startDate>
              <i:endDate>2020-12-14</i:endDate>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-06-30">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2021-06-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="As_Of_12_31_2020">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_custom_RelatedPartyMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cmmb:RelatedPartyMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_custom_RelatedPartyMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cmmb:RelatedPartyMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2020-01-01to2020-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_srt_MaximumMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000378" toRefs="FN_621deee6493d5b6a527b092b"></ix:relationship>
          <i:context id="From2021-01-01to2021-12-31_srt_MinimumMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000377" toRefs="FN_621deee6493d5b6a527b092b"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000380" toRefs="FN_621deee6493d5b6a527b0925"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000379" toRefs="FN_621deee6493d5b6a527b0925"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000382" toRefs="FN_621deee6493d5b6a527b0927"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000381" toRefs="FN_621deee6493d5b6a527b0927"></ix:relationship>
          <i:context id="As_Of_12_31_2019">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2019-12-31</i:instant>
            </i:period>
          </i:context>
          <i:unit id="USDperShare">
            <i:divide>
              <i:unitNumerator>
                <i:measure>iso4217:USD</i:measure>
              </i:unitNumerator>
              <i:unitDenominator>
                <i:measure>i:shares</i:measure>
              </i:unitDenominator>
            </i:divide>
          </i:unit>
          <i:context id="Duration_1_1_2019_To_12_31_2019">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:startDate>2019-01-01</i:startDate>
              <i:endDate>2019-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_srt_MaximumMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000374" toRefs="FN_621deee6493d5b6a527b0929"></ix:relationship>
          <i:context id="AsOf2021-12-31_srt_MinimumMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000373" toRefs="FN_621deee6493d5b6a527b0929"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000091" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000112" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <i:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2019-12-31</i:instant>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000109" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <i:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000122" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <i:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2019-12-31</i:instant>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000110" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <i:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2019-12-31</i:instant>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000111" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <i:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000123" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <i:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000124" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <i:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="From2021-03-14to2021-03-16">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:startDate>2021-03-14</i:startDate>
              <i:endDate>2021-03-16</i:endDate>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_currency_ILS">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_currency_ILS">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_currency_USD">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_currency_USD">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_currency_XXX">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_currency_XXX">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000105" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000104" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000107" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000106" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000108" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000121" toRefs="FN_6102973d32beaf4e6dd850f5"></ix:relationship>
          <i:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_us-gaap_CommonStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_us-gaap_ComputerEquipmentMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_us-gaap_ComputerEquipmentMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_us-gaap_SoftwareDevelopmentMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_us-gaap_SoftwareDevelopmentMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_custom_LaboratoryEquipmentMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cmmb:LaboratoryEquipmentMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_custom_LaboratoryEquipmentMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cmmb:LaboratoryEquipmentMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="As_Of_3_16_2021">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2021-03-16</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-03-16_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-03-16</i:instant>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_us-gaap_LeaseholdImprovementsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cmmb:TwoThousandsFifteenMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2020-05-01to2020-05-31">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:startDate>2020-05-01</i:startDate>
              <i:endDate>2020-05-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-10-01to2021-10-24">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:startDate>2021-10-01</i:startDate>
              <i:endDate>2021-10-24</i:endDate>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-05-31">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2020-05-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-10-24">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2021-10-24</i:instant>
            </i:period>
          </i:context>
          <i:context id="From2020-05-01to2020-05-31_currency_ILS">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-05-01</i:startDate>
              <i:endDate>2020-05-31</i:endDate>
            </i:period>
          </i:context>
          <i:unit id="ils">
            <i:measure>iso4217:ILS</i:measure>
          </i:unit>
          <i:context id="AsOf2021-12-12">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2021-12-12</i:instant>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_us-gaap_CapitalAdditionsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:CapitalAdditionsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_custom_CapitalAdditionsOneMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cmmb:CapitalAdditionsOneMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2015-06-01to2015-06-30_currency_EUR">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2015-06-01</i:startDate>
              <i:endDate>2015-06-30</i:endDate>
            </i:period>
          </i:context>
          <i:unit id="eur">
            <i:measure>iso4217:EUR</i:measure>
          </i:unit>
          <i:context id="From2021-06-01to2021-11-30_currency_EUR">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-06-01</i:startDate>
              <i:endDate>2021-11-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_country_US_us-gaap_DomesticCountryMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_country_IL">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-12-31_country_IL">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2021-12-31_country_IL">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2021-12-31</i:instant>
            </i:period>
          </i:context>
          <i:context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-01-01</i:startDate>
              <i:endDate>2020-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_us-gaap_EmployeeStockOptionMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2020-06-01to2020-12-31_custom_InvestorsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:InvestorsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-06-01</i:startDate>
              <i:endDate>2020-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="AsOf2019-09-30_us-gaap_SeriesCPreferredStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2019-09-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2019-11-30_us-gaap_SeriesCPreferredStockMember_custom_InvestorsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:InvestorsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2019-11-30</i:instant>
            </i:period>
          </i:context>
          <i:context id="AsOf2020-05-30_us-gaap_SeriesCPreferredStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:instant>2020-05-30</i:instant>
            </i:period>
          </i:context>
          <i:unit id="ILSperShare">
            <i:divide>
              <i:unitNumerator>
                <i:measure>iso4217:ILS</i:measure>
              </i:unitNumerator>
              <i:unitDenominator>
                <i:measure>i:shares</i:measure>
              </i:unitDenominator>
            </i:divide>
          </i:unit>
          <i:context id="From2019-09-01to2019-09-30_us-gaap_SeriesCPreferredStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2019-09-01</i:startDate>
              <i:endDate>2019-09-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2019-11-01to2019-11-30_us-gaap_SeriesCPreferredStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2019-11-01</i:startDate>
              <i:endDate>2019-11-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2019-11-01to2019-11-30_us-gaap_SeriesCPreferredStockMember_custom_InvestorsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:InvestorsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2019-11-01</i:startDate>
              <i:endDate>2019-11-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2020-05-01to2020-05-30_us-gaap_SeriesCPreferredStockMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-05-01</i:startDate>
              <i:endDate>2020-05-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-03-01to2021-03-15_us-gaap_PrivatePlacementMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-03-01</i:startDate>
              <i:endDate>2021-03-15</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-03-01to2021-03-23_us-gaap_PrivatePlacementMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-03-01</i:startDate>
              <i:endDate>2021-03-23</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-04-01to2021-04-30_custom_AtmAgreementMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtmAgreementMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-04-01</i:startDate>
              <i:endDate>2021-04-30</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_custom_AtmAgreementMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtmAgreementMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_custom_AmericanDepositarySharesMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2021-01-01to2021-12-31_custom_OrdinarySharesNoParValuePerShareMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2021-01-01</i:startDate>
              <i:endDate>2021-12-31</i:endDate>
            </i:period>
          </i:context>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="Fact_0000000000022" toRefs="FN_621deee6493d5b6a527b0922"></ix:relationship>
          <i:context id="AsOf2022-03-24">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
            </i:entity>
            <i:period>
              <i:instant>2022-03-24</i:instant>
            </i:period>
          </i:context>
          <i:context id="From2020-05-01to2020-05-31_us-gaap_LeaseAgreementsMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-05-01</i:startDate>
              <i:endDate>2020-05-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2020-05-01to2020-05-31_us-gaap_LeaseAgreementsMember_currency_ILS">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2020-05-01</i:startDate>
              <i:endDate>2020-05-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2022-01-01to2022-12-31_us-gaap_LeaseAgreementsMember_srt_ScenarioForecastMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2022-01-01</i:startDate>
              <i:endDate>2022-12-31</i:endDate>
            </i:period>
          </i:context>
          <i:context id="From2022-01-01to2022-12-31_us-gaap_LeaseAgreementsMember_currency_ILS_srt_ScenarioForecastMember">
            <i:entity>
              <i:identifier scheme="http://www.sec.gov/CIK">0001534248</i:identifier>
              <i:segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
              </i:segment>
            </i:entity>
            <i:period>
              <i:startDate>2022-01-01</i:startDate>
              <i:endDate>2022-12-31</i:endDate>
            </i:period>
          </i:context>
        </ix:resources>
      </ix:header>
    </div>
    <div> <div style="width:100%; clear:both;"> <hr style="height:3pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-left:0pt; text-align:left; "/><hr style="height:0.75pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; "></p> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:14pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">UNITED STATES</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:14pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">SECURITIES AND EXCHANGE COMMISSION</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Washington, D.C. 20549</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; border-bottom:1.5pt solid #000000; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:14pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">FORM </span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000001" contextRef="From2021-01-01to2021-12-31" name="dei:DocumentType">10-K</ix:nonNumeric></span> </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td colspan="2" style="width:3%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(Mark One)</span> </p> </td> </tr> <tr class="even" style=""> <td style="width:3%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000002" contextRef="From2021-01-01to2021-12-31" name="dei:DocumentAnnualReport" format="ixt:booleantrue">&#x2612;</ix:nonNumeric></span> </p> </td> <td style="width:97%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span> </p> </td> </tr> <tr class="odd" style=""> <td style="width:3%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:97%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:3%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:97%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">For the fiscal year ended </span><span style="font-weight:bold; "><span style="font-weight:bold; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000005" contextRef="From2021-01-01to2021-12-31" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><ix:nonNumeric id="Fact_0000000000003" contextRef="From2021-01-01to2021-12-31" name="dei:CurrentFiscalYearEndDate" format="ixt:datemonthdayen">December 31</ix:nonNumeric>, <ix:nonNumeric id="Fact_0000000000004" contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalYearFocus">2021</ix:nonNumeric></ix:nonNumeric></span></span></span> </p> </td> </tr> <tr class="odd" style=""> <td style="width:3%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:97%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> </tr> <tr class="even" style=""> <td colspan="2" style="width:3%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">OR</span> </p> </td> </tr> <tr class="odd" style=""> <td style="width:3%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:97%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> </tr> <tr class="even" style=""> <td style="width:3%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000006" contextRef="From2021-01-01to2021-12-31" name="dei:DocumentTransitionReport" format="ixt:booleanfalse">&#x2610;</ix:nonNumeric></span> </p> </td> <td style="width:97%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span> </p> </td> </tr> <tr class="odd" style=""> <td style="width:3%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:97%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> </tr> <tr class="even" style=""> <td style="width:3%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:97%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">For the transition period from to</span> </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; border-bottom:1.5pt solid #000000; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000007" contextRef="From2021-01-01to2021-12-31" name="dei:EntityFileNumber">001-38807</ix:nonNumeric></span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(Commission file number)</span> </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; border-bottom:1.5pt solid #000000; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:14pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">CHEMOMAB THERAPEUTICS LTD.</span> </p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(Exact name of registrant as specified in its charter)</span> </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <tbody> <tr class="odd" style=""> <td style="width:49%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; font-weight:bold; "><ix:nonNumeric id="Fact_0000000000008" contextRef="From2021-01-01to2021-12-31" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:49%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; font-weight:bold; "><ix:nonNumeric id="Fact_0000000000009" contextRef="From2021-01-01to2021-12-31" name="dei:EntityTaxIdentificationNumber">81-3676773</ix:nonNumeric></span> </p> </td> </tr> <tr class="even" style=""> <td style="width:49%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(State or other jurisdiction of</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">incorporation or organization)</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:49%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(I.R.S. Employer</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Identification No.)</span> </p> </td> </tr> <tr class="odd" style=""> <td style="width:49%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:-6pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:49%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:-6pt; margin-bottom:0pt; ">&#xA0; </p> </td> </tr> <tr class="even" style=""> <td style="width:49%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000010" contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine1">Kiryat Atidim</ix:nonNumeric></span><span style="font-weight:bold; ">, </span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000011" contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine2">Building 7</ix:nonNumeric></span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; font-weight:bold; "><ix:nonNumeric id="Fact_0000000000012" contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressCityOrTown">Tel Aviv</ix:nonNumeric></span><span style="text-decoration:underline #000000; font-weight:bold; ">, </span><span style="text-decoration:underline #000000; font-weight:bold; "><ix:nonNumeric id="Fact_0000000000013" contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:49%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; font-weight:bold; "><ix:nonNumeric id="Fact_0000000000014" contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressPostalZipCode">6158002</ix:nonNumeric></span> </p> </td> </tr> <tr class="odd" style=""> <td style="width:49%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(Address of principal executive offices)</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:49%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(Zip Code)</span> </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Registrant&#x2019;s telephone number, including area code: +</span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000015" contextRef="From2021-01-01to2021-12-31" name="dei:CityAreaCode">972</ix:nonNumeric></span><span style="font-weight:bold; ">-</span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000016" contextRef="From2021-01-01to2021-12-31" name="dei:LocalPhoneNumber">77-331-0156</ix:nonNumeric></span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Securities registered pursuant to Section 12(b) of the Act:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <tbody> <tr class="odd" style=""> <td style="width:40%; vertical-align:middle; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Title of each class</span> </p> </td> <td style="width:20%; vertical-align:middle; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Trading Symbol(s)</span> </p> </td> <td style="width:40%; vertical-align:middle; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Name of each exchange on which registered</span> </p> </td> </tr> <tr class="even" style=""> <td style="width:40%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000017" contextRef="From2021-01-01to2021-12-31_custom_AmericanDepositarySharesMember" name="dei:Security12bTitle">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</ix:nonNumeric></span></span> </p> </td> <td style="width:20%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000018" contextRef="From2021-01-01to2021-12-31_custom_AmericanDepositarySharesMember" name="dei:TradingSymbol">CMMB</ix:nonNumeric></span> </p> </td> <td style="width:40%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000019" contextRef="From2021-01-01to2021-12-31_custom_AmericanDepositarySharesMember" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric></span><span style="font-weight:bold; "> Capital Market</span> </p> </td> </tr> <tr class="odd" style=""> <td style="width:40%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:20%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:40%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:40%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000020" contextRef="From2021-01-01to2021-12-31_custom_OrdinarySharesNoParValuePerShareMember" name="dei:Security12bTitle">Ordinary shares, no par value per share</ix:nonNumeric></span> </p> </td> <td style="width:20%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000021" contextRef="From2021-01-01to2021-12-31_custom_OrdinarySharesNoParValuePerShareMember" name="dei:TradingSymbol">n/a</ix:nonNumeric></span> </p> </td> <td style="width:40%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000022" contextRef="From2021-01-01to2021-12-31_custom_OrdinarySharesNoParValuePerShareMember" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric></span><span style="font-weight:bold; "> Capital Market*</span> </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">*<ix:footnote id="FN_621deee6493d5b6a527b0922" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Not for trading; only in connection with the registration of American Depository Shares.</ix:footnote></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Securities registered pursuant to Section 12(g) of the Act:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">None</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; ">&#xA0; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#x2610; <ix:nonNumeric id="Fact_0000000000023" contextRef="From2021-01-01to2021-12-31" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric> &#x2612; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#x2610; <ix:nonNumeric id="Fact_0000000000024" contextRef="From2021-01-01to2021-12-31" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric> &#x2612; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric id="Fact_0000000000025" contextRef="From2021-01-01to2021-12-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric> &#x2612; No &#x2610; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#xA7;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric id="Fact_0000000000026" contextRef="From2021-01-01to2021-12-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric> &#x2612; No &#x2610; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of &#x201C;large accelerated filer,&#x201D; &#x201C;accelerated filer,&#x201D; &#x201C;smaller reporting company,&#x201D; and &#x201C;emerging growth company&#x201D; in Rule 12b-2 of the Exchange Act.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:32%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Large accelerated filer </p> </td> <td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#x2610; </p> </td> <td style="width:16%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:32%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accelerated filer </p> </td> <td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#x2610; </p> </td> </tr> <tr class="even" style=""> <td style="width:32%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_0000000000027" contextRef="From2021-01-01to2021-12-31" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen">Non-accelerated filer</ix:nonNumeric> </p> </td> <td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#x2612; </p> </td> <td style="width:16%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:32%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Smaller reporting company </p> </td> <td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_0000000000028" contextRef="From2021-01-01to2021-12-31" name="dei:EntitySmallBusiness" format="ixt:booleantrue">&#x2612;</ix:nonNumeric> </p> </td> </tr> <tr class="odd" style=""> <td style="width:32%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:16%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:32%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Emerging growth company </p> </td> <td style="width:10%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_0000000000029" contextRef="From2021-01-01to2021-12-31" name="dei:EntityEmergingGrowthCompany" format="ixt:booleantrue">&#x2612;</ix:nonNumeric> </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric id="Fact_0000000000030" contextRef="From2021-01-01to2021-12-31" name="dei:EntityExTransitionPeriod" format="ixt:booleanfalse">&#x2610;</ix:nonNumeric> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#x2019;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes &#x2610; No <ix:nonNumeric id="Fact_0000000000031" contextRef="From2021-01-01to2021-12-31" name="dei:IcfrAuditorAttestationFlag" format="ixt:booleanfalse">&#x2612;</ix:nonNumeric> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#x2610; No <ix:nonNumeric id="Fact_0000000000032" contextRef="From2021-01-01to2021-12-31" name="dei:EntityShellCompany" format="ixt:booleanfalse">&#x2612;</ix:nonNumeric> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">The aggregate market value of ordinary shares held by non-affiliates of the registrant on the last business day of the registrant&#x2019;s most recently completed second fiscal quarter was $<ix:nonFraction id="Fact_0000000000033" contextRef="AsOf2021-06-30" name="dei:EntityPublicFloat" unitRef="usd" decimals="0" scale="0" format="ixt:numdotdecimal">194,646,077</ix:nonFraction>, based on the closing sale price of the registrant&#x2019;s American Depositary Shares as reported on the Nasdaq Capital Market on June 30, 2021. For purposes of determining this number, all executive officers and directors of the registrant as of June 30, 2021 were considered affiliates of the registrant. This number is provided only for the purposes of this Annual Report on Form 10-K and does not represent an admission by either the registrant or any such person as to the affiliate status of such person. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">As of March 24, 2022, the registrant had <ix:nonFraction id="Fact_0000000000034" contextRef="AsOf2022-03-24" name="dei:EntityCommonStockSharesOutstanding" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">228,090,300</ix:nonFraction> ordinary shares outstanding (which is equivalent to 11,404,515 American Depositary Shares, each representing twenty ordinary shares, outstanding). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:9pt; margin-bottom:0pt; "><span style="font-weight:bold; ">DOCUMENTS INCORPORATED BY REFERENCE</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="text-decoration:underline #000000; ">None.</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
&#160;<!-- Field: Include-Text; File: PF\body.htm; Date: 2022%2D03%2D30T23:29:21; Size: 0x000E7AA8; Options: XMLPreprocess -->


<div><br />

<div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">FORM&#160;10-K</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">TABLE OF CONTENTS</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" border="0" id="z4373cedadd4647d1b32e1231ee424304" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"><a href="#PARTI">PART&#160;I</a></div> </td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top"><br /> </td> </tr>
  <tr>
    <td colspan="2" style="vertical-align: top">
        <div style="line-height: 1.25"><a href="#STATEMENTS">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;3</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item1">Item 1.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item1">Business<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;5</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item1A.">Item 1A.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item1A.">Risk Factors<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;38</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item1B.">Item 1B.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item1B.">Unresolved Staff Comments<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;56</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item2.">Item 2.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item2.">Properties</a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;56</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item3.">Item 3.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item3.">Legal Proceedings<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;56</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item4.">Item 4.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item4.">Mine Safety Disclosures</a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;56</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"><a href="#PARTII">PART&#160;II</a></div> </td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item5.">Item 5.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item5.">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases
        of Equity Securities</a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;57</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item6.">Item 6.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item6.">[Reserved]<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;57</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item7.">Item 7.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item7.">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations<br />
        </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;57</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item7A.">Item 7A</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item7A.">Quantitative and Qualitative Disclosures About Market Risk</a></div> </td>
    <td style="width: 4.81%; vertical-align: top">
        <div>&#160;63</div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 7%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 88%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item8.">Item 8.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item8.">Financial Statements and Supplementary Data<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;63</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item9.">Item 9.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item9.">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure<br />
        </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;63</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item9A.">Item 9A.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item9A.">Controls and Procedures<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;63</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item9B">Item 9B.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item9B">Other Information<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;64</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item9C.">Item 9C</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item9C.">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;64</td> </tr>
  <tr>
    <td rowspan="1" style="width: 7%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 88%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"><a href="#PARTIII">PART&#160;III</a></div> </td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item10.">Item 10.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item10.">Directors, Executive Officers and Corporate Governance<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;65</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item11.">Item 11.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item11.">Executive Compensation<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;68</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item12.">Item 12.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item12.">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
        Matters</a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;76</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item13">Item 13.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item13">Certain Relationships and Related Transactions, and Director Independence<br /> </a></div>
        </td>
    <td style="width: 4.81%; vertical-align: top">&#160;78</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item14">Item 14.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item14">Principal Accountant Fees and Services<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;80</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"><a href="#PARTIV">PART&#160;IV</a></div> </td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item15">Item 15.</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item15">Exhibits and Financial Statement Schedules<br /> </a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;81</td> </tr>
  <tr>
    <td rowspan="1" style="width: 7%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 88%; vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 4.81%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 7%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item16">Item 16</a></div> </td>
    <td style="width: 88%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#Item16">Form 10-K Summary</a></div> </td>
    <td style="width: 4.81%; vertical-align: top">&#160;82</td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">2</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTI"><!--Anchor--></span>PART&#160;I</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In this Annual Report on Form&#160;10-K, unless the context otherwise requires:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc8e6dbc332f94d92a9c7d2607c567188" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to &#8220;Chemomab Therapeutics Ltd.&#8221;, &#8220;Chemomab,&#8221; the &#8220;Company,&#8221; &#8220;us,&#8221; &#8220;we&#8221;
        and &#8220;our&#8221; refer to Chemomab Therapeutics Ltd. an Israeli company and its consolidated subsidiaries; however, with respect
        to the presentation of financial results for historical periods that preceded the Merger (as defined below), these terms refer to the
        financial results of the Company&#8217;s wholly owned subsidiary, Chemomab Ltd., which was the accounting acquirer in the Merger;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7ee5c05561b84f988d872afc02d9ed7d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to &#8220;ordinary shares,&#8221; &#8220;our shares&#8221; and similar expressions refer to the Company&#8217;s ordinary
        shares, no nominal (par) value;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfcd3e62578f8408684c3642a2ced22cd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to &#8220;ADS&#8221; refer to the American Depositary Shares listed on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;)
        under the symbol &#8220;CMMB,&#8221; each representing twenty (20) ordinary shares;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2240ca6dbff04f2fad83e1bc07333fd2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to &#8220;dollars,&#8221; &#8220;U.S. dollars&#8221; and &#8220;$&#8221; are to United States Dollars;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbe7b24b3748648b18524b4a8019a0019" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to &#8220;NIS&#8221; are to New Israeli Shekels;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2eb7b5f135bb4ba0a56cd386ea4cfa25" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to the &#8220;Companies Law&#8221; are to Israel&#8217;s Companies Law, 5759-1999, as amended;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc3695477c27a494f9d05941c0b0ac9ec" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to the &#8220;SEC&#8221; are to the U.S. Securities and Exchange Commission; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8e603d42c5364348b8dc9d458d3374d3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to the &#8220;Merger&#8221; refer to the merger involving Anchiano Therapeutics Ltd., or Anchiano, and Chemomab Ltd.,
        whereby a wholly owned subsidiary of Anchiano merged with and into Chemomab Ltd., with Chemomab Ltd. surviving as a wholly owned subsidiary
        of Anchiano. Upon consummation of the Merger on March 16, 2021, Anchiano changed its name to &#8220;Chemomab Therapeutics Ltd.&#8221;
        and the business conducted by Chemomab Ltd. became primarily the business conducted by the Company.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING <span id="STATEMENTS"><!--Anchor--></span>STATEMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The statements set forth under the captions &#8220;Business,&#8221; &#8220;Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Risk Factors,&#8221; and other statements included
elsewhere in this Annual Report on Form 10-K, which are not historical, constitute &#8220;forward-looking statements&#8221; within the
meanings of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities
Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), including statements regarding expectations, beliefs, intentions or
strategies for the future. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual
results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied
by the forward-looking statements. In some cases, you can identify forward-looking statements by terms including &#8220;anticipates,&#8221;
&#8220;believes,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221;
&#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;should,&#8221; &#8220;will,&#8221;
&#8220;would,&#8221; and similar expressions intended to identify forward-looking statements, but these are not the only ways these statements
are identified. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and subject
to risks and uncertainties. Factors that could cause our actual results to differ materially from those expressed or implied in such forward-looking
statements include, but are not limited to: the results of the strategic review that our board of directors initiated; the composition
of our board of directors; the initiation, timing, progress and results of our preclinical studies and other therapeutic candidate development
efforts; our ability to develop and advance a future therapeutic candidate into clinical trial or to successfully complete our preclinical
studies; our receipt of regulatory approvals for a future therapeutic candidate, and the timing of other regulatory filings and approvals;
the clinical development, commercialization and market acceptance of a future therapeutic candidate; our ability to establish and maintain
corporate collaborations and integrate new therapeutic candidates and new personnel; the interpretation of the properties and characteristics
of a future therapeutic candidates; the implementation of our business model and strategic plans for our business and future therapeutic
candidates; the scope of protection we are able to establish and maintain for intellectual property rights covering future therapeutic
candidates and our ability to operate our business without infringing the intellectual property rights of others; estimates of our expenses,
future revenues, capital requirements and our needs for additional financing; risks relating to our ability to finance our activities
and research programs; our dependence on performance by third-party providers of services and supplies, including without limitation,
clinical research organizations; the inherent risks and uncertainties in developing the types of preclinical products we are attempting
to develop; competitive companies, technologies and our industry; risks related to our ability to maintain compliance with the continued
listing standards of Nasdaq; and risks relating to changes in healthcare laws, rules and regulations in the United States or elsewhere.
risks related to previous announced combination with Chemomab including with respect to the change of our business prospects, new product
candidates, and clinical development plans following such combination; risks related to a failure to complete the previous announced combination
with Chemomab, including our ability to support our operation with limited cash runway.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">3</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Factors that could cause our actual results to differ materially from those expressed
or implied in such forward-looking statements include, but are not limited to:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z75bbe81715134166853a26d15c2a1482" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the results of the strategic review that our board of directors initiated;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2b389eabf9b8410caf991959ae2fec2a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the composition of our board of directors;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1644ec72ba11447a8040057dca651c2f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a limited operating history and funding, which may make it difficult to evaluate its prospects and likelihood of success;</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc12cd95c414548688e67839e644819e4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our business is highly dependent on the success of its lead product candidate, CM-101, and any other product candidates that it advances
        into clinical studies;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z83cf9d2b77304e2dacb483766b2b021b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our approach in the area of fibrotic diseases is novel and unproven and may not result in marketable products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z06fc03495efa4722b27cbdb5e7827726" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the initiation, timing, progress and results of our preclinical studies and other therapeutic candidate development efforts;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze285e556c13241f69ce7f81717aae6fb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our ability to develop and advance a future therapeutic candidate into clinical trial or to successfully complete our preclinical
        studies;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7bb9012cfb184a62a2ebe7cc97a3f366" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>additional costs or experience delays in completing the development and commercialization of CM-101 or any other product candidates;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zeea81e21d7074575aa1323bde7d68af4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our receipt of regulatory approvals for a future therapeutic candidate, and the timing of other regulatory filings and approvals;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1b20c5d6c04545499aeee58b4fda6393" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the clinical development, commercialization and market acceptance of a future therapeutic candidate;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf1710c1c0c3d4d68983cb9e524efb251" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>ongoing and future clinical studies may reveal significant adverse events or immunogenicity related responses and may result in a
        safety profile that could delay or prevent regulatory approval or market acceptance of its product candidate;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0c180dd2655b4077bf6df1275f551af9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>difficulties enrolling patients in our clinical studies, including due to COVID-19, its clinical development activities could be
        delayed or otherwise adversely affected;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z708ea0f46a294bafa34429ef2a08bbc9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our ability to establish and maintain corporate collaborations and integrate new therapeutic candidates and new personnel;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7c8d367ad99d401a9bf418b31ab60031" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>market opportunities for CM-101, if approved, may be smaller than we anticipate;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z698a7c5783cc45beaaf51e848b529ce5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the interpretation of the properties and characteristics of a future therapeutic candidates, and we may not be successful in our
        efforts to identify or discover additional product candidates in the future;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc804ed34bee04141a46f6ce7cf09f93c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the implementation of our business model and strategic plans for our business and future therapeutic candidates;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc0dc9ee359104733beda0b0457f69293" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>difficulties in managing our organizational growth, which could disrupt our operations;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z892b16c412054f60bcbad48fb9b4146c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the scope of protection we are able to establish and maintain for intellectual property rights covering future therapeutic candidates
        and our ability to operate our business without infringing the intellectual property rights of others;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd507a0d812304ceba2280a2a8ef6d317" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>estimates of our expenses, future revenues, capital requirements and our needs for additional financing;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbafd765ae3ae44279f012848a6d2a0e1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>risks related to the significant operating losses we have incurred since our inception and our expextation that we will incur continued
        losses for the foreseeable future;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2b3750b9523142e2a4f115a6e2e54bc3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>risks relating to our ability to finance our activities and research programs;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc301ab09b0f342cf91ed7eb06754adf2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>inability to identify relevant third-party patents or the risk that we may incorrectly interpret the relevance, scope or expiration
        of a third-party patent, which might adversely affect our ability to develop, manufacture and market our&#160; product candidates;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc4788d044bf2485f904ecc27be63d896" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our dependence on performance by third-party providers of services and supplies, including without limitation, clinical research
        organizations;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbd7d207a4cc24b339577f8c4433d8fb1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the inherent risks and uncertainties in developing the types of preclinical products we are attempting to develop;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z93720e97b21c4ed990b9d40a5cb62f7f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the substantial competition in our industry, which may result in others discovering, developing or commercializing products before
        or more successfully than ours;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z751f0fdf8d9642b7a01c0fed24085b74" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>even if CM-101 or any other product candidate we develop receives marketing approval, we may fail to achieve market acceptance by
        physicians, patients, third-party payors or others in the medical community necessary for commercial success;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">4</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<table cellspacing="0" cellpadding="0" id="zed10a4d85d8d4223aeb373c6b58a23c2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>risks related to our ability to maintain compliance with the continued listing standards of Nasdaq;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z317368a84c8441fd965379638b43ec9b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>changes in patent laws or patent jurisprudence, which can diminish the value of patents in general, thereby impairing our ability
        to protect our product candidate;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze9e48b2988d244a2b96b99b3dc6bf7c8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>regulatory approval processes of the FDA and comparable foreign authorities are lengthy, time consuming and inherently unpredictable,
        and if we are ultimately unable to obtain regulatory approval for CM-101 or any other product candidates, our business will be substantially
        harmed;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2633d286c10e477a9f002bbd7f916821" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not mean that we will be successful
        in obtaining regulatory approval of our product candidates in other jurisdictions; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z10e3038e3e5e451fb575a5dce2b4ee76" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>even if we obtain regulatory approval for CM-101 or any product candidate, we will still face extensive and ongoing regulatory requirements
        and obligations and any product candidates, if approved, may face future development and regulatory difficulties</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">Item 1<span id="Item1"><!--Anchor--></span>.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold">Business</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Overview</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab is a clinical-stage biotechnology company focused on the discovery and development
of innovative therapeutics for fibrotic and inflammatory diseases with high unmet needs. Based on the unique and pivotal role of the soluble
protein CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a monoclonal antibody designed to bind and block CCL24
activity. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab has pioneered the therapeutic targeting of CCL24, a chemokine that promotes
various types of cellular processes that regulate inflammatory and fibrotic activities through the CCR3 receptor. The chemokine is expressed
in various types of cells, including immune cells, endothelial cells and epithelial cells. We have developed a novel CCL24 inhibiting
product candidate with dual anti-fibrotic and anti-inflammatory activity that modulates the complex interplays of both of these inflammatory
and fibrotic mechanisms that drive abnormal states of fibrosis and clinical fibrotic diseases. This innovative approach is being developed
for difficult to treat rare diseases, also known as orphan indications or diseases, such as primary sclerosing cholangitis, or PSC and
systemic sclerosis, or SSc, for which patients have no established disease modifying standard of care treatment options.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">CM-101, the Company&#8217;s lead clinical product candidate, is a first-in-class humanized
monoclonal antibody that hinders the basic function of the soluble chemokine CCL24, also known as eotaxin-2, as a regulator of major inflammatory
and fibrotic pathways. We have demonstrated that CM-101 interferes with the underlying biology of inflammation and fibrosis through a
novel and differentiated mechanism of action. Based on these findings, Chemomab is actively advancing CM-101 into Phase 2 clinical studies
directed toward two distinct clinical indications including patients with liver, skin, and/or lung fibrosis. We are currently conducting
a Phase 2 clinical study in PSC, a rare obstructive and cholestatic liver disease.&#160; The study is actively recruiting patients in
Europe and Israel and is being expanded by adding additional dosing arms as well as an open label extension. The Company also plans to
extend the trial by adding new territories with significant recruitment potential. In addition, we are planning to initiate a Phase 2
clinical trial in SSc in the second half of 2022. The trial in SSc, a rare autoimmune rheumatic disease characterized by fibrosis in the
skin and the lung, will focus on establishing biological and clinical proof of concept in this patient population following treatment
with CM-101. Although our primary focus relates to these two rare indications, an additional Phase 2 clinical study is currently enrolling
patients with liver fibrosis derived due to non-alcoholic steatohepatitis, or NASH. This trial will provide important safety and PK data
that will support the development of a CM-101 subcutaneous formulation and results are expected by the end of the year.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Fibrosis is the abnormal and excessive accumulation of collagen and extracellular matrix,
the non-cellular component in all tissues and organs, that provides structural and biochemical support to surrounding cells. When present
in excessive amounts, collagen and extracellular matrix lead to scarring and thickening of connective tissues, affecting tissue properties
and potentially leading to organ failure. Fibrosis can occur in many different tissues, including lung, liver, kidney, muscle, skin, and
the gastrointestinal tract, resulting in a wide array of progressive fibrotic conditions. Fibrosis and inflammation are intrinsically
linked. While a healthy inflammatory response is necessary for efficient tissue repair; after disease or injury, an excessive, uncontrolled
inflammatory response can lead to tissue fibrosis.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Recent Developments</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">New Executive Appointments</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On February 10, 2022, our shareholders approved the appointment of Dr. Dale Pfost, our
Chief Executive Officer, to the additional role of Chairman of our Board of Directors. This appointment followed the resignation of our
previous Chairman of the Board, Dr. Stephen Squinto, who concurrent with his resignation effective December 19, 2021, became an ad-hoc
strategic advisor and consultant to us in connection with our corporate and business strategy and corporate development.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">5</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">On January 4, 2022, we announced the addition of Jack Lawler, who brings extensive experience
managing global clinical trials, as vice president of global clinical development operations.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On December 3, 2021, biotechnology executive and medical and clinical trial expert David
Weiner, MD, joined us as our interim chief medical officer.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On November 4, 2021, our Board of Directors approved the appointment of Mr. Donald Marvin
as our Chief Financial Officer, Executive Vice President and Chief Operating Officer. Following the commencement of Mr. Marvin&#8217;s
service as Chief Financial Officer, Ms. Sigal Fattal ceased her service as our Chief Financial Officer, however she continues to serve
in her capacity as our Vice President of Finance.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On October 25, 2021, our shareholders approved the appointment and compensation of Dr.
Dale Pfost as our Chief Executive. Simultaneous with the approval of Dr. Pfost&#8217;s service as our Chief Executive Officer, he commenced
his term as a Class III Director. Dr. Pfost is not compensated for his service as a Class III director. Following the commencement of
Dr. Pfost&#8217;s service as Chief Executive Officer, Dr. Adi Mor ceased her service as our Chief Executive Officer, however she continues
to serve in her role as our Chief Scientific Officer and a member of our Board of Directors.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Revisions to Chemomab&#8217;s Clinical Programs</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On March 9, 2022, we announced that following a comprehensive strategic review we are
making revisions to our current clinical programs. The changes are designed to optimize the clinical development of lead product candidate
CM-101 by maximizing the clinical information obtained, generating additional important data to support future advancement to registration
trials, and decreasing the overall risk in the CM-101 clinical development program in the lead indications of PSC and SSc, as well as
potentially in additional indications where the scientific rationale is strong. The key top-line changes to the clinical development programs
include the following:</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold">Expanding our commitment to primary sclerosing cholangitis
with an enlarged clinical trial that adds an important dose finding component</span>. We plan to significantly expand the Phase 2 clinical
trial in PSC by implementing a dose finding component to the CM-101 development program. We will be increasing the size of the study by
adding additional dose cohorts, including plans to evaluate both a lower and a higher dose level of CM-101 to support future potential
registrational trials. In addition, we plan to add an open-label extension to the trial to evaluate the safety, tolerability and durability
of effect over longer treatment durations.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold">Focusing our clinical efforts in systemic sclerosis
on establishing earlier biological and clinical proof of concept. </span>We plan to focus our SSc trial towards establishing biological
and clinical proof of concept in this patient population. We are revising the design of our planned SSc trial in a way that should enable
an expedited path to proof of concept data, as well as further elucidation of the different mechanisms of action of CM-101 in treating
the skin, lung and vascular damage seen in SSc patients.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold">Early completion of enrollment in our safety, pharmacokinetic
and biomarker liver fibrosis study, yielding a data readout targeted near the end of 2022.</span> We will be completing enrollment in
our ongoing safety, tolerability and biomarker trial that is evaluating the subcutaneous formulation of CM-101 in liver fibrosis patients.
We believe the early completion of this study should be sufficient to achieve our key objectives&#8212;exploring safety and providing
the pharmacokinetic data needed to assess next steps in the development of the subcutaneous formulation&#8212;while allowing us to focus
our resources on our lead indications of PSC and SSc.</div> </div>

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We expect that the proposed changes to the CM-101 development program will provide important
data on the clinical dose response relationship to inform the broader development program and to identify the optimal dose to advance
in later PSC trials. The modifications are also expected to generate proof of concept data on clinically relevant aspects of SSc, a complex
rheumatological disorder, to best inform the development path for a novel, first-in-class therapeutic like CM-101, along with relevant
safety and tolerability data to support the evaluation of higher doses and inform decisions on next steps in the development of the subcutaneous
formulation.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Shelf Registration Statement and ATM Offering</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">On April 30, 2021, we filed a shelf registration statement on Form S-3 with the SEC
(File No. 333-255658) for the issuance and sale by us of up to $200,000,000 of our ordinary shares, ADSs, debt securities, warrants and
units comprising any combination of the foregoing securities (the &#8220;Shelf Registration Statement&#8221;). On the same date, we entered
into a sales agreement with Cantor Fitzgerald &amp; Co. (&#8220;Sales Agreement&#8221; and &#8220;Cantor&#8221;, respectively), pursuant
to which we may offer and sell, from time to time, at our option, through or to Cantor, up to an aggregate of $75,000,000 of our ADSs.
Any ADSs to be offered and sold under the Sales Agreement will be issued and sold pursuant to the Shelf Registration Statement, by methods
deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended,
or if specified by us, by any other method permitted by law. During the period from April 30, 2021, through the date hereof, we sold an
aggregate of 699,806 ADSs pursuant to the Sales Agreement for total gross consideration of $15.9 million.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">6</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-style: italic">Merger Transaction with Chemomab Ltd.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On March 16, 2021, we consummated the Merger pursuant to that certain Agreement and
Plan of Merger, or the Merger Agreement, dated December 14, 2020, by and among us (formerly known as Anchiano Therapeutics Ltd.), CMB
Acquisition Ltd., an Israeli company and our wholly owned subsidiary (the &#8220;Merger Sub&#8221;), and Chemomab Ltd., an Israeli company.
Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into Chemomab Ltd., with Chemomab Ltd. surviving the Merger
as our wholly owned subsidiary. In connection with the Merger, on March 16, 2021, we changed our name from Anchiano Therapeutics Ltd.
to Chemomab Therapeutics Ltd.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In connection with the Merger, on March 15, 2021, we entered into Securities Purchase
Agreements with certain purchasers, pursuant to which we agreed to sell approximately $45.5 million of our ADSs in a private placement
transaction, or the Private Placement. The Private Placement closed on March 22, 2021, at which time we sold to the purchasers 2,619,270
ADSs together with warrants to purchase up to 261,929 ADSs at an exercise price of $17.35 per ADS. The warrants will expire five years
from the date of issuance, and if exercised in full, will provide proceeds of approximately $4.5 million.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Impact of COVID-19</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Since January 2020, the COVID-19 pandemic has dramatically expanded into a worldwide
pandemic, creating macro-economic uncertainty and disruption in the business and financial markets. Many countries around the world, including
Israel, have been taking measures designated to limit the continued spread of the COVID-19 pandemic, including the closure of workplaces,
restricting travel, prohibiting assembling, closing international borders and quarantining populated areas. Our clinical trial sites have
been affected by the COVID-19 pandemic, and as a result, commencement of the enrollment in our clinical trials of CM-101 in PSC was delayed,
and the enrollment rate has been affected as well. As a result, we expanded our patient recruiting efforts to additional territories.
In addition, after enrollment in these trials, patients might still drop out because of possible COVID-19 implications.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Based on management&#8217;s assessment, the extent to which the COVID-19 pandemic will
further impact our operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence,
including the duration and severity of the outbreak, and the actions that may be required to contain the coronavirus or treat its impact.
We are carefully monitoring the restrictions due to the COVID-19 pandemic and will adjust activities accordingly.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Corporate Information</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We were incorporated on September 22, 2011 under the laws of the State of Israel. In
March 2021, in connection with the Merger, we changed our name from Anchiano Therapeutics Ltd. to Chemomab Therapeutics Ltd. Our principal
executive offices are located at Kiryat Atidim, Building 7, Tel Aviv, Israel 6158002, and our phone number is +972-77-331-0156. Our website
is:&#160;<span style="font-style: italic">www.chemomab.com.</span>&#160;The information contained on, or that can be accessed through,
our website is not incorporated by reference into this Annual Report on Form 10-K. We have included our website address as an inactive
textual reference only.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">7</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Pipeline</div> </div> <br />

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: center; line-height: 1.25"><img src="image0.jpg" alt="" style="width: 609px; height: 347px" /></div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;<br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab&#8217;s lead product candidate, CM-101, is a first-in-class humanized monoclonal
antibody targeting CCL24 that is being advanced in two orphan indications: PSC and SSc. CCL24 has been extensively studied in airway inflammation
and, more recently, Chemomab has demonstrated in preclinical studies and early clinical studies that it plays an important role in additional
indication areas, including inflammation and fibrosis of the liver, skin and lung. Although found in low levels in blood or tissue samples
taken from healthy volunteers, elevated levels of both CCL24 and its receptor CCR3, have been found in patients with PSC, SSc and NASH.
CCL24 levels have even been correlated to different phases of disease. Chemomab expects that neutralizing CCL24 with an antibody will
exert anti-fibrotic and anti-inflammatory effects in patients. CM-101 has been granted orphan drug designation by both the FDA and the
EMA in its primary indications of PSC and SSc based on extensive preclinical and non-clinical data. This designation provides multiple
benefits, including exclusive marketing and development rights for a period of time for these indications.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">PSC is a rare, chronic cholestatic liver disease characterized by progressive inflammation,
fibrosis, and destruction of the intrahepatic and extrahepatic bile ducts with no identifiable cause. Cholestasis is a symptom of liver
injury and is characterized as the interruption of bile flow from hepatocytes to the intestine, which leads to bile acid accumulation
in the liver, resulting in oxidative stress, inflammation, apoptosis, and fibrosis. PSC affects approximately 30,000-45,000 patients in
the United States and is commonly associated with inflammatory bowel disease. Median survival is between 10-12&#160;years. Fibrosis and
inflammatory responses induce a progressive spread of the fibrotic condition. No treatment aside from a liver transplant has been associated
with change of the disease course or significant long-term improvement in the clinical outcome. PSC is a clear serious unmet medical need
with no FDA-approved therapeutics and for which the current standard of care is inadequate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">SSc is a connective tissue disease characterized by excessive fibrosis and extracellular
matrix accumulation in the skin, lung, and other visceral organs. The disease initiates with an early inflammatory phase involving the
immune cell network, as well as endothelial cells. As the disease progresses, the inflammation increases and fibroblasts and myofibroblasts
generate tissue fibrosis, while endothelial cells promote vascular injury, which can lead to skin fibrosis, interstitial lung disease,
myocardial insufficiency, vascular obliteration, distal ulcerations, and gangrene. SSC affects approximately 75,000-100,000 patients in
the United States. SSc has the highest mortality rate among the systemic rheumatic diseases and has high unmet need, as current treatments
manage only disease manifestations and there is no disease modifying drug available.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab is primarily focused on the orphan indications PSC and SSc, but believes that
it has additional opportunities in neighboring fibrotic-inflammatory disease areas such as idiopathic pulmonary fibrosis, or IPF and nonalcoholic
steatohepatitis, or NASH. CM-101 has shown promising anti-fibrotic and anti-inflammatory effects in preclinical studies of liver fibrosis
and PSC, with significant reductions in fibrotic genes<span style="font-style: italic">,</span>&#160;liver enzymes, bile acid and cholangiocyte
proliferation, all reflecting an improvement in disease status. In preclinical studies of SSc, CM-101 reduces inflammatory and fibrotic
injury resulting in reductions in dermal thickness, collagen concentration in the skin and the lung and immune cell infiltration in the
lung.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">8</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab has completed two Phase&#160;1a single ascending dose studies with intravenous,
or IV, and subcutaneous, or SC, administrations of CM-101 in 40 healthy volunteers. The drug was shown to be safe and well-tolerated,
with a PK profile supporting dosing once every 2-4 weeks. The Company also recently completed a Phase&#160;1b multiple administration
ascending dose study in 16 NAFLD patients, expanding its safety, tolerability, and pharmacodynamics database into patients where an initial
confirmation of an anti-fibrotic effect was already seen.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab is currently recruiting patients for two randomized, double-blind, placebo-controlled
studies, one in PSC patients and one in patients with Liver fibrosis, and is planning to initiate a new study in SSc patients later this
year. Following a comprehensive strategic review, Chemomab decided to make revisions to its current clinical programs. The changes are
designed to optimize the clinical development of CM-101 by maximizing the clinical information obtained, generating additional important
data to support future advancement to registration trials, and decreasing the overall risk in the CM-101 clinical development program
in the lead indications of PSC and SSc.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">A phase 2 randomized, double-blind, placebo-controlled study is currently enrolling
patients with PSC who are treated with CM-101 or placebo for 15 weeks. The company plans to implement a dose finding component to the
CM-101 development program by significantly expanding the Phase 2 trial for PSC. The company will be increasing the size of the study
by adding additional dose cohorts, including plans to evaluate both a lower and a higher dose level of CM-101 to support future potential
registrational trials. In addition, the company plans to add an open-label extension to the trial to evaluate the safety, tolerability
and durability of effect over longer treatment durations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab intends to initiate a global, randomized, double-blind, placebo-controlled
Phase&#160;2 clinical study in SSc in the second half of 2022. This study will assess safety and tolerability and will focus on establishing
biological and clinical proof of concept by assessing CM-101 effect on the skin, lung and vascular system in this patient population.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab is also planning to provide top-line results by the end of the year from its
Phase 2 randomized, double-blind, placebo-controlled study in patients with liver fibrosis derived due to NASH. The main goal of this
study is to explore the safety and pharmacokinetic profile of a SC formulation of CM-101 in patients. The Company plans to complete enrolment
in the coming months as it anticipates that the early completion of this study should be sufficient to achieve its key objectives&#8212;exploring
safety and providing the pharmacokinetic data needed to assess next steps in the development of the subcutaneous formulation&#8212;while
allowing the company to focus its resources on its lead indications of PSC and SSc.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab may also explore CM-101 in other indications, where the dual activity of CM-101
acting on both inflammation and fibrosis could provide new avenues for treating inflammatory and fibrotic conditions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab was founded in 2011, based on a novel discovery originating from the Sourasky
Medical Center in Tel-Aviv,&#160;Israel, where Professor Jacob George first identified CCL24 as a key regulator of unstable plaque formation
in atherosclerotic patients. In its early&#160;years, Chemomab focused on research directed at clarifying the role and effectiveness of
CCL24 blockade. In 2015, Chemomab selected its proprietary lead product candidate, CM-101, and started product development directed towards
human testing.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab has assembled an executive team with highly relevant experience in inflammation
and fibrosis, and biologics drug discovery and clinical development. Adi Mor, Ph.D., Chemomab&#8217;s Chief Scientific Officer and Co-founder
has 15&#160;years of experience in Immunology and has led the CM-101 program from discovery stage into Phase&#160;2 clinical studies.
David Weiner, M.D., Chemomab&#8217;s interim Chief Medical Officer, brings deep experience in clinical development.&#160;Dr. Weiner, who
is based in the U.S., has more than 25 years of experience in the discovery and clinical development of novel therapeutics and has held
senior executive roles at private and public biotechnology companies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Company strategy</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab aims to become a world-leading company for the treatment of diseases involving
inflammation and fibrosis, developing novel therapies across a wide range of indications. To achieve this, the company is focused on the
following key strategies:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z2222ac2f3d52456aa29af4c944087934" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif"><span style="font-weight: bold; font-style: italic">Advance
        Chemomab&#8217;s lead product, CM-101, for the treatment of PSC and SSc, through clinical development to approval</span></div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 21.3pt; line-height: 1.25">The Company has conducted a comprehensive strategic review of its current clinical
programs to optimize the clinical development of lead product candidate CM-101 to maximize the clinical information obtained, generating
additional important data to support future advancement to registration trials, and decreasing the overall risk in the CM-101 clinical
development program in the lead indications of PSC and SSc, as well as potentially in additional indications where the scientific rationale
is strong. <br /> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="text-indent: 21.3pt; line-height: 1.25">The Company expects that the proposed changes to the CM-101 development program will
provide important data on the clinical dose response relationship to inform the broader development program and to identify the optimal
dose to advance in later PSC trials. The modifications are also expected to generate proof of concept data on clinically relevant aspects
of SSc, a complex rheumatological disorder, to best inform the development path for a novel, first-in-class therapeutic like CM-101, along
with relevant safety and tolerability data to support the evaluation of higher doses and inform decisions on next steps in the development
of the subcutaneous formulation. <br /> <br /> </div> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">9</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zecb7d114b0e549f5b24b39700efb0217" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Expand Chemomab&#8217;s next generation
        pipeline</span></div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Based on the know-how, knowledge and experience it has gathered in diseases involving
both inflammation and fibrosis, Chemomab intends to expand its pipeline with novel products developed against new targets. Chemomab will
also explore targeting CCL24 with additional, complementary fibrotic and/or inflammatory mechanisms, including acquiring or in-licensing
innovative product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z07b393460968484692fb0685a61bd742" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Selectively evaluate partnership
        opportunities</span></div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab continuously explores partnership opportunities to advance CM-101 development
in PSC and SSc, identifying companies with drugs (either approved or in development) that could possibly be combined with CM-101, extending
the development of CM-101 to new indications beyond PSC and SSc, and seeking additional significant commercial or drug development capabilities
that may accelerate CM-101&#8217;s time to market.</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z823a81dda615411b87dcd838da9dbcd2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Explore opportunities for CM-101
        in additional inflammatory/fibrotic indications</span></div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab continuously evaluates the potential benefit of CM-101 outside of its two lead
indications, PSC and SSc, in order to maximize the product&#8217;s potential. CM-101 has shown anti-fibrotic activity in animal models
and human tissue studies of IPF and NASH. Chemomab will continue to assess ways to leverage the dual anti-inflammatory an anti-fibrotic
activity of CM-101 into new disease areas and to form additional collaborations with global medical researchers.</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zab28d5deeb944d448da227792b528299" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Strengthen Chemomab&#8217;s intellectual
        property portfolio</span></div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab believes that it has developed a strong intellectual property portfolio and
will continue to seek, maintain, and defend its patent rights, whether developed internally or licensed to protect and enhance the proprietary
technology, inventions, and improvements that are commercially important to the development of its business proprietary position in the
field of inflammation and fibrosis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Fibrosis and inflammation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Tissue damage activates a repair process that includes acute inflammation followed by
either successful complete repair or tissue replacement by fibrosis. However, persistent and repeated damage results in continuous activation
of the repair process leading to chronic inflammation, progressive tissue fibrosis and sclerosis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Fibrosis is an accumulation of non-functional tissue and can occur in many different
tissues, including lung, liver, kidney, muscle, skin and the gastrointestinal tract, resulting in a growing number of chronic fibrotic
conditions. Liver fibrosis is the process of excessive accumulation of extracellular matrix proteins, predominantly collagen, which occurs
as the result of liver injury. In cases of acute temporary damage, these changes are transient and liver fibrosis may resolve. In chronic
cases, however, the liver damage persists and chronic inflammation and accumulation of the extracellular matrix eventually leads to cirrhosis.
The various fibrotic manifestations in conditions like SSc are still not well understood. Disease progression is characterized by an early
inflammatory onset followed by tissue fibrosis, vascular injury and organ damage. Fibrosis, and specifically lung fibrosis, is the main
cause of disease progression and mortality.&#160;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">Fibrosis and inflammation are intrinsically linked; a healthy inflammatory response
is necessary for efficient wound healing, however, a prolonged response can contribute to the pathogenesis of fibrosis. The inflammatory
response during chronic liver injury is a dynamic process with intrahepatic accumulation of diverse immune cells. Recruitment and infiltration
of these cells to the liver and their localization is mainly determined by chemokines and cytokines that are produced by hepatocytes,
immune cells, biliary epithelial cells, and endothelial cells. Notably, activated liver fibroblasts, the hepatic stellate cells, or HSCs,
secrete various chemokines, thereby contributing to the ongoing immune response during fibrotic liver diseases. Similarly, for SSc, the
early inflammatory phase leading to fibrosis in multiple organs of the body includes activation of the immune cell network of lymphocytes,
eosinophils, and monocytes, as well as endothelial and endothelial progenitor cells. In the advanced SSc phase, fibroblasts and myofibroblasts
take the lead to generate tissue fibrosis.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">10</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemokine involvement in inflammation and fibrosis</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemokines are a group of small signaling proteins thought to be involved in the etiology,
or causation, of multiple inflammatory diseases. They are not only implicated in immune cell recruitment during inflammation, but also
contribute to immune surveillance, direct cells to target organs in homeostasis, and exert pleiotropic, or diverse, effects on nonimmune
cells, for instance, directly influencing the functionality of fibrogenic cells. Chemokines and their corresponding chemokine receptors
are key players in orchestrating the sequential influx of immune cells into damaged or diseased organs, driving inflammatory responses
to specific triggers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In the liver, chemokines have a key role in the development of inflammation and wound
healing responses, which can lead to either resolution of liver injury or promote, if ongoing, maladaptive responses with chronic inflammation,
fibrosis, and development of clinically manifest liver disease. Although the pathophysiology underlying PSC has not yet been fully clarified,
animal models of PSC have provided contributions in dissecting the molecular basis of this disease and focusing on the role of cytokines
and chemokines as important pathogenetic mediators of liver inflammation and fibrosis. Recently published studies demonstrated that in
most of the processes suggested for the onset and the development of PSC, chemokines and chemokine receptors play a key role. HSCs may
be the main producers of cytokines and play the initial role in the progression of liver fibrosis by attracting different types of immune
cells, resulting in further production of cytokines and liver injury in a vicious disease cycle. Extensive proliferation, trans-differentiation
and activation of HSCs result in ongoing chronic tissue remodeling and severe fibrosis. In addition, chemokines are also involved in promoting
polarization of the recruited immune cells. Therefore, chemokines may participate in PSC by either promoting migration of inflammatory
and fibrotic cells, by activating inflammatory and fibrotic cells locally, or by inducing cytokines that promote collagen and matrix deposition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Likewise, in SSc pathogenesis, chemokines foster migration and activation of inflammatory
and fibrotic cells, inducing the secretion of cytokines that promote collagen and matrix deposition in affected organs. Indeed, patients
with SSc exhibit increased systemic levels of proinflammatory chemokines and some have also been shown to correlate with limited or diffuse
cutaneous disease phenotype and/or to organ-specific pathology as lung disease or skin vascular inflammation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The role of CCL24</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">CCL24 is a chemokine that promotes various types of cellular processes that regulate
inflammatory and fibrotic activities through the CCR3 receptor. This chemokine is known to be expressed by activated T&#160;cells, monocytes,
epithelial cells and endothelial cells, as well as by activated fibroblasts. CCL24 induces chemotaxis and activation of CCR3-expressing
cells, including immune cells and fibroblasts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab has been the driving force in establishing the role of CCL24 in the pathogenesis
of PSC and SSc, however, others have highlighted its contribution to other indications. For example, published work has shown that both
CCL24 and CCR3 are involved in lung and skin inflammation and fibrosis. CCR3 is robustly expressed on eosinophils and recent data has
suggested that eosinophilic inflammation may be involved in the pathogenesis and progression of SSc. For example, in SSc patients, eosinophil
counts, but not total leukocytes, were significantly higher than in patients with other connective autoimmune diseases. Eosinophil counts
correlated positively with both interstitial lung disease severity and the modified Rodnan skin thickness score, or mRSS. Notably, CCR3
was shown to be expressed on oral and dermal fibroblasts where it modulates wound healing and tissue remodeling processes. A recent academic
study also demonstrated overexpression of CCR3 on monocyte populations isolated from SSc patients. CCL24 was shown to be involved in proinflammatory
reactions, specifically contributing to the type 2 immune reaction involving Th2 lymphocytes and M2 macrophages that were shown to be
present in skin lesions of SSc patients. Accordingly, CCL24 was found to play a dominant role in inducing profibrotic effects and to be
overexpressed in fibrotic lungs and bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis (IPF), a disease sharing
similar lung dysfunction features with SSc. Furthermore, CCL24 was shown to promote collagen production in human lung fibroblasts and
to be constitutively expressed by dermal fibroblasts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Prior studies support the role of CCL24/CCR3 signaling in the pathogenesis of SSc and
these findings have been further explored by Chemomab in SSc and for the first time, in PSC.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">11</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-align: center; line-height: 1.25">&#160;<img src="image1.jpg" alt="" style="width: 371px; height: 270px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">CCL24 is a critical mediator promoting inflammation and fibrosis</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Challenges to drug development in fibrosis and inflammation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Successful treatment of fibrotic disorders has in large part remained elusive, primarily
due to incomplete understanding of the complexity and multi-mechanism contributions to disease progression. This has complicated preclinical
investigations for new products and new targets, with animal models having limited resemblance to human disease. As such, preclinical
animal data is often of short treatment duration and does not capture the effects of treating chronic fibrotic indications. This is particularly
applicable to complex, orphan indications like SSc, where there is still no approved standard of care or proven target mechanism. Most
drug approvals in this space have been focused on fibrosis of the lungs i.e., idiopathic pulmonary fibrosis, or IPF, interstitial lung
disease, or ILD, and pulmonary arterial hypertension, or PAH.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Most approved anti-fibrotic products target extracellular components, given their biological
accessibility, and inhibition of receptors and ligands preventing downstream signaling is considered to be a potentially effective option
for alleviating fibrosis. PDGF and TGF-&#946; are commonly studied targets in fibrosis and there are two approved products that target
these pathways, pirfenidone and nintedanib. Both pirfenidone and nintedanib are approved for the treatment of IPF, with nintedanib also
recently approved for treatment of systemic sclerosis associated interstitial lung disease and chronic fibrosing interstitial lung diseases.
Due to the strong associations between inflammation and fibrosis, companies have devoted efforts to anti-inflammatory drugs with the hope
that reduction in inflammation will attenuate fibrosis. For example, companies have targeted TNF-&#945;, a commonly explored anti-inflammatory
mechanism in fibrotic indications. Despite the success of targeting cytokines, inflammatory factors and immune cells in pure inflammatory
autoimmune diseases, such as blocking TNF-&#945; , these results are merely reproduced in studies targeting inflammatory fibrotic indications.
Nonetheless, tocilizumab, a monoclonal antibody targeting IL-6R, was recently approved for the treatment of ILD associated with systemic
sclerosis. Treatments that inhibit certain pure anti-fibrotic pathways, such as nintedanib and pirfenidone, have resulted in limited clinical
benefit. Chemomab believes that these results highlight the importance of a dual mechanism that, with adequate selectivity, will target
inflammatory processes and will directly prevent fibrosis resulting in blockage of multiple disease-contributing mechanisms.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Notwithstanding challenges in the field of fibrosis and inflammation, there is still
significant industry interest given the associated unmet medical need and the continuing opportunity to identify optimal therapeutic targets.
For example, in 2019 Novartis completed two transactions related to the treatment of NASH, a liver metabolic fibrotic disease. It acquired
IFM Tre for NLRP3 antagonists for a $310&#160;million upfront payment and total potential consideration of $1.5&#160;billion and licensed
an integrin inhibitor from Pliant Therapeutics for an $80&#160;million upfront payment. Additionally, Gilead Sciences licensed two preclinical
programs, one in NASH for a $15&#160;million upfront payment (total potential consideration of $785&#160;million) and the other for TGF-&#946;
inhibitors in fibrosis for an $80&#160;million upfront payment and total potential consideration of $1.4&#160;billion. In 2020, Roche
acquired Promedior for a $390 million upfront payment and total potential consideration of $1&#160;billion in milestones for its Phase&#160;2
product in pulmonary fibrosis, and Bayer partnered with Recursion Pharmaceuticals to develop and commercialize preclinical-stage small
molecule treatments for fibrotic conditions for a $30&#160;million upfront payment and total potential consideration of $1&#160;billion.
Boehringer Ingelheim also acquired Enleofen Bio in a deal potentially worth $1&#160;billion for its NASH and ILD anti-IL11 platform.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">12</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Targeting chemokines as a treatment for fibrotic indications</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab believes that its approach, selectively targeting fibrotic conditions by attenuating
both inflammation and fibrosis, may be an optimal approach for both effectiveness and reduction of toxicity. As central regulators of
initiation and progression of fibrotic disorders, chemokines are an ideal target to impact both inflammation and fibrosis. Some chemokines
are also disease-specific, allowing for potential selectivity.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemokine receptors, or CCRs, have been more extensively studied as drug targets in
fibrotic conditions compared to chemokine ligands, however, the therapeutic effects of CCR inhibitors have generally fallen short in the
clinic. Pharmaceutical companies have previously explored the CCL24 ligand receptor, CCR3, and its other ligands CCL7 and CCL11, with
small or large molecule inhibitors. These programs were directed at inhibiting eosinophilic trafficking in respiratory and allergic inflammation,
however, despite promising preclinical data, most programs were discontinued largely due to poor safety profiles and limited efficacy
of the antagonist used. To Chemomab&#8217;s knowledge, only Alkahest has an active program that explores CCR3 inhibition, which is under
license from Boehringer Ingelheim and is being developed as a treatment for wet AMD. In contrast, Chemomab believes CCL24 presents a more
promising opportunity. Unlike other CCR3 ligands, CCL24 binds only to the CCR3 receptor and is also organ/disease-specific, which together
could provide enhanced selectivity and tolerability. For example, in PSC, CCL24 is elevated in the liver and cholangiocytes (bile duct
epithelia) and immune cells that play a key role in the progression of the disease.&#160; Likewise, elevation of CCL24 has been shown
in fibrotic lungs and bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis, or IPF, a disease sharing similar
lung dysfunction features with SSc and which recently was correlated, by Chemomab, with disease severity and lung involvement in a cohort
of SSc patients from the United Kingdom. Furthermore, CCL24 is constitutively expressed by skin and dermal fibroblasts. The use of an
antibody in targeting this chemokine is a novel approach to targeting fibrosis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Chemomab&#8217;s expertise and approach to drug discovery</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab is a clinical stage biotechnology company focused on the discovery and development
of novel drugs to address fibrotic indications with unmet medical needs. CCL24 is a key target promoting fibrosis as it regulates the
two main processes that drive fibrosis: fibroblast activation and immune cell migration and activation. Using Chemomab&#8217;s expertise
in monoclonal antibody, or mAb, development and deep knowledge of chemokines biology, Chemomab is developing CM-101, a proprietary, first-in-class,
fully humanized mAb that through research and studies to date, has been shown to neutralize CCL24 and by so doing inhibits its disease-related
functions in both inflammation and fibrosis. This represents an innovative approach to anti-fibrotic drug discovery and is a key differentiator
for Chemomab. The ability of CM-101 to directly attenuate fibroblast activation and concurrently attenuate recruitment of immune cells
is novel and could address a wide-range of hard-to-treat fibrotic diseases.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab&#8217;s ongoing collaborations are complementary in both preclinical and clinical
aspects of research and development. Chemomab has created an extensive panel of&#160;<span style="font-style: italic">in vitro</span>,&#160;<span style="font-style: italic">ex
vivo</span>&#160;and&#160;<span style="font-style: italic">in vivo</span>&#160;assays which it has used to further the understanding of
fibrotic processes together with the role of CCL24 in various diseases and the effects of its neutralization with CM-101. These assays
have allowed Chemomab to sequentially explore target validation and proof of mechanism in disease relevant human and animal samples that
continues to de-risk the translation of CM-101 into the clinic.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Target expression and engagement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab regularly collaborates with leading academic centers around the world to investigate
the role of CCL24 and CM-101 in various indications. For example, Chemomab works with The Royal Free Hospital, or RFH, in London, United
Kingdom to access liver biopsy and serum samples from patients with PSC. Using immunohistochemistry and florescence microscopy to stain
CCL24 and CCR3, it explores the expression patterns of these targets in disease relevant human samples and compares them to healthy volunteers.
Similarly, Chemomab has tested biopsies of SSc patients through a collaboration with Florence University in Italy and serum samples&#160;of
SSc patients through a collaboration with Leeds University in the UK.</div>

<div style="text-indent: 18pt; line-height: 1.25">.</div>

<div style="line-height: 1.25; font-style: italic">Proof of mechanism</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab explores fibroblast activation and immune cell recruitment in response to CM-101
treatment through inhouse&#160;<span style="font-style: italic">ex vivo</span>&#160;and&#160;<span style="font-style: italic">in vitro</span>&#160;assays.
Chemomab has executed multiple validated genetic and treatment-based disease models in fibrotic and inflammatory indications in which
it has investigated CM-101&#8217;s effects. Additionally, as part of a collaboration with Nordic Biosciences, Copenhagen, Denmark, Chemomab
has gained access to proprietary tools and expertise to explore the effects of CM-101 on key fibrogenesis and fibrolysis biomarkers. Nordic
Biosciences is a world-leading extracellular matrix specialist and continues to contribute as Chemomab analyses its clinical samples.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">13</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-align: center; line-height: 1.25"><img src="image2.jpg" alt="" style="width: 710px; height: 314px" /></div>

<div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif">&#160;<img src="image00017.jpg" alt="" /></div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"> <br /> </div>

<div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold">Chemomab has created a
broad array of biological assays to explore CCL24 and CM-101</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab plans to explore next generation biologic products, and, based on its wide
database of patient samples and extensive knowledge and experience in fibrosis, aims to identify targets that could complement CCL24 inhibition.
Next generation assets may therefore be dual targeting and will be screened through the panel of assays available at Chemomab that evaluated
target expression in fibrotic tissues as well as the anti-fibrotic activity of potential candidates. Similar to CM-101, this process will
establish proof-of-biological-mechanism in both animal models and human tissue prior to commencing product development and initiating
clinical studies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">The Chemomab pipeline</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">CM-101 in PSC and SSc</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab&#8217;s lead product, CM-101, is a first-in-class humanized monoclonal antibody
targeting CCL24 that is being developed initially for treatment of PSC and SSc, with potential future opportunities in other fibrotic-inflammatory
indications. Chemomab has completed two Phase&#160;1a studies of CM-101 in healthy volunteers as well as a Phase&#160;1b safety, tolerability
and proof-of-mechanism study in NAFLD patients. A Phase&#160;2 study in PSC is now ongoing in Europe and Israel and is currently expanding
to include additional dose levels cohorts as well as an open label extension. A global Phase&#160;2 study in SSc that will assess the
clinical and biological effects of CM-101 in this patient population, will follow this year. Although the primary focus of Chemomab is
these two orphan indications, a Phase&#160;2 study in patients with liver fibrosis will provide data readouts by the end of the year.
This study is exploring the safety tolerability and mechanism of action of an injectable formulation of CM-101 and will guide the Company
with regard to next steps for development of the injectable formulation.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">14</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Primary Sclerosing Cholangitis</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">PSC is a progressive, rare, and chronic cholestatic liver disorder that is characterized
by thickening, inflammation, and fibrosis of the bile ducts in which both intra- and extra-hepatic bile ducts are affected. This generally
leads to cholestasis, liver damage, cirrhosis, and eventually to liver failure. The exact cause of PSC remains mostly unknown; however,
immune system dysregulation, genes, viruses, and bacteria may be involved. PSC is commonly associated with inflammatory bowel disease,
or IBD. Approximately three in every four individuals with PSC also have ulcerative colitis. Most individuals affected with PSC are adults
with an average age of diagnosis being 40&#160;years; however, it may also occur in children. Disease progression, symptoms, and severity
may vary greatly between individuals. Patients in the initial stages of PSC are generally asymptomatic or have only mild symptoms.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Abdominal discomfort, fatigue, and pruritus, or itching, are common initial symptoms
of PSC which can be severe and debilitating. The initial step in diagnosing PSC is to evaluate liver enzyme levels through blood tests.
Physicians will then confirm a diagnosis with cholangiography ultrasound and, in rare cases, a liver biopsy. As the disease progresses,
bile flow from the liver is obstructed and is subsequently absorbed into the bloodstream leading to the yellowing of the mucous membranes,
whites of the eyes, and skin. Furthermore, individuals may also experience abdominal pain, malaise, light-colored stools, nausea, dark
urine, weight loss, and/or hepatomegaly or splenomegaly. PSC patients have a 40-fold increased risk of liver cancer and a 400-fold increased
risk of cholangiocarcinoma, and the disease may lead to other conditions including osteoporosis, bacterial cholangitis, portal hypertension,
bleeding, as well as vitamin deficiencies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">There are currently no specific medical therapies that can alter or cure the course
of the disease; instead, available treatments are directed towards slowing the progression of PSC and treating symptoms. In certain individuals,
endoscopic surgery may be performed to enlarge the narrowed bile ducts and to remove blockages. Complications due to vitamin deficiencies
can be prevented with the help of vitamin supplements, while infections and inflammation can be controlled by using antibiotics. Cholestyramine
and UCDA can be effective in managing itching and can be used with or without antihistamines. Patients with advanced symptoms such as
end-stage liver disease, recurrent bacterial cholangitis and intractable pruritus, will often undergo liver transplantation, however,
in 30% of cases, PSC will recur even after liver transplantation. The median survival is 10-12&#160;years without intervention.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Systemic Sclerosis</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">SSc is an autoimmune inflammatory condition that results in widespread fibrosis and
vascular abnormalities affecting the skin, lungs, gastrointestinal tract, heart and kidneys. Other key features of SSc include thickening
and hardening of the skin, autoantibody production and abnormal nail fold capillaries. The underlying mechanisms that cause SSc are complex
and for the most part unknown but most likely involve a combination of factors including the immune system, genetics, and environmental
triggers. Various pathways are involved in the pathogenesis of SSc including cytokines that injure blood vessels, growth factors that
stimulate collagen, integrin signaling, morphogen pathways, and co-stimulatory pathways. SSc is generally diagnosed between the age of
30 and 50&#160;years and is most prevalent in women.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Given that SSc can affect many different parts of the body there are a multitude of
different symptoms of the disease. The most widely observed symptoms include fatigue, arthralgia, and myalgia. However, the earliest sign
is often the Raynaud phenomenon in which the body&#8217;s normal response to cold or emotional stress is exaggerated, resulting in abnormal
spasms in arterioles. Cutaneous features include sclerosis of the skin, particularly the face and hands. Gastrointestinal symptoms of
the upper tract include acid reflux and of the lower tract include bloating, nausea and incontinence. Cardiopulmonary presentations include
interstitial lung disease, pulmonary arterial hypertension and cardiac scleroderma. Renal and ocular symptoms can also present and 20%
of SSc patients have an overlapping diagnosis with other connective tissue diseases and can develop arthritis, lupus or myositis. SSc
is subdivided into two main types related to the distribution of skin involvement: diffuse cutaneous (two-thirds of cases) and limited
cutaneous. Diffuse SSc, or dcSSc, is rapidly progressive with more significant organ involvement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">There is no cure for SSc. Established treatments can help with symptoms and may only
modify the disease outcome if given early in the disease course. Prescribed medications, used off-label, primarily focus on suppressing
inflammation with NSAIDs and dilating abnormal or constricted blood vessels with losartan, sildenafil, iloprost and SSRIs, as well as
treatments to manage individual organ involvement. The only three drugs that are approved for the treatment of SSc symptoms are Bosentan
by Actelion Pharmaceuticals, approved in Europe for the prevention of digital ulcer development, nintedanib by Boehringer Ingelheim, and
Tocilizumab by Roche ,recently approved in the United States, Europe and Japan for the treatment of SSc associated interstitial lung disease.
The clinical course of SSc is determined by the extent of vascular and fibrosis complications and has the highest mortality rate among
the systemic rheumatic diseases, as 40% of patients die within 10&#160;years from disease onset, with pulmonary involvement being the
leading cause of death.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">15</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab&#8217;s potential solution is CM-101</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The dual anti-fibrotic and anti-inflammatory activity of CM-101 enables the targeting
of a wide range of pathogenic mechanisms and affords patients a new treatment that may have a more impactful effect on disease progression.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25"><img src="image4.jpg" alt="" style="width: 569px; height: 239px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">Targeting CCL24 offers a dual activity approach</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In order to understand CCL24&#8217;s role in disease pathophysiology, Chemomab has collected
data on CCL24 levels from patients with multiple fibrotic-inflammatory indications, including those with PSC, SSc and NASH. PSC patients&#8217;
liver biopsies and SSc skin samples were stained for CCL24 and its receptor, CCR3. Blood samples taken from PSC and SSc patients were
used to further evaluate the role of the CCL24-CCR3 axis exploring levels of circulating CCL24 and CCR3. To explore the influence of CCL24
on disease status, CCL24 serum levels were correlated with fibrotic biomarkers and disease severity markers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">CCL24 levels in liver biopsies from PSC patients</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">PSC pathology generally initiates with bile duct damage leading to cholestasis, bile
duct inflammation and fibrosis and finally to substantial liver damage. Chemomab assessed the accumulation and cellular localization of
CCL24 in livers of PSC patients focusing on CCL24 levels in the periductal damaged zone that is most relevant to disease pathology. CCL24
was mainly found in inflammatory cells in the liver of PSC patients and due to the robust liver inflammatory insult in PSC, reflected
by massive accumulation of resident and recruited immune cells in the periductal space, CCL24 positive staining was extensive. Specific
and robust CCL24 staining was also shown in cholangiocytes, the epithelial cells of the bile ducts. Activated myofibroblasts that surround
the bile ducts, whether they originate from hepatic stellate cells or portal fibroblasts, are the main drivers of the excess extracellular
matrix accumulation in this area, comprising the unique &#8220;onion ring&#8221; shape seen in PSC liver sections. The collective expression
pattern shows high CCL24 levels in areas that are most affected in PSC and highlights its central role in PSC related liver pathology.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25"><img src="image5.jpg" alt="" style="width: 498px; height: 132px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">Elevated CCL24 staining in liver biopsies from PSC patients</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">CCR3 levels in liver biopsies from PSC patients</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">To evaluate the levels of CCR3, the receptor of CCL24, and identify the cells that can
potentially respond to CCL24 secretion, biopsies were stained for CCR3 As seen for CCL24, specific CCR3 staining was evident in cholangiocytes,
surrounding immune cells and fibroblasts.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">16</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-align: center; line-height: 1.25"><img src="image6.jpg" alt="" style="width: 398px; height: 119px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">Elevated CCR3 staining in liver biopsies from PSC patients</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">CCL24 levels in serum and correlation to a fibrotic biomarker in PSC patients</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Together with RFH, Chemomab analyzed serum levels of CCL24 in PSC patients at various
stages of disease. CCL24 levels showed a positive correlation to the liver fibrosis biomarker ELF score, which is a commercially available
test that reflects liver fibrosis stage based on serum concentrations of several fibrosis-related proteins. When dividing this cohort
of PSC serum samples by ALP levels, a circulating parameter used for monitoring PSC activity, there was a stronger relation of the fibrotic
biomarker and CCL24 with increased ALP reflected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25"><img src="image7.jpg" alt="" style="width: 605px; height: 185px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">CCL24 levels correlate with ELF score</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">CCR3 levels in circulating PBMCs in PSC patients</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chronic liver inflammation is driven in most hepatic injuries by several different immune
cell populations originating from either resident hepatic immune cells or recruited cells from the circulation to the damaged site. In
collaboration with the Kaplan Medical Center,&#160;Israel, Chemomab explored systemic changes of CCR3, given that this could impact cell
recruitment to the PSC damaged liver. PBMCs from ten PSC patients and healthy controls were stained for expression of CCR3 and demonstrated
that levels were significantly higher in PSC patient samples compared to healthy donors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25"><img src="image8.jpg" alt="" style="width: 447px; height: 197px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">PSC patients showed significantly higher expression of CCR3 on PBMCs</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">17</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-style: italic">CCL24 and CCR3 levels in skin biopsies from SSc patients</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab analyzed skin samples from diffuse SSc patients and healthy volunteers and
the SSc samples showed elevations in CCL24 and CCR3. Specifically, higher accumulation of CCL24 on immune cells skin infiltration was
shown in the SSc samples and CCR3 was evident in skin fibroblasts, immune cells and endothelial cells. These elevations led to a CCL24
mediated robust activation of CCR3 expressing cells which enhances the recruitment of immune cells and fibroblasts to the diseased organ.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25"><img src="image9.jpg" alt="" style="width: 582px; height: 197px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">SSc patients showed elevated levels of CCL24 in skin tissue</div>

<div style="text-align: center; line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25"><img src="image10.jpg" alt="" style="width: 710px; height: 208px" />&#160;</div>

<div style="text-align: center; line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">SSc patients showed elevated levels of CCR3 in skin tissue</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">CCL24 levels in serum samples from SSc patients and correlation with fibrotic biomarkers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company analyzed SSc serum samples which showed that CCL24 levels were significantly
increased in SSc patients compared with healthy individuals. Notably, in diffuse SSc patients, CCL24 levels were fourfold higher than
in healthy control patients.&#160; Additionally, the levels of CCL24 were correlated with a biomarker of SSc severity, anti-topoisomerase,
an autoantibody seen in diffuse SSc patients.</div>

<div style="text-align: center; text-indent: 18pt; line-height: 1.25"><img src="image11.jpg" alt="" style="width: 344px; height: 132px" /></div>

<div style="line-height: 1.25"><br /> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">18</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>
<!--PROfilePageNumberReset%Num%19%%%-->

<div style="line-height: 1.25"><span style="font-weight: bold">SSc patients showed elevated levels of CCL24 in serum samples</span>&#160;<span style="font-weight: bold">that
correlated with anti-topoisomerase autoantibodies</span></div>

<div style="line-height: 1.25">&#160;&#160;</div>

<div style="line-height: 1.25; font-style: italic">Preclinical Efficacy of CM-101 in models of PSC</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7aedd7d954e9450c8d6ef301032d1cc7" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 100%; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Preclinical experiments in models of PSC</div> </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">Human hepatic stellate cells demonstrated reduced transition to myofibroblasts following incubation of
        CM-101 with CCL24.</div> </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">Human hepatic stellate cells showed reduced motility towards CCL24 following treatment with CM-101.</div>
        </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">CM-101 demonstrated in vivo activity on liver fibrosis and cholangiocyte proliferation induced by bile
        duct ligation in Sprague Dawley rat model.</div> </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">CM-101 (D8) inhibits the progression of liver fibrosis and bile duct damage in a chronic cholangitis cholestasis
        model using the hepatobiliary toxin ANIT.</div> </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">CM-101 (D8) reduces bile duct epithelial cells (cholangiocyte) proliferation, collagen deposition, Macrophages
        infiltration, liver enzymes, bile acid and circulating inflammatory monocytes in an experimental cholangitis model in MDR2 knock out mice.</div>
        </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">CM-101 reduces liver enzymes, fibrosis, collagen, and fibrotic gene expression in a TAA-induced liver fibrosis
        model in rats.</div> </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">CM-101 (D8) prevented fibrosis and inflammation in a TAA-induced liver fibrosis model in mice.</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Of the experiments performed above, results from the multi-drug resistant 2, or MDR2,
knock out mouse model that reflects sclerosing cholangitis and the thioacetamide (TAA) rat model reflecting liver fibrosis are described
below.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">CM-101 demonstrates anti-cholestatic, anti-inflammatory, and anti-fibrotic activity
in MDR2 knock out mouse model in vivo</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Mice with targeted disruption of the MDR2, transporter gene develop chronic and progressive
hepatic sclerosing cholangitis that closely resembles PSC and therefore this model has been extensively used to study the pathogenesis
and progression of PSC. Using MDR2 knockout mice (six weeks of age), the Company tested the ability of CM-101 (D8) (murine surrogate of
CM-101) to attenuate PSC related symptoms. Mice (n=15/group) received either vehicle control, or CM-101 10 mg/kg SC twice weekly during
weeks 6-12 following established disease and were sacrificed at the end of week 12. In this study mice were tested for changes in alkaline
phosphatase, or ALP, bile acid levels, collagen deposition (histology, Sirius red), macrophage presence in the liver and cholangiocyte
proliferation. The Company observed a significant decrease in all three core pathologies that play a role in PSC: inflammation, fibrosis
and cholangiocyte proliferation after CM-101 (D8) treatment compared to non-active treatment. Reduction in the serum markers that represent
the cholestatic state, ALP and bile acid was also observed.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: center; text-indent: 18pt; line-height: 1.25"><img src="image12.jpg" alt="" style="width: 714px; height: 257px" /></div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">CM-101 reduces liver fibrosis, inflammation and bile duct epithelial
proliferation in MDR2 knockout model</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">19</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><span style="font-style: italic">CM-101 demonstrates in vivo activity in a thioacetamide induced liver
fibrosis model in rats</span>&#160;<span style="font-style: italic">using a therapeutic model</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">To assess potential efficacy of CM-101 on liver fibrosis, the Company used the TAA-induced
liver fibrosis model. Liver fibrosis was induced by intraperitoneal administration of TAA at a dose of 250 mg/kg twice weekly for eight
weeks. Rats (n=10/group) received either vehicle control or CM-101 2.5 mg/kg IV twice weekly during weeks four-eight following established
fibrosis and were sacrificed at week eight. After eight weeks of TAA treatment, all vehicle-treated animals had developed liver fibrosis,
as confirmed by Sirius-red-stained liver histology.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25"><img src="image13.jpg" alt="" style="width: 360px; height: 242px" />&#160;</div>

<div style="text-align: center; line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">CM-101 reduces fibrosis in rat livers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Plasma ALP, ALT, and AST levels decreased in the CM-101 study arm. Liver collagen content
and fibrotic areas were significantly reduced in the CM-101 treated group compared to non-active treatment. CM-101 was also shown to reduce
fibrotic markers in the TAA treated rats.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Efficacy CM-101 in models of SSc</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf56833d0e65a4f12a7da70303920f466" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 100%; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Preclinical experiments in models of SSc</div> </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">CM-101 reduces SSc serum-induced dermal fibroblast activation and transition to myofibroblasts and interferes
        with endothelial cell activation.</div> </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">CM-101 treatment attenuated skin fibrotic remodelling in the bleomycin (BLM)-induced dermal fibrosis mouse
        model.</div> </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 100%; vertical-align: top">
        <div style="line-height: 1.25">CM-101 attenuated lung fibrosis and inflammation in the bleomycin (BLM)-induced pulmonary fibrosis mouse
        model.</div> </td> </tr>
  </table>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Of the experiments listed above, results from the bleomycin (BLM)-induced dermal and
lung fibrosis mouse models are discussed below in more detail.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">CM-101 treatment attenuates skin fibrotic remodeling in the bleomycin (BLM)-induced
dermal fibrosis mouse model</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The activity of CM-101 (D8) (murine surrogate of CM-101) in SSc was tested in the dermal
bleomycin model. Treatment started after the onset of fibrotic signs, eight days following the first BLM injection. Histological assessment
of skin lesions stained with H&amp;E and Masson&#8217;s trichrome revealed significant elevation of dermal thickness and collagen deposition
following 21&#160;days of BLM administration. This elevation was significantly reduced when mice were treated with 2.5 mg/kg CM-101 with
significant reductions in both skin thickness and collagen deposition compared with the mouse group treated with BLM alone.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">20</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-align: center; line-height: 1.25"><img src="image14.jpg" alt="" style="width: 660px; height: 169px" />&#160;</div>

<div style="text-align: center; line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">CM-101 treatment attenuates skin fibrotic remodeling in the bleomycin-induced
dermal fibrosis mouse model</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Another feature that characterizes the BLM model and is representative of human SSc
is the development of bronchoalveolar inflammation. To evaluate the effect of CM-101 on lung inflammation, the Company collected bronchoalveolar
lavage, or, BAL, fluid, and assessed the number of white blood cells, or WBC, and mononuclear cells. Treatment with BLM for 21&#160;days
significantly increased WBC and mononuclear cells in BAL fluid and the number of WBC and mononuclear cells was decreased significantly
following CM-101 treatment compared with the group that was administered only with BLM. This data supports the anti-inflammatory effect
of CM-101 in SSc.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">CM-101 inhibits lung fibrosis in the BLM-induced pulmonary fibrosis mouse model</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company also tested CM-101 in the experimental lung SSc model where mice were given
a single intratracheal administration of BLM followed by either CM-101, non-active treatments (PBS or control immunoglobulin G (IgG))
or the approved anti-fibrosis drugs, pirfenidone and nintedanib. CM-101 had a significant anti-fibrotic and anti-inflammatory effect in
the experimental BLM-induced lung fibrosis model as compared with non-active treatment treated animals. BLM animals treated with non-active
treatments showed massive immune cell infiltration, extensive fibrosis and severe tissue injury. CM-101-treated mice exhibited significantly
reduced levels of lung fibrosis down to similar levels in healthy animals and showed superior effects compared to the approved fibrosis
drugs pirfenidone and nintedanib.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25"><img src="image15.jpg" alt="" style="width: 470px; height: 190px" />&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">CM-101 attenuates lung fibrosis and collagen deposition in the bleomycin (BLM)-induced
pulmonary fibrosis mouse model</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Preclinical safety and toxicology of CM-101</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Preclinical safety evaluation of CM-101 included tissue cross reactivity, assessment
of the effect of CM-101 on pro-inflammatory cytokine secretion&#160;ex-vivo, and&#160;in vivo&#160;GLP toxicology studies in mice and
non-human primates. No safety concerns were observed in these preclinical assessments. <br /> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Immunogenicity may be triggered following administration of humanized monoclonal antibodies,
an effect that is frequently seen with approved mAbs. To date, no meaningful ADA were identified in three clinical studies performed which
supports a preliminary conclusion that CM-101 may have of low immunogenic potential.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As summarized below, there were no safety concerns related to CM-101 in any of the other
safety experiments.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">21</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-align: center; line-height: 1.25">Summary of key preclinical safety experiments</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" border="0" id="z2c385615c663497e8124790a523cb405" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 52.92%; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Preclinical findings</div> </td>
    <td style="width: 2%; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25; font-weight: bold">&#8203;</div> </td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 45%; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Observation</div> </td> </tr>
  <tr>
    <td style="width: 52.92%; vertical-align: top">
        <div style="line-height: 1.25; font-style: italic">Ex vivo</div> </td>
    <td style="width: 2%; vertical-align: top">
        <div style="line-height: 1.25">&#8203;</div> </td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">&#8203;</div> </td> </tr>
  <tr>
    <td style="width: 52.92%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 2%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 52.92%; vertical-align: top">
        <div style="line-height: 1.25">Antibody dependent cell-cytotoxic (ADCC) and complement dependent cell-cytotoxic (CDC) activity was tested
        in PBMCs from healthy volunteers</div> </td>
    <td style="width: 2%; vertical-align: top">
        <div style="line-height: 1.25">&#8203;</div> </td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">CM-101 did not have Fc-related effector functions such as ADCC and CDC</div> </td> </tr>
  <tr>
    <td style="width: 52.92%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 2%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 52.92%; vertical-align: top">
        <div style="line-height: 1.25">Cytokine release was assessed in human whole blood from healthy volunteers.</div> </td>
    <td style="width: 2%; vertical-align: top">
        <div style="line-height: 1.25">&#8203;</div> </td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">CM-101 did not induce pro-inflammatory cytokine secretion</div> </td> </tr>
  <tr>
    <td style="width: 52.92%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 2%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 52.92%; vertical-align: top">
        <div style="line-height: 1.25">Tissue cross reactivity was evaluated from healthy human tissues.</div> </td>
    <td style="width: 2%; vertical-align: top">
        <div style="line-height: 1.25">&#8203;</div> </td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">CM-101 does not bind non-specifically to healthy tissues, and therefore is expected to only bind to its
        target, circulating CCL24</div> </td> </tr>
  <tr>
    <td style="width: 52.92%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 2%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 52.92%; vertical-align: top">
        <div style="line-height: 1.25; font-style: italic">In vivo</div> </td>
    <td style="width: 2%; vertical-align: top">
        <div style="line-height: 1.25">&#8203;</div> </td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">&#8203;</div> </td> </tr>
  <tr>
    <td style="width: 52.92%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 2%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 52.92%; vertical-align: top">
        <div style="line-height: 1.25">GLP repeated dose 4-week toxicity study of CM-101 (IV)&#160;in mice</div> </td>
    <td style="width: 2%; vertical-align: top">
        <div style="line-height: 1.25">&#8203;</div> </td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">1. No obvious treatment related adverse reactions</div>
        <div style="line-height: 1.25"> <br /> </div>
        <div style="line-height: 1.25">2. No gross or microscopic pathological findings</div>
        <div style="line-height: 1.25"> <br /> </div>
        <div style="line-height: 1.25">3. No cases of treatment related mortality were observed</div>
        <div style="line-height: 1.25"> <br /> </div>
        <div style="line-height: 1.25">4. No significant elevation was seen in IL1&#946;,&#160;IL2,&#160;IL4,&#160;IL5,&#160;IL10, GM-CSF,&#160;IFN&#160;&#160;&#160;
        and TNF&#945;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf19211198c8041b1939ce264d6044284" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 52.92%; vertical-align: top">
        <div style="line-height: 1.25">GLP repeated dose (up to 50 mg/kg) 6-month toxicity study of CM-101 (SC) in Cynomolgus Monkey</div> </td>
    <td style="width: 2%; vertical-align: top">
        <div style="line-height: 1.25">&#8203;</div> </td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">1. No obvious treatment related adverse reactions</div>
        <div style="line-height: 1.25"> <br /> </div>
        <div style="line-height: 1.25">2. No clinical signs or injection site reactions</div>
        <div style="line-height: 1.25"> <br /> </div>
        <div style="line-height: 1.25">3. No cases of treatment related mortality were observed</div>
        <div style="line-height: 1.25"> <br /> </div>
        <div style="line-height: 1.25">4. Blood and urine tests were found to be within normal ranges for monkeys</div>
        <div style="line-height: 1.25"> <br /> </div>
        <div style="line-height: 1.25">5. No treatment-related organ weight changes and no treatment-related necropsy findings</div>
        <div style="line-height: 1.25"> <br /> </div>
        <div style="line-height: 1.25">6. No treatment-related histopathology findings<br /> <br /> </div>
        <div style="line-height: 1.25">7. Three samples from treated animals were confirmed ADA positive but there was no obvious correlation
        between positive ADA results and CM-101 serum concentrations or systemic exposure</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Preclinical proof of mechanism studies for CM-101</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">The Company conducted a series of&#160;in vitro&#160;and&#160;in vivo&#160;studies to
demonstrate the proposed mechanism of action and provide proof-of-concept for administering CM-101 in the clinic for target indications.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">22</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-style: italic">Affinity, selectivity, and binding kinetics</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company evaluated the kinetic binding parameters of CM-101 to human CCL24, as well
as the specificity of CM-101 binding to other chemokines using commercial binding assays. CM-101 demonstrated a strong and stable, high
affinity, binding to CCL24.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">CM-101 reduced CCL24 dependent CCR3 activation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In an <span style="font-style: italic">in vitro</span> assay, CM-101 was shown to robustly
attenuate the ability of CCL24 to induce activation of the CCR3 receptor following pre-incubation of CCL24 with CM-101.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold"><img src="image16.jpg" alt="" style="width: 241px; height: 170px" />&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Clinical Development of CM-101</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Completed studies</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The CM-101 Phase&#160;1 program included two Phase&#160;1a single administration, or
SAD, studies, using IV and SC administration with doses ranging from 0.75-10 mg/kg, in healthy volunteers and a Phase&#160;1b multiple
administration (MAD) study (5 administrations) in NAFLD patients with normal liver function, testing 2.5 mg/kg IV and 5 mg/kg SC. In the
Phase 1 studies&#160; 42 subjects have received at least one CM-101 dose, the majority by IV infusion (12/42 subjects received SC).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Safety</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The first Phase&#160;1a study, which was a single-center, randomized double-blind, placebo-controlled,
single-dose, dose-escalation study, included four escalating dose groups of eight subjects each. In each dose group subjects were randomized
in a 3:1 ratio to receive a single IV infusion of either CM-101 (n=6) or placebo (n=2). A total of 24 subjects were enrolled into the
study and randomized to the treatment groups (0.75 mg/&#160;kg, 2.5 mg/kg, 5.0 mg/kg, 10 mg/kg) and eight subjects received a placebo.
All 32 subjects completed the study as planned. Single,&#160;IV doses of CM-101 were safe and well tolerated up to the highest dose level
(10 mg/&#160;kg) in healthy subjects. No severe or serious adverse events, or AEs, occurred during the study and all CM-101 related AEs
were mild, with one moderate AE reported in the placebo group (myalgia).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The second Phase&#160;1a study was also a single-center, randomized double-blind, placebo-controlled,
single-dose study, but evaluated only one dose group. Subjects were randomized in a 3:1 ratio to receive a single SC injection of either
CM-101 5 mg/kg (n=6) or matching placebo (n=2). A total of eight subjects were enrolled into the study and randomized; all eight subjects
completed the study as planned. Single, SC administration of 5 mg/kg of CM-101 was safe and well tolerated with no severe or serious AEs
occurring during the study. A total of 6 AEs were reported in two subjects treated with CM-101; only one AE was classified as related
to CM-101 (change in diastolic blood pressure) and that AE was classified as mild in intensity.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In both Phase&#160;1a studies, all AEs reported were resolved; no subjects discontinued
the study prematurely due to AEs, and no concomitant medications were required for treatment of any drug-related AEs. No clinically significant
changes in laboratory tests (hematology, chemistry or urinalysis), vital signs, ECG, physical examination or infusion site examination
were observed. In the first Phase&#160;1a study with CM-101 delivered by IV administration, the effect on cytokine secretion was tested
pre-treatment and one hour, eight hours and 24 hours post drug administration. Serum levels of a panel of cytokines including IL-6,&#160;IFN&#947;,
GM-CSF, TNF-&#945;,&#160;IL-2,&#160;IL-4,&#160;IL-8 and IL-10 showed no significant change at all tested CM-101 doses and timepoints.
These findings suggest that single CM-101 administration does not cause immune activation nor cytokine secretion. Additionally, none of
the subjects in either of the Phase&#160;1a studies tested positive for anti-drug antibodies (ADA).</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">23</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">The multiple administrations randomized, placebo-controlled, Phase&#160;1b study in
NAFLD patients with normal liver function tests evaluated two dose levels. The first dose level of 2.5 mg/kg CM-101 was administered as
IV infusions and the second dose level of 5 mg/kg was administered as SC injections. Both dose levels involved five drug administrations
over 12 weeks (Q3W), providing 15 weeks of treatment coverage. At both dose levels, subjects were randomized in a 3:1 ratio to receive
either CM-101 (n=6 per cohort) (2.5 mg/kg IV or 5 mg/kg SC) or matching placebo (n=2 per cohort). Five repeated IV and SC CM-101 administrations
were safe and well tolerated and there were no deaths, or severe or serious drug related AEs reported throughout the study. Only mild
to moderate AEs were reported in the CM-101 treatment groups of which only two AEs were classified as possibly related to CM-101. No injection
site reactions or clinically significant trends in laboratory tests (hematology, chemistry, or urinalysis), vital signs, ECG or physical
examination were observed. One patient experienced a non-drug-related SAE. This patient was a 61-year-old female that was subsequently
diagnosed with a non-treatment related meningioma. The tumor was treated surgically, and the patient was discontinued from the study.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Pharmacokinetics with single-dose administration</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">PK analysis was conducted for the Phase&#160;1 studies and the quantification of CM-101
in plasma samples was performed using a validated ELISA-based assay by Eurofins (UK). Following IV infusion in healthy volunteers, CM-101
exhibited a biphasic serum concentration vs. time curve (rapid distribution phase and slow elimination phase) which is typical for monoclonal
antibodies. Target-mediated drug disposition (TMDD), or presence of ADAs, was not evident in the analyzed concentration vs. time curves
of CM-101, which exhibited linear terminal slope without apparent TMDD kinetics or other concentration-dependent changes of the elimination
kinetics. Comparison of the PK data of 5 mg/kg CM-101 using IV administration against SC administration indicates consistent distribution
and elimination behavior of CM-101.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">At either IV or SC administration, the values of the PK parameters obtained in the non-compartmental
and compartmental analysis of CM-101 concentration vs. time data appear to be typical for monoclonal antibodies that undergo FcRn-mediated
recycling. The terminal half-life of CM-101 was long for both SC and IV formulations, which supports administration of CM-101 at a frequency
of once every 2-4&#160;weeks.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Pharmacokinetics with multiple-dose administration</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">PK analysis of the data from the Phase&#160;1b study was conducted to evaluate CM-101
following multiple IV infusion of 2.5 mg/kg or 5 mg/kg SC injections of CM-101 in NAFLD patients. Following repeated IV infusions (2.5
mg/kg Q3W) and SC injection (5 mg/kg Q3W), CM-101 exhibited a long terminal half-life, similar to the terminal half-life seen in the single
dose studies. CM-101 accumulated over time, resulting in significant systemic exposure over time and potentially reaching a steady state.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Overall, CM-101 reached steady state conditions more slowly following SC injection,
as compared to IV infusion. The inter-patient variability in CM-101 serum concentrations was higher for SC dosing injection, as compared
to IV. The trough CM-101 serum concentrations after repeated 5 mg/kg SC injections were proportionally higher than those after 2.5 mg/kg
IV infusions, considering the difference in administration modes. Comparison of the PK data of CM-101 in the Phase&#160;1b to the Phase&#160;1a
studies indicates a consistency in PK behavior of CM-101.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Pharmacodynamics and target engagement of CM-101</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Serum was taken from patients in all three Phase&#160;1 studies at different times and
the levels of both CCL24 and CM-101 were measured. Total CCL24 levels represent CM-101&#8217;s engagement to its target. Total CCL24 levels
were increased following administration of the drug, which indicates that CM-101 is effective in target engagement, as the higher levels
of CCL24 correlated significantly with greater doses of CM-101, and such levels decreased gradually from the peak of CM-101 administration.
These findings demonstrate that CM-101 effectively binds to CCL24 in the circulation, which reflects a strong drug-target interaction.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In the Phase&#160;1b study, CM-101 treatment of 2.5mg/kg IV attained the highest levels
of total CCL24 by the third administration, maintaining these levels until the end of treatment. CM-101 5mg/kg administered by SC injection
reached the highest levels of CCL24 by the fourth treatment and maintained these levels until the end of treatment. The matching placebo
did not have any effect on CCL24 levels.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As exemplified in the in-vitro studies, binding of CCL24 by CM-101 attenuates the binding
of CCL24 to its cognate CCR3 receptor, thereby reducing its downstream activation. Altogether, CCL24 levels following treatment with CM-101
provide strong evidence for target engagement and pharmacodynamic response of CM-101 in healthy volunteers and patients.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">24</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-style: italic">Phase&#160;1b exploratory endpoints</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Fibrotic biomarkers were analyzed as part of the Phase&#160;1b study in NAFLD patients
with normal liver function. Circulating fibrotic biomarkers were tested in serum pre- and post-treatment. The analysis included data from
patients that presented with more active disease, reflected by baseline elastography (FibroScanTM) score &gt;4 kPa. Tissue inhibitor of
metalloproteinases-1 (TIMP-1) and tissue inhibitor of metalloproteinases-2 (TIMP-2), considered well established fibrotic biomarkers,
were evaluated, and showed that CM-101 treatment led to reductions of both markers by week 15. The growth factor PDGF-AA, known as a pro-fibrotic
secreted factor, was also reduced in CM-101 treated patients. Conversely, in the placebo group TIMP-1, TIMP-2 and PDGF-AA all increased.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Evaluation of the fibrogenesis and fibrolysis/inflammatory biomarkers, Pro-C3, Pro-C4
and C3M measured in serum, conducted by Nordic Bioscience, Copenhagen, Denmark, were also used as sensitive indicators of the liver&#8217;s
fibrotic state. In accordance with reduced liver stiffness, Pro-C3, Pro-C4 and C3M were all reduced in the CM-101 treated groups. No reductions
were identified in the placebo control group.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Changes in liver stiffness, a measurement of liver fibrosis, were also evaluated using
FibroScan<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">TM</sup>&#160;measurements taken at screening and end
of treatment (EoT) following 15 weeks of treatment coverage. 80% of CM-101 treated patients had significant decreases in FibroScan<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">TM</sup>&#160;measurements,
unlike placebo patients where there was no significant change from baseline</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Overall, these encouraging results provide initial support for CM-101&#8217;s anti-fibrotic
and anti-inflammatory mechanisms in humans and support further testing of CM-101 in PSC and SSc patients.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Current and planned clinical studies for PSC and SSc</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company is currently recruiting and treating PSC patients in a Phase&#160;2 study
at multiple sites in Europe and Israel and expanding the trial to include additional dose levels and an open label extension in more territories,
including the US. The Company is also planning to initiate a Phase&#160;2 study in SSc this year that will enrol patients across multiple
sites in the United States and Europe.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The ongoing Phase&#160;2 study in PSC is a randomized, double-blind, placebo-controlled,
study designed to evaluate the safety and efficacy of CM-101 in adult subjects with PSC. Recruited subjects have a serum alkaline phosphatase,or
ALP, level of at least 1.5 times the upper limit of normal (x 1.5 ULN). Subjects with concomitant IBD are eligible for recruitment if
their disease is stable and there is an absence of high-grade dysplasia in colonic biopsies within 18&#160;months of randomization. To
date, subjects are randomized to receive 10 mg/kg CM-101 IV, or placebo, in a 2:1 ratio. Chemomab is planning to amend the study to include
higher and a lower dose level of CM-101. Subjects will receive a dose of investigational product once every three weeks for a total of
five administrations resulting in a total coverage of 15 weeks during the double-blind portion of the study. Chemomab intends to add an
open-label extension to the study.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The primary endpoints for the study are changes from baseline in serum alkaline phosphatase,
or ALP, levels and the fibrotic marker enhanced liver function, or ELF, score at week 15. ALP is a liver enzyme that is elevated in cholestasis
and the ELF score is a biochemical test panel made up of serum markers that are indicators of the extracellular matrix. Secondary endpoints
include evaluations of safety and tolerability, changes from baseline in other liver enzymes and additional fibrotic markers, to include
AST, ALT, Pro-C3 and Pro-C5. PK, PD and ADA parameters will also be collected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The measurement of ALP as a primary endpoint is common in other PSC studies, for example
the Phase&#160;2 and Phase&#160;3 studies for norUrsodeoxycholic acid (Dr.&#160;Falk Pharma GmbH, Freiburg, Germany) used ALP. However,
some studies have shown that improvements in ALP do not always correlate with improved outcomes. Accordingly, The Company has included
the ELF score as an additional-primary endpoint, a measurement that has also shown successful reductions in other Phase&#160;2 PSC clinical
studies, and is closely related to CM-101&#8217;s anti-fibrotic mechanism of action.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25">&#160;&#160; &#160; &#160; The planned Phase&#160;2 study in SSc will enable an expedited path to proof-of-concept
data and further elucidation of different CM-101 mechanisms of actions in treating SSc skin, lung and vascular damage. Chemomab is currently
finalizing the design of this Phase 2 study, the details of which will be disclosed in May 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Other clinical development plans for CM-101</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">To further assess CM-101&#8217;s mechanistic effects in liver fibrosis, and given the
string of effects seen preclinically, the Company is conducting a Phase&#160;2 study in liver fibrosis patients with NASH to further explore
the safety, tolerability and MoA of CM-101 on relevant fibrosis related biomarkers using the SC formulation. The study is currently enrolling
patients with confirmed NASH and fibrosis without cirrhosis, liver fat content &gt; 10% and at least one associated risk factor. Patients
will have a total of eight administrations of CM-101, every two weeks, given at two mg/kg by SC injection.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">25</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Primary endpoints for the study are safety and tolerability, however, the Company will
explore the pharmacokinetic profile of its SC formulation as well as relevant biomarkers that may provide further mechanistic understanding
of CM-101 effects on liver fibrosis. Data from this trial is expected to be available by the end of the year.&#160;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Competition</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The development and commercialization of new drug products is highly competitive across
major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies worldwide. The Company faces competition
with respect to its current product and expects to face competition with respect to any product candidates that it may develop or commercialize
in the future. Specifically, there are a number of companies developing treatments for fibrotic/inflammatory diseases, including multiple
major pharmaceutical and biotechnology companies with substantially greater resources than the Company. The Company is a small biotech
company with limited resources compared to the major pharmaceutical companies, however, the Company believes that the unique CM-101 platform
together with its knowledge and experience in inflammatory-fibrotic research provides it with competitive advantages.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Therapeutic options for PSC and SSc are limited and despite significant biopharmaceutical
industry investment, the FDA has not approved any disease modifying therapies for the treatment of PSC or SSc. Liver transplant is currently
the only treatment shown to improve clinical outcomes for PSC patients while SSc patients are being treated with drugs that were approved
for different manifestations of the disease like interstitial lung disease (nintedanib, Boehringer Ingelheim and tocilizumab, Hoffmann-La
Roche).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company is advancing CM-101, a first-in-class monoclonal antibody that interferes
directly with both inflammation and fibrosis, into clinical development for the treatment of PSC and SSc. There are a number of large
biopharmaceutical and biotechnology companies that are currently pursuing the development of products for the treatment of fibrotic indications
like PSC and SSc, such as Gilead Sciences, Mitsubishi Tanabe Pharma, Horizon Therapeutics, Pliant Therapeutics, Kadmon Holdings and others.
However, the Company knows of no other companies currently in clinical development with a monoclonal antibody that targets CCL24.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Although the approach is novel with respect to targeting both inflammation and fibrosis,
the Company will need to compete with products further advanced in the pipeline towards market approval. Investigational products, include:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z1c2859bd340948b4aa646a92cd4833a5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25"><span style="font-style: italic">PSC</span></div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">There are currently no FDA-approved therapies for the treatment of PSC. Companies currently developing
product candidates in Phase&#160;3 clinical studies include Gilead and Dr.&#160;Falk Pharma, targeting cholestasis and liver metabolism
(Gilead; Cilofexor, Dr.&#160;Falk; norUrso). Additional companies with clinical candidates in earlier stages of development include HighTide
Biopharmaceutical, Mirum Pharmaceuticals and Pliant Inc.</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z818fa30085e547998e1153f9a104b114" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25"><span style="font-style: italic">SSc</span></div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">There are currently two FDA approved products for the treatment of clinical manifestations of SSc--nintedanib,
marketed by Boehringer Ingelheim GmbH and tocilizumab, marketed by Hoffmann-La Roche for the treatment of interstitial lung disease. Companies
currently developing product candidates in SSc in early clinical stage include&#160; Horizon, Mitsubishi Tanabe, GS Johnson &amp; Johnson,
Vicore, Sanofi, Prometheos Biosciences and others.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The availability of reimbursement from government and other third-party payors will
affect the pricing and competitiveness of CM-101 and any future products. More advanced competitors also may obtain regulatory approval
for their products more rapidly than the Company, which could result in competitors establishing a strong market position.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Intellectual Property</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Overview</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company strives to protect and enhance the proprietary technology, inventions, and
improvements that are commercially important to the development of its business, including seeking, maintaining, and defending patent
rights, whether developed internally or licensed from third parties. The Company also relies on trade secrets relating to its proprietary
technology platform and know-how, continuing technological innovation and in-licensing opportunities to develop, strengthen, and maintain
its proprietary position in the field of inflammation and fibrosis that may present areas of opportunity for the development of its business.
The Company may also rely on regulatory protection afforded through data exclusivity, market exclusivity, and patent term extensions,
where available.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">26</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company&#8217;s commercial success may depend in part on its ability to: obtain
and maintain patent and other proprietary protection for commercially important technology, inventions and know-how related to its business;
defend and enforce its patents; preserve the confidentiality of its trade secrets; and operate without infringing the valid enforceable
patents and proprietary rights of third parties. The Company&#8217;s ability to prevent third parties from making, using, selling, offering
to sell, or importing the Company&#8217;s products may depend on the extent to which it has rights under valid and enforceable licenses,
patents, or trade secrets that cover these activities. In certain cases, enforcement of these rights may depend on third party licensors.
With respect to both licensed and company-owned intellectual property rights, the Company cannot be sure that patents will be granted
with respect to any of its pending patent applications or with respect to any patent applications that may be filed by the Company in
the future, nor can the Company be sure that any of its existing patents or any patents that may be granted to it in the future will be
commercially useful in protecting its commercial products and methods of manufacturing the same.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of the date of this Annual Report on Form 10-K, the Company owned or licensed five
pending or issued US patents and patent applications as well as patents and patent applications in other jurisdictions. The first patent
family has been issued in each of the United States, Europe (validated in France, Germany and the United Kingdom) and Israel to the Tel
Aviv Souraski Medical Center, whose rights have been licensed to the Company on an exclusive basis.&#160; A composition of matter patent
was issued in United States and certain corresponding foreign jurisdictions. To date, three additional patent families were filed by the
Company concerning the use of anti CCL24 antibodies in specific indications, dosing regimens, routes of administration, and additional
indications. The Company will seek United States and foreign patent protection for a variety of additional technologies, including: research
compounds and methods, candidate compounds and antibodies for modulating the activity of CCL24, methods for treating diseases of interest,
and methods for treating its products. The Company will seek additional protection, in part, through confidentiality and proprietary information
agreements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Company Owned Intellectual Property</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company owns multiple families of patent applications that pertain to anti-CCL24
monoclonal antibody compositions capable of blocking CCL24 activity and methods for treating or preventing diseases associated with inflammation
and fibrosis. Certain applications in these families relate to the Company&#8217;s CM-101 antibody, backup variants, various unit dosages,
dosing regimens, and other routes of administration. Patents that are or will be issued from these submissions will expire between the&#160;years
2035 to 2041, subject to possible patent term adjustments and/or extensions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition to the above, the Company has established expertise and development capabilities
focused in the areas of preclinical research and development, manufacturing and manufacturing process development, quality control, quality
assurance, regulatory affairs, and clinical study design and implementation. The Company believes that its focus and expertise will help
the Company develop products based on its proprietary intellectual property.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Licensed IP</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As mentioned above, the Company has obtained an exclusive license from the Tel Aviv
Souraski Medical Center for one patent, which is expected to expire in 2029. This patent was issued in each of the United States, Europe
and Israel, and pertains to anti CCL24 inhibitors and methods of using such inhibitors for treating inflammatory, autoimmune and cardiovascular
diseases.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Trade Secret Protection</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company may rely, in some circumstances, on trade secrets to protect its technology.
The Company seeks to protect its proprietary technology and processes, in part, by entering into confidentiality agreements with its employees,
consultants, scientific advisors, and contractors. The Company also seeks to preserve the integrity and confidentiality of its data and
trade secrets by maintaining physical security of its premises and physical and electronic security of its information technology systems.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Material Agreements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Tel-Aviv Souraski Medical Center (TASMC) License Agreement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In December&#160;2011, the Company entered into a license agreement, or the TASMC Agreement,
with the Medical Research,&#160;Infrastructure, Health Services Fund of the Tel Aviv Souraski Medical Center., or TASMC, for the research,
development and commercialization of the CCL24 platform and CCR3 blockade platform (CM-101), which license includes patent rights covering
the foregoing platforms and related know how and products. Under the terms of the TASMC Agreement, the Company is responsible for the
research, development, manufacturing and commercialization of CM-101. This license was granted on an exclusive basis and the Company was
also granted rights to sublicense the instant license to third parties pursuant to certain terms described therein.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">27</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In accordance with the TASMC Agreement, the Company paid TASMC a non-refundable and
non-creditable payment in four milestone installments, related to TASMC&#8217;s past patent maintenance and prosecution costs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Certain additional terms of the TASMC Agreement include:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z15635006f35f43aa9d43d399f74135fa" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">The Company will be required to pay TASMC non-refundable and non-creditable milestone
        payments of up to (i)&#160;$300,000 upon the submission of an NDA, BLA or equivalent for each of the licensed products to the FDA and
        to equivalent European and Asian foreign regulatory agencies, and (ii)&#160;$600,000 upon the grant by the FDA or equivalent European
        and/or Asian regulatory agencies of their marketing approval for each licensed product;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z4d249d9976414b55b5ec9eb3fa523666" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">In the event of an &#8220;exit,&#8221; as such term is defined therein, the Company must
        pay TASMC an exit fee of 1% of the transaction consideration (which shall be capped at $3&#160;million);</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z2c7a2240b0594993bc70d3997156b483" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">In the event the Company sublicenses a licensed product, the Company must pay TASMC a
        sublicense fee of 10% of all attributed income, in addition to a low-single digit&#160;percentage tiered royalty payment of our earned
        royalties.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Unless terminated earlier, the TASMC Agreement will expire upon the later of the expiration
of the last-to-expire valid patent claim and any extension granted prior thereto. The termination of the TASMC Agreement will not preclude
TASMC from receiving sublicense payments or royalties. In addition to the foregoing, the TASMC Agreement includes customary termination
provisions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">CMC Collaboration Agreement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In June&#160;2015, the Company entered into a collaboration agreement, or the CMC Agreement,
with CMC ICOS Biologics,&#160;Inc. (acquired by AGC Biologics in 2018), or CMC, which, under the terms thereof, granted the Company certain
licenses to use proprietary rights, materials and know-how of CMC for purposes of research and development of CM-101 as well as commercialization
thereof. Pursuant to the terms of the CMC Agreement, the Company received (i)&#160;a worldwide, non-exclusive, non-transferable, non-sublicensable
license for research purposes, or the Research License, and (ii)&#160;an option, or the Option License, to a worldwide, non-exclusive,
non-transferable, sublicensable license for commercialization purposes, subject to a fee schedule in addition to that described below.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In accordance with the terms of the CMC Agreement, the Company agreed to pay in exchange
for the foregoing license payments to CMC upon the achievement of certain pre-determined clinical and regulatory events, an amount stipulated
in the CMC Agreement, aggregating a six-digit number. Additionally, for any product that is commercialized pursuant to the CMC Agreement,
the Company is required to pay CMC a royalty payment based on annual aggregate worldwide net sales thresholds for such products. In the
event CMC exclusively manufactures the Company&#8217;s products, CMC agrees to waive the foregoing royalty.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Unless terminated earlier pursuant to the customary termination provisions set forth
in the CMC Agreement, the Research License will expire upon the conclusion of the term as defined therein, and the Option License will
expire upon the later of (a)&#160;the tenth anniversary following the Company&#8217;s obtainment of regulatory approval, or (b)&#160;the
last to expire of the patent rights and country-by-country basis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Manufacturing</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company&#8217;s product candidate, CM-101, is a monoclonal antibody amenable to
standard formulation technologies. The Company has developed the biological process and manufactured kilogram quantities through processes
similar to the manufacturing processes that will be required to provide drug product for the Phase&#160;2 clinical studies. The manufacturing
process of the drug substance used for such product candidates is robust, well established and requires the use of readily available starting
materials. The biological route is amenable to large-scale production and does not require unconventional equipment or handling during
the manufacturing process. The Company has obtained an adequate supply chain of the drug substance for CM-101 from the Company&#8217;s
first European contract manufacturing organization, or CMO, to satisfy both the Company&#8217;s clinical and preclinical requirements
for this year. The Company relies on a sole supplier for the manufacture of CM-101. The Company&#8217;s manufacturer has the capabilities
to support late stage clinical studies as well as product launch and marketing.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company does not own or operate facilities for clinical drug manufacturing, storage,
distribution or quality testing. Currently, all of the Company&#8217;s clinical manufacturing is outsourced to third-party manufacturers.
As the Company&#8217;s development programs expand and it builds new process efficiencies, the Company expects to continually evaluate
this strategy with the objective of satisfying demand for its clinical studies and, if approved, the manufacture, sale and distribution
of commercial products.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">28</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Commercialization</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company intends to develop and, if approved by the FDA, to commercialize its product
candidates alone or in collaboration with others. The Company may work in combination with one or more large pharmaceutical partners for
certain indications, where specialist capabilities are needed. The Company intends to enter into distribution or licensing arrangements
for global or regional commercialization rights. The Company will, however, continuously review its partnering strategy in the light of
new clinical data and market understanding.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Regulatory Matters</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Food and Drug Administration, or FDA, and comparable regulatory authorities in state
and local jurisdictions and in other countries impose substantial and burdensome requirements upon companies involved in the clinical
development, manufacture, marketing and distribution of drugs, such as those the Company is developing. These agencies and other federal,
state and local entities regulate, among other things, the research and development, testing, manufacture, quality control, safety, effectiveness,
labelling, storage, record keeping, approval, advertising and promotion, distribution, post-approval monitoring and reporting, sampling
and export and import of the Company&#8217;s product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">United States government regulation of drug products</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Drugs in the United States are subject to rigorous regulation under the Food, Drug,
and Cosmetic Act, or FDCA, and its implementing regulations. The FDA also regulates biological products under the FDCA and the Public
Health Service Act, or PHSA. If the Company advances clinical development of a biologic candidate in the future, these development activities
will be subject to additional regulatory requirements specific to biologics. The process of obtaining regulatory approvals and the subsequent
compliance with applicable federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and
financial resources. Failure to comply with the applicable United States requirements at any time during the product development process,
approval process or after approval, may subject an applicant to a variety of administrative or judicial sanctions, such as the FDA&#8217;s
refusal to approve a pending New Drug Application, or NDA, withdrawal of an approval, imposition of a clinical hold, issuance of warning
letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of
government contracts, restitution, disgorgement or civil or criminal penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The process required by the FDA before a drug or biologic may be marketed in the United
States generally involves the following:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z96c251fdae95486bbb55638bdce29386" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Completion of preclinical laboratory tests, animal studies and formulation studies in
        compliance with the FDA&#8217;s Good Laboratory Practice, or GLP, regulations;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z7985fa93095d4f0aa2140bbb490131e1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Submission to the FDA of an Investigational New Drug application, or IND, which must
        become effective before human clinical studies may begin;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z4db86fe3318849ce9538199cbfa0cef0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Approval by an Institutional Review Board, or IRB, at each clinical site before each
        study may be initiated;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z662daed9e4a0406e894eb012aedaff39" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Performance of adequate and well-controlled human clinical studies in accordance with
        Good Clinical Practice, or GCP requirements to establish the safety and efficacy of the proposed drug product for each indication;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zafa69f9e796745a68592d9a7fd4e34c9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Completion of all manufacturing requirements to ensure robust manufacturing process,
        and product quality and safety as per Good Manufacturing Practice, or cGMP guidelines;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z026fe215e29541369ed0e3c82e0fdf9c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Completion of non-clinical reproductive studies, as applicable, prior to late stage clinical
        studies and NDA or Biologics&#160;License Application, or BLA, submission;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zcacfc79e4d434fe3aafcf3ccd0fc8042" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Development of an appropriate pediatric plan for clinical testing or exclusion, pre-
        or post-approval, as applicable;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf96320179d4d467c90a66467c37bbe9f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Submission to the FDA of an NDA or BLA;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z35255de4e6754577833efed1b502d8a9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Satisfactory completion of an FDA advisory committee review, if applicable;</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z78054a8e27bb4ee08b2d58bd11720c23" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Satisfactory completion of an FDA inspection of the manufacturing facility or facilities
        at which the product is produced to assess compliance with cGMP requirements and to assure that the facilities, methods and controls are
        adequate to preserve the drug&#8217;s identity, strength, quality and purity;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">29</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div>

<table cellspacing="0" cellpadding="0" id="zce0b73cf2adf42678572d00ed70c511b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Satisfactory completion of FDA audits of clinical study sites to assure compliance with
        GCPs and the integrity of the clinical data;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zb7366b3bff09447f83620a59f7cf30ce" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Payment of user fees and securing FDA approval of the NDA;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zd857b3b7d1a84db0942a85b51acd5d9c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">FDA review and approval of an NDA or BLA; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z298d2e5a45214b89950620a2485e8ba5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Compliance with any post-approval requirements, including the potential requirement to
        implement a Risk Evaluation and Mitigation Strategies, or REMS, and the potential requirement to conduct post-approval studies.</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Preclinical studies</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Preclinical studies include laboratory evaluation of product chemistry, toxicity and
formulation, as well as animal studies to assess potential safety and efficacy. An IND sponsor must submit the results of the preclinical
tests, together with manufacturing information, analytical data and any available clinical data or literature, among other things, to
the FDA as part of an IND. Some preclinical testing may continue even after the IND is submitted. An IND automatically becomes effective
30&#160;days after receipt by the FDA, unless before that time the FDA raises concerns or questions related to one or more proposed clinical
studies and places the clinical study on a clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns
before the clinical study can begin. As a result, submission of an IND may not result in the FDA allowing clinical studies to initiate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Clinical studies</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Clinical studies involve the administration of the investigational new drug to human
subjects under the supervision of qualified investigators in accordance with GCP requirements, which include the requirement that all
research subjects provide their informed consent in writing for their participation in any clinical study. Clinical studies are conducted
under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety, and the effectiveness
criteria to be evaluated. A protocol for each clinical study and any subsequent protocol amendments must be submitted to the FDA as part
of the IND. In addition, an IRB at each institution participating in the clinical study must review and approve the plan for any clinical
study before it initiates at that institution. Information about certain clinical studies must be submitted within specific timeframes
to the National Institutes of Health, or NIH, for public dissemination on their www.clinicaltrials.gov website.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Human clinical studies are typically conducted in three sequential phases, which may
overlap or be combined.&#160; A fourth, or post-approval, phase may include additional clinical studies.&#160; These phases generally
include the following:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zb66a83523be54e3f9fbcc3a08f426ac4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25"><span style="font-weight: bold">Phase&#160;1:</span>&#160;The drug or biologic is initially
        introduced into healthy human subjects or patients with the target disease or condition and tested for safety, dosage tolerance, absorption,
        metabolism, distribution, excretion and, if possible, to gain an early indication of its effectiveness.&#160; For some products for severe
        or life-threatening diseases, especially if the product may be too toxic to administer to healthy humans, the initial clinical trials
        may be conducted in individuals having a specific disease for which use the tested product is indicated.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zfcae6745e1e4480e8caf884d22e1e202" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25"><span style="font-weight: bold">Phase&#160;2:</span>&#160;The drug or biologic is administered
        is administered to a limited patient population to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy
        of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z812374206afc4fc788ce8cd2542b6df6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25"><span style="font-weight: bold">Phase&#160;3:</span>&#160;The drug or biologic is administered
        to an expanded patient population, generally at geographically dispersed clinical study sites, in well-controlled clinical studies to
        generate enough data to statistically evaluate the efficacy and safety of the product for approval, to establish the overall risk-benefit
        profile of the product, and to provide adequate information for the labeling of the product.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z62a8a24c999146eda3ade31c4c8530dd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25"><span style="font-weight: bold">Phase&#160;4:</span>&#160;Phase 4 clinical trials are
        studies required of, or agreed to by, a sponsor that are conducted after the FDA has approved a product for marketing. These studies are
        used to gain additional experience from the treatment of patients in the intended therapeutic indication and to document a clinical benefit
        in the case of drugs approved under accelerated approval regulations. If the FDA approves a product while a company has ongoing clinical
        trials that were not necessary for approval, a company may be able to use the data from these clinical trials to meet all or part of any
        Phase 4 clinical trial requirement. Failure to promptly conduct Phase 4 clinical trials where necessary could result in withdrawal of
        approval for products approved under accelerated approval regulations.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Progress reports detailing the results of the clinical studies must be submitted at
least annually to the FDA and more frequently if serious adverse events occur. Phase&#160;1, Phase&#160;2 and Phase&#160;3 studies may
not be completed successfully within any specified period, or at all. Furthermore, the FDA or the sponsor may suspend or terminate a clinical
study at any time on various grounds, including a finding that the research subjects are being exposed to an unacceptable health risk.
Similarly, an IRB can suspend or terminate approval of a clinical study at its institution if the clinical study is not being conducted
in accordance with the IRB&#8217;s requirements or if the drug has been associated with unexpected serious harm to patients.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">30</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Marketing approval</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Assuming successful completion of the required clinical testing, the results of the
preclinical and clinical studies, together with detailed information relating to the product&#8217;s chemistry, manufacture, controls
and proposed labeling, among other things, are submitted to the FDA as part of an NDA or BLA requesting approval to market the product
for one or more indications. In most cases, the submission of an NDA is subject to a substantial application user fee. Under the Prescription
Drug User Fee Act, or PDUFA, guidelines that are currently in effect, the FDA has a goal of ten&#160;months from the date of &#8220;filing&#8221;
of a standard NDA, for a new molecular entity to review and act on the submission. This review typically takes twelve&#160;months from
the date the NDA is submitted to FDA because the FDA has approximately two&#160;months to make a &#8220;filing&#8221; decision.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, under the Pediatric Research Equity Act of 2003, or PREA, as amended and
reauthorized, certain NDAs or supplements to an NDA must contain data that are adequate to assess the safety and effectiveness of the
drug for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration for each pediatric
subpopulation for which the product is safe and effective. The FDA may, on its own initiative or at the request of the applicant, grant
deferrals for submission of some or all pediatric data until after approval of the product for use in adults, or full or partial waivers
from the pediatric data requirements. An Agreed Initial Pediatric Study Plan requesting a waiver from the requirement to conduct clinical
studies may be submitted to the FDA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The FDA also may require submission of a REMS plan to ensure that the benefits of the
drug outweigh its risks. The REMS plan could include medication guides, physician communication plans, assessment plans, and/or elements
to assure safe use, such as restricted distribution methods, patient registries, or other risk minimization tools.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The FDA conducts a preliminary review of all NDAs within the first 60&#160;days after
submission, before accepting them for filing, to determine whether they are sufficiently complete to permit substantive review. The FDA
may request additional information rather than accept an NDA for filing. In this event, the application must be resubmitted with the additional
information. The resubmitted application is also subject to review before the FDA accepts it for filing. Once the submission is accepted
for filing, the FDA begins an in-depth substantive review. The FDA reviews an NDA to determine, among other things, whether the drug is
safe and effective and whether the facility in which it is manufactured, processed, packaged or held meets standards designed to assure
the product&#8217;s continued safety, quality and purity.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The FDA may refer an application for a novel drug to an advisory committee. An advisory
committee is a panel of independent experts, including clinicians and other scientific experts, which reviews, evaluates and provides
a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations
of an advisory committee, but it considers such recommendations carefully when making decisions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Before approving an NDA, the FDA typically will inspect the facility or facilities where
the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities
are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally,
before approving an NDA, the FDA may inspect one or more clinical study sites to assure compliance with GCP requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">After evaluating the NDA and all related information, including the advisory committee
recommendation, if any, and inspection reports regarding the manufacturing facilities and clinical study sites, the FDA may issue an approval
letter, or, in some cases, a complete response letter. A complete response letter generally contains a statement of specific conditions
that must be met in order to secure final approval of the NDA and may require additional clinical or preclinical testing in order for
the FDA to reconsider the application. Even with submission of this additional information, the FDA ultimately may decide that the application
does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#8217;s satisfaction, the
FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the drug with specific prescribing
information for specific indications.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Even if the FDA approves a product, it may limit the approved indications for use of
the product, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies,
including Phase&#160;4 clinical studies, be conducted to further assess a drug&#8217;s safety after approval, require testing and surveillance
programs to monitor the product after commercialization, or impose other conditions, including distribution and use restrictions or other
risk management mechanisms under a REMS, which can materially affect the potential market and profitability of the product. The FDA may
prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval,
some types of changes to the approved product, such as adding new indications, manufacturing changes, and additional labeling claims,
are subject to further testing requirements and FDA review and approval.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">31</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Orphan drug designation and exclusivity</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Orphan Drug Act, the FDA may designate a drug product as an &#8220;orphan
drug&#8221; if it is intended to treat a rare disease or condition (generally meaning that it affects fewer than 200,000 individuals in
the United States, or more in cases in which there is no reasonable expectation that the cost of developing and making a drug product
available in the United States for treatment of the disease or condition will be recovered from sales of the product). A company must
request orphan product designation before submitting an NDA. If the request is granted, the FDA will disclose the identity of the therapeutic
agent and its potential use. Orphan product designation does not convey any advantage in or shorten the duration of the regulatory review
and approval process. As of the current date, the Company has obtained orphan drug designation for three indications, PSC, SSc and IPF.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If a product with orphan status receives the first FDA approval for the disease or condition
for which it has such designation or for a select indication or use within the rare disease or condition for which it was designated,
the product generally will be receiving orphan product exclusivity. Orphan product exclusivity means that the FDA may not approve any
other applications for the same product for the same indication for seven&#160;years, except in certain limited circumstances. If a drug
or drug product designated as an orphan product ultimately receives marketing approval for an indication broader than what was designated
in its orphan product application, it may not be entitled to exclusivity. Orphan exclusivity will not bar approval of another product
under certain circumstances, including if a subsequent product with the same active ingredient for the same indication is shown to be
clinically superior to the approved product on the basis of greater efficacy or safety, or providing a major contribution to patient care,
or if the company with orphan drug exclusivity is not able to meet market demand. Further, the FDA may approve more than one product for
the same orphan indication or disease as long as the products contain different active ingredients. Moreover, competitors may receive
approval of different products for the indication for which the orphan product has exclusivity or obtain approval for the same product
but for a different indication for which the orphan product has exclusivity.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">United States marketing exclusivity</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Market exclusivity provisions under the FDCA also can delay the submission or the approval
of certain applications. The FDCA provides a five-year period of non-patent marketing exclusivity within the United States to the first
applicant to gain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA has not previously approved
any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During
the exclusivity period, the FDA may not accept for review an Abbreviated New Drug Application, or ANDA, or a 505(b)(2)&#160;NDA submitted
by another company for another version of such drug where the applicant does not own or have a legal right of reference to all the data
required for approval. However, an application may be submitted after four&#160;years if it contains a certification of patent invalidity
or non-infringement. The FDCA also provides three&#160;years of marketing exclusivity for an NDA, 505(b)(2)&#160;NDA or supplement to
an existing NDA if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant
are deemed by the FDA to be essential to the approval of the application, for example, new indications, dosages or strengths of an existing
drug. This three-year exclusivity covers only the conditions of use associated with the new clinical investigations and does not prohibit
the FDA from approving ANDAs for the original non-modified version of the drug. Five-year and three-year exclusivity will not delay the
submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or obtain a right of reference
to all of the preclinical studies and adequate and well-controlled clinical studies necessary to demonstrate safety and effectiveness.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Pediatric exclusivity is another type of regulatory market exclusivity in the United
States. Pediatric exclusivity, if granted, adds six&#160;months to existing regulatory exclusivity periods. This six-month exclusivity
may be granted based on the voluntary completion of a pediatric study in accordance with an FDA-issued &#8220;Written Request&#8221; for
such a study.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Post-approval requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Drugs and biologics manufactured or distributed pursuant to FDA approvals are subject
to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting,
product sampling and distribution, advertising and promotion and reporting of adverse experiences with the product. After approval, most
changes to the approved product, such as adding new indications or other labeling claims are subject to prior FDA review and approval.
There are continuing, annual user fee requirements for any marketed products and the establishments where such products are manufactured,
as well as new application fees for supplemental applications with clinical data.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">32</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">The FDA may impose a number of post-approval requirements as a condition of approval
of an NDA. For example, the FDA may require post-marketing testing, including Phase&#160;4 clinical studies, and surveillance to further
assess and monitor the product&#8217;s safety and effectiveness after commercialization.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, drug and biologic manufacturers and other entities involved in the manufacture
and distribution of approved drugs and biologics are required to register their establishments with the FDA and state agencies, and are
subject to periodic unannounced inspections by the FDA and these state agencies for compliance with cGMP requirements. Changes to the
manufacturing process are strictly regulated and often require prior FDA approval before being implemented. FDA regulations also require
investigation and correction of any deviations from cGMP requirements and impose reporting and documentation requirements upon the sponsor
and any third-party manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money,
and effort in the area of production and quality control to maintain cGMP compliance.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Once an approval of a drug or biologic is granted, the FDA may withdraw the approval
if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market.
Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with
manufacturing processes, or failure to comply with regulatory requirements, may result in mandatory revisions to the approved labeling
to add new safety information; imposition of post-market studies or clinical studies to assess new safety risks; or imposition of distribution
or other restrictions under a REMS program. Other potential consequences include, among other things:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc43ef994c0f640da8f03c5e7fd89137f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Restrictions on the marketing or manufacturing of the product, complete withdrawal of
        the product from the market or product recalls;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6c112ba6abb44f13832f0fde7c96274d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Fines, warning letters or holds on post-approval clinical studies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zb9dcd1559311401dbdc4c74731dca0d2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Refusal of the FDA to approve pending NDAs or BLAs or supplements to approved NDAs or
        BLAs, or suspension or revocation of product approvals;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z338d60da19134ecc8a5986967f0d4e7a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Product seizure or detention, or refusal to permit the import or export of products;
        and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z8699b0be822a42448839b56920205327" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Injunctions or the imposition of civil or criminal penalties.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The FDA strictly regulates marketing, labeling, advertising and promotion of products
that are placed on the market. Drugs and biologics may be promoted by a manufacturer and any third parties acting on behalf of a manufacturer
only for the approved indications and in a manner consistent with the approved label for the product. The FDA and other agencies actively
enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted
off-label uses may be subject to significant liability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Other healthcare laws</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Healthcare providers, physicians, and third party payors play a primary role in the
recommendation and prescription of drug products for which the Company obtains marketing approval. Arrangements with third party payors,
healthcare providers and physicians, in connection with the clinical research, sales, marketing and promotion of products, once approved,
and related activities, may expose a pharmaceutical manufacturer to broadly applicable fraud and abuse and other healthcare laws and regulations.
In the United States, these laws include, without limitation, state and federal anti-kickback, physician self-referral prohibitions, false
claims, physician transparency, and patient data privacy and security laws and regulations, including but not limited to those described
below:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z1d63f77682b342abb3f071e8c628c53c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the federal Anti-Kickback Statute, or AKS, which makes it illegal for any person, including
        a prescription drug manufacturer (or a party acting on its behalf) to knowingly and willfully solicit, receive, offer or pay any remuneration
        (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, that is intended to induce
        or reward, referrals including the purchase recommendation, order or prescription of a particular drug for which payment may be made under
        a federal healthcare program, such as the Medicare and Medicaid programs. A person or entity does not need to have actual knowledge of
        the statute or specific intent to violate it in order to have committed a violation. In addition, the government may assert that a claim
        including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for
        purposes of the federal False Claims Act, or FCA;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z51d3c49d3a23489391e372136ff3038b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the federal physician self-referral law, or Stark Law, prohibits a physician (defined
        to include a doctor of medicine or osteopathy, a doctor of dental surgery or dental medicine, a doctor of podiatric medicine, a doctor
        of optometry, or a chiropractor) from referring Medicare and Medicaid patients to certain types of entities with which the physician or
        any of the physician&#8217;s immediate family members have a financial relationship, unless an exception to the law&#8217;s prohibition
        is met. Subject to adherence to their respective criteria requirements, the self-referral prohibition contains a number of exceptions,
        including exceptions covering employment or independent contractor arrangements, space and equipment leases, and recruitment agreements.&#160;
        Violations of the Stark Law may result in administrative sanctions, payment denials, false claim recoveries, civil monetary penalties,
        and/or federal program exclusion.&#160; Similar to the AKS, a person or entity does not need to have actual knowledge of the Stark Law
        or specific intent to violate it in order to have committed a violation.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">33</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze1ccb62aaf6747c3b88512923b542883" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the federal civil and criminal false claims laws, including the FCA, which can be enforced
        through &#8220;qui tam&#8221; or &#8220;whistleblower&#8221; actions, and civil monetary penalty laws, which impose criminal and civil
        penalties against individuals or entities for, among other things, knowingly presenting, or causing to be presented, claims for payment
        or approval from Medicare, Medicaid, or other federal health care programs that are false or fraudulent; knowingly making or causing a
        false statement material to a false or fraudulent claim or an obligation to pay or transmit money or property to the federal government;
        or knowingly concealing or knowingly and improperly avoiding or decreasing such an obligation. Similar to the AKS and Stark Law, a person
        or entity does not need to have actual knowledge of these statutes or specific intent to violate them in order to have committed a violation.</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zab73d910bf9648f6b908c8f16467f7af" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which
        created additional federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud
        any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or
        property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private)
        and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false
        statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zbd54467857f44c149b6a07ab7ea3258e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health
        Act of 2009, or HITECH, and their respective implementing regulations, which impose requirements on certain covered healthcare providers,
        health plans, and healthcare clearinghouses as well as their respective business associates that perform services for them that involve
        the creation, use, receipt, maintenance or disclosure of individually identifiable health information, relating to the privacy, security
        and transmission of individually identifiable health information;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z8413a019f3524b7d9980cd4ace056891" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the federal Physician Payments Sunshine Act, created under Patient Protection and Affordable
        Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively, the ACA, and its implementing regulations,
        which require manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid
        or the Children&#8217;s Health Insurance Program to report annually to the Centers for Medicare and Medicaid Services, or CMS, under the
        Open Payments Program, information related to payments or other transfers of value made to physicians (defined to include doctors, dentists,
        optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians
        and their immediate family members. Effective January&#160;1, 2022, these reporting obligations will extend to include transfers of value
        made during the previous year to certain non-physician providers such as physician assistants and nurse practitioners; and</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc3cdac946c1c470aac6f28f91bac06b6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">analogous state and foreign laws and regulations, such as state and foreign anti-kickback,
        physician self-referral prohibitions, false claims, consumer protection and unfair competition laws which may apply to pharmaceutical
        business practices, including but not limited to, research, distribution, sales and marketing arrangements as well as submitting claims
        involving healthcare items or services reimbursed by any third-party payor, including commercial insurers; state laws that require pharmaceutical
        companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated
        by the federal government that otherwise restricts payments that may be made to healthcare providers and other potential referral sources;
        state laws that require drug manufacturers to file reports with states regarding pricing and marketing information, such as the tracking
        and reporting of gifts, compensations and other remuneration and items of value provided to healthcare professionals and entities; state
        and local laws requiring the registration of pharmaceutical sales representatives; and state and foreign laws governing the privacy and
        security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the
        same effect, thus complicating compliance efforts.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Because of the breadth of these laws and the narrowness of the statutory exceptions
and regulatory safe harbors available, it is possible that some of a pharmaceutical manufacturer&#8217;s business activities could be
subject to challenge under one or more of such laws. Efforts to ensure that business arrangements comply with applicable healthcare laws
involve substantial costs. It is possible that governmental and enforcement authorities will conclude that a pharmaceutical manufacturer&#8217;s
business practices do not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other
healthcare laws and regulations. If any such actions are instituted against a pharmaceutical manufacturer, and it is not successful in
defending itself or asserting its rights, those actions could have a significant impact on its business, including the imposition of significant
civil, criminal and administrative penalties, damages, disgorgement, imprisonment, monetary fines, possible exclusion from participation
in Medicare, Medicaid and other federal healthcare programs, reporting obligations and oversight if the Company becomes subject to integrity
and oversight agreements to resolve allegations of non-compliance, contractual damages, reputational harm, diminished profits and future
earnings, and curtailment of operations, any of which could adversely affect a pharmaceutical manufacturer&#8217;s ability to operate
its business and the results of operations. In addition, commercialization of any drug product outside the United States will also likely
be subject to foreign equivalents of the healthcare laws mentioned above, among other foreign laws.</div>

<div style="line-height: 1.25"><br /> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">34</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Prescription drug advertising is subject to federal, state and foreign regulations.
In the United States, the FDA regulates prescription drug promotion, including direct-to-consumer advertising. Prescription drug promotional
materials must be submitted to the FDA in conjunction with their first use. Any distribution of prescription drug products and pharmaceutical
samples must comply with the United States Prescription Drug Marketing Act, or PDMA, a part of the FDCA. In addition, Title II of the
Federal Drug Quality and Security Act of 2013, known as the Drug Supply Chain Security Act, or DSCSA, has imposed new &#8220;track and
trace&#8221; requirements on the distribution of prescription drug products by manufacturers, distributors, and other entities in the
drug supply chain. The DSCSA requires product identifiers (i.e., serialization) on prescription drug products in order to eventually establish
an electronic interoperable prescription product system to identify and trace certain prescription drugs distributed in the United States
and preempts existing state drug pedigree laws and regulations on this topic. The DSCSA also establishes new requirements for the licensing
of wholesale distributors and third-party logistic providers. The FDA is in the process of finalizing regulations addressing national
standards for the licensure of wholesale distributors and third-party logistics providers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In the United States, numerous federal and state laws and regulations, including state
data breach notification laws, state health information privacy laws, and federal and state consumer protection laws, govern the collection,
use, disclosure, and protection of health-related and other personal information. For example, in June&#160;2018, the State of California
enacted the California Consumer Privacy Act of 2018, or the CCPA, which came into effect on January&#160;1, 2020 and provides new data
privacy rights for consumers and new operational requirements for companies, which may increase the Company&#8217;s compliance costs and
potential liability. The CCPA gives California residents expanded rights to access and delete their personal information, opt out of certain
personal information sharing, and receive detailed information about how their personal information is used. The CCPA provides for civil
penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation.
While there is currently an exception for protected health information that is subject to HIPAA and clinical study regulations, as currently
written, the CCPA may impact certain of the Company&#8217;s business activities. The CCPA could mark the beginning of a trend toward more
stringent state privacy legislation in the United States, which could increase the Company&#8217;s potential liability and adversely affect
its business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In the event the Company decides to conduct clinical studies or continue to enroll subjects
in its ongoing or future clinical studies, the Company may be subject to additional privacy restrictions. The collection, use, storage,
disclosure, transfer, or other processing of personal data regarding individuals in the European Economic Area, or EEA, including personal
health data, is subject to the EU General Data Protection Regulation, or GDPR, which became effective on May&#160;25, 2018. The GDPR is
wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements relating to processing
health and other sensitive data, obtaining consent of the individuals to whom the personal data relates, providing information to individuals
regarding data processing activities, implementing safeguards to protect the security and confidentiality of personal data, providing
notification of data breaches, and taking certain measures when engaging third-party processors. The GDPR also imposes strict rules&#160;on
the transfer of personal data to countries outside the EEA, including the United States, and permits data protection authorities to impose
large penalties for violations of the GDPR, including potential fines of up to &#8364;20&#160;million or 4% of annual global revenues,
whichever is greater. The GDPR also confers a private right of action on data subjects and consumer associations to lodge complaints with
supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. In addition,
the GDPR includes restrictions on cross-border data transfers. The GDPR may increase the Company&#8217;s responsibility and liability
with respect to personal data that the Company processes where such processing is subject to the GDPR, and it may be required to put in
place additional mechanisms to ensure compliance with the GDPR, including as implemented by individual countries. Compliance with the
GDPR will be a rigorous and time-intensive process that may increase the Company&#8217;s cost of doing business or require it to change
its business practices, and despite those efforts, there is a risk that the Company may be subject to fines and penalties, litigation,
and reputational harm in connection with its European activities. Further, the United Kingdom&#8217;s decision to leave the EU, often
referred to as Brexit, has created uncertainty with regard to data protection regulation in the United Kingdom and transfers of personal
data to the UK and from the UK to both the EEA and countries outside the UK/EEA. For the time being, transfers of personal data from the
EU to the UK are covered by an adequacy decision of the EU Commission, and the UK has recently implemented its own regime for safeguarding
transfers from the UK to countries outside the UK/EEA which sit alongside the new EU safeguards which were brought in during 2021.&#160;
However, both the adequacy decision and the UK regime remain vulnerable to withdrawal or legal challenge.&#160; Further both the new UK
and EU personal data transfer regimes remain relatively untested and therefore impose risk that a transfer of personal data and/or its
subsequent processing would be held unlawful and give rise to liabilities from administrative fines and/or damages claims from data subjects.</div>

<div style="text-indent: 18pt; line-height: 1.25"> <br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Current and future healthcare reform legislation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In both the United States and certain foreign jurisdictions, there have been a number
of legislative and regulatory changes to the health care system. In particular, in 2010 the ACA was enacted, which, among other things,
increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid Drug Rebate Program, extended the Medicaid Drug Rebate
Program to utilization of prescriptions of individuals enrolled in Medicaid managed care organizations, subjected manufacturers to new
annual fees and taxes for certain branded prescription drugs, and provided incentives to programs that increase the federal government&#8217;s
comparative effectiveness research.</div>

<div style="line-height: 1.25">&#160;&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">35</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, other legislative changes have been proposed and adopted in the United
States since the ACA was enacted. In August&#160;2011, the Budget Control Act of 2011, among other things, created measures for spending
reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least
$1.2 trillion for the&#160;years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic
reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of 2% per fiscal year,
which went into effect in 2013, and, due to subsequent legislative amendments, will remain in effect through 2030 unless additional Congressional
action is taken. The CARES Act, the Consolidated Appropriations Act of 2021, and the Act to Prevent Across-the-Board Direct Spending Cuts
suspended the 2% sequestration mandated by the Budget Control Act of 2011 and the American Relief Act of 2011 from May 1, 2020 through
December 31, 2021. In December 2021, Congress extended the suspension of the automatic 2% reduction through March 2022 and reduced the
sequestration adjustment to 1% beginning on April 1, 2022 through June 30, 2022, with the full 2% reduction for sequestration resuming
thereafter.&#160; The American Taxpayer Relief Act of 2012 further reduced Medicare payments to several providers, including hospitals
and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers
from three to five&#160;years. The Bipartisan Budget Act of 2018, also amended the ACA, effective January&#160;1, 2019, by increasing
the point-of-sale discount that is owed by pharmaceutical manufacturers who participate in Medicare Part&#160;D and closing the coverage
gap in most Medicare drug plans, commonly referred to as the &#8220;donut hole&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Additionally, there has been heightened governmental scrutiny in the United States of
pharmaceutical pricing practices in light of the rising cost of prescription drugs and biologics. Congress and the U.S. Presidential administration
have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs. Any reduction
in reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payers. In addition,
individual states in the United States have also increasingly passed legislation and implemented regulations designed to control pharmaceutical
product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing
cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Legislative and regulatory proposals, and enactment of laws, at the foreign, federal
and state levels, directed at containing or lowering the cost of healthcare, will continue into the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Rest of World Regulation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For other countries outside of the European Union and the United States, such as countries
in Eastern Europe, Latin America or Asia, the requirements governing product development, the conduct of clinical studies, manufacturing,
distribution, marketing approval, product licensing, pricing and reimbursement vary from country to country. Additionally, clinical studies
must be conducted in accordance with GCP requirements and the applicable regulatory requirements and the ethical principles that have
their origin in the Declaration of Helsinki.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If the Company fails to comply with applicable foreign regulatory requirements, the
Company may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products,
operating restrictions and criminal prosecution.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Additionally, to the extent that any of the Company&#8217;s product candidates, once
approved, are sold in a foreign country, it may be subject to applicable post-marketing requirements, including safety surveillance, anti-fraud
and abuse laws and implementation of corporate compliance programs and reporting of payments or other transfers of value to healthcare
professionals.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Coverage and reimbursement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Successful commercialization of new drug products depends in part on the extent to which
reimbursement for those drug products will be available from government health administration authorities, private health insurers, and
other organizations. Government authorities and third-party payors, such as private health insurers and health maintenance organizations,
decide which drug products they will pay for and establish reimbursement levels. The availability and extent of reimbursement by governmental
and private payors is essential for most patients to be able to afford a drug product. Sales of drug products depend substantially, both
domestically and abroad, on the extent to which the costs of drugs products are paid for by health maintenance, managed care, pharmacy
benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health
coverage insurers and other third-party payors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">A primary trend in the United States healthcare industry and elsewhere is cost containment.
Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for
particular drug products. In many countries, the prices of drug products are subject to varying price control mechanisms as part of national
health systems. In general, the prices of drug products under such systems are substantially lower than in the United States. Other countries
allow companies to fix their own prices for drug products, but monitor and control company profits. Accordingly, in markets outside the
United States, the reimbursement for drug products may be reduced compared with the United States.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">36</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In the United States, the principal decisions about reimbursement for new drug products
are typically made by CMS, an agency within the U.S. Department of Health and Human Services. CMS decides whether and to what extent a
new drug product will be covered and reimbursed under Medicare, and private payors tend to follow CMS to a substantial degree. However,
no uniform policy of coverage and reimbursement for drug products exists among third-party payors and coverage and reimbursement levels
for drug products can differ significantly from payor to payor.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Medicare Prescription Drug,&#160;Improvement, and Modernization Act of 2003, or
the MMA, established the Medicare Part&#160;D program to provide a voluntary prescription drug benefit to Medicare beneficiaries. Under
Part&#160;D, Medicare beneficiaries may enroll in prescription drug plans offered by private entities that provide coverage of outpatient
prescription drugs. While all Medicare drug plans must give at least a standard level of coverage set by Medicare, Part&#160;D prescription
drug plan sponsors are not required to pay for all covered Part&#160;D drugs, and each Part&#160;D prescription drug plan can develop
its own drug formulary that identifies which drugs it will cover and at what tier or level. However, Part&#160;D prescription drug formularies
must include drugs within each therapeutic category and class of covered Part&#160;D drugs, though not necessarily all the drugs in each
category or class. Any formulary used by a Part&#160;D prescription drug plan must be developed and reviewed by a pharmacy and therapeutic
committee. Government payment for some of the costs of prescription drugs may increase demand for drugs for which the Company obtains
marketing approval. Any negotiated prices for any of the Company&#8217;s products covered by a Part&#160;D prescription drug plan will
likely be lower than the prices it might otherwise obtain. Moreover, while the MMA applies only to drug benefits for Medicare beneficiaries,
private payors often follow Medicare coverage policy and payment limitations in setting their own payment rates. Any reduction in payment
that results from the MMA may result in a similar reduction in payments from non-governmental payors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For a drug product to receive federal reimbursement under the Medicaid or Medicare Part&#160;B
programs or to be sold directly to United States government agencies, the manufacturer must extend discounts to entities eligible to participate
in the 340B drug pricing program. The required 340B discount on a given product is calculated based on the average manufacturer price,
or AMP, and Medicaid rebate amounts reported by the manufacturer. As of 2010, the ACA expanded the types of entities eligible to receive
discounted 340B pricing, although under the current state of the law these newly eligible entities (with the exception of children&#8217;s
hospitals) will not be eligible to receive discounted 340B pricing on orphan drugs. As 340B drug pricing is determined based on AMP and
Medicaid rebate data, the revisions to the Medicaid rebate formula and AMP definition described above could cause the required 340B discount
to increase. If third-party payors do not consider the Company&#8217;s drugs to be cost-effective compared to other available therapies,
they may not cover the Company&#8217;s drugs after approval as a benefit under their plans or, if they do, the level of payment may not
be sufficient to allow the Company to sell its drugs on a profitable basis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">These laws, and state and federal healthcare reform measures that may be adopted in
the future, may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices the Company may
obtain for any product candidates for which it may obtain regulatory approval or the frequency with which any such product candidate is
prescribed or used.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Outside of the United States, the pricing of pharmaceutical products and medical devices
is subject to governmental control in many countries. For example, in the European Union, pricing and reimbursement schemes vary widely
from country to country. Some countries provide that products may be marketed only after a reimbursement price has been agreed. Some countries
may require the completion of additional studies that compare the cost effectiveness of a particular therapy to currently available therapies
or so-called health technology assessments, in order to obtain reimbursement or pricing approval. Other countries may allow companies
to fix their own prices for products, but monitor and control product volumes and issue guidance to physicians to limit prescriptions.
Efforts to control prices and utilization of pharmaceutical products and medical devices will likely continue as countries attempt to
manage healthcare expenditures.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Employees and Human Capital Resources</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of December 31, 2021, the Company had 20 full-time employees/consultants, including
10 with Ph.D. or M.D. degrees and 13 who are engaged in research and development activities. The Company is dependent on its management
and scientific personnel, and it is crucial that it continues to attract and retain valuable employees. To facilitate attraction and retention,
the Company strives to make itself an inclusive and safe workplace, with opportunities for its employees to grow and develop in their
careers, supported by strong compensation and benefits programs. None of the Company&#8217;s employees are represented by labor unions
or covered by collective bargaining agreements.</div>

<div style="line-height: 1.25"><br /> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">37</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Available Information</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our website address is <span style="font-style: italic">www.chemomab.com</span>,
and our investor relations website is <span style="font-style: italic">www.investors.chemomab.com</span>. We promptly make available on
our investor relations website, free of charge, the reports that we file or furnish with the SEC, corporate governance information (including
our Code of Business Conduct and Ethics) and select press releases. We file annual reports on Form 10-K, quarterly reports on Form 10-Q,
current reports on Form 8-K, proxy and information statements and amendments to reports filed or furnished pursuant to the Exchange Act.
The SEC maintains a website at www.sec.gov that contains reports, proxy and information statements and other information regarding Appgate
and other issuers that file electronically with the SEC.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">Item 1A.<span id="Item1A."><!--Anchor--></span></span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Risk Factors</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; font-style: italic">You should consider carefully the following information about the
risks described below, together with the other information contained in this Annual Report on Form 10-K and in our other public filings,
in evaluating our business. If any of the following risks actually occurs, our business, financial condition, results of operations and
future growth prospects would likely be materially and adversely affected. In these circumstances, the market price of our common stock
would likely decline.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Chemomab&#8217;s Business, Research and Development and the Biopharmaceutical
Industry</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab has a limited operating history and funding, which may
make it difficult to evaluate its prospects and likelihood of success.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab is a clinical-stage biopharmaceutical company with a limited operating history.
Chemomab was incorporated in 2015, has no products approved for commercial sale and has not generated any revenue. Its operations to date
have been limited to organizing and staffing the company, business planning, raising capital, establishing its intellectual property portfolio
and conducting research and development of its product candidates, technology related to CCL24 and novel therapies for the treatment of
inflammation and fibrosis. Chemomab&#8217;s approach to the discovery and development of product candidates is unproven, and Chemomab
does not know whether it will be able to develop any products of commercial value. In addition, Chemomab&#8217;s lead product candidate,
CM-101, is in early clinical development for the treatment of PSC and SSc. The clinical programs will require substantial additional development
and clinical research, both in time and resources, before Chemomab is in a position to apply for or receive regulatory approvals and begin
generating revenue in connection with the sale of such product candidates. Chemomab has not yet demonstrated the ability to successfully
complete a large-scale, pivotal clinical trial, obtain marketing approval, manufacture a commercial scale product, or arrange for a third
party to do so on its behalf, or conduct sales and marketing activities necessary for successful product commercialization. Consequently,
predictions about Chemomab&#8217;s future success or viability may not be as accurate as they could be if Chemomab had a longer operating
history or a history of successfully developing and commercializing pharmaceutical products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, as a business with a limited operating history, Chemomab may encounter
unforeseen expenses, difficulties, complications, delays and other known or unknown factors and risks frequently experienced by early-stage
biopharmaceutical companies in rapidly evolving fields. Consequently, Chemomab has no meaningful history of operations upon which to evaluate
its business, and predictions about its future success or viability may not be as accurate as they could be if Chemomab had a longer operating
history or a history of successfully developing and commercializing drug products. Chemomab will eventually need to transition from a
company with a research and development focus to a company capable of supporting commercial activities. Chemomab may not be successful
in such a transition and, as a result, its business may be adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As Chemomab continues to build its business, it expects its financial condition and
operating results to fluctuate significantly from quarter to quarter and year to year due to a variety of factors, many of which are beyond
Chemomab&#8217;s control.</div>

<div style="line-height: 1.25">&#160;&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab&#8217;s business is highly dependent on the success of
its lead product candidate, CM-101, and any other product candidates that it advances into clinical studies. All of Chemomab&#8217;s programs
will require significant additional clinical development.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab currently has no products that are approved for commercial sale and may never
be able to develop marketable products. Chemomab is very early in its development efforts and has only one product candidate, CM-101,
in early clinical development. Because CM-101 is Chemomab&#8217;s lead product candidate, if CM-101 encounters safety or efficacy problems,
development delays, regulatory issues or other problems, Chemomab&#8217;s development plans and business would be significantly harmed.
Chemomab has completed a Phase&#160;1a SAD study with healthy volunteers, a Phase&#160;1b MAD study of CM-101 in non-alcoholic fatty liver
disease, or NAFLD, and is recruiting volunteers to participate in its in Phase 2a Safety, Pk and biomarkers study in NASH patients. Chemomab
plans to initiate a Phase&#160;2 SSc study in the second hald of 2022, , however, for certain additional risks described herein, Chemomab
cannot guarantee it will reach this clinical milestone or produce desirable results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab expects that a substantial portion of its efforts and expenditures over the
next few&#160;years will be devoted to CM-101, which will require additional clinical development, management of clinical and manufacturing
activities, regulatory approval in multiple jurisdictions, obtaining manufacturing supply, building of a commercial organization, substantial
investment and significant marketing efforts before it can generate any revenues from any commercial sales. Chemomab cannot be certain
that it will be able to successfully complete any of these activities. In addition, if one or more of Chemomab&#8217;s product candidates
are approved, Chemomab must ensure access to sufficient commercial manufacturing capacity and conduct significant marketing efforts in
connection with any commercial launch. These efforts will require substantial investment, and Chemomab may not have the financial resources
to continue the development of its product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">38</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab&#8217;s approach in the area of fibrotic diseases is novel
and unproven and may not result in marketable products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab&#8217;s central objective is to design and develop targeted treatments for
inflammation and fibrosis with an initial focus on the antagonism of CCL24 signaling, which is known to regulate fibrotic and inflammatory
processes. While several studies are currently underway, this mechanism has not yet been definitively proven to successfully treat inflammation
and fibrosis. Targeting CCL24 to treat inflammation and fibrosis is a novel approach in a rapidly developing field, and there can be no
assurance that Chemomab can avoid unforeseen problems or delays in the development of its product candidates, that such problems or delays
will not result in unanticipated costs, or that any such development problems can or will be solved. Chemomab has only tested its lead
product candidate, CM-101, in healthy volunteers and NAFLD patients. Therefore, Chemomab may ultimately discover that its approach does
not possess properties required for therapeutic effectiveness. As a result, Chemomab may elect to abandon the program or never succeed
in developing a marketable product, which would have a significant effect on the success and profitability of its business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Clinical development involves a lengthy, complex and expensive process,
with an uncertain outcome.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Before obtaining the requisite regulatory approvals from the FDA or other comparable
foreign regulatory authorities for the sale of any of its product candidates, Chemomab must support its application with clinical studies
that prove that such product candidate is safe and effective in humans. Clinical testing is expensive and can take many&#160;years to
complete, and its outcome is inherently uncertain. In particular, the general approach for FDA approval of a new drug requires positive
data from two well-controlled Phase&#160;3 clinical studies of the relevant drug in the relevant patient population. Failure can occur
at any time during the clinical study process. Chemomab may experience delays in initiating and completing any clinical studies that it
is conducting or intends to conduct, including as a result of the COVID-19 pandemic, and Chemomab does not know whether its ongoing or
planned clinical studies will begin or progress on schedule, need to be redesigned, enroll patients on time or be completed on schedule,
or at all.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Phase&#160;3 clinical studies typically involve hundreds of patients, have significant
costs and take&#160;years to complete. A product candidate can fail at any stage of testing, even after observing promising signals of
activity in earlier preclinical studies or clinical trials. The results of preclinical studies and early clinical trials of Chemomab&#8217;s
product candidates may not be predictive of the results of later-stage clinical studies. In addition, initial or interim success in clinical
studies may not be indicative of results obtained when such studies are completed. There is typically an extremely high rate of attrition
from the failure of product candidates proceeding through clinical studies. Product candidates in later stages of clinical studies may
fail to show the desired safety and efficacy profile despite having progressed through preclinical studies and initial clinical trials.
A number of companies in the biopharmaceutical industry have suffered significant setbacks in advanced clinical studies due to lack of
efficacy or unacceptable safety issues, notwithstanding promising results in earlier studies. Most product candidates that commence clinical
studies are never approved as products and there can be no assurance that any of Chemomab&#8217;s future clinical studies will ultimately
be successful or support further clinical development of CM-101. Product candidates that appear promising in the early phases of development
may fail to reach the market for several reasons, including:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z65c1a7f1c29c47e58cce1550921e8f12" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the FDA or comparable foreign regulatory authorities disagreeing as to the design or
        implementation of Chemomab&#8217;s clinical studies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd5f6397215ec456e8be75bf96b2a3a15" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">obtaining regulatory authorizations to commence a trial or consensus with regulatory
        authorities on trial&#8217;s design;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z21d85e2b830c4e9b8fdb4d9cd5496237" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">reaching an agreement on acceptable terms with prospective clinical research organizations,
        or CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different
        CROs and trial sites;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6d3b2b2908e446779550209068769e33" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">obtaining IRB approval at each site, or Independent Ethics Committee, or IEC, approval
        at sites outside the United States;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z7fb30240c3594db2869926425636023c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">imposition of a clinical hold by regulatory authorities, including as a result of unforeseen
        safety issues or side effects or failure of trial sites to adhere to regulatory requirements or follow trial protocols;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd539ab1c6eb24b808e22500ec43cc3bf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">clinical studies may show the product candidates to be less effective than expected (e.g.,
        a clinical study could fail to meet its primary endpoint(s)) or to have unacceptable side effects or toxicities;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">39</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div>

<table cellspacing="0" cellpadding="0" id="z66befca99f95418f9cecc6857e0e24cf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">failure to establish clinical endpoints that applicable regulatory authorities would
        consider clinically meaningful;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z3c3a4490109c40a2b86c88ab31e662a6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the occurrence of serious adverse events in trials of the same class of agents conducted
        by other companies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zfdd4b01940ee470cabbddbd3e417bdc6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">adding a sufficient number of clinical study sites;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze682f106894d4a7eb3dfa6a9b8e7f599" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">manufacturing sufficient quantities of product candidate with sufficient quality for
        use in clinical studies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z66b6004c7eea41b185ea1f46d729aa14" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">having patients complete a trial or return for post-treatment follow-up;</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0c51553cc8b14c7e9ac8816d88987571" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">recruiting suitable patients to participate in a trial in a timely manner and in sufficient
        numbers;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zead83fd883b4470faff530a59adb1cbb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">a facility manufacturing Chemomab&#8217;s product candidates or any of their components
        being ordered by the FDA or comparable foreign regulatory authorities to temporarily or permanently shut down due to violations of current
        good manufacturing practice, or cGMP, regulations or other applicable requirements, or infections or cross-contaminations of product candidates
        in the manufacturing process;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5204b2fbdecb49a79a755185b9614589" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">third-party clinical investigators losing the licenses or permits necessary to perform
        Chemomab&#8217;s clinical studies, not performing its clinical studies on its anticipated schedule or consistent with the clinical study
        protocol, GCP, or other regulatory requirements;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zbcbf2480f4e94fd2bc8762ac4e24762e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">third-party contractors not performing data collection or analysis in a timely or accurate
        manner;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zccba116fed4242169804326957046c0c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">manufacturing costs, formulation issues, pricing or reimbursement issues, or other factors
        that make a product candidate uneconomical; or</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zfbf52da5fd954cbb8a511d88ef1d8bd5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the proprietary rights of others and their competing products and technologies that may
        prevent one of Chemomab&#8217;s product candidates from being commercialized.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, differences in trial design between early-stage clinical studies and later-stage
clinical studies make it difficult to extrapolate the results of earlier clinical studies to later clinical studies. Moreover, clinical
data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed
satisfactorily in clinical studies have nonetheless failed to obtain marketing approval of their products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, the standards used by the FDA and comparable foreign regulatory authorities
when regulating Chemomab require judgment and can change, which makes it difficult to predict with certainty how they will be applied.
For more information, see &#8220;<span style="font-style: italic">Risk Factors &#8212; Risks Related to Chemomab&#8217;s&#160;Regulatory
Approvals.&#8221;</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Successful completion of clinical studies is a prerequisite to submitting a marketing
application to the FDA and similar marketing applications to comparable foreign regulatory authorities, for each product candidate and,
consequently, the ultimate approval and commercial marketing of any product candidates. Chemomab may experience negative or inconclusive
results, which may result in it deciding, or it being required by regulators, to conduct additional clinical studies or trials or abandon
some or all of its product development programs, which could have a material adverse effect on Chemomab&#8217;s business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab may incur additional costs or experience delays in completing
the development and commercialization of CM-101 or any other product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab may experience delays in initiating or completing clinical studies. It also
may experience numerous unforeseen events during, or as a result of, any future clinical studies that could delay or prevent its ability
to receive marketing approval or commercialize CM-101 or any other product candidates, including:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z10d3c1970c3640f99f2ac08f63964f87" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">regulators,&#160;IRBs, or IECs may not authorize Chemomab or its investigators to commence
        a clinical study or conduct a clinical study at a prospective trial site;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze92405741cbc496a9f4076a9d610cd67" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the FDA or other comparable regulatory authorities may disagree with Chemomab&#8217;s
        clinical study design, including with respect to dosing levels administered in its planned clinical studies, which may delay or prevent
        Chemomab from initiating its clinical studies with its originally intended trial design;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zb0d56c0b5d944bde9de8e624aba80392" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab may experience delays in reaching, or fail to reach, agreement on acceptable
        terms with prospective trial sites and prospective CROs, which can be subject to extensive negotiation and may vary significantly among
        different CROs and trial sites;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">40</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div>

<table cellspacing="0" cellpadding="0" id="z655cc31791e44fad94df3850f15c4edd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the number of subjects required for clinical studies of any product candidates may be
        larger than Chemomab anticipates or subjects may drop out of these clinical studies or fail to return for post-treatment follow-up at
        a higher rate than it anticipates;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd8582ecdf79144f883194e7dbd13cbdd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab&#8217;s third-party contractors may fail to comply with regulatory requirements
        or meet its contractual obligations to Chemomab in a timely manner, or at all, or may deviate from the clinical study protocol or drop
        out of the trial, which may require that Chemomab add new clinical study sites or investigators;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf6dc74d126f846c79b244c63ce2a3a1f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">due to the impact of the COVID-19 pandemic, Chemomab has experienced, and may continue
        to experience, delays and interruptions to clinical studies, it may experience delays or interruptions to its manufacturing supply chain,
        or it could suffer delays in reaching, or it may fail to reach, agreement on acceptable terms with third-party service providers on whom
        it relies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zad3f6e28707f47468f884669a00ebc48" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">additional delays and interruptions to Chemomab&#8217;s clinical studies could extend
        the duration of the trials and increase the overall costs to finish the trials as its fixed costs are not substantially reduced during
        delays;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0dafb2673aaf4ad2aaccb80f014ce865" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab may elect to, or regulators,&#160;IRBs, Data Safety Monitoring Boards or ethics
        committees may require that it or its investigators, suspend or terminate clinical research or trials for various reasons, including noncompliance
        with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zac91767bc4b34b3aa75cd1bad7f70ffc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab may not have the financial resources available to begin and complete the planned
        trials, or the cost of clinical studies of any product candidates may be greater than it anticipates; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6f2b0a474b84465aa4722fc71c6aa12b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the supply or quality of Chemomab&#8217;s product candidates or other materials necessary
        to conduct clinical studies of its product candidates may be insufficient or inadequate to initiate or complete a given clinical study.</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab&#8217;s product development costs will increase if it experiences additional
delays in clinical testing or in obtaining marketing approvals. Chemomab does not know whether any of its clinical studies will begin
as planned, will need to be restructured or will be completed on schedule, or at all. If Chemomab does not achieve its product development
goals in the time frames it announces and expects, the approval and commercialization of its product candidates may be delayed or prevented
entirely. Significant clinical study delays also could shorten any periods during which it may have the exclusive right to commercialize
its product candidates and may allow its competitors to bring products to market before Chemomab does, potentially impairing its ability
to successfully commercialize its product candidates and harming its business and results of operations. Any delays in Chemomab&#8217;s
clinical development programs may harm its business, financial condition and results of operations significantly.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab&#8217;s ongoing and future clinical studies may reveal
significant adverse events or immunogenicity related responses and may result in a safety profile that could delay or prevent regulatory
approval or market acceptance of its product candidate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab completed its Phase&#160;1a and Phase&#160;1b clinical studies of its lead
product candidate, CM-101, in healthy volunteers and NAFLD patients, and, with the exception of a number of reported minor adverse events
(including mild headaches, changes in blood pressure and mild-moderate increases in liver enzymes), CM-101 was observed to be generally
well-tolerated across all doses in 42 trial participants. Some potential therapeutics developed in the biopharmaceutical industry that
initially showed therapeutic promise in early-stage trials have later been found to cause side effects that prevented their further development
and ultimately commercialization. Even if side effects do not preclude the product candidate from obtaining or maintaining marketing approval,
undesirable side effects may inhibit market acceptance of the approved product due to its tolerability versus other therapies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Protein biopharmaceuticals, including, monoclonal antibodies, or mAbs, may be immunogenic
and promote immune responses against themselves. In particular, anti-drug antibodies, or ADAs, may be produced by patients following infusion
mAbs and may disturb the pharmacokinetics of mAbs, neutralize their therapeutic activities or induce allergic or autoimmune symptoms.
Clinical immunogenicity can range from mild, transient antibody responses with no apparent clinical manifestations to loss of therapeutic
efficacy and even life-threatening reactions. Several approved therapeutic antibodies have been found to induce neutralizing antibodies,
as illustrated by the approved anti-TNFa antibodies infliximab and adalimumab as well as anti IL-17 approved mAb ixekizumab. Chemomab&#8217;s
product candidate, CM-101, is a humanized antibody that, similar to other humanized approved mAbs, was shown to include several non-germline
sequences that may serve as a source for immunogenicity in therapeutic antibodies. In vitro testing was conducted and revealed that while
T cell proliferation was not induced using the whole antibody (CM-101), specific fragments of the mAb that contained non-germline residues,
induced T cell proliferation. Clinical studies to date have shown a lack of anti-drug antibodies, or ADAs. Additional larger clinical
studies will be needed to address the risk of immunogenicity and, if discovered, Chemomab&#8217;s business will be materially and adversely
affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">41</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Additionally, if unacceptable side effects, including materialized risks of immunogenicity,
do arise in the development of Chemomab&#8217;s product candidates, Chemomab, the FDA or the IRBs at the institutions in which its studies
are conducted, or the Data Safety Monitoring Board, if constituted for its clinical studies, could recommend a suspension or termination
of Chemomab&#8217;s clinical studies, or the FDA or comparable foreign regulatory authorities could order Chemomab to cease further development
of or deny approval of a product candidate for any or all targeted indications. In addition, drug-related side effects could affect patient
recruitment or the ability of enrolled patients to complete a trial or result in potential product liability claims. In addition, these
side effects may not be appropriately recognized or managed by the treating medical staff. Chemomab expects to have to train medical personnel
using its product candidates to understand the side effect profiles for its clinical studies and upon any commercialization of any of
its product candidates. Inadequate training in recognizing or managing the potential side effects of its product candidates could result
in patient injury or death. Any of these occurrences may harm Chemomab&#8217;s business, financial condition and prospects significantly.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Additionally, if one or more of Chemomab&#8217;s product candidates receives marketing
approval, and Chemomab or others later identify undesirable side effects caused by such products, a number of potentially significant
negative consequences could result, including:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z60cd150387fa45b184fd197b1da515ee" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">regulatory authorities may withdraw approvals of such product;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z1ac01847d77b4a02931f0ffc7113d550" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">regulatory authorities may require additional warnings on the label, such as a &#8220;black
        box&#8221; warning or contraindication;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zcd425211996c418cad29cd5b7aa35f72" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">additional restrictions may be imposed on the marketing of the particular product or
        the manufacturing processes for the product or any component thereof;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze06bd4108fd2406cab2e8547c9a93730" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab may be required to implement a Risk Evaluation and Mitigation Strategy, or REMS,
        or create a medication guide outlining the risks of such side effects for distribution to patients;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zfe9525fd2bbe42a087463d853ce355ab" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab could be sued and held liable for harm caused to patients;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z1efbd2e4e37942a2b97bac596d687010" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the product may become less competitive; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5e2cf03c24184f19a751d40ac47e2ff4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab&#8217;s reputation may suffer.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Any of these events could prevent Chemomab from achieving or maintaining market acceptance
of a product candidate, if approved, and could significantly harm Chemomab&#8217;s business, results of operations and prospects.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If Chemomab encounters difficulties enrolling patients in its clinical
studies, including due to COVID-19, its clinical development activities could be delayed or otherwise adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab may experience difficulties in patient enrollment in its clinical studies for
a variety of reasons. The timely completion of clinical studies in accordance with its protocols depends, among other things, on Chemomab&#8217;s
ability to enroll a sufficient number of patients who remain in the trial until its conclusion. The enrollment of patients depends on
many factors, including:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z47bfd13f0581483ebdcd7ecd3ee0bd4d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the patient eligibility and exclusion criteria defined in the protocol;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd87bc4ede87d435086f623bb920300c8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the size of the patient population required for analysis of the trial&#8217;s primary
        endpoints and the process for identifying patients;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z593ebf2728264ca69f5fcfe268629b7b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the willingness or availability (including legality under any applicable COVID-19 shelter-in-place
        regulations) of patients to participate in Chemomab&#8217;s trials (including due to fears of contracting COVID-19);</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z841c60e3f84b4c84857467032df0a65f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the proximity of patients to trial sites;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc1a50d184d7845bb8a48c8a1a7d47abf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the design of the trial;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5131f766e886431cb2188bdd4d153b79" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab&#8217;s ability to recruit clinical study investigators with the appropriate
        competencies and experience;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="za833ed33fefa492985bb7fa44da0e390" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">clinicians&#8217; and patients&#8217; perceptions as to the potential advantages and
        risks of the product candidate being studied with respect to other available therapies, including any new products that may be approved
        for the indications Chemomab is investigating;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z2e5c7a449edf4406a89bb47d8f9698f8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the availability of competing commercially available therapies and other competing product
        candidates&#8217; clinical studies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">42</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd19c5a43a6ef473186b63a114a30aa40" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab&#8217;s ability to obtain and maintain patient informed consents; and</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zcc2ef7e474514f6ea3ac0657cd9fd5b5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the risk that patients enrolled in clinical studies will drop out of the trials before
        completion.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Further, timely enrollment in clinical studies is reliant on clinical study sites which
may be adversely affected by global health matters, including, among other things, pandemics. For example, Chemomab&#8217;s clinical study
sites have been affected by the COVID-19 pandemic. Commencement of the enrollment of Chemomab&#8217;s clinical studies of CM-101 in PSC
had been delayed. Further, Chemomab anticipates it may experience further delays in the enrollment for its CM-101 PSC Phase&#160;2 study,
and it could experience slower than expected enrollment. In addition, after enrollment in these trials, if patients contract COVID-19
during participation in Chemomab&#8217;s trials or are subject to isolation or shelter-in-place restrictions, this may cause them to drop
out of Chemomab&#8217;s trials, miss scheduled doses or follow-up visits or otherwise fail to follow trial protocols. If patients are
unable to follow the trial protocols or if Chemomab&#8217;s trial results are otherwise disputed due to the effects of the COVID-19 pandemic
or actions taken to mitigate its spread, the integrity of data from Chemomab&#8217;s trials may be compromised or not accepted by the
FDA or other regulatory authorities, which would represent a significant setback for the applicable program.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Some factors from the COVID-19 pandemic that Chemomab believes may adversely affect
enrollment in its trials include:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9806668647e944629586f9ef9c490757" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the diversion of healthcare resources away from the conduct of clinical study matters
        to focus on pandemic concerns, including the attention of infectious disease physicians serving as Chemomab&#8217;s clinical study investigators,
        hospitals serving as Chemomab&#8217;s clinical study sites and hospital staff supporting the conduct of its clinical studies;</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<div>

<div>

<table cellspacing="0" cellpadding="0" id="zeabd2ee9c33c458580e0243e730323b5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25"><span style="line-height: 1.25">&#8226;</span></div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the inability of patients to come to hospitals to participate in Chemomab&#8217;s trials,
        which may force Chemomab to conduct its trials in patients&#8217; homes, rendering the trials more difficult and costly to conduct;</div>
        </td> </tr>
  </table> </div> </div> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z282615aa5e734991b8296845889bbdbb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">limitations on travel that interrupt key trial activities, such as clinical study site
        initiations and monitoring; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5c06489b258e4a4388b1de99dd00f01d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">employee furlough days that delay necessary interactions with local regulators, ethics
        committees and other important agencies and contractors.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">These and other factors arising from the COVID-19 pandemic could worsen in countries
that are already afflicted with the virus or could continue to spread to additional countries, each of which may further adversely impact
Chemomab&#8217;s clinical studies. The global outbreak of the COVID-19 pandemic continues to evolve and the conduct of Chemomab&#8217;s
trials may continue to be adversely affected, despite efforts to mitigate this impact.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The market opportunities for CM-101, if approved, may be smaller
than Chemomab anticipates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab expects to initially seek approval of CM-101 for the treatment of PSC and SSc.
Its projections of the number of PSC and SSc patients is based on its beliefs and estimates. These estimates have been derived from a
variety of sources, including scientific literature, patient foundations and publicly available databases, and may prove to be incorrect.
Further, new sources may reveal a change in the estimated number of patients, and the number of patients may turn out to be lower than
Chemomab expected. The potential addressable patient population for Chemomab&#8217;s current programs or future product candidates may
be limited. The ultimate market opportunity for Chemomab&#8217;s product candidates will depend on, among other things, the final labeling
for such product candidates as agreed with the FDA or comparable foreign regulatory authorities, acceptance by the medical community and
patient access, potential competition and drug pricing and reimbursement. Even if Chemomab obtains significant market share for any product
candidate, if approved, if the potential target populations are small, Chemomab may never achieve profitability without obtaining marketing
approval for additional indications.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab may not be successful in its efforts to identify or discover
additional product candidates in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab&#8217;s research programs may initially show promise in identifying potential
product candidates, yet may fail to yield product candidates for clinical development for a number of reasons, including:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9d7a651b0f394eefa07ad5cb146a487b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab&#8217;s inability to design such product candidates with the pharmacological
        properties that it desires or attractive pharmacokinetics; or</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd305a1ff42294daf9ef1d25f9c71d9e8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">potential product candidates may, on further study, be shown to have harmful side effects
        or other characteristics that indicate that they are unlikely to be medicines that will receive marketing approval and achieve market
        acceptance.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">43</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Research programs to identify new product candidates require substantial technical,
financial and human resources. If Chemomab is unable to identify suitable compounds for preclinical and clinical development, it will
not be able to obtain product revenue in future periods, which likely would result in significant harm to Chemomab&#8217;s financial position
and adversely impact the price of its ADSs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Certain of Chemomab&#8217;s key strategic initiatives, including
investing in the internal discovery of new product candidates and in-licensing or acquiring new assets to expand Chemomab&#8217;s current
pipeline, involve various risks that may impair Chemomab&#8217;s ability to actualize the foregoing strategies.</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z8dc7b3cdb0624ce0a21822299227df29" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>The competitive landscape for in-licensing or acquiring assets in the biopharmaceutical sector is intense with several companies
        employing this growth and diversification strategy.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z69a52c37e5fb43c2bf37b5a504b98da9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Even if appropriate assets are identified, there can be no assurance that a potential transaction can be consummated between the
        parties.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zbfccccfdb3d94e8ca658d237c088fa76" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>If a transaction is concluded on acceptable terms, there can be assurance that the assets in-licensed or acquired will be successful
        in preclinical and subsequent clinical development.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zcdab25b6f3ee4118b4c5868cd8bf5e44" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>The Company will likely need to raise additional capital to close any transaction of significance.&#160; As such, there can be no
        assurance that a fundraising effort will be successful and if successful, it could result in dilution to current shareholders.</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Due to Chemomab&#8217;s limited resources and access to capital,
it must make decisions on the allocation of resources to certain programs and product candidates; these decisions may prove to be wrong
and may adversely affect Chemomab&#8217;s business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab has limited financial and human resources and intends to initially focus on
research programs and product candidates for a limited set of indications. As a result, Chemomab may forgo or delay pursuit of opportunities
with other product candidates or for other indications that later prove to have greater commercial potential or a greater likelihood of
success.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">There can be no assurance that Chemomab will ever be able to identify additional therapeutic
opportunities for its product candidates or to develop suitable potential product candidates through internal research programs, which
could materially adversely affect its future growth and prospects. Chemomab may focus its efforts and resources on potential product candidates
or other potential programs that ultimately prove to be unsuccessful.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If product liability lawsuits are brought against Chemomab, it may
incur substantial financial or other liabilities and may be required to limit commercialization of its product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab faces an inherent risk of product liability as a result of testing CM-101,
and will face an even greater risk if Chemomab commercializes any products. For example, Chemomab may be sued if any of its product candidates
cause or are perceived to cause injury or are found to be otherwise unsuitable during clinical studies, manufacturing, marketing or sale.
Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers
inherent in the product, negligence, strict liability or a breach of warranties. Claims could also be asserted under state consumer protection
acts. If Chemomab cannot successfully defend itself against product liability claims, it may incur substantial liabilities or be required
to limit commercialization of its product candidates. Even successful defense would require significant financial and management resources.
Chemomab&#8217;s inability to obtain sufficient product liability insurance at an acceptable cost to protect against potential product
liability claims could prevent or inhibit the commercialization of products Chemomab develops. Chemomab will need to obtain additional
insurance for clinical studies as it continues clinical development of CM-101 and as additional product candidates enter clinical studies.
However, Chemomab may be unable to obtain, or may obtain on unfavorable terms, clinical study insurance in amounts adequate to cover any
liabilities from any of its clinical studies. Chemomab&#8217;s insurance policies may also have various exclusions, and Chemomab may be
subject to a product liability claim for which it has no coverage. Chemomab may have to pay any amount awarded by a court or negotiated
in a settlement that exceed its coverage limitations or that are not covered by insurance, and Chemomab may not have, or be able to obtain,
sufficient capital to pay such amounts. Even if Chemomab&#8217;s agreements with any future corporate collaborators entitles Chemomab
to indemnification against losses, such indemnification may not be available or adequate should any claim arise.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">44</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab has been granted Orphan Drug Designation for CM-101 in
connection with three indications and may seek Orphan Drug Designation for other indications or product candidates, and Chemomab may be
unable to maintain the benefits associated with Orphan Drug Designation, including the potential for market exclusivity, and may not receive
Orphan Drug Designation for other indications or for its other product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Regulatory authorities in some jurisdictions, including the United States and Europe,
may designate drugs intended for relatively small patient populations as orphan drugs. Under the Orphan Drug Act, the FDA may designate
a drug as an orphan drug if it is a drug intended to treat a rare disease or condition, which is generally defined as a patient population
of fewer than 200,000 individuals in the United States, or a patient population greater than 200,000 in the United States where there
is no reasonable expectation that the cost of developing the drug will be recovered from sales in the United States. In the United States,
Orphan Drug Designation entitles a party to financial incentives such as opportunities for grant funding toward clinical study costs,
tax advantages and user-fee waivers. In addition, if a product that has Orphan Drug Designation subsequently receives the first FDA approval
for the disease for which it has such designation, the product is entitled to orphan drug exclusivity, which means that the FDA may not
approve any other applications, including a full NDA to market the same product for the same indication for seven&#160;years, except in
limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity or where the manufacturer
is unable to assure sufficient product quantity. However, Orphan Drug Designation neither shortens the development time or regulatory
review time of a drug nor gives the drug any advantage in the regulatory review or approval process.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The FDA and EMA granted Orphan Drug Designation to CM-101 in its primary indications
of PSC, SSc and IPF. Chemomab may seek Orphan Drug Designations for CM-101 in other indications or for other product candidates. There
can be no assurance that Chemomab will be able to obtain such designations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Even if Chemomab obtains Orphan Drug Designation for any product candidate in specific
indications, it may not be the first to obtain marketing approval of such product candidate for the orphan-designated indication due to
the uncertainties associated with developing pharmaceutical products. In addition, exclusive marketing rights in the United States may
be limited if Chemomab seeks approval for an indication broader than the orphan-designated indication or may be lost if the FDA later
determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities
of the product to meet the needs of patients with the rare disease or condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Further, even if Chemomab obtains orphan drug exclusivity in the United States for a
product, that exclusivity may not effectively protect the product from competition because different drugs with different active moieties
can be approved for the same condition. Even after an orphan product is approved, the FDA can subsequently approve the same drug with
the same active moiety for the same condition if the FDA concludes that the later drug is safer, more effective or makes a major contribution
to patient care.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab will need to expand its organization, and it may experience
difficulties in managing this growth, which could disrupt its operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of December&#160;31, 2021, the Company had 20 employees / full time consultants.
The Company expect to experience significant growth in the number of its employees and the scope of its operations, particularly in the
areas of product candidate development, regulatory affairs and sales and marketing. Chemomab may have difficulty identifying, hiring and
integrating new personnel. Future growth would impose significant additional responsibilities on its management, including the need to
identify, recruit, maintain, motivate and integrate additional employees, consultants and contractors. Also, Chemomab&#8217;s management
may need to divert a disproportionate amount of its attention away from its day-to-day activities and devote a substantial amount of time
to managing these growth activities. Chemomab may not be able to effectively manage the expansion of its operations, which may result
in weaknesses in its infrastructure, give rise to operational mistakes, loss of business opportunities, loss of employees and reduced
productivity among remaining employees. Chemomab&#8217;s expected growth could require significant capital expenditures and may divert
financial resources from other projects, such as the development of product candidates. If Chemomab&#8217;s management is unable to effectively
manage its growth, its expenses may increase more than expected, its ability to generate and/or grow revenues could be reduced, and it
may not be able to implement its business strategy. Chemomab&#8217;s future financial performance and its ability to commercialize its
product candidates and compete effectively will depend, in part, on its ability to effectively manage any future growth.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Many of the biopharmaceutical companies that Chemomab competes against for qualified
personnel and consultants have greater financial and other resources, different risk profiles and a longer history in the industry than
Chemomab does. If Chemomab is unable to continue to attract and retain high-quality personnel and consultants, the rate and success at
which it can discover and develop product candidates and operate its business will be limited.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab has incurred significant operating losses since its inception
and anticipates it will incur continued losses for the foreseeable future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company has funded its operations to date through proceeds from sales of its equity
and grants from the Israel Innovation Authority, or the IIA, which as of December&#160;31, 2021, resulted in gross proceeds of approximately
$96&#160;million. As of December&#160;31, 2021, Chemomab&#8217;s cash, cash equivalents and deposits were $61.2 million. Chemomab has
incurred net losses in each year since its inception, and it has an accumulated deficit of $36.2&#160;million as of December&#160;31,
2021. Chemomab expects its existing cash and cash equivalents will allow it to fund its operating expenses and capital expenditure requirements
through the end of 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">45</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Substantially all of Chemomab&#8217;s operating losses have resulted from general and
administrative costs associated with its operations, and costs associated with its research and development programs, including for its
preclinical and clinical product candidates. Chemomab expects to incur increasing levels of operating losses over the next several&#160;years
and for the foreseeable future. Chemomab&#8217;s prior losses, combined with expected future losses, have had and will continue to have
an adverse effect on its shareholders&#8217; deficit and working capital. In any particular quarter or quarters, Chemomab&#8217;s operating
results could be below the expectations of securities analysts or investors, which could cause the price of Chemomab&#8217;s ADSs to decline.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab expects its research and development expenses to significantly increase in
connection with its clinical studies of its product candidates. In addition, if Chemomab obtains marketing approval for its product candidates,
it will incur significant sales and marketing, legal, and outsourced-manufacturing expenses. As a public company, Chemomab expects to
continue to incur significant and increasing operating losses for the foreseeable future. Because of the numerous risks and uncertainties
associated with developing pharmaceutical products, Chemomab is also unable to predict the extent of any future losses or when it will
become profitable, if at all. Even if Chemomab does become profitable, it may not be able to sustain or increase its profitability on
a quarterly or annual basis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The current pandemic of COVID-19 and the future outbreak of other
highly infectious or contagious diseases could seriously harm Chemomab&#8217;s research, development and potential future commercialization
efforts, increase its costs and expenses and have a material adverse effect on its business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Broad-based business or economic disruptions have, and could continue to, adversely
affect Chemomab&#8217;s ongoing or planned research and development activities. For example, to date, the COVID-19 pandemic has caused
significant disruptions to the Israeli, United States and global economy and has contributed to significant volatility and negative pressure
in financial markets. The global impact of the outbreak is continually evolving and, as additional cases of the virus are identified,
many countries, including Israel and the United States, have reacted by instituting quarantines, restrictions on travel and mandatory
closures of businesses. Most countries, including where Chemomab or the third parties with whom it engages operate, have also reacted
by instituting quarantines, restrictions on travel, &#8220;shelter in place&#8221; rules, and restrictions on types of business that may
continue to operate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The extent to which COVID-19 may impact Chemomab&#8217;s preclinical studies or clinical
trial operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the duration
of the outbreak, the severity of COVID-19, or the effectiveness of actions to contain and treat COVID-19. The continued spread of COVID-19
globally could adversely impact Chemomab&#8217;s preclinical studies or clinical study operations in Israel and the United States, including
its ability to recruit and retain patients and principal investigators and site staff who, as healthcare providers, may have heightened
exposure to COVID-19 if an outbreak occurs in their geography. COVID-19 may also affect employees of third-party CROs located in affected
geographies that Chemomab relies upon to carry out its clinical studies. Any negative impact COVID-19 has on patient enrollment or treatment
or the execution of its current product candidates and any future product candidates could cause costly delays to clinical study activities,
which could adversely affect Chemomab&#8217;s ability to obtain regulatory approval for and to commercialize its current product candidates
and any future product candidates, increase its operating expenses, and have a material adverse effect on its financial results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab cannot presently predict the scope and severity of any potential business shutdowns
or disruptions. If Chemomab or any of the third parties with whom it engages, however, were to experience shutdowns or other business
disruptions, Chemomab&#8217;s ability to conduct its business in the manner and on the timelines presently planned could be materially
and negatively affected, which could have a material adverse impact on its business and its results of operation and financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Chemomab&#8217;s Intellectual Property Rights</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If Chemomab is unable to protect its patents or other proprietary
rights, or if Chemomab infringes the patents or other proprietary rights of others, its competitiveness and business prospects may be
materially damaged.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Patent and other proprietary rights are essential to Chemomab&#8217;s business. Chemomab&#8217;s
success depends to a significant degree on its ability to obtain and enforce patents and licenses to patent rights, both in the United
States and in other countries. Chemomab cannot guarantee that pending patent applications will result in issued patents, that patents
issued or licensed will not be challenged or circumvented by competitors, that the patents and other intellectual property rights of Chemomab
and its business partners will not be found to be invalid or that the intellectual property rights of others will not prevent Chemomab
from selling its products or from executing on its strategies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The patent position of a biopharmaceutical company is often uncertain and involves complex
legal and factual questions. Significant litigation concerning patents and products is pervasive in Chemomab&#8217;s industry. Patent
claims include challenges to the coverage and validity of Chemomab&#8217;s patents on products or processes as well as allegations that
its products infringe patents held by competitors or other third parties. A loss in any of these types of cases could result in a loss
of patent protection or the ability to market products, which could lead to a significant loss of sales, or otherwise materially affect
future results of operations. Chemomab also relies on trademarks, copyrights, trade secrets and know-how to develop, maintain and strengthen
its competitive positions. Third parties may know, discover or independently develop equivalent proprietary information or techniques,
or they may gain access to Chemomab&#8217;s trade secrets or disclose such trade secrets to the public.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">46</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Although Chemomab&#8217;s employees, consultants, parties to collaboration agreements
and other business partners are generally subject to confidentiality or similar agreements to protect its confidential and proprietary
information, these agreements may be breached, and Chemomab may not have adequate remedies for any breach. In addition, Chemomab&#8217;s
trade secrets may otherwise become known or be independently discovered by competitors. To the extent that Chemomab&#8217;s employees,
consultants, parties to collaboration agreements and other business partners use intellectual property owned by others in their work for
the company, disputes may arise as to the rights in related or resulting know-how and inventions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Furthermore, Chemomab&#8217;s intellectual property, other proprietary technology and
other sensitive company data is potentially vulnerable to loss, damage or misappropriation from system malfunction, computer viruses,
unauthorized access to data or misappropriation or misuse thereof by those with permitted access and other events. While Chemomab has
invested to protect its intellectual property and other data, and continue to work diligently in this area, there can be no assurance
that its precautionary measures will prevent breakdowns, breaches, cyber incidents or other events. Such events could have a material
adverse effect on Chemomab&#8217;s reputation, business, financial condition or results of operations. Misappropriation or other loss
of Chemomab&#8217;s intellectual property from any of the foregoing could have a material adverse effect on its competitive position and
may cause it to incur substantial litigation costs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab may not identify relevant third-party patents or may incorrectly
interpret the relevance, scope or expiration of a third-party patent, which might adversely affect its ability to develop, manufacture
and market its product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">From time to time Chemomab may identify patents or applications in the same general
area as its products and product candidates. Chemomab may determine these third-party patents are irrelevant to its business based on
various factors, including its interpretation of the scope of the patent claims and its interpretation of when the patent expires. If
the patents are asserted against Chemomab, however, a court may disagree with its determinations. Further, while Chemomab may determine
that the scope of claims that will issue from a patent application does not present a risk, it is difficult to accurately predict the
scope of claims that will issue from a patent application, its determination may be incorrect, and the issuing patent may be asserted
against Chemomab. Chemomab cannot guarantee that it will be able to successfully settle or otherwise resolve such infringement claims.
If Chemomab fails in any such dispute, in addition to being forced to pay monetary damages, it may be temporarily or permanently prohibited
from commercializing its product candidates or be required to obtain a license under such patent, which may not be available on reasonable
terms or at all. Chemomab might, if possible, also be forced to redesign its product candidates so that it no longer infringes, misappropriates
or otherwise violates the third-party intellectual property rights. Any of these events, even if Chemomab were ultimately to prevail,
could require it to divert substantial financial and management resources that it would otherwise be able to devote to its business. Any
of the foregoing could have a material adverse effect on Chemomab&#8217;s business, financial condition, results of operations, and prospects.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Changes in patent laws or patent jurisprudence could diminish the
value of patents in general, thereby impairing Chemomab&#8217;s ability to protect its product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As is the case with other biopharmaceutical and pharmaceutical companies, Chemomab&#8217;s
success is heavily dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biopharmaceutical
and pharmaceutical industries involve both technological and legal complexity. Therefore, obtaining and enforcing biopharmaceutical and
pharmaceutical patents is costly, time-consuming and inherently uncertain. In addition, the Leahy-Smith America Invents Act, or the AIA,
which was passed in September&#160;2011, resulted in significant changes to the United States patent system.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">An important change introduced by the AIA is that, as of March&#160;16, 2013, the United
States transitioned from a &#8220;first-to-invent&#8221; to a &#8220;first-to-file&#8221; system for deciding which party should be granted
a patent when two or more patent applications are filed by different parties claiming the same invention. Under a &#8220;first-to-file&#8221;
system, assuming the other requirements for patentability are met, the first inventor to file a patent application generally will be entitled
to a patent on the invention regardless of whether another inventor had made the invention earlier. A third party that files a patent
application in the USPTO after that date but before Chemomab could therefore be awarded a patent covering an invention of ours even if
it made the invention before it was made by the third party. This will require Chemomab to be cognizant of the time from invention to
filing of a patent application and be diligent in filing patent applications, but circumstances could prevent it from promptly filing
patent applications on its inventions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Among some of the other changes introduced by the AIA are changes that limit where a
patentee may file a patent infringement suit and providing opportunities for third parties to challenge any issued patent with the USPTO.
This applies to all of Chemomab&#8217;s United States patents, even those issued before March&#160;16, 2013. Because of a lower evidentiary
standard in USPTO proceedings compared to the evidentiary standard in United States federal courts necessary to invalidate a patent claim,
a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the
same evidence would be insufficient to invalidate the claim if first presented in a district court action.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">47</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Accordingly, a third party may attempt to use the USPTO procedures to invalidate Chemomab&#8217;s
patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. It
is not clear what, if any, impact the AIA will have on the operation of its business. However, the AIA and its implementation could increase
the uncertainties and costs surrounding the prosecution of Chemomab or its licensors&#8217; patent applications and the enforcement or
defense of Chemomab or its licensors&#8217; issued patents.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab may become involved in opposition, interference, derivation,&#160;<span style="font-style: italic">inter
partes</span>&#160;review, post-grant review, reexamination or other proceedings challenging Chemomab or its licensors&#8217; patent rights,
and the outcome of any proceedings are highly uncertain. An adverse determination in any such proceeding could reduce the scope of, or
invalidate, Chemomab&#8217;s owned or in-licensed patent rights, in whole or in part, allow third parties to commercialize its technology
or products and compete directly with Chemomab, without payment to it, or result in Chemomab&#8217;s inability to manufacture or commercialize
products without infringing third-party patent rights.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Additionally, the United States Supreme Court has ruled on several patent cases in recent&#160;years
either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain
situations. In addition to increasing uncertainty with regard to Chemomab&#8217;s ability to obtain patents in the future, this combination
of events has created uncertainty with respect to the validity, enforceability and value of patents, once obtained. Depending on decisions
by Congress, the federal courts and the USPTO, as well as similar bodies in other jurisdictions, the laws and regulations governing patents
could change in unpredictable ways that could weaken Chemomab&#8217;s ability to obtain new patents or to enforce its existing patents
and patents that it might obtain in the future. Similarly, the complexity and uncertainty of European patent laws have also increased
in recent&#160;years. In addition, the European patent system is relatively stringent in the type of amendments that are allowed during
prosecution. Complying with these laws and regulations could limit Chemomab&#8217;s ability to obtain new patents in the future that may
be important for its business, and these laws and regulations patents could continue to change in unpredictable ways that could have a
material adverse effect on Chemomab&#8217;s existing patent rights and its ability to protect and enforce its intellectual property in
the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Obtaining and maintaining Chemomab&#8217;s patent protection depends
on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies,
and Chemomab&#8217;s patent protection could be reduced or eliminated for non-compliance with these requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The USPTO and European and other patent agencies require compliance with a number of
procedural, documentary, fee payment and other similar provisions during the patent application process. In addition, periodic maintenance,
renewal and annuity fees on any issued patent are due to be paid to the USPTO and European and other patent agencies over the lifetime
of a patent. While an inadvertent failure to make payment of such fees or to comply with such provisions can in many cases be cured by
additional payment of a late fee or by other means in accordance with the applicable rules, there are situations in which such noncompliance
will result in the abandonment or lapse of the patent or patent application, and the partial or complete loss of patent rights in the
relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include failure
to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents
within prescribed time limits. If Chemomab or its licensors fails to maintain the patents and patent applications covering its product
candidates or if Chemomab or its licensors otherwise allow its patents or patent applications to be abandoned or lapse, its competitors
might be able to enter the market, which would hurt Chemomab&#8217;s competitive position and could impair its ability to successfully
commercialize its product candidates in any indication for which they are approved, which could have a material adverse effect on Chemomab&#8217;s
business, financial condition, results of operations, and prospects.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Chemomab&#8217;s Regulatory Approvals</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The regulatory approval processes of the FDA and comparable foreign
authorities are lengthy, time consuming and inherently unpredictable, and if Chemomab is ultimately unable to obtain regulatory approval
for CM-101 or any other product candidates, its business will be substantially harmed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The time required to obtain approval by the FDA and comparable foreign authorities is
unpredictable but typically takes many&#160;years following the commencement of clinical studies and depends upon numerous factors, including
the substantial discretion of the regulatory authorities. In addition, approval policies, regulations or the type and amount of clinical
data necessary to gain approval may change during the course of a product candidate&#8217;s clinical development and may vary among jurisdictions,
which may cause delays in the approval or the decision not to approve an application. Regulatory authorities have substantial discretion
in the approval process and may refuse to accept any application or may decide that Chemomab&#8217;s data is insufficient for approval
and require additional preclinical, clinical or other data. Even if Chemomab eventually completes clinical testing and receives approval
of any regulatory filing for its product candidates, the FDA and other comparable foreign regulatory authorities may approve Chemomab&#8217;s
product candidates for a more limited indication or a narrower patient population than it originally requested. Chemomab has not obtained
regulatory approval for any product candidate and it is possible that it will never obtain regulatory approval for CM-101 or any other
product candidate. Chemomab is not permitted to market any of its product candidates in the United States until it receives regulatory
approval of an NDA from the FDA.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">48</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Prior to obtaining approval to commercialize a product candidate in the United States
or abroad, Chemomab must demonstrate with substantial evidence from well-controlled clinical studies, and to the satisfaction of the FDA
or foreign regulatory agencies, that such product candidate is safe and effective for its intended use. Results from preclinical studies
and clinical trials can be interpreted in different ways. Even if Chemomab believes the preclinical or clinical data for its product candidates
are promising, such data may not be sufficient to support approval by the FDA and other regulatory authorities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The FDA or any foreign regulatory bodies can delay, limit or deny approval of Chemomab&#8217;s
product candidates or require it to conduct additional preclinical or clinical testing or abandon a program for many reasons, including:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf56d739d9a4346f6a4140804911d4c54" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the FDA or comparable foreign regulatory authorities may disagree with the design or
        implementation of Chemomab&#8217;s clinical studies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6da54169d3d2483184de214bac87f672" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab may be unable to demonstrate to the satisfaction of the FDA or comparable foreign
        regulatory authorities that a product candidate is safe and effective for its proposed indication;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z200732e32374441aa94e17ddabdd6faf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">serious and unexpected drug-related side effects experienced by participants in Chemomab&#8217;s
        clinical studies or by individuals using drugs similar to its product candidates, or other products containing the active ingredient in
        Chemomab&#8217;s product candidates;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z57dc6f8a449c4d938c3d35c7b36f128e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">negative or ambiguous results from Chemomab&#8217;s clinical studies or results that
        may not meet the level of statistical significance required by the FDA or comparable foreign regulatory authorities for approval;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6588dbcd522d40bd979d2aa879395e5c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the population studied in the clinical study may not be sufficiently broad or representative
        to assure efficacy and safety in the full population for which Chemomab seeks approval;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z4e090e249ef64c0a8e602aa6e2e2694f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab may be unable to demonstrate that a product candidate&#8217;s clinical and other
        benefits outweigh its safety risks;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z07c77fd4df954d2490ee50d445bcdf6b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the FDA or comparable foreign regulatory authorities may disagree with Chemomab&#8217;s
        interpretation of data from preclinical studies or clinical trials;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z1aa153ca92c443e0a103909c279339fc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the data collected from clinical studies of Chemomab&#8217;s product candidates may not
        be acceptable or sufficient to support the submission of an NDA or other submission or to obtain regulatory approval in the United States
        or elsewhere, and Chemomab may be required to conduct additional clinical studies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd7fc906d0fa548dcb6f3ad2eab25912f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the FDA&#8217;s or the applicable foreign regulatory agency&#8217;s disagreement regarding
        the formulation, labeling and/or the specifications of Chemomab&#8217;s product candidates;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z25e05da143fc42c6ab576efd5f8e0edf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the FDA or comparable foreign regulatory authorities may fail to approve or find deficiencies
        with the manufacturing processes or facilities of third-party manufacturers with which Chemomab contracts for clinical and commercial
        supplies; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="za33cdd1d54b1463da25d968e2e78d926" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the approval policies or regulations of the FDA or comparable foreign regulatory authorities
        may significantly change in a manner rendering Chemomab&#8217;s clinical data insufficient for approval.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Moreover, preclinical and clinical data are often susceptible to varying interpretations
and analyses and many companies that believed their product candidates performed satisfactorily in preclinical studies and clinical trials
nonetheless failed to obtain FDA or comparable foreign regulatory authority approval. Chemomab cannot guarantee that the FDA or foreign
regulatory authorities will interpret trial results as it does, and more trials could be required before Chemomab is able to submit applications
seeking approval of its product candidates. To the extent that the results of the trials are not satisfactory to the FDA or foreign regulatory
authorities for support of a marketing application, Chemomab may be required to expend significant resources, which may not be available
to it, to conduct additional trials in support of potential approval of Chemomab&#8217;s product candidates. Furthermore, the approval
policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering Chemomab&#8217;s
clinical data insufficient for approval, which may lead to the FDA or comparable foreign regulatory authorities delaying, limiting or
denying approval of its product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">49</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Of the large number of drugs in development, only a small&#160;percentage successfully
complete the regulatory approval processes and are commercialized. This lengthy approval process, as well as the unpredictability of future
clinical trial results, may result in Chemomab failing to obtain regulatory approval to market CM-101 or any other product candidate,
which would significantly harm Chemomab&#8217;s business, results of operations and prospects.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, the FDA or the applicable foreign regulatory agency also may approve a
product candidate for a more limited indication or patient population than Chemomab originally requested, and the FDA or applicable foreign
regulatory agency may approve a product candidate with a REMS or a label that does not include the labeling claims necessary or desirable
for the successful commercialization of that product candidate. Regulatory authorities may also grant approval contingent on the performance
of costly post-marketing clinical trials. Any of the foregoing scenarios could materially harm the commercial prospects for Chemomab&#8217;s
product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Obtaining and maintaining regulatory approval of Chemomab&#8217;s
product candidates in one jurisdiction does not mean that it will be successful in obtaining regulatory approval of its product candidates
in other jurisdictions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In order to market any product outside of the United States, Chemomab must establish
and comply with the numerous and varying safety, efficacy, and other regulatory requirements of other countries. Obtaining and maintaining
regulatory approval of its product candidates in one jurisdiction does not guarantee that Chemomab will be able to obtain or maintain
regulatory approval in any other jurisdiction, but a failure or delay in obtaining regulatory approval in one jurisdiction may have a
negative effect on the regulatory approval process in others. Chemomab&#8217;s product candidates may not receive marketing approval even
if they achieve their primary endpoints in future Phase&#160;3 clinical studies or registrational trials. The FDA or comparable foreign
regulatory authorities may disagree with Chemomab&#8217;s trial designs and its interpretation of data from preclinical studies or clinical
trials. In addition, any of these regulatory authorities may change requirements for the approval of a product candidate even after reviewing
and providing comments or advice on a protocol for a pivotal Phase&#160;3 or registrational clinical study. In addition, any of these
regulatory authorities may also approve a product candidate for fewer or more limited indications than Chemomab&#8217;s request or may
grant approval contingent on the performance of costly post-marketing clinical trials. The FDA or comparable foreign regulatory authorities
may not approve the labeling claims that Chemomab believes would be necessary or desirable for the successful commercialization of its
product candidates, if approved.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Furthermore, even if the FDA or other comparable foreign regulatory authority grants
marketing approval of a product candidate, comparable regulatory authorities in foreign jurisdictions must also approve the manufacturing,
marketing, and promotion of the product candidate in those countries. Approval procedures vary among jurisdictions and can involve requirements
and administrative review periods different from those in the United States, including additional preclinical studies or clinical trials
as clinical studies conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. The marketing
approval processes in other countries may implicate all of the risks detailed above regarding FDA approval in the United States, as well
as other risks. In many jurisdictions outside the United States, a product candidate must be approved for reimbursement before it can
be approved for sale in that jurisdiction. In some cases, the price that Chemomab intends to charge for its products is also subject to
approval.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements
could result in significant delays, difficulties, and costs for Chemomab and could delay or prevent the introduction of its products in
certain countries. Failure to obtain marketing approval in other countries or any delay or other setback in obtaining such approval would
impair its ability to market its product candidates in such foreign markets. Any such impairment would reduce the size of its potential
market, which could have a material adverse impact on its business, results of operations, and prospects.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Even if Chemomab obtains regulatory approval for CM-101 or any product
candidate, it will still face extensive and ongoing regulatory requirements and obligations and any product candidates, if approved, may
face future development and regulatory difficulties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Any product candidate for which Chemomab obtains marketing approval, along with the
manufacturing processes, post-approval clinical data, labeling, packaging, distribution, adverse event reporting, storage, recordkeeping,
export, import, advertising and promotional activities for such product, among other things, will be subject to extensive and ongoing
requirements of and review by the FDA and other regulatory authorities. These requirements include submissions of safety and other post-marketing
information and reports, establishment registration and drug listing requirements, continued compliance with cGMP requirements relating
to manufacturing, quality control, quality assurance and corresponding maintenance of records and documents, requirements regarding the
distribution of samples to physicians and recordkeeping and GCP requirements for any clinical studies that Chemomab conducts post-approval.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">50</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Even if marketing approval of a product candidate is granted, the approval may be subject
to limitations on the indicated uses for which the product candidate may be marketed or to the conditions of approval, including a requirement
to implement a REMS. If any of Chemomab&#8217;s product candidates receives marketing approval, the accompanying label may limit the approved
indicated use of the product candidate, which could limit sales of the product candidate. The FDA may also impose requirements for costly
post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of a product. Violations of the Federal Food,
Drug, and Cosmetic Act, or FDCA, relating to the promotion of prescription drugs may lead to FDA enforcement actions and investigations
alleging violations of federal and state healthcare fraud and abuse laws, as well as state consumer protection laws.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, later discovery of previously unknown adverse events or other problems
with Chemomab&#8217;s products, manufacturers or manufacturing processes or failure to comply with regulatory requirements, may yield
various results, including:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc7c33917e0dc427787f02602ea19118f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">restrictions on manufacturing such products;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zbe2da260ead84c86ac80f6f09b8032ca" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">restrictions on the labeling or marketing of products;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z96462ce3a09843109259fa5f0cf640da" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">restrictions on product manufacturing, distribution or use;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z38e8428d6f6046079d05fc03cebae3c8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">requirements to conduct post-marketing studies or clinical trials;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z4f5b0ab89c1f4f6fbce9abc5f032fdbf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">warning letters or untitled letters;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zea383b16acd34f5f8b9f36c2c6abd43d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">withdrawal of the products from the market;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z86f9899be74d41ac81fe02317155fff0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">refusal to approve pending applications or supplements to approved applications that
        Chemomab submits;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc661537dd1364935b209462e6da0d083" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">recall of products;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z302f8f3d8dce4786b24ab66bb1e2a47b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">fines, restitution or disgorgement of profits or revenues;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z08aceb51c91845fab645deca99940b32" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">suspension or withdrawal of marketing approvals;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zbe7672cf96f54075ad7f616264e94716" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">refusal to permit the import or export of Chemomab&#8217;s products;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zeb1ecc8b06be44b5a9ca65c936500455" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">product seizure; or</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf8e0ef2815f2457d93bc3b05becb2479" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">injunctions or the imposition of civil or criminal penalties.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Further, the FDA&#8217;s policies may change, and additional government regulations
may be enacted that could impose extensive and ongoing regulatory requirements and obligations on any product candidate for which Chemomab
obtains marketing approval. If Chemomab is slow or unable to adapt to changes in existing requirements or the adoption of new requirements
or policies, or if Chemomab is not able to maintain regulatory compliance, it may lose any marketing approval that it may have obtained,
which would adversely affect its business, prospects and ability to achieve or sustain profitability.&#160;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Disruptions at the FDA and other government agencies caused by funding
shortages or global health concerns could hinder Chemomab&#8217;s ability to hire, retain or deploy key leadership and other personnel,
or otherwise prevent new or modified products from being developed, approved or commercialized in a timely manner or at all, which could
negatively impact its business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The ability of the FDA to review and approve new products can be affected by a variety
of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees,
and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent&#160;years as a result. In
addition, government funding of other government agencies that fund research and development activities is subject to the political process,
which is inherently fluid and unpredictable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs
to be reviewed and/or approved by necessary government agencies, which would harm Chemomab&#8217;s business. For example, over the last
several&#160;years, including for 35&#160;days beginning on December&#160;22, 2018, the United States government has shut down several
times and certain regulatory agencies, such as the FDA, have had to furlough critical FDA employees and stop critical activities. If a
prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process Chemomab&#8217;s
regulatory submissions, which could harm its business.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">51</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">The COVID-19 pandemic has also resulted in the FDA imposing preventive measures, including
postponements of non-United States manufacturing and product inspections. If global health concerns continue to prevent the FDA or other
regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact
the ability of the FDA or other regulatory authorities to timely review and process Chemomab&#8217;s regulatory submissions, which could
have a material adverse effect on its business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Commercialization of Chemomab&#8217;s Product Candidates</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If Chemomab does not achieve its projected development and commercialization
goals in the timeframes it announces and expects, the commercialization of its product candidates may be delayed and Chemomab&#8217;s
business will be harmed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For planning purposes, Chemomab sometimes estimates the timing of the accomplishment
of various scientific, clinical, regulatory and other product development objectives. These milestones may include Chemomab&#8217;s expectations
regarding the commencement or completion of scientific studies and clinical trials, the regulatory submissions or commercialization objectives.
From time to time, Chemomab may publicly announce the expected timing of some of these milestones, such as the completion of an ongoing
clinical study, the initiation of other clinical studies, receipt of regulatory approval or the commercial launch of a product. The achievement
of many of these milestones may be outside of Chemomab&#8217;s control. All of these milestones are based on a variety of assumptions
which may cause the timing of achievement of the milestones to vary considerably from Chemomab&#8217;s estimates, including:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z99a82962432b4980ade55c1ff97254c1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab&#8217;s available capital resources or capital constraints it experiences;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z15772a19083d43a99d1dee44f639411c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the rate of progress, costs and results of Chemomab&#8217;s clinical studies and research
        and development activities, including the extent of scheduling conflicts with participating clinicians and collaborators;</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd7b568d35f654f8ca3bd3ad41c8695c2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab&#8217;s ability to identify and enroll patients who meet clinical study eligibility
        criteria;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z937ba2944355427989a27771a383cd99" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab&#8217;s receipt of authorizations by the FDA and comparable foreign regulatory
        authorities, and the timing thereof;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zffcbec52cc1c4106913f88fce90efb7e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">other actions, decisions or rules&#160;issued by regulators;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z12d4139de7d4426ebd9d93b9fff140cc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab&#8217;s ability to access sufficient, reliable and affordable supplies of materials
        used in the manufacture of its product candidates;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z659cf67840264c7eb716f348b498a0a2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab&#8217;s ability to manufacture and supply clinical study materials to its clinical
        sites on a timely basis;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze34914e73d6448508ef321bf4ef05ea0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the severity, duration and impact of the COVID-19 pandemic;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zb9eed34dd9904f5e9caeeb6841c447de" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the efforts of Chemomab&#8217;s collaborators with respect to the commercialization of
        its products, if any; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z3a6e22c623214c559adab964fffaf515" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the securing of, costs related to, and timing issues associated with, commercial product
        manufacturing as well as sales and marketing activities.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If Chemomab fails to achieve announced milestones in the timeframes it expects, the
commercialization of any of its product candidates may be delayed, and its business, results of operations, financial condition and prospects
may be adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab faces substantial competition, which may result in others
discovering, developing or commercializing products before or more successfully than it.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The development and commercialization of new drug products is highly competitive. Chemomab
may face competition with respect to any product candidates that it seeks to develop or commercialize in the future from major biopharmaceutical
companies, specialty biopharmaceutical companies, and biotechnology companies worldwide. Potential competitors also include academic institutions,
government agencies, and other public and private research organizations that conduct research, seek patent protection, and establish
collaborative arrangements for research, development, manufacturing, and commercialization.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">52</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">There are a number of large biopharmaceutical and biotechnology companies that are currently
pursuing the development of products for the treatment of inflammation and fibrosis. Companies that Chemomab is aware of that are targeting
the treatment of inflammation and fibrosis include large companies with significant financial resources such as Biogen,&#160;Inc., AbbVie
Inc., Gilead Sciences,&#160;Inc., FibroGen,&#160;Inc., Galapagos NV, Bristol Myers Squibb Co., and Novartis AG. However, Chemomab does
not know of any other companies currently in clinical development with an anti CCL24 mAb. For additional information regarding Chemomab&#8217;s
competition, see &#8220;<span style="font-style: italic">Chemomab Business &#8212; Competition.</span>&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Many of Chemomab&#8217;s current or potential competitors, either alone or with their
strategic partners, have significantly greater financial resources and expertise in research and development, manufacturing, preclinical
testing, conducting clinical studies, obtaining regulatory approvals, and marketing approved products than Chemomab does.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Even if CM-101 or any other product candidate Chemomab develops
receives marketing approval, it may fail to achieve market acceptance by physicians, patients, third-party payors or others in the medical
community necessary for commercial success.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If CM-101 or any other product candidate Chemomab develops receives marketing approval,
it may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors and others in the medical community.
If it does not achieve an adequate level of acceptance, Chemomab may not generate significant product revenues or become profitable. The
degree of market acceptance of Chemomab&#8217;s product candidates, if approved, will depend on a number of factors, including but not
limited to:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z40cda9d075064355b322560001573618" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the efficacy and potential advantages compared to alternative treatments;</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6065818f6e2042e3adaa9bb727cc640a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">effectiveness of sales and marketing efforts;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9f3eeb79f4284e22a9b885b92be0d6a0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the cost of treatment with respect to alternative treatments, including any similar generic
        treatments;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z65ab82caf7a943f69e80461c6310efb0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab&#8217;s ability to offer its products for sale at competitive prices;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z172542162a94463c8d0baa683d9bfcdd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the convenience and ease of administration compared to alternative treatments;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zba0200c70e5b4e3c9072f05b96c14d24" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the willingness of the target patient population to try new therapies and of physicians
        to prescribe these therapies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf41235cb428645f1823aca2cb3def781" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the strength of marketing and distribution support;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd5133fa041da48b39cb2731ef3bbfb16" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the timing of market introduction of competitive products;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z73b57815675a4029ab17f4eba97ab7f1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the availability of third-party coverage and adequate reimbursement;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5b91f886275a448dbab11e1f52312b9b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">product labeling or product insert requirements of the FDA, EMA or other regulatory authorities,
        including any limitations on warnings contained in a product&#8217;s approved labeling;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="za140a0e962ac4a26aa8f6b83c7c6e4e6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the prevalence and severity of any side effects; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6880dc42e8d0447e8e3a33e42647adea" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">any restrictions on the use of Chemomab&#8217; product together with other medications.</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Because Chemomab expects sales of its product candidates, if approved, to generate substantially
all of its revenues for the foreseeable future, the failure of its product candidates to find market acceptance would harm its business
and could require it to seek additional financing.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab relies completely on third-party suppliers to manufacture
its clinical drug supplies for its product candidates, and Chemomab intends to rely on third parties to produce preclinical, clinical,
and commercial supplies of any future product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab does not currently have, nor does Chemomab plan to acquire, the infrastructure
or capability to internally manufacture its clinical drug supply of its product candidates, or any future product candidates, for use
in the conduct of its preclinical studies and clinical trials.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab lacks the internal resources and the capabilities to manufacture any product
candidates on a clinical or commercial scale. The facilities used by its contract manufacturers to manufacture the active pharmaceutical
ingredient and final drug product must complete a pre-approval inspection by the FDA and other comparable foreign regulatory agencies
to assess compliance with applicable requirements, including cGMPs, after Chemomab submits its NDA or relevant foreign regulatory market
application to the applicable regulatory agency.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">53</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab is responsible for setting the product specifications and approving master
batch records, but does not oversee the manufacturing process itself, and is completely dependent on its contract manufacturers to comply
with cGMPs for manufacture of both active drug substances and finished drug products. If its contract manufacturers cannot successfully
manufacture material that conforms to its specifications and the strict regulatory requirements of the FDA or applicable foreign regulatory
agencies, they will not be able to pass a pre-approval inspection or secure and/or maintain regulatory approval for their manufacturing
facilities. In addition, Chemomab has no direct control over its contract manufacturers&#8217; ability to maintain adequate quality control,
quality assurance, and qualified personnel. Furthermore, all of its contract manufacturers are engaged with other companies to supply
and/or manufacture materials or products for such companies, which exposes its manufacturers to regulatory risks for the production of
such materials and products. As a result, failure to satisfy the regulatory requirements for the production of those materials and products
may affect the regulatory clearance of its contract manufacturers&#8217; facilities generally. If the FDA or an applicable foreign regulatory
agency determines now or in the future that these facilities for the manufacture of its product candidates are noncompliant, Chemomab
may need to find alternative manufacturing facilities, which would adversely impact its ability to develop, obtain regulatory approval
for or market its product candidates. Its reliance on contract manufacturers also exposes Chemomab to the possibility that they, or third
parties with access to their facilities, will have access to and may compromise its trade secrets or other proprietary information.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If Chemomab is unable to establish sales, marketing and distribution
capabilities either on its own or in collaboration with third parties, it may not be successful in commercializing CM-101, if approved.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab does not have any infrastructure for the sales, marketing or distribution of
CM-101, and the cost of establishing and maintaining such an organization may exceed the cost-effectiveness of doing so. In order to market
and successfully commercialize CM-101 or any other product candidate Chemomab develops, if approved, it must build its sales, distribution,
marketing, managerial and other non-technical capabilities or make arrangements with third parties to perform these services. Chemomab
expects to build a focused sales, distribution and marketing infrastructure to market CM-101, if approved. There are significant expenses
and risks involved with establishing Chemomab&#8217;s own sales, marketing and distribution capabilities, including its ability to hire,
retain and appropriately incentivize qualified individuals, generate sufficient sales leads, provide adequate training to sales and marketing
personnel and effectively manage a geographically dispersed sales and marketing team. Any failure or delay in the development of Chemomab&#8217;s
internal sales, marketing and distribution capabilities could delay any product launch, which would adversely impact the commercialization
of that product. Additionally, if the commercial launch of CM-101 for which Chemomab recruits a sales force and establishes marketing
capabilities is delayed or does not occur for any reason, it would have prematurely or unnecessarily incurred these commercialization
expenses. This may be costly, and Chemomab&#8217;s investment would be lost if it cannot retain or reposition its sales and marketing
personnel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Factors that may inhibit Chemomab&#8217;s efforts to commercialize its product candidates
on its own include:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z10dc0f074e1a4994822e72e24e531f67" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">Chemomab&#8217;s inability to recruit, train and retain adequate numbers of effective
        sales and marketing personnel;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z3aa43aee410d4960a18737c22f38f567" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">the inability of sales personnel to obtain access to physicians or attain adequate numbers
        of physicians to prescribe Chemomab&#8217;s products; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z45601756ddc84955a73ff8439afc33a5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">unforeseen costs and expenses associated with creating an independent sales and marketing
        organization.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab does not anticipate having the resources in the foreseeable future to allocate
to the sales and marketing of its product candidates, if approved, in certain markets overseas. Therefore, Chemomab&#8217;s future success
will depend, in part, on its ability to enter into and maintain collaborative relationships for such capabilities, the collaborator&#8217;s
strategic interest in a product and such collaborator&#8217;s ability to successfully market and sell the product. Chemomab intends to
pursue collaborative arrangements regarding the sale and marketing of CM-101, if approved, for certain markets overseas; however, Chemomab
cannot guarantee that it will be able to establish or maintain such collaborative arrangements, or if able to do so, that it will have
effective sales forces. To the extent that Chemomab depends on third parties for marketing and distribution, any revenues it receives
will depend upon the efforts of such third parties, and there can be no assurance that such efforts will be successful.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If Chemomab is unable to build its own sales force or negotiate a collaborative relationship
for the commercialization of CM-101, Chemomab may be forced to delay the potential commercialization of CM-101 or reduce the scope of
its sales or marketing activities for CM-101. If Chemomab needs to increase its expenditures to fund commercialization activities for
CM-101, it will need to obtain additional capital, which may not be available to it on acceptable terms, or at all. Chemomab may also
have to enter into collaborative arrangements for CM-101 at an earlier stage than otherwise would be ideal and it may be required to relinquish
rights to CM-101 or otherwise agree to terms unfavorable to it. Any of these occurrences may have an adverse effect on Chemomab&#8217;s
business, operating results and prospects.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">54</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">If Chemomab is unable to establish adequate sales, marketing and distribution capabilities,
either on its own or in collaboration with third parties, it will not be successful in commercializing its product candidates and may
never become profitable. Chemomab will be competing with many companies that currently have extensive and well-funded marketing and sales
operations. Without an internal team or the support of a third party to perform marketing and sales functions, it may be unable to compete
successfully against these more established companies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">A variety of risks associated with operating internationally could
materially adversely affect Chemomab&#8217;s business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab&#8217;s principal executive offices are located in Israel and certain of its
product candidates may be manufactured at third-party facilities located in Europe. In addition, Chemomab&#8217;s business strategy includes
potentially expanding internationally if any of its product candidates receives regulatory approval. Doing business internationally involves
a number of risks, including but not limited to:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze9f8164f33b34d68b860a8abe6f673c4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">multiple, conflicting and changing laws and regulations, such as privacy regulations,
        tax laws, export and import restrictions, employment laws, regulatory requirements and other governmental approvals, permits and licenses;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze188bbf562d34beea98096a3c6f7a4c0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">failure by Chemomab to obtain and maintain regulatory approvals for the use of its products
        in various countries;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd020ecf24d46425c90c2cdd8c368e970" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">additional potentially relevant third-party patent rights;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zfbaf22ab01a24613a680b48b90f30087" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">complexities and difficulties in obtaining protection and enforcing Chemomab&#8217;s
        intellectual property;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z201bd2f5012f443099b5c71e07faede9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">difficulties in staffing and managing foreign operations;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf856ab3ea031426ba77608791a6a2509" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">complexities associated with managing multiple payor reimbursement regimes, government
        payors or patient self-pay systems;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z7c1babeae3ff412983549cb54d392c90" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">limits in Chemomab&#8217;s ability to penetrate international markets;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z581c8a5df7f14752aea0be7752f1f928" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">financial risks, such as longer payment cycles, difficulty collecting accounts receivable,
        the impact of local and regional financial crises on demand and payment for Chemomab&#8217;s products and exposure to foreign currency
        exchange rate fluctuations;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zae795c73016b463a9fc9cce93c801adc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">natural disasters, political and economic instability, including wars, terrorism and
        political unrest, outbreak of disease, boycotts, curtailment of trade and other business restrictions;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z1caa82593c6643ad84a3defb625a2abe" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">certain expenses including, among others, expenses for travel, translation and insurance;
        and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z20b3da72dba84b92ba70edfb8afbdeda" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25">&#8226;</div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="text-align: left; line-height: 1.25">regulatory and compliance risks that relate to maintaining accurate information and control
        over sales and activities that may fall within the purview of the United States Foreign Corrupt Practices Act, its books and records provisions,
        or its anti-bribery provisions.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Any of these factors could significantly harm Chemomab&#8217;s international expansion
and operations and, consequently, its results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Chemomab&#8217;s Incorporation and Location in Israel</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Conditions in Israel could materially and adversely affect Chemomab&#8217;s
business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Many of Chemomab&#8217;s employees, including certain management members operate from
its offices that are located in Tel Aviv,&#160;Israel. In addition, a number of Chemomab&#8217;s officers and directors are residents
of Israel. Accordingly, political, economic, and military conditions in Israel and the surrounding region may directly affect its business
and operations. In recent&#160;years,&#160;Israel has been engaged in sporadic armed conflicts with Hamas, an Islamist terrorist group
that controls the Gaza Strip, with Hezbollah, an Islamist terrorist group that controls large portions of southern Lebanon, and with Iranian-backed
military forces in Syria. In addition,&#160;Iran has threatened to attack Israel and may be developing nuclear weapons. Some of these
hostilities were accompanied by missiles being fired from the Gaza Strip against civilian targets in various parts of Israel, including
areas in which Chemomab&#8217;s employees and some of its consultants are located, and negatively affected business conditions in Israel.
Any hostilities involving Israel or the interruption or curtailment of trade between Israel and its trading partners could adversely affect
Chemomab&#8217;s operations and results of operations<span style="font-weight: bold">.</span></div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">55</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab&#8217;s commercial insurance does not cover losses that may occur as a result
of events associated with war and terrorism. Although the Israeli government currently covers the reinstatement value of direct damages
that are caused by terrorist attacks or acts of war, Chemomab cannot guarantee that this government coverage will be maintained or that
it will sufficiently cover its potential damages. Any losses or damages incurred by Chemomab could have a material adverse effect on its
business. Any armed conflicts or political instability in the region would likely negatively affect business conditions and could harm
Chemomab&#8217;s results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Further, in the past, the State of Israel and Israeli companies have been subjected
to economic boycotts. Several countries still restrict business with the State of Israel and with Israeli companies. These restrictive
laws and policies may have an adverse impact on Chemomab&#8217;s operating results, financial condition or the expansion of its business.
A campaign of boycotts, divestment and sanctions has been undertaken against Israel, which could also adversely impact Chemomab&#8217;s
business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, many Israeli citizens are obligated to perform several days, and in some
cases more, of annual military reserve duty each year until they reach the age of 40 (or older, for reservists who are military officers
or who have certain occupations) and, in the event of a military conflict, may be called to active duty. In response to increases in terrorist
activity, there have been periods of significant call-ups of military reservists. It is possible that there will be military reserve duty
call-ups in the future. Chemomab&#8217;s operations could be disrupted by such call-ups, which may include the call-up of members of Chemomab&#8217;s
management. Such disruption could materially adversely affect Chemomab&#8217;s business, prospects, financial condition and results of
operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Israel&#8217;s internal political scene has recently become unstable, with four general
elections having been held within the last two years. The one government that was formed following one of the recent elections did not
succeed to pass a budget, given strong disagreements among the politicians and political parties that were partners to the government.
The COVID-19 pandemic has led to an increase in the national budget deficit, given the economic assistance that was granted to individuals
and businesses that were most severely hurt by the pandemic. To the extent the political system does not stabilize soon, that could lead
to economic problems that could adversely impact our business operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Because a certain portion of Chemomab&#8217;s expenses are incurred
in currencies other than the U.S. Dollar, its results of operations may be harmed by currency fluctuations and inflation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab&#8217;s reporting and functional currency is the United States Dollar, but
some portion of its clinical studies and operations expenses are in NIS. As a result, Chemomab is exposed to some currency fluctuation
risks. Fluctuation in the exchange rates of foreign currency has an influence on the cost of goods sold and Chemomab&#8217;s financing
revenues and expenses. Chemomab may, in the future, decide to enter into currency hedging transactions to decrease the risk of financial
exposure from fluctuations in the exchange rate of the currencies mentioned above with respect to the U.S. Dollar. These measures, however,
may not adequately protect Chemomab from adverse effects.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Chemomab received Israeli government grants for certain of their
research and development activities as detailed below. The terms of those grants require us to satisfy specified conditions in order to
transfer outside of Israel the manufacture of products based on know-how funded by the Israel Innovation Authority or to transfer outside
of Israel the know-how itself. If we fail to comply with the requirements of Israeli law in this regard, we may be required to pay penalties,
and it may impair our ability to sell our technology outside of Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Some of Chemomab&#8217;s research and development efforts were financed through grants
that were received from the Israel Innovation Authority of the Israeli Ministry of Economy and Industry, or the IIA (formerly known as
the Office of the Chief Scientist). When know-how is developed using IIA grants, the Encouragement of Research, Development and Technological
Innovation in Industry Law 5744-1984, or the Innovation Law, and the regulations thereunder, restrict our ability to transfer outside
of Israel either the manufacture of products based on IIA-funded know-how or the know-how itself. Such restrictions continue to apply
even after financial obligations to the IIA are paid in full. The consideration available to our shareholders in a future transaction
involving the transfer outside of Israel of know-how developed with IIA funding (such as a merger or similar transaction) may be reduced
by any amounts that we are required to pay to the IIA.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z304aa46bd32143c39cb527cfc79c2c54" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; font-weight: bold"><span id="Item1B."><!--Anchor--></span>Item 1B.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Unresolved Staff Comments</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4ed3bc184ba044cc9314cf3cfc97bf83" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; font-weight: bold"><span id="Item2."><!--Anchor--></span>Item 2.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Properties</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We lease a facility containing 3,961 square feet of laboratory and office space, which
is located at Kiryat Atidim, Building 7, Tel Aviv,&#160;Israel 6158002. The lease expires in October 30,&#160;2024 with an option to extend
for an additional 36&#160;months. We believe that our current facilities are sufficient to meet our current and near-term needs and that,
should it be needed, suitable additional space will be available.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z97bee2f4f1de4b789a3b7dce431ee950" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; font-weight: bold"><span id="Item3."><!--Anchor--></span>Item 3.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Legal Proceedings</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">From time to time, we may be party to litigation or other legal proceedings that we
consider to be a part of the ordinary course of our business. We are not currently involved in any legal proceedings that could reasonably
be expected to have a material adverse effect on our business, prospects, financial condition or results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z488274aebc0f415f81935f32a9258cea" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; font-weight: bold"><span id="Item4."><!--Anchor--></span>Item 4.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Mine Safety Disclosures</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25"> <br /> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">56</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-weight: bold"><span id="PARTII"><!--Anchor--></span>PART&#160;II</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze70c74f58cae4b0f9c2feec7d422824a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; font-weight: bold"><span id="Item5."><!--Anchor--></span>Item 5.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
        Securities</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Market for our ADSs</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The ADSs, representing our ordinary shares, have traded on Nasdaq under the symbol &#8220;CMMB&#8221;
since the closing of the Merger on March 16, 2021. From February 12, 2019 until the Merger, the ADSs, representing our ordinary shares,
traded on Nasdaq under the symbol &#8220;ANCN&#8221;. Prior to February 12, 2019, there was no public trading market for our ADSs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of March 30, 2022, there were seven holders of record of our ordinary shares.</div>

<div style="line-height: 1.25"> <br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold; font-style: italic"> Dividend Policy</span></div>

<div> <br /> </div>

<div style="text-indent: 18pt; line-height: 1.25"> We have never declared nor paid any cash dividends on our shares. We currently intend
to retain any future earnings and do not expect to pay any dividends in the foreseeable future. Any future determination to declare cash
dividends will be made at the discretion of our Board of Directors, subject to applicable laws, and will depend on a number of factors,
including our financial condition, results of operations, capital requirements, contractual restrictions, general business conditions,
and other factors that our Board of Directors may deem relevant.</div>

<div> <br /> </div>

<table cellspacing="0" cellpadding="0" id="zfff795e923054e38afb7149af857e7bb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; font-weight: bold"><span id="Item6."><!--Anchor--></span>Item 6.</td>
    <td style="width: auto; vertical-align: top">
        <div>[<span style="font-weight: bold">Reserved]</span></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zd6c8f687e9a449c183cdb4634d00c164" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top"><span id="Item7."><!--Anchor--></span><span style="font-weight: bold">Item 7.</span></td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">You should read the following
discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and the
related notes included elsewhere in this Annual Report on Form&#160;10-K. Some of the information contained in this discussion and analysis,
particularly with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve
risks and uncertainties. You should read &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; and Item 1A &#8220;Risk
Factors&#8221; of this Annual Report on Form&#160;10-K for a discussion of important factors that could cause actual results to differ
materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Overview</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company is a clinical-stage biotechnology company focused on the discovery and development
of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need. Based on the unique and pivotal role of the soluble
protein CCL24 in promoting fibrosis and inflammation, the Company developed CM-101, a monoclonal antibody designed to bind and block CCL24
activity. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company has pioneered the therapeutic targeting of CCL24, a chemokine that promotes
various types of cellular processes that regulate inflammatory and fibrotic activities through the CCR3 receptor. The chemokine is expressed
in various types of cells, including immune cells, endothelial cells and epithelial cells. We have developed a novel CCL24 inhibiting
product candidate with dual anti-fibrotic and anti-inflammatory activity that modulates the complex interplays of both of these inflammatory
and fibrotic mechanisms that drive abnormal states of fibrosis and clinical fibrotic diseases. This innovative approach is being developed
for difficult to treat rare diseases, also known as orphan indications or diseases, such as primary sclerosing cholangitis, or PSC and
systemic sclerosis, or SSc, for which patients have no established disease modifying standard of care treatment options.</div>

<div style="line-height: 1.25"><br />

<div style="line-height: 1.25"> <br /> </div> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">57</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">CM-101, the Company&#8217;s lead clinical product candidate, is a first-in-class humanized
monoclonal antibody that hinders the basic function of the soluble chemokine CCL24, also known as eotaxin-2, as a regulator of major inflammatory
and fibrotic pathways. We have demonstrated that CM-101 interferes with the underlying biology of inflammation and fibrosis through a
novel and differentiated mechanism of action. Based on these findings, the Company is actively developing CM-101 in Phase 2 clinical studies
directed toward two distinct clinical indications including patients with liver, skin, and/or lung fibrosis. We are currently conducting
a Phase 2 clinical study in PSC, a rare obstructive and cholestatic liver disease. In addition, we are planning a biological and clinical
proof of concept study in SSc focused on establishing biological and clinical proof of concept in this patient population. Although our
primary focus relates to these two rare indications, an additional Phase 2 clinical study is currently ongoing in non-alcoholic steatohepatitis,
or NASH. This trial will provide important safety and PK data to support the development of CM-101 subcutaneous formulation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Fibrosis is the abnormal and excessive accumulation of collagen and extracellular matrix,
the non-cellular component in all tissues and organs, that provides structural and biochemical support to surrounding cells. When present
in excessive amounts, collagen and extracellular matrix lead to scarring and thickening of connective tissues, affecting tissue properties
and potentially leading to organ failure. Fibrosis can occur in many different tissues, including lung, liver, kidney, muscle, skin, and
the gastrointestinal tract, resulting in a wide array of progressive fibrotic conditions. Fibrosis and inflammation are intrinsically
linked. While a healthy inflammatory response is necessary for efficient tissue repair; after injury, an excessive, uncontrolled inflammatory
response can lead to tissue fibrosis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Components of Operating Results</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Revenues</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">To date, the Company has not generated any revenue from product sales and does not expect
to generate any revenue from product sales in the near future. If development efforts for the Company&#8217;s product candidates are successful
and result in the Company&#8217;s receipt of necessary regulatory approvals, or if the Company&#8217;s development efforts otherwise lead
to any commercialized products or additional license agreements with third parties, then it may generate revenue in the future from product
sales.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Research and Development Expenses, net</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">Research and development expenses consist primarily of costs incurred in connection
with the development of the Company&#8217;s product candidates. These expenses include:</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z67bb1149ae084ecd983d617a4810736d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>expenses incurred under agreements with clinical research organizations (&#8220;CROs&#8221;), CMOs, as well as investigative sites
        and consultants that conduct the Company&#8217;s clinical trials, preclinical studies and other scientific development services;</div>
        </td> </tr>
  </table>

<div> <br /> </div>

<table cellspacing="0" cellpadding="0" id="z8786851cd1084ad0b44695b3733a5d85" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>manufacturing scale-up expenses and the cost of acquiring and manufacturing preclinical and clinical trial materials;</div> </td>
        </tr>
  </table>

<div> <br /> </div>

<table cellspacing="0" cellpadding="0" id="z1801b29c7a9e4ec895e2db4ab34205b7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>employee-related expenses, including salaries, related benefits, travel and share-based compensation expenses for employees engaged
        in research and development functions, as well as external costs, such as fees paid to outside consultants engaged in such activities;</div>
        </td> </tr>
  </table>

<div> <br /> </div>

<table cellspacing="0" cellpadding="0" id="z8de6bbd8906c48dfa746673ece42b95c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>license maintenance fees and milestone fees incurred in connection with various license agreements;</div> </td> </tr>
  </table>

<div> <br /> </div>

<table cellspacing="0" cellpadding="0" id="z1ff3cfa4430f443caadf37aeb1834b75" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>costs related to compliance with regulatory requirements; and</div> </td> </tr>
  </table>

<div> <br /> </div>

<table cellspacing="0" cellpadding="0" id="z091bc23fb38c4fe39564d5320d75d30e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>depreciation and other expenses.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">The Company recognizes external development costs based on an evaluation of the progress
to completion of specific tasks using information provided to it by its service providers.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">The Company does not allocate employee costs or facility expenses, including depreciation
or other indirect costs, to specific programs because these resources are deployed across multiple programs and, as such, the related
costs are not separately classified. The Company uses internal resources primarily to oversee its research, as well as for managing the
Company&#8217;s preclinical development, process development, manufacturing and clinical development activities. The Company&#8217;s employees
work across multiple programs; therefore, the Company does not track the related expenses by program.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">Research and development activities are fundamental to the Company&#8217;s business.
Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical
development, primarily due to the increased size and duration of later-stage clinical trials. As a result, the Company expects that its
research and development expenses will increase substantially over the next several years as it continues to advance the development of
its product candidates. The Company also expects to incur additional expenses related to milestone and royalty payments payable to third
parties with whom it has entered into license agreements to acquire the rights to its product candidates.</div>

<div style="line-height: 1.25"><br /> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">58</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">General and Administrative Expenses</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">General and administrative expenses consist primarily of salaries and related benefits,
share-based compensation expenses for personnel in executive and administrative functions, insurance and professional fees for legal,
consulting, accounting and audit services.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">The Company anticipates that its general and administrative expenses will increase in
the future as the Company expects to increase headcount and general activities to support its continued research activities and development
of its product candidates. It also anticipates that it will incur increased accounting, audit, legal, regulatory, compliance, director
and officer insurance costs, as well as investor and public relations expenses associated with being a public company. The Company anticipates
the additional costs for these services will substantially increase its general and administrative expenses. Additionally, if and when
the Company believes that regulatory approval of a product candidate appears likely, it will likely begin to incur a material increase
in payroll and related expenses as a result of preparation for commercial operations, particularly in respect of sales and marketing.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Financing Expenses, Net</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Financing expenses, net consist primarily of income or expenses related to revaluation
of foreign currencies and interest income on the Company's bank deposits.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Results of Operations</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">The following table summarizes the Company&#8217;s results of operations for the years
ended December 31, 2021 and 2020:</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z8b619a665ef646a6a09b5e706d20aaec" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2021</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2020</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">
        <div style="line-height: 1.25">Operating Expenses:</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">(in thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Research and development&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">6,334</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">4,684</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">General and administrative&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">6,033</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,288</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 25.9pt; line-height: 1.25">Total operating expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">12,367</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">5,972</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Financing (income) expense, net&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">111</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(21</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
        <div style="line-height: 1.25">Net loss&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">12,478</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">5,951</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our results of operations have varied in the past and can be expected to vary in the
future due to numerous factors.&#160; Please see Item 1&#8212;Business and Item 1A&#8212;Risk Factors.&#160; We believe that period-to-period
comparisons of our operating results are not necessarily meaningful and should not be relied upon as indications of future performance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Year ended December&#160;31, 2021 Compared to the Year Ended December&#160;31,
2020</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Research and development expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Research and development expenses increased by approximately $1.6 million, or 35%, to
approximately $6.3 million for the year ended December&#160;31, 2021 compared to approximately $4.7 million for the year ended December&#160;31,
2020. The increase resulted primarily from an increase in headcount and payments to consultants and subcontractors for clinical and pre-clinical
activities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">General and administrative expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">General and administrative expenses increased by approximately $4.7 million, or 368%,
to approximately $6.0 million for the year ended December&#160;31, 2021 compared to approximately $1.3 million for the year ended December&#160;31,
2020. The increase was primarily due to expenses related to becoming a public company, including increased professional fees and insurance
expense, share based compensation expenses and additional headcount.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">59</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Financing (income) expense,
net</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Financing expenses, net, increased by approximately $132 thousand, or 628%, to net expense
of $111 thousand for the year ended December&#160;31, 2021 compared to a net income of $21 thousand for the year ended December&#160;31,
2020. Financing expense, net for the year ended December&#160;31, 2021 was primarily related to foreign currency exchange rate differences,
offset by interest income on deposits. Financing income, net for 2020 was primarily related to interest income on deposits, offset by
foreign currency exchange rate differences.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Cash Flows</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The following table summarizes the Company's cash flows for the years ended December
31, 2021 and 2020:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zcde618b1c8c7476b9c235f4b39ee621f" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year ended<br /> December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Increase/(decrease)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2021</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2020</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">$</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">%</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">(in thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Net cash used in operating activities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(12,374</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(5,242</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(7,132</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">136</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%">
        <div style="line-height: 1.25">Net cash used in investing activities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(45,186</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(62</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(45,124</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">72,781</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Net cash provided by financing activities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">61,074</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">4,750</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">56,324</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,186</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px">
        <div style="margin-left: 17.3pt; line-height: 1.25; font-weight: bold">Net increase (decrease) in cash, cash equivalents and restricted
        cash</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25; font-weight: bold">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">3,514</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25; font-weight: bold">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">(554</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
        <div style="line-height: 1.25; font-weight: bold">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25; font-weight: bold">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">4,068</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold">734</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
        <div style="line-height: 1.25; font-weight: bold">%</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Operating activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Net cash used in operating activities for the year ended December 31, 2021 included
net loss of $12.5 million, net cash used by changes in operating assets and liabilities of approximately $1.9 million and non-cash charges
of $2 million, which mainly included share-based compensation expenses.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Net cash used in operating activities for the years ended December 31, 2020 included
net loss of $5.9 million, partially offset by net cash provided by changes in operating assets and liabilities of $0.6 million and non-cash
charges of $0.1 million, which mainly included share-based compensation expenses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Investing activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Net cash used in investing activities for the year ended December 31, 2021 was approximately
$45.2 million, which was primarily related to investment in short-term deposits offset by proceeds from the sale of an asset.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Net cash used in investing activities for the year ended December 31, 2020 was $62 thousands,
which was primarily related to purchase of fixed assets and investment in bank.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Financing activities</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">Net cash provided by financing activities for the year ended December 31, 2021, was
approximately $61.1 million, consisting of $58.7 million of proceeds from the sale of the Company&#8217;s ADS, primarily from the Private
Placement (as defined and described below) and issuances under the Sales Agreement with Cantor, and $2.4 million of cash acquired in the
Merger.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">Net cash provided by financing activities for the year ended December 31, 2020, was
$4.7 million, consisting of proceeds from the sale of Chemomab Ltd.&#8217;s Series C preferred shares and exercise of warrants to purchase
Chemomab Ltd.&#8217;s Series A preferred shares.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic; font-weight: bold; margin-left: 18pt">Funding
Requirements</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">The Company expects its expenses to increase substantially in connection with its ongoing
activities, particularly as it advances its clinical activities and clinical trials of its product candidates. In addition, it expects
to incur additional costs associated with operating as a public company.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">The Company believes that its existing cash and cash equivalents will enable it to fund
its operating expenses and capital expenditure requirements through the end of 2023. It has based these estimates on assumptions that
may prove to be wrong, and it could utilize the Company&#8217;s available capital resources sooner than it expects. If the Company receives
regulatory approval for any of its product candidates, then it expects to incur significant commercialization expenses related to product
manufacturing, sales, marketing and distribution.</div>

<div style="line-height: 1.25"><br /> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">60</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Until such time, if ever, that the Company generates product revenue sufficient to achieve
profitability, the Company expects to finance its cash needs through the sales of its securities and through other outside funding sources.
Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting the
Company&#8217;s ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends.
If it raises additional funds through government and other third-party funding, collaboration agreements, strategic alliances, licensing
arrangements or marketing and distribution arrangements, then the Company may have to relinquish valuable rights to its technologies,
future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to it. If it is unable
to raise additional funds through equity or debt financings when needed, then the Company may be required to delay, limit, reduce or terminate
its product development or future commercialization efforts or grant rights to develop and market products or product candidates that
it would otherwise prefer to develop and market by itself.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Liquidity and Capital Resources</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In connection with the Merger, on March 15, 2021, the Company entered into Securities
Purchase Agreements with certain investors, pursuant to which the Company agreed to sell approximately $45.5 million of its ADSs in a
private placement transaction, or the Private Placement. The Private Placement closed on March 22, 2021, at which time the Company sold
to the purchasers 2,619,270 ADSs together with warrants to purchase up to 261,929 ADSs at an exercise price of $17.35 per ADS. The warrants
expire five years from the date of issuance, and, if exercised in full, will provide proceeds of approximately $4.5 million.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On April 30, 2021, the Company entered into the Sales Agreement with Cantor. Pursuant
to the Sales Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $75 million
through Cantor. Sales of our ADSs, if any, under the Sales Agreement may be made in sales deemed to be an &#8220;at the market offering&#8221;
as defined in Rule 415(a)(4) promulgated under the Securities Act.&#160; Pursuant to the Sales Agreement, Cantor has agreed to act as
sales agent on a best efforts basis and use commercially reasonable efforts to sell on the Company&#8217;s behalf all of the ADSs requested
to be sold by the Company in accordance with the Sales Agreement, consistent with Cantor&#8217;s normal trading and sales practices, on
mutually agreed terms between Cantor and the Company.&#160; From April 30, 2021, through December 31, 2021, the Company issued and sold
699,806 ADSs at an average price of $22.75 per ADS through the ATM facility, resulting in gross proceeds of approximately $15.9 million.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In May 2020, Chemomab Ltd. issued 34,130 series preferred C shares NIS 0.01 par value
for a total consideration of USD 3,000 thousand. These shares were exchanged for ADSs upon consummation of the Merger.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As shown in the accompanying consolidated financial statements, the Company has incurred
losses and cash flow deficits from operations since inception, resulting in an accumulated deficit at December&#160;31, 2021 of approximately
$36 million. The Company has financed operations to date primarily through public and private placements of equity securities. We anticipate
that we will continue to incur net losses for the foreseeable future. We believe that our existing cash and cash equivalents will be sufficient
to fund our projected cash needs only through the end of 2023.&#160;To meet future capital needs we would need to raise additional capital
through equity or debt financing or other strategic transactions.&#160;However, any such financing may not be available to us on favorable
terms or at all.&#160;Our failure to obtain sufficient funds on commercially acceptable terms when needed would have a material adverse
effect on our business, results of operations and financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Current Outlook</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We estimate that our current cash resources will allow us to execute our business plans
through December 31, 2023.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Developing drugs, conducting preclinical and clinical trials, obtaining commercial manufacturing
capabilities and commercializing products is expensive, and we will need to raise substantial additional funds to achieve our strategic
objectives. We will require significant additional financing in the future to fund our operations, including if and when we progress into
clinical trials of our product candidates, obtain regulatory approval for one or more of our product candidates, obtain commercial manufacturing
capabilities and commercialize one or more of our product candidates. Our future capital requirements will depend on many factors, including,
but not limited to:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd9bbd0f7b97144a28e223a3097c503a8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>the progress and costs of our preclinical and clinical trials and other research and development activities;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5e1bba128be84e8db4dbdf273c26d9d1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>the scope, prioritization and number of our preclinical and clinical trials and other research and development programs;</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">61</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<table cellspacing="0" cellpadding="0" id="zb2f243c272ca4978a28fffb903149ff1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>the amount of revenues and contributions we receive under future licensing, collaboration, development and commercialization arrangements
        with respect to our product candidates;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z20861e6938fe4ba09935375ab2250c60" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>the costs of development and expansion of our operational infrastructure;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z84dd26dad37f4e689c6952e692df09f5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>the costs and timing of obtaining regulatory approval for one or more of our product candidates;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc3dd6e884e384c149f45e9426c6969c9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>our ability, or that of our collaborators, to achieve development milestones, marketing approval and other events or developments
        under potential future licensing agreements;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z12614b0b252548e9a6429a4a70321dbd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>the costs of filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd166a4a0130a48b188c9fcfac9a85476" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>the costs and timing of securing manufacturing arrangements for clinical or commercial production;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z89f89a053a974587bf8e844bf23030a9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>the costs of contracting with third parties to provide sales and marketing capabilities for us or establishing such capabilities
        ourselves;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0987b5d83db24eb1b7c0d07ffac52a3a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>the costs of acquiring or undertaking development and commercialization efforts for any future products, product candidates or technology;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8d7e4c5848564f60ad1232390c4bb355" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>the magnitude of our general and administrative expenses; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z754cde69299a41718ed4c03de853f20f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>any additional costs that we may incur under future in- and out-licensing arrangements relating to one or more of our product candidates.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Until we can generate significant recurring revenues, we would expect to satisfy our
future cash needs through capital raising or by out-licensing and/or co-developing applications of one or more of our product candidates.
We cannot be certain that additional funding will be available to us on acceptable terms, if at all. If funds are not available, we may
be required to delay, reduce the scope of or eliminate research or development plans for, or commercialization efforts with respect to,
one or more of our product candidates and make the necessary change to our operations to reduce the level of our expenditures in line
with available resources.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We are a development-stage company and it is not possible for us to predict with any
degree of accuracy the outcome of our research and development efforts. As such, it is not possible for us to predict with any degree
of accuracy any significant trends, uncertainties, demands, commitments or events that are reasonably likely to have a material effect
on our net loss, liquidity or capital resources, or that would cause financial information to not necessarily be indicative of future
operating results or financial condition. However, to the extent possible, certain trends, uncertainties, demands, commitments and events
are described in this item.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin-right: 30.95pt; line-height: 1.25; font-weight: bold">Critical Accounting Estimates</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Company&#8217;s financial statements are prepared in accordance with generally accepted
accounting principles in the United States (&#8220;GAAP&#8221;). The preparation of the Company&#8217;s financial statements and related
disclosures in accordance with GAAP requires it to make estimates and judgments that affect the reported amounts of assets, liabilities,
revenue, costs and expenses, and the disclosure of contingent assets and liabilities in the Company&#8217;s financial statements. The
Company bases its estimates on historical experience, known trends and events and various other factors that it believes are reasonable
under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources. The Company evaluates its estimates and assumptions on an ongoing basis. The Company&#8217;s
actual results may differ from these estimates under different assumptions or conditions.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">While the Company&#8217;s significant accounting policies are described in more detail
in Note 2 to the Company&#8217;s consolidated financial statements included elsewhere in this Annual Report on Form 10-K, the Company
believes that the following accounting estimates are those that include a higher degree of judgment or complexity and are reasonably likely
to have a material impact on our financial condition or results of operations and are therefore considered critical accounting estimates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Share-Based Compensation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We apply Accounting Standard Codification (ASC) 718-10, &#8220;Share-Based Payment,&#8221;
which requires the measurement and recognition of compensation expenses for all share-based payment awards made to employees and directors,
including employee options under the Company&#8217;s option plans based on estimated fair values.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">ASC 718-10 requires that we estimate the fair value of equity-based payment awards on
the date of grant using an option-pricing model. The fair value of the award is recognized as an expense over the requisite service periods
in the Company&#8217;s statements of comprehensive loss. The Company recognizes share-based award forfeitures as they occur, rather than
estimate by applying a forfeiture rate.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">62</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In June 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting
Standards Update (&#8220;ASU&#8221;) 2018-07, &#8220;Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based
Payment Accounting&#8221;, which simplifies the accounting for nonemployee share-based payment transactions by aligning the measurement
and classification guidance, with certain exceptions, to that for share-based payment awards to employees. The amendments expand the scope
of the accounting standard for share-based payment awards to include share-based payment awards granted to non-employees in exchange for
goods or services used or consumed in an entity&#8217;s own operations and supersedes the guidance related to equity-based payments to
non-employees. We adopted these amendments on January 1, 2019.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We recognize compensation expenses for the fair value of non-employee awards over the
requisite service period of each award.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We estimate the fair value of options granted as equity awards using a Black-Scholes
options pricing model. The option-pricing model requires a number of assumptions, of which the most significant are share price, expected
volatility and the expected option term (the time from the grant date until the options are exercised or expire). The Company determines
the fair value per share of the underlying stock by taking into consideration its most recent sales of stock, as well as additional factors
that the Company deems relevant. The Company&#8217;s board determined the fair value of ordinary shares based on valuations performed
using the Option Pricing Method subject to relevant facts and circumstances. The Company has historically been a private company and lacks
company-specific historical and implied volatility information of its stock. Expected volatility is estimated based on volatility of similar
companies in the biotechnology sector. The Company has historically not paid dividends and has no foreseeable plans to issue dividends.
The risk-free interest rate is based on the yield from governmental zero-coupon bonds with an equivalent term. The expected option term
is calculated for options granted to employees and directors using the &#8220;simplified&#8221; method. Grants to non-employees are based
on the contractual term. Changes in the determination of each of the inputs can affect the fair value of the options granted and the results
of operations of the Company.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Quantitative and Qualitative Disclosures about Market Risks</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Foreign Currency Exchange Risk</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">The Company&#8217;s functional currency is the U.S. Dollar. The Company is exposed to
foreign exchange rate risk. The Company is located in Israel, where part of its general and administrative expenses costs are incurred
in New Israeli Shekels. During each of the years ended December 31, 2021 and 2020, the Company recognized foreign currency transaction
loss of $176 thousand and $17 thousand, respectively. These foreign currency transaction gains and losses were recorded in financial expenses.
The Company believes that a 10% change in the exchange rate between the U.S. Dollar and New Israeli Shekel would not have a material impact
on its financial position or results of operations.</div> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">As the Company continues to grow its business, its results of operations and cash flows
will be subject to fluctuations due to changes in foreign currency exchange rates, which could adversely impact the Company&#8217;s results
of operations. To date, it has not entered into any foreign currency hedging contracts to mitigate The Company&#8217;s exposure to foreign
currency exchange risk.</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z9c16e09293ea4d8a9470349571995e90" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; font-weight: bold"><span id="Item7A."><!--Anchor--></span>Item 7A.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Quantitative and Qualitative Disclosures About Market Risk.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">As a smaller reporting company, we are not required to provide the information required
by this item.</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z995b34b7088e45f595f9d0e9e6b0c98d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top"><span id="Item8."><!--Anchor--></span><span style="font-weight: bold">Item 8.</span></td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Financial Statements and Supplementary Data</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">See the Index to Consolidated Financial Statements on Page&#160;F-1 attached hereto.</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zd836bf6649e3459b9456391ee6bc97bc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top"><span id="Item9."><!--Anchor--></span><span style="font-weight: bold">Item 9.</span></td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2e2189d590ff493fbe811d82a81526a2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top"><span id="Item9A."><!--Anchor--></span><span style="font-weight: bold">Item 9A.</span></td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Controls and Procedures</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf2f01426034a4b8cb302e3604198f1f2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">A.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Disclosure Controls and Procedures</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have evaluated, with the participation of our chief executive officer and chief financial
officer, the effectiveness of our disclosure controls and procedures (as that term is defined in Rule 13a-15(e) and 15d-15(e) under the
Exchange Act) as of December 31, 2021. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures,
including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective
disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based upon our evaluation,
our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective as of December
31, 2021 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the
Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the applicable rules and forms, and
that it is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate
to allow timely decisions regarding required disclosure.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">63</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<table cellspacing="0" cellpadding="0" id="za23a815e2c024f6ca654db24b8317f70" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">B.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Management&#8217;s Annual Report on Internal Controls Over Financial Reporting</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our management is responsible for establishing and maintaining adequate internal control
over our financial reporting. Internal control over financial reporting is defined in Rules&#160;13a-15(f)&#160;and 15d-15(f)&#160;promulgated
under the Exchange Act as a process designed by, or under the supervision of, our principal executive and principal financial officers
and effected by our board of directors, management and other personnel to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes those policies and procedures
that:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z88e3819c7ecd48e4aea4a94c5b4e6769" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt">&#160;</td>
    <td style="width: 18pt; vertical-align: top; font-family: Times New Roman,Times,serif">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of
        our assets;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5484d2db233d44dcb075dacf8ed6ee46" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt">&#160;</td>
    <td style="width: 18pt; vertical-align: top; font-family: Times New Roman,Times,serif">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
        with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management; and</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z450433a4252a4e03bce48205c6765fa5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt">&#160;</td>
    <td style="width: 18pt; vertical-align: top; font-family: Times New Roman,Times,serif">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets
        that could have a material effect on the financial statements.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Because of its inherent limitations, internal control over financial reporting may not
prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risks that controls
may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our management, including our Chief Executive Officer and Chief Financial Officer, assessed
the effectiveness of our internal control over financial reporting at December&#160;31, 2021. In making this assessment, management used
the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control&#8212;Integrated
Framework (2013). Based on that assessment under those criteria, management determined that, as of December&#160;31, 2021, our internal
control over financial reporting was effective.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdc616ec593184d0e8c68fcbffaa8a97e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">C.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Attestation Report of the Registered Public Accounting Firm</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">This Annual Report on Form 10-K does not include an attestation report of our registered
public accounting firm due to the Company&#8217;s status as an emerging growth company, as defined in Rule 12b-2 of the Exchange Act.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf73c7758aee34e81838f6e08af4739c2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">D.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Changes in Internal Control over Financial Reporting</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We consummated the Merger on March 16, 2021, which has been accounted for as a reverse
capitalization for accounting purposes, and, upon consummation of the Merger, we reconstituted our Board of Directors and our senior management
team. Following consummation of the Merger the Company&#8217;s management was in the process of strengthening the Company&#8217;s internal
control over financial reporting during the fiscal year ended December 31, 2021, including adopting new policies and procedures appropriate
to the Company&#8217;s current business and management team and onboarding new members to our finance team &#8211; including a new Chief
Financial Officer, VP Finance and director of finance. The foregoing actions were taken solely in connection with the changes effected
in connection with the Merger and not as the result of any material weakness or deficiency in the Company&#8217;s internal control over
financial reporting.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">Item 9B<span id="Item9B"><!--Anchor--></span>.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold">Other
Information</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Item 9C.<span id="Item9C."><!--Anchor--></span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">None.</div>

<div style="text-indent: 18pt; line-height: 1.25"> <br /> </div> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">64</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div><br />

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTIII"><!--Anchor--></span>PART&#160;III</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">Item 10.</span><span id="Item10."><!--Anchor--></span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Directors, Executive Officers and Corporate Governance</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our directors and executive officers, their ages and positions as of the date of this
Annual Report on Form 10-K are as follows:</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" border="0" id="z8444abaeaad14d85be1a9f016a9b2247" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 30%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Name</div> </td>
    <td style="width: 1.22%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="border-bottom: #000000 2px solid; width: 14.86%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Age</div> </td>
    <td style="width: 1.22%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 53%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Positions Held</div> </td> </tr>
  <tr>
    <td style="width: 30%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Dale Pfost*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 1.22%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 14.86%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">64</div> </td>
    <td style="width: 1.22%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 53%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Chairman of the Board, Chief Executive Officer</div> </td> </tr>
  <tr>
    <td style="width: 30%; vertical-align: top">
        <div style="line-height: 1.25">Donald Marvin*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 1.22%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 14.86%; vertical-align: top">
        <div style="line-height: 1.25">70</div> </td>
    <td style="width: 1.22%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 53%; vertical-align: top">
        <div style="line-height: 1.25">Chief Financial Officer, Executive Vice President and Chief Operating Officer&#160;</div> </td> </tr>
  <tr>
    <td style="width: 30%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Adi Mor*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 1.22%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 14.86%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">40</div> </td>
    <td style="width: 1.22%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 53%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Director, Chief Scientific Officer</div> </td> </tr>
  <tr>
    <td style="width: 30%; vertical-align: top">
        <div style="line-height: 1.25">Nissim Darvish<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#8224;</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 1.22%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 14.86%; vertical-align: top">
        <div style="line-height: 1.25">57</div> </td>
    <td style="width: 1.22%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 53%; vertical-align: top">
        <div style="line-height: 1.25">Director</div> </td> </tr>
  <tr>
    <td style="width: 30%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Joel Maryles<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#8224;</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 1.22%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 14.86%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">62</div> </td>
    <td style="width: 1.22%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 53%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Director</div> </td> </tr>
  <tr>
    <td style="width: 30%; vertical-align: top">
        <div style="line-height: 1.25">Alan Moses<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#8224;</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 1.22%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 14.86%; vertical-align: top">
        <div style="line-height: 1.25">74</div> </td>
    <td style="width: 1.22%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 53%; vertical-align: top">
        <div style="line-height: 1.25">Director</div> </td> </tr>
  <tr>
    <td style="width: 30%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Claude Nicaise<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#8224;</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 1.22%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 14.86%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">69</div> </td>
    <td style="width: 1.22%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 53%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Director</div> </td> </tr>
  <tr>
    <td style="width: 30%; vertical-align: top">
        <div style="line-height: 1.25">Neil Cohen<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#8224;</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 1.22%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 14.86%; vertical-align: top">
        <div style="line-height: 1.25">58</div> </td>
    <td style="width: 1.22%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 53%; vertical-align: top">
        <div style="line-height: 1.25">Director</div> </td> </tr>
  </table>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">*</sup>&#160; &#160;&#160; Executive
Officer</div>

<div style="line-height: 1.25"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#8224;</sup>&#160;&#160;&#160;&#160;
Independent Director</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Dr. Dale Pfost</span>&#160;has served
as our Chief Executive Officer and a member of our board of directors since October 25, 2021, and also as chairman of our board of directors
since February 2022. Dr. Pfost has 35 years of experience as an entrepreneur, investor and business executive. From 2019 to 2021, Dr.
Pfost served as Chief Executive Officer and Chairman of the Board of Lodo Therapeutics Corporation. From 2009 until 2019, Dr. Pfost served
in a variety of roles at Microbiome Therapeutics, LLC, a company which he co-founded, including as a board member and Chief Executive
Officer from 2009 until 2010 and again from 2016 until 2019. From 2010 until 2019, he served as a General Partner at Advent Life Sciences.
From 2013 until 2017, Dr. Pfost served in a variety of roles at Vestagen Protective Technologies, including Chairman, Executive Chairman
from 2013 until 2017, and Chief Executive Officer from 2015 until 2016. Prior to that, Dr. Pfost held various executive positions at the
following companies: Chief Executive Officer at Receptor Biologix Inc. (from 2008 until 2009), President, Chief Executive Officer and
Chairman at Acuity Pharmaceuticals, Inc. (from 2003 until 2007), President, Chief Executive Officer and Chairman at Orchid Biosciences,
Inc. (from 1996 until 2002), President, Chief Executive Officer and Managing Director at Oxford Glycosciences Ltd. (from 1988 until 1996)
and Director of Robotics and Automated Chemistry Systems at Smithkline Beckman from 1984 until 1988. In addition to the foregoing, Dr.
Pfost has served on the board of directors of several companies, including Bioelectronica Corp., AxoSim, Inc., JMB Companies LLC, Aura
Bioscience, Louisiana BIO, CN Creative and Ancilia Biosciences. Dr. Pfost earned his BS from the University of California, Santa Barbara,
and a PhD in physics from Brown University.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Donald Marvin</span> has served
as our Chief Financial Officer, Executive Vice President and Chief Operating Officer since November 8, 2021. Mr. Marvin more than 35 years
of experience at growth enterprises in corporate finance and fundraising, strategy, corporate development, mergers and acquisitions, and
operations.&#160; Mr. Marvin served as Executive Vice President and Chief Financial Officer of Lodo Therapeutics from 2020 until 2021.
He was previously Chairman, President and CEO of Concentric from 2014 to 2021. Prior to his positions at Concentric, Mr. Marvin was Managing
Partner of Cairn Associates from 2006 until 2014. He was President and CEO of IdentiGEN from 2006 until 2009. Mr. Marvin was a co-founder
of Orchid BioSciences, where he served as Chief Operating Officer, CFO and Senior Vice President of Corporate Development from 1997 to
2003, and President and Chief Executive Officer of Diatron Corporation from 1986 until 1994. Earlier in his career, Mr. Marvin held positions
of increasing responsibility at Abbott, Boehringer Ingelheim, Bayer, and PepsiCo. Mr. Marvin earned a Bachelor of Science degree from
The Ohio State University and an MBA from Iona College.</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Dr. Adi Mor</span>&#160;is the co-founder
of Chemomab Ltd. and served as Chemomab Ltd.&#8217;s Chief Executive Officer, Chief Scientific Officer and a member of Chemomab Ltd.&#8217;s
board of directors from its formation in 2011 until the Merger, and continued to serve in those capacities for our company thereafter.
Dr. Mor&#8217;s tenure as the Company&#8217;s Chief Executive Officer concluded simultaneous with the approval of Dr. Dale Pfost&#8217;s
employment by the Company&#8217;s shareholders on October 25, 2021. Dr. Mor has in-depth knowledge in immunology focusing on rare diseases
and broad experience in designing, developing and patenting a novel class of monoclonal antibodies to treat inflammatory and fibrotic
diseases. Dr. Mor received her Ph.D. in immunology from Tel Aviv University in the Department of Neurobiochemistry in Israel and is the
lead author of numerous scientific journal publications in immunology and inflammatory disorders.</div> </div>

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">65</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div> </div>

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Nissim Darvish, M.D., Ph.D.</span>&#160;has
served on our board of directors since March 16, 2021. Dr. Darvish is a General Partner at MeOhr Ventures, a venture capital fund. Dr.
Darvish currently serves as a director of several private companies. Prior to his current position, Dr. Darvish served as a Venture Partner
at OrbiMed Israel and as a member of the boards of directors of 9 Meters Biopharma Inc. and Medigus Ltd. Previously, Dr. Darvish was employed
at Pitango Venture Capital, where he was a General Partner managing life sciences investments. He was also the founder and CEO of Impulse
Dynamics, where he oversaw a $250 million realization event. Dr. Darvish obtained his M.D. and Ph.D. in Biophysics and Physiology from
the Technion in Israel, and subsequently conducted his post-doctoral research at NIH. He has published over 100 patents and authored over
20 publications.</div> </div> <br />

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Joel Maryles</span>&#160;has served
on our board of directors since March 16, 2021. Mr. Maryles currently serves on the board of directors and as the Chairman of Remuneration
Committee of Jefferies International Ltd., since 2016. Mr. Maryles previously served on the board of directors of Radware Ltd. (NASDAQ:
RDWR), from 2014 to 2020 and from 2014 to 2016, on the board of directors of EZchip Semiconductor Ltd., which was acquired by Mellanox
Technologies in 2016. From 2015 to 2018, Mr. Maryles was a Partner at OurCrowd and from 2007 to 2012, he served as a Portfolio Manager
at T-Cubed Investments, which he founded. Prior to that, Mr. Maryles served as a Managing Director in the Investment Banking division
of Citigroup, Israel and of Furman Selz. Mr. Maryles holds a Bachelor of Science in Mechanical Engineering from the University of Illinois
and an MBA from the University of Chicago, Illinois.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Alan Moses, MD, FACP</span>&#160;has
served on our board of directors since March 16, 2021. Dr. Moses is board certified by the ABIM with subspecialty certification in Endocrinology
and Metabolism and is a Fellow of the American College of Physicians. Dr. Moses currently serves on the board of directors of BioFabUSA,
since 2018. Prior to that time, from 2008 to 2018, Dr. Moses served as the Global Chief Medical Officer of Novo Nordisk A/S (CPH: NOVO-B),
which he joined in 2004. Dr. Moses served as a Professor of Medicine at Harvard Medical School from 2002 to 2006, and in collaboration
with MIT, he co-founded and co-directed the Clinical Investigator Training Program, which focused on training physician-scientists in
translational research. Dr. Moses previously served as the Senior Vice President and Chief Medical Officer of the Joslin Diabetes Center,
from 1998 to 2004. Dr. Moses holds a BS from Duke University, North Carolina and an MD from Washington University School of Medicine,
Missouri.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Claude Nicaise, MD</span>&#160;has
served on our board of directors since March 16, 2021. Dr. Nicaise is a physician with extensive US and international experience in clinical
drug development, strategic management, worldwide regulatory strategy, pharmaceuticals, biotechnology, including clinical cancer research,
infectious diseases and neuroscience. Dr. Nicaise is the owner and founder of Clinical Regulatory Services, which provides consulting
services to the life science and biotechnology industry in support of all aspects of clinical and regulatory development. Dr. Nicaise
currently serves on the board of directors and as the Chairman of the Compensation Committee of Sarepta Therapeutics, Inc. (NASDAQ: SRPT),
since 2015, as well as on the board of directors of Mynoryx Therapeutics, since 2017. Prior to that time, from 2008 to 2014, Dr. Nicaise
served as the Senior Vice President of Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), and between 1984 and 2008, he held numerous senior
management roles at Bristol Myers Squibb (NYSE: BMY). Dr. Nicaise holds an MD and a degree in Internal Medicine, Clinical Oncology, from
Brussels University, Belgium.</div>

<div style="text-indent: 18pt; line-height: 1.25"> <br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;<span style="font-weight: bold; font-style: italic">Neil Cohen</span>&#160;has
served as a member of our board of directors since April 2020 and served as our interim Chief Executive Officer from October 2020 until
the consummation of the Merger. Mr. Cohen has served as the Chairman and Chief Executive Officer of Castel Partners Ltd. since January
2012. In 1994, he co-founded Israel Seed Partners, a leading venture capital firm, and managed the firm until 2019. Mr. Cohen has invested
in and served on the boards of directors of many private technology companies, including a large number which were acquired or completed
successful initial public offerings, including Compugen (Nasdaq: CGEN), Shopping.com (Nasdaq: SHOP, acquired by EBAY), Broadlight (acquired
by Broadcom, Nasdaq: AVGO) and Cyota (acquired by RSA). He is a venture partner at SKY, an Israeli middle-market private equity firm,
Hetz Ventures Management Ltd., an early-stage Israeli venture capital fund, and Shavit Capital. Mr. Cohen was previously the Business
Editor of The Jerusalem Post and began his career in the private equity group at N M Rothschild &amp; Sons Limited in London. Mr. Cohen
received a B.A. and M.A. in Oriental Studies, with first class honors, from Oxford University.</div> <br /> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">66</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Family Relationships</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">There are no family relationships among directors or executive officers of our Company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Composition of the Board of Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The members of our board of directors are appointed to three staggered director classes,
which are as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdd6e605aa43948e68e707caeb61afb9f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Class I consists of Nissim Darvish and Joel Maryles, each with a term expiring at the 2022 annual meeting of shareholders.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6c8fd140d5ed4a4c909372bc892babac" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Class II consists of Neil Cohen and Claude Nicaise, each with a term expiring at the 2023 annual meeting of shareholders.</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze8c10801ca6a4ae6932eafaecf799e87" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Class III consists of Adi Mor, Alan Moses and Dale Pfost, each with a term expiring at the 2024 annual meeting of shareholders.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The division of our board of directors into three classes with staggered three-year
terms may delay or prevent a change of management or a change of control of our company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Committees of the Board of Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our board of directors has established the following committees. Each committee operates
in accordance with a written charter that sets forth the committee&#8217;s structure, operations, membership requirements, responsibilities
and authority to engage advisors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Audit Committee</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, the Exchange Act and Nasdaq rules, we are required to establish
an Audit Committee.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The responsibilities of an Audit Committee under the Companies Law include identifying
and addressing flaws in the business management of the company, reviewing and approving related party transactions, establishing whistleblower
procedures, overseeing the company&#8217;s internal audit system and the performance of its internal auditor, and assessing the scope
of the work and recommending the fees of the company&#8217;s independent accounting firm. In addition, the Audit Committee is required
to determine whether certain related party actions and transactions are &#8220;material&#8221; or &#8220;extraordinary&#8221; for the
purpose of the requisite approval procedures under the Companies Law and to establish procedures for considering proposed transactions
with a controlling shareholder.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In accordance with U.S. law and Nasdaq requirements, our Audit Committee is also responsible
for the appointment, compensation and oversight of the work of our independent auditors and for assisting our board of directors in monitoring
our financial statements, the effectiveness of our internal controls and our compliance with legal and regulatory requirements.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law and related regulations, the Audit Committee must consist of
at least three directors who meet certain independence criteria. Under the Nasdaq rules, we are required to maintain an Audit Committee
consisting of at least three independent directors, all of whom are financially literate and one of whom has accounting or related financial
management expertise. Each of the members of the Audit Committee is required to be &#8220;independent&#8221; as such term is defined in
Rule&#160;10A-3(b)(1)&#160;under the Exchange Act.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">The members of the audit committee are Joel Maryles, Alan Moses and Claude Nicaise.
Joel Maryles is the chairperson of the audit committee and is a financial expert under the rules of the SEC. Our board of directors has
concluded that the composition of the audit committee meets the requirements for independence under the rules and regulations of Nasdaq
and the SEC.</div> </div>

<div style="text-indent: 18pt; line-height: 1.25"> <br /> </div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">

<div style="line-height: 1.25; font-style: italic">Compensation Committee</div> </div>

<div style="text-indent: 18pt; line-height: 1.25"> <br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">Under both the Companies Law and Nasdaq rules, we are required to establish a Compensation
Committee.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The responsibilities of a Compensation Committee under the Companies Law include recommending
to the board of directors, for ultimate shareholder approval by a special majority, a policy governing the compensation of directors and
officers based on specified criteria, reviewing modifications to and implementing such compensation policy from time to time, and approving
the actual compensation terms of directors and officers prior to approval by the board of directors.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In accordance with U.S. law and Nasdaq requirements, our Compensation Committee is also
responsible for the appointment, compensation and oversight of the work of any compensation consultant, independent legal counsel and
other advisors retained by the Compensation Committee.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Companies Law and related regulations require the appointment of a Compensation
Committee that complies with the requirements of Nasdaq. Under Nasdaq rules, we are required to maintain a Compensation Committee consisting
of at least two independent directors; each of the members of the Compensation Committee is required to be independent under Nasdaq rules&#160;relating
to Compensation Committee members, which are different from the general test for independence of board and committee members. The members
of the compensation committee are Nissim Darvish and Neil Cohen. Nissim Darvish is the chairperson of the compensation committee. Our
board of directors has determined that each member of the compensation committee is independent within the meaning of the independent
director guidelines of Nasdaq and under Rule 10C-1 under the Exchange Act.</div>

<div style="text-indent: 18pt; line-height: 1.25"> <br /> </div> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">67</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Corporate Governance and Nominating Committee</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have established a Corporate Governance and Nominating Committee, responsible for
making recommendations to the board of directors regarding candidates for directorships and the size and composition of the board. In
addition, the committee is responsible for overseeing our corporate governance guidelines and reporting and making recommendations to
the board concerning corporate governance matters. Under the Companies Law, nominations for director may also, under certain circumstances,
be made by shareholders in accordance with the conditions prescribed by applicable law and our articles of association. The members of
the corporate governance and nominating committee are Neil Cohen and Joel Maryles. Neil Cohen is the chairperson of the corporate governance
and nominating committee. Our board of directors has determined that each member of the corporate governance and nominating committee
is independent within the meaning of the independent director guidelines of Nasdaq.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Internal Auditor</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, the board of directors is required to appoint an internal auditor
recommended by the Audit Committee. The role of the internal auditor is to examine, among other things, whether the company&#8217;s actions
comply with applicable law and proper business procedures. The internal auditor may not be an interested party, a director or an officer
of the company, or a relative of any of the foregoing, nor may the internal auditor be our independent accountant or a representative
thereof. Grant Thornton Israel currently serves as our internal auditor.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Section&#160;16(a)&#160;Beneficial Ownership Reporting Compliance</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Section&#160;16(a)&#160;of the Exchange Act requires our directors, executive officers
and holders of more than 10% of our ADSs to file with the SEC reports regarding their ownership and changes in ownership of our equity
securities. We believe that all Section&#160;16 filings requirements were met by such persons during the fiscal year ended December 31,
2021.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Code of Business Conduct and Ethics</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have adopted a Code of Business Conduct and Ethics that includes provisions ranging
from restrictions on gifts to conflicts of interest. All of our employees and directors are bound by this Code of Business Conduct and
Ethics. Violations of our Code of Business Conduct and Ethics may be reported to the Audit Committee. The Code of Business Conduct and
Ethics includes provisions applicable to all of our employees, including senior financial officers and members of our Board of Directors
and is posted on our website. We intend to post amendments to or waivers from any such Code of Business Conduct and Ethics.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">Item 11.</span> <span id="Item11."><!--Anchor--></span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Executive Compensation</span></div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">As approved by our shareholders, and as required by the Companies Law, we have adopted
a Compensation Policy regarding the terms of office and employment of its &#8220;office holders&#8221; (as defined in the Companies Law),
including cash compensation, equity-based awards, releases from liability, indemnification and insurance, severance and other benefits.
Each of the named executive officers is an &#8220;office holder&#8221; within the meaning of the Companies Law. The Compensation Policy
is reviewed from time to time by our compensation committee and our board of directors to ensure its appropriateness.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">Our Compensation Policy is designed to promote retention and motivation of directors
and executive officers, incentivize superior individual excellence, align the interests of our directors and executive officers with our
long-term performance, and provide a risk management tool. To that end, a portion of an executive officer&#8217;s compensation package
is targeted to reflect our short and long-term goals, as well as the executive officer&#8217;s individual performance. On the other hand,
our Compensation Policy includes measures designed to reduce the executive officer&#8217;s incentives to take excessive risks that may
harm us in the long-term, such as limits on the value of cash bonuses and equity-based compensation, limitations on the ratio between
the variable and the total compensation of an executive officer, and minimum vesting periods for equity-based compensation.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our Compensation Policy also addresses our executive officers&#8217; individual characteristics
(such as his or her respective position, education, scope of responsibilities, and contribution to the attainment of our goals) as the
basis for compensation variation among our executive officers and considers the internal ratios between compensation of our executive
officers and directors and other employees. Pursuant to our Compensation Policy, the compensation that may be granted to an executive
officer may include: base salary, annual bonuses, and other cash bonuses (such as a signing bonus and special bonuses with respect to
any special achievements, such as outstanding personal achievement, outstanding personal effort, or outstanding company performance),
equity-based compensation, benefits, and retirement and termination of service arrangements. All cash bonuses are limited to a maximum
amount linked to the executive officer&#8217;s base salary.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">68</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">An annual cash bonus may be awarded to executive officers upon the attainment&#160;of&#160;pre-set&#160;periodic&#160;objectives
and individual targets. The annual cash bonus that may be granted to our executive officers other than our chief executive officer will
be based on performance objectives and a discretionary evaluation of the executive officer&#8217;s overall performance by our chief executive
officer and subject to minimum thresholds. The annual cash bonus that may be granted to executive officers other than our chief executive
officer may alternatively be based entirely on a discretionary evaluation. Furthermore, our chief executive officer will be entitled to
approve performance objectives for executive officers who report to him. The performance objectives and the weight to be assigned to each
achievement in the overall evaluation will be based on overall company performance measures, which may be based on actual financial and
operational results, such as (but not limited to) revenues, operating income and cash flow, and may further include divisional or personal
objectives, which may include operational objectives, such as (but not limited to) market share, initiation of new markets and operational
efficiency, customer focused objectives, project milestones objectives and investment in human capital objectives, such as employee satisfaction,
employee retention and employee training and leadership programs.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The measurable performance objectives of our chief executive officer will be determined
annually by our compensation committee and board of directors. A&#160;portion of the chief executive officer&#8217;s annual cash bonus
may be based on a discretionary evaluation of the chief executive officer&#8217;s overall performance by the compensation committee and
the board of directors, based on quantitative and qualitative criteria. The measurable performance (which include the objectives and the
weight to be assigned to each achievement in the overall evaluation) will be based on overall company performance measures and personal
objectives. Company objectives may include actual financial and operational results, such as (but not limited to) revenues, sales, operating
income, cash flow or our annual operating plan and long-term plan.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The equity-based compensation under our Compensation Policy for our executive officers
(including members of our board of directors) is designed in a manner consistent with the underlying objectives in determining the base
salary and the annual cash bonus, with its main objectives being to enhance the alignment between the executive officers&#8217; interests
with our long-term interests and those of our shareholders and to strengthen the retention and the motivation of executive officers in
the long term. Our Compensation Policy provides for executive officer compensation in the form of equity-based awards, such as share options,
restricted shares and restricted share units, in accordance with our share incentive plan then in place. All equity-based incentives granted
to executive officers shall be subject to vesting periods in order to promote long-term retention of the awarded executive officers. The
equity-based compensation shall be granted from time to time and be individually determined and awarded according to the performance,
educational background, prior experience, qualifications, role, and the personal responsibilities of the executive officer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, our Compensation Policy contains compensation recovery, or clawback provisions,
in the event of an accounting restatement, provisions which allow us under certain conditions to recover bonuses, bonus compensation or
performance-based equity compensation paid in excess, enable our Chief Executive Officer to approve an immaterial change in the terms
of employment of an executive officer who reports directly to him (provided that the changes of the terms of employment are in accordance
with our Compensation Policy) and allow us to exculpate, indemnify, and insure our executive officers and directors to the maximum extent
permitted by Israeli law, subject to certain limitations set forth therein.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our Compensation Policy also provides for compensation to the members of our board of
directors either (i)&#160;in accordance with the amounts provided in the Companies Regulations (Rules Regarding the Compensation and Expenses
of an External Director) of 2000, as amended by the Companies Regulations (Relief for Public Companies Traded in Stock Exchange Outside
of Israel) of 2000, as such regulations may be amended from time to time, or (ii)&#160;in accordance with the amounts determined in our
Compensation Policy.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our Compensation Policy was amended and approved by our shareholders on July 19, 2021.</div>
</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Processes and Procedures for Compensation Decisions</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In accordance with the Companies Law, the decisions with respect to fiscal 2021 executive
officer compensation, including the compensation of our named executive officers, are governed by our Compensation Policy for directors
and officers, and made by our compensation committee and board of directors, with input from our chief executive officer (except with
respect to his own compensation) and Deloitte Israel, an independent compensation consultant within the meaning of the rules of the SEC
and Nasdaq. Deloitte Israel was engaged by our compensation committee pursuant to the authority delegated under its charter and serves
at the discretion of the compensation committee.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">Our compensation committee believes our chief executive officer has valuable insight
into&#160;the&#160;day-to-day&#160;contributions&#160;of our executive officers, and solicits the advice and input from him with respect
to performance objectives under our annual bonus plan and target compensation levels for our executive officers, including our named executive
officers, which are later being reviewed and approved by the board of directors. Our chief executive officer does not provide input on
his own compensation, which is determined by our compensation committee and the board of directors in accordance with the Companies Law.
At the request of our compensation committee, Deloitte Israel provides an assessment of the competitiveness of our executive compensation
program as compared with our competitors, and our compensation committee uses this assessment as one of several factors in approving target
levels of compensation for each executive officer. Other factors our compensation committee considers in setting executive compensation
include one or more of the following: individual performance and skills, management input, internal relative alignment of compensation
levels, anticipated future contributions to our company, and the judgment and experience of the members of our compensation committee.</div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">69</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Aggregate Compensation of Directors and Officers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The aggregate compensation we paid to our executive officers and directors for the year
ended December&#160;31, 2021 was approximately $979 thousand. This amount includes amounts paid, set aside or accrued to provide pension,
severance, retirement or similar benefits or expenses, but does not include share-based compensation expenses, or business travel, professional
and business association dues and expenses reimbursed to office holders, and other benefits commonly reimbursed or paid by companies in
our industry. As of December&#160;31, 2021, options to purchase 19,220,290 ordinary shares granted to our officers and directors were
outstanding under our share option plan at a weighted average exercise price of $0.45 per share.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Summary Compensation Table</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The table and summary below outlines the compensation granted to individuals who served
in the role of chief executive officer during the previous fiscal year and our three most highly compensated executive officers with respect
to the year ended December&#160;31, 2021. For purposes of the table and the summary below, &#8220;compensation&#8221; includes base salary,
bonuses, equity-based compensation, retirement or termination payments, benefits and perquisites such as car, phone and social benefits
and any undertaking to provide such compensation.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" border="0" id="z44340dc7ba7d4105818ba144e521bd34" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 42%">
        <div style="line-height: 1.25">Name and Principal Position</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 9%">
        <div style="text-align: center; line-height: 1.25">Year</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Salary<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)</sup>
        (USD in<br /> thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Bonus<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(2)</sup>
        (USD in<br /> thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Equity-Based<br /> Compensation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(3)(4)</sup><br />
        (USD in thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Total (USD in<br /> thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px; width: 1%">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 42%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Dale Pfost</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2020</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%">
        <div style="line-height: 1.25"><span style="font-style: italic">Chief Executive Officer and Chairman</span> (5)</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%">
        <div style="line-height: 1.25">2021</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">192</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">300</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">492</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%">
        <div style="line-height: 1.25">Adi Mor</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%">
        <div style="line-height: 1.25">2020</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">229 <br /> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">75</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">21</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">325</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><span style="font-style: italic">Chief Scientific Officer, Director and Previous Chief Executive Officer
        </span>(6)</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2021</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">313</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">167</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">8</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">519</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Donald Marvin</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2020</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%">
        <div style="line-height: 1.25"><span style="font-style: italic">Chief Financial Officer, Executive Vice President and Chief Operating
        Officer</span> (7)</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%">
        <div style="line-height: 1.25">2021</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">94</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">102</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">196</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%">
        <div style="line-height: 1.25">Sigal Fattal</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%">
        <div style="line-height: 1.25">2020</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><span style="font-style: italic">Previous Interim Chief Financial Officer</span> (8)</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2021</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">136</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">122</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">616</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">906</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Arnon Aharon</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2020</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">261</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">38</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">51</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">375</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 42%">
        <div style="line-height: 1.25"><span style="font-style: italic">Previous Chief Medical Officer</span> (9)</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 9%">
        <div style="line-height: 1.25">2021</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">264</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">91</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">15</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">370</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Salary includes gross salary plus payment by us of social
benefits on behalf of the officer. Such benefits may include, to the extent applicable, payments, contributions and/or allocations for
risk insurance (e.g., life, or work disability insurance), payments for social security, vacation, medical insurance and benefits, and
other benefits and perquisites consistent with our policies.</div>

<div style="line-height: 1.25"> <br /> </div>

<div style="line-height: 1.25">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Represents bonuses granted with respect to 2021.</div>

<div style="line-height: 1.25"> <br /> </div>

<div style="line-height: 1.25">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Represents the equity-based compensation expenses recorded
in our consolidated financial statements for the year ended December&#160;31, 2021, based on the options&#8217; fair value on the grant
date, calculated in accordance with applicable accounting guidance for equity-based compensation. For a discussion of the assumptions
used in reaching this valuation, see Note [2L] to our annual consolidated financial statements included in this Annual Report on Form&#160;10-K.</div>

<div style="line-height: 1.25"> <br /> </div>

<div style="line-height: 1.25">(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Represents option awards.<br /> <br /> </div>

<div style="line-height: 1.25">(5)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dr. Dale Pfost&#8217;s terms of compensation
were approved by the Company&#8217;s shareholders on October 25, 2021, which includes an annual base salary of $600,000. Dr. Pfost&#8217;s
compensation data set forth in the above table is pro-rated to reflect time served as the Company&#8217;s chief executive officer in 2021.</div>

<div style="line-height: 1.25"> <br /> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">70</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">(6)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In addition to her current positions of
Chief Scientific Officer and a member of our board of directors, Dr. Adi Mor previously served as our Chief Executive Officer, and resigned
from such role concurrent with the commencement of Dr. Dale Pfost&#8217;s service as our Chief Executive Officer on October 25, 2021.</div>

<div style="line-height: 1.25"> <br /> </div>

<div style="line-height: 1.25">(7)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mr. Donald Marvin&#8217;s employment with
the Company commenced on November 4, 2021, which include an annual base salary of $460,000. The compensation data set forth in the above
table is pro-rated to reflect time served as the Company&#8217;s Chief Financial Officer, Executive Vice President and Chief Operating
Officer in 2021.<br /> <br /> </div>

<div style="line-height: 1.25">(8)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In addition to her current position as Consulting
VP Finance, Ms. Fattal previously served as our interim Chief Financial Officer, and resigned from such role concurrent with the commencement
of Mr. Marvin&#8217;s service as our Chief Financial Officer on November 8, 2021. Ms. Fattal&#8217;s compensation data set forth in the
above table is pro-rated to reflect time served as the Company&#8217;s interim Chief Financial Officer in 2021.</div>

<div style="line-height: 1.25"> <br /> </div>

<div style="line-height: 1.25">(9)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dr. Arnon Aharon resigned from his position
as our Chief Medical Officer effective on February 1, 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Outstanding Equity Awards</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The table below outlines the outstanding options to purchase ADSs held by our named
executive officers outstanding as of December&#160;31, 2021.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb81ed5d9c34642ab80b0d6e557e5666f" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Option award</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Name</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Number of securities<br /> underlying<br /> unexercised options<br />
        (#) exercisable</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Number of<br /> securities<br /> underlying<br /> unexercised options<br />
        (#)<br /> unexercsiable</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Option<br /> exercise<br /> price ($)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Option expiration<br /> date</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Dale Pfost, <span style="font-style: italic">Chief Executive Officer and Chairman of the Board</span></div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">459,353</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)</sup>&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">10.05</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">25/10/2031</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Adi Mor, <span style="font-style: italic">Chief Scientific Officer, Director and Previous Chief Executive
        Officer</span></div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">123,466</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">8,232</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(2)</sup>&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1.49</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">15/03/2028</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Donald Marvin, <span style="font-style: italic">Chief Financial Officer, Executive Vice President and Chief
        Operating Officer</span>&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">196,875</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(3)</sup>&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">9.77</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">08/11/2031</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Arnon Aharon, <span style="font-style: italic">Previous Chief Medical Officer</span></div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td rowspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 52%">&#160;</td>
    <td colspan="1" class="cftguttercell" rowspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" rowspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" rowspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" rowspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" rowspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" rowspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" rowspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" rowspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" rowspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" rowspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" rowspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" rowspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" rowspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" rowspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" rowspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" rowspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Sigal Fattal, <span style="font-style: italic">Previous interim Chief Financial Officer</span></div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">8,900</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">26,700</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(4)</sup>&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">9.83</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">07/11/2030</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">(1) The options granted to Dr. Pfost vest and become exercisable over a period of four (4) years with one
quarter (1/4) of the options vesting on October 25, 2022, the first anniversary of the grant date, and the remainder in equal amounts
over the ensuing 36 monthly periods, subject to Dr. Pfost&#8217;s continued service.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">(2) The options granted to Dr. Mor vest and become exercisable over a period of four (4) years with one
quarter (1/4) of the options vesting on March 15, 2019 and the remainder in 12 quarterly equal instalments, subject to the Dr. Mor&#8217;s
continued service.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">(3) The options granted to Mr. Marvin vest and become exercisable over a period of four (4) years, with
one quarter (1/4) of the options vesting on November 8, 2022, the first anniversary of the grant date, and the remainder in equal amounts
over the ensuing 36 monthly periods, subject to Mr. Marvin&#8217;s continued service.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">(4) The options granted to Ms. Fattal vest and become exercisable over a period of four (4) years with
one quarter (1/4) of the options vesting on November 7, 2021 and the remainder in 12 quarterly equal instalments, subject to Ms. Fattal&#8217;s
continued service.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">71</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Director Compensation Table</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The table below outlines compensation earned by our directors for the fiscal year ended
December 31, 2021, including fees earned in cash and options awarded for services provided as a director:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9d709455c535459dad3e16b43b8c8841" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Name</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Fees earned or paid<br /> in cash ($)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Option<br /> awards ($)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Total ($)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25"><span style="font-weight: bold">Outstanding</span><br /> <span style="font-weight: bold">options
        as of</span><br /> <span style="font-weight: bold">December 31,</span><br /> <span style="font-weight: bold">2021</span> <span style="font-weight: bold">(ADSs)</span></div>
        </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Stephen Squinto<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)</sup></div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">49</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">141</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">190</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">102,858</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%">
        <div style="line-height: 1.25">Nissim Darvish&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">36</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">118</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">154</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">22,007</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Joel Maryles&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">43</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">118</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">161</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">11,884</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%">
        <div style="line-height: 1.25">Alan Moses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">34</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">118</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">152</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">11,884</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Claude Nicaise&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">34</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">118</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">152</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">11,884</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%">
        <div style="line-height: 1.25">Neil Cohen</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">38</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">121</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">159</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">12,572</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd6f48e1eb6504e61b05143688f612926" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top">
        <div>Dr. Squinto resigned from the Company&#8217;s Board of Directors effective on December 19, 2021.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Employment Agreements</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Employment Agreement with Dr. Dale Pfost,
our Chief Executive Officer</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">On September 1,&#160;2021, the Company&#8217;s board of directors approved the appointment
of Dr. Dale Pfost as Chief Executive Officer of the Company, and on October 25, 2021, the shareholders of the Company approved the terms
of employment of Dr. Pfost, pursuant to an Executive Employment Agreement entered into between Dr. Pfost and Chemomab Therapeutics Inc.,
the Company&#8217;s wholly owned subsidiary. In accordance with terms of Dr. Pfost&#8217;s employment agreement, Dr. Pfost receives: (i)
an annual base salary of $600,000 (the &#8220;Base Salary&#8221;); (ii) an initial target annual cash incentive bonus of 50% of the Base
Salary and an additional potential bonus of 10% of the Base Salary based on Dr. Pfost&#8217;s achievement of certain predetermined goals,
which shall be determined at the discretion of the Company&#8217;s board of directors; (iii) options to purchase&#160;459,353 ADSs of
the Company (the &#8216;Options&#8221;), constituting 3.5% of the outstanding and issued ADSs of the Company (on a fully diluted basis)
which will vest over a period of four (4) years with one quarter (1/4) of the Options vesting on the first anniversary of the grant date
and the remainder in equal amounts over the ensuing 36 monthly periods, unless such options have been cancelled in accordance with the
terms and conditions of the 2015 Plan (as defined below); (iv) a one-time signing bonus in an amount of $80,000; (v) a one-time bonus
in an amount of $80,000 upon the establishment of a new office in the United State and Dr. Pfost&#8217;s domiciling in the location of
the new office, which will be payable within 15 days of such domiciling; (vi) 25 days of paid time off (&#8220;PTO&#8221;) per year, capped
at 50 days of accrued PTO; and (vii) certain severance benefits payable in the event that the Company terminates Dr. Pfost&#8217;s employment
without Cause (as defined in the employment agreement), provided that the total amount of the cash portion of severance benefits will
not exceed two hundred percent (200%) of Dr. Pfost&#8217;s annual base salary at the rate in effect on the date of termination.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">Additionally, in the event of termination of Dr. Pfost&#8217;s employment without Cause
as the result of a merger or sale of all or substantially all of the Company&#8217;s capital stock or assets, (i.e. a change in control
of the Company), vesting of all unvested Options will accelerate and all unvested Options will immediately vest and become exercisable.
Furthermore, in the event of termination of Dr. Pfost&#8217;s employment without Cause, other than as a result of a merger or sale of
all or substantially all of the Company&#8217;s capital stock or assets (i.e. a change in control of the Company) or if Dr. Pfost terminates
his employment for Good Reason (as defined in the employment agreement): (a) any time-based Options then outstanding and due to vest on
the twelve (12) month anniversary of Dr. Pfost&#8217;s employment commencement date will accelerate and become exercisable if Dr. Pfost
has been employed by the Company at such time for six (6) months or more but less than twelve (12) months; and (b) all time-based Options
then outstanding will accelerate and become exercisable if Dr. Pfost has been employed by the Company at such time for twelve (12) months
or longer.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">The foregoing description of Dr. Pfost&#8217;s employment agreement is qualified in
its entirety by reference to the full text of the employment agreement, a copy of which is filed as Exhibit 10.10 to this Annual Report
on Form 10-K, and incorporated herein by reference.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><span style="font-style: italic">Employment Agreement with Dr.
Adi Mor, our Chief Scientific Officer (and former Chief Executive Officer</span>)</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the employment agreement, dated April 25, 2013, as amended (most recently as of
July 2021) that Chemomab Ltd. entered into with its then-Chief Executive Officer (currently Chief Scientific Officer), Dr. Adi Mor (which
contract was assumed by our company as a result of the consummation of the Merger), Dr. Mor is entitled to a gross monthly salary of NIS
52,500 (approximately $16,881). Dr. Mor is also entitled to an annual performance bonus in the aggregate amount of $75,000, subject to
her meeting certain performance milestones, as to be determined by our board of directors on an annual basis. Besides base salary and
bonus, Dr. Mor is entitled to other benefits that are provided for by Israeli law or that are customary for senior executives in Israel,
including reimbursement for reasonable expenses incurred in connection with her services, and the right to use (including certain related
fixed and variable costs in respect of) a leased car and a cellular phone. In lieu of a leased car, Dr. Mor may elect to receive a monthly
car allowance payment. Dr. Mor is furthermore entitled to company contributions equivalent to 8.33%, 2.5%, and 5% of her gross monthly
salary towards certain severance, disability and tax-advantaged savings funds (known as a manager&#8217;s insurance policy), respectively.
Dr. Mor also contributes 5.5% of her gross monthly salary towards the manager&#8217;s insurance policy. The employment engagement is terminable
by either party upon 60 days prior written notice, and contains customary provisions regarding noncompetition, confidentiality of information
and assignment of inventions. As required under Israeli law, the terms of Dr. Mor&#8217;s engagement with Chemomab Ltd. were approved
by Chemomab Ltd.&#8217;s board of directors and shareholders.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">72</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Dr. Mor has been granted, pursuant to her employment agreement, an aggregate of 10,239
options to purchase Chemomab Ltd. shares, which were fully vested on March 24,, 2022, under Chemomab Ltd.&#8217;s share option and incentive
plan (which was assumed by our company in the Merger). The options were converted to Chemomab options based on the exchange ratio in the
merger agreement for the Merger (the &#8220;Merger Agreement&#8221;), with a reciprocal adjustment to exercise price.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">At the annual meeting of our shareholders that took place on July 19, 2021, our shareholders
approved an amendment to Dr. Mor&#8217;s compensation, pursuant to which Dr. Mor will receive: (a) an annual base salary of $249,000;
(b) certain social benefits, including&#160;<span style="font-style: italic">keren hishtalmut</span>&#160;(advanced study fund); (c) car
and car related expenses; (d) a target annual gross cash bonus of $100,000 that can be achieved pursuant to certain pre-determined objectives
according to the discretion of the board of directors; and (e) a one-time cash bonus in the aggregate gross amount of $90,000 in connection
with Dr. Mor&#8217;s contribution to the consummation of the Merger and financing transaction.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The foregoing description of Dr. Mor&#8217;s employment agreement is qualified in its
entirety by reference to the full text of the employment agreement, a copy of which is filed as Exhibit 10.8 to this Annual Report on
Form 10-K, and incorporated herein by reference.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Employment Agreement with Mr. Donald Marvin,
our Chief Financial Officer, Executive Vice President and Chief Operating Officer</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">On November 8, 2021, Chemomab Therapeutics Inc. entered into an Executive Employment
Agreement with Mr. Donald Marvin. In accordance with his employment agreement, Mr. Marvin receives an annual base salary of $460,000,
and is a part of the Company&#8217;s bonus program with a yearly bonus potential of 45% of his base annual base salary, which bonus will
be based on the achievement of mutually agreeable objectives to be determined by Mr. Marvin and the Chief Executive Officer of the Company.
Additionally, in accordance with his employment agreement, Mr. Marvin received (i) 1.5% of the outstanding equity of the Company, which
exercise price is based on the average of Company&#8217;s ADS market value over the 30 calendar days preceding November 8, 2021, and vesting
over four years, (ii) an additional 0.5% of the outstanding equity of the Company for the achievement of strategic goals as agreed upon
with the Compensation Committee and approved by the Board of Directors, (iii) a $25,000 signing bonus, and (iv) a 12-month initial severance
package, which will increase by one month every two years that Mr. Marvin is employed by the Company, provided however that such amount
does not exceed 18 months.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">The foregoing description of Mr. Marvin&#8217;s employment agreement is qualified in
its entirety by reference to the full text of the employment agreement, a copy of which is filed as Exhibit 10.11 to this Annual Report
on Form 10-K, and incorporated herein by reference.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Equity Incentive Plans</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We maintain (i) the 2011 Share Option Plan (the &#8220;2011 Plan&#8221;), (ii) the 2017
Equity-Based Incentive Plan (the &#8220;2017 Plan&#8221;) and (iii) the Chemomab Ltd. 2015 Share Incentive Plan (the &#8220;2015 Plan&#8221;),
&#8201;which was assumed by our company from Chemomab Ltd. upon the effectiveness of the Merger. At that time, outstanding options under
the 2015 Plan became exercisable for such number of ADSs of our company (formerly known as Anchiano Therapeutics Ltd.) as was determined
based on the exchange ratio in the Merger Agreement, with a reciprocal adjustment to exercise price. As of December 31, 2021, a total
of 1,422,153 of our ADSs were reserved for issuance under the 2015 Plan, of which 73,776 ADSs had been issued pursuant to previous exercises
options, and 1,326,723 ADSs&#160;were issuable under outstanding options. Of such outstanding options, options to purchase 452,230 ADSs
had vested and were exercisable as of that date, with a weighted average exercise price of $2.75 per ADS.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">2011 Plan</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On December 19, 2011, our board of directors adopted 2011 Plan to allocate options to
purchase our ordinary shares to our directors, officers, employees and consultants, and those of our affiliated companies (as such term
is defined under the 2011 Plan), or the Grantees. The 2011 Plan is administered by our board of directors or a committee that was designated
by our board of directors for such purpose (the &#8220;Administrator&#8221;).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the 2011 Plan, we may grant options to purchase ordinary shares (&#8220;Options&#8221;),
under four tracks: (i) Approved 102 capital gains Options through a trustee, which was approved by the Israeli Tax Authority in accordance
with Section 102(a) of the Israeli Income Tax Ordinance (&#8220;ITO&#8221;), and granted under the tax track set forth in Section 102(b)(2)
of the ITO, or the Approved 102 Capital Gains Options. The holding period under this tax track is 24 months from the date of allocation
of Options to the trustee or such period as may be determined in any amendment of Section 102 of the ITO, or any applicable tax ruling
or guidelines; (ii) Approved 102 Earned Income Options through a trustee, granted under the tax track set forth is Section 102(b)(1) of
the ITO, or the Approved 102 Earned Income Options. The holding period under this tax track is 12 months from the date of allocation of
Options to the trustee or such period as may be determined in any amendment of Section 102 of the ITO; (iii) Unapproved 102 Options (the
Options will not be allocated through a trustee and will not be subject to a holding period), or the Unapproved 102 Options; and (iv)
3(i) Options (the Options will not be subject to a holding period). These Options shall be subject to taxation pursuant to Section 3(i)
of the ITO, or Section 3(i).</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">73</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Options pursuant to the first three tax tracks (under Section 102 of the ITO) can be
granted to our employees and directors and the grant of Options under Section 3(i) can be granted to our consultants and controlling shareholders
(a controlling shareholder is defined under the Section 102 of the ITO is a person who holds, directly or indirectly, alone or together
with a &#8220;relative,&#8221; (i) the right to at least 10% of the company&#8217;s issued capital or 10% of the voting power; (ii) the
right to hold at least 10% of the company&#8217;s issued capital or 10% of the voting power, or the right to purchase such rights; (iii)
the right to receive at least 10% of the company&#8217;s profits; or (iv) the right to appoint a company&#8217;s director). Grantees who
are not Israeli residents may be granted options that are subject to the applicable tax laws in their respective jurisdictions.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We determine, in our sole discretion, under which of the first three tax tracks above
the Options are granted and we notify the Grantee in a grant letter, as to the elected tax track. As mentioned above, consultants and
controlling shareholders can only be granted Section 3(i) Options.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The number of ordinary shares authorized to be issued under the 2011 Plan will be proportionately
adjusted for any increase or decrease in the number of ordinary shares issued as a result of a distribution of bonus shares, change in
our capitalization (split, combination, reclassification of the shares or other capital change), or issuance of rights to purchase ordinary
shares or payment of a dividend. We will not allocate fractions of ordinary shares and the number of ordinary shares shall be rounded
up to the closest number of ordinary shares.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Unless otherwise determined by the Administrator, the exercise price of an Option granted
under the 2011 Plan will be the average of the market price of the Company&#8217;s ordinary shares during the 22 business days prior to
the date on which our board of directors authorized the grant of Options; provided, however, that such exercise price cannot be lower
than the market price at the close of the trading day at which it was granted by our board of directors. The exercise price will be specified
in the grant letter every Grantee received from us in which the Grantee notifies of the decision to grant him/her Options under the 2011
Plan.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Unless otherwise determined by the Administrator, the Options granted under the Plan
will become vested and may be exercised in 16 equal portions of 6.25% of the total number of Options, at the end of each quarter following
the day the Options were granted. Unless otherwise determined by our board of directors, the Options may be exercised for ten years following
the date of grant, unless terminated earlier, and as long as the Grantee is employed by the Company (or by an affiliated company), or
provides service to the Company (or an affiliated company).</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Administrator may, in its absolute discretion, accelerate the time at which Options
granted under the 2011 Plan or any portion of which will vest.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Unless otherwise determined by the Administrator, in the event that the Grantee&#8217;s
employment was terminated, not for Cause (as defined in the 2011 Plan), the Grantee may exercise that portion of the Options that had
vested as of the date of such termination until the end of the specified term in the grant letter or the 2011 Plan. The portion of the
Options that had not vested at such date, will be forfeited and can be re-granted according to the terms of the 2011 Plan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">2015 Plan</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In November 2015, Chemomab Ltd.&#8217;s board of directors adopted, and its shareholders
subsequently approved, the 2015 Plan. The 2015 Plan provides for the grant of options, restricted shares, restricted share units and other
share-based awards to Chemomab Ltd.&#8217;s (following the Merger, the Company&#8217;s or Chemomab&#8217;s) and its subsidiaries&#8217;
and affiliates&#8217; directors, employees, officers, consultants, advisors, and any other person whose services are considered valuable
to Chemomab or its affiliates. Any such grants are intended to incentivize the foregoing persons to continue as service providers, to
increase their efforts on Chemomab&#8217;s behalf or on behalf of its subsidiaries or affiliates, and to promote the success of its business.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The 2015 Plan is administered by Chemomab&#8217;s board of directors or by a committee
designated by the board of directors, which determines, subject to Israeli law, the grantees of awards and the terms of the grant, including,
exercise prices, vesting schedules, acceleration of vesting and the other matters necessary in the administration of the 2015 Plan. The
2015 Plan enables Chemomab to issue awards under various tax regimes, including, without limitation, pursuant to Section 102 of the Israeli
Income Tax Ordinance, or the Ordinance, and under Section 3(i) of the Ordinance and Section 422 of the United States Internal Revenue
Code of 1986, as amended, or the Code.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">74</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">The 2015 Plan provides that options granted to Chemomab&#8217;s employees, directors
and officers who are not controlling shareholders and who are considered Israeli residents are intended to qualify for special tax treatment
under the &#8220;capital gain track&#8221; provisions of Section 102(b) of the Ordinance. Chemomab&#8217;s Israeli non-employee service
providers and controlling shareholders may only be granted options under Section 3(i) of the Ordinance, which does not provide for similar
tax benefits.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Options granted under the 2015 Plan to U.S. residents may qualify as &#8220;incentive
stock options&#8221; within the meaning of Section 422 of the Code, or may be non-qualified. The exercise price for &#8220;incentive stock
options&#8221; must not be less than the fair market value on the date on which an option is granted, or 110% of the fair market value
if the option holder holds more than 10% of Chemomab&#8217;s share capital.&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Options and other awards granted under the 2015 Plan generally vest over four years
commencing on the date of grant, such that 25% vests on the first anniversary of the date of grant and an additional 6.25% vests at the
end of each subsequent calendar quarter over the course of the next three years, provided that the participant remains continuously employed
or engaged by Chemomab.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Options, other than certain incentive share options, that are not exercised within ten
years from the grant date expire, unless otherwise determined by Chemomab&#8217;s board of directors or its designated committee, as applicable.
Share options that qualify as &#8220;incentive stock options&#8221; and are granted to a person holding more than 10% of Chemomab&#8217;s
voting power will expire within five years from the date of the grant. In the event of the death of a grantee while employed by or performing
service for Chemomab or its subsidiary or within three months after the date of the employee&#8217;s termination, or the termination of
a grantee&#8217;s employment or services for reasons of disability, the grantee, or in the case of death, his or her legal successor,
may exercise options or other awards that have vested prior to termination within a period of one year from the date of disability or
death. If Chemomab terminates a grantee&#8217;s employment or service for cause, all of the grantee&#8217;s vested and unvested options
or other awards will expire on the date of termination. If a grantee&#8217;s employment or service is terminated for any other reason,
the grantee may generally exercise his or her vested options or other award within three months of the date of termination. Any expired
or unvested options return to the pool and become available for reissuance. From time to time, Chemomab may consider issuing options with
slightly different terms or accelerating, extending or otherwise modifying options in accordance with applicable law and regulation and
the terms of the 2015 Plan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In the event of a merger or consolidation of Chemomab, or a sale of all, or substantially
all, of Chemomab&#8217;s shares or assets or other transaction having a similar effect on Chemomab, then without the consent of the option
holder, Chemomab&#8217;s board of directors or its designated committee, as applicable, may, but is not required, to (i) cause any outstanding
award to be assumed or an equivalent award to be substituted by such successor corporation, or (ii) in case the successor corporation
does not assume or substitute the award (a) provide the grantee with the option to exercise the award as to all or part of the shares
or (b) cancel the options and pay in cash an amount determined by the board of directors or the committee as fair in the circumstances.
Notwithstanding the foregoing, Chemomab&#8217;s board of directors or its designated committee may upon such event amend, modify or terminate
the terms of any award, including conferring the right to purchase any other security or asset that the board of directors or the committee
shall deem, in good faith, appropriate.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The 2015 plan was assumed by our company from Chemomab Ltd. upon the effectiveness of
the Merger.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">2017 Plan</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On February 22, 2017, our board of directors adopted the 2017 Plan to allocate a variety
of share-based awards to our directors, officers, employees, consultants, advisors and service providers, and those of our affiliates
(companies that control us, are controlled by us or are under common control with us) (the &#8220;Participants&#8221;). The 2017 Plan
is currently administered by our board of directors, and may be administered by a committee designated by our board of directors for such
purpose.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the 2017 Plan, we may grant options to purchase ordinary shares or ADSs, restricted
shares or ADSs, restricted share units and other awards based on our ordinary shares, all of which are referred to as Awards. We may grant
Awards under the same four tracks as described above with respect to the 2011 Plan, subject to the same conditions as apply for the 2011
Plan. In addition, we may grant incentive stock options and nonqualified stock options to Participants who are residents of the United
States, and we may grant awards to Participants who are residents of other countries that comply with the laws of those jurisdictions.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The number of ordinary shares authorized to be issued under the 2017 Plan will be proportionately
adjusted for any increase or decrease in the number of ordinary shares issued as a result of a distribution of bonus shares, change in
our capitalization (split, combination, reclassification of the shares or other capital change), issuance of rights to purchase ordinary
shares or payment of a dividend. We will not allocate fractions of ordinary shares and the number of ordinary shares shall be rounded
down to the closest number of ordinary shares.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">75</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In the event of a (i) merger, consolidation, amalgamation or the like with or into another
corporation, (ii) an acquisition (including an exchange) of all or substantially all of our ordinary shares, (iii) the sale of all or
substantially all of our assets, or (iv) any other event determined by the Administrator to have a similar impact, then &#8211; unless
otherwise determined by our board of directors in its sole and absolute discretion &#8211; any Award then outstanding will be assumed
or an equivalent Award shall be substituted by the successor corporation, under substantially the same terms as the Award.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The exercise price of an option granted under the 2017 Plan will, in general, be no
less than the fair market value of the Company&#8217;s ordinary shares on the date of grant, subject to any minimum exercise price prescribed
by law. The Administrator determines the vesting provisions for each Award and may, in its sole discretion, accelerate the time at which
options granted under the 2017 Plan will vest. Unless otherwise determined by the Administrator, options may be exercised for ten years
(five years in the case of an incentive stock option granted to a 10% shareholder), and as long as the Participant is employed by the
Company (or by an affiliated company) or provides services to the Company (or an affiliated company). If a Participant&#8217;s employment
is terminated, other than for cause, the Participant may generally exercise vested options for a limited period following termination<span style="font-style: italic">.</span></div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In accordance with the terms of the 2017 Plan, on January 1 of each calendar year during
the term of the 2017 Plan, the number of shares available for issuance under the 2017 Plan shall be increased by 4% of the total number
of company shares outstanding on December 31 of the immediately preceding calendar year, or such lesser number as shall be determined
by the administrator of the plan, subject to adjustments required for recapitalization events.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold"><span id="Item12."><!--Anchor--></span>Item 12.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold">Security
Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Security Ownership of Certain Beneficial Owners and Management</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The following table sets forth information, as of March 24, 2022, regarding beneficial
ownership of our ordinary shares (including ordinary shares represented by ADSs) by:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5828e4bc67c54cc29dff532109064f44" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>each person who is known by us to own beneficially more than 5% of our ordinary shares;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbdb12d3abb464d08a2a0bd009cde2aba" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>each director;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z760fc6269fd249b4bc417f0dbc362f3e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>each executive officer; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zcd35dc64df5d4f76891b64dc620c1187" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top">
        <div>all of our directors and executive officers collectively.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Beneficial ownership is determined in accordance with the rules&#160;of the SEC. Under
these rules, a person is deemed to be a beneficial owner of a security if that person has or shares voting power, which includes the power
to vote or to direct the voting of the security, or investment power, which includes the power to dispose of or to direct the disposition
of the security. For purposes of the table below, we deem ordinary shares issuable pursuant to options or warrants that are currently
exercisable or exercisable within 60 days of the date of this Annual Report on Form&#160;10-K, if any, to be outstanding and to be beneficially
owned by the person holding the options or warrants for the purposes of computing the percentage ownership of that person, but we do not
treat them as outstanding for the purpose of computing the percentage ownership of any other person.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Unless otherwise noted, the address of each director and current and former executive
officer of Chemomab is Kiryat Atidim, Building 7, Tel Aviv, Israel 6158002.</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zcb18697bfd7c4e39ad2067184920f376" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25; font-weight: bold">NAME OF BENEFICIAL OWNER</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"> <span style="font-weight: bold">Total</span></div>
        <div style="line-height: 1.25; font-weight: bold">Beneficial</div>
        <div style="line-height: 1.25; font-weight: bold">Ownership</div>
        <div style="line-height: 1.25; font-weight: bold"> (ADSs)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Percentage of</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">ADSs</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Beneficially</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Owned*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF">
        <div style="line-height: 1.25; font-weight: bold">5% and Greater Shareholders</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">OrbiMed Israel Partners Limited Partnership (1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">2,606,991</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">22.8</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
        <div style="line-height: 1.25">The Centillion Fund (2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">661,370</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">5.8</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Rivendell Investments 2017-9 (3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,131,563</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">9.9</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
        <div style="line-height: 1.25">Kobi George (4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,329,468</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">11.5</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Apeiron Group( 5)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">770,388</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">6.7</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  </table>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br />

<div style="line-height: 1.25"> <br /> </div> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">76</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div> </div>

<table cellspacing="0" cellpadding="0" id="z581744cb612f4e4f9dc00034c6df0380" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25; font-weight: bold">NAME OF BENEFICIAL OWNER</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Total</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Beneficial </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Ownership</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> (ADSs)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif"> <span style="font-weight: bold">Percentage</span></div>
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold">of ADSs</div>
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold">Beneficially</div>
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold">Owned*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">Directors and Executive Officers</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Dale Pfost (6)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2,500</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Donald Marvin (7)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,500</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Adi Mor(8)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,329,468</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">11.5</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Neil Cohen(9)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">15,430</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Nissim Darvish(10)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">15,944</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Joel Maryles (11)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">5,621</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Alan Moses (12)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">4,621</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Claude Nicaise (13)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">4,621</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25; font-weight: bold">All current executive officers and directors as a group (8 persons)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,379,705</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">11.89</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  </table>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br /> </div> </div>

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">* Percentage ownership based on 11,404,515 ADSs outstanding as of March 24, 2022.</div>
</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br /> </div> </div>

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">(1) Represents 2,578,174 ADSs, representing 51,563,480 ordinary shares, held by OrbiMed
Israel Partners Limited Partnership, or OIP and 28,817 ADSs, representing 576,340 Ordinary Shares, issuable upon the exercise of warrants
to purchase ADSs. The percentage is calculated based upon 11,397,803 ADSs outstanding, representing 227,956,060 Ordinary Shares, and giving
effect to the additional 28,817 ADSs, representing 576,340 Ordinary Shares, that would be outstanding following the exercise of the warrants
held by OIP. OIP is the shareholder of record. OrbiMed Israel BioFund GP Limited Partnership, or OrbiMed BioFund, is the general partner
of OIP, and OrbiMed Israel GP Ltd., or OrbiMed Israel GP, is the general partner of OrbiMed BioFund. By virtue of such relationships,
OrbiMed BioFund and OrbiMed Israel GP may be deemed to have voting and investment power with respect to the shares held directly by OIP
and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Israel GP exercises this investment and voting
power through a management committee comprised of Carl Gordon, Jonathan T. Silverstein, Nissim Darvish, Anat Naschitz and Erez Chimovits,
each of whom disclaims beneficial ownership of the shares held by OIP. The address of OIP is 89 Medinat HaYehudim St., Build E, 11th Floor,
Herzliya 46766 Israel.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">(2) The address of Centillion Fund, Inc. is 10 Manoel Street, Castries, Saint Lucia.</div>

<div style="line-height: 1.25">&#160;</div> </div> </div>

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">(3) Represents 1,108,509 ADSs, representing 22,170,180 ordinary shares, held by Rivendell
Investments 2017-9 LLC, or Rivendell, as reported by Rivendell on Schedule 13G filed with the SEC on March 26, 2021, and 23,054 ADSs,
representing 461,080 Ordinary Shares, issuable upon the exercise of warrants to purchase ADSs. The percentage is calculated based upon
11,397,803 ADSs outstanding, representing 227,956,060 Ordinary Shares, and giving effect to the additional 23,054 ADSs, representing 461,080
Ordinary Shares, that would be outstanding following the exercise of the warrants held by Rivendell. Rivendell is the shareholder of record.
Peter Thiel is the beneficial owner of Rivendell and has sole voting and investment power over the securities held by Rivendell. The address
of Rivendell is 1209 Orange Street, Wilmington, Delaware 19801.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;<br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">(4) Consists of (i) 514,495 ADSs owned directly by Dr. George, (ii) 649,550 ADSs owned
by Dr. Adi Mor&#160;(Dr. George&#8217;s spouse), (iii) 33,725 options to purchase 33,725 ADSs of the Company issued directly to Dr. George,
issuable upon the exercise of options, and (iv) 131,698 options to purchase 131,698 ADSs of the Company, issued to Dr. Mor, (Dr. George&#8217;s
spouse).</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">(5) The Apeiron Group consists of (i) Apeiron SICAV Ltd. &#8211; Presight Capital Fund
One, of which owns 438,993 ADSs, (ii) Apeiron Presight Capital Fund II, LP, of which owns 316,987 ADSs, and (iii) Apeiron Investment Group
Ltd., of which owns 14,408 ADSs issuable upon the exercise of warrants. Each of Fabian Hansen and Christian Angermayer may be deemed to
share voting and investment power with respect to the ADSs held by the Apeiron Group.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">(6) Represents 2,500 ADSs of the Company as reported by Dr. Dale Pfost on Form 4 filed
with the SEC on March 15, 2022</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">(7) Represents 1,500 ADSs of the Company as reported by Mr. Donald Marvin on Form 4
filed with the SEC on March 21, 2022.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">77</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">(8) Consists of (i) 649,550 ADSs owned directly by Dr. Mor, (ii) 514,495 ADSs owned
by Dr. George, (Dr. Mor&#8217;s spouse), (iii) 131,698 ADSs&#160;issued to Dr. Mor, issuable upon the exercise of options, and (iv) 33,725
options to purchase 33,725 ADSs of the Company issued to Dr. George, (Dr. Mor&#8217;s spouse) issuable upon the exercise of options, as
reported by Dr. Adi Mor on Schedule 13D filed with the SEC on January 20, 2022.</div> </div>

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">(9) Includes 10,409 ADSs of the Company, and 5,021 ADSs of the Company issuable upon
the exercise of options within 60 days of the date hereof, as reported by Mr. Neil Cohen on Form 4 filed with the SEC on March 15, 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">(10)&#160; Includes 1,200 ADSs of the Company, and 14,744 ADSs of the Company issuable
upon the exercise of options, as reported by Dr. Nissim Darvish on Form 4 filed with the SEC on March 14, 2022.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">(11) Represents 1,000 ADSs of the Company and 4,621 ADSs of the Company issuable upon
the exercise of options within 60 days of the date hereof, as reported by Mr. Joel Maryles on Form 4 filed with the SEC on March 21, 2022.</div>
</div>

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">(12) Represents 4,621 ADSs of the Company issuable upon the exercise of options within
60 days of the date hereof, as reported by Dr. Alan Moses on Form 4 filed with the SEC on March 9, 2022.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;<br /> </div>

<div style="text-indent: 18pt; line-height: 1.25">(13) Represents 4,621 ADSs of the Company issuable upon the exercise of options within
60 days of the date hereof, as reported by Dr. Claude Nicaise on Form 4 filed with the SEC on March 9, 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Securities Authorized for Issuance under Equity Compensation Plans</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">The following table provides certain information as of December 31, 2021, with respect
to our equity compensation plans under which our equity securities are authorized for issuance:</div> </div>

<div style="line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div> </div>

<table cellspacing="0" cellpadding="0" id="z710de406fcbb414ba9cfceeee9bc0139" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Plan Category</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Number of securities to be issued upon exercise of outstanding options,
        warrants and rights</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Weighted-average exercise price of outstanding options, warrants
        and rights</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Number of securities remaining available for future issuance under
        equity compensation plans (excluding securities reflected in column (a))</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-weight: bold"> (a)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-weight: bold">(b)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25; font-weight: bold">(c)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
        <div style="line-height: 1.25">Equity compensation plans approved by security holders</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,350,163</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">7.65</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">107,755</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%">
        <div style="line-height: 1.25">Equity compensation plans not approved by security holders</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
        <div style="line-height: 1.25">Total</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,350,163</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">7.65</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">107,755</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25"><span style="font-weight: bold"><span id="Item13"><!--Anchor--></span>Item 13.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold">Certain
Relationships and Related Transactions, and Director Independence</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Certain Relationships and Related Transactions</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Described below are any transactions occurring since January&#160;1, 2021, and any currently
proposed transactions to which either the Company was a party and in which:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za39d7a49ad7648848ed0b6b1a816c629" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt">&#160;</td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>The amounts involved exceeded or will exceed the lesser of&#8201; (i)&#160;$120,000 and (ii)&#160;one&#160;percent of the average
        of the Company&#8217;s&#160; total assets at year end for the last two completed fiscal&#160;years; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6ec92b3f6db84b66a6330e04e7416aaa" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt">&#160;</td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>A director, executive officer, holder of more than 5% of the outstanding share capital of the Company, or any member of such person&#8217;s
        immediate family had or will have a direct or indirect material interest.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold">Chemomab (f/k/a Anchiano) Transactions</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">&#160;</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; margin-left: 18pt">The following transactions relate to the Registrant,
formerly known as Anchiano Therapeutics Ltd., prior to the consummation of the Merger.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">78</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab entered into employment agreements with each of its executive officers.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Chemomab&#8217;s Articles of Association permit it to insure each of its directors and
officers to the fullest extent permitted by the Companies Law. Chemomab has obtained directors and officers insurance for its executive
officers and directors.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">All related party transactions are reviewed and approved by the audit committee of Chemomab,
as required by the audit committee charter.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold; font-style: italic">Related
Party Transactions</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Israel&#8217;s Companies Law, 5759-1999, or the Companies Law, a related party
transaction in which an &#8220;office holder&#8221; has a personal interest may be approved only if it is for the benefit of the company.
An office holder is defined in the Companies Law as a director, a general manager, chief business manager, deputy general manager, vice
general manager, any other person assuming the responsibilities of any of these positions regardless of such person&#8217;s title, and
any other manager directly subordinate to the general manager. A transaction that is not an extraordinary transaction in which an office
holder has a personal interest requires the approval of the board of directors, unless the articles of association of the company provide
otherwise. If the transaction is an extraordinary transaction, it must be approved by the audit committee and the board of directors,
and, under certain circumstances, by the shareholders of the company. An &#8220;extraordinary transaction&#8221; is a transaction other
than in the ordinary course of business, other than on market terms or that is likely to have a material impact on the company&#8217;s
profitability, assets or liabilities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Pursuant to the Companies Law, extraordinary transactions in which a controlling shareholder
has a personal interest require the approval of the audit committee, or the compensation committee if the transaction is in connection
with employment or service with the company, the board of directors and the shareholders of the company. The shareholder approval must
be by a simple majority of all votes cast, provided that (i)&#160;such majority includes a simple majority of the votes cast by non-controlling
shareholders having no personal interest in the matter or (ii)&#160;the total number of votes of shareholders mentioned in clause&#160;(i)&#160;above
who voted against such transaction does not exceed 2% of the total voting rights in the company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In most cases, the Companies Law prohibits any director who has a personal interest
in a transaction from being present for the discussion or voting pertaining to such transaction in the audit committee or board of directors.
Nevertheless, a director who has a personal interest may be present at the meeting and vote on the matter if a majority of the directors
or members of the audit committee have a personal interest in the approval of such transaction; in this case, however, the transaction
also requires shareholder approval.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic; font-weight: bold">Director
and Officer Compensation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, Chemomab is required to approve, at least once every three&#160;years,
a compensation policy with respect to office holders. Following the recommendation of Chemomab&#8217;s compensation committee, the compensation
policy must be approved by the board of directors and shareholders. The shareholder approval must be by a simple majority of all votes
cast, provided that (i)&#160;such majority includes a simple majority of the votes cast by non-controlling shareholders having no personal
interest in the matter or (ii)&#160;the total number of votes of shareholders mentioned in clause (i)&#160;above who voted against such
transaction does not exceed 2% of the total voting rights in the company. In general, the terms of compensation of directors, the chief
executive officer and any employee or service provider who is considered a controlling shareholder must be approved separately by the
compensation committee, the board of directors and the shareholders. The compensation terms of other officers who report directly to the
chief executive officer requires the approval of the compensation committee and the board of directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Corporate Governance and Independent Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In compliance with the listing requirements of Nasdaq, we have a comprehensive plan
of corporate governance for the purpose of defining responsibilities, setting high standards of professional and personal conduct and
assuring compliance with such responsibilities and standards. We currently regularly monitor developments in the area of corporate governance
to ensure we are in compliance with the standards and regulations required by Nasdaq.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Based upon information requested from and provided by each director concerning their
background, employment and affiliations, including family relationships, our board of directors has determined that each of the directors
is independent as defined under Nasdaq listing standards, with the exceptions of Dr. Mor and Dr. Pfost. Our board of directors also determined
that Nissim Darvish and Neil Cohen, who comprise the compensation committee and Neil Cohen and Joel Maryles, who comprise the corporate
governance and nominating committee, all satisfy the independence standards for such committees established by the SEC and Nasdaq listing
standards, as applicable. With respect to the Audit Committee, our board of directors has determined that Joel Maryles, Alan Moses and
Claude Nicaise satisfy the independence standards for such committee established by Rule 10A-3 under the Exchange Act, the SEC and Nasdaq
listing standards, as applicable, and that Joel Maryles is a financial expert under the rules of the SEC. The board of directors considered
the relationships between such directors and certain of the investors of the Registrant and determined that such relationships did not
affect such directors&#8217; independence under the standards of Nasdaq, or, where applicable, under SEC rules.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">79</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, our articles of association allow our board of directors to appoint new
directors to fill vacancies which occurred for any reason or as additional directors, provided that the number of board members shall
not exceed the maximum numbers of directors mentioned above. The appointment of a director by the board shall be in effect until the following
annual general meeting of the shareholders or until the end of his tenure in accordance with our articles of association. Our board of
directors may continue to operate for as long as the number of directors is not less than the minimum number of directors mentioned above.</div>

<div style="text-indent: 18pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, under the Companies Law, our board of directors must determine the minimum
number of directors who are required to have financial and accounting expertise. Under applicable regulations, a director with financial
and accounting expertise is a director who, by reason of his or her education, professional experience and skill, has a high level of
proficiency in and understanding of business accounting matters and financial statements. He or she must be able to thoroughly comprehend
the financial statements of the company and initiate discussion regarding the manner in which financial information is presented. In determining
the number of directors required to have such expertise, the board of directors must consider, among other things, the type and size of
the company and the scope and complexity of its operations. Our board of directors has determined that we require at least one director
with the requisite financial and accounting expertise and that Joel Maryles has such expertise.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold"><span id="Item14"><!--Anchor--></span>Item 14.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold">Principal
Accountant Fees and Services</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">Somekh Chaikin, Tel Aviv, Israel (PCAOB ID 1057), a member of KPMG International, has
served as our independent registered public accounting firm for 2021 and 2020. The following table sets forth fees billed to us by our
independent registered public accounting firm during the fiscal years ended December&#160;31, 2021 and 2020 for (i)&#160;services rendered
for the audit of our annual financial statements and the review of our quarterly financial statements; (ii)&#160;services by our independent
registered public accounting firm that are reasonably related to the performance of the audit or review of our financial statements and
that are not reported as Audit Fees; (iii)&#160;services rendered during the period in connection with tax compliance, tax advice and
tax planning; and (iv)&#160;all other fees for services rendered.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<table cellspacing="0" cellpadding="0" id="zc5d65a22593f44ccbc6ed65e9c4eb85c" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year Ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2021</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2020</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Audit Fees&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">173</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">121</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Tax Fees&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">29</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">35</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">All Other Fees&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Total&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">202</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">156</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of
Independent Auditors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our Audit Committee has the sole authority to approve the scope of the audit and any
audit-related services, as well as all audit fees and terms. The Audit Committee must pre-approve any audit and non-audit services provided
by our independent registered public accounting firm. The Audit Committee will not approve the engagement of the independent registered
public accounting firm to perform any services that the independent registered public accounting firm would be prohibited from providing
under applicable laws, rules&#160;and regulations, including those of self-regulating organizations. The Audit Committee will approve
permitted non-audit services by our independent registered public accounting firm only if it determines that using a different firm to
perform such services will be less efficient or cost-effective. The Audit Committee reviews and pre-approves the statutory audit fees
that can be provided by the independent registered public accounting firm on an annual basis.</div>

<div style="text-indent: 18pt; line-height: 1.25"> <br /> </div> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">80</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div><br />

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTIV"><!--Anchor--></span>PART&#160;IV</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold"><span id="Item15"><!--Anchor--></span>Item 15.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold">Exhibits
and Financial Statement Schedules</span></div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="e6d7a914b7ed4b2f8de0afcbf4b8661a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><span style="font-weight: bold">Exhibit&#160;No.</span></td>
    <td style="width: auto; vertical-align: top"><span style="font-weight: bold">Description</span></td> </tr>
  </table>

<div style="line-height: 1.25"> <br /> </div>

<table cellspacing="0" cellpadding="0" id="z3a099a3448864b658e0545b02d1bdfa3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1534248/000110465921037294/tm219877d1_ex3-1.htm">1.1</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1534248/000110465921037294/tm219877d1_ex3-1.htm">Amended and Restated Articles of
        Association (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s current report on Form 8-K filed with the SEC on March
        17, 2021)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc83b2e0883cf49548fbf5e7fef3a90d3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="exhibit_4-1.htm">4.1*</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_4-1.htm">Description of Share Capital</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf611cb4f5d70471a8de6fa99da6c04e2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1534248/000110465921019580/tm211883-4_s4a.htm#tANF">10.1</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1534248/000110465921019580/tm211883-4_s4a.htm#tANF">Form of Indemnification Agreement
        (incorporated by reference to Exhibit 10.7 of the Company&#8217;s Amendment No. 1 to its Registration Statement on Form S-4 filed with
        the Securities and Exchange Commission on February 10, 2021)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z885625b6a18446c0b834e4c99f75070f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="exhibit_10-2.htm">10.2*+</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_10-2.htm">Compensation Policy for Officers and Directors</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8e27bdacbc4c48879fba74e11ceea0c8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1534248/000114420419000925/tv507924_ex10-6.htm">10.3+</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1534248/000114420419000925/tv507924_ex10-6.htm">2011 Incentive Plan for Employees,
        Officers and Consultants (previously filed as Exhibit&#160;10.6 of our Registration Statement on Form&#160;F-1 (File No.&#160;333-229155)
        as filed with the SEC on January&#160;7, 2019 and incorporated by reference herein).</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb968b7fa4e83436d95a4b845b1815003" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1534248/000114420419000925/tv507924_ex10-8.htm">10.4+</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1534248/000114420419000925/tv507924_ex10-8.htm">2017 Equity-Based Incentive Plan
        (previously filed as Exhibit&#160;10.8 of our Registration Statement on Form&#160;F-1 (File No.&#160;333-229155) as filed with the SEC
        on January&#160;7, 2019 and incorporated by reference herein).</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd6ff744378f6477d9c88663c9874ebe9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1534248/000110465921003702/tm211883d2_ex10-4.htm">10.5+</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1534248/000110465921003702/tm211883d2_ex10-4.htm">Chemomab Ltd. 2015 Share Incentive
        Plan (incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s registration statement on Form S-4 (SEC file number 333- 252070),
        filed with the SEC on January 13, 2021)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z394fc795b3ae45c6b35a2e3e8f12dcba" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.8pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1534248/000110465921003702/tm211883d2_ex10-8.htm">10.6++</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1534248/000110465921003702/tm211883d2_ex10-8.htm">Tel-Aviv Souraski Medical Center
        (TASMC) License Agreement between Chemomab Ltd. and the Medical Research, Infrastructure, Health Services Fund of the Tel Aviv Souraski
        Medical Center., dated December 1, 2011, as amended on May 9, 2013 (incorporated by reference to Exhibit 10.8 of the Company&#8217;s Amendment
        No. 1 to its Registration Statement on Form S-4 filed with the Securities and Exchange Commission on February 10, 2021)</a></div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z747ec77f760e4fa78228333922c120e6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.8pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1534248/000110465921003702/tm211883d2_ex10-9.htm">10.7++</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1534248/000110465921003702/tm211883d2_ex10-9.htm">CMC Collaboration Agreement between
        Chemomab Ltd. and CMC ICOS Biologics, Inc., dated June 7, 2015 (incorporated by reference to Exhibit 10.9 of the Company&#8217;s Amendment
        No. 1 to its Registration Statement on Form S-4 filed with the Securities and Exchange Commission on February 10, 2021)</a></div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd3276d744172418c86b5a846dd86c777" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.8pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1534248/000110465921058967/tm2114615d1_ex1-2.htm">10.8</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1534248/000110465921058967/tm2114615d1_ex1-2.htm">Controlled Equity Offering<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">SM</sup>
        Sales Agreement, dated April 30, 2021, by and between the Company and Cantor Fitzgerald &amp; Co. (incorporated by reference to Exhibit
        1.2 of the Company&#8217;s Registration Statement on Form S-3 filed with the Securities and Exchange Commission on April 30, 2021)</a></div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z733fe00fae7a469893e4ae2a44c03543" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="exhibit_10-10.htm">10.9*+</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_10-10.htm">Employment Agreement, dated September 1</a><a href="exhibit_10-10.htm">, 2021, by and between Chemomab
        Therapeutics, Inc. and Dale Pfost</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z19b2f66f4935425887a170111871aaf5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="exhibit_10-11.htm">10.10*+</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_10-11.htm">Employment Agreement, dated November 8</a><a href="exhibit_10-11.htm">, 2021, by and between Chemomab
        Therapeutics, Inc. and Donald Marvin</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z534596ecab744c44949ab742f3f964d6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="exhibit_21-1.htm">21.1*</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_21-1.htm">List of Subsidiaries</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9ff4a47f59b2413bb970e663fe157994" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="exhibit_23-1.htm">23.1*</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_23-1.htm">Consent of Independent Registered Public Accounting Firm&#160;</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z714603ed558b4e47898081f4db9c9eb6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="#POWER">24.1*</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="#POWER">Power of Attorney</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z063e8c63ab364f91a6136693b61fa21b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="exhibit_31-1.htm">31.1*</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_31-1.htm">Certification of the Chief Executive Officer required by Rule&#160;13a-14(a)&#160;or Rule&#160;15d-14(a)&#160;of
        the Securities Exchange Act of 1934, as amended</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6541304c30244e7a8bd979eb3ffeefda" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="exhibit_31-2.htm">31.2*</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_31-2.htm">Certification of the Chief Financial Officer required by Rule&#160;13a-14(a)&#160;or Rule&#160;15d-14(a)&#160;of
        the Securities Exchange Act of 1934, as amended</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf87f171723684d3f9f4bc97d5c1d405f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="exhibit_32-1.htm">32.1**&#8224;</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_32-1.htm">Certification of the Chief Executive Officer Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of
        2002</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z343e2a73403f49eb8780e0904bbac277" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top"><a href="exhibit_32-2.htm">32.2**&#8224;</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_32-2.htm">Certification of the Chief Financial Officer Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of
        2002</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><br /> </div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-weight: normal; font-style: normal">81</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<table cellspacing="0" cellpadding="0" id="zfd1bd7f525614c06a04574db878da963" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top">101.INS</td>
    <td style="width: auto; vertical-align: top">
        <div>Inline XBRL Instance Document</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb698503ce48141daa3da6d0b88b9d62a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top">101.SCH</td>
    <td style="width: auto; vertical-align: top">
        <div>Inline XBRL Taxonomy Extension Schema Document</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z62ac7ffd443945348c834fd2b22e87ba" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top">101.CAL</td>
    <td style="width: auto; vertical-align: top">
        <div>Inline XBRL Taxonomy Extension Calculation Linkbase Document</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb1501a724c504d3d8dac12df699f8563" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top">101.DEF</td>
    <td style="width: auto; vertical-align: top">
        <div>Inline XBRL Taxonomy Extension Definition Linkbase Document</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zadf76392a4d74c50bb55a4c3168dd932" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top">101.LAB</td>
    <td style="width: auto; vertical-align: top">
        <div>Inline XBRL Taxonomy Extension Label Linkbase Document</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5977d3ddb9f14dd0a3c8a6112e335176" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top">101.PRE</td>
    <td style="width: auto; vertical-align: top">
        <div>Inline XBRL Taxonomy Extension Presentation Linkbase Document</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5321a82e3dc9400f831cd4521be16c1c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 64.59pt; vertical-align: top">104</td>
    <td style="width: auto; vertical-align: top">
        <div>Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">* Filed herewith.</div>

<div style="line-height: 1.25">** Furnished herewith.</div>

<div style="line-height: 1.25">+ Indicates management contract or compensatory plan.</div>

<div style="line-height: 1.25">&#8224; The certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Annual
Report on Form&#160;10-K&#160;and will not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 or the Securities Exchange Act
of 1934, as amended, except to the extent that the registrant specifically incorporates it by reference.</div>

<div style="line-height: 1.25">++ Portions of this Exhibit (indicated with [***]) have been omitted as the Registrant has determined that
(i)&#160;the omitted information is not material and (ii)&#160;the omitted information would likely cause competitive harm to the Registrant
if publicly disclosed.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold"><span id="Item16"><!--Anchor--></span>Item 16.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold">Form
10-K Summary</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">82</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">SIGNATURES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" border="0" id="z3eeb03a4aa094ff1ab86423b82021421" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="2" style="vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">CHEMOMAB THERAPEUTICS LTD.</div> </td> </tr>
  <tr>
    <td style="width: 50%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 47%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 50%; vertical-align: top">
        <div style="line-height: 1.25">Date: March 30, 2022</div> </td>
    <td style="width: 3%; vertical-align: top">
        <div style="line-height: 1.25">By:</div> </td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 47%; vertical-align: top">
        <div style="line-height: 1.25">/s/ Dale Pfost</div> </td> </tr>
  <tr>
    <td style="width: 50%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 47%; vertical-align: top">
        <div style="line-height: 1.25">Dale Pfost<br /> Chief Executive Officer</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="POWER"><!--Anchor--></span>POWER OF ATTORNEY</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints
Dale Pfost&#160;and Donald Marvin, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution
and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments
to this Annual Report on Form&#160;10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith,
with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority
to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and
purposes as he or she might or could do in person, hereby ratifying and confirming that said attorneys-in-fact and agents, or any of them,
or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below
by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9bdcfa0eb6f74f4d8f7a82c202d6e219" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 32.65%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Signature</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="border-bottom: #000000 2px solid; width: 32.66%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Title</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="border-bottom: #000000 2px solid; width: 32.66%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Date</div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">/s/ Dale Pfost</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Chief Executive Officer and Chairman of the Board</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">March 30, 2022</div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">Dale Pfost</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">(Principal Executive Officer)</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">/s/ Donald Marvin</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Chief Financial Officer, Executive Vice President and Chief Operating Officer</div>
        </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">
        <div style="line-height: 1.25">March 30, 2022</div> </div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">Donald Marvin</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">(Principal Financial and Accounting Officer)</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">/s/ Adi Mor</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Director, Chief Scientific Officer</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">
        <div style="line-height: 1.25">March 30, 2022</div> </div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">Adi Mor</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">/s/ Nissim Darvish</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Director</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">
        <div style="line-height: 1.25">March 30, 2022</div> </div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">Nissim Darvish</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">&#160;</td>
    <td style="width: 1.02%; vertical-align: top">&#160;</td>
    <td style="width: 32.66%; vertical-align: bottom">&#160;</td>
    <td style="width: 1.02%; vertical-align: top">&#160;</td>
    <td style="width: 32.66%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">/s/ Joel Maryles</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Director</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">
        <div style="line-height: 1.25">March 30, 2022</div> </div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">Joel Maryles</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">&#160;</td>
    <td style="width: 1.02%; vertical-align: top">&#160;</td>
    <td style="width: 32.66%; vertical-align: bottom">&#160;</td>
    <td style="width: 1.02%; vertical-align: top">&#160;</td>
    <td style="width: 32.66%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">/s/ Alan Moses</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Director</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">
        <div style="line-height: 1.25">March 30, 2022</div> </div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">Alan Moses</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">&#160;</td>
    <td style="width: 1.02%; vertical-align: top">&#160;</td>
    <td style="width: 32.66%; vertical-align: bottom">&#160;</td>
    <td style="width: 1.02%; vertical-align: top">&#160;</td>
    <td style="width: 32.66%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">/s/ Claude Nicaise</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Director</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">
        <div style="line-height: 1.25">March 30, 2022</div> </div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">Claude Nicaise</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">&#160;</td>
    <td style="width: 1.02%; vertical-align: top">&#160;</td>
    <td style="width: 32.66%; vertical-align: bottom">&#160;</td>
    <td style="width: 1.02%; vertical-align: top">&#160;</td>
    <td style="width: 32.66%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">/s/ Neil Cohen</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Director</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">
        <div style="line-height: 1.25">March 30, 2022</div> </div> </td> </tr>
  <tr>
    <td style="width: 32.65%; vertical-align: bottom">
        <div style="line-height: 1.25">Neil Cohen</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td>
    <td style="width: 1.02%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 32.66%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div  style="text-align: center"><span  style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">83</span></div>

<div  style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div> <br />

<div >

<div style="line-height: 1.25">&#160;</div>

<div> <br /> </div> </div> </div> </div>
<!-- Field: /Include-Text -->

<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:11pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Chemomab Therapeutics Ltd. </span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">and its subsidiaries</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:11pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Consolidated Financial </span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Statements </span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">As of December 31, 2021</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. </p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Consolidated Financial Statements as of December 31, 2021</span> </p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Contents</span> </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:92%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Page</span></p> </td> </tr> <tr class="even" style=""> <td style="width:92%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">&#xA0;</span></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">&#xA0;</span></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:92%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style=""><a href="#d1e697_anchor">Report of Independent Registered Public Accounting Firm</a></span></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="">F-2</span></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(PCAOB ID </span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000035" contextRef="From2021-01-01to2021-12-31" name="dei:AuditorFirmId">1057</ix:nonNumeric></span><span style="font-weight:bold; ">)</span> </p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:92%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style=""><a href="#d1e800_anchor">Consolidated Balance Sheets</a></span></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="">F-3</span></p> </td> </tr> <tr class="even" style=""> <td style="width:92%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;</p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;</p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:92%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style=""><a href="#d1e2568_anchor">Consolidated Statements of Operations</a></span></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="">F-4</span></p> </td> </tr> <tr class="even" style=""> <td style="width:92%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;</p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;</p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:92%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style=""><a href="#d1e3201_anchor">Consolidated Statements of Changes in Equity</a></span></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="">F-5</span></p> </td> </tr> <tr class="even" style=""> <td style="width:92%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;</p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;</p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:92%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style=""><a href="#d1e4356_anchor">Consolidated Statements of Cash Flows</a></span></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="">F-6</span></p> </td> </tr> <tr class="even" style=""> <td style="width:92%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;</p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;</p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:92%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style=""><a href="#d1e5453_anchor">Notes to the Consolidated Financial Statements</a></span></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="">F-7</span><span style="">&#x2009;-&#x2009;F-25</span></p> </td> </tr> <tr class="even" style=""> <td style="width:92%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;</p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;</p> </td> </tr> </tbody> </table> </div> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; " id="d1e697_anchor"></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:15%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><img src="kpmg.jpg" alt="image provided by client" style="width:96px; height:40.5px; "/>&#x2009;</p> </td> <td style="width:85%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:15%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:85%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Somekh Chaikin </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">KPMG Millennium Tower </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">17 Ha&#x2019;arba&#x2019;a Street, PO Box 609 </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Tel Aviv 61006, Israel </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">+972 3 684 8000 </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Report of Independent Registered Public Accounting Firm</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; ">To the Shareholders and Board of Directors,</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd.: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><span style="font-style:italic; ">Opinion on the Financial Statements</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">We have audited the accompanying balance sheets of Chemomab Therapeutics Ltd. (the Company) as of December 31, 2021 and 2020, the related statements of operations, changes in equity, and cash flows for each of the years in the two-year period ended December 31, 2021, and the related notes (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><span style="font-style:italic; ">Basis for Opinion</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">These financial statements are the responsibility of the Company&#x2019;s management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#x2019;s internal control over financial reporting. Accordingly, we express no such opinion. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_0000000000036" contextRef="From2021-01-01to2021-12-31" name="dei:AuditorName">Somekh Chaikin</ix:nonNumeric></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Member Firm of KPMG International </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; ">We have served as the Company&#x2019;s auditor since 2015. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_0000000000037" contextRef="From2021-01-01to2021-12-31" name="dei:AuditorLocation">Tel Aviv, Israel</ix:nonNumeric> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; ">March 30, 2022 </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">&#xA9; 2022 KPMG Somekh Chaikin, an Israeli partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;2</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; " id="d1e800_anchor"></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries </p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Consolidated Balance Sheets as of</span> </p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In USD thousands (except share and per share amounts) </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; margin:auto; "> <thead> <tr class="odd" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Assets</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Current assets</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash and cash equivalents </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">3 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000038" contextRef="AsOf2021-12-31" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">15,186</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000039" contextRef="As_Of_12_31_2020" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">11,674</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Short-term bank deposit </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000040" contextRef="AsOf2021-12-31" name="us-gaap:DepositsAssetsCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">45,975</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000041" contextRef="As_Of_12_31_2020" name="us-gaap:DepositsAssetsCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other receivables and prepaid expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">4 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000042" contextRef="AsOf2021-12-31" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,527</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000043" contextRef="As_Of_12_31_2020" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">141</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total current assets</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000044" contextRef="AsOf2021-12-31" name="us-gaap:AssetsCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">62,688</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000045" contextRef="As_Of_12_31_2020" name="us-gaap:AssetsCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">11,839</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Non-current assets</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Long-term deposits </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000046" contextRef="AsOf2021-12-31" name="us-gaap:DepositsAssetsNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000047" contextRef="As_Of_12_31_2020" name="us-gaap:DepositsAssetsNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">4</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Long-term prepaid expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000048" contextRef="AsOf2021-12-31" name="us-gaap:PrepaidExpenseNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">908</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000049" contextRef="As_Of_12_31_2020" name="us-gaap:PrepaidExpenseNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Restricted cash </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000050" contextRef="AsOf2021-12-31" name="us-gaap:RestrictedCashNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">55</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000051" contextRef="As_Of_12_31_2020" name="us-gaap:RestrictedCashNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">53</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Property and equipment, net </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">5 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000052" contextRef="AsOf2021-12-31" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">357</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000053" contextRef="As_Of_12_31_2020" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">152</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Operating lease right-of-use assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">6 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000054" contextRef="AsOf2021-12-31" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">345</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000055" contextRef="As_Of_12_31_2020" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">428</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total non-current assets</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000056" contextRef="AsOf2021-12-31" name="us-gaap:AssetsNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,665</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000057" contextRef="As_Of_12_31_2020" name="us-gaap:AssetsNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">637</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total assets</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000058" contextRef="AsOf2021-12-31" name="us-gaap:Assets" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">64,353</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000059" contextRef="As_Of_12_31_2020" name="us-gaap:Assets" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">12,476</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Current liabilities</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Trade payables </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000060" contextRef="AsOf2021-12-31" name="us-gaap:AccountsPayableTradeCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,336</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000061" contextRef="As_Of_12_31_2020" name="us-gaap:AccountsPayableTradeCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">93</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000062" contextRef="AsOf2021-12-31" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">555</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000063" contextRef="As_Of_12_31_2020" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">715</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Employee and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000064" contextRef="AsOf2021-12-31" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">653</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000065" contextRef="As_Of_12_31_2020" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">438</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Operating lease liabilities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">6 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000066" contextRef="AsOf2021-12-31" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">106</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000067" contextRef="As_Of_12_31_2020" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">70</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total current liabilities</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000068" contextRef="AsOf2021-12-31" name="us-gaap:LiabilitiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,650</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000069" contextRef="As_Of_12_31_2020" name="us-gaap:LiabilitiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,316</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Non-current liabilities</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Non-current operating lease liabilities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">6 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000070" contextRef="AsOf2021-12-31" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">237</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000071" contextRef="As_Of_12_31_2020" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">358</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total non-current liabilities</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000072" contextRef="AsOf2021-12-31" name="us-gaap:LiabilitiesNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">237</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000073" contextRef="As_Of_12_31_2020" name="us-gaap:LiabilitiesNoncurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">358</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Commitments and contingent liabilities</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">7 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total liabilities</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000074" contextRef="AsOf2021-12-31" name="us-gaap:Liabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,887</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000075" contextRef="As_Of_12_31_2020" name="us-gaap:Liabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,674</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Shareholders&apos; equity</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">8 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-10pt !important; padding-left:10pt !important; margin-bottom:0pt; ">Ordinary Shares <ix:nonFraction id="Fact_0000000000077" contextRef="As_Of_12_31_2020" name="us-gaap:CommonStockNoParValue" unitRef="USDperShare" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction id="Fact_0000000000076" contextRef="AsOf2021-12-31" name="us-gaap:CommonStockNoParValue" unitRef="USDperShare" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> par value - Authorized: <ix:nonFraction id="Fact_0000000000078" contextRef="AsOf2021-12-31" name="us-gaap:CommonStockSharesAuthorized" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">650,000,000</ix:nonFraction> shares as of December 31, 2021 and <ix:nonFraction id="Fact_0000000000079" contextRef="As_Of_12_31_2020" name="us-gaap:CommonStockSharesAuthorized" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">500,000,000</ix:nonFraction> shares as of December 31, 2020; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-10pt !important; padding-left:10pt !important; margin-bottom:0pt; ">Issued and outstanding: <ix:nonFraction id="Fact_0000000000081" contextRef="AsOf2021-12-31" name="us-gaap:CommonStockSharesIssued" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_0000000000080" contextRef="AsOf2021-12-31" name="us-gaap:SharesOutstanding" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">228,090,300</ix:nonFraction></ix:nonFraction> shares at December 31, 2021 and <ix:nonFraction id="Fact_0000000000083" contextRef="As_Of_12_31_2020" name="us-gaap:CommonStockSharesIssued" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_0000000000082" contextRef="As_Of_12_31_2020" name="us-gaap:SharesOutstanding" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">9,274,838</ix:nonFraction></ix:nonFraction> shares at December 31, 2020 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000084" contextRef="AsOf2021-12-31" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000085" contextRef="As_Of_12_31_2020" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Additional paid-in capital </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000086" contextRef="AsOf2021-12-31" name="us-gaap:AdditionalPaidInCapital" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">97,639</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000087" contextRef="As_Of_12_31_2020" name="us-gaap:AdditionalPaidInCapital" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">34,497</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accumulated deficit </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000088" contextRef="AsOf2021-12-31" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">36,173</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000089" contextRef="As_Of_12_31_2020" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">23,695</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total shareholders&#x2019; equity</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000090" contextRef="AsOf2021-12-31" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">61,466</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000091" contextRef="As_Of_12_31_2020" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">10,802</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total liabilities and shareholders&#x2019; equity</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000092" contextRef="AsOf2021-12-31" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">64,353</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000093" contextRef="As_Of_12_31_2020" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">12,476</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:16pt; margin-bottom:0pt; ">_____________________&#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0;_____________________ </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">Chief Executive Officer&#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; Chief Executive Officer </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">Date of approval of the financial statements: March 30, 2022 </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">The accompanying notes are an integral part of the consolidated financial statements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;3</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; " id="d1e2568_anchor"></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries </p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Consolidated Statements of Operations for the year ended</span> </p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In USD thousands (except share and per share amounts) </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; margin:auto; "> <thead> <tr class="odd" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span><span style="font-weight:bold; "></span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Operating expenses</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">9 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000094" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">6,334</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000095" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">4,684</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">General and administrative </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">10 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000096" contextRef="From2021-01-01to2021-12-31" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">6,033</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000097" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,288</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total operating expenses</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000098" contextRef="From2021-01-01to2021-12-31" name="us-gaap:OperatingExpenses" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">12,367</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000099" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:OperatingExpenses" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">5,972</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Financing expenses (income), net </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000100" contextRef="From2021-01-01to2021-12-31" name="cmmb:FinanceIncomeExpensesNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">111</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000101" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:FinanceIncomeExpensesNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">21</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Net loss for the year</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000102" contextRef="From2021-01-01to2021-12-31" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">12,478</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000103" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">5,951</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Basic and diluted loss per Ordinary Share* </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">13 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000104" contextRef="From2021-01-01to2021-12-31" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.060</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000105" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.044</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:60%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Weighted average number of Ordinary Shares outstanding, basic, and diluted* </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">13 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000106" contextRef="From2021-01-01to2021-12-31" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">207,468,650</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000107" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">136,755,498</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:16pt; margin-bottom:0pt; ">*&#xA0;<ix:footnote id="FN_6102973d32beaf4e6dd850f5" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1)</ix:footnote> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">The accompanying notes are an integral part of the consolidated financial statements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;4</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; " id="d1e3201_anchor"></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries </p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Consolidated Statements of Changes in Equity</span> </p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In USD thousands (except share amounts) </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; margin:auto; "> <thead> <tr class="odd" style=""> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Ordinary</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Shares</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Additional </span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">paid in</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">capital</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Accumulated</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Deficit</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total </span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Shareholders&#x2019;</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">equity</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Number</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Balance as of January 1, 2020*</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000108" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" name="us-gaap:SharesOutstanding" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">9,274,838</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000109" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000110" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">30,117</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000111" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">17,744</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000112" contextRef="As_Of_12_31_2019" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">12,373</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based compensation </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000113" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">130</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000114" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">130</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Issuance of shares </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000115" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,000</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000116" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,000</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercise of warrants </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000117" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,250</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000118" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,250</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss for the year </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000119" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">5,951</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000120" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">5,951</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Balance as of December 31, 2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000121" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" name="us-gaap:SharesOutstanding" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">9,274,838</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000122" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000123" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">34,497</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000124" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">23,695</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000125" contextRef="As_Of_12_31_2020" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">10,802</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Balance as of January 1, 2021*</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000126" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" name="us-gaap:SharesOutstanding" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">9,274,838</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000127" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000128" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">34,497</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000129" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">23,695</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000130" contextRef="As_Of_12_31_2020" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">10,802</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based compensation </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000131" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,019</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000132" contextRef="From2021-01-01to2021-12-31" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,019</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Effect of reverse capitalization transaction </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000133" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" name="cmmb:EffectOfReverseCapitalizationTransactionShares" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">152,299,702</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000134" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" name="cmmb:EffectOfReverseCapitalizationTransaction" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,476</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000135" contextRef="From2021-01-01to2021-12-31" name="cmmb:EffectOfReverseCapitalizationTransaction" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,476</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Issuance of shares and warrants, net of issuance costs </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000136" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" name="cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">66,381,520</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000137" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">58,637</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000138" contextRef="From2021-01-01to2021-12-31" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">58,637</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercise of options </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000139" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">134,240</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000140" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000141" contextRef="From2021-01-01to2021-12-31" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss for the year </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000142" contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">12,478</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000143" contextRef="From2021-01-01to2021-12-31" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">12,478</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:42%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Balance as of December 31, 2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000144" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" name="us-gaap:SharesOutstanding" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">228,090,300</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000145" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000146" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">97,639</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000147" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">36,173</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000148" contextRef="AsOf2021-12-31" name="us-gaap:StockholdersEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">61,466</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:16pt; margin-bottom:0pt; ">*&#x2009;Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1) </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">The accompanying notes are an integral part of the consolidated financial statements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;5</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; " id="d1e4356_anchor"></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries </p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Statements of Cash flows for the year ended</span> </p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In USD thousands </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; margin:auto; "> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31, </span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31, </span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cash flows from operating activities</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss for the year </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000149" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ProfitLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">12,478</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000150" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ProfitLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">5,951</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Adjustments for operating activities:</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Depreciation </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000151" contextRef="From2021-01-01to2021-12-31" name="us-gaap:Depreciation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">34</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000152" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:Depreciation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based compensation </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000153" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareBasedCompensation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,019</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000154" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ShareBasedCompensation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">130</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Change in other receivables and prepaid expenses </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000155" contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,058</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000156" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">99</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Change in trade payables </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000157" contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,175</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000158" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">68</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Change in accrued expenses </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000159" contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">1,279</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000160" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">392</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Change in employees and related expenses </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000161" contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">215</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000162" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">194</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Change in leases </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000163" contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">2</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000164" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Net cash used in operating activities</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000165" contextRef="From2021-01-01to2021-12-31" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">12,374</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000166" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">5,242</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cash flows from investing activities</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Investment in deposits </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000167" contextRef="From2021-01-01to2021-12-31" name="cmmb:PaymentsForInvestmentInDeposits" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">45,951</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000168" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:PaymentsForInvestmentInDeposits" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Long-term lease deposit </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000169" contextRef="From2021-01-01to2021-12-31" name="cmmb:LongtermLeaseDeposit" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">4</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000170" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:LongtermLeaseDeposit" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Sale of asset held for sale </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000171" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000172" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Purchase of property and equipment </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000173" contextRef="From2021-01-01to2021-12-31" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">239</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000174" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">38</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Net cash used in investing activities</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000175" contextRef="From2021-01-01to2021-12-31" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">45,186</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000176" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">62</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cash flows from financing activities</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash acquired in Merger </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000177" contextRef="From2021-01-01to2021-12-31" name="cmmb:CashAcquiredInMerger" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,427</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000178" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:CashAcquiredInMerger" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercise of options </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000179" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000180" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercise of warrants </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000181" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ProceedsFromIssuanceOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>-</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000182" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ProceedsFromIssuanceOfWarrants" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,250</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Issuance of shares and warrants, net of issuance costs </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000183" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ProceedsFromOtherEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">58,637</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000184" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ProceedsFromOtherEquity" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,500</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Net cash provided by financing activities</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000185" contextRef="From2021-01-01to2021-12-31" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">61,074</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000186" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">4,750</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Change in cash, cash equivalents and restricted cash</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000187" contextRef="From2021-01-01to2021-12-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,514</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000188" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">554</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cash, cash equivalents and restricted cash at beginning of the year</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000189" contextRef="As_Of_12_31_2020" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">11,727</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000190" contextRef="As_Of_12_31_2019" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">12,281</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cash, cash equivalents and restricted cash at end of the year</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000191" contextRef="AsOf2021-12-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">15,241</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000192" contextRef="As_Of_12_31_2020" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">11,727</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Significant non- cash transaction:</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Right-of-use asset recognized with corresponding lease liability</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000193" contextRef="From2021-01-01to2021-12-31" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">345</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000194" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">233</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Liabilities assumed, net of non-cash assets received in Merger</span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000195" contextRef="From2021-01-01to2021-12-31" name="us-gaap:LiabilitiesAssumed1" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">49</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:top; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000196" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:LiabilitiesAssumed1" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:16pt; margin-bottom:0pt; ">The accompanying notes are an integral part of the consolidated financial statements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;6</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:-10pt !important; margin-bottom:0pt; " id="d1e5453_anchor">&#xA0; </p> <ix:nonNumeric id="Fact_0000000000208" contextRef="From2021-01-01to2021-12-31" name="us-gaap:NatureOfOperations" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 1 - General</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; ">1.<span style="padding-left:28.5pt; ">Chemomab Therapeutics Ltd. (hereinafter - &quot;the Company&quot;) is an Israeli based company incorporated under the laws </span>of the State of Israel in September 2011. The Company&#x2019;s registered office is located in Kiryat Atidim, Tel Aviv, Israel. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; ">2.<span style="padding-left:28.5pt; ">The Company currently has no products approved for sale. The Company&#x2019;s operations are funded primarily by its </span>Shareholders. The Company has incurred operating losses in each year since its inception and does not expect to generate significant revenue unless and until it obtains marketing approval for its products. Continuation of the Company&#x2019;s development programs depend on its future ability to raise sources of financing. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; ">3.<span style="padding-left:28.5pt; ">Since January 2020, the COVID-19 outbreak has dramatically expanded into a worldwide pandemic creating </span>macro-economic uncertainty and disruption in the business and financial markets. Many countries around the world, including Israel, have been taking measures designated to limit the continued spread of the Coronavirus, including the closure of workplaces, restricting travel, prohibiting assembling, closing international borders and quarantining populated areas. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Chemomab&apos;s clinical trial sites have been affected by the COVID-19 pandemic, and as a result, enrollment rate of patients to Chemomab&#x2019;s clinical trials has been affected. There might be additional delays in the enrollment for Chemomab&#x2019;s CM-101 phase 2 trials. In addition, after enrollment in these trials, patients might drop out of Chemomab&#x2019;s trials because of the COVID-19 possible implications.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Based on management&#x2019;s assessment, the extent to which the coronavirus will further impact Chemomab&#x2019;s operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, and the actions that may be required to contain the coronavirus or treat its impact. Chemomab&#x2019;s is carefully monitoring the restrictions due to the COVID-19 outbreak and will adjust activities accordingly.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; ">4.<span style="padding-left:28.5pt; ">On December 14, 2020, the Company (formerly known as Anchiano Therapeutics Ltd.) entered into an Agreement and </span>Plan of Merger (the &#x201C;Merger Agreement&#x201D;) with Chemomab Ltd., an Israeli limited company, and CMB Acquisition Ltd., an Israeli limited company and a wholly owned subsidiary of the Company (&#x201C;Merger Sub&#x201D;). On March 16, 2021, (the &#x201C;Effective Time&#x201D;), the Company consummated a merger (the &#x201C;Merger&#x201D;) pursuant to the Merger Agreement by and among the Company, the Merger Sub and Chemomab Ltd. Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into Chemomab Ltd., with Chemomab Ltd. surviving the Merger as the Company&apos;s wholly owned subsidiary. In connection with the Merger, on March 16, 2021, the Company changed its name from &#x201C;Anchiano Therapeutics Ltd.&#x201D; To &#x201C;Chemomab Therapeutics Ltd&#x201D; and the business conducted by Chemomab Ltd. became primarily the business conducted by the Company. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">At the Effective Time(a) each Chemomab Ltd. ordinary share outstanding immediately prior to the Effective Time was converted solely into number of American Depository Shares equal to the exchange ratio described in the Merger Agreement, and each outstanding Chemomab Ltd. option was assumed by the Company, based on the same exchange ratio. Under the exchange ratio formula in the Merger Agreement, immediately following the closing of the Merger (the &#x201C;Closing&#x201D;), the former Chemomab Ltd security holders immediately before the Merger owned approximately 90% of the aggregate number of the outstanding securities of the Company, and the securityholders of the Company immediately prior to the Merger owned approximately <ix:nonFraction id="Fact_0000000000197" contextRef="From2020-12-13to2020-12-14_custom_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" name="cmmb:ShareholdingPercentageImmediatelyFollowingMerger" unitRef="Pure" decimals="2" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction>% of the number of issued and outstanding ordinary shares of the Company (all on a fully diluted basis). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;7</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 1 - General. (cont&#x2019;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">For accounting purposes, Chemomab Ltd. is considered to have acquired the Company based upon the terms of the Merger as well as other factors including; (i) Chemomab Ltd.&#x2019;s former shareholders owned approximately <ix:nonFraction id="Fact_0000000000198" contextRef="From2020-12-13to2020-12-14_custom_FormerChemomabSecurityHoldersMember_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" name="cmmb:ShareholdingPercentageImmediatelyFollowingMerger" unitRef="Pure" decimals="2" scale="-2" format="ixt:numdotdecimal">90</ix:nonFraction>% of the combined Company&#x2019;s outstanding ordinary shares immediately following the closing of the Merger, and (ii) Chemomab Ltd. Management holds key management positions of the combined Company. The Merger has been accounted for as an asset acquisition (reverse recapitalization transaction) rather than a business combination, as the assets acquired, and the liabilities assumed by Chemomab Ltd. do not meet the definition of a business under U.S. GAAP. The net assets acquired in connection with the Merger were recorded at their estimated acquisition date fair market value as of March 16, 2021, the date of completion of the Merger.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In connection with the Merger, and following the effective time of the Merger, the Company effected a reverse share split of the Company&#x2019;s ordinary shares at a ratio of <ix:nonFraction id="Fact_0000000000199" contextRef="From2021-03-14to2021-03-16" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" unitRef="Pure" decimals="INF" scale="0" format="ixt:numdotdecimal">4</ix:nonFraction>:1 (the &#x201C;Reverse Split&#x201D;) and increased the number of ordinary shares underlying each American Depositary Share (&#x201C;ADS&#x201D;) from 5 to 20 ordinary shares. At the effective time of the Merger, each Chemomab Ltd. ordinary shares outstanding immediately prior to the effective time of the Merger automatically converted into the right to receive approximately 12.86 ADSs, each representing <ix:nonFraction id="Fact_0000000000200" contextRef="From2021-03-14to2021-03-16_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" name="cmmb:NumberOfOrdinarySharesConsistedInDS" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">20</ix:nonFraction> ordinary shares of the Company, and a warrant to purchase additional ADSs that may become exercisable only under certain circumstances.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The exchange ratio was calculated by a formula that was determined through arms-length negotiations between the Company and Chemomab Ltd. The combined Company assumed all of the outstanding options of Chemomab Ltd., vested and not vested, under the Chemomab Share Incentive Plan (the &#x201C;2015 Plan&#x201D;), with such options representing the right to purchase a number of ADSs equal to approximately <ix:nonFraction id="Fact_0000000000201" contextRef="AsOf2021-03-16_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" name="cmmb:NumberOfAdsIssuedAndOutstandingAfterMerger" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">12.86</ix:nonFraction> multiplied by the number of Chemomab Ltd. ordinary shares previously represented by such options.</p> <ix:nonNumeric id="Fact_0000000000207" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "> The following table summarizes the net assets acquired based on their estimated fair values as of March 16, 2021, immediately prior to completion of the Merger (in USD thousands): </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:72pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash and cash equivalents </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000202" contextRef="As_Of_3_16_2021" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,427</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Asset held for sale </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000203" contextRef="As_Of_3_16_2021" name="cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Prepaid and other assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000204" contextRef="As_Of_3_16_2021" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">236</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued liabilities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000205" contextRef="As_Of_3_16_2021" name="cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">1,187</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net acquired assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000206" contextRef="As_Of_3_16_2021" name="cmmb:EstimatedFairValueOfNetAssetsAcquired" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,476</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;8</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div> <ix:nonNumeric id="Fact_0000000000234" contextRef="From2021-01-01to2021-12-31" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 2 - Summary of Significant Accounting Policies</span></p> <ix:nonNumeric id="Fact_0000000000209" contextRef="From2021-01-01to2021-12-31" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Basis of Preparation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201C;U.S GAAP&#x201D;). </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000210" contextRef="From2021-01-01to2021-12-31" name="us-gaap:UseOfEstimates" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">B.</span><span style="font-weight:bold; padding-left:26.83pt; ">Use of estimates</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000211" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">Foreign currency</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#x201C;dollar&#x201D; or &#x201C;$&#x201D;), thus; the dollar is the functional currency of the Company.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The transactions and balances of the Company denominated in U.S. dollars are presented at their original amounts as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Monetary assets and liabilities denominated in a non-U.S. dollar currency are translated using the current exchange rate and nonmonetary assets and liabilities and capital accounts denominated in a non-U.S. dollar currency are translated using historical exchange rates.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Statements of operations accounts denominated in a non-U.S. dollar currency are translated using the exchange rates in effect on the transaction dates, except for depreciation, which is translated using historical exchange rate. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000212" contextRef="From2021-01-01to2021-12-31" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">D.</span><span style="font-weight:bold; padding-left:26.28pt; ">Cash and cash equivalents</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at the date acquired. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000213" contextRef="From2021-01-01to2021-12-31" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">E.</span><span style="font-weight:bold; padding-left:26.83pt; ">Restricted cash</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Restricted cash is primarily invested in highly liquid deposits. These deposits were used to secure office rent payments. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000219" contextRef="From2021-01-01to2021-12-31" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">F.</span><span style="font-weight:bold; padding-left:28.31pt; ">Property and equipment</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Property and equipment are stated at cost less accumulated depreciation. Maintenance and repair expenses are charged to operation as incurred. Depreciation is calculated on the straight-line method based on the estimated useful lives of the assets and commences once the assets are ready for their intended use.</p> <ix:nonNumeric id="Fact_0000000000218" contextRef="From2021-01-01to2021-12-31" name="cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> Annual rates at depreciation are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:72pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Computers </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000214" contextRef="AsOf2021-12-31_us-gaap_ComputerEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">33</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Laboratory equipment </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000215" contextRef="AsOf2021-12-31_custom_LaboratoryEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Furniture and equipment </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000216" contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">7</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Leasehold improvement - <ix:nonNumeric id="Fact_0000000000217" contextRef="From2021-01-01to2021-12-31_us-gaap_LeaseholdImprovementsMember" name="cmmb:AnnualRatesOfDepreciation">over the shorter of the lease term or the estimated useful life of the improvement</ix:nonNumeric> </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;9</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 2 - Summary of Significant Accounting Policies (cont&#x2019;d)</span></p> <ix:nonNumeric id="Fact_0000000000220" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">G.</span><span style="font-weight:bold; padding-left:25.72pt; ">Impairment of long-lived assets</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company&#x2019;s property and equipment are reviewed for impairment in accordance with ASC 360, &#x201C;Property and Equipment&#x201D;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less selling costs. During the periods ended December 31, 2021 and 2020, no impairment losses have been recorded. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000221" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">H.</span><span style="font-weight:bold; padding-left:25.72pt; ">Research and Development</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Research and development costs are charged to operations as incurred. Most of the research and development expenses are for subcontractors and wages. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000222" contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">L.</span><span style="font-weight:bold; padding-left:26.83pt; ">Income taxes</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the income taxes expense.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50 percent likely of being realized. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000223" contextRef="From2021-01-01to2021-12-31" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">J.</span><span style="font-weight:bold; padding-left:28.5pt; ">Fair value of financial instruments</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">ASC 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. The ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity&#x2019;s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;10</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 2 - Summary of Significant Accounting Policies (cont&#x2019;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">J.</span><span style="font-weight:bold; padding-left:28.5pt; ">Fair value of financial instruments (cont&#x2019;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company&#x2019;s own credit risk.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The carrying amounts of cash and cash equivalents trade payables, other receivables and accrued expenses approximate their fair value due to the short-term maturity of such instruments. The fair value of long-term restricted deposits and restricted cash also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. None of the Company&#x2019;s non<span style="font-weight:bold; ">- </span>financial assets or liabilities are recorded at fair value on a non-recurring basis. No transfers between levels have occurred during the periods presented. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000224" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">K.</span><span style="font-weight:bold; padding-left:25.72pt; ">Share-based compensation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company accounts for share-based compensation as an expense in the financial statements based on ASC 718. All awards are equity classified and therefore such costs are measured at the grant date fair value of the award and graded vesting attribution approach to recognize compensation cost over the vesting period. The Company recognizes compensation cost for an award with only service conditions that has a graded vesting schedule on a straight-line basis over the requisite service period for the entire award, provided that the cumulative amount of compensation cost recognized at any date at least equals the portion of the grant-date value of such award that is vested at that date.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The fair value for the Company&#x2019;s stock options granted to employees, consultants and directors was estimated using Black-Scholes option-pricing model at the grant date, using the inputs detailed in Note 8(C).</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">The Company has historically not paid dividends and has no foreseeable plans to pay dividends. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000225" contextRef="From2021-01-01to2021-12-31" name="cmmb:GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">L.</span><span style="font-weight:bold; padding-left:26.83pt; ">Government-sponsored research and development</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Chemomab records grants received from the office of the Israel Innovation Authority (the &#x201C;IIA&#x201D;) as a liability, if it is probable that the Chemomab will have to repay the grants received. If it is not probable that the grants will be repaid, Chemomab records the grants as a reduction to research and development expenses. </p></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;11</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 2 - Summary of Significant Accounting Policies (cont&#x2019;d)</span></p> <ix:nonNumeric id="Fact_0000000000229" contextRef="From2021-01-01to2021-12-31" name="cmmb:SeverancePayPolicyPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">M.</span><span style="font-weight:bold; padding-left:24.06pt; ">Severance pay</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Pursuant to Section 14 of the Severance Compensation Law, 1963 (&quot;Section 14&quot;), all employees of the Company are entitled only to monthly deposits, at a rate of <ix:nonFraction id="Fact_0000000000226" contextRef="From2021-01-01to2021-12-31" name="cmmb:PercentageOfMonthlyDepositsRate" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">8.33</ix:nonFraction>% of their monthly salary, made on their behalf with insurance companies. Upon release of the policy to the employee, no additional liability exists between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. This plan has been accounted for as a defined contribution plan. Severance costs amounted to approximately <ix:nonFraction id="Fact_0000000000227" contextRef="From2021-01-01to2021-12-31" name="us-gaap:SeveranceCosts1" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">116</ix:nonFraction> and <ix:nonFraction id="Fact_0000000000228" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:SeveranceCosts1" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">77</ix:nonFraction> thousand USD for the year ended December 31, 2021 and 2020, respectively. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000230" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ConcentrationRiskCreditRisk" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">N.</span><span style="font-weight:bold; padding-left:26.28pt; ">Concentrations of credit risk:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Cash and cash equivalents and short term deposits are invested in banks in Israel. Management believes that the financial institutions that hold the Company&#x2019;s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000231" contextRef="From2021-01-01to2021-12-31" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">O.</span><span style="font-weight:bold; padding-left:25.72pt; ">Leases</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Under Topic 842, the Company determines if an arrangement is a lease at inception. ROU assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company&apos;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company&apos;s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be 5% in 2021. The Company&apos;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. When determining the probability of exercising such options, the Company considers contract-based, asset-based, entity-based, and market-based factors. For leases agreements, the Company has elected the practical expedient to account for the lease and non-lease maintenance components as a single lease component. Therefore, for those leases, the lease payments used to measure the lease liability include all the fixed consideration in the contract. The Company&apos;s lease agreements generally do not contain any residual value guarantees or restrictive covenants. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;12</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 2 - Summary of Significant Accounting Policies (cont&#x2019;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">O.</span><span style="font-weight:bold; padding-left:25.72pt; ">Leases (cont&#x2019;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">For operating leases, the ROU asset is subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">ROU assets for operating leases are periodically reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, Property, Plant, and Equipment &#x2013; Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize. See Note 2(G). </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000232" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ConsolidationPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">P.</span><span style="font-weight:bold; padding-left:28.31pt; ">Principles of consolidation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The consolidated financial statements include the accounts of the Company and the Subsidiary. Intercompany balances and transactions have been eliminated in consolidation. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000233" contextRef="From2021-01-01to2021-12-31" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Q.</span><span style="font-weight:bold; padding-left:25.72pt; ">Earnings per ordinary share</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Basic earnings per ordinary share is calculated using only weighted average ordinary shares outstanding. Diluted earnings per share, if relevant, gives effect to dilutive potential ordinary shares outstanding during the year. Such dilutive shares consist of incremental shares, using the treasury stock method, from the assumed exercise of share options. </p></ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000244" contextRef="From2021-01-01to2021-12-31" name="us-gaap:CashAndCashEquivalentsDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 3 - Cash and Cash Equivalents</span></p> <ix:nonNumeric id="Fact_0000000000243" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:36pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In NIS </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000235" contextRef="AsOf2021-12-31_currency_ILS" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,116</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000236" contextRef="AsOf2020-12-31_currency_ILS" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">95</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In USD </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000237" contextRef="AsOf2021-12-31_currency_USD" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">10,720</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000238" contextRef="AsOf2020-12-31_currency_USD" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">11,526</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In other currencies </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000239" contextRef="AsOf2021-12-31_currency_XXX" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,350</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000240" contextRef="AsOf2020-12-31_currency_XXX" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">53</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000241" contextRef="AsOf2021-12-31" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">15,186</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000242" contextRef="As_Of_12_31_2020" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">11,674</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000252" contextRef="From2021-01-01to2021-12-31" name="cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 4 - Other Receivables and Prepaid Expenses</span></p> <ix:nonNumeric id="Fact_0000000000251" contextRef="From2021-01-01to2021-12-31" name="cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:36pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Government institutions </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000245" contextRef="AsOf2021-12-31" name="cmmb:ReceivablesFromGovernmentInstitutions" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">179</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000246" contextRef="As_Of_12_31_2020" name="cmmb:ReceivablesFromGovernmentInstitutions" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">74</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Prepaid expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000247" contextRef="AsOf2021-12-31" name="us-gaap:PrepaidExpenseCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,348</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000248" contextRef="As_Of_12_31_2020" name="us-gaap:PrepaidExpenseCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">67</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000249" contextRef="AsOf2021-12-31" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,527</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000250" contextRef="As_Of_12_31_2020" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">141</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;13</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div> <ix:nonNumeric id="Fact_0000000000270" contextRef="From2021-01-01to2021-12-31" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 5 - Property and Equipment, Net</span></p> <ix:nonNumeric id="Fact_0000000000269" contextRef="From2021-01-01to2021-12-31" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:36pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cost:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Computers </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000253" contextRef="AsOf2021-12-31_us-gaap_ComputerEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">43</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000254" contextRef="AsOf2020-12-31_us-gaap_ComputerEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">31</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Furniture and equipment </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000255" contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">27</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000256" contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">16</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Laboratory equipment </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000257" contextRef="AsOf2021-12-31_custom_LaboratoryEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">364</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000258" contextRef="AsOf2020-12-31_custom_LaboratoryEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">159</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Website development </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000259" contextRef="AsOf2021-12-31_us-gaap_SoftwareDevelopmentMember" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">14</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000260" contextRef="AsOf2020-12-31_us-gaap_SoftwareDevelopmentMember" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">14</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Leasehold improvements </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000261" contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">16</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000262" contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">5</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000263" contextRef="AsOf2021-12-31" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">464</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000264" contextRef="As_Of_12_31_2020" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">225</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Less - accumulated depreciation</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000265" contextRef="AsOf2021-12-31" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">107</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000266" contextRef="As_Of_12_31_2020" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">73</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000267" contextRef="AsOf2021-12-31" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">357</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000268" contextRef="As_Of_12_31_2020" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">152</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000294" contextRef="From2021-01-01to2021-12-31" name="us-gaap:LesseeOperatingLeasesTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 6 - Leases</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">On May 10, 2020, Chemomab entered into an office and lab space lease agreement (hereinafter &#x2013; &#x201C;The Agreement&#x201D; .(According to the Agreement, Chemomab will rent space in Atidim Park, Tel-Aviv through <span style="-sec-ix-hidden:Fact_0000000000271">May 2023</span>. Chemomab was granted an option to extend the lease term by additional <ix:nonNumeric id="Fact_0000000000272" contextRef="AsOf2020-05-31" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen">three years</ix:nonNumeric>. The annual rent and management fees were approximately USD <ix:nonFraction id="Fact_0000000000273" contextRef="From2020-05-01to2020-05-31" name="cmmb:AnnualRentAndManagementFees" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">71</ix:nonFraction> thousand. Pursuant to the Agreement, a bank guarantee of NIS <ix:nonFraction id="Fact_0000000000274" contextRef="From2020-05-01to2020-05-31_currency_ILS" name="cmmb:BankGuaranteesToPropertyOwner" unitRef="ils" decimals="-3" scale="3" format="ixt:numdotdecimal">170</ix:nonFraction> thousand (approximately USD <ix:nonFraction id="Fact_0000000000275" contextRef="From2020-05-01to2020-05-31" name="cmmb:BankGuaranteesToPropertyOwner" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">49</ix:nonFraction> thousand) was issued to the property owner in 2020.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">On October 24, 2021, Chemomab signed an amendment to the Agreement (&quot;The Amendment&quot;). According to the Amendment, On December 12, 2021 Chemomab returned the previous office and lab space to the property owner and rented a larger space in Atidim Park Tel-Aviv, through <span style="-sec-ix-hidden:Fact_0000000000276">October 2024</span>. In addition, Chemomab was granted an option to extend the lease term by additional <ix:nonNumeric id="Fact_0000000000277" contextRef="AsOf2021-10-24" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen">three years</ix:nonNumeric>. The annual rent and management fees are approximately USD <ix:nonFraction id="Fact_0000000000278" contextRef="From2021-10-01to2021-10-24" name="cmmb:AnnualRentAndManagementFees" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">132</ix:nonFraction> thousand. Pursuant to the Amendment, the bank guarantee issued in 2020 was canceled and a substitute bank guarantee of approximately USD <ix:nonFraction id="Fact_0000000000279" contextRef="From2021-10-01to2021-10-24" name="cmmb:BankGuaranteesToPropertyOwner" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">86</ix:nonFraction> thousand was issued to the property owner during 2022.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">The above operating leases are included in &#x201C;Operating lease right-of-use assets&#x201D; on the Company&#x2019;s Consolidated Balance sheets as of December 31, 2021 and 2020 and represent the Company&#x2019;s right to use the underlying asset for the lease term. The Company&#x2019;s obligations to pay lease payments are included in the current liabilities as &#x201C;Operating lease liabilities&#x201D; and in the non-current liabilities as &#x201C;Non-current operating lease liabilities&#x201D; on the Company&#x2019;s Consolidated Balance sheets as of December 31, 2021 and 2020. Based on the present value of the lease payments for the remaining lease term of the Company&#x2019;s existing lease agreement, the Company recognized operating right-of-use assets and operating lease liabilities of approximately USD <ix:nonFraction id="Fact_0000000000280" contextRef="AsOf2021-12-12" name="cmmb:OperatingRightofuseAssetsAndOperatingLeaseLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">345</ix:nonFraction> thousand on December 12, 2021. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">During the years ended December 31, 2021 and 2020, the Company recognized an increase in right of use assets of USD <ix:nonFraction id="Fact_0000000000281" contextRef="From2021-01-01to2021-12-31" name="us-gaap:OperatingLeaseImpairmentLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">345</ix:nonFraction> thousand and USD <ix:nonFraction id="Fact_0000000000282" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:OperatingLeaseImpairmentLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">500</ix:nonFraction> thousand, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">As of December 31, 2021, operating right-of-use assets and operating lease liabilities were USD <ix:nonFraction id="Fact_0000000000283" contextRef="AsOf2021-12-31" name="cmmb:OperatingRightofuseAssetsAndOperatingLeaseLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">345</ix:nonFraction> thousand and USD <ix:nonFraction id="Fact_0000000000284" contextRef="As_Of_12_31_2020" name="cmmb:OperatingRightofuseAssetsAndOperatingLeaseLiabilities" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">343</ix:nonFraction> thousand, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;14</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 6 - Leases (cont&#x2019;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">As most of the Chemomab&#x2019;s leases do not provide an implicit rate, Chemomab uses its incremental borrowing rate based on the information available at the commencement date of each lease in determining the present value of lease payments. Chemomab&#x2019;s incremental borrowing rate is a hypothetical rate based on its estimation of what its credit rating would be the rate was<ix:nonFraction id="Fact_0000000000286" contextRef="From2021-01-01to2021-12-31" name="us-gaap:DebtInstrumentInterestRateIncreaseDecrease" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_0000000000285" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:DebtInstrumentInterestRateIncreaseDecrease" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">5.2</ix:nonFraction></ix:nonFraction>% in both 2021 and 2020.</p> <ix:nonNumeric id="Fact_0000000000293" contextRef="From2021-01-01to2021-12-31" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> Maturities of lease liabilities under noncancellable leases as of December 31, 2021, are as follows: (in thousands): </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:40pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2022 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000287" contextRef="AsOf2021-12-31" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">121</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2023 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000288" contextRef="AsOf2021-12-31" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">133</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2024 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000289" contextRef="AsOf2021-12-31" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">117</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total future minimum lease payments </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000290" contextRef="AsOf2021-12-31" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">371</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Less imputed interest: </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000291" contextRef="AsOf2021-12-31" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">28</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; "><span style="font-weight:bold; ">)</span> </p> </td> </tr> <tr class="even" style=""> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Present value of operating lease liabilities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000292" contextRef="AsOf2021-12-31" name="us-gaap:OperatingLeaseLiability" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">343</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000311" contextRef="From2021-01-01to2021-12-31" name="us-gaap:CommitmentsDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 7 - Commitments and Contingent Liabilities</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Exclusive License Agreement (hereinafter- &#x201C;the License Agreement&#x201D;)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In December 2011, Chemomab entered into a License Agreement with the Medical Research, Infrastructure, Health Services Fund of the Tel-Aviv Souraski Medical Center (&#x201C;Fund&#x201D;), pursuant to which it was granted with an exclusive license to certain inventions (as defined in the License Agreement) including patents, knowhow and products and the right to sublicense to third parties the rights granted, pursuant to and subject to certain terms and limitation fully set in the License Agreement.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Chemomab has agreed to pay the Fund a non-refundable and non-creditable sublicense fees as a percentage of all Attributed Income (as such term defined in the License Agreement), and shall further pay the Fund royalties from sales made by sublicensee;</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:108pt !important; margin-bottom:0pt; ">(i)<span style="padding-left:26.56pt; ">Royalties in percentage of the Net sales or Service Income (as defined in the License Agreement), subject to </span>certain additional terms set forth therein. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:108pt !important; margin-bottom:0pt; "><span style="padding-left:36pt; ">In addition, with respect to each Licensed Product (as defined therein), Chemomab has agreed to pay the Fund </span>the following non-refundable, non-creditable amounts: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:144pt !important; margin-bottom:0pt; ">(a)<span style="padding-left:24.9pt; "><ix:nonNumeric id="Fact_0000000000295" contextRef="From2021-01-01to2021-12-31_us-gaap_CapitalAdditionsMember" name="us-gaap:LongTermPurchaseCommitmentDescription">USD 100 thousand upon submission of a New Drug Application (&#x201C;NDA&#x201D;), Biological License Application (&#x201C;BLA&#x201D;) or equivalent for each Licensed Product to the United States Food and Drug Administration (&#x201C;FDA&#x201D;), USD 100 thousand upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Europe and one hundred thousand dollars upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Asia. Payment in the aggregate shall not be more than USD 300 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once;</ix:nonNumeric></span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:0pt; text-indent:-36pt !important; padding-left:144pt !important; margin-bottom:0pt; ">(b)<span style="padding-left:24.34pt; "><ix:nonNumeric id="Fact_0000000000296" contextRef="From2021-01-01to2021-12-31_custom_CapitalAdditionsOneMember" name="us-gaap:LongTermPurchaseCommitmentDescription">USD 200 thousand upon the grant of FDA or equivalent agency marketing approval in Europe and/or Asia for each Licensed Product. Payment in the aggregate shall not be more than USD 600 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once.</ix:nonNumeric></span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">As of December 31, 2021 no payments were made to the Fund. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;15</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 7 - Commitments and Contingent Liabilities (cont&#x2019;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Exclusive License Agreement (hereinafter- &#x201C;the License Agreement&#x201D;) (cont&#x2019;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In addition to the payments described above, <ix:nonNumeric id="Fact_0000000000297" contextRef="From2021-01-01to2021-12-31" name="us-gaap:OtherCommitmentsDescription">upon the occurrence of either (i) closing of a public offering of the ordinary shares of Chemomab; or (ii) a Change of Control Transaction, Chemomab shall pay the Fund a cash payment equal to one percent (1%) of the proceeds raised by Chemomab in its initial public offering, or 1% of the consideration received by Chemomab or its shareholders at the closing of a Change of Control Transaction (after deduction of amounts paid as liquidation preference to the shareholders of Chemomab on account of their investment in Chemomab , if any), but in any event not more than USD 3,000 thousand.</ix:nonNumeric></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">B.</span><span style="padding-left:26.83pt; ">Chemomab partially financed its research and development expenditures under programs sponsored by the Israel </span>Innovation Authority (&#x201C;IIA&#x201D;) for the support of certain research and development activities conducted in Israel. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In return for the IIA&#x2019;s participation, Chemomab is committed to pay royalties at rate of <ix:nonFraction id="Fact_0000000000298" contextRef="From2021-01-01to2021-12-31_us-gaap_CapitalAdditionsMember" name="cmmb:PercentageOfRoyaltyPaymentsOnSaleOfProduct" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">3</ix:nonFraction>% of sales of the developed product (linked to U.S. dollar), up to <ix:nonFraction id="Fact_0000000000299" contextRef="From2021-01-01to2021-12-31" name="cmmb:MaximumPercentageOfPaymentsOfRoyalties" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% of the amount of grants received (100% plus interest at LIBOR).</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Chemomab did not receive any grants from the IIA in the years ended December 31, 2021, and 2020.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Since Chemomab &#x2019;s incorporation through December 31, 2021 Chemomab received USD <ix:nonFraction id="Fact_0000000000300" contextRef="AsOf2021-12-31" name="cmmb:CumulativeAmountsOfGrantsReceivedAndRecognized" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,227</ix:nonFraction> thousand from the IIA, which were recognized as a reduction of research and development expenses.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">As of December 31, 2021, Chemomab has no commitment for royalties payable. In addition, the IIA may impose certain conditions to transfer technology or development out of Israel.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">C.</span><span style="padding-left:26.28pt; ">In June 2015, Chemomab entered into a license agreement with subcontractor (&#x201C;the Subcontractor&#x201D;), under which the </span>Subcontractor granted to Chemomab certain licenses to use proprietary rights of the subcontractor, materials and know how in the techniques and use of the same, for purposes of research and development of Chemomab &apos;s product CM-101, as well as commercialization thereof. Further to the agreement, the Subcontractor also provides manufacturing services of intermediates and active pharmaceutical ingredients. According to the related manufacturing agreement, the manufacturing of the product is carried out by the Subcontractor in accordance with Chemomab&apos;s specifications and timeline. The total amount of the agreement is Euro <ix:nonFraction id="Fact_0000000000301" contextRef="From2015-06-01to2015-06-30_currency_EUR" name="us-gaap:LongTermPurchaseCommitmentAmount" unitRef="eur" decimals="-3" scale="3" format="ixt:numdotdecimal">1,200</ix:nonFraction> thousand (excluding materials), of which Euro <ix:nonFraction id="Fact_0000000000302" contextRef="From2015-06-01to2015-06-30_currency_EUR" name="cmmb:PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" unitRef="eur" decimals="-3" scale="3" format="ixt:numdotdecimal">600</ix:nonFraction> thousand was paid upon the commencement of the agreement and the remaining amount was paid upon the achievement of a predetermined milestone. In June 2021 and November 2021, Chemomab and the Subcontractor signed three additional agreements for additional manufacturing and final process lock of the product for clinical use, that adds a total amount of Euro <ix:nonFraction id="Fact_0000000000303" contextRef="From2021-06-01to2021-11-30_currency_EUR" name="us-gaap:LongTermPurchaseCommitmentAmount" unitRef="eur" decimals="-3" scale="3" format="ixt:numdotdecimal">5,831</ix:nonFraction> thousand (excluding materials). Under the agreement, Chemomab is also obligated to pay the Subcontractor royalties determined as a percentage of net sales of each licensee product. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;16</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 7 - Commitments and Contingent Liabilities (cont&#x2019;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">(cont&#x2019;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">During 2021 and 2020, Chemomab recorded expenses related to the above agreements in the amounts of USD <ix:nonFraction id="Fact_0000000000304" contextRef="From2021-01-01to2021-12-31" name="us-gaap:RoyaltyExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,590</ix:nonFraction> thousand and USD <ix:nonFraction id="Fact_0000000000305" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:RoyaltyExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,177</ix:nonFraction> thousand, respectively. The expenses were recorded under research and development expenses. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">D.</span><span style="padding-left:26.28pt; ">In May 2020, Chemomab executed a lien bank deposit of NIS </span><ix:nonFraction id="Fact_0000000000306" contextRef="From2020-05-01to2020-05-31_us-gaap_LeaseAgreementsMember_currency_ILS" name="cmmb:LienOnBankDeposit" unitRef="ils" decimals="-3" scale="3" format="ixt:numdotdecimal">170</ix:nonFraction> thousand (approximately USD <ix:nonFraction id="Fact_0000000000307" contextRef="From2020-05-01to2020-05-31_us-gaap_LeaseAgreementsMember" name="cmmb:LienOnBankDeposit" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">49</ix:nonFraction> thousand) for the benefit of securing the lease payments under the lease agreement described in Note 6 (the &quot;2020 Lien&quot;). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">As of December 31, 2021 the bank restricted deposit amount was USD <ix:nonFraction id="Fact_0000000000308" contextRef="AsOf2021-12-31" name="us-gaap:RestrictedInvestments" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">55</ix:nonFraction> thousand. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In 2022, the 2020 Lien was canceled and Chemomab executed a substitute lien bank deposit of NIS <ix:nonFraction id="Fact_0000000000309" contextRef="From2022-01-01to2022-12-31_us-gaap_LeaseAgreementsMember_currency_ILS_srt_ScenarioForecastMember" name="cmmb:LienOnBankDeposit" unitRef="ils" decimals="-3" scale="3" format="ixt:numdotdecimal">269</ix:nonFraction> thousand (approximately USD <ix:nonFraction id="Fact_0000000000310" contextRef="From2022-01-01to2022-12-31_us-gaap_LeaseAgreementsMember_srt_ScenarioForecastMember" name="cmmb:LienOnBankDeposit" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">86</ix:nonFraction> thousand) for the benefit of securing the lease payments under the Amendment to the lease agreement described in Note 6. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000385" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 8 - Share Capital</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Right attached to shares</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; font-style:italic; ">Ordinary shares</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">All of the issued and outstanding ordinary shares of the Company are duly authorized, validly issued, fully paid and non-assessable. The ordinary are not redeemable, and each ordinary share is entitled to one vote. The holders of the ordinary shares have the right to vote and participate in shareholders&apos; meetings, the right to receive profits, and the right to participate in the accumulated earnings when the Company is dissolved.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1.</span><span style="font-weight:bold; padding-left:28.5pt; ">Voting</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">The holders of ordinary shares are entitled to vote on all matters submitted to shareholders for a vote.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2.</span><span style="font-weight:bold; padding-left:28.5pt; ">Dividends</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The holders of the ordinary shares are entitled to receive dividends, when and as declared by the Board of Directors, and out of funds legally available.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Since its inception, the Company has not declared any dividends.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">B.</span><span style="font-weight:bold; padding-left:26.83pt; ">Financing rounds</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">1.</span><span style="padding-left:28.5pt; ">In June 2015, September 2015 and November 2015, Chemomab entered into an agreement with investors according to </span>which the Company issued the investors warrants to purchase convertible preferred A shares (the &#x201C;Warrants&#x201D;). The warrants were classified as equity. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">2.</span><span style="padding-left:28.5pt; ">During June to December 2020, the Company&apos;s investors exercised the warrants for a total consideration of </span>approximately USD <ix:nonFraction id="Fact_0000000000312" contextRef="From2020-06-01to2020-12-31_custom_InvestorsMember" name="us-gaap:ProceedsFromWarrantExercises" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,250</ix:nonFraction> thousand. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;17</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 8 - Share Capital (cont&#x2019;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">B.</span><span style="font-weight:bold; padding-left:26.83pt; ">Financing rounds (cont&#x2019;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">3.</span><span style="padding-left:28.5pt; ">In September 2019, Chemomab Ltd entered into share purchase agreement with current and new investors (hereinafter </span>&#x2013; &#x201C;2019 SPA&#x201D;), pursuant to which Chemomab Ltd issued <ix:nonFraction id="Fact_0000000000313" contextRef="AsOf2019-09-30_us-gaap_SeriesCPreferredStockMember" name="us-gaap:PreferredStockSharesIssued" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">130,831</ix:nonFraction> series preferred C shares NIS <ix:nonFraction id="Fact_0000000000314" contextRef="AsOf2019-09-30_us-gaap_SeriesCPreferredStockMember" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="ILSperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction> par value for an aggregate consideration of approximately USD <ix:nonFraction id="Fact_0000000000315" contextRef="From2019-09-01to2019-09-30_us-gaap_SeriesCPreferredStockMember" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">11,484</ix:nonFraction> thousand. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">4.</span><span style="padding-left:28.5pt; ">In November 2019 Chemomab entered into a joinder agreement to 2019 SPA, pursuant to which it issued and sold to </span>investors an additional <ix:nonFraction id="Fact_0000000000316" contextRef="AsOf2019-11-30_us-gaap_SeriesCPreferredStockMember_custom_InvestorsMember" name="us-gaap:PreferredStockSharesIssued" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">34,130</ix:nonFraction> series preferred C shares NIS <ix:nonFraction id="Fact_0000000000317" contextRef="AsOf2019-11-30_us-gaap_SeriesCPreferredStockMember_custom_InvestorsMember" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="ILSperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction> par value, for an aggregate consideration of approximately USD <ix:nonFraction id="Fact_0000000000318" contextRef="From2019-11-01to2019-11-30_us-gaap_SeriesCPreferredStockMember_custom_InvestorsMember" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,000</ix:nonFraction> thousand, of which USD <ix:nonFraction id="Fact_0000000000319" contextRef="From2019-11-01to2019-11-30_us-gaap_SeriesCPreferredStockMember" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">500</ix:nonFraction> thousand from certain investors was received immediately after the balance sheet date. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">5.</span><span style="padding-left:28.5pt; ">In May 2020, Chemomab entered a joinder agreement to 2019 SPA, pursuant to which Chemomab issued </span><ix:nonFraction id="Fact_0000000000320" contextRef="AsOf2020-05-30_us-gaap_SeriesCPreferredStockMember" name="us-gaap:PreferredStockSharesIssued" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">34,130</ix:nonFraction> series preferred C shares NIS <ix:nonFraction id="Fact_0000000000321" contextRef="AsOf2020-05-30_us-gaap_SeriesCPreferredStockMember" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="ILSperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction> par value for a total consideration of approximately USD <ix:nonFraction id="Fact_0000000000322" contextRef="From2020-05-01to2020-05-30_us-gaap_SeriesCPreferredStockMember" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,000</ix:nonFraction> thousand. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">6.</span><span style="padding-left:28.5pt; ">In connection with the Merger, on March 15, 2021, the Company entered into Securities Purchase Agreements with </span>certain purchasers, pursuant to which the Company agreed to sell approximately USD <ix:nonFraction id="Fact_0000000000323" contextRef="From2021-03-01to2021-03-15_us-gaap_PrivatePlacementMember" name="cmmb:ProceedsFromSaleOfAdss" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">45.5</ix:nonFraction> million of its ADSs in a private placement transaction, (or &#x201C;The Private Placement&#x201D;). The Private Placement closed on March 22, 2021, at which time the Company sold to the purchasers <ix:nonFraction id="Fact_0000000000324" contextRef="From2021-03-01to2021-03-23_us-gaap_PrivatePlacementMember" name="cmmb:NumberOfWarrantsPurchaseUpAdss" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">2,619,270</ix:nonFraction> ADSs together with warrants to purchase up to <ix:nonFraction id="Fact_0000000000325" contextRef="From2021-03-01to2021-03-23_us-gaap_PrivatePlacementMember" name="cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">261,929</ix:nonFraction> ADSs at an exercise price of USD <ix:nonFraction id="Fact_0000000000326" contextRef="From2021-03-01to2021-03-23_us-gaap_PrivatePlacementMember" name="cmmb:SaleOfStocksPricePerShare" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">17.35</ix:nonFraction> per ADS. The warrants will expire five years from the date of issuance, and if exercised in full, will provide to the Company proceeds of approximately USD <ix:nonFraction id="Fact_0000000000327" contextRef="From2021-03-01to2021-03-23_us-gaap_PrivatePlacementMember" name="cmmb:ProceedsFromSaleOfAdss" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.5</ix:nonFraction> million. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">7.</span><span style="padding-left:28.5pt; ">On April 30, 2021, the Company entered into an At the Market Offering Agreement (the &#x201C;ATM Agreement&#x201D;) with </span>Cantor Fitzgerald &amp; Co., (&#x201C;Cantor&#x201D;). According to the ATM Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $<ix:nonFraction id="Fact_0000000000328" contextRef="From2021-04-01to2021-04-30_custom_AtmAgreementMember" name="cmmb:ProceedsFromSaleOfAdss" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">75</ix:nonFraction> million through Cantor or the ATM Agreement. From April 30, 2021, through December 31, 2021, the Company issued <ix:nonFraction id="Fact_0000000000329" contextRef="From2021-01-01to2021-12-31_custom_AtmAgreementMember" name="cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">699,806</ix:nonFraction> ADSs at an average price of USD <ix:nonFraction id="Fact_0000000000330" contextRef="From2021-01-01to2021-12-31_custom_AtmAgreementMember" name="cmmb:SaleOfStocksPricePerShare" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">22.75</ix:nonFraction> per ADS under the ATM Agreement, resulting in gross proceeds of USD <ix:nonFraction id="Fact_0000000000331" contextRef="From2021-01-01to2021-12-31_custom_AtmAgreementMember" name="cmmb:ProceedsFromSaleOfAdss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">15,917</ix:nonFraction> thousand. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">Share-based compensation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">(1)<span style="padding-left:24.34pt; ">Share-based compensation plan:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company maintains (i) the 2011 Share Option Plan (the &#x201C;2011 Plan&#x201D;), (ii) the 2017 Equity-Based Incentive Plan (the &#x201C;2017 Plan&#x201D;) and (iii) the Chemomab 2015 Share Incentive Plan (the &#x201C;2015 Plan&#x201D;), &#x2009;which was assumed by the Company from Chemomab Ltd. the effectiveness of the Merger. At that time, outstanding options under the 2015 Plan became exercisable for such number of ADSs of the Company as was determined based on the exchange ratio in the Merger Agreement, with a reciprocal adjustment to exercise price. As of December 31, 2021, a total of <ix:nonFraction id="Fact_0000000000332" contextRef="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember" name="cmmb:NumberOfStockAdssResveredForIssuance" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">1,422,153</ix:nonFraction> of our ADSs were reserved for issuance under the 2015 Plan, of which <ix:nonFraction id="Fact_0000000000333" contextRef="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember" name="cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">73,776</ix:nonFraction> ADSs had been issued pursuant to previous exercises options, and <ix:nonFraction id="Fact_0000000000334" contextRef="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember" name="cmmb:NumberOfAdssOptionsIssuableOutstanding" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">1,326,723</ix:nonFraction> ADSs were issuable under outstanding options. Of such outstanding options, options to purchase <ix:nonFraction id="Fact_0000000000335" contextRef="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember" name="cmmb:NumberOfAdssVestedAndExercisable" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">452,230</ix:nonFraction> ADSs had vested and were exercisable as of that date, with a weighted average exercise price of USD <ix:nonFraction id="Fact_0000000000336" contextRef="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">2.75</ix:nonFraction> per ADS. During the year ended December 31, 2021 options to purchase <ix:nonFraction id="Fact_0000000000337" contextRef="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">35,653</ix:nonFraction> ADS were canceled as per the request of an optionee </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;18</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 8 - Share Capital (cont&#x2019;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">Share-based compensation (cont&#x2019;d)</span></p> <ix:nonNumeric id="Fact_0000000000344" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "> (2)<span style="padding-left:24.34pt; ">The expenses that were recognized in the consolidated statements of operations for services received from employees </span>and service providers are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:72pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000338" contextRef="From2021-01-01to2021-12-31_us-gaap_ResearchAndDevelopmentExpenseMember" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">137</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000339" contextRef="From2020-01-01to2020-12-31_us-gaap_ResearchAndDevelopmentExpenseMember" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">84</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">General and administrative </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000340" contextRef="From2021-01-01to2021-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,882</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000341" contextRef="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">46</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total share-based compensation expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000342" contextRef="From2021-01-01to2021-12-31" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,019</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000343" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">130</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000372" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> (3)<span style="padding-left:24.34pt; ">The number and weighted average exercise price of options are as follows:</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:72pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted </span><span style="font-weight:bold; ">average</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">exercise price</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Number of </span><span style="font-weight:bold; ">options</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">average </span><span style="font-weight:bold; ">remaining </span><span style="font-weight:bold; ">contractual </span><span style="font-weight:bold; ">life (in years)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">average </span><span style="font-weight:bold; ">exercise price</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Number of </span><span style="font-weight:bold; ">options</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">average </span><span style="font-weight:bold; ">remaining </span><span style="font-weight:bold; ">contractual </span><span style="font-weight:bold; ">life (in years)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at January 1 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000345" contextRef="As_Of_12_31_2020" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.07</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000346" contextRef="As_Of_12_31_2020" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">10,455,580</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_0000000000347" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear">7.8</ix:nonNumeric> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000348" contextRef="As_Of_12_31_2019" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.07</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000349" contextRef="As_Of_12_31_2019" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">8,072,704</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_0000000000350" contextRef="Duration_1_1_2019_To_12_31_2019" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear">8.09</ix:nonNumeric> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Acquired in Merger </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000351" contextRef="From2021-01-01to2021-12-31" name="cmmb:StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">609,535</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercise </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000352" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.08</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000353" contextRef="From2021-01-01to2021-12-31" name="cmmb:StockIssuedDuringPeriodSharesStockOptionsExercised1" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">134,220</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000354" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="USDperShare" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000355" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:StockIssuedDuringPeriodSharesStockOptionsExercised1" unitRef="Share" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Forfeited </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000356" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">1.25</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000357" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">1,712,275</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000358" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.07</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000359" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">10,804</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Granted </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000360" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.62</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000361" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">17,784,640</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000362" contextRef="From2021-01-01to2021-12-31" name="cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear">9.79</ix:nonNumeric></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000363" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.08</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000364" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">2,393,680</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_0000000000365" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear">9.77</ix:nonNumeric> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:10pt; margin-bottom:0pt; ">December 31 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000366" contextRef="AsOf2021-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.38</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000367" contextRef="AsOf2021-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">27,003,260</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000368" contextRef="From2021-01-01to2021-12-31" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear">8.12</ix:nonNumeric></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000369" contextRef="As_Of_12_31_2020" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.07</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000370" contextRef="As_Of_12_31_2020" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">10,455,580</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_0000000000371" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear">7.8</ix:nonNumeric> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">(4)<span style="padding-left:24.34pt; ">Fair value measurement:</span></p> <ix:nonNumeric id="Fact_0000000000384" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "> The fair value of the options is measured at the grant date using the Black-Scholes Option pricing model and the assumptions used to calculate the fair value of the options are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:72pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021 grants</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Weighted average share price (in U.S. dollar)<sup>(a)</sup> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000373" contextRef="AsOf2021-12-31_srt_MinimumMember" name="us-gaap:SharePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">9.44</ix:nonFraction></span><span style="font-weight:bold; ">-</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000374" contextRef="AsOf2021-12-31_srt_MaximumMember" name="us-gaap:SharePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">27.26</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercise price (in U.S. dollar) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000375" contextRef="AsOf2021-12-31_srt_MinimumMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">9.44</ix:nonFraction></span><span style="font-weight:bold; ">-</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000376" contextRef="AsOf2021-12-31_srt_MaximumMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">27.26</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expected life of options (in years)<sup>(b)</sup> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000377" contextRef="From2021-01-01to2021-12-31_srt_MinimumMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear">5.73</ix:nonNumeric></span><span style="font-weight:bold; ">-</span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_0000000000378" contextRef="From2021-01-01to2021-12-31_srt_MaximumMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear">6.28</ix:nonNumeric></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expected volatility<sup>(c)</sup> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000379" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">65.93</ix:nonFraction></span><span style="font-weight:bold; ">%-</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000380" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">70.88</ix:nonFraction></span><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Risk-free interest rate<sup>(d)</sup> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000381" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">1.36</ix:nonFraction></span><span style="font-weight:bold; ">%-</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000382" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">1.64</ix:nonFraction></span><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Dividend yield </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000383" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;19</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 8 - Share Capital (cont&#x2019;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">Share-based compensation (cont&#x2019;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">(a)<ix:footnote id="FN_621deee6493d5b6a527b0929" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US"><span style="padding-left:8.9pt; ">The weighted average share price is based on the Company&#x2019;s ordinary share valuation as at the grant date.</span></ix:footnote> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:92pt !important; margin-bottom:0pt; ">(b)<ix:footnote id="FN_621deee6493d5b6a527b092b" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US"><span style="padding-left:8.34pt; ">Expected life for the periods presented was determined according to the simplified method since, at the date of </span>grant, the Company did not have enough history to make an estimate. This method effectively assumes that exercise occurs over the period from vesting until expiration, and therefore the expected term is the midpoint between the service period and the contractual term of the award. The simplified method is applicable to service conditions and for performance conditions that are probable of achievement. If meeting the performance condition is not probable, the Company will use the awards&#x2019; contractual term if the service period is implied, or the simplified method, if the service period is explicitly stated.</ix:footnote> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:92pt !important; margin-bottom:0pt; ">(c)<ix:footnote id="FN_621deee6493d5b6a527b0925" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US"><span style="padding-left:8.9pt; ">Expected volatility is based on historical volatility over the most recent period commensurate with the expected </span>term of the option. As the Company has a short trading history for its ordinary shares, when the Company&apos;s trading period is shorter than the expected term, the expected volatility is derived from the average historical share volatilities of several unrelated public companies within the Company&#x2019;s industry that the Company considers to be comparable to its own business over a period equivalent to the option&#x2019;s expected term.</ix:footnote> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:92pt !important; margin-bottom:0pt; ">(d)<ix:footnote id="FN_621deee6493d5b6a527b0927" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US"><span style="padding-left:8.34pt; ">The risk-free rate for the expected term of the options is based on the Black-Scholes option-pricing model on the </span>yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards.</ix:footnote> </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000399" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 9 - Research and Development</span></p> <ix:nonNumeric id="Fact_0000000000398" contextRef="From2021-01-01to2021-12-31" name="cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:36pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Consultants and subcontractors </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000386" contextRef="From2021-01-01to2021-12-31" name="cmmb:ConsultantsAndSubcontractorsExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,894</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000387" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:ConsultantsAndSubcontractorsExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,079</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Salaries and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000388" contextRef="From2021-01-01to2021-12-31" name="us-gaap:OfficersCompensation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,789</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000389" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:OfficersCompensation" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,158</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Rent and maintenance </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000390" contextRef="From2021-01-01to2021-12-31" name="cmmb:RentAndMaintenanceResearchAndDevelopmentExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">114</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000391" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:RentAndMaintenanceResearchAndDevelopmentExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">106</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based compensation </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000392" contextRef="From2021-01-01to2021-12-31" name="cmmb:SharebasedCompensationResearchAndDevelopmentExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">137</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000393" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:SharebasedCompensationResearchAndDevelopmentExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">84</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000394" contextRef="From2021-01-01to2021-12-31" name="us-gaap:OtherResearchAndDevelopmentExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">400</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000395" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:OtherResearchAndDevelopmentExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">257</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000396" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">6,334</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000397" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">4,684</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;20</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div> <ix:nonNumeric id="Fact_0000000000417" contextRef="From2021-01-01to2021-12-31" name="cmmb:GeneralAndAdministrativeDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 10 - General and Administrative</span></p> <ix:nonNumeric id="Fact_0000000000416" contextRef="From2021-01-01to2021-12-31" name="cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:36pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Salaries and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000400" contextRef="From2021-01-01to2021-12-31" name="us-gaap:SalariesAndWages" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">943</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000401" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:SalariesAndWages" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">334</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Professional services </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000402" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ProfessionalFees" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,695</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000403" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:ProfessionalFees" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">828</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based compensation </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000404" contextRef="From2021-01-01to2021-12-31" name="cmmb:ShareBasedCompensationGeneralAndAdministrativeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,882</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000405" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:ShareBasedCompensationGeneralAndAdministrativeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">46</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Fees to Directors </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000406" contextRef="From2021-01-01to2021-12-31" name="us-gaap:NoninterestExpenseDirectorsFees" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">244</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000407" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:NoninterestExpenseDirectorsFees" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Insurance </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000408" contextRef="From2021-01-01to2021-12-31" name="us-gaap:GeneralInsuranceExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,024</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000409" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:GeneralInsuranceExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">6</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Rent and maintenance </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000410" contextRef="From2021-01-01to2021-12-31" name="cmmb:RentAndMaintenanceGeneralAndAdministrativeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">29</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000411" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:RentAndMaintenanceGeneralAndAdministrativeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000412" contextRef="From2021-01-01to2021-12-31" name="us-gaap:OtherGeneralAndAdministrativeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">216</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000413" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:OtherGeneralAndAdministrativeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">50</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000414" contextRef="From2021-01-01to2021-12-31" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">6,033</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000415" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,288</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000458" contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 11 - Income Taxes</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Tax rates</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Ordinary taxable income in Israel is subject to a corporate tax rate of <ix:nonFraction id="Fact_0000000000418" contextRef="From2021-01-01to2021-12-31_country_IL" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">23</ix:nonFraction>%. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company&#x2019;s US subsidiary, Chemomab Therapeutics Inc. (&quot;Chemomab Inc.) is taxed separately under the U.S. tax laws. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Chemomab Inc. is subject to a federal flat tax rate of <ix:nonFraction id="Fact_0000000000419" contextRef="From2021-01-01to2021-12-31_country_US_us-gaap_DomesticCountryMember" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">21</ix:nonFraction>% and state tax as applicable. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Capital gain is subject to capital gain tax according to the corporate tax rate in the year the assets are sold. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">B.</span><span style="font-weight:bold; padding-left:26.83pt; ">Tax assessments</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">As of December 31, 2021, the Company&#x2019;s tax reports through December 31, 2016 are considered closed to audit inspections by the Israeli Tax Authority (&#x201C;ITA&#x201D;) due to statute of limitation rules effective in Israel. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">The Company has not yet been assessed by the ITA since inception. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">Losses for tax purposes carried forward to future years</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">As of December 31, 2021, the Company and its subsidiaries had approximately $<ix:nonFraction id="Fact_0000000000420" contextRef="AsOf2021-12-31_country_IL" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">143</ix:nonFraction> million (approximately $<ix:nonFraction id="Fact_0000000000421" contextRef="AsOf2020-12-31_country_IL" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">21</ix:nonFraction> million as of December 31, 2020) of net operating loss carryforwards which are available to reduce future taxable income with no limitation on the period of use. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;21</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 11 - Income Taxes (cont&#x2019;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">D.</span><span style="font-weight:bold; padding-left:26.28pt; ">Deferred taxes</span> </p> <ix:nonNumeric id="Fact_0000000000436" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> In respect of: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:72pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net operating loss carry-forwards </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000422" contextRef="AsOf2021-12-31" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">33,396</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000423" contextRef="As_Of_12_31_2020" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">4,874</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based compensation expense </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000424" contextRef="AsOf2021-12-31" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,147</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000425" contextRef="As_Of_12_31_2020" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">57</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development costs </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000426" contextRef="AsOf2021-12-31" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,449</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000427" contextRef="As_Of_12_31_2020" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,244</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000428" contextRef="AsOf2021-12-31" name="us-gaap:DeferredTaxAssetsOther" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">38</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000429" contextRef="As_Of_12_31_2020" name="us-gaap:DeferredTaxAssetsOther" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">25</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Gross deferred tax assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000430" contextRef="AsOf2021-12-31" name="us-gaap:DeferredTaxAssetsGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">36,030</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000431" contextRef="As_Of_12_31_2020" name="us-gaap:DeferredTaxAssetsGross" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">6,200</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Less - Valuation allowance </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000432" contextRef="AsOf2021-12-31" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">36,030</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000433" contextRef="As_Of_12_31_2020" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">6,200</ix:nonFraction>) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net deferred tax assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000434" contextRef="AsOf2021-12-31" name="us-gaap:DeferredTaxAssetsNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000435" contextRef="As_Of_12_31_2020" name="us-gaap:DeferredTaxAssetsNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company has established a valuation allowance to offset deferred tax assets on December 31, 2021 and 2020 due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. The net change in the total valuation allowance for the year ended at December 31, 2021 was an increase of approximately USD <ix:nonFraction id="Fact_0000000000437" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction> million. </p> <ix:nonNumeric id="Fact_0000000000446" contextRef="From2021-01-01to2021-12-31" name="us-gaap:SummaryOfValuationAllowanceTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">E.</span><span style="font-weight:bold; padding-left:26.83pt; ">Roll forward of valuation allowance</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:72pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance at January 1, 2020 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">$</span> </p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000438" contextRef="As_Of_12_31_2019" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">4,248</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Currency transaction loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000439" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:CurrencyTransactionLossValuationAllowance" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">583</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Income tax expense </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000440" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:IncomeTaxExpenseValuationAllowance" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,369</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance at December 31, 2020 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">$</span> </p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000441" contextRef="As_Of_12_31_2020" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">6,200</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Currency transaction loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000442" contextRef="From2021-01-01to2021-12-31" name="cmmb:CurrencyTransactionLossValuationAllowance" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,425</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Tax assets acquired through merger </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000443" contextRef="From2021-01-01to2021-12-31" name="cmmb:TaxAssetsAcquiredThroughMergerValuationAllowance" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">24,535</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Income tax expense </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000444" contextRef="From2021-01-01to2021-12-31" name="cmmb:IncomeTaxExpenseValuationAllowance" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">2,870</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance at December 31, 2021 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">$</span> </p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000445" contextRef="AsOf2021-12-31" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">36,030</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;22</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 11 - Income Taxes (cont&#x2019;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">F.</span><span style="font-weight:bold; padding-left:28.31pt; ">Reconciliation of theoretical income tax expense to actual income tax expense</span> </p> <ix:nonNumeric id="Fact_0000000000457" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> A reconciliation of the Company&#x2019;s theoretical income tax expense to actual income tax expense is as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:72pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss before income taxes </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000447" contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">12,478</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000448" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">5,951</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Statutory tax rate </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000449" contextRef="From2021-01-01to2021-12-31" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">23</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000450" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="Pure" decimals="INF" scale="-2" format="ixt:numdotdecimal">23</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">% </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Theoretical tax benefit </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000451" contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">2,870</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_0000000000452" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">1,369</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-10pt !important; padding-left:10pt !important; margin-bottom:0pt; ">Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000453" contextRef="From2021-01-01to2021-12-31" name="cmmb:LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">2,870</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000454" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">1,369</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Actual income tax expense </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000455" contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000456" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">G.</span><span style="font-weight:bold; padding-left:25.72pt; ">Accounting for uncertainty in income taxes</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">For the year ended December 31, 2021, the Company did not have any unrecognized tax benefits and does not expect that the amount of unrecognized tax benefits will change significantly within the next 12 months. The Company&#x2019;s accounting policy is to accrue interest and penalties related to unrecognized tax benefits as a component of income tax expense. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000477" contextRef="From2021-01-01to2021-12-31" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 12 - Related Parties Balances and Transactions</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Balances with Related Parties:</span></p> <ix:nonNumeric id="Fact_0000000000465" contextRef="From2021-01-01to2021-12-31" name="cmmb:ScheduleOfRelatedPartyPayablesTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> The following Related Party payables are included in the consolidated Balance Sheets: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:36pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Employee and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000459" contextRef="AsOf2021-12-31_custom_RelatedPartyMember" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">278</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000460" contextRef="AsOf2020-12-31_custom_RelatedPartyMember" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">214</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000461" contextRef="AsOf2021-12-31_custom_RelatedPartyMember" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">72</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000462" contextRef="AsOf2020-12-31_custom_RelatedPartyMember" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000463" contextRef="AsOf2021-12-31_custom_RelatedPartyMember" name="us-gaap:DueToRelatedPartiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">350</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000464" contextRef="AsOf2020-12-31_custom_RelatedPartyMember" name="us-gaap:DueToRelatedPartiesCurrent" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">217</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;23</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 12 - Related Parties Balances and Transactions (cont&apos;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">B.</span><span style="font-weight:bold; padding-left:26.83pt; ">Transactions with Related Parties:</span></p> <ix:nonNumeric id="Fact_0000000000476" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> The following transactions with related parties are included in the consolidated Statements of Operations: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:36pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Salaries and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000466" contextRef="From2021-01-01to2021-12-31" name="cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,255</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000467" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">605</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based payments </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000468" contextRef="From2021-01-01to2021-12-31" name="cmmb:RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">1,775</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000469" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">91</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Professional Services </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000470" contextRef="From2021-01-01to2021-12-31" name="cmmb:RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">244</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000471" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">45</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000472" contextRef="From2021-01-01to2021-12-31" name="cmmb:RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">36</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000473" contextRef="Duration_1_1_2020_To_12_31_2020" name="cmmb:RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">36</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000474" contextRef="From2021-01-01to2021-12-31" name="us-gaap:RelatedPartyCosts" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">3,310</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000475" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:RelatedPartyCosts" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal">777</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric id="Fact_0000000000488" contextRef="From2021-01-01to2021-12-31" name="us-gaap:EarningsPerShareTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 13 - Net Loss Per Share Attributable to Ordinary Shareholders</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">Basic net loss per share is computed by dividing the net loss available to common stockholders by the weighted-average number of ordinary shares outstanding. Diluted net loss per share is computed similarly to basic net loss per share except that the denominator is increased to include the number of additional ordinary shares that would have been outstanding if the potential ordinary shares had been issued and if the additional ordinary shares of were dilutive. Diluted net loss per share is the same as basic net loss per share of ordinary share, as the effect of potentially dilutive securities is antidilutive.</p> <ix:nonNumeric id="Fact_0000000000484" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "> The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods presented: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:36pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">In USD thousands, except share and per </span><span style="font-weight:bold; ">share data</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Numerator:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000478" contextRef="From2021-01-01to2021-12-31" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">12,478</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000479" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:NetIncomeLoss" unitRef="usd" decimals="-3" scale="3" format="ixt:numdotdecimal" sign="-">5,951</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Denominator:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-10pt !important; padding-left:10pt !important; margin-bottom:0pt; ">Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000480" contextRef="From2021-01-01to2021-12-31" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">207,468,650</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000481" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">136,755,498</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss per share attributable to ordinary shareholders, basic and diluted </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000482" contextRef="From2021-01-01to2021-12-31" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.060</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000483" contextRef="Duration_1_1_2020_To_12_31_2020" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" unitRef="USDperShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.044</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; ">&#xA0; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;24</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; "> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#x2009;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 13 - Net Loss Per Share Attributable to Ordinary Shareholders (cont&apos;d)</span> </p> <ix:nonNumeric id="Fact_0000000000487" contextRef="From2021-01-01to2021-12-31" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "> The potential number of weighted-average ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented since including them would have been anti-dilutive are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div style="margin-left:36pt; ">
<table width="100%" cellpadding="0" class="fin" style="border-spacing:0; "> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="6" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Number of shares</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding options to purchase ordinary shares </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonFraction id="Fact_0000000000485" contextRef="From2021-01-01to2021-12-31_us-gaap_EmployeeStockOptionMember" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">27,003,260</ix:nonFraction></span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_0000000000486" contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="Share" decimals="INF" scale="0" format="ixt:numdotdecimal">10,455,580</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p></td></tr></tbody></table></div></ix:nonNumeric></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#x2009;-&#x2009;25</p> </div> <div style="width:100%; clear:both;"> <hr style="height:0.75pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-left:0pt; text-align:left; "/><hr style="height:3pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; margin-bottom:0pt; "></p> </div> </div> </div>
  </div></div></div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>exhibit_4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman',Times,serif;">
  </font>
  <div>
    <div style="line-height: 1.25;">
      <div style="text-align: right; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><font style="font-family: 'Times New Roman',Times,serif;"><u>Exhibit 4.1</u></font></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES</div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">REGISTERED PURSUANT TO SECTION 12 OF THE</div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#160;</div>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">As of the date of this Annual Report on Form 10-K, Chemomab
      Therapeutics Ltd., an Israeli company (&#8220;we,&#8221; &#8220;our&#8221; and the &#8220;Company&#8221;) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: American Depositary Shares, each representing twenty (20) ordinary
      shares, no par value per share. The following description of such securities is intended as a summary of the terms of such securities as currently in effect and is qualified in its entirety by the provisions of our amended and restated articles of
      association, a copy of which is filed as an exhibit to this Annual Report on Form 10-K and is incorporated by reference herein. We encourage you to read our amended and restated articles of association and the applicable provisions of the Israeli
      Companies Law, 5759-1999 (the &#8220;Companies Law&#8221;), for additional information.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">DESCRIPTION OF ORDINARY SHARES</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Registration Number and Purposes of the Company</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">We are registered with the Israeli Registrar of Companies. Our registration number is
      51-4672625.&#160;Our affairs are governed by our amended and restated articles of association, applicable Israeli law and the Companies Law. Our purpose as set forth in our amended and restated articles of association is to engage in any lawful act or
      activity.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Voting Rights</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">All ordinary shares will have identical voting and other rights in all respects.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Transfer of Shares</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Our fully paid ordinary shares are issued in registered form and may be freely transferred
      under our amended and restated articles of association, unless the transfer is restricted or prohibited by another instrument, applicable law or the rules&#160;of the Nasdaq Capital Market. The ownership or voting of our ordinary shares by non-residents
      of Israel is not restricted in any way by our amended and restated articles of association or the laws of the State of Israel, except for ownership by nationals of some countries that are, have been, or will be, in a state of war with Israel.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Election of Directors</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Under our amended and restated articles of association, our board of directors must consist
      of not less than three (3)&#160;but no more than 11 (eleven) directors. Pursuant to our amended and restated articles of association, each of our directors will be appointed by a simple majority vote of holders of our ordinary shares, participating and
      voting at an annual general meeting of our shareholders, provided that (i)&#160;in the event of a contested election, the method of calculation of the votes and the manner in which the resolutions will be presented to our shareholders at the general
      meeting shall be determined by our board of directors in its discretion, and (ii)&#160;in the event that our board of directors does not or is unable to make a determination on such matter, then the directors will be elected by a majority of the voting
      power represented at the general meeting in person or by proxy and voting on the election of directors, provided that if the number of such nominees exceeds the number of directors to be elected, then as among such elected nominees the election shall
      be by a plurality of the votes cast. In addition, our directors are divided into three classes, one class being elected each year at the annual general meeting of our shareholders, and shall serve on our board of directors until the third annual
      general meeting following such election or re-election or until they are removed by a vote of 65% of the total voting power of our shareholders at a general meeting of our shareholders or upon the occurrence of certain events, in accordance with the
      Companies Law and our amended and restated articles of association. In addition, our amended and restated articles of association provide that vacancies on our board of directors may be filled by a vote of a simple majority of directors then in
      office. Any director so appointed will hold office until the next annual general meeting of our shareholders for the election of the class of directors in respect of which the vacancy was created, or in the case of a vacancy due to the number of
      directors being less than the maximum number of directors stated in our amended and restated articles of association, until the next annual general meeting of our shareholders for the election of the class of directors to which such director was
      assigned by our board of directors.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Dividend and Liquidation Rights</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">We may declare a dividend to be paid to the holders of our ordinary shares in proportion to
      their respective shareholdings. Under the Companies Law, dividend distributions are determined by the board of directors and do not require the approval of the shareholders of a company unless the company&#8217;s articles of association provide otherwise.
      Our amended and restated articles of association do not require shareholder approval of a dividend distribution and provide that dividend distributions may be determined by our board of directors.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Pursuant to the Companies Law, the distribution amount is limited to the greater of
      retained earnings or earnings generated over the previous two years, according to our then last reviewed or audited financial statements (less the amount of previously distributed dividends, if not reduced from the earnings), provided that the end of
      the period to which the financial statements relate is not more than six months prior to the date of the distribution. If we do not meet such criteria, then we may distribute dividends only with court approval. In each case, we are only permitted to
      distribute a dividend if our board of directors and, if applicable, the court determines that there is no reasonable concern that payment of the dividend will prevent us from satisfying our existing and foreseeable obligations as they become due.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">In the event of our liquidation, after satisfaction of liabilities to creditors, our assets
      will be distributed to the holders of our ordinary shares in proportion to their shareholdings. This right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to the holders of a
      class of shares with preferential rights that may be authorized in the future.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Exchange Controls</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">There are currently no Israeli currency control restrictions on remittances of dividends on
      our ordinary shares, proceeds from the sale of the ordinary shares or interest or other payments to non-residents of Israel, except for shareholders who are subjects of countries that are, have been, or will be, in a state of war with Israel.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Shareholder Meetings</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Under Israeli law, we are required to hold an annual general meeting of our shareholders
      once every calendar year and no later than 15 months after the date of the previous annual general meeting. All meetings other than the annual general meeting of shareholders are referred to in our amended and restated articles of association as
      special general meetings. Our board of directors may call special general meetings of our shareholders whenever it sees fit, at such time and place, within or outside of Israel, as it may determine. In addition, the Companies Law provides that our
      board of directors is required to convene a special general meeting of our shareholders upon the written request of (i)&#160;any two or more of our directors, (ii)&#160;one-quarter or more of the serving members of our board of directors or (iii)&#160;one or more
      shareholders holding, in the aggregate, either (a)&#160;5% or more of our outstanding issued shares and 1% or more of our outstanding voting power or (b)&#160;5% or more of our outstanding voting power.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Under Israeli law, one or more shareholders holding at least 1% of the voting rights at the
      general meeting of the shareholders may request that the board of directors include a matter in the agenda of a general meeting of the shareholders to be convened in the future, provided that it is appropriate to discuss such a matter at the general
      meeting. Our amended and restated articles of association contain procedural guidelines and disclosure items with respect to the submission of shareholder proposals for general meetings.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Subject to the provisions of the Companies Law and the regulations promulgated thereunder,
      shareholders entitled to participate and vote at general meetings of shareholders are the shareholders of record on a date to be decided by the board of directors, which, as a company listed on an exchange outside Israel, may be between four and 40
      days prior to the date of the meeting. Furthermore, the Companies Law requires that resolutions regarding the following matters must be passed at a general meeting of shareholders:</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="margin-left: 36pt;">
      <table cellspacing="0" cellpadding="0" id="zf7335e4b160845a3a563f570daf84226" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">amendments to our articles of association;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="margin-left: 36pt;">
      <table cellspacing="0" cellpadding="0" id="zb5a2b58653b947e1a8b77572f28cee89" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">appointment, terms of service or and termination of service of our auditors;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="margin-left: 36pt;">
      <table cellspacing="0" cellpadding="0" id="z3bc6e82f3bde4f25b88b657938f74755" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">appointment of directors, including external directors (if applicable);</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="margin-left: 36pt;">
      <table cellspacing="0" cellpadding="0" id="z620acba46a374424b6cc04e3824e1e7c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">approval of certain related party transactions;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="margin-left: 36pt;">
      <table cellspacing="0" cellpadding="0" id="zef782d905dab42b891d7c7d257688059" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">increases or reductions of our authorized share capital;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="margin-left: 36pt;">
      <table cellspacing="0" cellpadding="0" id="zcf3ee53f8221410bb6a006f71f374164" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">a merger; and</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;&#160;</div>
    <div style="margin-left: 36pt;">
      <table cellspacing="0" cellpadding="0" border="0" id="z8df7361b031a450c8e8da8b52a1ab8cd" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">the exercise of our board of directors&#8217; powers by a general meeting, if our board of directors is unable to exercise its powers and the exercise of any of its powers is
                required for our proper management.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The Companies Law requires that a notice of any annual general meeting or special general
      meeting be provided to shareholders at least 21 days prior to the meeting and if the agenda of the meeting includes, among other things, the appointment or removal of directors, the approval of transactions with office holders or interested or
      related parties, or an approval of a merger, notice must be provided at least 35 days prior to the meeting. Under the Companies Law and our amended and restated articles of association, shareholders are not permitted to take action by way of written
      consent in lieu of a meeting.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Quorum</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Pursuant to our amended and restated articles of association, holders of our ordinary
      shares have one vote for each ordinary share held on all matters submitted to a vote before the shareholders at a general meeting of shareholders. The quorum required for our general meetings of shareholders consists of at least two shareholders
      present in person or by proxy who hold or represent between them at least 33&#8531;% of the total outstanding voting rights, provided, however, that with respect to any general meeting that was convened pursuant to a resolution adopted by the board of
      directors and which at the time of such general meeting we qualify as a &#8220;foreign private issuer,&#8221; the requisite quorum shall consist of two or more shareholders present in person or by proxy who hold or represent between them at least 25% of the
      total outstanding voting rights. The requisite quorum shall be present within half an hour of the time fixed for the commencement of the general meeting. A general meeting adjourned for lack of a quorum shall be adjourned either to the same day in
      the next week, at the same time and place, to such day and at such time and place as indicated in the notice to such meeting, or to such day and at such time and place as the chairperson of the meeting shall determine. At the reconvened meeting, any
      number of shareholders present in person or by proxy shall constitute a quorum, unless a meeting was called pursuant to a request by our shareholders, in which case the quorum required is one or more shareholders, present in person or by proxy and
      holding the number of shares required to call the meeting as described above.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Vote Requirements</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Our amended and restated articles of association provide that all resolutions of our
      shareholders require a simple majority vote, unless otherwise required by the Companies Law or by our amended and restated articles of association. Under the Companies Law, certain actions require the approval of a special majority, including: (i)&#160;an
      extraordinary transaction with a controlling shareholder or in which the controlling shareholder has a personal interest, (ii)&#160;the terms of employment or other engagement of a controlling shareholder of the company or a controlling shareholder&#8217;s
      relative (even if such terms are not extraordinary) and (iii)&#160;certain compensation-related matters described above under &#8220;Management&#8212;Compensation Committee&#8212;Compensation Policy under the Companies Law.&#8221; Under our amended and restated articles of
      association, the alteration of the rights, privileges, preferences or obligations of any class of our shares (to the extent there are classes other than ordinary shares) requires the approval of a simple majority of the class so affected (or such
      other percentage of the relevant class that may be set forth in the governing documents relevant to such class), in addition to a majority of all classes of shares voting together as a single class at a shareholder meeting.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Under our amended and restated articles of association, the approval of the holders of at
      least 65% of the total voting power of our shareholders is generally required to remove any of our directors from office, to amend the provision requiring the approval of at least 65% of the total voting power of our shareholders to remove any of our
      directors from office, or certain other provisions regarding our staggered board, shareholder proposals, the size of our board and plurality voting in contested elections. Another exception to the simple majority vote requirement is a resolution for
      the voluntary winding up, or an approval of a scheme of arrangement or reorganization, of the company pursuant to Section&#160;350 of the Companies Law, which requires the approval of holders holding at least 75% of the voting rights represented at the
      meeting and voting on the resolution.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Access to Corporate Records</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Under the Companies Law, all shareholders generally have the right to review minutes of our
      general meetings, our shareholder register (including with respect to material shareholders), our articles of association, our financial statements, other documents as provided in the Companies Law and any document we are required by law to file
      publicly with the Israeli Registrar of Companies or the Israeli Securities Authority. Any shareholder who specifies the purpose of its request may request to review any document in our possession that relates to any action or transaction with a
      related party which requires shareholder approval under the Companies Law. We may deny a request to review a document if we determine that the request was not made in good faith, that the document contains a trade secret or a patent or that the
      document&#8217;s disclosure may otherwise impair our interests.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Acquisitions under Israeli Law</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic; font-weight: bold;">Full Tender Offer</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">A person wishing to acquire shares of a public Israeli company who would, as a result, hold
      over 90% of the target company&#8217;s voting rights or the target company&#8217;s issued and outstanding share capital (or of a class thereof), is required by the Companies Law to make a tender offer to all of the company&#8217;s shareholders for the purchase of all
      of the issued and outstanding shares of the company (or the applicable class). If (a)&#160;the shareholders who do not accept the offer hold less than 5% of the issued and outstanding share capital of the company (or the applicable class) and the
      shareholders who accept the offer constitute a majority of the offerees that do not have a personal interest in the acceptance of the tender offer or (b)&#160;the shareholders who did not accept the tender offer hold less than 2% of the issued and
      outstanding share capital of the company (or of the applicable class), all of the shares that the acquirer offered to purchase will be transferred to the acquirer by operation of law. A shareholder who had its shares so transferred may petition an
      Israeli court within six months from the date of acceptance of the full tender offer, regardless of whether such shareholder agreed to the offer, to determine whether the tender offer was for less than fair value and whether the fair value should be
      paid as determined by the court. However, an offeror may provide in the offer that a shareholder who accepted the offer will not be entitled to petition the court for appraisal rights as described in the preceding sentence, as long as the offeror and
      the company disclosed the information required by law in connection with the full tender offer. If the full tender offer was not accepted in accordance with any of the above alternatives, the acquirer may not acquire shares of the company that will
      increase its holdings to more than 90% of the company&#8217;s voting rights or the company&#8217;s issued and outstanding share capital (or of the applicable class) from shareholders who accepted the tender offer. Shares purchased in contradiction to the full
      tender offer rules&#160;under the Companies Law will have no rights and will become dormant shares.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic; font-weight: bold;">Special Tender Offer</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The Companies Law provides that an acquisition of shares of an Israeli public company must
      be made by means of a special tender offer if, as a result of the acquisition, the purchaser would become a holder of 25% or more of the voting rights in the company. This requirement does not apply if there is already another holder of 25% or more
      of the voting rights in the company. Similarly, the Companies Law provides that an acquisition of shares of an Israeli public company must be made by means of a special tender offer if, as a result of the acquisition, the purchaser would become a
      holder of more than 45% of the voting rights in the company, if there is no other shareholder of the company who holds more than 45% of the voting rights in the company. These requirements do not apply if (i)&#160;the acquisition occurs in the context of
      a private placement by the company that received shareholder approval as a private placement whose purpose is to give the purchaser 25% or more of the voting rights in the company, if there is no person who holds 25% or more of the voting rights in
      the company or as a private placement whose purpose is to give the purchaser 45% of the voting rights in the company, if there is no person who holds 45% of the voting rights in the company, (ii)&#160;the acquisition was from a shareholder holding 25% or
      more of the voting rights in the company and resulted in the purchaser becoming a holder of 25% or more of the voting rights in the company, or (iii)&#160;the acquisition was from a shareholder holding more than 45% of the voting rights in the company and
      resulted in the purchaser becoming a holder of more than 45% of the voting rights in the company. A special tender offer must be extended to all shareholders of a company. A special tender offer may be consummated only if (i)&#160;at least 5% of the
      voting power attached to the company&#8217;s outstanding shares will be acquired by the offeror and (ii)&#160;the number of shares tendered in the offer exceeds the number of shares whose holders objected to the offer (excluding the purchaser, its controlling
      shareholders, holders of 25% or more of the voting rights in the company and any person having a personal interest in the acceptance of the tender offer, or anyone on their behalf, including any such person&#8217;s relatives and entities under their
      control).</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">In the event that a special tender offer is made, a company&#8217;s board of directors is
      required to express its opinion on the advisability of the offer, or may abstain from expressing any opinion if it is unable to do so, provided that it gives the reasons for its abstention. The board of directors shall also disclose any personal
      interest that any of the directors has with respect to the special tender offer or in connection therewith. An office holder in a target company who, in his or her capacity as an office holder, performs an action the purpose of which is to cause the
      failure of an existing or foreseeable special tender offer or to impair the chances of its acceptance, is liable to the potential purchaser and shareholders for damages, unless such office holder acted in good faith and had reasonable grounds to
      believe he or she was acting for the benefit of the company. However, office holders of the target company may negotiate with the potential purchaser in order to improve the terms of the special tender offer, and may further negotiate with third
      parties in order to obtain a competing offer.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">If a special tender offer is accepted, then shareholders who did not respond to or that had
      objected the offer may accept the offer within four days of the last day set for the acceptance of the offer and they will be considered to have accepted the offer from the first day it was made.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">In the event that a special tender offer is accepted, then the purchaser or any person or
      entity controlling it or under common control with the purchaser or such controlling person or entity at the time of the offer may not make a subsequent tender offer for the purchase of shares of the target company and may not enter into a merger
      with the target company for a period of one year from the date of the offer, unless the purchaser or such person or entity undertook to effect such an offer or merger in the initial special tender offer.&#160;Shares purchased in contradiction to the
      special tender offer rules&#160;under the Companies Law will have no rights and will become dormant shares.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic; font-weight: bold;">Merger</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The Companies Law permits merger transactions if approved by each party&#8217;s board of
      directors and, unless certain conditions described under the Companies Law are met, a simple majority of the outstanding shares of each party to the merger that are represented and voting on the merger. The board of directors of a merging company is
      required pursuant to the Companies Law to discuss and determine whether in its opinion there exists a reasonable concern that as a result of a proposed merger, the surviving company will not be able to satisfy its obligations towards its creditors,
      such determination taking into account the financial status of the merging companies. If the board of directors determines that such a concern exists, it may not approve a proposed merger. Following the approval of the board of directors of each of
      the merging companies, the boards of directors must jointly prepare a merger proposal for submission to the Israeli Registrar of Companies.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">For purposes of the shareholder vote of a merging company whose shares are held by the
      other merging company, or by a person or entity holding 25% or more of the voting rights at the general meeting of shareholders of the other merging company, or by a person or entity holding the right to appoint 25% or more of the directors of the
      other merging company, unless a court rules&#160;otherwise, the merger will not be deemed approved if a majority of the shares voted on the matter at the general meeting of shareholders (excluding abstentions) that are held by shareholders other than the
      other party to the merger, or by any person or entity who holds 25% or more of the voting rights of the other party or the right to appoint 25% or more of the directors of the other party, or any one on their behalf including their relatives or
      corporations controlled by any of them, vote against the merger. In addition, if the non-surviving entity of the merger has more than one class of shares, the merger must be approved by each class of shareholders. If the transaction would have been
      approved but for the separate approval of each class or the exclusion of the votes of certain shareholders as provided above, a court may still approve the merger upon the request of holders of at least 25% of the voting rights of a company, if the
      court holds that the merger is fair and reasonable, taking into account the valuation of the merging companies and the consideration offered to the shareholders. If a merger is with a company&#8217;s controlling shareholder or if the controlling
      shareholder has a personal interest in the merger, then the merger is instead subject to the same special majority approval that governs all extraordinary transactions with controlling shareholders.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Under the Companies Law, each merging company must deliver to its secured creditors the
      merger proposal and inform its unsecured creditors of the merger proposal and its content. Upon the request of a creditor of either party to the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable
      concern that, as a result of the merger, the surviving company will be unable to satisfy the obligations of the merging company, and may further give instructions to secure the rights of creditors.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">In addition, a merger may not be completed unless at least 50 days have passed from the
      date that a proposal for approval of the merger is filed with the Israeli Registrar of Companies and 30 days from the date that shareholder approval of both merging companies is obtained.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Anti-Takeover Measures</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The Companies Law allows us to create and issue shares having rights different from those
      attached to our ordinary shares, including shares providing certain preferred rights with respect to voting, distributions or other matters and shares having preemptive rights. As of this Current Report on Form&#160;8-K, no preferred shares will be
      authorized under our amended and restated articles of association. In the future, if we do authorize, create and issue a specific class of preferred shares, such class of shares, depending on the specific rights that may be attached to it, may have
      the ability to frustrate or prevent a takeover or otherwise prevent our shareholders from realizing a potential premium over the market value of their ordinary shares. The authorization and designation of a class of preferred shares will require an
      amendment to our amended and restated articles of association, which requires the prior approval of the holders of a majority of the voting power attached to our issued and outstanding shares at a general meeting of our shareholders. The convening of
      the meeting, the shareholders entitled to participate and the vote required to be obtained at such a meeting will be subject to the requirements set forth in the Companies Law and our amended articles of association, as described above in
      &#8220;&#8212;Shareholder Meetings.&#8221; In addition, as disclosed under &#8220;&#8212;Election of Directors,&#8221; we have a classified board structure, which effectively limits the ability of any investor or potential investor or group of investors or potential investors to gain
      control of our board of directors.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Borrowing Powers</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Pursuant to the Companies Law and our amended and restated articles of association, our
      board of directors may exercise all powers and take all actions that are not required under law or under our amended and restated articles of association to be exercised or taken by our shareholders, including the power to borrow money for company
      purposes.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Changes in Capital</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Our amended and restated articles of association enable us to increase or reduce our share
      capital. Any such changes are subject to Israeli law and must be approved by a resolution duly passed by our shareholders at a general meeting of shareholders. In addition, transactions that have the effect of reducing capital, such as the
      declaration and payment of dividends in the absence of sufficient retained earnings or profits, require the approval of both our board of directors and an Israeli court.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Exclusive Forum</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Our amended and restated articles of association provide that unless we consent in writing
      to the selection of an alternative forum, the United States District Court for the Southern District of New York shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act and/or the
      Exchange Act. Our amended and restated articles of association also provide that unless we consent in writing to the selection of an alternative forum, the competent courts in Tel Aviv,&#160;Israel shall be the exclusive forum for any derivative action or
      proceeding brought on behalf of the Company, any action asserting a breach of a fiduciary duty owed by any of our directors, officers or other employees to the Company or our shareholders or any action asserting a claim arising pursuant to any
      provision of the Companies Law or the Israeli Securities Law.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Transfer Agent and Registrar</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The transfer agent and registrar for our ordinary shares and ADSs is Computershare. Its
      address is 1290 Avenue of the Americas, 9th Floor, New York, NY 10104, and its telephone number is (212) 805-7100.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Listing</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Our ordinary shares represented by American Depositary Shares are listed on the Nasdaq
      Capital Market under the symbol &#8220;CMMB.&#8221;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">DESCRIPTION OF AMERICAN DEPOSITARY SHARES</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">American Depositary Shares</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The Bank of New York Mellon, as depositary, registers and delivers our ADSs. Each ADS will
      represent ordinary shares (or a right to receive twenty (20) ordinary shares). Each ADS will also represent any other securities, cash or other property which may be held by the depositary. The depositary&#8217;s office at which our ADSs will be
      administered and its principal executive office are located at 240 Greenwich Street, New York, New&#160;York&#160;10286.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">You may hold ADSs either (A)&#160;directly (i)&#160;by having an ADR, which is a certificate
      evidencing a specific number of ADSs, registered in your name or (ii)&#160;by having uncertificated ADSs registered in your name or (B)&#160;indirectly by holding a security entitlement in ADSs through your broker or other financial institution that is a
      direct or indirect participant in DTC. If you hold ADSs directly, you are a registered ADS holder, also referred to as an ADS holder. This description assumes you are an ADS holder. If you hold our ADSs indirectly, you must rely on the procedures of
      your broker or other financial institution to assert the rights of ADS holders described in this section. You should consult with your broker or financial institution to find out what those procedures are.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Registered holders of uncertificated ADSs will receive statements from the depositary
      confirming their holdings.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">As an ADS holder, we will not treat you as one of our shareholders and you will not have
      shareholder rights. Israeli law governs shareholder rights. The depositary will be the holder of the ordinary shares underlying your ADSs. As a registered holder of ADSs, you will have ADS holder rights. A deposit agreement among us, the depositary,
      ADS holders and all other persons indirectly or beneficially holding ADSs sets out ADS holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement and our ADSs.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The following is a summary of the material provisions of the deposit agreement. For more
      complete information, you should read the entire deposit agreement and the form of ADR. For directions on how to obtain copies of those documents see &#8220;<font style="font-style: italic;">Where You Can Find More Information</font>.&#8221;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Dividends and Other Distributions</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">How will you receive dividends and other distributions on the shares?</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The depositary has agreed to pay or distribute to ADS holders the cash dividends or other
      distributions it or the custodian receives on ordinary shares or other deposited securities, upon payment or deduction of its fees and expenses. You will receive these distributions in proportion to the number of ordinary shares your ADSs represent.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Cash.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;The depositary will convert any cash dividend or other cash distribution we pay on the ordinary shares into U.S. dollars, if it can do so on a reasonable basis and can transfer the
        U.S. dollars to the United States. If that is not possible or if any government approval is needed and cannot be obtained, the deposit agreement allows the depositary to distribute the foreign currency only to those ADS holders to whom it is
        possible to do so. It will hold the foreign currency it cannot convert for the account of our ADS holders who have not been paid. It will not invest the foreign currency and it will not be liable for any interest.</font></div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Before making a distribution, any withholding taxes or other governmental charges that must
      be paid will be deducted. See &#8220;Taxation and Government Programs.&#8221; It will distribute only whole U.S. dollars and cents and will round fractional cents to the nearest whole cent. If the exchange rates fluctuate during a time when the depositary cannot
      convert the foreign currency, you may lose some or all of the value of the distribution.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Shares.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;The depositary may distribute additional ADSs representing any ordinary shares we distribute as a dividend or free distribution. The depositary will only distribute whole ADSs. It
        will sell ordinary shares which would require it to deliver a fraction of an ADS (or ADSs representing those ordinary shares) and distribute the net proceeds in the same way as it does with cash. If the depositary does not distribute additional
        ADSs, the outstanding ADSs will also represent the new shares. The depositary may sell a portion of the distributed ordinary shares (or ADSs representing those ordinary shares) sufficient to pay its fees and expenses in connection with that
        distribution.</font></div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Rights
        to purchase additional shares.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;If we offer holders of our securities any rights to subscribe for additional ordinary shares or any other rights, the depositary may
        (i)&#160;exercise those rights on behalf of ADS holders, (ii)&#160;distribute those rights to ADS holders or (iii)&#160;sell those rights and distribute the net proceeds to ADS holders, in each case after deduction or upon payment of its fees and expenses. To the
        extent the depositary does not do any of those things, it will allow the rights to lapse.&#160;<font style="font-style: italic;">In that case, you will receive no value for them.</font>&#160;The depositary will exercise or distribute rights
        only if we ask it to and provide satisfactory assurances to the depositary that it is legal to do so. If the depositary will exercise rights, it will purchase the securities to which the rights relate and distribute those securities or, in the case
        of ordinary shares, new ADSs representing the new ordinary shares, to subscribing ADS holders, but only if ADS holders have paid the exercise price to the depositary. U.S. securities laws may restrict the ability of the depositary to distribute
        rights or ADSs or other securities issued on exercise of rights to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer.</font></div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Other
        Distributions.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;The depositary will send to ADS holders anything else we distribute on deposited securities by any means it thinks is legal, fair and practical. If it
        cannot make the distribution in that way, the depositary will have a choice. It may decide to sell what we distributed and distribute the net proceeds, in the same way as it does with cash. Or, it may decide to hold what we distributed, in which
        case ADSs will also represent the newly distributed property. However, the depositary is not required to distribute any securities (other than ADSs) to ADS holders unless it receives satisfactory evidence from us that it is legal to make that
        distribution. The depositary may sell a portion of the distributed securities or property sufficient to pay its fees and expenses in connection with that distribution. U.S. securities laws may restrict the ability of the depositary to distribute
        securities to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer.</font></div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The depositary is not responsible if it decides that it is unlawful or impractical to make
      a distribution available to any ADS holders. We have no obligation to register ADSs, ordinary shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADSs, shares,
      rights or anything else to ADS holders. This means that you may not receive the distributions we make on our ordinary shares or any value for them if it is illegal or impractical for us to make them available to you.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Deposit, Withdrawal and Cancellation</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">How are ADSs issued?</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The depositary will deliver ADSs if you or your broker deposits ordinary shares or evidence
      of rights to receive ordinary shares with the custodian. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the appropriate number of ADSs in the names
      you request and will deliver our ADSs to or upon the order of the person or persons that made the deposit.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">How can ADS holders withdraw the deposited securities?</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">You may surrender your ADSs for the purpose of withdrawal at the depositary&#8217;s office. Upon
      payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will deliver the ordinary shares and any other deposited securities underlying our ADSs to the ADS holder or a person
      the ADS holder designates at the office of the custodian. Or, at your request, risk and expense, the depositary will deliver the deposited securities at its office, if feasible. However, the depositary is not required to accept surrender of ADSs to
      the extent it would require delivery of a fraction of a deposited share or other securities. The depositary may charge you a fee and its expenses for instructing the custodian regarding delivery of deposited securities.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">How do ADS holders interchange between certificated ADSs and uncertificated ADSs?</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">You may surrender your ADR to the depositary for the purpose of exchanging your ADR for
      uncertificated ADSs. The depositary will cancel that ADR and will send to the ADS holder a statement confirming that the ADS holder is the registered holder of uncertificated ADSs. Alternatively, upon receipt by the depositary of a proper instruction
      from a registered holder of uncertificated ADSs requesting the exchange of uncertificated ADSs for certificated ADSs, the depositary will execute and deliver to the ADS holder an ADR evidencing those ADSs.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Voting Rights</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">How do you vote?</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">ADS holders may instruct the depositary how to vote the number of deposited ordinary shares
      their ADSs represent. If we request the depositary to solicit your voting instructions (and we are not required to do so), the depositary will notify you of a shareholders&#8217; meeting and send or make voting materials available to you. Those materials
      will describe the matters to be voted on and explain how ADS holders may instruct the depositary how to vote. For instructions to be valid, they must reach the depositary by a date set by the depositary. The depositary will try, as far as practical,
      subject to the laws of Israel and the provisions of our articles of association or similar documents, to vote or to have its agents vote the ordinary shares or other deposited securities as instructed by ADS holders. If we do not request the
      depositary to solicit your voting instructions, you can still send voting instructions, and, in that case, the depositary may try to vote as you instruct, but it is not required to do so.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><font style="font-family: 'Times New Roman',Times,serif; font-style: italic;">Except
        by instructing the depositary as described above, you won&#8217;t be able to exercise voting rights unless you surrender your ADSs and withdraw the ordinary shares. However, you may not know about the meeting enough in advance to withdraw the ordinary
        shares.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;In any event, the depositary will not exercise any discretion in voting deposited securities and it will only vote or attempt to vote as instructed.</font></div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">We cannot assure you that you will receive the voting materials in time to ensure that you
      can instruct the depositary to vote your shares. In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions. This means that you may not be able to
      exercise your right to vote and there may be nothing you can do if your ordinary shares are not voted as you requested.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">In order to give you a reasonable opportunity to instruct the Depositary as to the exercise
      of voting rights relating to Deposited Securities, if we request the Depositary to act, we agree to give the Depositary notice of any such meeting and details concerning the matters to be voted upon at least 45&#160;days in advance of the meeting date.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Fees and Expenses</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zac2607b03fb742908485ef16f5357137" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 44.03%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; font-weight: bold;">Persons depositing or withdrawing ordinary shares or<br>
              ADS holders must pay</div>
          </td>
          <td style="width: 0.69%; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; font-weight: bold;">&#8203;</div>
          </td>
          <td style="width: 0.67%; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; font-weight: bold;">&#8203;</div>
          </td>
          <td style="width: 53.94%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; font-weight: bold;">For</div>
          </td>
          <td style="width: 0.67%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; font-weight: bold;">&#8203;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">$5.00 (or less) per 100 ADSs (or portion of 100 ADSs)</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">Issuance of ADSs, including issuances resulting from a distribution of ordinary shares or rights or other property Cancellation of ADSs for the purpose of withdrawal, including
              if the deposit agreement terminates</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">$.05 (or less) per ADS</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">Any cash distribution to ADS holders</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">A fee equivalent to the fee that would be payable if securities distributed to you had been ordinary shares and the ordinary shares had been deposited for issuance of ADSs</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">Distribution of securities distributed to holders of deposited securities (including rights) that are distributed by the depositary to ADS holders</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">$.05 (or less) per ADS per calendar year</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">Depositary services</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z97957b0d43774f4499d16a4a7926a6b2" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 44.03%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; font-weight: bold;">Persons depositing or withdrawing ordinary shares or<br>
              ADS holders must pay</div>
          </td>
          <td style="width: 0.69%; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; font-weight: bold;">&#8203;</div>
          </td>
          <td style="width: 0.67%; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; font-weight: bold;">&#8203;</div>
          </td>
          <td style="width: 53.94%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; font-weight: bold;">For</div>
          </td>
          <td style="width: 0.67%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; font-weight: bold;">&#8203;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">Registration or transfer fees</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">Transfer and registration of ordinary shares on our share register to or from the name of the depositary or its agent when you deposit or withdraw ordinary shares</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">Expenses of the depositary</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 53.94%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Cable, telex and facsimile transmissions (when expressly provided in the deposit agreement)</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Converting foreign currency to U.S. dollars</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">Taxes and other governmental charges the depositary or the custodian has to pay on any ADSs or ordinary shares underlying ADSs, such as stock transfer taxes, stamp duty or
              withholding taxes</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td nowrap="nowrap" style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">As necessary</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.03%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">Any charges incurred by the depositary or its agents for servicing the deposited securities</div>
          </td>
          <td style="width: 0.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
          <td nowrap="nowrap" style="width: 53.94%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">As necessary</div>
          </td>
          <td style="width: 0.67%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25;">&#8203;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The depositary collects its fees for delivery and surrender of ADSs directly from investors
      depositing ordinary shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by
      selling a portion of distributable property to pay the fees. The depositary may collect its annual fee for depositary services by deduction from cash distributions or by directly billing investors or by charging the book-entry system accounts of
      participants acting for them. The depositary may collect any of its fees by deduction from any cash distribution payable (or by selling a portion of securities or other property distributable) to ADS holders that are obligated to pay those fees. The
      depositary may generally refuse to provide fee-attracting services until its fees for those services are paid.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">From time to time, the depositary may make payments to us to reimburse us for costs and
      expenses generally arising out of establishment and maintenance of our ADS program, waive fees and expenses for services provided to us by the depositary or share revenue from the fees collected from ADS holders. In performing its duties under the
      deposit agreement, the depositary may use brokers, dealers, foreign currency or other service providers that are owned by or affiliated with the depositary and that may earn or share fees, spreads or commissions.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The depositary may convert foreign currency itself or through any of its affiliates and, in
      those cases, acts as principal for its own account and not as an agent, fiduciary or broker on behalf of any other person and earns revenue, including, without limitation, fees and spreads that it will retain for its own account. The revenue is based
      on, among other things, the difference between the exchange rate assigned to the currency conversion made under the deposit agreement and the rate that the depositary or its affiliate receives when buying or selling foreign currency for its own
      account. The depositary makes no representation that the exchange rate used or obtained in any currency conversion under the deposit agreement will be the most favorable rate that could be obtained at the time or that the method by which that rate
      will be determined will be most favorable to ADS holders, subject to its obligations under the deposit agreement. The methodology used to determine exchange rates used in currency conversions is available upon request.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Payment of Taxes</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">You will be responsible for any taxes or other governmental charges payable on your ADSs or
      on the deposited securities represented by any of your ADSs. The depositary may refuse to register any transfer of your ADSs or allow you to withdraw the deposited securities represented by your ADSs until such taxes or other charges are paid. It may
      apply payments owed to you or sell deposited securities represented by your ADSs to pay any taxes owed and you will remain liable for any deficiency. If the depositary sells deposited securities, it will, if appropriate, reduce the number of ADSs to
      reflect the sale and pay to ADS holders any proceeds, or send to ADS holders any property, remaining after it has paid the taxes.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Tender and Exchange Offers; Redemption, Replacement or Cancellation of Deposited Securities</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The depositary will not tender deposited securities in any voluntary tender or exchange
      offer unless instructed to do by an ADS holder surrendering ADSs and subject to any conditions or procedures the depositary may establish.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">If deposited securities are redeemed for cash in a transaction that is mandatory for the
      depositary as a holder of deposited securities, the depositary will call for surrender of a corresponding number of ADSs and distribute the net redemption money to the holders of called ADSs upon surrender of those ADSs.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">If there is any change in the deposited securities such as a subdivision, combination or
      other reclassification, or any merger, consolidation, recapitalization or reorganization affecting the issuer of deposited securities in which the depositary receives new securities in exchange for or in lieu of the old deposited securities, the
      depositary will hold those replacement securities as deposited securities under the deposit agreement. However, if the depositary decides it would not be lawful and practical to hold the replacement securities because those securities could not be
      distributed to ADS holders or for any other reason, the depositary may instead sell the replacement securities and distribute the net proceeds upon surrender of our ADSs.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">If there is a replacement of the deposited securities and the depositary will continue to
      hold the replacement securities, the depositary may distribute new ADSs representing the new deposited securities or ask you to surrender your outstanding ADRs in exchange for new ADRs identifying the new deposited securities.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">If there are no deposited securities underlying ADSs, including if the deposited securities
      are cancelled, or if the deposited securities underlying ADSs have become apparently worthless, the depositary may call for surrender or of those ADSs or cancel those ADSs upon notice to the ADS holders.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Amendment and Termination</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">How may the deposit agreement be amended?</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">We may agree with the depositary to amend the deposit agreement and the ADRs without your
      consent for any reason. If an amendment adds or increases fees or charges, except for taxes and other governmental charges or expenses of the depositary for registration fees, facsimile costs, delivery charges or similar items, or prejudices a
      substantial right of ADS holders, it will not become effective for outstanding ADSs until 30&#160;days after the depositary notifies ADS holders of the amendment. At the time an amendment becomes effective, you are considered, by continuing to hold your
      ADSs, to agree to the amendment and to be bound by the ADRs and the deposit agreement as amended.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">How may the deposit agreement be terminated?</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The depositary will initiate termination of the deposit agreement if we instruct it to do
      so. The depositary may initiate termination of the deposit agreement if:</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; 90&#160;days have passed since the depositary told us it wants to resign but a successor depositary has not been
      appointed and accepted its appointment;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; we delist our ADSs from an exchange on which they were listed and do not list our ADSs on another exchange
      within a reasonable time;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; we appear to be insolvent or enter insolvency proceedings;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; all or substantially all the value of the deposited securities has been distributed either in cash or in the
      form of securities;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; there are no deposited securities underlying our ADSs or the underlying deposited securities have become
      apparently worthless; or</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; there has been a replacement of deposited securities.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">If the deposit agreement will terminate, the depositary will notify ADS holders at least
      90&#160;days before the termination date. At any time after the termination date, the depositary may sell the deposited securities. After that, the depositary will hold the money it received on the sale, as well as any other cash it is holding under the
      deposit agreement, unsegregated and without liability for interest, for the pro&#160;rata benefit of the ADS holders that have not surrendered their ADSs. Normally, the depositary will sell as soon as practicable after the termination date.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">After the termination date and before the depositary sells, ADS holders can still surrender
      their ADSs and receive delivery of deposited securities, except that the depositary may refuse to accept a surrender for the purpose of withdrawing deposited securities or reverse previously accepted surrenders of that kind if it would interfere with
      the selling process. The depositary may refuse to accept a surrender for the purpose of withdrawing sale proceeds until all the deposited securities have been sold. The depositary will continue to collect distributions on deposited securities, but,
      after the termination date, the depositary is not required to register any transfer of ADSs or distribute any dividends or other distributions on deposited securities to the ADSs holder (until they surrender their ADSs) or give any notices or perform
      any other duties under the deposit agreement except as described in this paragraph.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Limitations on Obligations and Liability</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">Limits on our obligations and the obligations of the depositary; Limits on liability to
      holders of ADSs</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The deposit agreement expressly limits our obligations and the obligations of the
      depositary. It also limits our liability and the liability of the depositary. We and the depositary:</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; are only obligated to take the actions specifically set forth in the deposit agreement without negligence or
      bad faith and the depositary will not be a fiduciary or have any fiduciary duty to holders of ADSs;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; are not liable if we are or it is prevented or delayed by law or circumstances beyond our or its control
      from performing our or its obligations under the deposit agreement;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; are not liable if we exercise or it exercises discretion permitted under the deposit agreement;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited
      securities that is not made available to holders of ADSs under the terms of the deposit agreement, or for any special, consequential or punitive damages for any breach of the terms of the deposit agreement;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; have no obligation to become involved in a lawsuit or other proceeding related to our ADSs or the deposit
      agreement on your behalf or on behalf of any other person;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; are not liable for the acts or omissions of any securities depository, clearing agency or settlement system;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; may rely upon any documents we believe or it believes in good faith to be genuine and to have been signed or
      presented by the proper person; and</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; the depositary has no duty to make any determinations or provide any information as to our status, or any
      liability for any tax consequences that may be incurred by ADS holders as a result of owning or holding ADSs or liable for the inability or failure of an ADS holder to obtain the benefit of a foreign tax credit reduced rate of withholdings or refund
      of amounts withheld in respect of tax or any other tax benefit.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">In the deposit agreement, we and the depositary agree to indemnify each other under certain
      circumstances.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Requirements for Depositary Actions</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Before the depositary will deliver or register a transfer of ADSs, make a distribution on
      ADSs, or permit withdrawal of shares, the depositary may require:</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; payment of stock transfer or other taxes or other governmental charges and transfer or registration fees
      charged by third parties for the transfer of any ordinary shares or other deposited securities;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; satisfactory proof of the identity and genuineness of any signature or other information it deems necessary;
      and</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; compliance with regulations it may establish, from time to time, consistent with the deposit agreement,
      including presentation of transfer documents.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The depositary may refuse to deliver ADSs or register transfers of ADSs when the transfer
      books of the depositary or our transfer books are closed or at any time if the depositary or we think it advisable to do so.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Your Right to Receive the Ordinary Shares Underlying your ADSs</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">ADS holders have the right to cancel their ADSs and withdraw the underlying ordinary shares
      at any time except:</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; when temporary delays arise because: (i)&#160;the depositary has closed its transfer books or we have closed our
      transfer books; (ii)&#160;the transfer of ordinary shares is blocked to permit voting at a shareholders&#8217; meeting; or (iii)&#160;we are paying a dividend on our shares;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; when you owe money to pay fees, taxes and similar charges; or</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226; when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations
      that apply to ADSs or to the withdrawal of ordinary shares or other deposited securities.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">This right of withdrawal may not be limited by any other provision of the deposit agreement.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Direct Registration System</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">In the deposit agreement, all parties to the deposit agreement acknowledge that the Direct
      Registration System, or DRS, and Profile Modification System, or Profile, will apply to our ADSs. DRS is a system administered by DTC that facilitates interchange between registered holding of uncertificated ADSs and holding of security entitlements
      in ADSs through DTC and a DTC participant. Profile is a feature of DRS that allows a DTC participant, claiming to act on behalf of a registered holder of uncertificated ADSs, to direct the depositary to register a transfer of those ADSs to DTC or its
      nominee and to deliver those ADSs to the DTC account of that DTC participant without receipt by the depositary of prior authorization from the ADS holder to register that transfer.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">In connection with and in accordance with the arrangements and procedures relating to
      DRS/Profile, the parties to the deposit agreement understand that the depositary will not determine whether the DTC participant that is claiming to be acting on behalf of an ADS holder in requesting registration of transfer and delivery as described
      in the paragraph above has the actual authority to act on behalf of the ADS holder (notwithstanding any requirements under the Uniform Commercial Code). In the deposit agreement, the parties agree that the depositary&#8217;s reliance on and compliance with
      instructions received by the depositary through the DRS/Profile system and in accordance with the deposit agreement will not constitute negligence or bad faith on the part of the depositary.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Shareholder Communications; Inspection of Register of Holders of ADSs</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The depositary will make available for your inspection at its office all communications
      that it receives from us as a holder of deposited securities that we make generally available to holders of deposited securities. The depositary will send you copies of those communications or otherwise make those communications available to you if
      we ask it to. You have a right to inspect the register of holders of ADSs, but not for the purpose of contacting those holders about a matter unrelated to our business or our ADSs.</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Jury Trial Waiver</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The deposit agreement provides that, to the extent permitted by law, ADS holders waive the
      right to a jury trial of any claim they may have against us or the depositary arising out of or relating to our shares, our ADSs or the deposit agreement, including any claim under the U.S. federal securities laws. If we or the depositary opposed a
      jury trial demand based on the waiver, the court would determine whether the waiver was enforceable in the facts and circumstances of that case in accordance with applicable case law.</div>
    <div style="text-indent: 18pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"> <font style="font-family: 'Times New Roman',Times,serif;"><br>
      </font></div>
    <div style="text-indent: 18pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
  <font style="font-family: 'Times New Roman',Times,serif;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit_10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="line-height: 1.25;">
      <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',serif; font-weight: bold;"><u> </u>
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u>Exhibit 10.2</u><br>
      </div>
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">COMPENSATION POLICY</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Compensation Policy for Executive Officers and Directors</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">(As Adopted on July 19, 2021)</div>
      <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">A.&#160;<u>Overview and Objectives</u></div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfa8e41c1883141a49a4ae5b515dc4148">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">1.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Introduction</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br>
        <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">This document sets forth the Compensation Policy for Executive Officers and Directors (this &#8220;<font style="font-weight: bold;">Compensation
            Policy</font>&#8221;<font style="font-weight: bold;">&#160;</font>or &#8220;<font style="font-weight: bold;">Policy</font>&#8221;)<font style="font-weight: bold;">&#160;</font>of Chemomab Therapeutics Ltd.<font style="font-weight: bold;">&#160;</font>(&#8220;<font style="font-weight: bold;">Chemomab</font>&#8221;<font style="font-weight: bold;">&#160;</font>or the &#8220;<font style="font-weight: bold;">Company</font>&#8221;),<font style="font-weight: bold;">&#160;</font>in accordance with the requirements of the Companies Law,
          5759-1999 and the regulations promulgated thereunder (the &#8220;<font style="font-weight: bold;">Companies Law</font>&#8221;).</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Compensation is a key component of Chemomab&#8217;s overall human capital strategy to attract, retain, reward, and motivate highly skilled
        individuals that will enhance Chemomab&#8217;s value and otherwise assist Chemomab to reach its business and financial long-term goals. Accordingly, the structure of this Policy is established to tie the compensation of each officer to Chemomab&#8217;s goals
        and performance.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">For purposes of this Policy, &#8220;Executive Officers&#8221; shall mean &#8220;Office Holders&#8221; as such term is defined in Section 1 of the Companies Law,
        excluding, unless otherwise expressly indicated herein, Chemomab&#8217;s directors.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">This policy is subject to applicable law and is not intended, and should not be interpreted as limiting or derogating from, provisions of
        applicable law to the extent not permitted.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">This Policy shall apply to compensation agreements and arrangements which will be approved after the date on which this Policy is adopted and
        shall serve as Chemomab&#8217;s Compensation Policy for three (3) years, commencing as of its adoption, unless amended earlier.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The Compensation Committee and the Board of Directors of Chemomab (the &#8220;<font style="font-weight: bold;">Compensation Committee</font>&#8221; and
        the &#8220;<font style="font-weight: bold;">Board</font>&#8221;, respectively) shall review and reassess the adequacy of this Policy from time to time, as required by the Companies Law.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze8e0484a060c4155a0330d4e5f85775d">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">2.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Objectives</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chemomab&#8217;s objectives and goals in setting this Policy are to attract, motivate and retain experienced and talented leaders who will
        contribute to Chemomab&#8217;s success and enhance shareholder value, while demonstrating professionalism in an achievement-oriented and merit-based culture that rewards long-term excellence, and embedding and modeling Chemomab&#8217;s core values as part of a
        motivated behavior. To that end, this Policy is designed, among other things:</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z5ef21c33443b4a9a8b7258eca664774e">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">2.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">To closely align the interests of the Executive Officers with those of Chemomab&#8217;s shareholders in order to enhance shareholder value;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z93e865b819f944d5bcfbd1a69e309cc5">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">2.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">To align a significant portion of the Executive Officers&#8217; compensation with Chemomab&#8217;s&#160;short and long-term goals and performance;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc17e3fdebc204020b90f60d196647297">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">2.3.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">To provide the Executive Officers with a structured compensation package, including competitive salaries, performance-motivating cash
              and equity incentive programs and benefits, and to be able to present to each Executive Officer an opportunity to advance in a growing organization;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb19b515eb8b24023942ea0cf363aded0">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">2.4.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">To strengthen the retention and the motivation of Executive Officers in the long-term;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9d9678e0523a477aa069f1917b09706c">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">2.5.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">To provide appropriate awards in order to incentivize superior individual excellence and corporate performance; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb20a58be95054a409108d7127788ebbc">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">2.6.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">To maintain consistency in the way Executive Officers are compensated.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">A - 2</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4e92f9540ff84782a7f254b7365d5184">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">3.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Compensation Instruments</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 17.85pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Compensation instruments under this Policy may include the following:</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zeef872f176e84277bb73bef36e2b20d6">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">3.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Base salary;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zdfba97a59ce4445b9b26058b0e0a7f47">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">3.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Benefits;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z35174c0a7936476f8415a9920ea4e09f">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">3.3.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Cash bonuses;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc7fbd92cc08a441aa24a4fe2311dc539">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">3.4.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Equity based compensation;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z7251e929536b440a85f1d5463b928e64">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">3.5.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Change of control provisions; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zff3969619c5742ebb2f4707c58cda532">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">3.6.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Retirement and termination terms.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9737ea7027104847b9a8e2212c2132c5">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">4.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Overall Compensation - Ratio Between Fixed and Variable Compensation</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z74979ddb960c438ba98e3181e4009393">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">4.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">This Policy aims to balance the mix of &#8220;Fixed Compensation&#8221; (comprised of base salary&#160;and benefits) and &#8220;Variable Compensation&#8221;
              (comprised of cash bonuses and equity-based compensation) in order to, among other things, appropriately incentivize Executive Officers to meet Chemomab&#8217;s short and long-term goals while taking into consideration the Company&#8217;s need to manage
              a variety of business risks.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z69e3a0588254436f954ff3b35270d22d">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">4.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The total annual target bonus and equity-based compensation per vesting annum (based on the fair market value at the time of grant
              calculated on a linear basis) of each Executive Officer shall not exceed 95% of such Executive Officer&#8217;s total compensation package for such year.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z8a8364d47f9f49c2a0c4f6f72b7a8b89">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">5.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Inter-Company Compensation Ratio</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4df7be4768024f83a69a9533eca24ca3">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">5.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">In the process of drafting this Policy, Chemomab&#8217;s Board and Compensation Committee have examined the ratio between employer cost
              associated with the engagement of the Executive Officers, including directors, and the average and median employer cost associated with the engagement of Chemomab&#8217;s other employees (including contractor employees as defined in the Companies
              Law) (the &#8220;<font style="font-weight: bold;">Ratio</font>&#8221;).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zcece790b84f74755bf48e7540775264f">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">5.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The possible ramifications of the Ratio on the daily working environment in Chemomab were examined and will continue to be examined by
              Chemomab from time to time in order to ensure that levels of executive compensation, as compared to the overall workforce will not have a negative impact on work relations in Chemomab</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">B.&#160;<u>Base Salary&#160;and&#160;Benefits</u></div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z551f2ad56e084a6d826bef813315b55f">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">6.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Base Salary</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z97bff1a683044faea87e65431f439cd7">

        <tr>
          <td style="width: 2%; vertical-align: middle;"><br>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">6.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">A base salary provides stable compensation to Executive Officers and allows Chemomab to attract and retain competent executive talent
              and maintain a stable management team. The base salary varies among Executive Officers, and is individually determined according<font style="font-weight: bold;">&#160;</font>to the educational background, prior vocational experience,
              qualifications, corporate role, business responsibilities and past performance of each Executive Officer.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9d8217b8d6684aeb9cf58bb8e3d951aa">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">6.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Since a competitive base salary is essential to Chemomab&#8217;s ability to attract and retain highly skilled professionals, Chemomab will
              seek to establish a base salary that is competitive with base salaries paid to Executive Officers in a peer group of other companies operating in technology sectors that are as much as possible similar in their characteristics to Chemomab,
              the list of which shall be reviewed and approved by the Compensation Committee. To that end, Chemomab shall utilize comparative market data and practices as a reference, including a survey comparing and analyzing the level of the overall
              compensation package offered to an Executive Officer of the Company with compensation packages for persons serving in similar positions (to that of the relevant officer) in the peer group. Such compensation survey may be conducted internally
              or through an external independent consultant.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">A - 3</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z764f6867653d48c585ed414966b5847d">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">6.3.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The Compensation Committee and the Board may periodically consider and approve base salary adjustments for Executive Officers. The main
              considerations for salary adjustment will be similar to those used in initially determining the base salary, but may also include change of role or responsibilities, recognition for professional achievements, regulatory or contractual
              requirements, budgetary constraints or market trends. The Compensation Committee and the Board will also consider the previous and existing compensation arrangements of the Executive Officer whose base salary is being considered for
              adjustment. Any limitation herein based on the annual base salary shall be calculated based on the monthly base salary applicable at the time of consideration of the respective grant or benefit.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc8db6b2c31294a1fbdd9d8087a5c7f61">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">7.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Benefits</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z48ae507855c9498ba86815dd511908eb">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">7.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The following benefits may be granted to the Executive Officers in order, among other things, to comply with legal requirements:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z882d2008ed964ed286be661fb522fd72">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">7.1.1.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Vacation days in accordance with market practice;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9a31ce7f821e47978c9921c8ff41722f">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">7.1.2.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Sick days in accordance with market practice;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z14305c46233c4053a0a93d7ccd741576">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">7.1.3.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Convalescence pay according to applicable law;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zcdc5153802574b578dd412632862b068">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">7.1.4.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Monthly remuneration for a study fund, as allowed by applicable law and with reference to Chemomab&#8217;s practice and the practice in peer
              group companies (including contributions on bonus payments);</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf553b3fe8e73437ea66a91e09f05b229">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">7.1.5.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chemomab shall contribute on behalf of the Executive Officer to an insurance policy or a pension fund, as allowed by applicable law and
              with reference to Chemomab&#8217;s policies and procedures and the practice in peer group companies (including contributions on bonus payments); and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z5dc8fdd979aa4d30a9ed93190f4dc6c2">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">7.1.6.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chemomab shall contribute on behalf of the Executive Officer towards work disability insurance, as allowed by applicable law and with
              reference to Chemomab&#8217;s policies and procedures and to the practice in peer group companies.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z359f58f3146e434b8ca56ba7fadceef3">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">7.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', serif;"><font style="color: #000000;">Non-Israeli Executive Officers may receive other similar, comparable or customary benefits as applicable in the relevant
                jurisdiction in which they are employed. Such customary benefits shall be determined based on the methods described in Section&#160;</font><a href="https://www.sec.gov/Archives/edgar/data/0001534248/000117891321002068/zk2126186.htm">6.2</a><font style="color: #000000;">&#160;of this Policy (with the necessary changes and adjustments).</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z377d37c341cf4760baeaa0a71d9f2d3a">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">7.3.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">In the events of relocation and/or repatriation of an Executive Officer to another geography, such Executive Officer may receive other
              similar, comparable or customary benefits as applicable in the relevant jurisdiction in which he or she is employed or additional payments to reflect adjustments in the cost of living. Such benefits may include reimbursement for out-of-pocket
              one-time payments and other ongoing expenses, such as a housing allowance, a car allowance, home leave visit, etc.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z045c9ce853094a23aca487ccd12e4de8">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">7.4.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chemomab may offer additional benefits to its Executive Officers, which will be comparable to customary market practices, such as, but
              not limited to: cellular and land line phone benefits, company car and travel benefits, reimbursement of business travel including a daily stipend when traveling and other business related expenses, insurances, other benefits<font style="font-weight: bold;">&#160;</font>(such as newspaper subscriptions, academic and professional studies), etc., provided, however, that such additional benefits shall be determined in accordance with Chemomab&#8217;s policies and procedures.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">C.&#160;<u>Cash Bonuses</u></div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z3c249eb0966044a780e4dc01059a0ee0">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">8.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Annual Cash Bonuses - The Objective</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6cfe7a0f9e704b39bd94130342bae794">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">8.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Compensation in the form of an annual cash bonus is an important element in aligning the Executive Officers&#8217; compensation with
              Chemomab&#8217;s objectives and business goals. Therefore, annual cash bonuses will reflect a pay-for-performance element, with payout eligibility and levels determined based on actual financial and operational results, in addition to other factors
              the Compensation Committee may determine, including individual performance.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">A - 4</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z26d6372894d14b319882a3dc33b7c96b">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">8.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">An annual cash bonus may be awarded to Executive Officers upon the attainment of pre-set periodical objectives and individual targets
              determined by the Compensation Committee (and, if required by law, by the Board) for each fiscal year, or in connection with such officer&#8217;s engagement, in case of newly hired Executive Officers, taking into account Chemomab&#8217;s short and
              long-term goals, as well as its compliance and risk management policies. The Compensation Committee and the Board shall also determine applicable minimum thresholds that must be met for entitlement to the annual cash bonus (all or any portion
              thereof) and the formula for calculating any annual cash bonus payout, with respect to each fiscal year, for each Executive Officer. In special circumstances, as determined by the Compensation Committee and the Board (e.g., regulatory
              changes, significant changes in Chemomab&#8217;s business environment, a significant organizational change, significant merger and acquisition events, etc.), the Compensation Committee and the Board may modify the objectives and/or their relative
              weight during the fiscal year, or may modify payouts following the conclusion of the year.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6991a0ddc8a64072886d71b80fe16f74">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">8.3.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">In the event that the employment of an Executive Officer is terminated prior to the end of a fiscal year, the Company may (but shall not
              be obligated to) pay such Executive Officer an annual cash bonus (which may or may not be pro-rated) assuming the Executive Officer is otherwise entitled to an annual cash bonus.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z434c167c1cfc4950a869eb036fa4fdcc">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">8.4.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The actual annual cash bonus to be paid to Executive Officers shall be approved by the Compensation Committee and the Board.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z75dcbe1b51cc4e45a10bdda5b17a317f">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">9.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Annual Cash Bonuses - The Formula</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 17.85pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><u>Executive Officers other than the CEO</u></div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z2d2dccc441c4408c9e48908ca431390b">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">9.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The performance objectives for the annual cash bonus of Chemomab&#8217;s Executive Officers, other than the chief executive officer (the &#8220;<font style="font-weight: bold;">CEO</font>&#8221;), may be approved by Chemomab&#8217;s CEO (in lieu of the Compensation Committee) and may be based on company, division/ departmental/business unit and individual objectives. The Company may also grant
              annual cash bonuses to Chemomab&#8217;s Executive Officers, other than the CEO, on a discretionary basis.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6e59686a7d024819a908bec21d203c42">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">9.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The target annual cash bonus that an Executive Officer, other than the CEO, will be entitled to receive for any given fiscal year, will
              not exceed 100% of such Executive Officer&#8217;s annual base salary.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6f2e7e5a089d4eb686e851bb08bbdae8">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">9.3.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The maximum annual cash bonus, including for overachievement performance, that an Executive Officer, other than the CEO, will be
              entitled to receive for any given fiscal year, will not exceed 200% of such Executive Officer&#8217;s annual base salary.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><u>CEO</u></div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z5353467eaf7d490faabc9f7f86459399">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">9.4.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The annual cash bonus of Chemomab&#8217;s CEO will be mainly based on measurable performance objectives and subject to minimum thresholds as
              provided in Section 8.2 above. Such measurable performance objectives will be determined annually by Chemomab&#8217;s Compensation Committee (and, if required by law, by Chemomab&#8217;s Board) and will be based on company and personal objectives.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z98decf36fdae470d8f15ffbd5abd8981">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">9.5.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The less significant part of the annual cash bonus granted to Chemomab&#8217;s CEO, and in any event not more than 30% of the annual cash
              bonus, may be based on a discretionary evaluation of the CEO&#8217;s overall performance by the Compensation Committee and the Board based on quantitative and qualitative criteria.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">A - 5</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb9c73061be3241e19073bc9a2fdf54ba">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">9.6.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The target annual cash bonus that the CEO will be entitled to receive for any given fiscal year, will not exceed 100% of his or her
              annual base salary.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z3a6940c9061e447682f8de2e3a2e091a">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">9.7.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The maximum annual cash bonus including for overachievement performance that the CEO will be entitled to receive for any given fiscal
              year, will not exceed 200% of his or her annual base salary.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z7f435f152718470394e7eff08d77c85e">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">10.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Other&#160;Bonuses</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z39bd6c132e6a4e85bdbdfefd349cf231">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">10.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><u>Special Bonus</u>. Chemomab may grant its Executive Officers a special bonus as an award for special achievements (such as in
              connection with mergers and acquisitions, offerings, achieving target budget or business plan objectives under exceptional circumstances, or special recognition in case of retirement) or as a retention award at the CEO&#8217;s discretion for
              Executive Officers other than the CEO (and in the CEO&#8217;s case, at the Compensation Committee&#8217;s and the Board&#8217;s discretion), subject to any additional approval as may be required by the Companies Law (the &#8220;<font style="font-weight: bold;">Special
                Bonus</font>&#8221;). Any such Special Bonus will not exceed 200% of the Executive Officer&#8217;s annual base salary. A Special Bonus can be paid, in whole or in part, in equity in lieu of cash and the value of any such equity component of a Special
              Bonus shall be determined in accordance with Section 13.3 below.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z01caa4bd60804b68aa43737cb3f53305">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">10.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><u>Signing Bonus</u>. Chemomab may grant a newly recruited Executive Officer a signing bonus.&#160; Any such signing bonus shall be granted
              and determined at the CEO&#8217;s discretion for Executive Officers other than the CEO (and in the CEO&#8217;s case, at the Compensation Committee&#8217;s and the Board&#8217;s discretion), subject to any additional approval as may be required by the Companies Law
              (the &#8220;<font style="font-weight: bold;">Signing Bonus</font>&#8221;). Any such Signing Bonus will not exceed 100% of the Executive Officer&#8217;s annual base salary.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc45972374bc5484cbb08530aef770221">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">10.3.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><u>Relocation/ Repatriation Bonus</u>. Chemomab may grant its Executive Officers a special bonus in the event of relocation or
              repatriation of an Executive Officer to another geography, Any such bonus shall be granted and determined at the CEO&#8217;s discretion for Executive Officers other than the CEO (and in the CEO&#8217;s case, at the Compensation Committee&#8217;s and the
              Board&#8217;s discretion), subject to any additional approval as may be required by the Companies Law (the &#8220;<font style="font-weight: bold;">Relocation Bonus</font>&#8221;). Any such Relocation bonus will include customary benefits associated with such
              relocation and its monetary value will not exceed 100% of the Executive Officer&#8217;s annual base salary.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z2d7d3190817648d89a8d99673dcce579">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">11.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Compensation Recovery (&#8220;Clawback&#8221;)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zeec91cc98b5d4f13ae0616896c9ecdd3">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">11.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">In the event of an accounting restatement, Chemomab shall be entitled to recover from its Executive Officers the bonus compensation or
              performance-based equity compensation in the amount in which such compensation exceeded what would have been paid based on the financial statements, as restated, provided that a claim is made by Chemomab prior to the second anniversary
              following the filing of such restated financial statements.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z372ff2eae9f64bdb941a687fcf1931d9">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">11.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Notwithstanding the aforesaid, the compensation recovery will not be triggered in the following events:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z756b1a518c4149feb79937b8c00e5e90">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">11.2.1.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The financial restatement is required due to changes in the applicable financial reporting standards; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z458d132a384d4e38a75eac1efee8c2fc">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">11.2.2.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The Compensation Committee has determined that Clawback proceedings in the specific case would be impossible, impractical, or not
              commercially or legally efficient.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z80432af694ff43bda19b8a32ad79b461">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">11.3.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Nothing in this Section 11 derogates from any other &#8220;Clawback&#8221; or similar provisions regarding disgorging of profits imposed on
              Executive Officers by virtue of applicable securities laws or a separate contractual obligation.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">A - 6</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">D.&#160;<u>Equity Based Compensation</u></div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z31b5015b03bf4f288a87df92043ddbee">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">12.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">The Objective</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z231bd46c81294663947aef642ff16ce2">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">12.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The equity-based compensation for Chemomab&#8217;s Executive Officers will be designed in a manner consistent with the underlying objectives
              of the Company in determining the base salary and the annual cash bonus, with its main objectives being to enhance the alignment between the Executive Officers&#8217; interests with the long-term interests of Chemomab and its shareholders, and to
              strengthen the retention and the motivation of Executive Officers in the long term. In addition, since equity-based awards are structured to vest over several years, their incentive value to recipients is aligned with longer-term strategic
              plans.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9c057b004f7749f1b207d592b0d26a00">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">12.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The equity-based compensation offered by Chemomab is intended to be in the form of share options and/or other equity-based awards, such
              as restricted shares, RSUs or performance stock units, in accordance with the Company&#8217;s equity incentive plan in place as may be updated from time to time.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z572d4c24c18545b084f8849c825ded6a">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">12.3.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">All equity-based incentives granted to Executive Officers (other than bonuses paid in equity in lieu of cash) shall normally be subject
              to vesting periods in order to promote long-term retention of the awarded Executive Officers. Unless determined otherwise in a specific award agreement or in a specific compensation plan approved by the Compensation Committee and the Board,
              grants to Executive Officers other than non-employee directors shall vest based on time, gradually over a period of at least 2-4 years, or based on performance. The exercise price of options shall be determined in accordance with Chemomab&#8217;s
              policies, the main terms of which shall be disclosed in the annual report of Chemomab</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z0e2279fee9164fc094223cf79d0cd88b">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">12.4.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">All other terms of the equity awards shall be in accordance with Chemomab&#8217;s incentive plans and other related practices and policies.
              Accordingly, the Board may, following approval by the Compensation Committee, make modifications to such awards consistent with the terms of such incentive plans, subject to any additional approval as may be required by the Companies Law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf9bc591116fa47068388c5b238e16ff8">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">13.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">General Guidelines for the Grant of Awards</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z19270ccd74dc4b118d21846ae85b38e6">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">13.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The equity-based compensation shall be granted from time to time and be individually determined and awarded according to the
              performance, educational background, prior business experience, qualifications, corporate role and the personal responsibilities of the Executive Officer.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9db750eff9e84f7996bbe017e69e5d29">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">13.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">In determining the equity-based compensation granted to each Executive Officer, the Compensation Committee and the Board shall consider
              the factors specified in Section 13.1 above, and in any event, such equity-based compensation will not exceed: (i) with respect to the CEO &#8211;5% of the share capital of the Company on a fully diluted basis on the date of grant, in the
              aggregate; &#160;(ii) with respect to each of the other Executive Officers 2% of the share capital of the Company on a fully diluted basis (for initial grants following appointment) and 0.5% of the share capital of the Company on a fully diluted
              basis (for annual grants).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">E.&#160;<u>Retirement and Termination of Service Arrangements</u></div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z97fc571894894caeabfec284d3ab7b0d">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">14.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Advanced Notice Period</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chemomab may provide an Executive Officer, on the basis of his/her seniority in the Company, his/her contribution to the Company&#8217;s goals and
        achievements and the circumstances of his/her retirement prior notice of termination of up to six (6) months, during which the Executive Officer may be entitled to all of the compensation elements, and to the continuation of vesting of his/her
        equity-based compensation. Such advance notice may or may not be provided in addition to severance, provided, however, that the Compensation Committee shall take into consideration the Executive Officer&#8217;s entitlement to advance notice in
        establishing any entitlement to severance and vice versa.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">A - 7</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z68e1e998ab85460da67614b08ccbde86">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">15.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Adjustment Period</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chemomab may provide an additional adjustment period of up to six (6) months to the CEO or to any other Executive Officer according to his/her
        seniority in the Company, his/her contribution to the Company&#8217;s goals and achievements and the circumstances of retirement, during which the Executive Officer may be entitled to all of the compensation elements, and to the continuation of vesting
        of his/her equity-based compensation.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z07f689a19b974293ac7e4bb97d23668d">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">16.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Additional Retirement and Termination Benefits</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chemomab may provide additional retirement and terminations benefits and payments as may be required by applicable law (e.g., mandatory
        severance pay under Israeli labor laws), or which will be comparable to customary market practices.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zd7fa423527af4522a2350990d8fdfcde">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">17.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Non-Compete&#160;Grant</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Upon termination of employment and subject to applicable law, Chemomab may grant to its Executive Officers a non-compete grant as an incentive
        to refrain from competing with Chemomab for a defined period of time. The terms and conditions of the non-compete grant shall be decided by the Board and shall not exceed such Executive Officer&#8217;s monthly base salary multiplied by twelve (12).&#160; The
        Board shall consider the existing entitlements of the Executive Officer in connection with the consideration of any non-compete grant.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z23dad1c3da014d659fdb7f68358e52d3">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">18.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><font style="font-weight: bold;">Limitation</font>&#160;<font style="font-weight: bold;">Retirement and Termination of Service Arrangements</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The total non-statutory payments under Section 14-17 above for a given Executive Officer shall not exceed the Executive Officer&#8217;s monthly base
        salary multiplied by twenty-four (24). The limitation under this Section 18 does not apply to benefits and payments provided under other chapters of this Policy.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">F.&#160;<u>Exculpation, Indemnification and Insurance</u></div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z752f28acecb2438ca6c724f7489b5af3">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">19.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Exculpation</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Each and every Director and Executive Officer may be exempted in advance for all or any of his/her liability for damage in consequence of a
        breach of the duty of care, to the fullest extent permitted by applicable law.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc07fed77ce464e76b4d7e84c0c402edc">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">20.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Insurance and Indemnification</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z29f5149120d94cb0817e8b072eeeb096">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">20.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chemomab may indemnify its directors and Executive Officers to the fullest extent permitted by applicable law, for any liability and
              expense that may be imposed on the director or the Executive Officer, as provided in the indemnity agreement between such individuals and Chemomab all subject to applicable law and the Company&#8217;s articles of association.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za7dbc16ccd664ad093e1663703144cf3">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">20.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chemomab will provide directors&#8217; and officers&#8217; liability insurance (the&#160;<font style="font-weight: bold;">&#8220;Insurance Policy&#8221;)&#160;</font>for
              its directors and Executive Officers as follows:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb481aca7bbff4e34a0cb73e852981e8b">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">20.2.1.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The limit of liability of the insurer shall not exceed the greater of $50 million or 50% of the Company&#8217;s market valuation at the time
              of approval of the Insurance Policy by the Compensation Committee; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb1dc86fe20ee45bba541db0ca819e1e8">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">20.2.2.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The Insurance Policy, as well as the limit of liability and the premium for each extension or renewal shall be approved by the
              Compensation Committee (and, if required by law, by the Board) which shall determine that the sums are reasonable considering Chemomab&#8217;s exposures, the scope of coverage and the market conditions and that the Insurance Policy reflects the
              current market conditions and that it shall not materially affect the Company&#8217;s profitability, assets or liabilities.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">A - 8</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z91d7fd1998df4066b0f2814681d90fec">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">20.3.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Upon circumstances to be approved by the Compensation Committee (and, if required by law, by the Board), Chemomab shall be entitled to
              enter into a &#8220;run off&#8221; Insurance Policy (the&#160;<font style="font-weight: bold;">&#8220;Run-Off Policy&#8221;)&#160;</font>of up to seven (7) years, with the same insurer or any other insurance, as follows:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z47a0af9aeb304a86a2173af2f2dcdd2c">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">20.3.1.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The limit of liability of the insurer shall not exceed the greater of $50 million or 50% of the Company&#8217;s market valuation at the time
              of approval by the Compensation Committee; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfa9cf889761d4277b916b3cbaac1936a">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">20.3.2.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The Run-Off Policy, as well as the limit of liability and the premium for each extension or renewal shall be approved by the
              Compensation Committee (and, if required by law, by the Board) which shall determine that the sums are reasonable considering the Company&#8217;s exposures covered under such policy, the scope of coverage and the market conditions and that the
              Run-Off Policy reflects the current market conditions and that it shall not materially affect the Company&#8217;s profitability, assets or liabilities.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze3430dc6036e4ccb92cf26c5388dd36e">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">20.4.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chemomab may extend an Insurance Policy in effect to include coverage for liability pursuant to a future public offering of securities
              as follows:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9eea633ce4ca43e6bf523a93bae0a49e">

        <tr>
          <td style="width: 6%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">20.4.1.</div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The Insurance Policy, as well as the additional premium shall be approved by the Compensation Committee (and if required by law, by the
              Board) which shall determine that the sums are reasonable considering the exposures pursuant to such public offering of securities, the scope of coverage and the market conditions and that the Insurance Policy reflects the current market
              conditions, and that it does not materially affect the Company&#8217;s profitability, assets or liabilities.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">G.&#160;<u>Arrangements upon Change of Control</u></div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zd7b5d080cb044d0f96979b0900b1e790">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">21.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The following benefits may be granted to the Executive Officers&#160;<font style="font-weight: bold;">(</font>in addition to, or in lieu of,
              the benefits applicable in the case of any retirement or termination of service)&#160;upon&#160;or in connection with&#160;a &#8220;Change of Control&#8221;&#160;or, where applicable, in the event of a Change of Control&#160;following which the employment of the Executive
              Officer is terminated or adversely adjusted in a material way:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zd8d3a4eca646456884138ceb3a58af62">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">21.1.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Acceleration of vesting of outstanding options or other equity-based awards;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z2cb7ee4ef5a241669fc7d78de0ad990b">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">21.2.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Extension of the exercise period of equity-based grants for Chemomab&#8217;s Executive Officers for a period of up to one (1) year, following
              the date of termination of employment; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6b723c86cf464f0a9e7749806c7e38fb">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">21.3.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Up to an additional six (6) months of continued base salary&#160;and benefits following the date of termination of employment (the &#8220;<font style="font-weight: bold;">Additional Adjustment Period</font>&#8221;). For avoidance of doubt, such additional Adjustment Period may be in addition to the advance notice and adjustment periods pursuant to Sections 14 and 15 of this Policy, but
              subject to the limitation set forth in Section 18 of this Policy.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z512eec3705f0404d8b1cfe797b06da68">

        <tr>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">21.4.</div>
          </td>
          <td style="width: 94%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">A cash bonus not to exceed 200% of the Executive Officer&#8217;s annual base salary in case of an Executive Officer other than the CEO and
              250% in case of the CEO.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">H.&#160;<u>Board of Directors Compensation</u></div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">All Chemomab&#8217;s non-employee Board members may be entitled to an annual cash fee retainer of up to $50,000 (and up to $100,000 for the
        chairperson of Chemomab&#8217;s Board), an annual committee membership fee retainer of up to $7,500, and an annual committee chairperson cash fee retainer of up to $15,000 (it is being clarified that the payment for the chairperson would be in lieu of
        (and not in addition) to the payments referenced above for committee membership.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">A - 9</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z688b9bff5583459fbfd1d3394ee24bb1">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">23.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The compensation of the Company&#8217;s external directors, if any are required and elected, shall be in accordance with the Companies
              Regulations (Rules Regarding the Compensation and Expenses of an External Director), 5760-2000, as amended by the Companies Regulations (Relief for Public Companies Traded in Stock Exchange Outside of Israel), 5760-2000, as such regulations
              may be amended from time to time.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9243deb03fa44de994551fdd12146ba7">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">24.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Notwithstanding the provisions of Section 22 above, in special circumstances, such as in the case of a professional director, an expert
              director or a director who makes a unique contribution to the Company, such director&#8217;s compensation may be different than the compensation of all other directors and may be greater than the maximum amount allowed under Section 22.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6e960b2262744edaac766bde7b476732">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">25.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Each non-employee member of Chemomab&#8217;s Board (other than the chairperson of Chemomab&#8217;s Board) may be granted equity-based compensation
              not to exceed, per annum, 0.4% of the share capital of the Company on a fully diluted basis at the time of the grant. The chairperson of Chemomab&#8217;s Board may be granted equity-based compensation not to exceed, per annum, 1.0% of the share
              capital of the Company on a fully diluted basis at the time of the grant.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z50639c15ff67469da66cc1805239e95f">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">26.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">All other terms of the equity awards shall be in accordance with Chemomab&#8217;s incentive plans and other related practices and policies.
              Accordingly, the Board may, following approval by the Compensation Committee, make modifications to such awards consistent with the terms of such incentive plans, subject to any additional approval as may be required by the Companies Law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z18263031d1624c648a45d014d2de7b06">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">27.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">In addition, members of Chemomab&#8217;s Board may be entitled to reimbursement of expenses in connection with the performance of their
              duties.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z37eb303c32494996abe57f81897ca5e0">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">28.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The compensation (and limitations) stated under Section H will not apply to directors who serve as Executive Officers.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">I.&#160;<u>Miscellaneous</u></div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb4da4eba4e144c2cba6a5cc0c1f2de1d">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">29.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Nothing in this Policy shall be deemed to grant to any of Chemomab&#8217;s Executive Officers, employees, directors, or any third party any
              right or privilege in connection with their employment by or service to the Company, nor deemed to require Chemomab to provide any compensation or benefits to any person. Such rights and privileges shall be governed by applicable personal
              employment agreements or other separate compensation arrangements entered into between Chemomab and the recipient of such compensation or benefits. The Board may determine that none or only part of the payments, benefits and perquisites
              detailed in this Policy shall be granted, and is authorized to cancel or suspend a compensation package or any part of it.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z61c207cc43664c3c9087f76eb43ffad5">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">30.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">An Immaterial Change in the Terms of Employment of an Executive Officer other than the CEO may be approved by the CEO, provided that the
              amended terms of employment are in accordance with this Policy. An &#8220;Immaterial Change in the Terms of Employment&#8221; means a change in the terms of employment of an Executive Officer with an annual total cost to the Company not exceeding an
              amount equal to two (2) monthly base salaries of such employee.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfd69066c80f04ddc8f1225ac1c3c33af">

        <tr>
          <td style="width: 2%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">31.</div>
          </td>
          <td style="width: 98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">In the event that new regulations or law amendment in connection with Executive Officers&#8217; and directors&#8217; compensation will be enacted
              following the adoption of this Policy, Chemomab may follow such new regulations or law amendments, even if such new regulations are in contradiction to the compensation terms set forth herein.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">*********************</div>
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"> <br>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">This Policy is designed solely for the benefit of Chemomab and none of the provisions thereof are intended to provide any rights or remedies
        to any person other than Chemomab.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">A - 10</div>
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>4
<FILENAME>exhibit_10-10.htm
<DESCRIPTION>EXHIBIT 10.10
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div id="DSPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div style="line-height: 1.25; text-align: right;"><u><font style="font-weight: bold;">Exhibit 10.10</font></u><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25;">EXECUTIVE EMPLOYMENT AGREEMENT</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">THIS EXECUTIVE EMPLOYMENT AGREEMENT (this &#8220;Agreement&#8221;) is entered between Chemomab Therapeutics, Inc. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), a Delaware corporation, and Dale Pfost
      (the &#8220;<font style="font-weight: bold;">Executive</font>&#8221;), as of September 1, 2021 (the &#8220;<font style="font-weight: bold;">Effective Date</font>&#8221;).&#160; The Company is a wholly-owned subsidiary of Chemomab Therapeutics Ltd., an Israeli company and the
      parent company of the Company (the &#8220;<font style="font-weight: bold;">Parent</font>&#8221;), whose American Depositary Shares (&#8220;<font style="font-weight: bold;">ADSs</font>&#8221;) are listed for trading on the Nasdaq Stock Market.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Words or phrases which are initially capitalized or are within quotation marks shall have the meanings provided in Section 14 below and as provided elsewhere herein. In
      consideration of the mutual promises, terms, provisions and conditions set forth in this Agreement, the Company and the Executive agree as follows:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">1. <u>Employment</u>. Subject to, and as a condition subsequent of, the approval of the shareholders of Parent, the Company agrees to employ the Executive and the Executive agrees to serve as the
      Chief Executive Officer (&#8220;<font style="font-weight: bold;">CEO</font>&#8221;) of the Company.&#160; Executive&#8217;s term of employment will commence as of September 1, 2021 or such other date as the Company and the Executive may agree (the &#8220;<font style="font-weight: bold;">Commencement Date</font>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">2. <u>Term</u>. This Agreement will continue in effect until terminated in accordance with Section 5 hereof. The term of this Agreement is hereafter referred to as &#8220;<font style="font-weight: bold;">Term</font>&#8221;.
      While the Term of this Agreement begins on the date hereof, the term of Executive&#8217;s employment is subject to, and will begin following, the approval of this Agreement by the shareholders of Parent.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">3. <u>Capacity and Performance</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(a) The Executive shall be employed by the Company on a full-time basis in the exempt position of CEO.&#160; The Executive shall report to the Board of Directors of the Company (the &#8220;<font style="font-weight: bold;">Company Board</font>&#8221;).&#160; The Executive shall perform such duties and responsibilities on behalf of the Company and its Affiliates as may be designated from time to time by the Company Board. In addition, and without
      further compensation, the Executive shall serve on the Company Board, the Board of Directors of Parent (the &#8220;<font style="font-weight: bold;">Parent Board</font>&#8221;), and as the CEO of Parent as and when elected to such position by the Parent Board.&#160;&#160;
      After the current Chairman of the Parent Board and Company Board steps down (but no later than June 30, 2022), Executive shall serve as the Chairman of the Parent Board and Company Board or shall have the right to identify a candidate to serve as the
      Chairman of the Parent Board and Company Board, subject, in each case, to the Executive&#8217;s nomination&#160; (or the nomination of the candidate identified by the Executive) as a director by the nominating and corporate governance committee of the Parent
      Board (if then applicable) and the Company Board, and election by the Company&#8217;s shareholders, pursuant to the Parent&#8217;s articles of association, the Israeli Companies Law, 5759-1999 and the listing rules of the Nasdaq Stock Market.&#160;&#160;
      <div><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(b) The Executive shall devote the Executive&#8217;s best efforts, business judgment, skill and knowledge to the advancement of the business and interests of the Company and its Affiliates and to the
      discharge of the Executive&#8217;s duties and responsibilities hereunder. The Executive shall not engage in any other business activity or serve in any industry, trade, professional, governmental, academic, civic or charitable position, whether paid or
      unpaid, without the prior approval of the Company Board, to be granted or withheld in the Company Board&#8217;s reasonable determination.&#160; Notwithstanding the foregoing, with advance notice to the Company Board, Executive may hold positions on up to three
      (3) boards of directors at any time, subject to Board approval and so long as the Board determines that (i) this commitment does not interfere with the performance of the Executive&#8217;s duties for the Company, and (ii) the companies or institutions for
      which the Executive serves as a director are not competitive with, and do not conflict with the business or scientific pursuits of the Company.&#160; Pursuant to the foregoing sentence, the Company grants its approval of the Executive&#8217;s serving on the
      boards of Axosim, Inc., Ancilia Biosciences, and The JMB Companies.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">4. <u>Compensation and Benefits</u>. As compensation for all services performed by the Executive on behalf of the Company and its Affiliates, and subject to performance of the Executive&#8217;s duties and
      of the obligations of the Executive to the Company and its Affiliates, the Company will pay the following compensation and provide the following benefits to Executive:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(a) <u>Base Salary</u>. The Company shall pay the Executive a base salary at the initial gross annual rate of six hundred thousand dollars ($600,000.00), payable in accordance with the payroll
      practices of the Company and, subject to Executive&#8217;s right to resign for Good Reason pursuant to Section 5(e)(i), subject to adjustment by the Company Board, in its sole discretion (the &#8220;<font style="font-weight: bold;">Base Salary</font>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(b)&#160; <u>Incentive and Bonus Compensation</u>. The Executive shall be entitled to participate in the Company&#8217;s annual cash incentive program in accordance with the terms thereof, as such program or
      terms may be modified or amended by the Company from time to time. The Executive&#8217;s initial target annual cash incentive bonus is fifty percent (50%) of the Base Salary (gross) .&#160; The Executive will be eligible for an additional potential bonus of ten
      percent (10%) of the Base Salary (gross), based on the Executive&#8217;s achievement of additional goals to be determined by the Compensation Committee of the Company Board after consultation with Executive, and subject to the approval of the Company
      Board.&#160; The actual bonus, if any, will be determined by the Company Board. Subject to Executive&#8217;s right to resign for Good Reason pursuant to Section 5(e)(i), the Executive&#8217;s targets may be modified by the Company Board from time to time in its
      discretion.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(c) <u>Stock Options</u>.&#160; Subject to the approval of the Parent Board, the Executive will be granted an option to purchase up to 459,353 ADSs (the &#8220;<font style="font-weight: bold;">Option Shares</font>&#8221;),
      which the Company represents and warrants constitutes 3.5% of the number of ADSs of Parent issued and outstanding on a fully-diluted basis as of the Effective Date (including the Option Shares). This option will vest over a four year period, with 25%
      vesting on the first anniversary of the grant date and the remainder in equal amounts over the next 36 monthly periods. This option will be governed by the terms of the Parent&#8217;s 2015 Share Incentive Plan as amended from time to time (the &#8220;<font style="font-weight: bold;">Plan</font>&#8221;), and any award agreement thereunder.&#160; &#160; The option will be subject to accelerated vesting upon a Merger/Sale, as defined in Section 14.2.1 of the Plan, other than a Merger/Sale in which a majority of the
      shares or other equity interests of the surviving entity are held by the shareholders of the Parent or its Affiliates immediately prior to such Merger/Sale.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In addition, the Executive may be periodically granted performance-based equity awards including, but not limited to, awards based on the closing of financing rounds, acquisitions and/or licensing
      transactions and for other performance-based success.&#160; Assessment of the Executive&#8217;s potential qualification for additional grants shall be made by the Parent Board not less than annually.&#160; In making determinations as to whether to award additional
      grants, the Parent Board may consider, in its sole discretion, market-appropriate and situation-appropriate circumstances and developments, such as the dilutive effect of events such as future financings and the Parent compensation policy .</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(d)&#160; <u>Signing Bonus</u>. The Company will pay the Executive a one-time signing bonus in the gross amount of eighty thousand dollars ($80,000.00), payable on the next regular payroll date following
      the Commencement Date.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(e)&#160; <u>New Office Bonus</u>. The Company will pay the Executive a one-time bonus in the gross amount of eighty thousand dollars ($80,000.00) (the &#8220;<font style="font-weight: bold;">New Office Bonus</font>&#8221;)
      upon the establishment of a new office in the United States and the Executive&#8217;s domiciling in the location of the new office (the &#8220;<font style="font-weight: bold;">New Office</font>&#8221;), payable on the next regular payroll date following Executive&#8217;s
      establishment of the New Office and domiciling in the location of the New Office (the &#8220;<font style="font-weight: bold;">New Office Bonus Conditions</font>&#8221;).&#160; To be eligible for the New Office Bonus, New Office Bonus Conditions must have been
      satisfied within nine (9) months of the Commencement Date (unless mutually agreed that the New Office should be established at a later date, in which case the date for satisfying New Office Bonus Conditions will be extended the later date), and
      Executive must be an employee in good standing of the Company at the time of the establishment of the New Office.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(f) <u>Paid Time Off</u>. During the Term hereof, the Executive shall be entitled to accrue twenty-five (25) days of paid time off (&#8220;<font style="font-weight: bold;">PTO</font>&#8221;) per year, accruing
      at the rate of 2 and 1/25 days per month.&#160; Paid time off is inclusive of sick days.&#160; Executive may take PTO at such times and intervals as the Executive shall determine, subject to the business needs of the Company.&#160; Accrued but unused PTO will roll
      over to successive years, provided that if the Executive accrues fifty (50) days of PTO (the &#8220;<font style="font-weight: bold;">Ceiling</font>&#8221;), PTO will cease to accrue until the Executive shall have taken PTO and the accrual is again below the
      Ceiling.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(g) <u>Other Employee Benefits</u>. During the Term hereof and subject to any contribution therefor generally required of employees (including executives) of the Company, the Executive shall be
      entitled to participate in any and all employee benefit plans from time to time in effect for senior employees of the Company.&#160; The Executive&#8217;s participation shall be subject to (i) the terms of the applicable plan documents, (ii) generally
      applicable Company policies and (iii) the discretion of the Company Board, Committee or any administrative or other committee provided for in or contemplated by such plan. The Company may alter, modify, add to or terminate its employee benefit plans
      at any time as it, in its sole judgment, determines to be appropriate.&#160; Until such time as the Company shall have established a group medical insurance plan, the Company will increase the Executive&#8217;s compensation in an amount to be agreed, including
      tax equalization.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(h) <u>Business Expenses</u>. The Company shall pay or reimburse the Executive for all reasonable, customary and necessary business expenses incurred or paid by the Executive in the performance of
      the Executive&#8217;s duties and responsibilities, subject to the Company&#8217;s expense policy, to be updated within (3) months following the Commencement Date.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(i)&#160; <u>Tax Consultation</u>.&#160; In the event Executive is or is likely to be subject to payment of income tax under Israeli law, the Company will, at its expense, provide Executive with the services
      of a tax consultant to advise the Executive on the 1995 U.S. &#8211; Israel Convention With Respect to Taxes on Income.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">5. <u>Termination of Employment and Severance Benefits</u>. The Executive&#8217;s employment shall continue until terminated in accordance with this Section 5:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(a) Death. In the event of the Executive&#8217;s death during the Term, the Company shall pay to the Executive&#8217;s designated beneficiary or, if no beneficiary has been designated by the Executive, to the
      Executive&#8217;s estate, any earned and unpaid Base Salary and accrued but unused PTO through the date of the Executive&#8217;s death, together with all compensation and benefits payable to Executive based on his participation in any compensation or benefit
      plan, program or arrangement through the date of termination, and all vested options may be exercised in accordance with and to the extent permitted under the applicable award agreement and the Plan (the &#8220;<font style="font-weight: bold;">Final
        Compensation</font>&#8221;). For the avoidance of doubt, Final Compensation does not include incentive compensation.&#160; Upon payment of the Final Compensation, the Company shall have no further obligation or liability to the Executive or Executive&#8217;s
      designated beneficiary or estate.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(b) Disability.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(i) In the event that the Executive becomes disabled and, as a result, is unable to perform the essential functions of Executive&#8217;s duties and responsibilities, with or without a reasonable
      accommodation, for more than&#160; sixty (60) business days (which need not be consecutive) during any twelve (12)-month period (a &#8220;<font style="font-weight: bold;">Disability</font>&#8221;), the Company may terminate the Executive&#8217;s employment hereunder, ten
      (10) days after the Company gives notice to Executive of Executive&#8217;s termination on account of Executive&#8217;s Disability, unless the Company specifies a later date, in which case, termination shall be effective as of such later date, provided that
      Executive has not returned to the full time performance of Executive&#8217;s duties prior to such date,</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(ii) The Company Board may designate another employee to act in the Executive&#8217;s place during any period of the Executive&#8217;s disability.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(iii) If any question shall arise as to whether during any period the Executive is disabled so as to be unable to perform substantially all of the Executive&#8217;s duties and responsibilities hereunder,
      the Executive may, and at the request of the Company shall, submit to a medical examination by a physician selected by the Company to whom the Executive or the Executive&#8217;s duly appointed guardian, if any, has no reasonable objection to determine
      whether the Executive is so disabled. Such determination shall for the purposes of this Agreement be conclusive of the issue. If such question shall arise and the Executive shall fail to submit to such medical examination, the Company&#8217;s determination
      of the issue shall be binding on the Executive.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(iv) In the event the Company terminates the Executive&#8217;s employment hereunder due to Disability, the Company shall pay to the Executive any Final Compensation due to the Executive. The Company shall
      have no further obligation or liability to the Executive.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(v)&#160; Nothing in this Section shall be construed to waive the Executive&#8217;s rights, if any, under applicable state, federal or local law including, without limitation, the Family and Medical Leave Act
      of 1993, 29 U.S.C. &#167;2601 et seq. (if applicable) and the Americans with Disabilities Act, 42 U.S.C. &#167;12101 et seq.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(c) <u>By the Company for Cause</u>. The Company may terminate the Executive&#8217;s employment hereunder for Cause (as defined below) at any time upon notice to the Executive setting forth in reasonable
      detail the nature of such Cause. The following, as determined by vote of a majority of the Company Board (provided that Executive shall abstain from any such determination and Executive&#8217;s presence at the meeting in respect thereof shall not count
      towards a quorum in such meeting), shall constitute &#8220;Cause&#8221; for termination:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(i) the Executive&#8217;s misappropriation or use for non-business purposes of funds or property (whether tangible or intangible) of the Company or its Affiliates;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(ii) any violation of the Executive&#8217;s fiduciary duties to the Company or its Affiliates;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(iii) the commission by the Executive of any felony or a misdemeanor involving moral turpitude, deceit, dishonesty, or fraud that would reasonably be expected to result in material
      injury or reputational harm to the Company or its Affiliates;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(iv) a violation by the Executive of one of the Company&#8217;s material policies established by the Company in good faith which has not been cured as set forth below, including, but not
      limited to, the Company&#8217;s anti-discrimination and anti-harassment policies and the Company&#8217;s anti-corruption policies;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(v) conduct by the Executive constituting gross negligence or misconduct in connection with the performance of the Executive&#8217;s duties which causes or is reasonably likely to cause
      material harm to the Company or its Affiliates which has not been cured as set forth below;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(vi) nonperformance by the Executive of the Executive&#8217;s material duties (other than by reason of the Executive&#8217;s physical or mental illness, incapacity or disability) which, to the
      extent it is curable by the Executive, is not cured within ten (10) days after written notice thereof is given to the Executive by the Company Board (or, if such nonperformance cannot be cured within ten (10) days, failure to materially commence cure
      within such 10-day period);</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(vi) the Executive&#8217;s failure to comply with the lawful instructions of the Company Board, which failure has not been cured within ten (10) days following written notice from the
      Company Board;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(vii) a breach by the Executive of a material provision of this Agreement or any other agreement between the Company or an Affiliate and the Executive, which breach has not been
      cured&#160;within ten (10) days following written notice from the Company Board; or</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(viii) failure to cooperate with a bona fide internal investigation or an investigation by regulatory or law enforcement authorities, after being instructed by the Company to
      cooperate, which failure has not been cured within ten (10) days following written notice from the Company Board, or the willful destruction or failure to preserve documents or other materials known to be relevant to such investigation or the
      inducement of others to fail to cooperate or to produce documents or other materials in connection with such investigation.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Upon the giving of notice of termination of the Executive&#8217;s employment hereunder for Cause, the Company shall have no further obligation or liability to the Executive, other than payment of any Final
      Compensation due to the Executive.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(d) <u>By the Company Without Cause</u>. The Company may terminate the Executive&#8217;s employment with the Company without Cause at any time upon five (5) days&#8217; notice to the Executive&#160;unless the
      Company specifies a later date, in which case, termination shall be effective as of such later date; provided that the Company may set a termination date (the &#8220;<font style="font-weight: bold;">Separation Date</font>&#8221;) at any time between the date of
      notice and the end of the five (5) day period, so long as Executive receives compensation through the required notice period. In the event of such termination (which shall not, for the avoidance of doubt, include a termination of employment by reason
      of the Executive&#8217;s death or disability), in addition to any Final Compensation due to the Executive, subject to Section 6 below, the Company shall pay to the Executive the following (the &#8220;<font style="font-weight: bold;">Severance Benefits</font>&#8221;),
      provided that the total amount of the cash portion of Severance Benefits will not exceed two hundred percent (200%) of the Executive&#8217;s Base Salary at the rate in effect on the date of termination:</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(i) the Company will pay the Executive an amount equal to the Base Salary, at the rate in effect on the date of termination, for a period of twelve (12) months following the date
      of termination (the &#8220;<font style="font-weight: bold;">Severance Period</font>&#8221;).&#160; The Severance Period will be extended for one (1) month for each year of employment after twelve (12) months up to a maximum Severance Period of twenty-four (24)
      months.&#160; The foregoing payment will be paid in equal installments on the Company&#8217;s usually payroll dates over the six (6) month period following the Separation Date, except in the case of a termination in connection with a Merger/Sale, in which case
      such payment shall be made in a single, undiscounted, lump sum payment within thirty days following the date of termination of the Executive&#8217;s employment or at the close of the transaction, whichever is earlier.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(ii) the Company will pay the Executive an amount equal to the full premium cost of the Executive&#8217;s participation in the Company&#8217;s group medical plans pursuant to the federal law
      known as COBRA, provided that the Executive is entitled to continue such participation under applicable law and plan terms and timely and properly elects to receive COBRA continuation coverage, during the Severance Period.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(iii) the Company will pay to the Executive the portion of the bonus based on the Executive&#8217;s achievement, as of the termination date, of milestones and achievements, as determined
      by the Company Board or the compensation committee thereof; except in the case of a termination in connection with a Merger/Sale, in which case the Company will pay to the Executive an amount equal to a pro-rata portion (based on the number of months
      elapsed between the commencement of the Company&#8217;s fiscal year and the date of the termination of the Executive&#8217;s employment due to a Merger/Sale) of the maximum target incentive and bonus compensation that would have been payable to Executive in
      accordance with Section 4(b) above if the Executive&#8217;s employment continued through to the end of the then-current fiscal year.&#160; The pro rata bonus payment will be made together with and on the same schedule as the payment of the Base Salary portion
      of the Severance Benefits.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A) if Executive&#8217;s termination without Cause is the result of a Merger/Sale, the Parent Board will accelerate the vesting of any time-based stock option awards;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;(B) if Executive&#8217;s termination without Cause occurs outside the context of a Merger/Sale, or if Executive terminates the employment relationship for Good
      Reason, the Parent Board will approve acceleration of any time-based stock option awards as follows:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; line-height: 1.25;">(I)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the Executive has been employed by the Company for six (6) months or more but less than twelve (12) months, the Parent Board will approve
      acceleration of any time-based stock options due to vest on the 12-month anniversary of the Commencement Date;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">(II)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Executive has been employed by the Company for twelve (12) months or longer, the Parent Board will approve the acceleration of vesting of all time-based stock
      option awards.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(e)&#160;&#160; By the Executive. The Executive may terminate Executive&#8217;s employment hereunder at any time for any reason, including but not limited to, Good Reason.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(i) For purposes of this Agreement, &#8220;<font style="font-weight: bold;">Good Reason</font>&#8221; means (A) the&#160; diminution of Executive&#8217;s position with the Company (including status,
      offices, titles, and reporting requirements, authority, material duties, or material responsibilities as provided in this Agreement, or any other action by the Company which results in a material diminution in Executive&#8217;s position, authority,
      material duties, or material responsibilities); (B) a diminution in Executive&#8217;s Base Salary (as it may be increased from time to time) (other than consistent with a temporary across-the-board diminution of the base salary of all officers of the
      Company) or target bonus percentages (for purposes of clarity, any downward adjustment of Executive&#8217;s Base Salary pursuant to Section 4(a) and/or change in eligibility for the annual incentive bonuses pursuant to Section 4(b) shall be cause for Good
      Reason resignation); (C) following Executive&#8217;s relocation to the New Office location, a change in the geographic location(s) at which Executive provides services to the Company which would increase Executive&#8217;s commute by fifty (50) miles or more; or
      (D) the material, uncured breach of this Agreement by the Company. The Executive shall notify the Company Board in writing upon the first occurrence of the Good Reason condition, and the Company shall have a period of sixty (60) in which to remedy
      such condition. If the Company cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to have occurred.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(ii) In the event of termination by the Executive without Good Reason, the Company shall pay the Final Compensation.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(iii) In the event of termination by the Executive for Good Reason, in addition to any Final Compensation due to the Executive, subject to Section 6 below, the Company shall pay to
      the Executive the Severance<font style="font-weight: bold;">&#160;</font>Benefits.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">6. <u>Effect of Termination</u>. The provisions of this Section 6 shall apply to termination of the Executive&#8217;s employment for any reason.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(a) The payments and benefits described in Section 5 shall constitute the only payments and benefits the Executive is entitled to receive from the Company in connection with a termination of the
      Executive&#8217;s employment. In order to receive any Severance Benefits, the Executive must first execute, deliver to the Company, and not revoke a timely and effective separation agreement that includes a customary general release and waiver in favor of
      the Company in a form reasonably acceptable to the Company and restrictive covenants that remain in force for the greater of (i) one year following the termination of the Executive&#8217;s employment and (ii) the Severance Period during which the Executive
      is receiving payments pursuant to Section 5 hereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(b) Provisions of this Agreement shall survive any termination if so provided herein or if necessary or desirable fully to accomplish the purposes of such provision, including without limitation the
      obligations of the Executive under this Section 6 and Sections 7, 8 and 9 hereof. The obligation of the Company to provide Severance Benefits is expressly conditioned upon the Executive&#8217;s continued full performance of the Executive&#8217;s obligations
      under Sections 7, 8 and 9 hereof and under any separation agreement. The Executive recognizes that, except as expressly provided in Section 5, no compensation will be earned by, or in any way owing to, the Executive after termination of employment.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(c) Effective as of the date the Executive&#8217;s employment terminates, the Executive will be deemed to have resigned from any and all positions and offices that the Executive holds with the Company or
      any of its Affiliates, without any further action required.&#160; The Executive agrees to sign and return to the Company such documents confirming such resignations and provide such information in connection with such resignations as the Company or any of
      its Affiliates may reasonably require.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">7. <u>Confidential Information</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(a) The Executive acknowledges that the Company and its Affiliates continually develop Confidential Information, that the Executive has developed and may develop Confidential Information for the
      Company or its Affiliates and that the Executive has learned and may learn of Confidential Information during the course of employment. The Executive will comply with the policies and procedures of the Company and its Affiliates for protecting
      Confidential Information and shall never disclose to any Person (except as required by applicable law or for the proper performance of the Executive&#8217;s duties and responsibilities to the Company and its Affiliates), or use for the Executive&#8217;s own
      benefit or gain, any Confidential Information obtained by the Executive incident to the Executive&#8217;s employment or other association with the Company or any of its Affiliates. The Executive understands that the restriction shall continue to apply
      after the Executive&#8217;s employment terminates, regardless of the reason for such termination. Nothing in this Agreement limits, restricts or in any other way affects the Executive&#8217;s communicating with any governmental agency or entity, or communicating
      with any official or staff person of a governmental agency or entity, concerning matters relevant to the governmental agency or entity. The Executive cannot be held criminally or civilly liable under any federal or state trade secret law for
      disclosing a trade secret (1) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law, or (2) in a complaint
      or other document filed under seal in a lawsuit or other proceeding. Notwithstanding this immunity from liability, the Executive may be held liable if the Executive unlawfully accesses trade secrets by unauthorized means.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(b) All documents, records, tapes and other media of every kind and description relating to the business, present or otherwise, of the Company or its Affiliates and any copies, in whole or in part,
      thereof (the &#8220;<font style="font-weight: bold;">Documents</font>&#8221;), whether or not prepared by the Executive, shall be the sole and exclusive property of the Company and its Affiliates. The Executive shall safeguard all Documents and shall surrender
      to the Company at the time the Executive&#8217;s employment terminates, or at such earlier time or times as the Company Board or its designee may specify, all Documents then in the Executive&#8217;s possession or control. The Executive also agrees that, upon
      request of any duly authorized officer of the Company, the Executive shall disclose all passwords and passcodes necessary or desirable to obtain access to, or that would assist in obtaining access to, any information which the Executive has
      password-protected on any computer equipment, network or system of the Company or any of its Affiliates.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(c) The Executive acknowledges and agrees that all Confidential Information and proprietary materials that are provided by the Company to the Executive under this Agreement are and shall remain the
      exclusive property of the Company or the third party entrusting such Confidential Information or proprietary materials to the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">8. <u>Restricted Activities</u>. As a condition to and in consideration of the Executive&#8217;s continued employment and the terms and conditions of this Agreement, including the Severance Benefits and
      the grant of options, the Executive agrees that the following restrictions on the Executive&#8217;s activities during and after the Executive&#8217;s employment are necessary to protect the goodwill, Confidential Information and other legitimate interests of the
      Company and its Affiliates:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(a) While the Executive is employed by the Company or any Affiliate of the Company, and for the greater of (i) twelve (12) months after the Executive&#8217;s employment terminates or (ii) the Severance
      Period (the &#8220;<font style="font-weight: bold;">Non-Competition Period</font>&#8221;), the Executive shall not, directly or indirectly, whether as owner, partner, investor, consultant, agent, employee, co-venturer or otherwise, compete with the Company or
      any of its Affiliates in any geographic area in which the Company or any of its Affiliates does business or is actively planning to do business during the Executive&#8217;s employment, or with respect to the portion of the Non-Competition Period that
      follows the termination of the Executive&#8217;s employment, at the time the Executive&#8217;s employment terminates (the &#8220;<font style="font-weight: bold;">Restricted Area</font>&#8221;) or undertake any planning for any business competitive with the Company or any of
      its Affiliates in the Restricted Area. Specifically, but without limiting the foregoing, the Executive agrees not to engage in any manner in any biotech company in the field of inflammation and fibrosis therapies (the &#8220;<font style="font-weight: bold;">Restricted Field</font>&#8221;), within the Restricted Area.&#160; During the Non-Competition Period, except as required for the proper performance of the Executive&#8217;s duties and responsibilities to the Company and its Affiliates, the Executive further
      agrees not to work for or provide services, in any capacity, whether as an employee, independent contractor or otherwise, whether with or without compensation, to any Person that is engaged in any business in the Restricted Field. The foregoing shall
      not prohibit the Executive&#8217;s passive ownership of two percent (2%) or less of the equity securities of any publicly traded company.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(b) The Executive agrees that, during the Executive&#8217;s employment with the Company or any Affiliate of the Company, except with the consent of the Company Board, the Executive will not undertake any
      outside activity, whether or not competitive with the business of the Company or its Affiliates, that could reasonably give rise to a conflict of interest or otherwise interfere with the Executive&#8217;s duties and obligations to the Company or any of its
      Affiliates.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(c) The Executive further agrees that while the Executive is employed by the Company or any Affiliate of the Company and for the greater of (i) twelve (12) months after the Executive&#8217;s employment
      terminates or (ii) the Severance Period (the &#8220;<font style="font-weight: bold;">Non-Solicitation Period</font> &#8220;), except as required for the proper performance of the Executive&#8217;s duties and responsibilities to the Company and its Affiliates, the
      Executive will not, directly or indirectly solicit for employment or hire any employee of the Company or any of its Affiliates, assist in such solicitating or hiring, encourage any such employee to terminate such employee&#8217;s relationship with the
      Company or any of its Affiliates or solicit or encourage any customer or vendor of the Company or any of its Affiliates to terminate its relationship with them, or, in the case of a customer, to conduct with any Person any business or activity which
      such customer conducts or could conduct with the Company or any of its Affiliates. These restrictions shall apply (y) only with respect to those Persons who are or have been a customer or employee of the Company or any of its Affiliates at any time
      within the immediately preceding one-year period.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">9. <u>Assignment of Rights to Intellectual Property</u>. The Executive shall promptly and fully disclose, if the Executive has not done so already, all Intellectual Property to the Company. The
      Executive shall maintain adequate records (whether written, electronic, or otherwise) to document the Intellectual Property, including without limitation the conception and reduction to practice of all inventions, and shall make such records
      available to the Company upon request. The Company shall have sole ownership of all Intellectual Property and all such records with respect thereto. The Executive hereby assigns, conveys, and grants to the Company (or as otherwise directed by the
      Company) , and agrees to assign, convey and grant to the Company (or as otherwise directed by the Company) , all of the Executive&#8217;s right, title, and interest in and to the Intellectual Property and any and all patents, patent applications, and
      copyrights relating to the Intellectual Property. The Executive agrees to execute any and all applications for domestic and foreign patents, copyrights or other proprietary rights and to do such other acts (including without limitation the execution
      and delivery of instruments of further assurance or confirmation) requested by the Company to assign the Intellectual Property to the Company and to permit the Company to enforce any patents, copyrights or other proprietary rights to the Intellectual
      Property. The Executive will not charge the Company for time spent in complying with these obligations. All copyrightable works that the Executive creates shall be considered &#8220;work made for hire &#8220;&#160;&#160; and shall, upon creation, be owned exclusively by
      the Company.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Executive represents that the attached Exhibit A contains a complete list of all inventions, copyrightable works, tangible materials, and other intellectual property that the Executive (either
      alone or jointly with others) conceived, developed, discovered, created, or reduced to practice prior to the Executive&#8217;s employment with the Company (the &#8220;Prior IP&#8221;). The Prior IP is not assigned to the Company under this Agreement, except to the
      extent that the Executive expressly assigns such Prior IP to the Company under the terms of a separate written instrument. If no Prior IP is listed on Exhibit A , the Executive represents that no Prior IP exists. The Executive recognizes that the
      protection of the Intellectual Property of the Company against unauthorized disclosure and use is of critical importance to the Company, and therefore, the Executive agrees to use the Executive&#8217;s best efforts and exercise utmost diligence to protect
      and safeguard the Intellectual Property of the Company and its Affiliates, if any, and, except as may be expressly required by the Company in connection with the Executive&#8217;s performance of the Executive&#8217;s obligations to the Company under this
      Agreement, the Executive shall not, either during the Term of this Agreement or thereafter, directly or indirectly, use for the Executive&#8217;s own benefit or for the benefit of another, or disclose to another, any of such Intellectual Property.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">10. <u>Notification Requirement</u>. Until the conclusion of the Non-Competition Period the Executive shall give notice to the Company of each new business activity the Executive plans to undertake,
      at least one (1) month prior to beginning any such activity. Such notice shall state the name and address of the Person for whom such activity is undertaken and the nature of the Executive&#8217;s business relationship(s) and position(s) with such Person.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">11. <u>Enforcement of Covenants</u>. The Executive acknowledges that the Executive has carefully read and considered all the terms and conditions of this Agreement, including the restraints imposed
      upon Executive pursuant to Sections 7 and 8 hereof. The Executive agrees that said restraints are necessary for the reasonable and proper protection of the goodwill, Confidential Information and other legitimate interests of the Company and its
      Affiliates and that each and every one of the restraints is reasonable in respect to subject matter, length of time and geographic area. The Executive further acknowledges that, were the Executive to breach any of the covenants contained in Sections
      7 or 8 hereof, the damage to the Company would be irreparable. The Executive therefore agrees that the Company, in addition to any other remedies available to it, shall be entitled to preliminary and permanent injunctive relief against any breach or
      threatened breach by the Executive of any of said covenants, without having to post bond, together with an award of its attorneys&#8217; fees incurred in connection with securing any relief hereunder. The parties further agree that, in the event that any
      provision of Section 7 or 8 hereof shall be determined by any court of competent jurisdiction to be unenforceable by reason of its being extended over too great a time, too large a geographic area or too great a range of activities, such provision
      shall be deemed to be modified to permit its enforcement to the maximum extent permitted by law. The Executive agrees that the Non-Competition Period and Non-Solicitation Period shall be tolled, and shall not run, during any period of time in which
      the Executive is in violation of the terms thereof, in order that the Company and its Affiliates shall have all of the agreed-upon temporal protection recited herein. Each of the Company&#8217;s Affiliates shall have the right to enforce all of the
      Executive&#8217;s obligations to that Affiliate under this Agreement, including without limitation pursuant to Section 7 or 8 hereof. No breach of any provision of this Agreement by the Company, or any other claimed breach of contract or violation of law,
      or change in the nature or scope of the Executive&#8217;s employment or other relationship with the Company or any of its Affiliates, shall operate to extinguish the Executive&#8217;s obligation to comply with Sections 7 and 8 hereof.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">12. <u>Conflicting Agreements</u>. The Executive hereby represents and warrants that the execution of this Agreement and the performance of the Executive&#8217;s obligations hereunder will not breach or
      be in conflict with any other agreement to which the Executive is a party or is bound and that the Executive is not now subject to any covenants against competition or similar covenants, or any other obligations under any court order, judgment or
      decree, that would affect the performance of the Executive&#8217;s obligations hereunder. The Executive will not disclose to or use on behalf of the Company any proprietary information of a third party without such party&#8217;s consent.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">13. <u>Reimbursement of Counsel Fees</u>. The Company will reimburse the Executive for the reasonable legal fees incurred by the Executive&#8217;s counsel in the review of this Agreement, up to a maximum
      amount of seven thousand five hundred dollars ($7,500), subject to the Executive&#8217;s delivery of invoices in accordance with the Company&#8217;s expense policy.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">14. <u>Definitions</u>. For purposes of this Agreement, the following definitions apply:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(a) &#8220;<font style="font-weight: bold;">Affiliate</font>&#8220; means any Person or entity directly or indirectly controlling, controlled by or under common control with the Company, where control may be by
      either management authority or equity interest.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(b) &#8220;<font style="font-weight: bold;">Confidential Information</font>&#8221; means any and all information of the Company and its Affiliates that is not generally known by the public. Confidential
      Information includes without limitation such information relating to (i) the development, research, testing, manufacturing, marketing and financial activities of the Company and its Affiliates, (ii) the Company&#8217;s research and development, (iii) the
      costs, sources of supply, financial performance and strategic plans of the Company and its Affiliates, and (iv) the people and organizations with whom the Company and its Affiliates have business relationships and the nature and substance of those
      relationships. Confidential Information also includes comparable information that the Company or any of its Affiliates have received belonging to others or which was received by the Company or any of its Affiliates with any understanding that it
      would not be disclosed.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(c) &#8220;<font style="font-weight: bold;">Intellectual Property</font>&#8220; means inventions, discoveries, developments, methods, processes, compositions, works, concepts and ideas (whether or not patentable
      or copyrightable or constituting trade secrets) conceived, made, created, developed or reduced to practice by the Executive (whether alone or with others, whether or not during normal business hours or on or off Company premises) during the
      Executive&#8217;s employment and during the period of twelve (12) months immediately following termination of the Executive&#8217;s employment that relate to either the Products or any prospective activity of the Company or any of its Affiliates.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(d) &#8220;<font style="font-weight: bold;">Person</font>&#8221; means an individual, a corporation, an association, a partnership, an estate, a trust and any other entity or organization, other than the Company
      or any of its Affiliates.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">15. <u>Withholding</u>. All payments made by the Company under this Agreement shall be reduced by any tax or other amounts required to be withheld by the Company under applicable law.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">16. <u>Assignment</u>. Neither the Company nor the Executive may make any assignment of this Agreement or any interest herein, by operation of law or otherwise, without the prior written consent of
      the other; provided, however, that the Company may assign its rights and obligations under this Agreement without the consent of the Executive in the event that the Company shall hereafter effect a reorganization, consolidate with, or merge into, an
      Affiliate or any other Person or transfer all or substantially all of its properties, stock or assets to an Affiliate or any other Person. This Agreement shall inure to the benefit of and be binding upon the Company and the Executive, their
      respective successors, executors, administrators, heirs and permitted assigns.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">17. <u>Severability</u>. If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this
      Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and
      enforceable to the fullest extent permitted by law.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">18. <u>Waiver</u>. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of either party to require the performance of any term or
      obligation of this Agreement, or the waiver by either party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">19. <u>Notices</u>. Any and all notices, requests, demands and other communications provided for by this Agreement shall be in writing and shall be effective when delivered in person or deposited in
      the United States mail, postage prepaid, registered or certified, and addressed to the Executive at the Executive&#8217;s last known personal address on the books of the Company or, in the case of the Company, at its principal place of business, or to such
      other address as either party may specify by notice to the other actually received.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">20. <u>Entire Agreement</u>. This Agreement constitutes the entire agreement between the parties and supersedes all prior communications, agreements and understandings, written or oral, with respect
      to the terms and conditions of the Executive&#8217;s employment, excluding any obligations with respect to the securities of the Company or the grant of any stock options, all of which shall remain in full force and effect in accordance with their terms;
      provided, however, that this Agreement shall not supersede any effective assignment of any invention or other intellectual property to the Company or any of its Affiliates in effect on the Effective Date and shall not constitute a waiver by the
      Company or any of its Affiliates of any right that any of them now has or may now have under any agreement imposing obligations on the Executive with respect to confidentiality, non-competition, non-solicitation of employees, customers or independent
      contractors or like obligations.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">21. <u>Amendment</u>. This Agreement may be amended or modified only by a written instrument signed by the Executive and by an authorized representative of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">22. <u>Headings</u>. The headings and captions in this Agreement are for convenience only and in no way define or describe the scope or content of any provision of this Agreement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">23. <u>Counterparts</u>. This Agreement may be executed in two or more counterparts, each of which shall be an original and all of which together shall constitute one and the same instrument.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">24. <u>Governing Law; Arbitration</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(a)&#160; This is a contract and shall be construed and enforced under and be governed in all respects by the laws of the State of Louisiana, without regard to the conflict of laws principles thereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(b) Any controversy or claim arising out of or relating to this Agreement or the breach thereof or otherwise arising out of the Executive&#8217;s employment or the termination of that employment shall, to
      the fullest extent permitted by law, be settled by arbitration in any forum and form agreed upon by the parties or, in the absence of such an agreement, under the auspices of the American Arbitration Association (&#8220;AAA&#8221;) in New Orleans, Louisiana in
      accordance with the Employment Arbitration Rules and Mediation Procedures of the AAA, including, but not limited to, the rules and procedures applicable to the selection of arbitrators.&#160; To the greatest extent permitted by law and the AAA, Company
      and the Executive shall each pay one-half of the arbitration fees for any such arbitration including, but not limited to, AAA administrative fees and costs, and arbitrator fees. The Company and the Executive are each responsible for their own
      attorney&#8217;s fees. The Executive understands that the Executive may only bring such claims in the Executive&#8217;s individual capacity, and not as a plaintiff or class member in any purported class proceeding or any purported representative proceeding.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">25. <u>Consent to Jurisdiction</u>.&#160; To the extent that any court action is permitted consistent with or to enforce this Agreement, the parties hereby consent to the exclusive jurisdiction of the
      appropriate State or federal courts sitting in Orleans Paris, Louisiana.&#160; Accordingly, with respect to any such court action, the parties: (a) submits to the personal jurisdiction of such courts; (b) consent to service of process; and (c) waive any
      other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction or service of process.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">26. <u>Whistleblower Notice</u>. Pursuant to 18 USC &#167; 1833(b), an individual may not be held criminally or civilly liable under any federal or state trade secret law for disclosure of a trade secret: (i) made in
      confidence to a government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law; and/or (ii) in a complaint or other document filed in a lawsuit or other
      proceeding, if such filing is made under seal. Accordingly, the Parties to this Agreement have the right to disclose in confidence trade secrets to Federal, State, and local government officials, or to an attorney, for the sole purpose of reporting
      or investigating a suspected violation of law. The Parties also have the right to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">27. <u>Conditions</u>.&#160; Notwithstanding anything to the contrary herein, the effectiveness of this Agreement shall be conditioned on (i) the Executive&#8217;s satisfactory completion of reference and background checks, if so
      requested by the Company, and (ii) the Executive&#8217;s submission of satisfactory proof of the Executive&#8217;s legal authorization to work in the United States.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">28. <u>Acknowledgement</u>. The Executive acknowledges that the Company has advised the Executive to consult an attorney before signing this Agreement.&#160; The Executive has carefully read this Agreement and understands
      and agrees to all of the provisions in this Agreement.</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">IN WITNESS WHEREOF, the Company and the Executive have executed this Agreement as of the Effective Date.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">COMPANY:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; CHEMOMAB THERAPEUTICS, INC.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 108pt; line-height: 1.25;">Signed:<u> /s/ Adi Mor</u></div>
    <div style="text-indent: 108pt; line-height: 1.25;">Name:&#160;&#160; Adi Mor</div>
    <div style="text-indent: 108pt; line-height: 1.25;">Title:&#160; Chief Executive Officer</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">EXECUTIVE:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; DALE PFOST</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25;">Signed:&#160; <u>/s/ Dale Pfost</u></div>
    <div style="text-indent: 108pt; line-height: 1.25;"><u> <br>
      </u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>5
<FILENAME>exhibit_10-11.htm
<DESCRIPTION>EXHIBIT 10.11
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div>
      <div id="DSPFPageHeader">
        <div style="line-height: 1.25;">
          <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
        <div style="line-height: 1.25; text-align: right;"><u><font style="font-weight: bold;">Exhibit 10.11</font></u><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25;">EXECUTIVE EMPLOYMENT AGREEMENT</div>
      <br>
      <div style="text-align: justify; margin-right: 7.8pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">THIS EXECUTIVE EMPLOYMENT AGREEMENT (this &#8220;Agreement&#8221;) is entered between Chemomab<font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>Therapeutics, Inc. (the &#8220;<font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Company</font>&#8221;), a Delaware corporation, and <font style="font-family: 'Times New Roman', Times, serif;">Donald
          Marvin</font> (the &#8220;<font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Executive</font>&#8221;), as<font style="font-family: 'Times New Roman', Times, serif;"> of November 8</font>, 2021 (the &#8220;<font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Effective Date</font>&#8221;).<font style="font-family: 'Times New Roman', Times, serif;"> The Company is a wholly-owned subsidiary of Chemomab Therapeutics Ltd., an Israeli company and the parent
          company of the Company (the </font>&#8220;<font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Parent</font>&#8221;), whose American Depositary Shares (&#8220;<font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">ADSs</font>&#8221;)

        are listed for trading on t<font style="font-family: 'Times New Roman', Times, serif;">he Nasdaq Stock Market.</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-right: 8pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Words or phrases which are initially capitalized or are within quotation marks shall have the meanings provided in
        Section 14 below and as provided elsewhere herein. In consideration of the mutual promises, terms, provisions and conditions set forth in this Agreement, the Company and the Executive agree as follows: </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">1. <u>Employment</u>. The Company agrees to employ the Executive and the Executive agrees to serve as the Executive Vice President, Chief Financial Officer and Chief Operating Officer (&#8220;<font style="font-weight: bold;">CFO-COO</font>&#8221;) of the Company. Executive&#8217;s term of employment will commence on November 1, 2021 or such other date as the Company and the Executive may agree (the &#8220;<font style="font-weight: bold;">Commencement Date</font>&#8221;).&#160;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="font-family: 'Times New Roman',Times,serif;">
        <div>2.&#160; <u>Term</u>. This Agreement will continue in effect until terminated in accordance with Section 5 hereof. The term of this Agreement is hereafter referred to as &#8220;<font style="font-weight: bold;">Term</font>&#8221;.&#160; </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="font-family: 'Times New Roman',Times,serif;">
        <div>3.&#160; <u>Capacity and Performance.</u>&#160;</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-right: 8.05pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Executive shall be employed by the Company on a full-time basis in the exempt position of Executive Vice President, CFO-COO. The Executive shall report to the
        Chief Executive Officer of the Company (the &#8220;<font style="font-weight: bold;">CEO</font>&#8221;) Executive will also have a dotted line reporting relationship to the Audit Committee of the Company Board. The Executive shall perform such duties and
        responsibilities on behalf of the Company and its Affiliates as may be designated from time to time by the CEO. </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-right: 7.85pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Executive shall devote the Executive&#8217;s best efforts, business judgment, skill and knowledge to the advancement of the business and interests of the Company
        and its Affiliates and to the discharge of the Executive&#8217;s duties and responsibilities hereunder. The Executive shall not engage in any other business activity or serve in any industry, trade, professional, governmental, academic, civic or
        charitable position, whether paid or unpaid, without the prior written approval of the Company Board, to be granted or withheld in the Company Board&#8217;s reasonable determination. Notwithstanding the foregoing, with advance notice to the Company
        Board, Executive may hold positions on up to three (3) boards of directors at any time, subject to Company Board approval and so long as the Company Board determines that (i) this commitment does not interfere with the performance of the
        Executive&#8217;s duties for the Company, and (ii) the companies or institutions for which the Executive serves as a director are not competitive with, and do not conflict with, the business or scientific pursuits of the Company.&#160;</div>
      <div id="DSPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-right: 7.85pt; line-height: 1.25;">4.&#160; <u>Compensation and Benefits</u>. As compensation for all services performed by the Executive on behalf of the Company and its Affiliates, and subject to performance of
        the Executive&#8217;s duties and of the obligations of the Executive to the Company and its Affiliates, the Company will pay the following compensation and provide the following benefits to Executive: </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; margin-right: 7.85pt; line-height: 1.25;">(a)&#160; <u>Base Salary</u>. The Company shall pay the Executive a base salary at the initial gross annual rate of four hundred sixty thousand dollars ($460,000.00), payable in
        accordance with the payroll practices of the Company and, subject to Executive&#8217;s right to resign for Good Reason pursuant to Section 5(e)(i), subject to adjustment by the Company Board, in its sole discretion (the &#8220;<font style="font-weight: bold;">Base
          Salary</font>&#8221;).&#160;</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(b)&#160; <u>Incentive and Bonus Compensation</u>. The Executive shall be entitled to participate in the Company&#8217;s annual cash incentive program in accordance with the terms thereof, as such program or
        terms may be modified or amended by the Company from time to time. The Executive&#8217;s initial target annual cash incentive bonus is forty-five percent (45%) of the Base Salary (gross). The actual bonus, if any, will be determined by the Company Board.
        Subject to Executive&#8217;s right to resign for Good Reason pursuant to Section 5(e)(i), the Executive&#8217;s targets may be modified by the Company Board from time to time in its discretion. </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="font-family: 'Times New Roman',Times,serif;">
        <div>(c)&#160;&#160; <u>Stock Options</u>.</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(i) Time-Based Stock Option Grant. &#160; Subject to the approval of the Parent Board, the Executive will be granted an option to purchase up to 196,875&#160;ADSs (the &#8220;<font style="font-weight: bold;">Time-Based Option Shares</font>&#8221;), which the Company represents and warrants constitutes 1.5% of the number of ADSs of Parent issued and outstanding on a fully-diluted basis as of the Effective Date (including the
        Option Shares granted to Executive). This option will vest over a four year period, with 25% vesting on the first anniversary of the grant date and the remainder in equal amounts over the next 36 monthly periods. This option will be governed by the
        terms of the Parent&#8217;s 2015 Share Incentive Plan as amended from time to time (the &#8220;<font style="font-weight: bold;">Plan</font>&#8221;), and any award agreement thereunder.&#160;The option will be subject to accelerated vesting upon a Merger/Sale, as defined
        in Section 14.2.1 of the Plan, other than a Merger/Sale in which a majority of the shares or other equity interests of the surviving entity are held by the shareholders of the Parent or its Affiliates immediately prior to such Merger/Sale.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="text-align: justify;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (ii)&#160; Performance-Based Stock Option Grant. Subject to the Executive&#8217;s achievement of&#160;predefined strategic goals or milestones, as determined by the Company Board&#8217;s compensation committee and approved
          by the Parent Board and subject to the Executive&#8217;s fulfillment of agreed-upon milestones, the Company expects in the future to grant Executive an option to purchase up to 65,612 ADSs (the &#8220;Performance Option Shares&#8221;), which the Company represents
          and warrants constitute up to O.5% of the number of ADSs of Parent issued and outstanding on a fully-diluted basis as of the Effective Date (including the Option Shares granted to Executive). Once granted, the Performance- Based Option Shares
          will be subject to vesting, in three independent equal tranches.&#160; </div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; margin-right: 7.9pt; line-height: 1.25;">(d)&#160; <u>Signing Bonus</u>. The Company will pay the Executive a one-time signing bonus in the gross amount of twenty-five thousand dollars ($25,000.00), payable on the next
        regular payroll date following the Commencement Date. </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(e)&#160; <u>New Office Bonus</u>. The Company will pay the Executive a one-time bonus in the gross amount of seventy-five thousand dollars ($75,000.00) (the &#8220;<font style="font-weight: bold;">New
          Office Bonus</font>&#8221;) upon the establishment of a new office in the United States and the Executive&#8217;s establishment of a residence in the location of the new office (the &#8220;<font style="font-weight: bold;">New Office</font>&#8221;), payable on the next
        regular payroll date following Executive&#8217;s establishment of a residence in the location of the New Office (the &#8220;<font style="font-weight: bold;">New Office Bonus Conditions</font>&#8221;). To be eligible for the New Office Bonus, Executive must be an
        employee in good standing of the Company at the time of the establishment of the New Office.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; margin-right: 7.85pt; line-height: 1.25;">(f)&#160;&#160; <u>Paid Time Off</u>. During the Term hereof, the Executive shall be entitled to accrue twenty-five (25) days of paid time off (&#8220;<font style="font-weight: bold;">PTO</font>&#8221;)

        per year, accruing at the rate of 2 and 1/25 days per month. Paid time off is inclusive of sick days. Executive may take PTO at such times and intervals as the Executive shall determine, subject to the business needs of the Company. Accrued but
        unused PTO will roll over to successive years, provided that if the Executive accrues fifty (50) days of PTO (the &#8220;<font style="font-weight: bold;">Ceiling</font>&#8221;), PTO will cease to accrue until the Executive shall have taken PTO and the accrual
        is again below the Ceiling.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; margin-right: 7.85pt; line-height: 1.25;">(g)&#160; <u>Other Employee Benefits</u>. During the Term hereof and subject to any contribution therefor generally required of employees (including executives) of the Company,
        the Executive shall be entitled to participate in any and all employee benefit plans from time to time in effect for senior employees of the Company. The Executive&#8217;s participation shall be subject to (i) the terms of the applicable plan documents,
        (ii) generally applicable Company policies and (iii) the discretion of the Company Board, Committee or any administrative or other committee provided for in or contemplated by such plan. The Company may alter, modify, add to or terminate its
        employee benefit plans at any time as it, in its sole judgment, determines to be appropriate. Until such time as the Company shall have established a group medical insurance plan, if the Executive has elected COBRA continuation of benefits offered
        by a prior employer, the Company will reimburse the Executive for the COBRA payments made by Executive each month.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; margin-right: 8.2pt; line-height: 1.25;">(h)&#160;&#160; <u>Business Expenses</u>. The Company shall pay or reimburse the Executive for all reasonable, customary and necessary business expenses incurred or paid by the
        Executive in the performance of the Executive&#8217;s duties and responsibilities, subject to the Company&#8217;s expense policy, to be updated within (3) months following the Commencement Date. </div>
      <div style="text-align: justify; margin-right: 8.2pt; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div id="DSPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: justify; margin-right: 8.2pt; line-height: 1.25;">(i)&#160;&#160; <u>Tax Consultation</u>. In the event Executive is or is likely to be subject to payment of income tax under Israeli law, the Company will, at its expense, provide
        Executive with the services of a tax consultant to advise the Executive on the 1995 U.S. &#8211; Israel Convention With Respect to Taxes on Income. </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; margin-right: 7.95pt; line-height: 1.25;">(j)&#160;&#160; <u>Annual Reviews</u>. The Executive&#8217;s compensation will be reviewed at least annually (with the first full review to take place in 2023 for the 2022 fiscal year). In
        the Company Board&#8217;s discretion, and subject&#160;to the Executive&#8217;s performance and the performance of the Company as a whole, the Company may award the Executive additional compensation.</div>
      <div style="text-align: justify; margin-right: 7.95pt; margin-left: 8pt; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;">5. <u>Termination of Employment and Severance Benefits</u>. The Executive&#8217;s employment shall continue until terminated in accordance with this Section 5:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(a) Death. In the event of the Executive&#8217;s death during the Term, the Company shall pay to the Executive&#8217;s designated beneficiary or, if no beneficiary has been designated by the Executive, to the
        Executive&#8217;s estate, any earned and unpaid Base Salary and accrued but unused PTO through the date of the Executive&#8217;s death, together with all compensation and benefits payable to Executive based on his participation in any compensation or benefit
        plan, program or arrangement through the date of termination, and all vested options may be exercised in accordance with and to the extent permitted under the applicable award agreement and the Plan (the &#8220;<font style="font-weight: bold;">Final
          Compensation</font>&#8221;). For the avoidance of doubt, Final Compensation does not include incentive compensation.&#160; Upon payment of the Final Compensation, the Company shall have no further obligation or liability to the Executive or Executive&#8217;s
        designated beneficiary or estate.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(b) Disability.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; margin-left: 36pt;">(i) In the event that the Executive becomes disabled and, as a result, is unable to perform the essential functions of Executive&#8217;s duties and responsibilities, with or without a
        reasonable accommodation, for more than&#160; sixty (60) business days (which need not be consecutive) during any twelve (12)-month period (a &#8220;<font style="font-weight: bold;">Disability</font>&#8221;), the Company may terminate the Executive&#8217;s employment
        hereunder, ten (10) days after the Company gives notice to Executive of Executive&#8217;s termination on account of Executive&#8217;s Disability, unless the Company specifies a later date, in which case, termination shall be effective as of such later date,
        provided that Executive has not returned to the full time performance of Executive&#8217;s duties prior to such date,</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; margin-left: 36pt;">(ii) The Company Board may designate another employee to act in the Executive&#8217;s place during any period of the Executive&#8217;s disability.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; margin-left: 36pt;">(iii) If any question shall arise as to whether during any period the Executive is disabled so as to be unable to perform substantially all of the Executive&#8217;s duties and
        responsibilities hereunder, the Executive may, and at the request of the Company shall, submit to a medical examination by a physician selected by the Company to whom the Executive or the Executive&#8217;s duly appointed guardian, if any, has no
        reasonable objection to determine whether the Executive is so disabled. Such determination shall for the purposes of this Agreement be conclusive of the issue. If such question shall arise and the Executive shall fail to submit to such medical
        examination, the Company&#8217;s determination of the issue shall be binding on the Executive.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; margin-left: 36pt;">(iv) In the event the Company terminates the Executive&#8217;s employment hereunder due to Disability, the Company shall pay to the Executive any Final Compensation due to the
        Executive. The Company shall have no further obligation or liability to the Executive.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; margin-left: 36pt;">(v)&#160; Nothing in this Section shall be construed to waive the Executive&#8217;s rights, if any, under applicable state, federal or local law including, without limitation, the Family
        and Medical Leave Act of 1993, 29 U.S.C. &#167;2601 et seq. (if applicable) and the Americans with Disabilities Act, 42 U.S.C. &#167;12101 et seq.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(c) <u>By the Company for Cause</u>. The Company may terminate the Executive&#8217;s employment hereunder for Cause (as defined below) at any time upon notice to the Executive setting forth in
        reasonable detail the nature of such Cause. The following, as determined by vote of a majority of the Company Board (provided that Executive shall abstain from any such determination and Executive&#8217;s presence at the meeting in respect thereof shall
        not count towards a quorum in such meeting), shall constitute &#8220;Cause&#8221; for termination:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(i) the Executive&#8217;s misappropriation or use for non-business purposes of funds or property (whether tangible or intangible) of the Company or its Affiliates;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(ii) any violation of the Executive&#8217;s fiduciary duties to the Company or its Affiliates;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(iii) the commission by the Executive of any felony or a misdemeanor involving moral turpitude, deceit, dishonesty, or fraud that would reasonably be expected to result in
        material injury or reputational harm to the Company or its Affiliates;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(iv) a violation by the Executive of one of the Company&#8217;s material policies established by the Company in good faith which has not been cured as set forth below, including, but
        not limited to, the Company&#8217;s anti-discrimination and anti-harassment policies and the Company&#8217;s anti-corruption policies;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(v) conduct by the Executive constituting gross negligence or misconduct in connection with the performance of the Executive&#8217;s duties which causes or is reasonably likely to
        cause material harm to the Company or its Affiliates which has not been cured as set forth below;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(vi) nonperformance by the Executive of the Executive&#8217;s material duties (other than by reason of the Executive&#8217;s physical or mental illness, incapacity or disability) which, to
        the extent it is curable by the Executive, is not cured within ten (10) days after written notice thereof is given to the Executive by the Company Board (or, if such nonperformance cannot be cured within ten (10) days, failure to materially
        commence cure within such 10-day period);</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(vi) the Executive&#8217;s failure to comply with the lawful instructions of the Company Board, which failure has not been cured within ten (10) days following written notice from the
        Company Board;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(vii) a breach by the Executive of a material provision of this Agreement or any other agreement between the Company or an Affiliate and the Executive, which breach has not been
        cured&#160;within ten (10) days following written notice from the Company Board; or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(viii) failure to cooperate with a bona fide internal investigation or an investigation by regulatory or law enforcement authorities, after being instructed by the Company to
        cooperate, which failure has not been cured within ten (10) days following written notice from the Company Board, or the willful destruction or failure to preserve documents or other materials known to be relevant to such investigation or the
        inducement of others to fail to cooperate or to produce documents or other materials in connection with such investigation.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Upon the giving of notice of termination of the Executive&#8217;s employment hereunder for Cause, the Company shall have no further obligation or liability to the Executive, other than payment of any
        Final Compensation due to the Executive.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(d) <u>By the Company Without Cause</u>. The Company may terminate the Executive&#8217;s employment with the Company without Cause at any time upon five (5) days&#8217; notice to the Executive&#160;unless the
        Company specifies a later date, in which case, termination shall be effective as of such later date; provided that the Company may set a termination date (the &#8220;<font style="font-weight: bold;">Separation Date</font>&#8221;) at any time between the date
        of notice and the end of the five (5) day period, so long as Executive receives compensation through the required notice period. In the event of such termination (which shall not, for the avoidance of doubt, include a termination of employment by
        reason of the Executive&#8217;s death or disability), in addition to any Final Compensation due to the Executive, subject to Section 6 below, the Company shall pay to the Executive the following (the &#8220;<font style="font-weight: bold;">Severance Benefits</font>&#8221;),

        provided that the total amount of the cash portion of Severance Benefits will not exceed two hundred percent (200%) of the Executive&#8217;s Base Salary at the rate in effect on the date of termination:</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;
        <div style="text-align: justify; margin-right: 8pt; margin-left: 35.05pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160; <font style="font-family: 'Times New Roman', Times, serif;">the Company will pay the Executive an amount equal to the Base Salary, at the rate in effect on the date of termination, for a period of twelve (12) months following the date of termination (the &#8220;<font style="font-weight: bold;">Severance Period</font>&#8221;).&#160;The Severance Period will be extended for one (1) month for each</font> year of employment after twelve (12) months up to a maximum Severance Period of <font style="font-family: 'Times New Roman', Times, serif;">eighteen (18</font>) months. The foregoing payment will be paid <font style="font-family: 'Times New Roman', Times, serif;">in equal installments on the Company&#8217;s usual</font> payroll dates over the six (6) month period following the
          Separation Date, except in the case of a termination in connection with a Merger/Sale, in which case such payment shall be made in a single, undiscounted, lump sum payment within thirty <font style="font-family: 'Times New Roman', Times, serif;">(30)

          </font>days following the date of <font style="font-family: 'Times New Roman', Times, serif;">termination of the Executive&#8217;s employment</font> or at the close of the transaction, whichever is earlier<font style="font-family: 'Times New Roman', Times, serif;">. </font></div>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(ii) the Company will pay the Executive an amount equal to the full premium cost of the Executive&#8217;s participation in the Company&#8217;s group medical plans pursuant to the federal law
        known as COBRA, provided that the Executive is entitled to continue such participation under applicable law and plan terms and timely and properly elects to receive COBRA continuation coverage, during the Severance Period.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(iii) the Company will pay to the Executive the portion of the bonus based on the Executive&#8217;s achievement, as of the termination date, of milestones and achievements, as
        determined by the Company Board or the compensation committee thereof; except in the case of a termination in connection with a Merger/Sale, in which case the Company will pay to the Executive an amount equal to a pro-rata portion (based on the
        number of months elapsed between the commencement of the Company&#8217;s fiscal year and the date of the termination of the Executive&#8217;s employment due to a Merger/Sale) of the maximum target incentive and bonus compensation that would have been payable
        to Executive in accordance with Section 4(b) above if the Executive&#8217;s employment continued through to the end of the then-current fiscal year.&#160; The pro rata bonus payment will be made together with and on the same schedule as the payment of the
        Base Salary portion of the Severance Benefits.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A) if Executive&#8217;s termination without Cause is the result of a Merger/Sale, the Parent Board will accelerate the vesting of any time-based stock option awards;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160; (B) if Executive&#8217;s termination without Cause occurs outside the context of a Merger/Sale, or if Executive terminates the employment relationship for Good
        Reason, the Parent Board will approve acceleration of any time-based stock option awards as follows:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; line-height: 1.25;">(I)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the Executive has been employed by the Company for six (6) months or more but less than twelve (12) months, the Parent Board will approve
        acceleration of any time-based stock options due to vest on the 12-month anniversary of the Commencement Date;</div>
      <div style="line-height: 1.25">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 7.8pt; margin-left: 44.05pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(II)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Executive has been employed by the Company for twelve (12) months or longer, the Parent Board will
          approve the acceleration of vesting of any time-based stock option awards due to vest on or before December 31 of the year in which termination occurs.</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(e)&#160;&#160; By the Executive. The Executive may terminate Executive&#8217;s employment hereunder at any time for any reason, including but not limited to, Good Reason.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(i) For purposes of this Agreement, &#8220;<font style="font-weight: bold;">Good Reason</font>&#8221; means (A) the&#160; diminution of Executive&#8217;s position with the Company (including status,
        offices, titles, and reporting requirements, authority, material duties, or material responsibilities as provided in this Agreement, or any other action by the Company which results in a material diminution in Executive&#8217;s position, authority,
        material duties, or material responsibilities); (B) a diminution in Executive&#8217;s Base Salary (as it may be increased from time to time) (other than consistent with a temporary across-the-board diminution of the base salary of all officers of the
        Company) or target bonus percentages (for purposes of clarity, any downward adjustment of Executive&#8217;s Base Salary pursuant to Section 4(a) and/or change in eligibility for the annual incentive bonuses pursuant to Section 4(b) shall be cause for
        Good Reason resignation); (C) following Executive&#8217;s relocation to the New Office location, a change in the geographic location(s) at which Executive provides services to the Company which would increase Executive&#8217;s commute by fifty (50) miles or
        more; or (D) the material, uncured breach of this Agreement by the Company. The Executive shall notify the Company Board in writing upon the first occurrence of the Good Reason condition, and the Company shall have a period of sixty (60) in which
        to remedy such condition. If the Company cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to have occurred.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(ii) In the event of termination by the Executive without Good Reason, the Company shall pay the Final Compensation.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(iii) In the event of termination by the Executive for Good Reason, in addition to any Final Compensation due to the Executive, subject to Section 6 below, the Company shall pay
        to the Executive the Severance<font style="font-weight: bold;">&#160;</font>Benefits.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">6. <u>Effect of Termination</u>. The provisions of this Section 6 shall apply to termination of the Executive&#8217;s employment for any reason.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(a) The payments and benefits described in Section 5 shall constitute the only payments and benefits the Executive is entitled to receive from the Company in connection with a termination of the
        Executive&#8217;s employment. In order to receive any Severance Benefits, the Executive must first execute, deliver to the Company, and not revoke a timely and effective separation agreement that includes a customary general release and waiver in favor
        of the Company in a form reasonably acceptable to the Company and restrictive covenants that remain in force for the greater of (i) one year following the termination of the Executive&#8217;s employment and (ii) the Severance Period during which the
        Executive is receiving payments pursuant to Section 5 hereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(b) Provisions of this Agreement shall survive any termination if so provided herein or if necessary or desirable fully to accomplish the purposes of such provision, including without limitation
        the obligations of the Executive under this Section 6 and Sections 7, 8 and 9 hereof. The obligation of the Company to provide Severance Benefits is expressly conditioned upon the Executive&#8217;s continued full performance of the Executive&#8217;s
        obligations under Sections 7, 8 and 9 hereof and under any separation agreement. The Executive recognizes that, except as expressly provided in Section 5, no compensation will be earned by, or in any way owing to, the Executive after termination of
        employment.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(c) Effective as of the date the Executive&#8217;s employment terminates, the Executive will be deemed to have resigned from any and all positions and offices that the Executive holds with the Company or
        any of its Affiliates, without any further action required.&#160; The Executive agrees to sign and return to the Company such documents confirming such resignations and provide such information in connection with such resignations as the Company or any
        of its Affiliates may reasonably require.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">7. <u>Confidential Information</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(a) The Executive acknowledges that the Company and its Affiliates continually develop Confidential Information, that the Executive has developed and may develop Confidential Information for the
        Company or its Affiliates and that the Executive has learned and may learn of Confidential Information during the course of employment. The Executive will comply with the policies and procedures of the Company and its Affiliates for protecting
        Confidential Information and shall never disclose to any Person (except as required by applicable law or for the proper performance of the Executive&#8217;s duties and responsibilities to the Company and its Affiliates), or use for the Executive&#8217;s own
        benefit or gain, any Confidential Information obtained by the Executive incident to the Executive&#8217;s employment or other association with the Company or any of its Affiliates. The Executive understands that the restriction shall continue to apply
        after the Executive&#8217;s employment terminates, regardless of the reason for such termination. Nothing in this Agreement limits, restricts or in any other way affects the Executive&#8217;s communicating with any governmental agency or entity, or
        communicating with any official or staff person of a governmental agency or entity, concerning matters relevant to the governmental agency or entity. The Executive cannot be held criminally or civilly liable under any federal or state trade secret
        law for disclosing a trade secret (1) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law, or (2) in a
        complaint or other document filed under seal in a lawsuit or other proceeding. Notwithstanding this immunity from liability, the Executive may be held liable if the Executive unlawfully accesses trade secrets by unauthorized means.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(b) All documents, records, tapes and other media of every kind and description relating to the business, present or otherwise, of the Company or its Affiliates and any copies, in whole or in part,
        thereof (the &#8220;<font style="font-weight: bold;">Documents</font>&#8221;), whether or not prepared by the Executive, shall be the sole and exclusive property of the Company and its Affiliates. The Executive shall safeguard all Documents and shall surrender
        to the Company at the time the Executive&#8217;s employment terminates, or at such earlier time or times as the Company Board or its designee may specify, all Documents then in the Executive&#8217;s possession or control. The Executive also agrees that, upon
        request of any duly authorized officer of the Company, the Executive shall disclose all passwords and passcodes necessary or desirable to obtain access to, or that would assist in obtaining access to, any information which the Executive has
        password-protected on any computer equipment, network or system of the Company or any of its Affiliates.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(c) The Executive acknowledges and agrees that all Confidential Information and proprietary materials that are provided by the Company to the Executive under this Agreement are and shall remain the
        exclusive property of the Company or the third party entrusting such Confidential Information or proprietary materials to the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">8. <u>Restricted Activities</u>. As a condition to and in consideration of the Executive&#8217;s continued employment and the terms and conditions of this Agreement, including the Severance Benefits and
        the grant of options, the Executive agrees that the following restrictions on the Executive&#8217;s activities during and after the Executive&#8217;s employment are necessary to protect the goodwill, Confidential Information and other legitimate interests of
        the Company and its Affiliates:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(a) While the Executive is employed by the Company or any Affiliate of the Company, and for the greater of (i) twelve (12) months after the Executive&#8217;s employment terminates or (ii) the Severance
        Period (the &#8220;<font style="font-weight: bold;">Non-Competition Period</font>&#8221;), the Executive shall not, directly or indirectly, whether as owner, partner, investor, consultant, agent, employee, co-venturer or otherwise, compete with the Company or
        any of its Affiliates in any geographic area in which the Company or any of its Affiliates does business or is actively planning to do business during the Executive&#8217;s employment, or with respect to the portion of the Non-Competition Period that
        follows the termination of the Executive&#8217;s employment, at the time the Executive&#8217;s employment terminates (the &#8220;<font style="font-weight: bold;">Restricted Area</font>&#8221;) or undertake any planning for any business competitive with the Company or any
        of its Affiliates in the Restricted Area. Specifically, but without limiting the foregoing, the Executive agrees not to engage in any manner in any biotech company in the field of inflammation and fibrosis therapies (the &#8220;<font style="font-weight: bold;">Restricted Field</font>&#8221;), within the Restricted Area.&#160; During the Non-Competition Period, except as required for the proper performance of the Executive&#8217;s duties and responsibilities to the Company and its Affiliates, the Executive
        further agrees not to work for or provide services, in any capacity, whether as an employee, independent contractor or otherwise, whether with or without compensation, to any Person that is engaged in any business in the Restricted Field. The
        foregoing shall not prohibit the Executive&#8217;s passive ownership of two percent (2%) or less of the equity securities of any publicly traded company.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(b) The Executive agrees that, during the Executive&#8217;s employment with the Company or any Affiliate of the Company, except with the consent of the Company Board, the Executive will not undertake any
        outside activity, whether or not competitive with the business of the Company or its Affiliates, that could reasonably give rise to a conflict of interest or otherwise interfere with the Executive&#8217;s duties and obligations to the Company or any of
        its Affiliates.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(c) The Executive further agrees that while the Executive is employed by the Company or any Affiliate of the Company and for the greater of (i) twelve (12) months after the Executive&#8217;s employment
        terminates or (ii) the Severance Period (the &#8220;<font style="font-weight: bold;">Non-Solicitation Period</font> &#8220;), except as required for the proper performance of the Executive&#8217;s duties and responsibilities to the Company and its Affiliates, the
        Executive will not, directly or indirectly solicit for employment or hire any employee of the Company or any of its Affiliates, assist in such solicitating or hiring, encourage any such employee to terminate such employee&#8217;s relationship with the
        Company or any of its Affiliates or solicit or encourage any customer or vendor of the Company or any of its Affiliates to terminate its relationship with them, or, in the case of a customer, to conduct with any Person any business or activity
        which such customer conducts or could conduct with the Company or any of its Affiliates. These restrictions shall apply (y) only with respect to those Persons who are or have been a customer or employee of the Company or any of its Affiliates at
        any time within the immediately preceding one-year period.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">9. <u>Assignment of Rights to Intellectual Property</u>. The Executive shall promptly and fully disclose, if the Executive has not done so already, all Intellectual Property to the Company. The
        Executive shall maintain adequate records (whether written, electronic, or otherwise) to document the Intellectual Property, including without limitation the conception and reduction to practice of all inventions, and shall make such records
        available to the Company upon request. The Company shall have sole ownership of all Intellectual Property and all such records with respect thereto. The Executive hereby assigns, conveys, and grants to the Company (or as otherwise directed by the
        Company) , and agrees to assign, convey and grant to the Company (or as otherwise directed by the Company) , all of the Executive&#8217;s right, title, and interest in and to the Intellectual Property and any and all patents, patent applications, and
        copyrights relating to the Intellectual Property. The Executive agrees to execute any and all applications for domestic and foreign patents, copyrights or other proprietary rights and to do such other acts (including without limitation the
        execution and delivery of instruments of further assurance or confirmation) requested by the Company to assign the Intellectual Property to the Company and to permit the Company to enforce any patents, copyrights or other proprietary rights to the
        Intellectual Property. The Executive will not charge the Company for time spent in complying with these obligations. All copyrightable works that the Executive creates shall be considered &#8220;work made for hire &#8220;&#160;&#160; and shall, upon creation, be owned
        exclusively by the Company.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The Executive represents that the attached Exhibit A contains a complete list of all inventions, copyrightable works, tangible materials, and other intellectual property that the Executive (either
        alone or jointly with others) conceived, developed, discovered, created, or reduced to practice prior to the Executive&#8217;s employment with the Company (the &#8220;Prior IP&#8221;). The Prior IP is not assigned to the Company under this Agreement, except to the
        extent that the Executive expressly assigns such Prior IP to the Company under the terms of a separate written instrument. If no Prior IP is listed on Exhibit A , the Executive represents that no Prior IP exists. The Executive recognizes that the
        protection of the Intellectual Property of the Company against unauthorized disclosure and use is of critical importance to the Company, and therefore, the Executive agrees to use the Executive&#8217;s best efforts and exercise utmost diligence to
        protect and safeguard the Intellectual Property of the Company and its Affiliates, if any, and, except as may be expressly required by the Company in connection with the Executive&#8217;s performance of the Executive&#8217;s obligations to the Company under
        this Agreement, the Executive shall not, either during the Term of this Agreement or thereafter, directly or indirectly, use for the Executive&#8217;s own benefit or for the benefit of another, or disclose to another, any of such Intellectual Property.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">10. <u>Notification Requirement</u>. Until the conclusion of the Non-Competition Period the Executive shall give notice to the Company of each new business activity the Executive plans to
        undertake, at least one (1) month prior to beginning any such activity. Such notice shall state the name and address of the Person for whom such activity is undertaken and the nature of the Executive&#8217;s business relationship(s) and position(s) with
        such Person.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">11. <u>Enforcement of Covenants</u>. The Executive acknowledges that the Executive has carefully read and considered all the terms and conditions of this Agreement, including the restraints
        imposed upon Executive pursuant to Sections 7 and 8 hereof. The Executive agrees that said restraints are necessary for the reasonable and proper protection of the goodwill, Confidential Information and other legitimate interests of the Company and
        its Affiliates and that each and every one of the restraints is reasonable in respect to subject matter, length of time and geographic area. The Executive further acknowledges that, were the Executive to breach any of the covenants contained in
        Sections 7 or 8 hereof, the damage to the Company would be irreparable. The Executive therefore agrees that the Company, in addition to any other remedies available to it, shall be entitled to preliminary and permanent injunctive relief against any
        breach or threatened breach by the Executive of any of said covenants, without having to post bond, together with an award of its attorneys&#8217; fees incurred in connection with securing any relief hereunder. The parties further agree that, in the
        event that any provision of Section 7 or 8 hereof shall be determined by any court of competent jurisdiction to be unenforceable by reason of its being extended over too great a time, too large a geographic area or too great a range of activities,
        such provision shall be deemed to be modified to permit its enforcement to the maximum extent permitted by law. The Executive agrees that the Non-Competition Period and Non-Solicitation Period shall be tolled, and shall not run, during any period
        of time in which the Executive is in violation of the terms thereof, in order that the Company and its Affiliates shall have all of the agreed-upon temporal protection recited herein. Each of the Company&#8217;s Affiliates shall have the right to enforce
        all of the Executive&#8217;s obligations to that Affiliate under this Agreement, including without limitation pursuant to Section 7 or 8 hereof. No breach of any provision of this Agreement by the Company, or any other claimed breach of contract or
        violation of law, or change in the nature or scope of the Executive&#8217;s employment or other relationship with the Company or any of its Affiliates, shall operate to extinguish the Executive&#8217;s obligation to comply with Sections 7 and 8 hereof.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">12. <u>Conflicting Agreements</u>. The Executive hereby represents and warrants that the execution of this Agreement and the performance of the Executive&#8217;s obligations hereunder will not breach or
        be in conflict with any other agreement to which the Executive is a party or is bound and that the Executive is not now subject to any covenants against competition or similar covenants, or any other obligations under any court order, judgment or
        decree, that would affect the performance of the Executive&#8217;s obligations hereunder. The Executive will not disclose to or use on behalf of the Company any proprietary information of a third party without such party&#8217;s consent.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">13. <u>Reimbursement of Counsel Fees</u>. The Company will reimburse the Executive for the reasonable legal fees incurred by the Executive&#8217;s counsel in the review of this Agreement, up to a
        maximum amount of five thousand dollars ($5,000), subject to the Executive&#8217;s delivery of invoices in accordance with the Company&#8217;s expense policy.<br>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">14. <u>Definitions</u>. For purposes of this Agreement, the following definitions apply:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(a) &#8220;<font style="font-weight: bold;">Affiliate</font>&#8220; means any Person or entity directly or indirectly controlling, controlled by or under common control with the Company, where control may be
        by either management authority or equity interest.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(b) &#8220;<font style="font-weight: bold;">Confidential Information</font>&#8221; means any and all information of the Company and its Affiliates that is not generally known by the public. Confidential
        Information includes without limitation such information relating to (i) the development, research, testing, manufacturing, marketing and financial activities of the Company and its Affiliates, (ii) the Company&#8217;s research and development, (iii) the
        costs, sources of supply, financial performance and strategic plans of the Company and its Affiliates, and (iv) the people and organizations with whom the Company and its Affiliates have business relationships and the nature and substance of those
        relationships. Confidential Information also includes comparable information that the Company or any of its Affiliates have received belonging to others or which was received by the Company or any of its Affiliates with any understanding that it
        would not be disclosed.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(c) &#8220;<font style="font-weight: bold;">Intellectual Property</font>&#8220; means inventions, discoveries, developments, methods, processes, compositions, works, concepts and ideas (whether or not
        patentable or copyrightable or constituting trade secrets) conceived, made, created, developed or reduced to practice by the Executive (whether alone or with others, whether or not during normal business hours or on or off Company premises) during
        the Executive&#8217;s employment and during the period of twelve (12) months immediately following termination of the Executive&#8217;s employment that relate to either the Products or any prospective activity of the Company or any of its Affiliates.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(d) &#8220;<font style="font-weight: bold;">Person</font>&#8221; means an individual, a corporation, an association, a partnership, an estate, a trust and any other entity or organization, other than the
        Company or any of its Affiliates.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">15. <u>Withholding</u>. All payments made by the Company under this Agreement shall be reduced by any tax or other amounts required to be withheld by the Company under applicable law.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">16. <u>Assignment</u>. Neither the Company nor the Executive may make any assignment of this Agreement or any interest herein, by operation of law or otherwise, without the prior written consent
        of the other; provided, however, that the Company may assign its rights and obligations under this Agreement without the consent of the Executive in the event that the Company shall hereafter effect a reorganization, consolidate with, or merge
        into, an Affiliate or any other Person or transfer all or substantially all of its properties, stock or assets to an Affiliate or any other Person. This Agreement shall inure to the benefit of and be binding upon the Company and the Executive,
        their respective successors, executors, administrators, heirs and permitted assigns.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">17. <u>Severability</u>. If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this
        Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and
        enforceable to the fullest extent permitted by law.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">18. <u>Waiver</u>. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of either party to require the performance of any term
        or obligation of this Agreement, or the waiver by either party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">19. <u>Notices</u>. Any and all notices, requests, demands and other communications provided for by this Agreement shall be in writing and shall be effective when delivered in person or deposited
        in the United States mail, postage prepaid, registered or certified, and addressed to the Executive at the Executive&#8217;s last known personal address on the books of the Company or, in the case of the Company, at its principal place of business, or to
        such other address as either party may specify by notice to the other actually received.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;
        <div style="text-align: justify; margin-right: 7.8pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman', Times, serif;">20.</font>&#160; <font style="font-family: 'Times New Roman', Times, serif;"><u>Entire Agreement</u>. This Agreement constitutes the entire agreement between the parties and supersedes all prior communications, agreements and understandings, written or oral, with respect to</font> the terms and <font style="font-family: 'Times New Roman', Times, serif;">conditions of the Executive&#8217;s employment, excluding any obligations with respect to the</font> securities of the Company or the grant of any stock options, all of which shall remain in full
          force and effect in accordance with their terms; provided, however, that this Agreement shall not supersede any effective assignment of any invention or other intellectual property to the Company or any of its Affiliates in effect on the
          Effective Date and shall not constitute a waiver by the Company or any of its Affiliates of any right that any of them now has or may now have under any agreement imposing obligations on the Executive with respect to confidentiality<font style="font-family: 'Times New Roman', Times, serif;">. Upon the Effective Date, the Consulting Agreement between the Company and Executive dated October 21, 2021 (the &#8220;</font><font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Consulting Agreement</font><font style="font-family: 'Times New Roman', Times, serif;">&#8221;) shall terminate, and Section 8 of this Agreement shall replace any continuing obligations under Section 2.4 of the Consulting
            Agreement. </font></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">21. <u>Amendment</u>. This Agreement may be amended or modified only by a written instrument signed by the Executive and by an authorized representative of the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">22. <u>Headings</u>. The headings and captions in this Agreement are for convenience only and in no way define or describe the scope or content of any provision of this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">23. <u>Counterparts</u>. This Agreement may be executed in two or more counterparts, each of which shall be an original and all of which together shall constitute one and the same instrument.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">24. <u>Governing Law; Arbitration</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(a)&#160; This is a contract and shall be construed and enforced under and be governed in all respects by the laws of the State of Louisiana, without regard to the conflict of laws principles thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(b) Any controversy or claim arising out of or relating to this Agreement or the breach thereof or otherwise arising out of the Executive&#8217;s employment or the termination of that employment shall,
        to the fullest extent permitted by law, be settled by arbitration in any forum and form agreed upon by the parties or, in the absence of such an agreement, under the auspices of the American Arbitration Association (&#8220;AAA&#8221;) in New Orleans, Louisiana
        in accordance with the Employment Arbitration Rules and Mediation Procedures of the AAA, including, but not limited to, the rules and procedures applicable to the selection of arbitrators.&#160; To the greatest extent permitted by law and the AAA,
        Company and the Executive shall each pay one-half of the arbitration fees for any such arbitration including, but not limited to, AAA administrative fees and costs, and arbitrator fees. The Company and the Executive are each responsible for their
        own attorney&#8217;s fees. The Executive understands that the Executive may only bring such claims in the Executive&#8217;s individual capacity, and not as a plaintiff or class member in any purported class proceeding or any purported representative
        proceeding.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <div style="text-align: justify; margin-right: 8.05pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman', Times, serif;">25.</font>&#160; <font style="font-family: 'Times New Roman', Times, serif;"><u>Consent to Jurisdiction</u>. To the extent that any court action is permitted consistent with or to enforce this Agreement, the parties hereby consent to the exclusive jurisdiction of the appropriate State or federal courts sitting
            in Orleans Parish, Louisiana. Accordingly, with respect to any such court</font> action, the parties: (a) submits to the personal jurisdiction of such courts; (b) consent to service of process; and (c) waive any other requirement (whether
          imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction or service of process.</div>
      </div>
      <div style="text-align: justify; line-height: 1.25;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">26. <u>Whistleblower Notice</u>. Pursuant to 18 USC &#167; 1833(b), an individual may not be held criminally or civilly liable under any federal or state trade secret law for disclosure of a trade secret: (i) made in
        confidence to a government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law; and/or (ii) in a complaint or other document filed in a lawsuit or other
        proceeding, if such filing is made under seal. Accordingly, the Parties to this Agreement have the right to disclose in confidence trade secrets to Federal, State, and local government officials, or to an attorney, for the sole purpose of reporting
        or investigating a suspected violation of law. The Parties also have the right to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">27. <u>Conditions</u>.&#160; Notwithstanding anything to the contrary herein, the effectiveness of this Agreement shall be conditioned on (i) the Executive&#8217;s satisfactory completion of reference and background checks, if
        so requested by the Company, and (ii) the Executive&#8217;s submission of satisfactory proof of the Executive&#8217;s legal authorization to work in the United States.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">28. <u>Acknowledgement</u>. The Executive acknowledges that the Company has advised the Executive to consult an attorney before signing this Agreement.&#160; The Executive has carefully read this Agreement and understands
        and agrees to all of the provisions in this Agreement.</div>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">IN WITNESS WHEREOF, the Company and the Executive have executed this Agreement as of the Effective Date.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">COMPANY:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; CHEMOMAB THERAPEUTICS, INC.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 108pt; line-height: 1.25;">Signed:&#160;<u> /s/ Dale Pfost</u></div>
      <div style="text-indent: 108pt; line-height: 1.25;">Name:&#160;&#160; Dale Pfost</div>
      <div style="text-indent: 108pt; line-height: 1.25;">Title:&#160;&#160;&#160;&#160; CEO <br>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">EXECUTIVE:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; DONALD MARVIN</div>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="text-indent: 108pt; line-height: 1.25;">Signed:&#160;&#160; <u>/s/ Donald Marvin</u>&#160;&#160;&#160; <br>
      </div>
      <div style="text-indent: 108pt; line-height: 1.25;"><u> <br>
        </u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>6
<FILENAME>exhibit_21-1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<html style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left;">
  <head>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff">
  <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
  <div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z83e5f396ca71428da0cfb5727e20e53c">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50.00%;">
              <div style="text-align: right;">&#160;<font style="font-weight: bold;"><u>Exhibit&#160;21.1</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">Chemomab Therapeutics Ltd.</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">List of Subsidiaries</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5bb8f05e91fb4aff8b1eb6ca958e3f70" style="width: 100%;">

        <tr>
          <td style="width: 59.46%; font-weight: bold; text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="font-weight: bold; font-size: 10pt;">Name</div>
          </td>
          <td style="width: 1.6%; padding-bottom: 2px;">
            <div style="font-weight: bold; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 19.38%; text-align: center; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="font-weight: bold; font-size: 10pt;">Jurisdiction of<br>
              Incorporation</div>
          </td>
          <td style="width: 1.6%; padding-bottom: 2px;">
            <div style="font-weight: bold; font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 15.27%; text-align: center; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="font-weight: bold; font-size: 10pt;">% Ownership</div>
          </td>
          <td style="width: 2.68%; padding-bottom: 2px;">
            <div style="font-size: 10pt;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 59.46%; background-color: rgb(204, 238, 255);">
            <div style="font-size: 10pt;">Chemomab Ltd.</div>
          </td>
          <td style="width: 1.6%; background-color: rgb(204, 238, 255);">
            <div style="font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 19.38%; background-color: rgb(204, 238, 255);">
            <div style="font-size: 10pt;">Israel</div>
          </td>
          <td style="width: 1.6%; background-color: rgb(204, 238, 255);">
            <div style="font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.38%; background-color: rgb(204, 238, 255);">
            <div style="font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 13.88%; background-color: rgb(204, 238, 255);">
            <div style="font-size: 10pt;">100</div>
          </td>
          <td style="width: 2.68%; background-color: rgb(204, 238, 255);">
            <div style="font-size: 10pt;">%</div>
          </td>
        </tr>
        <tr>
          <td style="width: 59.46%;">
            <div style="font-size: 10pt;">Chemomab Therapeutics,&#160;Inc.</div>
          </td>
          <td style="width: 1.6%;">
            <div style="font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 19.38%;">
            <div style="font-size: 10pt;">Delaware</div>
          </td>
          <td style="width: 1.6%;">
            <div style="font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 1.38%;">
            <div style="font-size: 10pt;">&#160;</div>
          </td>
          <td style="width: 13.88%;">
            <div style="font-size: 10pt;">100</div>
          </td>
          <td style="width: 2.68%;">
            <div style="font-size: 10pt;">%</div>
          </td>
        </tr>
        <tr>
          <td style="width: 59.46%; background-color: rgb(204, 238, 255);">
            <div style="font-size: 10pt;">Chemomab Therapeutics Israel Ltd.</div>
          </td>
          <td style="width: 1.6%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td style="width: 19.38%; background-color: rgb(204, 238, 255);">
            <div style="font-size: 10pt;">Israel</div>
          </td>
          <td style="width: 1.6%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td style="width: 1.38%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td style="width: 13.88%; background-color: rgb(204, 238, 255);">
            <div style="font-size: 10pt;">100</div>
          </td>
          <td style="width: 2.68%; background-color: rgb(204, 238, 255);">
            <div style="font-size: 10pt;">%</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>exhibit_23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div> <br>
    </div>
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 23.1</font></u><br>
    </div>
    <div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Consent of Independent Registered Public Accounting Firm</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
      </div>
      <div style="line-height: 1.25;">The Board of Directors<br>
        Chemomab Therapeutics Ltd.:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">We consent to the incorporation by reference in the registration statements (No.333-255249 and No. 333-255659) on form S-3 and in the
        registration statement (No.333-259489) on form S-8 of our report dated March 30, 2022, with respect to the financial statements of Chemomab Therapeutics Ltd.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zebd538b9233a4be4bc920fd8f7eedb03" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 100%; vertical-align: middle;">
              <div style="line-height: 1.25;">/s/ Somekh Chaikin</div>
              <div style="line-height: 1.25;"> <br>
              </div>
              <div style="line-height: 1.25;">Somekh Chaikin</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 100%; vertical-align: middle;">
              <div style="line-height: 1.25;">Member Firm of KPMG International</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Tel Aviv, Israel<br>
          <br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">March 30, 2022</div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>exhibit_31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u>Exhibit 31.1</u></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14a OF</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">THE SECURITIES EXCHANGE ACT OF 1934</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION 302</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">OF THE SARBANES OXLEY ACT OF 2002</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">I, Dale Pfost, certify that:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z6b7f28f9ed144b5f8d9d6094857cb366" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">I have reviewed this Annual Report on Form 10-K of Chemomab Therapeutics Ltd.;<br>
              <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zf001f75c52ad4dfabba89b6f0765c53b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
              made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zafa9dc739b634fbb852d1bb8e57dc4d9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">3.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
              condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zace34e618c39420fb147ec10055f3e8f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
              Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zf2684546523243d0a75ed1110ed9687a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">a.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
              material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z266429a4f7234a7db33e518e32c3e233" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">b.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to
              provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z80e1d7f7052c4d2d8e98402c3892ef14" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">c.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
              disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zc9571baef6504623ba28e86f2b3a8c5b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">d.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal
              quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="ze0a24f32649945e7a5c0246dda84e568" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">5.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
              registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z19002ac9a65e4a258ae823db9a3b81c2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">a.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
              adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="za29a2533f61e43ddae353aa5b456e0b1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">b.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial
              reporting.</div>
          </td>
        </tr>

    </table>
    <div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 49.97%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
            <td style="width: 50.03%; vertical-align: bottom;">
              <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.97%; vertical-align: middle;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
            <td style="width: 50.03%; vertical-align: middle;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.97%; vertical-align: top;">
              <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Date: March 30, 2022</div>
            </td>
            <td style="width: 50.03%; vertical-align: bottom;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><u>/s/ Dale Pfost</u></div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.97%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
            <td style="width: 50.03%; vertical-align: bottom;">
              <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Dale Pfost</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.97%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
            <td style="width: 50.03%; vertical-align: bottom;">
              <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.97%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
            <td style="width: 50.03%; vertical-align: bottom;">
              <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-style: italic;">(Principal Executive Officer)</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 12pt;">&#160;</div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>exhibit_31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u>Exhibit 31.2</u></div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14a OF</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">THE SECURITIES EXCHANGE ACT OF 1934</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION 302</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">OF THE SARBANES OXLEY ACT OF 2002</div>
    <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">I, Donald Marvin, certify that:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z6a4d16c3566345aea724a250356f2cd2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">I have reviewed this Annual Report on Form 10-K of Chemomab Therapeutics Ltd.;</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z6a45954b5c574ca9b85db7d3680b6b9a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
              made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z93ddce5819804faeb33e48c6ec9f0d4d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">3.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
              condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z4943268713164455aeaeb9a6efc70c5a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
              Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z50ff9d6762424c9fbaf35cdf494805b7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">a.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
              material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z03b1b12dc8974cdeb142a63027b86d06" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">b.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to
              provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z4003b15d6c254a09bc9a3ad2e791f102" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">c.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
              disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zbd6e24903fd04c6d88690d40656fce45" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">d.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal
              quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
            <div style="color: #000000; font-family: 'Times New Roman', serif;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z67d1cb8d40754494a628d0e18702f9fd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">5.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
              registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):<br>
              <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zca6e793d4d7846d1b8f042e73ece3ee8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">a.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
              adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and<br>
              <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zea558d68d539481b9d0645bcfbccc88a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">b.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial
              reporting.</div>
          </td>
        </tr>

    </table>
    <div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 49.97%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
            <td style="width: 50.03%; vertical-align: bottom;">
              <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.97%; vertical-align: middle;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
            <td style="width: 50.03%; vertical-align: middle;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.97%; vertical-align: top;">
              <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Date: March 30, 2022</div>
            </td>
            <td style="width: 50.03%; vertical-align: bottom;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><u>/s/ Donald Marvin</u></div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.97%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
            <td style="width: 50.03%; vertical-align: bottom;">
              <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Donald Marvin</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.97%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
            <td style="width: 50.03%; vertical-align: bottom;">
              <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chief Financial Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.97%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
            <td style="width: 50.03%; vertical-align: bottom;">
              <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-style: italic;">(Principal Financial Officer)</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>10
<FILENAME>exhibit_32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u>Exhibit 32.1</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">PURSUANT TO 18 U.S.C. SECTION 1350,</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION 906</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">I, Dale Pfost, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
      that the Annual Report on Form 10-K of Chemomab Therapeutics Ltd. for the fiscal year ended December 31, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in
      such Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of Chemomab Therapeutics Ltd.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7316c228cef2403287648e1615c0c376" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49.97%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 50.03%; vertical-align: bottom;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.97%; vertical-align: middle;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 50.03%; vertical-align: middle;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.97%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Date: March 30, 2022</div>
          </td>
          <td style="width: 50.03%; vertical-align: bottom;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><u>/s/ Dale Pfost</u></div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.97%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 50.03%; vertical-align: bottom;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Dale Pfost</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.97%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 50.03%; vertical-align: bottom;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chief Executive Officer</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.97%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 50.03%; vertical-align: bottom;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-style: italic;">(Principal Executive Officer)</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: 40.8pt; line-height: 1.25; font-family: 'Times New Roman', serif;">&#160; <br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 8pt;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>11
<FILENAME>exhibit_32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u>Exhibit 32.2</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">PURSUANT TO 18 U.S.C. SECTION 1350,</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION 906</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">I, Donald Marvin, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
      2002, that the Annual Report on Form 10-K of Chemomab Therapeutics Ltd. for the fiscal year ended December 31, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information
      contained in such Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of Chemomab Therapeutics Ltd.</div>
    <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4adc373c14bb496eb09c4cb3be62a210" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49.97%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 50.03%; vertical-align: bottom;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.97%; vertical-align: middle;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 50.03%; vertical-align: middle;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.97%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Date: March 30, 2022</div>
          </td>
          <td style="width: 50.03%; vertical-align: bottom;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;"><u>/s/ Donald Marvin</u></div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.97%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 50.03%; vertical-align: bottom;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Donald Marvin</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.97%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 50.03%; vertical-align: bottom;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Chief Financial Officer</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.97%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 50.03%; vertical-align: bottom;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-style: italic;">(Principal Financial Officer)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;<br style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>cmmb-20211231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<schema attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" targetNamespace="http://anchiano.com/20211231" xmlns:cmmb="http://anchiano.com/20211231">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <annotation>
    <appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:roleType roleURI="http://anchiano.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00010 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>00020 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
        <link:definition>00030 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/StatementsOfOperations" id="StatementsOfOperations">
        <link:definition>00040 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/StatementsOfChangesInEquity" id="StatementsOfChangesInEquity">
        <link:definition>00050 - Statement - Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
        <link:definition>00060 - Statement - Statements of Cash flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/General" id="General">
        <link:definition>00070 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
        <link:definition>00080 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/CashAndCashEquivalents" id="CashAndCashEquivalents">
        <link:definition>00090 - Disclosure - Cash and Cash Equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/OtherReceivablesAndPrepaidExpenses" id="OtherReceivablesAndPrepaidExpenses">
        <link:definition>00100 - Disclosure - Other Receivables and Prepaid Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
        <link:definition>00110 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/Leases" id="Leases">
        <link:definition>00120 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/CommitmentsAndContingentLiabilities" id="CommitmentsAndContingentLiabilities">
        <link:definition>00130 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/ShareCapital" id="ShareCapital">
        <link:definition>00140 - Disclosure - Share Capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/ResearchAndDevelopment" id="ResearchAndDevelopment">
        <link:definition>00150 - Disclosure - Research and Development</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/GeneralAndAdministrative" id="GeneralAndAdministrative">
        <link:definition>00160 - Disclosure - General and Administrative</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>00170 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/RelatedPartiesBalancesAndTransactions" id="RelatedPartiesBalancesAndTransactions">
        <link:definition>00180 - Disclosure - Related Parties Balances and Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders" id="NetLossPerShareAttributableToOrdinaryShareholders">
        <link:definition>00190 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>00200 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/GeneralTables" id="GeneralTables">
        <link:definition>00210 - Disclosure - General (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
        <link:definition>00220 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/CashAndCashEquivalentsTables" id="CashAndCashEquivalentsTables">
        <link:definition>00230 - Disclosure - Cash and Cash Equivalents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables" id="OtherReceivablesAndPrepaidExpensesTables">
        <link:definition>00240 - Disclosure - Other Receivables and Prepaid Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
        <link:definition>00250 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/LeasesTables" id="LeasesTables">
        <link:definition>00260 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/ShareCapitalTables" id="ShareCapitalTables">
        <link:definition>00270 - Disclosure - Share Capital (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/ResearchAndDevelopmentTables" id="ResearchAndDevelopmentTables">
        <link:definition>00280 - Disclosure - Research and Development (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/GeneralAndAdministrativeTables" id="GeneralAndAdministrativeTables">
        <link:definition>00290 - Disclosure - General and Administrative (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <link:definition>00300 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables" id="RelatedPartiesBalancesAndTransactionsTables">
        <link:definition>00310 - Disclosure - Related Parties Balances and Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables" id="NetLossPerShareAttributableToOrdinaryShareholdersTables">
        <link:definition>00320 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/GeneralDetails" id="GeneralDetails">
        <link:definition>00330 - Disclosure - General (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails" id="GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails">
        <link:definition>00340 - Disclosure - General (Schedule of net assets acquired based on their estimated fair value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" id="SummaryOfSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>00350 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails" id="SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails">
        <link:definition>00360 - Disclosure - Summary of Significant Accounting Policies (Schedule of Annual rates of Depreciation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/CashAndCashEquivalentsDetails" id="CashAndCashEquivalentsDetails">
        <link:definition>00370 - Disclosure - Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails" id="OtherReceivablesAndPrepaidExpensesDetails">
        <link:definition>00380 - Disclosure - Other Receivables and Prepaid Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/PropertyAndEquipmentNetDetails" id="PropertyAndEquipmentNetDetails">
        <link:definition>00390 - Disclosure - Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/LeasesNarrativeDetails" id="LeasesNarrativeDetails">
        <link:definition>00400 - Disclosure - Leases (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails" id="LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails">
        <link:definition>00410 - Disclosure - Leases (Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails" id="CommitmentsAndContingentLiabilitiesDetails">
        <link:definition>00420 - Disclosure - Commitments and Contingent Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/ShareCapitalNarrativeDetails" id="ShareCapitalNarrativeDetails">
        <link:definition>00430 - Disclosure - Share Capital (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails" id="ShareCapitalShare-basedCompensationExpensesDetails">
        <link:definition>00440 - Disclosure - Share Capital (Share-based compensation expenses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails" id="ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails">
        <link:definition>00450 - Disclosure - Share Capital (Summary of number and weighted average exercise prices of option) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails" id="ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails">
        <link:definition>00460 - Disclosure - Share Capital (Summary of assumptions used to calculate the fair value of the options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails" id="ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails">
        <link:definition>00470 - Disclosure - Research and Development (Schedule of Research and Development) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails" id="GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails">
        <link:definition>00480 - Disclosure - General and Administrative (Schedule of General and Administrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
        <link:definition>00490 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails" id="IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails">
        <link:definition>00500 - Disclosure - Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails" id="IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails">
        <link:definition>00510 - Disclosure - Income Taxes (Schedule of Roll Forward of Valuation Allowance) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails" id="IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails">
        <link:definition>00520 - Disclosure - Income Taxes (Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails" id="RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails">
        <link:definition>00530 - Disclosure - Related Parties Balances and Transactions (Schedule of Related Party Payables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails" id="RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails">
        <link:definition>00540 - Disclosure - Related Parties Balances and Transactions (Schedule of Transaction With Related Parties) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails" id="NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails">
        <link:definition>00550 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Computation of Basic and Diluted Net Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails" id="NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails">
        <link:definition>00560 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Weighted Average Number of Shares) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd"/>
  <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd"/>
  <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd"/>
  <element name="AmericanDepositarySharesMember" id="cmmb_AmericanDepositarySharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="OrdinarySharesNoParValuePerShareMember" id="cmmb_OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="FinanceIncomeExpensesNet" id="cmmb_FinanceIncomeExpensesNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="EffectOfReverseCapitalizationTransaction" id="cmmb_EffectOfReverseCapitalizationTransaction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="EffectOfReverseCapitalizationTransactionShares" id="cmmb_EffectOfReverseCapitalizationTransactionShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="StockAndWarrantsIssuedDuringPeriodValueNewIssues" id="cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="StockAndWarrantsIssuedDuringPeriodNewIssues" id="cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="PaymentsForInvestmentInDeposits" id="cmmb_PaymentsForInvestmentInDeposits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="LongtermLeaseDeposit" id="cmmb_LongtermLeaseDeposit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="CashAcquiredInMerger" id="cmmb_CashAcquiredInMerger" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="NatureOfOperationsDisclosureAbstract" id="cmmb_NatureOfOperationsDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="OtherAccountsReceivableAndPrepaidExpensesTextBlock" id="cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="GeneralAndAdministrativeDisclosureTextBlock" id="cmmb_GeneralAndAdministrativeDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock" id="cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="SeverancePayPolicyPolicyTextBlock" id="cmmb_SeverancePayPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="ScheduleOfAnnualRateOfDeprecationTableTextBlock" id="cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" id="cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="ScheduleOfResearchAndDevelopmentTableTextBlock" id="cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="ScheduleOfGeneralAndAdministrativeTableTextBlock" id="cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="ScheduleOfRelatedPartyPayablesTableTextBlock" id="cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" id="cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="FormerChemomabSecurityHoldersMember" id="cmmb_FormerChemomabSecurityHoldersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" id="cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="ShareholdingPercentageImmediatelyFollowingMerger" id="cmmb_ShareholdingPercentageImmediatelyFollowingMerger" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="NumberOfOrdinarySharesConsistedInDS" id="cmmb_NumberOfOrdinarySharesConsistedInDS" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="NumberOfAdsIssuedAndOutstandingAfterMerger" id="cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" id="cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="debit"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" id="cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="credit"/>
  <element name="EstimatedFairValueOfNetAssetsAcquired" id="cmmb_EstimatedFairValueOfNetAssetsAcquired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="debit"/>
  <element name="PercentageOfMonthlyDepositsRate" id="cmmb_PercentageOfMonthlyDepositsRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="LaboratoryEquipmentMember" id="cmmb_LaboratoryEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="AnnualRatesOfDepreciation" id="cmmb_AnnualRatesOfDepreciation" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="ReceivablesFromGovernmentInstitutions" id="cmmb_ReceivablesFromGovernmentInstitutions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="debit"/>
  <element name="AnnualRentAndManagementFees" id="cmmb_AnnualRentAndManagementFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="BankGuaranteesToPropertyOwner" id="cmmb_BankGuaranteesToPropertyOwner" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="OperatingRightofuseAssetsAndOperatingLeaseLiabilities" id="cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="debit"/>
  <element name="CapitalAdditionsOneMember" id="cmmb_CapitalAdditionsOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="PercentageOfRoyaltyPaymentsOnSaleOfProduct" id="cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="MaximumPercentageOfPaymentsOfRoyalties" id="cmmb_MaximumPercentageOfPaymentsOfRoyalties" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="CumulativeAmountsOfGrantsReceivedAndRecognized" id="cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="debit"/>
  <element name="PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" id="cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="AggregateAmountCommitmentToPay" id="cmmb_AggregateAmountCommitmentToPay" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="AggregateAmountOfCommitmentPaid" id="cmmb_AggregateAmountOfCommitmentPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="AdditionalWorkOrderAmount" id="cmmb_AdditionalWorkOrderAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="LienOnBankDeposit" id="cmmb_LienOnBankDeposit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="SaleOfStockTable" id="cmmb_SaleOfStockTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="InvestorsMember" id="cmmb_InvestorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="AtmAgreementMember" id="cmmb_AtmAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="TwoThousandsFifteenMember" id="cmmb_TwoThousandsFifteenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="SaleOfStockLineItems" id="cmmb_SaleOfStockLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="ProceedsFromSaleOfAdss" id="cmmb_ProceedsFromSaleOfAdss" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" id="cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="NumberOfWarrantsPurchaseUpAdss" id="cmmb_NumberOfWarrantsPurchaseUpAdss" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="SaleOfStocksPricePerShare" id="cmmb_SaleOfStocksPricePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="NumberOfStockAdssResveredForIssuance" id="cmmb_NumberOfStockAdssResveredForIssuance" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="NumberOfAdssOptionsIssuableOutstanding" id="cmmb_NumberOfAdssOptionsIssuableOutstanding" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="NumberOfAdssVestedAndExercisable" id="cmmb_NumberOfAdssVestedAndExercisable" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" id="cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="StockIssuedDuringPeriodSharesStockOptionsExercised1" id="cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" id="cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="ConsultantsAndSubcontractorsExpense" id="cmmb_ConsultantsAndSubcontractorsExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="RentAndMaintenanceResearchAndDevelopmentExpense" id="cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="SharebasedCompensationResearchAndDevelopmentExpense" id="cmmb_SharebasedCompensationResearchAndDevelopmentExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="ShareBasedCompensationGeneralAndAdministrativeExpense" id="cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="RentAndMaintenanceGeneralAndAdministrativeExpense" id="cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="IncomeTaxDisclosureTable" id="cmmb_IncomeTaxDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="IncomeTaxDisclosureLineItems" id="cmmb_IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="CurrencyTransactionLossValuationAllowance" id="cmmb_CurrencyTransactionLossValuationAllowance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="TaxAssetsAcquiredThroughMergerValuationAllowance" id="cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="IncomeTaxExpenseValuationAllowance" id="cmmb_IncomeTaxExpenseValuationAllowance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" id="cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
  <element name="RelatedPartyMember" id="cmmb_RelatedPartyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" id="cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty" id="cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" id="cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" id="cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
  <element name="EarningsPerShareCalculationNumeratorAbstract" id="cmmb_EarningsPerShareCalculationNumeratorAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" id="cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>cmmb-20211231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <roleRef roleURI="http://anchiano.com/role/StatementConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cmmb-20211231.xsd#StatementConsolidatedBalanceSheets"/>
  <roleRef roleURI="http://anchiano.com/role/StatementsOfOperations" xlink:type="simple" xlink:href="cmmb-20211231.xsd#StatementsOfOperations"/>
  <roleRef roleURI="http://anchiano.com/role/StatementsOfCashFlows" xlink:type="simple" xlink:href="cmmb-20211231.xsd#StatementsOfCashFlows"/>
  <roleRef roleURI="http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#OtherReceivablesAndPrepaidExpensesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/PropertyAndEquipmentNetDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#PropertyAndEquipmentNetDetails"/>
  <roleRef roleURI="http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"/>
  <roleRef roleURI="http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"/>
  <roleRef roleURI="http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"/>
  <roleRef roleURI="http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"/>
  <roleRef roleURI="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"/>
  <calculationLink xlink:type="extended" xlink:role="http://anchiano.com/role/StatementConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="locator_us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="locator_us-gaap_AssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_Assets" xlink:to="locator_us-gaap_AssetsCurrent" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="locator_us-gaap_DepositsAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="locator_us-gaap_DepositsAssetsCurrent" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="locator_us-gaap_AssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_Assets" xlink:to="locator_us-gaap_AssetsNoncurrent" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="locator_us-gaap_DepositsAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsNoncurrent" xlink:to="locator_us-gaap_DepositsAssetsNoncurrent" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="locator_us-gaap_RestrictedCashNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsNoncurrent" xlink:to="locator_us-gaap_RestrictedCashNoncurrent" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="locator_us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsNoncurrent" xlink:to="locator_us-gaap_OperatingLeaseRightOfUseAsset" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="locator_us-gaap_PrepaidExpenseNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsNoncurrent" xlink:to="locator_us-gaap_PrepaidExpenseNoncurrent" use="optional" priority="0" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsNoncurrent" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentNet" use="optional" priority="0" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="locator_us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="locator_us-gaap_Liabilities" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="locator_us-gaap_LiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_Liabilities" xlink:to="locator_us-gaap_LiabilitiesCurrent" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="locator_us-gaap_AccountsPayableTradeCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="locator_us-gaap_AccountsPayableTradeCurrent" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="locator_us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="locator_us-gaap_AccruedLiabilitiesCurrent" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="locator_us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="locator_us-gaap_EmployeeRelatedLiabilitiesCurrent" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="locator_us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="locator_us-gaap_OperatingLeaseLiabilityCurrent" use="optional" priority="0" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="locator_us-gaap_LiabilitiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_Liabilities" xlink:to="locator_us-gaap_LiabilitiesNoncurrent" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="locator_us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesNoncurrent" xlink:to="locator_us-gaap_OperatingLeaseLiabilityNoncurrent" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="locator_us-gaap_CommitmentsAndContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="locator_us-gaap_CommitmentsAndContingencies" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="locator_us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="locator_us-gaap_CommonStockValue" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="locator_us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="locator_us-gaap_AdditionalPaidInCapital" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="locator_us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="locator_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" priority="0" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://anchiano.com/role/StatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="locator_us-gaap_OperatingExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetIncomeLoss" xlink:to="locator_us-gaap_OperatingExpenses" use="optional" priority="0" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_OperatingExpenses" xlink:to="locator_us-gaap_ResearchAndDevelopmentExpense" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_OperatingExpenses" xlink:to="locator_us-gaap_GeneralAndAdministrativeExpense" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="locator_cmmb_FinanceIncomeExpensesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetIncomeLoss" xlink:to="locator_cmmb_FinanceIncomeExpensesNet" use="optional" priority="0" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://anchiano.com/role/StatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="locator_us-gaap_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_ProfitLoss" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="locator_us-gaap_Depreciation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_Depreciation" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="locator_us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_ShareBasedCompensation" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="locator_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" use="optional" priority="0" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade" use="optional" priority="0" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInAccruedLiabilities" use="optional" priority="0" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" use="optional" priority="0" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="locator_us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" use="optional" priority="0" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_PaymentsForInvestmentInDeposits" xlink:label="locator_cmmb_PaymentsForInvestmentInDeposits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="locator_cmmb_PaymentsForInvestmentInDeposits" use="optional" priority="0" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LongtermLeaseDeposit" xlink:label="locator_cmmb_LongtermLeaseDeposit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="locator_cmmb_LongtermLeaseDeposit" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="locator_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="locator_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="locator_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="locator_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" priority="0" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_CashAcquiredInMerger" xlink:label="locator_cmmb_CashAcquiredInMerger"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="locator_cmmb_CashAcquiredInMerger" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="locator_us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="locator_us-gaap_ProceedsFromStockOptionsExercised" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="locator_us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="locator_us-gaap_ProceedsFromIssuanceOfWarrants" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="locator_us-gaap_ProceedsFromOtherEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="locator_us-gaap_ProceedsFromOtherEquity" use="optional" priority="0" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ReceivablesFromGovernmentInstitutions" xlink:label="locator_cmmb_ReceivablesFromGovernmentInstitutions"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="locator_cmmb_ReceivablesFromGovernmentInstitutions" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="locator_us-gaap_PrepaidExpenseCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="locator_us-gaap_PrepaidExpenseCurrent" use="optional" priority="0" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://anchiano.com/role/PropertyAndEquipmentNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentGross" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" priority="0" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" use="optional" priority="0" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpense"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ConsultantsAndSubcontractorsExpense" xlink:label="locator_cmmb_ConsultantsAndSubcontractorsExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_ResearchAndDevelopmentExpense" xlink:to="locator_cmmb_ConsultantsAndSubcontractorsExpense" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="locator_us-gaap_OfficersCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_ResearchAndDevelopmentExpense" xlink:to="locator_us-gaap_OfficersCompensation" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" xlink:label="locator_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_ResearchAndDevelopmentExpense" xlink:to="locator_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SharebasedCompensationResearchAndDevelopmentExpense" xlink:label="locator_cmmb_SharebasedCompensationResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_ResearchAndDevelopmentExpense" xlink:to="locator_cmmb_SharebasedCompensationResearchAndDevelopmentExpense" use="optional" priority="0" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="locator_us-gaap_OtherResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_ResearchAndDevelopmentExpense" xlink:to="locator_us-gaap_OtherResearchAndDevelopmentExpense" use="optional" priority="0" order="5" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="locator_us-gaap_SalariesAndWages"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpense" xlink:to="locator_us-gaap_SalariesAndWages" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" xlink:label="locator_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpense" xlink:to="locator_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="locator_us-gaap_ProfessionalFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpense" xlink:to="locator_us-gaap_ProfessionalFees" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoninterestExpenseDirectorsFees" xlink:label="locator_us-gaap_NoninterestExpenseDirectorsFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpense" xlink:to="locator_us-gaap_NoninterestExpenseDirectorsFees" use="optional" priority="0" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralInsuranceExpense" xlink:label="locator_us-gaap_GeneralInsuranceExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpense" xlink:to="locator_us-gaap_GeneralInsuranceExpense" use="optional" priority="0" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" xlink:label="locator_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpense" xlink:to="locator_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" use="optional" priority="0" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpense" xlink:to="locator_us-gaap_OtherGeneralAndAdministrativeExpense" use="optional" priority="0" order="7" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="locator_us-gaap_DeferredTaxAssetsNet"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="locator_us-gaap_DeferredTaxAssetsGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_DeferredTaxAssetsNet" xlink:to="locator_us-gaap_DeferredTaxAssetsGross" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="locator_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_DeferredTaxAssetsGross" xlink:to="locator_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_DeferredTaxAssetsGross" xlink:to="locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="locator_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_DeferredTaxAssetsGross" xlink:to="locator_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="locator_us-gaap_DeferredTaxAssetsOther"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_DeferredTaxAssetsGross" xlink:to="locator_us-gaap_DeferredTaxAssetsOther" use="optional" priority="0" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="locator_us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_DeferredTaxAssetsNet" xlink:to="locator_us-gaap_DeferredTaxAssetsValuationAllowance" use="optional" priority="0" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="locator_us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="locator_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_IncomeTaxExpenseBenefit" xlink:to="locator_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" xlink:label="locator_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_IncomeTaxExpenseBenefit" xlink:to="locator_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" use="optional" priority="0" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="locator_us-gaap_DueToRelatedPartiesCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="locator_us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_DueToRelatedPartiesCurrent" xlink:to="locator_us-gaap_EmployeeRelatedLiabilitiesCurrent" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="locator_us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_DueToRelatedPartiesCurrent" xlink:to="locator_us-gaap_AccruedLiabilitiesCurrent" use="optional" priority="0" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyCosts" xlink:label="locator_us-gaap_RelatedPartyCosts"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" xlink:label="locator_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_RelatedPartyCosts" xlink:to="locator_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" use="optional" priority="0" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty" xlink:label="locator_cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_RelatedPartyCosts" xlink:to="locator_cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty" use="optional" priority="0" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" xlink:label="locator_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_RelatedPartyCosts" xlink:to="locator_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" use="optional" priority="0" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" xlink:label="locator_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_RelatedPartyCosts" xlink:to="locator_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" use="optional" priority="0" order="4" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>cmmb-20211231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <roleRef roleURI="http://anchiano.com/role/DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="cmmb-20211231.xsd#DocumentDocumentAndEntityInformation"/>
  <roleRef roleURI="http://anchiano.com/role/StatementsOfChangesInEquity" xlink:type="simple" xlink:href="cmmb-20211231.xsd#StatementsOfChangesInEquity"/>
  <roleRef roleURI="http://anchiano.com/role/GeneralDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#GeneralDetails"/>
  <roleRef roleURI="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"/>
  <roleRef roleURI="http://anchiano.com/role/CashAndCashEquivalentsDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#CashAndCashEquivalentsDetails"/>
  <roleRef roleURI="http://anchiano.com/role/PropertyAndEquipmentNetDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#PropertyAndEquipmentNetDetails"/>
  <roleRef roleURI="http://anchiano.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#LeasesNarrativeDetails"/>
  <roleRef roleURI="http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#CommitmentsAndContingentLiabilitiesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/ShareCapitalNarrativeDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ShareCapitalNarrativeDetails"/>
  <roleRef roleURI="http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ShareCapitalShare-basedCompensationExpensesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"/>
  <roleRef roleURI="http://anchiano.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#IncomeTaxesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails"/>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/DocumentDocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="locator_dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="locator_dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityCentralIndexKey" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="locator_dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentFiscalPeriodFocus" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="locator_dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_AmendmentFlag" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="locator_dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentType" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="locator_dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_CurrentFiscalYearEndDate" use="optional" priority="0" order="4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="locator_dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentFiscalYearFocus" use="optional" priority="0" order="5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="locator_dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentPeriodEndDate" use="optional" priority="0" order="6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="locator_dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentAnnualReport" use="optional" priority="0" order="7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="locator_dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentTransitionReport" use="optional" priority="0" order="8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="locator_dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityFileNumber" use="optional" priority="0" order="9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="locator_dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentInformationTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="locator_us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_dei_DocumentInformationTable" xlink:to="locator_us-gaap_StatementClassOfStockAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="locator_cmmb_AmericanDepositarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockDomain" xlink:to="locator_cmmb_AmericanDepositarySharesMember" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="locator_cmmb_OrdinarySharesNoParValuePerShareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockDomain" xlink:to="locator_cmmb_OrdinarySharesNoParValuePerShareMember" use="optional" priority="0" order="21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="locator_dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityRegistrantName" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="locator_dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityIncorporationStateCountryCode" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="locator_dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityTaxIdentificationNumber" use="optional" priority="0" order="12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="locator_dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityAddressAddressLine1" use="optional" priority="0" order="13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="locator_dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityAddressAddressLine2" use="optional" priority="0" order="14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="locator_dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityAddressCityOrTown" use="optional" priority="0" order="15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="locator_dei_EntityAddressCountry"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityAddressCountry" use="optional" priority="0" order="16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="locator_dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityAddressPostalZipCode" use="optional" priority="0" order="17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="locator_dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_CityAreaCode" use="optional" priority="0" order="18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="locator_dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_LocalPhoneNumber" use="optional" priority="0" order="19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="locator_dei_EntityInformationFormerLegalOrRegisteredName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityInformationFormerLegalOrRegisteredName" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="locator_dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_Security12bTitle" use="optional" priority="0" order="21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="locator_dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_TradingSymbol" use="optional" priority="0" order="22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="locator_dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_SecurityExchangeName" use="optional" priority="0" order="23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="locator_dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityWellKnownSeasonedIssuer" use="optional" priority="0" order="24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="locator_dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityVoluntaryFilers" use="optional" priority="0" order="25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="locator_dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityCurrentReportingStatus" use="optional" priority="0" order="26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="locator_dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityInteractiveDataCurrent" use="optional" priority="0" order="27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="locator_dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityFilerCategory" use="optional" priority="0" order="28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="locator_dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntitySmallBusiness" use="optional" priority="0" order="29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="locator_dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityEmergingGrowthCompany" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="locator_dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityExTransitionPeriod" use="optional" priority="0" order="31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="locator_dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_IcfrAuditorAttestationFlag" use="optional" priority="0" order="32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="locator_dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityShellCompany" use="optional" priority="0" order="33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="locator_dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityPublicFloat" use="optional" priority="0" order="34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="locator_dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityCommonStockSharesOutstanding" use="optional" priority="0" order="35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="locator_dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_AuditorName" use="optional" priority="0" order="36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="locator_dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_AuditorLocation" use="optional" priority="0" order="37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="locator_dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_AuditorFirmId" use="optional" priority="0" order="38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain_f7ce11a0-8b97-c084-8b45-2aad3fa19c08_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain_f7ce11a0-8b97-c084-8b45-2aad3fa19c08_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/StatementsOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="locator_us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_SharesOutstanding" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueNewIssues" use="optional" priority="0" order="4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="0" order="5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" use="optional" priority="0" order="6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="locator_cmmb_EffectOfReverseCapitalizationTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cmmb_EffectOfReverseCapitalizationTransaction" use="optional" priority="0" order="7"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="locator_cmmb_EffectOfReverseCapitalizationTransactionShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cmmb_EffectOfReverseCapitalizationTransactionShares" use="optional" priority="0" order="8"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="locator_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" use="optional" priority="0" order="9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="locator_us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementEquityComponentsAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="locator_us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_EquityComponentDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="locator_us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_EquityComponentDomain" xlink:to="locator_us-gaap_CommonStockMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="locator_us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_EquityComponentDomain" xlink:to="locator_us-gaap_AdditionalPaidInCapitalMember" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="locator_us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_EquityComponentDomain" xlink:to="locator_us-gaap_RetainedEarningsMember" use="optional" priority="0" order="21"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:label="locator_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" use="optional" priority="0" order="12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="locator_us-gaap_EquityComponentDomain_e81965c7-1d4e-56b3-d9e1-93299642916b_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_EquityComponentDomain_e81965c7-1d4e-56b3-d9e1-93299642916b_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="locator_us-gaap_RestructuringCostAndReserveLineItems"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="locator_cmmb_ShareholdingPercentageImmediatelyFollowingMerger"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="locator_cmmb_ShareholdingPercentageImmediatelyFollowingMerger" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="locator_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="locator_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="locator_cmmb_NumberOfOrdinarySharesConsistedInDS"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="locator_cmmb_NumberOfOrdinarySharesConsistedInDS" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="locator_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="locator_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="locator_us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="locator_us-gaap_BusinessAcquisitionAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="locator_us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_BusinessAcquisitionAxis" xlink:to="locator_us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:label="locator_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="locator_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="locator_srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="locator_srt_TitleOfIndividualAxis" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_srt_TitleOfIndividualAxis" xlink:to="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="locator_cmmb_FormerChemomabSecurityHoldersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="locator_cmmb_FormerChemomabSecurityHoldersMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="locator_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="locator_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="locator_us-gaap_BusinessAcquisitionAcquireeDomain_dcf2fbdf-0ed5-ea85-cf01-316b58770472_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_BusinessAcquisitionAxis" xlink:to="locator_us-gaap_BusinessAcquisitionAcquireeDomain_dcf2fbdf-0ed5-ea85-cf01-316b58770472_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain_e80b8147-3079-7818-1405-ff76e549913a_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_srt_TitleOfIndividualAxis" xlink:to="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain_e80b8147-3079-7818-1405-ff76e549913a_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AnnualRatesOfDepreciation" xlink:label="locator_cmmb_AnnualRatesOfDepreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="locator_cmmb_AnnualRatesOfDepreciation" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="locator_us-gaap_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_ComputerEquipmentMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LaboratoryEquipmentMember" xlink:label="locator_cmmb_LaboratoryEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_cmmb_LaboratoryEquipmentMember" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="locator_us-gaap_FurnitureAndFixturesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_FurnitureAndFixturesMember" use="optional" priority="0" order="21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="locator_us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_LeaseholdImprovementsMember" use="optional" priority="0" order="31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_35e47e99-6499-0964-be8b-7804edf0ab7e_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_35e47e99-6499-0964-be8b-7804edf0ab7e_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/CashAndCashEquivalentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="locator_srt_CurrencyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_srt_CurrencyAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="locator_currency_AllCurrenciesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_srt_CurrencyAxis" xlink:to="locator_currency_AllCurrenciesDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_ILS" xlink:label="locator_currency_ILS"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_currency_AllCurrenciesDomain" xlink:to="locator_currency_ILS" use="optional" priority="0" order="21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="locator_currency_USD"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_currency_AllCurrenciesDomain" xlink:to="locator_currency_USD" use="optional" priority="0" order="41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_XXX" xlink:label="locator_currency_XXX"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_currency_AllCurrenciesDomain" xlink:to="locator_currency_XXX" use="optional" priority="0" order="61"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="locator_currency_AllCurrenciesDomain_28ab0eae-a480-b11b-0cf9-a59f5cc55735_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_srt_CurrencyAxis" xlink:to="locator_currency_AllCurrenciesDomain_28ab0eae-a480-b11b-0cf9-a59f5cc55735_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/PropertyAndEquipmentNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentGross" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentNet" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="locator_us-gaap_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_ComputerEquipmentMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="locator_us-gaap_FurnitureAndFixturesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_FurnitureAndFixturesMember" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LaboratoryEquipmentMember" xlink:label="locator_cmmb_LaboratoryEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_cmmb_LaboratoryEquipmentMember" use="optional" priority="0" order="21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="locator_us-gaap_SoftwareDevelopmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_SoftwareDevelopmentMember" use="optional" priority="0" order="31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="locator_us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_LeaseholdImprovementsMember" use="optional" priority="0" order="41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_f988c0e2-f4de-5ce8-5979-7b0f02f31ce7_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain_f988c0e2-f4de-5ce8-5979-7b0f02f31ce7_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/LeasesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="locator_us-gaap_LesseeLeaseDescriptionLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="locator_us-gaap_LeaseExpirationDate1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_us-gaap_LeaseExpirationDate1" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="locator_us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_us-gaap_LesseeOperatingLeaseTermOfContract" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AnnualRentAndManagementFees" xlink:label="locator_cmmb_AnnualRentAndManagementFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_cmmb_AnnualRentAndManagementFees" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_BankGuaranteesToPropertyOwner" xlink:label="locator_cmmb_BankGuaranteesToPropertyOwner"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_cmmb_BankGuaranteesToPropertyOwner" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities" xlink:label="locator_cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities" use="optional" priority="0" order="4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="locator_us-gaap_OperatingLeaseImpairmentLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_us-gaap_OperatingLeaseImpairmentLoss" use="optional" priority="0" order="5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="locator_us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" use="optional" priority="0" order="6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="locator_us-gaap_LesseeLeaseDescriptionTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_us-gaap_LesseeLeaseDescriptionTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="locator_srt_CurrencyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_LesseeLeaseDescriptionTable" xlink:to="locator_srt_CurrencyAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="locator_currency_AllCurrenciesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_srt_CurrencyAxis" xlink:to="locator_currency_AllCurrenciesDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_ILS" xlink:label="locator_currency_ILS"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_currency_AllCurrenciesDomain" xlink:to="locator_currency_ILS" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="locator_currency_AllCurrenciesDomain_ce1c40e0-4c39-d3ec-b76a-9d271fbc7a7b_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_srt_CurrencyAxis" xlink:to="locator_currency_AllCurrenciesDomain_ce1c40e0-4c39-d3ec-b76a-9d271fbc7a7b_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="locator_us-gaap_OtherCommitmentsLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentDescription" xlink:label="locator_us-gaap_LongTermPurchaseCommitmentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_LongTermPurchaseCommitmentDescription" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDescription" xlink:label="locator_us-gaap_OtherCommitmentsDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_OtherCommitmentsDescription" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" xlink:label="locator_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_MaximumPercentageOfPaymentsOfRoyalties" xlink:label="locator_cmmb_MaximumPercentageOfPaymentsOfRoyalties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_MaximumPercentageOfPaymentsOfRoyalties" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" xlink:label="locator_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" use="optional" priority="0" order="4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:label="locator_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" use="optional" priority="0" order="5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="locator_us-gaap_LongTermPurchaseCommitmentAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_LongTermPurchaseCommitmentAmount" use="optional" priority="0" order="6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" xlink:label="locator_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" use="optional" priority="0" order="7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="locator_us-gaap_RoyaltyExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_RoyaltyExpense" use="optional" priority="0" order="8"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AggregateAmountCommitmentToPay" xlink:label="locator_cmmb_AggregateAmountCommitmentToPay"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_AggregateAmountCommitmentToPay" use="optional" priority="0" order="9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="locator_us-gaap_OtherCommitmentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_OtherCommitmentsTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="locator_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_OtherCommitmentsTable" xlink:to="locator_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="locator_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="locator_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalAdditionsMember" xlink:label="locator_us-gaap_CapitalAdditionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="locator_us-gaap_CapitalAdditionsMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_CapitalAdditionsOneMember" xlink:label="locator_cmmb_CapitalAdditionsOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="locator_cmmb_CapitalAdditionsOneMember" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAgreementsMember" xlink:label="locator_us-gaap_LeaseAgreementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="locator_us-gaap_LeaseAgreementsMember" use="optional" priority="0" order="71"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="locator_srt_CurrencyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_OtherCommitmentsTable" xlink:to="locator_srt_CurrencyAxis" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="locator_currency_AllCurrenciesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_srt_CurrencyAxis" xlink:to="locator_currency_AllCurrenciesDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="locator_currency_EUR"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_currency_AllCurrenciesDomain" xlink:to="locator_currency_EUR" use="optional" priority="0" order="51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_ILS" xlink:label="locator_currency_ILS"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_currency_AllCurrenciesDomain" xlink:to="locator_currency_ILS" use="optional" priority="0" order="72"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="locator_srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_OtherCommitmentsTable" xlink:to="locator_srt_TitleOfIndividualAxis" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_srt_TitleOfIndividualAxis" xlink:to="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="locator_srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_OtherCommitmentsTable" xlink:to="locator_srt_StatementScenarioAxis" use="optional" priority="0" order="4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="locator_srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_srt_StatementScenarioAxis" xlink:to="locator_srt_ScenarioUnspecifiedDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="locator_srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_ScenarioUnspecifiedDomain" xlink:to="locator_srt_ScenarioForecastMember" use="optional" priority="0" order="93"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AggregateAmountOfCommitmentPaid" xlink:label="locator_cmmb_AggregateAmountOfCommitmentPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_AggregateAmountOfCommitmentPaid" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AdditionalWorkOrderAmount" xlink:label="locator_cmmb_AdditionalWorkOrderAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_AdditionalWorkOrderAmount" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LienOnBankDeposit" xlink:label="locator_cmmb_LienOnBankDeposit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_LienOnBankDeposit" use="optional" priority="0" order="12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedInvestments" xlink:label="locator_us-gaap_RestrictedInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_RestrictedInvestments" use="optional" priority="0" order="13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="locator_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7208e5c9-6fa2-df01-3ca4-222c307464b0_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="locator_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7208e5c9-6fa2-df01-3ca4-222c307464b0_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="locator_currency_AllCurrenciesDomain_d9bb1c74-509b-e5e9-494f-2f999a62d0c2_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_srt_CurrencyAxis" xlink:to="locator_currency_AllCurrenciesDomain_d9bb1c74-509b-e5e9-494f-2f999a62d0c2_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain_eb731c4d-61c2-2489-8490-45245e2291fa_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_srt_TitleOfIndividualAxis" xlink:to="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain_eb731c4d-61c2-2489-8490-45245e2291fa_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="locator_srt_ScenarioUnspecifiedDomain_b6a7e961-d643-ef48-0773-16d7bef209ad_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_srt_StatementScenarioAxis" xlink:to="locator_srt_ScenarioUnspecifiedDomain_b6a7e961-d643-ef48-0773-16d7bef209ad_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/ShareCapitalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SaleOfStockLineItems" xlink:label="locator_cmmb_SaleOfStockLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="locator_us-gaap_ProceedsFromWarrantExercises"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_us-gaap_ProceedsFromWarrantExercises" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="locator_us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_us-gaap_PreferredStockSharesIssued" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_us-gaap_PreferredStockParOrStatedValuePerShare" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="locator_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ProceedsFromSaleOfAdss" xlink:label="locator_cmmb_ProceedsFromSaleOfAdss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_ProceedsFromSaleOfAdss" use="optional" priority="0" order="4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" xlink:label="locator_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" use="optional" priority="0" order="5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfWarrantsPurchaseUpAdss" xlink:label="locator_cmmb_NumberOfWarrantsPurchaseUpAdss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_NumberOfWarrantsPurchaseUpAdss" use="optional" priority="0" order="6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SaleOfStocksPricePerShare" xlink:label="locator_cmmb_SaleOfStocksPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_SaleOfStocksPricePerShare" use="optional" priority="0" order="7"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfStockAdssResveredForIssuance" xlink:label="locator_cmmb_NumberOfStockAdssResveredForIssuance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_NumberOfStockAdssResveredForIssuance" use="optional" priority="0" order="8"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfAdssOptionsIssuableOutstanding" xlink:label="locator_cmmb_NumberOfAdssOptionsIssuableOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_NumberOfAdssOptionsIssuableOutstanding" use="optional" priority="0" order="9"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SaleOfStockTable" xlink:label="locator_cmmb_SaleOfStockTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_SaleOfStockTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="locator_us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_cmmb_SaleOfStockTable" xlink:to="locator_us-gaap_SubsidiarySaleOfStockAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="locator_us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="locator_us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_InvestorsMember" xlink:label="locator_cmmb_InvestorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="locator_cmmb_InvestorsMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="locator_us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="locator_us-gaap_PrivatePlacementMember" use="optional" priority="0" order="81"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AtmAgreementMember" xlink:label="locator_cmmb_AtmAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="locator_cmmb_AtmAgreementMember" use="optional" priority="0" order="101"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="locator_us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_cmmb_SaleOfStockTable" xlink:to="locator_us-gaap_StatementClassOfStockAxis" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="locator_us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockDomain" xlink:to="locator_us-gaap_SeriesCPreferredStockMember" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="locator_us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_cmmb_SaleOfStockTable" xlink:to="locator_us-gaap_PlanNameAxis" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="locator_us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_PlanNameAxis" xlink:to="locator_us-gaap_PlanNameDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_TwoThousandsFifteenMember" xlink:label="locator_cmmb_TwoThousandsFifteenMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_PlanNameDomain" xlink:to="locator_cmmb_TwoThousandsFifteenMember" use="optional" priority="0" order="121"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfAdssVestedAndExercisable" xlink:label="locator_cmmb_NumberOfAdssVestedAndExercisable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_NumberOfAdssVestedAndExercisable" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" use="optional" priority="0" order="12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="locator_us-gaap_SaleOfStockNameOfTransactionDomain_393586d2-f722-357f-fd63-5656f1a0f8a2_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="locator_us-gaap_SaleOfStockNameOfTransactionDomain_393586d2-f722-357f-fd63-5656f1a0f8a2_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain_8795bd2f-817a-fd01-30e5-23e0a4f5d7ca_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain_8795bd2f-817a-fd01-30e5-23e0a4f5d7ca_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="locator_us-gaap_PlanNameDomain_e3ac3487-e506-f15c-7f04-554dcc12dd7f_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_PlanNameAxis" xlink:to="locator_us-gaap_PlanNameDomain_e3ac3487-e506-f15c-7f04-554dcc12dd7f_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="locator_us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="locator_us-gaap_AllocatedShareBasedCompensationExpense" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="locator_us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="locator_us-gaap_IncomeStatementLocationAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="locator_us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_IncomeStatementLocationAxis" xlink:to="locator_us-gaap_IncomeStatementLocationDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_IncomeStatementLocationDomain" xlink:to="locator_us-gaap_ResearchAndDevelopmentExpenseMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_IncomeStatementLocationDomain" xlink:to="locator_us-gaap_GeneralAndAdministrativeExpenseMember" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="locator_us-gaap_IncomeStatementLocationDomain_ed6e7225-7c4c-3142-0e88-b442b6b9b763_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_IncomeStatementLocationAxis" xlink:to="locator_us-gaap_IncomeStatementLocationDomain_ed6e7225-7c4c-3142-0e88-b442b6b9b763_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="locator_us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_SharePrice" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" use="optional" priority="0" order="3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" use="optional" priority="0" order="4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" use="optional" priority="0" order="5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" use="optional" priority="0" order="6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" use="optional" priority="0" order="7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="locator_srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="locator_srt_RangeAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="locator_srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_srt_RangeAxis" xlink:to="locator_srt_RangeMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="locator_srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_RangeMember" xlink:to="locator_srt_MinimumMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="locator_srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_RangeMember" xlink:to="locator_srt_MaximumMember" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="locator_us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="locator_us-gaap_AwardTypeAxis" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_AwardTypeAxis" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="locator_srt_RangeMember_d14e6899-727e-4dd4-4c7e-b7527e7a5f22_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_srt_RangeAxis" xlink:to="locator_srt_RangeMember_d14e6899-727e-4dd4-4c7e-b7527e7a5f22_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e484f1d1-a0ee-f30a-dae0-d6a3712f5595_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_AwardTypeAxis" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e484f1d1-a0ee-f30a-dae0-d6a3712f5595_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_IncomeTaxDisclosureLineItems" xlink:label="locator_cmmb_IncomeTaxDisclosureLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="locator_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_IncomeTaxDisclosureLineItems" xlink:to="locator_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="locator_us-gaap_TaxCreditCarryforwardAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_cmmb_IncomeTaxDisclosureLineItems" xlink:to="locator_us-gaap_TaxCreditCarryforwardAmount" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_IncomeTaxDisclosureTable" xlink:label="locator_cmmb_IncomeTaxDisclosureTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_cmmb_IncomeTaxDisclosureLineItems" xlink:to="locator_cmmb_IncomeTaxDisclosureTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="locator_srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_cmmb_IncomeTaxDisclosureTable" xlink:to="locator_srt_StatementGeographicalAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="locator_srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_srt_StatementGeographicalAxis" xlink:to="locator_srt_SegmentGeographicalDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:label="locator_country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_SegmentGeographicalDomain" xlink:to="locator_country_IL" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="locator_country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_srt_SegmentGeographicalDomain" xlink:to="locator_country_US" use="optional" priority="0" order="11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="locator_us-gaap_IncomeTaxAuthorityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_cmmb_IncomeTaxDisclosureTable" xlink:to="locator_us-gaap_IncomeTaxAuthorityAxis" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="locator_us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_IncomeTaxAuthorityAxis" xlink:to="locator_us-gaap_IncomeTaxAuthorityDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="locator_us-gaap_DomesticCountryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_IncomeTaxAuthorityDomain" xlink:to="locator_us-gaap_DomesticCountryMember" use="optional" priority="0" order="12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="locator_srt_SegmentGeographicalDomain_71096917-311a-b72f-d507-8e1488c28dad_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_srt_StatementGeographicalAxis" xlink:to="locator_srt_SegmentGeographicalDomain_71096917-311a-b72f-d507-8e1488c28dad_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="locator_us-gaap_IncomeTaxAuthorityDomain_bfc384c2-c6d3-5bef-c9da-223b0f13bca6_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_IncomeTaxAuthorityAxis" xlink:to="locator_us-gaap_IncomeTaxAuthorityDomain_bfc384c2-c6d3-5bef-c9da-223b0f13bca6_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="locator_us-gaap_RelatedPartyTransactionLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="locator_us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_EmployeeRelatedLiabilitiesCurrent" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="locator_us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_AccruedLiabilitiesCurrent" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="locator_us-gaap_DueToRelatedPartiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_DueToRelatedPartiesCurrent" use="optional" priority="0" order="2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="locator_us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="locator_us-gaap_RelatedPartyDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyMember" xlink:label="locator_cmmb_RelatedPartyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RelatedPartyDomain" xlink:to="locator_cmmb_RelatedPartyMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="locator_us-gaap_RelatedPartyDomain_bdd178a1-e211-24ec-19e5-8a6e29879ca3_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="locator_us-gaap_RelatedPartyDomain_bdd178a1-e211-24ec-19e5-8a6e29879ca3_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="locator_us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="locator_us-gaap_AntidilutiveSecuritiesNameDomain" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="locator_us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="locator_us-gaap_EmployeeStockOptionMember" use="optional" priority="0" order="1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="locator_us-gaap_AntidilutiveSecuritiesNameDomain_d1c6d175-a6ea-32c5-3635-4f0e72375367_default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="locator_us-gaap_AntidilutiveSecuritiesNameDomain_d1c6d175-a6ea-32c5-3635-4f0e72375367_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>cmmb-20211231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="locator_dei_DocumentInformationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentInformationTable" xml:lang="en-US">Document Information [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentInformationTable" xlink:to="label_dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="locator_us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="label_us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="locator_cmmb_AmericanDepositarySharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_AmericanDepositarySharesMember" xml:lang="en-US">American Depositary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_AmericanDepositarySharesMember" xml:lang="en-US">American Depositary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_AmericanDepositarySharesMember" xlink:to="label_cmmb_AmericanDepositarySharesMember"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="locator_cmmb_OrdinarySharesNoParValuePerShareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_OrdinarySharesNoParValuePerShareMember" xml:lang="en-US">Ordinary Shares, No Par Value Per Share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_OrdinarySharesNoParValuePerShareMember" xml:lang="en-US">Ordinary Shares, No Par Value Per Share [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_OrdinarySharesNoParValuePerShareMember" xlink:to="label_cmmb_OrdinarySharesNoParValuePerShareMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="locator_dei_DocumentInformationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentInformationLineItems" xml:lang="en-US">Document Information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="label_dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="locator_dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityCentralIndexKey" xlink:to="label_dei_EntityCentralIndexKey"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="locator_dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentFiscalPeriodFocus" xlink:to="label_dei_DocumentFiscalPeriodFocus"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="locator_dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_AmendmentFlag" xlink:to="label_dei_AmendmentFlag"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="locator_dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentType" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentType" xlink:to="label_dei_DocumentType"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="locator_dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_CurrentFiscalYearEndDate" xlink:to="label_dei_CurrentFiscalYearEndDate"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="locator_dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentFiscalYearFocus" xlink:to="label_dei_DocumentFiscalYearFocus"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="locator_dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentPeriodEndDate" xlink:to="label_dei_DocumentPeriodEndDate"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="locator_dei_DocumentAnnualReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentAnnualReport" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentAnnualReport" xlink:to="label_dei_DocumentAnnualReport"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="locator_dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentTransitionReport" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentTransitionReport" xlink:to="label_dei_DocumentTransitionReport"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="locator_dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityFileNumber" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityFileNumber" xlink:to="label_dei_EntityFileNumber"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="locator_dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityRegistrantName" xlink:to="label_dei_EntityRegistrantName"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="locator_dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityIncorporationStateCountryCode" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityIncorporationStateCountryCode" xlink:to="label_dei_EntityIncorporationStateCountryCode"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="locator_dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityTaxIdentificationNumber" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityTaxIdentificationNumber" xlink:to="label_dei_EntityTaxIdentificationNumber"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="locator_dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressAddressLine1" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressAddressLine1" xlink:to="label_dei_EntityAddressAddressLine1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="locator_dei_EntityAddressAddressLine2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressAddressLine2" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressAddressLine2" xlink:to="label_dei_EntityAddressAddressLine2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="locator_dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressCityOrTown" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressCityOrTown" xlink:to="label_dei_EntityAddressCityOrTown"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="locator_dei_EntityAddressCountry"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressCountry" xml:lang="en-US">Entity Address, Country</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressCountry" xlink:to="label_dei_EntityAddressCountry"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="locator_dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressPostalZipCode" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressPostalZipCode" xlink:to="label_dei_EntityAddressPostalZipCode"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="locator_dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_CityAreaCode" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_CityAreaCode" xlink:to="label_dei_CityAreaCode"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="locator_dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_LocalPhoneNumber" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_LocalPhoneNumber" xlink:to="label_dei_LocalPhoneNumber"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="locator_dei_EntityInformationFormerLegalOrRegisteredName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityInformationFormerLegalOrRegisteredName" xml:lang="en-US">Entity Information, Former Legal or Registered Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="label_dei_EntityInformationFormerLegalOrRegisteredName"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="locator_dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_Security12bTitle" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_Security12bTitle" xlink:to="label_dei_Security12bTitle"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="locator_dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_TradingSymbol" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_TradingSymbol" xlink:to="label_dei_TradingSymbol"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="locator_dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_SecurityExchangeName" xml:lang="en-US">Name of Exchange on which Security is Registered</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_SecurityExchangeName" xlink:to="label_dei_SecurityExchangeName"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="locator_dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityWellKnownSeasonedIssuer" xml:lang="en-US">Entity Well Known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityWellKnownSeasonedIssuer" xlink:to="label_dei_EntityWellKnownSeasonedIssuer"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="locator_dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityVoluntaryFilers" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityVoluntaryFilers" xlink:to="label_dei_EntityVoluntaryFilers"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="locator_dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityCurrentReportingStatus" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityCurrentReportingStatus" xlink:to="label_dei_EntityCurrentReportingStatus"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="locator_dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityInteractiveDataCurrent" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityInteractiveDataCurrent" xlink:to="label_dei_EntityInteractiveDataCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="locator_dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityFilerCategory" xlink:to="label_dei_EntityFilerCategory"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="locator_dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntitySmallBusiness" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntitySmallBusiness" xlink:to="label_dei_EntitySmallBusiness"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="locator_dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityEmergingGrowthCompany" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityEmergingGrowthCompany" xlink:to="label_dei_EntityEmergingGrowthCompany"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="locator_dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityExTransitionPeriod" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityExTransitionPeriod" xlink:to="label_dei_EntityExTransitionPeriod"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="locator_dei_IcfrAuditorAttestationFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_IcfrAuditorAttestationFlag" xml:lang="en-US">Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_IcfrAuditorAttestationFlag" xlink:to="label_dei_IcfrAuditorAttestationFlag"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="locator_dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityShellCompany" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityShellCompany" xlink:to="label_dei_EntityShellCompany"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="locator_dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityPublicFloat" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityPublicFloat" xlink:to="label_dei_EntityPublicFloat"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="locator_dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityCommonStockSharesOutstanding" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityCommonStockSharesOutstanding" xlink:to="label_dei_EntityCommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="locator_dei_AuditorName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_AuditorName" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_AuditorName" xlink:to="label_dei_AuditorName"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="locator_dei_AuditorLocation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_AuditorLocation" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_AuditorLocation" xlink:to="label_dei_AuditorLocation"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="locator_dei_AuditorFirmId"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_AuditorFirmId" xml:lang="en-US">Auditor Firm Id</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_AuditorFirmId" xlink:to="label_dei_AuditorFirmId"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="locator_us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="label_us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="locator_us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AssetsAbstract" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="label_us-gaap_AssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="locator_us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="label_us-gaap_AssetsCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="locator_us-gaap_DepositsAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DepositsAssetsCurrent" xml:lang="en-US">Short-term bank deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DepositsAssetsCurrent" xlink:to="label_us-gaap_DepositsAssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Other receivables and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Other accounts receivable and prepaid expenses, Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="locator_us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_AssetsCurrent" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="label_us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="locator_us-gaap_AssetsNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AssetsNoncurrentAbstract" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="label_us-gaap_AssetsNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="locator_us-gaap_DepositsAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DepositsAssetsNoncurrent" xml:lang="en-US">Long-term deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DepositsAssetsNoncurrent" xlink:to="label_us-gaap_DepositsAssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="locator_us-gaap_PrepaidExpenseNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PrepaidExpenseNoncurrent" xml:lang="en-US">Long-term prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PrepaidExpenseNoncurrent" xlink:to="label_us-gaap_PrepaidExpenseNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="locator_us-gaap_RestrictedCashNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RestrictedCashNoncurrent" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RestrictedCashNoncurrent" xlink:to="label_us-gaap_RestrictedCashNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property Plant And Equipment Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="label_us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="locator_us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US">Operating lease right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="label_us-gaap_OperatingLeaseRightOfUseAsset"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="locator_us-gaap_AssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_AssetsNoncurrent" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AssetsNoncurrent" xml:lang="en-US">Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsNoncurrent" xlink:to="label_us-gaap_AssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="locator_us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_Assets" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_Assets" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_Assets" xlink:to="label_us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="locator_us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="label_us-gaap_LiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="locator_us-gaap_AccountsPayableTradeCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccountsPayableTradeCurrent" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccountsPayableTradeCurrent" xlink:to="label_us-gaap_AccountsPayableTradeCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="locator_us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccruedLiabilitiesCurrent" xlink:to="label_us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="locator_us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EmployeeRelatedLiabilitiesCurrent" xml:lang="en-US">Employee and related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="label_us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="locator_us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingLeaseLiabilityCurrent" xml:lang="en-US">Operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="label_us-gaap_OperatingLeaseLiabilityCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="locator_us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="label_us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="locator_us-gaap_LiabilitiesNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesNoncurrentAbstract" xml:lang="en-US">Non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="label_us-gaap_LiabilitiesNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="locator_us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingLeaseLiabilityNoncurrent" xml:lang="en-US">Non-current operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="label_us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="locator_us-gaap_LiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_LiabilitiesNoncurrent" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesNoncurrent" xml:lang="en-US">Liabilities, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesNoncurrent" xlink:to="label_us-gaap_LiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="locator_us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and contingent liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommitmentsAndContingencies" xlink:to="label_us-gaap_CommitmentsAndContingencies"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="locator_us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_Liabilities" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_Liabilities" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_Liabilities" xlink:to="label_us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xml:lang="en-US">Shareholders' equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="label_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="locator_us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockValue" xml:lang="en-US">Ordinary Shares no par value - Authorized: 650,000,000 shares as of December 31, 2021 and 500,000,000 shares as of December 31, 2020; Issued and outstanding: 228,090,300 shares at December 31, 2021 and 9,274,838 shares at December 31, 2020</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockValue" xlink:to="label_us-gaap_CommonStockValue"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="locator_us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AdditionalPaidInCapital" xlink:to="label_us-gaap_AdditionalPaidInCapital"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="locator_us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="label_us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_StockholdersEquity" xml:lang="en-US">Total shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="label_us-gaap_StockholdersEquity" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="label_us-gaap_StockholdersEquity" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total liabilities and shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="locator_us-gaap_CommonStockNoParValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockNoParValue" xml:lang="en-US">Common Stock, No Par Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockNoParValue" xlink:to="label_us-gaap_CommonStockNoParValue"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="locator_us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockSharesAuthorized" xlink:to="label_us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="locator_us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockSharesIssued" xlink:to="label_us-gaap_CommonStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="locator_us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="label_us-gaap_SharesOutstanding" xml:lang="en-US">Beginning balance (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="label_us-gaap_SharesOutstanding" xml:lang="en-US">Ending balance (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SharesOutstanding" xlink:to="label_us-gaap_SharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="locator_us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="label_us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="locator_us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingExpensesAbstract" xlink:to="label_us-gaap_OperatingExpensesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ResearchAndDevelopmentExpense" xlink:to="label_us-gaap_ResearchAndDevelopmentExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpense" xlink:to="label_us-gaap_GeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="locator_us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_OperatingExpenses" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingExpenses" xml:lang="en-US">Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingExpenses" xlink:to="label_us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="locator_cmmb_FinanceIncomeExpensesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_cmmb_FinanceIncomeExpensesNet" xml:lang="en-US">Financing expenses (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_FinanceIncomeExpensesNet" xml:lang="en-US">The net amount of finance income earned and finance expenses incurred during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_FinanceIncomeExpensesNet" xml:lang="en-US">Finance Income (Expenses), Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_FinanceIncomeExpensesNet" xlink:to="label_cmmb_FinanceIncomeExpensesNet"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="label_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetIncomeLoss" xlink:to="label_us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="locator_us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Basic and diluted loss per Ordinary Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="label_us-gaap_EarningsPerShareBasicAndDiluted"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted average number of Ordinary Shares outstanding, basic, and diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementTable" xlink:to="label_us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="locator_us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="label_us-gaap_StatementEquityComponentsAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="locator_us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_CommonStockMember" xml:lang="en-US">Ordinary shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockMember" xlink:to="label_us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="locator_us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid In Capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional paid in capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AdditionalPaidInCapitalMember" xlink:to="label_us-gaap_AdditionalPaidInCapitalMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="locator_us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RetainedEarningsMember" xml:lang="en-US">Retained Earnings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_RetainedEarningsMember" xml:lang="en-US">Accumulated deficit [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RetainedEarningsMember" xlink:to="label_us-gaap_RetainedEarningsMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="label_us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xml:lang="en-US">Share-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Issuance of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Issuance of shares (In shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="locator_cmmb_EffectOfReverseCapitalizationTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_EffectOfReverseCapitalizationTransaction" xml:lang="en-US">Effect of reverse capitalization transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_EffectOfReverseCapitalizationTransaction" xml:lang="en-US">The amount of effect due reverse capitalization transaction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_EffectOfReverseCapitalizationTransaction" xlink:to="label_cmmb_EffectOfReverseCapitalizationTransaction"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="locator_cmmb_EffectOfReverseCapitalizationTransactionShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_EffectOfReverseCapitalizationTransactionShares" xml:lang="en-US">Effect of reverse capitalization transaction (In shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_EffectOfReverseCapitalizationTransactionShares" xml:lang="en-US">The number of shares isued due to effect of reverse capitalization transaction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:to="label_cmmb_EffectOfReverseCapitalizationTransactionShares"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="locator_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:to="label_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:label="locator_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs (In shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xml:lang="en-US">it represents number of shares and warrants issued during period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:to="label_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xml:lang="en-US">Exercise of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Exercise of Options, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="locator_us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="label_us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Cash flows from operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="locator_us-gaap_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_ProfitLoss" xml:lang="en-US">Net loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProfitLoss" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProfitLoss" xlink:to="label_us-gaap_ProfitLoss"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments for operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="locator_us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_Depreciation" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_Depreciation" xlink:to="label_us-gaap_Depreciation"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="locator_us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_ShareBasedCompensation" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensation" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensation" xlink:to="label_us-gaap_ShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="locator_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Change in other receivables and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xml:lang="en-US">Change in trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInAccruedLiabilities" xml:lang="en-US">Change in accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xml:lang="en-US">Change in employees and related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="locator_us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xml:lang="en-US">Change in leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="label_us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">Cash flows from investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_PaymentsForInvestmentInDeposits" xlink:label="locator_cmmb_PaymentsForInvestmentInDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_cmmb_PaymentsForInvestmentInDeposits" xml:lang="en-US">Investment in deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_PaymentsForInvestmentInDeposits" xml:lang="en-US">The amount of payments for investm,ents in deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_PaymentsForInvestmentInDeposits" xml:lang="en-US">Payments for Investment in Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_PaymentsForInvestmentInDeposits" xlink:to="label_cmmb_PaymentsForInvestmentInDeposits"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LongtermLeaseDeposit" xlink:label="locator_cmmb_LongtermLeaseDeposit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_LongtermLeaseDeposit" xml:lang="en-US">Long-term lease deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_LongtermLeaseDeposit" xml:lang="en-US">Long-term lease deposit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_LongtermLeaseDeposit" xlink:to="label_cmmb_LongtermLeaseDeposit"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="locator_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xml:lang="en-US">Sale of asset held for sale</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:to="label_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="locator_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net cash used in investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Cash flows from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_CashAcquiredInMerger" xlink:label="locator_cmmb_CashAcquiredInMerger"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_CashAcquiredInMerger" xml:lang="en-US">Cash acquired in Merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_CashAcquiredInMerger" xml:lang="en-US">Cash acquired in merger.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_CashAcquiredInMerger" xlink:to="label_cmmb_CashAcquiredInMerger"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="locator_us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromStockOptionsExercised" xml:lang="en-US">Exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="label_us-gaap_ProceedsFromStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="locator_us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US">Exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="label_us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="locator_us-gaap_ProceedsFromOtherEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_ProceedsFromOtherEquity" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromOtherEquity" xml:lang="en-US">Proceeds from Other Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromOtherEquity" xlink:to="label_us-gaap_ProceedsFromOtherEquity"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net cash provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xml:lang="en-US">Change in cash, cash equivalents and restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="locator_us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xml:lang="en-US">Significant non- cash transaction:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="label_us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="locator_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xml:lang="en-US">Right-of-use asset recognized with corresponding lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="label_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="locator_us-gaap_LiabilitiesAssumed1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesAssumed1" xml:lang="en-US">Liabilities assumed, net of non-cash assets received in Merger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesAssumed1" xlink:to="label_us-gaap_LiabilitiesAssumed1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="locator_cmmb_NatureOfOperationsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_NatureOfOperationsDisclosureAbstract" xml:lang="en-US">NATURE OF OPERATIONS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_NatureOfOperationsDisclosureAbstract" xml:lang="en-US">No definition available.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_NatureOfOperationsDisclosureAbstract" xlink:to="label_cmmb_NatureOfOperationsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="locator_us-gaap_NatureOfOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NatureOfOperations" xml:lang="en-US">General</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NatureOfOperations" xlink:to="label_us-gaap_NatureOfOperations"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="locator_us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="label_us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="locator_us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Summary of Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="label_us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="locator_us-gaap_CashAndCashEquivalentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashAndCashEquivalentsAbstract" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="label_us-gaap_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:label="locator_us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xml:lang="en-US">Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:to="label_us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:label="locator_us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xml:lang="en-US">Prepaid Expense and Other Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:to="label_us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock" xlink:label="locator_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock" xml:lang="en-US">Other Receivables and Prepaid Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock" xml:lang="en-US">Other accounts receivable and prepaid expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock" xlink:to="label_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PropertyPlantAndEquipmentAbstract" xml:lang="en-US">Property, Plant and Equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="label_us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US">Property and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract" xlink:label="locator_us-gaap_LesseeDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LesseeDisclosureAbstract" xml:lang="en-US">Lessee Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LesseeDisclosureAbstract" xlink:to="label_us-gaap_LesseeDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="locator_us-gaap_LesseeOperatingLeasesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LesseeOperatingLeasesTextBlock" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="label_us-gaap_LesseeOperatingLeasesTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="locator_us-gaap_CommitmentsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommitmentsDisclosureTextBlock" xml:lang="en-US">Commitments and Contingent Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommitmentsDisclosureTextBlock" xlink:to="label_us-gaap_CommitmentsDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US">Stockholders' Equity Note [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="label_us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="locator_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xml:lang="en-US">Share Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="label_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="locator_us-gaap_ResearchAndDevelopmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ResearchAndDevelopmentAbstract" xml:lang="en-US">Research and Development [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="label_us-gaap_ResearchAndDevelopmentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="locator_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xml:lang="en-US">Research and Development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="label_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_GeneralAndAdministrativeExpenseAbstract" xml:lang="en-US">General and Administrative Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:to="label_us-gaap_GeneralAndAdministrativeExpenseAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_GeneralAndAdministrativeDisclosureTextBlock" xlink:label="locator_cmmb_GeneralAndAdministrativeDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_GeneralAndAdministrativeDisclosureTextBlock" xml:lang="en-US">General and Administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_GeneralAndAdministrativeDisclosureTextBlock" xml:lang="en-US">The entire disclosure of general and administrative expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_GeneralAndAdministrativeDisclosureTextBlock" xlink:to="label_cmmb_GeneralAndAdministrativeDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="locator_us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="label_us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="locator_us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="label_us-gaap_IncomeTaxDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="locator_us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="label_us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">Related Parties Balances and Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="locator_us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EarningsPerShareAbstract" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EarningsPerShareAbstract" xlink:to="label_us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="locator_us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US">Net Loss Per Share Attributable to Ordinary Shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EarningsPerShareTextBlock" xlink:to="label_us-gaap_EarningsPerShareTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="locator_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="locator_us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_UseOfEstimates" xml:lang="en-US">Use of estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_UseOfEstimates" xlink:to="label_us-gaap_UseOfEstimates"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="locator_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xml:lang="en-US">Functional currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="locator_us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="locator_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xml:lang="en-US">Restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="label_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="locator_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xml:lang="en-US">Impairment of long-lived assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="label_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="label_us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="locator_us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="label_us-gaap_IncomeTaxPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="locator_us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xml:lang="en-US">Fair value of financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock" xlink:label="locator_cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock" xml:lang="en-US">Government-sponsored research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock" xml:lang="en-US">Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock" xlink:to="label_cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SeverancePayPolicyPolicyTextBlock" xlink:label="locator_cmmb_SeverancePayPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_SeverancePayPolicyPolicyTextBlock" xml:lang="en-US">Severance pay</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_SeverancePayPolicyPolicyTextBlock" xml:lang="en-US">Disclosure of accounting policy for severance pay.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_SeverancePayPolicyPolicyTextBlock" xlink:to="label_cmmb_SeverancePayPolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="locator_us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration of credit risks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ConcentrationRiskCreditRisk" xlink:to="label_us-gaap_ConcentrationRiskCreditRisk"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="locator_us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_LesseeLeasesPolicyTextBlock" xml:lang="en-US">Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LesseeLeasesPolicyTextBlock" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="label_us-gaap_LesseeLeasesPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="locator_us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US">Principles of consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ConsolidationPolicyTextBlock" xlink:to="label_us-gaap_ConsolidationPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="locator_us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Earnings per ordinary share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="label_us-gaap_EarningsPerSharePolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xml:lang="en-US">Schedule of net assets acquired based on their estimated fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="label_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock" xlink:label="locator_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock" xml:lang="en-US">Schedule of Annual rate of Deprecation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock" xml:lang="en-US">Tabular disclosure of the annual rate of Deprecation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock" xlink:to="label_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xml:lang="en-US">Schedule of components of cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" xlink:label="locator_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" xml:lang="en-US">Schedule of other accounts receivable and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" xml:lang="en-US">Schedule of other accounts receivable and prepaid expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" xlink:to="label_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">Schedule of Property And Equpment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xml:lang="en-US">Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="label_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xml:lang="en-US">Summary of the effect of share-based compensation on the statements of operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="label_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xml:lang="en-US">Summary of number and weighted average exercise prices of option</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="label_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US">Summary of assumptions used to calculate the fair value of the options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock" xlink:label="locator_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock" xml:lang="en-US">Schedule of Research and Development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock" xml:lang="en-US">Tabular disclosure of research and development expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock" xlink:to="label_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock" xlink:label="locator_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock" xml:lang="en-US">Schedule of General and Administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock" xml:lang="en-US">Tabular disclosure of general and administrative expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock" xlink:to="label_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US">Schedule of Significant Components of the Company's Deferred Tax Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="locator_us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SummaryOfValuationAllowanceTextBlock" xml:lang="en-US">Schedule of Roll Forward of Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="label_us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US">Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock" xlink:label="locator_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock" xml:lang="en-US">Schedule of Related Party Payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock" xml:lang="en-US">Tabular disclosure of related party payables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock" xlink:to="label_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xml:lang="en-US">Schedule of Transaction With Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="label_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="locator_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xml:lang="en-US">Schedule of Weighted Average Number of Shares Excluded From Computation of Diluted Net Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="label_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="locator_us-gaap_BusinessAcquisitionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_BusinessAcquisitionAxis" xml:lang="en-US">Business Acquisition [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_BusinessAcquisitionAxis" xlink:to="label_us-gaap_BusinessAcquisitionAxis"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:label="locator_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xml:lang="en-US">Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xml:lang="en-US">This represents Merger Agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company inclued proposed merger of CMB Acquisition Ltd, wholly owned subsidiary of our company.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:to="label_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="locator_srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_TitleOfIndividualAxis" xml:lang="en-US">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_TitleOfIndividualAxis" xlink:to="label_srt_TitleOfIndividualAxis"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="locator_cmmb_FormerChemomabSecurityHoldersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_FormerChemomabSecurityHoldersMember" xml:lang="en-US">Former Chemomab Security Holders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_FormerChemomabSecurityHoldersMember" xml:lang="en-US">This represents former Chemomab security holders.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_FormerChemomabSecurityHoldersMember" xlink:to="label_cmmb_FormerChemomabSecurityHoldersMember"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="locator_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xml:lang="en-US">Security holders of Anchiano as of immediately prior to the merger [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xml:lang="en-US">This represents security holders of Anchiano as of immediately prior to the merger.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:to="label_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="locator_us-gaap_RestructuringCostAndReserveLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RestructuringCostAndReserveLineItems" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="label_us-gaap_RestructuringCostAndReserveLineItems"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="locator_cmmb_ShareholdingPercentageImmediatelyFollowingMerger"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xml:lang="en-US">Shareholding percentage immediately following the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xml:lang="en-US">shareholding percentage immediately following the merger.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:to="label_cmmb_ShareholdingPercentageImmediatelyFollowingMerger"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="locator_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xml:lang="en-US">Reverse stock split conversion ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="label_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="locator_cmmb_NumberOfOrdinarySharesConsistedInDS"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_NumberOfOrdinarySharesConsistedInDS" xml:lang="en-US">Number of ordinary shares represented by each ADS (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_NumberOfOrdinarySharesConsistedInDS" xml:lang="en-US">Represent the number of ordinary shares consisted in one American depository share (ADS).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:to="label_cmmb_NumberOfOrdinarySharesConsistedInDS"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="locator_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xml:lang="en-US">Number of ADS issued and outstanding after the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xml:lang="en-US">Number of ADS issued and outstanding after the merger.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:to="label_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="locator_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="label_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="locator_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xml:lang="en-US">Asset held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xml:lang="en-US">The amount of of asset held for sale recogized prior to the completion of merger.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:to="label_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="locator_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xml:lang="en-US">Prepaid and other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="label_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="locator_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xml:lang="en-US">Accrued liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xml:lang="en-US">Amount of accrued liabilities to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="label_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="locator_cmmb_EstimatedFairValueOfNetAssetsAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_EstimatedFairValueOfNetAssetsAcquired" xml:lang="en-US">Net acquired assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_EstimatedFairValueOfNetAssetsAcquired" xml:lang="en-US">The amount of estimated fair value of the net assets acquired.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:to="label_cmmb_EstimatedFairValueOfNetAssetsAcquired"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_PercentageOfMonthlyDepositsRate" xlink:label="locator_cmmb_PercentageOfMonthlyDepositsRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_PercentageOfMonthlyDepositsRate" xml:lang="en-US">Percentage of monthly deposits rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_PercentageOfMonthlyDepositsRate" xml:lang="en-US">Percentage of monthly deposits rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_PercentageOfMonthlyDepositsRate" xlink:to="label_cmmb_PercentageOfMonthlyDepositsRate"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="locator_us-gaap_SeveranceCosts1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SeveranceCosts1" xml:lang="en-US">Severance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SeveranceCosts1" xlink:to="label_us-gaap_SeveranceCosts1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="locator_us-gaap_ComputerEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ComputerEquipmentMember" xml:lang="en-US">Computers [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ComputerEquipmentMember" xlink:to="label_us-gaap_ComputerEquipmentMember"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LaboratoryEquipmentMember" xlink:label="locator_cmmb_LaboratoryEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_LaboratoryEquipmentMember" xml:lang="en-US">Laboratory Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_LaboratoryEquipmentMember" xml:lang="en-US">Laboratory equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_LaboratoryEquipmentMember" xlink:to="label_cmmb_LaboratoryEquipmentMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="locator_us-gaap_FurnitureAndFixturesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US">Furniture and Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_FurnitureAndFixturesMember" xlink:to="label_us-gaap_FurnitureAndFixturesMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="locator_us-gaap_LeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LeaseholdImprovementsMember" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LeaseholdImprovementsMember" xlink:to="label_us-gaap_LeaseholdImprovementsMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="label_us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xml:lang="en-US">Annual rates of depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:to="label_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AnnualRatesOfDepreciation" xlink:label="locator_cmmb_AnnualRatesOfDepreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_cmmb_AnnualRatesOfDepreciation" xml:lang="en-US">Annual rates of depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_AnnualRatesOfDepreciation" xml:lang="en-US">Annual rates of depreciation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_AnnualRatesOfDepreciation" xml:lang="en-US">AnnualRatesOfDepreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_AnnualRatesOfDepreciation" xlink:to="label_cmmb_AnnualRatesOfDepreciation"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="locator_srt_CurrencyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_CurrencyAxis" xml:lang="en-US">Currency [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_CurrencyAxis" xlink:to="label_srt_CurrencyAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_ILS" xlink:label="locator_currency_ILS"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_currency_ILS" xml:lang="en-US">ILS [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_currency_ILS" xlink:to="label_currency_ILS"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="locator_currency_USD"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_currency_USD" xml:lang="en-US">USD [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_currency_USD" xlink:to="label_currency_USD"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_XXX" xlink:label="locator_currency_XXX"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_currency_XXX" xml:lang="en-US">Other currencies [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_currency_XXX" xlink:to="label_currency_XXX"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ReceivablesFromGovernmentInstitutions" xlink:label="locator_cmmb_ReceivablesFromGovernmentInstitutions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_ReceivablesFromGovernmentInstitutions" xml:lang="en-US">Government institutions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_ReceivablesFromGovernmentInstitutions" xml:lang="en-US">Government institutions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_ReceivablesFromGovernmentInstitutions" xlink:to="label_cmmb_ReceivablesFromGovernmentInstitutions"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="locator_us-gaap_PrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PrepaidExpenseCurrent" xlink:to="label_us-gaap_PrepaidExpenseCurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="locator_us-gaap_SoftwareDevelopmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SoftwareDevelopmentMember" xml:lang="en-US">Website Development [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SoftwareDevelopmentMember" xlink:to="label_us-gaap_SoftwareDevelopmentMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="label_us-gaap_PropertyPlantAndEquipmentGross"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Less - accumulated depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="locator_us-gaap_LesseeLeaseDescriptionTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LesseeLeaseDescriptionTable" xml:lang="en-US">Lessee, Lease, Description [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LesseeLeaseDescriptionTable" xlink:to="label_us-gaap_LesseeLeaseDescriptionTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="locator_us-gaap_LesseeLeaseDescriptionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LesseeLeaseDescriptionLineItems" xml:lang="en-US">Lessee, Lease, Description [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="label_us-gaap_LesseeLeaseDescriptionLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="locator_us-gaap_LeaseExpirationDate1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LeaseExpirationDate1" xml:lang="en-US">Lease expiry date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LeaseExpirationDate1" xlink:to="label_us-gaap_LeaseExpirationDate1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="locator_us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LesseeOperatingLeaseTermOfContract" xml:lang="en-US">Lease term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="label_us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AnnualRentAndManagementFees" xlink:label="locator_cmmb_AnnualRentAndManagementFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_AnnualRentAndManagementFees" xml:lang="en-US">Annual rent and management fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_AnnualRentAndManagementFees" xml:lang="en-US">Annual rent and management fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_AnnualRentAndManagementFees" xlink:to="label_cmmb_AnnualRentAndManagementFees"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_BankGuaranteesToPropertyOwner" xlink:label="locator_cmmb_BankGuaranteesToPropertyOwner"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_BankGuaranteesToPropertyOwner" xml:lang="en-US">Bank guarantees to property owner</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_BankGuaranteesToPropertyOwner" xml:lang="en-US">Bank guarantees to property owner.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_BankGuaranteesToPropertyOwner" xlink:to="label_cmmb_BankGuaranteesToPropertyOwner"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities" xlink:label="locator_cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities" xml:lang="en-US">Operating right-of-use assets and operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities" xml:lang="en-US">Operating right-of-use assets and operating lease liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities" xlink:to="label_cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="locator_us-gaap_OperatingLeaseImpairmentLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingLeaseImpairmentLoss" xml:lang="en-US">Decrease in the carrying amount of the right-of-use asset due to impairment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="label_us-gaap_OperatingLeaseImpairmentLoss"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="locator_us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xml:lang="en-US">Incremental borrowing rate based on credit rating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:to="label_us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xml:lang="en-US">2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="label_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xml:lang="en-US">2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="label_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xml:lang="en-US">2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="label_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xml:lang="en-US">Total future minimum lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="label_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xml:lang="en-US">Less imputed interest:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="label_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="locator_us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_OperatingLeaseLiability" xml:lang="en-US">Present value of operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingLeaseLiability" xml:lang="en-US">Operating Lease, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingLeaseLiability" xlink:to="label_us-gaap_OperatingLeaseLiability"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="locator_us-gaap_OtherCommitmentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OtherCommitmentsTable" xml:lang="en-US">Other Commitments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OtherCommitmentsTable" xlink:to="label_us-gaap_OtherCommitmentsTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="locator_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xml:lang="en-US">Category of Item Purchased [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalAdditionsMember" xlink:label="locator_us-gaap_CapitalAdditionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CapitalAdditionsMember" xml:lang="en-US">New Drug Application and Biological License Application [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CapitalAdditionsMember" xlink:to="label_us-gaap_CapitalAdditionsMember"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_CapitalAdditionsOneMember" xlink:label="locator_cmmb_CapitalAdditionsOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_CapitalAdditionsOneMember" xml:lang="en-US">FDA or equivalent agency marketing approval [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_CapitalAdditionsOneMember" xml:lang="en-US">FDA or equivalent agency marketing approval [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_CapitalAdditionsOneMember" xlink:to="label_cmmb_CapitalAdditionsOneMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAgreementsMember" xlink:label="locator_us-gaap_LeaseAgreementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LeaseAgreementsMember" xml:lang="en-US">2020 Lien [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LeaseAgreementsMember" xlink:to="label_us-gaap_LeaseAgreementsMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="locator_currency_EUR"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_currency_EUR" xml:lang="en-US">Euro [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_currency_EUR" xlink:to="label_currency_EUR"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="locator_srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_StatementScenarioAxis" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_StatementScenarioAxis" xlink:to="label_srt_StatementScenarioAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="locator_srt_ScenarioForecastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_ScenarioForecastMember" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_ScenarioForecastMember" xlink:to="label_srt_ScenarioForecastMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="locator_us-gaap_OtherCommitmentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OtherCommitmentsLineItems" xml:lang="en-US">Other Commitments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="label_us-gaap_OtherCommitmentsLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentDescription" xlink:label="locator_us-gaap_LongTermPurchaseCommitmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LongTermPurchaseCommitmentDescription" xml:lang="en-US">Description of application payment for licensed product</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LongTermPurchaseCommitmentDescription" xlink:to="label_us-gaap_LongTermPurchaseCommitmentDescription"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDescription" xlink:label="locator_us-gaap_OtherCommitmentsDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OtherCommitmentsDescription" xml:lang="en-US">Decsription of occurrence for payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OtherCommitmentsDescription" xlink:to="label_us-gaap_OtherCommitmentsDescription"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" xlink:label="locator_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" xml:lang="en-US">Royalty payments on sale of product (as a percent)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" xml:lang="en-US">The percentage of royalty payments on sale of product developed with funding received from the IIA.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" xlink:to="label_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_MaximumPercentageOfPaymentsOfRoyalties" xlink:label="locator_cmmb_MaximumPercentageOfPaymentsOfRoyalties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_MaximumPercentageOfPaymentsOfRoyalties" xml:lang="en-US">Maximum percentage of payments of royalties (as a percent)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_MaximumPercentageOfPaymentsOfRoyalties" xml:lang="en-US">The maximum percentage of royalties payable on the amount of the grant received (dollar linked), plus interest at annual rate based on LIBOR.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_MaximumPercentageOfPaymentsOfRoyalties" xlink:to="label_cmmb_MaximumPercentageOfPaymentsOfRoyalties"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" xlink:label="locator_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" xml:lang="en-US">Cumulative amounts of grants received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" xml:lang="en-US">The cumulative amounts of grants received from the IIA and recognized by the company, as of the balance sheet date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" xlink:to="label_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:label="locator_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xml:lang="en-US">Recognized liability for royalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:to="label_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="locator_us-gaap_LongTermPurchaseCommitmentAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LongTermPurchaseCommitmentAmount" xml:lang="en-US">Payment for licensed agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="label_us-gaap_LongTermPurchaseCommitmentAmount"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" xlink:label="locator_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" xml:lang="en-US">Payment on commencement of agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" xml:lang="en-US">Payment on commencement of agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" xlink:to="label_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="locator_us-gaap_RoyaltyExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RoyaltyExpense" xml:lang="en-US">Royality expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RoyaltyExpense" xlink:to="label_us-gaap_RoyaltyExpense"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AggregateAmountCommitmentToPay" xlink:label="locator_cmmb_AggregateAmountCommitmentToPay"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_AggregateAmountCommitmentToPay" xml:lang="en-US">Aggregate amount commitment to pay</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_AggregateAmountCommitmentToPay" xml:lang="en-US">Aggregate amount commitment to pay.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_AggregateAmountCommitmentToPay" xlink:to="label_cmmb_AggregateAmountCommitmentToPay"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AggregateAmountOfCommitmentPaid" xlink:label="locator_cmmb_AggregateAmountOfCommitmentPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_AggregateAmountOfCommitmentPaid" xml:lang="en-US">Aggregate amount of commitment paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_AggregateAmountOfCommitmentPaid" xml:lang="en-US">Aggregate amount of commitment paid.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_AggregateAmountOfCommitmentPaid" xlink:to="label_cmmb_AggregateAmountOfCommitmentPaid"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AdditionalWorkOrderAmount" xlink:label="locator_cmmb_AdditionalWorkOrderAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_AdditionalWorkOrderAmount" xml:lang="en-US">Additional work order</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_AdditionalWorkOrderAmount" xml:lang="en-US">Additional work order amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_AdditionalWorkOrderAmount" xlink:to="label_cmmb_AdditionalWorkOrderAmount"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LienOnBankDeposit" xlink:label="locator_cmmb_LienOnBankDeposit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_LienOnBankDeposit" xml:lang="en-US">Lien on bank deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_LienOnBankDeposit" xml:lang="en-US">Lien on bank deposit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_LienOnBankDeposit" xlink:to="label_cmmb_LienOnBankDeposit"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedInvestments" xlink:label="locator_us-gaap_RestrictedInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RestrictedInvestments" xml:lang="en-US">Bank restricted deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RestrictedInvestments" xlink:to="label_us-gaap_RestrictedInvestments"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SaleOfStockTable" xlink:label="locator_cmmb_SaleOfStockTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_SaleOfStockTable" xml:lang="en-US">Sale Of Stock [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_SaleOfStockTable" xml:lang="en-US">Different names of stock transactions and the different attributes of each transaction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_SaleOfStockTable" xlink:to="label_cmmb_SaleOfStockTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="locator_us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="label_us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_InvestorsMember" xlink:label="locator_cmmb_InvestorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_InvestorsMember" xml:lang="en-US">Investors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_InvestorsMember" xml:lang="en-US">Investors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_InvestorsMember" xlink:to="label_cmmb_InvestorsMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="locator_us-gaap_PrivatePlacementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PrivatePlacementMember" xml:lang="en-US">The Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PrivatePlacementMember" xlink:to="label_us-gaap_PrivatePlacementMember"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AtmAgreementMember" xlink:label="locator_cmmb_AtmAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_AtmAgreementMember" xml:lang="en-US">ATM agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_AtmAgreementMember" xml:lang="en-US">ATM agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_AtmAgreementMember" xlink:to="label_cmmb_AtmAgreementMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="locator_us-gaap_SeriesCPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SeriesCPreferredStockMember" xml:lang="en-US">Series C Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SeriesCPreferredStockMember" xlink:to="label_us-gaap_SeriesCPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="locator_us-gaap_PlanNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PlanNameAxis" xml:lang="en-US">Plan Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PlanNameAxis" xlink:to="label_us-gaap_PlanNameAxis"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_TwoThousandsFifteenMember" xlink:label="locator_cmmb_TwoThousandsFifteenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_TwoThousandsFifteenMember" xml:lang="en-US">2015 plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_TwoThousandsFifteenMember" xml:lang="en-US">2015 plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_TwoThousandsFifteenMember" xlink:to="label_cmmb_TwoThousandsFifteenMember"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SaleOfStockLineItems" xlink:label="locator_cmmb_SaleOfStockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_SaleOfStockLineItems" xml:lang="en-US">Sale Of Stock [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_SaleOfStockLineItems" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="label_cmmb_SaleOfStockLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="locator_us-gaap_ProceedsFromWarrantExercises"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromWarrantExercises" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromWarrantExercises" xlink:to="label_us-gaap_ProceedsFromWarrantExercises"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="locator_us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PreferredStockSharesIssued" xlink:to="label_us-gaap_PreferredStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred shares par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="label_us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="locator_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xml:lang="en-US">Proceeds from preferred shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ProceedsFromSaleOfAdss" xlink:label="locator_cmmb_ProceedsFromSaleOfAdss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_ProceedsFromSaleOfAdss" xml:lang="en-US">Proceeds from sale of ADS's</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_ProceedsFromSaleOfAdss" xml:lang="en-US">Proceeds from sale of ADS's.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_ProceedsFromSaleOfAdss" xlink:to="label_cmmb_ProceedsFromSaleOfAdss"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" xlink:label="locator_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" xml:lang="en-US">Number of ADSs issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" xml:lang="en-US">Number of new stocks of American Depository Shares ("ADS") issued during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" xlink:to="label_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfWarrantsPurchaseUpAdss" xlink:label="locator_cmmb_NumberOfWarrantsPurchaseUpAdss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_NumberOfWarrantsPurchaseUpAdss" xml:lang="en-US">Number of warrants purchase ADS's</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_NumberOfWarrantsPurchaseUpAdss" xml:lang="en-US">Number of warrants purchase ADS's.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_NumberOfWarrantsPurchaseUpAdss" xlink:to="label_cmmb_NumberOfWarrantsPurchaseUpAdss"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SaleOfStocksPricePerShare" xlink:label="locator_cmmb_SaleOfStocksPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_SaleOfStocksPricePerShare" xml:lang="en-US">Share price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_SaleOfStocksPricePerShare" xml:lang="en-US">Per share amount received by the company for each share of common stock issued or sold in the stock transaction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_SaleOfStocksPricePerShare" xlink:to="label_cmmb_SaleOfStocksPricePerShare"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfStockAdssResveredForIssuance" xlink:label="locator_cmmb_NumberOfStockAdssResveredForIssuance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_NumberOfStockAdssResveredForIssuance" xml:lang="en-US">Number of stock option ADSs reversed for issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_NumberOfStockAdssResveredForIssuance" xml:lang="en-US">Number of stock option ADSs resvered for issuance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_NumberOfStockAdssResveredForIssuance" xlink:to="label_cmmb_NumberOfStockAdssResveredForIssuance"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfAdssOptionsIssuableOutstanding" xlink:label="locator_cmmb_NumberOfAdssOptionsIssuableOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_NumberOfAdssOptionsIssuableOutstanding" xml:lang="en-US">Number of ADSs options issuable outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_NumberOfAdssOptionsIssuableOutstanding" xml:lang="en-US">Number of ADSs options issuable outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_NumberOfAdssOptionsIssuableOutstanding" xlink:to="label_cmmb_NumberOfAdssOptionsIssuableOutstanding"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfAdssVestedAndExercisable" xlink:label="locator_cmmb_NumberOfAdssVestedAndExercisable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_NumberOfAdssVestedAndExercisable" xml:lang="en-US">Number of ADSs vested and exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_NumberOfAdssVestedAndExercisable" xml:lang="en-US">Number of ADSs vested and exercisable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_NumberOfAdssVestedAndExercisable" xlink:to="label_cmmb_NumberOfAdssVestedAndExercisable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xml:lang="en-US">Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Options to purchase ADS cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="label_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="locator_us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeStatementLocationAxis" xml:lang="en-US">Income Statement Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeStatementLocationAxis" xlink:to="label_us-gaap_IncomeStatementLocationAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ResearchAndDevelopmentExpenseMember" xml:lang="en-US">Research and development expenses [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="label_us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_GeneralAndAdministrativeExpenseMember" xml:lang="en-US">General and administrative [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="label_us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="locator_us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Share-based compensation expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="label_us-gaap_AllocatedShareBasedCompensationExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xml:lang="en-US">Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Outstanding at the beginning</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Outstanding at the end</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Exercise</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US">Number of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Outstanding at the beginning</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Outstanding at the end</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" xlink:label="locator_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" xml:lang="en-US">Acquired in Merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" xml:lang="en-US">Number of options acquired, including both vested and non-vested options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" xlink:to="label_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" xlink:label="locator_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" xml:lang="en-US">Exercise</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" xml:lang="en-US">Number of share options (or share units) exercised during the current period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" xml:lang="en-US">StockIssuedDuringPeriodSharesStockOptionsExercised1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" xlink:to="label_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xml:lang="en-US">Weighted Average Remaining Contractual Life in Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US">Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="locator_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xml:lang="en-US">Weighted average remaining contractual term for option awards granted during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants In Period, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:to="label_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="locator_srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_RangeAxis" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_RangeAxis" xlink:to="label_srt_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="locator_srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_MinimumMember" xlink:to="label_srt_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="locator_srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_MaximumMember" xlink:to="label_srt_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="locator_us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AwardTypeAxis" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AwardTypeAxis" xlink:to="label_us-gaap_AwardTypeAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="locator_us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SharePrice" xml:lang="en-US">Weighted average share price (in U.S. dollar)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SharePrice" xlink:to="label_us-gaap_SharePrice"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xml:lang="en-US">Exercise price (in U.S. dollar)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Expected life of options (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xml:lang="en-US">Expected volatility, minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xml:lang="en-US">Expected volatility, maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xml:lang="en-US">Risk-free interest rate, minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xml:lang="en-US">Risk-free interest rate, maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ConsultantsAndSubcontractorsExpense" xlink:label="locator_cmmb_ConsultantsAndSubcontractorsExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_ConsultantsAndSubcontractorsExpense" xml:lang="en-US">Consultants and subcontractors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_ConsultantsAndSubcontractorsExpense" xml:lang="en-US">Consultants and subcontractors expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_ConsultantsAndSubcontractorsExpense" xlink:to="label_cmmb_ConsultantsAndSubcontractorsExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="locator_us-gaap_OfficersCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OfficersCompensation" xml:lang="en-US">Salaries and related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OfficersCompensation" xlink:to="label_us-gaap_OfficersCompensation"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" xlink:label="locator_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" xml:lang="en-US">Rent and maintenance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" xml:lang="en-US">Research and development related rent and maintenance expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" xlink:to="label_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SharebasedCompensationResearchAndDevelopmentExpense" xlink:label="locator_cmmb_SharebasedCompensationResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_cmmb_SharebasedCompensationResearchAndDevelopmentExpense" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_SharebasedCompensationResearchAndDevelopmentExpense" xml:lang="en-US">Research and development related share-based compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_SharebasedCompensationResearchAndDevelopmentExpense" xml:lang="en-US">SharebasedCompensationResearchAndDevelopmentExpense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_SharebasedCompensationResearchAndDevelopmentExpense" xlink:to="label_cmmb_SharebasedCompensationResearchAndDevelopmentExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="locator_us-gaap_OtherResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OtherResearchAndDevelopmentExpense" xml:lang="en-US">Other expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="label_us-gaap_OtherResearchAndDevelopmentExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="locator_us-gaap_SalariesAndWages"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_SalariesAndWages" xml:lang="en-US">Salaries and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SalariesAndWages" xml:lang="en-US">Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SalariesAndWages" xlink:to="label_us-gaap_SalariesAndWages"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="locator_us-gaap_ProfessionalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProfessionalFees" xml:lang="en-US">Professional services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProfessionalFees" xlink:to="label_us-gaap_ProfessionalFees"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" xlink:label="locator_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" xml:lang="en-US">General and administrative related share-based compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" xml:lang="en-US">ShareBasedCompensationGeneralAndAdministrativeExpense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" xlink:to="label_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoninterestExpenseDirectorsFees" xlink:label="locator_us-gaap_NoninterestExpenseDirectorsFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NoninterestExpenseDirectorsFees" xml:lang="en-US">Fees to Directors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NoninterestExpenseDirectorsFees" xlink:to="label_us-gaap_NoninterestExpenseDirectorsFees"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralInsuranceExpense" xlink:label="locator_us-gaap_GeneralInsuranceExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_GeneralInsuranceExpense" xml:lang="en-US">Insurance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_GeneralInsuranceExpense" xlink:to="label_us-gaap_GeneralInsuranceExpense"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" xlink:label="locator_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" xml:lang="en-US">Rent and maintenance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" xml:lang="en-US">General and administrative related rent and maintenance expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" xml:lang="en-US">RentAndMaintenanceGeneralAndAdministrativeExpense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" xlink:to="label_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_OtherGeneralAndAdministrativeExpense" xml:lang="en-US">Other expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OtherGeneralAndAdministrativeExpense" xml:lang="en-US">Other General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="label_us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_IncomeTaxDisclosureTable" xlink:label="locator_cmmb_IncomeTaxDisclosureTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_IncomeTaxDisclosureTable" xml:lang="en-US">Income Tax Disclosure [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_IncomeTaxDisclosureTable" xml:lang="en-US">Disclosure of information pertaining to income taxes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_IncomeTaxDisclosureTable" xlink:to="label_cmmb_IncomeTaxDisclosureTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="locator_srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_srt_StatementGeographicalAxis" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_srt_StatementGeographicalAxis" xlink:to="label_srt_StatementGeographicalAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:label="locator_country_IL"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_country_IL" xml:lang="en-US">Israel [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_country_IL" xlink:to="label_country_IL"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="locator_country_US"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_country_US" xml:lang="en-US">U.S. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_country_US" xlink:to="label_country_US"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="locator_us-gaap_IncomeTaxAuthorityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeTaxAuthorityAxis" xml:lang="en-US">Income Tax Authority [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeTaxAuthorityAxis" xlink:to="label_us-gaap_IncomeTaxAuthorityAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="locator_us-gaap_DomesticCountryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DomesticCountryMember" xml:lang="en-US">Federal [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DomesticCountryMember" xlink:to="label_us-gaap_DomesticCountryMember"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_IncomeTaxDisclosureLineItems" xlink:label="locator_cmmb_IncomeTaxDisclosureLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_IncomeTaxDisclosureLineItems" xml:lang="en-US">Income Tax Disclosure [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_IncomeTaxDisclosureLineItems" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_IncomeTaxDisclosureLineItems" xlink:to="label_cmmb_IncomeTaxDisclosureLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="locator_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">Corporate tax rate (as a percent)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="locator_us-gaap_TaxCreditCarryforwardAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_TaxCreditCarryforwardAmount" xml:lang="en-US">Capital losses carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_TaxCreditCarryforwardAmount" xlink:to="label_us-gaap_TaxCreditCarryforwardAmount"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="locator_us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xml:lang="en-US">Deferred taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="label_us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="locator_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xml:lang="en-US">Net operating loss carry-forwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xml:lang="en-US">Share-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="label_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="locator_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xml:lang="en-US">Research and development costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="label_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="locator_us-gaap_DeferredTaxAssetsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DeferredTaxAssetsOther" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DeferredTaxAssetsOther" xlink:to="label_us-gaap_DeferredTaxAssetsOther"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="locator_us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_DeferredTaxAssetsGross" xml:lang="en-US">Gross deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DeferredTaxAssetsGross" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DeferredTaxAssetsGross" xlink:to="label_us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="locator_us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Less - valuation allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="label_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Balance at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="label_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Balance at December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="locator_us-gaap_DeferredTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_DeferredTaxAssetsNet" xml:lang="en-US">Net deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DeferredTaxAssetsNet" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DeferredTaxAssetsNet" xlink:to="label_us-gaap_DeferredTaxAssetsNet"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="locator_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xml:lang="en-US">Net change in the total valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_CurrencyTransactionLossValuationAllowance" xlink:label="locator_cmmb_CurrencyTransactionLossValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_CurrencyTransactionLossValuationAllowance" xml:lang="en-US">Currency transaction loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_CurrencyTransactionLossValuationAllowance" xml:lang="en-US">Amount of increase (decrease) in the valuation allowance due to currency transaction loss.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_CurrencyTransactionLossValuationAllowance" xlink:to="label_cmmb_CurrencyTransactionLossValuationAllowance"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance" xlink:label="locator_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance" xml:lang="en-US">Tax assets acquired through merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance" xml:lang="en-US">Amount of increase (decrease) in the valuation allowance due to tax assets acquired through merger.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance" xlink:to="label_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_IncomeTaxExpenseValuationAllowance" xlink:label="locator_cmmb_IncomeTaxExpenseValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_IncomeTaxExpenseValuationAllowance" xml:lang="en-US">Income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_IncomeTaxExpenseValuationAllowance" xml:lang="en-US">Amount of increase (decrease) in the valuation allowance due to income tax expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_IncomeTaxExpenseValuationAllowance" xlink:to="label_cmmb_IncomeTaxExpenseValuationAllowance"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xml:lang="en-US">Theoretical tax benefit on the above amount Decrease (increase) in tax refund resulting from:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="label_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Loss before income tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="locator_us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US">Statutory tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="label_us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="locator_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">Theoretical tax benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" xlink:label="locator_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" xml:lang="en-US">Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" xml:lang="en-US">Represents losses and benefits for tax purposes for the year, for which deferred taxes were not recorded.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" xml:lang="en-US">Losses And Benefits For Tax Purposes For The Year For Which Deferred Taxes Were Not Recorded</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" xlink:to="label_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="locator_us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Actual income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeTaxExpenseBenefit" xlink:to="label_us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyMember" xlink:label="locator_cmmb_RelatedPartyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_RelatedPartyMember" xml:lang="en-US">Related Party [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_RelatedPartyMember" xml:lang="en-US">Related Party [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_RelatedPartyMember" xlink:to="label_cmmb_RelatedPartyMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="locator_us-gaap_RelatedPartyTransactionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US">Related Party Transaction [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="label_us-gaap_RelatedPartyTransactionLineItems"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="locator_us-gaap_DueToRelatedPartiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_DueToRelatedPartiesCurrent" xml:lang="en-US">Related Party Payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DueToRelatedPartiesCurrent" xml:lang="en-US">Due to Related Parties, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DueToRelatedPartiesCurrent" xlink:to="label_us-gaap_DueToRelatedPartiesCurrent"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" xlink:label="locator_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" xml:lang="en-US">Salaries and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" xml:lang="en-US">Related party expenses related to salaries and related expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" xml:lang="en-US">RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" xlink:to="label_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty" xlink:label="locator_cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty" xml:lang="en-US">Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty" xml:lang="en-US">Related party expenses related to share based payments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty" xlink:to="label_cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" xlink:label="locator_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" xml:lang="en-US">Professional Services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" xml:lang="en-US">Related party expenses related to professional services.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" xlink:to="label_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" xlink:label="locator_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" xml:lang="en-US">Related party expenses related to research and develeopment expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" xml:lang="en-US">RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" xlink:to="label_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyCosts" xlink:label="locator_us-gaap_RelatedPartyCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_RelatedPartyCosts" xml:lang="en-US">Total related party expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RelatedPartyCosts" xml:lang="en-US">Related Party Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RelatedPartyCosts" xlink:to="label_us-gaap_RelatedPartyCosts"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_EarningsPerShareCalculationNumeratorAbstract" xlink:label="locator_cmmb_EarningsPerShareCalculationNumeratorAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_EarningsPerShareCalculationNumeratorAbstract" xml:lang="en-US">Numerator:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_EarningsPerShareCalculationNumeratorAbstract" xml:lang="en-US">Earnings Per Share Calculation Numerator Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_EarningsPerShareCalculationNumeratorAbstract" xlink:to="label_cmmb_EarningsPerShareCalculationNumeratorAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" xlink:label="locator_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" xml:lang="en-US">Denominator:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" xml:lang="en-US">Earnings Per Share Calculation Denominator For Basic Net Income Loss Per Share Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" xlink:to="label_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:label="locator_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xml:lang="en-US">Net loss per share attributable to ordinary shareholders, basic and diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:to="label_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xml:lang="en-US">Antidilutive Securities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="locator_us-gaap_EmployeeStockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EmployeeStockOptionMember" xml:lang="en-US">Stock Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EmployeeStockOptionMember" xlink:to="label_us-gaap_EmployeeStockOptionMember"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Outstanding options to purchase ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>cmmb-20211231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- XBRL Document Created with XML Edge from P3 Data Systems -->
  <roleRef roleURI="http://anchiano.com/role/DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="cmmb-20211231.xsd#DocumentDocumentAndEntityInformation"/>
  <roleRef roleURI="http://anchiano.com/role/StatementConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cmmb-20211231.xsd#StatementConsolidatedBalanceSheets"/>
  <roleRef roleURI="http://anchiano.com/role/BalanceSheetsParenthetical" xlink:type="simple" xlink:href="cmmb-20211231.xsd#BalanceSheetsParenthetical"/>
  <roleRef roleURI="http://anchiano.com/role/StatementsOfOperations" xlink:type="simple" xlink:href="cmmb-20211231.xsd#StatementsOfOperations"/>
  <roleRef roleURI="http://anchiano.com/role/StatementsOfChangesInEquity" xlink:type="simple" xlink:href="cmmb-20211231.xsd#StatementsOfChangesInEquity"/>
  <roleRef roleURI="http://anchiano.com/role/StatementsOfCashFlows" xlink:type="simple" xlink:href="cmmb-20211231.xsd#StatementsOfCashFlows"/>
  <roleRef roleURI="http://anchiano.com/role/General" xlink:type="simple" xlink:href="cmmb-20211231.xsd#General"/>
  <roleRef roleURI="http://anchiano.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="cmmb-20211231.xsd#SummaryOfSignificantAccountingPolicies"/>
  <roleRef roleURI="http://anchiano.com/role/CashAndCashEquivalents" xlink:type="simple" xlink:href="cmmb-20211231.xsd#CashAndCashEquivalents"/>
  <roleRef roleURI="http://anchiano.com/role/OtherReceivablesAndPrepaidExpenses" xlink:type="simple" xlink:href="cmmb-20211231.xsd#OtherReceivablesAndPrepaidExpenses"/>
  <roleRef roleURI="http://anchiano.com/role/PropertyAndEquipmentNet" xlink:type="simple" xlink:href="cmmb-20211231.xsd#PropertyAndEquipmentNet"/>
  <roleRef roleURI="http://anchiano.com/role/Leases" xlink:type="simple" xlink:href="cmmb-20211231.xsd#Leases"/>
  <roleRef roleURI="http://anchiano.com/role/CommitmentsAndContingentLiabilities" xlink:type="simple" xlink:href="cmmb-20211231.xsd#CommitmentsAndContingentLiabilities"/>
  <roleRef roleURI="http://anchiano.com/role/ShareCapital" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ShareCapital"/>
  <roleRef roleURI="http://anchiano.com/role/ResearchAndDevelopment" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ResearchAndDevelopment"/>
  <roleRef roleURI="http://anchiano.com/role/GeneralAndAdministrative" xlink:type="simple" xlink:href="cmmb-20211231.xsd#GeneralAndAdministrative"/>
  <roleRef roleURI="http://anchiano.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cmmb-20211231.xsd#IncomeTaxes"/>
  <roleRef roleURI="http://anchiano.com/role/RelatedPartiesBalancesAndTransactions" xlink:type="simple" xlink:href="cmmb-20211231.xsd#RelatedPartiesBalancesAndTransactions"/>
  <roleRef roleURI="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders" xlink:type="simple" xlink:href="cmmb-20211231.xsd#NetLossPerShareAttributableToOrdinaryShareholders"/>
  <roleRef roleURI="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cmmb-20211231.xsd#SummaryOfSignificantAccountingPoliciesPolicies"/>
  <roleRef roleURI="http://anchiano.com/role/GeneralTables" xlink:type="simple" xlink:href="cmmb-20211231.xsd#GeneralTables"/>
  <roleRef roleURI="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cmmb-20211231.xsd#SummaryOfSignificantAccountingPoliciesTables"/>
  <roleRef roleURI="http://anchiano.com/role/CashAndCashEquivalentsTables" xlink:type="simple" xlink:href="cmmb-20211231.xsd#CashAndCashEquivalentsTables"/>
  <roleRef roleURI="http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables" xlink:type="simple" xlink:href="cmmb-20211231.xsd#OtherReceivablesAndPrepaidExpensesTables"/>
  <roleRef roleURI="http://anchiano.com/role/PropertyAndEquipmentNetTables" xlink:type="simple" xlink:href="cmmb-20211231.xsd#PropertyAndEquipmentNetTables"/>
  <roleRef roleURI="http://anchiano.com/role/LeasesTables" xlink:type="simple" xlink:href="cmmb-20211231.xsd#LeasesTables"/>
  <roleRef roleURI="http://anchiano.com/role/ShareCapitalTables" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ShareCapitalTables"/>
  <roleRef roleURI="http://anchiano.com/role/ResearchAndDevelopmentTables" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ResearchAndDevelopmentTables"/>
  <roleRef roleURI="http://anchiano.com/role/GeneralAndAdministrativeTables" xlink:type="simple" xlink:href="cmmb-20211231.xsd#GeneralAndAdministrativeTables"/>
  <roleRef roleURI="http://anchiano.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cmmb-20211231.xsd#IncomeTaxesTables"/>
  <roleRef roleURI="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables" xlink:type="simple" xlink:href="cmmb-20211231.xsd#RelatedPartiesBalancesAndTransactionsTables"/>
  <roleRef roleURI="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables" xlink:type="simple" xlink:href="cmmb-20211231.xsd#NetLossPerShareAttributableToOrdinaryShareholdersTables"/>
  <roleRef roleURI="http://anchiano.com/role/GeneralDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#GeneralDetails"/>
  <roleRef roleURI="http://anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"/>
  <roleRef roleURI="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#SummaryOfSignificantAccountingPoliciesNarrativeDetails"/>
  <roleRef roleURI="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"/>
  <roleRef roleURI="http://anchiano.com/role/CashAndCashEquivalentsDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#CashAndCashEquivalentsDetails"/>
  <roleRef roleURI="http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#OtherReceivablesAndPrepaidExpensesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/PropertyAndEquipmentNetDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#PropertyAndEquipmentNetDetails"/>
  <roleRef roleURI="http://anchiano.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#LeasesNarrativeDetails"/>
  <roleRef roleURI="http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#CommitmentsAndContingentLiabilitiesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/ShareCapitalNarrativeDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ShareCapitalNarrativeDetails"/>
  <roleRef roleURI="http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ShareCapitalShare-basedCompensationExpensesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"/>
  <roleRef roleURI="http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"/>
  <roleRef roleURI="http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"/>
  <roleRef roleURI="http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"/>
  <roleRef roleURI="http://anchiano.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#IncomeTaxesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"/>
  <roleRef roleURI="http://anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails"/>
  <roleRef roleURI="http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"/>
  <roleRef roleURI="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"/>
  <roleRef roleURI="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails"/>
  <roleRef roleURI="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails" xlink:type="simple" xlink:href="cmmb-20211231.xsd#NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails"/>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/DocumentDocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="locator_dei_CoverAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="locator_dei_DocumentInformationTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_CoverAbstract" xlink:to="locator_dei_DocumentInformationTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="locator_us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationTable" xlink:to="locator_us-gaap_StatementClassOfStockAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="locator_cmmb_AmericanDepositarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockDomain" xlink:to="locator_cmmb_AmericanDepositarySharesMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="locator_cmmb_OrdinarySharesNoParValuePerShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockDomain" xlink:to="locator_cmmb_OrdinarySharesNoParValuePerShareMember" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="locator_dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationTable" xlink:to="locator_dei_DocumentInformationLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="locator_dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityCentralIndexKey" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="locator_dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentFiscalPeriodFocus" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="locator_dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_AmendmentFlag" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="locator_dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentType" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="locator_dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_CurrentFiscalYearEndDate" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="locator_dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentFiscalYearFocus" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="locator_dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentPeriodEndDate" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="locator_dei_DocumentAnnualReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentAnnualReport" use="optional" priority="0" order="70"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="locator_dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_DocumentTransitionReport" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="locator_dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityFileNumber" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="locator_dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityRegistrantName" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="locator_dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityIncorporationStateCountryCode" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="locator_dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityTaxIdentificationNumber" use="optional" priority="0" order="120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="locator_dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityAddressAddressLine1" use="optional" priority="0" order="130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="locator_dei_EntityAddressAddressLine2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityAddressAddressLine2" use="optional" priority="0" order="140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="locator_dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityAddressCityOrTown" use="optional" priority="0" order="150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="locator_dei_EntityAddressCountry"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityAddressCountry" use="optional" priority="0" order="160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="locator_dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityAddressPostalZipCode" use="optional" priority="0" order="170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="locator_dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_CityAreaCode" use="optional" priority="0" order="180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="locator_dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_LocalPhoneNumber" use="optional" priority="0" order="190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="locator_dei_EntityInformationFormerLegalOrRegisteredName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityInformationFormerLegalOrRegisteredName" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="locator_dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_Security12bTitle" use="optional" priority="0" order="210"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="locator_dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_TradingSymbol" use="optional" priority="0" order="220"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="locator_dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_SecurityExchangeName" use="optional" priority="0" order="230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="locator_dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityWellKnownSeasonedIssuer" use="optional" priority="0" order="240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="locator_dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityVoluntaryFilers" use="optional" priority="0" order="250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="locator_dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityCurrentReportingStatus" use="optional" priority="0" order="260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="locator_dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityInteractiveDataCurrent" use="optional" priority="0" order="270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="locator_dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityFilerCategory" use="optional" priority="0" order="280"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="locator_dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntitySmallBusiness" use="optional" priority="0" order="290"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="locator_dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityEmergingGrowthCompany" use="optional" priority="0" order="300"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="locator_dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityExTransitionPeriod" use="optional" priority="0" order="310"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="locator_dei_IcfrAuditorAttestationFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_IcfrAuditorAttestationFlag" use="optional" priority="0" order="320"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="locator_dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityShellCompany" use="optional" priority="0" order="330"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="locator_dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityPublicFloat" use="optional" priority="0" order="340"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="locator_dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_EntityCommonStockSharesOutstanding" use="optional" priority="0" order="350"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="locator_dei_AuditorName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_AuditorName" use="optional" priority="0" order="360"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="locator_dei_AuditorLocation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_AuditorLocation" use="optional" priority="0" order="370"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="locator_dei_AuditorFirmId"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_dei_DocumentInformationLineItems" xlink:to="locator_dei_AuditorFirmId" use="optional" priority="0" order="380"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/StatementConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="locator_us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="locator_us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_AssetsAbstract" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="locator_us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="locator_us-gaap_AssetsCurrentAbstract" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="locator_us-gaap_DepositsAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_DepositsAssetsCurrent" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="locator_us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_AssetsCurrent" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="locator_us-gaap_AssetsNoncurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="locator_us-gaap_AssetsNoncurrentAbstract" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="locator_us-gaap_DepositsAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="locator_us-gaap_DepositsAssetsNoncurrent" use="optional" priority="0" order="70"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="locator_us-gaap_PrepaidExpenseNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="locator_us-gaap_PrepaidExpenseNoncurrent" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="locator_us-gaap_RestrictedCashNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="locator_us-gaap_RestrictedCashNoncurrent" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentNet" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="locator_us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="locator_us-gaap_OperatingLeaseRightOfUseAsset" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="locator_us-gaap_AssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsNoncurrentAbstract" xlink:to="locator_us-gaap_AssetsNoncurrent" use="optional" priority="0" order="120" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="locator_us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="locator_us-gaap_Assets" use="optional" priority="0" order="130" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" use="optional" priority="0" order="140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="locator_us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_LiabilitiesCurrentAbstract" use="optional" priority="0" order="150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="locator_us-gaap_AccountsPayableTradeCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_AccountsPayableTradeCurrent" use="optional" priority="0" order="160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="locator_us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_AccruedLiabilitiesCurrent" use="optional" priority="0" order="170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="locator_us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_EmployeeRelatedLiabilitiesCurrent" use="optional" priority="0" order="180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="locator_us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_OperatingLeaseLiabilityCurrent" use="optional" priority="0" order="190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="locator_us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_LiabilitiesCurrent" use="optional" priority="0" order="200" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="locator_us-gaap_LiabilitiesNoncurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_LiabilitiesNoncurrentAbstract" use="optional" priority="0" order="210"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="locator_us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="locator_us-gaap_OperatingLeaseLiabilityNoncurrent" use="optional" priority="0" order="220"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="locator_us-gaap_LiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="locator_us-gaap_LiabilitiesNoncurrent" use="optional" priority="0" order="230" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="locator_us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_CommitmentsAndContingencies" use="optional" priority="0" order="240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="locator_us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_Liabilities" use="optional" priority="0" order="250" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" use="optional" priority="0" order="260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="locator_us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_CommonStockValue" use="optional" priority="0" order="270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="locator_us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_AdditionalPaidInCapital" use="optional" priority="0" order="280"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="locator_us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" priority="0" order="290"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="300" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_LiabilitiesAndStockholdersEquity" use="optional" priority="0" order="310" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/BalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="locator_us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="locator_us-gaap_CommonStockNoParValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_CommonStockNoParValue" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="locator_us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_CommonStockSharesAuthorized" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="locator_us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_CommonStockSharesIssued" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="locator_us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_SharesOutstanding" use="optional" priority="0" order="30"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/StatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="locator_us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="locator_us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_OperatingExpensesAbstract" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OperatingExpensesAbstract" xlink:to="locator_us-gaap_ResearchAndDevelopmentExpense" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OperatingExpensesAbstract" xlink:to="locator_us-gaap_GeneralAndAdministrativeExpense" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="locator_us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OperatingExpensesAbstract" xlink:to="locator_us-gaap_OperatingExpenses" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="locator_cmmb_FinanceIncomeExpensesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_cmmb_FinanceIncomeExpensesNet" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="locator_us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_EarningsPerShareBasicAndDiluted" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" use="optional" priority="0" order="70"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/StatementsOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="locator_us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="locator_us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementEquityComponentsAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="locator_us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_CommonStockMember" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="locator_us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_AdditionalPaidInCapitalMember" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="locator_us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_RetainedEarningsMember" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="locator_us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_EquityComponentDomain" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="locator_us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_SharesOutstanding" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueNewIssues" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="locator_cmmb_EffectOfReverseCapitalizationTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cmmb_EffectOfReverseCapitalizationTransaction" use="optional" priority="0" order="70"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="locator_cmmb_EffectOfReverseCapitalizationTransactionShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cmmb_EffectOfReverseCapitalizationTransactionShares" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="locator_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:label="locator_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" use="optional" priority="0" order="120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity_969aed43-38a5-9d33-fa05-7aa0d051ef36"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockholdersEquity_969aed43-38a5-9d33-fa05-7aa0d051ef36" use="optional" priority="0" order="140" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="locator_us-gaap_SharesOutstanding_d829170f-8207-c3bf-ec4f-cce219cdcab2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_SharesOutstanding_d829170f-8207-c3bf-ec4f-cce219cdcab2" use="optional" priority="0" order="150" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/StatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="locator_us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="locator_us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_ProfitLoss" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="locator_us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_Depreciation" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="locator_us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_ShareBasedCompensation" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="locator_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInAccountsPayableTrade" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInAccruedLiabilities" use="optional" priority="0" order="70"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="locator_us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" priority="0" order="100" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_PaymentsForInvestmentInDeposits" xlink:label="locator_cmmb_PaymentsForInvestmentInDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="locator_cmmb_PaymentsForInvestmentInDeposits" use="optional" priority="0" order="120" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LongtermLeaseDeposit" xlink:label="locator_cmmb_LongtermLeaseDeposit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="locator_cmmb_LongtermLeaseDeposit" use="optional" priority="0" order="130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="locator_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="locator_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" use="optional" priority="0" order="140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="locator_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="locator_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" priority="0" order="150" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" priority="0" order="160" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" use="optional" priority="0" order="170"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_CashAcquiredInMerger" xlink:label="locator_cmmb_CashAcquiredInMerger"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="locator_cmmb_CashAcquiredInMerger" use="optional" priority="0" order="180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="locator_us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="locator_us-gaap_ProceedsFromStockOptionsExercised" use="optional" priority="0" order="190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="locator_us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="locator_us-gaap_ProceedsFromIssuanceOfWarrants" use="optional" priority="0" order="200" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="locator_us-gaap_ProceedsFromOtherEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="locator_us-gaap_ProceedsFromOtherEquity" use="optional" priority="0" order="210" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" priority="0" order="220" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" use="optional" priority="0" order="230" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" use="optional" priority="0" order="240" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4f7dfe20-db5e-9fd2-ca8b-9c626c28aa5b"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4f7dfe20-db5e-9fd2-ca8b-9c626c28aa5b" use="optional" priority="0" order="250" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="locator_us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_NoncashInvestingAndFinancingItemsAbstract" use="optional" priority="0" order="260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="locator_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="locator_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" use="optional" priority="0" order="270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="locator_us-gaap_LiabilitiesAssumed1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="locator_us-gaap_LiabilitiesAssumed1" use="optional" priority="0" order="280"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/General">
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="locator_cmmb_NatureOfOperationsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="locator_us-gaap_NatureOfOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_NatureOfOperationsDisclosureAbstract" xlink:to="locator_us-gaap_NatureOfOperations" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/SummaryOfSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="locator_us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="locator_us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_SignificantAccountingPoliciesTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/CashAndCashEquivalents">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="locator_us-gaap_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:label="locator_us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="locator_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/OtherReceivablesAndPrepaidExpenses">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:label="locator_us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock" xlink:label="locator_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:to="locator_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/PropertyAndEquipmentNet">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/Leases">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract" xlink:label="locator_us-gaap_LesseeDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="locator_us-gaap_LesseeOperatingLeasesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeDisclosureAbstract" xlink:to="locator_us-gaap_LesseeOperatingLeasesTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/CommitmentsAndContingentLiabilities">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="locator_us-gaap_CommitmentsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="locator_us-gaap_CommitmentsDisclosureTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/ShareCapital">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="locator_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/ResearchAndDevelopment">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="locator_us-gaap_ResearchAndDevelopmentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="locator_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="locator_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/GeneralAndAdministrative">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_GeneralAndAdministrativeDisclosureTextBlock" xlink:label="locator_cmmb_GeneralAndAdministrativeDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:to="locator_cmmb_GeneralAndAdministrativeDisclosureTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="locator_us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="locator_us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_us-gaap_IncomeTaxDisclosureTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/RelatedPartiesBalancesAndTransactions">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="locator_us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="locator_us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="locator_us-gaap_EarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_EarningsPerShareAbstract" xlink:to="locator_us-gaap_EarningsPerShareTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="locator_us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="locator_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="locator_us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_UseOfEstimates" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="locator_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="locator_us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_CashAndCashEquivalentsPolicyTextBlock" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="locator_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="locator_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_ResearchAndDevelopmentExpensePolicy" use="optional" priority="0" order="70" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="locator_us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_IncomeTaxPolicyTextBlock" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="locator_us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" use="optional" priority="0" order="100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock" xlink:label="locator_cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SeverancePayPolicyPolicyTextBlock" xlink:label="locator_cmmb_SeverancePayPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_cmmb_SeverancePayPolicyPolicyTextBlock" use="optional" priority="0" order="120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="locator_us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_ConcentrationRiskCreditRisk" use="optional" priority="0" order="130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="locator_us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_LesseeLeasesPolicyTextBlock" use="optional" priority="0" order="140" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="locator_us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_ConsolidationPolicyTextBlock" use="optional" priority="0" order="150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="locator_us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_EarningsPerSharePolicyTextBlock" use="optional" priority="0" order="160"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/GeneralTables">
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="locator_cmmb_NatureOfOperationsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_NatureOfOperationsDisclosureAbstract" xlink:to="locator_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="locator_us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock" xlink:label="locator_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/CashAndCashEquivalentsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="locator_us-gaap_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="locator_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:label="locator_us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" xlink:label="locator_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:to="locator_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/PropertyAndEquipmentNetTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/LeasesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract" xlink:label="locator_us-gaap_LesseeDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeDisclosureAbstract" xlink:to="locator_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/ShareCapitalTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" use="optional" priority="0" order="20"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/ResearchAndDevelopmentTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="locator_us-gaap_ResearchAndDevelopmentAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock" xlink:label="locator_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="locator_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/GeneralAndAdministrativeTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock" xlink:label="locator_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:to="locator_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/IncomeTaxesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="locator_us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="locator_us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_us-gaap_SummaryOfValuationAllowanceTextBlock" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" use="optional" priority="0" order="20"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="locator_us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock" xlink:label="locator_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" use="optional" priority="0" order="10"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="locator_us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="locator_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_EarningsPerShareAbstract" xlink:to="locator_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="locator_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_EarningsPerShareAbstract" xlink:to="locator_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" use="optional" priority="0" order="10"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="locator_cmmb_NatureOfOperationsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_NatureOfOperationsDisclosureAbstract" xlink:to="locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="locator_us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="locator_us-gaap_BusinessAcquisitionAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="locator_us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_BusinessAcquisitionAxis" xlink:to="locator_us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:label="locator_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="locator_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="locator_srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="locator_srt_TitleOfIndividualAxis" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_TitleOfIndividualAxis" xlink:to="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="locator_cmmb_FormerChemomabSecurityHoldersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="locator_cmmb_FormerChemomabSecurityHoldersMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="locator_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="locator_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="locator_us-gaap_RestructuringCostAndReserveLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="locator_us-gaap_RestructuringCostAndReserveLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="locator_cmmb_ShareholdingPercentageImmediatelyFollowingMerger"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="locator_cmmb_ShareholdingPercentageImmediatelyFollowingMerger" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="locator_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="locator_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="locator_cmmb_NumberOfOrdinarySharesConsistedInDS"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="locator_cmmb_NumberOfOrdinarySharesConsistedInDS" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="locator_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="locator_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" use="optional" priority="0" order="30"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails">
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="locator_cmmb_NatureOfOperationsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="locator_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_NatureOfOperationsDisclosureAbstract" xlink:to="locator_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" use="optional" priority="0" order="0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="locator_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_NatureOfOperationsDisclosureAbstract" xlink:to="locator_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="locator_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_NatureOfOperationsDisclosureAbstract" xlink:to="locator_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="locator_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_NatureOfOperationsDisclosureAbstract" xlink:to="locator_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="locator_cmmb_EstimatedFairValueOfNetAssetsAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_NatureOfOperationsDisclosureAbstract" xlink:to="locator_cmmb_EstimatedFairValueOfNetAssetsAcquired" use="optional" priority="0" order="40"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="locator_us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_PercentageOfMonthlyDepositsRate" xlink:label="locator_cmmb_PercentageOfMonthlyDepositsRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_cmmb_PercentageOfMonthlyDepositsRate" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="locator_us-gaap_SeveranceCosts1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_SeveranceCosts1" use="optional" priority="0" order="10"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="locator_us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="locator_us-gaap_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_ComputerEquipmentMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LaboratoryEquipmentMember" xlink:label="locator_cmmb_LaboratoryEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_cmmb_LaboratoryEquipmentMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="locator_us-gaap_FurnitureAndFixturesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_FurnitureAndFixturesMember" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="locator_us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_LeaseholdImprovementsMember" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AnnualRatesOfDepreciation" xlink:label="locator_cmmb_AnnualRatesOfDepreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="locator_cmmb_AnnualRatesOfDepreciation" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/CashAndCashEquivalentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="locator_us-gaap_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="locator_srt_CurrencyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_srt_CurrencyAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="locator_currency_AllCurrenciesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_CurrencyAxis" xlink:to="locator_currency_AllCurrenciesDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_ILS" xlink:label="locator_currency_ILS"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_currency_AllCurrenciesDomain" xlink:to="locator_currency_ILS" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="locator_currency_USD"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_currency_AllCurrenciesDomain" xlink:to="locator_currency_USD" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_XXX" xlink:label="locator_currency_XXX"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_currency_AllCurrenciesDomain" xlink:to="locator_currency_XXX" use="optional" priority="0" order="70"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:label="locator_us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ReceivablesFromGovernmentInstitutions" xlink:label="locator_cmmb_ReceivablesFromGovernmentInstitutions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:to="locator_cmmb_ReceivablesFromGovernmentInstitutions" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="locator_us-gaap_PrepaidExpenseCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:to="locator_us-gaap_PrepaidExpenseCurrent" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:to="locator_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/PropertyAndEquipmentNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="locator_us-gaap_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_ComputerEquipmentMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="locator_us-gaap_FurnitureAndFixturesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_FurnitureAndFixturesMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LaboratoryEquipmentMember" xlink:label="locator_cmmb_LaboratoryEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_cmmb_LaboratoryEquipmentMember" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="locator_us-gaap_SoftwareDevelopmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_SoftwareDevelopmentMember" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="locator_us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="locator_us-gaap_LeaseholdImprovementsMember" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentGross" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="locator_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="locator_us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="locator_us-gaap_PropertyPlantAndEquipmentNet" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/LeasesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract" xlink:label="locator_us-gaap_LesseeDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="locator_us-gaap_LesseeLeaseDescriptionTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeDisclosureAbstract" xlink:to="locator_us-gaap_LesseeLeaseDescriptionTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="locator_srt_CurrencyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeLeaseDescriptionTable" xlink:to="locator_srt_CurrencyAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="locator_currency_AllCurrenciesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_CurrencyAxis" xlink:to="locator_currency_AllCurrenciesDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_ILS" xlink:label="locator_currency_ILS"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_currency_AllCurrenciesDomain" xlink:to="locator_currency_ILS" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="locator_us-gaap_LesseeLeaseDescriptionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeLeaseDescriptionTable" xlink:to="locator_us-gaap_LesseeLeaseDescriptionLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="locator_us-gaap_LeaseExpirationDate1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_us-gaap_LeaseExpirationDate1" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="locator_us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_us-gaap_LesseeOperatingLeaseTermOfContract" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AnnualRentAndManagementFees" xlink:label="locator_cmmb_AnnualRentAndManagementFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_cmmb_AnnualRentAndManagementFees" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_BankGuaranteesToPropertyOwner" xlink:label="locator_cmmb_BankGuaranteesToPropertyOwner"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_cmmb_BankGuaranteesToPropertyOwner" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities" xlink:label="locator_cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="locator_us-gaap_OperatingLeaseImpairmentLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_us-gaap_OperatingLeaseImpairmentLoss" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="locator_us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="locator_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" use="optional" priority="0" order="60"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract" xlink:label="locator_us-gaap_LesseeDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeDisclosureAbstract" xlink:to="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeDisclosureAbstract" xlink:to="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeDisclosureAbstract" xlink:to="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeDisclosureAbstract" xlink:to="locator_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="locator_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeDisclosureAbstract" xlink:to="locator_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="locator_us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LesseeDisclosureAbstract" xlink:to="locator_us-gaap_OperatingLeaseLiability" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="locator_us-gaap_OtherCommitmentsTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="locator_us-gaap_OtherCommitmentsTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="locator_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsTable" xlink:to="locator_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="locator_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="locator_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalAdditionsMember" xlink:label="locator_us-gaap_CapitalAdditionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="locator_us-gaap_CapitalAdditionsMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_CapitalAdditionsOneMember" xlink:label="locator_cmmb_CapitalAdditionsOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="locator_cmmb_CapitalAdditionsOneMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAgreementsMember" xlink:label="locator_us-gaap_LeaseAgreementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="locator_us-gaap_LeaseAgreementsMember" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="locator_srt_CurrencyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsTable" xlink:to="locator_srt_CurrencyAxis" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="locator_currency_AllCurrenciesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_CurrencyAxis" xlink:to="locator_currency_AllCurrenciesDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="locator_currency_EUR"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_currency_AllCurrenciesDomain" xlink:to="locator_currency_EUR" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_ILS" xlink:label="locator_currency_ILS"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_currency_AllCurrenciesDomain" xlink:to="locator_currency_ILS" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="locator_srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsTable" xlink:to="locator_srt_TitleOfIndividualAxis" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_TitleOfIndividualAxis" xlink:to="locator_srt_TitleOfIndividualWithRelationshipToEntityDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="locator_srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsTable" xlink:to="locator_srt_StatementScenarioAxis" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="locator_srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_StatementScenarioAxis" xlink:to="locator_srt_ScenarioUnspecifiedDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="locator_srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_ScenarioUnspecifiedDomain" xlink:to="locator_srt_ScenarioForecastMember" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="locator_us-gaap_OtherCommitmentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsTable" xlink:to="locator_us-gaap_OtherCommitmentsLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentDescription" xlink:label="locator_us-gaap_LongTermPurchaseCommitmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_LongTermPurchaseCommitmentDescription" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDescription" xlink:label="locator_us-gaap_OtherCommitmentsDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_OtherCommitmentsDescription" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" xlink:label="locator_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_MaximumPercentageOfPaymentsOfRoyalties" xlink:label="locator_cmmb_MaximumPercentageOfPaymentsOfRoyalties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_MaximumPercentageOfPaymentsOfRoyalties" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" xlink:label="locator_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:label="locator_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="locator_us-gaap_LongTermPurchaseCommitmentAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_LongTermPurchaseCommitmentAmount" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" xlink:label="locator_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" use="optional" priority="0" order="70"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="locator_us-gaap_RoyaltyExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_RoyaltyExpense" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AggregateAmountCommitmentToPay" xlink:label="locator_cmmb_AggregateAmountCommitmentToPay"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_AggregateAmountCommitmentToPay" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AggregateAmountOfCommitmentPaid" xlink:label="locator_cmmb_AggregateAmountOfCommitmentPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_AggregateAmountOfCommitmentPaid" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AdditionalWorkOrderAmount" xlink:label="locator_cmmb_AdditionalWorkOrderAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_AdditionalWorkOrderAmount" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LienOnBankDeposit" xlink:label="locator_cmmb_LienOnBankDeposit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_cmmb_LienOnBankDeposit" use="optional" priority="0" order="120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedInvestments" xlink:label="locator_us-gaap_RestrictedInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OtherCommitmentsLineItems" xlink:to="locator_us-gaap_RestrictedInvestments" use="optional" priority="0" order="130"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/ShareCapitalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SaleOfStockTable" xlink:label="locator_cmmb_SaleOfStockTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_cmmb_SaleOfStockTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="locator_us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockTable" xlink:to="locator_us-gaap_SubsidiarySaleOfStockAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="locator_us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="locator_us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_InvestorsMember" xlink:label="locator_cmmb_InvestorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="locator_cmmb_InvestorsMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="locator_us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="locator_us-gaap_PrivatePlacementMember" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_AtmAgreementMember" xlink:label="locator_cmmb_AtmAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="locator_cmmb_AtmAgreementMember" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="locator_us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockTable" xlink:to="locator_us-gaap_StatementClassOfStockAxis" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="locator_us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockDomain" xlink:to="locator_us-gaap_SeriesCPreferredStockMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="locator_us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockTable" xlink:to="locator_us-gaap_PlanNameAxis" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="locator_us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PlanNameAxis" xlink:to="locator_us-gaap_PlanNameDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_TwoThousandsFifteenMember" xlink:label="locator_cmmb_TwoThousandsFifteenMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_PlanNameDomain" xlink:to="locator_cmmb_TwoThousandsFifteenMember" use="optional" priority="0" order="130"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SaleOfStockLineItems" xlink:label="locator_cmmb_SaleOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockTable" xlink:to="locator_cmmb_SaleOfStockLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="locator_us-gaap_ProceedsFromWarrantExercises"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_us-gaap_ProceedsFromWarrantExercises" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="locator_us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_us-gaap_PreferredStockSharesIssued" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_us-gaap_PreferredStockParOrStatedValuePerShare" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="locator_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ProceedsFromSaleOfAdss" xlink:label="locator_cmmb_ProceedsFromSaleOfAdss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_ProceedsFromSaleOfAdss" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" xlink:label="locator_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfWarrantsPurchaseUpAdss" xlink:label="locator_cmmb_NumberOfWarrantsPurchaseUpAdss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_NumberOfWarrantsPurchaseUpAdss" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SaleOfStocksPricePerShare" xlink:label="locator_cmmb_SaleOfStocksPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_SaleOfStocksPricePerShare" use="optional" priority="0" order="70"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfStockAdssResveredForIssuance" xlink:label="locator_cmmb_NumberOfStockAdssResveredForIssuance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_NumberOfStockAdssResveredForIssuance" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfAdssOptionsIssuableOutstanding" xlink:label="locator_cmmb_NumberOfAdssOptionsIssuableOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_NumberOfAdssOptionsIssuableOutstanding" use="optional" priority="0" order="90"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_NumberOfAdssVestedAndExercisable" xlink:label="locator_cmmb_NumberOfAdssVestedAndExercisable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_cmmb_NumberOfAdssVestedAndExercisable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" use="optional" priority="0" order="110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_SaleOfStockLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" use="optional" priority="0" order="120"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="locator_us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="locator_us-gaap_IncomeStatementLocationAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="locator_us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementLocationAxis" xlink:to="locator_us-gaap_IncomeStatementLocationDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementLocationDomain" xlink:to="locator_us-gaap_ResearchAndDevelopmentExpenseMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementLocationDomain" xlink:to="locator_us-gaap_GeneralAndAdministrativeExpenseMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="locator_us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="locator_us-gaap_AllocatedShareBasedCompensationExpense" use="optional" priority="0" order="0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79ca72f7-8104-f0a2-c207-78e818e91002"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79ca72f7-8104-f0a2-c207-78e818e91002" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" use="optional" priority="0" order="70" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" xlink:label="locator_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="locator_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" use="optional" priority="0" order="80"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" xlink:label="locator_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="locator_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" use="optional" priority="0" order="90" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" use="optional" priority="0" order="100" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" use="optional" priority="0" order="110" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_62a32448-7bd9-d44c-49d4-8bb8094af742"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_62a32448-7bd9-d44c-49d4-8bb8094af742" use="optional" priority="0" order="120" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" use="optional" priority="0" order="130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" use="optional" priority="0" order="140"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="locator_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="locator_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" use="optional" priority="0" order="150" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="locator_srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="locator_srt_RangeAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="locator_srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_RangeAxis" xlink:to="locator_srt_RangeMember" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="locator_srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_RangeMember" xlink:to="locator_srt_MinimumMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="locator_srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_RangeMember" xlink:to="locator_srt_MaximumMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="locator_us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="locator_us-gaap_AwardTypeAxis" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AwardTypeAxis" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="locator_us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_SharePrice" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" use="optional" priority="0" order="50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" use="optional" priority="0" order="60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="locator_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" use="optional" priority="0" order="70"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="locator_us-gaap_ResearchAndDevelopmentAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ConsultantsAndSubcontractorsExpense" xlink:label="locator_cmmb_ConsultantsAndSubcontractorsExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="locator_cmmb_ConsultantsAndSubcontractorsExpense" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="locator_us-gaap_OfficersCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="locator_us-gaap_OfficersCompensation" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" xlink:label="locator_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="locator_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_SharebasedCompensationResearchAndDevelopmentExpense" xlink:label="locator_cmmb_SharebasedCompensationResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="locator_cmmb_SharebasedCompensationResearchAndDevelopmentExpense" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="locator_us-gaap_OtherResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="locator_us-gaap_OtherResearchAndDevelopmentExpense" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="locator_us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="locator_us-gaap_ResearchAndDevelopmentExpense" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="locator_us-gaap_SalariesAndWages"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:to="locator_us-gaap_SalariesAndWages" use="optional" priority="0" order="0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="locator_us-gaap_ProfessionalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:to="locator_us-gaap_ProfessionalFees" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" xlink:label="locator_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:to="locator_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoninterestExpenseDirectorsFees" xlink:label="locator_us-gaap_NoninterestExpenseDirectorsFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:to="locator_us-gaap_NoninterestExpenseDirectorsFees" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralInsuranceExpense" xlink:label="locator_us-gaap_GeneralInsuranceExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:to="locator_us-gaap_GeneralInsuranceExpense" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" xlink:label="locator_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:to="locator_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:to="locator_us-gaap_OtherGeneralAndAdministrativeExpense" use="optional" priority="0" order="60" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:to="locator_us-gaap_GeneralAndAdministrativeExpense" use="optional" priority="0" order="70" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="locator_us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_IncomeTaxDisclosureTable" xlink:label="locator_cmmb_IncomeTaxDisclosureTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_cmmb_IncomeTaxDisclosureTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="locator_srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_IncomeTaxDisclosureTable" xlink:to="locator_srt_StatementGeographicalAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="locator_srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_StatementGeographicalAxis" xlink:to="locator_srt_SegmentGeographicalDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:label="locator_country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_SegmentGeographicalDomain" xlink:to="locator_country_IL" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="locator_country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_srt_SegmentGeographicalDomain" xlink:to="locator_country_US" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="locator_us-gaap_IncomeTaxAuthorityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_IncomeTaxDisclosureTable" xlink:to="locator_us-gaap_IncomeTaxAuthorityAxis" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="locator_us-gaap_IncomeTaxAuthorityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxAuthorityAxis" xlink:to="locator_us-gaap_IncomeTaxAuthorityDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="locator_us-gaap_DomesticCountryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxAuthorityDomain" xlink:to="locator_us-gaap_DomesticCountryMember" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_IncomeTaxDisclosureLineItems" xlink:label="locator_cmmb_IncomeTaxDisclosureLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_IncomeTaxDisclosureTable" xlink:to="locator_cmmb_IncomeTaxDisclosureLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="locator_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_IncomeTaxDisclosureLineItems" xlink:to="locator_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="locator_us-gaap_TaxCreditCarryforwardAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_IncomeTaxDisclosureLineItems" xlink:to="locator_us-gaap_TaxCreditCarryforwardAmount" use="optional" priority="0" order="10"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="locator_us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="locator_us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="locator_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="locator_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="locator_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="locator_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="locator_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="locator_us-gaap_DeferredTaxAssetsOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="locator_us-gaap_DeferredTaxAssetsOther" use="optional" priority="0" order="40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="locator_us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="locator_us-gaap_DeferredTaxAssetsGross" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="locator_us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="locator_us-gaap_DeferredTaxAssetsValuationAllowance" use="optional" priority="0" order="60" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="locator_us-gaap_DeferredTaxAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="locator_us-gaap_DeferredTaxAssetsNet" use="optional" priority="0" order="70" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="locator_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" use="optional" priority="0" order="80"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="locator_us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="locator_us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_us-gaap_DeferredTaxAssetsValuationAllowance" use="optional" priority="0" order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_CurrencyTransactionLossValuationAllowance" xlink:label="locator_cmmb_CurrencyTransactionLossValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_cmmb_CurrencyTransactionLossValuationAllowance" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance" xlink:label="locator_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_IncomeTaxExpenseValuationAllowance" xlink:label="locator_cmmb_IncomeTaxExpenseValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_cmmb_IncomeTaxExpenseValuationAllowance" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="locator_us-gaap_DeferredTaxAssetsValuationAllowance_aa47b888-f6a1-19c0-e6b7-6943416ad96d"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_us-gaap_DeferredTaxAssetsValuationAllowance_aa47b888-f6a1-19c0-e6b7-6943416ad96d" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="locator_us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="locator_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="locator_us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="locator_us-gaap_EffectiveIncomeTaxRateContinuingOperations" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="locator_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="locator_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" use="optional" priority="0" order="30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" xlink:label="locator_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="locator_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="locator_us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="locator_us-gaap_IncomeTaxExpenseBenefit" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="locator_us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="locator_us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="locator_us-gaap_RelatedPartyDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyMember" xlink:label="locator_cmmb_RelatedPartyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyDomain" xlink:to="locator_cmmb_RelatedPartyMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="locator_us-gaap_RelatedPartyTransactionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="locator_us-gaap_RelatedPartyTransactionLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="locator_us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_EmployeeRelatedLiabilitiesCurrent" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="locator_us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_AccruedLiabilitiesCurrent" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="locator_us-gaap_DueToRelatedPartiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_DueToRelatedPartiesCurrent" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="locator_us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" xlink:label="locator_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" use="optional" priority="0" order="0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty" xlink:label="locator_cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" xlink:label="locator_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" xlink:label="locator_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyCosts" xlink:label="locator_us-gaap_RelatedPartyCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_us-gaap_RelatedPartyCosts" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="locator_us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_EarningsPerShareCalculationNumeratorAbstract" xlink:label="locator_cmmb_EarningsPerShareCalculationNumeratorAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_EarningsPerShareAbstract" xlink:to="locator_cmmb_EarningsPerShareCalculationNumeratorAbstract" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_EarningsPerShareCalculationNumeratorAbstract" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="cmmb-20211231.xsd#cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" xlink:label="locator_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_EarningsPerShareAbstract" xlink:to="locator_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" use="optional" priority="0" order="20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" xlink:to="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:label="locator_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" xlink:to="locator_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" use="optional" priority="0" order="40"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="locator_us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_EarningsPerShareAbstract" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="locator_us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="locator_us-gaap_AntidilutiveSecuritiesNameDomain" use="optional" priority="0" order="0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="locator_us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="locator_us-gaap_EmployeeStockOptionMember" use="optional" priority="0" order="10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementLineItems" use="optional" priority="0" order="200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" use="optional" priority="0" order="0"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>kpmg.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 kpmg.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#<17AI9@  34T *@    @ ! $[  (
M   &   (2H=I  0    !   (4)R=  $    ,   0R.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 &AE;&5N   %
MD ,  @   !0  !">D 0  @   !0  !"RDI$  @    ,Q,@  DI(  @    ,Q
M,@  ZAP !P  " P   B2     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M1GN3R?6NV^-_Q!/AS11H6E3%-3U!,O(C8:"+."?8MR![9/I4U\+-XE48ZO\
MICIUHJE[1GJU8OBO_D"P_P#81L?_ $KBKX_;Q'KZ'#ZQJ2G .#=2=",COZ5]
M):SJ*^$/@GI5QJDS37-N+&4I+)\\\BRQRLH)Y)^5OP%55P,L/.&M[L4,2JL9
M:6LCI?!AQI^J$\#^V+[_ -'M6G)K^CQ2;)=6L4?^ZUR@/Y9KY234O%GQ(U]M
M)TZ24I=W$MQ]CB<K#%YCEG9O8%NIR>P]*ZK6?V?=9TGPY<ZDFK6MU/;1-*]M
M'&PW!1DA6/4X'H,UI4P5.,_WM2S?2UR(XB;C[D;I'TA#-%<1"2"1)8VZ.C @
M_B*Q[?\ Y'[4?^P9:?\ HVXKYD^&6L:_X;\<:;]ABN1;W=S';W$#(VR1'8*<
MCID9R#VKZ;M_^1^U'_L&6G_HVXKFQ&%>&;C>]U^J-J5;VJ3M;4M>(-7BT'P[
M?ZK<$!+2W>7GN0.!^)P/QKXOM-7O++6!JMO+B]5VD64CE7.?F'N"<CWKZ(_:
M%UK[#X%MM+1L2:E<C</6./YC_P"/;*YKX9_#=/$'P=UEKJ)!<ZL^ZRD8<H8L
MA&SV!<N#[5W8&4,/AW5J?:=OE_5SFQ"E5JJ$>BN<O\(_#7AS6]5GU7Q=J]G%
M%9R*4L[J94-PQR=S%B,J,=!U/7CK]&CQ=X950!XATD = +V/C_QZOEKX;^(F
M\%_$.VFOP8K=I#:7J./NJ3@DC_98 _A7T/\ %K5HM!^&6J3Q!4FN$%K"5 !S
M(<''_ =Q_"IS"G*>(C%W:>P\+)1I-KIN?,/BW6O^$@\::IJS?/'<W3.F#C]W
MG"C_ +Y KOM=^/>K:GX?ETG3-)M=-CEA,!D61I&5",87H <<9YJ3]GG0Q?\
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?V@Z>MCH]G%9VRDL(HEP,GJ?<U=HHKG;;=V:[;'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ,W!:,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **YW5O'7AO0]0>PU+4O(N4 +)
MY$C8!&1RJD59T7Q9H7B%VCTO4HKB11DQX*/CUVL <>] &S1110 4444 %%%%
M !1110 4444 %%%% !1110!6L>;8Y_YZ2?\ H9JS5:Q_X]C_ -=9/_0VJS3>
MX(***S]9US3O#]C]MU2X\BW+A-^QFY/084$]J0&A14-I=P7]G!=VS[X)XUDC
M?!&Y2,@X//2IJ "BBLCQ)XBM/"^DG4KV.>2$.J;8%!;)^I _6@#7HKG-5\:Z
M9H_AJSUVYCN3;7@0Q1H@,GS+N&1G X]ZW;6YCO+.&ZASY<T:R)D8.",CB@":
MBBB@ HHJO]NM#?&Q%U!]K">88/,'F;?7;UQ[T 6**P/$GC#3/"TME'?K<,UX
MY6/R4#8QC).2..1TR?:M^@ HHHH **** "BBB@"LG_(2G'_3&/\ F]6:K)_R
M$Y_^N,?\WJS38!1112 ***Y[5_'/AS0;]K'4M1\BY50Q3R)&X/3E5(H Z&BN
M07XH>#G8*NL9).!_HTW_ ,177]J "BBB@ HHHH **** "BJ_VZT-\;$74'VL
M)YA@\P>9M]=O7'O5B@ HHHH *BNO^/2;_KFW\JEJ*Z_X])O^N;?RH =#_J(_
M]T?RI],A_P!1'_NC^5/H **S]9US3O#]C]MU2X\BW+A-^QFY/084$]JQ(/B7
MX/N)EB36HPS=#)#(@_-E % '5T5''/%- L\4B20LNY70[@P]01UK$\,>+]-\
M6)=OIR7"BV<(_G(%SG.",$\<'W]J -^BBB@ HHHH **** "BBB@ HHHH ***
M* "FR?ZMOH:=39/]4_\ NF@"*S_X\K?_ *YK_*IZ@L_^/&W_ .N:_P JGH8!
M117(O\3O!T<C(^L89201]FFX/_?% '7452TO6-.UJT^U:;>17,.<%HST/H1U
M!]C5V@ HHHH ***KW]Y'IVG7-[,K-%;Q-*X09)"@DX]^* +%%<_I'C#3=8\-
M7.O0QW,5G;[]XE0;_D&3@ G^=6?#?B.R\4Z5_:-@DZ1>88RLRA6!'T)'<=Z
M->BBJ]]>0Z=I]Q>W!(AMXVE?:,G &3B@"Q161X;\1V7BG2O[1L$G2+S#&5F4
M*P(^A([CO6O0 4444 %%<_J?C#3]*\36.@SPW375Z%,;HJE!N8J,DL#U'H:Z
M"@ J"\_X\KC_ *YM_*IZ@O/^/&X_ZYM_*A 2Q_ZM?H*=38_]4G^Z*=0 4444
M %%%% !116'K?C#0?#ES';ZM??9Y9$WHODN^1G&?E4T ;E%8&D>-O#>NW0M=
M.U6*6<_=C96C9OH& S^%)J?C#3]*\36.@SPW375Z%,;HJE!N8J,DL#U'H: .
M@HHHH **** "BBB@ HHILDB11M)(ZI&@+,S' 4#J2: '45D:-XHT;Q!-<Q:5
M>K<O;8\W:C #.0,$@ ]#TS6O0 4444 %%%% !1110!6L.;*//O\ S-6:K6'_
M !Y1_C_,U9IO<$%%%%( HHHH **** "BBB@ HHKG=6\=>&]#U![#4M2\BY0
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M_&H? D;)\6+]_P"S#ID<MHTL5J5"E(R4*\#H<<D=CFKO@'_DJOBS_?E_]&T
M6_$'B;Q-IDGA_P .13VZ:Q?HHN+QT5@K%MOR@#;Z]O2J#ZEXUM?B#:^&+CQ0
MK+,HD$Z6,1RNTG!7''W2.OO4_P 8);2.?0OM<0\D3,99H' N448X0$].O)!&
M0.G>GX-\1>![;Q$LD1UA]3N2(EO=4*N<G@#*GC/ SC\<4 :'B3QOJESXNF\/
MZ-JFG:3%:C]]>WK* 6&,J-V1WQC&>#R*E\)>-M4E\3R>&]6OM/U*1XRUM?6;
M H[ ;L';QTSV!&.^:Y_7].B\+?$.]U76]$?4M#O=SAQ$'",<'OP""",$C@YK
MI_!^I^%-8UU3H/AE[=H(V<WK6RHJ'I@$$\D$^G0T <9I\?BW4/BAJD=KJMI;
MZQ'&RRS^7F/8NT;5!4^W;M7MNGI=1:=;1WTJS7:Q*)I%& [XY(&!U/M7C]UJ
MJ^!_BWJ>IZI:736MTC>4T2 E@VTY&2 <$8/->OZ=>KJ6FVU\D<D27$:R*DHP
MR@C."/6@"U1110 5%=?\>DW_ %S;^52U%=?\>DW_ %S;^5 #H?\ 41_[H_E3
MZ9#_ *B/_='\J?0!Y]\8_P#D2%_Z^X_Y-5K1O!?AW5_!.EBYTFU$LUC$6GBB
M"2;B@^;<!G.>>:J_&/\ Y$A?^ON/^35A:7\58;;PW8Z5I>D7MWJ<%LD*@J-A
M8*!D;221GM@?A0!9^$=[=6MYK?AZ:5I(;*0M%D_=(8JV/8D X^OK5GX;>)=0
MO=&\07=\R3_9&\Q$CA2+/RL3]Q1DG Y.:N?#/PI?Z+:WVJ:NACU"_;)C)&47
MD\XZ$DYQVP/<5A_""<VND>)+A8VE,3JXC7JV%8X'UH @T'Q-XX\6O/<Z;KFD
M021OQILB*&88SD94DCWW?E73^.?&&I^'X=,TO3HX9M:O\+G;\JG@?*I/=CQD
M]N]>;>)[SPSK4\<OAG2=5L]<,V3#'& I/?Y58D,#TV@>]=1XZTK6[8>%_$CV
MSW<^GPQ?;$7)(=2&)..<$Y!/:@#J/#MG\0+;686U[4["ZT]D8R+&BAE.. ,(
MO.?J.#6 ?%'B[QCXAU"S\*7%K8V5B<&:9 3)R0,DJW7!(  XZUO>'OB58^)]
M7@T[3]-O@74M-+*JA8@ 3V)SD\<XZUQ>D:H_PN\3ZS!J^GW<EG>,&@GB4'?@
MDKC) /#<\Y!'2@#HO#?BW7=?TW7-&F:.V\1:>C>5*B##D''*D$9R,=,?,*L>
M#?'$U]X#U#5-5F$MYIWF>:=H4OQN3@  9^[^%9_PRTR_NO$&M>*;NUDM8;YF
M\F.12"VY]Q(SV' SWS[5Q_BZTN_#_BG6M"LD9;?6VB>)1T.7R!_WUN% '7Z%
MXUUJR^'M]XFUNX%W))+Y5E$8T0$]/X0,C.?P6LAO&7BR#2EUP^*- FR!(=*#
MQ^8%.., ;LCN-V?QXKKO%G@^6?X:Q:)IBF2:R6-XT&,R%?O?B<D_6N*TGQ%X
M-LM,M['6O",O]K0H(Y56T0F1AQGD@Y.,G(_.@#J/%7CB^'PZTSQ#H\OV6:YG
M17!17QP^Y?F!_B7K[4NG7OC[7DN=34QZ;82VCO91!(V<OC*$[@3S^'7I6=\2
M4MT^%^EFUT_^SX7NHY!:[=IBW(Y((]<FO1M!_P"1=TS_ *](O_0!0!QO@WQS
M<7O@C5-0U>;S+W3=YE)14+#&5X  !SE>G:KWPTU/7=;\/RZGK5V9Q-*5MQY2
M)A5X)^4#J<CGTKS7QK87F@^*]5T>RC/V?73&\:^N7S@?\#R/I7N&B:8FC:'9
M:;'@K;0K&2.Y Y/XG)_&@"_39/\ 5/\ [IIU-D_U3_[IH BL_P#CQM_^N:_R
MJ>H+/_CQM_\ KFO\JGH8 >E>%_#L^&A>>(#XB_LS:'3ROMH3/5]VS=SZ9Q[5
M[H>E>'?#;POHWB34==_M>S^T^1(GE_O73;DOG[I&>@ZT :/PH"?\)?XA?2PX
MT?!$><XQO/E]><[=W6H- \7^/O$UI/8Z48I+F*8M+?2)&HC0XVKC&W.0W8FO
M6]/TNQTBR^RZ?:16T YV1+@$^I]3[FO-O@I_QZZY_P!=X_Y-0!<\8>--4T_5
M['PYIEY96E[)"K7-]>,H2(D9[C:.F>AZC JKHWCC5M-\66>C:OK&F:U:WI"I
M=V3(3&Q. #M '7L1W!SVJKX_TB73/'=MXDN-*;4](=%6YC";PN 5.1VXP03Q
MGC-7O#VL^"M9UVSM]&\*2"??O-PUJBK!@9!)!/.0/SZT 2:YXL\2:OXSE\,^
M%'MX&MES-=2J&P1C/4$  D#H3FM)(/%5OX.\1Q^)[NUNF%I)Y$D"@9'EMG.
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M?'GS32",$XRPVD#\<8JIX3^(<'A'0DT#5M(U!;ZV=@B(@^;<Q;D,00<G' -
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MZS^<O_QFCV%3^F@]I$]4HKRO_A:?BK_HF.L_G+_\9H_X6GXJ_P"B8ZS^<O\
M\9H]A4_IH/:1/5**\K_X6GXJ_P"B8ZS^<O\ \9H_X6GXJ_Z)CK/YR_\ QFCV
M%3^F@]I$]4HKRO\ X6GXJ_Z)CK/YR_\ QFC_ (6GXJ_Z)CK/YR__ !FCV%3^
MF@]I$]4JMJ+WD>F73Z?$DMXL3&"-SA6?' /(XS[BO-/^%I^*O^B8ZS^<O_QF
MC_A:?BK_ *)CK/YR_P#QFCV%3^F@]I$M:)X5\2:UXPA\2>+4@@^R#%O:1,&
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MZS^<O_QFCV%3^F@]I$]4HKRO_A:?BK_HF.L_G+_\9H_X6GXJ_P"B8ZS^<O\
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MZS^<O_QFCV%3^F@]I$]4HKRO_A:?BK_HF.L_G+_\9H_X6GXJ_P"B8ZS^<O\
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MI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5D_P"0G/\
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ME'^/\S5FF]P04444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *K7O^IC_ .NT?_H8JS5:]_U,?_7:
M/_T,4UN#+-%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"M8_\ 'L?^
MNLG_ *&U6:K6/_'L?^NLG_H;59IO<$%%<[JWCKPWH>H/8:EJ7D7* %D\B1L
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M .N:_P JGJ"S_P"/&W_ZYK_*IZ& 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5!>?\>-Q_P!<V_E4]07G_'C<?]<V_E0@)8_]4G^Z*=38
M_P#5)_NBG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 5K#_CRC_'^9JS5:P_X\H_Q_F:LTWN""BBBD 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF?\ X2CQ#_T'=3_\"Y/\:/\ A*/$/_0=U/\ \"Y/\:/J$NX?65V/IBBOF?\
MX2CQ#_T'=3_\"Y/\:/\ A*/$/_0=U/\ \"Y/\:/J$NX?65V/IBBOF?\ X2CQ
M#_T'=3_\"Y/\:/\ A*/$/_0=U/\ \"Y/\:/J$NX?65V/IBFR?ZI_]TU\T_\
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M3)?1)*5]3'U!]LYI ==163J/B"ST?0TU34EDMD95Q PS(78<( .K?X'M6/\
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M=!1116904444 %%%% !1110 4444 %%%% !1110 4444 %5KW_4Q_P#7:/\
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MD$=<UZ;XG\%3>)?!>FV =+?4;**,H7Y7<$ 921GCW&>@K/MKSXIK!'8MI6F
MJ GVV20'(QC<0'Z]_N_A0!C?$W4;V2V\&ZE&IM[YLS!6&#'(1&<$'T-;::%<
M> /#^M^(9-2EU'59K<;Y)5X#YP",Y) )[^E.^)'AK6=?DT%M.M1<FU=FG(D1
M-N=G/S$9Z'I7:ZSI<.M:-=Z;.<1W,10L!G:>Q_ X- 'C>G>#&UOP/<>,+K5[
MXZL$EGC?S. (R>"<;L_*>A&,BM9=<\0^(/@X\UF]Q)?P3^1/+$?WCQKR3QR3
M@J#CDX/O44'A[XBZ7H=QX6M;>RFTV7<@N_-4%$;[P&6! //\)/)Q75V7A[6_
M"'@FWLO#PMKK4TE\V<3<)*2#N R1_L@<CI0!Q7P\M_"=QJNGS6^J:G::RAS+
M;32 )<-CD @#(R>A.2!T-:L/_)PD_P#UQ_\ : I+?PIXI\0>-;#6]9TNPTE;
M21))&MW!:;:<\[6;)XQDXXK6C\-:NOQCEUXVG_$L:+:)_,3KY07[N=W7VH Y
MG5["YU;XUWNF07LUG'=1(EQ)"V',0B5BH/;.T?YXI=!L9/!GQ>BT*QNYY+"X
M3YDE;J#&6&<8!((ZXZ5TL?AK5U^,<NO&T_XEC1;1/YB=?*"_=SNZ^U-OO#.L
M3?%^SUV.TSIL: -/YJ<'RV'W<[NI]* .;O\ [!JOQ.U2T\:7DD-C"K&SBEE,
M<>.-I!]QD^Y_*I_A#HMH^KZMJD<#R0VTOE65RY89!W \="=NWMQFJ]\^J^(?
M'.JZEX?TJU\06D2K;XU*)3#$1C(C#,,\C.1_>/'.3T_@[Q=JDGB.7POK>C6N
MGW,47F1K:#"*.#C&2.0<Y!H ]!HHHH **** *R?\A.?_ *XQ_P WJS59/^0G
M/_UQC_F]6:; XOQ*HN?B)X3M9UW6Z_:)E5NAD5?E./4=17:5SWBOP]/K<%I<
M6%RMKJEA+YUK,PRN>ZM_LGC-4DUOQFJB*7P?#)*.&F34XUC;CJ 06 ]J0$/B
M51<_$3PG:SKNMU^T3*K=#(J_*<>HZBNTKG/$WAZZUVSL;FTN$L]8L7$UO*?F
M0-CYE/\ LGZ=NE5$UOQFJB*7P?#)*.&F34XUC;CJ 06 ]J %\7_\A[PG_P!A
M+_V1JZVN2\6V>L7#Z#>Z?IHO)[*Z\^:!9UC_ ("#AFQW-6K+6O$=Q>PQ77A*
M2U@9L/.=0B?8/7:.30!HZ[K=KH&F/>W1+<[(HDY>9ST11W)K%T"(^%/"EYJ6
MM%89YYI+ZZ1.=C.>$'J>@^M8D*>*V\23:QJ7A-[V6,E+%!J$*QVZ>H!/+GNW
M\JZ:*";Q1IT]IXD\/&S@#*5B>[63S/?*'C'% '(^)=,NAX UW7-6CVZIJ B)
MCSG[/")5V1#Z=3ZD^U>FQ_ZM?H*\_P#%/PTT=_#EVNA:*G]I?+Y.)B#]X9^\
MV.F>M=GI&D6.AZ>MEI]N(( 2VP,3R>O4F@"_1110 4444 %%%% !7RC7U=7R
MC7HY?]KY?J<F*Z';_"[1H=4\4&XN5#Q64?G!3W?("_ER?P%.NO'.MZIXVADM
M+ZXBM?M2QPV\;D(4W8&Y>A)[Y]:A^''B6T\/:W,NH-LM;N/RVDQG8P.03[=1
M6_8Z+X,\,ZK_ &Y+XE@O8X6,EO:PE6<-VSM))Q] ,]:VJ-*HW)7TT(CK!6?J
M3>,]'MM6^*VD63H"EQ"C7 4X+!2Y.<<_=7%9/B[3_!F@C4K"U@EFU5L&$!W\
MNVSCC.[DXR><\GMTJWX5\1VNK_$6]U[4[JWLX4@*P+/,JX'  &>IQDGZUR=B
M&\1>/HF(WB[O][9_NE\G]*4(R32D](H<FGJNK.XO/#/@S0[S1+/4K2XEN[N-
M(VBB=L,YP#(YW# SV7WX-9-UX3MM-^+&G:99[A:O)'<JC'<5498KGO\ =/X5
MU>MVWAR?QQ'K&HZ[! ^EJJO92$!BR_,I'.2/F!P >E87AWQ%8:Q\2K[7;VZM
M[2UB@*6WVB14..%&,GKC<3]:RA.?*Y7;T_'H5*,;V\SHM1L?"WB7QO=:7?07
M-UJ*6X/F!RL<(&/E&#][YL\@CFN'\*^#++4-6U:?4IF&D:7(ZNV<>9M)ZD=!
M@9./45H^"-:L(=9\2Z_?7MM%*X8PK+(JN^26PH/)Z*.*3P/JFF7GA/6]$U'4
MX+"XNW9Q-.P4$,H'<@'!'3/>JM.G%I-Z6_X-@O&33?F3#1?!6H>%=5\0Z?I]
MS'';QO$D,TK +* -K##$G.Y>"2/:J6A^&/#_ /PKTZ]K:R@^>6#Q,=Y0,%V*
M,[<D@\D=_P 1/K]UHFD?#-=&TC58;R26Y E9& 9\$DL5!R%RH SVQUJ#Q;J%
MDO@/P]HEG?VLT@VO.(958(0O.['3ECU]*<>=Z)O5_@A/E6K2V_$A\<>']"M/
M#>DZUHMO+:I>$ Q.Y;(*E@3DG!&.QQS5+P)X5M-<>\U'5G:/2[%=TN#C><9Q
MGK@ 9./:M#XEZG8RV^BZ7IMY;W$%I!\QMY Z@X"@9'?"G\ZG\!ZCI4_@_6=
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M99HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIRX-M##(%P,D8)R/NC/6D\*W+R^.-?C;Q-)J&UFQ8F.0"WP^/XAM&.GR]>M
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M10 56O?]3'_UVC_]#%6:K7O^IC_Z[1_^ABFMP99HHHI %%%% !1110 4444
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M%Y%786#$G(&3@\^_2@# ^%6G6)\%6%Z;.W-V'EQ/Y2[_ +[#[V,].*QO /\
MR57Q9_OR_P#HVMKPS\.[OPWJD,R>)KR:PB9F%B%*(Q((Y^<@]<].U:.@>"_[
M#\5:MK?]H>?_ &@7/D^3M\O<^[[VXY].@H \YO-$U7P!J5_>WF@V.N:/.^6F
MEB#%1DD<D$H>><@CI7K7A>_L-2\-6-UID/D6;1XCB(QY>#@K^!!KD+KX9:E=
M"2V;QGJ7]FR-S:LI8;?[N=^,?ACVKM]%TBUT'2+;3+,-Y%NNU2YRQYR2?<DD
MT 7Z*** *R?\A.?_ *XQ_P WJS59/^0G/_UQC_F]6:; ****0!1110 4444
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M_4P?^2?_ -G1_P *6_ZF#_R3_P#LZ]7HH^MUN_Y!["GV/*/^%+?]3!_Y)_\
MV='_  I;_J8/_)/_ .SKU>BCZW6[_D'L*?8\H_X4M_U,'_DG_P#9T?\ "EO^
MI@_\D_\ [.O5Z*/K=;O^0>PI]CRC_A2W_4P?^2?_ -G1_P *6_ZF#_R3_P#L
MZ]7HH^MUN_Y!["GV/*/^%+?]3!_Y)_\ V=(WP7VJ6_M_H,_\>?\ ]G7K%-D_
MU3_[IH^MUN_Y!["GV/)X?@UYL$<G]O8WJ&Q]CZ9'^_3_ /A2W_4P?^2?_P!G
M7J%G_P >-O\ ]<U_E4]'UNMW_(7L*?8\H_X4M_U,'_DG_P#9T?\ "EO^I@_\
MD_\ [.O5Z*/K=;O^0_84^QY1_P *6_ZF#_R3_P#LZ/\ A2W_ %,'_DG_ /9U
MZO11];K=_P @]A3['E'_  I;_J8/_)/_ .SH_P"%+?\ 4P?^2?\ ]G7J]%'U
MNMW_ "#V%/L>4?\ "EO^I@_\D_\ [.C_ (4M_P!3!_Y)_P#V=>KT4?6ZW?\
M(/84^QY1_P *6_ZF#_R3_P#LZ/\ A2W_ %,'_DG_ /9UZO11];K=_P @]A3[
M'E'_  I;_J8/_)/_ .SH_P"%+?\ 4P?^2?\ ]G7J]%'UNMW_ "#V%/L>4?\
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M_J8/_)/_ .SKU>BCZW6[_D'L*?8\H_X4M_U,'_DG_P#9T?\ "EO^I@_\D_\
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M30!%9_\ 'C;_ /7-?Y5/4%G_ ,>-O_US7^53T, HHHH **** "BBB@ HHHH
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M1_\ ?9_PI6 GHJ#=<_\ /*/_ +[/^%&ZY_YY1_\ ?9_PHL!/14&ZY_YY1_\
M?9_PHW7/_/*/_OL_X46 GHJ#=<_\\H_^^S_A1NN?^>4?_?9_PHL!/14&ZY_Y
MY1_]]G_"C=<_\\H_^^S_ (46 GHJ#=<_\\H_^^S_ (4;KG_GE'_WV?\ "BP$
M]%0;KG_GE'_WV?\ "C=<_P#/*/\ [[/^%%@)Z*@W7/\ SRC_ .^S_A1NN?\
MGE'_ -]G_"BP$]%0;KG_ )Y1_P#?9_PHW7/_ #RC_P"^S_A18">BH-US_P \
MH_\ OL_X4;KG_GE'_P!]G_"BP$]%0;KG_GE'_P!]G_"C=<_\\H_^^S_A18">
MBH-US_SRC_[[/^%&ZY_YY1_]]G_"BP#;#_CRC_'^9JS5&S:<6B;(T*\X);'?
MZ5/NN?\ GE'_ -]G_"F]Q(GHJ#=<_P#/*/\ [[/^%&ZY_P">4?\ WV?\*5AD
M]%0;KG_GE'_WV?\ "C=<_P#/*/\ [[/^%%@)Z*@W7/\ SRC_ .^S_A1NN?\
MGE'_ -]G_"BP$]%0;KG_ )Y1_P#?9_PHW7/_ #RC_P"^S_A18">BH-US_P \
MH_\ OL_X4;KG_GE'_P!]G_"BP$]%0;KG_GE'_P!]G_"C=<_\\H_^^S_A18">
MBH-US_SRC_[[/^%&ZY_YY1_]]G_"BP$]%0;KG_GE'_WV?\*-US_SRC_[[/\
MA18">BH-US_SRC_[[/\ A1NN?^>4?_?9_P *+ 3T5!NN?^>4?_?9_P *-US_
M ,\H_P#OL_X46 GHJ#=<_P#/*/\ [[/^%&ZY_P">4?\ WV?\*+ 3T5!NN?\
MGE'_ -]G_"C=<_\ /*/_ +[/^%%@)Z*@W7/_ #RC_P"^S_A1NN?^>4?_ 'V?
M\*+ 3T5!NN?^>4?_ 'V?\*-US_SRC_[[/^%%@)Z*@W7/_/*/_OL_X4;KG_GE
M'_WV?\*+ 3U6O?\ 4Q_]=H__ $,4[=<_\\H_^^S_ (5!=M.8DWQH!YJ8PV>=
MPQVIK<3+U%0;KG_GE'_WV?\ "C=<_P#/*/\ [[/^%*PR>BH-US_SRC_[[/\
MA1NN?^>4?_?9_P *+ 3T4#..>M% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6L?^/8
M_P#763_T-JLU6L?^/8_]=9/_ $-JLTWN""BBBD 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!63_D)S_\ 7&/^;U9JLG_(3G_ZXQ_S>K--
M@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BNO^/2;_KFW\JEJ
M*Z_X])O^N;?RH =#_J(_]T?RI],A_P!1'_NC^5/H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ ILG^J?\ W33J;)_JG_W30!%9_P#'C;_]<U_E
M4]06?_'C;_\ 7-?Y5/0P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "H+S_CQN/^N;?RJ>H+S_ (\;C_KFW\J$!+'_ *I/]T4ZFQ_ZI/\
M=%.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH K6'_'E'^/\ ,U9JM8?\>4?X_P S5FF]P04444@"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *K7O\ J8_^NT?_ *&*LU6O?]3'_P!=H_\ T,4UN#+-%%%( HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@"M8_\>Q_ZZR?^AM5FJUC_P >Q_ZZR?\ H;59
MIO<$%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"LG
M_(3G_P"N,?\ -ZLU63_D)S_]<8_YO5FFP"BBBD 4444 %%%% !1110 4444
M%%%% !1110 4444 %177_'I-_P!<V_E4M177_'I-_P!<V_E0 Z'_ %$?^Z/Y
M4^F0_P"HC_W1_*GT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4V3_ %3_ .Z:=39/]4_^Z: (K/\ X\;?_KFO\JGJ"S_X\;?_ *YK_*IZ& 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!>?\ 'C<?]<V_
ME4]07G_'C<?]<V_E0@)8_P#5)_NBG4V/_5)_NBG4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5K#_CRC_'^9JS5:
MP_X\H_Q_F:LTWN""BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !5:]_U,?_ %VC_P#0Q5FJU[_J
M8_\ KM'_ .ABFMP99HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5K
M'_CV/_763_T-JLU6L?\ CV/_ %UD_P#0VJS3>X(****0!1110 4444 %%%%
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M_P#A:.B?\^NH?]^T_P#BZ/\ A:.B?\^NH?\ ?M/_ (NO)**/[/HA]:J'K?\
MPM'1/^?74/\ OVG_ ,71_P +1T3_ )]=0_[]I_\ %UY)11_9]$/K50];_P"%
MHZ)_SZZA_P!^T_\ BZ:_Q0T1D8"UU#D8_P!6G_Q=>344?V?1#ZU4/5K?XFZ+
M%;11M:W^40*<1IV'^_4O_"T=$_Y]=0_[]I_\77DE%']GT0^M5#UO_A:.B?\
M/KJ'_?M/_BZ/^%HZ)_SZZA_W[3_XNO)**/[/HA]:J'K?_"T=$_Y]=0_[]I_\
M71_PM'1/^?74/^_:?_%UY)11_9]$/K50];_X6CHG_/KJ'_?M/_BZ/^%HZ)_S
MZZA_W[3_ .+KR2BC^SZ(?6JAZW_PM'1/^?74/^_:?_%T?\+1T3_GUU#_ +]I
M_P#%UY)11_9]$/K50];_ .%HZ)_SZZA_W[3_ .+H_P"%HZ)_SZZA_P!^T_\
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M ,71_P +1T3_ )]=0_[]I_\ %UY)11_9]$/K50];_P"%HZ)_SZZA_P!^T_\
MBZ/^%HZ)_P ^NH?]^T_^+KR2BC^SZ(?6JAZW_P +1T3_ )]=0_[]I_\ %T?\
M+1T3_GUU#_OVG_Q=>244?V?1#ZU4/6_^%HZ)_P ^NH?]^T_^+H_X6CHG_/KJ
M'_?M/_BZ\DHH_L^B'UJH>M_\+1T3_GUU#_OVG_Q='_"T=$_Y]=0_[]I_\77D
ME%']GT0^M5#UO_A:.B?\^NH?]^T_^+H_X6CHG_/KJ'_?M/\ XNO)**/[/HA]
M:J'K?_"T=$_Y]=0_[]I_\71_PM'1/^?74/\ OVG_ ,77DE%']GT0^M5#UO\
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M^(GA.UG7=;K]HF56Z&15^4X]1U%=I2 R=1\06>CZ&FJ:DLELC*N(&&9"[#A
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M_P _6G_]_'_^(H_X5=K?_/UI_P#W\?\ ^(H^MT?Y@]A4['$T5VW_  J[6_\
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M_B*/^%7:W_S]:?\ ]_'_ /B*/K='^8/85.QQ-%=M_P *NUO_ )^M/_[^/_\
M$4?\*NUO_GZT_P#[^/\ _$4?6Z/\P>PJ=CB:*[;_ (5=K?\ S]:?_P!_'_\
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M7%C<J6@N(S&X'7!&./>K-% 'DZ_#CQ=9V,^AV/B.V&ASL=Z.I#X/48VG'T#
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M444 %%%% !1110 4444 5D_Y"<__ %QC_F]6:K)_R$Y_^N,?\WJS38!1112
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M12 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K)_R$Y_\
MKC'_ #>K-5D_Y"<__7&/^;U9IL HHHI %%%% !1110 4444 %%%% !1110 4
M444 %%%% !45U_QZ3?\ 7-OY5+45U_QZ3?\ 7-OY4 .A_P!1'_NC^5/ID/\
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M_@H\ZX_Y]3_W\%%AEBBJ_G7'_/J?^_@H\ZX_Y]3_ -_!18"Q15?SKC_GU/\
MW\%'G7'_ #ZG_OX*+ 6**K^=<?\ /J?^_@H\ZX_Y]3_W\%%@+%%5_.N/^?4_
M]_!1YUQ_SZG_ +^"BP%BBJ_G7'_/J?\ OX*/.N/^?4_]_!18"Q15?SKC_GU/
M_?P4>=<?\^I_[^"BP%BBJ_G7'_/J?^_@H\ZX_P"?4_\ ?P46 L457\ZX_P"?
M4_\ ?P4>=<?\^I_[^"BP%BBJ_G7'_/J?^_@H\ZX_Y]3_ -_!18!$_P"0G/\
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M%5_.N/\ GU/_ '\%'G7'_/J?^_@HL!8HJOYUQ_SZG_OX*/.N/^?4_P#?P46
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M!18"Q15?SKC_ )]3_P!_!1YUQ_SZG_OX*+ 6**K^=<?\^I_[^"CSKC_GU/\
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M10 4444 %%%% %:Q_P"/8_\ 763_ -#:K-5K'_CV/_763_T-JLTWN""BBBD
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!63_D)S_]<8_Y
MO5FJR?\ (3G_ .N,?\WJS38!1112 **** "BBB@ HHHH **** "BBB@ HHHH
M **** "HKK_CTF_ZYM_*I:BNO^/2;_KFW\J '0_ZB/\ W1_*GTR'_41_[H_E
M3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;)_JG_P!TTZFR
M?ZI_]TT 16?_ !XV_P#US7^53U!9_P#'C;_]<U_E4]# **** "BBB@ HHHH
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M_-ZLTV 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*Z_X])O\
MKFW\JEJ*Z_X])O\ KFW\J '0_P"HC_W1_*GTR'_41_[H_E3Z "BBB@ HHHH
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M* "BBB@ JM>_ZF/_ *[1_P#H8JS5:]_U,?\ UVC_ /0Q36X,LT444@"BBB@
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M  &?N_A65\%/^/77/^N\?\FKE/%UI=^'_%.M:%9(RV^MM$\2CH<OD#_OK<*
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MI_\ S_VO_?Y?\:\SHK?ZG'N9^W?8],_M33_^?^U_[_+_ (T?VII__/\ VO\
MW^7_ !KS.BCZG'N'MWV/3/[4T_\ Y_[7_O\ +_C1_:FG_P#/_:_]_E_QKS.B
MCZG'N'MWV/3/[4T__G_M?^_R_P"-']J:?_S_ -K_ -_E_P :\SHH^IQ[A[=]
MCTS^U-/_ .?^U_[_ "_XT?VII_\ S_VO_?Y?\:\SHH^IQ[A[=]CTS^U-/_Y_
M[7_O\O\ C1_:FG_\_P#:_P#?Y?\ &O,Z*/J<>X>W?8],_M33_P#G_M?^_P O
M^-']J:?_ ,_]K_W^7_&O,Z*/J<>X>W?8],_M33_^?^U_[_+_ (T?VII__/\
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M #_VO_?Y?\:\SHH^IQ[A[=]CTS^U-/\ ^?\ M?\ O\O^-']J:?\ \_\ :_\
M?Y?\:\SHH^IQ[A[=]CTS^U-/_P"?^U_[_+_C1_:FG_\ /_:_]_E_QKS.BCZG
M'N'MWV/3/[4T_P#Y_P"U_P"_R_XT?VII_P#S_P!K_P!_E_QKS.BCZG'N'MWV
M/3/[4T__ )_[7_O\O^-']J:?_P _]K_W^7_&O,Z*/J<>X>W?8],_M33_ /G_
M +7_ +_+_C1_:FG_ //_ &O_ '^7_&O,Z*/J<>X>W?8],_M33_\ G_M?^_R_
MXT?VII__ #_VO_?Y?\:\SHH^IQ[A[=]CTS^U-/\ ^?\ M?\ O\O^-']J:?\
M\_\ :_\ ?Y?\:\SHH^IQ[A[=]CTS^U-/_P"?^U_[_+_C1_:FG_\ /_:_]_E_
MQKS.BCZG'N'MWV/3/[4T_P#Y_P"U_P"_R_XT?VII_P#S_P!K_P!_E_QKS.BC
MZG'N'MWV/3/[4T__ )_[7_O\O^-']J:?_P _]K_W^7_&O,Z*/J<>X>W?8],_
MM33_ /G_ +7_ +_+_C1_:FG_ //_ &O_ '^7_&O,Z*/J<>X>W?8],_M33_\
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M%4(***O:981W\[QRW<=LJINW/W_44FTE=C2N[%&BE888@$$ ]1WI*8@HHHH
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MI!\R_P![W%>?7H<OO1V.JG4OHS7HHHKE-@HHHH **** "BBB@ HHHH ****
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MJR:K:?9VGE1HQYB/N #9^Z3CJ.M<YX:\,^/_  G;W=WIME9M)<2;7L[B16)
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MOJQMQV]#0V:2-5CT9=/1L#YIOX@0,]>I_/O5:TM+:[\77""WB^SP@_NP@VY
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M.I.,(WD5&+D[(Z'2[FXN].BFN8?*D8<CU]_;-7***\EN[N=JV"BBBD,****
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M![%16<=9M1X=_MO=_HHMOM.?]G;NKR_P'XU\3ZSXRM;/5+S=:7$4DJQ>3&O
M!QR%SC(]: /8:*R-:\4:)X="?VKJ$5NS\JF"SD>NU03CWQ4NCZ_I6OV[3Z5>
MQ7*+PVW(9?3*G!'XB@#2HK@_B-XEU72I-)TO0IQ%J5_/@-L5OEZ 88$<DCG_
M &35KX;>);OQ'X>E.HR^9J%K.T4S;0I(ZJ<  #N/^ T =E17EGC_ ,>JNF:C
MI5LFJZ=J$,X2*Y12B28;G#@@\C/:NF\-^,+?Q*SZ?8PZA$8K;(O9H@%8\ %<
MDY/.>?2@#K:*XOP-XCU&_N]5T/6Y!)JFG2D&4(J>:A/!P.../P(KM* "BBB@
M HHHH **** "BBB@"LG_ "$Y_P#KC'_-ZLU63_D)S_\ 7&/^;U9IL HHHI %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7E%>KUY17;@_M?(YZ_0****
M[CG"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J:UF2"ZCEDA69%.3&W1
MJAHI-7T U-5UI]2CBA2!;>WB^[&ISS^0K+HHI1BHJR&VV[L****H04444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!M3>
M( =,:RM;*.V#C$C*?O>O8=:Q:**F,%'8;DWN%%%%4(**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK
MJO#WA[=LO;U..L<1'7W/^%9U*B@KLJ,7)V0>'O#V[9>WJ<=8XB.ON?\ "NMH
MHKRZE1S=V=D8J*L@HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "JU[_J8_^NT?_H8JS5:]_P!3'_UVC_\ 0Q36X,LT444@"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** *UC_ ,>Q_P"NLG_H;59JM8_\>Q_ZZR?^AM5F
MF]P1YE\, )/$_C">3_7&\P>>@WR?Y_"L[5K!-6^,U]ILAPEUI[1$XZ9AX/X'
M!_"M*P0^$?BW=PS*4L->&^"3MYN<D?7)8?\  A71_P#"'?\ %P/^$J^W_P#+
M+R_LWD_[&W.[=^/2D!Y@GB&XF^&D?A53_P 3-[\6(C)^;9NW?ENPM;NF6,>F
M?&RTL(?]5;6"Q+]!#BNBA^&UK#X\;Q*+W,?FF<6GD\!R.N[=_>.[I6A_PAW_
M !<#_A*OM_\ RR\O[-Y/^QMSNW?CTH XC2;.WU[XU:S'K,*7*P))Y44Z@K\I
M55^4\'Y23^M.T6*+1?CI=Z?IB+#:2QD/$GW1F,.0 .GS?E75>)OAY!KFKKK%
MAJ=QI6I@ -/ ,[L#&>""#CC(/2I?#/@*#PX;R[&H37FK7491KV=<[<]PN<]<
M$Y)SCM0!YSJOC&Q3XN-J]^DTUEIQ:"%8%#$E01GD@?>+'\JL_#_Q+9+\2]12
MT$L=AJ[,8TE4*ROG<,@$CNP'/<5W_@OP-#X2BO-]V+ZXNG#-*T.S ';&3W)-
M,\3>!%U[7--U>UOQ875D0<B#?OPVY?XAC'/YT 2^(_!\GB77]/GO;M7TFV5M
M]EMQN<@C=GOV^F/<U;\':%>^'-#&FWE^MVL<C>20I'EH3PN>_P"0QG%=!3)9
M8X(7FE<)'&I9F)X '4T >:V.(/CUJ"Q=);/]YCL=B'^@KTVO-_A_#)KGBG7/
M&$D;+!</]GM"V?F08R>?95'UR.U>D4 %%%% !1110 4444 %%%% %9/^0G/_
M -<8_P";U9JLG_(3G_ZXQ_S>K--@%%%%( HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *YN;PE81P2.)KG*J2,LOI]*Z2HKK_ (])O^N;?RJX3E'X63**
M>Y@Q^$-/>-6,USD@'[R__$T[_A#]/_Y[77_?2_\ Q-;T/^HC_P!T?RI]5[>I
MW%[./8Y[_A#]/_Y[77_?2_\ Q-'_  A^G_\ /:Z_[Z7_ .)KH:*/;U.X>SCV
M.>_X0_3_ /GM=?\ ?2__ !-'_"'Z?_SVNO\ OI?_ (FNAHH]O4[A[./8Y[_A
M#]/_ .>UU_WTO_Q-'_"'Z?\ \]KK_OI?_B:Z&BCV]3N'LX]CGO\ A#]/_P">
MUU_WTO\ \31_PA^G_P#/:Z_[Z7_XFNAHH]O4[A[./8Y[_A#]/_Y[77_?2_\
MQ-'_  A^G_\ /:Z_[Z7_ .)KH:*/;U.X>SCV.>_X0_3_ /GM=?\ ?2__ !-'
M_"'Z?_SVNO\ OI?_ (FNAHH]O4[A[./8Y[_A#]/_ .>UU_WTO_Q-'_"'Z?\
M\]KK_OI?_B:Z&BCV]3N'LX]CGO\ A#]/_P">UU_WTO\ \31_PA^G_P#/:Z_[
MZ7_XFNAHH]O4[A[./8Y[_A#]/_Y[77_?2_\ Q-(_A#3U1B)KG@9^\O\ \371
M4V3_ %3_ .Z:/;U.X>SCV.<M_"5A+;12--<Y= QPR]Q]*D_X0_3_ /GM=?\
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MA^G_ //:Z_[Z7_XFNAHH]O4[A[./8Y[_ (0_3_\ GM=?]]+_ /$T?\(?I_\
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M(?I__/:Z_P"^E_\ B:V+#_CRC_'^9JS0ZU3N"IQ['/?\(?I__/:Z_P"^E_\
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M "$Y_P#KC'_-ZLTV 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBHF-QN.Q8MO;).?Y4
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M96'&#_$?\*+ .L_^/&W_ .N:_P JGJG:FX^R0[%BV^6N,DYQCZ5+FZ_NP_\
M?1_PH:$3T5!FZ_NP_P#?1_PHS=?W8?\ OH_X46&3T5!FZ_NP_P#?1_PHS=?W
M8?\ OH_X46 GHJ#-U_=A_P"^C_A1FZ_NP_\ ?1_PHL!/14&;K^[#_P!]'_"C
M-U_=A_[Z/^%%@)Z*@S=?W8?^^C_A1FZ_NP_]]'_"BP$]%09NO[L/_?1_PHS=
M?W8?^^C_ (46 GHJ#-U_=A_[Z/\ A1FZ_NP_]]'_  HL!/14&;K^[#_WT?\
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M@ HHHH **** "BBB@ HHHH *BNO^/2;_ *YM_*I:BNO^/2;_ *YM_*@!T/\
MJ(_]T?RI],A_U$?^Z/Y4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "FR?ZI_]TTZFR?ZI_\ =- $5G_QXV__ %S7^53U!9_\>-O_ -<U_E4]
M# **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *@O/\ CQN/
M^N;?RJ>H+S_CQN/^N;?RH0$L?^J3_=%.IL?^J3_=%.H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K6'_ !Y1_C_,
MU9JM8?\ 'E'^/\S5FF]P04444@"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7O^IC_P"NT?\ Z&*L
MU6O?]3'_ -=H_P#T,4UN#+-%%%( HHHH **** "BBB@ HHHH **** "BBB@
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M_P ?YFK--[@@HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 56O?]3'_ -=H_P#T,59JM>_ZF/\
MZ[1_^ABFMP99HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%<;XN\8W?AG7-.B2TCGT]XVEO&"DR1H&"[EY[;@3P?PH [*BH#<H]
MB;J!UDC:/S$8'(88R#]*H>&-4GUKPSI^I7*1I-<1!W6,$*#GMDD_K0!K4444
M %%%4;'5K;4+R_MH-Y>QE$,I(&"Q4-Q],X^M %ZBBB@ HHHH **** "BBB@
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MI[?-Y,S1AUPL?]X>I_I3$SI:;)_JG_W33J;)_JG_ -TT"(K/_CQM_P#KFO\
M*IZ@L_\ CQM_^N:_RJ>A@%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %07G_'C<?\ 7-OY5/4%Y_QXW'_7-OY4("6/_5)_NBG4V/\ U2?[
MHIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% %:P_X\H_Q_F:LU6L/^/*/\?YFK--[@@HHHI %%%% !1110 4444
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MM(I)&QU8J"36E6?H=C+IF@:?83,C2VUM'$Y0DJ2J@'&>W%:% !1110!6L?\
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M0I &#D#GCMF@#&\)0MI.O^)M!LG<V5GY,EI%(Y;RC(A)4$Y.,@5RUA'X1N=
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M4 %%%% !1110 4444 %%%% !1110 4444 %07G_'C<?]<V_E4]07G_'C<?\
M7-OY4("6/_5)_NBG4V/_ %2?[HIU !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% %:P_P"/*/\ '^9JS5:P_P"/*/\
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M7_XFC_A$;#_GM<_]]+_\36_10!BVWAC3[:X6;,LA4Y"R$$9_ 5M444 %%%%
M!39/]4_^Z:=39/\ 5/\ [IH BL_^/&W_ .N:_P JGJ"S_P"/&W_ZYK_*IZ&
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!>?\>-Q_P!<
MV_E4]07G_'C<?]<V_E0@)8_]4G^Z*=38_P#5)_NBG4 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5K#_CRC_'^9JS
M5:P_X\H_Q_F:LTWN""BBBD 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !5:]_U,?_7:/_T,59JM>_ZF
M/_KM'_Z&*:W!EFBBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6L?\
MCV/_ %UD_P#0VJS5:Q_X]C_UUD_]#:K--[@@HHHI %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 5D_Y"<__7&/^;U9JLG_ "$Y_P#KC'_-
MZLTV 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*Z_X])O^N;?
MRJ6HKK_CTF_ZYM_*@!T/^HC_ -T?RI],A_U$?^Z/Y4^@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "FR?ZI_\ =-.ILG^J?_=- $5G_P >-O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@"M8_P#'L?\ KK)_Z&U6:K6/_'L?^NLG_H;59IO<
M$%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"LG_(3
MG_ZXQ_S>K-5D_P"0G/\ ]<8_YO5FFP"BBBD 4444 %%%% !1110 4444 %%%
M% !1110 4444 %177_'I-_US;^52U%=?\>DW_7-OY4 .A_U$?^Z/Y4^F0_ZB
M/_='\J?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !39/]4_\
MNFG4V3_5/_NF@"*S_P"/&W_ZYK_*IZ@L_P#CQM_^N:_RJ>A@%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %07G_'C<?]<V_E4]07G_ !XW
M'_7-OY4("6/_ %2?[HIU-C_U2?[HIU !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% %:P_X\H_Q_F:LU6L/^/*/\?YF
MK--[@@HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 56O?\ 4Q_]=H__ $,59JM>_P"IC_Z[1_\
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M  B_QA_Z&_3/S/\ \9H]DOYD'.^QZW17DG_"+_&'_H;],_,__&:/^$7^,/\
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M_P 8?^AOTS\S_P#&:/\ A%_C#_T-^F?F?_C-'LE_,@YWV/6Z*\D_X1?XP_\
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M9^9_^,T?\(O\8?\ H;],_,__ !FCV2_F0<[['K=177_'I-_US;^5>4_\(O\
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MP_\ 0WZ9^9_^,T>R7\R#G?8]2L/^/*/\?YFK->11^%/B_&@1/%NF*HZ#<?\
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M'J#D?\L:?LE_,@YGV/7:*\D_X1?XP_\ 0WZ9^9_^,T?\(O\ &'_H;],_,_\
MQFE[)?S(.=]CUNBO)/\ A%_C#_T-^F?F?_C-'_"+_&'_ *&_3/S/_P 9H]DO
MYD'.^QZW14-JLR6<"7#AYUC42,.C-CD_G16)9-1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !14-S>6UFL;75S# LDBQ(97"AG8X51GJ2>@
M[U-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%5Y;ZT@NX+26Z@CN;
M@,887D >3:,MM7J<#KCI5B@ HHHH ***:)$9V174LF-R@\C/3- #J*** "BB
MB@ HHHH **HW&M:5::A#I]SJ=E#>S_ZJVDG59)/]U2<G\*O4 %%%% !112,R
MHI9B H&22>!0 M%(K*ZAE(92,@@\$4M !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!X_\3+'Q"VN13Z;)<6EM)?V2)+=W2R023[AL,46QS&5/WFX!_NMUJWXKMKV
MU^ NK0ZC!?0W80^:M]>"ZD)\X<^8, @]1@# ["O5:XGXN_\ )*]>_P"N*_\
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MPO;2X:UO+25@QAE7&0&'##D8-8?A#_DIWC[_ *ZV?_HDT?#[_D8_'7_8:/\
MZ+6@#O:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
=** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0T!WL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSY9J)M=<''EF@9O45B)K3M_RS-#ZTZG_ %9H%<VL49K#_MU_^>=*=;?&?+-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH **** "BBB@ HHHH **** $S12,V!0K$U-K@+1111RA<*6BDXIV: 6BBBF
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC(8&H!JT9.&8"L+4)VCMU())(J@ELUS%O+E: .O;48PN8V#?0U4CUY6N/+;
MK&L+8Q!L2%ZJ7-DWV@N&.: .Z2YB90584K740'WA7%1WLUHA!R:I#4[B:X(
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M6L6U/2F)HM#I2T44AA1110 4444 %%%% !BBBB@#%UO1H]0M73 R1UKRF_\
M#M[H-PTML)'R<X%>VECG&*BE@B<?-&K?44 >16_B?68X/*-G)]<5T6A+<:Q"
MXNX2I(_B%=Q]AM<9\A/RJ2&&./[D87Z"@#QK5_!<]IJ+W<!<\YP*GL];U?3T
M\O[-(V..E>P211L/F0'\*B6SMFZPI^5# \TLM=U2>?Y[9P/I6Y<V]Q?V$F]6
M!(Z5V0LK=>D2C\*7RT' 08^E*W0#PRRL[_1=6DGCMG;YO2NE@\5:M)<*ALW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ICQAQT%/HH I26
M*O5<:6,]:U:*=Q6,O^R5)ZT-I"MWK4I#1<+(RQI"CO3ETI1WK3HHN,S/[)7.
M<TR31E<YW8K6I#TI7 S$TE5[TXZ<,]:O!SNQBGXIW$9_]FKCK3#I"ELYK3I:
M ,PZ2I'6D&E*.]:E%(+&6VDJ>](-(4=ZU:*!F6=)4]Z1M(4KC=6K10%C,CTI
M44C-1_V*N[.ZM>B@#,&E+C&:1=(13G-:E% &<=+4CK3%TA0>M:>:*!:&:VEK
MCK3!I()^]6M10,S#I2E<9IG]CJ/XJT]QW8Q3Z ,I=(4'.:5](5N]:;' I%)-
M 6,Q=)4=Z<=*4]ZTZ*!6,L:2H[T?V2N<YK3Q2T 9ATE3WH_LE<8S6G10.QF#
M25'>D_LE<YS6I10!EG25)ZTITE2.M:=% &8-)4#K2#25!ZUJ44 9?]DKG.:4
MZ2I[UIT4 9G]E+C&:!I*CO6G10!EC25SG-*VDJW>M.B@#*_L=?6IHM-1/>K]
M% $,=NJ=JF Q110 4444 %%%% !1110 QF(/2G#I2T4 %%%% !3&..U/HH 0
M<BEQ110 C#(I%7;3J3-  QP*9N/I3B:I76HP6J$NZ@CU-4A,LM\_7BE1 !UK
MB=2\9B$D18;'I6='X]N,X,?%7R.P)GI(0"C'/6N/T_Q@+H@/@5T<%_!)'O,@
M'XT.G):L+EXCWHQQBJ3:I9]#.OYT]+ZV;[LJG\:SLRNA:5<4ZF)*C_=8&GTA
M!@"BBBA@)2TE%2@%KG_$.F"^A/'05OGI49&\$$5I%V=Q,\.U2RDM+DJ$. ?2
MJ(G>/JM>P:IX<BN=SX&:XS4_"[H3L0G\*]"G631FT<?+.67.*K*S,V<8K>E\
M/W2](6/X5!_8UX.?(;\JZ54CW(L1PSE$'%7H;C<M9TUG>H,&!ORJ%9KB'Y6C
M(JN>-@LS;\_WJE<7&'JIY\G4*33?+N9SD1L?PJ)317*PF9IR HKMO"NGY",R
M?I67X=T.>ZF'G1%1GN*],TS2DM(@ .E<E2JDBT:$42+&N%'2IAB@# Q1BN%L
MH,4M%)GFD M%%%)#"BBBF 4444 %%%% !15>2Z6/J15234L?=YH%=&G16*VK
M2#HM,_MB;NE S=HK#76)2>4H.L2 _=H W**Q/[8D/W5S2?VPX'*\T ;E%8:Z
MQ*?X*#JTPY,?% &Y16%_;+GHM..KR@9V4["N;=%8BZO*PX2D_M:;/*46"YN4
M5A'69,XVTK:O*HR4HL%S<HK#&L2$9V4#5Y3_  4@N;E%87]L2YQLI3J\O9*!
MFY16&=8DQ]WF@:Q(?X*!7-RBL+^V),_<I3J\O9*!W-RBL,ZR^/NTHU>4C.RG
M85S;HK"&L29^Y1_;$F?NTK#-VBL/^UY3]U,T?VO*!RE KFY16&-8D/\ !2?V
MS)G[E S=HK".LR9X6G?VO*1PF: N;=%8G]K2CJF*0:O,3]R@#<HK".LR X*T
MO]L2=DS0!N45A_VR_3;S1_:TP^\F* N;E%87]LR9^Y2G5Y>R4 ;E%89U>3'W
M*!K$F/N4["N;E%88U>7/*4'6),_<HL,W**PSJ\N.$H_M>3'*4A7-RBL,:Q)_
M<I#K$O\ <IV&;M%87]L2]DIQU:3'W.:0&W16(-7EQRE(-7ESRE &Y16&=7ES
MPE*=7EQPE &W16(NKN>JXJU%J&_KQ0!HT5 ERC?Q"I@P/0T +1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 &!1110 4444 %%%% !1110 4444 %%%%
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ME+O'6L:^+?:#Q5_2J;6@)&O1114C"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBC- !129%&10 M%%)D"@!:
M*,T4 %%%% !1110 4444 %%%% !1110 4444 %%%)D4 +1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)D&@!:***
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MK:K&XSPU>(+XDU>XE\Z6W='!^[BNY\*Z[J%\"MQ R!1QD4 =R(T'113)69>
M*XB\\6WT&K?9DA)7.,XKJM/O)KF(-*F.* )MJQGS)&Q]:DCNHY1^[8-]*R-:
MF=X60<?2J^@QM%"Y))^M &]))M&5Y-/AD9U^88KF+G698;AE5<X-6X-9F> L
M4P0* .@ &>M!3)S7+VNO3/<,K+@"L;5/'%U9Z@L"1Y4GK0!Z$65!R:4,&'!K
MF;#6?[0B#2':<5GS>)KBWU 6\:;ESUH [1WVU'O7KFJ=K-)=1AI%VY%5[R7R
M<[3DT :ZR!N]*$YS6/I]R\B,S#&*BAUMGOS!C@&@#==B.@IB2,S8(K&U369+
M20*JYS6?=^(;J*W\R.+)Q0!UA4$]:CF=HU^49KSN/QKJ37BQM;D*3Z5U<FM,
MEFLC ;B,XH VX79URPQ3V ->=7/C+5([K;%:DQYZXKHM'UN744^=<,!TH Z%
MB43*\U#$[RGYABN+U_Q3J6FR,(;8LH[XJ;PIXIO-75S<0[,>U ':/E4XJ-'(
M!S7%:WXOO;.5H[>'>1V%&@^);Z__ ./R Q?44 =FD[M)C'%/DO((CAW -8FK
M:P]I8^9;+O?'05P4FNZA?78\^-HSGI0!ZP+F-_N,#3MQ/:N>T-)?*5VSTK/U
M;Q5=66IK;QQ94G% '6RS)!RS8IT=RDBY5@:Y/4KZYN+9'*$9%2VMZ(+ L&S(
M!PM '3EQGYCBI4(QP:X'_A(KZ2;;+"57/!K;_M>2'3_- R<4 =!([*>!3U)(
MR:\QN_'&KK/M@M"ZYZ@5U.AZW=WJ+Y\11CU% '39%+3"N[!IPQTH 6DQ2T4
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M<O;Z<Q"-(<J. <55L+>X>Z621&"YKM!I400# .*8T&!Y03CUQ0!A:PJLB"!
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M44 %%%% !1110 4444 %%%% !1110 4444 %)M'I2T4 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCQ46MV9O(  ,FM;&. *7:/3-" Y_2TGLP(]AVU:U72TU*,;^M:X52.@I0@%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HP* ,O[.PX XH^RLO05J8'I1@4 98M">2*M00[>HJW@44 (!BEHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% #6) XH&2.:&)QQ0#QS0 ! *=49F0=33!<H6P&H E8GM2C..::Q/:G+
MG'- "TF:6D(R* ,'5-5%K-MP*?I^JBY8 8J#5K"">?,C8YJ?3-.MH"&C;)JA
M&TI)'-.IA)!XIXZ4F,****0!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 44S)S3Z "D) I:8V.]- /HJ!Y0@ZU6:^PV,T^4#0HJO%<JXZ\U.#FE8
M!:***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB/1A19A<E&<<TM1B>,G -/# T68Q:***0!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 'I6!J^IRVP81]:WCT-<CK!/VKG[N: ,7^V=5FD8+&2*KKJVKQ70+Q
MD+72Z:]D#RPS3]8^R?8V:,C=B@"YHNJ27B@/UK;.<5P?A6]$<[B4X&>*[5;V
M&3A6!H G4GO2YIJ$FG8H Y/7UOC<?N$)&:?HJWHD'G(0*T[_ %.&UDVN1^-2
MVFHPW! 0@FF*Y?W#O3Z9L!.:>.!2!!1110,**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% #6)QQ32N]<-6;K-^UE#N4UR4GC&9&QNH [*33HLY"BH;N-+
M.U:4  BN6A\72M]YJS]4\5RW$;0ALYH ZK1M7EO960] <5TJYQS7 ^"?,:5F
M8=37?T -*@TN,"EHH Y77M/GN)<Q@D5%HNGSV\X+ U<UG4Y;63:G2F:3J<ES
M-AJ8F=(H..:=2#I2TAH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4A.!2U'+NV'% $%Q>QPCYFQ6!J*V5PC2;_ )^W
M-5_$,&H-&?LZDFN3%OKG0QM0!8GU"[LY"(3Q3H)7O'#2GYC5,Z?JS_?C-5H[
M#78[H;(CMH ]#T. Q8*UT8SM]ZYGPVMZBC[4N*ZF@!JY[TX]**9\V:>X'/ZS
MK#6<FT&H=+UI[N;:#6IJ&CVMXVZ:H+#2[*UFS%]Z@6ILQDD<T^DI:0PHHHH
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M>MIG;7BOPY##69-W]ZO:Q]SBIDV]RZ:7049-/%1INSS4E1<W2"BBB@84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD
M4444P"BBB@!IZ&N#\8LWDR>F*[P]#7!>,MWDR>F*UI;G/7^$Y'P"Q_M=\?WJ
M]GA/R#->+^ ?^0N^/[U>T0_<&:JJ11W)J***P.L**** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%(3B@ (R*Q]5DMH(6=^"*
MUO,4\9KFM>A,Z.@[T#1R%WK\#R,BOTK)ANXY]04,>":Z#2/"<4]RQG7@FKFH
M>%+>RS-$F,4".AT"*!(U,?7%;YSCBN+\-S2ER@Z#BNRCSM^:@ 7=WH^;-.+
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MHAI!2F@59/46BBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 (>AK@O&.?(D^E=X>AK@O&6[R),>E:TOB.>O\)R/@'_D+OC^
M]7L\/W!FO%O &?[7?']ZO:8?NC-75(H[DU%%%<YUA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD@US'H*YVC-/IJ_=%+7'U.Y;!S1BEHJA6"BBB@84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 AS@UP/C+=Y$GIBN])X-<%XRW>
M1)Z8K6DO>.>N_=.0\ G_ (F[XZ[J]GASM&:\7\ ?\AA\?WJ]HASM&:NJ947J
M3T4PL!UIP((XKG.T6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ IK(&'-.HH RK_1+:_0B9<BN/U#0=-MI3&%P*]%
M/(K"U;2DF1I%7Y^U '*6.A:0&RXJQJ&B:6MLS1#FLNZL]2BE8(.,\4^UT[6K
MA@'4F,T ;'@^!(I6"],UW-<_H>EM9#++@GK704 %)2TF* ,+5],-VQ.*HZ3H
MWV:ZWD=ZMZS<WD3'R>E4-)O+V6ZVR=,TTA'7*NT4ZF)G;S3Z0PHHHH ****
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MFEJ%%%%26)FEI,4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4E+24G< H[44=J4093O+CR4)S7F?BO783OB+\FO3;NW$L9!':O&/&VB7(
MO&EC0[ :ZZ+2.*LFRIX4U*'3[]I6;&37KFFZPMVBLC96O!-,L[F]N1'""6!Y
MKW#PII9M].43KA\5522ZDTHLZ9&64"I@,#BHXX@G2I:Y7:YVQV"BBBD4%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M "-G'%<[J][<1*RQFNA;..*P=7M)6C9U% '#7-]JAFZ\9KK+&ZNHM)\QR-P%
M<3J5U/:RG?Q@T^#7+RZM_L\3$YXH [G1-4GO)65FS@UTJDXYKC/"-C>0.7N!
MC/-=F1QQ0 ZF?-FE7/>G4]@,C4;RS@)$YJGIU_ILMQB _-3=<TJ2\<E5S6=H
M^A36EUO*XYH)ZG:@@CBEJ.+(7!J2D4%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4E+12L 4444P G%4KF9ESM-3N6K*O967-5%7 @GO&Z
M\U%'.[=ZIN2[<=:F@5@?FK5(ALMAY#UJ1)G4]>*<I3;S3& )XJU%";U+<4SM
MC::OQEBG/6L=-Z'*UHP2DI@]:QFK,T3NBR-W>HY(A(,,.*D7/>@YJ4R)HX#Q
M/X7:]N5:./(S6MH'A]+&-&*885T_EAOO"EQC@5?.[6,E#6XY1Q3J:/>G5D;H
M*:V>U.HH&(N<<TM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""XNH[=<N<"JC
M16^H1$XR#69XJF:*VRIQ5/2-65-/(9_FQ0!%JGA:S<Y1.:BLO"R C<GR4R?6
M93+R_&:WM.UF#[.!(PS0!;L-*M[$#R%P:U%SCFJMM=PW'^K.:MT %(:6DQ0!
M@:Q;7DV?)Z5E:5IFH07F^3IFMC6-1>T!(/2L;1O$3WE^8BV>:=Q:'81,P4!N
MM34Q1D FGT,84444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP>*Y\:B9#\YXJ[#?QJ.#2T WATI-XSBLZ.\,OW35Z+D9/6D*Y+1110,****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 '2H)&/\-/8,34;(_:@"%IG0<FH_,BG!$G-3>0S?>IPM$'
M:J3 Y;7/#5C>PL5B!8UYW?>!-15R;2/"U[A]F3'2JTUN^<(/EJE*VP'SS?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5+THHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M110 4444 %%%% !1110 4444 %%%(6Q0 M%(#D4M !1110 57FAW]JL44T[
M8\^DI+U450D\/1$_<%=,:82,\U:J,EQ.8'AY0>4&*NP:,D8^X*W,#%* .U/V
MK%R(J6]J(N@JV**6LV[E)6"BBBD,**** "BFEP#3AS0 4444 %%%% !1110
M4444 %%(2 * V: %HHHH **** "BBF[QG% #J*** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH \X^(7W:Y?PI_R$D^M=1\0ONUR_A3_D))]:W7
MP')+XSVB'_4KCTJ04R#_ %*?2I!UK!G0AU%%%!84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%-9@HR:1) _
M2@!]&,444 %%%% !1110 4444 %%%-WC.* '4444 %%%% !1110 4444 %%%
M% !1110 4444 %%(6 H!R* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M* +.[:O-,+'KVJM!?PSML##(]ZMY4C&1B@!$E#\"I*C41KT(IY88S0 A8"@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ,+Q%=R6MOF-L&N'-KK6I2>9%,=GUKJ/&D<KVG[LUS>D^(DTVW\J8,6^
ME $D=M-IQ!OCNKL](BMI[<21J*\\U?7TOL;0WY5KZ7XK@L[#RR&W8H ] "GH
M#4HZ5RVB:V=3<[2>O>NH3.WFGT =2'BEHI 9>HZ@MO&W7.*YJPUEIK\J,XS7
M6W=M;O&QD -8MHFG"[(C0!LTTQ&];/O0$U8J!% 'R]*G'2AC"BBBD 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6O+6*[A,4BY4]:YY/
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MV]I%;P^6J@"K5,(.: .<UGPK8:N?WT*M]145OX#T>*$+]E7\JZH#%#9QQ19
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M6XU)HLMP:I$W.TMMT:A7.35L<BJUL-R M5FDQH****0PHHHH **** "BBB@
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M)FC-,!:*,T4 %%(:* %HI**GF 6BD%+30!1113 **** "BBB@ HHHH ****
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MQ#O1Y QG%'U&)7UEGK0^(VG'H#2?\+(TW/0UY.L0QQ2>2I/2E]1B'UAGK/\
MPLC3<]#2_P#"QM.]#7DIA53R*-@Q1]1B'UAL];_X6-IV.AI!\1]./0&O)?+%
M C7TH^HQ#ZQ)GK7_  L;3L]#0WQ'TX=C7DNQ<]*#&.]'U&(?6)'KG_"QM.VY
MP:0?$?3CV->3", <]*/+4_=%3]2B/ZPSUC_A8^FYZ&C_ (6/IOH:\E\M<]*/
M*7TJE@(A]89ZU_PLC3?0TY?B)IS=,UY'Y:CM1]DD?E#@4/ Q'[=L]EB\;V,Y
MPIK7M-:M[G&T]:\"V7,/*N1BM72-<N8+M$:0XSZUA/"I&BJ.Y[XK!AD48.:P
M-!U$W<2Y;/%=!7%.'*[&Z=T%%%%2,**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHI#0!5O7CBA:1A]T9KF;#Q1;W6HM;!3D'%=#>V[3J5S\IZUDVV@6T%P
M94"!R>M,DZ".52!BIJ@@BVKS4])E!1110 4444 %%%% !1110 4444 %%%%
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M?#^_:X;:2>*]+'2O*_AP@$IQ7JM>16OS:G=3V"BBBL2PHHHH **** "BBB@
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MN"V/6I;>YI!HXN&RB@NL%1UKM[:.SATX2R1C&/2N4MHB]T=S _-72Z@5312
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/<T;3US05(ZFC)II"W $BD/-+@FCI56[#$ (I23ZT4F#0T@%VD]#0 >U&30
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12,,BD
M4$=30 ZBD)Q3.6.::0$E,=U5<DBFRG"=<5R6N:HT*LBR<_6KA!RV)<K&_-JT
M,)P6'YU/;W<<Z[@X_.O%[[4+UY6(F;&?6D@U^]MQ@S-^=;>P;V%S'N7FQ_WQ
M^=&Z,GAA7C*>*+I^DK?G6G8^)IO, >1C^-2\/)#YCU4\C@U6V.K[B>*RM'U4
M7*#DFMT$.*PE!IZCO<KW$:W$#*>X[UR\'AX1WS2[EY-=->JPMW*'!Q7"!]0:
M_8>8VW--".[ME$"8)%4]7U)+:(D-V]:SC<RV]@Q=CN KSK5=<GEN'0R,1FMJ
M=-R=T0Y619UK4WGG)#G%8H:1V^5L4A225=Y:HHY"C5Z=&F3SZ%R.[N8#Q(>*
MM+J5S+]Z4G'O5<SQ>3R.:IK=JI(Q6LJ:$I7.CL=4N4D \TX^M>@Z#=O<0_,V
M:\AB9R^X'BNW\-:N+<*CGDUYE>!<9GH(#;NM2U#;2B:(..]35Q6L:(****!A
M1110 4444 (:YOQ?;M<Z:R+Z5TA%075LMQ&5(!JHNS)DF?/EU;R6;,ISUJM:
MY:;YC7IGB+PT9')117$W'AN[A<E<UZ=&H<4X7*LT1*Y#"J:HP;K5W^QKYCU:
MI1H=T@R0:ZU65M3'V11YI3GUJ]_94_\ =/Y4G]DW']TT_;P'[-F?M;.<\4\9
MJ]_9-P/X3^5']E3G^$_E1[> >S90H^M7O[)N/[IH_LBX_NG\J7MX![-E+MUH
MY]:N?V/<YZ'\J=_9%Q_=/Y4_;0#V;* ZTIJX=(N>P-']CW/H?RH]M /9LI8/
MK2\^M7/[)N5ZJ?RI/[)N2<X./I4^VB4J12(/8TH!]:NG2KANBG\J/[*N,8VG
M/TH]M#N'LV4R#ZTW:V>M71I5PO53^5']DW.<[3^5'MH=P]FRISZTA![&KATF
MY;D _E2_V5<'@*?RH]M$/9E( ]S2\^M7/[*N!QM/Y4+I%R#D@_E1[:(>S*6*
M7D=ZN'2+DG.#^5!TBY/8TU6AW%[,I4N/>KG]CW&/NG\J!I%R.H-'MH=P]FRG
MDXZTG6KO]CW.>A_*@Z/<]@?RI^VCW#V;*?3O03ZU<_LBYQC!H&CW..0?RH]O
M'N'LV4\>]'XU<&D7(/0T?V/<GL?RH]M#N'LV4J7%7#H]SV4_E2C2;C&-IS]*
M7MH J;*6<=:.M7/[&N1U!_*C^Q[D'H?RI^VAW'R/8IXI-PZ5>.CW+= ?RI/[
M'N/[I_*CV\&'LVBGBC..M71I%R!@@_E2?V-<]2#^5'MX![-E+KTI<5<_L>YS
MP#^5*=(N2, '\J7MH+J'L[E'<.E+BKG]C7']TY^E.&CW*]0?RI^VB'LRCSZT
M8J[_ &-<YS@X^E!T>Y/0'\J7M87#V;*.,4=>M7O['N,8VG/TH&CW(Z@_E4NI
M$/9E1=\?S*V*OVVMW=MPLK ?6H/[)N@<D'%/&DSD9VG\JCG@]P4&:)\373K@
MRM^=9\^IRR-N+DFF'2+AN I'X4HT6Y[@U#E ;ILDM]9N8#\LK#\:L'Q%>+\W
MG-^=4SI-PG53^5*=)G=/NG\JJ/LF]04&B>3Q#<W2E3*WYUFVL\\6H"8N>M2I
MH]PC?=/Y5.VG3>7PAS]*OEHE\K+NH:[/(JJ)6_.JEKJUU;R>896Q]:K+I=R3
M\RL?PJS_ &3.R8VG\JGEHCY7<CO]2EOY Y<G'K4UKK4T  5R,5$-&N /NG\J
MC&CW!;[I_*DXT1<KW+DOB>\#X$S?G22:U?3KCSV_.JQT2<G)4_E3AI5Q'_"?
MRJ>6B'*QUE'>RWRN9CU]:[L6=_<0((KG;@>M<1!;W44H8!N*UCJMW"@"[Q64
MX4_LLJ,3L+(7-E@SS[L>]8_BK6(9$QU.*PI-2O9TP"^:S9+"]NCERQ^M*%.%
M]35HSXM0FCO-\;D#-;']O7QQ^_; ]ZH/HMQ'SM/Y4L>F7+#[I_*MU&!DT:C>
M(9WCV>:V?K6)<7MPUTK^8>#4QTJXS]T_E2G2IR.5.?I6BC SY&7FUR<VP3S3
MP/6L5IKA[L2^8>#5J/1[K?R#BIFTF=5^Z?RIM00N1E[_ (2"=( @E;@>M8=U
M/-=3;V<FIAI5S(W1ORJ?^RIPNW:<_2HM3'R,SQN&"#6A;ZW<VH 65@![TS^Q
M[E>H/Y4TZ)<'DJ<?2JM GED73XBO)R")FX]ZG'B>ZC3:9F_.LY-,FC'W#^51
M/ID\AP%/Y4<M-H+2'7M_-?-YA<DBC3]7N[>7'FM@>]30:3/&N&4G\*2;2I4&
MX(?RJ7&F"YS0?Q#<XR)F_.LR]U:XO<*9"?QI$TRYD'W3^5!T>X'.T_E4<M,?
MO'H?A*81Z<-S#.*B\3:R]JGR2$?0UR-I<WEJHB&\4M]!=WB_-N/UJ%3C>[*]
MX9+XCNI8R/-;'UK)FN9KAL[S5L:/.%Y4_E4;:9.#PI_*MU&D)Q;U&VT\T)!#
MG-: \0W<(P)F_.JB:=<=-K?E3CI,[=5/Y535$7*RQ_PDUV3S,V/K5&>^GN9A
M)O/%/_L6<'.T_E2_V9.!PI_*DHT;C<&RW'KUQ%&%$K#'O5@>);CRBIE;/UK*
M_LBX<\*?RIITNX5MNT_E1:CN'LV/EU>YWY\UOSJ^=;GDL#&9#R/6J2Z-.1DJ
M?RJ,Z3<A\ '%%J+#V;*<,EPDQ=7(YS6[%XEN(H/*\UL_6JHTJ;;]T_E55](N
M/,^Z?RHM1'R%N36;J1\F5C^-3MK]SY&SS6_.J2:7.HY4_E3?[*N-V=IQ]*.6
MB+D93GNKF682"0\&MBU\174<0C$K#'O4*Z3,5^X?RJ'^R)]_"G\J+40Y&:#^
M)+KH9F_.LZ_U.XNEP9"?QI6TBX_NG\J='HUP#\RG'THM1!P)-,U">W4'S#Q4
MFKZM->1A1(?SJO+IERH^53^50Q:5=2-R&_*BU%AR-#;*2:"02[SQ6K/K\LB;
M2[53_LRX'R[3^5)_8\_]T_E3YZ<=B'!E>6>25LEB1483/-73I-P!]T_E3!I5
MRW0'\JKVT!>S97)&,"F&KATBY/&TY^E*-'N0.0?RI^WB'LV4L4O;K5S^Q[GN
M#^5']CW/H?RH]M#N/V;*7XT=ZNG1[GLI_*C^R+C'0_E2]M 7LV4S]:3%71H]
MSW!_*C^Q[GT/Y4_;1[C]FRGR.])U-73I%R>QH_L>XQ]T_E1[:/</9LIX]Z"3
MZU<&D7([&C^Q[G/0_E1[>'</9LI 9I<5=_LBX_NG\J0Z1<GH#0JT0Y&4\48J
MZ-(N1V-+_9-Q_=/Y4>VB'(RCCWHQ[U<_L>YST/Y4'2+D] ?RH]M /9E/'O03
MZFKG]D7.,8- T>Y[J?RH]O'N'LV4\4<@=:N?V1<@]#^5!TBY/8T>VAW#V92Z
MTN/>KG]CW/8'\J/[(N<8P:7MH=P]FRF2>YI,9JZ-'N>X/Y4?V/<YZ'\J?MH]
MP]FRGR.])WJZ=(N3V-']CW&/NG\J/;Q[A[-E/'O1TJZ-(N1U!_*D_L:YSG!_
M*CV\.X_9LI9STI<5<_L>Y[ _E2_V1<$8VG\J7MH(/9W*6[%&,]ZN?V-<#JI_
M*@:1<@\@T>VAW#D*?3O29STJ\='N3S@_E2'1[CLI_*G[:#ZA[.Q3Q2U<_LFX
MQC::3^Q[D=0?RI>WA8/9LI&E&1WJY_9%Q_=/Y4O]CW!['\JS6(5P]G<HGGI0
M,CJ:N_V1<?W3^5+_ &1<>AK:.*1/LV4NG>E$189#5;&CW.>0?RIC:->%OEW
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MBM^[A,T)7U%<_#X?"732;EY-<C2L45M:N5D@;9P,5YG<X^TL2,\UZAJ^FO\
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MOY4?V+9?\\%_*M"BCF8<J,_^QK(_\L%_*C^QK+'^H7\JT**.9ARHS_[&LO\
MG@OY4?V-9?\ /!?RK0HHYF'*C/\ [&LO^>"_E1_8UE_SP7\JT*2CF8<J*']C
M67_/!?RI?[&LO^>"_E5^BCF8<J,_^Q[+_GBOY4?V/9?\\%_*M"BCF8N5&?\
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M6A11S,+(S_[&L?\ G@OY4O\ 9%E_SQ7\JOT4<S"QGG1K%O\ E@OY4#1K(?\
M+%?RK0HHYF%D9YT6Q_YX+^5)_8UC_P \%_*M&BGS,+(S_P"Q;'_G@OY4O]CV
M7_/%?RJ_12YF%D4#H]E_SQ7\J3^QK$?\L%_*KY%+1S,5D9W]E66?]0OY4IT>
MQ(_U"_E5_ I:+L$C-_L:Q_YX+^5-;1=//6W7\JT\48%*\@L9@T73^UNOY5*N
MCV0_Y8K^57L4A!I<\D.Q2.CV1',*_E2+HUB.D"_E5\"C%5SR"R*']C6/_/!?
MRI/[&L?^>"_E6A1BCGD'*BA_9%B/^6*_E0='LC_RQ7\JO$&@ BE[20610&C6
M*](%_*C^R+'.?)7\JNNK,.#2HI YI>TE<+%%M*L?^>"_E2C2+(C_ %*_E5QW
M1?O$#ZU&)XR<!Q^=5S2)O%%8Z+8_\\%_*@:+8#_E@OY5?!S2.3CBCGDAZ;E/
M^R++_GBOY4AT:R;K OY5<3/>GTN>0[(H#1;%>D"_E2_V/8_\\%_*KU%'/(+(
MSO["T_.?LZY^E._LBR _U"_E5_M1BCGD%D4/['LC_P L5_*C^Q;'_G@OY5H4
M4^9A9&?_ &+8_P#/!?RH_L>R_P">"_E6A28HYF'*BA_8]E_SQ7\J3^QK'_G@
MOY5HTE',PY2B-&L1_P L%_*FG1K$G_4+^5:-)BCFD%D4/[(L@/\ 4K^5)_8U
MB>?)7\JT",T 4<S%8H?V/9?\\5_*C^Q;'_G@OY5?Q2T<S'RHSSHUC_SP7\J/
M[&L?^>"_E6A11S,+&?\ V-9#_EBOY4?V-8_\\%_*M"BCF861G_V/8_\ /!?R
MH_LBR'_+%?RK0HI\S%RHSCHUB?\ E@OY4HT6P7I OY5H4Q@3T-+F8[(I'1;$
MG/D+^5']C67_ #P7\JOJ"!S2T<S#E1G_ -C61_Y8+^5 T:Q'_+!?RK0HHYF'
M*BA_8UC_ ,\%_*D_L>R_YXK^5:%%',Q<J,_^Q[+_ )X+^5+_ &/9?\\%_*K]
M%',Q\J*']CV7_/!?RI/[&LO^>"_E6A11S,.5%#^Q[+_G@OY4?V/9?\\%_*K]
M%',PY49_]CV7_/!?RH_L>R_YXK^5:%%',Q<J,_\ L:R_YX+^5']CV7_/%?RK
M0HHYF/E1G_V/9?\ /%?RI?['LO\ G@OY5?HHYF+E1G_V/9?\\5_*E_L>R_YX
MK^57Z*?,PY49_P#8]E_SQ7\J/['LO^>*_E6A11S,.5&?_8UE_P \%_*C^Q[+
M_GBOY5H44N9ARHS_ .Q[+_GBOY4?V/9?\\%_*M"BCF8^5&?_ &/9?\\5_*C^
MQK+_ )X+^5:%%',Q<J,_^Q[+_GBOY4?V/9?\\5_*M"BGS,.5&?\ V/9?\\%_
M*C^Q[+_GBOY5H44N9ARHS_[&LO\ G@OY4O\ 8]E_SQ7\JOT4<S'RHH?V/9?\
M\%_*D_L:R_YX+^5:%%',PY44/['LO^>*_E2?V-9?\\%_*M"BCF8<J*']CV7_
M #Q7\J/['LO^>"_E5^BCF8<J,_\ L:R_YX+^5+_8]E_SQ7\JOT4<S#E1G_V-
M9?\ /!?RI?['LO\ GBOY5?HHYF%D9_\ 8UE_SP7\J7^Q[+_G@OY5?HHYF'*C
M/_L>R_YXK^5)_8]E_P \5_*M&BGS,7*BBNF6J](E'X5,EG AR$ J<B@@XI78
M)(!@# I:8H(/-/I%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 -P<UD:V<6<GTK9K(UBV>:VD /
M4547J&YXO=#SM0D ]:@=6B?!-:>HV4EG=R2$'K64]QO?[IKTJ%2R,)IEB-]W
M!&:NQVBNN[:*J6^ <D5IK<(B5U^U1*B95[ L9^48IUM(6 1<YJ2Z?[2V%%:N
MA:2TLZY6LZE;0I1*T&D7-Q*IR2,UZ-H6CFUA1V'-7M.TB*%%+(":UU157 &!
M7FU:U]$:113O6;[*Y7J!7#6UU?-J;*7?;FO0IMBQ,6'&*P%OK 71 C7=GK7.
MY%)%R!#-;%)!DD=ZPK_PKYY9@!S766SQRIE *E88ZU<)N.P['E-YX,N58LAP
M*SFT2ZAXR>*]G\F.0<J*K3:9;R?\LQ^5;+$,GE/&383E]N#5NVT.XD=>O6O4
M1H=OOW>6OY5<CTZW3I&/RIO$!8P=$T;[+$LC 9KIHWW+]*-BA=H&!2J M82E
MS:L:%W<TN ::V,<4U7K,HDP*.W%'44TJ<]:! H.:<>E'04M #5!%.IK-MI00
M:0#6!IPX%!X%1B;+;<46'<EHI.U-#Y.*8A]%)2TK@)@4M)FBBX"T4F:,BBX"
MT45!+<B-L8HN@)Z*:C;ES3&F"MC%%P):0T!LC-&ZBZ 0 TZDS03@473 6F[N
M:%?=02!S3N@ FD&>M"L&[4K#(XHNAB]J3!!Y-(N1U-)("PX-),0\\CBHT1@V
M2::A*<&ILT7 6BBBBX!1113N 44447 ****5P"BBBG< HHHHN 44447 ****
M5P"BBBG< HHHHN 44447 **** "BBBBX!1110 4444KH HHHI@%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %(:6D8X% F<)XWU.:P7]VY
M'TKF?#GB"YN=15'D8@GN:W?'K(5^89KD?"T8_M="/6NA)<ISM7D>V0Y:%3ZB
MI<5%"/W"?2I2"16!LD XIU-4$=:=2*04AI:*!B44M% 6"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****+@%%%%*X!1113
MN 4444K@%%%%.X!1111< HHHHN 44447 ****5P"BBBG< HHHI7 ****8!11
M12N 4444[@%%%%%P"BBBBX!1111< HHHHN 44447 **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBBEU *8Z!U(/>E8$CBA01UI@<[JOAM+U
M3M49-<Z_@9EYP*]&J,D9P16D:K1+C<\MNO"DT(XK/_X1NZ9NIQ7K\D,3#YE!
MI@M;?_GF*U]OH'*CS6Q\*3,P+5W&E:,EK&N5&16I]GC7[H J91@5G*HV"W%
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M]="*5D,6DI:*+ )2T446 ****+ )12T46 ****+ %)2T46 ****+ %)2T46
M2EHHHL 444A;%%@%HI <TM, HHHI6 2BEHHL 4E+118 HHHI@%%%% !1110
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M<YS3Z *D=C%&^Y4 J5[>*3[R@U-3"I)H BCLH(FW(@!I9+."4Y>,$U,.!2T
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MNH3L<G,N;0[;3;(6\*C':KIST%<,OQ$MAQY9J4?$&V(^Y6;I3OL;J4;:,[=
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M) H[UOVE\ERH*D<T.G)(<9)ERBDI:@L**3-+2N 4444P"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<4R298T+$BLPZY&)"F.E &LH('-.JI#?),."*G3/7- $E%%% !1110 4444
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MZ;SK,,/2ME@37D5%9V.N+T'4M-4$4ZLXE!1115 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!3'1&."H-'G1R?=D!_&I% QZT@(=J0]%H6*,G?M&:G;;CYL5")8M^!(N?3-
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M.017*7^NI=2&VC.W=QF@#.TJXNK:?8\S/@^M=Y:71^R>8WZUS>D:)]G?SY)
MX/.*M:GK @A:%(S^% #=7\0&-66-2?I7+:?>W=QK 8R,%)Z$U<MM24%S+"6S
MZBLR'4HQJ^53'/2@#TZW5WC4[NU)J$K06V1DFHM*O1<1+QCBKLT:NOSD8]Z
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M* .(UG0Y+G5DE4\ UUNG0-#;(I/059$"9RP!-2  #B@!:*** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME2'P[:D<1)^56L:'L)'AQBN,X\EORI##<#_EBWY5[D/#MJ!S$GY4O_".VO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -0!WH# 2(  A$! Q$!_\0
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M4D,2PQA%[=3ZTP(?L\[<R7+ ^B# %+]E/_/Q/_WT/\*L447 K_93_P _$_\
MWT/\*/LI_P"?B?\ [Z'^%6**+@5_LI_Y^)_^^A_A1]E/_/Q/_P!]#_"K%%%P
M*_V4_P#/Q/\ ]]#_  H^RG_GXG_[Z'^%6**+@5_LI_Y^)_\ OH?X4?93_P _
M$_\ WT/\*L447 K_ &4_\_$__?0_PH^RG_GXG_[Z'^%6**+@5_LI_P"?B?\
M[Z'^%'V4_P#/Q/\ ]]#_  JQ11<"O]E/_/Q/_P!]#_"C[*?^?B?_ +Z'^%6*
M*+@5_LI_Y^)_^^A_A1]E/_/Q/_WT/\*L447 K_93_P _$_\ WT/\*/LI_P"?
MB?\ [Z'^%6**+@5_LI_Y^)_^^A_A1]E/_/Q/_P!]#_"K%%%P*_V4_P#/Q/\
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M_P!]#_"C[*?^?B?_ +Z'^%6**+@5_LI_Y^)_^^A_A1]E/_/Q/_WT/\*L447
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M>A8 _IQ7$:'X\U#PC8+HVKZ1,Q@R(BS&-@,]"".1[BNPLKNX\>^$=2BNK!K
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M##5)UIS6S2TMTUZ'1BJ<*,(/=-ZW>^G4T/A[HEG-XVO8Y%>9=/9G@D#8&5?
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M+?=U_$\S"J4JL:<O^7=_OZ?@<;XETOPQ-KUW+K/BV?:6REM&3*8?49^;'/;
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M^'E_0RA34:$*J^+F_4]8HHHKP3Z **** "BBB@ HHHH **** "BBB@ HHHH
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MUKANO&?@"]GN-)EL+JVD,D4,N2QV@$D94=06'2M;X?:N=6\(VI=LS6W^CO\
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M?@10G*G4G6>[CS?B6)?BW&99&M-"N9[2,_-,TNT@>I 4@?G79>'_ !'8>);
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M>]7IJO**?V6K^C5_T/GZ%5T(R:^TG;U3M^I4\*6<EGXTT$RGYIRLP'H&SC]
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M,9=_E;,9 &,9/I7045HJLE!P3T9FZ4'-5&M4%<KX7\&?\(WJM_>_;_M'VO\
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M?R<8RNW[V[^E=912>(J.4I7UEHQK#4E&,;:1U04445B;A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5SAZFNCKG#U-7$F1MV/_'FGX_S-6*KV/\ QYI^/\S5BI>Y2"BB
MBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>R:S=2S'43"+@'?\HR1A<=^#^==E\-+RXO/!L/VAV<Q2/$C,<G:,8_+./PH
MW/$&L1Z#H=UJ,@#>4OR(3C<QX _.LCP;=ZS>^&7U/5KOS9;@,\">6BB-!TZ
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M1K4.L:6+(7IU*S%J3M$_GKL)]-V<9KC/"_AB[\.>"]8:_"K<W4#L8P0=@"'
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MC&>U9XUW1VN1;#5;$SEMHB%PF[/IC.<US/AV_LW^%L$NN3XM#"\,KMDG;N*
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M+XD:C/:^$4NM/O)(F:X0"6WE*DJ0>X/2M+0];LH/#FD_VGJD$=U-:QN?M-P
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MX)[XS[T =7HT-^GCC4I)O$MM=6S!MFGI<;GCY&,I_#MZ9'7O4L_CK3X/%_\
M8CO D*H3+=R3A51\$[>>/3OU-<OX94/\7-<5AE668$?\"6LNT\-Z3+\5;C17
MM,Z>@;;#YC\?NP>N<]?>@#T#Q9*^I>&5ETGQ!:6 >48NS<[(W R"HD7ISZ>F
M*U]+?[/H-J]U?Q7.R!3)=[QL?C[V?3WKC/B)IMII'@"&QL8O*MX[I=B;BV,[
MB>22>IJAXCTS4]2^&F@?8(I)HX84>:*/EB-G!QWQS^= 'HMIK&EW\OE6>I6=
MQ(!DK#.KG\@:NUY/X-E\&7FK6&VQFT[5H6^5'E9HY7QCJ2>>^..?6O6* "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO??\>4GX
M?SJQ5>^_X\I/P_G36X,L4444@"BBB@"O_P Q+_MC_6K%5_\ F)?]L?ZU8IL
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M%=CX!NIKSP3ILL[EW",FX]<*Q4?H!0 OCC6I="\+W-S;2I'=,5CB+$9R2,D
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M;V]^V7MQPA\KRQ$/0#)SQ@?3ZT =+1110 4444 %%%% !1110 4444 %%%%
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MMD #'W@?6@#N:*9"Q>"-F.25!/Y4^@ HHJIJDTEMI%[/$VV2.!W1L9P0I(H
MMT5QOPYUS4M>T6ZN-3N?/E2XV*VQ5P-H./E ]:[*@ HHHH **** "BBN:\+?
M\)5]HO\ _A(O)\K</L^S9[YQM[=/O<T =+16-8>);+4?$%]H]NLAFLQF23 V
M'D @<YR"<=.QJKXM_P"$H\NS_P"$:\K=YA\_?LSCC'WNW7..>E '1T4U-_EK
MYFW?@;MO3/?%.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@"O=](/^NRU8JO=](/\ KLM6*8!1112 *KP_\?MS_P  _E5B
MJ\/_ !^W/_ /Y4T!8HHHI %%5[V]MM.LY+N\F2&",99W/ J'2M9T_7+0W6FW
M*SPABI(!!!]"" 10!>HHHH **Y/QA%)K4]EX:@D*?:MT]RP_AB3I^;8_*M+P
MKJ$FH:!#]HXN[<FVN%])$.#^?!_&@#:HKS,SW6B>*]9\00[Y+*.]%O?PCG$9
M12' ]5)_7ZUTWC61)?"Z21L'1[FW964Y!!D7!% '345S'BG_ )#7AG_L(?\
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M.TKA(884WR2L>RCN: +DUS!;F,3SQQ&5PD>]PN]CT SU/M4M<%KFO0ZI>:#
M;.]LKA=4B<0WD/ELR\C*\D$9(Z'O7>T %-=TBC:21E1%!9F8X  [DUF:QX@L
M]%,,<RSSW,^?)MK:,R2R8ZX6J<NL#5O#^K?\2_4+)HK9P5O(/+)RIY')!Z4
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MKJS\76^GQZ;?S6X@D9TBA4M*<C#+DCY1SSQUH ZVBH;6<W-K'.8982Z[O+E
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M^F"'R/,W'[F<XQG'7OC- '-:5>ZUXFM[B_BU6+3+5)GB2**!9' 4]79\@'V
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M>65U2-%+,[' 4#J2>PH =12*P90RD%2,@@]:6@ HHHH **** "BBB@ HHHH
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MK=UXG\,VT>JRZK!J,1E6.6S-LL2C<<?*P);@\<YZUJ>,;:>ZL]-6W@DE*:E
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M/$NT31MT;;V(/6N=\(V>O7WAX?8M733+>.>94VVRS-(=Y)8[N ,G&!Z=:W-
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MI6GFMJ.L/J#OPO[A8E0>P7O]32>']'_L+24L?/\ /VR.^_9M^\Q;ID^M:E%
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M=D&5W@BM%A\PJ<C<V2<9';%=/10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!7N^D'_79:L57N^D'_79:L4P"BBBD 57A_P"/VY_X!_*K%5X?^/VY_P"
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M?U>?6Q>W86); 3F*U*@[G"\,Q.<8)Z8 Z4 ;5%%% !139)%BB:1V"H@+,3V
MJI9WXU71XKZR^3[1%OA\Y<X)'&X _P C0!=HK(\.:PVM:5YTT:Q7<,C07,:]
M%D4X./;H?QK7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *KWW_'E)^'
M\ZL57OO^/*3\/YTUN#+%%%%( HHHH K_ /,2_P"V/]:L57_YB7_;'^M6*; *
M***0!1110 4444 %%%% !1110 4452U>_P#[+T:\OPF\V\+2!?4@9Q0!=HKE
M+(>*5TE=4^W1:A// LB6!A2)%+$'A^O SUZU<U?4;RU\0>'[6*39%=R2+.FT
M'< F0,D9'/I0!OT444 %%%% !16#K.HW=IXBT&U@EV0W4LJS+M!W )D<D9'/
MI6]0 45@'4;O_A/ETSS?]#.FF?R]H^_YF,YQGIVSBM^@ HHHH **IRZG;Q:O
M;Z8=QN)XGE7 & JX!S]<\?0U<H **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *YP]371USAZFKB3(V['_CS3\?
MYFK%5['_ (\T_'^9JQ4O<I!116#XL\40^%=-2ZDMWN'E?9'&K;03C/)YP/P-
M(#>HK(\-:_#XDT6/4(8FBRQ1XV.=K#J,]QTYK7H *SM5U[2]#C5]2O8K<-]U
M6R6;Z*,D_E6C7'^$(4U/4]8UZZ0/=&\>V@9N?*B3@!?3.>: -K2O$^BZU*T6
MGW\<LJYS&04?CK\K &M:N6\>6B?\(_)JL0$=_IY6>"<#YEP1D9]"">.E6(->
MN1XDL["YCB6UOK,36S@$,9!RR'G'3GH* .AHK#U+6;F'Q)I>CV21/)<!I;DR
M*3Y<*]Q@CDG@9JH=8US5KR[30(-/6VM)3 T]Z7/FR#[P4+T ]30!T]%<[8>(
MI[K2=6:>VC@U+3-ZS1!BR%@N58'@[3^=0:+J_B'7([&^BM+&WTV15,IG+^;)
MQ\Q11PHSD#).>M '4T5S!UC7-6O+M- @T];:TE,#3WI<^;(/O!0O0#U-2Z=K
M6HZKINHPQ06]OK5BYB>*0EXBW4$$$':P_*@#HJ*Y-O&)GT> 65NIUN>4VRV4
MG_+.9?O[L?PKUSZ8JQKFN:CH]SH]K%;0W=Q>LT3@ H"X48(Y.U<G)SGB@#I*
M*Y276]?T6[M6UVWTY["YE$'FV1<&%VZ;@W4>XQ_0S:OX@U"S\1PZ18V4=S)<
M6IDCW$J%;=@EF[*!D],DX'>@#I:*YVYUC5-&T:)]3AM+G5+B<06\%F65'9N@
MRW([DFJL^M>(=#D@GUR#39+"6587>S9PT)8X!(;[P^F* .LHKF]0UG59M?DT
M;1X[%)H85FDEO7;#!L\*J\G'<YJ>34]4TCP_?7^LV]K)+;*75;-VVR#'^T,K
MS]: -VJWV^U&HC3_ #T^UF/S1%GYMF<9_.L.RN?%MQY%R4T-[27:Q2-Y-X0^
MC="<>U3F_/\ PGBZ?]FM\'3C-Y^S][_K,;=W]WOCUH WJ*Y8:UKFL7MW'H-O
M8I:VDI@>XOBY\UQU"JO8>I-7=#UR>^NKS3=1MEMM2L]ID6-MT<BGHZ$\X^O2
M@#<HKC-*UWQ1X@T[[3I]KI< CD>-GNC)B1@3]U5Z#&.2>N>*VO#>LRZS83-<
MP+!=VT[VUQ&IRH=>N#Z<B@#9HK/UO5HM#TB?4)D:18P L:]78G  ^I(K#EU+
MQA9VC:C<:?I;VR+YCVD3R>>J]2-Q^4D#VH Z/4+^VTNPFO;R01V\*[G;&?\
M)JII&M?VOYF--U&S" $-=P^6'!S]WDYZ?RKF?&][-JG@RWO; P&QG>%V,H._
MEQ@ #C@]?QKK=,&IBW8:J]HTV[Y3:HRKMP.NXDYSF@"W)(D,;22NJ1H,LS'
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M>*/Y5/X\UU5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2)[N7RUEE6%#M)R[=!P*M4 %%%% !1110 4444 %1);6\5Q+/'!$DTV/,D5
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M1T608X.UAD$@\C(]:;I^HVNJ6@NK*7S82S*&VE>0<'@@'J* +5%%% !1110
M455T_4;75+075E+YL)9E#;2O(.#P0#U%2W-Q%:6LMS.VR&%"[M@G"@9)P* )
M:*BM;F&]M(;JW??#,@DC;!&5(R#@\U+0 4444 %%%% !1110 4444 %%%(S*
MBEF(50,DD\ 4 +15.[U2RLH[:2><*ES*L,+*"P=V^Z.,]?7I5GS8_-\KS%\P
MKNV9YQZX]* 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX]_Y$C5/^N:_^A"MBPN-/E@$6G3VTD,*A L#JP0=AQTZ5C^/?^1(U3_KFO\
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M+9: DUTN+R]=KNX_WG.<?@,"N@H **** "BBB@ HHHH **** "BBB@ HHHH
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M;VRN<L((E3/UP*9=:3IM],LMYI]I<2*,*\T*N1]"15RB@"*.V@BE>6."-)'
M5G5 "P'0$]P.U0MI>GM?"]:PM3=CI.85\P?\"QFK=% $4-M;VWF>1!%%YKF2
M3RT"[V/5CCJ?>JTNC:7/=?:IM-LY+C.?->!2_P"9&:O44 %1"V@%TUT((Q<,
MFPRA!O*]<9ZX]JEHH B2VMXYY9XX(DFFQYDBH SXX&3U./>JTVBZ5<11Q3Z9
M9RQQYV(\"D+GK@$<5>HH C\B+R/(\I/)V[/+VC;MZ8QTQ[4L,,5O"D,,:1Q(
M-J(B@*H] !TI]% %6\TRPU';]ML;:YV?=\^)7Q],BIXHHX(EBBC2.-1A41<
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M\8W=GIB:5>VVGPW FNYKR'RPP7HJ9Y.?45VM% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5SAZFNCKG#U-7$F1MV/_ !YI^/\ ,U8JO8_\>:?C_,U8J7N4@HHHI %<
MIXH\'3^);Z.3^VI[2U$8CDMD0E7P2<_> SSZ'I75T4 4-&T>ST'2XM/LD(BC
MY)8Y9R>I)]:OT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% %>[Z0?]=EJQ5>[Z0?\ 79:L4P"BBBD 57A_X_;G_@'\
MJL57A_X_;G_@'\J: L4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBJ]
MM?6=XTBVMU!.T3;9!%(&V'T..AH L4444 %%%% !1110 455M-3L+]Y$L[ZV
MN6C^^(95<K]<'BK5 !1110 4444 %%%% !15>.^LYKJ2UBNH'N(AF2)9 73Z
MCJ*L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5
M[[_CRD_#^=6*KWW_ !Y2?A_.FMP98HHHI %%%% %?_F)?]L?ZU8JO_S$O^V/
M]:L4V 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJE=:OIEC*
M(KS4;2WD89"33JA/X$T 7:*K7&I6-I;I<7-[;PP/C;))*JJV>F"3@TZUO+6^
MA\ZTN8;B+.-\3AQGZB@">BBB@ HHHH **** "BBB@ HHHH **** "BH;J[MK
M* SW=Q%;P@X,DKA5'XFI$=)(UDC971AE64Y!'J* '4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1154ZG8+?"Q:^MA>'I;F5?,/&?NYSTH M455
M.IV"WPL6OK87AZ6YE7S#QG[N<]*M4 %%%% !114-U=VUE 9[NXBMX0<&25PJ
MC\30!-134=)(UDC971AE64Y!'J*=0 4444 %%%% !115>:^L[>XBMY[J"*:8
MXCC>0*S_ $!Y/X4 6**** "BBB@ HHHH **** "N</4UT=<X>IJXDR-NQ_X\
MT_'^9JQ5>Q_X\T_'^9JQ4O<I!45Q<P6D#3W,\<,*_>DD<*H^I-2US/C?PQ/X
MHTB*VMKE(9HI?,429V-P1@XZ=>N#2 Z.&:*YA2:"5)8G&5=&#*P]01UI]8?A
M+09/#GA^+3YKCSY S.Q&=H)[+GM_]>MR@ KB+/3)M<\1:]Y^LZO EM<JD4=M
M>,BJ"@/2NWK@].T,:KXF\1R'4M3M-EVJ[;.Y,0;Y!R0.IH UK_3TT+PW?%O$
M&I0*Q0F\N':X:+Y@/E'7GI^-0>)IXK7Q'X9GGE5(HY)V>1S@ "/J:K^+M,&E
M?#W5(1>7MUN9&WW<QD8?.@P">W'2I?%$4$WB/PHER%:,W+G#="P4%?UQ0!K:
M;XMT+5KS[)9:@DEP1E49&0L/]G<!N_"K=YK>FZ=,\5Y=I R0^>V\$ )G;G/3
MKQCK6%X_55TFQG0#[7%?PFV/?<6Z#\,\>U-O[2"[^)VG^?&)!%I[R(&Z!@^
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MS2")\*2<#''/X9J2'Q)I%SK#:3!>I+>J#NC16(&.N6 P"/3-4/'@ \#ZF ,
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M ,N?XHHOB_S4>=]#C0IY<<2[I&P?F^;!'/OT%=Y:>*--NO#:Z\[O;6)!.9P
MPPQ7H">21P!7#V'_ "7&Z^C?^BA5KXP/*-&TY%SY37!+>F0O'\S0!H0_%3P[
M+<B)A>11DX\]X1L_0D_I70:[XCLM TE-2N%EFMW954VX#$Y&0>2!C\:X2ZTS
MQCK7A>#2_P"R]'%B8T,3Q-\P P00=Q&3].YI?%EC>:;\*=/LK_'VB&9$;#9
M'S8&?IB@#=O?BAX=L[A85-S<Y )>!%*KGMDL,_AFI+_XF>'+**%TFFNC*N_;
M;H"4'^UDC!]NM9[Z;9)\'<+;1\V0G)V\[SSNSZYI/ACI=G)X.GDEMXY&N976
M0L@)*@8"_3K^= '6Z%X@T_Q'8&ZL)&95.UT<89#Z$5R_P^_X1W[?JPT2+4%E
M!7S3=E< 9; 7:>G7KS63\(.'UI03M!BP/^^ZK_#EY(V\4O$<2+%E"/7Y\4 =
M9J_Q(T#2+Q[1FN+F6-BLGV9 P4^F20/RS6WH6NV?B'3A?6(E$6XH1*FT@C]#
M^%<'\(K:SEM-2G>.-[L2*I+#+!"/T!.?KBO2H((+:/RK>*.*,$G9&H4 GD\"
M@"EK>O:?X>L?M>H3%$)VHJC+.?0"L+1_B/HFM:E%80QWL4TIVQ^;$,,?3Y2?
MUJ;QSX5F\4Z9#';3K%<6[ET#YVOD8(/I]:YO1?%.K:9K]AH7BC38C/D1V]SM
M7>N[Y0<C@@],C'XT ==X@\8:1X:*QWTKM.R[E@A7<^/7L!^)J/P[XTTOQ/-+
M!91W221)O99HP.,XZ@D?K7%:='#>_&B]%^J2%&<Q+)R,JHV\=\+S^%>I);6T
M,SRQP1)-(,.ZH S =,GOC/ZT >:?"C_D+:]]4_\ 0GKH]6^(^@Z3>O:$W%U+
M&2)/LR!@I'49)'3VKD_ARTB/XH>'/FK%E,=<_/BL_P"'[^(H[>^DT&STZXW.
MHF:Z)WC@X'##CK0!ZMH?B#3O$5F;G3YBZJ<.C##(?0C_ "*Q/^%DZ +"XNI#
M<Q^3+Y0A9%\R0X_A ;I[DBJ'@CPYK>CZ_J-[J,%O!!=H28X'!4/NR !V R:Y
M_P"&VD6&I:[JTU[:Q7!@(\M95#*"6;)P>,\4 =[=^--'L-%M-3NI9(DNX_,A
MA*YE8?0''XYQ[U1TGXD^']6O$M0]Q:RN=J?:4"ACZ9!('XXKE?$-O;R?%O3+
M.[BC%DJQ)'$1A,<D#'3&[M5SXNVMG'IVG3+'&EUYI12H )3'/U ./IGWH [/
MQ#XITOPS#&]_(Y>3/EQ1+N=L=?8?B15+P_X\TCQ'?&SM$NHY]I8+-&!D#KRI
M('XXK$\2>$]4\1:9HVJV<X74K:V0M'+QN; ;(/0'/KQ2^%O%U[<>)1HNOZ;%
M#JJH46X5 &.!NP?8@9R#CIQ0!+H'_".CXBZH+.+4!JG[PRF4KY(^8;MN#GDG
MO5O5/B9H&EWTEH?M5R\;%7:WC!4$=1EB,_A7/^%_^2O:U])O_0EJ&[T+Q)X%
MU*]U?1_*O+"3+S*RY(3)/S#KQGJI^M 'H^C:S9Z]IJ7]B7,+$K\Z%2".H_\
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M,MU!&H6.*#RT [ 1J!6Q?:O\0(]0N$M-!L9+596$3L>63/!/[P=O:@"YXO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 57OO^/*3\/YU
M8JO??\>4GX?SIK<&6****0!1110!7_YB7_;'^M6*K_\ ,2_[8_UJQ38!1112
M XOQ!\.+#6-0;4+.ZET^\=MSO&NY6;^]C(P?<&IO#?@?^PM5;4[G5[B_NC&8
MP9%P,'ZDGMZUUU% '.:?X4^P>,;_ ,0?;=_VM"GD>5C;G;_%GG[OIWK/TKX?
M0:7XMDUQ;W>A>1X[;R<!"V?XMW;)[5V=% ',6WA#[/XWN/$?V[=YRD?9_)QC
M*@?>W>WI73T54GU33[:ZCM;B^MHKB3&R&295=LG P"<G)H MGD8KEO"'@[_A
M%'OF^W_:OM13_ECLV[=W^T<_>KJ:* .1\2^!+?7M134[:^ET^_4 &:-<[L=#
MC(.<<9!J;PKX)L_#,LMU]HDN[Z4;7GD&,#.3@<]3UR37444 9?B+1_[?T*YT
MSS_(\\+^\V;MN&!Z9'IZTGAO1?\ A']!M],^T?:/)W?O-FW.6)Z9/KZUJT4
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M '(+X'E;P\^G3Z[>RW+3B<79SN4@8 &23C'O5&#X;/+?P7&M>(+S5$@.Y(I
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MYECFMHTB5U5CC<FPY./0T >@445RLUYK&N:_>V&EWZZ;:Z?M26?R%E>61AG
M#<  ?Y] #6&L9\3MHWD?=M!<^=O_ -K;MQC]<UJ5Q6D+J$?Q&GAU*6.>:/3
M%G1-GFKYF02O8YR./2H9/$<VK7]ZL/B?3]#MK:9H(UD$;RS%>K$.>%STQUH
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MB&TUN"\60$QI&KP,BYYV'&#SUJO!I^KS^/-7CBUZ6"1;>(F1;:-LJ2<+@@X
M_7- '8'5+8:R-*_>?:3!Y_W#MVYQU]<U=KGQJ%XOCN/2VGW6O]F>>4V+S)YF
MW=G&>G;I5&WNM=\2W5Y+I^I)I=A;3M;Q%;=97F*\,QW< 9Z8H ZZBN>T+5;]
MM4OM$U4Q27EHJR)<1+M$T;=&V]B#UK(T*7Q1XCTG[4-:CL%222-66T21I<,?
MF.> !TP!VSF@#N**PO"NJW>I6%U'?[&N[*ZDM99(QA9"N/FQVSFMV@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH KW?2#_KLM6*K
MW?2#_KLM6*8!1112 *KP_P#'[<_\ _E5BJ\/_'[<_P# /Y4T!8HHHI %%9?B
M'7(?#VC3:C/&\JQX 1.K,3@#/:J7A'Q9#XKL9ITMFMI87VR1E]PYZ$' S^5
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M* "BBB@ HHHH **** "BBB@ JO??\>4GX?SJQ5>^_P"/*3\/YTUN#+%%%%(
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M#Q=J$5D#Q;H&  ].'Q^E>@T4 8E]X7L-2\.0Z+=&1X88U6.7(WJ5& V<=?\
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M P,D\<>M;-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@"O=](/^NRU8JO=](/\ KLM6*8!1112 *KP_\?MS_P
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M&]K+'<QI.BRLRSQL<%6#$Y/.<U/K5DVI?$"ULS<20V\FG,9Q$VUI$$GW=PY
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M-6*KV/\ QYI^/\S5BI>Y2"BBH;J[MK& SW=Q%;P@X,DKA%'XFD!-14<$\-S
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 5[OI!_P!=EJQ5>[Z0?]=EJQ3 ****0!5>
M'_C]N?\ @'\JL57A_P"/VY_X!_*F@+%%%%( HHHH **** "BBB@ HHHH ***
M* "BBB@ K"E\+6ESJJWUY>7UV$E\V*VGFS#&W8A0!T[9S6[10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "$!@00"#P0:Y
MU?!\$&4L=6U>RMR21;V]R!&F>NT,I('T-='10!0TK1K/1XI%M5<O*V^::5R\
MDK>K,>35^BB@ HHHH **** "BBB@ HHHH **** "HI+:WEGBGD@B>:'/E2,@
M+)G@X/;/M4M% !1110 4444 %%%% #9(XYHGBE17C=2K(PR&!Z@CN*2**.")
M(H8UCC10J(@P% Z #L*?10 4444 %%%% !1110 4444 %%%% !1110 57OO^
M/*3\/YU8JO??\>4GX?SIK<&6****0!1110!7_P"8E_VQ_K5BJ_\ S$O^V/\
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MXHTRTG@M?[,O0A,NUMZYX;G=C@D'IT-3^./%UWX<:PMM.@AGO+IC\DJEAMX
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M35[.[N?$FK1R8M&ECF+'^%1$"<^XP?RH B\6PW>OZM_9M@Y4Z9!]M8C/,_\
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MVD5_XULK2==T4^FW$;CV)45U=9%QI<\OBFSU16C$$%M)"RDG<2Q!&.,8X]:
M.>TW79M,\#WD,IW:EICM8JN#\[YVQ_7.5_(TFGZ6-'\4>&['@O'I\_F-_><D
M%C^9-7[WPD]UXTM]7$R"Q!26>W).7F0$(V,8X!]>U:-UI,\WBNPU57C$%O;R
M1.I)W$MC&.,8X]: ,1-.A\5^)M8356DFL;!T@@M-[*F[;DN0",GTI]E /#?C
M2VTFRDD&FWUL\BVSN6$+IW4GD CM5Z]T;5;36;C5-!N+19+M5%S;W@;RW*C
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M+O;ZQTJ.PL)Y_+=]RV\)?8,#'"C@4 :7A?PC>V.K#7]4U1KN^GA(=-G";L'
M.>WT KJ[ZT%]8S6K330B5"ADA;:ZY[@]C4D (MX@000@R#]*DH \0\)^$K#6
M?%>J:?<S7*Q63,8VC90QVOM&<@_TK=O./CA:CV7_ -%&K?@73+^T\;Z]<7-C
M<PPRF3RY)(F57S)D8)&#Q1=Z9?M\8[>^6QN39@#-P(F\L?NR/O8QUH R/$5M
M<WOQ>2UM;I[66543SD^\BF/YL>^,U#JVG2_#KQ7IUQI][/+;W)S(LAY8 @,&
MQP>N1Q6EK^EZ^WQ,;4]*T^23R(UD5Y$(C?"8*[NF3R.M5[FR\1>.O%-D]_I$
MVG6-J1N\U2 !G+8) W$XQQ[?6@";XBS7<'C?17T]PEV8@L+-T#,Q _G5B\TN
M\^'_ (>U/51J;7>I7OEQ>:Z?<8DY.23GC/7T%2^.-,O[OQSH-Q;6-S-!$8_,
MDCB9E3$F>2!@<5UGBS0CXB\/7&GHX24X>)CT##IGV/3\: . T[X?RZQX;77;
MC5KDZI-&9XV+9 ZD D\Y/KGC/>KOACQ'K.K^ =7BCDEGU.S3;%*.9&4CCGJ6
M&&]^G>JUGJ_C/2-"_P"$?'ARXDF1##%=*A95!Z<@%3CL<^F:VO"_A_5?"/A"
M]GBMDGU>8B3[/G( ' 7(/)QN/'KWH X3P]9^']5!_M+6K_3]:,AQ-(P\LG/!
MSC(/U(KI_BW&(M-T:,,S!&==S'). O)/<UF>(DU?Q>\,4?@J>ROM^7NV!4.,
M8P2548^I/2M;XA:)J+Z!H-G:VMQ>R6J;)&@B9^BJ,G XSB@"+XG37\<>DH3<
MKI+(//\ ). S<<'MG'3/O5_P'I?AY-1-[H6M7<H$1\RRG8!@3CYB !G'3H1D
M]:UO$.L:QI7V:*W\.MJUC) !*J*2P;T( /&,=JYGP?H.HS^-VUS^QGT:P0,1
M ^1R5VX (!QDYZ 4 >IT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM$T,UPVZ3:ZDX8]\8ZUU% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 5[OI!_UV6K%5[OI!_UV6K%,
M HHHI %5X?\ C]N?^ ?RJQ5>'_C]N?\ @'\J: L4444@"BBB@ HHHH ****
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MX&/0CFJ>A^)]#?0;-CJ5I;F.%$>*654:,@8(()XY%5O$^W2=9TGQ&I"QQO\
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M,[\1PM9R2-C[JC&37;6M]:7R%K2Z@N%&,F*0,!GITH L4444 %%%% !1110
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M &9X>M)['PYIUI<ILGAMT21<@X('(R.*SM#T>[@MO$$%U'Y0O;Z>2([@<HX
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MYIUW876M/<Q;%N;]YHCN!W(0,'@\=.];U% &!I>G7=MXMUZ^EBVVUT+?R7W
M[MJ$-QG(P?6M^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** *]WT@_P"NRU8JO=](/^NRU8I@%%%%
M( JO#_Q^W/\ P#^56*KP_P#'[<_\ _E30%BBBBD 45A^+M.U#5?#5U9Z9+Y=
MRX&/FV[@#RN>V169\/-"U;0=&F@U1MI>7=%!O#>6,<\CCD]A_6@#KZ9,KO!(
MD4GE2,I"R;0=I['!ZXI]% '":ZGB?1UT\KXI>7[7>QVIS80C;NS\W3G&.E=+
MI6GZM9SN^H:XVH1E<*C6J1;3GKE:S/&WW-!_[#%O_6K?C"_FLO#\L=HI>]O&
M%K;H.I=^/T&3^% &5H?B6^OO$SK<'_B5WWF+IWR <Q'#<]3N&3R>U=G7G.II
MK]MX?LDB\,);KI)2>*47R.0$'S?* ,Y&<_6NA\1ZTQ\(K/IH,EQJ2I#:*.I:
M0?T&3^% %'0_$M]?>)G6X/\ Q*[[S%T[Y .8CAN>IW#)Y/:NSKSG4TU^V\/V
M21>&$MUTDI/%*+Y'("#YOE &<C.?K76W.KW[V-G=Z-I2ZC%<Q^8=URL.P$ C
MJ#G.3^5 $^L37,*V?V:\M+4O=(CFY./,4]47_:/:K<MY:PR-'+<PQNJ>8RNX
M!"9QNQZ9[URGB::[N-/\/2WMH+2X.L0;H1*)-O+8^8 9XYHU73K;4OB38Q7<
M:RPIISN8G&5<A^ PZ$<YP>X% '46>IV&H[OL-];76S[WD2J^WZX-+>:C9:>B
MO>WEO;*QPIFE5 ?IDUR^H6%IIGCSP[)86T5J;E;B.80H$$BA 1D#KS1I5E:Z
MSXOU^YU*".Z>TD2W@290RQ)MR< \9)[T 6[>_>X^(#117;26;:6)45),QD^9
MC<!TSCO70PW-O<^9Y$\4OE.8Y/+<-L8=5..A]JY'3=.M=-^)EU%9QK%$^FB3
MRD&%0F3!P.@!QGCU-6O!?W_$/_88G_\ 9: .DCNK>6>6".>)YH<>;&K@LF>F
M1U&?>J]UJ^F6,HBO-1M+>1AD)-.J$_@37-Z1*8O&7C"5!O9$@8*.Y$;<4>#]
M#TR^\-P:C?V=O>WE]NFGFN(ED9B3TYS@# &!Z4 =:T\*0&=Y8UA"[C(6 7'K
MGIBH;/4K#40QLKVVN0OWC!*KX^N#7(^+%E?7]"TBWTZ*[M%227[&\HBCD* !
M0>#D+UQBD32-5?Q#IE_;^';/21!(1<26]RK>9$1@J5"C/K0!V%YJ-EIZ*][>
M6]LK'"F:54!^F36%;W[W'Q :**[:2S;2Q*BI)F,GS,;@.F<=ZJ:596NL^+]?
MN=2@CNGM)$MX$F4,L2;<G /&2>]-TW3K73?B9=16<:Q1/IHD\I!A4)DP<#H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*IZIXHT71IQ!?WRQS$;C&J,[ >I"@X'UH UZ*IP:K8W.FG48+F.6T"%S*AR
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M_'%=#10!3TK3;?1],M]/M=WDP+M4L<D]R3[D\UB^,[>5+.RUBW0M+I=P+AE
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MOLVW(V;=V[.,9SGWH P_ Z(8=6N) /MSZC,MP2<L,'@?0#I3=)5(/B)KD-J
ML#VT4DRKT$O]"1S6A?\ A6TO+^2]@O+_ $^XEQYSV,_E^;CIN!!!/O5S2-$L
MM%@DCM%<O*V^::5R\DK>K,>M &)\.[>*+PP940!YKF5I&QRQ#D#] *=X)41C
M7HD&V--7G"J.BCY>!6WH^DP:)IRV5L\CQJ[.#(03EB2>@'K1IFD6^DF\,#RM
M]KN7N9/,(.&;&0, <<4 8_C\L/"<RDD0O-$LY!QB,N,UIZM:6)\-7=M+'$+)
M;9AMP JJ%XQZ8J_<VT-Y;26UQ&LL,JE71APP-<[_ ,(-8%1!+J.K36(Z64EV
M3#@=!C&<#TS0!@WLD\OPBTY[@DR$VXRW4@2 +^F*]%K.U31;75M+&G2[XK<,
MA API&T@@#((QQ6C0!R'B61-/\9>&]2N&V6H:6W=R?E1F7Y<_7^E=?5;4-/M
M-4LI+.^@2>WD'S(W\_8^XK 3P3#&HCBUW7H[=?NP)?$(HZ8'&<>V: (/$LB:
M?XR\-ZE<-LM0TMN[D_*C,ORY^O\ 2NOJG=Z79ZAIQL+R 3VQ4*5D)/3H<]<^
M_6L-/!,,:B.+7=>CMU^[ E\0BCI@<9Q[9H 7Q3_R&O#/_80_]D-=/6/K'AVW
MUF"SCDNKRW:S</%+;R!7!QCJ0:AL_##6EW%<'7];G\ML^5-<JR-[$;1D4 1Z
MWJ]S/=G0M$(.HNN9I^J6B'^)O]H]E_&B[@E\+>$6M]$M)KFXC7;&%7>S.QY=
MO7J3^E5H/ D%K).]MKNN0&>0R2>7<J-S'N?DYK:TG23I22J=2O[WS"#F\E#E
M<>F ,4 >?:W?QVG@&ZTN+0];AW;6DNKNW"AW+J69VW'DG^@KT72K\ZC8+.;.
MZM.=OEW4>Q^.^,GBFZSI,&N:5-IUR\B0S8W-$0&&"#QD'T]*O 8 'I0!SUYK
M%]<>(9-)TFTMFGMHEDFN;IB%0-T4 #))'N!67IIOU^)CKJ$MH]P=*R_V1&1?
M]8,9W$DGWK;U/PQ:ZCJ*ZA'=WUC>;/+>6SFV&1>P;((.*-.\+V&F:F-1A>X>
MZ,)ADDFEWF7)!W,3R3P!UQCM0!G>$+>(:OXFN0@\YM1:,OCG: "!^9-1Z9NA
M\6^,!;C:PC@=57^^8V.?J370Z=I,&F2WLD+R,;RX-Q)O(.&( P,#IQ1:Z1;V
MFKW^I1O*9KT1B16(VC8,#'&?S)H R/ <4'_"%V+1JK&96>8]2[ECNSZGM^%0
M> (H8=/U6*W $*:G.J = HQBK+>#+(7,TEK?ZG9PS.9);6UNBD3,>IQC(S[$
M5IZ/HEGH5O-!8AEBEF:;8QR%)QP/;B@#)^(%O)<>#;PQ*S-"4F*CN%8$_ID_
MA6_8WD&H6$%W;2"2&9 R,#VJ=E#*58 J1@@C@US+>![&.20Z?J&JZ9'(2S0V
M5ULCR>^"#C\* #X@6\EQX-O#$K,T)28J.X5@3^F3^%;]C>0:A807=M()(9D#
M(P/:HM/TV/3['[()KBY4DEGNI#([9ZY)K%;P/8QR2'3]0U73(Y"6:&RNMD>3
MWP0<?A0!/XX_Y$K5?^N/]17+ZM9:Q9Z!I\VI:W<7FBR>6E[## D3)$0/XE&2
MO8^U=B_AVVE\/SZ/+=7DL,X(>:6;?*<G/WB#_*KS6,#Z;]@E3S+<Q>2ROSN7
M&.: $^RP2:6+2V=H;=H?+C:W;:47& 5(Z<=#7':II)\*7EGK4%]<7SF=+=TU
M!A,Y5SC]VY&Y3R> >:W?^$5MQI-K8)J.IQ_9 5AGCN-DJJ?X<@ $<#J.U):>
M$[2"\BNKJ]U#4986W0_;;C>(V]0H &??% &_1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% %>[Z0?]=EJQ5>[Z0?]=EJQ3 ****0!5>'_C]N
M?^ ?RJQ5>'_C]N?^ ?RIH"Q1112 **QO%D\MMX3U.:"5XI4@8JZ,593Z@CI6
M7\-[RZOO",<UW<S7$IF<;YG+MC/J: .GNKNVLH#/=W$5O"#@R2N%4?B:D1TD
MC62-E=&&593D$>HKE_B -(_X1M3K2WAMA.NTVFW>&P<'YN,8S4 \7Z)X;TK1
M8/LU\MG=6ZFW<JIVKQ]\[NHR"<9H [&BLO7]?L_#FF&_O1(T6\(%B +,3Z9(
M'J>O:J[^*],@\.P:W=M);6TZYC251YC9Z  $\GK]* -RBN-T_P")OA^_O4MC
M]JMC(<))<1@(QSCJ"<?4XK9U[Q-8^'7LUO4G;[7)Y:&-00IXY.2..?>@#9HK
MGM-\9Z3J^O2:18M+-+&C,9E4>4<'!P<Y/7TQ[UT- !17&GXF^'UM)YW-RCQ2
M^7Y!1?,<^H ;&/<D4^T^)?ARZLY[AIY;<PC)BF0!W[?* 2#^= '7T5RFB?$/
M0]=U!;&#[1!._$8N$ #GT!!//UK4U[Q+IGANW274)BK2?ZN)!N=\=<#^IH U
MZ*Y31?B%H>MWRV41N+:XD.(UN4"[SZ @D?G6)X\\>/I=_#INE3NEQ#(&NG$8
M.!CA1N'.<Y_*@#T:BN?\-^,-/\4"Z-E#=1_9@I?SD49SG&-I.>AK&G^*_AV*
MX,2QWTJ@X\Q(0%_\>8']* .W=TBC:21E1%!9F8X  [DU#9W]GJ$;265W!<QJ
M=I:&0. ?3(K-N=2M-7\)7M[8S":WDM9=K $?PG((/0UYSX%\7Z5X7\-W OFE
M>:6Z)6&%0SXVKR<D #\: /8**RM \1:?XDL3=6$C$*=LD;C#H?<?X5C:O\1]
M T>\>T9Y[J6,E9!;(&"$=B20/RS0!UU58M3L)[Q[.&^MI+J/.^%)5+KCKE0<
MBJ6@^)M+\20-)I\Y9DQYD3C:Z9]1_49%<+X6_P"2O:U])O\ T): /28[ZSFN
MI+6*Z@>XB&9(ED!=/J.HJQ7!Z!_PCH^(NJ"SBU :I^\,IE*^2/F&[;@YY)[U
M;U3XF:!I=]):'[5<O&Q5VMXP5!'498C/X4 =C16$OBW39/#$NOQ">2SC^\HC
MP^<@$8) /7UQ6/<_%'P];06\@^U3-,@<QQ(I:/V;+  ^P)H [6BN0G^)?AN#
M3HKM9Y93*2!!&G[Q<==P) 'Y\]LUI^'?%FE^)XY#8/(LD6-\4J[74'H>"01]
M#0!N445QFI_$W0=,OI;-X[V:2)BCF*$ *P."/F(- '9T5FZ+KNG^(+#[9I\Q
M>,':ZL,,C>A%<_\ \+-\/K:3SN;E'BD\L0%%\QSZ@!L8]R10!V5%<[X=\:Z1
MXFF>"S::.X1=WE3J%8KZC!(/YTGB+QOH_AJ=+>[::6X8;C% H9E'J<D ?GF@
M#8GU33[:ZCM;B^MHKB3&R&295=LG P"<G)JW7C6N:S9:_P#$#P]?V$A:)G@4
MJPPR,)3D$?B*]EH KS7UG;W$5O/=0133'$<;R!6?Z \G\*L5P?B__A'?^$QT
M?^U(M0:^.P0_9ROEGY_EWY.>OI6_J_B[3-#U>UTZ^,L;7";Q-A?+0<_>).>W
MI0!NTA(4$D@ <DFN*C^*?AR2]%N3=HA;:+AHAY?UZ[L?A4?Q.UVWL_#3:>DS
MBYO@-FP<% 06R?0CC\: .KBUW2)Y&CAU6QD= 2RI<(2 .I//;%3V=_9ZA&TE
ME=P7,:G:6AD#@'TR*\D\&Q^';C2KOR;.Y_MFVL)Y))Y#^[.05^4;O0^@[UT'
MPC(7PW?$YP+HG@9_@6@#T.BN&G^*_AV*X,2QWTJ@X\Q(0%_\>8']*ZFWUNQN
M]%;5K67S[18VDR@YPN<C!QSQWH T**XI_BCX>33XKK_2F:1B/LZHID7'<C=@
M#\:F7XE^&VTMKWSY58-M^S%/WI/TSC'OG% '7T5SGA[QOH_B6X:VM#-%<*NX
M13H%+#N1@D'\Z-0\;Z/I>M3Z7>M+#)#%YK2LHV'C.!SDGGIB@#HZ*XW3_B=X
M=O[P6[/<6N>!+<HJH?Q#''XXJ-?BGX<-[]GS=B/=C[08AL^O7=C\* .VHJCJ
M6K6>E:6^HW4A%J@!+HI?.>!T]<BN6MOBKX=N+I876\@5CCS98EV#ZX8G]* .
MWHKE?&WBR'P[HY$,A^W72'[-M7('3+9Z<9_&LSP=\0;?5OL&DW2W4FJ2*P>8
MQH(R0"W8^@]* .UCOK.:ZDM8KJ![B(9DB60%T^HZBK%<'H'_  CH^(NJ"SBU
M :I^\,IE*^2/F&[;@YY)[UK:]X\T3P]<FUN9)9KE<;XK= Q3ZDD ?3.: .FH
MK \/^,M'\2,T=E*Z7"C<8)EVOCU'4'\#4=_XWT?2]:FTN^>6"2&+S6E91L(Q
MG YR3STQ0!T=%<=IGQ,T#4]1CLE^U0/(VU'GC 5B>@R"<9]Z[&@ HHHH ***
M* "BBB@ HHHH **** "J]]_QY2?A_.K%5[[_ (\I/P_G36X,L4444@"BBB@"
MO_S$O^V/]:L57_YB7_;'^M6*; ****0!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7.'J:Z.N</4U<29&
MW8_\>:?C_,U8JO8_\>:?C_,U8J7N4@HHHI %%%% !1110 4444 %%%% !111
M0 4444 %126T$TT4TL$;RPDF-V0$H3P<'M^%2T4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]A>'+[2!?>?]J9SYOE;=NY0O3)SC'K6%'\*DM]/$5KKES;W3;EFFC0A94/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0!OT52DUC3(K2.ZDU&T2VD^Y,TZA&^AS@U8M[F"[@6>VGCFB;[LD;AE/T(H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %5[[_CRD_#^=6*KWW_'E)^'\Z:W!EBBBBD 4444
M -=%D0HPRI&#599'M/DERT0^[(.WL:MT4 -21)!E&##V-.J!K.W<Y,0S[<4G
MV*W_ +A_[Z/^-/0"Q15?[%;_ -P_]]'_ !I/L4']P_\ ?1_QHT LT56^QP?W
M#_WT?\::;.'^Z?\ OHT: 6Z*I&TB_NG_ +Z---K'Z'_OHT: 7Z*S_LT?H?\
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M/K[8K0^(>F:A>^*-%FM+&YN(HP-[Q0LP7Y\\D#B@#TJO//B]_P B]8_]??\
M[(U>AUPGQ3L+W4-"LX[*TGN76YW,L,9<@;6YP!0!D:*QT'XFPQDD0ZM:(_3
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MIGVC_IA/_P!^S1]H_P"F$_\ W[HL [;1MIOVC_IA/_W[-)]H_P"F$W_?LT6
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M110!7L?^/-/Q_F:L57L?^/-/Q_F:L4WN""BBBD 4444 %%%% !1110 4444
M%%%% !1110!S6L^$AJ/B"QURSO?L5[;'#-Y6\2KZ$9'8D?0UTM%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S6L>$1KGB
M*RU&]O=]G:<I9B'@GKDMGGD#MT&*Z6BB@ HHHH **** "BBB@ HHHH ****
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M>3"[(%:65^% 4<=^@["M#0-,&C:!9:?P6@B"N1W;JQ_,FM*B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *KWW_ !Y2?A_.K%5[[_CRD_#^=-;@RQ1112 **** $)"@DG '4U4 >].2
M2MOV ZO_ /6I]WES';@_ZP_-]!5@    8 Z4Q")&D:X10H]A3J**0PHHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.BV%[-J$+6YN74QPL>0 #R?3.>A]*[NB@ HHHH **** "BBB@ HHHH ****
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MLWE-NC;<593[,I!'YU:L[."PM(K6V39#$NU%W$X'U/)H YUO^2I)_P!@<_\
MHVCP@BC4?$KA1N;4W!/J !C^9K?_ +.M/[5&I^5_I@A\CS-Q^YG.,9QU[XS1
M9Z=:V#W+VT6QKF4S2G<3N<]3R>.G:@#FM/5V\8>+UBXD:&W"X]?+;%6? <L'
M_"%V*QE5,*LDPZ%'#'=GT/?\:W(-.M+:_NKZ*+;<W6SSGW$[MHPO&<# ]*S+
MKP=X?O;Y[V?3(VG=MSD,RJY]64'!_$4 <[H1CF\%>*C:@-$]Q>&/9R""O&*Z
M#0+NWB\"Z?<O,@ACL4WN6X&$P>?;%:MEIMGIR3):0+$DTAE=03@L>IQVZ=!Q
M65%X*\.0WGVJ/2XA)OW@;F*!O4)G;^E '&P@M\&;5L$PK.&G &<QB<YKTV&6
M&6WCEA=&A90493P0>F*@L]+LM/T\6%M;JMH-P\HDL/F))'.>#DUEP>"O#MM>
MI>0Z8B3))YB8D?:K#H0N=H_*@# M+:_E\<^(((=;?3KF1HY%06\;^;'MP""P
M/3IQ6S:>'KFRO[_4)M6DO;ZXM#" T21]/NG"XK3U;P_I6N"/^T;))VC^X^2K
M+]&4@X_&C2= TO0UD&G6BP&4Y=MS,S?4L2: ,OP'+!_PA=BL953"K),.A1PQ
MW9]#W_&H/ #PR:?JKV^TPMJ<Y0KTV\8Q[5H77@[P_>WSWL^F1M.[;G(9E5SZ
MLH.#^(K3L=.M--25+.!85ED,KJI."QZGVZ=!Q0!:KD?#.GV^J^$KVQNTWP37
M=RK#_MH>1[CK7756L;"VTV!H+2+RXV=I"-Q/S,<D\^] 'GR:A<IJNA^']38G
M4-/U%0LA_P"6\.QMK_T-;.MPW?B#Q9!I]A?"T72HQ<RR^4),2OP@VMQD+D_C
M7176BZ=>ZC:ZA<6P>[M3^YEW$%?R//XYJ6UTVTLKBZGMXMLMT_F3.6+%R!@=
M3QQV'% '&ZK9:KX>U+3_ !#?:TU_%!(+><&V2+;%(<$_+UP<'FNPO;+3]7@>
MTO(8+F,?>C< [<C@^H/O4M[9V^HV4UG=QB2WF7:Z$D9'U'-95]X/T'4I(Y;N
MP\R2-!&L@E=6V@8 )# GCUH Q[&$>'O&UKH^F74LFGW%N[R6;R&06Q7&&!/(
M!Z8/O[8IZ3X;TC7/$?B274K);AX[W:A9V&!M]B*Z_2M!TO1(V33;**WW?>89
M+-]6.2?SJ:TTVTL9[J>VAV274GF3-N)W-TSR>/PH XG6O#6CZ)KOAN;3;);>
M234%5B'8Y&,]R:] /0U5O--M+^:UEN8?,>UE\V$[B-K>O!Y_&K= '*?#P_\
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MGG25[F\==K3.,8'<*.WYFNHHI/$57%POHP6&I*:FHZH****Q-PHHHH ****
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MJW^]C)_7-1ZUX>LM>:R:\\P&TF$R;"!DCL<@\'VQ6K0!RVB?\CYXH_W;7_T
MUU-4+72+>TU>_P!2C>4S7HC$BL1M&P8&.,_F35^@#EF_Y*DG_8'/_HVF>$+>
M(:OXFN0@\YM1:,OCG: "!^9-;ITBW.OC6=\OV@6WV;;D;-N[=G&,YS[T:=I,
M&F2WLD+R,;RX-Q)O(.&( P,#IQ0!B:"HC\<^*$0;5/V9MHZ9*')^M=%?_P#(
M.N?^N3?R-06ND6]IJ]_J4;RF:]$8D5B-HV# QQG\R:N2QB:&2)B0KJ5..O-
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ML_"5C::C;:B;F]N+VWW?O[B;>SAAC#9'0=@,4 5=$(_X3WQ0,\[;7_T U&K
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MM:W/'$P*P2WA*''0$  D>Q-7-8\/6FLRP3R2W-M=V^?*N;63RY%!ZC/<'W%
M&/J\,"_$CP],JJ)WAG5R!R5"\9_,UUU8%GX2L;34;;43<WMQ>V^[]_<3;V<,
M,8;(Z#L!BM^@ HHHH KW?2#_ *[+5BJ]WT@_Z[+5BF 4444@"J\/_'[<_P#
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MR:^BMXVAD"*(%8 @C/.2:/"WB&[\2^$KV]O(X(Y5,D8$*D# 4'N3ZUA_!_\
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M#[PQU-:VF6$>EZ7:V,/,=O&L8.,9P.OXT ><?"?4WAGO]#N \;C]_&CC!4C
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M[[_CRD_#^=-;@RQ1112 **** *__ #$O^V/]:L57_P"8E_VQ_K5BFP"BBBD
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M6$4<TDE[;)'"VR5FE4"-O1CG@^QH M457M+^SOXS)97<%S&#@M#(' /U%6*
M"BJ4FKZ9#;"YEU&T2 L4$K3J%+#@C.<9JQ;W,%W L]M/'-$WW9(W#*?H10!+
M155]2L(HYI)+VV2.!MDK-*H$;>C'/!]C5"^O)IKG2)=/U6QCM9ICY@=U/VE,
M=(SSD_2@#9HJ&2[MHIO)DN(DEV&38S@-M'5L>@]:BM-5T[4&9;*_M;EE^\(9
ME<CZX- %NBJ4&L:9<W1M8-1M);@9S%'.K/QUX!S5J66.")I9I$CC499W8 #Z
MDT /HJG9ZMIVH.R66H6MRRC)$,RN0/P-9VI>*]-TO6[/3)[BW5IPYE=YU40
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MJ .UHHKFI=9UY?&T>F)I&[22H)N]K?W<D[L[>O&.M '2T444 %%<]XQ\3?\
M"+:,MVD FFDD$4:,<+G!.3[<5ST/BSQ='H-[JNH:39P0QVRS6[X;#DLH (WD
M]"3V[4 >A45A>$-9N=?\-V^HW:1)-(S@K$"%X8CN3Z>M;M !1110 4444 %%
M%% !1110 4453U35+/1K![V_F\JW0@%MI/).!P.: +E%1PS)<6\<\1W1R('0
MXQD$9%<]X6UG7M4N+]-8TC[#'"P$+;67=UXY/S?4<4 =+1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 5[OI!_P!=EJQ5>[Z0?]=EJQ3 ****0!5>
M'_C]N?\ @'\JL57A_P"/VY_X!_*F@+%%%%("CJ^K6FB:;+?WKE88\9VC))/
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MW,<*(\4LJHT9 P003QR*QO$VDR:[XUAL([V2U672GWO&H)8;^GTSC..H&.]
M'2Z3K9UFXN'M;;_B71G9'>%_]<P.#L7'*C^]GGM6G<3Q6MO)<3N$BB4N['H
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MBPVM]9+%#/(0$#JQ)0GMD<U%K%]:ZWXJT"STR>.YDM9S=3O"P98D [D>O3%
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MWE[:Q7<IO)8U$Z!Q&H/10>!DDDX]:N65M#H7Q&:PT]!%:7UD9Y+=!A$=6P&
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M88 Q)%>*V&]P5Y!JA8:+J\^O0ZQKEQ9^;;1/%!!9(VT;NI+-R3CM0!TM%%%
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M,LUWIUI<2KT>6%78?B15K8GE^7M79C;MQQCTQ3J* ,K_ (1G0/\ H!Z;_P"
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M?_KK/TCQ5HFNW#V^FWPGE1=[)Y;J<<#/S >HH V:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** ,_1]'M]$LVM;9Y71I7E)D()RQR>@'%:%5-0U*TTN!9[V7RHVD6,-M+99
MN . :MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<X>
MIKHZYP]35Q)D;=C_ ,>:?C_,U8JO8_\ 'FGX_P S5BI>Y2"BBBD 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!7N^D'_79:L57N^D'_79:L4P"BBBD 57A_P"/VY_X!_*K%5X?^/VY_P"
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MQC^E;GAC_D5-(_Z\XO\ T 5A:G*FK?$;1K2U82?V8DL]RRG(3<  #[YQQ[T
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M!]OL[V/1M/=C]G!MA--*N<;FW<*#VQ^O6M:R@UG3[&]_M'4XKXK'NAE6W$3
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M &9K.@:;K]NL.H0>9Y9S&ZDJ\9]01_GBLR+P7#',C2ZYKMQ&K B&:^)0XZ9
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M>\0Z1_;VAW.F^?Y'G;?WFS=C# ],CT]:TZ* ,G6="CU:*W9;B2VO+5M]O<Q
M;HSC!X/!![BJ$7AB[N;VVN=<UE]26U<20PK;K#&''1F SN([5TM% &)K'AXZ
MA>PZC97TNGZE"AC6XC0.&0_PLIX84MOI&IFPOK;4M:-ZUS$8T86RQK$"",@
M\]>Y[5M44 <_-X5@N/#%II$D[":S1/L]VB[6CD4<.!G],U-J.@-J=E9^?>NF
MI6?S17T*!2'Q@G:<C![BMJB@#FHO#%W<WMM<ZYK+ZDMJXDAA6W6&,..C,!G<
M1VJQK/AZ74-1M]3T_47T_4($,7FB(2*\9.=K*>O-;M% ',P^%+C^W-/UB^UB
M6[N[3>#NA"(RLI "J#A<9SGDFIM2\.W<VM'5=+U=M/N9(A%,# LJ2*.G!(P1
MZUT%% #8U98D5WWL% 9L8W'UQ6%XH\-'Q%#;^5>FRN8&;;.L>\[&4JRXR.H/
MZ5OT4 4A8&WTA;"PF-KY<0CBD"!MF.!P>#6+-X9U/4@D&L:^;NR#*[P16BP^
M85.1N;).,CMBNGHH S)M+N)?$-MJ2ZC/';PPM&UF/N2$Y^8\^_IV%:=%% &
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MSW) LHY;<S$]%/E_*3[ T =+IOB9=1O4MO['UBU#@E9;FUV1G'ODXZ=Z2_\
M%5K9WLMG!9:AJ$\./.6Q@\SRL] QR!GVZUN;A@'(YZ<]:\^\,66ISSZQ;P>(
M)+&YCOY6GMQ:Q.3D\/E@3@C^5 '4B?3?%_A^YBC)>&4-#(DB%6B<=B#T8'!J
M+P=J,^H^'8OM;;KNV=K:<YR2Z'&3[D8/XT_0-#;1[C4)9=0:]GNY%DE9HU3#
M 8Z+QS6?X&.Z+7'&?+;5IRASU'% '5T444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!7N^D'_ %V6K%5[OI!_UV6K%, HHHI %5X?^/VY_P" ?RJQ5>'_
M (_;G_@'\J: L4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M** "N</4UT=<X>IJXDR-NQ_X\T_'^9JQ5>Q_X\T_'^9JQ4O<I!1112 ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6FFZ1IUQ+:2O?7T:R1V4;989]3CUXZ9/I0!U]%<5IGQ!$VK0Z;K&C76DS7!
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M<29&W8_\>:?C_,U8JO8_\>:?C_,U8J7N4@HHHI %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5[OI!_P!=
MEJQ5>[Z0?]=EJQ3 ****0!5>'_C]N?\ @'\JL57A_P"/VY_X!_*F@+%%%%(
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ JO??\>4GX?SJQ5>^_P"/*3\/YTUN#+%%%%( HHHH K_\Q+_M
MC_6K%5_^8E_VQ_K5BFP"N6\<>%9?%.F0Q6UPD-Q!(73S,[6R,$$CD5U-%(#G
M_!WAU_#.@K8S3+-,TAED9/N@G P.^.*Z"BB@ KRSXP_ZW1_^VO\ [+7J=8'B
M3PAI_BEK8WTUS']GW;/(91G.,YRI]* -U?\ 5K]*\K^&20R77B1+DJ(&4"0L
M< +E\Y/;BO50,*!Z#%<]HW@O3-$_M 027,JWZ[9EF<$8YZ8 Q]XT <+?:)K/
M@2"76- U>.?2V8%D8@Y!.!D=&],C!KHKRTM/B%X1TR:[N$L+V7<T//!8':P"
MGD@X'TX_$'PG\.B<2&6_*YSY9E7;]/NY_6MK5_!NCZSIEKI\L<D,%H,0>0^"
M@QCOG/XT <9I6M^(_"GBBQ\.ZO/'>V\S(B-NW,JL< ANO![-V'XTR[GCM?CB
MDL[B.,E5W,<#)AP/U.*ZO0_A[H>@WRWL(N)[A#F-KAP=A]0  /SJUXB\%Z1X
MFECFO5FCG0;1- P5BOH<@@_E0!Q/Q7O+>;5=(MHI4>6+<TBJ<[0Q7&?R-)\5
MEE&M:+(9!'%L(61AE58,,DC\NU=+_P *Q\/?88K9!<HT<GF&<.OF/[$E<8]@
M!72:MHNGZY8FSU"W$T6<KS@J?4$=#0!P6L>%_$NN:6G]I^*-.FL01*KF-47H
M<'<%'&">]>AZ=;O::9:VTCB1X841G'\1  S7'P_"CP[%.)&DOI5!SY;RKM_1
M0?UKN0,# [4 >5?%(K'XDT.6Y&;0#Y@1D8#C=^F*]+&HV.V$B[M]LQ BQ(/G
M)Z;?6H-:T/3]?LOLFHP>9&#N4@X9#Z@U@:3\-=#TC4H;^*2\FEA;=&)9!M![
M'Y5% '-:G!#<_&RVBGC62,["589!(C)'Z@5?^+\<S:-I[J&,*SG?CH"5XS^M
M=/+X2L)?%4?B)IKD7B8P@9?+^[MZ8ST]ZU[ZQM=2LI;.\A6:WE&'1N_^!]Z
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M+52?.0#.5;:0<<'KP1^M=Z>E8GA[PII?AF.1;"-S))@232MN=@.@]!^ %;=
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M#6N=5AENW,<+;VF<-M0<G 51Z4 >?S7;^"M3\4:2,JEU 1;[>VX_+CZ*[?\
M?->@?#K2#I7A&W9UQ-=G[0_T/W1^0'YUQ/B"XLO'_C;3;;28I)(D4+<3E2N4
MW9)YZ #/)[G%>P(BQ1K&BA44!5 [ 4 .HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YP
M]371USAZFKB3(V['_CS3\?YFK%5K+B I_<<C]:LU+W*04444@"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M *]WT@_Z[+5BJUUS);IW,@/Y59I@%%%%( JO#_Q^W/\ P#^56*K)\M_*/[R!
MORXIH"S1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *KWW_'E)^'\ZL56OO^/4KW9@H_.FMP99HHHI
M %%%% %?_F)?]L?ZU8JL>-17WB(_6K--@%%%%( HHHH **** "BBB@ HHHH
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MM]#3Z0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1JUMHVT786*OV=?0_P#?1H^SKZ'_ +Z-6MM&VB["Q5^SKZ'_ +Z-'V=?0_\
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M_OHU;*TW;1=A8J_9T]#_ -]&D^SIZ'_OHU:VT;:+L+%7[.GH?^^C1]G7T/\
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M4 ,Q1BGXHQ0 S%&*?BC% #,48I^*,4 ,Q1BGXHQ0 S%&*?BC% #,48I^*,4
M,Q1BGXHQ0 S%&*?BC% #,48I^*,4 ,Q1BGXHQ0 S%&*?BC% #,48I^*,4 ,Q
M1BGXHQ0 S%&*?BC% #,48I^*,4 ,Q1BGXHQ0 S%&*?BC% #,48I^*,4 ,Q1B
MGXHQ0 S%&*?BC% #,4N*=BEQ0 S%+BG44 -Q3L444 %+110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0T!WT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BFY.[%*>!0 M%-4DCFAB10 ZBD'
M2EH **** "BC-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4A('6HKBX6!"S5P'B7XB6^G2&!>6Z<"@#T+S$]:?7B]
MM\2=]PH(;!/I7I]MK"'2UNFZ;<T ;!8+U-)YB^M>8^(?B-#;2!8\\'G%8A^*
M"X!PWY4 >U;AC.: P;H:XO4O%*VFAVUT?^6B;JF\$>(AK=G*^<X;'ZF@#KZ0
MD#K0S;5+>@K@?%/Q @T=VA()8<<"@#O0ZDX!IU>.6/Q2B$WFR [ ?2O3M'UJ
M+5[=98_XAF@#5I"0.II@.T\UQ'BSQK#H[R0D_,IQ0!W8.1D4A(49-4-%N_MV
MD6]R/^6BYJ+Q!.]OI4KH<, : -!;B)SA7!-2UXMX3\0WTVMR+-(Q3(P*]CMG
M\RW1CW% $U%)N&<4M !12'@4!@1UH 6BFE@*7/% "T5&)06(I1("3[4 /I"P
M49)Q0K9K%\2W+VNDW,B'#",D?E0!K)<Q2-A7!-2UX;\/M?U&_P#$$\<TC% 3
MC)KW$=!0 $@=:8)HR<!AFJNJ,R6<CJ<8%>::1KUU/K;1&0[1(1U]Z /6:*B:
M4*!FI%8, : %HHHH *:SJ@RQQ2Y%<SXUNY;+1998FP0I- '2)*DGW6!I]>>?
M#O5KC41)YSEL-7H)8 XH =G%("#TK \1^((]'@#/WJMX4\0+K1F93PM '4T4
M@8&ER* "BFEL&E+ "@!:*3=\N::D@>@!]%,>0(*<K!AD4 +132P!Q2A@3B@!
M:3<!WJ*YG%M;O*W11FN"G\?0'4OLZ_WL4 >AT57L9Q<6<<H_B&:L4 1O*J'Y
MCBD2XBD.%<$UYCX]\8&RO#8PL5D!(I_@B'597%W<3%HY.0,T >H44R,_(,T[
M(]: %HII;!I=PSB@!:*0L!2T %%&12%@* %HHI-PSB@!:**,T %&<453O9]D
M9 ZT 3^='NV[AFI,C&:\?M?$5VWCBYLC(2JXXS[FN\UKQ"FC:;&\G5A0!T@(
M[4QIHU.&8"N=\,:XNLV\DBGI7+^,=5O+/4X%B<A6=1Q]: /3001Q2U0TAW>P
MB=SDE:L^>/-V4 34UI%3[QQ2A@:XWQM>SV=K(\3E<"@#K8Y8Y'^5P:FKR3X;
M:Y=ZC=NL\A8#'4UZT6 H 6BDR*0-\V* '4449H ***C:4*VV@"2BDW#.*6@
MHI,B@L!0 M%%)D>M "T444 %%%(6P: %HII<"EW#&: %HIH<'-*&!% "T4A8
M"D# T .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM-:YC@60;B<=:[6"036\<@Z,H(KP[0O!,UW)!>R[@2<U[=9IY5G#'_<0#]*
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MZ:(R#.<=:A\:3I>Z3)+&<J4S^E>:^)]%/A_60T;'#'/6NNEN_M7A%FSDB/\
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M1/NXVY-85YXZL(KAD$@^4X/-5-?*^'_#[>0V1LP*X3PCHC>(C)-.2-SMW]Z
M/1+;QY8//M,@P>G-=*VHPMIQO%(V 9S7D_C+PLGAVSAN(&)))[UL^&]8?4?!
M]U&YYCC_ *B@#6/Q TU;O[.T@W_6H-0^(5A:N@,@ 8@=:\HL-/6_\5!-YSSQ
MGWKH?'WA-+#0X+M6._=GK[B@#UO3=?M+ZR:>-@55<GFL2Z\>:?#*4$@X/K7$
M>!KZ9] OD&3MB_J*Y&S"76N>7=2%5+\\T >TZ=XQM;^;RT<'\:;J_C:RTJ;R
MY' ./6LO0?#FG1R+);3;F/O5;Q1X(.IW8D&>@H [?0M?M]8MEDA8'-;5<CX/
MT$Z/:K'SQZUUU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 <UXFO#;J.>U<KH^L%M6"D^M
M;7C4D!/]VN$L'*ZRK9QQ7;2I\T2&['6^*+X[5*GM5#PSJ;&]6,G.35?77+Q*
MV:I^%VQJD>?[U:RI6B0I'L<7^K4^HI]1P_ZE?I4E><S8****0!1110 4444
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MZUW=AC_A73 ?\\OZUP_Q&M9IO$F41B-W8>]=W81.GP^9"IW>5T_&@#@/ _\
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MFR-0![47-K'=1E)%!4CO4]% &5:Z!8V<OF10JK'N!5B\TNVOD*S1A@?6KM%
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M1110 4444 %%%% !1110 4444 %%%% !1110 44A( R:C,R#N* $FN(X1EF
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M!%-,97\*1B;PR(U/++VKD]-\(S6OB62YW2$%B>?K7I/AC1#I5@D3'/%;GV2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*&X#H.>:G7%9-6W*%P,8IAB5NHJ2BI$(%"CB@C(YI:* &"-0>E/HHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4445QF@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_$*]GLM,A:!RK$G.*9X O+B[M6:=RQQWH [6BBC- !12$@=Z 01F@ /2FCY
M2QXIV1ZUE^(97ATB9XSA@#B@"\EU$[[5=2?K4]>+^#=:O[O6I(9)6;&.IKV.
M#/D+NZXH EHHR/6B@!"0HR3@"H4NHG?:K@GV-4_$,CQ:%=/&2'"\$5YEX'UB
M]N=8CCGD8Y8 YH ]>8$FG#I29'K1D>HH 6BBB@ HHS29'K0 M%)D>M-YW]:
M'T4F1ZBEH **3(]10&!H 6BDR/6F X;DT 244A/'6D3I0 ZBBDR/6@!:3('4
MT,P12QZ"N6N_$]N=6BM$D^;=@B@#J'=47<Q 'J:CCN8I6VHX/T-<YXXNYK?P
MI+-;L1)C@CZ&N.^'6J7M]J(2>1FX/6@#UJBD!XZT$@=Z %HIBYR:?D>M !12
M9'K2-DD8H =4$UQ%'@-(JGW-/ED$419CVKQ3QGJ>JWFN_9M.F8;<$@'WH ]H
M^U0E>)%_.G1R(5R&!'K7BS7>LV6EN9I7W[>.:['P;>7=WX?1I78RE.IH [E9
MXV8@."1[U)FO)_#VL7ESXAO(&E8A),8S["O48R2B<]AWH GHHI,CUH 6BBDR
M/6@!:*3(Q1N!&: #(]:C:XB5MID4'TS4!WA9#GZ5Y%XEUS4+?Q4MO'*X0L.!
M0![0"",@YI:S]&=WTZ-I#EL=ZOY'J* %HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *C>0(A8GI4E<Q
MXOU)K#2Y60X;%-;@7[FY@O$,!8<UYEK=H()Y.XKC&\<W=KJ>YI#M!]:ZZ_U!
M;[2DG'WFQ7H4(M,SF1Z+)AO)]35_7=,\JV=P.<=:R-*?R[M,^M>CW=BM]I!P
M/F*UM.IR/4S2/)[>8P-M;D&I-3\,QZK#Y\9"G%7]3T:2&3..E16M^T(V$_*.
M*TC9ZC/,-6M9M*NVBVE@*SC/([!=A&:]>NDTZ\&98@7/?%8MWH-LX)C0 ]N*
M3IW&F<AH;7$6J1A7(!_QKZ-TG7?L^DH&.2%KQNQTE;>8,1R.E=$;^7R?*4D8
M%92PZ8^:QUUUXR;SSC/!K6TKQ;]H948=:\O67Y_GY)-7(;A[=Q*IP!S4O#JP
MN;4]TAF$L:L#UJ6N)\(Z]]L0HQS@XKM0<@'UKSYP<78U0M%%%0,**** "BBB
M@ I,\4M03SK"A)--)MB;.*\;ZR]G"%C)!/I7!&\N;LY,AK7\77@NM3,?4?\
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MVJ1K' J$-N6H?#:%/",S$8W!C62G@G6+Z6/[7*7">IKT*/0OL_A_[(@PVS%
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MY%.V_-FG4 ,0+C H\M<YP*55Q3J &L@;J*:53=T%24TKDYH 7:*"H(P12T4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%-4$$TZ@ HIK D<4HX%
M"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !2$@#F@G S6!K6L):<;P*J,7)@V1>,;9K
MW1)4CY.PU\RWVAW$6I.'7JW%>WWOB:1@Z;P4(Q7%W:I<7/F-CKFO0P])K<R<
MB[X3A6TT62(@"0XQ5R\B9@FWJ2*QFFE@P8ONUOZ$S7US&K\\UT37*B$=[X5L
MO*LD)7!Q73U4L(1!;(%&/EJW7CU9<TC:.PM%%%241SKOMY%]5(KS'6](FMY7
MD1< GG%>I51O;&.ZC(9<UI2GRLF1X=<I)YNTYI!"T&';IFNF\2Z:+2_4JN%Y
MKG[IS*FQ:]:G45C*S%FF5E"@\XIJ1,(LGK38-/N92&"&M 6-RPV;#FE*HK D
M=-X*,A+#)X:O1E^X/I7)^%M-:U@#,A!/-=8O2O,KRYF:K06BBBL2@HHHH **
M** "L_6+8W5@T8&36A2$9&#0G9@>-ZI8R65RV5(%94L,LW,8/'6O7=7T6&[&
M=F35*W\-6Z C9UKMA6T,I1/*XT9)0'!K0MD\VZA4#^,5U>K>&L3 PQG'M5C1
M_#VR=6DC(P<U<J]T)1L=;IT 2SBXYV"KHIL2[(U7T&*?7!)W9JE8****0PHH
MHH *J7]L+F%E(SD5;HIIV=Q-7.!N_#4AF8I'P34$GA1FC),0SBO0]H)Z4A4=
M,"MUB)(CE/'&TBYAN&C"D#-=CX8T>2!Q*Z<XKI'TJ!Y=Y49J[%$L2!5&*4ZS
MDAJ-AXZ4M%%8%A1110 4444 %)2T4,!*S]5LEN;1P5!..*T:1AE2*<6TQ-7/
M&M6TY[:\P%QG-)IFG-/= ,N037IM]HL%TV]ER:6UT.WMR'5.:Z_;Z$.)SP\,
M(RJ5B'2M/3/#\=M.KF,#!KI40*H %)SOZ5C*M)E*-AP 48%+116)04444 %8
M/B2(R6;#':MZJ&J1&2U<8S\M73TD)GBFI1M%=L?0TS7[3SO##RXR^S.:T=9C
MQ/)N'.351YQ/I!MF.?EQBO7C[R,6M3R:*1DN4YP5-?2/POU$7.@A6;)  _G7
MSIJ=NUO>O@8&:]7^$>H28\D-\O\ ]>N7$QT-%H>YT4BG*@TM>>6%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4@8&FOGM6/K]S-9V!DBZYH VMP]103D'!KSRWU/5YX]Z!B,^E=1H4U
MT\;?:00>V: -I,XYIU1Y;;3QG'- #9)5B4LQP!20S+,FY3D5S_BV\DM-,ED0
MXP*;X)O7OM#BE<Y)44 =-2'IQ0>E(N>] "(>QZT^DVC.:6@ HIF3O]J?0 44
MF<4M !13&SGBGCI0 4444 %(2%!)[4M9.NW+VUD[(<'% &C%.DI(4YQ4A.!7
M(^#K^6\FG$AS@5UQ&10 HY%%)T'%(N>] #J*** "D)P,^E-YW^U1W;[+25AU
M"'% #HYED) /2I:XSP[?W$VH2K(3M'2NR/W?PH C-P@;&:D5@PR*XT/J)U60
M%6\O=Q77P@B%,]<#- $E%%)G- "T4C9V\4#IS0 !@:6D"@4M !1110 44F1G
M%-8G(Q0 ^BF9.Z@9W>U #Z*** "BD)Q2T %%%% !1110 UW"#DU&]PB1[R>*
MY[Q/?36FSRSC)JM/?2_\([YI/S;: .N1PZ!AT-.JEI+F32X'/4K5V@ HIKYQ
MQ2CIS0 M(3BEI",T +1110 4444 %(>G%+10!7-PL;;6/-3*P9<@URVN_;1?
M)Y"DKWQ5F2]FM-+B:0X<MCG\* .BHJE8W!GAW9SQ5M<XYH =112'..* %HI%
MSMYI: "B@G%,4DM[4 /HI#TXI%SMYH =FBN;N]5=+H1JW\6*Z&%BT*,>XS0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSVZW<=PIVR+CGZUDZEI>K:?*PT\,%!XQ0!J^*KD/<Q)&>@YQ69<#R+R&8C@
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MSB@!?B!(8[NUQW']:Z#2CG1HR?[E9WC#2I=0N+=D!.T<ULV%J\&F)&PY"XH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-:?8[*-/516G7(]S8****0!1110 4444 %%%% !1110 4444 %%%% !1110
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M3MIW9S7%^&-8\Z]N$=R<=*[ SJD6\GB@">BJL5]%*<*:L;A0 ZBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(%"H* .9\3"<^'IN#PO-8/@%+G[-&Y4[<5VOB-5&@77 ^Y65X#53H$9 'W:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 AZ5\Q_%FVV>([F<#^,FOIVO"O
MB]I85;F[QZFM:7Q$35SG_A3>_9;2\R<;F_I7(^,W\[7';U<U)X=U)M.A(7_E
MIS5'Q#(6O%<\ECFN]P25S&[/;?A?#GPZ_';^E>4>./W?BFY_W_Z5[3\+H/\
MBC_,QUS_ "KQWXA1$>)IVQCY_P"E<]-^^7;0P'G9K<K5[PLN[6K8?]-!_.J
M&8]_I6SX(@\[7X3Z.*WJOW3-'M'CN#/AM6QT@'\J^=]-F:&;</6OISQI!O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **:
M&R2*=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUCGC/RL,UH*,"N+^'UQ/+H\(DS@#BNUH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***9+((
MD+-T% "@'=3JPU\3V37K6H<>8.V:UGN42V,Y/R@9H FHK%A\2V4]V+=7&\^]
M;*L&&10 M%(2 ::Q(R>U #\T5R5GXMMGU2:U9_F1L=:ZM&#HK#H1F@!U%)N&
M<4M !1110 4444 %%-;.>*=VH **** "BBB@ HHHH ***P]=UV'248R-C H
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M/%2T %%%(3@4 +2;AG%074X@@:0G@"N,A\:6\FK?9=XW;L8S0!W=%(.0#2T
M%%%% !112%@* #&*7-94&NVL]R\","R'!YK$\3^+[?0[CRY7P< ]: .PHK*\
M/:HFL:3'=QG*MWK37.3F@!U)D4A8"N3U?Q=;6&HI:L^&9@.OO0!UU%5X;E6L
MUGS\I&:B@U*&XDV(02: +M%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP<UYQ\,VE^P@/G&:]&48% #J*** "BBB@ HHHH **** "BBB@ HHHH ****
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M>YD+,%+<4 >X6NI6UX/W+AOQI)-2MHGVLX!KRSX?:X7OQ:LV2U1>+-<ELM1
M7)S(!^M 'JLNKVD.-\@&>G-6H)X[B,/&<J:\0UW5+QK:&;RV"CDFO2?!6HK<
M^'HIBW\ - '07>HV]D0)G"YKSSQ_=07MM(8Y,Y7L?:L;QEXEDOM1\BV&[R^#
MBN6U;4+I8=DL;#*]Z /5/AA'Y?AB$9S_ /J%=WG%<+\,^?#D)_ST%=PX'4G
M% #+BYCM8C)*V%'>N7\1:I97VE7"1R@GRSW]JPOB'XG-M;FRA^9WSTKS]+F]
MALI)9$;#(?Y4 :7P[B']M7'S''/\ZUM8T"WE\6&<.=V_.,UC_#)C)?W#-P<?
MUJ]JFJF#QDR'_GI0!VVLZO;V&B+#Y@#!/6O./#FCV.OW\ES/-A_,.!GWJSXV
MCN6MHY$#%67-8?@J.YCNE**Q&[G\Z /2O%E[;:/H<=G%)EAG/-<EX&TFSU36
M3>2R_O$;(&:J_$%;CSO,8$*<XJ+X;QSC4%< [<\T >]23Q6-H'D;"*.M5X-:
ML[E@L4@)/O7$>._$21:>+!&&]Q7":5K\FFW<!=CAG Y]Z />I[Z"V4-(P -0
M?VS9A-_F#'UKA_%FI[M%2XC;H,G%<)9ZW>7UHL<:,0>XH ]_6='A$H/RD9S5
M!M>L5D*&4;@<=:Y*Z\2C2M @BE(#E.]>:7.M2/<27(8XW$T ?01OH%@$Q8;#
MWJK'KMC+YFR4'R_O<]*\]L_$ O\ PM& WS ?T%<78:Q<Q76H01@N7./ITH ]
MXMM:L[N7RXI 6],U5U[5H;*PF+. =AKQSPQK4]CXFBCGR-QZ'ZBNM\?":72&
MFCR<CM0!)X)\00W%_<":0#TYJMXTT:#4;F2??P3GK7G_ (52Z_M= BM@GFNR
M\4:DUDC1L.10!Z'X=C@T_1(!OX5:M#Q)IK.4$RY!QUKGK0O-X8B=.KI7EMT+
MBQO)I'<CYR?UH ^A([F.6+S$;*^M>>>.O$<-KJUC"D@P6PWZT>"_$PU.S:TS
M\Z+ZUYQX\BN'\0X8$8?Y?>@#W+P_J5K/;!8Y Q('>M.ZU*VM!F9POXUY;X"2
MXMX_-F!"@=ZK>,?$1N+]K6-ONC/% 'K=IJ-O>Y\EPV*GE=40ES@5XYX.\3&Q
MOT@D;/F<<UUOB[Q4EA;2*A!(!H V=4UBQDLIHQ*-P&.M>*:?\WC,,&.#+_6I
M8KN^NEFN-C;&Y%4O#,AG\2QEQ@B3^M 'TDIQ&"?2LZXUVQM7*2R@$>]7V_X]
MS_NUXOXS2Y_M&0J6"YH ]?M-4MKW_4R!OQJX2%4L>@&:\3\&>(FM=56S<YW#
MO7I'B#Q%%IVDF4L,LI H TI==L87V/* <^M4-9\06]I8//'(,A2>M>,SZC?Z
ME>F6.-BH.>*V]5CNW\,-*RL#LZ4 3>$-<BGUNY>>3&^3CGVK6\?:);ZI,LSO
MC*C'/M7F'A^"X?4XC&#][G%>A^.=0:SC@0]?*7/Y"@#KO!QM]&\,01N^$'0D
M^PKIK>^@N5W1,"*\UMY'N_ =K*F<@D_H*N> ]3,Z7<4C?ZGCG\* .WFU*UCF
M\MY '(Z9KSWQ)I%K>:U#<^9SO7O[U!J5T]SXPAAC8E=K=/PJMKMP]MJMO$<_
M?7^= '>:MJ$6E^%W.[#!/EKE_!GB""[\N260!R>F:C\=^<_AZ,H"5(YKSGPH
MET+J/8K%<T ?0S:Y9*X4RC)Z<U>,R+$)"?E(SFO$_$LMQIE]8DY_> $_G7I5
M_?K%X3CE#?-Y(/Z4 ;T%Y#<?ZM@:L5P?@.[DO;03MG!KO* "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** (+S_CU?Z5D^&L>1/@?QG^9K6N
M_P#CU?Z5E>&\>1/C^^?YF@#<HHHH 04M%% !1110 F!2T44 %(0",&EHH 0*
M%' J*2$21LI&01BIJ*+@>/\ B[P?<MJ#7%J-HSG@5A26FK):[?,DSCU->[S6
M\<PPX!JH=%M&&#$OY4 </X<T*XNM-(NLN6'&[FN6U3PKJ&F:DQ@9E1B3A>*]
ML@MH[= L8  J.XLH;E\R*#]:74#QFSL=4:X7,DF ?4UT/BS1[F]T:S09+!>?
MUKT%-)M4.1&M326<4J!64$#I3 Y#P+I#VNB3P3#[Q'45PFN>%KN'6UN( 5 D
M!.![U[;# D"[4& :AET^"8Y= : /+/$5KJ%S'"87<;8U!P3Z5S\&B:I?8BE9
MR#QSFO<6TRW88*"DCTJVB;*Q@&@#*\+:.=,L45@ ?I71TB@*,"EH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *I:JI>Q<"KM1S)YD3+ZB@#YZ;CQ],A., ?S->RWC*O@N3YA
M_J_ZUY=XL\.7UGXF?48T(C8#D5H2^+%?0_[-+MYS+MQB@##\)QE_&J2#H"?Y
MBG^)%!UZ,.,@S#^=;G@3P]=)JOVR5/DZY-8_B.%SXB3@X$P_G0!V/B'3K9/!
MLD@C7=Y8YQ63\+F/V*(9[5O>(<OX-D3G/EBL/X8QM%:1*P(.* (-"4?\)9J!
M_P"FO]!47BYO/\?V<3?ZORN0?HM3:4CCQ7>X!P9?Z"CQY836^NVVIJI$:Q@$
MCZ"@#M)-/LDT+/EIT/8>E<'X,*Q^)=051QOXQ^%3GQ0+K1A#&[;AG/%4O  /
M]M7;2?>=N/TH TM2^;Q[9*#@D'^8KJ?&3!-!8%A]VN,\5E].\4VMZP(10>1]
M12>*-:?5M("6[,3QF@"KX8=H]&U5USQ'_45R.B02ZA?!LDY:N]\$:?)=:+J$
M&WYWBQ^HKGM(M&\-ZV/MJD1H_/% !IWAN[M]9$BY +9KWNQS'8VZ-U$8'Z5Q
M&FZC8ZG<!K<=#Z5WT2CR4_W10!7U&\2SMC(_3%>0:[?1>([FX2W3!A/S'_/U
MKT_Q-!)-IY"=@<UY+H]Q;V.H:A%(N)'..GTH K>"K62V\:P*3QZ?B*TO$D0N
M-=12/^6P_G47AX,_CVV=0=F/ZBKOB*-O[<C* _ZT?SH ZGQ)86Z^")R(UWB/
M@XK&\#.\/@5&W'(CKH?$JLW@B8#KY8K$^'UK)-X1CB8'E,8- '*^#K<7WB.]
M:?!'F\;OH*WOB!9VT,6$50=@Z#VKF&2Y\/>(IW;<J.^1BIO&&H2ZF$:(L5V#
M/Y4 >B?#(8\+P_Y["NPOB19R8ZXKC?AHKIX;A#9'_P"H5VMPGF0,OJ* /$]2
MC-]XWM[>4Y4YZ_45W&OZ/:Q>'I J("L9YQ7$^-+*YT[78K^,%0F>15O4?$K:
MIH#00NQDV<\4 9?P\ &K7 7H/\:@UU#)X[;'_/7^M2_#A'6_N"X.<>GO1K*G
M_A,RP!_UE '>Z_;0_P#"/1;U!/E^E9'PQM87MYBZ D2-CCW-:GB4M_8$ &>8
MZH?#-&CM9-P/,C?SH D^*UO"FD0LJ ')YQ6=\-HXQI-S)M&Y5XX^E:_Q14RZ
M5$@&2":H?"R$M9W43#J,<_A0!Q'BAIKWQ;"F3MYX_$4Z\T">=X-@(PZGI[UO
M^+M(DT_Q%#J#)B!,[C^5:-IXATNX\F-!\Y8#I0!%K%C+;^&G64Y^3C-:'PXT
MJ"31H7DC4G:.HJQXS4MH1*#@BI?APQ71X4.?NB@#BOBIO%[#%$2J@8P*QK/0
MYKK3@5&<K7;_ !&\/W-Y<QSQ)E5'-9FBZW9:?:BWN/OJ,'B@"IIND7&G:4?,
M)VXZ4?#VWBNO$%\)%# /W'TKK=2:.Z\/K- /E(..*YGX:*4UW4"P(^;_  H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $%W_QZO]*RO#>/
M(GQ_?/\ ,UJWG_'K)]*R?#/^HG_WS_,T^@&[1112 **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEO5N3'\X.:NW/A>RN4VNF16]10!DOH-J]HMN5&U1@5DQ^!--C9B(^IS7644
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (+S_ (]9
M/I63X9_U$_\ OG^9K6O/^/63Z5D>&?\ 43_[Y_F:8&]1112 **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH ****  ]*B1$WDA>:EI,8H 6BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***:6P<4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@"-H8W.64$T\  8%+10 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 07G_'K)]*R/#/^
MHG_WS_,UKWG_ !ZR?2LCPS_J)_\ ?/\ ,T ;U%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 456NKZ"S7=,P4&JJZ]8N<"4?G0!IT5%#<
M1SKNC.14M !1110 444UVVKF@!U%8T>JA[YH >E;"G*@T +2!@3BEIH7!S0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB:A!%<3%O-/'- 'I.13%GC:3RPP+#M34RT:MG^&N.:_?3_$[/*Q\M@ !GZT
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M.>,L"&$R?=W<5M:+SI%MM^[MK%\=PR36$/E@G#'.*DT#6((=+A@DD =%P0:
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MUH O:OSX@L-__/3C\C7?:J2+$D'^&O/?%.ZVUO3Y#PHDY_(UU&MZS$VCDQR
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MS,;N33E4Y&[YORK6\2Z,]UISQP+R5KG/!HEN[UEF!/E=*[N_U".U4[V QZT
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M0$=2:HZ9\0C?:HMJ$."V,T >AT4R-M\:MZC-/H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#*UO1X]
M7@6-^-IK)C\'Q1J@$C?+75TA.!F@#G9O"\4T!B9B16E:Z7%;6IA X*XJ^K9H
M9L4 96FZ)'83O(I/S5KT#I10!AZWX?AUB>*23K'6FD(BMTA X50*G"X-#]*
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MK"TG5O$&M7EQ'#<OQTYKHKJ%],^'$"GAG<@_I5[X<:3##8WMY*HRL><D>XH
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MT=<5+\+8UUN5)1Q)#RV:T_&'B3PSJD'ESLAD"UR_P[U,6OB5X=./[AWP<>E
M'T9&A55'H*EJ. EH$)ZD5)0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% #=WS8I2RC@D56O+J.SC\QS
MBN1N=8O-1NF%@250_-B@#M@5[$4I&:Y33+^\6]2.X)P?6NJW@KF@!U-W?-BD
M4\\T[:,YH 0MBEZBFG!-!SGCI0 \<4QY K >M+O&<4CH&Y[B@ \P;POK3B0.
MIJ-4&=QZBL'Q%J,UF(O+.,N!^M '0E@#3JKVC>;:QNW4BIMXW8S0 ZDR/6F3
M-LB9O2N?37 +LP,WS9Q0!TE(&R:B5B4'K4B@"@!U,=P@YH)(;/:AE5QS0 HP
M%S2@Y% QC% &!0 M-+8.*=2%03F@!:;O&<9H?.PXZXKG8O[1&I.7SY0/% '1
M[AG%& .:Q9=3":A'#NY(JUJ$\D=FSH>0* +^\9P#3JYSP[>S7DL@E.=HXKHB
M0!0 A;%*>1Q36P<9I2P% "KPO--+( >14=TY6W9EZ@5PFG:W>W6L75L6)5&P
M/TH [Y)$8X!&:>S8KB8CK">)("V[[)CYOS%=ID,,T .X/-+2"EH *16S1D&@
M "@!:A\P,Q7TJ4D4T1J#NH B$@60(>IJ5EZ$4W8A?=W%.9NPH <.E+358&E)
MP* %I#TI1R** $7(7FD!!R*=4?\ %Q0 $;3GM3LAAFE(R,&FL,# H 4,,?2@
M$'FFL5CC+'IWK"@UI)=7^S*W&[% &^&R<4I.!28QTI!R.: ' Y&:"<"DX44B
M\YS0 Y6S32^#BE(PO%($SR: 'TF!G-&0!0""*  C--) ;%*S "F#YAF@"6BF
MK]WFE!!- "T44F0* %HIK-@4U=V>: )*:6&<4C'GBE('4T !(44NX>O6HS\V
M?2N<U6_N+;5+:)2=CMS0!TQ89Q3?+0-N[TD9W(I/4BLOQ!?M86893AFX'UH
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MC)=HP",5VDMC#+('9 2*G,"-'L9010!YQ\)-)N-/TNZ%TA1V<$9'UKTH5'%
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ML).2@IZ1)']U0* $4%-JCH!4E%% !1110 4444 %%%% !1110 4444 %%%%
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M=-3>X/FP?-&>XJS<ZND4"J&_>$=*H>$[;RO#:;N2!_2L>!DOM<E620*(FZ4
M;MMKNR8"X.T&JGBR1)(('4Y!D7^=9?B^*.'3_/@D!9>PINH2&70[(G[V]/YB
M@#MH)#%I*N.H6N>.KW:S[V4[,]<5N1NBZ2@=L?+7 Z[XAE@+VL4!91D;A0!W
M:ZG%=Z>YC8%U'(KS7[7.VLL^#D.<?G6EX&NGN4N]^<[NGX4L-JIUD^[_ -:
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M0 4444 %%%% !1110 4444 %%%% '.:UI5U=OF%R*JZ+HM[:7!::0D9KK:*
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M27T<5JHR#G/2N8>)HO#>HS]G3(_2F0V.H7NU)MS8/>NEO]-)\-26JK\[)C%
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M:* *K6432E]HS5A4"KM%.HH 0* *CEMTE7# 5+10!!%;1Q'Y0*E9 PY%.HH
MC6)5Z"H6LHF.2HJU10!7BM(XFW*HJ5XP_44^B@!J($& ,4T0J)-^.:DHH :Z
M!T*D<&FQ0K$FT#BI** *QLXR^[:,U,D:H, "GT4 1"W02F3')ISQB08(I]%
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M"XM7\U 1BAG3AZSIR/EEH'MPP=3P:MZ7JTME<HZD@ UV/C.TM;=F\J+'7M7
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!=G$#5/5:\_X]VIH3
M.0T/!\73'OM_QKN*X?0E_P"*LF/^S_C7<4/<([!1112&%%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5R(_-7<!TS4LE[!"%#R*,],FO"[_ %F\TGQ!O:1MC$ "NB\5:C<_V3IM[&[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J.K?\>+?6KU4-8_X\
M6^M-">QBZ!C[>WTKJ:Y?P_C[:Q[UU%#%'8****104444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG+(>N>M=]8V2V5HD"]%&*MT4 (HQ2T44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !69KG_ "#F
M^M:=9>N?\@UOK30F9WAP?.372US7AT')/:NEHD*+N@HHHI%!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5YPQ_XK[_MK_6O1Z\X;_D?O^VO]:<1,]&'2EI!TI:0P
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDD2R##
M&GT4 1QPI%]Q0*DHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.2%)<;U!Q
MZBI** (E5(>%7'TJ0'(S05!I1Q0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5EZ]QIS?6M2LKQ!_R#&^M-;B:NBEX=Y7
M\:Z$5SWAK_5?C714Y.[)BK!1114EA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y
MTP'_  GGOYM>BUYRW_(_?]M?ZT7L)JYZ*.E+2#I2T#"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M32+L;OWT*\UDVFI:F=/VB$\CTJ/1K:Z2RU:6Y0KO&1D?2@!NEZAJ>HR. 6*
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MR*]1[4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 A&17.>
M*=--[IK #)S724R2,2+@C(JHR:(G#F1R'A+0/[/C\YAR377_ '>*(XUC7 &!
M3L42ES"A3Y1:***DT"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!",UD-HR-J'VG'
M?-:Y&12*,"@328V/@;?2GBEQ10.P4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%%  >E,P)!\PI]% $ B3=@*!4P&!BEQ10 444
M4 %%%% !65>ZF+6[$;=#WK5K"US2Y+[F+@T /O-1MWM"2RL2.E<SHL4BIJLA
M4[7^[^E2IX:OMXW.=N:ZFWTY8M/\K:-Q&#QUH YO3+-K[3IXB,$FLSPS,UCK
MSQ3#:@)&37<V5E]F## &:QM:T47'S6[*CYZB@#G/B)JI6.-(1O#-SBFQ!Y/
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MH>NO%L)CXP:OZP6N-5TN91G<V3[=:Z_5=(CO%5E0;^YQ52'0V$L+. ?+Z<4
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MF//2@!VC6#JUQ>$'YHV/Z5%X59VGFW*1^\;^==C;6BQ6GE8'*XJK9:6+5V(
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MAJ]6[S&Y$>>@H Z/3KF.65@B >]:]9NFV)M4^;KBM*@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HJ"5V1\]JKQ:M:RW36ZR R+U% %^BCJ** "BBB@ HHHH **** "BBB@
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M *R]5$OD,(B<XK4J&5-YP10!B:#I[P,\DHY8YKH::BA5  IU !1110 4444
M%%%-;..* '4Q@=W%.'3FD+@'&: '4444 %%%% !1110 4444 %%%% !1110
M4'FBB@ IC [N*%D5B0#TIP(- "T444 13)O3%1V]I'$V\* Q[U9HH **** &
M+G)S3Z** "BBB@ HHHH 9*@>,J>]1V\"Q( !BIZ* "BBB@ HHHH **** &-G
M(Q39P3&0.N*EIG._VH X]A?K<2C<V">*33]'N);L7%RN6!R":ZUK9&;<14P4
M 8 H !TI:9SO]J?0 @&*6BB@ HHHH **** "BBB@ HHHH 8V<C%/HHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M".U?+NAZ?>^(M:99+IDP_0GWKZ4T"R:QTV.%GW%1C- &M1110 4444 %%%%
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M@ HHHH **** $/2D4DTZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDR#M[UW-<7XM7#0D?\]%_G0!H7=G#;^%I_*4#,=<QX/TIYXHS+S&>U=???\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQP0A(Q@ 59H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** $P*6BHY02GR]: %ED$<3.>P
MKQ_QKXW6/5/L<;,K<]Z]4U"ZCM+%FF(  YS7S%XZU2WO?$[7%MRBDJ2!WXH
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M #"I+5S>LZ-<W<I>%L$BNGHH X_2?#L\4^^Z._'3-=<B+&NU1@4ZB@ HHHH
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MN1*HYSGI0!P7C1+F\_LH!2<(,X'O72^+(&@^'\-O&N'8(<?A797'A:WN##N
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MT2-",<UN+R*KPPB"W1%'0587[HH 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M27$+G"R*?H:>SJ@RS #WH =147VB'&?,7\Z$N(7^Y(I^AH EHHIN\#))P!0
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MZ&@!]%1_:(=VWS%SZ9IY( R30 M%1?:8"VWS5SZ9J7/&: "BBD9@HRQP!WH
M:\@0_-P*KKJ5HTWE"92_IFJVJW4)LGV3+N]C7CFE7EX_Q#DC,S&, <9X[T >
M[ @C(I:JPSQQVZ>9(JG'<U*MS YPLJD^@- $M%-9U099@![TS[1#C/F+CZT
M2T5&EQ#)]R16^AI#<0AMID4'TS0!+14?FKNP*1KJ!#AI5!]": ):*9'-'+_J
MW5OH:<6"C).!0 M%1?:8,X\U?SH^TP?\]5_.@"6BD5U9<J01ZBHVN84.&E4'
MT)H EHIJNKC*L"/:G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%^(?B*[-[#!I\K!E.&V_C4/AZ74M*T7;*K*,=Z?X'L$\0:WJ#W@W;&^7/X4
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M$+J60P'J"?<5+XI*#7(6[^<O\Z]<LO#=G;;)D0!@O6O%?&,ICU=CG[KY'YT
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MXHTZ&72X96 W%,U%\/=%MIH6G9065S@_C0!S_CC5+J#5XX4D8$'FNQN9KQO
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MUKR?QA?:Y_;TJVLSB,+G -=M\/;M$\/W+S-A0P&3^-<OXHF:XU"5K'#G;VH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTE(0,W&3CTKTG0=&:ST)+&1MQ4=3]*X_Q)\/WN+T7%O)L).3B@#G_B%JZWR
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I",BEHH 88D/44X
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M*HW?2M#MB@!H88/M3#$DG)%2;10!@4 (J*@P!3B,T44 ,,2GM3MHVXQQ2T4
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M!5!Q[5JH@C4*!P* *VGV:65HL*#"CM4S6\;')%2T4 -2-8QA13J** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHS
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPE> ZH5/ W5K>.9@T5N$.3YB_P Q4$?A:XM[@R0G!S5N#0+J:X4W3;E4YY-
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M0*8E<B/TS5G1O"QLK]KAQ\S')- &%KP)\66N>FP\_E71ZQ@:"F.<?_6J76M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1@>E%% "8XH"@=J6B@""[C,EJZ*.2*Y[0=.N+-Y-XP"Y/ZUU%( !T% !CV
MI:** # ]**** "BBB@ HP/2BB@ HHHH ,#THHHH **** $P/2EHHH **** "
MC ]*** "BBB@!"H-+110 4444 (1D4 8I:* $*C-+110 4444 &!Z4444 %%
M%% !1BBB@ HHHH **** "BBB@ P/2C%%% !1110 48'I110 5#=(9+65!U*D
M"IJ* .+T32+JTU&21E.TFNSP,4;0.U+0 4F!Z4M% !1110!B>);&2]TQHXAE
MLU5\+:?/8P;)ACFND(!ZB@ #H* %HHHH 3 ]*6BB@ HHHH ,#THHHH ,#THP
M/2BB@ HHHH **** # ]**** "BBB@ HHHH ,#THHHH **** "BBB@ HHHH ,
M#THHHH **** "BBB@ HHHH **** #%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0P!WP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<N#]U,USNF>,II/$!A+G'FXZ^]7/ +F;1+P_],C_ "KRZQNFB\9;<_\ +?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU&ZF5V)P: /=@<BES4<1S&I]J&/S"@"2B@=** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!XS\2--DMM;^U1(<J.U9-E=75]IGENK<U[AK_AF/5G+,H.:S+3P1#;Q[0@H
M\@\ :?-!\059D(6NM^+UG)-I[[%)YKN]+\(16.K"[" 'UJ_K_AZ/5H2C*#0!
MXY\&;"6WU8.Z$<5Z7\2],_M'2 NW..:T/#WA>/2)MZJ!6[J=B+V#81F@#Y2T
MR6\T;6RJ(P&_'%=A\0EN-1T6U;:2=M>C2_#V"2[\[RQG=FM._P#"$5W:1Q%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTG@V]3U4T >:XQXJ3/\ ?KZE\!D?V,N*^6M2!MO$:L>/FKZ3^&MV)O#X;/-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH;G8#Y:]]&I6Q./,7\Z^._#GB"?1Y=RDCBNPM?B'=/=1KO;EA0!V7QX*RZ=
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "FJ,4ZB@"O?0"YM'B/\0Q7GEW\/XI;GS3&.N:]+IN 1
MTH Q_#FEKI=EY0&*VJ:J[13J "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%&: "BC-% !11FB@ HI,TN: "BDR*7- !11FC- !11FC-
M !129HS0 M%)D4N: "BDR*7- !129%+F@ HHS10 449HS0 449I,T +129%+
MF@ HHS29% "T4F:7- !11FDR* %HI,BC(H 6BC-)D4 +11FDR* %HI,BC(H
M6BDR*,B@!:*,TF10 M%)D4N: "BC-)D4 +129%&10 M%)FC- "T4F11D4 +1
M1FC- !11FC- !11FC- !11FC- !11FC- !129%&10 M%&:3(H 6BC-)D4 +1
M29%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4F!2T4 &*:1DTZ
MB@ HQ110 F!2T44 %%%% "8%&!2T4 %%%% !1@444 %%%% !1@444 (:*6B@
M0T+S3J**!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVH'8WO,7UIVY?6N+BUXM_%6A'JN8=V: L=)N&.M&Y?6LF&^WV>_-4Y-4*]Z
ML=#O7UHWKZUR_P#;!]:0:S\V-U 6.JW#UI-Z^M8,&I[^_:JTNL;9=N[O0(ZC
M(I-Z^M9:WN8 V>U9DFL;9,;N] ['4;AZT;AZUAP:COQS3I=0VS*N>M C;HJO
M!+O7-2,V#0!)148;YJ7=\V* 'T5&6YH#<T 24FX>M02R;5S64VHXE(S2N.QN
M;AZT;AZUBMJ&%SFFQ:CN)YHN%C<W#UH!!Z5AMJ. >:N:9=?: W/2F%C1HHHH
M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !113-WSXH ?1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@\.-F-JPK>W\Q6-=!X?38CBJ0F;U%%%40%%%% !1110 4444 %%%% !1110
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M?I31++M%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCH*>5 !P.U%K"/*03_PLO&>,UZGN4H!FO&]:O/L/CQYL]*TD\=$WOE;_ -:
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M?B#Q0?M).ZNL\$:_]KBCC)ZT >B%@.IIH=2>M<9XC\2_V<[ -TK&TOQI]IN
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M6$OVG!'-;'D9^*)8CO76^.8U31P0!U%-@8U_JG]E^#+>0MC(Q7,VNA/K8^T
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MJC(\XN]>\O5?+W?QXKT2RD\RSC?U6O$]31O[?SG_ ):?UKV*PE$>FP9/\(H
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M./>L'5W_ .*VC3UH SD_Y*'&QKU69PML6]J\KU%?LGBQ;CTKNYK\/H/G9[4
M<EI'S>.)FH\:G][_ ,"K.\+WWG^-)5S5WQL?WP_WJ!#O$'R^&K _2N\\.D?V
M/;X_NBN#\3<>$;)_0 U=\!^)!?HUMN_U2T#*'Q7&ZZL<?WQ63XDC,9TO/?;5
MGQ_>?:]3M$'.V05+XR@V6%A-C[B T >DZ'M.GQ8_NBK&H0^;8RQ_WA7)?#_7
M!J=HZ[L^7Q762W \T)GK0!Y3?7W]A:F(,[=QS71Z+!_:5['>8SCO7%?%)##K
MD<J\ #-=Q\,9OM.B;SR0: %\2'%]MIFK@GP8P'I4?BM]FH$U=\O[9X3*]>*
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M\ *33O#S-Y4V.N#0,[[3)?-@4^U7ZH:= 8( /:KJG- #J*** "BBB@ HHHH
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MO\* .NA@5/#[' _U?]*Y'PY$&U!CC^.NT5L^'3_US_I7)>%1F\D/^W0!)XQ
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MS3Y;*X"D MS7?MH'[P?)WJQ+X>^0'9VJDC-ZGF,-E<@$9;FI18W*<9:O0XM
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M"U+'&NS=BHU&Z<&J0F]1K6X+=*GB^1=M3. .:KAOWE:QV L=1BF@<TY?6C<
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MGC4\FN4TF]+-C-=?"P>+/M2OJ+H36Y%/F4FH(3\U7MN15=0((#Y8YI+B<.I
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M2VY_=+]*FJ"V_P!4/I4],05B:F^UR:VZP=9'WL4#1DRN)%(K)N6VMBK$4_\
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MR\=_\C)9@?WA7J'AW_CP3Z"J,Y&U11102%%%% !1110 4444 %%%% !1110
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M&WX9MA""SCJ*U-0)D&!45F@2!=OI4N/,XJ6M2&S,MX3YGXUJ&%ECQZT10@2
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M36G%<^:@ -<=<7W(P>E:^C7GF<$T(&<CXX_Y&&S'JPKT[PVN+!?I7F'CIO\
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MPO1:\AOK0VEV4QC)KZ*ECCFLWR,_+7BGBRU":HFT?Q52(3Z&EX90B#'K74-
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M70(X/%9[W>V;K63#J@DBZTPRM+)P:R:&SL;67S(5-6L8&:RM/8K;*#6GNW(
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MC?'K4=[J$B7( /%1Z8_[N3ZU5OD8R[J+V&MCJ-.F-Q;C)S5I_P!V,5G^'?\
M5J#5R]G477EU:&".^_-:5M<.O4U!;P;XPV*G,)5>*TZ"-.TNCYG)K9AD+"N7
MBW*1706C9C6I>Q.[+S?=IL Y.:'Y44Z/@5FQM:DJ-B09]:NS*)(?PK*=L.*T
M[=PT>#30,YR]B,;&LU6829KHM3BR<BL;ROGS5/8$))$L\9+C)K*OBMM;-C@U
MLM\JUROB*["1. :!F'I^H._B +GO7L.FC?8H3Z5X1H3F3Q"K]LU[OI$@^QJ/
M:A@0ZI_Q[[1UKF &6<GWKIKWYG8=JQ9(L29]ZRF4%W&7MUQ5",,) />MQ4#0
MX/I6>(MLWXT1$:<>?*7Z5/;?ZP?6F0C$?/I3HOE?-6!R/Q%C=H_D_NUYAH1G
MCU) 2<;J]G\2VPO(L8SQ7"VNB&*^4[>_I33$>B:1(39 GTJR[[CS5;3XS':[
M:D=L#%#%?4H7ULLH((IUA9+$H(%3D;AS5Q% @%%BB'&U\U-'\YIDH_=<=:=:
M.-V#0V Z8[4Q5>S),QJ>Z^;@5%:KM8FD!K>8J)]::NV0'-9MQ,<@ U:M9<BE
M<"G>P[3D5!;RY^4UJW@#1GZ5B1JPG'IFD]P+KQ?+D40,R<58XP*C8 '-%KB+
M N&QC-:EI/F( GFN?\X&7%:5JYW#TH$8?Q#?.B$>]7? G_(&A^E9OC_)T8_6
MM/P+_P @>'Z4">QV-%%%,S"N4\7-M5*ZNN2\8_ZI:3V&MSE6VS6[XZ@5AV/G
M1WH!SC=6MI88LZMW-6Y; )<HP'>L[:FQJ*?E7/I4W\/%5FRI4581OX3WJXB9
M-%Q'S2HP+\5'.XC@-06<NXC-4MQ+<NWD9EM]M<_=.T$>P=JZC>HCYKG-3B\V
M0[>F:&'4P=2W/"A;IFNVLPG]A0[>NVN8UBU*Z9&0.<UN:6['2XT/9:@.IR7B
M!FWGZUSAGD65,'O76Z];$DG'>N;^S;WX'0TF:+8Z[32MQ N[DXJRT,<1RPK*
MT>78=IJYK=T$ARI[46&D:]K!;W,1*@9%9&J6+*Q*CI1X2O\ S$=7/4UTM]%'
M]G9B.U,GH<58),+Q1SC-;.IQ2?9CUSBIM.AC:<,!WK4U%(_(/TIHEF3H#E5"
MMUK+U%&?76QZU;L)P-2$:T.4.ML&JNHR[/<?9=.4YP:Y>ZOVGW GBMGQ%N%C
M\E<PL$@@+G/(I2W B\.N%U6<BNILKCS9I5)KB=!8C5;BMW2[T)?R*QZFH8RC
MK\TMA>1LI(#-7H'A?51<6ZAFR<"N+\:V_F102(/>HO"NH/!(J,>XI(=CURY)
M9<KTQ5**#S'S5B"X66TS[4VUN(XPQ;M5DL);8B0$"G$,HYJRM[#*N015*YO(
MUR,BDV)/0C)_>58?/V;(K):]4R=:TQ<(;'- S.1S]H(JP[D8-5(CON<BK=P,
M(*9+V-6%C]G4^U4-17,3'UJXK@62'VJI<2+*NT4(1Y_<:2TUVS%>]=+HEJ;9
M2"*UX-/1CG%%TBVP&*3*8LA'E-GTK%:+S)>/6K-S>*J'FHM,N8YY,>]1<1/'
M9J"-PJZMFC1$@5+/'@C%/BE6-/FH+,B6W\AM^.E,$AEYJ36KZ*.T=@1Q6-I>
MI1RXY%6D(VU!QBITX%,B8/R.E._BIDM$L3[GQ4=Y"'7@<TR'*SDGI5@."QS5
MIDF3+'L K6T=R V:JW2!\;:L6O[I<4WL4D0ZL_[U<>M5)LN%Q4]]G.XU6MY
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MT<J.M<<;*?S#P: -3^TSD#=75Z7-YL"GVKS\64^\<&NWT2-TA4-Z4 ;5%%%
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MP*ADD\ODUG1WH:8<]ZL7S^9"2GI3"Q*+L/P#5:6 O-NJCIXE,XW9QFNC6)2
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M:EHBL@ JAK$?E0LQJ]HI+;0U5O%SK%8Y%(I'(^$5\S6[K\:GU: I<2$#O2>
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M*<:L.M3-'YD; ^E3NJJ:4@9&.]0!S,NE!I<[>];6F6X@C(Q6B]O'@&HF41G
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ME0:M&4EJ<MXH)^U0?6DDSOAI_B8#[3!]:1@-\-42=':_ZL?2IZKVO^K%6*3
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MD20L3FHG&T\=ZD0#(I7&,NI?+B8^U<M+J3&?;GO6_K,@C@/TKA8[D/J"C/\
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MTK-E7,J[U$^>%SWK:23]RA'<5Q%X[_;!_O5UEK)FV3/I30-E[S,+7)^)+B0
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MN&\+'R]2F(KH8+K-XXSWI"-BX@$T1'M7*W6G>5< @=Z[.'YH_P *J7-D)/F
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MU5UWGO4GDC.!VI!;02!.E)?PB1/PJVB;5I GF=:U Y@ VKX'K5Z"^"CDT:K
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M#4KS845SNGWOFR8S6JS$BK$V%_ LL(/K5'3[013$XK05]XVFED"Q+D4"N.G
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M:*(I,#UKH(%RR8IQ$]CB_&I_XG]E]17I_AW_ (\$^E>9>.!C7[+ZBO3/#O\
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M@+GK4$%7S"'R:FLWW76:AOE\M213]+^\&-/H/9&C=+W%-W%(01UI3(LDQ3-
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MKS'QB,:S8_A7IWAK_CP7Z"M492-RBBBF9A1110 4444 %%%% !1110 4444
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MBI=$O6EC!-+S Z"9P6V4L46:HM,3<5K1#]P&K2(KG/:O:F?Y,9YJ">$V=BA
MQQ72?9EE?)JGKD"_8PH[58&5H>J,\[(QZ5T,S;P#7$V"M!=D@=37:0?/$N?2
MF38JWL>^$GT%<A).Z2D<]:[NZB_=8]17,S:=F;..IJ6RBO;7)&"QK?LK@2ID
M'-<OJP-FOR^E7_"MR9XCN/>A,3W.K0Y3FI$7O5=I560*#4\9YQ57%L<KXGD9
M5?%+X4+%E8BKVMV?G[ABK6A6(@B4XQ6ER1VH0>;*3BH[FSQ:(0*U)45I34JP
MB5=A[4KC*MM$([93[5FZB5#KSWK7N/W4>T=JXG6=0*3*,]ZI C8U"(?8OE[K
M7.>';$_:Y&*_Q5T%E+]LM@#SQ5[2]-$)9L=:B8[&A 3$H K!\1W+*^!Z5T\<
M0,9)[5S>MP>:2<=*Q>X(P=+E9KY/K7H$<G[D+[5QNDV6)E8CH:[",=!3&RA<
MVVZ7)%4I+H0-Y>>E;]Y&$M6>O.M4U K>L,U28MSN=.O%E 0M6DY51D&O/-*U
M0K*.:ZA+\RH.:8K%]I.36;-='>1GO5QC^ZS6)=,0_P"-- ;EE/N%2W#%XG'M
M6=IK5J[-R'WH0T>>ZC:&2\#8Z&I+J=K6''3BNFGT]6ESCO6!K]L5=5 [4V(L
M^'KIYHB3GK72%=T!:L3PQ9[;9B1WKHRH$16DP9G0.5;%274(FC)-,9=LE$LN
MU*=QHSOLJ0-O'6KD;!TK*O;S!(S5C39Q)@9I +J5F)8AQ5>"V\B/@=JVI%#C
M%(]N/+J6A7//M4@*WBMCJU>F^%C_ *(@_P!FN.U:S'F*<=ZZ_P +G]UM]!0D
M#(O%'_'U!]:'.'A_"G^)AFY@^M-<9>&J,SI+7_5#Z5/4%K_JQ]*GIL KD/%J
M%K:3 [5U]8>O6XEMGJ6"."T.$><,U:O6_P!+,8Z4V+%K<8Z4C?O;K?ZU*1HB
MQ#"W7%))<M"<5T-M8JUFKXY(K UBW,0SCO5")EF\]!DU)L!@D^E9UE+P!FM$
MM_H[X]*!GFVJ)OO']FK3T2<PG!.*A> RW<O'>FL#;2+@=Z%N,]$L$6X@+=>*
MP_$-H?LTC8Z"M#PS=>:FTGK6QK%@LMLP SD4V)L\5M9'@N,\C!KL]*U#?M)-
M96J:7]F9B%JA9W30R >](+'H,O[^#/6HHR8(LT_2'%Q: ]:=>H$4BGT"Q1L[
MXOJ)4FNC*8C\P=ZX:T9EU<^F:]$MD$EFN?2I8'/7,K)N-9NBRLVH2Y]:W[ZV
M&&S65H]N%NY333$;$JB48-0,H@C8BD64^8P]*9-)OMY/84,96LK_ ,R4KGO6
M?XL<K:-C^[532IC]J<'^]5[Q'$9=/=L=%J2SGO!DI*M_O5Z/ 20*\Z\%I@,/
M]JO2XHP(,UK%">X,^&J:3!M=U5)#\A-212;X=IJK$O<LVK;H@IK-U6T$B-Q6
MA%\@ITZ>9$34L:9XSJ2O;ZA)@=ZFT^5Y'PV>*W-<TO-RS;>IJJ+'[-"' ZBI
M>Y45J5=2FW1JOI2Z1-B3KWJE</N9@>U0V-QLGQ[U!5F>AI<#[,3GH*HV5^)9
M&7=WJC)>;;)N?X:PM'U F[89_BH):/1DE$<).:XCQ)<^;,6!Z5LW]_Y=O@'M
M7'W5S]H<Y-(I$*7!%N>:FL(EFE#FLR9MGRCI5BPN?+8#-"W!FIJL 6V.*;X:
M0B\4XI9I?/BVDUL>';,"=3BMHD/<]"LC_HB_2FRN0:6W^6,+39!EJ;1 @R<&
MK2G$9^E%M#N%#X&X4D!A7,>9&(]:AB8^: ?6M)8Q(7S6=.GE29]Z&BS0F 7;
M]*RKXC?@5++=97KTK/:4RS"H8QR3M%\M:%M> <9JE/#B,OCI66MX4GVYH6X-
M">,IO-T^10:\GMIFAOMOO7J&L-Y]JP/>O.+FVV7Y('>M;BL>J^%;LR6\:D]J
MZZ*3:Q^E>?>%W,<$?TKME?$0;UI@<_K"$W!8#O6]H\SR0!#V%5)K<3OT[UM6
M-H(8P0.HK-@36D66;-8^OP;XFX[5OIB//O6;J2>:AH \TCM2LS''>L;7;EX[
MI *[B2SVNW'>N2UZRWW\8Q5+5 ;OA2Y=HU)]:[.2Y^7K7*Z#:>1 .,5MN^6Q
M4V G68EZOP?,0:S(E)D%:UN,8I/8#'\:<:)GWK<\"\Z/#]*Q?&@SHOXUM>!N
M-(A^E)$R.QHHHIF85!<5/5>Z8*A)I/8:W*5QC[.^/2O-M63.H+]:[P3F177-
M<AJ\6VZ4^]82W-HD$\QMXLCTJWI%S]ICR3WK-O\ YK-V'84WPS,?*(/K3AN5
MT.T0A8JS;F0ER!TITMSM7&:<B"6#?6B%+5'.:@SQDL :U]-A^U62[AVJ2ZT\
M2VV<5=TJ(1Q!/058NA@:FOV88]#5*YD^UVR(#G%7?%68XR1ZUC>')#>79C;G
M%0!TVD0^3#R,<4R:'<SG%:5T@M($[9J %&C)R.104<T$+3G/8U0UR9O,C"UM
MSQB-R1WK.EMQ=3KGUH$S6\/$/I\@?T[UEZC9@S[E%3W4QTT+&G&14UA_IBY/
M- ,MZ%:!HP6'-.U >1>Y%6;8BUN%CZ9J#6,&;</2@HYFYO)#JO&<5M6$!FE#
MD=:J1622SB0]:Z33+=58"F29-RYLIBXXK+N[IID8GN*V=;C'FL/>L6\B$=IN
M]J;U"Q!\/!CQ%<&O5P<,:\O^'*AM>N#7I;S(LI!(ZTB;ZBL-QK(U=2D?U%;:
M;6Z&L_6(P8_PH#J>3^(8B\F<5DZ>/+<?6NKUBVW*QQTKEXQL+'T-<TS:)H7*
M"1A6-?1E,@"M**;>X!-27UJ&MF?':L^HWW.2B=A= 5Z-X?N3]F1<UQ$=J,[\
M<UU6AMM"BM(LEJ[.YX>V%%A*1/M[55MIP0$)J]#&$;>*N]P-)@K+S7,:U?FT
MZ''-:,U^L9QNKE_%\P%HC@]:=B'HQT&M;W7+=Z[?1KH319SG KPAM5,,B_-W
MKU#P5J0N(B"W:J2)9UEU>-NVU3>'S!OQTJY) '.:GB@'D-]*&2CE;V-9#AJ@
MBTY&B) %,UZ<V]SM6KGA]S< !NYK.]C5,YK4]);S"P2M[P[8[;=<BNJN-%25
M<X%0QVBVB[0,8IIDMDT>G(8PV!FDNM/66WVD58M9]S;,T^\D$:'FJMH281TF
M*'G JU91)&_:LJ\U)@Y4&H8=3VORU [Z'4W<@CAR#VK&BO3*[*34SW0GMQSV
MK(BRL[8]:L?4TT^5B:>LY\Y1[TV)2RTP*1*#Z&@#5O)O*08]*X#Q/=EBV3VK
MMIW\Q.?2O/O%(*RD>HJ)(#C#<;KC!/>M:Q&)U85S=PY2[&*Z31\R*K&LQVL=
MWI.I,%6+-=QI\V81DUYA8/MO5&:] LI,6BD4)Z T&H*'D:L&Y3&:VKE\KFLF
MZY7-4)Z&?$W[PBI)+3[0O(JLF1-^-=%:P Q XZBF"W.5DTD-(/E[UM:?IGEL
MIV]*OBV'FC([UKQVZA5Q30,\Y\:?\ARR'N*].\-?\>"_2O,_' QXALQ_M"O3
MO#HQ8)]*U1FS:HHHID!1110 4444 %%%% !1110 4444 %%%% !45Q'YL14]
MZEHH \F\3:4;+4GO$7D&NFT'5 =*0R-@X[UL:QI"WT; KG->;:]=RZ,&A0$!
M: .KT6=9O$4A!S7;.<"O)_ %\;O5BS'DBO5OO-B@"1>E+2#@4M !37^Z:=2-
M]TT <]>Y6Y7ZUDZA_P ?T=;EXH:8&L:]7-]'2>P%SL!3U.U<4\)\HJ.3BI>Q
M2&LPZ5GR7(6<KFI+B<(I.:YZ6[+7?!J#56.E2<NN*N6YQ6=8KNB5C6FHVK31
M/4HZHOF1FN1-NWVD\=Z[J6(2+BL^;355@V.IJXL'L2Z0I\OIT%:\?WN:@L+<
M(O2K4B^60:IL98D($><]JS)) Y/--OKSRTZ]JPEU#,V,]328(W%.!Q2;S26Q
M$B9IY3#5+U%8ADF*56FE\Q#3KT%2<57M@9&"T="&.L+ &Y\S%:LHVC;4UG"$
M&2*AG/[UA04B"9]L=<SJ]UY0SGO6W)+N=E]*Y'Q"[;30V:%S3=0WAAN[5D:H
MS+.&'<U1T2Y8W#*?6NAO+,2A&Q6;0[F4^Z=%!%;.A6YB;..]-AL0,<5MVL"1
M0D\9K1+0"U<?.5/I569<KBGI)O4GTIK_ .J+5G;41R^K$@F(=ZTM!AVVR\5!
M/;^?<9(K9T^ 11A:;0GN-(/VJMF%OW %4IH,+O%7(>+4$U426.$NTFL>[N6F
ME*'I5OSAYA&:@N[?8OF =:HHKV]BI?=BMJW(4!?2LF&8J.:=!>9EQGO0V+J;
MK@.M4VM06SBK,;Y4>]*]0QHY3Q!:>9&<#M5#0P;.SD)XP:ZZYM1/P16)J-I]
MDMW51U%"T$]2O;ZFTUXHSWKJ86^4-7!:4CF^7(/6NY7Y4 K2(GJ3O")AFK$:
M""'TJ*U;<P%/U-_)M2138D9YN\W14&M2V;O7'V4[2ZD1VKKK?A14H;$OTS$3
M7FOB12LR_P"]7JL\8>'\*\_\061DG''1JT0-%CPYEHAQVKK[=0J'-8OAZR\N
M'D=JTKNX$"'G%3(-29I@N0#UK*ND\R0#UJ&"]$TF,]ZT=FXAJS:"Q#;V@B&0
M*O0?ZT TL:YI[J(UW#M32'LK!JS8L& ]*\CU02-J3<'%>I3.;B(J>]85QH*R
M2F3;0+8XVTWQR D&NITN4R, :;<:0(ER%J;3H3')TJD!T07,('M6-<Q%I#QW
MK:C_ -6*8]J"<XZU0V5-/0KG-:L)R&JNL0B'UJ:W/./6BQ+9$P);I67J-GY[
M@D5T;0#&?6JL\ /:F(JZ7 (+-J>),J:=GRXBH[U .(B34L9#(_SU!<M^Y)J*
M68>;@&I&^>+%(:.0U.X82$5?T.X)9<U6U.U+3MQ5C2(624#% TCJ=QV U+(W
M[I:8BYB%*WS#'I02U8S-3BW(IQ6GX;?:2*CGA\R/D=*-$^2X8>]("?Q,W^D6
M_P!:'.'AI?$8S-;GWH<9>&J,SI+7_5#Z5/4%K_JQ]*GH8!6/JK_*RUL5AZJ<
M.:!HX#4I#'>MZ58M?F16HU>#):04:>/W2@U)9VVE'S+95/I6=KMGNC.!6MI4
M>VU5O:II[<7&010A=3S2$O'<,I!XK9A<- X)[5HW^C+$2ZKUKG[N1[:-Q@CB
MAB;,^V@5[F7ZU%J=F0-P'2J^D7327C@_WJZRXLA-;9QVH0T8GANY,3X)QS7?
M1RK<18)[5YIDV=X%'&371VVJ^6Z+NZU3*L)XBL 0Q [5P%W 8<MCI7JL^R[@
M))'2N,UJS158#%("]X6N-UBH)YK3OLL#7+^'Y_+G6$'C-=E)#OCS30T8=K9C
M[3YF*ZRREP@2L9$V/5ZWDVMUJ02U%UE_+A+>M8>B3;[N09J_KTV;7K7/^%9O
M,OYAGI0B;'2S(%#,*S(9=RRJ:T2^]G6L>;,#M[TP95L[<I=\#JU;FMP#^R9"
M?[E1:/"L[ECV-6O$C!-*F _NU/4I'%>%#ME8#^]7HZ/\@7VKS7PCEV9O]JO1
M(6Z9K6)-Q)2=^VB$[9=M3,@9\U%(-C;JT$BV#EL5;1<IBJMK\Z@FK0=5.,UF
MQK<Y[4[/?(>.]9UW:?Z-C'05U%S$'YK/NH 8L8J9%QT/*[]&CF<8[U1LR?-)
M/K7::II626"]:YU[)H9.%ZFH*N6)9B;-Q_LUS^DS;+EB?[U=') 1:MQU%<JH
M,%R0.YH![G1W]\7@//:N?6YSGFK%U(?)/TK(@<F8+[T"N7Y,O&6J&"0B3%;,
M=IOM3Q66;9DN<;30#9H)*=HKMO#@)1&KCK.W+N%(KO\ 0[?RXD&*VB3<Z7.V
M$&HT;<U3%<P@5%"O[PBAD&E"0D>3Z5E7-THD(![T^_NO(AZ]JXZ74V>Y(SWI
M)CL=4KX(QWJMJ:[5!IFGR&903VIVIY*?A292,;S"3BI(8\S+]:B@4LQSZUI6
M\8W ^E2RK%BZA LF/M7"SN1J.T>M=S?SA;1AGM7&^4LEYO\ >BX;CKL$VYKD
MIK1I+PG:>M>@O:"2VX%0VNAB1PQ6K0BOH5N8XDR*ZESMMQ3(]/%O$,#I2MDJ
M%HN%AUIEWYK;M3NX]*RK:/9SZULV"9)J6PL17#[.M5$=9E;FEU^3[.F<USVE
MZEOF9=W>A,5B[<6QR2!7-7]B9+Q&*]#7?K LJ9]:S;S3@)@<528S*M8#'!TJ
M2)&9LXK52U^7;BI?LBQIDT$HIH@5<U=@8;:S;BX5'V@BG0W/;-1)EK8@\9L/
M[$_&MOP.?^)/#]*Y3Q;<;]+VY[UU?@?_ ) \/TI(F1V Z4M%%48A6+KMUY"J
M,XS6U7'^-)C$J$4GL..X6DZMGGK6'XB(6="*S;/5B'QN[U)J<QN5#=<"N>3U
M-UN(0);"3Z53T0&*;9ZFIK)RUNRFK%A"%N5^M4BGL2ZA,R3A:T]/EW6P%4]2
MM]TX8"K-D/+A&:T)-$\Q[:JV4^+\QYJXA4Q9S6&K,FJ,PZ4R6F'B>,20M7.>
M$T*:L_%;^K2^;&1530[7RKPR8ZT#-GQ'*R6B$5S%KJDC,RDGBNWU2S%S9+QG
MBN033/+D?B@ ^T>:C9-166YI2<=#43AHI=OJ:Z+3-/4Q%L=:+ 86K_O&4GL*
MNZ!]S ]:I^(U,,H %6?"Y+XSZTAEJ_F:+4D]*2[E\Y<@Y.*MZ];!"91V%8VG
M2&YN0G4&F%]2.*X:.XV5OVMUL0-FLNZLC'?9 HDD9%VC--(+DNJ3>8-P[FL^
M_P#FT\?2I0'F."#3IH]T#(>@%'4+F=\.I=NNW6>P-;^KZT8;XJ&_BKF_!(\O
M7KS'H:34_-FU=A@XWTT)[GHFF7IDB4D]15G46WIQZ5DVZFWM(2.XK10^<G-+
MH*YR6JP'8W%<;<1^66KTZ_M \+G':N U2#9N..E<]0TCL84<I6X45NG][:$>
MU<^@^?<>QKH-,'G(%-8;&ACF,H^W%;.E#:ZT7EGLESBG6W[OFG%D[&FEYLN<
M9KI+>;?;9SVKSR2[/VX\UV.G3EK->>U:Q9)SNM:HT-TRY_BJEK5Y]KTZ,9SQ
M3?$<#>:S@=ZRK24W*M$>=HK2),MSE;URLOT-=U\/-2(E*,W>N)U>$QSD8[UJ
M^&9S:7<>W^)A5>1,CZ'0[HT([BK(&VU?'I6?I3^=:1D_W16TD0,9'K3D)'G&
MLPF:\Y%:&D*MK'DG&*E\01)!>*.*YW4-3^RH0K5S2>I29Z197J3(!N%5=2?!
M.*X'0/$+/=K&6ZFNU=_M'/K51U&QEE-B89-.U.<^4<50D8PS\5=1/M,7-:HA
MG-W(&"S5SE]J*P2 !N];_BAS96Q*UY#=ZP\NH;"3]Z@$>SZ-<-<P#OQ6G%;@
MN:I^"[;SM.5R/X*T$?9=,OH:I;#OK8O10A1BF3P[6&!4LTJQA.>M65"3P%@0
M<"F-[&+/)LE5?6N2\51AI,CTKJ[N-LEL=*Y#5Y#+<!6K.0T<#+:/)?KA3C-=
M786;0VX.TUKZ;H*7#"3:#72_V*BVF O-9;C./LM_V\'!KT+2\O"JFLFRT91,
M&*UT-O$(.!5Q6@BI>$*2M9K#>2*L7LI,["F0IGFJL2]S,:+$O3O72Z<NZ''M
M64T0\RMFP&U/PH$BG=R>2_IS5[3KD3J>>E8GB.0PE2.].\.7!?--#OH<UXZ_
MY&&S_P!X5Z9X;.;!?I7F?CG_ )&&S^HKTWPX,6"?2K1FS:HHHJB0HHHH ***
M* "BBB@ HHHH **** "BBB@ HHI"0HR:  C(KA?%WA\74;R[<DUVINHEZN/S
MJ"Z1+N$J"#F@#R?P# ]MXG>(J0HKV,+@YKF=-T%+'5&NL 9[UTRN&Z&@!U%%
M% !39/N&G4U_N&@##N7_ 'P'O61>'_B8QBM:[&)Q]:Q[_C4(S28&QV'TJK,?
MGQ4X;,8/M4<@!C+5-RT<QK-WY6Y<UG:8GVFX#&J7B6Y87C(*UO#D>;='/6I+
M2.FLTVX6K,C8XJ.$8^:EDY-,74FMCO8@TDIW/CTHC_=KGUJ6- YS5(&6;3&.
M:EN,%<U4ED\G&*BDN20!GK0-&3JKGRF/H*Y&*Y;S_H:[6]A\R%O<5S L-L_3
MO0#1U&BR&2VR:OOZU1TQ/)BVU>ZMB@1!/#YEN6Q1IMKEP2*TUA#0;:FMH!$,
MT[$LBGQ"G%9[\Y;UJ>^ES*5J%N(:EZ%+8R)<B4GUK*UFQ\R -CK6\\89J'MQ
M,FW'2HO<HX/3]/,-P6QWKI90-B"K$FGB(,V.E8QN6:?;Z&A(;-?8%BW>U9<N
MILLOE@]35JZN/+M_PK$LHS<W0;&<&MDM"6SI;0DISWJPVW[GK375;>T+'@@5
MD6]^9;@ 'O4-#N7'BV3BK\'&*K2 E@:G@SD5(C2">9'BFW'[JWP.U68UQ &J
MI<NK*1FF,Y@WK"]*Y[UTJ()[1<^E<O+!_II;WKIX6V6B?2J$9EXAA4X%95E,
MS7)'O737]N'MP?45CV%EBX8X[T@9N1MB-?I4HDR*;(H2-?I51YPK8S28%L2
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MIF94K-N[+1)K\A?3QGUKO?!'&CP_2N*\1V_EZ6#[UVO@?G1X?I5HF1V Z4M
MHJC$*XSQNFZ-*[.N4\7J&B7Z4F-;GEK2&*X ]ZZ&W G@_"N>O4Q*2.QK7T.8
MO$P/:N>6YT(L)'Y3;1WJ>%]EV@IS*"^:J2/MO%HB-G3^4LV":JW/[C(%007V
M)U3-6KE?-YK5,DJ+?%4P36G:60GC\[N16!?+Y46172:!+OLE!]*H1SUZ#]K:
M,] :NVD(C56I-8@\NY9P.IJS%_QZH?:BPFS4BD$L6T]A6>]LH9B>].@F*&H-
M7NO)C4J>M [F3=VBF=2/6MJQ;8@6L:SG-RQ)[5JP\.*KJ%REKUB)W!QVINC6
MOV9,@=ZTKX;Y$%6K6W41<U(KF9K<F^PD/?%9'AN F59".]:.L9+F$=#4MC;B
MTT\R8QBG89?O;>,Y?C-9T-FLTV*H3ZP7E,8-:&EW&9@30!<GTQ+>#?@9K#U3
M$-L6'<5KZI?-L*"N<OIC/ 5-)L"KX!3SM?N<]Z[>?PVC7)EV]\UQ?P^(CU^X
MS7JT,JRNPSTI(6QER6?[I%Q]T5'M\I<5KR*O-94_4U0F4;A\QL/6N0U6UW!N
M.M=<ZY!K-NK8/FL)(N+/-Y8&2;;CK6YH\>V50:O76FIYN[%%O$L4@([5A)&J
M+%];Y;.*P[@^4Y%=.Z^9%NKG-4CVAFJ!2,4G==[J[;0_GC5?:N*A0M+FNWT$
M;=OTK:! W6-+$L3G;VKS_1DQK%Q$>@)%>S3VPDMFX[5Y.]LUIKDS =6K=;",
M_P 0Z8<;U7WK.\/PN]\H8'Y6KTZ+2%U"TRRY^6L:VT+['?9"X^:A/4E['I.A
MMMMHQ["NA\P+;LV>@KEK*40PH,]JT6O0;9@#VIR>@CA?%VJ,-0&#7'7]ZTYQ
MFND\10^==;JYTVP:<"N5O4I(=X?++J4?!ZUZ[8C,*DUP&A::/[0C..]>@DBW
M3:*VBAM:$-U &?-7H$V6X(K-\_?+@UJVI$@V5I8S1QOC"$RVAP*\;DTR3^T\
M[#]_TKZ%U?3Q.A7%<[!X122YWE.^:0T=)X,M_)T>/(Q\E4+YC%>,1_>KI;.%
M;*S6,<8&*R;JU$KLU4GH%M3$U3462-3GH*D\/ZUYY,;-U.*HZS 3$V!T%<KI
M.H&TU *3C+55RCV)K)98CQU%>;^*X?L6HJ ,"O1M*O%N(DYSD5Q?Q#MR)?,
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M/DI)'\QJ63A0*+"\RFQ^>K*\KFF"+)S4P&%Q2 :HSS2M'QFD4X.*<[<8JT!
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M%:9I@CU"1\=6S7;1KB(#VH\@%3]YFLC5[/=EL=!6Q&-AIMQ%YJD>M CA)(R
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MMMC#5/<Z2+F(MC.:L;1%\E:EL080M2D#//O$&C"VT_?M[UZ%X#7&CP_2N?\
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M^3^^?SH ]5\:3)_9HPPZU5\(#Y@?:O(M8^($E_"L>XGGUKU3P!.9[.*0]UH
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MUI3AX:QIVS<1_6MF09>&FB)'1VO^J'TJQ5>U_P!4/I5BF2%&*** $P*7%%%
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M*].\-G-@GTKS#QP,>([,?[0KU'P\NVP3Z"J,V;-%%%!(4444 %%%% !1110
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M8_O(1ZXKG8SYURGL:Z"7B:#\*M(S9U%N,1#Z5+4-N<Q+]*FIB"BBB@ HHHH
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M>NHL250>XK$M]./GYQWKIX;7;$#Z"@"93\N/6H&'EMCUH$F'QZ58\KS?F]*
M'PG]W5689EQ4V=@Q3-NX[J=R>ID:L^+9DKE[.Y,5Z!FNLU*'S%:N9%@?MN<4
M;C.NM;CSK=1FIB.,55T^(QQKFM+RLKF@70KJ^\[?2I1&/2E@M_WA-/D_=UHG
MH!4F;!'M4@F#J!Z52U"3REW>M4+6^W28SWK)O49OQC-3I\E00G"@^M.>3BFK
MB6PEQ)SFJV_<<T.=YQ3TA[50R&3KFEBEV'=4KQ<[:C,'&VI8F6X;CS)*6ZCP
MNZH(8C&V:DGFW)MJ4!$%^7-<KXA4HN[WKJH6WG;5/6M,\^ <507U.6T20EVK
M0N6P?K3;2Q-JS'%5=0FVGZ5DQ]2:WCQ<(?4UTLWRR0URNG7(FG49Z&NIF^:2
M'\*<26=%:_ZH58JO:?ZH?2K%:""BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *Q/%1_XD%U_N&MNL3Q4/^)!=?[AH \R^'K8
MN&'_ $TKV=/N#Z5XO\/5S<L?^FE>T)]P?2@!:*** "BBB@ HHHH **** "J\
M\>^K%(1D4 8US9;U)Q7-:EIY +8Z5W90%2,5G7ED)8V&.M'4I,\Q>Z-M+MK1
MM+K[0 /6DUO1RDY(%1:7;F-P#3+-F&+8V^G$Y>IE&?EJ/9B7;4W*&[]AS5Q(
M_-0&HY+;,8-.CF\M0OI3]!-E6YM@IZ5"UMM .*U& FQ3;E-L7T%4+J5H&V#%
M7;?AOK63;R>9*1Z&MRVBW#=Z5-M!&E&0L>/6F;@ 1ZU2N;ORAUZ5F_VL#*!F
MFMAHT[F3:"*Y+5(C/<5OSS>9&6S6<D?FS T@-3PY!Y,2\5U 8'BLS3;?;"#B
MKLS"&,MGI2$<UXPQ)9,E>0VBE=8=?>N[\2ZV#/)%NKF-,LC-J!EQUH [S3UW
M6D8]JT8  >>U06\7D6B'VJE/J(A8C/6H98[7;\+%@'H*X"XNR]QG/>MG7KPF
M/.>M<E%(9)C]:J(,ZVQN"4SGI4TVH;6ZUG67RICUJOJ),9K>(CJ]-U(,.M7[
MBZW"N'TFZ/G*N>IKL5@,D6:*B$B""+S+L28K92/,@JE:)MD"UH!MLV*P91A>
M-8O+T;?[UO\ @4[M'A/M6)XW;?H>WWK:\"#&CPCVIQV)EL=C1113,@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N?\5_\
M(./TKH*Y_P 5_P#(./TH \U\!\>)[H^YKT.[FV,:\Z\"G/B>Z'N:[V]&YC]:
MAW-EJ5+FXP/K7.:R=T9^E;<\>X#VK.O;?S8S["HD6>?3QD3_ (U<@F,;*,U=
MNK'YB<=*H>7^\!]*PD@.ST=]\.*MW+>6*I: F;?/I5R^7*FKBB9,LZ9+O=:Z
MZ$;K8"N-T=#YBUVUNN( :W2,VV9=W:[L\5DRPX)6NK>+<,XK+>TW2MQ1)#BS
MSG7(RN[ZUR<HWDBO2/$>FXC+8[UPDEKLD;BL'J:IF3'#^]Z=ZZ73;;SP!CI6
M?#:[I.G>NMTBR\I-Q%2@*TUCY(#8Z4V&]Q(%S4NOWP@ 7VK LYC+,&SWJKC2
M.RCQ)@U)/:>9 PQUK.@N@A5<UJK<C95)B:.5_LQH=1#XJ6^BW-6^(A/+N K/
MU*+RR3BJN)HY]M),J[L5D7L;69/;%=I:2*T>VN3\1'=,RCUI[L92AOFXYKJM
M,D+HIKC],M3<3!/2N^TZP\J$<=!28C3CG$2"I4U<6X)W5S&L:E]E^7/0UC2:
MN95P&I7"QZ#%XB4R %N]=#:WZ3@<CFO%?M[1MOW'BM[1/%&Z54+]#ZU(^AZ;
M=P*Y!P*I>7@[1WIJ:D)8 V>U3V9$YW^E NA6N(=L1KEM=AW6$F*ZG6IQ! QS
MT%<VK_VA:LO7-!70\O$9&HX]Z]1\*S%8HTKD[C1]FI]*[#0K;R2M6B39\6VW
MG:*#7GNCN4OC&?I7J6O*#H:YKSBSM-FHE_4U36@D;&I>'O.MXY@O7FM?0;0V
MR8/85I7,ZKI<(QVJOYPAB#=,BHD");X;D-0:-&/,8^AJE+J(?<,U=T&7>S#W
MIH4CE?'4F[Q#9#W%>G^'/^/!/H*\N\=IM\1V7^\*]2\._P#'@GT%:1,Y(V:*
M**HD**** "BBB@ HHHH **** "BBB@ HHHH 0G J-P)(B#Z5(PR*:.%YH \.
M\>>&Y(]6DU!00N:L:9XI-IHJVQ8Y QUKTWQ+IB:CIC1A06/M7FTG@F4GA3C-
M &1X<TM]2\4271R58YKW73X?(LT3'05R7A70!ISJS+@XKM1CH* '4444 %-?
M[AIU-?[AH P+SY;A1[UBZKS=H*VKWYKA3Z5B:I_Q_P 8H:&MRW#_ ,>Q3UJ%
M$V-BKL,/[K=5>;Y6SZ5.Q1<CCW15F7"8G*U;AO $QFH91ODWTEN4A(N.*EC
M,G-,0<YJ5/E.:;!$XQT%*5W@BH@^#4B28/UJ&/T.;UJW"NIQWJ[HLFQ:L:M;
M>9M.*;9VIB%"0VS1E'FX;TKE?$F2AQV%=6ORH0:P]6M/.1N.U/4#G_#&3*,_
MWJ[]N(MWM7*:'8&"0<=ZZZ1/W&/:A[@51+D4Q&/G9J2*#/%/$&)*9++4?3=4
M=PV%-3HN$Q4%PN5Q32T#H<_=_.Y'O5NQM\#)%-:',IJXA$:BG;4:%VB)P<5L
M13@VS'T%8[_O1QVJQ$^+67GHM.UA-)G.:AJ@6X*9[TV%C(F:Y75;HC4#S_%7
M2:0_FQ"I#H$A*S >M;%B. *KR6)>0/CI5R >6128WL3SOL^6F+)E,4RY.X[J
MAC/>F@+#ME-M56':K4:;VI+F'RQNIB* .7Q5VU^]51%^;=ZU>A7:-U#!LMSN
M&BQZ"L%HR9&-69[S8Q&:AB?>3[TK#Z:%=G_2G0W.Y2*L-:''3K4(LC"":&*Y
MQ7BJ(R7 (J;PMIY9E8CO5K7(P[Y]*T_"B#:..]0WJ6:5W;8(7':KVEP^4 U3
M7D.90<59MH_W>*:8F3"X FS5#6/WT+>]3-&1+BDN8\PU9!Q]M8D7I;'>NSL_
MW,"_2J%M:#S,XJ]-\D86I8Q7;+9J>1@8@*C@C\P5(4SQZ4P3U*L,863..]:9
M<+'CU%5 F#4WW^/2C<"L$R_XUH0'9&14'EXYJ13D4(3(Y1E\4Y5PF*5ASFES
M\N:8BC.N<BLT0#[5TK7E7/S56\KY]]6@1,@V1BIDN 1MINS,-55!60FH8&A'
M. U),/,&16)=WGV<YSWJ:SU(2C&:=]!="+61NB ':L'3P?M!]C71WJ^:AK-L
M;/;,QQWJ$,Z"#YHQ["A^6 J2&/9'4.[,P^M:(%H1S?NFS4UO,).:J:S+Y8_"
ML[3;_+A,]33!(WY'Q)F@-EMU02'/-.0Y7%2]Q6++<IFJ$N0QJZO*XJ!XMSXI
M(.EB*W.U\UHSR!H!5408%.;E=OI5,&9MRHYP.M<KK2F-"U===+A:YO6HO-@;
MZ5DQK8Q?#$YENR,]&KT*7Y981ZXKSKPG"8[Y\_WJ]%G^:6$^E"$SH[<8B'TJ
M:HK<YB'TJ6M"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "L7Q2?^)!=#_8-;58OBD?\2&Z_P!PT(:/,/A^VVZ8?]-*]G3[
M@^E>,> 5S=L?^FE>SI]Q?I0#'4444""BBB@ HHHH **** "BBB@ I"!BEI#T
MH Y_6+029;%<_';^7)G%=O<P^8A&*PKBTV$\4[EQ,\'8=]49[P)-G-6KA\92
MN=U1S&I-0RUL=5#=++;CFJLA.^N;TW6-SB+=TKIXH_-C#4TV-HLVS8'-2SCS
M(R/:J'F;#CTJ:"XWDC-4F38S54VTI)[FMRQNAL(SUK,OXLX853AO/*/7I4M@
M7]8EV1L<]JY!+T_:@,]ZW+V[%TFT'M7/26ACG#>]*Y5CJH9]UJ>:M::N]Q]:
MR+-LV^*V]*7;@TTQ/<ZF B*"N:\0:XL".F[I6MJ%U]GTUI<]!7B7BKQ&7NY%
M#G\Z0DBGJ6IFZU9ANSDUW7AVV!A1\=J\EL9#<:B'SG)KVW0(_+TR)O:J'8T-
M2N!!9J*X:^U$O, #WKIM9E\R':#TK@+S*7&<]ZAC-+5\O:H?:L;3(O,E;V-:
M-Y<![9%SVJ/1H\3'W-..X,UXUV 55U%?,7/M71_V:6B#8[5CWT'E@@BMT[$F
M;I4)64/Z&NVM;L>4%S7$QW M\BM"QU O*JYJIZB6K.WMX]W[RHIY=LV:FL)
M;/%5;E-SUSLM&1XMGSHN?>NG\"G=H\)]JY3Q7$?[$ ]ZZOP(-NC0CVII:$2.
MQHHHH,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444 %%%% !63KNH#3[%IB<8K6KD?':L^ARJM &GH6I+J=FLA.0:UOL\?\
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M[UT?@8YTB'Z5S7C _P#$C_&ND\"?\@>'Z4B)'8T444S,**** "BBB@ HHHH
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M&QT-K_JA]*L57M?]4/I5BJ$%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5B^*_^1=N_]PUM5C>*1GP_=?[AH \I^';;;IA_
MTTKVU/N+]*\'\%S>1?-S_P M*]OL)Q/ &![4#9;HHHH$%%%% !1110 4444
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MF=:F^S!NU=?;)B +ZBN/\6VS88#TJ1IC/#U_]H(&>]=]&-MI7F?A&!DD7/\
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M\@+/O70>!1_Q)H3[5S_C(YT3'O70^!C_ ,2:$>U21(ZZBBBJ,PHHHH ****
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M1Z](C<&,"HN5:^AMZ=<YPN:V0<BN3MG,+AB:Z"TN1*HYIW&T7J***H@****
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MG=5B*=Y.(<DURFKWID! -:FNW.T8!KF(PUU+CKS2Z#':.DGVH$D_>KT>U8)
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M':0S!ZGK%LKC@9-;"-N7--&;0ZBBBF(**** "BBB@ HHHH **** "D(S2T4
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV(DCH:*@BF#J#4]60%%%% !1110 4444 %%%% !1110 4444 (1Q34&*?10
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M-W-=?,?WL-8Q@"SQ[1WK9E_UL(H(.EM3^Z'TJQ4%L,1+]*GH **** "BBB@
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M,?\ 281[TQKZ(XQBEC_TBXC8=C02=7#_ *I?I4E1PC$:_2I* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *QO%'_(!NO\
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M5<UY_'IFIA?XJ0Z5J3/_ !4,=ST.#7K-%QE:MIXDM!_$OYUYA_9.I!^-U/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $)Q2U&^<BGCI0
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MBBP&.= M3_ /RIJZ#:@_<%;5,8<T6'<RO[ M?[@I?[ M?[@_*M8=*6F(Q_\
MA'[3^X*&T"UQ]P?E6Q10.YBC0+7;]P?E3?[ M<?<'Y5MXHQ0%S&'A^TQG8/R
MIW]@6G]P?E6Q12L(Q_[ M/[@_*E_L&U ^X*UJ6BP&,V@VO\ <%*- M<?<%:^
M*6BV@[F1_8-K_<%)_85J/X!6Q4;]12:$9T>B6T;!@@K2CC6-<"G#I2TT 444
M4P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** $QFEHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,4M% "8I:** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DQ2T4
M %%%% !1110 4444 %%%% !1110 4444 %)BEHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
IHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0O!WL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **,BB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***CFD$:;C0 K/@TJMFN0UCQ7#8S;6<#\:SX_'EM_ST7\Z /0
M,TM<(OCRU)QO7\ZV=.\1PWN-K Y]Z .BI&.!4+3A8M_M7,:IXL@LW*,X&/>@
M#JU?(H5\FN!3QY;!3^\7\ZOZ1XKAOIMJN#^- '945%#*)4W"J6H:FEF"6(&*
M -*D)P*XB;QS;1N5+KQ[U"_CVUV_ZQ?SH [Q6S3JY+2?%$-Z0%8'/O751/YD
M88=Z 'T452O;U;6-F8]* +F:,\5R$?BZ"2Y,0<9!QUKI;2X%S '4T 6E.:R]
M8U)=/BW,<5H [5)-><?$O5OLUC\K8Q0!UFG:ZEVP 8'-;ZG*@UX3X)\1>?>Q
MQE\Y/K7N<!W0H?44 24444 %%%% !1110 4444 %%%% !1110 4A-(S;1FL#
M4O$$5D2&8#'O0!T --WC-<*?'=LI(WK^=1+X[MB_WU_.@#T(45FZ1J*:C;"5
M""*??WZVBDL: +A;%+NXS7#W?C2WAD*EUX]ZA'CRVV?ZQ?SH [Y6S0S8%<CI
M7BN"\;"N#^-:6JZU'9VGFLP H V@X)IS-BO/E\=VP;_6+^=.?QY;?\]%_.@#
MT '(I:X>W\<6TA"AU_.NHT[4$O8@ZD&@#0I,\UFZGJB6*Y8@5R\GCFVCE*EU
MX]Z .ZS2$XKA5\=VS.!O7\ZZ#2]8CU+[A!H VQ2TB]*6@ HHHH **** "BJT
M]RL0R35%=7C,P3(YH UZ*:C;D!]:=0 444@.: &R/L7-8-WKJ6\X0L*U=1?R
M[<FO%O%6O&VU8#?CGUH ]EL;X7(R#FKV[FN!\#:N+]0 V:[L??H EI"<4M,<
M4 .!R*CN)/*A9SVJ1>E9VN2^3I<S^BT 8TWB:..;9N'7%=#8W(N;<2 ]:^==
M0\2,-79/,Z/ZU[?X/N_M&CQ-G.10!TM(3BEICB@!P.12TB]*6@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW@6"2#1H5?J *I_V'8F[+,!G/I78:;;QPVRK'TH OTF*@ENDB;#&E6Y1AP:
M)Z3-5C>QAL;J>LHDY!H F)HS3'Z5$UPL8RQH LT546_B8\-3GO(T&2: +-%5
MX[M)#@&K% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5-0&;<U;JI?_P"H
M- 'S'\53Y6M!O1JQ](\5R6<84-T%;'Q9&[6 O^U7.:-H+78!"F@"?6_$TFH0
M,A8G-6/ NCM<ZA%*5Z-FK=KX0::\$93]*]7\(^$/L(1MF,>U '83Z4+K0XXR
MN<)7S]X[\/FVNI'5.A-?44482U"'TQ7 >*O"XU'>0N<^U 'S-I]_)9/R2,&O
M9?ACXA-W<;"_3WKB?$OA$Z>7(3&/:H?A[>FPU5E)Q\U 'JWQ)DWZ3*?:O,O
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MKCK0!S'A*?\ LGQ/(@. 'KVKQ)=?:_!4TF<_+7S_ *-<-<:^\W]YJ]QOV)\
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M^>O4M5UO[?ILG?(KR3S?*UA3ZR?UH ^G=,;?X6C/^S7SYX_'_$_ _P!JO>]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ JO=KNA(JQ5>[;;"30!\T?%.'/B*-?5JZ;P1H8DA0[>HK
MG_B:X?Q/%_OUZ?\ #Y$-K%QVH MV7AP1WP<I^E=I:VRQ( !4XA0'.!2DA10!
MBZ[JHTZ,$G%0Z?J,=_$#D'-<E\4-0-K:@AL5R/A[QLEM$H:3I[T =3X]TQ7M
M97"CI7A6BYBUUU']^O5?$?C:"[L9$#@DK7F?ABV.H:\[*,Y>@#V74X?.\#-Q
MGY:\*L93I^LJ3QAZ^DSIA?PIY&.=M?.OC#3VTO5,XQ\U 'T3X-\1+=V<,6_.
M!7;^:"F<U\R>"_%7V%EWR=/>O24^(D/EX\P4 >B37PCD"YZU?@^90WK7E]IX
MG74;M-KYR:].L&W6B'U% %FN/\9MC3I_]TUV%<7XV_Y!\W^Z: /G;2!N\3S?
M[]?3?A# TE.>U?*]K>BS\13,3CYZ]DT'Q]#;6*H9!P* /896&PC->)_&5<:<
M3776?C:*\8*'!S7&_%R<3Z,KCN* .#^&O_(9A^M?1VM6WFZ$W'_+.OF_X:M_
MQ.H?]ZOJ"Z3S-%(]8Z /F[3V_LWQ)</T^:J/B;5_MD[1[LYK2\60&PU":7ID
MFN#AF:\U51G.30![M\&[7R[9B1UJ7XTIC1_PK5^%]KY%F..HIOQ:LS=Z5M S
MQ0!\\:#HKW\RJ!U-=\OP\F:(-MZBL+P]>1Z3?HLF!@]Z]53QM9"W5<IT]* .
M4T'P*T%[DIW]*]"\161LO!4T9&,+3?"VNVVIW^Q-IY]*VOB H7PM/@?PT ?*
M6EG_ (J(?]=?ZU]?^$A_Q(;?_=%?(&F?\C&O_77^M?7_ (3./#]O_NB@#>J&
MY7?;NOJ*E!S0PR,4 ?/7Q4THP1/-MZUS'@37Q9SQQEL<UZU\6-.%QI+87G%?
M.%N[Z=J8Y(P: /L3P_J@OK=#NSQ6G>7 ACSFO#O"7CA+.!5>0=*W=2^(,4T8
M42"@#I/%L/V[0IF'.17S<Z'3-8W'C]Y7TIIDXUCPXY'.17@_Q TIK&]+A<?-
MF@#V3P-XE6XLX8=_0>M>B><##NS7RQX,\2'3[A=SX ]Z]4'Q#A^S[?,'2@#T
M*:_"DKFO,/BS\^BLWJ*MV7BA=0F&U\\U1^)S[_#6[_9H \/\+0^?K4:>K5ZS
MXD\'&?3DD$?1,]*\N\#$'Q- #_>KZON;&.;05^4']UZ>U 'S+X9OAX?\0$,=
MNUJ^DO#&O+J=HKAL\5\T^--->RUB:500-U>@?#7Q%Y5O'"[\T >V7VH" J">
MM30+'-#YA Y%>=^,/$*V8B;=CI4%E\0X4M ID'2@#E_BD%6XDVUB_"N0_;&Y
M_BJGXZ\1)J4[E6!S6I\(K4SW)8#O0!]%:=S:+]*MU7LD\NW5:L4 <SXG020L
MA[C%>+:QX$:YNGG5.ISTKU?QIJ:V)4L<5R3^,[06^TE<XH \=U"S?1K\*>,&
MO7OACJWVF!EW9P*\G\8ZG'?Z@3&1R>U=]\'X'PY.>E #OB>V8)#7)?#RY"7\
M2Y_BKL?BA 5LY#7EGA/4?LFIQL3C#4 ?3>NZB+71U.>J5X5),VJ>(GC!SEJ]
M U;5_P"T])54;.$[5Y3I=^+#Q0SR'@-WH ]+?PZT&B2.1T6O'[M/^)RJ^DG]
M:]CO_&=M)HTD09<E<5XS)<"76@WK)_6@#Z;\-+_Q1T(_V?Z5X1\0!CQ"/]ZO
M>?#;?\4?"?\ 9KP;XA-GQ"/]Z@#TOX7?\>K?[M<C\2U_TF4^]=9\+3_HS?[M
M<E\2Y ;J4>] ':_!J/.E9]J[+QE'NL7_ -VN1^##?\2C\*[#QBX6R?\ W: /
MGG3D_P"*S8?[5>\2+M\)S_\ 7.O"]+.[QLQ_VJ]YNN/"D_\ USH ^5M4_P"1
MD;_KK_6OJWX=#_BF(?\ =KY1U(_\5(__ %U_K7U?\.C_ ,4O#_NT >,_%\9\
M2H/]JNT^$Z;=IKC/B]_R,R?[U=M\*6!"_2@#IOBDN[PU(/8U\S^'?D\20C_I
MI7TS\4&QX;D/L:^8]!;=XFAQ_P ]* /8_B5&9/#-OC_GF*\H\&-]GU]2?6O;
M_&%@;OPQ!@9Q'7A$3_V;K9SQ@T ?5NAWRMI?F9Z+7C7Q;U9;L>6#G!K1T?QM
M'%I31&09*XKS3Q?J9O;AFW9!- '7_#$9O8OJ*^D;<8B7Z5\V?"]O].B^HKZ3
M@.85^E $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1AN&*6B@#,N-)BGE
M#L.:MP6RP !15BB@ HHHH BFA$HP:SI=%AD;)4?E6M10!C#0H V=H_*M"WM5
M@ VBK-% !44L(D&#4M% &1+HL,IR5'Y4P:# /X1^5;5% %*UL([8845=' HH
MH *BEA$JD'O4M% &/)H<$C$E1S[4S^P(,8VC\JVZ* ,J#1X83D**GNM/CN8@
MC#@5>HH S+;2(K=@54<5I 8&*6B@"G=V*72X89JG#HD,3A@H_*MBB@"..((,
M"I.U%% %"YTZ.=LL*J?V#!NSM'Y5M44 5+>R2#[HJ2XMUGC*D<&IZ* ,=-#@
M63<%'7TK5B01H%':GT4 %%%% !56>T2;.15JB@#&;0H&.=H_*G)HD*'(4?E6
MO10!%!"(4VBEDC$@P:DHH RIM&AE))4?E42Z# I^Z/RK:HH HV^GQP?=%/N;
M))TVL*MT4 94.C0Q2!@HR/:M11A0*6B@"K=6B7";6%48]#@CD#A1D>U;%% %
M.6R21<$53?0X&.2H_*MBB@#+BTB*/HH_*K\4(C' J6B@!,<TM%% %>XMEG'S
M"L]M#@+9VC\JV** ,V+2HHCD 5?2,(,"GT4 12PB08(K-ET2&23<5&?I6O10
M!4MK)+<845#<:9%.<L*T:* ,Z'2XHDV@4UM(B9LX%:=% $*0*D6P#BJ$^CPS
M2[V49^E:M% %2VLDMUPHJ&YTR*<Y85HT4 4[2Q2U7"BIY81(N#4M% &4NCPK
M/YFT9^E7S #&4QP:FHH QI-"@>3<5'7TK3MX%@B"*.!4U% &?=:;'<2;F%2V
MUDEO]T5;HH AN8%N(]K#BJ$>C0H^X*/RK5HH S;UUMHL= !7-RW]DTQ$C#-:
M7BF5H[5BN>!7SQXA\5W5KJ;HK,,'UH ]BUG4+&&PD,;C(%?/WB74WO\ 4&C!
MR-U/N?%]W<QE"S<^]4--LI[Z^5RA.6H!'LOPRTUEBAD*^E>WIQ&H]JXCP%I0
MM](B8K@XKN1P* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4FT>E+10 W8OI2X I:* "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M )J*K->1KWIOV^+^]0!;HJD=1B'\5-74X6. PH"Q?HJG]OBQ]ZF_VE#G[PH
MO452.HQ 9W"HSJT _B% 6-&BL[^UH/[XJ6/4(I#PU 6+E%5C=IZTHNT/>@"Q
M14/VA?6C[0OK0!-140F4]Z/.7UH EHJ+SU]://7UH EHJ'[0OK2^<OK0!+14
M?FKZT"4'O0!)14?FCUI/.7UH EHJ+SU]://7UH EHIJN&Z4Z@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD
M;I0 M%,0YI] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12 TW=\V*
M'T444 %%%% !2$9%!.* <T (HQ3J** "BBB@ HHHH **** "BBB@ HI-PI:
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M\H:HBN]\UH1)\@%)L+%0#;)FIV.Y:5H_WF*E,>$H3%8H;_FQ6E:G( K/\O\
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M?M3Q9?/G%7E7%/Q2W BBCV"I:**8!1110 4444 %%%% !1110 4444 %%%%
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MZ$F*,IR!7#^(],6X1B%ZU#"QXUIUXUE,$)QS7I?A^^^T*HS7GVLZ0]O<;P"
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MLS1(Q93B0GWIS-F*HY3DTT/D;:J+$T-B_P!:/K6N\.^$?2LA?EF6NFLXO-B
M]JI[$F;9H?M(2NC^RXCZ=JJ6FFL+X-CO71R08CQCM68S BMOWAXK3@BV$4^*
MW^<\5.4QQ2*+$,@XJ\A#BLR-2*O6S<T10KEDCY<58MX>*C5<G-:=G%N'2M$M
M#-L2W@^?I6[:VOR XJ&VM?FSBMF) D>*UAL92(!'M-6D(QBHGX-$9YJT26NH
MJ%U^:IEZ4UADT(5Q<96HQ'\V:F'2C% 7"BBBD(6BBBJ **** "BBB@ HHHH
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MDM1>,Y1)IJ..XJUX/ .GJ: -^YNUMQR:HOKD2'!855U\OT6N&U26XMQN).*
M/5+6Z6YBW*:HW^K)8R!6(&363X4U(2V:JQYKDOB+JCVFH1!6QEA0!Z*=7C$(
M?(P:+?6(YI H(YK@;:\ENM*CV'G%1Z5?R1ZJD3MWH ]3<_+NJC/J:0<$BK+2
M 66X_P!VO/M3U!I[IXHVY!H [,:U&5SN%6(+Y;J)L'/%><7$\]K9L[D\"M?P
M9JGVR&7YLXS0!=O@AN#P.M=!I&%M*Y"_NP+QAGO7165VL6E&4G@"@"]=:DEL
M>2*K+KD1/WA7&ZEJIOY6$+9P>U9[/<P89B<4 >KVMP)X]PI9IA$,FL+PW>>9
M9C)YHU[45MQC.": +3ZS&C8W"I5U1#'NR*X&1KB>3<A.#5YWFM]-9V)X% ';
MV=\MR3M-37,X@3<:XSP5J/VN5QNS@UN>)K@P698'% %;6=70:?)@]JYSPKK0
M^TN&;J:SKV6:XTV1@3C%8'AI+@WQQG[U 'N,,H>,..]4[G5D@DVDBH4N/LFE
MJSGG%<7J=Y)=7>8CQF@#NH-624X!%:(D!3=7F5O?26<J"5L9-=NE\HTQ92>H
MH FN=52!\$BEM]42<X!%<3J5Q+<SYC)Q5K1_.1QO)H [U&W+FEJ&U.814])@
M03#*UAWMEYA/%=%C-1M"IZBDD4F<K#IF#]VM6"T5(R2.@K2$"CM1,@6!\>E6
M@OJ<)X@OTMPPR!BN1?5TD!7<.:/&]\R2R &N MM1<S@%N]3)FT#J;RW-R<@=
M:AM=(?S,[36MHX6Y5<\UU%MIR#!VUE*-S9/0H:39-$ ,5T\:[$%,@M53D"I9
MW &!6;!D+\FH"VUJDWBH)CP30B'N/N+A=E<GKNLI!"P# 5>OKLQHV3VKRWQ1
MJCLSJK5<3)LJW32:GJJ%22"U>O\ @W2EMXD9UZBO,/!5H;J='<9YKW2T@6"U
MCVC'%:D[FD=L:Y'2LZXU..)\$BI[J7;:D^U>;Z_K!AN=N[OZT#2/0TU..88!
M%./S\BO/-#U@R2 %N]=]92"2$-0F58L*N%IN*>S@"FQG?FJ1.Q"AQ+4[\GBJ
MYXFQ4X<*0#0QW(Y$.*JW-H)(CD5JD!P,4]H08^E0T&YY7XDT421N53]*\U2V
METZ]9FR!FOH6_P!/62-LK7E7B_2"@9HUYJ'L#[EK0M=4*JEA75I=BX *FO$[
M:XFM+D!B1BO2O#=^)[<9.>*44-,Z)Y=HYJO<7@$?6H+V7:N<UB7%V<8S6R0W
MW-#[9EL$U9A(>N929B_6M_3WSC-#!,?);DR9JW:H4(%65C5A3EBPPQ6+T'<M
MJORBK*OA,5&BX2F,2#4-E(62<*#6<]SA^M-OIMG>L:6[^;K23*L=99W.0.:O
M/-@CFN;TV?=CFM:5SUJFQ&@LH85'+R*JVTN6QFKA4L,TFA%3I1M)I\@PU/7!
M%!)653YM7ATJMD"2IRWRT7*2&N<]*:Q(CH0Y:FS' I%(S+G):I;,G=3)<,:D
MMAAJ3!%QVP,TB/FHY7^3%1P/@\TN@7+H;%6T?,>*S\\9JS;MR*M:DBL"N:KF
M3::NW&,5E7#XJQ7(+S+@XKFK^S:0D@5TP(9.:8;564Y%(M'"BR82=*[_ ,)P
M%63BL>2R'FGCO78>'+;;L.*J.XI;'=0#$2_2I:9']Q?I3ZV.1A1110(****
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M1PK\]4265'%+BEHHL E+110@$I:**+ ':BBBBP!1113 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *YSQE.8-%D<>E='7*^/<_P!@2X]* /*M E>^
MU$,W.&KW/3!ML8Q[5XEX$BS<L6_O5[C9#%J@]J )VZ5DZYG^RI_7::UZR]8
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M'M*"O.=+O#97Z(QP,UZA:74-U FU@3B@"];#$(%34U  O%*2!0 9IK.*BDE
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5S_BZ'S]'D7':N@JGJ5O]IMF3'6@#QSP_
M']BO=IXRU>RZ>VZSC/M7E&LP'3M6C &,M7I6B7 >PBR>U &O61K;8LY?I6FT
MB@=:RM6^>QE^E '!^$7SX@E_WJ[7Q:N_19![5Q7A%<>(9?\ >KMO%AQHTGTH
M XGPW$$T6\Q_=-<)X*^7QO<$_P#/2O0/"_[S2KM?4&N(T> V?BJ:3&,O0![]
M9G, /M7DOQ&;&NV_^^*].T:X$EF"3VKS+XB(7UR CGYQ0!LZL^WPS;G_ &16
MSX5?&DACZ5AZV"/#%N/]D5H:+(8?#9<=A0!SGC3Q');:G%"C'#-CBMQ+%;G1
MXYV'++FN(U. ZIJZ.W.UZ]#NG%GX>B4=EH Y&PC$6OHH]:Q?BG_R%[/_ 'A6
MMI<IEUY&]ZROBF"=7L_]X4 >N^#_ /D7+?\ W!65K"9OLUK>#Q_Q3EO_ +@K
M.U@?Z430!Q7B E9% K<\&H//4]ZI:I:&<;L=*E\(3[-1\L]C0!V?BPXT.7_=
MKBO 3[DN?QKJ_&4X&A38/:N)^',F^.Z_&@"+5CNU&0>]02@FT*GIBI-5S_:<
MGUJY=VQ30)+@#D"@#8^'T*QEMN*[B_($)SZ5YC\+M0-Q-*K'H37H&N7(BMB0
M>U 'EVJ$_P#"3H1_>K>U "0P;O:L];4W6K++C/-6?$4AM)K<#U% 'H>CC&GQ
M@>E+J\7G6#IZBH-!F#Z7$2>U7Y@)$*^M 'E;N-(NCSMRU;B3B_MU&<YKD?B9
M.VFW"%>,FI_ VIF^>-"<T =Y)#Y&@R#':L/P><W4O^\:ZK5HMFC2 >E<MX.&
MVZESZF@ ^(7SZ65-4_ FDI-IV[ K0^(B8TK<*/AQ,/[,P: -&^\*QW,BL4'!
MK331E2R$6WH*VMR^U*2-M 'AOC%9-,O&>,$8/:KO@+Q)+=R[)&/!QS77>*/#
MZ:@';&<UPMCIW]B7HVC&6H ]LM7\R$-4=Q(5S4.BR&33D8]Q4EV.":3&C-N;
MDCO6?)=D=ZFN.2:RIC@U$F:I%AKLMWJ,SDFJ(?\ > 5-.=@!K)R*+N1(F*HS
MZ8DW) I8Y_EZU9CGR*$QHBL=/%N_ K99 L.:BM0'YI\[\;:VB25'.0:I3/UJ
MX?2J=PN*)(IF=N/FU,TGR8I#'@YJM-)M/6LW&X7.+\:2>5&<=Z\[L(3+J.['
M4UW7C>3<@YKGO#EGYUXIQWIH1Z%X8B*!.*])M6Q&M<;I5IY)48KL;?[BUI80
MGB)/-T@CVKY^\16K+=D =Z^BM1026!7VKRK7=%\R8MM[TP2.0\-6Q\\<=Z]9
MAD^SZ8"/2N1T/2O+F^[WKK+Q2FG[1Z4#9E_VHSSA<]ZZ?35\Y 37"P(3=K]:
M]$TF+; OTJB!_P!Q\55NAO:KDXPY-1B/>,T!UN44S&:T[>3Y159H>:EC^48I
M=0N:"ME:@9>33!)@XJ0GBI8&3JNG+=P,I&<UX3XSTLZ?K"%5P-U?13#*UYEX
M[T?SV:;;]WFEL)F3X8N_-C1">@KKVM0T6[%>8^%+LIJ+1$_=.*]4MY!)"!3;
M&FBDEF&.<59$6T8JTJ!:D$8--O0JQ50<XIPR)!4YBV\TY(MWS>E9R'8NH 8A
M6=>+C)JU'+_#Z53NVR2*S:+1S.IC<37/M&2YXKJ;R+<367]E^;.*AE7([(E2
M!72VDAP!61#;X.:VK.+I0)LTH!WJ:1MJYHA3BDN!A33 JE]](A^:HP<9J,R;
M34,$BQ+)A<55\W%0SS_*3FH[=_,I#+T#9>K<HQ"35:!<&KVW?'BF!D9)8YJ2
M,\TZ>+RVI%&!FK1)<BY%-F&#2Q'Y:60;A0!&)<5H6[93-9'\5:-NWR8JDQ25
MBT6S36&X4UFP:7/RT-B&^4*8R8XJPG(I&4&D.Q D6TYKIM*'R"L$"MS3#@ 5
M<3.3.@7I2TB_=%+6R,0HHHI@%%%% !1110 4444 %0W/^I-35%<#,1H YYCE
MS]:D\PE<4V1<.:0"J-$/S\N*J3<5>"C;5*YQFIOJ4]RLQ-;VDKF($UDV\/FM
MC%=%90^5'BFR)%EN$/TKGKZ4^8PKH)/N&N:U#AVJ11,J>0[ZRM2<[#6FXR<U
MF:@N1BI:-T<A=1%Y3Q4MI998'%:!M=S]*NVUMAAQ6=BBQ8V(P.*UXT,8QBGV
M4. .*ORVX$><4R+E:)MS &M ( M9R_(<U82?/%:P1!;2,;LU8W[%J@)\4&?/
M&:;&/FD,IJK<?+'5R%-W-4-481Q&LVPM<XO5\O=\>M:>D08P<57:$7$X;KS6
M[96_EJ.*:&B["F#5T+E:KQ#+8JZ!@5H!5(P34#2G=BK,_P M5_+R<TR61$G>
M*EE<JHJ18<\TR9>*AC0D9XS52_N-BGFK0X6L/5YMN1FLI&J,B[N]^X$UQFJ2
M$RM6S>W.TGFL2X7S"37.]RC,5CFDE?&*?*FTU#]\TAVT-*V.Z,5IVMOO&<5D
M61RX2NNTZVRG2M$@:&V]EN[5<-D-F,5>AM]M3F/BK2)V*=E#Y3#BMMC^[%4$
M3!J_"-XQ1U)9$X^3-,1CBK3IVJ2"TW=JI$7L2:6IDEY%=C:18C K&TRQV/G%
M='&NU:I(B3'*,4ZDI:M&8UCQ35YIY&12*,4P#;2;:?10!2N.&IA8J*M21[CF
MHVC&*&4AT1RN:E!XJ$$(N,U$\X7O2N.URWN&:-XS6>]R!WJ,W?O1<?*:NX4;
MU]:R?MO'6JDNI;2>:+D\IT/F+ZT%ABN:CU3=)C=5[[;\G6DV'+J:!E /6L^X
MN\28!JA/J&T]:@$WFG=2OJ4T=%8R;Q5VLS2S\M:=69A1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %1L<G%.8XI@&3F@#B?%&E>?=+*!]TYJ&RU4VR"//W:[
M#4+431D8[5RCZ$QF8@4 3KKQ>3;FM42_:;"3W%8<6A.)LXKH[2S,=JR$=10!
MR?AJV\O7)&Q_%75>)H_,TIU]J@TW3?(OFDQU-:NI0>?:LF.M '%^%+0K;3)C
M[V:RM3T/['=-<!<9.:[G1[#[-GC&33];L!<P8 H Y"RUPVT 3-1R67]NW:38
MSM.:FD\.N3PM='X>TS[(GS"@#*\1V6S1XXL=!5G1K+S=!,6.HK7UBT^U1;0*
MFTRW^S6FTB@#SC4-/_L^[W8[U-?Z@9[!8O05U&N:9]MDRJUD_P#"/-C&V@##
MT"S)U%'QWJA\2+,RZK:G'1A7?Z7I'V>53MZ55\2Z$;^[B?;G:10!M^%EV:#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6SCVK.AO09=N:NR2!UQZU+974\\U*Q=[DG'>MW3K0K:+Q6E-8([YQ5Z&V5(
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MM !1110 4C' S2U6O91%;LQ/2@"9'#=#3ZQ]*O5N'8!LX-;% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<W-OYRE,4MEIHA_AK1;"'V=@(X1QVI FV?%:?W$Q5=XOFWU,M0L.=]L!'M7
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MK)DOM=4H3@F@#TV#Q$)-OS=:=XB3[7I08=Q7/Z?I$P6)CGM76W4&-+52.@H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFIJ#Y:&8**H02'Y:;&>:@>X )R:2.<,X --,3V-$=**0=*6@D**** "BBB@
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M!K)#'-:MF1M&:<62]3T+PD,15UE<IX2_U==771'8PEN%%%%42%%%% !1110
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M7P)+OB-=U73#8YI;A1115$A1110 4444 %%%% !1110 4444 %%%% !1110
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M+]O=DSGFK\LVZ'%8D/RMNJ^),I5O8"C-P]36TNTBDD3()JF)-LF*@9V%DP=
M<UHF,%,US>F7665<UT#R[8OPJ9(9FW+A6(K,FNL'&:=?W.&/-9+RECFI2U!Z
MGKWPYDWQ&O1J\S^&1S":],KICL<\MPHHHJB0HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;<V*=<IO8FIM/MBSCBG<+'1:'I_F2@XZUZ=I&C#R5;;7)^'+<!EXKT_32JP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&TRKU- $M%0+=(QP#3I)UCZF@"6BHDF5^AJ0G H 6D)Q4,ERD?4TT722<*:
M))91%&7/055MM1CN&(4]*KZY*8M*E<=0*XWPGJ$EQ=R!CT8T >D Y&:6HX3F
M,5)0 'I40SNHEG6+[QJ".]B=\!N: )SG=2OFG#!YJ*:=(OO&@"9>E5;NZ6V0
MNQX%21W"/T-<WXQG>#29I$[ T :UAK$-ZS!&!Q4HU*/SC'GD5Y1\-M6FO+JZ
M#DG!-;$>I2'Q \>>,T >F(X<9%/JG8,6B!/I5R@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8MF ?2K2')H ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8\>U1VD/E +BKI7BI:U)N4UBWO398]G%6U78<U%*-YH2U$54;!Q7)^/%_P!
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MJXJX-5-._P!2/I5V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *R=3.(VK6K!UF7;&PI,J&YR-Y-\YJLESSC-07D_SM
MS6?Y^'ZUC)FZ.CAGW'&:THA@9KF;2?,@YKHHI@RBI0B\J!J<80!TI(&S4SG
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI"0*3>OK0!%>/Y=I(WH*\H;Q++_;<D(8X#5ZGJ# V$V/[IKP^&'?XGES_>H
M]FT.X-Q:!CZ5J]JQ]""Q68&>U:P8'H: &@_-4E,P <TN]?6@!U%-WKZT[- !
M6%KEVUNA(-;9=1WK U]%DB;GM0!B:)K#W&IF,D]:[L=!7F'AU-NN'ZUZ>OW1
M0 M%(6 ZTF]?6@!U%(&!Z&@L!U- "T4W>OK2[AC.: %HI@D4]Z=D&@!:*:6
M[T>8OK0 ZD;I1N!I"PZ9H 1#DT^F*,<TN]<XS0 ZF/(J=33B0*Y;Q-JILF7:
M>IH Z4D$9%.0Y%9NCW:W5BC$\D5IJ,"@!U%%% !1110 4444 %%%% !1110
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MZ4 >6>$+8V]X^1_%7K43*MHI;TKSG1(Q]I9@.C5UUUJ*Q6@7/.* 9%K.HQ)
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M)XL>,==U>KZ/&4MQ]*\1TR1Y?B X/W=U>]6J!(5QZ4 3T444 %%%% !1110
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MJ41W]*ZT6N(^E9MW9;GZ520S&T:T+3C([UZ/80QQVHSC-<UI]D(CNQ5B?4S
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !67J1Q&QK4K'U5OW;"IEL5'<XG4CYF^O/=8C/FM
M7H=RN6:N5U.QW,QQ6=S5;'#'*R8K<TJ0H:1M,R^<5H6=CM[4TP-:VF+8%=-8
M6_FP=*YBUCQ(!79:2/W8%4+J8VJ:6&&<5BV\ @N.E=UJD6(LX[5Q%S)LN3]:
MA;C.STL[K>IW^4U4\/MYEIFM0P[\U39+*ADVC-9EQJ&)@N:OS##%:X[6KHV]
MX/K20UH==! MTH/6D>Q$1SBL[P[J7FX!-;5_-MA+4(9PWB2_^S;D!KSZ763'
M<\-WK:\97I,S8->?&1I;C\:V0'LFB:H9+-3GM5;5M2*S9S63H$A%HJ^U0:S(
M?/Q14U1-]3=T_4_..TM5R^C1[8G-<.M\;(;LU'<^+#Y>S=^M86+N+J-W]FGP
M#WK1T74?-<#=7!ZCJAN)=V:N:#J)6X49[T[$MGK4]B)[+?C.16&FF8EZ=Z[+
M14^UZ8ON*@N[+R9AQ0"#1;%8R"1BNM@ " "N!U/5O[,53G&:Z/0=3^VVROGK
M51*;T.BV\U.IP*A0Y(JXD0(JV0P3I5:^?;"Q]!5[:%'6L;6)MD#CVJ1'%:CJ
MI25AN[U2M-5+W &ZL36KDK._/>J-A=$3!LU+*:N>O:?<;H>O:H[K))-9_AZ?
MSX1S6[<6X\O-"8T9:/M%8NLW94'FME@ ^VN8\2?(K5HGH!S5UJ!>0C/>KVGW
M9X&:Y;>7N6'O74:7;%E4XJ&@.UT>;<H%;TD :,&N=TU#$!70PS[U I,+E"6W
MVG.*2*/)S6H8/,H%L$J ZE&3[N*A0G?BM"2(5&+<;LTBDR)FQQ2HFZIC#DU8
MA@I 4_(P<XJY ,+4S0\5%]WBBQ)!<'=Q4 ?;Q4T_ S6-=W?E9.:I($:98/QZ
MUB^(--#VQ;;U%+9:AYL@&>];US"+FT QVJ[:#N>$ZEIQ6Z/RU=TJTVLO%=?J
MVB?OBVVL-HQ:R =.:;V*3.W\.,(RM=MOWP5YIHMYM9>:]!LY/,M,^U0.YGW@
MX8>M<U=Z6LCEL5T]WT)KG[F]"N1FJ1++6F6HMT! Z5L^?N K(LY_,CJX3M4F
MM40]C3MW#L :Z.R4",5YR^K?9Y/O5U6AZJ+A%YID,ZJBFJ<J*=4D!1110 44
M44 %%%% !1110 5#<C,)%35'-_JS0".7G3;(?K44XQ%FM*6'>Q.*JW4>(L4E
MJ:',7J;@37(:M!DYKLKOARM<SK:[%S19FB.>A?;)MS6E;S_O0,U@/-LE)J];
M3$D-296AZ/H; @5TY&(LUPOAZ\R0,UV@EW0"F8LKOR^:G09%0$_-5B+I3L U
MN3BJ-]Q;L/:M,)DYJAJ*?NFJ64CS'74Q*3[U8\,\7:U+K$&]SQWJ/01LO0*@
M1ZE:OB(?2I@^XUEP3X0"K<3U2&B/4?F@(KQ[Q9#B[/UKV"]/[HUY;XJCW2LV
M*S91S6F';,/K7K/A=\*AKR.P/^D?C7J?AA^$%" [MCN%1%:FB7*BGF.KZ$/<
MSIHO,XK'N[$*W2NAD7;S5&X&\$TK%1T.?,.PU;C3"9I)E^:FK)_#20[D\9RX
MK0"Y45GP#+BM)OE05I'<B0$X7%5_,P]3-RN:K,.<UI8A(TH?WBTR2 !LU!;S
M[>*F:?<:S:+3*5Q;;^<5FR6F[/%=&D>]*J3V^SM7/*):D<X+7$N,59$&.,5I
M/:X7?BJ^.:2B5?0KFVQVIHL\G.*O ;JF6/BG85S-_LX/VJ1-(!_AK350#BM&
MWA#"E;4::.2EL=K[<5G75EB0<5VDUF#/TK,U&SVG.*=AIG,7*"WAS[5QFI7G
M[\\UU>NW&R(BO/KR4O.:30-A+<;CG-26\Q9L9K.E8@U9L,L]"0NATUD<X%;T
M"_NL5B628 -=)81>8E5L#>A@ZC;$Y.*Q)("#TKO[G3MZ]*Q7TO,VW%);B3*F
MA6'FR*2.]>E6E@$MUX[5@:/IWD$'%=9Y@6$#VK2P[E-N'VT[[M,)!ES4I&1F
MJMJ)[ %[U:5<1YJJK<XJXGS)BKMH2V1J=U-<9J<1XI3'2L2Q\*8CJ*1]K8JP
MIQ'BJ[KN.:8AQ;Y<T(,MFHR>,5-!R0*I,1L:?]VK]5+--JU;I$LHZI:B[M&C
MQUK$TC0192%MN,FNII, =J!#47:@%/Q110 4444 &**** "C%%% !1110 44
M44 %%%% !1110 4444 %%%% !1BBB@ HHHH **** "BBB@ HHHH **** "F;
M>:?10!$QYQ6;J&GBY(.*U"N33L<4 06<(A@"XZ58HHH **** "BBB@ HHHH
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M:C'<KC@YH!E31+!K5^16Y>(9("M68[8!=P'6FS+M7FJ*/+?$FB-/*3MKDO[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)GF@!:***
M "BBB@ HHHH **** "BBB@ HHHH **** $W<TM1'.^I1TH **** "BBB@ HH
MHH **** "BBB@ HHHH **3/-+0 444A.* %HI <TM !6)JWW&K;K#U@_NVJ9
M;%1W.4ZR-]:S]5R(#BKRG;(V?6J&JSJ(#FLKG0D<NCO]H R>M=/9CY!NKE5N
M$^U#ZUTUK<*R+@U:&]C8MD ?-;UMC;6';$$"MJV^Y6AF]&33\KQ6:<[ZTCR#
M6>2/.-)Q$RS!GI5;50RPGZ5<@^\#5;7)%6W/TJ+B>YY3K,DGVIL$]:T?#;R>
M:F2>M9FKS)]J;ZUJ>'9%:1<4QV/3X &MU^E4[T84BK=F<0+GTJM>'.:8VRC$
M!LP:X;QT?*AR..*[E 2W%<=X^M'EMOE':I$SB/!$[OXA4$G&:]RND'D X[5X
MEX(LWB\0*6'>O;KU@+;\*-Q(Y>Z4%R*PM:&+0XK8DE'FMFL76Y1]F:J3L6>?
MS9-SSZUZ!X+0;AD5Y_+(#<CZUZ'X,7<PQ6HI':70(AXJK:-D\UH7,?[C%9L"
ME'J&A)E^1<IS6,S$7. :V9I5$7X5DA"USFI'?0O*Q^S-SVKSOQ9G#9KT*5A'
M"<^E>?>*B)U8)UH>YG8\LU&5XY"5.*NZ!>3O,H+G&:;J&GR$$XI=%46TR[^.
M::&EJ>O:2FZW4GTJ'4U49XYHT.^C>)5![5)J,+/EQTIM&B.4N<A^*SKV1BF,
MUKW*?-69=PG;4E7T*VE,WVQ<GO7J.C']TOTKS72X#]L7ZUZ;I$+"$?2D2W<W
MX?F%7(QVJG:@@\U:#;6R:M(FUV9VJ;@>*I::6,QSZU/JUY&K<FJNEW*/-Q4M
M"V-^5?W-<W?*2];\]TB0D$US-[?1F3K4-"&!!BJ]P#M.*F2=6'%0RR+G%!21
M8TO(ZUT$9)45@6+#(Q6[&X"C-3L!>13LS44V0#4D=RFS&>:BE(8'%:(HS6)+
MFK$,08X(J(C#G-3P2JKC-,FY*\0C'2I[(?/5:[ND)&#4^GR!FXJD03ZC@0-7
M ZDJM<=.]=_J"%X& KB[JQD,I..]*0TS6T *=H KIYQ^X(%<[H%LZ2C(KI9^
M$P:ALI'*:@"-V:YBY7YR175:N1DXKE+J95)S0/9E9"_FCDUJQL=G7M6/'=1^
M9C-:L+ATXJR9&9J**W:NI\'*%EC%<_<6[2-TKJ/"]LT<\?%/<EGJT/\ J5^E
M/J.'_5+]*DH("BBB@ HHHH **** "BBB@ IK_=IU-;[M %)@0:B/6IY&&:B-
M)C1GW2]:Q;E QYK<N2,$5CRJ2:DUB4_*C]!4$R+TQ5WR&ZU5F0AJ9;(84 -:
M< QBJ$:\UHQ\(*:,I&A#]VE?VID!^6I&(JMA(=&=QQ6/JHPQK8@7+YK-U>$E
MB10]2T8MNWSUM6B#@UA1@B3\:Z"U(\H>M0R4-O!SQ5)2<U>G&0:I*/F-5:R'
MT$()-172_P"CL#Z59X%5[HYC-0T.^AP]\NRX_&O0/"2GRT/M7#:E$6G&/6O0
M/"P"6R9]*40OH6]=+!\BN=61R_![UTFML#FN:B($AS3>XUL;=B[, ":URG[H
M_2L.QE D%;IF4Q&@'H9\:_.U4;P;6-:2$;FK/O\ !!Q0 ZQ^:/-+<$FET[B
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** .8\6WIM+;<#BLK0-5:X903UJ7X@MBR%8_A!=VQJ /2X^$!IV]?
M6H))ECAY/:L4ZD?.(S0!O%N:3<">352*X5X<YYK/N=0\N<#/>@#H!TH)&*@M
M9UDA4Y[5!<701L9H N!E'>G9S6!+J&) ,]ZUH+A7B!SVH E8KFG(<UAS:AB^
MV9XS6U"X9 0>U $F:CW?-4,]P$[TZ%A(NZ@"QD49XJG<7(C< FI?-'E!LT .
M;[V:D#@]ZI3SJ("P-9]MJ&Z3!/>@#<<\4*?ER::C"2,&H;N80V['/- %GS%]
M:7.:YF#4RTI&>];MM.KJ.: +5%%-9@ <T *6 ZFD#@]#6/J%]Y0X-16-^96
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M,I*]Z]?T&P%O$AQ7.Z1I*V[#BNSMR(XE JR#31]IK!U[5#:N &Q6IYGRYS7
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MC-:5OK/G@#-<7<JS3,/>K5A(4D )J'N4>B6+"4BM6YLO-@'':L'1I<[:ZLR
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M5IBFB&%%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:A?#LN!_#7$_#;_57/U-=QXS&?#TO^[7$?#=?W5S]30!7\0D&\;ZUWGA$?\
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MDWTQ[KQ=%. <!JZSQF/+%FI[;:M:=IPCU!"Z_-FJ_P 0/EFM@/44 =UX=_Y
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH X7XB'_0A5'P:R^2E:/Q MWGL@$&:R
M?"%O+$$# T 6/%; :E#]1766I']C+_NUR?BJVDDU&$J. 1750(PT95[[: /#
MKJ3_ (N.@_V_ZU[CJ!_XIQ_^N7]*\5N-,G/Q 2;:=N_K7M5\C-X?9!U\O^E
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M6Z* ,BTTB.WG,@ S3]1TM+V(JP!S6I10!PW_  @MMYN_8O7/2M_3=%CL<;5
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ME7)-3^(1]HG8=>:ATJV*2*<5%QV/3-)?=!GVJ\3FLS1LBW_"M(\5JA,A<<U
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS6[TMHW;Y>]4F",RP3<X%=WHUM\JG%<KIMFRS\CO7>:8JQQC-4F)LTUC15Y
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M>*.@R8<M6C"0L=9L)%6#.%&,T,#5@.14]4+"3>.M7Z"&%%%% @HHHH ****
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MS3POJM 'E^N2F34G5NF:]"\'*JZ<-OI7GGCF,V#-.!CFNO\ AQ??:M'#,>U
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MI38V;'@:W\F(BNXKE_"Z;4-=109L****!!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4QL-P:?46/GH XGQ'8%]1C9!W[5TVF1;+1 WI27UJ)9U8C/-78H]L2@4
M2>2AYVBC[/'_ '13UZ4Z@!@C5>@J,PQE\E1FIZBP=]  ;>,_PBE6-1T%244
M1F%"<D"@0H.PJ2B@!I0$8(IAP!@5+41'S4 -"CO3]JKR!2,.:5A\M !Y:OR0
M*3R$'\(IZ=*4]* &*%!X%.9 W44U1\U24 1?9X_[HI1 @.0!4E% "< 4@.:5
MNE,04 !A1NH%-\A!R%%344 0@ <&GK&HY I''-/7I0 TQJ3G%.P .*6B@"+9
MD\T&WC)^Z*EHH 8L:IT%*44]13J* $"@#%,:)#U J2@]* (!%'GH*>0H&,4@
M'S4.#F@!!$C=A2^2@!P!2QBI* //M<TMY]75@#MS74:-9BVB7"XXJW-:H\VX
MK5N- B@ 4 /J"<_(:GJE=2;0::&C!U,$JPKSS4]+:6X8XZFO1K@><2!5"330
MQR5IFBV..M-'(MR-M9=[I# DA:]+BL56/&VLZ]TX;3\M0T:=#Q[5;=H8SUK!
MC9BV,UZ%XATT[6PM<O::+(\P^4]:BP+8U/#=NQD4^]>HVP,-FI/I7,>']':(
M*2M=%J$ZV]GMZ8%-",[4M0 C89KAKZ^*S9SWJ[J6H;F(W5RU_,6.0:L;6AV5
MAK0,"INJO=YN9@>N:XRRO7CF&6KL=*D%PZGK4DWU.@T2RV*3CM6/XIF\N)QF
MNWTZW'V?(':O/?&;$-(M)C.&C+R7BG)ZUZ7X<0NJ5YOIV#. ?6O5O"\'RJ<4
MX[BDC=UF[%IH^<XP*\QD\1!I\;^]=MXX9H]%< ]J\#-Y(MYRQ^]6CV,F]3W;
MPQ?>=SFIO$4NZ!AFN:\"3F4=>U;&O2\,":@NYD:=8&<[L5UNE6(C(RM9?AW8
M8>172P.JFD4:D* )@"I'PJ$&FPGY=U5[J<9QF@#.O6V[JX_56R6KJ+Z3*FN0
MU%\L14[B6ICI!YDPX[UHW=GBW'':BPAW.#BM74 J6PSZ5FRDCC&A/G;:OV>G
M.UPAP>M/BB$EWG%=386BJ58CI0I682.@T>/[/;+GTKFO$>H>7*W-="]TL<&T
M$=*\]\33-(SX-:)W(96@UC,X&[O73I(+JW&.>*\OMA)]K7D]:]1T"V9X5SZ5
M+1H<MJUJ5D8XK%$IB?&:]%U71V?)"UQ&HZ5)'+T/6HMJ.XL5V0!S5SS2T6<U
MD-$R "M:UMVE@Q0(Q;MBURI'K6S'<%+8<]JI7EDT4XR#UJ9H6\CCTH8T<W/^
M]U;/O766(\J'GTK$@T]S?AR#UKH)%\M!]*S;'8I7SU=T23]ZM95R2YP*O:0V
MR5<U2':QWP7?!GVKG-0(5FKI;-@]K^%<QK2E&8UH)F1)+SP:N:=<$2+SWK(9
MLFI[6;9(O- FK'<R/OM!GTKS;Q#%_I+&N\MK@3P!0>U<YK.FM+*2!1U!G(V<
M?S8KK-'A*-FLJ#3FBD&1WKJK"VVQ@X[4[B1CZO=;25S7.ABTP^M;&MPM]I-9
MMM;EI ?>FGH#.DL'\N)2:M270QG-9K/Y< 'M5-[OC&::0=2_-J&UNM;?A^\\
M^8+G-<4P>9Q@FNR\):=*MPK,#BA+43.Z33A.F=M7[#2%B8$K^E:FG6P\H9%:
M3(D:YP*;V$5Y-L4 '2DM)@T@YK&UG54MT/(J#1]56>90&ZFE$AG=*?E%.ID1
MS&I]J?6AF%%%% !1110 4444 %%%% !3)/N&GTR7E#0!D739)K.D:K]PIR:S
MIE(YH*B.$@"$57,@S43R8XJ$L2:;199DY7-4W&#FK.[*8J&0?+2>Q2*DK[J;
MGY:&0YI,8J16'QR8.*M>8,5G8._-6 3Q5H3=C3M?OYJ:8\YJM!( !3Y)0:8+
M<CE.150_>JP>:KLN&S28QRG%7+4G-9Q;!JY:2#(J=A7-^%L)4<\HQ34D_=U3
MN).U5N!5N7R:C23C%13MS42O@YH8-6)I9</BJ]S/L3K22$L^:S]3E*Q]:D5Q
M8;L>?UK16;<X(KDK:X)N<9KH(&.!0BC<5]P%7HB-H%95LV<5IQ*<9H9+W+*2
M;1BID< &J9!+5)DXI]!D4C9FS36/S4USAJ0')IW))&;BI$;Y:AVFI A"YHZC
M1%.V015%$PY-6I>6IA7BAC$4X:I]V4JOBK$2$K4 BB\19ZT;2#@#%-$6&YJ[
M;X4@TBGJ3+;[1TJ: A&IDMR@':J;7R@\&E<70UY)U5<UAWUR&8X-,GU$%, U
ME27!9NM%R5H6HV+-5R*3G%9ULV35M,^93B#1-<<BJD"[9,U<="PI@CYHZBZ%
MR,@K4JKSD540X.*M+* *8RRS_+BJLMP%&,TUIL9K(N[GYCS0-%UKP8QFJWGY
M;.:S?-9VX-651B!2&DC4A.1FK.152V4A0*G8[:I:B',12-]RH6DQ2><,55A7
M')\IJ;S-HJJ9 33)I?EI,=RTUQ[UF7LNXU&]QCO5*:?/>D'0D1@322R #%55
MEP2:H76H!'P30*YW7AK[AKI*Y#P?=">/@UU],S84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !28I:* &,@8YIV!BEHH **** "DQ2T4 %%%% !1110 4F*6
MB@!,48I:* "BBB@!,4M%% !1110 4F*6B@ HHHH 3%+110 4444 %%%% !11
M10 4444 )BC%+10 @&*6BB@!-HS2T44 %8FJ7 0D9K;/2N0UXOYQQTH0T26,
MHD<YK4*IMKF=-F*,<UJ&]!&,U5C2)8DD1#5&[NH2IZ5GZC?[$8YKE;C63N8;
MJEHTW+NK".;(%,TG3(V(RM9<5\)I>376Z,%.VIL#1LVME'!#G;VKC_%$Q17
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M6(]*Q(KH^=@&M"9BULWTIB>QYKXQU%H]P#4SP9>2374>3WK.\:QR%FP.]7/
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M781Q[EKG=7M"TIP*"6=;\-Y&:([C7I%>>?#Z$QQGBO0ATID/<6BBB@04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** $/2O/?&L_E1R'->A'I7FOCS_
M %4E)E1/'[C4#)<.,]ZLZ9+NGZUA396Z?ZUH:;+ME!J4S5'17TV(2,]JXZZ/
M[QC[UT%[/F(G/:N8F?<YH92")OGKO?#!X6N$M4+2@8KT'P[%L5:EC>QZ?I#_
M "+70??BQ7*Z9)M5:Z6VD!4529#,V]M>IQ6#<6OFDC%=A=(#&36$(\R'ZT7
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M@Y[UCWM[ESS4=E<DS*,]ZN))ZEHEQD+S7417NWC-<=H0_=*:V+B;RD+9K1;
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!S(:W=&ZK4";T.L3[HI::GW!3J" HHHH **** "BBB@ HHHH *:XRM.I&Z4
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M.YT,82MRL#P_*)(\BM^J1FPHHHIB"BBB@ HHHH **** "BBB@ HHHH ****
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M<RI[(K%G%8-W.(25S7=WT2BWZ=J\UUO=]J8+32$1K=,UPN#WKM+!P+92WI7
M6B-YZD^M=FLFVR7'I5I"OH9FIW,?VPCBKFGR( ",5RU^TC:A^-;FG*_E?A5$
M[FY<ZCMBP#VKC=4N7FG(#&M6Y$G-9JV3RW )%4A;"Z19L\JDCO7IFEA8(%R.
MU<WI=B(P"16W)+Y<6!3B]1[FG)? /UJ:.[#H<&N4DNF+8S6A82,8SDU;%LRW
M+,#*1[UT6B2#*UR)#&8_6NFT0$.M9L3WL=NGW!3J;']P?2G4$!1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ JE<Q[C5VF,F: ,I82IX%2R19BJ[Y(I3&"N*!
MIV.:N+=MV0*Q-3MY70@"NZ:T5NU5Y=,20<@4,=]3QN?2)9+@Y6MK2]&*8RM=
M^= BW9VC\JL1:3''T H%<Q;"Q\L#BM.:UW0]*T8[15[5*8 5Q2L.YRDED?2J
MDEDW/%=B;-3VIAT]#VI<HDSSZXL9"3\M):V,@D'RUWC:4C'H*$TJ-3G II#N
M9-I:E0O%:Q4B'BK26BJ.E2F$%<4Q-F!(KEJ3RF(Z5MFT4]J7[*OI0"9B0P-Y
MG2G7%N6D'%;2VR@YQ0UL"<XI-7"Y@RV(*]*J&Q.[I75&W!'2H_L:YZ4E$+ZF
M"ME^Y/':N7UG37D#86O2?LJ[<8JI-I22YR!3L%]3PRYT:8S'Y#5VRTN:-?NF
MO5V\-PLV=H_*GIX>B7^$4PN<#8V$I."M:T>BA^2M=?'HT:'A15I;!5["@+Z'
M$W'AY&A;Y.WI7.-H!CE8A/TKUMK)2N,54;1XR2<"IL(\=N=%D9R-E6K70V6V
M8;.U>HMH$1.=HJ1=$C5<;15+0:9X+J.@2F8X0]:V-%T.2,*Q2O6)?#,,C9*C
M\JF@\/Q1# 4?E57"YQ/]FNT>"O:L'5?#IE'W/TKUX:3&!T%12Z)&_514@F>1
MV'A8#&4_2NQTO0E@CX7]*ZR/18TZ**MQV*H,8I-7"YY]KVG,T.%6N030Y#<Y
M*5[7<:6DPP0*ICP_$&SM%"0U(RO"EF;:#&,<5OWJEHB/:K%K9+;K@"IWA##%
M%A\QY/J^GRR7Y(7C-;.A63Q 9%=9-HT<DFXJ*L0::D/0"E8FYFW-IO@QCM7!
M:]H1D+,$KUAK<%<51N-)CF!R!3L%SP*;P](2?D_2F6WAR3S>4_2O<CX:A/\
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M4:CH*=PN<4NGONSMK?TNV*%>*V1IB>@J>*T6/H*07)XONBI*0# I:!!1110
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M &*VATJ**$1]*FID,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 2EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
>*** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0R!WT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*3-+0 4449H **** "BBB@ HHHH ***3- "T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !11WHH **** "BC-% !129I: "BDSS2T %%%% !
M1110 4444 %%%% !1110 444F>: %HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **3/-+F@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BDS2T %%%% !1110 4444 %%%% !1110 4444 %%%)GF@!:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI,T +1110 4
M49HH ***3- "T444 %%%% !1110 44F:6@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8Z&G54^WV[MM#C/UJT#D4 +124M !1110 4444 %%%% !1110 4444 %%%%
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M=XGOS;:K"OJHH ]IT"9IM.B9CD[:V*YWPC)YFCP/ZH*Z'- #J*04M !1110
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M3NI+AOG8GBH_&,_EZ5N_V*I^ +CSORH V?%UQ);Z?(R'! KQ.XUR^-XP65L
M^M>N_$&X\C2)F]J\<T:V.HRS/CH": /2_ ^KR3A5E<DY[FO2%;<*^>?#VNMI
MOB&.T]6KWW3Y?.LHY?44 6CFE7CK59[L*^":L(P=00: '$U'</M@<^U2 <55
MOB1:R8]* /*?%6JW*7C+'(16MX-UAYCLD<D_6N=U^%Y;USM-8/AS7&M-:,7^
MWB@#U7QAJ36UHVQL&O/=%UNZ.J*'E.TMZT_QIXB,MSY [@5S<<SV=S;RD$;C
MF@#WF>^V:+YF[G%>2W>N77]LC$IVA_6MC4O%.SPXHSUXKA)9W<-<X/'- 'O_
M (9O?M6G1DG)K7NV(MGQUQ7GWPTU4WEJB$]J] O>+60^U 'EUYJ=PGB!H]YQ
MFMCQ!?30VT15R,K7!ZIJ97QB\7^T*Z;QA=^3I\#>L8H Z[0;IY=$#LV3M-<.
MVK7'_"2)%YAP6Z9KIO"ESYGAD/\ [!KS$ZI_Q6D:?[9H ]YAD(TO>3SMKS34
MM6G.J[$<XSZUW-S=^3X=\S_8->.6FI&]UEF]&(H Z*PU:X;5UB,A^\.]>O0'
M,,9]5%?/NG:A_P 588_1Q7T!;<V\1_V10!9H-)FEH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $;I6'
MXBOAIUB92V.*VV'->;?%?4OLVCI&K89FQ0!5\/>+DN]96W\T'+8QFNR\4W+0
M:+++&>=A-?-GAU[G2_&=J97;:[;N:^A/$,XG\)O)ZQ'^5 'GOP[UVXO7N=[$
MD2$5>\)ZS<7/CW4+9B2J-Q7-?"P?Z1<G_IJU;/@10?B5JW^]0![6O#*?:GM(
MN<$TN/D_"N,U;Q-%879C9L8.* .P\U?, S3BP')KSP>.+?\ M-(=XY]ZZZXU
M%5TY9\\,N: -+[1'G&:;<S+!;/*3@ 9KS^7Q9'%<<MQGUK8U_6%_X1:2=6ZQ
M9H NV&N0W4S(L@)P:\Q\3:G>)XNM$CSL,O-8G@GQ*TNMLK.2,GO6_JL\4GB&
MT8@$E^* /7].DW6*._7%6!,CM@&L*]U%--T-9F.!BN=L?%T1O%4M]X\<T >@
MM(J'DT&5%'7K7'Z_XFBLK992W!/K6/>^.8(HHSO'S#UH ]%DE5(C)GC%8MOK
ML$MWY8D!(..M9C:^D_A@W*MU4UX[HGBISXD=#(<>8>] 'TCO7;OSP:%F1C@&
MN2O?$4=GHT4S-][BH-%\0K=WT<8;[QH [FBFYIP- "T444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6=K
M2E](N5'4H:T":@N0#;2 ],4 ?+$]H]MXV9Y00N>]>W^'7L9XX/F4L *YGQ/X
M/DO;Q[N!<>XKF=(U2;1-?M[69S\SXP30!H_$/7+FP\2B&)B%W@5V6OZC/!X&
M6X0G=Y(/Z5YK\1)EG\0I+ZNM>@^(G4?#I<_\^X_E0!SL6HRW_P /8WF.<YKB
MO#=_):6UZ(3\Q8XQ756/_)-(2/4USG@+29-2NK@#D;SF@#H_ _BFX_MIX;AR
M..YJWXS\1W%GXFLU1R%89KC;Z%]&\9N@^7Y@*T_&,37GB+3 O5D% $&J^)K^
M/58Y-QV%QS7KZ>(8SX4-SY@W*@[UY?XL\//:Z';7!'S9SFJD6J2_\(;<Q;SD
M<4 9FN>)-1GU%WA+%=W:N^^'_BF691;S2?.>Q-8OA?PLVH:+]I==Q*$YK"T9
M9=*\=0VQ)"DGB@"_XB\3WEOXFNHU8[=V!S64OB?4(-8B>1F"4:[ ;OQ<5'\4
MHK6\;^'6T[25N@N"%'- &SXT\27,.A:?-$Y^<<UMZ%J\\WP_ENB3O!K@O$C>
M9X/THMS\HKK/#;@?#.8GUH I^!==NM0OM2BD8D+P*LZ(,>/USZ5C_#/#:GJI
M]ZV-+.WX@ _[- &G\0[^YCC46^>/2N8\%>([LWQMYF(;!X-=#X@U"&:[>)\'
M!Q7"Z0X3Q[L3A2.E &/X_ENI-95F!SO^6NBTB]U"T\-K*P8"IOB!9(-7TWY1
M\[<UU^IZ=%;^ U(0 T 9_P .]?FFCO'F;A#WK \;>*;N34'2U<G![&H_"<OV
M?1=6<'&,U5\*:3)KFH22O\P(/6@#I?A[XKF-VD%T^&8XP34/Q!\27%IK[+$Y
MV[A7*W$4FC>-+.-257?T%3>-";W6%(ZEA0 NN>)M03[/(K';M&:]G^'.I/J6
MA0/(V6(KS/6O"LG_  BWVHK]V,'.*[7X2971XD/9: /3L#I7E_Q9F!M+6('_
M ): &O3S\H)KPKXH:PO]HI$3]R0&@#EM9LET_5;6X48^4'->S:!>BZ\(2\Y_
M<G^5>(>*=;BNK6,IU5 *]$^'>IBY\,3QYR1"?Y4 <)X2&/B&O_70_P Z^C-0
M_P"1?G_ZYFOG;PK_ ,E 7_KH?YU]%7V/[ F_ZYF@#YFTW8/B$IE.!N-6_'$,
M4FIVIAY^?M6'?2-'XUW(<'<:Z^T\/W&L74,F"0K9H ]7^'T9CT),BM7Q)))'
M;!D["I?#E@;'34B(Q@5:UBW%Q9LN.U '&Z1XA,9VS/CGO7;6%]'=H"K UXAX
MD$NG7#%6(P>U=G\/=4:\C*LQ.* /26]*Y?Q?I2:C -RY %=0!SFJU_&&LY21
MVH ^>-*L$L?'S)&,8KW2_NEM?#Q8G#>77CD0 ^)4@KL_B%K T_2(HLXWQT >
M6>*8C?7JW)YS(.?QKTR&41> )PIZ15Y3=:Q$VEQ9QNWUW%EJBW7@:\53T3%
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M)H \:\88U#43$W/)%<]X=A_LSQ %48&11JFO1KX@.X\!S5--9BD\0*R8Y84
M>S>,"'\.[N_EBL_X:YSSZ5-K\XN/#2D?\\Q3/AR #^% %KXEX_L2;Z5Y_P"
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M%% !24M-H 4]*\/^+5X)KFWM]W28<?C7M=Q)Y<#,>PKY?^(.J-<^,&C#95)
M?UH /%D:Z=XCTN1/^>:DU[!/-Y_P_63UB/\ *O$/&5W]KGLYU.?+0#->N:9=
M+<_#2( Y80G/Y4 <;\*S^_N1_P!-6K:\!\?$K5O]ZL3X6?\ 'S<_]=6K;\"?
M\E*U;_>H ]M)POX5\Z?$G59;;765,\R8KZ*/W?PKYV\=PQS>,(5<?*9AG\Z
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M%G:,N<86O;_%.A)J>@"$KGBO,=)\!+%K$<AC/ROZ4 1_$!?-TN J,#S!75S
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M7:PXHB79"@]!BI.U %0:?!CA!4D=K'"#L4#/6IP,#%+VH J_8(#)OV#-(]A
MS*Q49'2K5)UH B,"NNQAQ4*:;;JVY4&:N9H'% %>2SBF7#J#BG&VC\KR\?+C
M&*FQ01Q0!!!;10#"*!36L89&W,H)JP!BEH JR:?!*H5E! IT5I% ,(H%3BC%
M "CI2BCM2T (:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBDS0 M%%)0 M!Z4F>:6@!!TI#TI310 T9VTZ@4IZ4
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M9YQ2TWO0 X=<4M-[TN: "D4]:.]% !WI>]% ZT '>EI,\T"@!:*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ;2T4M #32T&EH 2BEHH ;WI
MCKD]*D[T<&@!H'RTO:E(I: &TO-+10 E%!HQ0 44M% "<T<TM% "44M)B@ H
MYH%+0 =J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***0F@!.]+1WHH 0T9]:4D 4QAG!H <>!1FF$Y.*4' H =WH)
MYIN:!ZT /HIH]:* 'T4@I: $I*7O2T )1WI:3O0 M%%% "4444 +1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 G>EHI#0 "@=:!THH 0GFEHHSD4 %(>M**#0 =Z6
MD[T \T +1128H *#2T4 )0*6B@ I#2T'I0 E%% H !2T44 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 444E !VII.*=378*N3VH 4
M<TN*@2ZC<X!H>X6(_,<9H F:EJ-95=-X/%1I=1NVT'F@"<GFE'%123HA^8T_
M=N&10 ['-+2#I2T (:!2T4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *0TM)WH .U)WHSS3#(H..] $AZ4
M57DG6/[QI4N4<9!H G/%'7%0?:HR^S/-/>98P"QH DH J,2"1<K4@/% "T44
M4 %%%% !1110 4444 )WI:** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4:]:?0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU(_X1>$#U-=GGB@!:*!THH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI":
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M!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 G\5%!/-':@!#TI>U1
M^8HZFF+.I;&: )SZ"DH!R:4&@ %+1WHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3:<B@#G-0_Y"]='!_J$^E<[??\A>NAA_U*?2@":BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!II'.(R:=WIC\HP]: .$\1^)!ILS*9,8]ZI:-XK2\
MND02@Y/K7"?%\W-O<2.C$#-<U\-&O+O5(R78@.* /J6W</$&S4PJE8QNEL@/
MI5T_=H ,\TM(O2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M->'ZI\09[6^,6X\''6N_\':Y)JL&YLG(H [,\C-.'04P=,5(!Q0 &D-.---
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ,?[I%>/_ !6T/S;-Y@O12:]@;I7)>-[/[9IKIC.5H \I
M^$VC+*ZETS^%>\VUJL"!5&*\_P#AWI)L,97'X5Z4.M #AP*!1FEH ::#RM+3
M<X4F@!H4TX\"J,^I0PL0S@?C38M1AG.%<'\: -$=*7J*8IR@-.7I0 HI:2EH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***0T +128I: "BBB@!.]%'>CO0 DG^K;Z5Y%K'_)2+#ZUZ[)]QOI7D
M6L?\E(L/K0!Z\OW1]*6D7[H^E+0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%)UI,T .HI* >* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KGO&?_ "*M[_N&
MNAKGO&?_ "*M[_N&@#*^&G_(KP_4UVO>N*^&G_(KP_4UVO>@!:*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ I*6B@!.]4=6CWZ9<*.I4U?-03KOA=/44 ?(_C.*>+Q&8ESRW]:][^&ED
M\.CQ.XZH*\^\5^'&NO'.T+QUKVKPY9"STF&+&,(!0!K\#FG@\4PK\N*<.@H
M=332BEH 80"N#WJFNGP0L750&/-76&12%<T -C'RT^FKP=M/ H *6BB@!K9K
MRCXM7EW9V[O;L1A>U>L&O/\ XFZ=]JT29\9PM '@GAOQ)JMWJ\<9E8_.,\U]
M1Z"9&TV-I/O;17S-\/\ 2S+XHD0K]UA7U+91B&UC3_9% %H4X4U:?0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% "&E%%% "&EI,TM !1110 44
M44 <Q?\ _(8KHX/]0OTKG+__ )#%='!_J%^E $E%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% $9^]52\MEN%VL,BKN,TA7F@"C9V$=I]Q<5>%+B@#%
M "TM%% "&H[C(@;'I4A&::XRA% 'AOC[Q%<:;=N!(5&[UI/ 7B"YU*\0-(6&
M:SOC%IS^:77/+U-\(=+?(D;/#4 >]6_,0SZ5*.*:@V(!3Q0 M%(:6@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHI#0 M%)VH- "T4E% !WI:2B@!'_ -6WTKR+6/\ DI%A]:]<?_5M]*\CUC_D
MI-A]: /7E^Z/I2TB_='TI: "BBB@ HHHH **** "BBB@ HHHH **** "D-+2
M4 )12-R.*3[J\T +GFE%5TG7!YJ17##B@"44M,ZFGT %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5SWC/_ )%6]_W#70USWC/_ )%6]_W#0!E?#3_D5X?J:[7O7%?#3_D5X?J:
M[7O0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 )VIC"G]J:>E ',W.@Q3ZY]K*\XKHXHQ%$%'
M84!1G/>GB@!5Y'-+B@4M !1110 AZ4=J6B@!N.<THI:* $[TM%% "5DZ]9+?
M:7+$1G(K6/2H\!E*F@#R/PKX8&G^(IY0F 3Z5ZTBX1?8572QB28NJ@$U<Z<4
M "T^F=Z=VH *6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $
MQ2T44 %%%% !112"@#F;_P#Y#%='!_J%^E<Y?_\ (8KHX/\ 4+]* )**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** $'2@4M% !1110 @I:** $-(>M
M.IO>@#S;XD:,+ZW4A<G=5SX>:,ME8LVW!S75:M9+=Q@%<\T[2K46T!4#% %_
M-/[4P"G"@!:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!!2T4E !VH!HI* %S2]J2C- !B@]:*.] "/\ ZMOI
M7D6L?\E(L/K7KLG^K;Z5Y%K'_)2+#ZT >O+]T?2EI%^Z/I0>E "T444 %%%%
M !1110 4444 %%%% !1110 =J3J*6D/2@!N<&LK7]0-AI[S#L":UB.,UE:_:
MBZTB=2,_(?Y4 >'7/Q?>"[EBS]UB*]0\"^)&U^V64]US7RMK&GR1^(IXBI^:
M4X_.OJ+X7Z:MIX7MI,88KS0!WB=#3QTJ,<&I* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y[
MQG_R*M[_ +AKH:Y[QG_R*M[_ +AH ROAI_R*\/U-=KWKBOAI_P BO#]37:]Z
M %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "B@T4 !IM.I* &[:7%.HH 0=:6BB@ HHHH **** "BBB
M@ HHHH .U, YIQHQ0 @7FD/WJ=GFCWH 2G4@I: "BBB@ HHHH **** "BBB@
M HHHH **** "BBD[T +1110 4444 %%%% !1110 4@I:04 <S?\ _(8KHX/]
M0OTKG+__ )#%='!_J%^E $E%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !333J* &%=R\T*NT8IQH% "8I<4M% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !129HH
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M1110 444T]: '44F*#0 N:*;WI2<4 +12$T T +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% "'K10::#R: '4"F"5?44GFJ#U% $F>:6F9
M#'(-.S0 M%)WI: "BDI: "BDZFEH 0US_C/_ )%6]_W#70&N?\9_\BK>_P"X
M: ,KX:?\BO#]37:]ZXKX:?\ (KP_4UVO>@!:*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7CB@!U+2"EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%-IU
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MO?\ <- &5\-/^17A^IKM>]<5\-/^17A^IKM>] "T444 %%%% !1110 4444
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M44AH ,TM,8X&33!/&?XA^= $U%0"=7;"D&IAS0 M%%% !1110 4444 %%%%
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M*\/U-=K7%_#3_D5H?J:[2@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M]6E,C@<YY- #O#/B-KR\C3<3FO58#OA!]JX/0O!EMI]RDB."0?6N\B'EH%H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 (>E)TIU-89% #6/#8]*\#^*^MZAI-_&8V95)KWP"O)/C
M'X?.HZ>;I%_U*DGB@#BOAIXBU+5O$ C=V9<5]&P9\A,]<5\__!'3,7XN67C&
M*^@Q_*@!W:E%)UIU !24M-/% 'FGQ:THW]C:!%R?-&:Z3P18&PT=4*XR!6IJ
M^GB_CC!&=K9J[!$L$"J!C H ?_%4B]*8@[T]>E "TAI:1NE %6_?R[&9Q_"I
M->47'C=;2X>.2;!!]:]7O8C/8S1CJRD5\F_$NTN=*\1-'O89YZT >_\ @KQ"
MFL3S!9-VVN[&=U>'_ ^RG19II&)##/->XJ: '4444 %%%% !1110 4444 %%
M%% !1110 R3A:83\F:D<96JUPWEVDC?W5)H XGXC/-<>'YXK7)8CM7B,)\2P
MA442;1]:]#UGQS#;7[6LJ[@3WKH?#T]CK" K$G3TH M_#1KYM)_TW._/>N[?
M[PQ533K6.UBVQJ /:K@')H \G^+6E+-8M<E>A'-86GC9H4$8^Z4P:[WXHJ!X
M3E..=U<-I\9D\/B0?P1YH T5M8XO#19!QFL73<S).).@Z5;M-56X\/FV'WMU
M52WV"W9B,;A0 V\398HJ]-]=%J47[K3"1SM&*Y]O])T>.4#^*MN_O5D?3(AU
M  H ZF;6(]+T5))'VUR>O^-K2ZT"ZA$P+,N ,UM>(_#5SK6@K% 2#[5Y?JOP
MTU.RL9KAW?:HR: /8OA;()/"%N1WKMAG=7#?"N$P>$+93VKNZ %HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BDQ2T %%)10 M%(*6@ HHHH *8
M].-(>E %#67>+3)&C^\!7SSXC\;7]GJ<D2RD8;'6OHR]3[1:O'ZBOE;X@Z5)
M!XG;KAY,"@#U_P"&VM76I6/FSL2,]ZZ"_P#&%C973123 $'!YK&^&FE-:^'<
M$<D9KQ7XE37=IK]QMD8 N>] 'T;IOB>TU"98[>4,3Z&NFB.5YKP+X-V5U>>7
M>2.S*#W->^H. /2@"04M%(: %S3&ZC%!-&<B@ ;IQ36("9-.'2LC6-16S7;G
MK0!-<ZC"J,@8;JY25;N\O0I!,9-6+:SFU";SP3M-=/:6:0H RC- $&G:9%;1
MA@N&K444@7!I]  :!010*  ]*@DSY;%>M2N>*8G0@T ?/'Q+US4-.U"38S!=
MW%6/A;K6H:I?QM*S,N>:O?&72,*D@7[[5;^#FC&WLQ(R\[J /9H,[1FI: ,+
M0* %HHHH **** "BBB@ HHHH **** &TG'2G'I3,9% $%W@0,/45XCXDU6]T
M_6IC"Q"YKU'Q+K2Z80K=Q7"R:4/$<QE3'/- !X3\07ES?1K*Y()YKUA3OB5A
M7 :%X1>QG5_0UW\8\J!5- &7XD>;^RY/L^=^.,5XUX?MKI/$EU+< YW9YKWG
MR0Z'>,BO-[J.-=;N%10#GM0!SGB2-+_5$63D;:HG_1=D"<*>*T-7C,.JJ3Z5
M4N(C))&P]: ->VT6W2V-PJC=CK7)VD(O=2NXWY"-Q7>VS ::5SSBN%T23;K=
M_G^]0!Z'X(@%HRJHP!757GB_3;&0QRS*&!QUKG?#'S/D>E>9>.M(U"?5I&BD
M<*7/0T >KIKMGJFJ@P2!L^E=K!_J$^E>!_#ZPNK;4D\]V/UKWR#_ (]T^E $
MHZ4M(*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD- H 6B
MBB@ HI#2T %(:6B@ HHI#0 'I52ZN8[5-\AP*M$X%<MXV=ETEF0D8!H M_\
M"5:>'V^:N?K6E:7D-XNZ-@17RI-XBG35C%YK?>]:^@?A_(\VF1R,2<K0!VHZ
MT^FJ*=0 AI!2FFYYH 4]:#TH/2DS0 W/'-9]YJ$2(RAOF[5%JNJK9*0:P+>*
M74KCS5)VYS0 Y;::^O,R E*ZNSMDM80JC'%)9VRPP@$<U8*YZ4 *O)I_ IJC
M!IQ% !2T"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH 1N5(]J\QUKP[B[N;E5.22:].-4KR& 0N\@&,9-
M'C"ZWJ.F*1'&W!]*ZGPWXHN;R=$F!!)[U->ZIH$<C1R!,US4.M6$>L1F @+O
M[4 >S [E'TIX7%5-/NTO+598SD8JYVH ,\TM-6G4 %%(*6@ HI#10 U_]6WT
MKR/6/^2D6'UKUQ_]6WTKR/6/^2D6'UH ]>7[H^E+2+]T?2EH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ IN>#2F@=* (V.%S7.>,K7[5X6OE RQC.*Z4]*K7$"W%K)$PRK#% 'GGP
MITC[%I*2,N&R>U>EISFJ&F6$=C;B.-< 5>7KQ0 _I2T44 +36%+10 T\ 4T\
M\5)BDQQ0 B\<4Y>E(!2B@!:0TM(: &'T]:^>?C3I1DUCSU7L*^AB.E<!X\T+
M^TQD)D\4 1?"NP^R:)$Y7&Y!7HHX-8_ARP6QT2WC"X(0 UL)R,T /HHHH **
M** "BBB@ HHHH **** "BBB@!&.!5>9/-A9#_$,58/2F-VQ0!Y?XA^'=I-<-
M=MC/6N;%W)X<<I;Y(''%>G^--06PT264G&!7B<GB6RG\SS6!- 'LO@K6I-6T
MWS9#\P.*ZW/2O(?AMXBM9)5M$898]*];4Y.>U '+?$2T:[\-21J,DFN>T31C
M_P (S.C+SY7%>D75M'=Q>7(,J:CCL8883$J@*1C% 'AWAW2IVUDVSQL(\^E;
M_C'0VA@A6)"<CG KTJ'1;."?SDC ;UQ4USI\%W@2*#CI0!YQI&@%O"X#)\PY
MQBL&PM;FYUV)'1ML3X'%>T1V4,,'DJH"^E5HM%M(YC*L8#9SG% $]F@CMU0C
MM65XR"CPM>G:/N&MX* ,"L'QI_R*E]_N&@#-^&QW>%H/J:[.N+^&?_(J0?4U
MV?.: '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2&EIIH ,THZ
M4PYIPZ4 .I,\T4E "YI:3O2T (>E(>E*>E)0 PK@&O%?B+H)FUBWF5,YE!Z5
M[7_":Q-:TF.\:%B@)5LT -\*VGV?1T7&/EKP;XNZ9MU8/M^^]?2-I$L, 0#'
M%>4?%+0WO;RS:-,_/S0!;^#UE]ET%01CFO4EX-<EX*L/L6EI'MQ76XZ4 /I#
M12$T (:!@ TE4;^^2UC(8X)% $&J:B+:,A&^;TK 'FZM,/,!P#58&>_U0D$F
M,UV5K8Q0Q*0H#8H 2QM%M+=44=*N@9.::.#BG]* $-*M+C-)]* '44=J2@!&
M&130,<T^D'2@#S_XE:8=0MK8!<X:K_@C318:<%VXYKIKZSCNU =0<=*=:6ZV
MZ;5&!0!8!-.[4<4&@!:*0=*6@ HHHH **** "BBB@ HHHH ;UXHZ#%**9T;F
M@#DO%VE_;D+XR0*\Z;4[_0W*0QL0..E>W3QQO&2X&*XC5[[0[>9DG5-P]: ,
M[PMXHO;VZ6.=2,GO7HXS(H->6P:YI,.IQM;[0/:O2]-O8KRV5T(((H MYP,>
MU>=W%J__  D$K;3@M7HI'-9<MA&;GS-O.: /+_'-K-!<+)$A/RCI2:;I\MQI
M?G,AW!<]*]-U'1X+V/,B FG6FD016QC"#!&* /';"^O&U3[(R-L-5]3TR;3;
MAYXD.9#D\5ZL/#=NFH^<L0_*K>HZ#;W,:#RP<>U ',^ EEEME>52#[UTE[X7
M@O)-[ 9)J_I.FQ6,.U% K35N: .'CT6+3M3^0 8KMK?_ %"_2N<U'/\ :V*Z
M*W_U"?2@"44M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (:
M!124 *:*;10 Z@4@I1UH 6BBD- "T444 -(R*QO$=H+K2YE/936R>!56[3?:
M3 ]U- 'R1?Z6P\7K$%."Q_G7TUX+LQ::';\8^6O*Y]$$OC%'V<;C7M>FP^1I
MT* 8P* -!:7--3I2F@!2:;C'-./2F$Y!%  6JA?WRP1G##=BIIKA8(R7-<9<
MO<7E_A"2FZ@"PR2:K/AP<9KI=-TY+.+ I--LDBA!*_-5_D&@!1UQ2CK3@.]&
M!0 =Z6DI.<T +WI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@!&Z5FZUG^RI\?W#6D:Q]=9O[+N O]PT
M?/%]9W%[KKQJ[8R>]55M)K.[)9CE37;Z#]A756>[=5?)ZUDZRD-QJCBU(9=W
M.* /5_A_=FXT- 3DUV KC? 4'D:4BUV=  *6DI: $ I:** $I:3O1WH 23_5
MM]*\BUC_ )*18?6O79/]6WTKR+6/^2D6'UH ]>7[H^E+2+]T?2EH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ I *6B@!I'%)CBG&CM0 WH,4(,4"E% "D9HQ2T4 %)BEHH *04M%
M"8H%+10 4E+10 T\U7GMEF/(S5@TF: $50D80=A3E&!2#DT^@ HHHH ****
M"BBB@ HHHH **** "BBB@!#TI@IYZ4WMF@#B?B/9&[\/3Q@XS7DL7PODFTW[
M5YO5<]:]?^(S2IX7N'B!+#I7B<?C;4XK/[(,],8H N^!])DTCQ1%ER0I]:^B
M;9_,MU;VKP3P.+JZU5)9T()/>O>;4;+=![4 65YI2,T#@4O- #2M 6G<T4 -
M9<F@#%.HH *Y_P 9_P#(JWO^X:Z"N?\ &?\ R*M[_N&@#*^&G_(K0#W-=K7%
M?#3_ )%>'ZFNU[T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M(:6D/2@!F><5B:GKJ6,QC9@,&MKO7S]\5=?O-.UF81DA0>* /88O$D<DR(&'
MS5OQ2>9&&'>OE;PGXLU#4->MH\L5W8/-?3FCN[6B;^N* -$4ZD%+0 4F*6B@
M!"*8RANM/--H ;]T5F:II:WYC8@':<UJ8SUH)Q@"@"M9V@MXPH'2K8.2:6F]
M,T *3@4W/RY-!/'-9>IZ@L5K($;YL<4 -U#5A: X.:QF9]:/&1BLW3OM.HWN
MV=3L]Z[*QTZ.T'RCK0!6TO2A:XW#FMG'2DZ-0">: %(YIV.*0=*=0 @Z4"EI
M!0 M%%% "&BEHH ;BC%*:* $Q3J2EH **** "BBB@ HHHH **** "BBB@!.]
M,?FGFFD=Z *]Y\MH_P!*\)\5Z;/>ZM+L=NO8U[M?9-H^.N*\R\VS76I1=.J\
M]Z /+KRQN-+(D9FXKU[X<ZT;RS2(GD"N9\;16,\'^BLK<=JO_#:%H2 !VH ]
M?7GFD*<YH7@#Z4Z@!",KB@#C%+10 FT>E  [T<T4 )CTH5>:=2B@#F;_ /Y"
M]=%!_J4^E<[?_P#(7KHK?_4)]* ):*** "BBB@ HHHH **** "BBB@ HHHH
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MX!^M36NK17# *X.?>@#7%.J)3Q4@H 6BBB@ HHHH **** $-%+28H *6DI:
M"BBB@ HHHH **** "BBB@ HHHH 0]:"*":!TH CE3?&1[5X?X[\,:I+J,DUH
MS*">U>Y%L5Y)\0/&ITF=HE7)!Q0!S&A^%-5DM6-RS-@]Z],\(:,UARZXXKF_
M /B[^VQY3KC<U>J10K&HQ0!.*6@<4M #:,4N*6@!,48I:* $H%+2"@#F;_\
MY"]=%;_ZA/I7.W__ "%ZZ*W_ -0GTH EHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!#TK/U2#S[)UQS@UH&HW&48>U 'R+X^M);77BHR-S
MFO9_A%9/'I<4CCM7$?$G23+XDMR%X+^E>P> + 6N@0\8XH ZSO3Z9WI] !11
M10 4444 )4>WYLU(:,<4 )UI">U(3M%-4Y)- #P<#FH+JY6WCW-2O( >3BN9
MU'4&N+G[.O3.* %U"_-^AC@/S>U2:/IDB-OF&?K5G3]#$#K(><\UNJ@"X H
M8J8 "]*DQP*4<<49YH .E+1BC% "T444 %%%% !1110 4444 %%%% !1110
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M37:]ZXKX:?\ (KP_4UVO>@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH 3O5#5;)+ZW\MQD5?-,:@#*T73(K%6"+C)K5YW4P#8<>M2B@!1
M2T44 %%%% !2&EI#0 AZ5&S; 2>@J0]*YO6]>CL_W/=N* +E_J40A*1L-]<_
MY$^H3;9@2F:;I]C/>7(GR2AKL8+1(XU^49% %73[".PA"1C%:)SM%(5RW%.Z
M8%  H[FFNN4;%/)I >: /GKXHZOJ6FZQ*8BPC'2HOAOKNIZG?IO9B@;FNF^,
MFGJUD90HR6ZU#\(M($$#2,G).1Q0![+#DQ+GKBIQ347"@4Z@!:04M% !1110
M 44AI: "BBB@ HHHH **0TM !1110 4444 %%%% !1110 AIHZFG&DH @G;;
M"Q]J\)\6:8VJZ].K+N7->Y7Q_P!&<CL*\/USQ3;Z9KTPD R#0 >'-/?1-7A5
M5VJ3FO<+*<36J-GDBOGF\\?6DEY'(@ Q7JG@KQ,FKP(JGH* .^I::.QIU !1
M110 44F:6@ HHHH YB__ .0O716_^H3Z5SM__P A>NBM_P#4)]* ):*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #3".#3Z:W2@#AO$'AU+
M[4(IBF=IS75:1;BUL$B QBK91&Z@4J@+TH <.M/IIIU !1110 4444 %(.M+
M2=Z &L.:AEE2%<DXJ9V"C)KE=9U'YS$IY/% #]6OFE!%L<GVINCV#2/YLZ_-
MUYI=$TV1/WDO()SS72"-%'R@"@!R\8%.IJG=S3NM "FE[4@I1WH !2T@I: "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@!.]9^K6_VFPFC_O*15]NE-*AD(/>@#Y_U;X?
M+/?,^T\GTJI_PK1.#M/Y5[Z=-@9MQ44X:9;_ -T4 <_X"T8:/HJP#L:ZT-R:
MBBC6#Y5&!4=Q<I;Q-*QPJC)H LAUW[<\TDD\<6-[ 9KCM-\30ZAXE:VBDR .
MF:SO'?B+^SIHE63&?>@#T'SE9=P.1ZTB7,3G 8$UQ6C^)8I?#BR-)\Y'K6%H
MOB=FUORI).&?CF@#U%KA(Y,,P%2[@>1TKS3Q)XKC34OLL,GSJ1D9KM-!U!;^
MQ5E;) YH UG/[MOI7DNJ@'XC6)]Z]8DXA;Z5Y+J>?^%CV/UH ]=7H/I3J1?N
MCZ4=Z %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D[TM% "=Z6
MBB@ HHHH **** "CM12&@!NZDW<TPY+\=*>1\M "[J4'BHT!QS4O:@!">*,]
M*.U)W^E #L\TM)WH-  :,T4WI0 [-&:!TI.] "YI :;SNI#D&@!P;DTFXXI"
M0HS6=?ZS;6"DR,!0!H&XC0?,P%5Y[Z-0=K#\ZY"\OY]2;=:,2OM4=M;Z@91Y
MF[% &AJ.NW$3XC!//:LZ2>?5E\N13@UT=EIL<R_OER?>KT>FV\3?*H% &9H&
MB+IP,@ZM70@\5$K*IVBI>U #LTM-%.% !1110 4444 %%%% !1110 4444 (
M>M,5LN13FZ4T#'- &/XAT=-9L'MWZ-7!'X2VARVT?E7JF#N]JJWFHPV;HLA
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MYL7N,Y![T ?1F=JCZ4HYYJ-?F.#Z5)TH =1110 4444 %%%% !1110 4444
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M37:]ZXKX:?\ (KP_4UVO>@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
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MVKRK50$^(]@ .IH ];0<_A3Z:. /I2]Z '4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% "&@=**.@H 3/-%,) .32>=%_?'YT /)H!I 5<94YI<4
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MWH^=3615^4/7O4*;(U7TKRGX9 [6+K@A^]>K%\ &@"4<&G5&AW<U)0 4444
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M/>64A8YPY%=GUKS3X37'VK19)!WD)KTH<4 .I:2EH **** "DI:3O0 &N?\
M&?\ R*M[_N&N@-<_XS_Y%6]_W#0!E?#/_D5X?J:[7O7%?#3_ )%>'ZFNU[T
M+1110 4444 %%%% !1110 44F:,T +1110 444AH 6BBB@ I.U!Y-(: %I.]
M&>*:S[5S0 X]:BD<1C)Z5)GC-<OK&O(D[6H/S#B@"[J>H9C(A;+>U8EO;3ZA
M.!<*2H.>:M:98RR2"1\E2<UTT<$<2@A0#0!';6J6T(5!VJPHXSWIP%*!S0 C
M#C- P!3NHIG>@#B_&VJW&FPM*A(4"O-K3QY<S:A'$)2<MCK7I7Q)M#-X:G91
M\V*^>O"5A/>>)2F2=DE 'T_HTKWEDK2<Y%;*@!0!VK/T>U-MI\:'K@5H#I0
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M/2/[4N_M<G4G-6["TGN#^_!(/K716]LEL@"#% #X(!!"% Z"IOO+5>XO8K;
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M (I)EB.6.!5%M7M$D(\Y<_6J'B^2:+1Y7@)#@<8KYHU/Q9K%OK31&5@-^.M
M'UE!=1SKE&!^E6.U>;_#:[O+RP22X).?6O2* %HI!2T %%%% !1110 4444
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M;%OF7% 'J/PZ)&GS9.?WAKNAQSZUYI\)+B2ZT9WD')>O3,4 +VHS2,<"FYH
M?FC-,SCK1NSTH ?14>ZE).* 'YKG_&?_ "*M[_N&MQ36'XS_ .15OO\ <- &
M5\,_^17@^IKMJXGX9_\ (KP?4UVU !1110 4444 %(:6D/6@ Z49IK=.*3F@
M!^:6F@TZ@ HHHH ***0T +29II--+&@!Q&3FAV 3.>E1><J ESBN=U35I%E*
M0G(]J ':GK ^:%>IXJ#2=->27SVR0:DL=,%X/-E'/6NBM8%@C"#H* '1QHBX
M %#GI4NVD*4 >;_$;6CI+!\D +FN T3QY]LU".,,3\P'6NZ^+>F?:='FFQRJ
MUXA\.M/-SXC*$'Y6S0!]8:;+Y]K$_JHJYGFJFGPB"QC'HHJVHSS0 [O0110*
M &;?EQ0% '2GTT\4 -(R,4(-IIY'&::W:@#QKXS6.^RDFQ6/\&+ QO,Q7J:]
M+^(.CC4M%90N2353P!H"Z; Q*X)'I0!WB#" 5(*;3ATH 6BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $/6F]Z=33P:
M $!&>:0 !R<UCZQJB:>A9W"\5S?_  FD'_/9?SH 7Q,[+XC@"MQBNST]O]!C
MSZ5Y9<:U'J?B& JX;\:]3L!_H,?TH N44B\T$T .I*9FG9H =29IN:3- #\T
M"FYIPH YF_\ ^0Q71P?ZA?I7.7__ "&*Z.#_ %"_2@"2BBB@ HHHH *0]:6D
M- !1FFL>*,T .S1FFYH!YH ?1110 4444 %%%% !24M-)H =3<\XINZF22+&
MI9CB@!99 D9;/2N5U>]-X# AYS3M4U27SQ'%D@G!Q5K3M-$N)7'S&@"AIM@U
MA;232<]^:Q[WXA0:=<-$<#%=Y=6P:R>,#J*^:/B4LEAJTFW(&: /;_#OC6+6
M90BXZXKM.HKP'X0"2:0.V?O5[^!@"@!>E&:*,4 (1D5$\:N K#.*F-)CO0 R
M*,1K@#%2&D[TN* ,[5K;[39/&1G(KYE\5Z(4\4* O66OJ=QN!!KRKQ%X=%QK
MB2A,_O,]* .M\"V0M-#C&,' KJQ6=H\ M[!$QC K1H 7O2TG>EH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!KYV-]*^?O$^DZN^L7SQ%MI8XKZ";[IKC]8$*+
M<2$#(R: /GLZ'K[9.Y\5O>"O#FI+K<<MP&.UP>:]7T:UAO\ 27N-@X)[4_PO
MY-QJ-R@ S&U ';P B! >P%2#BD'RI2@Y% "BEI!TI: "BBB@!.]'>CO1WH 2
M3_5M]*\BUC_DI%A]:]=D_P!6WTKR+6/^2D6'UH ]>7[H^E+2+]T?2EH ****
M "BBB@ HHHH **** "D-+2$T ':CM1UH)H *04N:3H: %SBDSS2?>I<<4 '>
M@\BE/2F]J &$X:DP2<T,4S]X5RVK>)C8S-&O.* .AN+Z.W/S&LF_UF.5-L;<
MU@P:D^L/MP1FM2+P^W#$GF@#!NH;^ZN@T;-LKI-+TK="//7)QWK3M+!80%(%
M:2H%4 "@"I:6$-N<HH%6@,-3\8%(1WH =VI.M .:0=30 8^>N+^(:7#:+,\!
M(*H>E=HQPK-Z"O)O&/C18X;NS;'0K0!X&^N:C%J"Q-*V=_K[U]4^ Q*="@DE
M))9 >:^4HXO[0\1*%'5P?UK[ \,P^1X?LDQ_RS% &T*!12T %-;K3NE,/6@!
MBQJ)2V.:D2F_Q4]: '4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJYGPCXRDOO$$,&2030!]'HPD (J0U3TYBUHC'N*N=Z  49I,TM  :#1UI#0
MQ <FHYG$?)[5-N"CDUSFLZIY<AC7G/% $&K:EY^8X&^8<<5%HUA)(P><9^M/
ML='+N)F_BYKHX8!$@4"@!418P%08JPG2HQ'@YJ5: %HI:3M0!S/C>S%WX<N5
M R2M>-?#31'M_%MPSKQ7O^H6XNK5X3_$*YK0_#2V&JR3@?>H ZQ<"%5'I3T'
M%($Q3AZ4 .HHHH *0T'I1UH !TJ-^M2#I2$4 030I.FR09%)%;QP#$8 J4]:
M!0 M/'2FBGT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 !J,^M//2F=L4 >;?$JTO;JW;[(3]WM7BIT37\GYGKZ:U
M]8X[&1W X'>N;TVTAO(G<(O"YH \O\%Z%JBZS#)<;B >]?0UDICM(U/4"N,T
M,PG4-@4 AL5W*],4 2"D]:44W- #%Y.:?CBL;5]6&FH<FH-.U];N-FST% &^
M.%YHZU@Q:ZDMWY6X5;U#4TLXT.X?-0!I=\T[/-4=/O!>0;@<U>V]* .;O_\
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M* %HHHH **** "BBB@!K"DQ3L4M # .:6E-&* %HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!K<@CVKQWQ)X?,-W>WBJ=V2U>QUDZE9VLEO,90,$<T > V
M/Q#U#38&M!&^,XZ5U?@*QDU?49+Z92"6W<UK_P#"':7=[IXXE*YZXKK?#-I9
M6T;Q6P 91@XH WRO[H#TJ1!A:;VQ3UZ4 **6BDS0 M%)D8HS0 =Z.]&:#ZT
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M2'KBEHH S=6M!=VQC/<8JGX>TE=+MV11U;-;9&ZD5=HP* '*<DTN*!P*0&@
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MHHH **** "BBB@ HHHH **** $/2FTXTAZ4 <5X\TG[;I\DP&645Y#!XVOM
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M@ HHHH ***3- "T4F:,T +11FB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:C< +G -=!86BQ6X!7YJKV.EI%ANYK7V@+@4 "X Q3Q30*<* %HHHH ****
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MX?[K&@#N,'RFSZ5Y+K"G_A96GGWK3U;X@FRO9(-I^6N3L-;_ +:\>6,N.AH
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M_2O(O'UW-9W\6&(!- '-:JJV^K)!'_JE<8KJ?$DL<S:8BD$[!6 --EOK1;T
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MYOQ'XEAT55,K8W5AZ;X_M+^]6!&&X^] 'H$SK#"TAX &:\NUWQ;/#K7EQ/\
MN\XKT'4I#/H$S(>3'Q7D9T"ZNHO/;);=UH ]8@OU.@BXW?-Y>37$6WBJ9M9\
MMG_=YI7U(VFC&S=OG*;17--IEQ!:1WO/S/UH ]MMI!+;HX_B%3 <XK/T;/\
M95N3_<%:(YYH ".:\<^-/_'I:?\ 7=?YU[)7C7QH_P"/:T_Z[K_.@#T?PCSH
M-KG_ )YBM^L'PE_R ;7_ *YC^5;U !1110 C=*:%XS3CR*,<4 ,*!QS31"J\
MXJ2@T (M+SFDQ\U.H .]%!ZTO:@!***6@!!THI:* &FL#QG_ ,BK>_[E=!VK
MG_&?_(JWO^X: ,KX:?\ (KP_4UVO>N*^&G_(KP_4UVO>@!:*** "BBB@ I#2
MTAH BE421L#W%94&EHMQOQWK8(H"@<T (D048':E(YIPHQ0 =J!TYH[T,.*
M"EI*6@ I#2TE "T4E&: %HHI,T +1110 AH%%!H ,4"EI.] "T444 %%%% !
M1110 4444 %%%% !1110 E<KXPTA-1TZ0%<G%=54$\:RQLI&<B@#C/"%M::+
M8H'(4CUKICKUC_SV7\Z\N\97\EI>O;PL5P>U<TL>JR#>)'P: /=O[>L/^>R_
MG1_;UC_SV7\Z\+^SZMU\QZ/(U7_GH] 'NG]O6/\ SV7\Z/[>L/\ GLOYUX7Y
M&JG_ ):/0(-5)QYCT >Z?V]8?\]E_.C^WK#_ )[+^=>%&#50?]8]'D:K_P ]
M'H ]U_MZP_Y[+^=']O6'_/9?SKPKR-5_YZ/1Y&J_\]'H ]U_MZP_Y[+^=']O
MV'_/9?SKPKR-5_YZ/2K!JNW_ %CT >Y_V[8$Y\Y?SJW!>0W2[HF#?2OG]HM5
MCADD,CX49KT/X<7LMQ9KYK$G/>@#T<4M-!S3J "BBB@ HHHH 0TUNE/I* (R
M-RX-59--BD.2!5RES0!!!:I N%%2GCI3J * "EHQ2T (*#1WI: $%)2]Z6@!
M!2T44 <Q?_\ (7KHX/\ 4)]*YV__ .0O710?ZA/I0!)1110 4444 %%%% !2
M=J,TWH* &@Y<TR>=8N2<"E)"98USNJW_ )Y,,9^8T 5-0OI;BZ\M,E<UM:;I
MJ",.PYK/TNP;<&D&373( J "@ 5 !BE(Q3AQ28YH ;U/-/(R*"*!0 M%%&:
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M(E>-LYH ZJBD'2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZKX=2+1[EL#[AK*^'L/E1;?]HUW.NC_B277^X:XWP'W_ -XT >@K3Z:!S3J
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M,TTT T /I!0*6@!N.:7%)2B@ [TM(*!0 M%%% !1110 4444 %%%% !1110
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MF6NCI%IDD&/O+BL&#PC''=>9CO0!TVDH4TVU7T05K]L57AB$4,:#^$5,#S0
M^O&OC1_Q[6G_ %W7^=>R"O&_C1_Q[6G_ %W7^= 'I'A+_D VO_7,?RK>K!\)
M_P#(!M?^N8_E6]0 4444 %%%% !1110 4444 %%%% !1110 4444 %<]XS_Y
M%6]_W#70USWC/_D5;W_<- &5\-/^17A^IKM>]<5\-/\ D5X?J:[7O0 M%%%
M!1110 4444 )1BEHH **** "BBB@ HHHH **** $/2N=\6W!M=(9P<8KH&ZU
MC>*+,7>D2IZ*30!X!=^,V6]>/S#D-CK7MW@*[-[H$,I.<BOEV]M&/BPV_.#*
M17U'X!M/LGAVWCQT% '64G>CO2T %%(*6@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH 3O36/-.-)B@#Q7Q(/^*TD_WA7>+K\>F6$8<_PBN$\2G'C&7_
M 'J?K<KS75K;C.&44 >E:1K\6I_=(JWJ>HKI]NTK= ,UP?A0M:ZB8>< 5V'B
M*!)M+;>< K0!SS_$2V239QUKHM&UR/5E#ITKR:72K)KDYE7KZUZ%X,MXHK;]
MVP/- %_QA=FUT>8@XRAKS[X<S27EG.I8DF0UZ)XNLQ=:--GLAK@_A=;B/S5_
MZ:&@#*\3>%;MKF>8%L$Y%;_PSL)[6'$A/WN]=1XG4(L:X'SG%6?#UBMK & Z
MG- '0TX'(IN.*<.* ,[7O^0+=?[AKC? 0Y_X$:['7O\ D"W7^X:X[P$?_0C0
M!Z&*#TH%+0 4444 %%%% !2=Z6D[T +112=Z %HHHH **** "BBB@ HHHH *
M*** .8O_ /D+UT5O_J$^E<[?_P#(7KHK?_4)]* ):*** "BBB@ H/2B@]* &
MYXJC<Q!W&15['%1LF30!#%$JJ,"IQUI","G+ZT .-***!0 "EI!2T %%%% "
M4P\$M[4ZF$_>'M0!Q'B#QA#I=QL8@<U1TSQ_!>7HA5AD^]<1\5U>VG\Q<]2:
MYGX=B2^U9)#DT ?3MK*+B)''<59SS5338_+LXQ_LU;QSF@!:*04M !1110 4
M444 %%%% !1110 4444 %%%% !1110 G>B@T"@#S;Q5SK>/<5VEM=K;Z;!DC
M[@KB?%AVZT3[BHM;UN:VMK:-,\K0!Z%:WBW#<&IKJY$"Y-<%X;UB9Y55\\UU
MNJN/L6\G'RT 0OXAC5MN:OVM^MTORUYK/>Q_:#\XZ^M=?X:F65.#F@"]KU^+
M2SSFL'0]4,Z2/GH:U/%<'F65<_X6MOW<B>K4 <CXQ>ZO=2/DNP"-DX-=EX&U
M@R6ZVSMENE.U708T\V8CDBL+P=$\6M  ';NH ];4]J4<4BCFG4 8'BD9T]OH
M:Y+P.,7O_ C76^*3C3V^AKDO!!_TW_@1H ]-HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ -)2TA% !0*7M28H 6DHH
MZ&@!K_ZMOI7D>K?\E(L/K7KC_<;Z5Y)J_P#R4BP^M 'KJ_='TH'2A?NCZ4M
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M&@&,"N6_X1@'5Q=;>C9KM8$V0JOI0!+WI:*0T  I:** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!#3><4ZCM0!XKXD'_%8S?6M+R%FU6T)&<"L_P 3
M\>+I3ZM706EJ6O;9L=A0!)8QA/$$@45M>,$G?09%@SO*\8JC9VQ7Q!(V*ZV>
MW%Q $(R,4 ?,,VF^(/MK$;\9KV'X;07L-ABZSG/>NI.@09SY:_E5^QL4M$VJ
MH% ":T VCW.?^>9KSCX<G_290/\ GH?YUZ/K"DZ5<+ZH:X+P!9M!/*2/^6AH
M W_%$JO/ H/(:M_2U'V-?I7*ZJ&FU0+Z-77:>FRV5?:@"S]*49S2#Y33\\T
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M !^?\"-==XH'_$N?_=-<CX''^F_\"- 'IM%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 G>CO1WH[T ))
M_JV^E>1:Q_R4BP^M>NR?ZMOI7D6L?\E(L/K0!Z\OW1]*6D7[H^E+0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% #&&5-?.?Q;DFL=1DF3(RU?1A
M/S8KQKXSZ*UQ8I(B\EZ .<^$2RZC?QW+@G:W6OH<5Y-\&-'^QZ1(TB_-NXKU
MGJ: 'CI2T@I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6D[T %
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M!2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4@I:04 <S?_\
M(8KHX/\ 4+]*YR__ .0Q71P?ZA?I0!)1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 )33UI],89H 9+&LJ8-1P0",X J9>O-.XS0 =Z4TT]:=0 HH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $/(HH[T&@#S?Q2 =:P?
M45TEKI:/!;R8Y"BN9\59_MW\17=Z>N=/M_\ =% %&73E:?>16FH^14[ 5*ZC
M%(!@C- "B%<=*"H4\4_/-(PS0!7NX1<0[367;:2B0R+CJ:VE&&YH*@=* /.;
M[P5!<7\DI3J?2MC0=!33YUVK@ UUIA0\XH5$4\#F@"3/&*7/%- P:7J* ,/Q
M0?\ B7-_NFN1\#_\?N?]HUUGBH'^SF^AKE/ K#[5CON- 'IE%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 G>CO1WH[T ))_JV^E>1:Q_R4BP^M>NR?ZMOI7D6L?\E(L/K0!Z\OW1]*6D
M7[H^E+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #&7G-<OXST
MT:E8QIC.&KJ6Z56G@$R ,.E &+X3TT:?8-&!C)KH@,5#;Q")<+5B@!112"EH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "D-+10 E+110 4A-+2&@#-
M\0?\@"\_ZY'^5<#\+F_XIF]_ZZM7?>(/^0!>?]<C_*O/_A>"?#-Z/^FS4 5;
M+31>WVK<=C3_  )%]@U3[*PY+$UO^&;-AJM]O7Y7JJMB]IX[C\M<1XR: .RU
MBW\[3)X_[RD5XY-X-=G9^>6KVZ8>9&5]15)=+B,?*B@#G_ FEG3HI >XK"U7
M]SX]:4]-O6O1K:V2W!V"N*\:6+*S7<*_O/44 9&IR"]UVQ9>=CUZ-),(K-3G
MG%>;>$K2>[FDEN%.4.1FNN9YY)GCYVA>* (M8FCN])N6)&56LC0[5+W1DC8@
M8/6N:O+G4A<SP -L9B*UE^V6'AZ-H@0^: "ZLEM/%5@JG(W5G_&88M+,_P#3
M9?YU=\/I=:CJ\,]PI.QN]5/C/_QYV8_Z;+_.@#TCPD<Z#:_]<Q_*MZL#PGQH
M-K_US'\JWATH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KGO&?_(JW
MO^X:Z&N>\9_\BK>_[AH ROAI_P BO#]37:]ZXKX:?\BO#]37:]Z %HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "DQ0:!TH 0\THZ4=Z6@ HHHH
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MXVLI;C5"RYKTCP_C^S_^ UDWEC!=WQ\PC\: ,7P+?*C?9WZKQ6SXCGB>\%L
M,GFN:TN)++6YQ&> W:M*X+7?B-#U&* .I\@0^&)^,?NJP_ 0SD_[1KJ=039X
M9F'_ $SKE_ /W?\ @1H ]"%+110 4444 %%%% !1110 4444 %%%% !1110
M444AH 6BDSQ1F@!:049HSS0!S-__ ,ABNC@_U"_2N<O_ /D+UT4'^H3Z4 2T
M444 %%%% !1110 444F: %HHHH **** "BBB@ HHHH 2EHHH 2BC%+0 AH[4
MM% "4M%% !1110 4444 %%%% !12=Z6@ HHHH **** "BBB@ I,<T=Z* /-O
M%7_(:/UJGJ][';&T:0 @"K7BO_D-M]:S-?M/M*6P_P!F@"AKVLVUY:)'"H#;
MNU=MX%C==+D+9Y%><_V/LN5#=,BO7]!M5M=+4)W6@#B?%UK=/.QC<CGM6=X9
MM+R.^0R2,1FMGQ9=R12-M4GFL_PY>RRWB;E/6@#N=;)72D!ZUSEGIH:REF*\
M@UTFN#=IJ$U3T_!T:?- %G09,6[+Z+7$>(M10:N%;D5V6C<)-_NFO.]<@:?7
M,<]30!UVG&*]M52( '%/O-)6"V9V49KG]#U V5Z(2<#.*Z76;]I)$@49#*.E
M %(<:?)Z!:@\$<WN1_>-:EU:^3HQ?'+)67X'XO<?[1H ]-HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0]*8:
M>:8>* %S@<T'[O%-8C')Q2JW:@ /^I;Z5Y+JO_)1['/K7K3GY&'M7D>L'_BY
M5A]: /7EZ#Z4M-4\#Z4Z@!:*3%&* %HI,44 +1110 4444 %%%% !1110 44
M4F* %HI!2T %)BEHH *2EI,4 %+28I: "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "D-+3'H S-=S_8E[Z>4:\U^''B2RTG3+J&=PK&8G
MGZUZCJD?GZ5<1#JR$5\]W7A.\BN9A&S ,Q/% 'M'_"<Z7C/G+^='_"<Z7_SV
M7\Z\0/AN_/'F/Q[T?\(S?_\ /1_SH ]O_P"$YTO_ )[+^='_  G.E_\ /5?S
MKQ#_ (1J_P#[[_G1_P (U?X_UC_G0![=_P )UI?_ #V7\Z!XZTOIYR_G7B \
M,:AR?,?\Z!X9U#=GS'_.@#W#_A.=+_YZK^=)_P )SI?_ #U7\Z\0_P"$;O\
M/^L?\Z7_ (1J_P#^>C_G0![=_P )SI?_ #U7\Z7_ (3G2_\ GJOYUX@/#5__
M ,]'_.C_ (1J_P#^>C_G0![?_P )SI?_ #V7\Z\P^*OB"TU2VM$@<,?.4\?6
MN?/AJ_S_ *Q_SJ&;PE=SSP;RS .#S0!] ^$FSH-K_P!<Q_*M\=*QO#EJ;72(
M(SV0"M@=* %HHHH **** "BBB@ HHHH **** "D-+2&@!#UJ)<Y.:5W"@GTK
M,35HWN#&",@XH U?>L+QG_R*E[_N&MQ3O2L/QDO_ !2MZ/\ 8- &5\,_^16@
M^IKM37%?#08\,0K[FNU)Q0 #I2T44 %%%)B@ HHQ1B@ H-(12T  H[TM)F@!
M:*** "BBB@ HHHH **2@T !Z4#I0** %IHSFES10 M%%% !112&@ HHQ1B@!
M:;U-+TI* %[T4 4 Y)H 6BDQ1B@!:*3%+0 4444 -;I24XTG44 >+^(\_P#"
M9R_[PJ?5K5Y=>T]@. HJ+Q,<>,)/]X5V4.D_:9+:?'W5% &5XDTK.G02(OS;
MA71^$G<V.V3J.*OWMB+BT6+'W:32;,VHV^] !?:8ES(Q9<U'8Z3'"^X)C!K<
MP,T  =J .?\ $]N7TT[1RHKR:.]O6E:U+'!;I7N%_")[=DQU%<(GA8KJ@DV\
M9S0!IZ/YD&F1ANI6N5\075U:Z@2A(&*[];3$:1@?=K&U[03=-N H XCPW!<W
M-[<2N"<G-=?I=F6U-9&%:&AZ&+2%LKR16K;6/E3;L4 2ZS@:!< =HS7'^ LY
M_P"!&NPUL;=#NO\ <-<AX"/_ *$: /0Q2T@I: "BBB@ HHHH **** "BBB@
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M>(='-Y9@ =Z?X6L6LXF1J ':KHRW;DE,U6TS0DMK@,$Q@UUAVEL$4A55Y H
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MK3^\/SH Z&BN>_X2JT_O"C_A*K3^\/SH Z&DKG_^$JM/[P_.D_X2JT_O#\Z
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M (6C)TP:G/@9"<>5^E-_X01<_P"J/Y4 1?\ "SY?0TO_  M"7'0U+_P@B_\
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M#7_GE^E'_""+_P \OTH C_X6?)CH::?B?+Z&I_\ A!5_YY'\J0^!%Q_JC^5
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M/LLWJ:/LLWJ:]*_L"'^[1_8$/]V@#S7[+-ZFC[+-ZFO2O[ A_NT?V!#_ ':
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M')?%PT>=I]* ,A?'=P%QAJ0>.KC/1J[4_#N+?_J?TI/^%=Q9_P!3^E '%_\
M"=W ;HU*?'EP3T:NR/P[B+?ZG]*7_A7<7_/']* .,'CNX!Z-2?\ "=7!/\5=
MI_PKN+_GC^E ^'<6?]3^E '%_P#"=W&<8:E;QW<8QAJ[+_A7<6X_N?TI?^%=
M19_U/Z4 <8?'4Y4?>J[8>,);N=4)/-=(WP]B /[KI[5S\GAY-/UJ.,)B@#HY
M;*:_M4?)^85V_@+2C9("?6M+1=#A?2+=BO)6M^QLDM" HP* -.BBB@ HHHH
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MB@!-HI"HQ3A39#Q0!GZJH&FS'VKC/#(']M/7<7R>;92)ZBN=T;3OL^HL^.M
M'5A0<4_:*8IX%/S0 8%&!2XHQ0 F!1M%+BCI0 W8-U+M%+FF@]: # KQSXQL
M/M6G ?WZ]ASA<UYW\1-$_M*:S?&=K9H VO V/[%08[5U8Q7/^%[7[)IRIZ"N
MA [T +M%&T4N** $P*,"EQ1B@!,"C I<48H 3:*K7&! _P!*L]ZK3KN1E]:
M/#]/8?\ "U+L5[I#C[/'_NUY=:^'_+\=7%WM^]7I\7^J0>@H GP,48%(/2G
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MLC=ZF+8+>PKEM5UQ;.0@F@#?MT2& (G2K0X KF=$UM=1F\M372AN10!*.E%
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M_P!32QCW,:JZ?KL=Z^%QUH W.AIU-'S*#2CI0 ZDHHQ0 448HQ0 44=J,\4
M-:LS4+!+KEADYK3;A2:P;W7H[6?RV(H U+.!;:+:!CBK2]:HV5VM\@9:OCB@
M!U%)UHQ0 M%)BC% "T4F*#0 AY%-(RF*#5&ZU)+8A21UH FBM527<!5D]:RK
MC5XX(/,)%&G:NE^V%(XH UZ6FTZ@ HHHH ***3% "=Z:,Y-*S;:9)*(XBY["
M@""]A$T.PC-0Z=9K;[L#&:2WOEN9]@-)>ZE'9,JD@9H TN]*:JVMR+B$..]6
MQTH !TI:3O2T %%%)B@ [T'I2CI32.: &D9S61>:5'/<"0KDBK]U>+;+R14*
M:@CVC3<8% %NVC\J%4'05(>M8$/B*.2X\H$9SBMM7R@>@"8=*6D4Y4&EH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH 0T"EHH 2FCH:=28H S-8B,MHP]J\:U:9[+6TB4GYC7N-T%\A\]A7BNK0?;
MO&UN(QE0V#0!ZUX==FT6 MU(K7JEIT'V>QCCQC J\,4 +1110 4AI:* $I:*
M* &/TKSOQWJ#P(T:FO16Z5Y5\0O]:Y[4 6_A[J+SF52:]* P*\D^%_S33_6O
M6L\8H <*6DI: "BBB@ HHHH 8U5[P[;"9O1":L&J>IY_LZ<#^X: /(/M4DXN
M;KG]VY%>H^&)_/T."0]2*\IM[B*V\.ZFLF/,,AQ^=>D>")/,\-6K>HH ZH4&
MD':E- "T444 %%%&: $ P*KWTGDV4LGH,U8JGJJF33)U7J5H \67Q/--X\:W
MR=H%7_%>IRW5Q;1KDX.*YB"QDM_'CM(.<&NEMH!>:H PSM:@#0\$:S(/$7]G
M,3@+G%>K$985XCX?S#\7WA7A0G2O;\C- #J*** "BBB@ IK4ZFF@#F/&FJ/I
MNDET/)!K%^&NI-?Z3=3.>0YK1\=VCWFD.J#.U2:YKX2*PT&^7N)"* .=U_Q-
M-_PF0M<G:)0/UKW&Q;=8P-ZH*^=/$MI)#XW64CAIA_.OHK3O^0=;_P#7,?RH
M LT444 %%%(* %IM.I* (YV\N%V]!7C?BWQ3/'J_D*3MW"O8+X%K*4+U*UX;
MXLTR470G8?QCF@#I_$^K3PZ3IRQY_?(,XKGO#NHRQ:^(WR*[&[TK[9I6ERE<
MK&@S7(>4I\8E(1TQTH ]JM'WVJ$]Q4Z\+52R!2SA!Z[15P=* %HHHH ****
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MBIU![4 >T1G"#'I3U.3BHH?]4N?2I5'- #A2T@I: "BBB@!.U,8=ZDIC="*
M/,OB5JL]M9NB9Q5OPQ=-+X6,CGGRLT[XA:=YVER.5SS572!Y/ADJ./W= '-R
M;FB>YYX>O5?#,ADTN$G^[7G442MX9E<CGS*]"\+$?V7"/1: -^BBB@ HHHH
M**** *U\Y2U<CT-?/>N:O/\ \)O;1G.-]?0UVN^!E]J\#\4V @\;V;%>KYH
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MF@#Q#6=.*Z=>%3_&:]+\!QE/"UJ#Z5P%ZL\PN(2IPSFO3O"=OY'A^W0C! H
MW5%*:!0: #%&*6B@!,48XI:* $7I3)%W(5]:?TI&Z9H \6U^,6_CIL#^&I=+
MF$.J#=QO:K^OV+S>-#)M.,=:RO%%K/I]Q:20*>3DXH ;HXS\99&'397M>,&O
M)_!6G23^)O[2E4[BN,UZNAY.: )**** "BBB@ IIIU-- &5JZ!]-N\CI$W\J
MX3X0'S--U(?]-V_G7H>I1[M-N@.\9'Z5Q/PKLVM+*_#+C=,Q_6@#C?B!&(/$
M5JP'6<?SKVW3>=-MO^N8_E7DWCS3Y+G7+9@I($P/ZUZUIXVZ?;KZ(/Y4 6:*
M** "BBB@ IM.I* &.-T97U%>=>/[=8+!7Q_&*]&[UP_C^W>XLU11GYA0!:DO
M4M/!\+MC/D\5R/A.P&H:T=0)ZU/XQEN(/#EG#$#S%@UF^!KBY@C16!'- 'L<
M:811Z"IATJM"Q,"'N15A/N\T .HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@!K5PWCR[,4:P#^,5W)ZUQ7C&R:[O(,+D4 :'@N+9H47%=)V
MK,T"W^SZ9''C&*T^] #ATI:.E% !1110 4444 (QQ6-XD<QZ/*16RPXK.U2W
M^TZ>\9'6@#Y_\1RYNXFQSNKU[X?R&31ES7GNL:')+JJIY9VA_2O4_"UA]AT]
M8P,4 =$.E ZT=J!0 M%%% !1110 F::W(IV*1NE '!>.G$3(2.<5QW@T&7Q,
M\F.HKN_&]DUS$&5<X%8_@S1S#<^<RX)% 'H\0_=K]*E Q4/("BIAR* %HI!2
MT %%%% "=Z8W6GGK2$4 <WXV0?\ "/RG%<_IT1?P[(?2.NK\30&YT:2,#.:S
M=*L=NCR1$=4Q0!YRFJ;-+DM.Y>O4O"@/]EQ'U6O-9]%D74B@0[2V:]8T.W^S
MZ="N,86@#3HHHH **** "BBB@!K#Y3]*\4\>C'C2PP/XJ]L;[IKS#Q7I+77B
M2UFV$[3UH ZZ!0WAWD?P5S?@GF[N./\ EH:ZR&$C11'C^'%8OABQ-M<3';C+
MDT =D.M*#24HH .]+110 4444 -;BJ.JJ&L7R.U7B,U4U%2UJRCTH \G\/-Y
M/B"];'1JH^*M=,VMK "<5T^GZ4T=]>2;?O&N2UG1I9-9$VP]: /5_"9!TR,_
M[-=#UKG/"J-'81JPQA:Z+O0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "J]X^RTD;T%6*JZ@,V$P'=: .&M#]JUK=7>P+MA4>U<9HEJP
MU#<17:Q\*!0!)1110 4444 %%%% !3.O-/IAX- 'D7CV3S+QH_\ :K'\.IY&
MIQ+ZFNA\>V,C3F1%)):L?PQ:32:A&SJ>#0!['9<V<?TJTHJO9KMMD'H*LCI0
M M%)2T %%%%  >E)VH]:!0!!=#-M(/:O'?%MH1.T@..:]DN1^X8>U>1^+TF:
M[**IQF@#5\ 0E%8FO2E/RUQG@FS,=KEA@XKL\8&* '"EI.U+0 4444 %(:6F
MF@!K#<I%>9>-+<)<*V.K5Z?7 >+[9YYUPN1NH XRY^21'/85JZ1^_NXB.S"H
M]7T^1;+>JG(%6O"%K*TZEU/% 'JD(Q%'_NBI:8@PBCVI] !1110 4444 -/6
MJ&LH'TJ?_=JZ]5=1!?3)@.ZT <!X/0+KC+BJ/Q0A"3Q-CM6UX7M7BUIF(Q57
MXCVCW31[5)P* -SX>-N\,0UUHKE_ <#0>'8488Q74B@ '6EHHH *0]*6B@!!
MTIK#*FG=Z#TH XOQK:J;-6Q53PK.+;PY.Q[-6UXNB:6Q4*,URB+-;>&+A4!R
M30!#IJ#4=<D;/1LUZ? OEQ*/05XQX5GNH]3<N",FO8;%VDM@6ZT 71R*6D7[
MM+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 (:*** &2KOB9?45G:79"T\P 8W-FM2FXYH *=VI,4 T .HH
MHH **** "BBB@!#6/K.EI>P$%036P:0\G% &+H>EI8*V% S6WU%( .:!QQ0
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MG&B@ /6EHHH **** "BBB@ HHHH 048YI:* $(YH-+37% "DT@--/)I3QWH
M=FDS2#KUI/NF@!^:0FFDYXH&,8S0 [/%(.M':D4Y- #S2&ESQ24 )BG"DI:
M%HHHH **** "D-+10 W%':E-)0 HH%)2B@!:*** "BBB@ HHHH :11WIU(:
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M:* $H]Z6D- "8H)P*7M36.10 HI<TT'-'&>M #LT9IN>*3% #\T9IN<T#ZT
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M )BEHHH **** "BBB@ HHHH *0]*6B@!*6DI: "BBB@ HHHH **** "BBB@
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M$0IGTJ>@ HHHH **** "BBB@ HHHH ,4F*6B@!,4M%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %(>E+29[4 ,Z@U3ETV&9MS 9-7=O-!% %&/
M288VW!13IM,BE'(%7J6@#.M]*A@D\Q5&:FCLXXY6D4<FK)]*.E "'K3A0**
M#O2T"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2#
MK2TE  >E(3Q0*7CI0 T<BG9HQ@44 &.<T4G:EH !10>E% !FEI.]+0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 444&@ HIM+0 M%)2T %%%% !1110 4E+10 E!-%)W
MH 44=Z.U)0 O>@T44 %+2"D[T +WI:2EH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ I,TM)WH **#2T )THI:0T )GFC'-+2T -Z&
MEZTAZTHH .]+2=Z6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)0* #J*!TH[T4  H-+24  XHS124 .HI#10 M%)VH[4  .:,T#I10 M% I*
M%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D'6EI#Q0 M-/-+U%
M-R!0 H.12]J:*=TH .U(*4FFD\4 &<'-.S3&^[0,%1S0 [J:!U-)G'%.Z4 %
M%':DH 4449HSQ0 &DI0:,T )G%&<TT\F@#% #Z.U)UI>@H **,TG:@!>]+2#
MI1F@ [T#K1BC.!0 9HS33BDH <#S0>N*:*7WH 7.*.](3GD4!LT .H[T@X&:
M4'(H *.M%(.M "T4F>:4F@ /2D[4=:.!0 4=Z-PQUH!![T *>E':D)YQ1GM0
M  TM-HH 4]:2@FD)QB@!]!H!R*3/:@!:*2ES0 =*.M!IH.* '=Z,T TG>@!?
M:BCO1F@ ;I3:7J:.,T ***.@I : %[T4F>:4T '6D[TO2CK0 AZ4=J0T<8H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK*/XA76)I,:/N'K3FTU&;=B@#$FM3_:5JW]U:S+K3F?59WQP179_9%:17/\
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M],2-2,5&ND1^9OQ0!DZO$9FA9>PK-U6P:>QC('.ZNN>R5UP>U-^P+(@0C@4
M<K+IA-D!CG;2MI[?V9&N.E=<UBGE[:0V*&'9B@#E+105\HBHI(?(N.G>NHCT
MF-)-]$NEQRODT 8;0^;(C8Z"E\06;3Z? H'0UOIIZ*O':I9+-9HE0]J ,WPU
M"8+/::BUZW)^8>M;<%NMNN!1<6RW*@&@#A(+>1]05CG%=1J4)?2=@Z[:L1Z5
M'&^X#D5<>%9(MAZ8H \KCTR1$96SRU=#I]FP6/CI71G1HB>@J:*P2/@#I0!Q
MFM::\U[N [5%%"]O$5YY%=U)IR2MN(J!]&B;M0!A^'XF$X8UUX&<53M=/2V^
M[5T<+0!S-];%]9+5T"#;: >@IGV17E\T]:GQE"M '$>(86G;"^M.M+-U6/.>
ME=)/IJ2R9(J=+!  /2@#(U.V,^DK&*X^TTA[*=GP1SFO2C;*P\L]!5>72HW/
M04 <=:Z8US=22$9XJNFDNUWTZ&N\M]/2W+8'44Q-/17+8[T <OI^FF*^)QWK
MJ-1A+:6T8ZD5)%9*)BV*MRQATVT >8WUDY.TYX-=/X6MS##@UIRZ/'(^2!5V
MULDME^6@#AM88KJ4F/[U02Z:]_%MP3FM:ZM5N-58-_>KH[;3(X4!P.E '"VU
MD]FK1<\\5;@T]HX2Q%=:^D1R2;L"I3IR>7LQ0!YII^E3#4IGYP6KIWM&%OBM
MZ+2(XV+ #FK!L59<8H X>YM&=E%6I],8Z2,#G-=1_949/:IFLU,/E8XH Y?3
M-/864H([56M+?R;OD5V<5FD<;*.]53I:>;NQ0!8LR##P.U<CKUFQOS,/6NTC
MA$2A15>XT]+@_,* ..N87FB3KP*(D=H1%SQ75G2HQA<4J:/&C;L4 <PFG,LZ
MG%7;RU)BC&.AK?:R3S%XZ5(]DC@>U '&ZSI;3Q*^.@J?1\1VOE$=!74S6*2)
ML-0Q:3'$21WH YLVC.K$>M<MJNGN\^,'K7J L452*J3:%%*V\@4 <?I-@]O9
M\YJW+8/.H//%=;'I4:Q[0!4BZ:BC&* .)MX7MKH=:?<6+37"28[YKKI-(C9]
MV*>--0 <=* *'E'^R/+J3083$9,]ZTC;*(=E/@@6$$CO0!/VIU,'2GT %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4QZ** '=
MJ.U%% #?X33EZ444 '>D[T44 .I#THHH 1>E'>BB@ ;I0.@HHH /XJ&ZBBB@
M _BI1110 ?Q4'K110 #K2GI110 G:BBB@!.]+VHHH 6BBB@!#1VHHH #1VHH
MH #VHHHH !2?QT44 .I.]%%  *0?>HHH 5NE"_=HHH .U HHH #TH/W:** &
MQ]*=110 "D;J*** #^*ANHHHH *=110 G>EHHH 0]:6BB@ IK?>%%% "]Z.]
M%% !WI.]%% #ATII^_110 -2?Q444 */O&C^.BB@ ;J*7O110 &CO110 M(>
ME%% "TC=*** #M0.E%% !WI:** $[TM%% #3]VE7[M%% !VHHHH .]+110 W
MM2T44 !H]***  ]:.U%%  .M!HHH .]+110 G>CO110 M!Z444 )VH%%%  .
MM!Z444 (:7M110 @I>U%% !Z4G\5%% #J3O110 'I0O2BB@ -!HHH #TH[44
M4 +1110 4G>BB@!:0T44 (:6BB@ /2@444 +2444 (.E.HHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0S!WP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **9*^R)G]!FO,-2^)7V/5I+3'
MW3B@#U*BN)TGQ>U^1P>:Z^VF,T>Z@">BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"
M*Y!:VD [J:^?]7\.W4GBB:8QG86ZU]"$9!%8MYIEO(S,0NZ@#B= ^R6)59B
MPKT:QFBFA#1'*UX_XAC>WOV\MCC/:O0_!3N^E N3G'>@#J*AFN4A&6.*FK.U
M&R:Y4A3B@ _MFUW8WC-6X;A)AE3FN.ET">*0ON/YULZ*2K;"<XH WJ*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI"0.IK.N]3CMWQN% &E
M17":UX^ATM]IP:Q/^%LV_I0!ZM17E4/Q8@E?;BNHTKQA#J!'(&: .MI,C-10
MSI*FX,.:?CYLT /HHHH **** &R9\ML=<5YMK5[JZ7KK"K;<\5Z75=[*!VRT
M8)^E 'F.GZ5=:A<AKI#SZUZ/I5BEC;B-!@8JREK#&?E0#\*FQB@ HHHH @N4
M#0L?:L72<_;7'O6[/_J&^E8FEL#>O]: -^BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3_ZAOI6)I9!O7^M &_1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.2*R8_"Q^U%VCXSZ5V&FV0MHE7&,4 :0Z4M%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%95YJ\-HY#L!B@#5I,BN4F\:Z>DOEF49^M7[+7;>[(V.#F@#=
MHI%.Y0?6EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[@90YJ:@ HJ">ZCMQESBF07T,[;48$T 6J*** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME/\ A)V!QS0?$[ XR:ZO_A"[3.<"@^#+0GH* .4/B=AZT'Q.P[FNK/@RT/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!0>E%,)
M.:8'FNN_\C=#_O5Z1;?\>T?^Z*\YUP ^+(3_ +5>C6__ ![Q_P"Z* ):***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MQ_$O_(&F^E;%9'B3G1YOI50^)$S^%G@5T ;B3/\ >-0B-#T%37G%U(!_>-1?
M=KZ2E&R/FZCO( B'M1L0\8IP&.:0\<UJB+B;$SC%&Q.F*4#O01CFD@N)L3.,
M4>6GI2@9.:4CO3"XTQH.U'EIZ4#YJ<1D4!<:40=J7RTQG%)][BEQGBA;@,V
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5D>)/^0--]*UZR/$AQHTWTJZ?Q(BI\+/ KOBYDSUW&HU''-27
M?S7,A_VC3%.17TL/A/FI;B#@\T@!)YH^\:4'M5DAR#[4G);VI2<G% .#BC<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ J":ZC@&7(%/FE$498UY)XU\=?8;T
MVJ]2<<4 >H1ZK;2MM5P33;[5[73TW3.%%>&6GC26V/G-NP.:=?\ BR3Q9MMX
M68'IQ0!ZS_PG6C^9L\]<YQUK=L]1@O8P\3 @U\]W7P_U*%5O/.DQ][K7<?#_
M %MC=#3W8EDX.: /5>-U/I@7YLT^@ JM<WT-L/WC 59KEO$,#SR;%;&: -:+
M7+25]JR FM)6#J&'0UY'/%+H]['F4G<WK7I&CWOVFUC^E &E)(L8RQK,F\06
M4+[6D /UIFO7?V>W/.,BO/&TZ74[PE9B,GUH ]0MM2@NO]6P.:N5S&@Z1)9*
MNYRV/>NG[4 %%%(2!UH 9/\ ZEOI6)I>/MKX]:V9W4PL,CI6+I2XO7/O0!T%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M  GI8'XSO:***\<]@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP'CM7:?#G1+>SU3S4QN)J[_PA-UZ&M_POX<GTV[WR9QF@#NJ:W2E)P* =PH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M445XY[ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% $4\@BC+,< 5YAXR\82V3M%;'<W8"N_\0,R::Y4X.*\3
M-C-?^)(S+EDW<@T 8X\:Z\LVXP2;<]<5Z3X&\73:E\MU\I'K72S>%-.;2>+=
M-Y3KBO-S8R:-JX"?*I?M0![;$RR(& &#4N .U4M(8OIL+'J5J]0 A&10!@4M
M% !28%+10 FT>E+110 8%)M'H*6B@ HHHH **** (Y_]0_TK#THDWS_6MR?_
M %#?2L32R#>OCUH WZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHHH **** "BBB@ HHHH **** (Y_]0WTK$TM0+U_K6W/_J'^E8>E _;GSZT
M=!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!'/_ *AOI6'I39OG^M;D_P#J6^E8FEX^VOCUH WZ*** "BBB@ HHHH ****
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M*4CTH 4C(IO7B@G(XI<<<=: %QQBF_[-*3\N.] 'R^] "@8&*;]WBES@8[T
M<<T *!BFGY:4<=: .>:0 !WH(P<T@R#STH&2WM0 H&3F@CO2<AO:CDM[4  &
M[FG$9I".>*0Y)XI@'WOPIQ&12$>E(3D<4 '7BG8XQ28XXZT9XQWH CF_U>*]
M?^&@QI7X5X]-GR_>O8?AGG^R>?2O,Q_PGI8'XCO:***\<]@**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQQWH "<#--_VJ._/2G<8H AF/R9KV#X9G.D_A7C\O(]J]B^&P TGCTKS<?\
M >G@5[QW=%%%>,>N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5#<MMA8U-5:^S]E;'I0!X)\47GDOQY3,.
M>U<5IM_>V%U$S%R :]2\00VT^JJ+G&"W>K%]HNA+9*XV[]M &WX?\2?VCI'E
M$_,$KS"\T*Y\0^(;F%9& !/>NH\.J8Y9EB^X <5=\*"(^))^F[)S0!P'ARQN
MM!\5F&1V*J>YKZ,T>?[19JWM7E?B:TMX=5>:/'F9KT/P>[/I*EJ .BHHHH *
M*** &N<*:P+D1SRLA8 UNS@F%\=<<5Y'J4FMIK<OE*WEYXH ;K*_8]0+*<\]
MJ] \)3FXTT,:X&STN_OKT&Y0X/K7INC62V5J(U&* -.F2)N&*?10!GS6NV-F
M]JS]);_3'7WK;N/]0_TK#TD$7S_6@#H:*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&.T9I:K7SF.U9AV% '$^,
MO&,>C90GFO,)_B7F1L$]:U_%ULVKZU'$^2I;%;</PHT^6UBD*C+#)XH XM?B
M1&?O@FNS\"^+(M>O_(*Y&>]2M\)-/P,(/RKH_#/@.ST"X\Z$ -0!U\=M%'RJ
M 5-110 4444 %%%% !1110 4444 %%%% $5Q_J'^E86D_P#'_)]:WI_]0WTK
M$TL#[:^/6@#?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *K7Z[[1P/2K-0W.3"V* /'M:N([#
M6X_, SOKT;3]:@>RBY'W:\I^(=I>-J2RPQL=ISP*Q(==UJ"(*(9.!Z4 >_?V
MI#CJ*DM=2CN)-BD5X OBC7#D>3)77_#[5M2O-5*W,;JN>] 'L%%':B@ HHHH
M **** "BBB@ HHHH **** (Y_P#4/]*P]*4B^?ZUN3_ZA_I6'I39OG'O0!T%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAE,U[#\-#_Q*?PKQ^0_+CM7L/PU &E<>E>;C_@/2P'Q'="EI!2UXY[ 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% "$[1DTW<KKU%9'B:]EL-)DFB!+ =JX?0O%FH78821N.>] 'H%SI=E='
M=+&I^M4QH.E$_P"I2O.?%?C;5-,<+!$Y!]!7*#XE:X#_ *B7\J /<E\.Z4?^
M6"?E5FRTNQM)<P1JK>U>#K\3=<'_ "PD_*NP\ >,-2UK4S'<QNJY[T >N444
M4 %9]]J<=DI+]JOG@5B:II_VX[3WH @M_%5M<2[ 1G.*Z"-Q)&&'>O*=8LET
M/4(MK?>:O0]%N6FLHR?2@"]=72VR%F[5SDOC2TBG,9(R*L>))S';D>HKS^VL
M;*[OR99U!)[F@#TZPUJ*^QL/6M6N<TC38+9%:%PP]JWE<YH EHHICRI&,L0*
M &W'^H?Z5A:3_P ?\GUK5FOK=HF42+G'K69I6TWCE3GF@#H**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH8!1110 5D>)/\
MD#S?2M>LCQ(<:/-]*N'Q(F?PL\$NU/VB3/\ >-0<CK5B[;-Q)_O&J_WJ^EI[
M'S53XF*H]:.AYH4YI/O'%7L0 !SGM2]#GM0#SBD)R<4; '4Y[4I'-'0XH)YQ
M1L A^8\4I'I1]VACCI0 AY&!2XXH^[S2DX&: &YXQWI<?+[TG;=3L_+F@!,X
M&.] ''-)U&:<#D4 )]WK0H]:3[U.!H 3H>:0 YSVH^\<4H/.*-P#H<]J3J<]
MJ"<G%+T.*-P CFD/S'BE)YQ1]VC< (]*0DG@4I.*3[O- #BORTASMQ2EN*,_
M+F@".48B]Z]>^&F?[)Y]*\AF/[K->O?#,YTGGTKR\=\)Z6 OS'>"EHI :\@]
M<6BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %4]2!-FX]JN5'/'YL17UH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI&.T9K-EU...X$>X9)H
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MHDWS_6MRX_U#_2L+2?\ C_D^M '14444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %9'B/\ Y \WTK7K(\2<Z/-]*J'Q
M(F?PL\%O,?:9,?WC5<^U6+L8N)/]XU %Q7TM/X4?,U/B8HQVI#[4?=H YS6A
M(HQ^-(<?C01@YH R=U  /?K2G%(1SFDQN.: %'O1]:4C/--^]^%#&@'7FG<8
MH(R*;UXH$'?VIW&/:C'&*;_LT !Z\=*<,=J ,#%-^[Q0 'VIPQVH Q2?=-
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M$'C@:7<&-!N^E '>52NM2AM'"R, 37$Z;X\:\CW%2/PKCO&WC.2*\C9<C!H
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M]#7.?".0_P!FN#ZUO_$2X5M"EBSR16+\*K4II[L>!F@#O-?S_8EQ_NUP?PT
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M2S*.M>QGI7F_BL8O&:@"]X*T2WM[/<BC(%=LJ93:>E<SX.?_ $ GVKIXY U
M'!>,M$M+B93(!R:31O#-G%;F15' S5SQD2)X\>M7-(?.G/\ [AH XV74HIM2
M>RG;]VIQBC6;+2K:P$T17=6*NERZCXHG1&(^:NCOO!%U<V@CWM^= $XU-H/!
MQDMF^8#M7/: L.M29OSER>]=C9>%9(="^R.<\=ZRHO"DNG2^>I.T'/% '06O
MA>RA"^4HVFN&\?:!;"^A&T8)YKJ[?Q4EK=):/]XG%8GCN;S+JW?^]@T ;O@C
M1+2S@1H@,D5/XZ3_ $>,#UJ7P:#]G0Y[4>./]3']: -GPT,:/%]*V*R/#G_(
M(B^E:] !1110 4444 %%%% !1110 C=*:IXR:?5>\D\FV9_2@#EO%_B%=-M9
M C@/CBO&K7X@:NVLB,EMA? KKO%=I/K>HJL3';NZ5CWGA!M.N+>1EYR#0!ZO
M::A<2Z*DYSN*9KG_  WXDN+SQ%+:NW"MBN@TK:=!V$=(Z\]\(9_X3NX';?0!
M[5G I::P)6A1@4 .HHHH **** "J]Q>16R[I& %2R-LC9O09KS?5M=;5]0DT
MZ$D,I[4 >A07T-Q_JV!JQD5Y;I.MMINI"SF8EAZUZ/:3_:D#CI0!<HHHH CG
M_P!0_P!*P]*)^W/GUK;N"! _TK#TF0-?.!ZT =#1110 4444 %%%% !1110
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M+MF/4FMR2W3RF^4=*S--3;=O]: -RBBB@ HHHH **** "BBB@ HHHH ****
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M6IE.10 M%(3@4*V: %I"H-+10 G:F9):G!LG%+B@ P/2EHHH **** $P/2C
M]*6B@ I,#TI:* $(!% 4"EHH 0]*:AYI2V#BE% "U0U-2UL^T<XJ_2,H88(H
M \@TFVO!XO8M&?+W=:];A4",<5"NG6R2^:(P&]<5:/RB@!A)W8J2FC#<TZ@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT44TN : '44@.:6@ HHHH **** "BBB@ HHHH CG_P!0WTK$TM0+U_K6W/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K(\1C.CS?2M>LCQ)_R!IL>E7#XD3/X6>"7@Q<R#_:-1*,5+=@_
M:),_WC4(..M?2P^%'S53XF!^6A1WH R>:!P>:O<@#QS0!DYI!DM[4O(/M1N
M$=Z0#<<T<EO:E/!XH 4C/--^]^%!R>E*1Z4 *1D4WKQ03D<4N..* %QQBF_[
M-*3QCO0!\OO0 H&!BF_=XI<\>] ''- "@8I#\M ..M &3S0 *.]!XYH'!YI!
MDM[4; *!DYH([T<@^U)R6]J  #<<TXC-(>#Q2')/% !][\*<1D4A'I2$Y'%
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MIQ.!F@XQS3>_/2@ _P!JG9XS1QCVIO?VH .O-.!R*.,4T]>* W#[WX4X'/%
MQVI#[4 )G<<4H/.*48_&D/MUH "<G;0.#B@8_&E./QH 1CSBC[M ]^M*<=Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %9'B09T>;Z5KUD>)/\
MD#3?2KA\2)G\+/!+P;;F0?[1J(#%279S<29_O&HESCFOI8?"CYJI\3% Q2?=
MYH!YYI!DGFKV(% YS01@YH&0?:DY+>U&P"@9.:".]'(/M2$G/% !]XTXC-(>
M#Q0Q]* $^]Q3L<8I",#B@GCCK0 G^S3L<8I,<9[T9^7WH 3IQ3@,"D XR>M
M/'- !]W\:%&.: ,]: ?6@ ^[S0!SFD&2>:49!]J-P C!S0!DYI.2WM2\@^U&
MX 1WI/O&@DYXI3QTH 4C(IOWN*4GTH(P.* %QQBC'&*0GCCK1SM]Z0$4R_N\
M5[!\-!C2?PKR";_4^]>O?#//]E<^E>;CW[IZ6!^([VEHHKQSV HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4S:=V:?10 4444 %-<9IU% "#@4M%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %1S)YD94]ZDJ*XD\N$MZ4 <3K]]9
MZ,Y>:-21SS6#:?%>Q%TMNB@9.*K>,6?4]52 <JS8-86L>![?3KFTG0?,Q!-
M'LAO8+[3!.Z@JRYKD_#M]:2>(I(HD4,&[5T%G;[/#:KZ1UYWX.<_\)O<+_M4
M >U]J*0=*6@ HHHH **** &*I#4^BB@ (S2 8I:* "BBB@".?_4-]*Q-+8&]
M?ZUMS_ZAOI6)I8 O7^M &_1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5D>).=&F^E:]9'B0XT:;Z5=/XD1/X6>"7
MG%S(#_>-1*I J2[.;F0G^\:B4G%?2P^$^;G\0H&#0!SF@$D\T@//-60'0YI
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MH'S=:<1D4 *2,9I,\9[4WJ<4_ VXH 9*1Y6:]>^&I!TKCTKQV7[F.U>Q?#4
M:5^%>7C_ (3T\!\1W=%%%>0>N%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 5;NSCN8F5U!S7)W?@VS
MFD+>0IS[5VU)@>E '&67@^TMY P@48/I776T(@@5%& *EP/2EH :^2.*%SCF
MG44 %%%% !1110 444UG5!ECB@!U%,65&Z$&GT %%%% $<_^H;Z5B:61]M?'
MK6W/_J&^E8FEJ!>O]: -^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **C>9(_O,
M!47V^V'_ "U7\Z +-%5UOK=C@2+^=3@AAD=* %HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ K(\2?\@:;Z5KUD>).-'F^E73^)$5/A9X#=\7,F?[QJ->!S4UX,W,A_VC4(
M^:OI8;(^:DO>8H%'0Y-*#3?O'%62 &3GM2]#GM0#SB@G)Q1L G4Y[4I'/%'0
MXH)YQ1L A^8\4I'I1]VACB@!#R,"E(XI/N\TXG S0 W/&.]+CY?>D[;J=GY<
MT )G QWH XYI.O-.!R* $''6@#UI/O4X&@!.AYI ,G/:C[QQ2@\XHW .ASVI
M.ISVI2<G%'0XHW ".>*0_,>*4GG%'W:-P CTI#R,"E)Q2?=YH 7'%)GC'>G$
MX&:0#O0 R4?NO>O7OAIG^R?PKR*?_5YKU[X9G.D_A7EX_P"$]+ ?$=V*6BBO
M(/8"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***1F5>IQ0 M%1B>,G <?G1)/'$,NX'U- $E%5/[2M,X\]
M,_6K"2I(,HP(]J 'T444 %%%% !1110 A.!FN<U_5!%%M1L-71D94CUKF-:T
MCS,OGK0 FAWKS%0S9KJ>U<;HL?DW(2NR'2@ I,TM9>J7CVL;,H)Q0!?N"/(;
MZ5B:4#]M?/K7/-XJN'D:,HV,XZ5MZ!.9Y2Q')H Z:BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHZ4PRH.K"A /HIGG1_P!X4>='
M_>%%@N/HIGG1_P!X4>='_>%%A70^BH_.C_O"E\Z/^\*+!=#Z*9YT?]X4>='_
M 'A18=Q]%,\Z/^\*/.C_ +PHL*Z'T4SSH_[PI/.C_O"BS"Z,#7X;N4'R"?PK
MSC4YM5LK@([L-QXKV7S(CU(->?>,Q$=3@QC[PH28712TFTUAVCD9F*GFO2+#
M<+5%?[V.:@TOR1IT/W?NU<5XP>&%.P[DU%,\Z/\ O"CSH_[PI6"X^BF>='_>
M%'G1_P!X46%=#Z*9YT?]X4>='_>%%@NA]%,\Z/\ O"CSH_[PHL.X^BF>='_>
M%'G1_P!X46%=#Z*C\Z/^\*7SH_[PHL.X^BFJZMT(-.H **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.%=X"T445@=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &NX1<FO-
M/&WBPZ?(T<,GS]N:[[5Y?)L6;VKP/Q#:S:OXD158[2U $VE>-]2.H()G(C+>
MM>K)XQL!IZDS+OV\\UP&H> Y;?2C<J,;4S7F4,M[<:BUJLK\-MZT >A^*/&=
M]-*4L'+<]C6S\.[C5KB]$EXK!2>]5?"O@28^7<3Y8-SS7J^GZ=#80*%C 8>@
MH TJ*0'(I: "BBB@ HHHH **** "BBB@ HHHH CG_P!2WTK%TPC[:_UK9N/]
M0_TK"TG_ (_Y/K0!T5%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYKU[X:9_LG\*\BF8>3FO7?AH<Z5^%>9C_A/2P/Q'>"EHHKR#V HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@#G-  !W[TI]>](1@YI,9.: %'/)I3CO2$<YI/O'B@ '/6G'&.:".*:?FXH
M.IQVI^!BFD<8I<?+B@+D,WW,=J]@^&@ TKCTKR";_58KU[X9@C2?PKS,=\)Z
M6!^([ZBD%+7CGL!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<B@ 'S=:4'UI0>.*:>>E !]XTH.#BE!'2D)SP.M "9RV.U+T.*!Z=Z">W>@
M)YP*/N]*!QP:4G% ",?2CIR*0<=:<3@4 (3QFCG;FD[Y-/R-N:3 AF_U6>]>
MO?#,DZ5SZ5Y!-]S/:O8/AH0=*X]*\W'?">E@?B.]HHHKQSV HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ(Q.G2E [T#WHZ'/:O:6QXS!AWI ,\T8).>U&"#GM3$.([T@^;K0>3D4'VH
M4C--^\<&@\]*4CCB@!<<8IO7B@G(P.M+CCWH 7'&*;TXI<\8[T <>] "@8%-
M/'2EZ#!H ]: % Q2'CD4#CK0!SDT  '>@\<T=#GM2=6SVH 4#/-*1WI",'/:
MD/)XH 4?,>:4C-(1Z4AYZ4 '7@T8R<4I''%)U&!UH =@8Q3>^*7!Q2=L=Z-@
M6H['&*1E C- !VTUB1&0:SG\)4-ST;X8  /BO4QTKROX8 X?->J+TKP,1\;/
M>PWPBT445SG4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1VK=HHH **** (Y_]0WTK#TIB;Y_K6Y/_J6^E8FEX^VOCUH WZ*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *NH?\ 'C+_ +M>$Z^<
MWTOUKW?4/^/*7_=KPOQ !]MDQZUZ&!W9Y^/^%&(.>*3J<4'D<4X8_&O:6QXS
M$S@XI,Y.*5L?C2+C\:8A?N\4$XX'>E.*0>] !]VE)P*#CO31UYH .G-.)XS1
MQBF]_:@ [;J=GC-'&*;U/'2@ 'S<TX'(HXQQ33R>* #[QI0>U*,4AYZ4 )G)
MQ2@X.*48_&D./QH "><4?=.*![]:4D4 (3VH^[0/>E..]  3@4WIS0.O-.XQ
M0 F[C-)CC=1W]J=QCVH8+0 >,U$YRIJ7(J.094XJ)[%0W/2/AB?E:O4EZ5Y;
M\,?NM7J0Z5\_B/C9[V%^$6BBBN<Z@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *R/$G_ "!IOI6O63XC_P"0/-]*NG\2)G\+/ KL9N9#_M&H@<U8
MO"/M$F/[QJL>>E?30^%'S53XF'WC2@\XI1BD//2J($SDXI0<'%*,?C2''XT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?Q'QL]W#?"+1116!U!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_9[%<D4 7QKBDTXZTHK.73VQG% L&/4&@#0.MJ*4ZTH&:SA8,>JT"P8G!!H
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MM3BH]'!$'- &E1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 C#*D55@M]DI;'6K=% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,E7?&13Z* *UM!Y6
M>*LT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!%<1^9'MIMM%Y28J>B@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBD) ZF@,#T- "T444 %%%(6 ZF@!:*0$'I2T %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]=5W 9IS)=VK;LOQ0!]$VM[%=Q[XSD&K5>,^#/&<[ZDFGNC>F2*]E4Y4'U%
M"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 07G_'G-_N&OC_QJ,^-)O\ ?_K7V!>?
M\><W^X:^/O&S;?&<Q_V_ZT ?2?PR&/#$7T%;GB;/]DR8]*X?X?Z]%;>'(U+
M<"M?7O$D,FF2#<.E 'S[K^1XI3/]^OH'X>$G3E_W:^>=9N5N?$T;+_?KZ"\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH @O/^/.;_ '#7QQX_W#Q=<;>N[^M?8]Y_QYS?[AKX^\;*
M&\:3 _W_ .M %S1YO$ L5%M&YC[8JQ=R^)#;D21R;:]P^'6D6DWAF)GA4G Y
M(K:\0Z-91Z3(1 @./2@#Y-M#/_;D7V@$'=WKZ5\*.%\.NR]HZ\&UV%%\3HJ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZW>N.HH =14 N4,FP,,U/0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'^S2K31@L.Y% '0^&-!2UT41[<;TP:\@^)/@O[%<M=VT9+$[C@5]%PQK#$J
M8P*R-?T6+4[9E* DCTH ^?/"OC.ZTME@E8J%XY-=U/\ $,_9<I,-V/6L#6/A
M5?S7CR0 J">,"J<'PKUA6&YG(H Z+PMXNU#4O$2QL28R:]N0Y13[5YCX/\$R
MZ5.DDJ_,.^*]/484"@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM% #2N:7'%+10 FQ?[HI-B_W13J* $P!T%+110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 (54]0#30B@\**** 'T444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>image9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0S!WT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HH)P,FHQ/&7VAAGTH DHIHD5F*@\BG4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !129%1_:8M^W>,GMF@"6BBB@
MHHJ-9D9RH8$CK0!)11FHQ,C.4##<.U $E%%% !112$@#)H 6BF>:F"<CBDCG
MCE^XP./2@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHI"<*30 M%<+XG\63:1<HBJ=IZFG-XOQX?%[GYB>E '<45PN@>,#J$VR0XR
M>,UV^_,8;UH ?12*<C-+0 4444 %%%% !1110 4444 %%%% !1110 444A.!
M0 M%1F50IYY%<[=^)88+U8?,7DX/- '345!:W"7$(=6!!]*6YF6"!I&.,#-
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MZ@#OZ*0=*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3- '4,"UL0>I6O(O"2MI7Q!U.6X^5)'PI->Q8^7%<;JOA=KC4%N8OE(;)(H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK#\3Z1'JNERQNN2%.*W*K7=PD*@.1AN.: /D/6_#NH:-JDEQ'$P56)!Q71^"
M/B!>Q:DEK<R$(..37N?B;PW:ZMI\BQQIN9>N*^7_ !%I4F@^*/)4XVN.GUH
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M "#I4!M$-P)L?,*L44 &**** "BBB@ HHHH :^=O%"#C-.HH 8<[Q3L9I:*
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MIWC>2]OTBC<-\PZ5ZY;,7MHV/4J#7B?@WX=:AI>H^=<%B,]Z]M@79 B^@Q0
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M]*=\+=%^W:W%<!<^5(.:]S^(GA/^WM&6"V3# YX%9/PT\$2^&UF-PO+'(R*
M/3XAB)1Z"GTBG*TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 8/BTD:'<X_YYG^5>+_"8G^UY_P#KL?YU[1XL(&AW/_7,_P J\8^$
MS#^UIQ_TW/\ .@#Z$'W12T@Z"EH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#!\6$C0[G_ *YG^5>+_"9C_:\X_P"FY_G7M/BP@:'<Y_YY
MG^5>+_"4C^UKC_KN?YT ?0@^Z*6D'04M !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !43W$2'#, :D)P":\O\4^*/[/U.2/>1@T >EBZB
M/1A2K<1L<!AFO&$^(,49\MI/F;IS6KH_C%9;Y0SY!]Z /5Z*@M)1/:I(.C#-
M3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU[]MM_\ GJOYT?;;?_GJOYU\A?\ "R]9_P">S?G3E^)>LY&9F_.BVH'UX+N
M])%_.E^U0?\ /1?SKY?T_P"(.J2Q\RMGZUH+XTU8G_6-^=;QH-E<I]'?:(<Y
M\Q?SH^VV_P#SU7\Z^>W\8:JUN2KMG'K7-WOC77X<OO?;]:)T)1U!H^J/MMO_
M ,]5_.C[;;_\]5_.OD,_$K6@<&9OSI/^%EZSG'G-^=86)/KPWEN?^6J_G3OM
M<&/]8OYU\AI\2]8WKF9L9]:V6^(NIM;Y68YQZU48N6@F['U%]MM_^>J_G1]M
MM_\ GJOYU\EO\0M<SD2MCZU7;XE:TIP9F_.AQ:!,^O/MMO\ \]5_.C[;;_\
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MYZ+^='VJ'_GHOYU\S#XDWFX_OC^=-_X65><_OC^=# ^F_M4/_/1?SH^U0_\
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MAW/_ %S/\J\8^$R_\3><_P#3<_SKV?Q;G^P[G'_/,_RKQ?X39_M>?_KL?YT
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M4 %%%% !1110!G:V<:9+]*^-_&(\SQ?<+ZR5]D:T,Z;+]*^._%HQXTF_ZZT
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MWN:TG9-6 Z^TEBE7&!22Q1O'* !P*Y^SGG4C&:U'ED6W8GJ173RIPN2CF[E
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MAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%% !1110 4444 %%%% !1110 4444 9VM'&FR_2OCKQ=SXTF_P"NE?8FN_\
M(,E^E?'7BS/_  F<W_72@#Z!\"V8O/!LT#=&6DB\"Q!D8!<ALU1\/ZA+I?P[
MN[I.&1,BO.+3XK:I)?1Q;C@N!U]Z .[^+"BWCT^V_P!G%6+,FQ^&)9.#[50^
M)LINM+TV\?[QC#&M#PW+%J_P_P#LNX&3TH ^>M2N97U69]QW%J2:\NVB\IY&
M*'L36UJGAF^77I56%MN_CBM[4/#"6?A:2YG3;,.F10(\_P ;D ':FXYS2HV*
M0GGBJ06#'.:,4O:D!]:FPPQ\N*.V*4GBCM5,0T#G-(P.:=_%5M;1I8P5&:<8
MMA>Q2P>E7M-NS:7 8'&*K2PR1-\P(J/G.15<M@:YD>BS>(4N=*9 >0N*Y&UO
M&%Q]XXK/CNG12F>#2(^V7(K.3=B\-[L]3LK$$MN8YS6]$(RFPJ,FN<T6;S0
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M5CEV@<YK,M;)VM]_O6CXGG!U%EST:I;1D73"<CK54[1@>S1]Z-V>T?"=&2W
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MIM)1/:/A VZQ3/797K%>3?!\?Z A_P!BO6*X9;G=!60M%%%(H**** "BBB@
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M #'A2V^E=32 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYI1QJ<7UH ^P_A_QX4MOI74URW@ Y\*6WTKJ:0!1110 4444 %%%% !1110
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MB1K$X_Z;'^=>T^+&QH=S_P!<S_*O%?A/_P AB?\ Z['^= 'T./NBEI!]T4M
M!1110 4444 %%%% !1110 4444 %%%% !1110!%<_P#'M)_NFOC7X@?\C-=_
M]=#7V3='%M)_NFOC;Q__ ,C-=_\ 70T <O31G-+GG%+0 WG%'.*,\9I<\9I@
M!SD4=Z,X-&><4  SS2<XI0:3/&:  YP*O:3SJD/UJEGBKND?\A2+ZT ?8?@'
M_D5;;'I745R_@'_D5;;Z5U%( HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "H;G_ %#?2IJ9(N^,KZT)Z@>#:C>"Q\>7$K' I?&&N1:@]JT3
M9V#FNNUWX?-J6JR72G&ZLU?AA)M;<Q.?>NR-6-M3/E8OA_Q;;V>EI&T@!SZU
MZ5HVH)?VJ.ASD9KRQ_AFR #SL 'UKTCPSI7]F6:1;MV%QUK"I9[#29<UTD:7
M+CTKXX\9<^*;O_>K['UW_D%R_2OCCQE_R-%W_O5D68/%'&*,<8I,<8I@+1Q2
MTF.<T@ 8HXHQC\:-O&*8!QBBC'&*6D F>:5L=J;CG-'7BF2]Q>,4@'6E*X^6
ME'2D4-7WZTM&.<T8YI@'&*.*,<8HQQB@ .*6DQG\*6D E I,=Z4<G%4E<EO4
M.*7H.*-OS$>E'>E<:8<;>>M-Z-D4I7)S2@8I^91?M+^2$XW<5>_M+?&P9NW%
M8>,\4AR.,UNL0^6Q(^9MSDTTG*8IIIRI\R^YK&/O,3);8R*?EZ4V=F,A+5U&
MFZ*)H,^M8VLV?V69E]#75.-HB,O%+QF@#(SZ4!?XJXF]2D'%)U^E&,?C0!@8
MH&' H[4A&>*=0 @/%&*!US2FFV WO[4[BD(XQ1C/X4(!:.,TA'.: .<T, X%
M''X4'THQQBD@%XHI,9_"EIB$I#UI<8_&DV]J 9;L75)@6]:Z.?4$%MPW.*Y/
MIC':I#*S+UKKHU+(EHV=,;S+XR-WKJ#=QQP%6/:N(M+K[.-U37&IF9=H-=<:
MVA-KG1)?Q!N",5.ET'R0:XZ&5BX7)KJ;2V*VZL>XKII5.>)%BIJMRI@92?FK
M+T\1L_S5=O;0S784&JDMJ;)U/J:PE3O(KJ:$]G$1\@J&R1+:Y+/PO:M&S594
M&361K+B.4HIZ&JG!15T.YI^8LS;>QI]K,+:\\O.$K,TMS-SZ59NU(DW"KI[7
M)ZFI>FWP&&.>M4DEB0<'BLB[O6"JN3Q54WA\LC-82J6N6F3:G=!W*J:@L[4R
MG)%5.9'W$UK:;<*& -<?-S2U&@FLMI4 <YKZ%^"JA=.F%>'2E<AN.37NOP:'
M^@SFKQ$%&**6QZM7AG[07_'K:5[G7AG[07_'K:5PC/GE,?C2\9IJCG-.QS3
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MN?\ KF?Y5XQ\)E_XF\Y_Z;G^= 'T(.@I:0=!2T %%%% !1110 4444 %%%%
M!1110 4444 %%%% $5S_ ,>TG^Z:^-?'_P#R,UW_ -=#7V5<_P#'M)_NFOC7
MX@?\C-=_]=#0!RU%+2 <YH .,4<4F.,4N.,4P#BBC&31CG-( HXQ0!28XQ3
M7BKFE_\ (3BQZU3QQ5S2C_Q,XOK0!]A_#_\ Y%2V^E=37+?#\Y\*6WTKJ:3
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MWTKIZ0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGS$]Z^=X-/:.<,PXS7T;\'8_+L):Y*Z:CJ:1=SU.O"_V@QFVLZ]TKPS]H/\
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MKG7X2&!->SCD5XAX$\&:EI6NPSSD[5ZU[>@PHH 6BBB@ HHHH **** ,'Q8
M=#N<_P#/,_RKQCX3 ?VM.?\ IN?YU[/XL!.AW./^>9_E7B_PF!_M>?\ Z['^
M= 'T*.@I:0?=%+0 4444 %%%% !1110 4444 %%%% !1110 4444 17/_'M)
M_NFOC7Q__P C-=_]=#7V5<_\>TG^Z:^-?B!_R,UW_P!=#0!RV.]%+30.30 N
M!BC':DYQ1CBF N*.^:.I%'>@ Q1@8Q0!UI.<8H 7&:NZ3_R%(OK5+M5W2/\
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MQFEXQ1QBF $]*,\XHH[T &<T9XI1BDXH 3/&:4GG%'&*.,T &><49S1WHXH
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MXHL F>,TI/ZTO&*04T 9YQ0#DT'K3EYZ415Q#:,XI"<-3CC&:&F@+-E=-:R
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M&: -/P7XXU35/$,-M/ ZHW4D5[4O*UPFB2:$-3C%K&@E[$5W:G(XH 6BBB@
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MSBCG%,!<9-&.<T'J*.]  !1CC%(,\T<XH =VJWHYSJD7UJES@5>TG U2+ZT
M?8G@+_D5;;Z5T]<OX!.?"MM]*ZBD 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !44J;HF7UJ6D8\8H&MSQ?QQHDT=\UPI;#-1I7@I]2M/,\
MPYQZUZ1XATI+VUQMRU5/"5I-:B9)AA<\5BHZGJ?6VJ*Y=SB&^',J8?>W7UKT
M7PWI9TZT5"<X%:S*C?+4B *,"J4;,XJM:4]RCK@SI<H]J^./&8QXIN_]ZOL;
M6\_V7+]*^._&$3R>*[L#^]6J.;S.?!XS0AY)JQ)9R1KDCBJW0^U:2CH+<13\
MQI<\XI6*]J08K(8M-SQFEI>,4#$SQ1G!HXI3BF F><4 T#%'%(!,\9I2:.,4
M<4P#/.*,Y-!H&* #/%)GC-+Q1QB@ )HSSBCBCB@ SFC/&:!BCB@ SQF@GG%'
M&*.*0"TW[Q^E+2CBF A/>@G]:.":4CBBPD-/RFIDG^7'I216TD_W139('B;!
M%5RNUQNTM!S7#$]36CH__'T&;O69MJS:2^5+FB%E,3I.VAWTH06HP!R*Y*^L
M3+.2!6I;ZB)$"LU71+:A/FQNKU/=E$RM,XR2U*Y[8JNQ9.YK=U%HFD_=>M9D
MUH[\J*X:LE!^Z=$*,I(J!CC/7- #8)Q5^STV663;MK;FT)_)PJ<D5,4YJY3I
M26YR9;(Q0&S6LVA7(8C8:H7%G);MAABE*FXDRB0[N:0G!SZT<9I1@U$E8F3L
M&:0'M12XJ&2@SP:V-$O_ +/. :R .?:G@F-PR^M;4=PD>EK(DD:MQR*HW\$<
MRD<5@PZHP@"[N<4->S>7DDUZ,I1Y;'.MS*U& 12<>M4>IS5N[F\UN353/S<=
M*\^HUT.B($XH)H.*.*Q10=J <_A1VH&*&A(,X&:3-+Q1P*.@,2IXK@Q]#TJ'
MM1QBM(2Y=B2W+=F4<U59N<T<"DZFE.5V-)(!Q^-&<G%%%9W8[BYX^E(#QFDI
MW&*%J,4=,TUCCBE!I.#UK1H2$0_.H]Z^G/@@V=-F^E?,N '7ZU]-?!'']F38
M]*EL9Z[7A7[0C8MK.O=:\,_:" -K:5('SPAYQ3LY.*1,4[B@!,\4*<FCB@=:
M:0A2,D"G!<-3H4+MBB9&C.#UK51ZBOJ:.G6*W)))'%1:K;B&3"^E1V5VT(.#
MUITZ37(\TY(IU)*V@W(HJ=B_6IH86D0MBHU7]YM-=':6\::>Y8<XHPZN]23G
M).#BM[PW8_:KE21T-8LX#7.!ZUV?A^#[.JRXP!R:Y,5[KLCJP\6W<ZO[(EJ@
MX%2PPP7",N5Z5C:EK,;(41OFQ7+Q:S>1W+X8[<UE1A.]S>O52A8]&TS2HH[U
M1D$4GC2T5;!511^%<SI6NR_:%W/\U=?=3QZE:Q*3DCK6F(K5(6L<\*D9))GC
M\UO)"&RIQFLF1B'->S:MX>@FLF:%!G%>5:OISV<S!UQS3C6E47O#Q"2:2,TG
MBD4]J7((H Q6O0QZ$\$Y56%1;]S[C2 @4< 52=T38&/--'!QZT#EJ?Q22&-Z
MMBC-.\L@;J::&A7#'.:"<444@ 'G%+GG%-/3WI>U !GBA>>:*4<4(8 ['K7L
M=3\HA#6/ZYI02!D=:T3T%8T-2NA<$8[5G9^6E+YZT@QN]J4]0%#8'UI0"!P*
M:?O'TK3TY8GC._K3IQN%[:D$4W"J1T->B^'IDEM,D@;17FUWA+LA.@K3MM7>
MUAVHV,CFHJ1U.6O#FU-GQ0ZLS,I%<87Y-:%S?/<L=[9%5K6#SY2H&<FLXJ[L
M537)&[(D1FB. ::2>A'2NRLM%$=F6E2N;U&-([EE7UK7EL5&HFRCG+ UV_AZ
M=(K7)QRM<E:V;S,"!Q6RL5Q;PX4$#%#I70YW*6N[6N21W-9&[C;5B[>1I?G]
M:22UEMKJ2"YB>&:)RDD<BE61@<$$'D$'M4VL7".A/I5Q]EEWGL:W8+[^T=5C
M)Z8KG8X6E;$8^M;>EVS0SJY&,5?L^;4J.]SI5N/(EVXR!6Y:ZB"H7;UKGUDB
M#9D[UL6K0E1C&:[:$(O1GE9@W?0M3:AY9JYI\D=[&SD#*UDW$)E)VBG6#20;
M@.G>I<5&1X].\;LEOM+6^E/ &*DMU!M982?]4,5*+@1Y8GBLE[SR%N&)^_G%
M<]>/O\R/;RR//'4Y[5%4*[YZ&L;2K?[3>MQWI^H7Q:-TSR36OX3CC+[GZXJN
M;F5CKK?N]BCKEL+29&QVK3T;6%2VVG' J'QC+$TJA#VKE()Y8^ >*YW[KT,X
M1YU=E[6M2:\G8=@:SH4=R  :T(;43QLV,FM/2H;:-L3 9J)R;W*<E%61IZ(!
M-&J$8*BMJXT(7:YK%T_*73F/[N:Z^POHD $AK;V;4;GFU+\]ST+X:V/V--GH
MM>DUP?@:19)&*],5W?>LCUJ#]Q"T444S8**** "BBB@ HHHH **** "BBB@
MHHHH **** (IT#Q,I[BO.+OP?;RWL\IG4%SGK7H5_O\ LK^7]['%>%ZM_P )
M1_:=UY6_9N.WK0!=T_1DTGQW \<H;'H:]LMW\R%6]17@7@[2]>F\60W%^K;!
MU)KWZ%=D2KZ"@"2BBB@ HHHH **** ,'Q8V-#N?^N9_E7C'PF;_B;SC_ *;G
M^=>T>*\?V'<Y_P">9_E7B_PEQ_:UQ_UW/\Z /H0=!2T@Z"EH **** "BBB@
MHHHH **** "BBB@ HHHH **** (KG_CVD_W37QO\01CQ+=?]=#7V1<_\>TG^
MZ:^-?B <^)KO_KH: .7I,Y-%+0 F>,TF>,TO%+QBF A-&><4<9HXH ,YHSQF
M@8HX_"@!1ZU;TH9U2+ZU4JYI'_(4B^M 'V'X &/"MM]*ZBN8\!?\BM;?2NGI
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<CV?X;G"8)S\M>CXYKS+X8L63G^[7IU<51+F/4PZ_=H****@W"BBB@ HHHH
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M24N!6!JA<C%)GM1Q104'M0#^E'>EXI#&Y[TI-+QBDXIL SSBC.31QFEXS2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3HQ*@;MM>8>')1%=*Q.,&NMU_P 1M]E\L'M5*HDK'!BZ<I5(M">$K='NY%<
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MWPGS_;$__78_SKVGQ8<:'<_]<S_*O%?A/_R&)_\ KL?YT ?0X^Z*6D'W12T
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M\F\46<FGZ])>HIY-;.G^,'6SVGL*Q@[-W/=QE/VM&#@)\2(H!:M)@;\]:V_
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MI6:*:4K'TQ\(%_XET9_V*]7KR?X//NTR,?[%>L4+8N.P4444QA1110 4444
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M '/A2V/M74T@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5CZ?^#O_ "#8_P#<KUFO)O@[_P @R/\ W*]9K(84444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBES1GO0 G.*4GFC/%&>: #/-'/-&><4 T )D[:.>*7/>@F@ [T \FCOBC/-
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M;Z5T] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ,"F#.:7G-24D.90.E(..*3)Z&D (-"5AEC[00F*A8!EW'K36YH[53N2QS*
MHQ3>A ]Z7M1W'UJ&-'T_\'?^09'_ +E>LUY-\'?^09'_ +E>LT#"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH \7^)/BR\L=0DL[8,2.PK'\&>+[
MX7@CO4**YQ\U7_&7DV_C9YKI<Q'CFK/B+0%N].M+[3$V!5W,5% &RVLJ/'%O
M!"P*LN>*],B;=&#7SKX6N9IO']L)6)(XYKZ*A_U8H ?1110 4444 %%%% &#
MXL .AW.?^>9_E7C'PF4?VM.?^FY_G7L_BP$Z'<X_YYG^5>+_  F!_M>?_KL?
MYT ?0HZ"EI!]T4M !1110 4444 %%%% !1110 4444 %%%% !1110!%<C-M)
M_NFOC7Q^/^*FN_\ KH:^RKG_ (]I/]TU\;_$'_D9;K_KH: .4QSFEHIH')H
M7 Q1CM2<XHP<4P%(HQSFCJ11WI &*,#&* .M)SC%,!<5=TG_ )"D7UJD<X%7
M=((.J0_6@#[#\ _\BK;?2NHKF/ /_(JVWTKIZ0!1110 4444 %%%% !1110
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M8I#$SQ1G!HI30 F><4 ]:.]% "9I2:.!S12$@[XHSDTM'%,8F>*!TS11P*0
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MTO#,K26B GH*5._.5'1V+VN_\@N7Z5\<>,O^1HN_]ZOLC7/^07+]*^./&?\
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M7G_Z['^= 'T*.@I:0?=%+0 4444 %%%% !1110 4444 %%%% !1110 4444
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M*I*\41<7.:3-&1BEXQS7+=W&)G!Q1G)Q2=O>E'ZU0@S1GC-%+VJ0$)HSSBE
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MK5/BKND?\A.+ZT ?8?@ 8\*VWTKJ*Y?P#_R*MM]*ZBD 4444 %%%% !1110
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M[.$+;M(>PK*NI/,F+5*+QTA*9ZBJ?)/-;RDK6)6Y(JX_&AXBF/K3K8AI@&Z
MUI7RP^2"O6L6BD?0_P '?^09'_N5ZS7DWP=_Y!L?^Y7K-2QA1112 **** "B
MBB@ HHHH **** "BBB@ HHHH *1AE2*6B@#PWQ1.=*\>/=LN5KOK#Q9#)I@D
MW+PN<50^(/AP7=J]S$F9:\79?$5O*\*1OY><4 =U#J8USXB0%!QTR*]KMHC%
M"JGL*\A^&N@2_:H[ZY0B0'J:]DH **** "N;\66Z7>G-$P%=)7->*8YVLF\D
M$L: /)],CDMO$$:)G;YG:O=-ADL5'<K7">%_#QDN'GN4PP.1FO0(QB/;Z<4
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M;?2NGKEOA_\ \BI;9]*ZFD 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!0O;-;A""N<US,GAR0S$@<$UVM)@5G[-$."9S^F:/]G<,Z
MUO!-H %.Q2T1II#44C,UW_D%R_2OCGQE_P C1=_[U?8^N_\ (+E^E?&_C/\
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MZT \\T=Q]:0SZ?\ @[_R#(_]RO6:\F^#O_(,C_W*]9H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "@]*** /$_%_P#Q)_&;ZHX^2MBW^*EHEH!Q\HKI
MO%OA>'6+=BRY)KR:[\%2170B2,[2<4 :FE:D/$_Q"M[^(?(.*]PC7;&!7!>"
M/!T.E(EQMPXKT"@ HHHH **** "BBB@#!\6 G0[G_KF?Y5XK\)_^0Q/_ -=C
M_.O:O%A(T.YQ_P \S_*O%OA-G^V)_P#KL?YT ?0P^Z*6D'W12T %%%% !111
M0 4444 %%%% !1110 4444 %%%% $5S_ ,>TG^Z:^-_B"<^);K_KH:^R+G_C
MVD_W37QKX_\ ^1FN_P#KH: .7I .329^;%.H ;CC%+CBDYQ1GBF N,FC'.:.
MA%'>@  ZTF#C%*#UI.<9H 7M5S2C_P 32+ZU2).!5[21_P 3.+ZT ?8?@ Y\
M*VWTKJ*Y?P ,>%;;Z5U%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** ,S7?^07+]*^./&?_ "-%W_O5]CZ[_P @N7Z5
M\<>,O^1HN_\ >H P,TN1BDQ2X[4Q!1GG%!%&.<T# &C(Q1BC'&* #(Q1WHQV
MH(I +GM1GB@#O24P#.1FES2 8&*.M)/4"S:2".4$UO?VH@BVYKFAP-W>C>37
M52J\I#.A@DCN7Z"JNHZ>R9E X-5=-GV3*">,UT%Y-'+:;<BM^92U$<[I\HM[
MI6;L:Z:_U>*2SV\9KD9L+(2.QI&F9H\9K/GZ#W%F</(2*CR,4 <4F.,5RS>I
M25A5QUI8Y#&V0<4T\"@#*DUF)EF>Z:6(*3FJV:,<4K#&*>B$(2,4O:D//%+T
M%,L::UM-O_LQ'.*R^^:,5K3=B3JCJ,%R0" 36?J5L"FY1Q63'(8F# U>:^,L
M.TUT.5T(SA\N0::>N*5N6)IH'>N.:U*'4F1UHHP,8I(8N11FDQVH(HN OM1D
M4F.<T8HN 9[T9%&.,48H .^*.]&.<T =Z #/%&>]&*,#&*  FC/.*,48YS2
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M<_SH ^A!T%+2#H*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BN?\
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M%% !1110!F:[_P @N7Z5\<>,O^1IN_\ >K['UW_D%R_2OCGQE_R--W_O&@#
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MQKPS]H+_ (];.@#YY4CD4]&PX([&B./.32;<,:J+U W[:2.:'YN<5CWN%N6
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M!8CRV_*@#9_X6#J__/PWYTG_  L'5_\ GX;\ZQQH=QM)\MORH&A7!7/EM^5
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MS?W>U;=EX/FACQM:I)_"DT@QM-=,)0Y=3"44<-J-RKYP:@TB#[5<E,9KK9/
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M#Q9J7_/5OSKH&\!2A<[#35\#2]-A_*@#!'B[4A_RU;\Z/^$OU+_GJWYUT#>
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MK^5=E10!QO\ PK_2^GDK^5+_ ,(!I?\ SQ7\J[&B@#C?^$ TL_\ +%?RI?\
MA -+SGR5_*NQHH XW_A -+_YXK^5'_"O]+QCR5_*NRHH XW_ (5_I?\ SQ7\
MJ7_A -+_ .>*_E78T4 <;_P@&EYSY*_E70:5I$&EQE(5 !K2HH *I7^FPWX
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M?7D5O&Q&[CB@#J+36[2^E\N)P6K3&.E><:;I<V@WHGD<D>YKOX)M]J)O49H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !113=WS8H =1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%%  >E>6>/]5U:QO3]B1BN.U>IU1O=,M[P9DC5C
M[B@#R?P5_:/B&ZD34XV"J,C-'B^"_P!$N =/C8X':O6+33+>S&88U4]\"BZT
MVWNG!EC#?44 >.2/JNHZ'%+-&WF@Y-9T']K7^KVHFB;;$V*]S&E6JIL$2[?3
M%1P:-:1.6$2YSQQ0!Q":?/)JV&0[=M<MXJ&IZ!<J^G1L?,/.*]L^R1!MP09J
MK>:3;797S(E;'J* .6^'U_?WVFA[Y2'SWKMU;+$5!:64-HFV) H]JG5<,30!
MYOX\MKG^V(KB!"2H[5S.CW&KZMK9M+N-O(7D9KV>YLHKDY= 3[U#;Z3:P2^8
MD2AO7% 'G'CFRN[46LMHA+1KVK"\+)J5[KGVFZC8$C'->UW-C!<KB1 V/457
MM])MK=]R1*/PH Y[PU;2VU_<,RD!C6;XFN+]/$4:PJQCQVKOA;HC950#44]C
M#-)O9 6]: &:4SMIT9?[V.:\[\>ZOJMEJL:6:L4(YQ7I\:!$"@<"J%]I4%Y*
M'DC#$>HH \T\%K?:IK#-?(P4CO6AXZM;JSFAELD)*C/%=]9:;!:-NCC"GV%3
MW-G#=+^]0-]: /+/"-QJ>J:FJWJ,$]Z]*O%\K2YD'0(:DM=-M[9MT<:J?84N
MIC_B73?[IH \*O=6U:UU@I9JQ3)Z5J^'SJ@NIIY(V#2#FNO\-Z7!/*7EB#'<
M>HKKQI=LGW(E'X4 <WX:@FB+;U(R<TFGV\R^+KF0J=A'!KKH[>./[J@4"WC6
M0R!1N/>@#G;BU=]4B?!P&KIE^Z*C,*%@V.:EH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#"\5@?V'<Y_YYG^5>+_"4#^UKC_KN?YU[/XL!.AW
M/_7,_P J\7^$RG^UYS_TW/\ .@#Z%'04M(/NBEH **** "BBB@#A/BI_R*%W
M_NUF_"'_ )%V#Z5I?%3_ )%"[_W:S?A#_P B[!]* /3:*** "BBB@ HHHH *
M*** (KG_ (]I/]TU\:^/_P#D9KO_ *Z&OLFZ&;63_=-?&WC_ /Y&:[_ZZ&@#
MEJ,=Z3'.:6@ ZT8&,4 <4$<8H .]%!'-&.<TP 8HP*.F:,<8H .U6]*S_:<7
MUJGC@"KNE'&J1?6@#[#^'_\ R*EMGTKJ:Y?P <^%;;Z5U%( HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHK&\1Z[#H&G-=2D;10!LT5Y]I_Q+LKZXCB4
MC+G KOXW\R-7'<9H =1110 4444 %%%% !1110 4W;\V:'8(I)[5P^M?$2ST
MF_-M(1N!Q0!V[$AA3ZQ]&UN+5X!+'T(S537_ !3;Z(K&0CB@#HZ*Y/PQXSMO
M$3S+"?\ 5]:WDU%'N!$#R: +QZ4U"3UIL\HA@>0]%&:\_?XG6*:@;4D;MV*
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M!2T %%%% !1110!PGQ4_Y%"[_P!VLWX0_P#(NP?2M+XI_P#(H7?^[6;\(?\
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M*I:CJ$>GVYED. * +M%8NFZ]!J;E8B.*VNU &#XL .AW.?\ GF?Y5XK\)_\
MD,3_ /78_P Z]J\6 G0[G'_/,_RKQ7X3C_B<3_\ 78_SH ^AQ]T4M(/NBEH
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MM"TMQ;@ UT'P^7RO#RQ=S5GQ;I)U&2,A<XK)T74XM(O182G##M0!SOC#P_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHCOXS[UN'P+J0_@/Y4J^"-21P0AS]* /I/P1K5K#X4M@TRAL=,UT/_"0V?\
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M "BBB@ HHHH **8<[Z?0 44C=.*1<[>: '44QL[ABGT %%%% !1110 4444
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M[37+N.;(4MA<U;U"_F7Q_:P@_NRM 'H-%01W4<DIC4_,.M$EU'',L;'YCTH
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M .PC8/&K>HI]9^EW F@ SR!S6A0 4444 %%%% !1110 4444 %%%% !1110
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MJ,4LWWTX%6?'UFCZ=$Q'1Q0!5UVY%XUG/Z@&M4WZVV@A\X[5RID:22SC/W0
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MG,LEPF?NMBNGKD?"'_'U>?[YKKJ "BBB@ HHHH **** "BBB@ HHHH ****
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M 8^KC=(@Q6!9*B>(=K8Z5U=W )64XZ5YQKK7]KXB9[=&*XZB@"]XG NM6M!
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M&VGG%5_#FGK96H;&&<9-;A&5(]: /%?"9;2/&FI,_ FEXK3\::ZB:]%9CDN
M:T_%&A-:7BW5JF79LG%8HT&;5=3CO+A#O7CF@#7U@YT73#_M"L+QC-*_BC2[
M56(5T&:[?4-+,FGV<87[C"J7B;01*T%^BYFA08H XKX@I!:Z-9PJ@\P2KD@5
MOW>0=#8?W%K-U72;G6+: S1DD.#783:27&FC;_JU H I?$E]_A-2!_$*?IF5
M\!M[P?TK3\8:9]LT(0*N>118V#+X8:V*_P#++&* .(\.-M\#7A(_Y:FMNYA-
MYX>LV4?ZOYJFTG1#%X9N+8IC<^<5T%MIBKH7E$<A#0!5TW6(Y-%D;(_=C%<'
MX:N?M7CV_<=#&:F1-0M[B6U1&\MV.:U/"NA/;:W/<LA!9,9H L>'LQ-J1/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ IDL8DC*D9S3Z* ,G3-*CLKF:14 WGTJ.^T:*ZO!*R X]JVJ*
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M>5][Q@M]*LTS)WXH 9#:Q0$F- N?2GF%#)O(^;UI]% $$MM'.?WB@@>M-%C
M)%?RQN'0XJS1F@".6".9=KJ"*BCL8(CE8P#]*F!._%/H C\E/,WX&[UIS('&
M",TZB@!D<:QC"C%-FMXY\>8H..F:EHH 8T2-'L(^7TJ!=/ME.1&N?I5JC- #
M3&I381\OI5==/ME;(C7/TJU10!!)#'@ J..E#6T<J;9%!'O4Q7-(W"\4 0PV
M4$!S&@'TJ1H49PQ'(Z4]>12T ':H#;([AW4$CI4](>E #9(DE7:P!%*J*J;0
M.!0A)'-.S0!6DL+>4Y>,$_2I8X(XTVJH J2B@!B1)'G:,9IDUK%.,2(#]:FH
MH K16<4!_=H%^E3L,KBG44 5GLH)<%T!-31Q)$NU!@4*26-/H JMI]N\F]HU
M+'OBI5A5" HP*EHH K264$K;GC!-2);Q(NU5 !J6B@"'R$4848I([:.(EU4!
MCUJ>@\B@" P12MO9033GMXY$"LH(%2*,"EH KQV4$3;E0 _2GF%=VX#FI<T4
M 02VL4X'F*#CUIT5M%",(H%2T4 0R6T4K!G4$CI1):Q2CYT!J:B@"K'!"&VJ
M@&*G,2%@2.10L85BWK3Z (S"A;=M&:;);QR$,R@D=*FHH A:VCD3:Z@BF)86
M\9RL8!^E3N2!Q2CI0!'+!',NUU!%1K86ZXQ&!CVJS10 @  P*BD@2;AU!%34
M4 5H[&WB.5C /TI9;*"4Y= :L4S)WXH C^SHBA54 4\0H$V[1BE4DDT^@"$P
MJ/NC%,FB586*C!J9R139 6^7UH \\U;3'N;QSC.:TO"7AZ33V>24?>.1FNE;
M3D:7<15]$"(% Z4 .I",C!I:8Q((Q0 ")%.0.:AO(_-CV^M6:1@#UH S],L1
M:QNN/O&IVL+=GW&,$_2K5% $?EA<!1@"I*** (IK>.?_ %B@X]:8EE GW4 _
M"I5))-/H 88D8 $=*22%)%VLH(I^:6@"M]@M\8\L8'M4ODIQP..E244 ,DB2
M5=KC(H$2!-H'%/HH B6"-4*A1@T\(H7;CBG44 5?[.MB^[RUS]*DCMHHSE5
M-344 ,6)5S@=::45&SBI:1AD4 ,6) =P49--EMHIA\Z@_6I0,"EH @AM(;<Y
MC0*?:IZ*82=PH <RAQ@C(JH=,M2V3$N3[59!._%/H @BM(83E$ J609C(]J=
M3')R* .7;1_,UY)W7*BNDBLX83E$ -/\H;]W>I* &&-6.2.:'B21<,,BGT4
M1>2I0HP^7TJ)=/ME;(C4'Z5.Q(84^@",PH<94<=*1XP_!'%2TUSA: .%\4:?
M<3NJ0DA=W05O>&-,;3K+:PY;FM.2T68AF'3FK*@!0!VH 3RUW;L<TAA0]5%2
M4AZ4 1K$JMD"@01AMVT9-+D[,T\=* ()+*"5MSH"?I3DM8H_NH!4U% $4MO'
M,,.H-1Q6-O"V4C /TJS10 QHU;J*0PHR;2HQ2L2&%/H JC3[97W"-<_2K(
MP*6B@#(U;3?M+1L@Y!R:MI91O$HE0$@=ZLN>E/'2@"HFG6R-E8U!^E63&I3:
M1Q3J* (TA2/[J@4]E#KAAD&EHH A2VB1=JJ #3D3:>.E244 ,>)'^\,UFZA8
M&=%5!P#6K10!#;1"*%5 Y J:BB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+7%Z\3'HV*Z4=* "BBB@!"V*6FE=U.H *0'-9>MWS64"L.YQ5G3YC/ KGN*
M+E%%% !29'K5'5[O['8M*#R*Y&[\2W$4'F '!'% '>;AZBC(]:\A/CC4<,P1
MMH/6NHM_$LDF@I<D_O".E ';9'J*6O*;/QCJ-Q<2*$8@'%>@:3?/-IGG3<-C
MO0!JY'K1D>M>9ZMXNOH;R2.!695..*U?#&O7E_.JSHP!]: .XHR#TK+UJ_\
ML%D\N<$*2*Q?!7B!]:@G:0\JY H Z[('6BN1\=Z_)H.GPS1G[S@&M;P_JBZG
MI\<H8$E030!L49%8?B?5#I6F&=3CFJ'A'7GUCS-QSMH ZNBBL77M733;8N7
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M/<U<D\8VD$LD+,-T?!KE/"^H-H_@02=#NQ5VT\(+JD)O2W,XW4 =9IFNP:G
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MRUB.1"2JF@#MO&4JNL;]BXKM-(YTJ#_<%>=:S*;O1+:4]2XKT71SC2;?V04
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MOO$-O9(C.P^:H+/Q3:WMT+=&&YA7F.JZA)J&IR68)Q"V*KV#W&G^)(2H8C%
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MJ8E)._EP._\ =!-<IHGB1K^^FB)X1\4 =?14:SQLVT,-WI4E !1110 4444
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MMG3[^"'3[%&(RZ#;7#Z_/-XDT^WB92-K@]*N:L\UG?:+ @.!@&@#TB3F%O\
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M:F9E(- 'E>MV>KZAXLO/LA;:'XQ53[)K6F:[;WEZS>7'U)KV3P_I*KJ<URZ
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M<A=1R:1[.-I0Y'(JS10!1DTN"6X\YE&ZF76C6UVH61 0*T:* ,^RTJ"QXB4
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MH JQVB9WD?,:>;=3*&QR*GHH @N;:.ZCV2#(J@F@6<;9"#FM:B@"!+:-(?+
M^6J#Z!9O(7*#)-:U% %6"PA@7"*!3TMDC9F4<FIZ* *ZVR;]^.:K7>CVUXQ:
M1 2:T:* ,^UTBVM(V2-  W6HAH5H)O-V#=6K10!3-E&Y7</N=*GEA66+RV'%
M2T4 8P\-V0G\T1C=G/2M1H$:'RR/EQBI:* *\<"HOE@?+2P6R0%B@QGK4]%
M$-Q;)<+M<9%(;:,PB,CY0,5/10!32RCC4QJ/E-21VD<6=HZU8HH R;G0+.YD
MWN@)J[:V45K%Y<8P!5FB@"!+2-'+ <FJUWI%O>,3*H.:T** ,^RTFWT_<85
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M<:+RO4"N+T-B/&5[QQNH D\7VD:Z[:R@?,JC%8OBW+Z=9MW\P5T?C('^TH6
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MCX50 :3[+"3N,:Y^E '+6/AZ-=%;<G[QHSFN'L]$OK9I[54(AD<DU[(0J+M
MXI@M8<Y\M<_2@#B_#6@?86D?9@LA%+H>AFVO[ABF [DUVRQHO10*!&BG(44
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ";><TM
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4BKBEHH RM8T>/581'(. <T[2=)CTR,J@ZUIT4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>image10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0S!WT# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB!.!VH [[PQXEA\16QFAQ@#-;X;)(KR_X-6\D&C-Y@(RHZUZ@  2: %HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-J*_9;U_](4<@F@#TZLKQ!?+8Z3-(QQ\AQ6FQ.!BO+OC-K$NG>'1Y;8+-@T
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M^9Q6M\=P386Y'I0!S&EHX^&UTR$_ZGM1\!7@-WJ NPIR>-U;?@2P.J> ;RW
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M35+2;"/3[".&-=N%Q5X#% "T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M(0",$9IODQ_W!^5/HH C4 /@ "G%%;JH-.QSFB@!GDQ_W%_*E*C&!3J* &E%
M;JH-((D7HH'X4^B@ IK(K?>4&G44 ,$48.0@'X4XHK=5!I:* $"JHP  *;Y2
M Y"#/TI]% #?+0G.T9I2JD8(!%+10 SA6  P*7RT)SM&:=CG-% !32N3FG44
M ,,2$Y*@T,B[?N@T^B@!BHNW&T4>3'_<'Y4^B@!-BD8P,4T0QC^ ?E3Z* $P
M ,5&\:;@=@S]*EHQ0 SRT/5108QGI3Z* &>3&>J#\J/+4?= %/HH **** &M
M&C?>4&D$,8Z(/RI]% #=HW9I#%&>J#\J?10 T1HO10*1HT;DJ":?10 Q.F,4
M&-"<E1GZ4_&** (F1"X!4'\*<(HQT0#\*?CG-% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%07EP+:V>1NB
MC- $P8'O1D9Q7"67CNUFO98MP^0$]?2GZ)X]M-7U5K:,C(.* .YHI@D!8#U&
M:?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9ZT51TR]6\MPZU>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKPLDC!?+'>EO;"YT35HKB21MO QF@#U<'(R.]5;K4;>S.)7"UR]]XP33Y[>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*** "BBB@ HHHH **** "BBB@ HI >:6@ HHHH **** "BBB@ HHHH ****
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M()_UB_G1_P +7TC&?,7\Z^3OM,HYWG\Z/M,N,;S^=,#ZQ_X6OI&<>8OYT?\
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M (2VWQ[5['7CGQ$ 'BVW_"@#UC2_^09;?]<Q5NJFE_\ (+MO^N8JW0 4444
M%%%% !1110!')"DN-PSBGJH50HZ"EIK$AA0 ZBBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *;PQ^E.I%&.?6@!:*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FO\ <;Z4ZD?[C?2@
M#Y/^,2D^(\>YK!\$^'9=;U%409P<&N@^,9(\1@^YK;^!JQFZE9\;PW H%N=S
MJ/@USX>^R1@"79@5X'JNCW,&M_8')+[\5[-=^*]9B\5SPR1,+=)" >V*XRY>
MVOOB)9M(PVO)EJ5B.0]$\%>&'L=#42C#2IQFN"^(W@RZMO,O3]P9->C>-M4O
MM(LK3^S4+(J]5KEO$WB&74/!["[^65H^AIB5-)W/!2>HQ0 2!QTKM/"_A&6_
M;SYHCY!.=V*M>*/![V$+3V\9,0&<@4&G0X5(R^<5-;V3W,JQ*#G-3Z2@DNUC
M?H3BO3-*\.V:,DW&>M:.*L<]>JX(\QO=-DL7*N*HXR0*],\8:5'L,B#I7F[+
MM<^HK/J.A4<UJ.BMFEEVBDF@,$FP]14UG*4FWGI5G4=CH)0?F-;**L;LS,4@
M&!0":7/%96 3'.:,<8I12'.,TABXI-O&*7O03Q0 F.:-O%.IN3B@ QSFC;P:
M7/-!)Q0 F.<T^/\ URTSJ,4Y,AU--$O5'H.BX-E^%7A!EN>]9&DR$68V^E:T
M<SDC(KV*:_=(\3%5.65BP;<>7D#I6;*K),!ZUL;R8MOK5,Q[YUW=JM4URF49
MOE)([9@BL>]1W41C /K6@SXV*.E5-0;=@"LJO0YN=WL16=RI?RNYJ,#%\Z'N
M>*IHDD5XC@'K6E;A&NFD<X.:TC-G1=JQGZFNR*3V%<U]M14QWK7\17A1W53P
MU<>7SNYKS:E1^T=SU,/&ZNR:>=GGW9XIF\L^0:A#9'-68D&P&LINZ.N2]TZO
MP[N9 I[UMW]J8XT]S67X33>^6[5N7\AEN2G\*]*WP\['A59251D=D"!@]13Y
M560MQT%00NRS\]#4I/[YP.A%>M92@9SDVRAYJM&R+U%,L(G ))JS]G6.(O\
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M,L952V!D54=QLS/LS  X^]Q6C'X<N'MC/M. ,]*Z[PKHMKJL48D(R#FO4/\
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MYBK= !1110 4444 %%%% !1BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0'RC\9)-WB(>Q->;#C\:])^,8 \1CZFO.",8JD  \$8IA7YOK4C8X- (Q0A
M3\H]J:!D_6D/)I2<4# KL;Z4\D28I"05]^]-7@YH$A^=G'I32W&?6E+ XI4
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M;*8LXCB(SS74Y*2-Z<N<ANY]L&!ZXJQ;#?&!CK60^YY,G[N:VDGBAMU!^]7
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MMS7*!?6M1XVWH/6G&BXRL<E3W)6*-Y'LA45]!^ EQX1LO]VO!=0B*0Y:O>_
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MK,)&,UE5CRNQO!W5PI#TS2]J3-9/0:U#/-)DXS2GTHR,4##/(H:@=:,\YI-
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MFG33)MVIWKI;BI&L;K49;MB\4>]:\LP\^/FL))0DRL>U2M=YF#9Z]*\^K/\
M>IHY<1#FE=&IJDF^#Z5[MX!_Y%&R_P!RO C()X3[5] >!ACPI9C_ &:6)E>Q
MZ&6;,Z.BBBN0]8*YSQ1J_P#95KY@X)KHZ\Y^*)<::K+GY3DT >6ZSX^OKCQ"
ML:*2D;@FO>O".IG5= @N6ZD5\]Z38+,MU>R1YWH=IQWKVWX8*Z^$8-WJ: .U
MHHHH **** "BDW*>XHW ]"*  ]*\;^(?'BBW/?C^=>R'H:\;^('S>*K<]N*
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M:,T=1FJ5[FJW--YC+:*#ZUN:;,\%MAN%Q6)#Y-W>%+9'CA,A,:2.'95SP"P
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MKJQ4Z?*-Q0.M HQQ7,T1$.]& *,<YH/I2&'>C HQTHQP:8!2X&*3'3VHQUH
M4]*3T%+T% '?UJKB$ P31CCZT'EOI2FI;&)@4N,L*3'2E(V@'UI (_#X'2E
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MI7A_T-_]VOBSQD?^*PU'_KJ:X3V$8?/-'/%&?THST]Z!ASS2<\4N>OM1G]:
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M '-*%[^E*8P0#3;"Y/:QB4,G\3=*^I_AUX9M8_"%N\D8W21_-Q7S1X9LVO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZXI * 33BO.::&/6C>3Q0NXGN&#^-=+X9L_.NE9AP*YZV!EG"XKN-*B^PH&
MZBBS;T.3%U.70WK@(,1^U"Q+%;L2*HI.9IPQZBKDTI,.T\5[%.:BDF>/*HU(
MR9_,RS9KE=9DQ)Q^-=)J=V((3CTKB[N<W$W-<F.:Y]#UZ$;^\=3X;'F6Y"]:
MR?$H9;D U=T6Z6QM6?(R*R=3N_MUR6/K7GI%0A:=S.1B>#5_3B$D+>AK.Z,?
M:KMIEF"C^*G*+-ZB]T[2RGW0CGJ.*O)&RKN[&L?3T8;%QTKJDB5K7GTKU:-1
MQH-,\+&+0RF)[_A7T3X&_P"14L_]VOG:Z^0\=J^A_ ASX3LC_LUYLUS2YCLR
MS2+.EHHHI'JA6#XFMXKK3WB< DCBMZO&_B#XPU#3-9-M#$Q0-Q@4 8@\*7-O
MJHF=?]'W5[-HD<2:3"ML,(/2O&Y?&&I75@J?9WY]J]4\!S2S>'(6F4ACV- '
M4=JCF/ P>]<MXNU^XTF+,"ECGM7GDWQ%U@'B"3KZ4 >X \4CYQQ7FGA7QE?:
ME=".XC90?45Z6AW(#ZB@!W:BBB@ /2O&?B)D^*[?\/YU[*>E>-_$'_D;+?\
M"@#UG2O^07;?]<Q5RJFE_P#(,MO^N8JW0 4444 %%%% !1110 4444 %%%%
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MG%>6W%LT%Q)$1C#'%33=KER=W8T=,TV673&N5S@'%=]\';1_[<:X;HN<U%X
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M6HE)C0'WI/$GP_L+Y9)Q&#(<GI7D-WIOB#1+YDLHW$8/&*T<KH48V/I*&*V
M#0A?PJSC]VWTKR3X<:UJMU<^3J&[.<<UZX2/+/TK).[&X6=SY2^,9_XJ,?4U
MYOG]:])^,>#XC'U->;'%, )Y^E&?UI>,4E, S1GI1Q1Q0 9Z^U&>E'%'% "]
M* W/UH;MBF]#2:T![6.K\+2$7&TGBM#Q-$LC$**YW0KH07:%CC)YKL[RU-ZO
MFH,J1Q6#T/*JQ<*O,>?$/ V%."#6\UX)M&16&6]ZS[RV9-3$1'5L5K7.D3I"
MB(A^;I5\]E<Z9S329@V)(OEQV.:]8T>Z62WC+8.*\ZBL&L;IA<+M8"NCT.\^
M\N> .*Z\%#GGS&5?6.A%\09?-8,.E>?=!79>*)&FMLGKFN-'3FM\6O>-\+'E
M@!YXH7@4I]:!UYKB>AU7%CX;%+G+4['R;JCZ&GT$][FMHDGDW0YKT+3&$EF\
MF.17F-K+Y<H:O1/#5[ UJ8W8<UOA:BC='G8J-YW1P^OEFU!@Q/6LD?RKH_%T
M(CO]R=#7-Y K&H[S.VE\(=#BC/% ZYHXJ#4.U#-TI1UQ5M[)C!Y@' '-)DR=
MB)9-CQL.,5W=CKBR:#-"YSA<<UP&/E]ZLVUTR1.F>#UHBS*<;ZD4Q!FD/J>*
MBSG'M3I",Y]::<8XJ^6YIT&EOF^M+28%%)JQ2V"@'M10/6D"#/ZT>U'>D;K3
M&.0_K3F&P8(I]O'YD\:CN:U=;L1;0H<8)J.I#:V*VA/LOU/J:]%NB?*C)]J\
MYT3 U) ?45Z?<HCVZA>H6JC+EE<\G,5J9,LA>X&.F*R/$S!+;8/O5K,52,N>
MU<CJUVUS.1G(%$JS:)P4'S79C>>ZCJ:E6=RG4YJ$J"U.X"\=:M<UKGL6!W9A
MDG-1GCCUI><8H49I7;>I28H88S6EH?\ R$4S6:1@XJWI[LMVNS[U/EO*QG4^
M$[Z8><%(/"BH;=V)9 >]1VAE\L;NXJY8Q E_[Q/%=,\.SPJ^X^WDQ+M-=C\/
MU"^($/JU</*&2\7'3O7:^ 'SK\/UK&<9(UPFC/<KL_Z(_P#NU\6^,S_Q6.I?
M]=37VE=_\>3_ .[7Q;XR_P"1PU+_ *ZFL3W%L86?THSTHXS1Q0,,]?:C/2CB
MCBF 9_2C/%'%'&* %S\WTI&;G- Q2<$TA,=U2KMHO[C<:I#@XK0LV4_N_6IN
M:TE=V(Y)@8=O>H(961^O%6;NT=,X%0VMNTN1CI0S:2:DHH2ZE#''>M3PW+Y=
MYN]JHK8222$;>E6-._T>^VMQ3IKFE8TIQ=*?.ST..8-;D]\5Y[KQQJ)-=K;M
M^YQ[5Q6O8^WFO3J0Y:5C'$UO:-LRFZTBM@TG\7-!QNS7G'-'87=\N*3^(&E
M!7'>G%,,,],4T).P#B-OK5_3)@MRM9_M3HG,<H(JZ7NS382NT=G?8?3V([BN
M,D_UA]C74I>1R:?M+<XKEYL><_IFNS%34XJQ"@R'/-.S2$=Z0^U>=L:;"]!]
M:0?RH'/%.X!%*X1C<13@'WJU:SF.12#C!JN0*=P-N/QH3-8>[*YJ:E="6%,\
MDUE9'Y5)(^] #VJ&C=BKRNQ,\T9YQ0<9I/>KG&R,HL#QSZTH-'%'&:E##/>C
M/-'%*,4QB9XHHXI>])@ Y%.A;9,N>QIIX;CI1[U479W$=Q_:4?\ 9>!@'&*X
MR29C*QSWI?MC^7LSQ4!/.:['6LC.UB224NX/I2R2OD#<:B? /%&<C/>N93;9
M2+'GL%^\:KLQ;(/>@'-''6G*3>@Q1QBAA\PI2,XQ0>O-9<K;N/<!\Y ':K*V
MK>2S8IVFP>;< $<5TLEBD=DP(Y(XKKHT]+DLYVQLS,&XZ4])6LY77..:VM,B
MCC5LUEZC!NO,(.IKMI1T(.\^$4IE\1AL_P 8KWKQ\?\ BCKX>L=>$_"& Q:^
M-PP=XKW3X@D#P?>_]<S7G8A>^:Q/C>YXNI/K46>/K4MQS<R'WJ/M6"W&)GMZ
M49HHXQ0P#/-&>**.* #/-)U-+WI5P.:3V$P!VM@T^)B)E*G&346<MFI8\"53
MV!J"9;'J6EQJWAK#C+$=37G>JVQAF8_[5=WHLYNM(6*(Y:L7Q+I$T%OO9,'.
M:YXU.6?*8TKIE?PEJ3V=VZNQ*E#Q65K5RLFI/(HP#6_X4T.>]@DG5"<*:J7?
MANZ,3W)C.P,1G%"JI3:-+ZG1_"Z_%K.0_P!T]J]"\2ZG#'H$T:  MD\5Y#H<
M_P!BNE5#@YYKJM;OC<0! <J4YKU<-A>9<Y3J:6/*KLYNI3ZL346>,U-=KMN7
MSZTVW=(YBSPI,I1EVN6 !*D!N"#D$Y';(&01D'&K#ED.*ZD/0T_< P/I2'&<
MT1C=G-2H-E WWOK3^F#3#P"?2E)R%Q52LE8B2.[TF<SPPIGH*7Q1,6MDC7C
MQ6)H5^L=U&K-\O>NB\2PI+:))'SE<U4=(GGS@^<\\D3:WUIO]*DF)\S![5&>
MO%9,]&&PH/4>M)GM2'@T'J,4D,7O3AR^?2I;:/SI-HZTDT1@F=6&*F^MA=3H
M/"VKFRU%"&PI/-7_ !SJ45[<(4 R#SBN/CD\ED=.H-2WERUP0S'FFXZAL5Y"
M/,..] &!2=6R:5CGI6_+9#0AY-)GG%'0^U+CO6(Q,\9HSS1Q10 9[THZXI.,
M4+U]Z ';O:FMP:U;2R$UJ9,=*RY1B0CT-3<SB^AWGA*7_0C6K))^[?'K69X-
MV&R8&M(*%E=7[GBKA4Y3QL3']Z,1!-:2$]J\YNRR7\F#T8UV.IZA]E1HXSUK
MC)LM(S-U)S3E6YF=N"A9"><Y.<FG-,^W&X\U$F-U-8_-6KJG;8"_/--SM_&E
M<#(I^S<O%9KWBD,STKKO#,HBB;_:KDU W &NCT(EDDV]J4(.<N4YL2KP-Z6,
MAS(#5@.WEJ33'/$*GOUJ]<P!+12/2NA4>26IXN(5I()Y%>V3VKZ \#?\BG9_
M[M?.;,PB0&OHSP-_R*=GC^[45D>EESO%G1T445@>D17.?L[X]*\;\4)<^=>$
M,V"IQ7M#*&4J>]8]UX>M;LMO4?-UH ^7TL+U_*.7^_S7T=X"WQ^&K>-\[AZT
MY?!&G+C$8X/I6[9V,5A L48PHH =J,RP6$TK=%4FOF[Q)XQ0ZU-L7(&1Q7OO
MBMI!HDQC_N'->"Z3I6G7%S<3WV,<XSZT >I?"O4SJ.C*YSUKM]8F\G3)V_V#
M7%?#:.UBM"MH08P3C%=3XDW?V)/C[VTX_*@#R[07EQ=SM*3G<!S47@Z*YM[]
M[R1V*F0CGZUR>G7]_;M)$V0#*<_3->F::]HVFQ10$&0L"10!Z8D@%LKDX&W-
M>,^/)TN?%MNRL"!@<?6O1O$\US;^&MUMGS G;Z5\[VM_J5SXL3[;G&_O]: /
MJ+2_^09;?]<Q5NJFF?\ (,M_^N8JW0 4444 %%%% !1110 4444 %%%% !VK
MYO\ CH<WD?LU?2':OF_XZ8^V1_[U" \7SP*,_I1QBE[4P$SQ1GFCBCO2 ,]Z
M,\T<8HH ,\9KL_AE_P C3'^%<9Q79_#+_D:D_"@#[ MO^/:+_=%2U%;?\>T7
M^Z*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBD8X4GT% $<A0*=V,>]<CX@U"QM<GRXR<>@J+7_ !+'
M!(T*OAOK7F.LW&I33&5R?+)K.51(]C"8&ZYYG9^$9ENM5:5$VJ&["O3L?N\^
MU<?X(TI8-.28K\S#-=F>(R/:B'<\_$64VD?*'QC7'B,?4UYQUY]*](^,N?\
MA(A]37FPS6IS"X_6C'3VI.:7GB@88Z^]&.GM1SS1SQ0 8Z^]&.GM1SS2<\4
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M%XLT'[);I=*.)*Y>T<Q7<3]PU>L^([-KKP+:W6,_)G-<M6?+)$K<\;494^U
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MYF.*VJRN@L-]_6C/-*<8I!7*RP)H[4<4>U @!XS1GG%' HI##/%&>:,BCO3
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M@\XH:EXSF@XJ$'0.6_"GK@ MZ4*0%^M1DG.!0.PN_))IZ@%2WI3,CTIZ(Q/
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MCKK;X8B3&8SS[5TNG_!^V?:S*/RKV*PL[6:TCE5!@KFJ^M:O::%:M-)@!13
M\<\7> -/\/:-+<!E$@&0*\7!$-^KJ>IKT3XJ>.!KTL<=I)B-1A@#7ER,Q(8G
MO4M:"FO=/5-<E\_PC$?2.O*2.?K7J-S;O+X,23/ CKR]_OX]ZF".>AIH,Z_A
M3XW,8W4TCD4N,C%:\UCJ'ES,"Q[5'C]:4?*,4G7--NX"XQ2 48/%'<U("$9R
M/2@?= HQQ2CKFAB+>F1AM2B0]"PKO-<\/QQ6?V@#JM>?6DABO8G]&!KTW6-8
MAE\+1 'YCQ6,DWL854SS&1!YC+[U'C:V*?*"K$GN::1QFM$FC6"T&G@XHZ<T
M=J!US6FC*ZA@=**3!I34L!0.,4T+S3N:"/F%)LI;"$ <4Y."/K2%"& ]:M6E
MN;B=444-ZF<VK'?:+*%TP#VI;N<MQ5:PB>&%8S5F6V9F5NU>FFO9V/GY_$Q4
M4QVY/][FNG^&*X\0J?\ :K E42695>H%=%\,E(UU >S56)GS4SIPK]X]ZO/^
M/-_]VOBWQG_R.&H_]=37VE=_\>;_ .[7Q;XS_P"1QU+_ *ZFO*/:1A8ZT8Z4
M8/-&.GM3 ,48S^%(>/QI>@%)@&.M+T%)SS28.*8!CO2X_2CM0!Q2$)[T8[4[
M%-((-+4+CL<YI%&&-':C%-/0I&[HVL/: 0CH:ZB.+[=$RL.-N:\^A.)U;WKT
MG0V$MGN'7%>AADI+4ZJ4G+W3@[NQ,,[\<9-46X;%=IK=H/+9@.:X\0,TA7O6
M-:'+*YS2@U/E(6IM.92'Q3:Y]R9QY78,<9I>V*2@^E+J0@')^E+C%(.M+@XI
M%@.M*0 ?K28P12<TQ,Z'PQH?]M7'EXSSBO1;7X6))C<GZ5SWPDO((O$44$P!
MWMWKZGALK;RU94&"*3W'T/%[+X/VQPQ4<>U9?C3P18Z#I3.&4.5X%>Q:_P"(
M[+P^H\S:,BOGKXG^-!KES&EK)\BDY -- M#C=&.R_(]ZCUL?Z6Y]33-'?=J,
M(]^:M^)X#%<!NS&FM#N4U[*Q@CD'VH S2_=Q[TJX&?>BYY_4?'*55AZ"HOO<
M^M&.M(.%IN0"X[48YHP<"CN:AZE!CBC'.:,'&*.], QGBC'>D'3%+U-) &!B
MCOFG!"5IM6XM*XK@1D4O:C:12=ZA#%P,4F.:.<8HQSFJ8!CM01CFD -.[4D]
M0&;BW%+BE44'@XI]1,<AQ(*ZNVD+6:X["N26-C(*ZW3(B;< ^E=^%3(D8MTF
M)R3W-=)"P73D]EK%U--LA^M:*D_88QG^&NR&C,V==\* 3XFW>KU[C\0?^1/O
M?^N9KQ;X3Q[=>R>[BO:/B%G_ (1"]/\ TS->5BOC-X(^.+G_ (^)/K4('Z5-
M<<W$GUJ$"L'L#W%H Q2 &@\\4@#'>E(S0!1@YH .U)C%!'-+C- @]Z,9XH X
MH XQ0AIB8^:G=#BD([TA!S5+074>@^96]#7IOASQA):Z3]B4YKS'FM30IS%J
M48<_*2*A*[)G$])NXY=8\-2M*IW;N,UYW]E>T9\@C!Q7O%I8PW&@AXE&TKS7
MF'BFT2WW*%P<UNHJ6B,GM8R-$Q+$Z/U)-86KVX@NR!T-:]I)LO(]O Q@U+XE
MTMXX5GQP1FN9RM/E"-U(Y7WIN.:7WI1R<>M:2.@8>12@<8I2,-0!26PP_I1@
M&@T@!Q3%U)$4&-B>W2NM\)>%6UR"5]A.WVKD.2O'XU[]\#Y+2:VGA=06X%#&
M9.G_  JCGV[TQGVKHK;X0680EP *]B6RMXAD*!7$^,O&]GH5O) 6 =@0.:5P
M/'/'OABQT&W"0.I;VK-^'%R8;?4U!^\F*Y_Q1X@GUF^=O,)3/'-:?P^RUQ<0
M \R# I5DG&Q#1SFMG?JLV>QK.QG)K<\6:=)8:U,K>M81X4'UJ4O=&G="J-P/
MM4GG,(PM0CBG8XS6\7:(=1"M&.]./2FUG<88[48YI,'%+WS3&&.*5A\N:0=*
M#TI,3.S\-:0FI6/S=0:RO$]DMAJ2HG]VMSP/J"6^Z-SV)K"\470O-29UZ#BE
M"-S%:2,-P ^:0#*DTCJ=X%*>E.S-GL&.,4 ;:".*#U!IZC0#BD([TII3R!4]
M1-C10>N:,<4JB@5[(,9(K>\+MMU%?8U@<DG%=%X;@99_-/0&M*2?.F88A_NV
M=I//F0U0B/F3/CL:G:-I22.]-M8&A:0OWKU*DDK'A61#=<E5]37T=X#&WPE9
M#T2OG"Y4B4'L3Q7TAX$_Y%.S_P!VN'$N[3/4P$M&CI****YCT@KD?'FM/I&C
MNR?>8$"NNKS[XG0M-96Y'W5;+?2@#QJU\6:L+T2K;/@MUQ7T'X/OY=1\/P7,
MR;9&ZYKC]&MM&ET>%C F_P!<5Z!HD446G(D2@(.@% #M9G>#3970$MM->3Z+
MXZNX->DM+D%(@>":]CN41X&#C*XKYY^)YCMKO%BNR4OU6@#WO3-4M]0A4Q2!
MCCL:T:\ ^&VOW.EW:QWTC$.,#->]6\@EA5Q_$,T 2T444 (>AKQOX@QC_A*+
M<_3^=>R'I7CGQ#.?%%NH]OYT >L:5_R"[;_KF*N53TK_ )!=M_US%7* "BBB
M@ HHHH **** "BBB@ HHHH .U?-_QT ^V1^[5](=J^;OCH#]L3_>IH#QC'%&
M*3!P*=0 F*,<T8.!1WH ,<48[TF#BE[T &.U=G\,O^1J3\*XS!Q79_#+_D:8
M_P *0'V!;?\ 'M%_NBI:BMO^/:+_ '14M !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4V0;HV'J*=2'@$T
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M7ZUO^$M7_L;6HK@G"JV332N/8^E?B!XT70XX1#(-Q'/-?-_BOQ+/K^HEI&.
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M2 ,# H 6BBD4Y% #23NQ7CGQ$R/%=N1[?SKV4UXY\0V \4VX/M_.@#UC2O\
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M5$6B[B)12.U=M:GSRN5$;<0Q[(R/QKZ(\#X_X12SQTVU\ZRJ?(7FOHCP&?\
MBD[,?[->?BX<K1[."7NG2T445QG:-=0Z%3WK!U31;0V\CRX QS705R/CC4S9
MZ8T8."XQ0!RJV/AR&0%I4$A->BZ&(%TM!;$&/MBO#(O!E]J21WRW#!6;.,U[
M1X3LWL="BAD8LR]S0!7\4:;::K9-#<D<5Q-CX0T&&)A(R@DUV'B*.0L64G!X
MK@-4L[E9>)& SZT >D^%].L--M/+LR"OM70A@>E<CX+MY$L078MFNCG?[+;2
M2G^%2: +6X'BD4CH*XC2?&27MQ,F?N9_2I=$\6+J&H-%Z$B@#M#TKQSXA 'Q
M1;Y]OYU[%N&S<3@$5XW\0]K^*K?:P/3I0!ZUI7_(+MO^N8JY5/2O^07;?]<Q
M5R@ HHHH **** "BBB@ HHHH **** #M7S?\= /MD?\ O5](=J^;OCHN+Q/=
MJ$!XQ@8HI,<"EQU/K0 <8H&*,?I1CFF <4=Z,<48YS0 <8KL_AE_R-,?X5Q>
M.,5VGPR_Y&I/PI ?8%M_Q[1?[HJ6HK;_ (]HO]T5+0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(QPI/M2
MTR8X@D/HIH!'!:OK$2:RL ;YO2L#Q=K)AN84A;DKS3!8-J7B*6Z+'$9(J)-#
M;7-0=\Y$65KDE>^A]#2A&*4GT1UW@+4OMMFX9LN#BNV(Q&WTKR[P@ATG5FM<
MY!<UZCG="3[5M3V/+QT.6I?N?*/QCS_PD?XFO-SU%>D?&-O^*CSZ$UYQUK8X
M@R5.1VJ[#J$J@(3\M4L\&E/RJ/>D0T:=U &M_-QR169VK1-UYECL_NBL[.!]
M:!(0]*!G%)FE)Z4%H7!P:N:?>-;MUQ50OD8]*9[^M7%C+E]=M<RMD\=JJ 8%
M']*-W%.3$)SFEYXHHSCFH6X 6.[%='X>O/(D7)Y%<WC,F:L0SF*8L/2M5*Q%
M171TFLW8GUI9 <CBN\T*[\^W:)CG]W7EH+RA)N?O=:[SP[+L);/5<5$9/G1Y
MV)C:-R;19!;ZM(G0$FD\9:?'Y!E4<D56DS::IN/&3FK?B>\#Z1GKQ6F.JNT4
M<E*3YT>53C#$#UIG;WJ21M[L/>HR><UC%Z'T"^$2@9H-&[BDQ(=D].U'M2 T
M=3FG8!XVY J-LEL4[RSV[T#(.2.E*+LPN)C IR98$4AZ_6I(%_>CZT]]29/2
MYU>FZ/YEHKLO44R33%2WN3M^[76:<%&FVX '*U!<6F=,OWQT%<]VF>9[=N=C
MS"3ACBF \5*X^=Q26\?F/MKH@[GI1T5R/DCBD'O5ZXM3;J"1]ZJ@7)/M0U9F
MBE<:<]*.@Q2@_.32,=Q^E,'N'.*7!'/:DSQFE)R@'I4]0)+==T\:^K8KVWPC
MI*06*S[<';7B=DW^F0D]F%>VZ+K<::4T.1\L="=G<\_')\BL<A\0KH22[5/(
M->>2?>XK>\27YN]0D.<C-<_NW&K<N8Z,*N6"N!)Q12^])4F\MPYI3U]J,X&:
M <\4UL"$.<5I:;<>2V0:S<\5H6%MYIZXK*2(JZH['3[LMISN3\V:T+!3.A=N
MF:P[12EF4'/-;UK+]GMA%_>&:[,-#WD>'4A[]R:=@JX%5EE$9P._6FM*7?/I
M5-Y"9MOK7LK0)QT+MN=S.QZ9KK?ARV_Q$GLU<A_JH3[UU?PTR/$$?NU85U>F
MV=V%C8]YO/\ CT?_ ':^*_&>?^$QU'_KJ:^U+S_CT?Z5\6>,S_Q6.H_]=37B
M'I&%SS2Y((([49H'\Z: F,[/&5)Z=*KIGG-*.N*4G!I@)SS2<X%+GK[49I %
M*I*D-WI,\_2C/%$=P-B'4W2W,>[C%9#LSR%CWI.>GI1NXS6DI:6%8!2<TN><
M4A/-9)AL./3-.C8H0W>HR>-M+N^6KIRLP9U-M>"33#N/:J_AZ8QWIP><UCQW
M12W\NK.FSF"Z#D=:NK*^ITX.=JB/0+^026X]*K1,MQI[H>U.B'VBUQGMFL)=
M2-D[Q'N373SM43TZ\DY7.?U1!'<L!TS5(@[:OZF=\^?[W-47:N&/O*YY5=KF
M$'Z4'(IP'RTUV^8>U&ES%.Z!>O-(?6ACVI&/&*!+1CH^3STI=P.?;I3 2!CU
MI",8H*:',<XH (_I0*?G)7CI4I7)2L(V<#]::OWL?E4@!:0#'6GS1&(JV*V5
M+2X$6"*9SFGL^?QIHX'TK.VH"<FEQQFK-M!YBL?45%(-A*>E5RNUP(AF@T9H
M%9O<!:3G%&>]+FFM&#0G.,]ZDA&9E%,S3HWV.#Z&KC\0F]#M[:/9I@8#FN7U
M64O*1VK4760MEM]L5@3S>8Y/O7;.I>!$="'MGO2<YI<\9I:X):FHTYQ2TF>]
M+GG%)( YQ1SD4;N*,\XI@)DAABKUM;%R&8<52ZL#Z5M>:(;=?<5TT'K8E['2
MZ6@AMN*HZU.3-&@/7K4UA=&2VR!T%17=L9I5<U[=-VA8Y6M26%ML28]*MPH0
M=]5(H_EQZ5?9A' !ZBJBT#.A^&C%O%//]_BO9/B'_P B?>_]<S7C?PO4OXD)
M]'KV7XA?\BA>#_IF:\+&_&=%-^Z?',W^OE^M1+Q4EQQ<R?6HL\#WKD6QH3QW
M+P-N4U?CG:\7#')K+QN7'I5FQE\J49[FF921'=PF)\57&>]7]2E#R\52)R<T
M%K4:<YH.<4ZDSS36XQ86*.#Z&MM]5<VFS=VK$)INX[<UIS +DNQ)HYQ2(W%+
MGO4L8M-YQGO2YYQ03@5 %[2Y_L]SOS@8KH;_ %+SO#LBEOFW5R(8A>*T+3==
MP^0,GVK=3M"QDXIRN>B_".]6WN0"<9:N_P#B*$V1WB_>"CFO(/!\S:=JBQG(
MYS7I/B>_.HZ 2.=N!7!2;5=,Z*DK4S4T%DU/P](DG/RUX!K\*PZU=(HZ2'%>
ML^%=9^R6KVY/4&O*/$+[];N)/5S6U2;==LY:;NC'#'=BEYP:,<[J=FK;-AIS
M0"<&E)QQZTG3FA!U%YQ0.#S^%&<D>]*QR1CM2#J*Y&!C\:8#C-+L/4BDP<_2
MARTL*^HH8[36AH]H]U/P,@'FLX],#O75>#L!Y0PYQ0V[$5Y\L&S3DT>-8T8K
MRU<UK%H+:X( QZ5Z5-!OCMQCJ:X?Q@@AOR@[&L:<O>L>?A:SG.QRQ#%R:6G;
M_F/%7K6Q,\#.!]T9KI2U/3E*QG@'-)GFGG(8Y'M3".=M2QIBBDZM[4F<-3AP
M*310'/:E!'>D#8Y]:-O.*"3M_ &GI?7VUAFO0?$:+8Z*\8X6N#^'=XEC?>8Q
M'3'-='X\UA9+(Q*PY&>*TI5.4\NNFZAY5?R;YW/O52GR,68M[TSOBIF[GI4]
M(V$YI>XHSBC//UI="D!Z4"DSFC/--"8[E7!KM?#=R971">,<UQ8^=E%=5HW^
MALC9^\*S>YRXN/- Z,OYER\?H<5<-NL2 D=:S;+YII)CZYJ]-=><@ [5Z.%W
MN>,H6D5YGVGC\*))=\: =>]59W.T_P"S3K;Y@'->K'X;FM*&H^8D1X/X5]$^
M O\ D4;(_P"S7SE<R[VP.U?1O@(Y\(V7^Y7E8Y^\CU,+I='2T445P'8%<#\3
M&CCTD2,>1S7>L<*37$^-=.CUNQ:W,@''K0!YAH_C>.&PBM_-&0<8S7M/A2]%
M]H<4N<YKPF+X:HEQN%R.#G&ZO</!M@-/T"*$-G'>@#5OX8FM7DD^Z@S7D_BW
MQ!I\-B'BD&X/BO4->D,>AW.WJ8S7S!<6%QJUU+:%V^5RW6@#Z"^'.HQZAX?2
M16R<UTNK(TFG3(G4H17 ?"JV;3K 69)('.:]&NY/*MV?&<"@#P6**XT._E:<
M%5=B/SKI]+LS:Q)<QC!9QS53Q"'U^\:-(BOEG=P/2K?AJ_DU"9-/:,@(>I'I
M0!W'B/4&L/#GV@'#!/Z5\ZCQ%<ZUXQC$CEL/C]:^D=?T<ZMHGV,''RXKP.\\
M'GPQXKB<G.YL_K0!]&:7_P @RW_ZYBK=5-,.=,MSZQBK= !1110 4444 %%%
M% !1110 4444 ':OF[XZ9^V)_O5](]J^;OCHV;R/V:F@/%^<"G=J3/ HS^E
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M3B-U>:MS5;%_3''G!3T-,U.$QW;$#BH;1MEW'[-6SJ\2M$) 1DUTVO$1S_%
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MJUA81:,Z6BBBL3L \"O'O'?CRWL-9:Q;K&>:]A/(KQGX@^!8[_63>A<M(W-
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M@=ZZ?287&X,.M.G!.9A7T5C4N%_=H1WKZ3\ C'A"R'^Q7SM-%_HRY[=*^B?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'%(:0@S^M*,@@TG%!H <>6SZTP\\>E.S24T BC'-300M<3+&.<G%1$XXKM?
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MD-&#FI$WJ'O10>:"#C%%QG7?#'_D=+?Z&M/XL@?V]%]*S?A@<>-+?Z&M#XL
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ML@6BDQDYH'I31I9AUH &<>M+VIN#FG<$A<\UZ]\+!GPOJ7UKQ\?>KV#X7?\
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M@ZM /5A7M'Q%S_PA]YZ>77E8F?-*YO'8^:?%H_XI_2_I5KP!KS6E]':G[KD
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M2@#U;2O^07;?]<Q5RJFE_P#(+MO^N8JW0 4444 %%%% !1110 4444 %%%%
M!VKYN^.A/VQ/]ZOI'M7S?\=#F\C]FIH#Q;)P*=VI,\"C/Z4@$YP*7O1GBC/-
M,!,G%+WHSWHSS0 F3C-=I\,O^1J3\*XS/&:[/X9?\C3'^%(#[ MO^/:+_=%2
MU%;?\>T7^Z*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "D/0TM-?A&/M0!SE\ME]L"2$;C4D]C:06_F-@
M+7/7,$E_X@4*QP#73ZG8-<:5Y0)R%KDT;9A%7N/TM+9TW0D&M4_ZMOI7'>%I
M&MYI+=R2=W>NQ/\ JV^E719I%W/'^OCKVW-7@_C''_"6:C_UV->\#Y?'!]V:
MO!O&(_XJS43_ --C74C5(PSC'%*.1\WX4F.*5N5 ]*BVHTT:.B:@]A?*Z' S
M7K:6MMK6CF5\-(5S7B@^4J:],\$:IYBBW9NG%92A=GFXN+^)''ZKI$EO=2X0
M[0:Q2FUL&O:[O0DU&XD0 ?-7%^)O!YTU&D';FNCV;2(P^*3?*SA3C)I.,4I7
M!-)C@5)Z*=T+Q2<48_6C''TIC%XI#P*,<YH(XI/8!%&15J"W+YX[4RTB,LNT
M#.:Z6STQE7E3TK6DKF$ZJC(Y>:,QC!J/'%:^JVVQR:RCR,5=569IS<P< 9I.
M#2LO[O-(!@5@T6'04< TJKN-2I9R2-PI-0Y*XIS5B#WIQ_2I)X6@<!@1Q4?0
M8JHZCB[HZ[X8<>-;?Z&M+XLX_M^/'I6=\,3_ ,5K;_0UH?%A<:_'[BF(\_HX
MI:3'% PXHXHQR/:@BD <4<48Z>U&.OO3 .*.*,=/:C'7WH .*.*,=/:C'ZT
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M3VHQU]Z #BCBC'3VHQ^M !QBCBC'Z48_6D <4=Z,<48YS3 .,4HZTF.U&.:
M%X-)QFC'%&.<T '&**3'&*7'.: #BBC'%&.<T ' J0/@!N]18XQ4IBRM(#Z"
M^#6IZ;IVAR--(JR%Z]%\77D-]X4N&C8%2M?)NGZQ-IL'EI(P&<\&NY3XGG^P
M&L6))88YH \WU,[=1N0/[YJKVJTP-[?R$?QL344L1B<J>U7L@2&( 3S3,8)Q
M2@8I14W & P*0]*",TA'&?2DF%CT[X+Y_P"$@'^^*]^^(A_XHV]'_3.O O@N
MW_%0#W<5[]\0USX-OF](Z /F;Q<,>']+^AKC,"NS\7'.@:6?:N+')^E+4!>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M48_6@ XHHQQ1BD <8HXHQ1CF@ XH[T8XHQWI@'&**,=J,<T '%'>C'%&.<T
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MZ]N/YT >M:7_ ,@RV_ZYBK=5-+_Y!EM_US%6Z "BBB@ HHHH **** "BBB@
MHHHH .U?-_QTQ]LC_P!ZOI#M7S?\= !>1^[4(#Q?C%%&.!1BF <8HXHQ1CFD
M <4OM28XHQSF@ X%=G\,O^1J3\*XS&>*[/X9?\C4GX4 ?8%M_P >T7^Z*EJ*
MV_X]HO\ =%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !3)>(G/M3Z9+S$X]C0!P^GVYO-6DD?G:Y%=7-
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M: #BC/.*4$XI P4'-:FASFWU%.>XK,4\U;TU6DU!=HSS6D)6,JT4Z;1ZYJL
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MU]J,]*&-:%BS_P"/R(?[5?9/@ 8\'6/^Y7QI:?\ '[$?]JOLOP <^#K'_<H
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M7X!Q_P (?8X_N4@.FHHHH *X3XC1JNG"9AE5Y-=T2 ,GM7*^*IK&]LWMYG&
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M\="/MD?LU?2':OF_XZ ?;(_]ZA >+YXI>U)@8%% !FC/-&!B@8H ,\4M)10
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MBSDZ_&/:J>Y1Y^>2/:D(XQ1SNH&:!AVHQU]Z#U%!SB@ QT]J,=?>CGBCGFF
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M\T &/THQS2<X%+SF@ QQ1CG-'.*!2 ,<8HQS2<XI<\TP # I!US1SBEZ'VH
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M_N_%,#?2O8F&5R*\<^( (\46^[IQ0!ZWI9SI=L?^F8JW5/2_^07;?]<Q5R@
MHHHH **** "BBB@ HHHH **** #M7S?\=&S>1^S5](=J^;_CIC[9'_O4(#Q?
M/ HS^E'&*7M3 3/%&><4<4=Z0 /6C/.*7M24 !.*[/X9_P#(U1_A7&<&NR^&
M?_(U1_A0!]@VW_'M%_NBI:BMO^/:+_=%2T %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-?\
MU;?2G4U_]6WTH \=V?\ %;DC^\:\-\8V=P?%5^PB;!E/:O8K[68-)\=AK@_*
M7-4]7GT:\O9+CRU.\Y)H \/^P7/'[IN?:C[!<\_NFX]J]C\O2, ^4M&S2/\
MGFM 'CAL;GC]TW/M2"QN3_RR;\J]C*:1_P \UH"Z0"/W:T"9XX;"Y!'[IORH
M^P7.3^Z;CVKV0KH^?]4M)MT@G_5K[TT%CQW[#<\?NFY]J/L%SD_NFX]J]B*Z
M.,?NUI=FD#GRU_*D,\<^PW.!^Z;GVH^P7.3^Z;CVKV,)I!'^K6G%-(V_ZM:
M/&OL-S@'RFY]J0V-SG'E-^5>RA-(_P">2_E2;-(Z^4OY4 >-_8;D#_5-^5+]
M@N?^>3?E7L>S2"/]4M+LTC;CRUS0*QXU]AN=N?*;\J7[!<YQY3?E7L>S2,?Z
MI?RH":1C_5+0#T9XW]AN<9\IORH^P7.?]4WY5[)Y>D?\\E_*EVZ/C_5KFA S
MQO[#<[<^4WY4GV*YS_JF_*O95&C@\Q+2;-'S_JE_*@?0\;^Q7/\ SR;\J0V-
MS_SR;\J]EQH^<^4N*7;H^,>4M(1Q7PQM)U\9V[-&P ![5/\ %@9U]![5WNA7
MFD:;JBW(11M!YKS+XB:I%JFO&6+E033&<DW0'TI ./K2$_,.*0DXZ4 .QDY]
M*"*0'IQ2 GGB@!U 'ZTTDY'%*2<'B@!<9/TH--!.!Q0"<GB@!V,"@#G/K323
MQQ2YX/% "XS^%%-!.!Q1DY/% #L8% '.::2>.M+N]J %Q3BOR9J+)P.#3MQQ
MB@#6TB$3*R'TJG=VI@F88J72;GR9QG.#6GK+1,F]1U%;Q5XD['/8[5Z%\-O$
MW]@7!?..*\YR=W0U,ES)"?D)%8-%'T8?BR<_>H_X6T?[U?.OV^X_O&C[=<?W
MC0!]%?\ "V3_ 'J/^%M'^]7SK]ON/[QH^W7']XT ?17_  MH_P!ZE'Q8.PG=
M7SI]NN/[QH^WW&,;C0!]%K\626QNI&^+)Y&ZOG47]P#]XT?;[C^\: .M^(&N
M?VWJ*2YS71?!5 VOQGT:O+))GE&7R37J7P4)&OQ_[U 'TYJ S8R#VKYXUR%Y
M8=:5 3\QZ5]$7O-F_P!*\(T_5;&/4==MKH LTA S0!X@^GW +?NF_*FC3KG;
MN\IORKV1AI&[!C7FC9I&,>6OY4 >.?8+G _=-S[4GV"Y!/[IN/:O9-FD?\\U
MHV:1_P \UH \;^PW/'[IN?:C[#<\_NFX]J]CV:1G_5+2[-(S_JE_*F(\;^PW
M.!^Z;\J/L%SD_NF_*O9/+TC_ )Y+^5)LTC/^K6@+'CGV&YZ^4W/M1]AN<X\I
MORKV/9I'_/-:79I'_/)?RI >-_8;G'^J;\J/L%SN_P!4WY5[)LT@C_5+^5&S
M2/\ GFM,+'C?V"YQGRF_*C[!<DX\IORKV0KI '^K6C9I'7RUI#/&_L-S_P \
MF_*G?8+G./*;\J]A":.?^62TNW2/^>:T(#QO[#<[<^4WY4OV&YZ>4WY5[$5T
M<#_5K2[-(_YY+^5 K7/&_L-SC/E-^5+]@N0<>4WY5[%MT<C_ %2TNW2/^>2T
MQGCGV"YZ^4W'M2_8+G('E-S[5[%MTC_GFM&S2.OEK0!XR;*YW?ZIORKUKX96
MTD?AG4/,4KSWJXB:.6YB6K\>LZ=IV@WD4 "EO2D!XGK0_P")W=>TAJD1D59U
M*82ZC/(.C,35,,>>* '4 ?K323D<4I)P>* %QD_2@TT$X'% )R>* '8P* .<
M^M-)/'%+G@\4 +C/X44T$X'%&3D\4 .Q@4 <YII)XZTN[VH 6C%-!..E&>>E
M AV.,4I7H:CR<=Z=N/I0QL>0-ZCWK?2W6:QR.N*YO<>O-;VDWBCY'Z8K6G8E
MF,Z%693ZU+:MY,\4O]UP:EU0K]H.P53W'%1+L-'T'I7Q/-II<,6[[J 5;_X6
MT?[U?.OV^X P&.*/MUQ_>-2,^BO^%M'^]1_PMH_WJ^=?MUQ_>-'VZX_O&@#Z
M*_X6T?[U'_"VC_>KYU^W7']XT?;KC^\: /HM?BR2<;J/^%L$OC=7SH+^X'\1
MIRW]P&SN- 'T0?BP>1NKPOQ-??VIKEU=?WG)K*-_<;OO&HFD9FR<Y/6@#U#X
M+_\ (?\ ^!BO??B&,^"[\^D=>"?!5@-=.1U85[S\0LCP;?GMY= 'S7XHLY9?
M#^F&-"W'.*X\:=<@G]TW'M7KNDZEIMQHMO!<*&91@9J=TTA@,1+QUH \<^P7
M/!\IN?:C[!<Y/[IN/:O8]ND$#]VM&S2/^>:T >.?8;G _=-S[4AL;G./*;\J
M]CV:1_SR6EV:1G_5K2 \;^P7. ?*;\J/L%R3CRFX]J]D\O2/^>2T;-(_YYK3
M \;^P7.,^4W/M2_V?<YQY3?E7L>S2,?ZM:7;I&/]6N: /&_L-SC/E-^5'V"Y
MSCRF_*O8]FD8_P!6OY4;=(S_ *M: /&_L-SC/E-^5+]@N<X\IORKV(+I!'^J
M6EV:1_SS6D!XW]@N<?ZIORH^P7.<>4WY5[)LT@?\LE_*C9I&?]6M4]16L>-_
M8;G&?*;\J#87.?\ 5-^5>Q[-(_YY+1LTC_GFM2MQO8\<%A<_\\F_*G?8+G./
M*;\J]C":0/\ EDOY4;-(S_JU_*GU$CQO[#<X_P!4W'M1]@N0?]4W/M7LFW1\
M_P"J7\J79H^/]4M+4+GC/V"Y//E-Q[4?8;D8_=-^5>S;-'X_=+3)$TC:3Y:_
ME30&)!$\7@N4."I\O@&O,Y5Y/O7K?BS5;)-)A@MP -N& KR65PTDF!QGBD@(
M\=/:@TT$^E )R>*8#L<#VHII8\<4I/'2@8N./I0!SFD#''2DR<GB@!Q&:4CB
MDW?(..:0$]\T"#':E[4%OE''-)NYZ4 *!@8HQSFDW>U)D[NE QV.*7'.:9N.
MVEW'=TI@+4UN@,JY]:@SQTH1V5P1FB.XCJ+W3E;3]R\\5S 78Y]JZ:QOU>S*
M2<\5S<K?OGP.,UI-:"6H1GRYT?T8&O?M*^*36>CVT.[[D8%?/A)]*L&]F"A0
M3@"LD4?12?%DDCYJ0_%D@_>KYW%_.%^\:1K^X_O&@#Z+;XL$ ?-3?^%M'^]7
MSK]ON#_$:/MUQ_>- 'T6/BR21\U(?BR03\U?.OV^X_O&C[?<?WC0!]%?\+:/
M]ZL_6_B>;S1KB'=]Y<5X+]ON/[QI&O9V4J2<&@"ZK_:-927^\^:^Q/ @QX1L
MA_L5\::<2;R+CG=7V5X"S_PB%EG^Y0!TM-89(IU-;.1B@!LT?F0LGJ,5Y=96
M!3QEJ-NT>5D7&2*]5KAM4\1:5I7B'RI HG=@": ,7Q=$VF:''IL460YVD@>M
M=/\ #W3?[,\+PP>Y-1>)=3TQ-.2XN0IW?=K4\)74=WH<<L7W2>* -VBBB@ J
MO>Q>=:2IZJ15BJNHR^383OZ(3^E 'ALED^C>*+AD<LKJ1U]:O>%=)?3M6_M
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M#_<%'V.'^X*!'S__ ,*EAR/D_2C_ (5+#S\GZ5] ?8X?[@H^QP_W!0,^?_\
MA4L/'R?I1_PJ6'GY/TKZ ^QP_P!P4?8X?[@H$?/_ /PJ6'CY/TH_X5+#S\GZ
M5] ?8X?[@H^QP_W!0,^?_P#A4L.!\GZ4?\*EAR?D_2OH#['#_<%'V.'^X*!'
MS_\ \*EAP/D_2C_A4L.3\GZ5] ?8X?[@H^QP_P!P4#/G_P#X5+#MSL_2D'PF
MAY^3]*^@/L</]P4?8X?[@H \ 7X41*0P3H?2IYOAE'-%M*=/:O>/L</]P4?8
MH?[@K13LK"L?/Z_":$QYV?I2K\)82?N?I7O_ -CAQC8*7['#_<%0QGS_ /\
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M'^X*/L</]P4"/G__ (5+#@?)^E'_  J6')^3]*^@/L</]P4?8X?[@H&?/_\
MPJ6' ^3]*/\ A4L.?N?I7O\ ]CA_N"E^QP_W!0!\_P#_  J6''W/TH_X5+#G
M[GZ5] ?8X?[@H^QP_P!P4@/G_P#X5+#MSL_2EC^%D<4G"?I7OWV.'^X*/L4.
M?N"M(RL(\$D^%,4@WE.?I48^$L.?N?I7O_V.''W!1]CA_N"I;N,\ _X5+#MS
ML_2E_P"%20[@-GZ5[_\ 8X?[@H^R0_W12 ^?_P#A4L.TG9W]*7_A4D.X?)^E
M>_\ V.'^X*/LD/\ =% 'S_\ \*EAP?D_2E_X5)#D?)^E>_\ V.'^Z*/LD/\
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M 4444 %%%% !1110 =J^;OCH3]L3V:OI'M7SA\="/MD?^]30'BN>!3N@I,C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"N3FEHH
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MM933"@;^*BZU9(--6\/W2,T :U%<QJWBN+3=-ANFZ2+D5S=M\4[:=)FQ_JZ
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MV@#1HK(T+5O[5MVDQC%:] !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP+;_ (]HO]T5+45M_P >T7^Z*EH **** "BBB@ HHHH **** "BBB@ HHHH
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MS,;35]%G/"JG)JCXC\0/=:U:"/YESVH ]2TH$:;"#U"U=JCI+;M,@8]UJ]0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:?#+_D:H_P *XS/&:[/X9?\ (TQ_A2 ^P+;_ (]HO]T5+45M_P >T7^Z*EH
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M2"* '4444 !X%(#D9IKGH*<HP,4 +11FB@ HHHH ***,T %%(3P:B1R4S[T
M344=J* "BBFL<"@!U%(#P*"1G% "T4U23FG4 %%(QPN13=WR9H ?12!N!FEH
M **:IR33J "BBB@ HHHH **** "BBB@ HHHH **#TIJG(YH =12 @]*3)WXH
M =13-V7P*'8@T /HI-P YI%.0: '44U23FG4 %%%% !1322& H8D,!0 ZBBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "O&_B#X%N-6U26[MD^=NX%>R
M4A13U - 'SIX=^&^HQ:O;S72$A'!.17T/;1""W2-1@  4X1(&R%%/H ****
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MBBB@ HHHH *9(N]"OJ*?10!C0Z/#%.\@C +"IK#3X[64E5 )-:&</[4['.:
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MD\.:Q&[D[6PM;VBECXQDW?\ /$55\=MBYM0GWO-7/YT 7(K@#QF[^D&ZN/\
M$?B(:OK4EDG.T&NG53_PDLK=_LO]*X[PAI\=]XTN/.&2<T 7/AYJKKXE.GMG
M&":[/5+L2>*8[+_9S5[3O"=EIVJ_;8E DQBL&]R/B7$3]WRJ -CQ I18F[#
MK?AYTU?^N?\ 2L+Q&0=B^XK9A;;I>3_SS_I0!@>&W"272CNY-4(HX[OQ UP2
M,("*L>')%^QZA.3RKL!7EE]?Z^+R\>Q1BOF'&* /5_!ZA!J.#G,AQ6):ZP-/
MU2Z!YRYK)^'&IWL-Q):ZAE9923@UTFD:1#?ZA=M*.DAH SX9?MFFZA<XP U'
MPUVSQ:FH'\=='JNEP:;X?NEB& W6N:^%;!1JA[;Z -CPJWE:AJ0])*[6,[D!
MKC-!"F_U)E[R5V,'^I7Z4 24444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 -89IPZ444 (>E>-_$/CQ5;M]/YU[+7CGQ%Q_
MPE=N.W'\Z /5]*_Y!=M_US%7*IZ7_P @NV_ZYBKE !1110 5YIXR'_%=:6WH
M*]+KS/QD?^*[TL=L4 >C6IS;1_2IJAM?^/:/'I4U !1110 4444 ':OF_P".
MA!O(_9J^D.U?-_QTQ]LC_P!ZA >+YX%&:.,4O:F F>*,T<4=Z #/>C/-'&**
M #/%=G\,O^1J3\*XS KL_AE_R-2?A0!]@6W_ ![1?[HJ6HK?_CVB_P!T5+2
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M#R+Q5>S:\;5%5AAU->O64?\ Q)X8S_SR _2L\>&;$,OR#(Y'%:[*4B55[<4
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M110 4444 %%%% !3=OS9IU% #<_-BG4F.<TM #6&13J** "BBB@!JC%.HHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;^= $WQ 7?HF/]L5S7Q _P"291@=BE=%\0K@)H_EXY+BN=\?1LOPSCX)R4-
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M3W7@4;R2P ZUV?A^!H=/0M_$,T :U%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU\XXIU% "#I01D4M% !33G>*=10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1110 4444 %%%% !1110 4444 %%%% " 8I:** "BBB@ HHHH *8!\YS3Z*
M$*@]:6BB@!-HSFEHI#TH -HW9[TM-4Y%.H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HIK$@BG4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!&84+AR.13V4.N#TI:* &)&J#"C%5I=-MIGW/&"?I5RB@"N+*$)
MLV#%3+&J)L X%"DDFG4 ,6)%)('6D6!%8L!R>M244 4FTNU>;S3&-WKBIWAC
M,?ED?*>U34A&: *T>GV\1!5 *G,2L02.E/HH KW%G#<@>8@..F:?';1Q+A5
M J6B@""4)#NFQSCK7%:@S:UK"1Q](V#5W$T0EC*'O6=8Z-%9WC3KU84 :,/R
MQHGHH%.DC612K#(-+M^;-+0!3@TVVMY/,CC 8]Z=<6$%RV94#?6K5-R=^* &
M0V\<$>Q%POI0L*HQVC -2T4 ,6)$S@=:@%E$MQYH4;O6K5% $:0HA)48S4=Q
M90W)S*@-6** (;>UBME*Q* #2R6\<BE64$&I:* *L6GV\+[T0 U:HHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:?6;9I'.>*ZT# Q0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y]\4HU>QT\.,J;A
M?YUZ#7F?QE>5-!M&A&9!."* +'BRPLK7P[;R0QH)& Y'TJ_X'=[;PZ992>"3
MS7G&D:MJ.H7,-IJ@98N,9KT3Q%*F@>'H/+.V-V - %T>,82X7'5MM;&HZLEC
M9K.W1@*\WO=2T5+*%HYU\PL">:U=5U..>T@,C_N#M&: .CL/$\5[=F #D+FK
M]CJB7\4C)_ 2*SK71;:VMC>1_>,7!_"LKP6\CP7I/3S&H W4UN.XN)+48W;3
M7/\ ANZ6UAOV(Y\QJR].ED_X3"1/X=K5H^&(5G2_1_\ GHU #_!NN?:[J[0G
MI(:V+CQ5%#(Z]=K8K(\'Z9# -0F3J)&JEH/V'5-1N[:5P9?-.!0!Z#9W(NK=
M91_$,U1U?68]+ W]ZMP0?9@D2?= Q7%^/!))>01)D[A0!O6WB:*>!I>PJM+X
MPAC//2L;6H(M&\%O<YVOL!-<IK&LZ4/!7VF*93=; <9[T >HWGB&*UMH9B1B
M09%5/^$MA^7WKS_[;+J6F:*BDDO&,UV-[HD5OX>-P1B15S0!T=QJ\<&G"[/W
M2,U0T_Q/%?!BO\-<[K%P[>%K8)_$G-2VEE'I_A$WO1O+R30!LR^+(HY)%_N5
M?;7(ETM;PD;6&:\^75M%DT1YI)U\]EY&:H^)-6EA\-Z8;8YA8_.1Z4 >@V?B
MN*ZEC11]XXJUJ?B"/3Y0AZFN?\(VEG>Z=;W$3!G')K(NM9L7\7WEK?RA5B^[
MDT =Q8:]'>&3'\ R:SY_&,,,C)Q\M8VEZA8S3Z@ME(&Q'Q@UG:!I;:E-<O,#
MT.* .LG\11W6ASS)_<->?_#W7GG\4W,;L2"#BMO2X#]HOM/D^XD9.*Q? .F0
MQ^,[L+V7- 'L,DH@M7E/15S7,Q^,X'B=QC"DBMS5B1HEWCJ(C_*O*/!UHU]I
M=\TH/R[R* .\M_&4%Q;-*I!VUH:'X@BUB%G0CY3BO'_ 'G7WB&[L)P?+ ;%;
M>@WDNE^/;G2ER(1$SXH ]!OO$D5I.8SVJ[INK)?V33KT6N"M=8TFY6=KV91*
MK$8)K9\*ZA:7"R06\@:/)Z4 7+GQA#;R["/XL5H:AK\5C9I.Q&& -<5XGGTB
MW0CS5$V_IFJ'BB]DG\*1O"<D,H&/2@#M)/&,"!2>C5T=G<K=6ZRKT89KS/Q!
MIHM?!$%\H_>[5-=3X'OFO-#5B<E0!0!U1( R36%>Z@B:];P;Q\P]:?XHGN;?
M09I+4$RCIBO!+O7/$9UU&:-_,7[M 'THK*P^4@U1U0,-/FQUQ7'_  UU#5;Z
MWN#J2LK!OES7>3Q":)D/0B@#RCP';07&KZHEX@?,O&ZN_ETZ"RMI7B0*N.U>
M;:]!?>']3FN+-#L=\DBN]TS54U/PTI+9E\OYA[T <OX'L;*ZUO5VFC0_/WKL
M_$%O''X=N(HE 79QBO#+?4=;LM<U86*,1YG:O8H;F:7P/')><3-'\P- '+?"
MU#!J&H*W0GBMKXF3,FD>4AQO4BL;0Y1I>IVY!Q]I;\ZV?%:?VC<+$W*H>: *
M_P +;=H=-^;N*]%KC_!L0@>6%?NJ.*["@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O/OB>5%IIX89!N%'ZUZ#7#?$FQEO;/3Q$I)6X4G\Z ,CQCI2VMC97L"!<%2
M<"H_%UU_;W@NW6)OFWA>*[C5-.6^\.>4ZY98>/KBO,/"VGZC)]IL[I3L3<R
M^O:@#%M_A=?S&*0W3$9#8W5WVJ>$97\+PVN_#QN&SGTKG=+O]<AOA!,&"B3
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>image11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %, UT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,QVL%Q&L:;B<#!]:]6KS3P!_R4?QU_U]1_R- 'I=%%% !1110 4444 %%%%
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M[CNK8L5\R,Y&1U% %^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=S8Y.?K7NFEFW.E6IM%*VQB7R@1R%QQ7FNF:IX[LM,MK27P/:.T,:H769<'
MQFO3K)Y9+*%YX1#*R O&#]T]Q0!/1110 4444 %%%% !1110 5YIX _Y*/XZ
M_P"OJ/\ D:]+KS3P!_R4?QU_U]1_R- 'I=%%% !1110 9 ZFDW#U'YU7O+"U
MU"-8[J(2*IR 21S^%4O^$9T?_GR7_OMO\: -7</4?G1N'J/SK*_X1G1_^?)?
M^^V_QH_X1G1_^?)?^^V_QH U=P]1^=&X>H_.LK_A&='_ .?)?^^V_P :/^$9
MT?\ Y\E_[[;_ !H U=P]1^=&X>H_.LK_ (1G1_\ GR7_ +[;_&C_ (1G1_\
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M)/:RK&]Q))AI,G&4'>O1J\6^(GB?3=5@OK"[CN;/6M+G!L8=I83MGY6 Z$4
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MQ2I-$LL3J\;C*LIR"*2DGLS2=*I!7E%H?1113,PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "HI[:"ZC,=Q#'*AZJZ@BI:\
MZ^(^I^-M%DCOM 2&3354?:/W>YX_5L=QB@#I4\#^%X[G[0NAV(FSG=Y0ZUNQ
M0Q0($BC2-1T51@5X7<Z_XRO?$GAJ.R\36,ZWY?888\*,#D.O6O<;19UM(5N7
M5YP@$C*, MWQ0!-1110 4444 %%%% !1110 5YIX _Y*/XZ_Z^H_Y&O2Z\T\
M ?\ )1_'7_7U'_(T >ET444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M ",JLI5@"#U!%(J*B[44*H[ 8JIJFKZ?HMFUWJ5W%;0+U>1L"F:1KFF:]:_:
M=+O8;J$'!:-LX- &A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M0W;-'9S2)&LCHA95;H2!Q4U9'B348=.T6=[B.=XY%,1,4+2;<@C)"\XH \VT
M?QMJNI&UFF\4^%[5I7&^S,+>8ASRF<]>V:]?'2O%?"J3)'9V-IKGA"582JA)
M;(I.0#T^;!W5[6.E !16##XT\.W&OMH<6J0MJ*L5,(S]X=5!Q@GVS1#XT\.S
MZ^VAQ:I"VHJ2IA&?O#JN<8S[9H WJ*P;?QIX=NM?;0X=4A?45)4PC/4=0#C!
M(],T6WC3P[>:\^B6^J0OJ"$J8AGDCJ <8)'H#0 OC7_D1]<_Z\9?_037%_ '
M_DF4?_7W+_2NT\:_\B/KG_7C+_Z":XOX _\ ),H_^ON7^E 'J-%%% !1110
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MIQ.K>-W;QA:W]]X96/4+(&,Q&XZMVS\O;FO3O#6MZ_JT\RZMX=.F0J@:*4W
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MC3;:ZG+C,QK8N%.%3:"M_P '\@HHHK4\\**** "BBB@ HHHH **** "BBB@
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M5G=]GW?/TYQTS7;URWCW7+S1- C.GK$;N\N8[2)Y5W(A<XW$=_I0!R?C'5-
MU1?#P\-7\5QK4%W$MDMI+N98LC>& Z+M'.:]4ZC!K@/$@G\%+I>KZ?;:<(C/
M';Z@B6RH\V\@;E(Z8/.*] ZB@#C[7X9^&K+4?M]O#=1SF;SV(NY,,^<Y(S@U
M=@\"^';;Q"=<BT]5OBYD#;SM5SU8+G )]<5T=% '.6_@7P[::^=;ATY5O2YD
M!W':KGJP7. 3ZXHM/ OAVRU]M:M]/5;TLS@[R55FZL%S@$^H%='10!A>-?\
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MKKNG%F. !<KR?SH VJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+-+TO5="OM4@MM+U) )7MV+NI![ XZC@UT_@CX/1>!_$"ZI9ZY<2@H8Y(6B
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M<BNGAZQ5E(((BZ&NGHH .@P**** "BBB@ HHHH **** "BBB@ HHHH ****
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M2.=WXC'YT ?3%%(HVJ%R3@8R:6@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *Q/&!U$>$M2.DY^VB!O+V]?P]ZVZXS6O$6J'QYI
M_AW2Q$L8B-S>RR=1&#T6@#R"TU#2[5=5LK$:NUU=6</EIA_,-T#SR>G-?0FB
MBZ&B6(OL_:A GG9Z[L<UY)-XO\2WCZSXFTJ'3UT?2YS&$>+]Y.H/S<]C7KVF
M7JZEI=K?(I5;B)9 #VR,T 6Z*** "BBB@ HHHH **** "O-/ '_)1_'7_7U'
M_(UZ77FG@#_DH_CK_KZC_D: /2Z*** "BBFNZQHSNP55&22> * %+!1EB /4
MT!E*[@01Z@U\U?&/XHMJM^FD^'[^5;2 D3R1':)&]CZ5J? +Q/K.HZA?:/>3
M2W-EY1D$DC$F-NF,^] &G\0/CK'I=S=:3H$'F7,9,;7+_=4]\#O6'\)_BQKM
M]XJBT?69VO(;LD(Y'S(W^%<YXP^$VMP>,I8;9X)8;R9FBD,H& 3GGTKT7P_X
M%T/X1Z0_BG6KC[5?1IA0H^56/9??WH ]IHKR;P=\<],\3:\FE7-D]DTQQ"[-
MD,>P->LT %%%% !7C/[0.CZ3<:#;:C=78@OX25@3&?-'<5[-7C/QV\$ZOXB@
MLM2TJ.2Y^S I);IUP?X@* / ++4AHVGM)92HUU<JT<FY,F-?;W-:MO\ $KQ'
M:>&AH=M="& -GS(UVN1Z$UUOP]^"U]XA-S+K\%Q86P3$1(PS-]/2I_B-X4\.
M_#CP_'ID5J;_ %&^.X7,QQY0'IB@#SJZ\9>(K[2AIUQJMS):@YV%S^M5K>WU
MO5]/:.W2ZNK6V.XJN6"9[UZ1\*)-!UG1]9T#4-&ADN#;-.MQCD[1TSVKT"]\
M4^'_ (4>"--2QTR-[R_A5_+'\1QRS'TH \@\!^([SX<ZE+JMW:3A9HBB6[Y7
MS#Z_05T?CKXF^'/'7A*,WNER1ZU$^(PK<*.YSW'M4.L7$OQH\F73;=+;6;&(
MJUKNPLJ9ZK[TEC\ ?$UUHLEU*\,%X&'EVSM]X=\GM0!UG[/5[H)%Y:P6K1ZO
MMW/*QSO3V]*]YKR3X1?"R]\&7%QJ>K2I]LE7RUBC.0J^N?6O6Z "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#"\:_P#(CZY_UXR_
M^@FN+^ /_),H_P#K[E_I7:>-?^1'US_KQE_]!-<7\ ?^291_]?<O]* /4:**
M* "H+R6:"RGEMX#/,B%DB!QO(' S[U/4-Y<K9V4URRLZQ(7*H,DX&< 4 >=+
M\0/&$EW+9Q^!7:YB4.\0ODW*#G!(]\5Y7%X5^)\7CW_A+?[$E-X;@S%?-7!4
M_P '7ICBI_"GB+Q7;_%J3Q!?:1J8M-1E\J=3;OA(R<+V_AX_6O28/BO;S?%R
M7PN&0V C\A)/6X')&?3M]: /%=6\+ZY=>.=EY97RZ[>NUW''YL>XX.<CGMV^
ME;GB+PM\3]?\50:\^C3I/;",0?O4^79WZ]2>3]:N:]X0\?W_ ,4!KB):QWYE
M\^T@-TNX1(0  /3&,_6O8M1\?6.C^)-#T'4%$=[J29<!P1"V. ?J<B@#QGQ[
M\3]8B\1:#'J>A+97VD3K=21&8/O) ].E5OB/XR\5>,TTZ*VT"\L[> K<J8<R
MB1B 5;<HQP*ZKXL:-X/L/&GA^:^MD\[4+W??DNQ+Q\#GG@9KT?4M:\/?#C0M
M,MMODV4DZV]O&K9VACDGGL,YH \+\:?$W4+WP_9VU[X:ALM3DV%[N= 9) AY
MX(R 2/YU+XNUK7_&OP^MY],\.0:;H<3F:YEAE0+(XXY'&.>U>_:IX-\,Z_=B
M^U+1[.\G9 !+*FXE>WX5Y=\7] O[3P[!X>\): T.ENYN;Q[=0L>1P >?Q_*@
M#"LO#OB34?"6EZ7X@\%W>JQ6(8VLL>H",;&Y&0#SCU]*]%^%?A[^PQJ&/#5S
MHBR[/EEO/.$G7D>F*X6Y\:Z[X2^"_P#96L6D]GK#G[):-)U:(C[X^@X_*N\^
M#7C#_A*?!<45Q+NO[#$$V3RP_A;\1_*@#T6BBB@ HHHH \Q^*/Q'UKP!=V;6
M^E6]U8W*D"5W8%7'4''M6QX*UB]^(/@F:[US38;:WO0T<<2$G?'C!)S[YQ6I
MXU\(VGC3P[)I5VVS+J\<H&2C ]1^&1^-;.GV,&F:?;V-J@2"",1HH[ #% 'C
M'PI^%L_A[QSJVH:C$3'82&&R9AP^[G>/^ D#\:9\:/AM<ZYXCTK5-*A)DO95
MM;G:.A_A<_AG\A7LFLPZE<:5/%I-U%:WS >5-*F]5Y&<COQFOGOXCS?$OPIK
M-IYGB:YN$U!L1&TRB!^FT+VH ]@UFXT3X>_#Z*UO+::32XHA:N(8]_48RP]"
M>_O7"_ ;Q%H8LI]!L;:Y^WO+)<2R>7\@3.%RV?3'%:?_  @WQ!U+PJVDZGXI
MLYX+F+$R7%L7<9YQN]JRO GPN\:^$[6XDL=9TZRGN&*R"2W\UMJD@<^AZXH
M]&U3P+IFJ^-M,\3SJ/M-BA79CAS_  D_3FN>^-3:!<>#9-/U>[2VNI 9;)V0
MG,B]L@=^GXUYEK^K?%#1_'D/AC_A()YKBZ=?(DC4!&5NX&. .?RKO?$WP^\4
M^(/!M]8Z[K%MJ=Q!&);$QP;'$B]<GOD<4 2?!1]%M?!3V.BW<5UJH3S[OY6
M$C#Y5)QT'3\ZY"P^*^LW'Q#^QQ^$[%=<F<6,DGF-D*&^G0<FO2_A/X._X0_P
M7!#/'MO[K]_<Y'()Z+^ _K5ZW\!:;;?$*X\7*!]IF@$?EXX5^A?ZD8% '5KG
M:-V-V.<4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY(4$^@K/3X&>&XW=TOM55WY9ENB"WUH ],\Z+_GHG_?0H\Z+_GHG_?0KS?\
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M*2T#_H)ZQ_X%F@#TCSHO^>B?]]"CSHO^>B?]]"O-_P#A26@?]!/6/_ LT?\
M"DM _P"@GK'_ (%F@#TCSHO^>B?]]"L/Q/X8T/Q=IXL]6C25%.48-AE/L:Y/
M_A26@?\ 03UC_P "S1_PI+0/^@GK'_@6: .C\)^"_#W@V&1-*B17D^_*[Y8_
MC5_Q!H.B^)]/-EJT,4\)Y&6P5/L>U<#JGP;T2STF\N8]3UC?#"[KF[.,@$UB
M?#_X8Z7XF\%V&K7VI:J+B<,7V73 <$B@#U/PWX6T#PG:M;Z/;Q0*YRS;LLWU
M-;GG1?\ /1/^^A7F_P#PI+0/^@GK'_@6:/\ A26@?]!/6/\ P+- 'I'G1?\
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M9?\ ?)KLJ* ..7X5^"$8,OARS# Y!VFNP551%11A5& /04M% !1110 4444
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MY\":1=Z#X*TO2[Y56YMXMD@4Y&<^M='10 4444 %%%% !1110 4444 %%%%
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M8*0GN,D\D>@KSNPLM1LM4L3X:T77]&U9KI?MMFV6L F?G(8\8],5T6C7NH^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
+ **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>image12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image12.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )5!G4# 2(  A$! Q$!_\0
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M(J>BBX$'DR_\_#?]\BCR9?\ GX;_ +Y%3T47 @\F7_GX;_OD4>3+_P _#?\
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M?^?AO^^14]%%P(/)E_Y^&_[Y%'DR_P#/PW_?(J>BBX$'DR_\_#?]\BCR9?\
MGX;_ +Y%3T47 K[+E>5E5_9ABECN,OY<BE)/0]#]*GJ.:)9DVGKV/I3 DHJ"
MWD9E9)/]8AP??WJ>D 4444 5[+FW#=W8M^M6*KV/_'G']#_.K%-@@HHHI %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %>['R(W<.*L5!=_ZI
M?]]?YU/3Z %5[/F$OW=B:L=J@L_^/2/Z4= )Z***0!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 57F^6ZA;URM6*@G_UL'^__2A 3TR5MD3M
MZ*33ZCN/^/:7_</\J &VJ[;:,>HR:FID7^IC_P!T4^@ HHHH **** "BBB@
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M8'CGICCBM<)2A4;C)%.3/H9OVBK-83,?#UYY6[;OWK@FHO\ AI/3O^@#=?\
M?Q:\ EN)6MEMY)&,:?<3/ S50@9QWKEE!QDXR5F@BVUJ?2%I^T9IES=1PMHM
MQ$';!=Y5P*U]#^.&G:]XKM=#MM,G_P!(F\I9RXQ]<5\M$C ('(-=E\*D?_A9
MFA,1P+E>:E4Y2=T&O->^A]DT444BPHHHH **** "BBB@ HHHH ***J?VGI^<
M?;K;/3'G+_C0!;HI%974,K!E/0@YI: "BBHKBXAM+>2XN)%CAC&YW8\ 4 2T
M53TW5;#6+7[5IUW%=09V^9$V1FKE#5MP"BBB@ HHHH ***SIM>TJ#5X])EOX
M$U"0 I;EOG8'V_"FDWL!HT444@"BBB@ HHHH **** "BBB@ J"?_ %L'^_\
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M<@BD M%4)=:TR#5(M,EOH$OI1F. M\S#V%7Z+, HHHH **** "BBB@ HHHH
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M5RFH4444 5W_ ./V+_=-6*KO_P ?L7^Z:L4P"BBBD!7L?^/./Z'^=6*KV/\
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M$,<CN>M=E&O["G[/E_KS)44E:)<N([=+*U\F4M-(")0>U=/\+0/^%EZ%@_\
M+R*XI.9-V<?6NW^%I'_"Q]!QR?M*CBL*7LU&7M+M] 2<=#[#HHHK V"BBB@
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M05R?&[IPHS]:ZGX5G_BZ&AE<@&Y&:UQ&']BUK<I:GV51117(:!1110 4444
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M=WL 0$=?>H^^:<,],T5RU'%I)*Q20PTY<;N:0TH!QFLTO> <^"?EX%,YZ5(
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MI'4$52T>'4XM7UI[XL;62X4V>6! 38,X';G- &S6=J_^HC_WJT:S=9&8(_\
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M4445J<H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.20:(;MYZY%*W [4A(.,<4JX!RW(]JS26Q0P#)YKZG_9\Q_PKJ7'_/\ 2?\
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M,VN3P&6UA1"K*%9W 9C^-8[S&27:1M7T%8*<ZT5*24=5TO?\K&\'5:VM^/\
M7XD042S  A QX)Z"I6\QW\EG!V=,'@UI:C-;26*$6NU\;5E' ./:J&G6LEW<
MK#$HRQY8]J<HO#5FL0[1>K_I%*I>'.]+%4_*Q!ZTA%=?K_A2STW38+J*]!8\
M2!NY]L5S%S8SVQ7>O#+N!'I7#2DL1'GHZK7UT\B</BJ5>/-!_P!(KB@\'BBE
M(*@$J<'H<=:>ATC_ # 3DCYB,4T\L<X%6)]/FMHHI)"N)5W* <\4G^B,L:@2
M*P'S$\Y-:.O.JE=W1FI1WCJ1*1C&,BD&%/;BKXT:^EM1<P0$VY1F+AAMX&3^
M/M6?C(R><U.G,XP:=NP1G&5[,4J7Z#WKL?A3\OQ+T(<'-RM<<'(X''M78?"K
M'_"S="Q_S\K0^7ENM^I2/LJBBBN<L**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H)_\
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MLM"_I!_TP*<_=-;U8.E?\?P^AK>KKH? >?B?C"BBBMCG"BBB@ HHHH ****
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M %_2?^@K7RUOQQ7U+^SX<_#J7_K^D_\ 05KDK2I2A[NY2N>KT445R#"BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%FF,061  ,FOH[X!_P#(@S\@_P"GR=/]U:^:O+%O:K$@!,@RS@]:^DOV?O\
MDGLPSG%_(/\ QU:P=&LL/[2I\+=EWT)QE6+Y:=O>W=N[U/5J***Y3A"BBB@
MHHHH ***I7>KZ;82+'>7]M;R/]U990I/YT 7:*165U#*05(R"#UI: "BBB@
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"N_\
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ML3M)YJ,1;'PV#B@PM(QV#('6MXT\2J7LTGS;)+==PC)*7,6+NX\_(0!D ^7
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M%@1?B;H(5MV;A2>.E<SUT9O<^R:***R&%%%% !1110 4444 %%%% 'E.C_\
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MS&&'4<W%7K36K^YN4BE\,:M:HQYFFDM2J_79,S?D#0!LT444 %%%% !1110
M4444 %%%% !1110 4444 %%%% $%W_JE_P!]?YU/4%W_ *I?]]?YU/3Z ':H
M+/\ X](_I4_:H+/_ (](_I1T GHHHI %%%% 'Q]\3VB7Q]KRK&'D:XY+'[O
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MBBB@ HHHH **** &3?ZB3_=/\J\O^ /_ "3J7_L(3?R6O4)O]1)_NG^5>7_
M'_DG4O\ V$)OY+0!ZG1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 5W_X_8O]TU8JN_\ Q^Q?[IJQ3 ****0%>Q_X\X_H?YU8
MJO8_\><?T/\ .K%#!!1110 5QOQ1T#4?$W@6[TS2H5FNY'0JC.%!P<GD\5V5
M>?\ Q,^)+_#V.Q=-+6^^U%A@S^7MQ_P$YIIV8'AS_!'QXT>/[(BR?6\BX_\
M'JC7X&^/0<'2H@#_ -/<7_Q5=HG[2DS _P#%+Q@^GVT__$4W_AI:XS@>%8__
M  ./_P ;KLK8BM.4:D[/^O(2BDCCI/@=X^;:!I,/'?[7%_\ %4S_ (49X_S_
M ,@F'_P+B_\ BJ[4_M*7(7)\*I_X''_XW3?^&EY_^A6C_P# X_\ QNL:TJCE
MS35F"1QG_"C/'_?28?\ P,B_^*I[_!#Q\R@#1H%QZ7D7_P 578?\-+S_ /0K
M1_\ @<?_ (W1_P -+S_]"M'_ .!Q_P#C=*-:<8N*Z[CL<='\#?'H<%M)AQ_U
M]Q?_ !52'X'^/?*(.FQ-GH#=Q<'_ +ZKK?\ AI>XS_R*T?\ X''_ .-T_P#X
M:3N0NX^%8\?]?Q_^-UO0K5HP<81NM;[]?G^9+2OJ<8GP/\>J"#I$)/K]KB_^
M*IA^!GCXDG^R8?\ P+B_^*KM/^&EY_\ H5H__ X__&Z3_AI>?_H5H_\ P./_
M ,;K"5:<HJ#V15CD8/@AX]C?YM)A^OVN+_XJF/\  OQZ&.W2H2.W^EQ?_%5V
M/_#2\_\ T*T?_@<?_C=/3]I28MAO"Z*/7[:?_B*V5:I5IQH66CT?KYWM]XK6
M=SC%^"'Q 48&E0$>]W%_\536^!OC]N3I4)/_ %]Q?_%5VC?M+3J2!X7C/_;\
M?_C=-_X:8G_Z%:/_ ,#C_P#&ZSG5JV]G)Z+H%EN<?_PI'XA;-G]E0X_Z^XO_
M (JI)?@?X[:%%728=PZ_Z7%_\576_P##2T^,_P#"+1_^!Q_^-T#]I:<C_D5H
M_P#P./\ \;K:&,K\LH/6ZMKT7D)Q6YR,7P0\>QCC2H<YYS=Q=/\ OJG#X*_$
M!&.S2(,>]W%_\576?\-+SYQ_PBT?_@<?_C='_#2\_P#T*T?_ (''_P"-U4,P
MQ-."C!V2#D39R$GP1\?. /[(A ';[9%_\549^!OC[MI,/_@7%_\ %5V7_#2]
MQ_T*L?\ X''_ .-T?\-+SY_Y%:/_ ,#C_P#&ZYZN(J59<TWJ4HV.0;X(^/W4
M*VDPG'_3W%_\55F#X*>.%E4MI,00#H+N+K_WU73?\-+S_P#0K1_^!Q_^-TY/
MVE)W./\ A%HQ_P!OQ_\ C==%/&XES7*]7;UT\P247>QR=U\$O'DK#R]*B"CL
M;N+_ .*J#_A1WC_H=*A_\"XO_BJ[-OVE9P>/"\9'K]N/_P ;I/\ AI:?&?\
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MO_C5)?\ _(W:1_USF_\ 0:W* (X4>*%$>5I648,C@ M[G  _(5)110 4444
M%%%% !1110 4444 %%%% !1110 4444 %03_ .M@_P!_^E3U!/\ ZV#_ '_Z
M4(">H[C_ (]I?]P_RJ2H[C_CVE_W#_*@!8O]3'_NBGTR+_4Q_P"Z*?0 4444
M %5;VT%W&J;]F#G.,U:K.U-F79M)'':HJ-*.I=._,K$']AC&/M/_ (Y_]>H_
M[ &[/VOZ_N__ *]4Q/+YV&=CGT/2E/GJQ9)3]#S7.IP['=:JOM?@7_[#7&/M
M'_CG_P!>G#1@/^7C_P <_P#KU3$LFT99OSH\V0C[[?G4\U._P_B1^\_F+G]C
M#&/M'_CG_P!>@Z./^?C_ ,<_^O5)99,\NWYTQY9/.3$C8QZT<T/Y02J/[7X&
MA_8P_P"?@?\ ?'_UZ#HP/_+Q_P".?_7JEYLF?O-^=)YDG.6;\Z.>'\H6J?S%
ML:$,'-UG/^Q_]>G_ -C#I]H_\<_^O5+S'R/G;\Z7S9,_?;\Z?M(/[(W[5_:_
M MG1LIM%S_XY_P#7H71%5<?:/_'/_KU3\Q\<.WYTAED_OM^='M(+[(?O?YOP
M+C:'N&/M6/\ @'_UZ/[$& /M/_CG_P!>J?FR<?.WYU%+-.A#+(^T')&:.>'8
M:55Z<WX&D-% '_'Q_P".?_7I!H8!_P"/@?\ ?'_UZI&20X.]OSI/-D_OMCZT
M>T@OL@E5_F_ O_V(-V?M//\ N?\ UZ#HH(_X^?\ QS_Z]4?.DQ]]OSH\Z0?Q
MM^=+GA_**U7^;\"^NBJN/](_\<_^O37T0/\ \O./^ ?_ %ZH^=)S\[?G0)9.
MSM^='M(?RCM5WYOP-BUT]+6#RT<%NI;;U-5'T/?UNN=VXG9U_6J8DEW$^8W
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M_NG^5>7_  !_Y)U+_P!A";^2T >IT444 %%%% !1110 4444 %%%% !1110
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MHH **** "BBB@ HHHH **** "BBB@""[_P!4O^^O\ZGJ"[_U2_[Z_P ZGI]
M#M4%G_QZ1_2I^U06?_'I']*.@$]%%<9+\0HUUB^TRW\/ZQ=3V;[9?)@!'/0]
M>A]:0'9T5R">.+EG5?\ A$M?7)QDVPP/UKKE.5!P1D9P: /C'XFL5^)NO$?\
M_/\ [**Y)W+GGL*Z_P"):;_B=KW./])_]E%<H\:!3@G<*[Z=&O.A=/W?7<EM
M7(T;:<TYI25VC@5'UJ7R3C!.#CI2H2Q$H.%/8';=D5/$3D XZTSH:GR#@A^
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M+P9Z7_\ WX_^O7RM10!]+77QT\)3:]87BB]\J!) ^8>?F'%:?_#07@STO_\
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M)?EY%Q5GH1P_.0K$G'0'M22 #M@]Q3!UZXH).<D\UR^VA['V?+KW-;:CA&S
M'/7I78?"L$?$_0AC&+D<5R0=?+Y^\#78?"Q2?B;H3=<W(JZM.ER+V>K$F[ZG
MV11117"6%%%% '.>.TTR3P??)J\LL-F0-TL2DLAR,$ >]<-HGPXN7OH[K4/&
M#WUA)*EP8 H4RLH 7<?8 5WOC"VT;4/#]Q8:W>+;6<P^=O,"' KQFVMO \7B
M"SL?#KZ[JMTDJG$$S>5&,]23P10!]"    = .*6FI_JUXQP*=0 4444 >4Z/
M_P G,>(?^P(G\X*]6KRG1_\ DYCQ#_V!$_G!7JU !7A'[2G_ "#M#_ZZR?RK
MW>O"/VE/^0=H?_763^5 'SO1110 4444 %>G_ 3_ )*=#_UZR_TKS"O3_@)_
MR4Z'_KUE_I0!]84444 %%%% !1110 4444 %%%% !1110 4444 %03_ZV#_?
M_I4]03_ZV#_?_I0@)ZCN/^/:7_</\JDJ.X_X]I?]P_RH 6+_ %,?^Z*?3(O]
M3'_NBGT <?K^E^&K+Q!#K^IW-E:R;"DXG52LR]LY[CUJ2PU7P)J=P(+*71)Y
M3T1(TR?TK$O9M-T?QYJ=WXGM&E@N$C-C<R0F2.-0,,O<*<\_C4/B+5O".M:1
M/9:191WFHR+MMA:6V&5_X3N &,4 >EHBQHJ(H5%&%51@ 50U3^#Z5-I45Q!I
M%G#=OON4@196]6"C/ZU#JG.SZ5E6^!FE+XT9E&>.M)S4<PVH6'6N%'<E=V),
M\?6@C%,@?S(P2*?P>*8-6=A >]&12#I]:3W[]Z5@'TE+W%!H ;GDT8]Z7'I2
M 4#%]J3//%&:.W6F*P8YSG\*3//-+W^E-(!H8T*.>]-P!TXI0,<#I1UI#%[T
MR>0Q)N49/I0&/1C\U+L&[)YIH>B>I7CNBP!*-CN/2K*2(T8<,,'WH9%88(Z5
M!):@1OY8^=N>33T*]R3[%@BD89(IL3,8E+CYL<_6G[@2,?C2L1JF(!S3&#%A
M@X'>G_Q8I&X.>M"'U':>9/[2B4<H&Y-=17/6/%[%[FNAKLH?"<>*=Y(X3XJ6
MEA<>'K::ZU-].N(;E&M9T3<PD/  '?K7(^"[3PQ!XYL=(BUF>ZO-+1]L;1[8
MY9CR[ ]S[5UOQ3TN^O-%LM0T_P"SM/IMRMP([APJ-CU)KCO 7A>[DUK0[J6Z
ML'2#S;V9X9 SO*Q^Z,=0*V.8]3\77%U:>$M4GLL_:$MW*$=0<5R?P_T_1IOA
MHMN^HF9;^-GNY&F^;>WWN>U=QK-_;Z7HUY?7:[K>&)G=<=0!TKY]TRUT/7/$
MMHNH^&=1T;3]6<FUDBN6$<I]U]Z /0O@[/*L.O:;%=R7>F6-\8K.9VW97'0'
MN*].K/T71-/\/Z;'I^F6ZP6\?15[GU/O6A0!Y#\=]*L+;P/-?PVL27=Q?P^;
M,%^9L*P&37J%G/#!I=F9I4C#1(!N;&3BJWB/PWIOBK2QIVJ1-);B02;0V/F&
M<?SIFL^%M,UZUL[:^1VCLY%DB"N1AATH \ZT*]MM*^-GC,:A/'!YUHDD9D;&
MY1UQGZBCX1VVJR?#'7'TF:.&[N]4N)+*64$H!A%!QZ95J[?Q+\/O#GBRXBN-
M5L1)/&NP2*Q5BOH<=:W=,TRST;3H=/L(%@M85VI&HX H \VDT;XN^4^[Q#HI
M7:<_N6_PI?V?\_\ "N),]?M\N?R2O4)O]1)_NG^5>7_ '_DG4O\ V$)OY+0!
MZG1110!X]XT^.)\)>*;O1?[%^T?9R/WGG;<Y&>F*YNX_:3N&A86^@(DG9GFR
M/Y5P?QG_ .2I:M]4_P#017 T >U_\-':Y_T";3_OHT?\-':Y_P! FT_[Z->*
M44 >VQ?M'ZP)5,NCVK1Y^8*Y!(K2_P"&E3_T+O\ Y,?_ %J\ HH ^R_AMX\_
MX3_1;K4/L/V3R+CR-F_=GY5;/ZUVE>,?LW?\B9JO_80/_HM*]GH **** "BB
MB@ HHHH **** "BBB@ HHHH KO\ \?L7^Z:L57?_ (_8O]TU8I@%%%%("O8_
M\><?T/\ .K%5['_CSC^A_G5BA@CD/%]E>IK.C:Y:V!U".P:19;52-Q#C&]0>
M,C'ZU&?'8F4Q1>'-7DE;CRVM\ ^V3Q5OQ?XJNO#'V)H=*>\BN)/+:02!%B;M
MDGUJL/$OBD@$>$'(/3_2EH N^"=(NM(T687D:PRW5U)<^0AR(0W1?\^M>4?M
M)_\ 'OH?^^_\J]JT:\OKZR\W4-/-C-N(\HN'X]<BO%?VDQ_H^AG_ &W_ )4T
M!\^YJ1Y-Z!<#BF %VP.]*T93GMWKIINM&G+D^%[B=F]1F>:,FBE%<Q0=:E,6
M%SSFH<XJ;S<QX/4UUX7V/O>T[:$ROT$$N.2O.,5'US3XT$C8W4UAM)%*JZTZ
M:G/8%9.PW\:53M<''2@<CFDSSFN>,G%J2*9+N R2W7H*BI<^U'UK2K6=1H2C
M82GA01DDBF4H)6IIN*E>6P.Y8M_DEVD\'BMBVAG5BC$!20H53VK&MOFF&3^=
M:(#6\UNL3ES(^2WI7;5Q"^J>SZ:V^?\ PQW9?'EJ<[7;K\OU&ZDXAN"I)+$Y
M-4X"'9RV!DU:NX<WZH6WMR2?6JL>/M;8!/H*[,)B+\LIR7+S6MZK?_(Y\9"7
MMY:#I+*0+N 8!N5SWIJ73+$L!R-I['K6D]H_V=999V('W4'O5-K5A<'*\$9Y
M[5FXTZC5:DK6DU?=6UUL:5*-2B^5=4OZ^\J-*Q$@;DL:AJ6YQYQ"XQ[5%7F5
MI7E9.Z6QS--/7<7M2HQ0Y%)TH-1&3C)2CN!(,R'FOKWX-#'PNT@>S_\ H9KY
M 5MIR/RKZ_\ @VY?X7:2QZD/_P"AFMJDX2I7?Q7_  %K<[RO#-?MO$GPCUF^
MUO1PVHZ'>R-));R$_N78YSQVS7N=>(:IX5M]4\8W'AT^.=4>ZN"\CVRJ&2-3
MSM-<H$'A[P=K7Q3$/B#Q5K0.G.=T5E:MQ]#Z5[E#$EM;QPH,)$@5?H!BO XO
M!&E^%_$4/AI/'.IV,\X#H@4*C$]L],U[Y!$8;:*)G+E$"ECU; ZT >7ZU\2K
M'4-4NM-T/P]_;&H6N5=Y@JHF.O)Y/X5;^&/]O:MO\0:B=/M[.="D5I:P[2A!
MZD]ZV==^&GAO77>=K5K2[?)^TVCF-\^^.M0^"/!VK^#YY;-M:-]HVT^1#(F'
MC;/K0!VU%%% !535/^01>?\ 7!__ $$U;JIJG_((O/\ K@__ *": .$^!G_)
M*=-_ZZ3?^C&KT:O.?@9_R2G3?^NDW_HQJ]&H *^-/BU_R5/7_P#KNO\ Z M?
M9=?&GQ:_Y*GK_P#UW7_T!: .+HHHH **** "OJ+]GC_D0+C_ *_&_D*^7:^H
MOV>/^1 N/^OQOY"@#UVBBB@ HHHH **** "BBB@ HHHH **** "BBB@""[_U
M2_[Z_P ZGJ"[_P!4O^^O\ZGI] #M4%G_ ,>D?TJ?M4%G_P >D?THZ 3UP$_B
MKQ@WBJ\T6TT33<Q#S(&GN&4S1_WAQCZUW],,49E64HID4$!L<@&D!R":A\02
MZA]#T8+GDB\;./RKL5SM&X8..<5C:/JMU?ZSK=I/!Y<5E.D<+X(W@H&)_.MJ
M@#XN^)__ "4S7O\ KY_]E%<EWXKK?BA_R4O7O^OG_P!E%<K$0I)/7MFMJ45.
M2BW9">@S!I*ED8$ <9]JBHK4U"?*G<$PJ[IEVMI=98L$=2C%3R,]ZITE9"E%
M2BXLZB=8YM+ECOV D11]EFS]X>GTK#N--NK:-))(_P!W(,JP.0:JL[L &8D+
MP 3TJU::@]N"CH)HB"/+<\ ^M;N:J5>:IHO+]/F80I3I+W7?R_R*E%!I*Q9T
MBCUH)SU.:2I!'E=V16E.$YIQ@)V0RDIP4E6;TI,5+A))-K<!X<8]ZFAR(F.>
MO057V.5W!3M]<5)'R.>179AJLI329,DK 6!EZUJ:A:Q1VD+*06*9(]#67'#E
MQGOT%:4EV]RDT$D:AN,$#I6L:=6=6+G"]V].MVM#&I?F3CT#3KD0I&]POF6Z
MMRHHO;R&\FE\FW$49Z;NM4?+VQ\$D9Z41-@!6QG/.:[XJ;G"-3W5RVWT=^XO
M91YN=;CHIB+1X"^(W;<R^XJH>O%:%[:+#:03*1^\R<>E9_>O(Q?)&2IQMIU7
M4UIM-.2)8'B1B98]XQP,XJ,\_A24<UR6-+:W%'7K7;?"AU_X63H8.<_:1BN(
M[UV7PIQ_PLW0O^OE:UI594[M== :N?9E(64=6 ^II:\Y^*O@S4_$.G+J&C:A
M=0WUJAQ!%(564=Q]:P&>B>8G]]?SI00>A!^E>/Z-\)TU#2+6ZN]?UVTN)4!D
M@>?E6[CK7H?A3PRGA73'LDO[J\#.7\RY;<P]J ,#X@?#C_A,[FUOH=1:VNK1
M<1QNF^)^<_,*Y31+#Q;X0\:?VAJ6A07=M/"EIYFF@*J@'[Q6O5M?UJV\/:+<
M:G=!C%"N2JC)8] !7':;\3S<6[3W^B75FBWR6C!B"4W*"K'VYH ]"!RH.,9%
M+2 @J".A%+0 4444 >4Z/_R<QXA_[ B?S@KU:O*='_Y.8\0_]@1/YP5ZM0 5
MX1^TI_R#M#_ZZR?RKW>O"/VE/^0=H?\ UUD_E0!\[T444 %%%% !7I_P$_Y*
M=#_UZR_TKS"O3_@)_P E.A_Z]9?Z4 ?6%%%% !1110 4444 %%%% !1110 4
M444 %%%% !4$_P#K8/\ ?_I4]03_ .M@_P!_^E" GJ.X_P"/:7_</\JDJ.X_
MX]I?]P_RH 6+_4Q_[HI],B_U,?\ NBGT <AJOCO3++7)]%FTZ_N;F)0[+';%
MU*GN/6H8_'.GPG,7A[5D)[K8D5T\^DV5SJ=OJ,D/^E6X(CD!P<'J#ZBF0:Q#
M/KMUI*HPFMXDE9CT(8D#^5 %RWF%Q;13A&02(&"N,$9'0CUJGJG\%:-9NJ?\
MLZRK? S2E\:,M<Y.3GFDE!;:HZ$T_P#R*:&)9O;BN([D];B]. ,4QR0A*C\*
M>3S2'.*5P0#H/I2=^:=GO30:!CJ3K0>1^%-C;?&#TS3L*W4>.E)T(YIDBN<;
M6QZT;<;23R!@^]%AV'4G.?:EI,<T@#O2D8Z4O<4A8!2U.P"=AVI,4H;<N<8^
MM)_6DQB<>9[D4N<?C44N499>PX/TJ7(*Y'(/(IC:TN HS@Y-)WQTXS2KTHU%
M8.*,BCG/- ;#*V <'.#WI=0$Z4F>:<>26 QD]*;VH&BS8<WT1]ZZ*N=T_B]B
M^M=%79A_A./$_$C@/BQ875[H-D\5I+>VEO=+)=VD1PTT8Z@>M<)\/K2ZO_%.
MDM9:+=Z?!82SO--*I53&Q^6/'>NZ^*ZZPNCV%UH\3R36MTLS 2;%VCKN]JJ^
M$OB!KNOZM!:2>'H8;=CB:>*X#!/? K<YCL?%FF7&L^%=1TZUV^?<0E$W' R:
M\CG\(_%:XM]'@=='V:2P>VPPZ@8Y]:]UK@O%'Q(&AZ]_9-GIDMY)%L-U*#A(
M0YP,^] &KX-/C P7/_"7"R$NX>3]EZ8[YKJ*YSPIXKC\2_;XFM9+6ZL9S#-$
M_P"8(]B*Z.@ HHHH **** &3?ZB3_=/\J\O^ /\ R3J7_L(3?R6O4)O]1)_N
MG^5>7_ '_DG4O_80F_DM 'J=%%% 'Q]\9_\ DJ6K?5/_ $$5P-=]\9_^2I:M
M]4_]!%<#0 4444 %%%% 'TQ^S=_R)FJ_]A _^BTKV>O&/V;O^1,U7_L('_T6
ME>ST %%%% !1110 4444 %%%% !1110 4444 5W_ ./V+_=-6*KO_P ?L7^Z
M:L4P"BBBD!7L?^/./Z'^=6*KV/\ QYQ_0_SJQ0P1%<VT%Y T-S$DL3=4<9!K
M,U36#IFI:39+"&6]F,.<_< 4G^E9?C37M?T);6;1](^W6[;OM+@;C%C&#M')
M[]*R-*\4ZWKX5[)M#EE0_P"K=F61#_NMR* /0Z\$_:3_ ./?0_\ >?\ E7MF
MDMJ;V>=52!+C<>("2N.W6O%/VD\?9]#_ -]_Y4T"/GU6VG/K2M)E<#//7-,[
M4H4]0.*WA4J<O)'85E>XG6E/\J*4 D'%8E#.]./:@]>:./2BP  >HH^M/# #
MI3#6LU%)6=Q(3M2@$C..* "0>.E/W@)CFBG"+UF[ V$>S^*A0IDYZ5'G-+]*
MI5DE%<JT_$+!CDBG1Q-(V%IG:I(2P;"'K105.56*FG;RW!WMH.A4B4@=>E;\
MMR]O%;Q*J!U.,XYQ6/$5CD:0<E>U2%C+AV;:6Z"O1I8&4I<CBG%7>ZMV.JAB
MO80DX.TGI^HVZ^:Y&TD*3QS4D<:QNV"!N7J:9<Q$ )M;=W)JO(^]$4 _+P37
M54EAZ$IJ-I2T:>_JOU9S-SYN:2MN:<L\*6X WJ>,<\MBJDDLLBL,[1C)S43S
M@HBA2%!Y-022EF."2/>L76HX;FY)73Z+3=:^>]BZM>=:U]+#*.HI<\8QUIOI
MBO$:2(#ZTN*,<4H QUH2N[ )TXK[ ^#''PLTCZ/_ .AFOC_TYKZ_^#'_ "2O
M2/H__H9I/8#OJ\?^%OD6OCGQ=!J;1KK#7A93)PS1YXQGVQ7L%<CXJ^'.A>++
MA;N[26"]4;1<V[['Q[D=:D1R/QS%A+H^G11")M::\C%L%_U@Y_/%>JV(D73[
M99O]:(E#_P"]@9KQKX8^'M$_X3G6X6M9;BYTB;9#<7,ID/UP>AKVR@#S#XG>
M,=6T;5+72M-O[?3!+;/<-=3KG<5_@7WJUX'\97FN>)KK3GNX+ZU2RBG$L0YC
M<C#*Q]21FD^)MGJ%P8)3I^D:AI<:YDAOI!&P;U5C[5#\+/$OAS4&NM+T;0O[
M,N(1NG" ,C=OOCK0!Z9113)9HK>)I9I$CC7[SNP 'XF@!]5-4_Y!%Y_UP?\
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ML[0?6NAN=63<%;T*T6XFX@8I,GI13D4L>!G%914Y/E6K&::W5J]GY01T<+@
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M@N QZDC_ !KV;P5X3_X1#1WLFOY[V220R233'))- "^/!8MX.OEU&WN)[4J
MZVZDR#G@@#TZUY;X-T'PUJVK)*_C2ZNU699OL%TWELSJ,+N!ZXKU'QAK::?I
M<UM;:M96.I.FZ-KH\!<X)Q7G&E^'?"5_K5KJ6O>,+74=11P8TA98TW9XP!0!
M[6,  #I2TBXVC'3'%8?B_P 20^%?#MQJ,B^9,!LMX1R99#PJ@?6@#=HKR?X*
MZGK.HR>)AKEQ)+=PWVQD=LB,XY ]LUZ+)XCT**1HY-:TY)$)5E:Z0$$=B,T
M>>:/_P G,>(?^P(G\X*]6KR/P[=VU]^TCK\]I<17$+:*H$D3AU.&@SR.*]<H
M *\(_:4_Y!VA_P#763^5>[UX1^TI_P @[0_^NLG\J /G>BBB@ HHHH *]/\
M@)_R4Z'_ *]9?Z5YA7I_P$_Y*=#_ ->LO]* /K"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ J"?_ %L'^_\ TJ>H)_\ 6P?[_P#2A 3U'<?\>TO^X?Y5
M)4=Q_P >TO\ N'^5 "Q?ZF/_ '13Z9%_J8_]T4^@#A=;^(ZZ+XBETB32ILKM
MV3R.(XY,C/#'BI8=:U'[6^H0^$9#-.@5IEF4EU'3GTYK5\2ZSX:L;9H-=FM7
M## MW7S';/H@R:X2WT_7+JZ2;P59WVC6;-N+7[XB8>T1R1^E 'J\$CRV\<DD
M9C=E!9"?NGTJCJO\'TJ[;B9;:(7#*TP0"1E& 6QSBJ6J]8_I65;X&:4?C1E[
M\=CQWH3&S([FE894CU%-C_U8]JX3NZ"\],T9 X/>E[XQ44[%0,#)ST]*:U&E
M=V)#TQ28''K3N2!3<BD(4#(ZTR-MYR4VXP/KQUIV<'B@<52>E@'=*0GTII]:
M7M4W"P=*/>@=:6GN!'*Y1"<\]A38%8H"YR33I<L=H ((Y-/Z 4WL5?W;!VQ3
M212GBF9.<$=/>I!(5QNA9<9S5=7-NP1_N'H?2K(_6FRHLL95N]4F5&26CV''
M![=J3I5:"1D81MZXJU2:L$DXZ ,8H'3BFCKUIV.<TB0 H]J0L%4DXXI SF,2
ME"(V.%-4D&NY:L1_IT7L:Z&N?L,_;(_K705U4/A9QXCXD>9?&FXMH=!TQ+^Z
MDATZ2]0721DAI(^XKAK37O /A_Q]I-[X:U%K2S6-A>DEBCKC@8]:](^*]Q)I
M_AZ'4DDL,6LN]H+T K,/[H]ZX3PCK5MXZ\7VL":1I6E6=N!)+:RQ#S;CCMD=
M*W.<]MTO5+/6=.BO["42VTHRC@=:\1^+#:=:^+9O[/U>ZMM1N(H_MD$,!D4A
M3E2<=#7NMM;06<"P6T211+]U$& *\AUB[UVW^+&JGPOHL-\_V6(7?V@@#/8K
MF@#8^#S64FFZE-%/>W-_-.)+NXNHBA=L<8![8KTNN9\'W7B*ZAN3K^DVVGN&
M'EK P.X>]=-0 4444 %%%% #)O\ 42?[I_E7E_P!_P"2=2_]A";^2UZA-_J)
M/]T_RKR_X _\DZE_["$W\EH ]3HHHH ^/OC/_P E2U;ZI_Z"*X&N^^,__)4M
M6^J?^@BN!H **** "BBB@#Z8_9N_Y$S5?^P@?_1:5[/7C'[-W_(F:K_V$#_Z
M+2O9Z "BBB@ HHHH **** "BBB@ HHHH **** *[_P#'[%_NFK%5W_X_8O\
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M: W$RQ*0-QZFH<>U*I(Y!.:SU+@TI+FU1)/$(IB@;=COBOKOX,?\DLTCZ/\
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M."O5J "O"/VE/^0=H?\ UUD_E7N]>$?M*?\ (.T/_KK)_*@#YWHHHH ****
M"O3_ ("?\E.A_P"O67^E>85Z?\!/^2G0_P#7K+_2@#ZPHHHH **** "BBB@
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MBI@<G_PEOQD_Y^;7_OS#_A5>/Q#\78KR:[2>V$TP"N?*AY Z=J[2BBP')_\
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M?7-/":1J$5XMLJQR-'G@XK=KS+X2P7EG-KMGJ-Q:2WD$ZJWV2W2*/;MR"-@
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M4U3_ )!%Y_UP?_T$T <)\#/^24Z;_P!=)O\ T8U>C5YS\#/^24Z;_P!=)O\
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M\5=(TC6_$.HW*2$,\37TDD;*<]03@]*^FZ^;K3_DO^B?]<T_]FKZ1I %%%%
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MDD0*1P<GVII%Q5I:EC--!PV2H;CH13N, ^M)WXI:ID%BP_X_8OK715SUB/\
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M=%%% !1110 5]1?L\?\ (@7'_7XW\A7R[7U%^SQ_R(%Q_P!?C?R% 'KM%%%
M'S]\7/\ DN'AG_KRB_\ 1LM=%7._%S_DN'AG_KRB_P#1LM=%30!1113 *CG_
M ./>7_</\JDJ.?\ X]Y?]P_RH J?LZ?\>/B7_K\3^35[=7B/[.G_ !X^)?\
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M8%NH=I/0Y^Z?>I=/\<?#S3/#MMI3:U;7L,"@!77<S'UVXH ](B54A1%.550
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MP1:,&5KB3>YW-"3DX'K7MM>4Z/\ \G,>(?\ L")_."O5J "O"/VE/^0=H?\
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M5H VZ***H HHHH #TKD?@+_R477_ /KF_P#Z,-=<>E<C\!?^2BZ__P!<W_\
M1AI,#Z-HHHI %%%% %=_^/V+_=-6*KO_ ,?L7^Z:L4P"BBBD!7L?^/./Z'^=
M6*KV/_'G']#_ #JQ0P10U>)'L))MD)F@4R0O*H(C< X/M7+:'\1_#MWI4::E
MJ]K'>H-EPCG'S=\>QK2\2W_B.TD/]F:99W5D(BTKW$VW'J,>F*Y#3Y_$NIV
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M&/V;O^1,U7_L('_T6E>ST %>"_&W_DI?@S_?7_T:M>]5X+\;?^2E^#/]]?\
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M*** (+O_ %2_[Z_SJ>H+O_5+_OK_ #J>GT .U06?_'I']*G[5!9_\>D?THZ
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M-?-UI_R7_1/^N:?^S5](U(!1110 4444 %03_P"M@_W_ .E3U!/_ *V#_?\
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M# D;]M.)[5'&#RQZFI"1ZTV)[C>O6@'%)Y@SMP<TN >,U)5NX&CV%+CBDIB
MX'7I1VYIKC<%YQ@\TY^![4= #Z4N,4Q?O4_/?WH0V-/7-+N#.Q X)S2<\^E(
M!QZ47TL!-9$KJ4!QP3BNEKG;)<WT7LV:Z*NS#_"<>)=Y(****W.8**** "BB
MB@ HHHH **** &3?ZB3_ '3_ "KR_P" /_).I?\ L(3?R6O4)O\ 42?[I_E7
ME_P!_P"2=2_]A";^2T >IT444 ?'WQG_ .2I:M]4_P#017 UWWQG_P"2I:M]
M4_\ 017 T %%%% !1110!],?LW?\B9JO_80/_HM*]GKQC]F[_D3-5_["!_\
M1:5[/0 5X+\;?^2E^#/]]?\ T:M>]5X+\;?^2E^#/]]?_1JT ;=%%%4 4444
M !Z5R/P%_P"2BZ__ -<W_P#1AKKCTKD?@+_R477_ /KF_P#Z,-)@?1M%%%(
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MT2P\:_&7Q3#KD7VJ#3[-8[>)C\J9[@>O7\ZO_"7Q'%I/PMU2ZU*20V>C7\\
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MLT'_ #PC_P"^!0!\N^/O'.E^(_B7HVOV,%[]BL[9(I?,APV0\C' SZ,*U_\
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M?_SUO_\ O]_]:O6:* /FYOA/X?'Q@7PMONOL!L?M&?,^?=CU]*[C_AGKP?\
M\];_ /[_ '_UJZL^#)#\3E\7?;5\L6?V;[-Y?.?7=G^E==0!Y-_PSUX/_P">
MM_\ ]_O_ *U.C_9_\)Q-NCN-21O59\'^5>KT4 >7?\*)\-_\_P#JW_@4:/\
MA1/AO_G_ -6_\"C7J-% 'EC_  %\,2ILDO-4=3U#7)(IH^ 7A50 MUJ8 Z 7
M%>JT4 >5_P#"@_"__/YJG_@17$>-_A?HWA[Q%X3L+.ZOS#JNH+;3[YB2%+*.
M/0\FOHNN2\6^#I/$NN>&]12]6W&CWHNF0Q[O- *G .1C[O7F@#F/^%!^%_\
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MS_Y](/\ OV*BTO5]/UJT^UZ9>175ON*^9$VX9':EBU6PGU.;38KJ)[V!0\L
M;YD4]"10!YAX7M;=OC[XNC,$11;.,A2@P/\ 5]J]3^P6?_/I!_W[%9%S:^'/
M#FI77B*Z-M975THCFNI7V[P,8'/T%:FG:G8ZM:+=:?=PW4#' DB<,/TH ?\
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M25 !]L"NNKF+GP!X<U":PNK_ $U)KJRB2.*0NPVA>G .*Z8   #H* %HHHH
M**** "H)_P#6P?[_ /2IZ@G_ -;!_O\ ]*$!/4=Q_P >TO\ N'^525'<?\>T
MO^X?Y4 +%_J8_P#=%/ID7^IC_P!T4^@ HHHH **** "BBB@ HHHH **** "B
MFR;_ "VV8WX.W/K7DOAK3?#6NRO!XDO+P>*A,YGCN+V6"0'<=OE@,!MQC&*
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M%TP, ^Q- 'J8((R.114-K_QZ0_[@_E4U !1110 4444 %%%% !1110 4444
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M[4 <GI&L6FAZ5XZO;V!KB$:[*AA7K(62,!?QS61XBT^;3$T.\3PSHNC?\3&
M126KCSQN897Y5 .1UYKT=O!NCO8:M92Q22P:K<-<W"L_\9 &5(Z?=&*S4^&V
MC$P-=W>J7SV\B20->7C2>45.1M!X'3TS0!EW&B:?K/Q?G&HVT=U%%IB,L,RA
MD)WGDJ>"13=(TZ+3O&/BO2]*6.QMWLXY$CB4+&CD,"P Z?A7;)HEI'K\FLKY
MGVN2 0-\WR[0<]/6L?Q#I<NF6NM:[HT#SZO<6P3RS\RL%SC"^O)H \]T_1#K
MW@:VTFU\)QF\$FTZJZQ["RMS(&/S'/TKJM2A^R_%'PO$@7,>G7 PHP"0!VKD
M;<^%8=)$&F>)?$W]K;<I9VT\RXE/)7R@, 9[=*])T;0I+D:+K6L^;_;-I:F)
MN0!\W7</6@#G?!7AW1=?L-3U+6;"VU#4)[R5)GND$C1@' 49^Z /2N;BO;E/
M >H:6EW+_9J:S]BCG\PY$!;E0WIVKT/4? &DW^H37D=SJ5A)<<W"V-VT*3'U
M91P36DGA?1H_#W]A+8Q_V:5VF$]_<GKGWZT 58/!7AF&R:*VT33X?-@,)DBM
MU5RK#!^8#)_.O/\ ^V;W3O ]UX/61CJZW8TN XR?+8\-] F:[6U\-:7X2$FJ
MR:OK#6ULA_=W5Z\L4:^R^WXUSV@6EIXK^)4WBRT@D_LZV@$4$SH56:0]6 /H
M.,T -N?#.DV7Q!\+:<UA:RQ)ITRL)(E;>5V@$Y')J#Q/!=WWQ0L](BTO3[VS
MM=-\ZVL;R3RX2Q;!<+M(8@ #&.*[KQ!X4T_Q&]K-=/=6]U:,6@N;28Q2)GJ
M1V-1:IX,TO5[2SBNI+S[19C$%['<,MPGK^\'//>@#E]&\%:S%<>(8VBL]&L=
M4M!&EM82EDBE (+@8&W(ZXJ/3;6S\*WNEVNN^$=+@<S)!;:K91(09", MD;E
M)_'ZUUVF^$[73+6ZA74M6N'N5VM-<WKO(H_V#_#^%5;3P)IT%_;W=U?ZKJ+6
MS[X8[Z\:5$<=&"\ D>IS0!U-%%% !1110 4444 %%%% !1110 4444 %%%%
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M]\-ZC;6Z&2:6!E11W)%<1XE\,:X_AG0;S18<:W81+ R$C.QEVN.N..M>ET4
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M@MXHX88QM2.-0JJ/0 =!0!)1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5MULGJ!@U-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+_+_ '6I@6:*KA[GO$I_X%2^9<?\\5_[ZHL!/15?S9_^>2_]]4AGF'_+(?\
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M6BP%^BJ(OG/_ "R_6G"[D/\ RR'YT6 N455%Q,?^60_[ZIWG3_\ /(?]]46
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M-E6?+H\N@"MLHV59\NCRZ *VRC95GRZ/+H K;*-E6?+H\N@"MLHV59\NCRZ
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MB@!N*7%+10 E%+10 E+110 4444 %%%% !1110 4444 %%%% !1110 4444
M%)2T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4
M)12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4
M)12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )2T44 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>image13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image13.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0T!WL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK/N]:L[+/G2A<>]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<1RD<]C5?P9XMN;^^C1F<@F@#WX$$<4M06F6MT8]Q4] !1110 4444 %%%%
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MT"N.XKY"\(:M):ZC#$7(RU?5WA^83:3"V<Y6@#5HHHH **** "BBB@ HHHH
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M-<+K%@+.\5<=#0![-\.]3FF,*N['IU->W1G]TI]J\)^&P&Z'CTKW0'%N#[4
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MSFGT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #7^X?I7BOQ(1
M<3''K7M3_<;Z5XE\2-W[W\: /!?,GCOG\DD'=VKHK+5?$,<8$,\@7\:B\/V\
M$^J,)A_%7T%X7\&Z5=V"N8P>/2@#P]=5\4-_R\2?K5:[U7Q)Y166XD*_C7TT
M/ NE+TC'Y5DZ_P""M+ATZ201C('I0!\HW4UU)-^^8DY[U[)\-@VR+\*X#Q79
MV]M=L(AC#5Z!\-MVR*@#V#6;\V>F@AL?+7S7XTUJ\O-8:)93M)]:]]\8;_[+
M7;_=KYG\2&0:N=OWLT >A_#7P_:SS[[]5<'UKT+Q9X<T*WT*62"&,.%X(Q7B
MWAS_ (2&4@66[\*Z2]T[QI=VK12ARA'- 'GL.LSZ;J[K#(54/V-?2'@?5GU#
M0E#OEB*\%'PXUR6Y\QHCG.3Q7J6A6M_X<T<&8%=HH [#5/"RZB=T^&7WJO;>
M'?#UJ/*F@C+?A7F'B'XFWR,8K64[@<=:S;*[\5ZP!/$6.: .L^(?AO36M]UC
M&BG':O+M"FGTW78TWD -6]K:^)[>+_2MVW'>N7TAI9-=C,_7- 'U%X9U)KK3
M@&;/R5XC\382=5E;W->P>%$ T\;.NRO'/B6MQ_:DO]W- %+X=JYN\*>]>])X
M>L;K22\\09B.I%>"_#MREY^-?1<#DZ$2.N* /GWXBZ1:V,A\F,+SVJCX&TRV
MN]0B69 P)YK3^)+R-*V[UJI\/P_]IPX]: /H>P\(:1'9(Z6R@[?2O/?'UJEK
M93)$,* >*]<L=W]GIG^[7E/Q'W?9IOH: /GN.!YM1*KW:O>/!'@:.\L(Y9XM
MP(YXKQS1@AU/YO[]?5/@4#^PX]OI0!Y'\3_!]M9P@VT04@=A7EF@M-8ZN@!(
M(->__%-RL)SZ5X/8#S->4?[5 'T/X58ZGIQ6?YOD[UXK\1-"DAUB66-2%!]*
M]V\"6X6V4>JU7^(?ANUDTF:X"#?CTH \S^$=\;:7:S8YKV'Q+K"Q:"\@;G;7
MS+INJS:+J#A3M :NZU#Q;]L\/M&SY)7UH XC7=1?5M2V9+?/7LOPY\.QK;0S
MF/YN.<5YIX'T1=6OR[KGYLU])^'-+2RL40+C H W(5VQ*/04^@<"B@ HHHH
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MJ'VVV5\YXK7R&XH 2,DBGT@ %+0 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAX#&IZ/J>\V\G!]* /H+Q9KJV>GRKNP2M?+GB+4)]1U.94R<M7HWC#5]4O\
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MR-&2I/7%?3/AC2_L-NHVXXK+\-^!X-)5&VKD>U=NB!%  QB@!U5=0_X\I/\
M=JRQP*@G4RP,OJ* /F;XAEOM,WU-9/@4L+E,?WJ];\3^ _[4E<XZFJ7A[X=_
MV;*K8Z&@#U3P_P#\@N/Z5JU1TZ'[-9JGH*MJQ(H ?13 QSBGT %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !3616ZC-.HH B%O$IR$%2  =*6B@
MHQFBB@"-H(VZJ#2K$B?=4"GT4 %!&>M%% $;01MU4&HO(ASCRQ5FF$C- ")$
MB?=4"I*** &LBMU&:C^S0AMVP9J:D/2@!"BL,$4WR(_[HI5!!YI] "!5'04U
MHD;JH-/HH C6&->B@5)110 8S4;01MU45)10!$+>(=$%/,:D8QQ3J* (A;1
MY""I H48 I:* &LBMU&:9Y$6<[14M1MD'- &-K.KKI498)G [5Y1XE^*;+OM
MTC8'V%>O:CIR7R%67-<%J7PXANK@OY(Y]J /!=7U:]UVZ'R2,"WI7KOP[\(D
M0Q7,D>#P>176:%\.M/M6W3VX./:NWM+&VLD$<*!5% $L, CB55&,"IE7%.[4
MW>,XH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% &3?Z':7S;IH58^XJ&S\.6-K)N2W0'V%;9Z4T [J !(D1<*
M,"J=]IL%Y'MD0-]:O'I4.26H P8_"=@L@;[.F<^E;EO906Z )&%QZ5.H..:=
M0 PJ2:4H&&",TZB@#.N=&LKK)D@5C[BJ4/ABPBDW+;H/PK>I"<4 8LWARQE.
M3;H?PHM_#EA;MN6W0'Z5M!LTC XXH 9#!'"N$4 >U2U&&V\&I!TH 9+$LJ%6
M&0:P[KPO87#%C;(2?:M^B@#)L=#M+-<)"H_"M+:L8X&*DIK$8YH %;-.IJD8
MXIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %(5!ZBEI"V* (S;Q'J@IRQ(GW5 IP.:6@ ICPQO\
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M%,&KR2Y%1  +BF%MIHN:*-T78+N>"4,KD"NNT?6W; =S^-<7'*H&6IYOMO\
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MJ&SIA&Q:CDW-4NX"H8(_2I'4#K1?N;6U'[P:-PJ-!DU*8SB@IH;D-1D#BA5
M-/\ *4\]ZHD949C).>U3[1WI<@<4,DKD*.M*-AI\BH>]1;5'(H%<9+&M,5S%
MRO:G/(.]5RVXX'2BPF=7X=U^2WE +=_6O8M!UQ+BV4%N37SGO: @I75:#XEE
MMV52QX]Z+&$D?00DW@$'K4B+)G/:N#TOQ6KJN]ZZNQU^VD #2"H,VEU-U!D<
MTR01@<=:=#>V<B\2"HYY[4<[Q4BT*[L^>*9O&,M3'U&T7[T@JE-JEF3CS14L
M=BXTZ]C43'/(JB+^TSQ(/SJ_;W%K(!AQ4L30T#/WJ>L8!R*MB.%Q\I%-,1'
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M'%>-^+=>\V5XP_6H;-H(Y76=4:[N'&[O6'(HVYW43%O-9B>IJI(S9ZTMSJC
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M6I$C)H3$.CR*MQS;1BJ[8"TU7Q1=@:,)W/FMRT^[7.VI)>NBM/N50%JBBB@
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MA5)HZX(@7=VIYSCFGA0.E(Q%,T8D4/F'FG/:;>0*?"X0\TZ6?(P*6^YF[%8
MC@4AD .T]:4 L3BJ<I*S<]:5C-LOI'NI3&V<9ID#MMJ&2642\=* 3N6A;$TP
MVYS@"A;A^*W]&A@GE7S.]!K$P1;O'R0:=DYQBO4O[#T]X <#.*Y+5]*B@E8Q
M#BDF:(YSR2W2EVE1MJ4[U; IK9QD]:3=P<>I7>/'6F8Q4A)/6H7!S3)M<:S9
M^[2_-M]Z;M8'BIU V<]:39+B0!V4\FK$<Q]:@D0FD4,M(7+<N-,1T-/6X&WG
MK5%B6'%1$L#18GE-/SCZU(MRX_BK,C9^].W/GVIJPDKFRE])V:M"WU!&PK<F
MN5,[#I4T,YSD'FBP26AV\3 X*'%:MCJT]M(!O.!7!1:C/&1SQ6S9WPD W&G8
MR<=#UK2-:%R &;-=$BK(NY:\=M=0DA93$:[?1]<9HU1F^:I:,FCIY%9*A(<<
MYXI\;-<*#3VB<#GI2,VF5RS-T-1[CGWJ1E*]*BS\WO31+18C)[U9"Y&>U5X?
M]JK /'M5HEC&]JB;-3-[5$:K4:&KN[U(I.<4VG*ISFFF,G"Y'%-*_G3@<4UB
M:=Q#>GWJ #GVIC9[TH)%4WH!,"13&?/'>FE_2E7!^M"T <H/>HY<CFI2<"JD
MSL?I1<#2TTECQ7019V#-<WI;$&NCB.4%,"2BBB@!C@GI3%CYR:FHH 8QVK6;
M-(=QYXJ_,0 :RI,^8<]*:8#2-YXI_08J,MC[M.&30VK"9(O'6IA42J>].7<3
MBLN8%8<V>U1D5*RL#4%]((+<MWQ47-8HPM;UE=.1@6P<5Y7K?BZ:ZE>))3CZ
MU=\<:I(\Q4-7GRQR--O:LVSIC$O/)+.VYSFI86^;%)"N14IC"\CK4^9LDD6E
M7Y:B*/NZ\4L3L:6638N357N5838,<U4F?;]VFO<EN%-5I&8BC8I1$9RWWC35
M3G-5WF"G!J>VW3-@4,I(DP_\-)M)ZUKQ6+>7DBLV[0H2%ZUFVQV("0O%,*EO
MI3%W$_-4XX6A,EHJR1D#BJ,EN6-:K#=43)QQ6L26C#E_=<55:0D]:NWXP>:S
MHPSR8K0YY(F2!I>14HLCV%:=A9L4SBK3P # '-/4A1U,^UA*#FM #(Q2)">]
M3(A!YJ6;I$6UL\5(L32<"IA$6/ J[;6_S#BI9ML4ETYV'(J:#2'#Y(XKH[:U
M&S)'-(ZM&>>E),+F68_(C(%4TD+RD5<O')SBLU)!')FF.Y=>--AW#FLQX07/
MI3[B\/8U36Y8OR:0KET0 1DXK-=PLA JX;@[" :H@;Y#0*YJ6D@\OFG,<FJJ
M'8N* [[O:AA8L'('%59-W8U)YG/-.^5QQUHN)Q&Q9V\U*AVG)J+E>*3YC2(:
M+OG<8J-R#TJJ=P&:02%C@4 6=H\L^M55C+R$'I4X+;,5!^\1LFA"L6%MMGS+
MVK=T35Y+68 O@ U@QW!/!Z5/)A%W)UJTS.2T/:-$\0QRP@.P)/O70I,DPRI%
M?/UCK4UO(HW5Z1X:UU[@JKM5IF$EH=X68=#Q2*^32P_O8]PIK)M/%:QL86L3
MAACFHG([U"78<=Z10['YNE6(1T9CD=*?$#G%2 8%*J\\5#&!XIR=>:"..:$Q
MGFI EP,9IA8_PTC$]J2/K0K 2>3O3+=:H3Q&,YK2W'&*J7 +#FG=@,@F.S&:
M;.IZBHXP1(/2KTRJT8V]: )M.?& :WDY45SUF"KC-=!']P4P'T444 ,D^X:Q
M;P'G-;4F=AK'NN^Z@#,V9:G,F1Q0V=W'2E(8CB@!!&"/>D$6T\T\$KUZT%B:
M:)D1L#BFJN34NTD4TC'2A@G8L$*8"IZUYKXYM/W9.*[XRL.*Y#Q<AEA.?2N6
MIN=,)'CTL95\57F7CBKM^K)<D=LU2E)QQ4HZHLB'3'>DV'-*H)-2@<<U18("
MM$C%A\M-.<^U,9\=*&%AXR.M*233 <CWIP!'WJ06&^6V<]J>,CI2^: *C,H/
MW:$/E)"2::%]:9YH'UH$N:8T3Y*CBHY"SC@T#)ZT%L=*:T'L4W4[L&FLN.M6
MF QGO55V]:HEE5XVW9'2G(6SUIV23[4V3*_=I,DV].U,6;!L\BNDC\=E8]AD
M[8ZUYYN9OE/6K$%H7.34CN=%<ZPUY<&3=P:C>X=Q\IJG%:LJ\"K,2%>M(I:B
M 2,>34RH5'S5)OC5?>H69I/NU+1:1'(O.141DVGBK/EMCFH'B!/%%A-EBU_>
M,*W;>-43D5C6NV,@FM5;A2,9K17);LB*91YA..*B8C'%3O\ -3!'DU1FV9\H
MR:C78O#"M.:!1'GO6'=,5-)HF4B9[97^8#BH6@"?=J!;F4< \58CD+_>H21*
M9"0<XI=A[U9**1QUIJ1L3S2*3(5@RV3TJ<1J!P*F\O"YJNY.>*=DRKC]BD]*
MD4!>M5]^![TUI3WI,$VR]@$4WS#&?E.*J"9L4QG=CQ20,W+:_N(R,.:ZK1M?
MDC=0[]ZX6WD(QNJ_'/M==IILRDCW73-56>W4%LYJW(=W*UYGH.J2 HI;BO0M
M/E,\8.:JY@XDX)J0-@<TV0;:C7)J&18&8@Y[4Y92>AI?+)%1F)ATJ1%A9,_6
MGY/>JPR*D#^M"8F2%R*<KYZ5 V32*Q%7&06+9;BA6]:AW9'% ;'6M+B6A([T
MBOZ5 [FD#^E+F&2LV[BHF3'6D#\TK/ZTP&!.:&4]J 3G)Z4UW/:FT*Y&^[&*
M:@/>I0C-3MNP?-0AEFU.UA70V392N8@8F2NET_[E4(O4444P"BBB@ HHHH *
M*** "BBB@ HHHH :_2L34$=\J!P:V93@51=QNY% '.Q:8R2[\=:UX856/YNM
M6GD55X -5\%SGI0!'RC<4N]C4K1DCD4BKM% "1L^:M*35<OLZ"IX7W\T 3@,
MW44]4(XI\9XZ5+B@!BKBGT44 %(1FEHH :$ -*>E+10!7=2U2(H5<&B1UC&2
M<5SVK^(X[)&PPR*!I&X_ECJ:H76J6UJA^< BO-+_ .(CJ[*M<AJ?C6>X<\MS
M63>IM&D>@^(_%0V,J/\ K7FFI:K+<RGDX-9DFK2W9^8FHO.P>:S;NS6-,)L]
M:HRR=JN2SC;Q6>XWOFDBTK$>W)R::S%>!5@KQ4?E%CP*I&T2H9&SQ3<DG)JZ
MUJ0,XJ"12O:J0W)C<\4FTDTQ6)-3"0 8H,V21C:.*S+@DW%:<<GI69<G]_FG
M8@N09(HD4YZ4MFX/!I]RV <"D"0R-0QJY%=/:?,G45CI.\;=#5])!(F34[&B
M-=/%EX!MYQ44FM37+8?O67N53VI-P+<5+9=[&HA5N:BG7CY>M5TD*BIH&,LP
M!Z5*#G*@5\\BC^+!K?FLT$>>.E8=PFV3 JKC;&28'2D7IFD;(IZKE<T>H=!,
MYJ,Y)Q4G--SSBJ2N"$5<4,G>GXI#Q0D(A+$=J/,.,4KG/:HR"11H@L-8D]*?
M$2IR:9RO:G$\47&T63-GO4L=S(G*UF@G-7(WPF*+F31M6.JL#AS72Z?J15PR
MFO/RYW#%;NGW>U ">:1BXGJVF>)A& )&Q6]%XAAF&-XKQ>>\DQE21447B":!
ML;FXI,7*>\1W,,W1@:F%JK?,*\?TWQE)&P#$UWNE>*XY8E+,,T(B4+'2&)EZ
MBF;V!Q20:I%=#[PJ?:K#(-4O,S:(PYI2I(S3@NVG XIW,R-4/>IE6FEP:/-[
M8IK48YACI49;%*S8J(GG-,FP_ENM,)/2GJU(Q]J:=P&@$U*$P,U#YNPU()LB
MM!B,2>M02;L=.*G+9--D/R=*&!9TP'/%=)#]P5SFEM@UTD1R@I+<!]%%%, I
MDC%5R*?5>:3 H K32DU4.YCR.*E=\FG*<C&*EL95=<'BGHV*67Y3Q3-I W4K
MBM<F+-GBITR!DU#"<]15@NI7!XK-C2&O)\I/I7(^)]9\BU95;D5N:EJ$=I"_
MSCI7COB37&GN)$W<9J&=$(W.;UO4'NIR6]:HP2ASM--N096)J*W1EDZ&I:N=
M*5D:Z#8.*CEF(%2Q?<JK<(>HI#3)8)SCFH;F=F7%,C!Q2.=W&*K8T171R#4C
MME>*8R8Z4W?MI;EE.:-V;)%7M/E\EP6X%*O[T9Q4<T3XX&*=@-QM64+M4U49
MUF;.>M8@WHV,FKD<A0 T<H7+,MN<9453#2;]K# KI=+@6Z@+-Z5GZK D0.W%
M-1L)LRWD*G"TTD[<TV,YZT.V*:5C.3,C4&RQS69'(5DK6O(C*2<5E-&4;D52
M9@Y'3Z5/(T6 *MO'*3G;5'1+A50 UT\/ER+GBJ&M687SKU%6;6)YWP15VZ@3
M.>!3+*X2*;MQ4LVBC7M=)'EY(J=+.-'XJ-M96./:,=*S1K!\XFI:*.F01QQ'
M)K!U*_5-P!JK/J[$8S6-=RO.#UI Q\M^7/%9]S.RC(I "AP:<Z>8O%*X[-F<
M;J1J6.60MR*O)9 C)%2BV'3%%RN4@1F*T^+ALU,T6Q>!5-IC&W2BX<MS0&">
M35F-8R.36)]K8GO4L5V[''-)E*)9NR%?"]*CAD8-Q3MADY--"F(Y I":+/+'
MFI0.*@5R1DBG"<YP10[&36HK[NF.*A V-FIFF&*@WY;B@EHL)(#UI96RM1K$
M2N::S'H::(YB/+*W%6/,=EQ4*]>E3;@!57 @.0V[O71^'=5:WG&3WK!8;AFG
M6S&-\T[D2BCWC1-<22 !FK<\])!E#DUX19^(9;4A03BNTT'Q7YC@.WYU49&+
M@=^RG.<4Y)!T-48=6AGC^^,U)&?-;@UKS(RY-2V6YXZ4N\KTIJC:,4O3FB]Q
M-"E\CFD5B3S2%<\T@/:G<EZ$X;M3NG(JOOP<5*K$46 E&<5$^6'-2[N*;][C
M% %$Y$F!5I"0!BHI1M:G1R\T :=I$&()K84845G62[E!K1'2A +1113 :_W:
MQ[^M>0X0UBWK$T 4P#BGI2*_&* V#0 CC)I8X\]:"?FS2^9Q0)H>0 ,5!+Q]
MVD:<]*:K$T^A-BNH9I,$50U^P#VY)':MM(ANW54U@[[<C':N:>YM!G@7B)1#
M>LH]:Q02U=!XK0_VBW'>L%?EJ%8[(AC IN3WJ0GO43'-6;I70A?M36'I3"3G
M%/5L5+"PJ_*,]Z9)(YXQ4I&1FA!N;I2N+89';RRC[IJ==.F'136WIZ# !45K
M^6BJ/E%*X)W.,.G2D_=-*+)TZK78^2C<[15:ZMP5X6G<T43D9"Z<8JNTC=JU
M;N [B-M9[0E>U4F5RE8SMTIH!<\U8%L6.<5<ALP<9HN2T4$@<]!5J'3WE(&V
MM5+=43M4UO.(&^Z#2;(:$MO"^]0Y6GSZ2+4=*V8M=6.'&T5EW^K?:3THN%BB
MB,7V@58>QFQD*:;;S['#8K:@U%'7# 4)C1STEFZC+"F1@IVK?O&B="P(K#:3
M#' S0.XT>=(^ O%/>TF49VFK-E=*)0& K;:2!H^J]*5@=SET1M^"*NK$0*6Y
MV)*6&*C%Z.E:(ADRE@<5*&(Z57CF,C8 K3MK3S%R:9FRA/(?+K&G0.>:Z"^A
M6)#S7.S/N;BF20F/'2F[BO2IEY&,4,@6HN/E&I,14GV@YYJ C'-,8DT#Y2_]
MHRN#4#R>E0@DC%)M*4KB<1Q?\ZC+$]:<%YS2E0:+@G8:KG\*D\S'2F[>,4P@
MK0F#98CE+' ZU;1F49-9D+[),U?\_P Q:8F:>GZQ)#.%SP*](\/^(3M4%J\>
M3(ES6_INI- ZX)ZTVT2T>YPS_:(PP[U(%*C)%<GX?UU9%12PKLDD6>/(/:LV
MS-Q*INBIP:8]YCI4-R,.16?(Y0XK-LEQ-$7)8U80DC-9<+\YK1BE&*FY/+<F
MWMTII)[4"0$XI_2K4A-6!21S0SYZTUCCFF_?K5,D:[FFJS=J78<U*J8[55R6
MB$EAR*0.Q/-6]@ZU&R#K0"$7+<&D*8-'F8XI?,)[5:8R9651UYJ.4AZA(;.:
M>JDC-43J%MN\WD<5U.G_ '*YN!OGQBNDT_[E,9>HHHI@%%%% !1110 4444
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M*K7 99,]J=S%O4OV:DGBK,B^HI-#3SGQ6O?6HCA9L4C1:G/N%':HBQ'2I(I
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M_N4[ 7J*** "BBB@ HHHH **** "BBB@ HHHH :YP*I2X+<U:F.%K+FE/F4
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MC6L?4;M@V*TWNE9,<5CWH!-5%D;D]F1)@EL5:N$X^]6/$6C.[/%6C<F08IM
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M?O02S/\ -W'%2QP/(:KLNTY%3P7#(>:6J)(;F-XVP#4*E@>M.O9G>3(JJTC
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M37/G]JA(\@[P* +\=JFW)--<B'[IJLEZ6'/%)YWF'!-,=RQ#>OYR\<9K>FU
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M"-P4&?2LG$SEH2]::5]J:K?-[58&"*AQ,FR$*#QBG8"\$5*%&:1EYJ>4ELC
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M.(5ZTC,J1PC;SUI5B&[FKFQ:/*!H*"&-<5,R*!Q4/*' IS/@4BNA&R*3S3&
M'6I3@KDU5=N<&@5A_F(.*0.<YCZU5(R]7K>+'2FF-'7>'-6^S;0[8->H:9J\
M=S&J[J\-0^6V[.,5T_A_6FBE +529C-'L29)R.E6"P*XK"TS5!/$.<UK1G=R
M*TCJ<KC8F&,4TL!UI^T8YJ-E!J[F9&9.>*#)QQ2;#GCI3O+%  I!Z]:E4#O4
M04 U(2*"EJ:-IG(QTK77[HK(LFZ8K77[M(&K"T444Q#7^[63=@&M=NE9EX !
MQ3 H*@I6QCFDW "F@ANM(!-W.!TH) Z4A'-*%!H$VAF>]2(P;K0T8VTV!.>:
MF1I!7'.PC7=VKB/&&O?9XB(V[>M=5K$X@M'.>@KQ+Q9JOFNRAL\UCN=<('.Z
MI=F[N2[')J@65*9YF[G/--(#]:E'2D2!U/-.W#M5?&#CM3B0O2FT#1-O7\:<
M']:K\'G/-*&R>:.@K%O@BFC&>*8K<8[4N0O2IN%AQQGWI0<=:;P1G/- .X\T
MP'@TX<]*;QBG)QTIH8\8'7K3@XIA (R>M(H!ZTA$OEAZ7[&>PI(9,2A>U;MN
ML;+U%%PM<Y]K;:>G-*D1[BMNYMX@"0>:SB0I--:!8B6W#-@U;CTKS1\HJG]H
M(D]JT[74O)'6AB:*DVDO"-X7FJ9$N<'M72#4(K@;7(YJO<QVRJ2&%(2W.?,Q
M'!J*7>WW:E:,/=8'3-:T6GC9G':C4NYSVSUZT](ESS5N[@6-SBJRXSS0NX$R
MI@<=*:^>U.WX7%,9O2F(1<?C3B >M- '6ER.]+4!O0^U.R.U'7BDVXIW$+M!
MII %!--Z]:-17&'K2;<]*=WI2=HXI"9$5 -2+C'-,/)S13$#8%*C$]*C;)X-
M30@ <4;#'@#/O3BP HQSFD*@T ,#9:I,5&%PU.8GM3:$(V!]:A<CO3GZ9[U6
M<DGFEL-H=_*D..U)NXQ3<CM31(' Z4 @]:0XH0 ]:9HAZ9W>U7(FYXJJ,5/'
M@=*SD-G5>'K@"Z49KU"RQ)&/I7CNC2^7= YKU+1;P.@R:AF4S;\H+R:>H!Z4
M_P"^F:6-=M)HPD/11FGF(&FI]ZK*KGK2M<RDRL%Q]*"N3Q5IHQBF*G/%:1CV
M)>HB1C''6ID3UIZ1@#-2 "MEH)C=N!36SVJ3=GBD8#'%:(0D&-_O71V'W*YR
M$ 25T>G_ '*N^@B]1112 **** "BBB@ HHHH **** "BBB@".5=PK)N(!YF<
MUK2MM%9=QEFSF@!GE@C%(4"\"FLYQBD#\8-)BL*(@3UJ"]D6"V8YZ"I@2.:Y
MGQ%?F*)QNQQ426AK")P/C'62P= U>=/,97R3FMGQ#=&>5QGO7/1Y'%9-'9!:
M$LLNU>*C5RW-/>' R32!,"HL;K0&;<,4SIQ2]>E,(P:=B):L=]WFD(W<TA!H
MYJB;#33>:DV[J0KBE83W'0L0:T8G&SK68IVU,KG'!JD26I0)!UJC(FTXJ<,3
MWJ*09[T6+7D1H=IZU+D$9S5;[AIP)/.:5BD29YI1R:CSNX%.7(XH>A1.!CO4
MBM@YJ 96I0N5S0B;DI<RC%+$KHX(S38!EJT41=M5<D:VI21)C)JC-,;CYB:F
MNE"BJ+-@9HOJ2TQNSGK2ABIQ4/F[CBG[LKBE<I$A<4AQC.:@R4-* 6.<TR["
ML-U*!@8IP7-!.!B@5^A#+55E'6K$BD54<G/6CIH)B4S<<XJ15W4A7!H6XA57
M'-.S[TG2CRR><T^I=P!HS2[<TQABBXF[$@;'>I01C.:J@&I "!G-#"Z+*\TQ
MASBFJ^:-_P V*$A7% Q2[L=Z.U1,ISG--L";.^HSP::&S2GD4C,,U(JC&<U!
MM(-2J#C.:0KC]N:-O:E4YIX%&J$D-5,4NSO3L8IP7C-!:T(]N:79Q4JKFF/Z
M46*(R-OO4?4T\_+UYIAZT@&LF:7;\N*<%S2$4[@,VXINWG.:<QQ3 I)S31+%
M(W4W94A%--!#N,)VTA&>:1N*;FFQ#@,U8LCMG%5P,U8M!^] J6Q,],\,W)5!
MS77QR[AG-<%X>)11S796@)(.:DREL=EH0W8KM;<8B%<=H";@,5V4 Q&!6T#-
MDM%%%6212=*S91EC6G(/E-9,SYD*T 1,N.E-QQ4GW1S2JN3F@!BIGK4IX%(R
MYZ4Y4+<5,AK<JW%HMQ"V[TKR_P 3Z-&CNX(KU"^<V\3<]J\N\2:AO=US7+-:
MG1$X*>W"L>:@, ;C-371+/P:A!*C-0M&=,6K$36FT9J*#B;!J\)0RX-4IU\D
MF3-;;HTN7Y641GGM7/SRL9R!1-J#,< TZU03/S4=26@2-G(ZUHV^G*<,33Q"
ML8I1<;#5K00^2-8!69<WA;*@59N)#+T-4C%N:J);(48^E2$\=*E6# Z4ABQR
M129#1!YAZ8H^S&;M4Z6_F,"*TX+8;0*+@HF?;V/EBK$D6U:T/*""H9$%.YHH
MF4R9J,*<UH-!NZ5#)#@4#L,0[1BACCFHLE3BI=IQFI%<%;-/,F1BHB*3.>*3
M+W'%L<4BCG-/6+BE*8H$V,(!YS2*V#4;D@]:!EJ=PN3EO>HFQZU$[%.*:H;.
M<TO4+BLH)ZU+;P@M4)4ENM78%]Z>P<QIVZJBXI+APBY!J')4=:K2,6XS2%S(
MIW$Y:2GPL7XJ<6/FC=3XK7#8HN FTA:KE3NK82W'EGD50DB\MR: 3*$EKO;=
MFEVE!BK8 <U(]L'3@TP*2IN&:<%P>M*Z^4=M(JG.:0$Z)GFED3*XI$D XJ21
M@5H$1Q+M.*NE,+FL])<2 5K)@Q@TR64F.#4L3!N#4=QPU1*YS@4%(N.%'&:@
M90.<U$9"#4B9;O2&0N^*JNY-77MB3FH)(<"G8+#81E@#6G&@C4&LV,8-758A
M>32L-%AAO&:;#*T$F034?G4%Q)P*:(D>C>&=29D52:]%M)/W:M7D'AR<)(BY
M[UZK9/\ N%/M6L3DFC3+[N:%&ZH 234W:JU,6B4* ,4UE J/>0<4[)Q1820P
MKSG-*PS2%3G-1NV>*;&:MD<8K:7[HK"L#TK<3[HH07N.HHHI@(W(K,O%XK2;
ME:H3KZTT[ 9;)WIJKDU._P!ZFG':E)@,V]J7R]O-.4<TLA"BI39+6HWJ*%7:
M"30C@MBDNV"1$].*F3-Z:.-\6ZIY-M(F[M7A>J71GN'^;/->A^-;XF21 U>6
MO&WGL2>IK*YW00Y4XSFG!<TH4A<TB?,:#:V@8YQ1Y>>]!!SBE&4H$Q-F.]&W
M-&"><T=:0KV%R1Q2CCO3<CI3E&.M NA(!QFDS[T9IK#-"0(D5L\5,AVU4!QQ
M4R&C498(R,YIE."DKG--[T"'H,'-6EO#".#53S1C%-/- R^;PR=3569\]Z@+
M[:3F2A /!SWH.>QJ(Y7BI(^13'8=N9>0QI#*[\%C4;$AJ4?/TH%Y%JU"K(&)
MK2FU 0I@<\5A$LIX-(69NIS0.Q)<7'FN3ZU$JY[TICXS3.0>*'=DD^.,4!<4
MU7[4_M2N PKSG-&W/>@J1S3>M,3W'=**0'G%.(Q02-*XYII&ZGDX%1GYNE "
M=\4$;:3'.*&!%#"XG6E5<]:%XYIQ^;I0!&X'2GP#'>F..U$65I("T5&,T 9I
MF32@TQ >N*:QQ3B,U&>.M/0"-F[U"PW^U2%3G-,=<]*&#(2.U-/RU(5SQ3?+
MV]:$+9";>,YI*4J0,YI -U,M.R'JQ/%3*Q6HT7M5@1X%2QWZEJRFV2@UW>AZ
MA]T;J\\7Y#FMO2KLK(O/>L[$R5SVBRF\V%:M$;36#H%V)(D7-=#+P*3.>:'P
M!=W6K3 5EQ,?,ZU?&2.M-6.=DP7=Q4BQ 5"AR<5:3@<FM(H5QI0 =:;MSWIS
M@]<U'FM+#8A%,+8XIV-U'EX'-4B!T"_/G-='I_W*YR%3YE='I_W*L"]1110
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M=:K'<#[46&D+@#I1322>E*,XH$.Z]:7ITIBY[TO.:I#1(,GI2'WHY XICO\
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MH,^6,UM R9+1115B(Y0=IK%E!\XUM2YVFL28D3&@!2C'K2JK TJ2>M29&,T
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MJ3=QS3LC'O3#36P6(V&&S33\W2@M\W/2AB.U%ABY!&,4PC%+YB].],9\=:+
M.'O2L1VIN1C--SNZ50F!?G%.5L#FF9&<=Z=T%.Y+0K$#FFJV33-WS<]*=UZ5
M+1:+ ((Q0"5-1!^U3)SUJ&B]B_8/B4&O1O#T^5%>;VG$@KO/#SY"XJ+&,SO8
MWWQ 4X#;UIMJ 8A5D)ZU2B<DF1@D5/%-BCRN,XH\OTII$O74L"<-QBGAABJZ
MI@U84C'--(1&[8YJ%WSTJRZC&:K.!VJD%A;5_P!]BNOTS_5UR%J1YU=?I?\
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M,DX[4#&>>M,#8Z4\8/-+8!Q('6F]3[4XKNI0,4N@(4 #I3ABD J0*,>]#-$
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MUT%EX2FB3?/&0.O-.P7L<>(6#[B*>S**V]5AMK9616&X=JYY?F)S2Y0OJ/W
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M0?<7BRYYK)EOE1\$U%>W*VRG<<9KGQ-+=76%Y!-:1!Q/2?#CBZ8%:]'LE*P
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MSTH5B34ZD>E(L8,CM1SG-2DXZ"A1N/2D+4:K$]:D\S Q4R6Y;M3OL3>AI,9
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M8XN":V)3\IK%E;$QH G9\CFH@QS[4QF)HW';C% $^0:3(J%6(XI6^4;J '.
M>M1'BCS"]1DDG% D2J^.E2L=RU5SLIX?'- P/R]::TS=.U*Q\SGI3>O&* '(
MV:5N!Q2*-O2E)XH 12>II?-;.#TI%.:",T !8]J<.E,'RT_/%4 M(RDCD4*2
M>M/+Y&*8%=LKTIK8Q4CY]*A(.:EHD0J&0@UPOC*P+6C$+7>"LW6;,75L5([5
MA-&L)'SK<Q/#*1M[TT/Q[UWNL^&3N8JM<A<Z5);N3M-1L=49&:S-FIXMS<$4
MA&TX(JPF,4:&O-<:3L/%2^>0O%5YG^;BF9.,TAC9W+G-0IDM@TYWYYIJR9-
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M4Y0!1T 1\?C4EJ"6YJ/ 9JT+2 $TP+\  6I::J[13J "BBB@".;'EG-<YJ!
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M?PW%(!%?C%+C;SUIFTAL5(JD=:8" 9YJ0&F;"3D4_%4+T'#GBG_<J,#M3G!
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M!JU$FY3+K3/,&:N#2I&[&G?V0_H::0BLLH44R25<9!YJ[_9+^AIG]C/G.#5
M9WF[CS1), E:3:,Y[&HWT-R,8- #]'FRP^M=I:G,(KE]-TIK<C(-=5;KMB H
M EHHHH I7C$(<5R<TK"Z/UKLIX]ZD5A3:86F+8H JQ2[L9JV,%:0:>1VJ=;5
MB-M %1L \4N%V]:LM9,#2_8#C- %08I"1FK@L#1]@- BGFG< 5:-@:46!'-
M%3(/6C<#Q5S["33?L!S2 J' Z4!L<U<^P&D-@0*H"OD-0&YQ5A;$FG_83C%
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M44 %%%% !1110 4444 %,,:DY(I]% #/*3TH\E/[HI]% #/*3T%'E)Z"GT4
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MW8OI3J* &^6OI1Y:^E.HH ;L7THV+Z4ZB@!NQ?2C8OI3J* &[%]*78OI2T4
M-V+Z4;%]*=10 W8OI1L7TIU% #=B^E+M7TI:* &[%]*78OI2T4 -V+Z4;%]*
M=10 W8OI1L7TIU% #=B^E&Q?2G44 -V+Z4;%]*=10 WRU]*-B^E.HH ;L7TH
MV+Z4ZB@!NQ1VI=H]*6B@!NQ?2EV+Z4M% ";1Z4GEKZ4ZB@!OEKZ4>6OI3J*
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MA#ZT)H+%RBJ?V^(]#1]OBZ9IB+E%5!?1=S2?;XL_>H N455^W1>M'VZ+UI7
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MVU:_WQ0-:M3_ !BBX&E169_;EK_?%']MVO\ ?% &G169_;=K_>%']MVO]\4
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MT^7_ $@5ZAX<;= /I7;29RU%8Z"BBBN@Q"BBB@ HHHH **** "BBB@ HHHH
MH:CGRCBN$U3'FG/6N[U(XB-<'JF#/7)7W.N@4%SGFG&E1<TXK@UPL[UJ1A>>
M*D4 =>M.50*' SFD(..],/MTI1SUIP4=!0A;(:,4OR]^M+LQS3A&#R:+"V8
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M4& PJ#]: N.M2!>]# 'K1JA61&13".*E[X/2D< #BB+&UH+8)_I'%>G^&@1
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M]1CBE88Q@1TH"YY-3,H H"C&:.@$;8[T#&*&7-&.,4@$7&>*5F%(%Q1LR<T
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M\U(!3!Z"-C/%-IW&:"H[4$L48Q[TC>]*% YH^]UI"U&#K2M@=*?L&*8R@=*
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M%*RYI%&*91)A0,CK2<'K2D#;UH0 ]: L 7UZ4_ QQ3B!BHR=O I@T-9%S[T
M#O2G!YH"@CFA["0F<\4UE]*7'.*&.W@5*W$[$MECSA7H>@_ZFO/;(9F!KT+0
MO]37?0.2IL;=%%%=9SA1110 4444 %%%% !1110 4444 4-2;$1K@M4&Z?-=
MYJ'$9S7"ZH,SY'K7+6.J@BE&N:D/!Q35Y&!2$'->?+<]&.Q(%'7-/J, CO3@
MISFE<-V/5<FD88J3J,"HR.<4R0&:>HSS2HF*&4]C3N!(H![T.,=*@&XG@T_<
M1P:& !>:F"CK4<?RG)J4C<,BD C-GBF'D448SQ0 Q5P:?2>65Y)I0>: #FE
M)-/X88%'"C%,0JJ!0RCK4>30"<T[# TE2<-TIFW!Q1< I*4KBE"9&:38#:!U
MI0N:,8.*0"E<#BF_6I!\HYJM*Q+<4 /8;N]-!VG%)&3WJ0@&@!&; IA&X9S2
M.I%*H.,T (JYI,?-BG_>Z4T##4 !3 I0N!FGD@"F$$C(H 7.ZF,O.,TG(I#D
MT +Y87O3"G.:4*P/)IU $97(J,C!J9E)Z5#M.<46!"<T5( $ZTA7(S3 :!F@
MC%)T-.R",5(#:3%*5Q123#<4#-1L3G;4@&:0@ U0#57%*QXI:C93US0 W-(R
M%A2["_2I1A5P:IQN65E'EGDU* K"HI\]J;$&!R3Q6,J1#L$T1["H%+;MIK54
MJZU7DA!;BLW!D,K,-O.:5)L'&:>\#"HQ:N#NI*#,V[%M(Q*.32/;[>G-1#?V
MR*N0<CYJVC<?,9SR-&>E*)-XK3FMED' K/:S>-]W:M8HI2$$>: O.*<7"\4*
MP<X%.QJF.\L4FT ]:<T3#O3 I!ZT#8,N:A8=JG(-1'DXJ!6*_*FG.OR9J;R_
M6FRQD)FG RG:QM^&_O#GO7HUI_J!7FWAU27&/6O2+(8@%>A0."J6 ,4,<"EI
M#TKH>QBCDO$(+-7,;B'Q75^(< URC8+8%>96W/1H;$N>*9M^;.:097K0%.<Y
MK#J=).@]Z,@G%1D$]#2C- ="=5Q36XIJMCBAE.,T":&ELFGJQIB)DU:"#;0]
MA;$?:H905Y%6=E(T?'-+H,K19?K5@#M2+'W%/]J5Q#=N#BI!%@9S3,[3S4@)
M(HNQ,8PR>M YXH92:3/:F) 5P:D1<<FA%]:=*-J9H3+*]P<MQ21Y/%1EMS59
M3!7 ZTU<8[8/6@( <T@1L]:E\L@9)IDC2*80:?3LAABDQ,B [4OE8YS3B-M)
MSB@0PKDTI&1BD*DGBG 50AH&VEI2.*:%(- 6'>7NYII7M4@'%1OSTH0F-^[Q
M1CO31QUIR]>::!7>Q6F4DYJ%+HHV,U;G *\5ENA9SBJ-$7S=[AC--"9.ZL\(
MRN,FM*%QM&:!V'A1CKBDW9.*1U+'(-(%-2R7J3A0144D>WG- 8KQ2L>,U)&I
M!CFG+S2E=W-(%YQ0,:XYI$CYZT]A@TTMMH"Q(8QC.:@<4[S"><TTG?Q0);C0
MV.*=L'7--VXH8$#K0]"QQ4>M- W'%1X8GK3AD4(&.*8.*"N!29I&)%'4+=A0
MF1G-)C/%(&.*;NR>*-26@*G.*/L^.:D4@=:5I0!31-F4I(N<U&JY.*MN-_(J
MN6 --E6%V<4@7!J5&!7%-,9!S4,:0X(,9HZ\4 '%-P2:E6N)["YQQ2XV\TX+
MQ3'.VJ9*&N01UJ#&32E6=LYXI[+\M1UT*>Q >&Q75>%CB:N6V_-BNK\+Q?O1
M7527<YZIW\1RM25'",+4E>DMCC>Y#<C]R:XK6/D)KM+K_4FN(U@$EJY\1L;4
MD81;+9S4RMNJJ4.^I0<"O-EN>A!:%H/VI]4P3GK5A3@<U(.))[TH-,P2<U(!
M3)L'-)BI1C&*:RXIW&T.1>^:<5S3%4]<U(1FFMP$*_+BH=I!JQVQ2!,50=",
M6VX;LU&\)7O5K)IK#-("*-2*F[4FWB@#%-@)M^;.:?U%,P<T\4@ #FI N*9O
M'2G!L=:8F@*\9J.G,>]1YW4#2) <\4,N*:@.:L;>.:3!(I.*B\HR&IYUP2:=
M9NN[FJB0T6[2VX&15Q[9,=J='*A3 QFFE&SG-="5D25YM/&S<*Y^^C*/@'O7
M33S^7"<U@3_Z4_'K650:"%/W&<TZ%>>:DCC*Q[::5*GBL#1,<W% 7=3TB)&X
MFAE]*I V'3BE#;:;C%*"!UH,VQ2,C--S0:3K3L2KC2<G%)]WWIS8 IBMSS2L
M4!'&<TS/O4A4]1414FBS&*>>],+;:0@YQ2^6>]%@$QGG-*JY[TI0@4SFCH4M
M";9QUJ-EQ2[B1BFD&A ANWOF@KGO28.:"#0]RAQ7Y>M1$4[)/%,VD=31J/J,
M*<YI-N>]24Q@3TI7'U#/&*8PQ1[4TMCK1<JPFW'.:>J@]ZB.>M(-U(&BR5&,
M9IF0O&:B+,1BF[6SR:";$S+QG-0D<U*<JO-1??/%%Q.(\=,48YHQQ2BFF%AY
MBPF<TU5R?2G*#GD\4./2JN0..-N,U W!H(8\9H"E3S0(<%(&:=C<*<,8I"#V
MIL2(P,MBDD7%+SFFN#4K<<MB;3SB<5Z+H9S$/I7G5BG[\&O1-"_U(^E=]!''
M4-NBBBNLYPHHHH **** "BBB@ HHHH **** *&H_ZHYKA-4!,QQ7>:B,QFN#
MU7(G(%<M8Z\.4DS3_KUJ-2>U2@'J:\^1WIBJ#WI]1AB#S3P<]*0V*<G[M)\P
MZTX9[4[C'/6F)L17QUIQRQXZ5$>M*'(H$3 8%(Q&?>F!B>E-.<TV!(H.>:DR
M:C3=WH.[-(!7R>E*F:< 32'(H D&1]ZD*Y.1TJ(,Q/-2*3T[4 .Z_=IVWCFF
M_P"[3@W'/6@",J0:3:<9J3KUI#GMTJ@&C.>*DV\<]:B&<\5+NXYZTF @4YYI
M^!3 QSS2,3VZ4 .9?2HN<TN]J3G-(!XX^]4;*I-.;..:CP^?:@!ZIGI2,"*0
MLR]*3?D<]: &]/O48)/'2FL2>M*I(^E #BO'%1\YJ0L3TH"\9[T (./O4<]1
MTIK9[T?-M]J '$!NE,P<XH7/:@YW>] "D$=:-IQFG#I\U(S8''2@!E,8C/O0
MS$_=J+G- $BJ3UI=IS[4B/ZU)GB@"-DR.*B/!J5G]*3@CWH C))%,P<^U2$$
M4E)(!,GM0<XH^E**8D-4'O2$'//2GU&<D^U QV?2F$\TC CI3E&>M',+F&;<
M]:780*DZ=:;DY]J+M@B+Y\_+3MY YZT__=IAC)HL#3)8'!/S5=1$;Z5EX9:E
MAGD5N>E-HS:-%[9,<"JDAV=*M+.''!IDT6]<CK5*.AF[D,$I)P35PQJZ5D.)
M(C4MM=2;P&Z5:1-V+<V;'E15-4:-\&N@#+(O%49[8DD@4-&D9E;<2.:7;WJ)
MU=:8)F!P>E*QMS(GVYZ5&5 -.60=J1LGI6<D.]QIILV?+I0K=Z)58Q^U$$9R
M-7P[DN,>M>C66?(%>?>'4PPQ7H5I_J17H4&<-4L4C' I:1L8YKHEL8(Y/Q%E
MFXKE"#NKJO$1PW%<J2=]>=5W/2H;$JJ<<T -N]J17('-('.ZN<W)A3Q@\=ZC
M'/2I0N!D=:+#%"8ZTIX% )/6HVW&@3W)%(SQ3V;Y..M0*K]JD&<<T@&B1@>:
M=N)IK+DTX# J1:"C/:E/ZTW)[4#-(-Q=I/6E4$&I$!(YI2I%,3(V#'I1MX]Z
M4DCI1SBB["PJD@<U',[$8S0S$+54,S28/2@I$D<;-TJPL; 4Z$8'%/<G'%6M
M@!,]Z60L%IBMZU+C<.>E B!0S5*JTI4I]VHV9ATH%<E..],93U[5$'/\52;\
MCFI$(!3L<4#':ALXXJK%)#33.0>:> >],8'O31-AV[/2EQFH@&'2ERW:EU%R
MCL#I0R[1FHG8KUZU6>Y8G!Z52*BA9Y#G@U"J[CQ1AI&XJSY+(F<55B[%=HS2
M"-UY[4DDVU\&IT?>O-,+(C#L#UJP)D JI,K9^6H2DQZ"H;)=C1WJU)@]^E44
M$R]14GF2]ZEW%8M$'M3"K=J@\V3M3A,: L2X.,'K4;1MWI1*#UZT>=Z]* LQ
MGEMVI-I6I/,R>*<WS#B@=BLTF.M-#DGFDE7!I(\YYIA8F"G&128)X%3)TI&&
MWD4B2+&.M!'K0Q)%,!;/-.P"[3VI53)XI0>:<6 'R]:5]1; 0 ,=ZK.#GFIM
MV>M*1FF!" =OM5>;GIUJTP(X'2H&7TIC1%$2#@U=49'-4>0WO5N!F;K4-C6H
MI4YXZ4,O'%2MQ43-GI47U$T SBHW4]ZD!-*>1S5MD(K $-[5))RO%+L.:>4X
MXJ+ZEE/O[UU7A<E9N:YK9\]=/X<4^8,UU4D<U5'>1'*U)44/W!4M>E'X3C>Y
M!<_ZDUQ6L*037:W/^I-<=JP))S7/7-J.YSAZTTG/2IG7FH6&.E>=+<]*-K#D
MS4R ]ZACR35U$XYJ1@H/7M4E-R1TZ4F3VIV)9," />F'/>D )I2#WH$ 8BGY
M+=*BYIRY[4R=Q^3TIP)'6HN<T[GO3&D/YSGM2')Z4#/X4'_9IC8N>,=Z%![T
MS)SS4HSB@3&G.:"2>E!SFD)QTI#$YS3QGO4>>:>I/>F#!@U,Z4]F/X5$P8]*
M!DOF #WH$K=S480X]Z,$=:0"R!G%)#!)U%2)G//2K2NJCBJ3L0T4S+)$W)J[
M:WN1AC4,J+)]:B2(H:WYE8BQ9N=TN<=#55(#&<FIO,*BH9)MW2LINY5A&E&<
M"F\GK3"IZ]Z56(^]62+2) [#Z4I8GI30"?I3PA[51+8TYQ30#WJ7%)00T- -
M(P/:C+;J4Y[4=02(B&/%-"D=:G_G3&]Z+CL(">_2E;GI3<&FDGM1N UC^=(K
M>M.*Y%(%]:-@T%YZ]J3;NZ4N3T[4TMMZ4ABGT'6F'(ZT9/6D))ZT">@N#UIC
M9/2I%SWZ4R3(^[0AH;[=Z:0>])ALYIX/]Z@I,B*MG/:D(/:GLY_"HV?TI/8I
M:LC;/XU$21UJ;K2,G'-3L40[\=>E/653TJ!XI,].*8L;@TA%[@C-(7 ZTQ3\
MN.](R-WH*W%9LTBCTI C4]5;M5:C G(QWI5!'6@KB@'UI]"6+DTN":*D0$BA
M$M:#57-*RXZT[&#QUIK9[TS)C #FG$'M28;/M021TH8+<3KP.M&WCFF G-29
M)'-(;V)+$$7'/3->A:&1Y0QZ5YY9[C/^->A:$,0BO0H''5-NBBBNLYPHHHH
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M UB2>12=12LV: <\8JA,C\UHCQ4\5Z3P:88\TPP;>0:=R;)LO[4G'-,-KM/
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ME1L\T$ T* *!#V((J%F'I4S$8XJ%BM QBMSS4N1C-1*1GFG8)/'2@!&;TH#
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MZTJX;K3 1L=J0 4_9S3@@HO80@VX]Z8QSUI[*!2(@8\U6X6$1<GVJ<HN.*3
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MBF-%M%"+EMH3:?\ ZT5WVC_ZH5Y_8*1/7H&C',0KMH;G!B#7HHHKN.,****
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MUH#$G-.P%U7SUI&8U'%E^M2$X&*2 A<D=*;MXS4F*,'TH8$0!?K4@&!2XHI
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M<TCH35BN,=Z=N'>G^6O4FHW3M23,I"Y!Z4TX[=: N!2;<<BJ1 GUIZA3UI
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MG-+[4N*7;FF(8:;]VGD8INTCK0 G7FGJN:3RR>:<%-( ;Y:;FA@>E-"$')I
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M>U.*,:8'P>*F5\]: & 8ZT\..@HD!(JOM<-0!88$CBDW8'/6FACC%-.2>:
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M$FG 8Z5&&.?:GYSTI!<4@D<4S:PZTI?'UH63/6@!K;A2#<:F #=:8XV_=IW
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M(QR*<6QUHR"* N(K9XJ4,,=*B!&>*E&W% "*0#S02,YI5P#S33C/% #BW'%
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MY5]:KJV!4F\UQL]%,G4XZTK#/(JL7:E65AQ4@2T<YJ-GXXZTY&]:![DNUC0
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M@6Y*J8YIV:B,Q Z4WS"><4#L65 /6AEQTJNLQ]*E$_&"*!#E;%(QSS2%L<T
MYH"V@U22>:EWX&*3K0>F*!V!7P:"><TT#;SFG<&@+"ELBD )IVT'O3O,5>*
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M[(F>E*;9",8J>BERH7,R 6R 8Q0+5,]*GHHY4',R VJ$]*#:H1TJ>BCE079
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% #>].HHIL2"BBBD,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "FFBBA"8HI:**!A33110A,44M%% PIIZT44(3'4444#"BBB@ HHHH **
%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>image14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image14.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0R!WT# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 !Z5\X_%C5WLM:E )'S5]''I7R_P#&I/\ B<N?5Z .(;Q!/(,@MBM'2/&,
MVGW"L6(P:ET'PK-?Z0LRQYR?2LWQ#X>N-,7S&0A1[4 ?3'P[\2C7+$EGR5%=
MW7S+\&_$#0:@+9VP'8 <U],*P*!NV* '4C#(JC/JUO;MM=P#4MM?170S&V:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 56O+E+>%F9@,"K)X&:\S^(_B4:="
MT:/AB/6@#$\4>/\ ['/)&DG0XKE[#XERR7T4>\\L!7FM_?7>K7TA7+9:HK6P
MN[:_@=U(&\4 ?9/A^]^WZ9'-G.16K7)?#]V?P]%NZXKK: "BBB@#Q'XR:J]E
MD*2.:T?@UJ+:CH<SL22#7/?'1>I]ZU?@:NS09@.YH XGQ=K3Q>-&C#'B7%?0
M'@^8S^'+:0]Q7S+XT!_X3V3/_/8U]*^!O^16M?\ =H Z2BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *AN)T@3<[ 5-7GGQ/\0'1]/4HV&8''- ';6]XD_*,"/:K
M:'(KSOX7ZI+JNEI+*2<CO7HH&* %HHHH **** &J<YJA>:A%"X7>,U?;"HQ]
MJ\0USQ8X\6?8U<\2XQF@#V1Y=^GO(/[IKYM\:ZS/'XR55SC>/YU]$Z63/H:Y
MZLM>/^(_"3W?B@3>7D;L]* /7?#CF;0[9CU,8K8 P*S="A-OID,9&-J@5IT
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M?Q[;_B>QK_L59^".N-]O-BSD[1ZU5^/*;M<C?_8% '6? ;']D7.*]CP*\;^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/$MO>:;'&K#@4:AKFG0:D(I OF&O*/AC=3,61BV%6LCQIK4L'C.)1(0,@=:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ8!AS7G'B7Q*+[19H0<X0U#\1?$4TNIO9PL2VXC&:Y>VTR_;2[F696V[">:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 8GBF3R]&F/^R:^3;51=>.2I[R'^=?5_BT9T.;_=
M-?)FG/Y7CAF;M*?YT ?7OAV,1Z%:J.R"M%CC%9_AYM^A6K#N@J_C+\T <OX_
MU#^S_#LDF<9!%?*D<4FM^(64 MN<U]%_&65XO"C%?6O)?A'I"ZCK:R2+D!^:
M *VO>##8:/\ : F"%S6Q\&-;:+4FMF;@<5ZUXZT*'_A%[G:H^6,XXKY^\ RM
M8^+@@XRX% 'H/QP&;<-ZD5L? I\^')Q_M5C_ !J.;!/<"M;X#+_Q35P3_>-
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M<_\ "1R'U:@#V'XKR"/PWENAKA/@MSY[#^\U=E\8LGPNN/6N-^"A^69?]HT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA^$3J_@6W(KM)F BE4]=IKPGX9^-%TWPW%9L^"O/6NWT;QFNKZY]C#9W*>]
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M\?6!T[Q)% PP>*[#X8:U%IEIN?&=O>N/^(FJKJ_BY)UZ9 H ^AOAOA?"P/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKH;WPW:W5W]H= 6SGI6F+&/[+Y&/EQ0!\P^&-%N+'QFLGED*LE>H?$RRDO\
MP[#M4DA*[(>%+2*Y,ZH-V<]*T;O28;VT6*100!B@#S#X,:9)9Q[Y$*DK5GXP
M:=)>V+!$+5Z/I.C0:6,0J /I3M5TB'4H]LJ@_A0!YK\$+"2PTFZ21"N6[U%\
M4_"OVX+,B9/)KTS2-(ATI&2%0 3Z59O]-BOTVR &@#Y ;PO<B;'E-C/I7LOP
MO\/-8H960@E37H#^#;#(/EK^5:UEI4%@FV-0* /GWQO87-OKCO$C$%B>*Q+/
M0KG5KZ%9HFQN[U]%W_ABTOYO,D0$_2FP>$[.VE1T0 @^E '$ZOX>-AX0BBB3
MD#M7DOV2]VO'Y;8)-?4EWIL=S;^2XRHK%_X0RQW9\L=?2@#S'X9>%2+O[3+'
M@AL\U[M$GEQ*@["L_3=&@TY<1*!^%:= !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 1OR2OJ*\2^*/A/[5<&X6/) KW#'.:S-6TJ&_A8.H/'I0!\9(MSI=Y
M( K#!JZE]=WUW;H0Q&\5ZYK_ ($#W,S1Q=3Z57T;P*4N(6>+HP[4 =OI>G-=
M^ Q"Z\XZ?A7SSXDTJ?2=<9TC(&XFOKS3]/CATU8 /EQ7GOCGP9%=EI(XP6QZ
M4 ?/-Q?7=\B0[6/:O9_@UX<:W<W,B8++WK,TGP&1>1EXN,\\5[;X>T>'3+-!
M&H''I0!XY\<%D;*J"0"*V/@<'_X1Z?<",,:V_B)H!U4$A<G/I5WX<:*=)T::
M,K@EO2@#PGQC;R?\)Z[!3CSC7JFNZ8;_ .'$ VY*(35'Q'X4DN?$/VA8\_/G
MI7H]II:OX5%K(O\ !C% 'R+8FYL[\HJ-]_%7?%MI.+JW=D/*@UZO_P (*/[=
MW>5\F[/2M+QUX*6:&$P1\A!T% $GPKMVG\*W43#[R8KQCQKIL]EXIG98R%#\
M5]*?#W1SIVD&-UQN7GBN=\=>#8[R9IHXP68\\4 >'V3W.I1&*16V@4_PDGV3
MQI;A>QKTV#PFFFZ+),Z8;:>U>;>&%,WCI,= Y'ZT >[>.]+.I^%XG"Y(BKYQ
M47.C:A*%5AS7V"+%+O08XW&?DQ7D/BCP+YEX6BBZGTH \NTJ\N[W68,JQ^<?
MSKZ/\71E?A[@#GRQ_*N%\+^!Q#J"/)'T(/2O5/$EB;GPV;91GY0* /GSX912
M+XOR5./-KW;Q\"WABY '_+(UQ/@WPN]CKAF9,?/GI7I'B:T-WI$L0&<H10!\
MY_"&.2+QA*64@<_SKZEB_P!4OTKQSP9X6;3M7:8I@D^E>QI\L2Y]* %"XS7C
MWQ;\/&^MO-5,D9->QUF:MID.HVSI( >* /C:&:ZTR1HPK#%>@_"5Y[GQ?#(Z
MG&#UK>U_P(&OW,<7&?2NI^'OA8:9<K,R88'TH Y3XO\ AUI6:YC3)'/%>0VM
M_=V<+0X89&*^O/$>BPZG9R*Z@G'I7BVH^ F^WG9%\N?2@#SWPII$^K:\IDC)
M&0>:^H+:T_L_PLT:C'R?TKE_!7@V*RG$KQ@''I7HE];AM.>)1_#B@#Y2TZ*5
M_B27VG'G'^=?3ESG_A#YO7RJ\QT[P@R>)WNC'_RTSG%>MRV^[0WAQU3% 'RK
M:+*/'8;:?]8/YU[]X[TC^T_!JKMRWEC^5<5;>#W'BHSF/Y=P/3WKV>2T2XTY
M;=QQL H ^+9+:YTK4WPC *U=)X3O;F]\26BD-CS!FO4?%7@6.2Y9XHNI]*K>
M"_!9M=7662/&U@1Q0!9^*GATSZ*DJ)ENM>&V5W=:9NB"L.:^PM=TJ/4-.\IU
M!P*\5U?P&3?DI%\I/I0!S_PXDN+KQ%"75L%J])^,4+'08549PII_@GPD-/O(
MY3'@@^E=-X\TK^T].$:KG"T >9_ A'2^D# @;:['XW@MX(E4#^*E^&WA]M)F
M9F3&1Z5L?$C3'U3P\T"+DDT >;_ :-TMY=P(^:MSXXZ6U_IT$BKGRP36I\--
M!?28&#+C)]*[#Q3I,>J:1,C+E@AQQ0!\F^%)KF'4X(@K8#BO1?B<))-(B)!S
MA:T/#_@CR=8#O'P&STKI_'_AQKRRC2),XQVH K?!H.FDD,,5?^,&FM?:(75<
ME$)K8\ :0=-TT*RX/TK>\0Z<FH:5-&PSE<"@#X^T:YNK>=;=5;EL4_Q+830Z
MS"Q0\X->KZ=X$VZ_N:+Y V>E:7C?P8)KR%X8\XQT% '6_#16?PR%8?PC^5>%
M?%+2)+3Q%).B'YI":^DO"-A_9^C1QD8.T9KC_B'X574G61$R>O2@#@?A1<W#
M&>-P=OEUR/C>"0>-HB%/WQ_.O;?!'A<:=;[BF&(P>*YWQ5X1>Z\4).L>5!!Z
M4 >C+9_VCX&@MV&<PC^5?,_C#1)M(UOS(XR '[5]9:3;B/28(&'1 *X7QWX0
MBOBLB1@MWXH ^<KK4;N]A$.&.*]/^"^@R)JJW<D9''>GZ9X"/VX[XOE^E>P^
M%/#\.E6JE% ;Z4 >>?&^%FL3M&<+65\!4DC^U;@1G%>@_$;1FU2P957)QZ52
M^&F@'2(Y-R8+>U &#\;"[Z>JJ">:S/@?&Z2_,,=:[SX@:(=4M@H7.#Z52^'6
M@MI;Y9,?A0!Z;1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=+"W#[P@S1-90SR?.@.*M*,"F_\ +2@!JQ+''M48%1R6T5PN'4'%6::JX)H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H[444 (!
M@4Q1DYJ2D Q0!'<Q^;;NA[BOFWQOX3EE\17$B1D@M7TN>161=>'[6[F,CH"3
M[4 ?.6A>"))KN,21'&1UKZ&\-Z)'I-C&B #@5-;^'K2W<,B $>U:ZC:H [4
M+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (
MPR* ,"EHH :A)S3J0#%+0!&>7Q4E)CG-+0 A&10!@8I:* "BBB@ J$9#U-2;
M1G- "TF/FS2T4 %%%% !1110 4444 (1FEHHH *1NE+10 U>5IU &** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *0G S2TC#(Q0 #D4M(.!2T %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !129YQ2T %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1130<L10 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HII
M.& IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%-S\^*=0 4444 %%%% !1110 44S=\^*?0 4444 %%
M%-)^?% #J**:QP10 ZBHS(%)R<4BRAT)4YYH EHIN?DS35?KF@"2BD5@PX-+
M0 4444 %%%% !1110 444S/SXH ?1136."* '4444 %%%% !1110 444A( R
M: $ ^<FG5$DRNY52#BGL<"@!U%(.E-D<(N2<4 /HID;AT# YI] !1110 44A
MZ4BG(H =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !28P<TM(QXH "P I:@<'8,>M2
MYPHH =10.E% !2;A2]JAP: )J*0=*#TH ,BEJ+G&*E'2@ HHHH 3-&13<'>:
M;@[#0!)C)S2TU3Q5)M1C6Y\HD9SB@"_10.110 F:6HF;8C,:@MKU)Y&0'E:
M+>>:6F '?3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >
M0?&F!IX;<+UQ6]\*[D_\(Y!:,?F1:B^(]L+F:U0]Z@\ ?Z+J$L!X % '8^*9
MO)T:8CC*FO!/ =NY\=^8Q/\ K#_.O;O%\F[3VCSU%>7>%+7[-XKC..2Q- 'J
M_B'7!HE@)2>BYK!\/^/$U:X$>[J<5I^*M+&JVD<)Z,,&O.7TI/#&I6VTXW2
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MD"P[R>V:X/4/'J6>M)99^\^VKVM:[]CT&&7=@M&#7%WOAY+W3FUS/S1KYF:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9*^[P+"#T\H5V7A-47PK&0/^6= '!>'K''CRXX[5N?$.Q5(8Y@.012:"B_\
M";W#8[5J?$-0VF*/]H4 <=XYOFBT*RB!Y,0JY9ZB3\/YH2?F,&*Q_',;3)IB
M#IY0S6MI^@W,VBQJH.QEI,"[\(99A8")\X&:]0;F-_7!KE?!FC'2XL%<<5UF
M,L?2F!XMJ8>R\7)*_"[B:]/TI[:]BCD4@L!FN9\;>'Y+N=9;=3N [5G>$]1E
MTN^6TN6Y<[1FD!2\20!O&Q/^V*]1_=PZ6F_ 78/Y5YOK@SXS)/=A73^*]4^Q
MZ(D8;#$ 4 <QXHU)6L;A$;BLKP1,TVA:TI[1FFZEI5TVCR7+9VL,TWP%\NBZ
MV#V2F!;^&^1?7@/38:;H-JLOQ-,A'\)J?X>8-Q>,/^>9J;PN/^*^8]\&@"7X
MGVHAVSJ/NBIM6??X%LF/>*K7Q3P=-8=\54U%2? =B/\ IC0!-:@O\/(5]5-+
M\/=+2/3I6 ZDU-IR[? ,(/\ =-:G@)0-$?UW&@#A(8_L/Q-MXEX#DFH]6WZK
MX_M0/F6";FK^J)M^*5BPZ8-1>&V1O'5_YO)\[Y<T =EX]L$E\,R@C[L9/Z5E
M_!8;?"##TE-;_CN0)X<N,]XS_*L'X,G/A)R/^>IH ](Z44U_NTJ]* %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** (I#NC85\]^(M!EU?QC>1QDYW=J^A6&$:O)-.(;X@W@/
M]Z@#E7^%U\(F;<^,9J;X<V+:/XNCMGSG)/->\W"J+"0[1Q&?Y5XSX><2^/\
M?W!84 7_ !O<'6]<AL4.?FVXJ'6?!<EKIEM<A2/LWSFH[%A/X^.\_=FXS7KF
MJVR7.D3PD##)B@#SB'Q(E]X9B&>=VW%=3H-O]C\/S$C[^37C@F^Q>)O[&0_(
MK[OUKWCR@F@J/6/^E '@C>$I]?UZ^>(L,2GI7H_@7PA<:),6E+<^M1^!F"ZU
M?KC.9:]/"@=!0! Z[B!Z5YG\6[!WTEKL9PF*]2V\YK'\1Z5'J^ER6;X^:@#C
M?AMXCAU/3H[8@9B4+6A\1XT.FHV!@"N'>T;P5JT<<0(61LG%=5XNNS=^&+>8
M_P 2T ;7P^V'PM&^!U-8WB_QI#HUPT> 3BK'A6Z^Q^ Q(#T!KB].TG_A-I)Y
MI>=KE>: *GA7Q"-7\6PLO +UN:B=GC>//>45CZ+H46B>-+:*,C[W-;>I*&\:
M1D_\]10!9\5VWG:_$?\ :6NQU[3XY_#.S8,B,=O:N;\28&M1?[RUVU^,Z$?^
MN7]* /+?AZQETO6H<_<D(J]X&CV:AJX]JSOAN<0>(/\ KL:UO!1!U'5S[4 2
M^'M.$GBV>4C(Q3OB5;)!9K,J@$,*O^&7'_"23 >E0?%+_D#?\"% '.ZQ?&Y3
M2X,]8Q7H^GV,9\.+'L&2GI7F#PC[1I<C< (*];M)%30U?/RA* . \'0BU\>7
MD(&,)7J2G(KS+PLZS?$&]D4YRE>FJ,"@!:*** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0>>*//&<4<K"Y/14'GC\J7SAC-%F%R:BH?.&<4OFBBS"Y+14?FBCS!19C)*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%%% !1110 4444 %%%% !1110 4444 %%%% !112=Z %HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "FR'$;'T%.IDO,3?2@#D+W4RER>:K?VF<]
M>M4M8&V\(]ZK+R ?2MX*[,]3<&I?+UZ4J:K[]:Q U/45KRDWU-H:G\V,TXZI
MSG/2L8=<TX#)QZT^5#OH;":GR3GK3O[1W]^E8P& 1Z4^,_+FCE$;']I?+G-
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M-P14DBXN&^M.8CK77%&5]1 N13@.*52-IHSTJT@ \"A1DTK=<TJ\<5=M"6P
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M[5$IP<5(C J3GI18M,<BY;Z4_&&S35.#]:&/-*P=24#)Q0!S38VJ1N"/>D]
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M44M,0E(:6FN>*"0ZT4G:G"F2**=24M)FJ"BBBD,**** "BBB@ HHHH ****
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M6&131(E I#]X4M,ED@I::M.J&:K8****!A1110 4444 %%%% !1110 4444
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M!:2EHI%"&EHHH 04&BEH$%%%% PHHHH **** "BBB@ HHHH **** "BBC/-
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M=QJ*5]BYK&QSVU)R :3[IJBMXN[!-3+.';K19E<I<HI%.12U @HHHH ****
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M$<53<****S("BBB@ HHHH 0TAZ4IJ-FYQ31$AN.M.P<"E4Y%+57$+12=Z6I
M*0]*6B@8BCBG=Z2E% PHH%%(8=Z.U+2=J %I*,T4 ':CO11WH *44@I: 044
M4"@84444 %%%% !1110 4444 %%%% !112=Z $I:6DIBL+2=J6D-(&!H[4$T
MW?B@5M1PZ5FZC&Q4D5H[N*AN5#1GZ4T6CE[(R&[VY[UU*@F-1[5AV,(%YN]#
M6\#@5314D*S;(^:PKG4U2?;GO6K>OMM7;T%>>7EXS79.3UH2'%:'H5K=+*HQ
M4EP<0L:YO1KLL54FM6_O EL_/057*'*5["7?>,,]#6^.E<AH4_FWSG/6NO'2
MHDK,F0M%%%22%%%% !1110 4444 %%%% !1110 4444 %,E_U3?2GTR7_5-]
M* //]2R+TU4*EB#5W5.;LM55#VKTJ7PF<@4'!%2(A44@/S?2I=WRY]:;>I(#
MELU+CBHEX.*ES0MAH.A%2 9.>U,J1#D8I,=AP'.*;,_E$9J0'!S5:_\ F7(]
M*5P@[2&1W@,N,]36FOS*"*Y2-V%UWX-=1;/F%3ZU+1K4V+&*>%VPL#WIBGY\
M5'<7848K-D0C<J7S;H]M9ULGE$L.]27=S@9]:CMI!*,>E),[J4;'!>-9'%T5
MS7/6D>'5S73>,H]]UNK 7Y8P*Z:<+FLJO*6;F3]WA:KQLY0@F@_,![4BO\Q%
M=$*=CDKUKH6$X/-$M-'W\4VX;D>U=<=$><I<S)5FRF/2FAN3[U73(5O>I(/G
M;'I3:(DA3Q3URJ[NU17+;)*LXS9L:EFL'9%0$M(?K5R%\?+5.V&^7\:L/^[E
M^M5%:&-5DQ7+U/@[<571\FI/-R?I2E<SA(84R:KNK*2?6K6>?K3)<-QZ4U(5
M74@7/EXJ:WX?/:F!:EC&!BANYI2\QM\N5^M$>5M<#THE?>P'I0QVIBIB:R>A
M24$RDFI'4U(J<YILCX&?2G)&<=6:-O:GR@^.U9U\-KL:Z"R8/:8]16+JD>T-
M6:.J*1!8R;E(]JB20B_ SQ45@^Q2WK0QQ<!ZF2N;P9J:F6$*[>XK/@B9XR3U
M%7HW^VE4ZXXK4CTSRX&..HJ::LRZZO$YI.'(-6%A)J"Y'DW17T-78Y 8]U=4
MF<2B.B(12*?PQ6LR6[V,P]:(;W+J/>L7J@:L>\>  !I48]J[2N&^'LOF:;&?
M:NYKQ,0O?-8;!4-S_J6^E35%<_ZEOI6*+.1N1^_)J,9-2W)_>D5&IP:[J?PF
M+)*4#GZTG]:>#P/:I$//W<=Z1.#F@-\V?6E'I3Z#%'>GKTIOO3EXS[T WV%6
M@ @8[TB]?I3B><U+0A>XIV*3/(IW?Z4+80N#TH]Z7=SGUI?]FBXQHR32@'-*
MO4GTI0>?K2*0 $TO.W%.7@8]*%Y.:!CATJ"Z;"5/GYL5!=KD4A! Q:%14V#F
MHK9<1BK'M0,C"G!I2,X]J>>M%#!#0#DTW:<5)WH8X6D40L,C--/*U+VQZU$>
M,^U4@&["RCVJO/#ELU:5\#/K36()Q1U"Q JE%Q3P"13I.HIH;''K3"Q&!\QJ
M-S\^*ED.T9JOG>^ZD!*@YSVI".<T_HF*:3Q]*$]2K!U%1E#G/:I <?C36? Q
M5(FQ%@].](QP*7=\^:KW3[/QJTB9+0-^6I9%)2JD;DO5UFPF:5K$IK8IJF'S
M5GK&1WI M .&^E-/4U5FC*NU8./K5FUSY>3Z5+=Q;L'UI539;'Z5I'4SD[%6
M*?=*1GO7::%_J#7!VJG[03[UWFA_Z@URXC<<=S7[T4E+7(C0*ANHQ-;LAY!%
M2.VU"?2L@:J&M[A\_P"KI@8=U!9P7&UD7(/-:&EV5M)<^9&@QBN"O=::[U*;
M:3A371^%=9W3"%CSB@#O@, "EI%.5!]:6@ HHHH **** $/(H P*6D;[A^E
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M<[+U1[UJ7MN\5XRXXK)D5DFW5NI: E='HMC?I':+\W05RWBC5BY"J<Y-9_\
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M)<XZUNMKFM_=/3?!<8B@7CM7:5RWAJ+RP$]!74UYM;XCAJ?$%%%%9&84444
M%%%% "&HW]*D-,(^;--$L1>E.IH&*=BF2'>EI.]+2 ****!B]J.]':BD4+12
M"EH&%)2TF*!"T444#"BBB@ HHHH **** "BBB@ HHHH *0GFEI".: %HHHH
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M%<]Y;76H2)U^;BM98GTO8W3<<5;1D]SL'(P2.]4=OE[AZFGQ2[K%9#WHD&Z
ML*PD4B DQ L.]5C(6;-:)57MO<"J#Q[8\U211)%\W%7[*#+9/K6?9@FM9)4B
M3WIO0F1I^6D<)QZ5S]V-SOBM!KH^0V3U'%9\<BL_S=Z:(L8UOO2]W8K8F;S-
MJ>HJ1K-/,WJ*A49N@*)(I;C=-C_?N#ZTZZM!]IW>]2VZ[+DX]:GGXER>E2.9
M&X*Q;:SYX_-0UISNGD>]4%9<\]*<6.&Q06S"GIUJI=0!95QZUM3E5CR*S)&$
MC+Z@UNIEP5R_;1CR 33I65("*2)PL6*S-0N"$(!I7U'*)5U9E,/'I7.>47P,
M5?O+DL5!/UI]J(SUKK@U8YI:%(P$)C'2MO0+XP<9JI<; 2HJM YBFXZ5G*(B
M?Q /-FW^M+X=DQ<;?2GWB^=;%NX%5=!RE\ ?6I;M$IK0];T(GS ?:NFKGM"
M)!'I70UYM1ZG#4W"BBBLS,**** "BBB@!#2&E----$L:#G-.I*6F2+2"EHI
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M>38JOH@Q&U2<YKT444 %%%% !1110 4444 %%%% !1110 4R7_5-]*?3)/\
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MI'10=B^W# ^M:=O>%% )Z52BC\U%;VJ<6_%:R1V;EV28.F?6J4R?NPU3F+"
M5+/#BR5L5*>I<2BLH"8K-UJU$T60.U7T3+8J22(31X/:M(LM[&)8ZH+*V:(G
M'&*S+"4S:^\P/!J[J.EE26 ZT:/8;'\PCI6C9@E[QT=U)@KGTJQ9?O5K%O+@
MD_2MG1_]5DUDT;2V+<8,+GWIC8:5FJS(FY68=JIH<AC[5&QG'<SKB3_2,BJE
MXI%W$WM6BMMYC9]Z?+9^<0<?=IIFC9S/B$^:D0'45;TVSWZ?$&&<U%JT!$J#
M'>K]I-Y5M&H[&K4A,T%MQ;VXCQS3V8%1[57N+S>0:?G,6:5]1HBDDVN!ZU=A
M<"/'I5,0^9\W]VEC?#$4U(:0KS#[3BM"-A@+ZUAN?]-Q6JC8E3Z5,M0Y="O?
MC;#+]*BT8Y@DS_=J_=PB5,?WJATZ#RFE3T%..Y#.59"VMD>]=!?:6\:QW&.
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M]3H=>?[?)O0]\U7MXV,.TFJFFWGVB!2QZUL0IA>E:Z+0VDM"F T0.?6NEM9
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MC ZU-:PM)Y;$5E*:&W?0LPZ4UQ!@#M2VN@/$^XCBNLTFU'D@D=15^Y@6.WR
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M%:.\+?PUKM(LMOQUHO<I*[*Y.8R#6+=V^<L!6RZD+FJS1^8I]ZKGL4]C=\$
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MFZ[_ ,@N7Z4 1:&,VX;U%:%W_P >DO\ NFLWP^V;-1[5I7?_ !Z2_P"Z::W
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M[L*/6K^HLWFE *9IUK(EPKE34RJ%J)VUKIR?V>#M'2N5OK/%VP ZFNL@NV$
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M5SHY5\J0*.AJ"<C@5)+<+(58=Q59R6D4T[60U*Z)7@#V_3FH;.W$;<BK\9!
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MO:OA;G^SI/I6-;8WJ0M ]$HHI!TKD.46L+Q:6&@7!7KMK=K'\3@?V%<9_NT
M>>Z=IT)TS[0P&\C--;5I+6&W5">9 *HIKD<5H8 1P,53MV.H30(G.) : /<+
M5]UI"Q[H#4AQD5#;J18PKZ(*EP<B@!]%%% !1110 AX%(IR,TIY% &!0!Y1X
MIMVG^(,(/*^7TIJV:6PF!4<FNMU72A+X@2[ R0N*XWQ;--9/A%//I0!TG@<?
MZ3< =*[I1@5Q/@"-OLOG.,%Q7;T 8^NG%KGWJSI?_'JI]JKZZ,VV/>K&E_\
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MD&X<9Z&M^:$31%L=JYY2U,G(XD(8CS5G =0XZBHM7F6%R@ZYJ&SNP8SFJB5
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M:JP1A=19STS5+3YBCL">]7XV$LC!>HI3V$U[IZ/X=F22-0O7%='7%^$=RO\
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M4CN:P=9W#:/0U:0)H?!'YB8]JK;##/N]*M6+_N@3UIMZ !D5I$4GH-NI?-C
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M?)W,I/:I),DJHZ5L_P!FG)7%(=)8'<1TJ&SDE4-?18PMHO'.*TQ@<U3TU-D
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MYHL)6%T8?,6JX,ZZ.QK:=*2JYJW)Q-GU-10Q"*V1AUQ4NX&/<:LZKZ&@HWQ
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MU+BCH4<.>#TJ:L+1;LW SFMVLV)A1112$%%%% !1110 4444 %%%% !1110
M4444 %5[W_CSE_W35BJ][_QYR_[IH&MSYT\4C&M./<U@,/GS70>*AG6'^IK
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MT'%(D8_6G)]VDD^[]*2%]PI$=20]*'_U9H(S0P^2F-%-R0G%16K'SLFK)CW
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M:3ZUE>([167('2ES:!S&GX7F\ZT4FNEKDO"/$(6NMK&6YC)W84445)(4444
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M#M35[TZB@ I.]+2&@3%HHH- Q*#11FF*X44"FL<<T .HI,YQ0: N%+VI*0G
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M=XVD 8'UK5T?58=0CS&P.*=@-7('6FY^?%96K:I%8L@=L;FQ6K&0\:N.XS2
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MYJL=I>[)&QGB@#8Q\V:=42ON"L.A&:EH **** "BBB@ HHHH **** "BBB@
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MSBD![V3M4FO#?B1KTB>*8K>)\9QTKVVY<+:.WHN:^:_%NZ^\<))R0&Q^M%M
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M[5J_$&<MX=L78\EJ .W\,WS:AIBSL<DU=UFX-KIDDHZ@5A_#\[O#J'WK4\3
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MAF&Q2.17 ZJOV'Q1;OT#-F@#TE&R:?5>UD$D"..XJQ0 4444 %%%% !1110
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M(Z?>6<@&!(PKTCQP0-#F]<5Q4UMMTW3)P.G)H ]#U>\\O1PX/WABO%]2L/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPQF2NB^'( TF3']ZLSQDGV/P=&!QEA6A\-23HSD^M '<4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M &)X\LC=^'(X4'((J;X?6YMM)9#V-;VI68N+<(1FETBQ%E R@8R<T :-%%%
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M]%(!]VMRR0QVD:GL*?)&'.2*D484"@!:;(H>-E/<4ZB@#R3Q1I4EIK*7,8(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !3&&6%/HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
@@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>image15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image15.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0R!WP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+=BC$;AP?6M/2/B/::G*J*PY]Z ._HJO!<K/$'4YR,US7B#QE;Z).L<A )-
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MJJ,.?>NS$ZFV\T'C&: 'N3GBG#I7%ZQX[M=,NUA<C+'%=-INH)J%JDJ=&&:
M+V<TM0NWE(SGH!FN'U?XBVFF7!B=AD''6@#OJ3-<OX>\76^N'$9'-=,H.<T
M/HK+UG5X]*M_-D(QBN,_X6A9?:?)W#.<=: /1Z*H:7J":C:+.G1JOT %%%%
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M2.-PRC=CFOI#PWK3:EH18G)"5X=\0192ZQ$MDH#;^U>I_#ZUGM]#<RYP4XH
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M'VKP'QGX;;1+AI8H]J@]: /I+P[K"ZM8+-D9-;=>,?"K5Y9K2.-F/:O9AT%
M"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 <1\0%SHUP?]DUX7X)CW>(00?\ EI_6O=OB
M #_85P1_=->&^ @QUXY_YZ?UH ^GK-<V$0/]T5X-\;+51>QN !@U[O#*L.FQ
MNQP E?/GQ@U2.^U...%L\XH U_A/%]NT^6)CCC%/\2^'H=.N3*7!R<]:@^'S
M/I6D2RGY?ES7*>(]?U#5]0:*!BP#8XH R_%LZRJJ)@8]*WOAQ:-/:7 )S\IK
ME-:T75%A662-L$9KM_A$K,TT3]<$4 <A>V[Z9XH#<C,M>X:IJHMO!L)W<M%_
M2O.?B/I@LK^*<+CYP<U4\1>)Q+X?MK:.3)"@$9H I>%+!]7\4R/R1OS7T[HT
M'V;38HO05XC\(=.$E]YSKU.:]\10BX':@ 9<TC(-AR.U.R*:Y^4_2@#Q3XP,
M/L( '>M#X5?\>$7X5F?%_P#X]/QK0^%(;[%%Z<4 ;7Q8G*^'V'M7D?PP3S?$
MJGWKU_XL0[_#K8':O(/AA((O$JJ3@YH ^@?$B[=&(]J^=+-2WCP#_:KZ-\0R
MH-'+.>,5\]:<%G^(0\OD;J /I#04*6"@^E0ZWJ_]G0,_I5W2XS':*".U<YXU
MLY[C39!"I+$=J .0N?BGY-SY>>]=IX9\3?VQ"'SUKYQU+PQK;W;,L+]?2O9/
MACIM[:6*BY0@^] 'JHY%>.?%I,PRFO8U^Z/I7D7Q7Q]EE^AH \.T37;C3O,2
M(,1D]*35-:N+R<-(K?B*]!^&'A6SUF"1YT!.?2MKQUX(LM/LGD@B P/2@#6^
M#<ZSZ8PZ'%<A\;8=FI1\]35SX1WS6[21 XYQ5'XU,SW\)]: .I^"$>RT;Z5Z
M[J/_ !X2_P"[7DGP2#"T;=Z5ZUJ7_(/F_P!V@#YC\>?-XAB'_32KOBG2R^E6
MDRK]U0:H>. P\1Q9_P">E>G0Z7'J'A4,ZY*Q4 8?PVUS;;31,<;%(KE_&-X=
M8UD1 YP]8VG:J='U*]C#;1D@5?\ !L3ZYKSNPW /FBX%CQAIGV31+)L8SBO2
M_A6?]$B^E<W\5[=;?1[2-1@C%;OPH#_9X\],4@/7:***8!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %>(_&OI^%>W5XA\:STH$S-^!B;I9OJ:]
MXNES9.#_ ':\)^!V?-EV^IKW+4)UAL)&8XPM SYR^(D2PZ["RC_EH*].T>'^
MU?#<4;'&(Z\G\;7T>H>(8TC;.)!7I;7XT3PM$^=I,= ''W^CPZ7>3/N!)-<!
MXDN,S+L..>U7+C4=6U[5)4M]SKN[5FZ[H]_9K')=(PY[T =WX4L7U?32C$G:
ME9WA64Z3XSFC)P ^/UKJ_A7Y<MLZ#D[#_*N/\1HVE>*9I_N@OG/XT >C_%*^
MW>$XG5OO"N*^$^E-/JXG.>34'BSQ"FH^';> 29;@8KO_ (4Z48;2*?;UQS0!
MZU!'Y407TIV[YL4KYQQ2*.,F@"-@(R7)Q7C/Q7\3A[*2R5L]17?>,?$46FZ>
M^) & />OG._GN_$FN%4RZDT =)\+/#1EU*.]*]Q7TC$@2,+CM7&?#[P^NG:/
M'O3:X [5W'&: ./^(R*/#$V!V-?._@X[O%:+_MU]%?$49\,S?0U\Y>#58>,8
M_P#?_K0!]6Z4FRT0?[(J_533O^/6/_=%6Z .2\3^)_[&5CGI7$VWQ5\ZX\O/
M?%7OB5IEY>!_LZ$Y]*\6M?"VN1WV[R7QN]* /J+P_JXU:U\P'M6R%P*X7X<6
MMU;:=MN5(..]=VWW: /G_P"-_%VI%>>>'O$]QIMI)#&K'<,<"O1/C,-U\H;N
M:C^&'A"RU:W=KB,$X[B@#R\W\USK<4DJL 7SS7TMX2N4N/#VU2,B.O,?B3X6
MM=$<26R!2.>!6Q\(M2FN[*YCD)(4$"@#C/'$6SQ'&?\ IH*]Z\#_ /('M_\
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M4M0/+_#VNG0M:>$G&*1;DZ]XO;N":YOQPQT_Q5,(^.374?#"T:[UM9G&<T;
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M*P8_!ES/(2\+?E4T/@RX@N5*Q-P?2@#V_76'B7PQYB#.5KP"TO&\+>+"[@@
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MH37Z1>6A;GM6KX"T@V%K'E<'%(#OJ*** "BBB@ HHHH **** "BBB@ HHHH
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M2*"3[5I:/X?ATF$1Q@8%(9Y;\4K*2:!]H-3_  LM7AMHP017H^L>'(-50K(
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MU(#PC0-#NO$.JJ6W$$]Z^D_#>E_V+HRPD<@53T/P3::-*)(E&1[5U3QADVT
M?/?Q \1S6^MO&I;'/2O,+OS[N\^TX;-?3FL_#JRU:\-Q(HW'VJHOPLT]4V[1
M^5,6IY?X"UV:*^CMV+=J^B=-E\VV5O:N/T[X;V-A=+.BC(]J[:V@6WC"#M1T
M&3T444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "CJ*** *LVGP3G,B
MU)#;1P#"*!4U% !364,,$4ZB@"A)I%I*VYHE)/M3!HED#D0K^5:#' I5.10!
M##:Q0C"*!3Y(4E7##(J2B@#-?0[*1MS0J3]*GATZW@_U: 5;HH 0#'2EHHH
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M%3T4 59[**Z/[U V/6I(;:. 810 *FHH **** "BBB@ HHHH **** "BBB@
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M4D%A]%,WC'6G9H;"PM%)FEHNA!12%E'>D+J!UI@.HI@D4C@BG @T!86BBB@
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M-C-7-FTFE79DYJUH&ESPZAN8G&:TBQ3II(](5MRYIU10J1& :EK0XWN%%%%
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M_I7GUG$QG\WWKJ9Y5N5\E#D&LU($M[D1MQFDU<J$%%6.FT*_W%8B:Z&\U/\
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MWE;Q =Q)7/2M/4UCA3( JUI]MYS^>1\QK%U:68ZD8F!"5E=G=*UC?TBP:[M
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M#?6\I/"URDLDOD,S C KFK37KDW[1+D@'%4I"E!'J\"V\[, B_E6/K&FX1V
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MS6!6T]R(F%68P,YJ#3HP0V:FE98Y H/6G<TEL6O-41$>U8-U&7D)3UK0N'V
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M#O6A;H;UE&.AK-W')W12L;.]:0. <9KM-+2Y55#YJ_864<=LF5&<>E:$:J.
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M&B0K-*N5[UZ']B3["ORCI3L#DDSS."VE^UD.#C-:.LP;+)#$/FJ;69DL9"P
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M<LU=DV?6HY8A(A!'6D1Q+R#4W6LWV%L<Y?Z1&59E7GM7,36M]$S! <=J]&=
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MC!^XI^CZ!=)G<IYJ_<:5+&,R+Q56*<T5_#][)$ICP<=*N:B#L+^M1V0BM\Y
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MTDU_R#C-/9#F[;G>:1IBH [*.:W(XD0_*H%-MDVVJ?2IR,#-<]25C@G-MD>
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MU2;[+ <'%5;76I6F\KM4&L3^:A4FE<Y[ZE-M!FU.#[0N<&L>13I\WDOVKO\
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M=/L+JO&%JD[)$0BD5GZS=M;VK;>XK/GU)<>8\VUV,R:@Q']ZD9"8DQVJ0O\
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M&#1J1Z5Y+HMONU9"/6O6;9-D*CVK5(\?%?$34444SE"BBB@#&UH V[Y]*P]
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M5GQS2I($;N:ZR\,9B;@<"N4D8/> CL:''025CI+#28YHM\B]16A9P6EF&W@
M]JIQZJEO:8]!7/W.LFZE95..:$M3.47)#O%!2YSLY JMX15?M)63IFA@9D.>
M:@L)#:7.>G-#1JHV5CT"ZMK98E; HM+NWC!5B/:L6?43+:C!Z"L#^T'DN-@)
M&#674R<>AVLDQ:0E#\IK)U.T#IN<58L;@>4N3S3M9F M5P*2=F/8Y'4K?]T
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M:'8JMD20.5KDM:!M;MSZFLY.XH2N[#+A%<9%-L-4:RN% ;'-,B<F/<>XK(O
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M0BGZG]GB3 4 U5LIC]E8 TFB=T4[AOLEZ%A[FKEQJDD=MASCBHH+)[B[5SR
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M%]:Z2+PO,8 ^WM5+^PYOM:'!PII-&JJIZ(L+I^RT\W'(&:Y__A)+NUN6B!.
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MJ$WE[O(S\U9VJ":(HCYY%=9X+MEC3<PYIK4<K*+L=W'"HM0N!TK"OHDMBS'
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MZUT6E>%5V;B*V-'TI-BL5[5T\-ND:8 K*2N>=6GJ>;ZMI'V6[3'0&I?LRR1
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MVU.:BB<7\0.>M=?>VRMIV .2M5IM/1)PP'2M5$,EJ5;TI7(<K.YYX)7T^5P
M>349D-S,I;UKK7T>.9V9UKG=9MUL[A!'ZTD=$)7-:UF6U"5T=I=K.JX(K@KV
M>2*T#^@J'PSK<TUX49C@&CH155SU+=M%,E&87'J*6W(D@4]\4DC!00:%8XDO
M>/,O$>CN]RSKGDU@2VTL487FO6VLX;ICN -9USH5N<DJ,"BS.R,M;'GNE::P
MF\QL\FNIGAW6JH*BNQ#:.54@8IUI>1.<.PQ0=M_=#3=+)E)]:@UG0F'SY-;9
MOK:! 485;FFAN;(,2#Q57.2_O&-I=D([9=QK<L(T$O05QE[J<EK,54_*#72>
M';O[1M+'K39=32)U:8':GDT*!C-'4UC)ZG"]SF?$=J)H&.*\TN#]FF*XKUG6
MT_T9L5YGJ%J3.6(XS5)GJX1W0ZT;S4!KN-#<1VV:X>R(5PO:NCBN_)AP#6E]
M#?$QNK'6QW"O(*9JL@6T8CTK#TR\,LZ\UIZTV+%C[5%SS>5<YSD4(N49SV-<
M[K,?E.:W=/G/D2$&L'5YU>4@GO5IZ'HTHZ'.RW'45IZ%9&[F4X[UG36KO<+L
M&0:]$\':4HB#,O-.^A->?*B"_P##>^V# =!7(MIC0W8R#P:]JDMT:/9CC%<S
MJ^C1A6=%YK.]CEC7ON4=*=/L14XX6L[.V20CUK,DGNK61D4$+FI;:<L?F/)Z
MTVS=:ZFC86HO92#6]!H82)C[5@VL_P!EE4J<9-=G:7 E@7GJ*1E5NMCAK_3#
M'=<#O70Z79JD()]*FUF.$#<,;JQ3JA@7;NXJ5N"ES+0GUV(3(%4=*RHYVM@J
MX[UK:9<1W\Q#G-3ZI8V\<>X8R*3$GT+$,B0V:S$#)%2:9<?:+O@=ZYJ74#M$
M(/RBNI\.B$A6R-U7'4BHFE=G50\(!4U1H/2I*Z%L>;+<****8@J&=0Z8-35#
M.<)D4#CN<!XHTP -**Y?1-6,.HK;GUKO-?5I+5ABO.K:PD75@X4YS4,]*GMJ
M>ER1_:( !W%1V6C[90YYJUI43-;KO'.*UD78*Q?<SJ3Z(5(E50N*Y/Q9;*T+
M@"NP7[N:Y'Q3,%1@35J>A-!^^>=0#[)OSZU3N=5(N  .]7"CSS$*,Y-:=IX:
M\\AW3GZ5?,=[GH3Z-KKQ0X.>E6YM4^TG.*M6_AX1KC923:7Y#?=Q4W(4D94^
MJM;1LO/-8JZH4E)(ZFNDN-*\\CY:R]1T<0[<+S5;FJ:1T/A:]61N@YKLIYE2
MS?W%>>Z##);G.,"MZ?43LV,U"9SU(<S. \3RLE\7 /WJO:9=+>0I&1TJ_JEE
M;W*EFQDUCPVTMHQ9%..U"&D:]U9K!&&!ZU9TK3Q&_FD]:YJ74;AY-KDX!J]%
MJLBQJJGI3-XG0ZO"OV;(QTKC5N?)N6&*VA?R7*[7-56TW>Y?;0S9;"VLPEDS
MBMN"Y8KY8%<W&#!/CIS7=Z+:VTD*N^,FBQA4ER[G%Z[92R#/-='X(M?**%JW
M+BPM)6(.,5EBYBTZY*QD "I9R5).2._:1%&<BDW!UR*\VG\42?:MF_CZUU6D
M:Q'+"-[BI9R*#L:-[<"*(\5F6MPL\GW15F^N(I00",51M6C2;@T+5G1"+L8O
MB_5_L=NT0KF=#C&H0&1JL>,2;C4MG534.EG[%%M7@5JM#IIP=A\]FJW(3BNB
MTGPVLVV7 XKC;K4B=70;N,UZIX;E#V8QZ5,F17<E'0'T1?*Z=!7(ZCIX@U6/
MCO7I.23@USFOV:B42@=*SW1RQF[V9RWB*Q$B),/X15#1?$0MY1%Z'%:.HSF6
MSD'H*X2V5UO2W;=31W1UC8]6GU\F# [BN9O8I+QC(0>.:T]$@6^1<\XKJH]&
MMQ;G@=*I*YQRCR2/,)+8W2,N.E+HEO\ 9+D@]S78SZ=!;>82 *Y*]N8[>[!0
MC@TSNA*\32\1Z>6@CE3Z\5=\(7O)C;^&GV]Y;ZC9;"P) K+LI%LKXA#C)J&K
MF$H,] AF%Q(RD=*YWQ6 ;9@!T%;=JI\A9%ZM575[,W$!R,DBI=T3!I2/&%#/
M?LI'0UTNFSB)@#2W^C_996D"XS5"TW-.5':KC([D[H[VQG5D!XK*\2ZH$M]@
M-9L.H/$VS/2LC7YI9H<CFKL9.&I&\YD@S4FC6HNKT*1WJO9 -:@-UK4TC$%V
M&%3RG1:T3U'2K:."S5,"ILQK+U&:Y>37T@M_O@&L6S\12W&J[ ^5S3=F>;4@
MTV>M6QS'4U4=+<O:@FKU4MC@EN%%%%,D*Y?Q'=_9U8FNGR.E<;XT4_8I&'7%
M-&M'XCBI[M)'-Q@'::8VN"ZMV0#':LFRN0UK+'(?F)-/M(52)R:H]VFKQ3*C
M(7G^IJ^+(Y4#O4ENL)4LQ&14T,Z-.O/ -*US96*\MJ]K(K9.*TDD6\B"^@J7
M4?*FM\H<D"L2REDA=MW'-'*P;TN77MUMW^M/F58[=CWQ6;>ZASRU10WK3_*Q
MXIJ)C)G.:DTLUP0">M=5X/TPW!RYS]:IWEI#PPQDUIZ/=?8HV*G'%:<IA(TM
M:ECTH#&*6P\4B*!N>HKCM8U.:]N2KDD U2GG:. !3VJ5&YG)75CHH_$O_$S=
MB<Y-=1'>F2)) >M>4V@<W =O6NWM[]%M$7=TJ)0'&.AW\>K"&QY/\->6ZYJ!
MO]2DCSQFM*ZUDI!MW\8KF"Q:[,WK1&&HE329)#I^R4-[UU<;K!8J:P+>89RQ
MXI9]2'^K#<"M''0Z.AZEX8U)6B52174S7B1KOW"O"K#7Y+60!7P*Z#_A))Y8
M>7./K6<D<=2CS2N=QJWB)8+8L&%><7^NM=W!(-9.K:S<2Y3)Q4&C*;BY ?O6
M94*2B6'W-/YIS5F5_-MCQ6M?:7LMBR+VJIID 9@DHXK5:'3'0QK"5H+L<'K6
M[>Q_;8MWM6A+HL6\/&M,N(Q;V[9XQ4MFJ9S=OIIBN!)G@&M*YN5\O;CM212"
M2-L51F5S+@]*:8F;.B6*WAW8%7-;MEM+9NG2J^E2M;096LW7-5:8E"U",V9=
MC!]KD;ZU<EM39R*1573I/LY+=,UN(4O8B>I JTR4RK-,)(OH*K6EQB3!]:>T
M$F\@#BHI(O)((H;-X%J]<% 16?"Y:4#T-2R.7 %/AA"L#66YHT798RT:8-2-
M=&&';GM5>XEPJA:@N) 549J+!%HBD)GD)J>WNWM6ZGBIPD20!NY%5PBRLP7F
MDXF56"9LQ>+"%$>>E5=0U8WL6,UA-92B8D*:D>.1$'%1R:G.J=F)/;EH\@TR
MTM&>4 YZU>$4C0#BM&QAC0 M]ZM+::G0EI<Z#0=-R%KO;6(0P!<5Q^C7L,;A
M=PKL(;F.1."*QD>=B+W)UYXI'  IH89XJI>7/E@\US-(Y9+4M?PUS?B>;_07
M3%:T%ZC1\MS69JJI=1E1SFM*9M2C<XKPY 6U-3CO7K]JNV%1[5QNBZ2L4P?;
MS7;1<(![5U0,JRLQ]%%%:'.%%%!H PO$";K.0>U<%I5DIG<L!UKT35UW6SCV
MK@/WL$C[!WH.Z@[(I>))DMBJ@#FLBUE5E/3FK6JVEU>'<5)Q64L,]L?G!%5<
M[(LZ;0V6"0Y&<UU,<"W2?=%<7I$P9P":[K3'54R34-A-:&;/X?!#/CI7)7\K
M6DIBYP3BO3TECD#+FN.\3Z='S(@YZU+.9ME#1-+P_GYSNYK9N+$Y4X[UF^$+
MHO=&*8_*#@5Z +**0 XXK-D2G9V(M+B46>TJ,XKB/$5ALNVD'<UW\JB"$[?2
MO/?$%^/.*L>]"?04-^8MZ)9F3;GFNOEMUCLQ\HX%<]X:FBV*2173RL)8R!TQ
M5):#<FV<5JVL&',2\8JGI^H-YF]LT_4K8/J+!AQFG"VC@BW=!0=%O=)-7O/M
M=J4 KF=)L'M]3$Q4XS7865I'=8'6MQ="@6'<%YJ3&4[,=IVH(RA< 5IE-_S"
MN.G\VSO. 0H-;MCJ:,H#-4LSDM;HU/)#+R*YCQ!I@:)G45U<4BR+E33;BU6>
M(JPZU46PC4LSQ.Z0Q,RD=ZDTE0+Q&SWKHO%6DB!'=%KA;.\DAN>3@ UK%G9&
M=T>Y:+*C6ZC(Z5=N[H6ZYS7G>B>(,3QQ[^M;>N7SD*4/!%-LY9PO,J:YK8=R
MGK6*D)EA:0?6J,\AFO5#>M=9:VT2Z<V?[M2S>FN5')0:>U]=#KP:WYH#ID*G
MVJQH=O&;EL>M;6LV GB4*,\5 YSL['%R:V71QMZ57TO4O-:48Q6\GAT%')3K
M5&/1Q:R-M7&320HRN8-XCR3E@3UJQ$'DCQSQ6I+IY# E>M6&M8X(">A(JM+&
MKL9-I%Y\P7/0UK:JPM+)<=0*Q(9_(N68'O4LMY]O(B)S2V(8RQNFO9=F#P:Z
MBTNQ%&8SZ5%HFC(@W[>HJGKX:SYCXS4W-(.^A&(!+J)?U-=OIL(6W45Q%I+B
M%9&ZFNOT:[65 H/-0S&J]"_>6BS1XP*RM6LPVG>4!TK;:0;L54O$,D>!31C
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MYKN+#4%$2KN[4+<SG%VT-)K?<V:L(FU<57CNE;O5H$,.*F6YS2O?4KR@+&S
M5QVHP&]O%([&NQNR$@;)[5R:3*+O .>::V-J5R/5=+:2QP!T6L7PKH<@OG;T
M-=O=M']C))'2L_PS(IN9-N.M.VI<Y-QN=1:QF*( ]A5+5)_+C)]*OAR3534;
M436S_2I.5/WM3E[?Q$B7#(3T-7I]<C>!B/2N+N;5XM1; /WJZ""P#VH+=Q3.
MN,4W<Y:^O6NKQU4GK4;B6- 036M)I4<-R7]36F-(6:%2!3;L;\UHF#:VUQ>[
M5#-70&"6VLPC$\"MG2=&2W ;%2ZI:@Q' [5,7=G/3DG*QYKK#$_7-=%X1E)"
MKFL'6(664@BM;PJ^V=16ATU4K'I:'* 4X<"FPC,8-/8?+6,SS7N9VI#? 17%
MZA:91L#FNPU9S%:%JY#[4)B0QH5STL&<T"8;K::UB6>'@UCZH?+OLKZUMZ>O
MF66\^E7<[Z]FB[HF4F4'UKH=9!?37QZ5SVG$"X%=/=H9-.;CM4'ESTE<XO3\
MK!(AZDUS.M1O%>#DXS70"7R+X1GC)JMXAM0V) .U:):'?1DK$>CPK/MR :]%
MT2(0PX [5Y9I5ZUN^T\<UZ-H5]YL0R>U)LQQ,;K0Z0"HIX1)$V12K,I'6FSW
M $+8/:L5>YYUG<XK5[1(W;@<USXB99,CUK8U>\+7>UC@$U.+*)X X(SC-:WN
M=],P;R8Q;#Z5T>A:LKPE2>@K(DM%N-P/;I4%@&M)RIX!-*Y4TFC;NYVN9F4$
M]:I7FCS-'N&>:W]-L$FPY[UL26T00*V !32.1RL<1HME+8S%W)Q4FMZEL0@F
MNM-G RG!%<?XDL./E%3):EPE=G.+<EGW5U7A>]+707/>LRQT4R0@E>U:&BVC
M6VHX [TX$57H>F0G,8-2BJUH281FK5=2/->X4444P"H)^$R:GJAJ<ICMR105
M#<Q=4D1HR.*YB'RX[L.0.M5-6UQUNC'FJ<=XTAS4L]6E"Z/0;+58OE48K1EN
MT$>_-><0W4R." :U?[1N)(MN#6$CFJP2>AV$&H+)&2*YG7[5[]CLS5_1D=XO
MG!YK5:S7-2F13M%G$Z3X;=)-SC/-=K:Z>D<8^4<"K$$ 3H*L.=I JFQU*K>A
M6,"9^Z*R=8A4(7 Z5ND5GZI#OM)..<4KL4):G)0:M"K,& XJAJFI0SR+M XK
M(O(;B*XDVHV,UGN+@MRIK5/0[8.YV%C>Q2J%4#-2WNGR2@.IKCDN9K-U(!KK
M=,U;[1$!(>U-FCBV9EXCQE%)[UK0V*W%H, 9Q6?K<\*X97&:-%UD$[&;@4T@
MY2&7PV\LK8%4Y-$DMB2U=)/J\<+###DU2UZ\Q8+*G)(JK%1NGJ9-M ?,QZ5L
MJR)%@@9Q7,:;J#27!!K;DE^6D;W,N]8&<X]:TK35_LT 7/2J=Y$GEAP?F-3C
M3E:R$AZT=3&:N7!KN[^+K35LIM1D\Q">:Q6MF#@ 'K7=Z+"(=/5SUJ#FG$Y2
MZ\,7,;&4DU3BU-["7RBQXKT7494.GD\9KS&]M&GOBP%%A4XWW-?_ (20 <M4
MUKXA1Y0H:N4U"W,$1/>LNRN9$G!YII';"DCL]5833^;UJNC^9"0*:SM-IY<<
MG%4K.5PA##FKZ%2C%(IRVLG]HJ^3UKU3PI<B.!8V/:O/%#27 .*ZW2'>#:Q!
M&*QD[LY*L4TST8X)!K'UIPT93N:B35U\OEN0*S9K\7%VH+=Z2U9PJ#3U,]=(
MDDAD'/-<OJ&EG3][,*]6ABC\D'(Z5R'BN%&5A6G+I<ZZ,[NQE>#M72.0QMZU
MW=UJ:6T 8G@BO)M,C:VN2R^M;&KZO-)$J+D\8IIV*J4KNY>UKQ#&X95/)KA+
MR1Y69@3S6A'9W-TVYT:KT>B2/&<H?RH)BTG8R=!OY+9W#L<&KSZB/M2MGO65
MJ-I+9.<*168US(#GG(I\O<VGJCW70-1CNK2- 02!6U-"&7I7E'@+5Y'N?+D.
M #7K,;B2,&L).S."6C.7\162FU8A>U>86FH):ZK*C]C7MNH6HN+=U(_A->):
MWI,EMJTL@0X)JHZG31J=&.>]#WA8=":O.@N(/6L,IL0-WK3TJ<R2;&Z5T)7.
MV*3*4LGV5\=JOV%P&.X&JVJP*9#BJ5K,T3A13E&R'-]C4U".:0%E8XI_AZT=
M=05V.>:O%-]AO(JIHEP_]K"+'&:R2.*HCVO1_P#CS7Z5HUGZ0,6@K0JSRI_$
MQ.]+1102,*G=FN;\4P^992#VKIZYWQ*V+.3Z4T:T?B/$+F)X;X@9QNK4#_Z,
M<>E/F@6:5G]#2K$/+*U1[<)>Z9R.Q# $TL+LDH4GDFI7A,;<"J4TA2Z0^]5T
M-%.R.B56BC!<Y!%5+EU*DKQ5"_U9U,:"@S9ASGJ*=B>:YGW(:>7"GO5J*,VZ
M FJL3'SLCUJ>^F(AX]*N*,V]1LEX"<9JW:2&5&P>U<W%(\DI!]:TEN&M5&.]
M63K<E^S^;.WUJ"ZM2!]*M02D OW-5VFDED(QQ22ZB:*Y(10 .:M6HDN/E4GB
MHC!N;D5L6$"1+N'7%)I%1V,Z]M973:"<BJQ;RH@A^\*T9KD"=@36<X$LIHC%
M">X_YFB^4U1:.3S.IK2CP/EJ00H6YJV%[F.B/YO4UT=JK&W S5":W5!N7K6E
MIH>0 8K"12UV"+2VNYM@')K:TOP]);7BDBKVDVVVY!(K8O93;MO Z5GH$B>]
MME33R2!TKB9+E8KGCCFNBN=6,UF4)YKEI(&>0MBGHR8WOJ=%::O&(]K8)JGJ
M]PLUNVRLLQF./>>U-AG$QV$\5+1JB+2@QF\H]S70W.BLL6_';-9UG#'%J,9R
M.M=7JEU&E@<$9VTDF)[G,H?)@9#UKE=21S=@YXS6[%<>>S<]ZHWD:F4$U21#
M,RXF\M0@ZFM70[@Q(0YZUE7T2EU([5:L<[,^E6D9)G86D*2(QP.:Q]4C\M^E
M2:=J)!V$UH7-H;I-^,U,CHILYV-?F&:O&$B,&HGA,<N,=#6K$BO%\WI69TO8
MQBA!YJ*6!B0:M7WR/\M$(:5,8H5C#FU(65WC"@]*2S)MY?G[FM&QMBTQ#C J
M75;*.&-67&:JZ!LT;6T2>,.%'-1:GI/D0^;CBI])E;RD%:FN2*=, )YQ4JQC
M)V9Q_P!NBB3:0.*JK>[Y?EZ4V.T:XN2,$BM%]'^SQ>81BB1JI*Q%!<R12[]Q
MQ72Z;XB"$!FKEBH(VBK^E6!FN "#BL);F52"9W]MK:28-1:A=^<I*TRTTD*@
MXJW_ &?GY2*PDKG!.*N8+7#PQ[B3BH8-65YP":WK[2D%J>*XIH3#J 4>M5!:
MFU/5'H>FSH^T@5OQG*URNB(V%XKJHQA:Z8HY*^X^BBBM#G"BBB@#/U%-T3"N
M:73_ #)2<=ZZ:_;"FL-KM(0W(I=3MH7:$-E$$P5%<WKVF*Z$H ,5>O-<1 V'
M'YUS-YXA,A9-V<T'=3B^IGV(:WN#D]#730ZPJ18!Z"N1><DLR]Z;;W$C/@YH
M9JXG96^NA9"":OOC4HB!SD5QQCV@,*Z30+H!@K&HDC&=,S6MVTB[\SH":[K1
M=46\@50>:P/$\"-:AQUQ63X8U!X+HJ3P*S>YS2AS;'I-PN^)E]J\L\3:=*UR
MS GK7I$%\DJ_>'2L'5X8YGXP3FG8B,6M&<O8WC6-LH)/%=#8^)HS'M)YQ5>[
MT,-9!@.<5RTT$EI+@ U5RHI-FU=ZBEQ?';W-:,UFT^G@J>:PQ9LEL+G!R:U-
M,U,NHA8T6-W\.A;T&7R+D0OU%=P,-'Q7F]W/]CN/.4UUFBZL+JU!9N:5^AR3
M@[W*^MA-K  ;JP;."5IAAC4GB/42EPRJ:?X?=YV4D4FBK:'4V):&(!C6I"PD
M2LN5EC')Q5JTES%E:E;F$C/\1:>+BR? [5XYJ.EO!,V..:]UO3OLGSZ5YOJ]
M@TA9@O>M+V-Z4W:S..TD2KJ48R>M>FR6C36(8\_+7"6EOY%^I88(->CVTR-I
M;9(R%JD;2VN<0UJPOU'O6_<S&WM-GJ*AMX%GN]WH:V+O31.B\=J;+5EN8FB7
MGE3'/<UW=HZW,8R,\5Y]>6YL9UVCO76^'KHM&-QK$Y:LC=,,:(1M'-<_?QHD
MO0<FM>_NQ''G/:N4O-2663[PXI)CHW6I9OD1(U; KGM2N@VV-3UXJ6_U8-%M
MW=!7,_:WFO4STW5I='6MCH1X=FFA$@S\PI+'PU/;W&]\XS7;:44DT^('&<5/
M<JJH<8Z5,]-3'F92MF6W@QCH*YO66%[+L4=ZW[;]_,Z'I5>/3 ;UB1QFLG*Y
M<96N8DUB\-BI]JL>&9F6]*L:VM0@46^SL*R-)@\J_+ <9H3N1+4Z&^N/L[;R
M>*DBOD: .:S/$#$68:L<7QBT\9-4B;*QOW]Y&T!QBN95&ENL]JIV^I2W5UY7
M)%:D\;6T/F 4F:01IB_2VMO+[U@+9O>:H)NV:2RF-[>!&[UU2VD5G'O.!BA:
ME-)&3K&GM)IYB7N*E\+Z4+:R^<<TV[U.-VVAABC3M647"P!A@U443.+M<L7R
MXN>.!65>Q,9-ZGI6EK4HC.Y#DUD6]RTQP_ J6M2H;&[9Q>=HT@;DXK*TB-K>
M[QT^:K1U%+:V,2L,$5GVEUNO5VG.35K4QG%J[/2[,YB7Z5:JAIK;H%^E7ZW2
MT.">X4444R0HHHH ***:S8H YOQ=ILNH63I&,DKBOGO4/AAJDVI2R",X)]*^
MJ,!AR,TS[/%_<'Y4 ?)6H_#K4;* N4(P,]*Y[2M NK_4&MD!+*<&OJWQG%&F
MFR80?=/:O%O "JWC*?*@C?0!C?\ "K]3>,,(SS[5T'@_X=ZCI^I"26,@9]*^
MA+2WB-NOR#\JL"")3P@'X4 5=)@:WL4C;J!5SO3L "DQ28&9JMRL<!YYKC+.
M/S]7+GD$UUNM6^Z FL+3( ESFL];G12\BQK=K$+(G:,XK@(U22]\H"O3-3C6
M:V*YKD#HHM9OM5-L[*3T,J:)K.?<.,5KQ7S7%EL#?-5#4&-QG JUHMKR U0U
M<WEL4($?^T0C=S7?6\ 73]N.<5QVH@6FHB0=JZ?3=0^T6F?:A*QS2BV9KZ:7
MN=Q7O6];HEM:D..U0QS*9P#BIM2*_96(/:BP26MF<AK=Q%]IRG8TRPGEE<!2
M:BGM3<.S'UK<T'35 W$]*E(INRN65DE@4%R:UM-U-'&":R=:D6-=H(K)LIVA
MRW-+J82AS'2:_J"QV[8/:N(L;QGN68GH:U[F3^T(V!/2J>FZ4,N:HZ:<%%"Z
MIK02'R]W)&*M^#9629FD/#'BN?UO3V%U'UZUNV&+)(N<9I;$U4FK(] C((SZ
MT28,; ]Q4%C*)8%.>U3R >6Q]!25[G"UKJ<G=:<INB^WO3KNXCM+8 \<4E_J
M8CF*@]ZR=5<W, JT=U-:&?=ZK$TH />NTT/9/:H3SQ7F<EBWF \]:[_PQ,1&
ML9[5+3N35>AU!"HN!5:Y"B,ENF*F'S/BLS6[D06QY[4HZ2.>DKR2.(\2M%EM
MH&:J>&)\7H&>]5;V<W=RRGI3]$01:B!GO6\K6/3G'W3UVV<- *F^M5-..ZW7
MFK,G KF>YY,E[UC*UTC[$U>;23-'<'GBO0M8?=;,*X"\@^8FKL>K@URQ,B[D
M\Z[%=CI=L?[)+8[5QT<6Z^ ]Z]'L(O+T4\=J:1>(J:HP;%]M^JGUKNP@>QZ=
MJX&VYU91[UZ F([0 GM0EW..ONCR_75:#6T(X&ZKMP5NK<'KQ3O$L2/>[@1U
MJ"T/[K;UIVT.NC>QS-TA@N,C@9K?TC65@4 M6?K$.TDBL2/>&XS4'3**:/2_
M^$CB6/[_ .M-@\1Q2JP+5YK<74BG;D\U<T[>?7FI.5P5S<UB7[7<JT/8U>M[
MTPP!7/:HK"Q!7)IMY;'S%';-4AJQ+'.!(6[&H[ZXCD>,1?>SS6A%I:O;Y!R<
M5F&Q:&XR<\&AHSDSLM#W);*S>E9OB7Q%'9#&[!JUIMS^Y$8],5SWBO03=J'R
M>:BYSZ7+6D>(UNC@/FIM3U*!]H;&<UB^'M"^S')-.UBR,;9!SS5&L5;8['3I
M[4V:\#I26+0OJ!V@=:YK29G*"/FNCTFS(NMY]:(LYZB2.PA $8Q4M,B&$ I]
M=2V.%[A1113$%9FKC-JU:=9NKG;:,::+A\1XIKQ9=5(]ZO:7$TK+2ZO9&>],
M@'>DMK@V.#CI6<KGLTFN4["VTY3#RO.*U+'3X\8916#I6LM< #%=1:W"C!)Q
M6;5T<]9-FE#;I F ,4[&:194D&0PJ1?NU#5CBV%08ZTCD%J4'(S3>"<DU%G<
ME]QV0, U'.JF,@]ZJ7EXD4@^84Y+I)X\AA6B70J*ZF)?QV<.[>HR:Q?(M9]Q
M11Q5?QE?M;-\IK!T35Y)-RD'FM$CT*42?5S!$<8%8Z:@8<A6Q6GJ%JUUEB#6
M#<6C(W /%6H-G8MB"]FNKAL[B13[1I[<9R14\ )X8=*=<D)'5<I+=BN;BYGG
M4!CUKKVM9)]+4/S\M<;IL^;KGL:[>TU!)(1'D<"G82:.6AC-G?,6X&:V//$D
M>0:@U>W!.]:98H2NTT:6*N0/=D3;6/&:ZB!A-IZA?2N:.G^==8]ZZ>U@^SV@
M'H*S9#:95;R[8;I!5Q/$5LMOY:L*PM6F:7,8K,M]/9CG)J"79G3W&OQS1>4&
MYJWI6G"XQ*5R*Y%=.D2XW8.*Z_1]4$*B$U:,V[:(P?$MJ(YF4#BN76(!N!75
M^*+@O*Q K"TJV^UW 5N,U5T=,)VB;.D.CP^0W4U<?097F'EKP:K6=GY&N1Q#
MH37J$%BJ1JQ Z4;G)5K69PT.@R6[B61?E%:9,30E8P,UMZS.D=BXX!Q7#6VH
MLDI[C-9-(F$F]QE]<S6TFTL>:B@O74^:Q.!4]TJZA<KS6A-H(72I'_V:21<D
MDBWI_B..:/:&Z51UJ?[0"0<BN:TF$PRN-W>M\1B6,@GM5IEPCKH9$$L:!L]:
MDM3'/<*6Y -5=1@^SDX[UDKJ,EM*  >33-6KH]3MAI_EH BYQ6U;65L\1(0=
M*\I@UF5&0G-=YHNMK)" 6'2J6YPU*;6QG^(=#2<-Y:"O/KK17CD;*\"O6+R^
MC"M\PYKD-0E5W;&.:NZ.J";6ISFA-]EO0%X.:]FTQR]E&<]J\D^RBWG$H]<U
MZ#X>U59HDBW#BN.=[G-5@=2,,,&N9\2Z)'+ TBH-V*Z48P&!J.]Q) 5]13IN
MVYS)M/0\*U& PSF/'0U<TZR=4\P#M6YXFT?RG,X'6JVF2J8?+/7%=4&>C2D<
M[=3A[LQ'K48@Q)G%+=0A=8=L]Z?+*%K:=FC=,V1=QBP\OO3- C5]45@.<UST
MMTP'%;?A:?-^I-<Z6IA6M8]NTP;;8"KU4=+;?; U>JF>-/X@HHHI$A7,^+)
MFG2_2NFKD/&7_(/E^E-&E+XCR^"X#"3GO3%O5CDVL>M0V:9$GU-17-HQ;S!G
MBM$CV8?"; V3)D5BWZA)QGUJU87)'RFHM3022JPICLRC<6KSLK#M3W)2/:?2
MM2U4&W)/85GRIYC-[46N FGQ;BQ(IE^1$"&JYI@P2#4&L0;^E63U,>!XUD^I
MJ],GF*I%9GDE7%;]C#YD8SV%4!78>5&N:LVZ)U(ZU'>)R%]*EB7;&#Z4G<M#
M+O; NXTNES^=(R@\55OI/M"[ >E1:1)]GN"#21+:L-U2*19V(HM8VVY:M"\
MF.:CB3"XJHD,I^9Y<W/2K#*^SS!TJM=Q9;BI1<D6PBQ3EH))EJWC:;WK>THQ
M0S!& K.T9 [ &I93Y6HX!K"6QLHM'7P7,,=P",8JWJ16:S,BUQD]Z8AD&M&U
MU?S['RR:SL3)&6TS)<8)^7-:T/EM%NQ63<1Y?BM"-#'II:KBBHD.H.AMV"5@
M6Y>-\GUK7MA]J;8>YINH6(MD.*3+2*\4LCW2N#TK1U"::2WQN/2LBSDVGFM&
M68&$_2A T9=I(8F(;UI]WF5@RU QS)^-,ENO).T<YK1(QF1RQL>3VJ:WNXHH
MRIZU'Y^X8/>L^YC(D!4]:T2T)-"&X(NE(/&:]!TVXA-EEL<+7F&XQ%372:7J
M!D@,8/48K"2+1<N[R"2X8)C@T]'+)\M8\MJ\,^_GYC73Z-8^? Q([5C8UY]#
M&9?,?!JY:HL3#<.M$L'DW1&.]6+FW*1QN!4W,^;4TIK0&V#Q#'&:Y?4K[YQ$
MQY!KK[2Y7['M)'W:X#68F_M!G4'&ZJ+4CM=%"_9E<^E9NNZCN_=*>E-LK_R;
M!%SSBJLMH;IS)ZUDF[F<C5\.0QS.N0":WO$-LD>G?*,'%<WX?F-M?;#T!KK=
M8VS6 .>M:W,I-W.$L;22>XV@5T]H\.GD>8 "*-'M%CEW\55UN+S9F"FLW8N[
M>AU-EXCLY6$0(W5NK-$8MXQ7B=J9;74LG.!7:2>(##I_!YQ6=M3DG1=SK;V5
M)("!7$2Q#^TAD=ZBM_$[2_*U4I]4Q>!Z:W-Z=-QB>EZ1&H@''-;*]*XW0=7\
MU%6NOB?>N:WB>?7BU(DHHHJC *#110!D:O,(H&)KS+5]:V,ZAJ]&\1)FTD/M
M7B6KY:Z89[T]#OPZNAKW5Q<%L,>:ACL[DDLV:T=(MBY&171_8 (ON]JR;U.Y
M2L<_I\1P0]2.BV[[B*T$M=DAX[U3UA-J#M6L=C52N217*2#%7K+S(Y0P/!-<
MM;3[9!SWKJ;"<2!<T-()1NC>OHY+FS4=>*P&7[ Q8\&NOM3');@$CI7-:]%N
M# 5@]SGLKV*UGXB\N8AG_6MC2[IK^[ZY&:\Z:)A<XYZUZ3X-L2"KD55M"*EH
MH[%+93;;6':N1U?3E,W"]Z[LIM3'M7/7JJTY!(ZTCDA*[*-U9JFA*-O.*YBQ
MLIA=[AG%=KJ'_(,"BL:!EACW&ANY<'T,C6H7: J/O5+HR7%K:AV)VU9#+>W7
MEU>NE$%IY(%2:W.:ORUS>;NHKL/#D*1Q*2*XZ601/R:W-,U8)$%!II#<;Q+^
MO7_E3X4X%:WA^\66SW,:YFYA.I7'UK5CC_LJP(SVJK'-*&ECH+F57C(7I5!;
M".:)B5!JCI=_]L.W/>NDCC6--N1S2)^$\WUO1I$O1)&N%!I8;QHH/))Y(Q7=
M7MFLL9XK@=7M_LMZ /6H3L=,:BL:^CVCL?,[=:ZB)590".E9&@2!K7'M6F9!
M "2<5HY:"DW(Y_Q' OVA,#O5G2H'"KMK/U:^$]\B YYKJM,MQ' C>HK-LYY1
M:W*.K6<\MN=F<XKBCHU^7D8YQ7J4C#;C%4S&FUL@<TDM1P;/&[ZVN8YPA)ZU
MIVVBRNB2!?>M_6]/3SO,7'!S187RX$6!Z4SKB]"YI<[0*L;'I6P\GGIA:Y[4
M6^R!9!_%6IH\_G*#G.:E]A22W+5I;LDI.*O>2.H'-2!0@S4;3A,DFH,KM[&3
MJN0F*33;7< V.:;?RB9L"I;>\6VB4$BB*U+=[#M>@W6.,<UP>I3%+7RP>:]%
MNW2ZL]V1R*XN]TP3SX'/-;$PVU#PMIK2R+*PKK-7LU-F5 YQ3-)M1862MCI4
M.J:J!"3FIL%W?0YS2[=HM4 ([UJ^(KPI:,B'#8JG8SK)<^;D5%J[&9S0C>&^
MIRT37,C\L:M6*7"ZDA)-7K> (=Q%,EG\BX$@'2J-96L;5R'>10QSQ56YB*1'
M9P:(+TW0#8JP2TC!2.M22CE;R2X ;+&M7PR'ED4MSS5W4-,3[*SDC-+X7B4-
MQV-5$RJ['I.F#$(^E7ZIV'^J'TJY6R/+EN%%%%,D**** "D(S2]J:K9- ".Z
MQCFH/MT6[&X5D>)M4_LZU9_05X_<_%%;>]=">AH ]/\ &]U&-,DR1RIKQ?P#
M<QIXPG8G@O2^)/B2NIV9B4]L5PNAZ\=/U5KDY&3F@#[#M;V(6RG<*G2]B<X#
M"OGV+XJ*ELJ9Z5M>'/B*M_>B//>F![AG(R*054TZ?[39K)ZBK@I"ZF5KLJQ6
MF6-<_I]PA?<#6UXE@:>P(7TK@=/OC'??93G(K.6YUT%=&U>ZKB\,>[BEN+Z*
M:T\L,"U9M]ITAE,P)K,59(;C>Q.*FYVQC9&M;632-\PXI[M]CN..!6A97"-;
M;\"N?UF]'FD"F7?N.U".2\.]!FM/1HI8+3YP14&A7"/#AQGZU9U'5X[7]TH'
M-%B7Y%>:\=-04 \9J6\U%WF6/=P:QUN?.G#U?CMC<7"OGI4IBT-);8?9&<#M
M4%K>M;Q.<X K:2,"U\ON165<Z6_V60#O3,WV,"[U)[R^55;(SS6\;8)8EL=J
MYVRTY[>[W/D\]ZW+[5%6$0#J1BH"#5S'2\*&09Z5J:!="=V&<\UCM8/Y3OSS
MS1X>E-I<D-W-5$Z-&=%KMLNY'QTK"U&]VO"J'H:W]7G$L*X[BN8FLF:57)[T
M2W,^6ZU.]T"X9[=,GM6GJ%R(K9SGM7.Z%.(T"D]*?XBOA':D9ZBFEH8.E[QQ
MTM\]QJCJ#D!JV+YU^QQ[>O>N4LV(OI)#W-;$-P;M_+]*JQT^ST-BRLTN8Q@9
M:M&UB>REZ8&:KZ.XMI/FK4U.11$KKCFI>QSU5K8V[>0-!N[XKC/$]]@,N:Z*
MRF_T4'VKE/$%F]P[,,\U$5J9T8VD<PS*%WCK2:7*S:AQUS4MU9/;VV3FF:%$
M?MP<^M:2/3WB>K:.S?9ES6E(<C%4=-(%LIJV6YW5DUJ>347OF+K7RVK&N"O;
ME0IR>:[/Q%= 6["O+]0G)<X--H]3"I\IJZ3 ;B^4@9YKT&8"WTHJ>.*XSPF/
MWBL174:Y> 6Q0>E-&=6\IV,6P :\$GO6WJNJBWL6^;! K TV7 W5E^);MFC9
M030:2IWU,>[U66ZN3\V>:WM)RT'S=:YC1K)YY<G/6NX@L?L\.?:F:0T,J_@+
MGD53BLT(/'-;$SB1MH%(EH5;-2UJ;G/W&E,\H(7BM*TM$AC^88-;.Q-O056>
M S2A5&*BQSS[CM/D/FA>V:TM4M@MN' YQFJKV7V(+(3[U9%XNHV[(/X1BK2,
M'+L4= OBUPT<IXS@5O:C8*\0>->M<K:VK1WV1_>KT&U426J CH*3,)R=S%TB
MSD20EQP*L:J\3)L)&:V"%CB; [5Q=[.TM\5S_%4-F:>H\I+$-R#BJ,C>>Q#U
MUJ68DL5XYQ60^BN'=_:F;1EH4M,,,=Q@XZUV]@(M@9:\IEO&M]3,63PU>D:$
M3-9HV:([F5;5'2ITXIU,C&$Q3ZZUL<#"BBBF(CYW51U2-I+<J*T>],E4%>:!
MQ>IP!TW_ $C,B\5CZSIX$F47Y:[O480J%@*YJ]&Z!@1S429ZE%W12T**., M
M1K>L_8Y?D? K!EUK[!-Y596IW+ZB?ESS4&THW.UT3Q.)7"M)^M=Q!J4+Q@[A
MTKP_2+*>*=>6ZUV\=Q);PC)/ J6CCJTSN)M2A12=PK&N=?C7(5ZYY;N2Z0J"
M:R;NVFC?<6-*Q,:98UW7)O,RCG%2Z%KLKJ0[U@SPM<,%ZUIZ=HTD:9YYK1*Q
MO&"'>([B.[=<G-3^'+"W(S@5E:Q920_,2>*BTC71:[D/:KBCIC ZW5EMX$P,
M5A)%!*6)Q56^U0WIX-49KTVB8SUK9#;Y5874);>!\(165JD^Z)=AZU)'8S:G
M+N&>M6[O0I8H1D$T-F3J:V,FW1O+W)]ZK6F2W8NB#G&:L:?;F.4(PZG%=QI_
MAC=&LX7KS4IB=5+<Q95+0*9*=&\*)A3\U;]]HS>3M Z5S%U826DFXDXS6;W*
M4[FK963R2;P*TY[>18L8IN@7D;JL9 R*VKUD$7 %2Q.5V<@UF)'.1S4$$)6\
M\O%;MK%YMV:M)HA^V^;4@Y#X],A:UW%?FQ7&32-%K?E)ZUZ//'Y%IGVKS>X.
MS7_//3--.YG%W9JSZ5+=+EE)JB-+EL9-X4C%=]I/EW-N)-HZ5-J&F+/"=JBK
M2N@E5UL<)I4R-K,;2'Y@:]-:X3[."#QBO-[G2)+*\\_G -;,6M;K,IGG&*FY
MC*+D[E#Q-JN6:%&Y-9VF6;26+R,.:H:C%)/?B0YQFM2VU5($%N0,D8J&S:*L
M9\+RQ7R@],UV,MVIT=USR5K+BTK[6PE7ZU-=6[0P%2>U$2])'(0%TN']S6M'
M.T:\GK445J'FS[U+=PX9<&J-X%*[)FD /.:D30O.96V5)Y'S*_I6]87T03!
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M>M333O?1?/WI9PLS%0.:C5A'^Z_BIWL.RN5X;=HI,(.*GOY#]C(-2B\BM^'
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M#[05=>@JXD57[IU-@"(AGTJY4, "H!4U:H\R6X4444R0HHHH **** "BBB@
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MX\ORJ[C6+%)(& '->:ZE92V\Y8*<4K'J4G=%:XM3=7P<'C-=OI>G*=-(/I7
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M"2.:&.H_=T)-&\/O9SL[#@<UF^(]85"8 >1Q7?7,D<5NS CD5Y!XBBDDU!W
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M]CKCH^PJ:WK=S>D97%-.Z"]S!EME@;?CBH[J\46V%-=%J^GJ++@\UR;6;O\
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MY[2=+V6^X^E=#I_[OY:<695;6L;B=*?3(^E/KJ6QY[W"BBBF(**** "BBB@
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M!!1110 4444 %%%% !1110 4444 %%%% %>[B$L>TU@'3EBG,E;LQ(K.OR1
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M(9ASFCQ%:2+<<"GN7I<I7,6;%W'I4'AL![M=Q[UKV%JTVENC#+$5CI!+8W6
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M,:@&-R'&>M:^EAI5'7BM"ZT@,P^6K6GZ?Y71:3B6JA:@/V> D^E<KK>KKYA
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M !1110 A&:84YI]+4VU'>Q 8%8_,*A:RC+?=&*MYYI13L'.RFMH%DR!Q5M5
M&*=12Y4%V,V_-2L.*=2&GRH39$%P*8T"R]1FIR.U*!BG96!292-DG913DM%
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MIII=P]:0LOK0F)H,9I12;E]:7<#WHN%A:,4F11N'K0,3'-%&]?6@L/6C87*
MIU-W+ZT;U]: 2'44S>OK3MZ^M ["TG>DWKZTN]?6@+!2$4NY?6DW#UH%8!3J
M:&7UI=P]: 2&D'-*:7</6FE@>,T!RAG- .:% QUH48H"PZC%&X>M)O7UH'84
MBBC<#WHR/6AL+ :!11D5/,%A:*;FC(I<Z'8=12;@.II-Z^M6(7%+3=Z^M!=?
M6BP#J3/-)O7UI,KGK0,<:!2;E]:"X]:!6'4&FAP>]+N'K0%A.].IN1GK3J!)
M!1110,**** "BBDR/6E<!:*;D4N10F M%)D49%%P%HI,BC(HN M%)D49%%P
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M)&DQ7S!^=>>6M])-,7W'FL^[GEDO2 Y_.J4Q^Q/55\21;<F08^M6K+78YY@
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M9Q+!(WS5Z-:3"Y0..12<CFFK.YYEXET9;.VD9%Z5P5J#(S9[&O;?%5JLUA(
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M'TJ:J]J?W8^E6*]&G\)P/<****L04444 %%%% !1110 4444 %%%% !1110
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M.;#05L:O'''9[4ZUS*RM]TFGRV+3N5I"Q.S%=!X7B_TY0156"U249QS6]HD
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M_F X/6NJM]0:2%5(K'TO2_.D "UTKZ0\$ ;;CBD9-E=D693FL/4+0$G%:3W
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MI'W3VNU $2X]*GJEIK%K=2?2KM=BV/-EN%%%%,D**** "BBB@ HHHH ****
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M2>A2OK39)MI+;3I%/G D 5HQE;E=S=:M$HML4!YK5I&4EJ8-U.TDX0\U=LK
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MT]1QFD5N(%XQ2JO:G4H!ZT"L&WM3@ORXI<<9I5S2:!B(N.*?MP<4<T<]:GJ
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ME:I'.V<](X:\*^]:J92(>E8[ ?VHP]ZZ$0@VXH<2TS2M)H5M@2!FJ-Y<[6+
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M%*IVTX#'/K0%@/3CK2X.VE YS4G2D/J-4$BG8.: <<U)[T" =/>I%6FJO>I
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M3U"T7;&/I5BH;<YC'TJ:NZ.QY$MPHHHJB0HHHH **** "BBB@ HHHH ****
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MU#<9$1J6-;G"^*I0=R5YK.6$^T=,UVWB>?%PRDURNU6.XBN6>YZ='8J) 9)
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M0M%*J=JQKBZEE?#FF&W=AN4<U+1*5SK[C45N4 SU%<YJUB#\X%16DDRR /G
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MOM&U+RK?!/:N-2$!LM6A!<^6A -.4.I25]"WKFIAY,>IJM;7XLX]Q[BJ$O\
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MM]*FP18]X@<D=JH2W)1MIJ6PN3+*58\9JUJ=K"BJRXR:4D;(Q;F3<ZD"NO\
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MFI,"N8Z42#Y!]:>H[TQ>>M2]J '=*<!MI%P>M28S2;UL,%XYJ1>*1 .].--
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M0;#BN9OM:"7_ !TS3I)KA[?>P-9#64MR?,"DF@3=MCK++75E C/>M<QK+#D
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MM4'B*:0DHH)!J-S+J:$)6_TV1NM8^FQ?9[X*./FJWHTWV?1Y-YP<=ZIZ9/\
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MFI$Q7S <X]Z^A?!\+6_ANUC<88*,USVO:C86LQ,D:;@?2HH/B!9P1"-2H H
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MJ)Q)-, @R,U!!&P! [UM:4@CD!<9JD0Q8=(D=/F0\U)_9J6T;$C%=5%<0>6
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MSE;W>J)<J?+?K7T1\/99Y+"(R@@X[TG_  @]IY^1 N,^E==I.F1V,2JB@8I
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M3P*7Y'>@D]7L+6SO;7YF7.*XCQ9I*6K,8AG/I5#1]=GBG\LR'KCK6SK-]'+
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MUW^O[;E2HKCKFV:U!?IFM(G53U(8)!9W!*FI[[53<0;":RWW9+D]:J*DLLV
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M6.W.#VKA0Q,A;WKH=4NI+PD(<BL?[.85)<8J5*QK!HT]+NO+(8]JT;O4_.(
MKFEF C)0U):W0+_,:TBRY(V4.X\U!?6X8;AVJ03(4RIJ(7 =L,>*U.:2(+/5
M'M3MQ4]PYU'YJBN8H2P*8K2TRUWKD#BI;%8SXM/P=Q[5'J5\((&0>E;ET@C4
M@=:Y?4K665^ <5',-1,O296FN78\8-:NH732*J_W:K6]KY/W!@]ZGDBR,FI<
MQJE=C[.X9\+Z5=O0P@!&>E9L#I'(/K720+#<0 -SQ0YE*E8Y-9GDD*D&KUOI
MQG.2*ORV,2S94=ZZ&ST\>0I5:R<[#2LCF5L,ML(QBM>SAV *.<5-JJQV\0V\
M-WJ30BL\H#5E*9<2Y%9-<KMP:S+VQ:!R.>*]#MK:"*+<0.E8.HI!-.53!-<[
M[E\QS4$SH-N#5NVF_?9)JZ]DB1YQS6+<Q3(Y9 <4XD[LT;K50C;*S[@"YCW&
MLV5GW_/UJ;SS]GP#S6UM N7+)UM6SFB;53]M%8YEESBGQH2^YNM9/<J6QV^A
M7?FWJ5ZI9G,*_2O'_#7%XF:]?LC^X7Z5T43R\0M2U11170<HF:6BB@#/U$?N
M6K@M0OO)=D'<UW&M2!+.3UQ7E[;Y[MBW0-7'5W.R@KHG0ELL:8]ZL)V^M+>R
M+%%A>N*YF>>0R\GO6*1U)&Q?R[ER.]1Z>20V15>T<R#$E;-M'&J'%6M#5&3+
M$6F_&M&V@W!0:$C4NQ-+'.(7^8\4-W!W'ZC#LB7%-AMSY0/K4SW$<^ 3FM"#
MRC'BD-:&%)9'<2*9:NT$W2MQ!&LK;^E4YEA,I*T)FL9$%W\T>\UE)>&.8 >M
M:6H9^S86L&%3YV7]:'J:/5'?6&HE+-6S6A9ZIOEY-<K:R$PA1TJ[;[XI-QZ5
M+.2I%,[>*4,V^I))QZUAVVI1[-N[FH9=2 FQNXJ;V,E2YF3ZF?,0U@[C$*V#
M.LJYS69*%\_G[M-:G0J=BD\!N&W$5=M8!$*<\L*# (J$.S\ITJC1)%N4AEJJ
M#M;.:1B]1!)'D&.E -6+O]HF$5(FKLZX(JA+;ON!(XH#1+\HZU5B5%/49?MY
M^35*!BJE,]:L7!VGGI5'SE%T@SQFCEN;)JQ-]B+98U ULP?I6Y(\6$V]QS4L
MB0! W%2]#-JYST\9C -:>C2M/D-VJO>R122JJ$=:U8+=8+?<@QD5-P<;!>7A
MA("U!-=/-%G!Z5 )%DGQ(>];L-I%-;_*!G%!#LC"L=3:*4CTK1DUIF7%9\]@
MT,['&!4?DEN@H,G%$5YJ!#9/>J&J2>?: @=J+]2[!$Z@U?ATZ22T&Y>U5%V+
MAH<4]T<F/'2K>BD37FUO6EU*R\J=L"H;7-K()!QS5\US>^AW%Y8HE@&7&:Q4
M+/\ NS5^RU 7< B9LT^XMUC7<HYI6,[E"4?N_+J@]EGFK%Q+Z=:L(-UKGO2;
M!FQX? 4+&:U+W25FDW8K*T16\P&NDNY1'!DGFI>IFWJ<5J<7V,D 5EQ7^#R*
MW=0DBGSDY-<GJ,B0$A3S3C'4I7(M5F%RQ JKIND&28/CBFP/YKX-=?8BW@TQ
MF; ?%=D59&4SD]9N38W"Q+WKJO!MV6*YKC]23[;?9'/-=?X6MF@9 1BIOJ8S
M6A['IK;H5^E7JS-'SY SZ5IULMCSY;A1113)"BBB@ HHHH ***9*VV)F]!0
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M;%!*FDM=,6)<D8HN4B[':BZ <=J=+:F)<^E-6X^S_*IJP)?/@8FF7$HQ/O;
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M\SD4/$ICNI_E KDI]/.[('%7KK42\N2:1;I95Y(K-S/0A2DS,%LJMR*)@H&
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M1VUN<H/I4]5[48C'TJQ7HQ5D>7+<****H04444 %%%% !1110 4444 %%%%
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M0X8#-6V<RNV8]O-)8+Y8R!5.Z?[5/N/-:.L >80O%8\3[),&L9.YV0IV1/\
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MZ4ZICFK=W/OD '2N<AG:).M7K6[#_>/-3;0Z+$D\SI)@"J]PLDD9.#5QRCR
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MB@ HHHH **** "N>\5QE].;%=#61X@4-8L#Z4GL5#XCR6W&;ORS65J:BVO\
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M;)]:74G6Y#-<E(U'K42W.SJ>M6C;+,@[D5GW5O*LB@*<9H8S9T]P,L>]-N9
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MZFC9B9G2WS27) />KLV9+91FLM8QYN[WJ_+,JPJ :I:LECX+8!<D51O-H8C
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M[#>]7 )O0]E\*,OV-!WQ75UQWA'FV0UV-=4-CSY[A1115$!4%T<1&IZ@N_\
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MF08S19EE^ZNHY$PQK*CTTW$^57C-+?1F( YK7\/3HS;3B@AZFM9V\-K:CS
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MCC<:;%A4W/UK*6AZD-8CFA!C)[U)IMD3)YY'*G-);(]U<J$^[FNEEACL;3#
M D5,;W![%BW\0LD6PG[HQ5#4=1:\!!KGY)':8E#QFKUN"V,UTI.QSS5R;3("
MLN[WK0U:=TC7':FP21PX)I;J:*Y3 P<5C49UT*;:*-KK#J=IK6M2EZ<N17+S
M0MO)2I[.\>W;!-<;W/3I*S.BO+:-$P,5SEU;(&)S6E+>FX0!3S52;3[BX7Y
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MEN(RC=ZQ#X5MRQ;:.?:LY0N;0J<IY?+"=GW:2S4H_2O4#X5MR,8%-7PE;*>
M*R]CJ;?6#SVX<NHP#Q5&0%OX:]2/A6W/84S_ (1&V_NBG[$/K!YK9C$H^7O7
M4'#VRC;VKHX_"5LC9 %75T*$+C%'L@>(/.Y;<ECA:IS6Q;C;TKTT^'H">E,/
MAJ GH*/8C^LHX?3&\KC;TJ/5;CS!M"UWB>&X$.0*9)X7MY#D@4O8!]9//K-!
MC)6J=VH\XX7]*]/C\,P(.!43^$[9VR0*I4K"^L'F$4OS;=M9NKL?+.%KUT>#
M[4/NP*BN/!-I.,$"J4!K$V/*_#%IY]TI=,_45Z/&D42A!&,_2M2P\(VUDP*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **2EH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "DS2TF*!,6BBB@84444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 (3B@'(H89% &!0 M%%% !1110 4444 %%%%
M!1110 4444 %)2T4F 4444P"BBB@ HHHH **** "BBB@ HHHH **** $S2TF
M*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **3%+0 4444 %%%
M% !1110 F:6DQ2T %%%% !1110 4444 )FC-&*,4"U%HHHH&%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>image16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image16.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0R!W@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU$/<5YB^OS&3C=3TUV8<X:@#U".[5SUJXN",UY[I.M22S '-=S;3 P@L<<4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHI"<4@8&@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 (3Q5"^E=8&*=<5;8'-,:(.,$4
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ML^F6\GWD% '@^A>&)[?4%;RR #Z5[?H\)BL44CH*G31[5&W*@S5U(U1< <4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI"P7
MJ:  FDW#UK/OM0C@3.\5A'Q"F_'F#\Z .N# TM8%EJJSL &!K;1]RYH DI-P
M]:SM1NS A(KE;OQ'+&3C- '=[AZT9%>=P^*GW_.V/K6_INNQW+ >8#0!TC#-
M, QU-,^U1A,EA6)JVM+;H2C@T =%N7UHR/6O-)/%TJN1DUI:9XG\YP'?% '=
M450M;^*8##@U>!R* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#/;2('7!4?E59_#EHW5!^5;=-84 <W)X4LG_ (!^5+!X4LXVR$'Y5T(6GXH
MH6VE06WW% J^!@8I:* "BBB@ HHHH *0]*6FL.* ,/5QD&JVD@[ZN:F.#4&F
M8WT ="OW12TB_=I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FL>*=2'I0!BZF>#4&F
M??J35N <57THDO0!TJ_=I:1?NBEH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:W2G4A
MZ4 8FIC(-0Z8 'J;5GV@UG6%X$>@#K%^[2U1AO0X%6EDW4 24444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4AZ4M!Z4 <]K>=IK$LT8O72:G$'!JI86B[NE $MM&1BM2'-.
M2V4"I50"@!_:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **,TFY?44 +15>>Y2)<[A6:^LQJV-PH VJ*YZ7Q!'&,[Q5(^+(
MPV-XH ZZBN6C\3QN?OBK\&M)*?O"@#:HJM'=(X^\*G#J>XH =13'<**C6;)Q
M0!/12 Y%+0 44F1ZTQI57N* )**A6<,< U,.E !129%-:11W% #Z*K_:%_O"
MGK,K=Z ):*3(J.24)WH EHJBU\J_Q"G17BN>HH N44S>,=: ^: 'T444 %%%
M% !2$TM-:@#.OF%0V)&ZI+U,U'8IAJ -@=*6D'2EH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** &.VT57-P >M/N<[#BL=O.\SO0
M!/J&H_9XBV:XC4_&;P%@C=*VM=BN'M&" YQ7G']CWMQ?,'0[2: $O_'UZV0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH 0J#UJ/R4]*D)Q3-^30!7N(X=
MGSJ,5G1PV)EX1<U8U5RD!(K@+[7WL96;)X- 'I<=O#M&T"I!"@Z"O*[/XB[I
M?++5UVG>)DNPOSCGWH WKN[6T0LQX%<U?>,[:#(+#BHO%NHF/3F=3VKPRYU6
M6]OVBWMU]: /81X_M0_+BK]OXWLIR!E:\?CT*21 _F'GWI'MI-/^;S#Q[T >
M\6VI6E[@ *<UJ)IULXW!!7BWA/7GDO%C+$\^M>VZ>^^U1O44 .2RAC/RJ!4Q
M7 P*?10!$ <U)@$<TM5[F?RES0!2U-$\L\5YSXAC7:V*Z?7-;\J-N:\QUOQ$
M6W"@#6\+1XOA]:]2F)%F,>E>'^&M>*W@)]:]9L]4^VP*N>U ' ^/)#Y#Y]*Y
M+P(RMJG_  *N]\<:6TMJQ [5YOX?+Z5J!<@C#4 >VZPO_$N&/[M>0^((I&9]
MM=;>^+3-:B/VK 0'4I"-N<T >?M'*DN6)ZUZ-\/F_P!)7ZU5O?"[;-P3]*DT
M4MHTP8@C!H ]QEQ]D'TKS#QNNZ-MM6W\;DQ;,]JP-2U0ZGD8SF@"/P'&ZWPS
MZU[M;#]POTKR7P=8%+A6V]Z]>MUQ"OTH 49%/#9I&7-"KB@!](WW32TUCQ0!
MY)\3O,\A]I/2OG+4?.\YMQ/6OK7Q5H7]J1L-N<UY#K7P\92S"/\ 2@#QR)P#
MS4DDHR-M=-J/A1[0GY2/PJ/3O##74@&TGF@#2\'F5I%VD]:]\\*+( FXFN%\
M'^##"R$I^E>OZ5I7V5%XQB@#;3[@IU(!@4M !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $%Q'YB$5F#
M3SYF<5M4T\4 <OKND-=6;(H[5Y%JW@&[>=W3<,FOH!OFX(J"2R1Q]T4 ?,EQ
MX0U*TRV]QBL^2*_M3@R/Q[U]+WN@1W"D;!S[5S-[X CG).P<^U 'A']KW<)P
M9&J1/$5ST\QJ]9E^%J.Q^3]*@_X52BG.S]* /+Y-4N[A<"1JKI::A<OQ(_->
MP6_PT1&^Y^E;=GX!CA(.P?E0!XI#X5U*YQEW.:Z70_ EXDRLVZO9+7PU'!CY
M!Q[5L0:>D6/E% '+:%H$EH%+ \5VL";(P*<J!1T%.H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "FN.#3J0]* .$\71YC;/I7A/
MBA-KMCUKZ!\4Q[HV^E>#^,(]C-0!K?#>8QSISWKZ T^??$OTKYU^'I_TA?K7
MT!I/^J6@#<'2EI!TI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "D(S2T4 -V"EQ2T4 )B@@49II:@ VB@H".E-&<U(.E #!$ >E/ Q2
MT4 %)N%(U1$'- $C-35)S0 :D H !TI:** "BBB@ HHIK9H 7(I:B4'-/+8%
M #J,TP.#0WM0 [(I:B4'-24 +12%@*0.#0 ZBBB@ HHHH **** "D/2EI#TH
M Y7Q&I,;?2O#O&47S-FO>M<3*-]*\4\;0\MB@#-\#'R[A<>M>\Z)*61:\"\'
MYCN%SZU[GX>E#*M '7K]VEI%^Z*6@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHXKS?3/&L=P5W2CGWKK;/6[>91^]7\Z -RBH8[F*0?*P-39S0 4444 %%%%
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MFAN* ."T >5..W->Q^%I=P7FO(XH_LTN?>O2?!EP7910!Z>GW!3J9']P4^@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ7Z5)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%&:1B!UK+U+4$MHBQ8#% $&O.!;-SVKS"\M!>W#)G.36CXA\6($=1*/SK@H_
M%(6[+;^] '<Z5X/02B0J#^%=Y8:-;P(N47CVKS;3/&B?*#(*Z#_A,XA%GS1^
M= '<S?9K:/.U!CVK&N=?AMR<%1BN"U?QP/+.V7]:X+4?&,LCL%<F@#WFQ\21
MW,VP,*Z:';)&&P.:^=O!NMSW.H*&S@FOH+3&+6B$^E %O8HZ 4ZBB@ HHHH
M*:PS3J* (PF#5>[@,J$"KE% 'EGC'P^]S"V 3Q7GNE:,^EWA<J>OI7T/>V"W
M2D$"L*;PE#(2=HH \]N=1,T CV]L5E)HKWTG"GFO41X,AS]T5>M/#45N<A10
M!P.D^#VA8,5JQKFCM'!\J]!7IL=DJ#  JM>:2ETI! H \2M9I=/F)^;K5N[O
M'U9-F":]%G\%PRDG:*6V\&0P-D** .0\*^'VAG#E>]>IVUOLC457L]+2VQ@#
MBM$_*.* %"XI]1JQ-24 %%%% !0>E%-8\4 8VK'@UB11>9FMO4QD&J-I'UH
M\U\<Q>4#2?#I\W"_6K'Q%^5&K/\ ALV;E?K0![Q#_JE^E25'!_JE^E24 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH 0G%,W<T\C--V\T 8VO7QL[5G'85YJ?'$JWI3G@UZEJUDMY
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M/@,>5<CZUT_CY,QM7.^#DVW SZT >T64NZ-:O5E:>1L6M0=* %HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK=*=10! 5)/-.$*^E2XHH
M QM98Q6Y*UYKJ>M2VTC%FX'O7J>I6QN(BHKSO7O"$UVK; >: ,6P\:6Z3XED
M'7UKLK/QOI9C4;US]:\HN?AOJ/G,RLPY]:@/@S4[3DROQ[T >X1>*M/FX#K^
M=7X-1M)C\I%?/A>[TSEY6X]ZOZ;X\^SRA6DZ>] 'T-$8SRM6!TKS;P]XVCOF
M5 V<UZ);2^;"K>HH FHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "FMTIU,=L"@#&U3H<U7TW&>*?JKY%0:5G=0!SWC:/?&:
MY;P[^YG'UKNO%%H9HSQ7#(OV*7)XYH ]0TB?>J\UT Z5POAJ]\XJ,UW*?<%
M#J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(:6
MB@"!P<5ROBB&XEM&$).<=JZ]AD56FM5D&",T ?,7B'1]8\Z1BS[<UR*Z9?>?
M@%LYKZHUGP_%<1-^[7GVKB'\(1Q7!?8.OI0!Y)!I&KX&UGJXFD:X>CR5[)8Z
M+"2%\M?RKHH/#D6T'RE_*@#Y];P]K<PPS.14UEX&OY909%8U[_-H\$"9,:_E
M4%M]F27&U?RH XOPMX.DL9E=D(Q[5ZW8KY<"KZ"H+=H"HVA:NHOI0!+1110
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MXB\0V;VS?..GK7BOB._AN&<1D$YH [3PQXVEO+U8BQZXKV6PE,ULKGN*^8_
M\$O]JJV#C=7TOI (L8\^E &A1110 4444 %%%% !1110 TKFJTUFLHY JW10
M!EII2*V<"K<5JL?059HH 0# J&:W$HP14]% &4VDHQZ"I(=,2(\ 5HT4 1I&
M%'2G$4ZF-F@ "@4^HES4M !1110 4AZ4M-/2@#"U<<&J^D_?JQJ_0U7TG[]
M'2?\L_PKR[X@Q;U:O4O^6?X5YWXV@,B-@4 >;:$?(G_&O6O#=QY@7FO(XP;:
M;GCFO1O!]R)"HS0!Z4OW12TV/[@IU !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1110 4444 %%%% !1110 4444 %-8<4ZD)XH P]4.,U!I; O4NKG@U7TG[]
M'3+]T4R490T]?NBD?[AH \4^*"?*]>?^%@1<#ZUZ;\28/,5Z\VT4?9[C\: /
M9_#A.U>:[BW^Z*\^\+7'F!>:]!M_NB@"U1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]<UZ_;,"@H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2TT,#3J "BBB@ IK=*=2'I0!AZI[U#I>-]2ZMR#BJ^E [Z .E7[M+2+]T4M
M$$\"R(<^E>+_ !*@\O=M%>VO]PUY+\18?,W<4 <M\/&?[0N?6O=+$GRUKQ7P
M2JPSC/K7LNG3!D7% &L.E%(.E+0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU,BLX8S\J@5:48'% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !2,0!2U%(I(H Q=6.X'%5])4AZFU(;<YINEL-PH Z)?N
MBAONFA?NT'I0!YGX\MWDC?:*\!\0V<B.^0:^J-<TK[8K#;G->4^)?!;R[BJ&
M@#P/R]K<U+' SL-HKH]:\-2V+G*D5H>%_#3W\B_+GF@#=\"6DX9, U[OH,<B
MHNZN9\*^$S8A"R5Z);6RQ* !B@"TO2EI,XH!H 6BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"6,2E?I69H>JRZ+(/-8\>M 'T&L@=.*P=8 )-86C^,XKI -PJ'7/$\4?.X4
M=)HX -=".E>8:5XQA# ;A7;:9K<=Z!AA0!M44W>,=:4&@!:*** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "DR*:Y('%5B[9H S/$<7FVC >E>%>);)K>21]IZU] W41GC((KS_Q
M;X>,MJY1,F@#R3PYK/D:F%)Q@U[QH>O0RVL:F5>GK7SI?:-?6-XTB1L,&GQ>
M)]4L?E <8H ^K(KNV(!\U?SJ<W]LH_UJ_G7RJ/B+JB#&Y_SI?^%C:JW\3_G0
M![UXPUF&*S<K(IX]:\$U?53?W3QCGFH;CQ/J>J+L;<<U<\/Z%<75V'D0\F@#
M7\$:2XOTD*GDYKZ*TM=EF@]JXCPWX=6V5&VX->@6Z;(@/:@"6BBB@ HHHH *
M*** "BBB@ I"0.M12W,<(RQQ6/>ZY;H#MD% &[N![TM<E;^(X!)\\@Q6W;:Q
M:W  20$T :5%1^:N,YJK/J,$ ^=@* +N11D>M8$OB"US@2#\Z9'K]OGF04 =
M'169;ZK!/PC@U=WY&10!-14:DU)0 4444 %-;I3J:W2@#%U/H:BTS[]2ZGT-
M1:9]^@#H%^Z*6D7[HI: "J%VN:O]JS[PD=* *'E\U=M8QWJFI.>:O0$T 4]3
MT=+Q#\HKR[Q5X8\O<57%>TC)6N8\06/GHW% 'S_)J4FB,1N(Q61?^+GO,C>?
MSK=\>Z>82Y KRQMR.: .J@\1O"X.\_G7H/A3QLR%07_6O%0V3S6SI=X8'7!H
M ^LM UW^T57YLYKIP>*\2\!:]$@02/BO7;35+:Y4;7!H TU.:=4:.K#@T,30
M!)14:MZT_- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% "$9INP4^D- $3[5'-95_/:[")<8J?5;C[/"6SV
MKRSQ+XF,2NH?I0!MZE;Z7>%E1%+&N2U#P2MQN:*/K[5D>']?>ZU4*7)&ZO<]
M(MXIK-&9 <B@#P*;X>7!<XC/Y4D'P\N0W,9_*OI#[#;8_P!6OY4@L[;_ )Y+
M^5 'AMCX+%H0TL?'TKKM*MK&T905 (KI_$:Q6]JS*H'%>3W>N&*Y8!L8- 'L
MUA>6Q4*F*V4(*Y%>0^&M;,]PJ[\\UZO9/O@4^U %FBBB@ HHHH **** "FMT
MIU% '-:_#<21$19S7G\^F:J\AR6QFO8GC1_O &J-REO"I)1: /"==74=.C+%
MF&*3P=XCN7O0DDA//K74>/)(IK=E11T[5POA'3W?4<@'[U 'N!UA5M@2W:N-
M\1:O-*C"%CGVJWJT<EI9 Y/2N5MKC[3/M;GF@"G9KJEQ,?F;%3:F=1L8]S,P
MKOM!T^+()052\=6D8M#M4#B@#G_"&N3RW(61R>:]@LIA)$M>#>%4,=]^->T:
M1(3&HH Z  8I:1?NTM !1110 4AZ4M-8<4 8VJ=#4&F??J75#@&H-+?+T =&
MOW12TB_=%+0 51NR.]7JHW49:@"B",\5=MA5(1E35ZVH N@<55NK=9$.15OM
M3'- 'COCSPU)>!_+0_E7C=_X.NHG;*'\J^M[JRCN =R UR.L>'X7)Q&/RH ^
M:XO"%Y*?E0_E6M9^ ]0."$;\J]XTOPW#N&8A^5=7::);1J,PK^5 'SK;>'-6
MT\@KO&*Z[1=:N=,VBY<\>M>N7FB6\BG$2_E7"Z_X*DN=QB4CZ4 :EAXYM, ,
MX_.MN'Q9:3XPP_.O'KGPC>V1)W/Q5!KNYTQOF=N* /H6VOX[G[A%7EZ5XAH?
MCO[/M5V_.O1-(\5QWZCYAS0!UU%5(;M''WA5A74]Q0 ^BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI-PH YWQ0
MQ6R;'I7@?B!GEN)%.>M?0VN0>?;,N.U>+>*M(>+S'5: ,'PE91KJ2L6'6OHC
M1GC6RC 8=*^6=/U*:QU#DD &O5_#WC6)519)?UH ]BW T#:.]<M'XPT\P@^<
M,X]:K2^,;(=)1^= %WQ5L:S8$CI7@OB#$4SLI[UZ!XG\7V\MLP24'CUKR>2Z
M?4KQE'()H W_  3?R-J:KSC-?1VDL6LHR?2O#O!F@-'<I(4[YZ5[IIR>7:HO
MM0!<HHHH **** "BBB@ HHJ*5B!0!#=7:0*2S 5PGB?Q,D$3;) 3[&I?&5S=
MI;MY&<X[5XU=-J]Y<,LBMMS0!T<&H'6K@QN<@FNZ\.^'(;9ED&,]:\WT73[F
MVD#[2#7HNDWMPH4-F@#1\56X:T*J,\5Y[90&WNB6&.:]-E7[;'AN:Y77=(EA
M1FB7F@#<T.^B& 7 K.\;W4;VIVL#Q7#I/J=M(<!JDF;4-0&UU8T ,\,;GO>G
M>O9-(C(1>*X'PIH,D4RLZ8YKU6UMUBB7B@"TOW:6D!%+0 4444 %(3Q2TAZ4
M 8.K]#5?21\]7-44$&J^EKAZ .B7[HI:1?NBEH 0D#J:JSRJ.]-NF8#BL:Y>
M<YQF@"\TJD]:LVSKZUS#FYSP#5NS>X!Y!H ZH,".M(1FJ%L[GK5WG% "$JHY
M-8>J3*#P14^HR2J#MS6!.MQ*>0: -C2YE)&36\KJ1P:XVV2XB/ -;=I++QNS
M0!L\&HW QTI(V)'-2'% &1>:6EV#E1S7+:IX"CO,G:*]  %*1D8H \'U7P.;
M%B44\>E8W]HWFC'"(W%?0-WI45UG<!S6'=>"K*XR61?RH \HM?'M^I *O78Z
M+XREG"^:2/K6K+X!L4!*HOY5RFLZ'/8$_9D/'I0!Z78:W!*!NE'YUJI>P/TD
M4_C7SU)>ZU;-\JO@5IZ=XJO8,"X9A]30![P)D;HPIP(/2O,]-\:0$#S)?UKJ
M;'Q-9S 8D'YT =)15:"\BN!E#FK.: "BBDR* %HI-PHS0 M%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 C=*CP<U+10!6EBWK@BN3\1:$+JW8*O)%=IB
MHWB5Q@C- 'S;K?@FY25W1".?2N3FT?5+1SM9ABOJR\TF*=2/+'/M7,7W@Z.?
M.(AS[4 ?.9N=6BX,C\4GVW4Y./,:O;KGX="0G$?Z56A^&A1\F/\ 2@#Q^/3M
M4O3@LQS77^%_!MR+E7E4GFO4-.\$);L"8AQ[5UEEH\5N!B,#'M0!GZ)HJ6T*
M?)@@5U$:[4 H2,*, 4^@ HHHH **** "BBB@ J.1<BI** ,J[TV.Y7#KFL>7
MPM:9R(AGZ5UF!1M'I0!QO_".1K]U/TJ1-&*=%KK=B^E&Q?04 8=G8LA^85>G
MTZ*9,,H-7PH'04M '+7/ARW;D1C\J2S\/0(W,8_*NIVCTHV@=J *EOI\$ &U
M0*LD<8%/HH C4&I*** "BBB@ IK=*=36/% &)JAP#4.EMEZFU49!JOI28>@#
MI%^[2TB_=%+0!&\8;K41MD/459HH K?8XO[HH^R1CH*LT4 1)$%[5)BEHH A
MD@5^HJ,647]T5:HH K_9(A_#2^0J]!4]% $:+BA@:DHH 8H-/HHH *8P-/HH
M AV9ZU7ETRWG^^@-7J* ,"Y\.63J<1#/TKS?Q3X/G=V-LA'T%>S8%1O;Q./F
M0'\* /E^Y\,:S _REP!5S3VU*P8>:[<5] 7>CP3 XB7\JYC4O!XGR53'X4 8
MFA^,DLT F?D>M=3#XXM)L88?G7"W_@*?<2NX5G?V!<V!Y+<4 >Q6NOPW &"*
MT(YQ*,@UXG%K4NG'!+<5J6GQ!\G +4 >N &I%KA=/\;)=8RX_.NFLM6CN /G
M'YT :]%1I*K=&%29H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *3 ]*6B@!-H]*-H]!2T4 )@>E+110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4C#BEIK=* ,/5C@&H-*8EZL:
MI[U#I>-] '1+]T4M(OW12T %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "D/2EIK#B@##U89'%0:4I#U8U4X%5]*?+T =(OW12TB_=%+0 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'2F?81Z4 8*HX/4U)L=NYK:^PCTI5L@.U &'Y$B\Y-+A_4UNFT!'2F?81Z4
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M,'M0MF!VH P_*=>YIRHY[FMIK,'M0MF!VH Q61QW-,\IV[FMUK,'M0MF!VH
MP_*=>YIRHY'4UM-9@]J%LP.U &*R..YIGDNW<UNM9@]J5;,#M0!A>6Z]S3Q&
MY'4ULM9@]J5;,#M0!B,CCN:889&[FMUK('M2K: =J ,+RW7N:>(W(ZFMEK('
MM2K9@=J ,1D<=S3/)D;N:W6L@>U*MH!VH PO+=>YIXC<CJ:V6L@>U*+, =*
M,1E<=S3/)D;N:W6L@3TI5M .U &$(W7N:>(W(ZFMEK($]*46@ Z4 8C*X[FF
M>3(W.36X;($]*<+0 =* ,((Z]S3Q&Y'4ULFR!/2E%H * ,-E<=S3?(D;G)K<
M-D">E.%H .E &$$=>,FGB-R.IK8-D">E.%H * ,-E<=S4120GJ:WVL@>U)]A
M'I0!B*KCN:5PZKG)K:^PCTJ.>S B/TH Y2;46BFP6[UL6&I;P.:Y[4K;%S^-
M7]-AQB@#L;>3>N:GJG9C$8JY0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%(3CBI:0@
M&@#/EMA/D,*Y#Q-H68F,:\UW^T"HI;:.88<9H \&33K^VF)1&ZUIPZ?>7V%F
M0X]Z];.C6A.3&*>FE6T9^5!0!QWA[PZMHZMMP?I7>1+MC IJ6Z)]T5+0 444
M4 %%%% !44F<<5+2$ T 8E[$TG:C3[<HW(K7>%6[4B1*IX% $@'%*!2T4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !3'&5I]% &1<6Y+$XJ!(G5^E;9C4]J3R5]* &6X(3FIZ0 #I2
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!BZO TBG K/TNT>.7)'>NG>)7ZBFK B'(% #TX44
MZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *BG&8B*EI",B@#B]0M)'N,@=ZMV%LZ@9%=&UK&QR12
M"W53P* "V7"U8IJKBG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !112&@!:*B+
M'-/4YH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !4$MRD7WC45W>K;J237#>(O%"0JV&% ':G5K<?Q"@:O;G^(5XW'XG>X<[
M7I+CQ.]IRST >V17D<OW35@'->4^&O&"7+J"]>C66H+<*,&@#1HH'2B@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0G
MH 1G"C)JE)JL$1PS"H=3N_)MV;/05Y%KOBPPWQC$G>@#V#^V;;^\*0:U;$XW
M#\Z\DL]6FNH@RN>:N0/=-,/G/6@#UF.]CE^Z:FWC&:Y/2VE6)2Q-7;K6$MH&
MR>@H V)+Z*/J:K_VS;[L;A7F6J>,D^T&-7YS56/4IY?WH<XH ]?COHI.AJPK
M!AQ7E5AXJ$4JQ._.:] TK4%NH0P/6@#7HI <BEH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJM^GUKUVQ _L0_[M 'C]^KV^KX!(PU>G^%M1(MT4FO.M<4?VN?K77^&SA4H
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MI!P*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZVENJE>0* +]A&8X@#5RD4 #BEH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3:*6B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH 3&:,"EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!,"EHHH **** $
MVBEHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT ;]%-0Y7-(V: 'T5$K'/-2 B@!:*3-&10 M%%% !136<+UK.N]7M[4?.X%
M&G1FL.#Q'93-A9 ?QJTVIPL,JU &CN'K1D5SUUKL%M]]P*?8:_;73820&@#?
MHJ-)5<9!J3- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMZ#WH ]_\.62C3XQ@=*B\46*FP?@=*T?#IS8)]*C\3?\>#_2@#YZNK01:NS
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!S7A#06MY4<IBO7+1=L*CVJK::9! HVJ.*T54 <4 .JI=6:W"X-6Z* .3O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 (PR*B\O)YJ:B@"'[/&>JBE6WC4Y"BI:* &-$C
M#!'%1?8H,YV"K%% $:PHO114G2BB@ HHHH 0J#UJ-K:)_O*#4M% %0Z=;'K&
MOY4G]FVO_/)?RJTQQ30^30!$+*!/NH!4JQJO05)10 TH".13#"HZ"GL<4T/F
M@ 5<5)110 4444 %%%% !1110 4444 %%%% !1110 4UD5NHIU% $#6<+]4!
MI4M88_NH!4U% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #'Z5&O6BB@"
M8=*6BB@!C]*C3K110!,.E+110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
..%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>image00017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00017.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $  G0# 2(  A$! Q$!_\0
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MJ>$+FYU/4;BVN8HX9D>2"(J?W<[@*TGX@'\S5&/P+?H)<W%KAXKI !NPAE5
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M@11Q/;I#A8P1C(7[N<'=DG[_ %]!^.SIKSM:H;Q0LWS*<=\$X/XCF@"[6+J
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M0Z;'PY&\>]6K&T%LSE7+# 09[ 9_J35VB@"K?_ZE?^ND??'\8J*Z_P"/FPR
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M0 4_O=?T/I5L:K EW<0.2#"4!PA/WL8X ]3C_P#4:<FD6:3+*D;JZG<-LK
MX Z9QV%2&PMS<27!C EDP68$_-C!&?IC^?K0!%_;-CMYGP" 0=A[C('3KCMU
MIECK%O=37D(+(\#["'!'&T')R..N.?2I/['L2NWR#C.[ D; /3/7K[]:=%I5
MG!-)-'%^\E^^Q8G=P ,Y//04 *FJ6DCD"3D>H(W=>GK]T_E4::K!)8W-U%'*
MT<!8$;<%B/3US3O[(LBI!BZ^C$8Z\#G@<GCWJ1K"'[-+ BE$EZX/.<8R/R%
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MV7BZX!F9@;J"6Y^SS%(20C* F$Z>O4Y]?2NUT8W9TNU_M$8O/*7S>0?GQST
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M:B,CR"2238')'E=3Y6Y8\].DG7CI5ZP35!)$UU)E2QW+\G"8.,X'WLXZ<=:
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MVY]<@8Y)&#VJ*/7M/?R]L[$.AD#&-P,#)Y..#\K<'G@T]=$TY5N?*LH(_M(
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M,]R* .AHKG+;7A)<!5B8JS(I.1B/)8<G/JN,8'/'6K=YJHMKKRWB)'SG?N
M"J"2<_7% &Q16+9:O]J:5GMVABBB+NTC8P0[*1C_ (">:J)XHA*NSVMPJQ#]
M\3CY/F*=,Y/(H Z6BL)-9>.SNKF>V<>5-'$L2D$G<$QSG'5Z9_;HVM))!)$$
M+9!P20!)GH>.8S^E '045A_VPP>=7M)8V@_UI/('0XR.,X;-;:_=H 6BBB@
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MDZ>YK7TK3A8>8%96W!<G;@DA0O7\*TZ* "BBB@ HHHH **** "BBB@ HHHH
M*Q;[_D8--R>TG&XC^'TSS^5;58]\C-KFGR*2 BR97!YR/IC\R* -BBBB@ HH
MHH *SM4X^R$C/^D)Z<=?4'],'WK1K/U8@"SW''^DKW^M %\<YHP*1>15/38)
M[:U\NZNGN9-[MYC( <%B0,#T! _"@"M#HEC$TICCDS(S.0T[L%);<=H)^7)Y
MXQ21Z'81C"I+T8,3/(=^<YW9/S=3USBLH:9>I<++!$([Y)9'EN X/VA/GV(3
MUQDKP>F#CW?]GUS=-YEQL9U'E^4HP,@;ADGJ#D#CH![T :$?A_3T7:(I3@$
MFXD++DY)!SG.0.>OO5F73K>6&"-_-9(75US,_)'(R<_-SZYK(:#6%F8I-*Z>
M<!@[?]5ST.<[L8Z@<U!9QZW,UO*)Y%@(#,9"F20LG8#[N?*]^M &VFD62)&H
MBW")B4WN7V9&"!D\#';I[4L&F6D2!$#LJ_\ /29Y".0>I)[@<5E0PZND41EF
MF9S&RMA4&PX./XOFYZ?A[YBAM]86:20!HWD*D %3R%C^\>I'#T :MII4=K?&
M>(](_+0$DD G<>6)SST'04-HUAYZDI)N!+A3/)CKG&,XVYQ\O3VJI%!JJ0W:
M&9G+1QF-B4W*^3Y@'&.@&,\9IT%G>,;N5FD$SVQBB+L,J=TF,X[X*4 7O[+L
M_L_D+&R1[54;)&! 4Y7!!R,$TV31K*2X29X7WH00PE89QC&>>?NCK_4UFRZ6
MC318TL"R_>&>V(CW22';MD/.#C#<DYR<U#)I]W+IHLY[%I#]JFD$I="8@TCE
M9(^?O $8Z8S[4 :RZ%IZ%"L+_*P/^N?G&, \\C@<'BKEI96]IQ;IM^14ZD\#
M./YFLH6VHP-J,K,LK.B"':V#P3QSWQCZFH5M]8\K=YTGF!60 E>F),$]><^7
MWH Z7(/0BEKF[73[E=)DBD1WWW32M'(RDR1E\X)''2FMID92<1Z8JGRRMH=J
M#R,H05'/R\YZ>M '345R(T:6*+R8K2(&.Y$L+Q(J1QK\O"C.8^A! SGGUKK1
MP* %HHHH **** "J=MG?<Y_YZ'U]!5RJEL/WEQQ_RU/;V% "V'_'E%CT['/\
MJL@ 57L23;(<YXZ_Y)KEO$7BE]$\0):2VZFQ:V\Z2?/,;ERJY_V<@#/;(H Z
MR2)'8&0*Q'0D>^?Z#\J:;2W)D)@C)E&)#L'S_7UKE-#\907MK8&:WF$T\=N)
MGB \J&2895>3G\@>HS4EGXYT^ZB,GV>Z@'D"Y3SS%&)$,GE\$O@'/J10!U#6
M\+,2T498\$E1DU ^GVC%R]K =QW-E!R>>3^9_,URMAXU2YU"=!;RRQ.UNEI'
M"H\UFDC9B');;QL/?\Z-<\;P6=OJ"VL$XNH4F2)IU'E/-''YACX;/ ]L=>:
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MJ DXNX=O'!@Y[?[7LWYBECAOPA#WEN6]1!CL/]KUR?QJ;9=$9\R,-Z8.._\
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M@D'  ]C5'_A)=,D6X^QW N98E9VCC4D_)USQQVY^E3MH&GM)(^R4,[;MZ3R
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MJ@F7()E$7[P?\L\ELC/4#- '?9HKAKKQA<0:#KEX;6'[7I\LT8B60LH"'JY
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MB@ K$U"2-?$.F*S@2$2[%R/F^7ZY_0UMU@:BY'B;25W$9$O&[K\OIN'\C^%
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M'XT ;E%%% !1110 5FZQG_0\9_X^4Z''K[C^OTK2K.UG/^A8!/\ I*=!TZT
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M"&XFGG,>V"0+Y(V9WN 7(7CDG!'7%=#J7B-K6^MK2.PN)9+G_5-@J.&P_4=
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MP^4'G!/?/2I8M(7SA.[GS3(TAXZ9=6QGVV8_&@"G;Z*PV2)<0MM=67?;G#H
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M%)N ZU7^PVW_ #QCZ[NG?.:3^S[3_GA'^7T_P% %K-&X56%E;C'[J/CV^G^
MH^PV^/\ 51],=/;% %C<!U-+N![U7^QVYSF).<]OK_B:;_9]I_SPC_+Z_P")
MH L;QZTNX8SD56^P6W_/)/\ )S2+I]H/^6*>O\O\!0!:W"EW"JRV5LJ@)#&
M.G'3I_@*/L-MM_U,?3'3VQ0!9R*3</QJ!K*W.?W2<^WU_P 32-8V[,28(\GV
M_P ^IH L[A1N%5A86P.1!'GZ4U=/M!C$"<=/T_P% $=XXDEB@";B6#MT^0 Y
MR?Q I+S:LUI))P(W.6)X&5(]/\/Z5:@@AA4K#&L8_P!D8SV_I4K*I7# $>]
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L!^[D=^#_ #'XU?\ L=MNS]GASZ[!3X88X5Q$BH/11@4 2T444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876643297064">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 24, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">0001534248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">001-38807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">CHEMOMAB THERAPEUTICS LTD.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">L3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">81-3676773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Kiryat Atidim<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Building 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Tel Aviv<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">6158002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">77-331-0156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well Known Seasoned Issuer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">Auditor Attestation Flag</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 194,646,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,090,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Somekh Chaikin<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Tel Aviv, Israel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm Id</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesMember', window );">American Depositary Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">CMMB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Name of Exchange on which Security is Registered</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember', window );">Ordinary Shares, No Par Value Per Share [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Ordinary shares, no par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">n/a<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Name of Exchange on which Security is Registered</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Not for trading; only in connection with the registration of American Depository Shares.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876641785144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 15,186<span></span>
</td>
<td class="nump">$ 11,674<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Short-term bank deposit</a></td>
<td class="nump">45,975<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other receivables and prepaid expenses</a></td>
<td class="nump">1,527<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">62,688<span></span>
</td>
<td class="nump">11,839<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Long-term deposits</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Long-term prepaid expenses</a></td>
<td class="nump">908<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">357<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">1,665<span></span>
</td>
<td class="nump">637<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">64,353<span></span>
</td>
<td class="nump">12,476<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade payables</a></td>
<td class="nump">1,336<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">555<span></span>
</td>
<td class="nump">715<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee and related expenses</a></td>
<td class="nump">653<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingent liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,887<span></span>
</td>
<td class="nump">1,674<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary Shares no par value - Authorized: 650,000,000 shares as of December 31, 2021 and 500,000,000 shares as of December 31, 2020; Issued and outstanding: 228,090,300 shares at December 31, 2021 and 9,274,838 shares at December 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">97,639<span></span>
</td>
<td class="nump">34,497<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(36,173)<span></span>
</td>
<td class="num">(23,695)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">61,466<span></span>
</td>
<td class="nump">10,802<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 64,353<span></span>
</td>
<td class="nump">$ 12,476<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1)</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876646592392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common Stock, No Par Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">650,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="nump">9,274,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="nump">9,274,838<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876646848952">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,334<span></span>
</td>
<td class="nump">$ 4,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,033<span></span>
</td>
<td class="nump">1,288<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,367<span></span>
</td>
<td class="nump">5,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_FinanceIncomeExpensesNet', window );">Financing expenses (income), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">111<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 12,478<span></span>
</td>
<td class="nump">$ 5,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted loss per Ordinary Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0.060<span></span>
</td>
<td class="nump">$ 0.044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of Ordinary Shares outstanding, basic, and diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">207,468,650<span></span>
</td>
<td class="nump">136,755,498<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1)</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_FinanceIncomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of finance income earned and finance expenses incurred during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_FinanceIncomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876643097240">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Ordinary shares [Member]</div></th>
<th class="th"><div>Additional paid in capital [Member]</div></th>
<th class="th"><div>Accumulated deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 30,117<span></span>
</td>
<td class="num">$ (17,744)<span></span>
</td>
<td class="nump">$ 12,373<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,274,838<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Exercise of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,951)<span></span>
</td>
<td class="num">(5,951)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">34,497<span></span>
</td>
<td class="num">(23,695)<span></span>
</td>
<td class="nump">$ 10,802<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,274,838<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,274,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_EffectOfReverseCapitalizationTransaction', window );">Effect of reverse capitalization transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_EffectOfReverseCapitalizationTransactionShares', window );">Effect of reverse capitalization transaction (In shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">152,299,702<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues', window );">Issuance of shares and warrants, net of issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">58,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues', window );">Issuance of shares and warrants, net of issuance costs (In shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">66,381,520<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of Options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of Options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">134,240<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,478)<span></span>
</td>
<td class="num">(12,478)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 97,639<span></span>
</td>
<td class="num">$ (36,173)<span></span>
</td>
<td class="nump">$ 61,466<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,090,300<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1)</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_EffectOfReverseCapitalizationTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of effect due reverse capitalization transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_EffectOfReverseCapitalizationTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_EffectOfReverseCapitalizationTransactionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares isued due to effect of reverse capitalization transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_EffectOfReverseCapitalizationTransactionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>it represents number of shares and warrants issued during period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647018008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss for the year</a></td>
<td class="num">$ (12,478)<span></span>
</td>
<td class="num">$ (5,951)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments for operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">2,019<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Change in other receivables and prepaid expenses</a></td>
<td class="num">(2,058)<span></span>
</td>
<td class="num">(99)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Change in trade payables</a></td>
<td class="nump">1,175<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Change in accrued expenses</a></td>
<td class="num">(1,279)<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Change in employees and related expenses</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Change in leases</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(12,374)<span></span>
</td>
<td class="num">(5,242)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_PaymentsForInvestmentInDeposits', window );">Investment in deposits</a></td>
<td class="num">(45,951)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_LongtermLeaseDeposit', window );">Long-term lease deposit</a></td>
<td class="nump">4<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities', window );">Sale of asset held for sale</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(239)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(45,186)<span></span>
</td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_CashAcquiredInMerger', window );">Cash acquired in Merger</a></td>
<td class="nump">2,427<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">10<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Exercise of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Issuance of shares and warrants, net of issuance costs</a></td>
<td class="nump">58,637<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">61,074<span></span>
</td>
<td class="nump">4,750<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash, cash equivalents and restricted cash</a></td>
<td class="nump">3,514<span></span>
</td>
<td class="num">(554)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of the year</a></td>
<td class="nump">11,727<span></span>
</td>
<td class="nump">12,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of the year</a></td>
<td class="nump">15,241<span></span>
</td>
<td class="nump">11,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Significant non- cash transaction:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use asset recognized with corresponding lease liability</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Liabilities assumed, net of non-cash assets received in Merger</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_CashAcquiredInMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash acquired in merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_CashAcquiredInMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_LongtermLeaseDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term lease deposit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_LongtermLeaseDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_PaymentsForInvestmentInDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payments for investm,ents in deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_PaymentsForInvestmentInDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of other assets recognized in investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647861624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NatureOfOperationsDisclosureAbstract', window );"><strong>NATURE OF OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">General</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 1 - General</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; ">1.<span style="padding-left:28.5pt; ">Chemomab Therapeutics Ltd. (hereinafter - "the Company") is an Israeli based company incorporated under the laws </span>of the State of Israel in September 2011. The Company&#8217;s registered office is located in Kiryat Atidim, Tel Aviv, Israel. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; ">2.<span style="padding-left:28.5pt; ">The Company currently has no products approved for sale. The Company&#8217;s operations are funded primarily by its </span>Shareholders. The Company has incurred operating losses in each year since its inception and does not expect to generate significant revenue unless and until it obtains marketing approval for its products. Continuation of the Company&#8217;s development programs depend on its future ability to raise sources of financing. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; ">3.<span style="padding-left:28.5pt; ">Since January 2020, the COVID-19 outbreak has dramatically expanded into a worldwide pandemic creating </span>macro-economic uncertainty and disruption in the business and financial markets. Many countries around the world, including Israel, have been taking measures designated to limit the continued spread of the Coronavirus, including the closure of workplaces, restricting travel, prohibiting assembling, closing international borders and quarantining populated areas. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Chemomab's clinical trial sites have been affected by the COVID-19 pandemic, and as a result, enrollment rate of patients to Chemomab&#8217;s clinical trials has been affected. There might be additional delays in the enrollment for Chemomab&#8217;s CM-101 phase 2 trials. In addition, after enrollment in these trials, patients might drop out of Chemomab&#8217;s trials because of the COVID-19 possible implications.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Based on management&#8217;s assessment, the extent to which the coronavirus will further impact Chemomab&#8217;s operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, and the actions that may be required to contain the coronavirus or treat its impact. Chemomab&#8217;s is carefully monitoring the restrictions due to the COVID-19 outbreak and will adjust activities accordingly.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; ">4.<span style="padding-left:28.5pt; ">On December 14, 2020, the Company (formerly known as Anchiano Therapeutics Ltd.) entered into an Agreement and </span>Plan of Merger (the &#8220;Merger Agreement&#8221;) with Chemomab Ltd., an Israeli limited company, and CMB Acquisition Ltd., an Israeli limited company and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;). On March 16, 2021, (the &#8220;Effective Time&#8221;), the Company consummated a merger (the &#8220;Merger&#8221;) pursuant to the Merger Agreement by and among the Company, the Merger Sub and Chemomab Ltd. Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into Chemomab Ltd., with Chemomab Ltd. surviving the Merger as the Company's wholly owned subsidiary. In connection with the Merger, on March 16, 2021, the Company changed its name from &#8220;Anchiano Therapeutics Ltd.&#8221; To &#8220;Chemomab Therapeutics Ltd&#8221; and the business conducted by Chemomab Ltd. became primarily the business conducted by the Company. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">At the Effective Time(a) each Chemomab Ltd. ordinary share outstanding immediately prior to the Effective Time was converted solely into number of American Depository Shares equal to the exchange ratio described in the Merger Agreement, and each outstanding Chemomab Ltd. option was assumed by the Company, based on the same exchange ratio. Under the exchange ratio formula in the Merger Agreement, immediately following the closing of the Merger (the &#8220;Closing&#8221;), the former Chemomab Ltd security holders immediately before the Merger owned approximately 90% of the aggregate number of the outstanding securities of the Company, and the securityholders of the Company immediately prior to the Merger owned approximately 10% of the number of issued and outstanding ordinary shares of the Company (all on a fully diluted basis). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;7</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 1 - General. (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">For accounting purposes, Chemomab Ltd. is considered to have acquired the Company based upon the terms of the Merger as well as other factors including; (i) Chemomab Ltd.&#8217;s former shareholders owned approximately 90% of the combined Company&#8217;s outstanding ordinary shares immediately following the closing of the Merger, and (ii) Chemomab Ltd. Management holds key management positions of the combined Company. The Merger has been accounted for as an asset acquisition (reverse recapitalization transaction) rather than a business combination, as the assets acquired, and the liabilities assumed by Chemomab Ltd. do not meet the definition of a business under U.S. GAAP. The net assets acquired in connection with the Merger were recorded at their estimated acquisition date fair market value as of March 16, 2021, the date of completion of the Merger.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In connection with the Merger, and following the effective time of the Merger, the Company effected a reverse share split of the Company&#8217;s ordinary shares at a ratio of 4:1 (the &#8220;Reverse Split&#8221;) and increased the number of ordinary shares underlying each American Depositary Share (&#8220;ADS&#8221;) from 5 to 20 ordinary shares. At the effective time of the Merger, each Chemomab Ltd. ordinary shares outstanding immediately prior to the effective time of the Merger automatically converted into the right to receive approximately 12.86 ADSs, each representing 20 ordinary shares of the Company, and a warrant to purchase additional ADSs that may become exercisable only under certain circumstances.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The exchange ratio was calculated by a formula that was determined through arms-length negotiations between the Company and Chemomab Ltd. The combined Company assumed all of the outstanding options of Chemomab Ltd., vested and not vested, under the Chemomab Share Incentive Plan (the &#8220;2015 Plan&#8221;), with such options representing the right to purchase a number of ADSs equal to approximately 12.86 multiplied by the number of Chemomab Ltd. ordinary shares previously represented by such options.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "> The following table summarizes the net assets acquired based on their estimated fair values as of March 16, 2021, immediately prior to completion of the Merger (in USD thousands): </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash and cash equivalents </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,427 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Asset held for sale </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,000 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Prepaid and other assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">236 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued liabilities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,187 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net acquired assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,476 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NatureOfOperationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NatureOfOperationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647960632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 2 - Summary of Significant Accounting Policies</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Basis of Preparation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S GAAP&#8221;). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">B.</span><span style="font-weight:bold; padding-left:26.83pt; ">Use of estimates</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">Foreign currency</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#8220;dollar&#8221; or &#8220;$&#8221;), thus; the dollar is the functional currency of the Company.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The transactions and balances of the Company denominated in U.S. dollars are presented at their original amounts as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Monetary assets and liabilities denominated in a non-U.S. dollar currency are translated using the current exchange rate and nonmonetary assets and liabilities and capital accounts denominated in a non-U.S. dollar currency are translated using historical exchange rates.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Statements of operations accounts denominated in a non-U.S. dollar currency are translated using the exchange rates in effect on the transaction dates, except for depreciation, which is translated using historical exchange rate. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">D.</span><span style="font-weight:bold; padding-left:26.28pt; ">Cash and cash equivalents</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at the date acquired. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">E.</span><span style="font-weight:bold; padding-left:26.83pt; ">Restricted cash</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Restricted cash is primarily invested in highly liquid deposits. These deposits were used to secure office rent payments. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">F.</span><span style="font-weight:bold; padding-left:28.31pt; ">Property and equipment</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Property and equipment are stated at cost less accumulated depreciation. Maintenance and repair expenses are charged to operation as incurred. Depreciation is calculated on the straight-line method based on the estimated useful lives of the assets and commences once the assets are ready for their intended use.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> Annual rates at depreciation are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Computers </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">33 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Laboratory equipment </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Furniture and equipment </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">7 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Leasehold improvement - over the shorter of the lease term or the estimated useful life of the improvement </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;9</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 2 - Summary of Significant Accounting Policies (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">G.</span><span style="font-weight:bold; padding-left:25.72pt; ">Impairment of long-lived assets</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company&#8217;s property and equipment are reviewed for impairment in accordance with ASC 360, &#8220;Property and Equipment&#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less selling costs. During the periods ended December 31, 2021 and 2020, no impairment losses have been recorded. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">H.</span><span style="font-weight:bold; padding-left:25.72pt; ">Research and Development</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Research and development costs are charged to operations as incurred. Most of the research and development expenses are for subcontractors and wages. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">L.</span><span style="font-weight:bold; padding-left:26.83pt; ">Income taxes</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the income taxes expense.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50 percent likely of being realized. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">J.</span><span style="font-weight:bold; padding-left:28.5pt; ">Fair value of financial instruments</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">ASC 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. The ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity&#8217;s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;10</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 2 - Summary of Significant Accounting Policies (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">J.</span><span style="font-weight:bold; padding-left:28.5pt; ">Fair value of financial instruments (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company&#8217;s own credit risk.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The carrying amounts of cash and cash equivalents trade payables, other receivables and accrued expenses approximate their fair value due to the short-term maturity of such instruments. The fair value of long-term restricted deposits and restricted cash also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. None of the Company&#8217;s non<span style="font-weight:bold; ">- </span>financial assets or liabilities are recorded at fair value on a non-recurring basis. No transfers between levels have occurred during the periods presented. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">K.</span><span style="font-weight:bold; padding-left:25.72pt; ">Share-based compensation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company accounts for share-based compensation as an expense in the financial statements based on ASC 718. All awards are equity classified and therefore such costs are measured at the grant date fair value of the award and graded vesting attribution approach to recognize compensation cost over the vesting period. The Company recognizes compensation cost for an award with only service conditions that has a graded vesting schedule on a straight-line basis over the requisite service period for the entire award, provided that the cumulative amount of compensation cost recognized at any date at least equals the portion of the grant-date value of such award that is vested at that date.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The fair value for the Company&#8217;s stock options granted to employees, consultants and directors was estimated using Black-Scholes option-pricing model at the grant date, using the inputs detailed in Note 8(C).</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">The Company has historically not paid dividends and has no foreseeable plans to pay dividends. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">L.</span><span style="font-weight:bold; padding-left:26.83pt; ">Government-sponsored research and development</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Chemomab records grants received from the office of the Israel Innovation Authority (the &#8220;IIA&#8221;) as a liability, if it is probable that the Chemomab will have to repay the grants received. If it is not probable that the grants will be repaid, Chemomab records the grants as a reduction to research and development expenses. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;11</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 2 - Summary of Significant Accounting Policies (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">M.</span><span style="font-weight:bold; padding-left:24.06pt; ">Severance pay</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Pursuant to Section 14 of the Severance Compensation Law, 1963 ("Section 14"), all employees of the Company are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made on their behalf with insurance companies. Upon release of the policy to the employee, no additional liability exists between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. This plan has been accounted for as a defined contribution plan. Severance costs amounted to approximately 116 and 77 thousand USD for the year ended December 31, 2021 and 2020, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">N.</span><span style="font-weight:bold; padding-left:26.28pt; ">Concentrations of credit risk:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Cash and cash equivalents and short term deposits are invested in banks in Israel. Management believes that the financial institutions that hold the Company&#8217;s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">O.</span><span style="font-weight:bold; padding-left:25.72pt; ">Leases</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Under Topic 842, the Company determines if an arrangement is a lease at inception. ROU assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be 5% in 2021. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. When determining the probability of exercising such options, the Company considers contract-based, asset-based, entity-based, and market-based factors. For leases agreements, the Company has elected the practical expedient to account for the lease and non-lease maintenance components as a single lease component. Therefore, for those leases, the lease payments used to measure the lease liability include all the fixed consideration in the contract. The Company's lease agreements generally do not contain any residual value guarantees or restrictive covenants. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;12</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 2 - Summary of Significant Accounting Policies (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">O.</span><span style="font-weight:bold; padding-left:25.72pt; ">Leases (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">For operating leases, the ROU asset is subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">ROU assets for operating leases are periodically reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, Property, Plant, and Equipment &#8211; Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize. See Note 2(G). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">P.</span><span style="font-weight:bold; padding-left:28.31pt; ">Principles of consolidation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The consolidated financial statements include the accounts of the Company and the Subsidiary. Intercompany balances and transactions have been eliminated in consolidation. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Q.</span><span style="font-weight:bold; padding-left:25.72pt; ">Earnings per ordinary share</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Basic earnings per ordinary share is calculated using only weighted average ordinary shares outstanding. Diluted earnings per share, if relevant, gives effect to dilutive potential ordinary shares outstanding during the year. Such dilutive shares consist of incremental shares, using the treasury stock method, from the assumed exercise of share options. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647828168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and Cash Equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 3 - Cash and Cash Equivalents</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In NIS </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,116</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">95 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In USD </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">10,720</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">11,526 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In other currencies </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">3,350</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">53 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">15,186</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">11,674 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for cash and cash equivalent footnotes,  which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647908120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Receivables and Prepaid Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock', window );">Other Receivables and Prepaid Expenses</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 4 - Other Receivables and Prepaid Expenses</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Government institutions </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">179</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">74 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Prepaid expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,348</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">67 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,527</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">141 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other accounts receivable and prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647088200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 5 - Property and Equipment, Net</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cost:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Computers </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">43</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">31 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Furniture and equipment </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">27</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">16 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Laboratory equipment </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">364</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">159 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Website development </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">14</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">14 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Leasehold improvements </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">16</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">464</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">225 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Less - accumulated depreciation</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; ">107</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(73 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">357</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">152 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647919496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 6 - Leases</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">On May 10, 2020, Chemomab entered into an office and lab space lease agreement (hereinafter &#8211; &#8220;The Agreement&#8221; .(According to the Agreement, Chemomab will rent space in Atidim Park, Tel-Aviv through <span style="-sec-ix-hidden:Fact_0000000000271">May 2023</span>. Chemomab was granted an option to extend the lease term by additional three years. The annual rent and management fees were approximately USD 71 thousand. Pursuant to the Agreement, a bank guarantee of NIS 170 thousand (approximately USD 49 thousand) was issued to the property owner in 2020.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">On October 24, 2021, Chemomab signed an amendment to the Agreement ("The Amendment"). According to the Amendment, On December 12, 2021 Chemomab returned the previous office and lab space to the property owner and rented a larger space in Atidim Park Tel-Aviv, through <span style="-sec-ix-hidden:Fact_0000000000276">October 2024</span>. In addition, Chemomab was granted an option to extend the lease term by additional three years. The annual rent and management fees are approximately USD 132 thousand. Pursuant to the Amendment, the bank guarantee issued in 2020 was canceled and a substitute bank guarantee of approximately USD 86 thousand was issued to the property owner during 2022.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">The above operating leases are included in &#8220;Operating lease right-of-use assets&#8221; on the Company&#8217;s Consolidated Balance sheets as of December 31, 2021 and 2020 and represent the Company&#8217;s right to use the underlying asset for the lease term. The Company&#8217;s obligations to pay lease payments are included in the current liabilities as &#8220;Operating lease liabilities&#8221; and in the non-current liabilities as &#8220;Non-current operating lease liabilities&#8221; on the Company&#8217;s Consolidated Balance sheets as of December 31, 2021 and 2020. Based on the present value of the lease payments for the remaining lease term of the Company&#8217;s existing lease agreement, the Company recognized operating right-of-use assets and operating lease liabilities of approximately USD 345 thousand on December 12, 2021. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">During the years ended December 31, 2021 and 2020, the Company recognized an increase in right of use assets of USD 345 thousand and USD 500 thousand, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">As of December 31, 2021, operating right-of-use assets and operating lease liabilities were USD 345 thousand and USD 343 thousand, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;14</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 6 - Leases (cont&#8217;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">As most of the Chemomab&#8217;s leases do not provide an implicit rate, Chemomab uses its incremental borrowing rate based on the information available at the commencement date of each lease in determining the present value of lease payments. Chemomab&#8217;s incremental borrowing rate is a hypothetical rate based on its estimation of what its credit rating would be the rate was5.2% in both 2021 and 2020.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> Maturities of lease liabilities under noncancellable leases as of December 31, 2021, are as follows: (in thousands): </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:40pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2022 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">121</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2023 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">133</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2024 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">117</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total future minimum lease payments </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">371</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Less imputed interest: </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; ">28</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; "><span style="font-weight:bold; ">)</span> </p> </td> </tr> <tr class="even" style=""> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Present value of operating lease liabilities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">343</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647842520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Commitments and Contingent Liabilities</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 7 - Commitments and Contingent Liabilities</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Exclusive License Agreement (hereinafter- &#8220;the License Agreement&#8221;)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In December 2011, Chemomab entered into a License Agreement with the Medical Research, Infrastructure, Health Services Fund of the Tel-Aviv Souraski Medical Center (&#8220;Fund&#8221;), pursuant to which it was granted with an exclusive license to certain inventions (as defined in the License Agreement) including patents, knowhow and products and the right to sublicense to third parties the rights granted, pursuant to and subject to certain terms and limitation fully set in the License Agreement.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Chemomab has agreed to pay the Fund a non-refundable and non-creditable sublicense fees as a percentage of all Attributed Income (as such term defined in the License Agreement), and shall further pay the Fund royalties from sales made by sublicensee;</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:108pt !important; margin-bottom:0pt; ">(i)<span style="padding-left:26.56pt; ">Royalties in percentage of the Net sales or Service Income (as defined in the License Agreement), subject to </span>certain additional terms set forth therein. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:108pt !important; margin-bottom:0pt; "><span style="padding-left:36pt; ">In addition, with respect to each Licensed Product (as defined therein), Chemomab has agreed to pay the Fund </span>the following non-refundable, non-creditable amounts: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:144pt !important; margin-bottom:0pt; ">(a)<span style="padding-left:24.9pt; ">USD 100 thousand upon submission of a New Drug Application (&#8220;NDA&#8221;), Biological License Application (&#8220;BLA&#8221;) or equivalent for each Licensed Product to the United States Food and Drug Administration (&#8220;FDA&#8221;), USD 100 thousand upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Europe and one hundred thousand dollars upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Asia. Payment in the aggregate shall not be more than USD 300 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once;</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:0pt; text-indent:-36pt !important; padding-left:144pt !important; margin-bottom:0pt; ">(b)<span style="padding-left:24.34pt; ">USD 200 thousand upon the grant of FDA or equivalent agency marketing approval in Europe and/or Asia for each Licensed Product. Payment in the aggregate shall not be more than USD 600 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once.</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">As of December 31, 2021 no payments were made to the Fund. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;15</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 7 - Commitments and Contingent Liabilities (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Exclusive License Agreement (hereinafter- &#8220;the License Agreement&#8221;) (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In addition to the payments described above, upon the occurrence of either (i) closing of a public offering of the ordinary shares of Chemomab; or (ii) a Change of Control Transaction, Chemomab shall pay the Fund a cash payment equal to one percent (1%) of the proceeds raised by Chemomab in its initial public offering, or 1% of the consideration received by Chemomab or its shareholders at the closing of a Change of Control Transaction (after deduction of amounts paid as liquidation preference to the shareholders of Chemomab on account of their investment in Chemomab , if any), but in any event not more than USD 3,000 thousand.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">B.</span><span style="padding-left:26.83pt; ">Chemomab partially financed its research and development expenditures under programs sponsored by the Israel </span>Innovation Authority (&#8220;IIA&#8221;) for the support of certain research and development activities conducted in Israel. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In return for the IIA&#8217;s participation, Chemomab is committed to pay royalties at rate of 3% of sales of the developed product (linked to U.S. dollar), up to 100% of the amount of grants received (100% plus interest at LIBOR).</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Chemomab did not receive any grants from the IIA in the years ended December 31, 2021, and 2020.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Since Chemomab &#8217;s incorporation through December 31, 2021 Chemomab received USD 1,227 thousand from the IIA, which were recognized as a reduction of research and development expenses.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">As of December 31, 2021, Chemomab has no commitment for royalties payable. In addition, the IIA may impose certain conditions to transfer technology or development out of Israel.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">C.</span><span style="padding-left:26.28pt; ">In June 2015, Chemomab entered into a license agreement with subcontractor (&#8220;the Subcontractor&#8221;), under which the </span>Subcontractor granted to Chemomab certain licenses to use proprietary rights of the subcontractor, materials and know how in the techniques and use of the same, for purposes of research and development of Chemomab 's product CM-101, as well as commercialization thereof. Further to the agreement, the Subcontractor also provides manufacturing services of intermediates and active pharmaceutical ingredients. According to the related manufacturing agreement, the manufacturing of the product is carried out by the Subcontractor in accordance with Chemomab's specifications and timeline. The total amount of the agreement is Euro 1,200 thousand (excluding materials), of which Euro 600 thousand was paid upon the commencement of the agreement and the remaining amount was paid upon the achievement of a predetermined milestone. In June 2021 and November 2021, Chemomab and the Subcontractor signed three additional agreements for additional manufacturing and final process lock of the product for clinical use, that adds a total amount of Euro 5,831 thousand (excluding materials). Under the agreement, Chemomab is also obligated to pay the Subcontractor royalties determined as a percentage of net sales of each licensee product. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;16</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 7 - Commitments and Contingent Liabilities (cont&#8217;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">(cont&#8217;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">During 2021 and 2020, Chemomab recorded expenses related to the above agreements in the amounts of USD 2,590 thousand and USD 1,177 thousand, respectively. The expenses were recorded under research and development expenses. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">D.</span><span style="padding-left:26.28pt; ">In May 2020, Chemomab executed a lien bank deposit of NIS </span>170 thousand (approximately USD 49 thousand) for the benefit of securing the lease payments under the lease agreement described in Note 6 (the "2020 Lien"). </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">As of December 31, 2021 the bank restricted deposit amount was USD 55 thousand. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In 2022, the 2020 Lien was canceled and Chemomab executed a substitute lien bank deposit of NIS 269 thousand (approximately USD 86 thousand) for the benefit of securing the lease payments under the Amendment to the lease agreement described in Note 6. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876646584680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Share Capital</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 8 - Share Capital</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Right attached to shares</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; font-style:italic; ">Ordinary shares</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">All of the issued and outstanding ordinary shares of the Company are duly authorized, validly issued, fully paid and non-assessable. The ordinary are not redeemable, and each ordinary share is entitled to one vote. The holders of the ordinary shares have the right to vote and participate in shareholders' meetings, the right to receive profits, and the right to participate in the accumulated earnings when the Company is dissolved.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1.</span><span style="font-weight:bold; padding-left:28.5pt; ">Voting</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">The holders of ordinary shares are entitled to vote on all matters submitted to shareholders for a vote.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2.</span><span style="font-weight:bold; padding-left:28.5pt; ">Dividends</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The holders of the ordinary shares are entitled to receive dividends, when and as declared by the Board of Directors, and out of funds legally available.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Since its inception, the Company has not declared any dividends.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">B.</span><span style="font-weight:bold; padding-left:26.83pt; ">Financing rounds</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">1.</span><span style="padding-left:28.5pt; ">In June 2015, September 2015 and November 2015, Chemomab entered into an agreement with investors according to </span>which the Company issued the investors warrants to purchase convertible preferred A shares (the &#8220;Warrants&#8221;). The warrants were classified as equity. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">2.</span><span style="padding-left:28.5pt; ">During June to December 2020, the Company's investors exercised the warrants for a total consideration of </span>approximately USD 1,250 thousand. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;17</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 8 - Share Capital (cont&#8217;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">B.</span><span style="font-weight:bold; padding-left:26.83pt; ">Financing rounds (cont&#8217;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">3.</span><span style="padding-left:28.5pt; ">In September 2019, Chemomab Ltd entered into share purchase agreement with current and new investors (hereinafter </span>&#8211; &#8220;2019 SPA&#8221;), pursuant to which Chemomab Ltd issued 130,831 series preferred C shares NIS 0.01 par value for an aggregate consideration of approximately USD 11,484 thousand. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">4.</span><span style="padding-left:28.5pt; ">In November 2019 Chemomab entered into a joinder agreement to 2019 SPA, pursuant to which it issued and sold to </span>investors an additional 34,130 series preferred C shares NIS 0.01 par value, for an aggregate consideration of approximately USD 3,000 thousand, of which USD 500 thousand from certain investors was received immediately after the balance sheet date. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">5.</span><span style="padding-left:28.5pt; ">In May 2020, Chemomab entered a joinder agreement to 2019 SPA, pursuant to which Chemomab issued </span>34,130 series preferred C shares NIS 0.01 par value for a total consideration of approximately USD 3,000 thousand. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">6.</span><span style="padding-left:28.5pt; ">In connection with the Merger, on March 15, 2021, the Company entered into Securities Purchase Agreements with </span>certain purchasers, pursuant to which the Company agreed to sell approximately USD 45.5 million of its ADSs in a private placement transaction, (or &#8220;The Private Placement&#8221;). The Private Placement closed on March 22, 2021, at which time the Company sold to the purchasers 2,619,270 ADSs together with warrants to purchase up to 261,929 ADSs at an exercise price of USD 17.35 per ADS. The warrants will expire five years from the date of issuance, and if exercised in full, will provide to the Company proceeds of approximately USD 4.5 million. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">7.</span><span style="padding-left:28.5pt; ">On April 30, 2021, the Company entered into an At the Market Offering Agreement (the &#8220;ATM Agreement&#8221;) with </span>Cantor Fitzgerald &amp; Co., (&#8220;Cantor&#8221;). According to the ATM Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $75 million through Cantor or the ATM Agreement. From April 30, 2021, through December 31, 2021, the Company issued 699,806 ADSs at an average price of USD 22.75 per ADS under the ATM Agreement, resulting in gross proceeds of USD 15,917 thousand. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">Share-based compensation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">(1)<span style="padding-left:24.34pt; ">Share-based compensation plan:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company maintains (i) the 2011 Share Option Plan (the &#8220;2011 Plan&#8221;), (ii) the 2017 Equity-Based Incentive Plan (the &#8220;2017 Plan&#8221;) and (iii) the Chemomab 2015 Share Incentive Plan (the &#8220;2015 Plan&#8221;), &#8201;which was assumed by the Company from Chemomab Ltd. the effectiveness of the Merger. At that time, outstanding options under the 2015 Plan became exercisable for such number of ADSs of the Company as was determined based on the exchange ratio in the Merger Agreement, with a reciprocal adjustment to exercise price. As of December 31, 2021, a total of 1,422,153 of our ADSs were reserved for issuance under the 2015 Plan, of which 73,776 ADSs had been issued pursuant to previous exercises options, and 1,326,723 ADSs were issuable under outstanding options. Of such outstanding options, options to purchase 452,230 ADSs had vested and were exercisable as of that date, with a weighted average exercise price of USD 2.75 per ADS. During the year ended December 31, 2021 options to purchase 35,653 ADS were canceled as per the request of an optionee </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;18</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 8 - Share Capital (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">Share-based compensation (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "> (2)<span style="padding-left:24.34pt; ">The expenses that were recognized in the consolidated statements of operations for services received from employees </span>and service providers are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">137</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">84 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">General and administrative </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,882</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">46 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total share-based compensation expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2,019</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">130 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> (3)<span style="padding-left:24.34pt; ">The number and weighted average exercise price of options are as follows:</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted </span><span style="font-weight:bold; ">average</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">exercise price</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Number of </span><span style="font-weight:bold; ">options</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">average </span><span style="font-weight:bold; ">remaining </span><span style="font-weight:bold; ">contractual </span><span style="font-weight:bold; ">life (in years)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">average </span><span style="font-weight:bold; ">exercise price</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Number of </span><span style="font-weight:bold; ">options</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">average </span><span style="font-weight:bold; ">remaining </span><span style="font-weight:bold; ">contractual </span><span style="font-weight:bold; ">life (in years)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at January 1 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">0.07</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">10,455,580</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">7.8 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.07 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">8,072,704 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">8.09 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Acquired in Merger </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">609,535</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercise </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">0.08</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; ">134,220</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Forfeited </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1.25</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; ">1,712,275</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.07 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(10,804 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Granted </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">0.62</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">17,784,640</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">9.79</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.08 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,393,680 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">9.77 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:10pt; margin-bottom:0pt; ">December 31 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">0.38</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">27,003,260</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">8.12</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.07 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10,455,580 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">7.8 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">(4)<span style="padding-left:24.34pt; ">Fair value measurement:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "> The fair value of the options is measured at the grant date using the Black-Scholes Option pricing model and the assumptions used to calculate the fair value of the options are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021 grants</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Weighted average share price (in U.S. dollar)<sup>(a)</sup> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">9.44</span><span style="font-weight:bold; ">-</span><span style="font-weight:bold; ">27.26</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercise price (in U.S. dollar) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">9.44</span><span style="font-weight:bold; ">-</span><span style="font-weight:bold; ">27.26</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expected life of options (in years)<sup>(b)</sup> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">5.73</span><span style="font-weight:bold; ">-</span><span style="font-weight:bold; ">6.28</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expected volatility<sup>(c)</sup> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">65.93</span><span style="font-weight:bold; ">%-</span><span style="font-weight:bold; ">70.88</span><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Risk-free interest rate<sup>(d)</sup> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1.36</span><span style="font-weight:bold; ">%-</span><span style="font-weight:bold; ">1.64</span><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Dividend yield </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">0</span><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;19</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 8 - Share Capital (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">Share-based compensation (cont&#8217;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">(a)<span style="padding-left:8.9pt; ">The weighted average share price is based on the Company&#8217;s ordinary share valuation as at the grant date.</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:92pt !important; margin-bottom:0pt; ">(b)<span style="padding-left:8.34pt; ">Expected life for the periods presented was determined according to the simplified method since, at the date of </span>grant, the Company did not have enough history to make an estimate. This method effectively assumes that exercise occurs over the period from vesting until expiration, and therefore the expected term is the midpoint between the service period and the contractual term of the award. The simplified method is applicable to service conditions and for performance conditions that are probable of achievement. If meeting the performance condition is not probable, the Company will use the awards&#8217; contractual term if the service period is implied, or the simplified method, if the service period is explicitly stated. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:92pt !important; margin-bottom:0pt; ">(c)<span style="padding-left:8.9pt; ">Expected volatility is based on historical volatility over the most recent period commensurate with the expected </span>term of the option. As the Company has a short trading history for its ordinary shares, when the Company's trading period is shorter than the expected term, the expected volatility is derived from the average historical share volatilities of several unrelated public companies within the Company&#8217;s industry that the Company considers to be comparable to its own business over a period equivalent to the option&#8217;s expected term. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:92pt !important; margin-bottom:0pt; ">(d)<span style="padding-left:8.34pt; ">The risk-free rate for the expected term of the options is based on the Black-Scholes option-pricing model on the </span>yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647828168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research and Development</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 9 - Research and Development</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Consultants and subcontractors </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">3,894</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,079 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Salaries and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,789</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,158 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Rent and maintenance </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">114</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">106 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based compensation </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">137</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">84 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">400</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">257 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">6,334</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,684 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI http://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647843080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General and Administrative Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_GeneralAndAdministrativeDisclosureTextBlock', window );">General and Administrative</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 10 - General and Administrative</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Salaries and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">943</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">334 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Professional services </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,695</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">828 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based compensation </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,882</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">46 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Fees to Directors </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">244</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Insurance </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,024</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">6 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Rent and maintenance </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">29</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">24 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">216</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">50 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">6,033</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,288 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_GeneralAndAdministrativeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of general and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_GeneralAndAdministrativeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647808472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 11 - Income Taxes</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Tax rates</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Ordinary taxable income in Israel is subject to a corporate tax rate of 23%. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company&#8217;s US subsidiary, Chemomab Therapeutics Inc. ("Chemomab Inc.) is taxed separately under the U.S. tax laws. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Chemomab Inc. is subject to a federal flat tax rate of 21% and state tax as applicable. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Capital gain is subject to capital gain tax according to the corporate tax rate in the year the assets are sold. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">B.</span><span style="font-weight:bold; padding-left:26.83pt; ">Tax assessments</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">As of December 31, 2021, the Company&#8217;s tax reports through December 31, 2016 are considered closed to audit inspections by the Israeli Tax Authority (&#8220;ITA&#8221;) due to statute of limitation rules effective in Israel. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">The Company has not yet been assessed by the ITA since inception. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">Losses for tax purposes carried forward to future years</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">As of December 31, 2021, the Company and its subsidiaries had approximately $143 million (approximately $21 million as of December 31, 2020) of net operating loss carryforwards which are available to reduce future taxable income with no limitation on the period of use. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;21</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 11 - Income Taxes (cont&#8217;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">D.</span><span style="font-weight:bold; padding-left:26.28pt; ">Deferred taxes</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> In respect of: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net operating loss carry-forwards </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">33,396</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,874 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based compensation expense </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,147</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">57 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development costs </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,449</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,244 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">38</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">25 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Gross deferred tax assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">36,030</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">6,200 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Less - Valuation allowance </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; ">36,030</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(6,200) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net deferred tax assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company has established a valuation allowance to offset deferred tax assets on December 31, 2021 and 2020 due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. The net change in the total valuation allowance for the year ended at December 31, 2021 was an increase of approximately USD 2.6 million. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">E.</span><span style="font-weight:bold; padding-left:26.83pt; ">Roll forward of valuation allowance</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance at January 1, 2020 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">$</span> </p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">4,248</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Currency transaction loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">583</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Income tax expense </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,369</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance at December 31, 2020 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">$</span> </p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">6,200</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Currency transaction loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2,425</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Tax assets acquired through merger </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">24,535</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Income tax expense </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2,870</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance at December 31, 2021 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">$</span> </p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">36,030</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;22</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 11 - Income Taxes (cont&#8217;d)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">F.</span><span style="font-weight:bold; padding-left:28.31pt; ">Reconciliation of theoretical income tax expense to actual income tax expense</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> A reconciliation of the Company&#8217;s theoretical income tax expense to actual income tax expense is as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss before income taxes </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; ">12,478</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(5,951 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Statutory tax rate </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">23</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">23 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">% </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Theoretical tax benefit </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<span style="font-weight:bold; ">2,870</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,369 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-10pt !important; padding-left:10pt !important; margin-bottom:0pt; ">Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2,870</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,369 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Actual income tax expense </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">G.</span><span style="font-weight:bold; padding-left:25.72pt; ">Accounting for uncertainty in income taxes</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">For the year ended December 31, 2021, the Company did not have any unrecognized tax benefits and does not expect that the amount of unrecognized tax benefits will change significantly within the next 12 months. The Company&#8217;s accounting policy is to accrue interest and penalties related to unrecognized tax benefits as a component of income tax expense. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647828168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties Balances and Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties Balances and Transactions</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 12 - Related Parties Balances and Transactions</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Balances with Related Parties:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> The following Related Party payables are included in the consolidated Balance Sheets: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Employee and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">278</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">214 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">72</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">350</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">217 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;23</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 12 - Related Parties Balances and Transactions (cont'd)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">B.</span><span style="font-weight:bold; padding-left:26.83pt; ">Transactions with Related Parties:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> The following transactions with related parties are included in the consolidated Statements of Operations: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Salaries and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,255</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">605 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based payments </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,775</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">91 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Professional Services </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">244</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">45 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">36</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">36 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">3,310</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">777 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647960632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Ordinary Shareholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share Attributable to Ordinary Shareholders</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Note 13 - Net Loss Per Share Attributable to Ordinary Shareholders</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; ">Basic net loss per share is computed by dividing the net loss available to common stockholders by the weighted-average number of ordinary shares outstanding. Diluted net loss per share is computed similarly to basic net loss per share except that the denominator is increased to include the number of additional ordinary shares that would have been outstanding if the potential ordinary shares had been issued and if the additional ordinary shares of were dilutive. Diluted net loss per share is the same as basic net loss per share of ordinary share, as the effect of potentially dilutive securities is antidilutive.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "> The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods presented: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">In USD thousands, except share and per </span><span style="font-weight:bold; ">share data</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Numerator:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">12,478</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5,951 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Denominator:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-10pt !important; padding-left:10pt !important; margin-bottom:0pt; ">Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">207,468,650</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">136,755,498 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss per share attributable to ordinary shareholders, basic and diluted </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">0.060</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.044 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; ">&#160; </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;24</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 13 - Net Loss Per Share Attributable to Ordinary Shareholders (cont'd)</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "> The potential number of weighted-average ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented since including them would have been anti-dilutive are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Number of shares</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding options to purchase ordinary shares </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">27,003,260</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10,455,580 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876644357880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">A.</span><span style="font-weight:bold; padding-left:26.28pt; ">Basis of Preparation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S GAAP&#8221;). </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">B.</span><span style="font-weight:bold; padding-left:26.83pt; ">Use of estimates</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional currency</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">C.</span><span style="font-weight:bold; padding-left:26.28pt; ">Foreign currency</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#8220;dollar&#8221; or &#8220;$&#8221;), thus; the dollar is the functional currency of the Company.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The transactions and balances of the Company denominated in U.S. dollars are presented at their original amounts as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Monetary assets and liabilities denominated in a non-U.S. dollar currency are translated using the current exchange rate and nonmonetary assets and liabilities and capital accounts denominated in a non-U.S. dollar currency are translated using historical exchange rates.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Statements of operations accounts denominated in a non-U.S. dollar currency are translated using the exchange rates in effect on the transaction dates, except for depreciation, which is translated using historical exchange rate. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">D.</span><span style="font-weight:bold; padding-left:26.28pt; ">Cash and cash equivalents</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at the date acquired. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted cash</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">E.</span><span style="font-weight:bold; padding-left:26.83pt; ">Restricted cash</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">Restricted cash is primarily invested in highly liquid deposits. These deposits were used to secure office rent payments. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">F.</span><span style="font-weight:bold; padding-left:28.31pt; ">Property and equipment</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Property and equipment are stated at cost less accumulated depreciation. Maintenance and repair expenses are charged to operation as incurred. Depreciation is calculated on the straight-line method based on the estimated useful lives of the assets and commences once the assets are ready for their intended use.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> Annual rates at depreciation are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Computers </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">33 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Laboratory equipment </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Furniture and equipment </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">7 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Leasehold improvement - over the shorter of the lease term or the estimated useful life of the improvement </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">G.</span><span style="font-weight:bold; padding-left:25.72pt; ">Impairment of long-lived assets</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company&#8217;s property and equipment are reviewed for impairment in accordance with ASC 360, &#8220;Property and Equipment&#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less selling costs. During the periods ended December 31, 2021 and 2020, no impairment losses have been recorded. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">H.</span><span style="font-weight:bold; padding-left:25.72pt; ">Research and Development</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Research and development costs are charged to operations as incurred. Most of the research and development expenses are for subcontractors and wages. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">L.</span><span style="font-weight:bold; padding-left:26.83pt; ">Income taxes</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the income taxes expense.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50 percent likely of being realized. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value of financial instruments</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">J.</span><span style="font-weight:bold; padding-left:28.5pt; ">Fair value of financial instruments</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">ASC 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. The ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity&#8217;s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;10</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 2 - Summary of Significant Accounting Policies (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">J.</span><span style="font-weight:bold; padding-left:28.5pt; ">Fair value of financial instruments (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company&#8217;s own credit risk.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The carrying amounts of cash and cash equivalents trade payables, other receivables and accrued expenses approximate their fair value due to the short-term maturity of such instruments. The fair value of long-term restricted deposits and restricted cash also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. None of the Company&#8217;s non<span style="font-weight:bold; ">- </span>financial assets or liabilities are recorded at fair value on a non-recurring basis. No transfers between levels have occurred during the periods presented. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based compensation</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">K.</span><span style="font-weight:bold; padding-left:25.72pt; ">Share-based compensation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company accounts for share-based compensation as an expense in the financial statements based on ASC 718. All awards are equity classified and therefore such costs are measured at the grant date fair value of the award and graded vesting attribution approach to recognize compensation cost over the vesting period. The Company recognizes compensation cost for an award with only service conditions that has a graded vesting schedule on a straight-line basis over the requisite service period for the entire award, provided that the cumulative amount of compensation cost recognized at any date at least equals the portion of the grant-date value of such award that is vested at that date.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The fair value for the Company&#8217;s stock options granted to employees, consultants and directors was estimated using Black-Scholes option-pricing model at the grant date, using the inputs detailed in Note 8(C).</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; ">The Company has historically not paid dividends and has no foreseeable plans to pay dividends. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock', window );">Government-sponsored research and development</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">L.</span><span style="font-weight:bold; padding-left:26.83pt; ">Government-sponsored research and development</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Chemomab records grants received from the office of the Israel Innovation Authority (the &#8220;IIA&#8221;) as a liability, if it is probable that the Chemomab will have to repay the grants received. If it is not probable that the grants will be repaid, Chemomab records the grants as a reduction to research and development expenses. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_SeverancePayPolicyPolicyTextBlock', window );">Severance pay</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">M.</span><span style="font-weight:bold; padding-left:24.06pt; ">Severance pay</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Pursuant to Section 14 of the Severance Compensation Law, 1963 ("Section 14"), all employees of the Company are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made on their behalf with insurance companies. Upon release of the policy to the employee, no additional liability exists between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. This plan has been accounted for as a defined contribution plan. Severance costs amounted to approximately 116 and 77 thousand USD for the year ended December 31, 2021 and 2020, respectively. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of credit risks</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">N.</span><span style="font-weight:bold; padding-left:26.28pt; ">Concentrations of credit risk:</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Cash and cash equivalents and short term deposits are invested in banks in Israel. Management believes that the financial institutions that hold the Company&#8217;s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The Company have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">O.</span><span style="font-weight:bold; padding-left:25.72pt; ">Leases</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Under Topic 842, the Company determines if an arrangement is a lease at inception. ROU assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be 5% in 2021. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. When determining the probability of exercising such options, the Company considers contract-based, asset-based, entity-based, and market-based factors. For leases agreements, the Company has elected the practical expedient to account for the lease and non-lease maintenance components as a single lease component. Therefore, for those leases, the lease payments used to measure the lease liability include all the fixed consideration in the contract. The Company's lease agreements generally do not contain any residual value guarantees or restrictive covenants. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F&#8201;-&#8201;12</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div>
<table cellpadding="0" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">Chemomab Therapeutics Ltd. and its subsidiaries</p> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Notes to the Financial Statements as at December 31, 2021</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:100%; vertical-align:top; "> <hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160;&#8201;</p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Note 2 - Summary of Significant Accounting Policies (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "><span style="font-weight:bold; ">O.</span><span style="font-weight:bold; padding-left:25.72pt; ">Leases (cont&#8217;d)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">For operating leases, the ROU asset is subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">ROU assets for operating leases are periodically reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, Property, Plant, and Equipment &#8211; Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize. See Note 2(G). </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">P.</span><span style="font-weight:bold; padding-left:28.31pt; ">Principles of consolidation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">The consolidated financial statements include the accounts of the Company and the Subsidiary. Intercompany balances and transactions have been eliminated in consolidation. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per ordinary share</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Q.</span><span style="font-weight:bold; padding-left:25.72pt; ">Earnings per ordinary share</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; ">Basic earnings per ordinary share is calculated using only weighted average ordinary shares outstanding. Diluted earnings per share, if relevant, gives effect to dilutive potential ordinary shares outstanding during the year. Such dilutive shares consist of incremental shares, using the treasury stock method, from the assumed exercise of share options. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_SeverancePayPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for severance pay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_SeverancePayPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647943976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NatureOfOperationsDisclosureAbstract', window );"><strong>NATURE OF OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of net assets acquired based on their estimated fair value</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "> The following table summarizes the net assets acquired based on their estimated fair values as of March 16, 2021, immediately prior to completion of the Merger (in USD thousands): </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash and cash equivalents </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,427 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Asset held for sale </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,000 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Prepaid and other assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">236 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued liabilities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,187 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net acquired assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,476 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NatureOfOperationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NatureOfOperationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647943976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock', window );">Schedule of Annual rate of Deprecation</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> Annual rates at depreciation are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:86%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Computers </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">33 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Laboratory equipment </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Furniture and equipment </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">7 </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:86%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Leasehold improvement - over the shorter of the lease term or the estimated useful life of the improvement </p> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:11%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the annual rate of Deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647882328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and Cash Equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of components of cash and cash equivalents</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In NIS </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,116</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">95 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In USD </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">10,720</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">11,526 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">In other currencies </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">3,350</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">53 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">15,186</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">11,674 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647808472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Receivables and Prepaid Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock', window );">Schedule of other accounts receivable and prepaid expenses</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Government institutions </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">179</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">74 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Prepaid expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,348</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">67 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,527</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">141 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of other accounts receivable and prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647088200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property And Equpment, Net</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cost:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Computers </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">43</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">31 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Furniture and equipment </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">27</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">16 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Laboratory equipment </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">364</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">159 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Website development </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">14</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">14 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Leasehold improvements </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">16</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">464</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">225 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Less - accumulated depreciation</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; ">107</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(73 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">) </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">357</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">152 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647841960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> Maturities of lease liabilities under noncancellable leases as of December 31, 2021, are as follows: (in thousands): </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:40pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2022 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">121</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2023 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">133</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2024 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">117</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total future minimum lease payments </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">371</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Less imputed interest: </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; ">28</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; "><span style="font-weight:bold; ">)</span> </p> </td> </tr> <tr class="even" style=""> <td style="width:87%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Present value of operating lease liabilities </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">343</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876643199416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary of the effect of share-based compensation on the statements of operations</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "> (2)<span style="padding-left:24.34pt; ">The expenses that were recognized in the consolidated statements of operations for services received from employees </span>and service providers are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">137</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">84 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">General and administrative </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,882</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">46 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total share-based compensation expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2,019</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">130 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Summary of number and weighted average exercise prices of option</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> (3)<span style="padding-left:24.34pt; ">The number and weighted average exercise price of options are as follows:</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted </span><span style="font-weight:bold; ">average</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">exercise price</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Number of </span><span style="font-weight:bold; ">options</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">average </span><span style="font-weight:bold; ">remaining </span><span style="font-weight:bold; ">contractual </span><span style="font-weight:bold; ">life (in years)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">average </span><span style="font-weight:bold; ">exercise price</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Number of </span><span style="font-weight:bold; ">options</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">average </span><span style="font-weight:bold; ">remaining </span><span style="font-weight:bold; ">contractual </span><span style="font-weight:bold; ">life (in years)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at January 1 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">0.07</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">10,455,580</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">7.8 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.07 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">8,072,704 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">8.09 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Acquired in Merger </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">609,535</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercise </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">0.08</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; ">134,220</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Forfeited </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1.25</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; ">1,712,275</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">-</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.07 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(10,804 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Granted </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">0.62</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">17,784,640</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">9.79</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.08 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,393,680 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">9.77 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:22%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:10pt; margin-bottom:0pt; ">December 31 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">0.38</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">27,003,260</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">8.12</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.07 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10,455,580 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">7.8 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of assumptions used to calculate the fair value of the options</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "> The fair value of the options is measured at the grant date using the Black-Scholes Option pricing model and the assumptions used to calculate the fair value of the options are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021 grants</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Weighted average share price (in U.S. dollar)<sup>(a)</sup> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">9.44</span><span style="font-weight:bold; ">-</span><span style="font-weight:bold; ">27.26</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercise price (in U.S. dollar) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">9.44</span><span style="font-weight:bold; ">-</span><span style="font-weight:bold; ">27.26</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expected life of options (in years)<sup>(b)</sup> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">5.73</span><span style="font-weight:bold; ">-</span><span style="font-weight:bold; ">6.28</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expected volatility<sup>(c)</sup> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">65.93</span><span style="font-weight:bold; ">%-</span><span style="font-weight:bold; ">70.88</span><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Risk-free interest rate<sup>(d)</sup> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1.36</span><span style="font-weight:bold; ">%-</span><span style="font-weight:bold; ">1.64</span><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:81%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Dividend yield </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">0</span><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876644452616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock', window );">Schedule of Research and Development</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Consultants and subcontractors </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">3,894</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,079 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Salaries and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,789</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,158 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Rent and maintenance </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">114</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">106 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based compensation </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">137</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">84 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">400</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">257 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">6,334</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,684 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647943976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General and Administrative Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock', window );">Schedule of General and Administrative</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Salaries and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">943</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">334 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Professional services </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,695</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">828 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based compensation </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,882</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">46 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Fees to Directors </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">244</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Insurance </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,024</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">6 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Rent and maintenance </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">29</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">24 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">216</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">50 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:70%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">6,033</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,288 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of general and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876641718632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Significant Components of the Company's Deferred Tax Asset</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> In respect of: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net operating loss carry-forwards </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">33,396</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,874 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based compensation expense </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,147</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">57 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development costs </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,449</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,244 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">38</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">25 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Gross deferred tax assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">36,030</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">6,200 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Less - Valuation allowance </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; ">36,030</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(6,200) </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net deferred tax assets </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Schedule of Roll Forward of Valuation Allowance</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">E.</span><span style="font-weight:bold; padding-left:26.83pt; ">Roll forward of valuation allowance</span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance at January 1, 2020 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">$</span> </p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">4,248</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Currency transaction loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">583</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Income tax expense </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,369</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance at December 31, 2020 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">$</span> </p> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">6,200</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Currency transaction loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2,425</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Tax assets acquired through merger </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">24,535</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Income tax expense </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2,870</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:83%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Balance at December 31, 2021 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">$</span> </p> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">36,030</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> A reconciliation of the Company&#8217;s theoretical income tax expense to actual income tax expense is as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:72pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss before income taxes </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">(</span><span style="font-weight:bold; ">12,478</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(5,951 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Statutory tax rate </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">23</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "><span style="font-weight:bold; ">%</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">23 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; ">% </p> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Theoretical tax benefit </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<span style="font-weight:bold; ">2,870</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">)</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,369 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-10pt !important; padding-left:10pt !important; margin-bottom:0pt; ">Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2,870</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,369 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Actual income tax expense </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647086504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties Balances and Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock', window );">Schedule of Related Party Payables</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> The following Related Party payables are included in the consolidated Balance Sheets: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Employee and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">278</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">214 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">72</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">350</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">217 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Transaction With Related Parties</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "> The following transactions with related parties are included in the consolidated Statements of Operations: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31,</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">USD thousands</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Salaries and related expenses </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,255</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">605 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Share-based payments </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">1,775</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">91 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Professional Services </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">244</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">45 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Research and development </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">36</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">36 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">3,310</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">777 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876762980808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Ordinary Shareholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Loss Per Share</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "> The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods presented: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">In USD thousands, except share and per </span><span style="font-weight:bold; ">share data</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Numerator:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">12,478</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5,951 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Denominator:</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-10pt !important; padding-left:10pt !important; margin-bottom:0pt; ">Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">207,468,650</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">136,755,498 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#160; </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss per share attributable to ordinary shareholders, basic and diluted </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">0.060</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.044 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Weighted Average Number of Shares Excluded From Computation of Diluted Net Loss Per Share</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "> The potential number of weighted-average ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented since including them would have been anti-dilutive are as follows: </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> <div style="margin-left:36pt; ">
<table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"> <thead> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Year ended</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">December 31</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td colspan="6" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Number of shares</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> </tr> </thead> <tbody> <tr class="odd" style="background-color:#CCEEFF; "> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding options to purchase ordinary shares </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">27,003,260</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/> </td> <td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10,455,580 </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876641656552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 16, 2021 </div>
<div>shares</div>
</th>
<th class="th"><div>Dec. 14, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split conversion ratio</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember', window );">Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NumberOfOrdinarySharesConsistedInDS', window );">Number of ordinary shares represented by each ADS (in shares)</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger', window );">Number of ADS issued and outstanding after the merger</a></td>
<td class="nump">12.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember', window );">Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member] | Former Chemomab Security Holders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ShareholdingPercentageImmediatelyFollowingMerger', window );">Shareholding percentage immediately following the merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember', window );">Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member] | Security holders of Anchiano as of immediately prior to the merger [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ShareholdingPercentageImmediatelyFollowingMerger', window );">Shareholding percentage immediately following the merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of ADS issued and outstanding after the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfOrdinarySharesConsistedInDS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the number of ordinary shares consisted in one American depository share (ADS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfOrdinarySharesConsistedInDS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ShareholdingPercentageImmediatelyFollowingMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>shareholding percentage immediately following the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ShareholdingPercentageImmediatelyFollowingMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cmmb_FormerChemomabSecurityHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cmmb_FormerChemomabSecurityHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876641678040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General (Schedule of net assets acquired based on their estimated fair value) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 16, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NatureOfOperationsDisclosureAbstract', window );"><strong>NATURE OF OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale', window );">Asset held for sale</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid and other assets</a></td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Accrued liabilities</a></td>
<td class="num">(1,187)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_EstimatedFairValueOfNetAssetsAcquired', window );">Net acquired assets</a></td>
<td class="nump">$ 2,476<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of of asset held for sale recogized prior to the completion of merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued liabilities to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_EstimatedFairValueOfNetAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated fair value of the net assets acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_EstimatedFairValueOfNetAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NatureOfOperationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NatureOfOperationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876643294312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_PercentageOfMonthlyDepositsRate', window );">Percentage of monthly deposits rate</a></td>
<td class="nump">8.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">$ 116<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_PercentageOfMonthlyDepositsRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of monthly deposits rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_PercentageOfMonthlyDepositsRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876641746248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Schedule of Annual rates of Depreciation) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Annual rates of depreciation</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cmmb_LaboratoryEquipmentMember', window );">Laboratory Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Annual rates of depreciation</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Annual rates of depreciation</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_AnnualRatesOfDepreciation', window );">Annual rates of depreciation</a></td>
<td class="text">over the shorter of the lease term or the estimated useful life of the improvement<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_AnnualRatesOfDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual rates of depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_AnnualRatesOfDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cmmb_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cmmb_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876644340056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 15,186<span></span>
</td>
<td class="nump">$ 11,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_ILS', window );">ILS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">1,116<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">USD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">10,720<span></span>
</td>
<td class="nump">11,526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_XXX', window );">Other currencies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 3,350<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_ILS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_ILS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_XXX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_XXX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876646944312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Receivables and Prepaid Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ReceivablesFromGovernmentInstitutions', window );">Government institutions</a></td>
<td class="nump">$ 179<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">1,348<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other accounts receivable and prepaid expenses, Total</a></td>
<td class="nump">$ 1,527<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ReceivablesFromGovernmentInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Government institutions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ReceivablesFromGovernmentInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876638885960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">$ 464<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less - accumulated depreciation</a></td>
<td class="num">(107)<span></span>
</td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property Plant And Equipment Net</a></td>
<td class="nump">357<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cmmb_LaboratoryEquipmentMember', window );">Laboratory Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Website Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cmmb_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cmmb_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876644212984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Narrative) (Details)<br> &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 24, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 12, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiry date</a></td>
<td class="text">Oct. 31,  2024<span></span>
</td>
<td class="text">May 31,  2023<span></span>
</td>
<td class="text">May 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_AnnualRentAndManagementFees', window );">Annual rent and management fees</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_BankGuaranteesToPropertyOwner', window );">Bank guarantees to property owner</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities', window );">Operating right-of-use assets and operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
<td class="nump">$ 343<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Decrease in the carrying amount of the right-of-use asset due to impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease', window );">Incremental borrowing rate based on credit rating</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_ILS', window );">ILS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_BankGuaranteesToPropertyOwner', window );">Bank guarantees to property owner | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_AnnualRentAndManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual rent and management fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_AnnualRentAndManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_BankGuaranteesToPropertyOwner">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Bank guarantees to property owner.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_BankGuaranteesToPropertyOwner</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating right-of-use assets and operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental percentage increase (decrease) in the stated rate on a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_ILS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_ILS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876644662152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">$ 121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest:</a></td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of operating lease liabilities</a></td>
<td class="nump">$ 343<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876638522360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Details)<br> &#8364; in Thousands, &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsDescription', window );">Decsription of occurrence for payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">upon the occurrence of either (i) closing of a public offering of the ordinary shares of Chemomab; or (ii) a Change of Control Transaction, Chemomab shall pay the Fund a cash payment equal to one percent (1%) of the proceeds raised by Chemomab in its initial public offering, or 1% of the consideration received by Chemomab or its shareholders at the closing of a Change of Control Transaction (after deduction of amounts paid as liquidation preference to the shareholders of Chemomab on account of their investment in Chemomab , if any), but in any event not more than USD 3,000 thousand.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_MaximumPercentageOfPaymentsOfRoyalties', window );">Maximum percentage of payments of royalties (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized', window );">Cumulative amounts of grants received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royality expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,590<span></span>
</td>
<td class="nump">$ 1,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestments', window );">Bank restricted deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Payment for licensed agreement | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,200<span></span>
</td>
<td class="nump">&#8364; 5,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement', window );">Payment on commencement of agreement | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_CapitalAdditionsMember', window );">New Drug Application and Biological License Application [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentDescription', window );">Description of application payment for licensed product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USD 100 thousand upon submission of a New Drug Application (&#8220;NDA&#8221;), Biological License Application (&#8220;BLA&#8221;) or equivalent for each Licensed Product to the United States Food and Drug Administration (&#8220;FDA&#8221;), USD 100 thousand upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Europe and one hundred thousand dollars upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Asia. Payment in the aggregate shall not be more than USD 300 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct', window );">Royalty payments on sale of product (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cmmb_CapitalAdditionsOneMember', window );">FDA or equivalent agency marketing approval [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentDescription', window );">Description of application payment for licensed product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USD 200 thousand upon the grant of FDA or equivalent agency marketing approval in Europe and/or Asia for each Licensed Product. Payment in the aggregate shall not be more than USD 600 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_LeaseAgreementsMember', window );">2020 Lien [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_LienOnBankDeposit', window );">Lien on bank deposit</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_LeaseAgreementsMember', window );">2020 Lien [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_LienOnBankDeposit', window );">Lien on bank deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_LeaseAgreementsMember', window );">2020 Lien [Member] | ILS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_LienOnBankDeposit', window );">Lien on bank deposit | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_LeaseAgreementsMember', window );">2020 Lien [Member] | ILS [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_LienOnBankDeposit', window );">Lien on bank deposit | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amounts of grants received from the IIA and recognized by the company, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_LienOnBankDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lien on bank deposit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_LienOnBankDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_MaximumPercentageOfPaymentsOfRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum percentage of royalties payable on the amount of the grant received (dollar linked), plus interest at annual rate based on LIBOR.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_MaximumPercentageOfPaymentsOfRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment on commencement of agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of royalty payments on sale of product developed with funding received from the IIA.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the terms of a significant arrangement with a supplier (excluding an unconditional purchase obligation) to acquire goods or services over a period of time beyond one year or the normal operating cycle, if longer, which may include identification of the goods or services to be purchased, pricing, effects on pricing of failing to reach minimum quantities required to be purchased, cancellation rights, and termination provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the nature and terms of commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments which are not defined as or included in marketable (debt, equity, or other) securities whose use is restricted in whole or in part, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_CapitalAdditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_CapitalAdditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cmmb_CapitalAdditionsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cmmb_CapitalAdditionsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_LeaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_LeaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_ILS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_ILS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876637697560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Narrative) (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 15, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 23, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 30, 2020 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options to purchase ADS cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,712,275<span></span>
</td>
<td class="nump">10,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cmmb_TwoThousandsFifteenMember', window );">2015 plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues', window );">Number of ADSs issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NumberOfStockAdssResveredForIssuance', window );">Number of stock option ADSs reversed for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,422,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NumberOfAdssOptionsIssuableOutstanding', window );">Number of ADSs options issuable outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,326,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NumberOfAdssVestedAndExercisable', window );">Number of ADSs vested and exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options to purchase ADS cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares par value | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from preferred shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 11,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cmmb_InvestorsMember', window );">Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cmmb_InvestorsMember', window );">Investors [Member] | Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares par value | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from preferred shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">The Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ProceedsFromSaleOfAdss', window );">Proceeds from sale of ADS's | $</a></td>
<td class="nump">$ 45,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues', window );">Number of ADSs issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NumberOfWarrantsPurchaseUpAdss', window );">Number of warrants purchase ADS's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,619,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_SaleOfStocksPricePerShare', window );">Share price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cmmb_AtmAgreementMember', window );">ATM agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ProceedsFromSaleOfAdss', window );">Proceeds from sale of ADS's | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues', window );">Number of ADSs issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">699,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_SaleOfStocksPricePerShare', window );">Share price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfAdssOptionsIssuableOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of ADSs options issuable outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfAdssOptionsIssuableOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfAdssVestedAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of ADSs vested and exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfAdssVestedAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfStockAdssResveredForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock option ADSs resvered for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfStockAdssResveredForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfWarrantsPurchaseUpAdss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants purchase ADS's.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfWarrantsPurchaseUpAdss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ProceedsFromSaleOfAdss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of ADS's.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ProceedsFromSaleOfAdss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_SaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_SaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_SaleOfStocksPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by the company for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_SaleOfStocksPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stocks of American Depository Shares ("ADS") issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in the weighted average exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cmmb_TwoThousandsFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cmmb_TwoThousandsFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cmmb_InvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cmmb_InvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cmmb_AtmAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cmmb_AtmAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876644212392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Share-based compensation expenses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">$ 2,019<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">$ 1,882<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876644199528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Summary of number and weighted average exercise prices of option) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the beginning</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercise</a></td>
<td class="nump">0.08<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="nump">1.25<span></span>
</td>
<td class="nump">0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">0.62<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the end</a></td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the beginning</a></td>
<td class="nump">10,455,580<span></span>
</td>
<td class="nump">8,072,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger', window );">Acquired in Merger</a></td>
<td class="nump">609,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1', window );">Exercise</a></td>
<td class="num">(134,220)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="num">(1,712,275)<span></span>
</td>
<td class="num">(10,804)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">17,784,640<span></span>
</td>
<td class="nump">2,393,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the end</a></td>
<td class="nump">27,003,260<span></span>
</td>
<td class="nump">10,455,580<span></span>
</td>
<td class="nump">8,072,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Life in Years</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">8 years 1 month 13 days<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">8 years 1 month 2 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm', window );">Granted</a></td>
<td class="text">9 years 9 months 14 days<span></span>
</td>
<td class="text">9 years 9 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards granted during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options acquired, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876638503624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Summary of assumptions used to calculate the fair value of the options) (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">65.93%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">70.88%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">1.36%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">1.64%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Weighted average share price (in U.S. dollar)</a></td>
<td class="nump">$ 9.44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (in U.S. dollar)</a></td>
<td class="nump">$ 9.44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of options (in years)</a></td>
<td class="text">5 years 8 months 23 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Weighted average share price (in U.S. dollar)</a></td>
<td class="nump">$ 27.26<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (in U.S. dollar)</a></td>
<td class="nump">$ 27.26<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of options (in years)</a></td>
<td class="text">6 years 3 months 10 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="padding-left:8.9pt; ">Expected volatility is based on historical volatility over the most recent period commensurate with the expected </span>term of the option. As the Company has a short trading history for its ordinary shares, when the Company's trading period is shorter than the expected term, the expected volatility is derived from the average historical share volatilities of several unrelated public companies within the Company&#8217;s industry that the Company considers to be comparable to its own business over a period equivalent to the option&#8217;s expected term.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="padding-left:8.34pt; ">The risk-free rate for the expected term of the options is based on the Black-Scholes option-pricing model on the </span>yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="padding-left:8.9pt; ">The weighted average share price is based on the Company&#8217;s ordinary share valuation as at the grant date.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="padding-left:8.34pt; ">Expected life for the periods presented was determined according to the simplified method since, at the date of </span>grant, the Company did not have enough history to make an estimate. This method effectively assumes that exercise occurs over the period from vesting until expiration, and therefore the expected term is the midpoint between the service period and the contractual term of the award. The simplified method is applicable to service conditions and for performance conditions that are probable of achievement. If meeting the performance condition is not probable, the Company will use the awards&#8217; contractual term if the service period is implied, or the simplified method, if the service period is explicitly stated.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876641705752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development (Schedule of Research and Development) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ConsultantsAndSubcontractorsExpense', window );">Consultants and subcontractors</a></td>
<td class="nump">$ 3,894<span></span>
</td>
<td class="nump">$ 3,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Salaries and related expenses</a></td>
<td class="nump">1,789<span></span>
</td>
<td class="nump">1,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense', window );">Rent and maintenance</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_SharebasedCompensationResearchAndDevelopmentExpense', window );">Share-based compensation</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Other expenses</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total</a></td>
<td class="nump">$ 6,334<span></span>
</td>
<td class="nump">$ 4,684<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ConsultantsAndSubcontractorsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consultants and subcontractors expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ConsultantsAndSubcontractorsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and development related rent and maintenance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RentAndMaintenanceResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_SharebasedCompensationResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and development related share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_SharebasedCompensationResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876644328488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative (Schedule of General and Administrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General and Administrative Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and related expenses</a></td>
<td class="nump">$ 943<span></span>
</td>
<td class="nump">$ 334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional services</a></td>
<td class="nump">1,695<span></span>
</td>
<td class="nump">828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense', window );">Share-based compensation</a></td>
<td class="nump">1,882<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoninterestExpenseDirectorsFees', window );">Fees to Directors</a></td>
<td class="nump">244<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralInsuranceExpense', window );">Insurance</a></td>
<td class="nump">1,024<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense', window );">Rent and maintenance</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Other expenses</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Total</a></td>
<td class="nump">$ 6,033<span></span>
</td>
<td class="nump">$ 1,288<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General and administrative related rent and maintenance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General and administrative related share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralInsuranceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralInsuranceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoninterestExpenseDirectorsFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noninterest expense related to directors' fees which are fees paid by an Entity to its directors. Directors' fees may be paid in addition to salary and other benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoninterestExpenseDirectorsFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesAndWages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesAndWages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876638935176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Corporate tax rate (as a percent)</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Capital losses carryforwards</a></td>
<td class="nump">$ 143<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S. [Member] | Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Corporate tax rate (as a percent)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876643315336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carry-forwards</a></td>
<td class="nump">$ 33,396<span></span>
</td>
<td class="nump">$ 4,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation expense</a></td>
<td class="nump">1,147<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development costs</a></td>
<td class="nump">1,449<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">36,030<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less - valuation allowance</a></td>
<td class="num">(36,030)<span></span>
</td>
<td class="num">(6,200)<span></span>
</td>
<td class="num">$ (4,248)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876638939512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Roll Forward of Valuation Allowance) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at January 1</a></td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="nump">$ 4,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_CurrencyTransactionLossValuationAllowance', window );">Currency transaction loss</a></td>
<td class="nump">2,425<span></span>
</td>
<td class="nump">583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance', window );">Tax assets acquired through merger</a></td>
<td class="nump">24,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_IncomeTaxExpenseValuationAllowance', window );">Income tax expense</a></td>
<td class="nump">2,870<span></span>
</td>
<td class="nump">1,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at December 31</a></td>
<td class="nump">$ 36,030<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_CurrencyTransactionLossValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance due to currency transaction loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_CurrencyTransactionLossValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_IncomeTaxExpenseValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance due to income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_IncomeTaxExpenseValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance due to tax assets acquired through merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876644630776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Theoretical tax benefit on the above amount Decrease (increase) in tax refund resulting from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax</a></td>
<td class="num">$ (12,478)<span></span>
</td>
<td class="num">$ (5,951)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Statutory tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Theoretical tax benefit</a></td>
<td class="num">$ (2,870)<span></span>
</td>
<td class="num">$ (1,369)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded', window );">Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards</a></td>
<td class="nump">2,870<span></span>
</td>
<td class="nump">1,369<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Actual income tax expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents losses and benefits for tax purposes for the year, for which deferred taxes were not recorded.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876644321016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Parties Balances and Transactions (Schedule of Related Party Payables) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee and related expenses</a></td>
<td class="nump">$ 653<span></span>
</td>
<td class="nump">$ 438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">555<span></span>
</td>
<td class="nump">715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cmmb_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee and related expenses</a></td>
<td class="nump">278<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Related Party Payables</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cmmb_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cmmb_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876644626392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties Balances and Transactions (Schedule of Transaction With Related Parties) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty', window );">Salaries and related expenses</a></td>
<td class="nump">$ 1,255<span></span>
</td>
<td class="nump">$ 605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty', window );">Share-based payments</a></td>
<td class="nump">1,775<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty', window );">Professional Services</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty', window );">Research and development</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyCosts', window );">Total related party expenses</a></td>
<td class="nump">$ 3,310<span></span>
</td>
<td class="nump">$ 777<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party expenses related to professional services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party expenses related to research and develeopment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party expenses related to salaries and related expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party expenses related to share based payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876644676776">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Computation of Basic and Diluted Net Loss) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 12,478<span></span>
</td>
<td class="nump">$ 5,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">207,468,650<span></span>
</td>
<td class="nump">136,755,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare', window );">Net loss per share attributable to ordinary shareholders, basic and diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.060<span></span>
</td>
<td class="nump">$ 0.044<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1)</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share Calculation Denominator For Basic Net Income Loss Per Share Abstract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139876647868472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Weighted Average Number of Shares) (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Outstanding options to purchase ordinary shares</a></td>
<td class="nump">27,003,260<span></span>
</td>
<td class="nump">10,455,580<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>zk2227534_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cmmb="http://anchiano.com/20211231"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:currency="http://xbrl.sec.gov/currency/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cmmb-20211231.xsd" xlink:type="simple"/>
    <context id="Duration_1_1_2020_To_12_31_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-03-14to2021-03-16_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-14</startDate>
            <endDate>2021-03-16</endDate>
        </period>
    </context>
    <context id="From2020-12-13to2020-12-14_custom_FormerChemomabSecurityHoldersMember_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cmmb:FormerChemomabSecurityHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-13</startDate>
            <endDate>2020-12-14</endDate>
        </period>
    </context>
    <context id="From2020-12-13to2020-12-14_custom_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cmmb:SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-13</startDate>
            <endDate>2020-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cmmb:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cmmb:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-01to2020-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-03-14to2021-03-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2021-03-14</startDate>
            <endDate>2021-03-16</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_currency_ILS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_currency_ILS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_currency_XXX">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_currency_XXX">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_SoftwareDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_SoftwareDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LaboratoryEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cmmb:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_LaboratoryEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cmmb:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_3_16_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-03-16</instant>
        </period>
    </context>
    <context id="AsOf2021-03-16_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-16</instant>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cmmb:TwoThousandsFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-05-01to2020-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="From2021-10-01to2021-10-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-24</endDate>
        </period>
    </context>
    <context id="AsOf2020-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="AsOf2021-10-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-10-24</instant>
        </period>
    </context>
    <context id="From2020-05-01to2020-05-31_currency_ILS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-12-12</instant>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_CapitalAdditionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:CapitalAdditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_custom_CapitalAdditionsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cmmb:CapitalAdditionsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2015-06-01to2015-06-30_currency_EUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-06-01</startDate>
            <endDate>2015-06-30</endDate>
        </period>
    </context>
    <context id="From2021-06-01to2021-11-30_currency_EUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_country_US_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_country_IL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_country_IL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_country_IL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-06-01to2020-12-31_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:InvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-09-30_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-11-30_us-gaap_SeriesCPreferredStockMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:InvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="AsOf2020-05-30_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-30</instant>
        </period>
    </context>
    <context id="From2019-09-01to2019-09-30_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-11-01to2019-11-30_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="From2019-11-01to2019-11-30_us-gaap_SeriesCPreferredStockMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:InvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="From2020-05-01to2020-05-30_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-30</endDate>
        </period>
    </context>
    <context id="From2021-03-01to2021-03-15_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-15</endDate>
        </period>
    </context>
    <context id="From2021-03-01to2021-03-23_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-23</endDate>
        </period>
    </context>
    <context id="From2021-04-01to2021-04-30_custom_AtmAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtmAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_custom_AtmAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtmAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_custom_AmericanDepositarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_custom_OrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2022-03-24</instant>
        </period>
    </context>
    <context id="From2020-05-01to2020-05-31_us-gaap_LeaseAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="From2020-05-01to2020-05-31_us-gaap_LeaseAgreementsMember_currency_ILS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-12-31_us-gaap_LeaseAgreementsMember_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-12-31_us-gaap_LeaseAgreementsMember_currency_ILS_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Share">
        <measure>shares</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="USDperShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="ILSperShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000489">0001534248</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000490">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000491">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000492">CHEMOMAB THERAPEUTICS LTD.</dei:EntityRegistrantName>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_12_31_2020"
      id="Fact_0000000000493"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2021-12-31"
      id="Fact_0000000000494"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LeaseExpirationDate1
      contextRef="From2020-05-01to2020-05-31"
      id="Fact_0000000000271">2023-05-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1
      contextRef="From2021-10-01to2021-10-24"
      id="Fact_0000000000276">2024-10-31</us-gaap:LeaseExpirationDate1>
    <dei:DocumentType
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000001">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000002">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000005">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000003">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000004">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000006">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000007">001-38807</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000008">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000009">81-3676773</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000010">Kiryat Atidim</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000011">Building 7</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000012">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000013">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000014">6158002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000015">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000016">77-331-0156</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="From2021-01-01to2021-12-31_custom_AmericanDepositarySharesMember"
      id="Fact_0000000000017">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2021-01-01to2021-12-31_custom_AmericanDepositarySharesMember"
      id="Fact_0000000000018">CMMB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2021-01-01to2021-12-31_custom_AmericanDepositarySharesMember"
      id="Fact_0000000000019">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2021-01-01to2021-12-31_custom_OrdinarySharesNoParValuePerShareMember"
      id="Fact_0000000000020">Ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2021-01-01to2021-12-31_custom_OrdinarySharesNoParValuePerShareMember"
      id="Fact_0000000000021">n/a</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2021-01-01to2021-12-31_custom_OrdinarySharesNoParValuePerShareMember"
      id="Fact_0000000000022">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000023">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000024">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000025">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000026">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000027">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000028">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000030">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000031">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000032">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2021-06-30"
      decimals="0"
      id="Fact_0000000000033"
      unitRef="usd">194646077</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2022-03-24"
      decimals="INF"
      id="Fact_0000000000034"
      unitRef="Share">228090300</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorFirmId
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000035">1057</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000036">Somekh Chaikin</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000037">Tel Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000038"
      unitRef="usd">15186000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000039"
      unitRef="usd">11674000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DepositsAssetsCurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000040"
      unitRef="usd">45975000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000041"
      unitRef="usd">24000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000042"
      unitRef="usd">1527000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000043"
      unitRef="usd">141000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000044"
      unitRef="usd">62688000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000045"
      unitRef="usd">11839000</us-gaap:AssetsCurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2021-12-31"
      id="Fact_0000000000046"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000047"
      unitRef="usd">4000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000048"
      unitRef="usd">908000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="As_Of_12_31_2020"
      id="Fact_0000000000049"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000050"
      unitRef="usd">55000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000051"
      unitRef="usd">53000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000052"
      unitRef="usd">357000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000053"
      unitRef="usd">152000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000054"
      unitRef="usd">345000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000055"
      unitRef="usd">428000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000056"
      unitRef="usd">1665000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000057"
      unitRef="usd">637000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000058"
      unitRef="usd">64353000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000059"
      unitRef="usd">12476000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000060"
      unitRef="usd">1336000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000061"
      unitRef="usd">93000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000062"
      unitRef="usd">555000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000063"
      unitRef="usd">715000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000064"
      unitRef="usd">653000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000065"
      unitRef="usd">438000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000066"
      unitRef="usd">106000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000067"
      unitRef="usd">70000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000068"
      unitRef="usd">2650000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000069"
      unitRef="usd">1316000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000070"
      unitRef="usd">237000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000071"
      unitRef="usd">358000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000072"
      unitRef="usd">237000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000073"
      unitRef="usd">358000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000074"
      unitRef="usd">2887000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000075"
      unitRef="usd">1674000</us-gaap:Liabilities>
    <us-gaap:CommonStockNoParValue
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="Fact_0000000000077"
      unitRef="USDperShare">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockNoParValue
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact_0000000000076"
      unitRef="USDperShare">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact_0000000000078"
      unitRef="Share">650000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="Fact_0000000000079"
      unitRef="Share">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact_0000000000081"
      unitRef="Share">228090300</us-gaap:CommonStockSharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact_0000000000080"
      unitRef="Share">228090300</us-gaap:SharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="Fact_0000000000083"
      unitRef="Share">9274838</us-gaap:CommonStockSharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="Fact_0000000000082"
      unitRef="Share">9274838</us-gaap:SharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-12-31"
      id="Fact_0000000000084"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2020"
      id="Fact_0000000000085"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000086"
      unitRef="usd">97639000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000087"
      unitRef="usd">34497000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000088"
      unitRef="usd">-36173000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000089"
      unitRef="usd">-23695000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000090"
      unitRef="usd">61466000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000091"
      unitRef="usd">10802000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000092"
      unitRef="usd">64353000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000093"
      unitRef="usd">12476000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000094"
      unitRef="usd">6334000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000095"
      unitRef="usd">4684000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000096"
      unitRef="usd">6033000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000097"
      unitRef="usd">1288000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000098"
      unitRef="usd">12367000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000099"
      unitRef="usd">5972000</us-gaap:OperatingExpenses>
    <cmmb:FinanceIncomeExpensesNet
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000100"
      unitRef="usd">-111000</cmmb:FinanceIncomeExpensesNet>
    <cmmb:FinanceIncomeExpensesNet
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000101"
      unitRef="usd">21000</cmmb:FinanceIncomeExpensesNet>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000102"
      unitRef="usd">-12478000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000103"
      unitRef="usd">-5951000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000104"
      unitRef="USDperShare">0.060</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="INF"
      id="Fact_0000000000105"
      unitRef="USDperShare">0.044</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000106"
      unitRef="Share">207468650</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="INF"
      id="Fact_0000000000107"
      unitRef="Share">136755498</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_0000000000108"
      unitRef="Share">9274838</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      id="Fact_0000000000109"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0000000000110"
      unitRef="usd">30117000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0000000000111"
      unitRef="usd">-17744000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019"
      decimals="-3"
      id="Fact_0000000000112"
      unitRef="usd">12373000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0000000000113"
      unitRef="usd">130000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000114"
      unitRef="usd">130000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0000000000115"
      unitRef="usd">3000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000116"
      unitRef="usd">3000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0000000000117"
      unitRef="usd">1250000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000118"
      unitRef="usd">1250000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0000000000119"
      unitRef="usd">-5951000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000120"
      unitRef="usd">-5951000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_0000000000121"
      unitRef="Share">9274838</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      id="Fact_0000000000122"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0000000000123"
      unitRef="usd">34497000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0000000000124"
      unitRef="usd">-23695000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000125"
      unitRef="usd">10802000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_0000000000126"
      unitRef="Share">9274838</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      id="Fact_0000000000127"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0000000000128"
      unitRef="usd">34497000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0000000000129"
      unitRef="usd">-23695000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000130"
      unitRef="usd">10802000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0000000000131"
      unitRef="usd">2019000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000132"
      unitRef="usd">2019000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <cmmb:EffectOfReverseCapitalizationTransactionShares
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_0000000000133"
      unitRef="Share">152299702</cmmb:EffectOfReverseCapitalizationTransactionShares>
    <cmmb:EffectOfReverseCapitalizationTransaction
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0000000000134"
      unitRef="usd">2476000</cmmb:EffectOfReverseCapitalizationTransaction>
    <cmmb:EffectOfReverseCapitalizationTransaction
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000135"
      unitRef="usd">2476000</cmmb:EffectOfReverseCapitalizationTransaction>
    <cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_0000000000136"
      unitRef="Share">66381520</cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0000000000137"
      unitRef="usd">58637000</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000138"
      unitRef="usd">58637000</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_0000000000139"
      unitRef="Share">134240</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0000000000140"
      unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000141"
      unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0000000000142"
      unitRef="usd">-12478000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000143"
      unitRef="usd">-12478000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact_0000000000144"
      unitRef="Share">228090300</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      id="Fact_0000000000145"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0000000000146"
      unitRef="usd">97639000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0000000000147"
      unitRef="usd">-36173000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000148"
      unitRef="usd">61466000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000149"
      unitRef="usd">-12478000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000150"
      unitRef="usd">-5951000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000151"
      unitRef="usd">34000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000152"
      unitRef="usd">24000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000153"
      unitRef="usd">2019000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000154"
      unitRef="usd">130000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000155"
      unitRef="usd">2058000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000156"
      unitRef="usd">99000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000157"
      unitRef="usd">1175000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000158"
      unitRef="usd">68000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000159"
      unitRef="usd">-1279000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000160"
      unitRef="usd">392000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000161"
      unitRef="usd">215000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000162"
      unitRef="usd">194000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000163"
      unitRef="usd">-2000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000164"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000165"
      unitRef="usd">-12374000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000166"
      unitRef="usd">-5242000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <cmmb:PaymentsForInvestmentInDeposits
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000167"
      unitRef="usd">45951000</cmmb:PaymentsForInvestmentInDeposits>
    <cmmb:PaymentsForInvestmentInDeposits
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000168"
      unitRef="usd">24000</cmmb:PaymentsForInvestmentInDeposits>
    <cmmb:LongtermLeaseDeposit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000169"
      unitRef="usd">4000</cmmb:LongtermLeaseDeposit>
    <cmmb:LongtermLeaseDeposit
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000170"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000171"
      unitRef="usd">1000000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000172"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000173"
      unitRef="usd">239000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000174"
      unitRef="usd">38000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000175"
      unitRef="usd">-45186000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000176"
      unitRef="usd">-62000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <cmmb:CashAcquiredInMerger
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000177"
      unitRef="usd">2427000</cmmb:CashAcquiredInMerger>
    <cmmb:CashAcquiredInMerger
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000178"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000179"
      unitRef="usd">10000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000180"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000181"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000182"
      unitRef="usd">1250000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000183"
      unitRef="usd">58637000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000184"
      unitRef="usd">3500000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000185"
      unitRef="usd">61074000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000186"
      unitRef="usd">4750000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000187"
      unitRef="usd">3514000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000188"
      unitRef="usd">-554000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000189"
      unitRef="usd">11727000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2019"
      decimals="-3"
      id="Fact_0000000000190"
      unitRef="usd">12281000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000191"
      unitRef="usd">15241000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000192"
      unitRef="usd">11727000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000193"
      unitRef="usd">345000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000194"
      unitRef="usd">233000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LiabilitiesAssumed1
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000195"
      unitRef="usd">49000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000196"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NatureOfOperations
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000208">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 1 - General&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;1.&lt;span style="padding-left:28.5pt; "&gt;Chemomab Therapeutics Ltd. (hereinafter - "the Company") is an Israeli based company incorporated under the laws &lt;/span&gt;of the State of Israel in September 2011. The Company&#x2019;s registered office is located in Kiryat Atidim, Tel Aviv, Israel. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;2.&lt;span style="padding-left:28.5pt; "&gt;The Company currently has no products approved for sale. The Company&#x2019;s operations are funded primarily by its &lt;/span&gt;Shareholders. The Company has incurred operating losses in each year since its inception and does not expect to generate significant revenue unless and until it obtains marketing approval for its products. Continuation of the Company&#x2019;s development programs depend on its future ability to raise sources of financing. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;3.&lt;span style="padding-left:28.5pt; "&gt;Since January 2020, the COVID-19 outbreak has dramatically expanded into a worldwide pandemic creating &lt;/span&gt;macro-economic uncertainty and disruption in the business and financial markets. Many countries around the world, including Israel, have been taking measures designated to limit the continued spread of the Coronavirus, including the closure of workplaces, restricting travel, prohibiting assembling, closing international borders and quarantining populated areas. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Chemomab's clinical trial sites have been affected by the COVID-19 pandemic, and as a result, enrollment rate of patients to Chemomab&#x2019;s clinical trials has been affected. There might be additional delays in the enrollment for Chemomab&#x2019;s CM-101 phase 2 trials. In addition, after enrollment in these trials, patients might drop out of Chemomab&#x2019;s trials because of the COVID-19 possible implications.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Based on management&#x2019;s assessment, the extent to which the coronavirus will further impact Chemomab&#x2019;s operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, and the actions that may be required to contain the coronavirus or treat its impact. Chemomab&#x2019;s is carefully monitoring the restrictions due to the COVID-19 outbreak and will adjust activities accordingly.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;4.&lt;span style="padding-left:28.5pt; "&gt;On December 14, 2020, the Company (formerly known as Anchiano Therapeutics Ltd.) entered into an Agreement and &lt;/span&gt;Plan of Merger (the &#x201c;Merger Agreement&#x201d;) with Chemomab Ltd., an Israeli limited company, and CMB Acquisition Ltd., an Israeli limited company and a wholly owned subsidiary of the Company (&#x201c;Merger Sub&#x201d;). On March 16, 2021, (the &#x201c;Effective Time&#x201d;), the Company consummated a merger (the &#x201c;Merger&#x201d;) pursuant to the Merger Agreement by and among the Company, the Merger Sub and Chemomab Ltd. Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into Chemomab Ltd., with Chemomab Ltd. surviving the Merger as the Company's wholly owned subsidiary. In connection with the Merger, on March 16, 2021, the Company changed its name from &#x201c;Anchiano Therapeutics Ltd.&#x201d; To &#x201c;Chemomab Therapeutics Ltd&#x201d; and the business conducted by Chemomab Ltd. became primarily the business conducted by the Company. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;At the Effective Time(a) each Chemomab Ltd. ordinary share outstanding immediately prior to the Effective Time was converted solely into number of American Depository Shares equal to the exchange ratio described in the Merger Agreement, and each outstanding Chemomab Ltd. option was assumed by the Company, based on the same exchange ratio. Under the exchange ratio formula in the Merger Agreement, immediately following the closing of the Merger (the &#x201c;Closing&#x201d;), the former Chemomab Ltd security holders immediately before the Merger owned approximately 90% of the aggregate number of the outstanding securities of the Company, and the securityholders of the Company immediately prior to the Merger owned approximately 10% of the number of issued and outstanding ordinary shares of the Company (all on a fully diluted basis). &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;7&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 1 - General. (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;For accounting purposes, Chemomab Ltd. is considered to have acquired the Company based upon the terms of the Merger as well as other factors including; (i) Chemomab Ltd.&#x2019;s former shareholders owned approximately 90% of the combined Company&#x2019;s outstanding ordinary shares immediately following the closing of the Merger, and (ii) Chemomab Ltd. Management holds key management positions of the combined Company. The Merger has been accounted for as an asset acquisition (reverse recapitalization transaction) rather than a business combination, as the assets acquired, and the liabilities assumed by Chemomab Ltd. do not meet the definition of a business under U.S. GAAP. The net assets acquired in connection with the Merger were recorded at their estimated acquisition date fair market value as of March 16, 2021, the date of completion of the Merger.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;In connection with the Merger, and following the effective time of the Merger, the Company effected a reverse share split of the Company&#x2019;s ordinary shares at a ratio of 4:1 (the &#x201c;Reverse Split&#x201d;) and increased the number of ordinary shares underlying each American Depositary Share (&#x201c;ADS&#x201d;) from 5 to 20 ordinary shares. At the effective time of the Merger, each Chemomab Ltd. ordinary shares outstanding immediately prior to the effective time of the Merger automatically converted into the right to receive approximately 12.86 ADSs, each representing 20 ordinary shares of the Company, and a warrant to purchase additional ADSs that may become exercisable only under certain circumstances.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The exchange ratio was calculated by a formula that was determined through arms-length negotiations between the Company and Chemomab Ltd. The combined Company assumed all of the outstanding options of Chemomab Ltd., vested and not vested, under the Chemomab Share Incentive Plan (the &#x201c;2015 Plan&#x201d;), with such options representing the right to purchase a number of ADSs equal to approximately 12.86 multiplied by the number of Chemomab Ltd. ordinary shares previously represented by such options.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt; The following table summarizes the net assets acquired based on their estimated fair values as of March 16, 2021, immediately prior to completion of the Merger (in USD thousands): &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Cash and cash equivalents &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;2,427 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Asset held for sale &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;1,000 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Prepaid and other assets &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;236 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Accrued liabilities &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(1,187 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "&gt;) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Net acquired assets &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;2,476 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <cmmb:ShareholdingPercentageImmediatelyFollowingMerger
      contextRef="From2020-12-13to2020-12-14_custom_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"
      decimals="2"
      id="Fact_0000000000197"
      unitRef="Pure">0.10</cmmb:ShareholdingPercentageImmediatelyFollowingMerger>
    <cmmb:ShareholdingPercentageImmediatelyFollowingMerger
      contextRef="From2020-12-13to2020-12-14_custom_FormerChemomabSecurityHoldersMember_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"
      decimals="2"
      id="Fact_0000000000198"
      unitRef="Pure">0.90</cmmb:ShareholdingPercentageImmediatelyFollowingMerger>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="From2021-03-14to2021-03-16"
      decimals="INF"
      id="Fact_0000000000199"
      unitRef="Pure">4</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <cmmb:NumberOfOrdinarySharesConsistedInDS
      contextRef="From2021-03-14to2021-03-16_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"
      decimals="INF"
      id="Fact_0000000000200"
      unitRef="Share">20</cmmb:NumberOfOrdinarySharesConsistedInDS>
    <cmmb:NumberOfAdsIssuedAndOutstandingAfterMerger
      contextRef="AsOf2021-03-16_custom_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"
      decimals="INF"
      id="Fact_0000000000201"
      unitRef="Share">12.86</cmmb:NumberOfAdsIssuedAndOutstandingAfterMerger>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000207">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt; The following table summarizes the net assets acquired based on their estimated fair values as of March 16, 2021, immediately prior to completion of the Merger (in USD thousands): &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Cash and cash equivalents &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;2,427 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Asset held for sale &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;1,000 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Prepaid and other assets &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;236 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Accrued liabilities &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(1,187 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "&gt;) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Net acquired assets &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;2,476 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="As_Of_3_16_2021"
      decimals="-3"
      id="Fact_0000000000202"
      unitRef="usd">2427000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale
      contextRef="As_Of_3_16_2021"
      decimals="-3"
      id="Fact_0000000000203"
      unitRef="usd">1000000</cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="As_Of_3_16_2021"
      decimals="-3"
      id="Fact_0000000000204"
      unitRef="usd">236000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="As_Of_3_16_2021"
      decimals="-3"
      id="Fact_0000000000205"
      unitRef="usd">-1187000</cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <cmmb:EstimatedFairValueOfNetAssetsAcquired
      contextRef="As_Of_3_16_2021"
      decimals="-3"
      id="Fact_0000000000206"
      unitRef="usd">2476000</cmmb:EstimatedFairValueOfNetAssetsAcquired>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000234">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 2 - Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Basis of Preparation&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S GAAP&#x201d;). &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;B.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Use of estimates&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;C.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Foreign currency&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#x201c;dollar&#x201d; or &#x201c;$&#x201d;), thus; the dollar is the functional currency of the Company.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The transactions and balances of the Company denominated in U.S. dollars are presented at their original amounts as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Monetary assets and liabilities denominated in a non-U.S. dollar currency are translated using the current exchange rate and nonmonetary assets and liabilities and capital accounts denominated in a non-U.S. dollar currency are translated using historical exchange rates.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Statements of operations accounts denominated in a non-U.S. dollar currency are translated using the exchange rates in effect on the transaction dates, except for depreciation, which is translated using historical exchange rate. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;D.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at the date acquired. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;E.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;Restricted cash is primarily invested in highly liquid deposits. These deposits were used to secure office rent payments. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;F.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:28.31pt; "&gt;Property and equipment&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Property and equipment are stated at cost less accumulated depreciation. Maintenance and repair expenses are charged to operation as incurred. Depreciation is calculated on the straight-line method based on the estimated useful lives of the assets and commences once the assets are ready for their intended use.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt; Annual rates at depreciation are as follows: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;%&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:86%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Computers &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;33 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:86%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Laboratory equipment &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;10 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:86%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Furniture and equipment &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;7 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:86%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Leasehold improvement - over the shorter of the lease term or the estimated useful life of the improvement &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;9&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 2 - Summary of Significant Accounting Policies (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;G.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company&#x2019;s property and equipment are reviewed for impairment in accordance with ASC 360, &#x201c;Property and Equipment&#x201d;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less selling costs. During the periods ended December 31, 2021 and 2020, no impairment losses have been recorded. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;H.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Research and Development&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Research and development costs are charged to operations as incurred. Most of the research and development expenses are for subcontractors and wages. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;L.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Income taxes&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the income taxes expense.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50 percent likely of being realized. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;J.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:28.5pt; "&gt;Fair value of financial instruments&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;ASC 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. The ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity&#x2019;s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;10&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 2 - Summary of Significant Accounting Policies (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;J.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:28.5pt; "&gt;Fair value of financial instruments (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company&#x2019;s own credit risk.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The carrying amounts of cash and cash equivalents trade payables, other receivables and accrued expenses approximate their fair value due to the short-term maturity of such instruments. The fair value of long-term restricted deposits and restricted cash also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. None of the Company&#x2019;s non&lt;span style="font-weight:bold; "&gt;- &lt;/span&gt;financial assets or liabilities are recorded at fair value on a non-recurring basis. No transfers between levels have occurred during the periods presented. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;K.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Share-based compensation&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company accounts for share-based compensation as an expense in the financial statements based on ASC 718. All awards are equity classified and therefore such costs are measured at the grant date fair value of the award and graded vesting attribution approach to recognize compensation cost over the vesting period. The Company recognizes compensation cost for an award with only service conditions that has a graded vesting schedule on a straight-line basis over the requisite service period for the entire award, provided that the cumulative amount of compensation cost recognized at any date at least equals the portion of the grant-date value of such award that is vested at that date.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The fair value for the Company&#x2019;s stock options granted to employees, consultants and directors was estimated using Black-Scholes option-pricing model at the grant date, using the inputs detailed in Note 8(C).&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;The Company has historically not paid dividends and has no foreseeable plans to pay dividends. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;L.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Government-sponsored research and development&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Chemomab records grants received from the office of the Israel Innovation Authority (the &#x201c;IIA&#x201d;) as a liability, if it is probable that the Chemomab will have to repay the grants received. If it is not probable that the grants will be repaid, Chemomab records the grants as a reduction to research and development expenses. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;11&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 2 - Summary of Significant Accounting Policies (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;M.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:24.06pt; "&gt;Severance pay&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Pursuant to Section 14 of the Severance Compensation Law, 1963 ("Section 14"), all employees of the Company are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made on their behalf with insurance companies. Upon release of the policy to the employee, no additional liability exists between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. This plan has been accounted for as a defined contribution plan. Severance costs amounted to approximately 116 and 77 thousand USD for the year ended December 31, 2021 and 2020, respectively. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;N.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Concentrations of credit risk:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Cash and cash equivalents and short term deposits are invested in banks in Israel. Management believes that the financial institutions that hold the Company&#x2019;s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;O.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Leases&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Under Topic 842, the Company determines if an arrangement is a lease at inception. ROU assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be 5% in 2021. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. When determining the probability of exercising such options, the Company considers contract-based, asset-based, entity-based, and market-based factors. For leases agreements, the Company has elected the practical expedient to account for the lease and non-lease maintenance components as a single lease component. Therefore, for those leases, the lease payments used to measure the lease liability include all the fixed consideration in the contract. The Company's lease agreements generally do not contain any residual value guarantees or restrictive covenants. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;12&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 2 - Summary of Significant Accounting Policies (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;O.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Leases (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;For operating leases, the ROU asset is subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;ROU assets for operating leases are periodically reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, Property, Plant, and Equipment &#x2013; Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize. See Note 2(G). &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;P.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:28.31pt; "&gt;Principles of consolidation&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The consolidated financial statements include the accounts of the Company and the Subsidiary. Intercompany balances and transactions have been eliminated in consolidation. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Q.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Earnings per ordinary share&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Basic earnings per ordinary share is calculated using only weighted average ordinary shares outstanding. Diluted earnings per share, if relevant, gives effect to dilutive potential ordinary shares outstanding during the year. Such dilutive shares consist of incremental shares, using the treasury stock method, from the assumed exercise of share options. &lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000209">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Basis of Preparation&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S GAAP&#x201d;). &lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000210">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;B.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Use of estimates&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. &lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000211">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;C.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Foreign currency&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#x201c;dollar&#x201d; or &#x201c;$&#x201d;), thus; the dollar is the functional currency of the Company.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The transactions and balances of the Company denominated in U.S. dollars are presented at their original amounts as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Monetary assets and liabilities denominated in a non-U.S. dollar currency are translated using the current exchange rate and nonmonetary assets and liabilities and capital accounts denominated in a non-U.S. dollar currency are translated using historical exchange rates.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Statements of operations accounts denominated in a non-U.S. dollar currency are translated using the exchange rates in effect on the transaction dates, except for depreciation, which is translated using historical exchange rate. &lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000212">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;D.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at the date acquired. &lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000213">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;E.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;Restricted cash is primarily invested in highly liquid deposits. These deposits were used to secure office rent payments. &lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000219">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;F.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:28.31pt; "&gt;Property and equipment&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Property and equipment are stated at cost less accumulated depreciation. Maintenance and repair expenses are charged to operation as incurred. Depreciation is calculated on the straight-line method based on the estimated useful lives of the assets and commences once the assets are ready for their intended use.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt; Annual rates at depreciation are as follows: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;%&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:86%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Computers &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;33 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:86%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Laboratory equipment &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;10 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:86%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Furniture and equipment &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;7 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:86%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Leasehold improvement - over the shorter of the lease term or the estimated useful life of the improvement &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000218">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt; Annual rates at depreciation are as follows: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:86%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;%&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:86%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Computers &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;33 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:86%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Laboratory equipment &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;10 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:86%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Furniture and equipment &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;7 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:86%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Leasehold improvement - over the shorter of the lease term or the estimated useful life of the improvement &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:11%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="AsOf2021-12-31_us-gaap_ComputerEquipmentMember"
      decimals="INF"
      id="Fact_0000000000214"
      unitRef="Pure">0.33</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="AsOf2021-12-31_custom_LaboratoryEquipmentMember"
      decimals="INF"
      id="Fact_0000000000215"
      unitRef="Pure">0.10</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="INF"
      id="Fact_0000000000216"
      unitRef="Pure">0.07</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <cmmb:AnnualRatesOfDepreciation
      contextRef="From2021-01-01to2021-12-31_us-gaap_LeaseholdImprovementsMember"
      id="Fact_0000000000217">over the shorter of the lease term or the estimated useful life of the improvement</cmmb:AnnualRatesOfDepreciation>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000220">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;G.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company&#x2019;s property and equipment are reviewed for impairment in accordance with ASC 360, &#x201c;Property and Equipment&#x201d;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less selling costs. During the periods ended December 31, 2021 and 2020, no impairment losses have been recorded. &lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000221">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;H.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Research and Development&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Research and development costs are charged to operations as incurred. Most of the research and development expenses are for subcontractors and wages. &lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000222">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;L.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Income taxes&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the income taxes expense.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50 percent likely of being realized. &lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000223">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;J.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:28.5pt; "&gt;Fair value of financial instruments&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;ASC 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. The ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity&#x2019;s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;10&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 2 - Summary of Significant Accounting Policies (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;J.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:28.5pt; "&gt;Fair value of financial instruments (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company&#x2019;s own credit risk.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The carrying amounts of cash and cash equivalents trade payables, other receivables and accrued expenses approximate their fair value due to the short-term maturity of such instruments. The fair value of long-term restricted deposits and restricted cash also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. None of the Company&#x2019;s non&lt;span style="font-weight:bold; "&gt;- &lt;/span&gt;financial assets or liabilities are recorded at fair value on a non-recurring basis. No transfers between levels have occurred during the periods presented. &lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000224">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;K.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Share-based compensation&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company accounts for share-based compensation as an expense in the financial statements based on ASC 718. All awards are equity classified and therefore such costs are measured at the grant date fair value of the award and graded vesting attribution approach to recognize compensation cost over the vesting period. The Company recognizes compensation cost for an award with only service conditions that has a graded vesting schedule on a straight-line basis over the requisite service period for the entire award, provided that the cumulative amount of compensation cost recognized at any date at least equals the portion of the grant-date value of such award that is vested at that date.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The fair value for the Company&#x2019;s stock options granted to employees, consultants and directors was estimated using Black-Scholes option-pricing model at the grant date, using the inputs detailed in Note 8(C).&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;The Company has historically not paid dividends and has no foreseeable plans to pay dividends. &lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <cmmb:GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000225">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;L.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Government-sponsored research and development&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Chemomab records grants received from the office of the Israel Innovation Authority (the &#x201c;IIA&#x201d;) as a liability, if it is probable that the Chemomab will have to repay the grants received. If it is not probable that the grants will be repaid, Chemomab records the grants as a reduction to research and development expenses. &lt;/p&gt;</cmmb:GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock>
    <cmmb:SeverancePayPolicyPolicyTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000229">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;M.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:24.06pt; "&gt;Severance pay&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Pursuant to Section 14 of the Severance Compensation Law, 1963 ("Section 14"), all employees of the Company are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made on their behalf with insurance companies. Upon release of the policy to the employee, no additional liability exists between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. This plan has been accounted for as a defined contribution plan. Severance costs amounted to approximately 116 and 77 thousand USD for the year ended December 31, 2021 and 2020, respectively. &lt;/p&gt;</cmmb:SeverancePayPolicyPolicyTextBlock>
    <cmmb:PercentageOfMonthlyDepositsRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000226"
      unitRef="Pure">0.0833</cmmb:PercentageOfMonthlyDepositsRate>
    <us-gaap:SeveranceCosts1
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000227"
      unitRef="usd">116000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000228"
      unitRef="usd">77000</us-gaap:SeveranceCosts1>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000230">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;N.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Concentrations of credit risk:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Cash and cash equivalents and short term deposits are invested in banks in Israel. Management believes that the financial institutions that hold the Company&#x2019;s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements. &lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000231">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;O.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Leases&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Under Topic 842, the Company determines if an arrangement is a lease at inception. ROU assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be 5% in 2021. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. When determining the probability of exercising such options, the Company considers contract-based, asset-based, entity-based, and market-based factors. For leases agreements, the Company has elected the practical expedient to account for the lease and non-lease maintenance components as a single lease component. Therefore, for those leases, the lease payments used to measure the lease liability include all the fixed consideration in the contract. The Company's lease agreements generally do not contain any residual value guarantees or restrictive covenants. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;12&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 2 - Summary of Significant Accounting Policies (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;O.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Leases (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;For operating leases, the ROU asset is subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;ROU assets for operating leases are periodically reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, Property, Plant, and Equipment &#x2013; Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize. See Note 2(G). &lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000232">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;P.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:28.31pt; "&gt;Principles of consolidation&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The consolidated financial statements include the accounts of the Company and the Subsidiary. Intercompany balances and transactions have been eliminated in consolidation. &lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000233">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Q.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Earnings per ordinary share&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Basic earnings per ordinary share is calculated using only weighted average ordinary shares outstanding. Diluted earnings per share, if relevant, gives effect to dilutive potential ordinary shares outstanding during the year. Such dilutive shares consist of incremental shares, using the treasury stock method, from the assumed exercise of share options. &lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsDisclosureTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000244">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 3 - Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;In NIS &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,116&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;95 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;In USD &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;10,720&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;11,526 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;In other currencies &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;3,350&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;53 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;15,186&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;11,674 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsDisclosureTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000243">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;In NIS &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,116&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;95 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;In USD &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;10,720&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;11,526 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;In other currencies &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;3,350&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;53 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;15,186&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;11,674 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-12-31_currency_ILS"
      decimals="-3"
      id="Fact_0000000000235"
      unitRef="usd">1116000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31_currency_ILS"
      decimals="-3"
      id="Fact_0000000000236"
      unitRef="usd">95000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-12-31_currency_USD"
      decimals="-3"
      id="Fact_0000000000237"
      unitRef="usd">10720000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31_currency_USD"
      decimals="-3"
      id="Fact_0000000000238"
      unitRef="usd">11526000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-12-31_currency_XXX"
      decimals="-3"
      id="Fact_0000000000239"
      unitRef="usd">3350000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31_currency_XXX"
      decimals="-3"
      id="Fact_0000000000240"
      unitRef="usd">53000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000241"
      unitRef="usd">15186000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000242"
      unitRef="usd">11674000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000252">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 4 - Other Receivables and Prepaid Expenses&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Government institutions &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;179&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;74 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Prepaid expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,348&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;67 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,527&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;141 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock>
    <cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000251">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Government institutions &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;179&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;74 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Prepaid expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,348&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;67 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,527&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;141 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock>
    <cmmb:ReceivablesFromGovernmentInstitutions
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000245"
      unitRef="usd">179000</cmmb:ReceivablesFromGovernmentInstitutions>
    <cmmb:ReceivablesFromGovernmentInstitutions
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000246"
      unitRef="usd">74000</cmmb:ReceivablesFromGovernmentInstitutions>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000247"
      unitRef="usd">1348000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000248"
      unitRef="usd">67000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000249"
      unitRef="usd">1527000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000250"
      unitRef="usd">141000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000270">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 5 - Property and Equipment, Net&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Cost:&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Computers &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;43&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;31 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Furniture and equipment &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;27&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;16 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Laboratory equipment &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;364&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;159 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Website development &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;14&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;14 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Leasehold improvements &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;16&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;5 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;464&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;225 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Less - accumulated depreciation&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;(&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;107&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(73 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "&gt;) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;357&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;152 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000269">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Cost:&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Computers &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;43&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;31 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Furniture and equipment &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;27&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;16 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Laboratory equipment &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;364&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;159 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Website development &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;14&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;14 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Leasehold improvements &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;16&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;5 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;464&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;225 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Less - accumulated depreciation&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;(&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;107&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(73 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "&gt;) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;357&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;152 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_ComputerEquipmentMember"
      decimals="-3"
      id="Fact_0000000000253"
      unitRef="usd">43000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_ComputerEquipmentMember"
      decimals="-3"
      id="Fact_0000000000254"
      unitRef="usd">31000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="-3"
      id="Fact_0000000000255"
      unitRef="usd">27000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="-3"
      id="Fact_0000000000256"
      unitRef="usd">16000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_LaboratoryEquipmentMember"
      decimals="-3"
      id="Fact_0000000000257"
      unitRef="usd">364000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_custom_LaboratoryEquipmentMember"
      decimals="-3"
      id="Fact_0000000000258"
      unitRef="usd">159000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_SoftwareDevelopmentMember"
      decimals="-3"
      id="Fact_0000000000259"
      unitRef="usd">14000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_SoftwareDevelopmentMember"
      decimals="-3"
      id="Fact_0000000000260"
      unitRef="usd">14000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact_0000000000261"
      unitRef="usd">16000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact_0000000000262"
      unitRef="usd">5000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000263"
      unitRef="usd">464000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000264"
      unitRef="usd">225000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000265"
      unitRef="usd">107000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000266"
      unitRef="usd">73000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000267"
      unitRef="usd">357000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000268"
      unitRef="usd">152000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000294">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 6 - Leases&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "&gt;On May 10, 2020, Chemomab entered into an office and lab space lease agreement (hereinafter &#x2013; &#x201c;The Agreement&#x201d; .(According to the Agreement, Chemomab will rent space in Atidim Park, Tel-Aviv through &lt;span style="-sec-ix-hidden:Fact_0000000000271"&gt;May 2023&lt;/span&gt;. Chemomab was granted an option to extend the lease term by additional three years. The annual rent and management fees were approximately USD 71 thousand. Pursuant to the Agreement, a bank guarantee of NIS 170 thousand (approximately USD 49 thousand) was issued to the property owner in 2020.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "&gt;On October 24, 2021, Chemomab signed an amendment to the Agreement ("The Amendment"). According to the Amendment, On December 12, 2021 Chemomab returned the previous office and lab space to the property owner and rented a larger space in Atidim Park Tel-Aviv, through &lt;span style="-sec-ix-hidden:Fact_0000000000276"&gt;October 2024&lt;/span&gt;. In addition, Chemomab was granted an option to extend the lease term by additional three years. The annual rent and management fees are approximately USD 132 thousand. Pursuant to the Amendment, the bank guarantee issued in 2020 was canceled and a substitute bank guarantee of approximately USD 86 thousand was issued to the property owner during 2022.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "&gt;The above operating leases are included in &#x201c;Operating lease right-of-use assets&#x201d; on the Company&#x2019;s Consolidated Balance sheets as of December 31, 2021 and 2020 and represent the Company&#x2019;s right to use the underlying asset for the lease term. The Company&#x2019;s obligations to pay lease payments are included in the current liabilities as &#x201c;Operating lease liabilities&#x201d; and in the non-current liabilities as &#x201c;Non-current operating lease liabilities&#x201d; on the Company&#x2019;s Consolidated Balance sheets as of December 31, 2021 and 2020. Based on the present value of the lease payments for the remaining lease term of the Company&#x2019;s existing lease agreement, the Company recognized operating right-of-use assets and operating lease liabilities of approximately USD 345 thousand on December 12, 2021. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "&gt;During the years ended December 31, 2021 and 2020, the Company recognized an increase in right of use assets of USD 345 thousand and USD 500 thousand, respectively. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "&gt;As of December 31, 2021, operating right-of-use assets and operating lease liabilities were USD 345 thousand and USD 343 thousand, respectively. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;14&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 6 - Leases (cont&#x2019;d)&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "&gt;As most of the Chemomab&#x2019;s leases do not provide an implicit rate, Chemomab uses its incremental borrowing rate based on the information available at the commencement date of each lease in determining the present value of lease payments. Chemomab&#x2019;s incremental borrowing rate is a hypothetical rate based on its estimation of what its credit rating would be the rate was5.2% in both 2021 and 2020.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; Maturities of lease liabilities under noncancellable leases as of December 31, 2021, are as follows: (in thousands): &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:40pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:87%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;2022 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;121&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:87%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;2023 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;133&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:87%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;2024 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;117&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:87%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Total future minimum lease payments &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;371&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:87%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Less imputed interest: &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;(&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;28&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:87%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Present value of operating lease liabilities &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;343&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="AsOf2020-05-31" id="Fact_0000000000272">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <cmmb:AnnualRentAndManagementFees
      contextRef="From2020-05-01to2020-05-31"
      decimals="-3"
      id="Fact_0000000000273"
      unitRef="usd">71000</cmmb:AnnualRentAndManagementFees>
    <cmmb:BankGuaranteesToPropertyOwner
      contextRef="From2020-05-01to2020-05-31_currency_ILS"
      decimals="-3"
      id="Fact_0000000000274"
      unitRef="ils">170000</cmmb:BankGuaranteesToPropertyOwner>
    <cmmb:BankGuaranteesToPropertyOwner
      contextRef="From2020-05-01to2020-05-31"
      decimals="-3"
      id="Fact_0000000000275"
      unitRef="usd">49000</cmmb:BankGuaranteesToPropertyOwner>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="AsOf2021-10-24" id="Fact_0000000000277">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <cmmb:AnnualRentAndManagementFees
      contextRef="From2021-10-01to2021-10-24"
      decimals="-3"
      id="Fact_0000000000278"
      unitRef="usd">132000</cmmb:AnnualRentAndManagementFees>
    <cmmb:BankGuaranteesToPropertyOwner
      contextRef="From2021-10-01to2021-10-24"
      decimals="-3"
      id="Fact_0000000000279"
      unitRef="usd">86000</cmmb:BankGuaranteesToPropertyOwner>
    <cmmb:OperatingRightofuseAssetsAndOperatingLeaseLiabilities
      contextRef="AsOf2021-12-12"
      decimals="-3"
      id="Fact_0000000000280"
      unitRef="usd">345000</cmmb:OperatingRightofuseAssetsAndOperatingLeaseLiabilities>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000281"
      unitRef="usd">345000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000282"
      unitRef="usd">500000</us-gaap:OperatingLeaseImpairmentLoss>
    <cmmb:OperatingRightofuseAssetsAndOperatingLeaseLiabilities
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000283"
      unitRef="usd">345000</cmmb:OperatingRightofuseAssetsAndOperatingLeaseLiabilities>
    <cmmb:OperatingRightofuseAssetsAndOperatingLeaseLiabilities
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000284"
      unitRef="usd">343000</cmmb:OperatingRightofuseAssetsAndOperatingLeaseLiabilities>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000286"
      unitRef="Pure">0.052</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="INF"
      id="Fact_0000000000285"
      unitRef="Pure">0.052</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000293">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; Maturities of lease liabilities under noncancellable leases as of December 31, 2021, are as follows: (in thousands): &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:40pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:87%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;2022 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;121&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:87%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;2023 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;133&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:87%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;2024 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;117&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:87%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Total future minimum lease payments &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;371&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:87%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Less imputed interest: &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;(&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;28&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:87%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Present value of operating lease liabilities &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;343&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000287"
      unitRef="usd">121000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000288"
      unitRef="usd">133000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000289"
      unitRef="usd">117000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000290"
      unitRef="usd">371000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000291"
      unitRef="usd">28000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000292"
      unitRef="usd">343000</us-gaap:OperatingLeaseLiability>
    <us-gaap:CommitmentsDisclosureTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000311">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 7 - Commitments and Contingent Liabilities&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Exclusive License Agreement (hereinafter- &#x201c;the License Agreement&#x201d;)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;In December 2011, Chemomab entered into a License Agreement with the Medical Research, Infrastructure, Health Services Fund of the Tel-Aviv Souraski Medical Center (&#x201c;Fund&#x201d;), pursuant to which it was granted with an exclusive license to certain inventions (as defined in the License Agreement) including patents, knowhow and products and the right to sublicense to third parties the rights granted, pursuant to and subject to certain terms and limitation fully set in the License Agreement.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Chemomab has agreed to pay the Fund a non-refundable and non-creditable sublicense fees as a percentage of all Attributed Income (as such term defined in the License Agreement), and shall further pay the Fund royalties from sales made by sublicensee;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:108pt !important; margin-bottom:0pt; "&gt;(i)&lt;span style="padding-left:26.56pt; "&gt;Royalties in percentage of the Net sales or Service Income (as defined in the License Agreement), subject to &lt;/span&gt;certain additional terms set forth therein. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:108pt !important; margin-bottom:0pt; "&gt;&lt;span style="padding-left:36pt; "&gt;In addition, with respect to each Licensed Product (as defined therein), Chemomab has agreed to pay the Fund &lt;/span&gt;the following non-refundable, non-creditable amounts: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:144pt !important; margin-bottom:0pt; "&gt;(a)&lt;span style="padding-left:24.9pt; "&gt;USD 100 thousand upon submission of a New Drug Application (&#x201c;NDA&#x201d;), Biological License Application (&#x201c;BLA&#x201d;) or equivalent for each Licensed Product to the United States Food and Drug Administration (&#x201c;FDA&#x201d;), USD 100 thousand upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Europe and one hundred thousand dollars upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Asia. Payment in the aggregate shall not be more than USD 300 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once;&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:0pt; text-indent:-36pt !important; padding-left:144pt !important; margin-bottom:0pt; "&gt;(b)&lt;span style="padding-left:24.34pt; "&gt;USD 200 thousand upon the grant of FDA or equivalent agency marketing approval in Europe and/or Asia for each Licensed Product. Payment in the aggregate shall not be more than USD 600 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once.&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;As of December 31, 2021 no payments were made to the Fund. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;15&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 7 - Commitments and Contingent Liabilities (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Exclusive License Agreement (hereinafter- &#x201c;the License Agreement&#x201d;) (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;In addition to the payments described above, upon the occurrence of either (i) closing of a public offering of the ordinary shares of Chemomab; or (ii) a Change of Control Transaction, Chemomab shall pay the Fund a cash payment equal to one percent (1%) of the proceeds raised by Chemomab in its initial public offering, or 1% of the consideration received by Chemomab or its shareholders at the closing of a Change of Control Transaction (after deduction of amounts paid as liquidation preference to the shareholders of Chemomab on account of their investment in Chemomab , if any), but in any event not more than USD 3,000 thousand.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;B.&lt;/span&gt;&lt;span style="padding-left:26.83pt; "&gt;Chemomab partially financed its research and development expenditures under programs sponsored by the Israel &lt;/span&gt;Innovation Authority (&#x201c;IIA&#x201d;) for the support of certain research and development activities conducted in Israel. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;In return for the IIA&#x2019;s participation, Chemomab is committed to pay royalties at rate of 3% of sales of the developed product (linked to U.S. dollar), up to 100% of the amount of grants received (100% plus interest at LIBOR).&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;Chemomab did not receive any grants from the IIA in the years ended December 31, 2021, and 2020.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;Since Chemomab &#x2019;s incorporation through December 31, 2021 Chemomab received USD 1,227 thousand from the IIA, which were recognized as a reduction of research and development expenses.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;As of December 31, 2021, Chemomab has no commitment for royalties payable. In addition, the IIA may impose certain conditions to transfer technology or development out of Israel.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;C.&lt;/span&gt;&lt;span style="padding-left:26.28pt; "&gt;In June 2015, Chemomab entered into a license agreement with subcontractor (&#x201c;the Subcontractor&#x201d;), under which the &lt;/span&gt;Subcontractor granted to Chemomab certain licenses to use proprietary rights of the subcontractor, materials and know how in the techniques and use of the same, for purposes of research and development of Chemomab 's product CM-101, as well as commercialization thereof. Further to the agreement, the Subcontractor also provides manufacturing services of intermediates and active pharmaceutical ingredients. According to the related manufacturing agreement, the manufacturing of the product is carried out by the Subcontractor in accordance with Chemomab's specifications and timeline. The total amount of the agreement is Euro 1,200 thousand (excluding materials), of which Euro 600 thousand was paid upon the commencement of the agreement and the remaining amount was paid upon the achievement of a predetermined milestone. In June 2021 and November 2021, Chemomab and the Subcontractor signed three additional agreements for additional manufacturing and final process lock of the product for clinical use, that adds a total amount of Euro 5,831 thousand (excluding materials). Under the agreement, Chemomab is also obligated to pay the Subcontractor royalties determined as a percentage of net sales of each licensee product. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;16&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 7 - Commitments and Contingent Liabilities (cont&#x2019;d)&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;C.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;(cont&#x2019;d)&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;During 2021 and 2020, Chemomab recorded expenses related to the above agreements in the amounts of USD 2,590 thousand and USD 1,177 thousand, respectively. The expenses were recorded under research and development expenses. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;D.&lt;/span&gt;&lt;span style="padding-left:26.28pt; "&gt;In May 2020, Chemomab executed a lien bank deposit of NIS &lt;/span&gt;170 thousand (approximately USD 49 thousand) for the benefit of securing the lease payments under the lease agreement described in Note 6 (the "2020 Lien"). &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;As of December 31, 2021 the bank restricted deposit amount was USD 55 thousand. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;In 2022, the 2020 Lien was canceled and Chemomab executed a substitute lien bank deposit of NIS 269 thousand (approximately USD 86 thousand) for the benefit of securing the lease payments under the Amendment to the lease agreement described in Note 6. &lt;/p&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:LongTermPurchaseCommitmentDescription
      contextRef="From2021-01-01to2021-12-31_us-gaap_CapitalAdditionsMember"
      id="Fact_0000000000295">USD 100 thousand upon submission of a New Drug Application (&#x201c;NDA&#x201d;), Biological License Application (&#x201c;BLA&#x201d;) or equivalent for each Licensed Product to the United States Food and Drug Administration (&#x201c;FDA&#x201d;), USD 100 thousand upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Europe and one hundred thousand dollars upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Asia. Payment in the aggregate shall not be more than USD 300 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once;</us-gaap:LongTermPurchaseCommitmentDescription>
    <us-gaap:LongTermPurchaseCommitmentDescription
      contextRef="From2021-01-01to2021-12-31_custom_CapitalAdditionsOneMember"
      id="Fact_0000000000296">USD 200 thousand upon the grant of FDA or equivalent agency marketing approval in Europe and/or Asia for each Licensed Product. Payment in the aggregate shall not be more than USD 600 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once.</us-gaap:LongTermPurchaseCommitmentDescription>
    <us-gaap:OtherCommitmentsDescription
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000297">upon the occurrence of either (i) closing of a public offering of the ordinary shares of Chemomab; or (ii) a Change of Control Transaction, Chemomab shall pay the Fund a cash payment equal to one percent (1%) of the proceeds raised by Chemomab in its initial public offering, or 1% of the consideration received by Chemomab or its shareholders at the closing of a Change of Control Transaction (after deduction of amounts paid as liquidation preference to the shareholders of Chemomab on account of their investment in Chemomab , if any), but in any event not more than USD 3,000 thousand.</us-gaap:OtherCommitmentsDescription>
    <cmmb:PercentageOfRoyaltyPaymentsOnSaleOfProduct
      contextRef="From2021-01-01to2021-12-31_us-gaap_CapitalAdditionsMember"
      decimals="INF"
      id="Fact_0000000000298"
      unitRef="Pure">0.03</cmmb:PercentageOfRoyaltyPaymentsOnSaleOfProduct>
    <cmmb:MaximumPercentageOfPaymentsOfRoyalties
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000299"
      unitRef="Pure">1</cmmb:MaximumPercentageOfPaymentsOfRoyalties>
    <cmmb:CumulativeAmountsOfGrantsReceivedAndRecognized
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000300"
      unitRef="usd">1227000</cmmb:CumulativeAmountsOfGrantsReceivedAndRecognized>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="From2015-06-01to2015-06-30_currency_EUR"
      decimals="-3"
      id="Fact_0000000000301"
      unitRef="eur">1200000</us-gaap:LongTermPurchaseCommitmentAmount>
    <cmmb:PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement
      contextRef="From2015-06-01to2015-06-30_currency_EUR"
      decimals="-3"
      id="Fact_0000000000302"
      unitRef="eur">600000</cmmb:PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="From2021-06-01to2021-11-30_currency_EUR"
      decimals="-3"
      id="Fact_0000000000303"
      unitRef="eur">5831000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:RoyaltyExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000304"
      unitRef="usd">2590000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000305"
      unitRef="usd">1177000</us-gaap:RoyaltyExpense>
    <cmmb:LienOnBankDeposit
      contextRef="From2020-05-01to2020-05-31_us-gaap_LeaseAgreementsMember_currency_ILS"
      decimals="-3"
      id="Fact_0000000000306"
      unitRef="ils">170000</cmmb:LienOnBankDeposit>
    <cmmb:LienOnBankDeposit
      contextRef="From2020-05-01to2020-05-31_us-gaap_LeaseAgreementsMember"
      decimals="-3"
      id="Fact_0000000000307"
      unitRef="usd">49000</cmmb:LienOnBankDeposit>
    <us-gaap:RestrictedInvestments
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000308"
      unitRef="usd">55000</us-gaap:RestrictedInvestments>
    <cmmb:LienOnBankDeposit
      contextRef="From2022-01-01to2022-12-31_us-gaap_LeaseAgreementsMember_currency_ILS_srt_ScenarioForecastMember"
      decimals="-3"
      id="Fact_0000000000309"
      unitRef="ils">269000</cmmb:LienOnBankDeposit>
    <cmmb:LienOnBankDeposit
      contextRef="From2022-01-01to2022-12-31_us-gaap_LeaseAgreementsMember_srt_ScenarioForecastMember"
      decimals="-3"
      id="Fact_0000000000310"
      unitRef="usd">86000</cmmb:LienOnBankDeposit>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000385">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 8 - Share Capital&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Right attached to shares&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; font-style:italic; "&gt;Ordinary shares&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;All of the issued and outstanding ordinary shares of the Company are duly authorized, validly issued, fully paid and non-assessable. The ordinary are not redeemable, and each ordinary share is entitled to one vote. The holders of the ordinary shares have the right to vote and participate in shareholders' meetings, the right to receive profits, and the right to participate in the accumulated earnings when the Company is dissolved.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:28.5pt; "&gt;Voting&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;The holders of ordinary shares are entitled to vote on all matters submitted to shareholders for a vote.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:28.5pt; "&gt;Dividends&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The holders of the ordinary shares are entitled to receive dividends, when and as declared by the Board of Directors, and out of funds legally available.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;Since its inception, the Company has not declared any dividends.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;B.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Financing rounds&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1.&lt;/span&gt;&lt;span style="padding-left:28.5pt; "&gt;In June 2015, September 2015 and November 2015, Chemomab entered into an agreement with investors according to &lt;/span&gt;which the Company issued the investors warrants to purchase convertible preferred A shares (the &#x201c;Warrants&#x201d;). The warrants were classified as equity. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2.&lt;/span&gt;&lt;span style="padding-left:28.5pt; "&gt;During June to December 2020, the Company's investors exercised the warrants for a total consideration of &lt;/span&gt;approximately USD 1,250 thousand. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;17&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 8 - Share Capital (cont&#x2019;d)&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;B.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Financing rounds (cont&#x2019;d)&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;3.&lt;/span&gt;&lt;span style="padding-left:28.5pt; "&gt;In September 2019, Chemomab Ltd entered into share purchase agreement with current and new investors (hereinafter &lt;/span&gt;&#x2013; &#x201c;2019 SPA&#x201d;), pursuant to which Chemomab Ltd issued 130,831 series preferred C shares NIS 0.01 par value for an aggregate consideration of approximately USD 11,484 thousand. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;4.&lt;/span&gt;&lt;span style="padding-left:28.5pt; "&gt;In November 2019 Chemomab entered into a joinder agreement to 2019 SPA, pursuant to which it issued and sold to &lt;/span&gt;investors an additional 34,130 series preferred C shares NIS 0.01 par value, for an aggregate consideration of approximately USD 3,000 thousand, of which USD 500 thousand from certain investors was received immediately after the balance sheet date. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;5.&lt;/span&gt;&lt;span style="padding-left:28.5pt; "&gt;In May 2020, Chemomab entered a joinder agreement to 2019 SPA, pursuant to which Chemomab issued &lt;/span&gt;34,130 series preferred C shares NIS 0.01 par value for a total consideration of approximately USD 3,000 thousand. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;6.&lt;/span&gt;&lt;span style="padding-left:28.5pt; "&gt;In connection with the Merger, on March 15, 2021, the Company entered into Securities Purchase Agreements with &lt;/span&gt;certain purchasers, pursuant to which the Company agreed to sell approximately USD 45.5 million of its ADSs in a private placement transaction, (or &#x201c;The Private Placement&#x201d;). The Private Placement closed on March 22, 2021, at which time the Company sold to the purchasers 2,619,270 ADSs together with warrants to purchase up to 261,929 ADSs at an exercise price of USD 17.35 per ADS. The warrants will expire five years from the date of issuance, and if exercised in full, will provide to the Company proceeds of approximately USD 4.5 million. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;7.&lt;/span&gt;&lt;span style="padding-left:28.5pt; "&gt;On April 30, 2021, the Company entered into an At the Market Offering Agreement (the &#x201c;ATM Agreement&#x201d;) with &lt;/span&gt;Cantor Fitzgerald &amp;amp; Co., (&#x201c;Cantor&#x201d;). According to the ATM Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $75 million through Cantor or the ATM Agreement. From April 30, 2021, through December 31, 2021, the Company issued 699,806 ADSs at an average price of USD 22.75 per ADS under the ATM Agreement, resulting in gross proceeds of USD 15,917 thousand. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;C.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Share-based compensation&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;(1)&lt;span style="padding-left:24.34pt; "&gt;Share-based compensation plan:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company maintains (i) the 2011 Share Option Plan (the &#x201c;2011 Plan&#x201d;), (ii) the 2017 Equity-Based Incentive Plan (the &#x201c;2017 Plan&#x201d;) and (iii) the Chemomab 2015 Share Incentive Plan (the &#x201c;2015 Plan&#x201d;), &#x2009;which was assumed by the Company from Chemomab Ltd. the effectiveness of the Merger. At that time, outstanding options under the 2015 Plan became exercisable for such number of ADSs of the Company as was determined based on the exchange ratio in the Merger Agreement, with a reciprocal adjustment to exercise price. As of December 31, 2021, a total of 1,422,153 of our ADSs were reserved for issuance under the 2015 Plan, of which 73,776 ADSs had been issued pursuant to previous exercises options, and 1,326,723 ADSs were issuable under outstanding options. Of such outstanding options, options to purchase 452,230 ADSs had vested and were exercisable as of that date, with a weighted average exercise price of USD 2.75 per ADS. During the year ended December 31, 2021 options to purchase 35,653 ADS were canceled as per the request of an optionee &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;18&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 8 - Share Capital (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;C.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Share-based compensation (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt; (2)&lt;span style="padding-left:24.34pt; "&gt;The expenses that were recognized in the consolidated statements of operations for services received from employees &lt;/span&gt;and service providers are as follows: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Research and development &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;137&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;84 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;General and administrative &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,882&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;46 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Total share-based compensation expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2,019&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;130 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; (3)&lt;span style="padding-left:24.34pt; "&gt;The number and weighted average exercise price of options are as follows:&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Weighted &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;average&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;exercise price&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Number of &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;options&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Weighted&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;average &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;remaining &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;contractual &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;life (in years)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Weighted&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;average &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;exercise price&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Number of &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;options&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Weighted&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;average &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;remaining &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;contractual &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;life (in years)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Outstanding at January 1 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;0.07&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;10,455,580&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;7.8 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;0.07 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;8,072,704 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;8.09 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Acquired in Merger &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;609,535&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Exercise &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;0.08&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;(&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;134,220&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;-&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Forfeited &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1.25&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;(&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;1,712,275&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;-&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;0.07 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(10,804 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Granted &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;0.62&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;17,784,640&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;9.79&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;0.08 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;2,393,680 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;9.77 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Outstanding at&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:10pt; margin-bottom:0pt; "&gt;December 31 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;0.38&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;27,003,260&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;8.12&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;0.07 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;10,455,580 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;7.8 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;(4)&lt;span style="padding-left:24.34pt; "&gt;Fair value measurement:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt; The fair value of the options is measured at the grant date using the Black-Scholes Option pricing model and the assumptions used to calculate the fair value of the options are as follows: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021 grants&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Weighted average share price (in U.S. dollar)&lt;sup&gt;(a)&lt;/sup&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:15%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;9.44&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;-&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;27.26&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Exercise price (in U.S. dollar) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:15%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;9.44&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;-&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;27.26&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Expected life of options (in years)&lt;sup&gt;(b)&lt;/sup&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:15%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;5.73&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;-&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;6.28&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Expected volatility&lt;sup&gt;(c)&lt;/sup&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:15%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;65.93&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;%-&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;70.88&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;%&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Risk-free interest rate&lt;sup&gt;(d)&lt;/sup&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:15%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1.36&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;%-&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;1.64&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;%&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Dividend yield &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:15%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;0&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;%&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;19&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 8 - Share Capital (cont&#x2019;d)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;C.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Share-based compensation (cont&#x2019;d)&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;(a)&lt;span style="padding-left:8.9pt; "&gt;The weighted average share price is based on the Company&#x2019;s ordinary share valuation as at the grant date.&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:92pt !important; margin-bottom:0pt; "&gt;(b)&lt;span style="padding-left:8.34pt; "&gt;Expected life for the periods presented was determined according to the simplified method since, at the date of &lt;/span&gt;grant, the Company did not have enough history to make an estimate. This method effectively assumes that exercise occurs over the period from vesting until expiration, and therefore the expected term is the midpoint between the service period and the contractual term of the award. The simplified method is applicable to service conditions and for performance conditions that are probable of achievement. If meeting the performance condition is not probable, the Company will use the awards&#x2019; contractual term if the service period is implied, or the simplified method, if the service period is explicitly stated. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:92pt !important; margin-bottom:0pt; "&gt;(c)&lt;span style="padding-left:8.9pt; "&gt;Expected volatility is based on historical volatility over the most recent period commensurate with the expected &lt;/span&gt;term of the option. As the Company has a short trading history for its ordinary shares, when the Company's trading period is shorter than the expected term, the expected volatility is derived from the average historical share volatilities of several unrelated public companies within the Company&#x2019;s industry that the Company considers to be comparable to its own business over a period equivalent to the option&#x2019;s expected term. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-20pt !important; padding-left:92pt !important; margin-bottom:0pt; "&gt;(d)&lt;span style="padding-left:8.34pt; "&gt;The risk-free rate for the expected term of the options is based on the Black-Scholes option-pricing model on the &lt;/span&gt;yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards. &lt;/p&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2020-06-01to2020-12-31_custom_InvestorsMember"
      decimals="-3"
      id="Fact_0000000000312"
      unitRef="usd">1250000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2019-09-30_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact_0000000000313"
      unitRef="Share">130831</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2019-09-30_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact_0000000000314"
      unitRef="ILSperShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2019-09-01to2019-09-30_us-gaap_SeriesCPreferredStockMember"
      decimals="-3"
      id="Fact_0000000000315"
      unitRef="usd">11484000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2019-11-30_us-gaap_SeriesCPreferredStockMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact_0000000000316"
      unitRef="Share">34130</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2019-11-30_us-gaap_SeriesCPreferredStockMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact_0000000000317"
      unitRef="ILSperShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2019-11-01to2019-11-30_us-gaap_SeriesCPreferredStockMember_custom_InvestorsMember"
      decimals="-3"
      id="Fact_0000000000318"
      unitRef="usd">3000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2019-11-01to2019-11-30_us-gaap_SeriesCPreferredStockMember"
      decimals="-3"
      id="Fact_0000000000319"
      unitRef="usd">500000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2020-05-30_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact_0000000000320"
      unitRef="Share">34130</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-05-30_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact_0000000000321"
      unitRef="ILSperShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2020-05-01to2020-05-30_us-gaap_SeriesCPreferredStockMember"
      decimals="-3"
      id="Fact_0000000000322"
      unitRef="usd">3000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <cmmb:ProceedsFromSaleOfAdss
      contextRef="From2021-03-01to2021-03-15_us-gaap_PrivatePlacementMember"
      decimals="-5"
      id="Fact_0000000000323"
      unitRef="usd">45500000</cmmb:ProceedsFromSaleOfAdss>
    <cmmb:NumberOfWarrantsPurchaseUpAdss
      contextRef="From2021-03-01to2021-03-23_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact_0000000000324"
      unitRef="Share">2619270</cmmb:NumberOfWarrantsPurchaseUpAdss>
    <cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues
      contextRef="From2021-03-01to2021-03-23_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact_0000000000325"
      unitRef="Share">261929</cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues>
    <cmmb:SaleOfStocksPricePerShare
      contextRef="From2021-03-01to2021-03-23_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact_0000000000326"
      unitRef="USDperShare">17.35</cmmb:SaleOfStocksPricePerShare>
    <cmmb:ProceedsFromSaleOfAdss
      contextRef="From2021-03-01to2021-03-23_us-gaap_PrivatePlacementMember"
      decimals="-5"
      id="Fact_0000000000327"
      unitRef="usd">4500000</cmmb:ProceedsFromSaleOfAdss>
    <cmmb:ProceedsFromSaleOfAdss
      contextRef="From2021-04-01to2021-04-30_custom_AtmAgreementMember"
      decimals="-6"
      id="Fact_0000000000328"
      unitRef="usd">75000000</cmmb:ProceedsFromSaleOfAdss>
    <cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues
      contextRef="From2021-01-01to2021-12-31_custom_AtmAgreementMember"
      decimals="INF"
      id="Fact_0000000000329"
      unitRef="Share">699806</cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues>
    <cmmb:SaleOfStocksPricePerShare
      contextRef="From2021-01-01to2021-12-31_custom_AtmAgreementMember"
      decimals="INF"
      id="Fact_0000000000330"
      unitRef="USDperShare">22.75</cmmb:SaleOfStocksPricePerShare>
    <cmmb:ProceedsFromSaleOfAdss
      contextRef="From2021-01-01to2021-12-31_custom_AtmAgreementMember"
      decimals="-3"
      id="Fact_0000000000331"
      unitRef="usd">15917000</cmmb:ProceedsFromSaleOfAdss>
    <cmmb:NumberOfStockAdssResveredForIssuance
      contextRef="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember"
      decimals="INF"
      id="Fact_0000000000332"
      unitRef="Share">1422153</cmmb:NumberOfStockAdssResveredForIssuance>
    <cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues
      contextRef="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember"
      decimals="INF"
      id="Fact_0000000000333"
      unitRef="Share">73776</cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues>
    <cmmb:NumberOfAdssOptionsIssuableOutstanding
      contextRef="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember"
      decimals="INF"
      id="Fact_0000000000334"
      unitRef="Share">1326723</cmmb:NumberOfAdssOptionsIssuableOutstanding>
    <cmmb:NumberOfAdssVestedAndExercisable
      contextRef="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember"
      decimals="INF"
      id="Fact_0000000000335"
      unitRef="Share">452230</cmmb:NumberOfAdssVestedAndExercisable>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
      contextRef="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember"
      decimals="INF"
      id="Fact_0000000000336"
      unitRef="USDperShare">2.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember"
      decimals="INF"
      id="Fact_0000000000337"
      unitRef="Share">35653</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000344">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; text-indent:-36pt !important; padding-left:72pt !important; margin-bottom:0pt; "&gt; (2)&lt;span style="padding-left:24.34pt; "&gt;The expenses that were recognized in the consolidated statements of operations for services received from employees &lt;/span&gt;and service providers are as follows: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Research and development &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;137&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;84 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;General and administrative &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,882&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;46 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Total share-based compensation expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2,019&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;130 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-01to2021-12-31_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_0000000000338"
      unitRef="usd">137000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-01to2020-12-31_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_0000000000339"
      unitRef="usd">84000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-01to2021-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_0000000000340"
      unitRef="usd">1882000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_0000000000341"
      unitRef="usd">46000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000342"
      unitRef="usd">2019000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000343"
      unitRef="usd">130000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000372">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; (3)&lt;span style="padding-left:24.34pt; "&gt;The number and weighted average exercise price of options are as follows:&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Weighted &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;average&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;exercise price&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Number of &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;options&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Weighted&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;average &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;remaining &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;contractual &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;life (in years)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Weighted&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;average &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;exercise price&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Number of &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;options&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Weighted&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;average &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;remaining &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;contractual &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;life (in years)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Outstanding at January 1 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;0.07&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;10,455,580&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;7.8 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;0.07 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;8,072,704 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;8.09 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Acquired in Merger &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;609,535&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Exercise &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;0.08&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;(&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;134,220&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;-&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Forfeited &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1.25&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;(&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;1,712,275&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;-&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;0.07 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(10,804 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Granted &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;0.62&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;17,784,640&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;9.79&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;0.08 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;2,393,680 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;9.77 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:22%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Outstanding at&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:10pt; margin-bottom:0pt; "&gt;December 31 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;0.38&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;27,003,260&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;8.12&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;0.07 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;10,455,580 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;7.8 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="Fact_0000000000345"
      unitRef="USDperShare">0.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="Fact_0000000000346"
      unitRef="Share">10455580</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000347">P7Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2019"
      decimals="INF"
      id="Fact_0000000000348"
      unitRef="USDperShare">0.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2019"
      decimals="INF"
      id="Fact_0000000000349"
      unitRef="Share">8072704</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="Duration_1_1_2019_To_12_31_2019"
      id="Fact_0000000000350">P8Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <cmmb:StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000351"
      unitRef="Share">609535</cmmb:StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000352"
      unitRef="USDperShare">0.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <cmmb:StockIssuedDuringPeriodSharesStockOptionsExercised1
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000353"
      unitRef="Share">134220</cmmb:StockIssuedDuringPeriodSharesStockOptionsExercised1>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000354"
      unitRef="USDperShare"
      xsi:nil="true"/>
    <cmmb:StockIssuedDuringPeriodSharesStockOptionsExercised1
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000355"
      unitRef="Share"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000356"
      unitRef="USDperShare">1.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000357"
      unitRef="Share">1712275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="INF"
      id="Fact_0000000000358"
      unitRef="USDperShare">0.07</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="INF"
      id="Fact_0000000000359"
      unitRef="Share">10804</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000360"
      unitRef="USDperShare">0.62</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000361"
      unitRef="Share">17784640</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000362">P9Y9M14D</cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="INF"
      id="Fact_0000000000363"
      unitRef="USDperShare">0.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="INF"
      id="Fact_0000000000364"
      unitRef="Share">2393680</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000365">P9Y9M7D</cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact_0000000000366"
      unitRef="USDperShare">0.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact_0000000000367"
      unitRef="Share">27003260</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000368">P8Y1M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="Fact_0000000000369"
      unitRef="USDperShare">0.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2020"
      decimals="INF"
      id="Fact_0000000000370"
      unitRef="Share">10455580</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000371">P7Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000384">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt; The fair value of the options is measured at the grant date using the Black-Scholes Option pricing model and the assumptions used to calculate the fair value of the options are as follows: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021 grants&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Weighted average share price (in U.S. dollar)&lt;sup&gt;(a)&lt;/sup&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:15%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;9.44&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;-&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;27.26&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Exercise price (in U.S. dollar) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:15%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;9.44&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;-&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;27.26&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Expected life of options (in years)&lt;sup&gt;(b)&lt;/sup&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:15%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;5.73&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;-&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;6.28&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Expected volatility&lt;sup&gt;(c)&lt;/sup&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:15%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;65.93&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;%-&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;70.88&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;%&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Risk-free interest rate&lt;sup&gt;(d)&lt;/sup&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:15%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1.36&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;%-&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;1.64&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;%&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:81%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Dividend yield &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:15%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;0&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;%&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2021-12-31_srt_MinimumMember"
      decimals="INF"
      id="Fact_0000000000373"
      unitRef="USDperShare">9.44</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2021-12-31_srt_MaximumMember"
      decimals="INF"
      id="Fact_0000000000374"
      unitRef="USDperShare">27.26</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2021-12-31_srt_MinimumMember"
      decimals="INF"
      id="Fact_0000000000375"
      unitRef="USDperShare">9.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2021-12-31_srt_MaximumMember"
      decimals="INF"
      id="Fact_0000000000376"
      unitRef="USDperShare">27.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2021-01-01to2021-12-31_srt_MinimumMember"
      id="Fact_0000000000377">P5Y8M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2021-01-01to2021-12-31_srt_MaximumMember"
      id="Fact_0000000000378">P6Y3M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000379"
      unitRef="Pure">0.6593</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000380"
      unitRef="Pure">0.7088</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000381"
      unitRef="Pure">0.0136</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000382"
      unitRef="Pure">0.0164</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000383"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000399">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 9 - Research and Development&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Consultants and subcontractors &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;3,894&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;3,079 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Salaries and related expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,789&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;1,158 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Rent and maintenance &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;114&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;106 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Share-based compensation &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;137&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;84 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Other expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;400&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;257 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;6,334&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;4,684 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000398">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Consultants and subcontractors &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;3,894&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;3,079 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Salaries and related expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,789&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;1,158 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Rent and maintenance &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;114&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;106 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Share-based compensation &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;137&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;84 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Other expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;400&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;257 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;6,334&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;4,684 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock>
    <cmmb:ConsultantsAndSubcontractorsExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000386"
      unitRef="usd">3894000</cmmb:ConsultantsAndSubcontractorsExpense>
    <cmmb:ConsultantsAndSubcontractorsExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000387"
      unitRef="usd">3079000</cmmb:ConsultantsAndSubcontractorsExpense>
    <us-gaap:OfficersCompensation
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000388"
      unitRef="usd">1789000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000389"
      unitRef="usd">1158000</us-gaap:OfficersCompensation>
    <cmmb:RentAndMaintenanceResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000390"
      unitRef="usd">114000</cmmb:RentAndMaintenanceResearchAndDevelopmentExpense>
    <cmmb:RentAndMaintenanceResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000391"
      unitRef="usd">106000</cmmb:RentAndMaintenanceResearchAndDevelopmentExpense>
    <cmmb:SharebasedCompensationResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000392"
      unitRef="usd">137000</cmmb:SharebasedCompensationResearchAndDevelopmentExpense>
    <cmmb:SharebasedCompensationResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000393"
      unitRef="usd">84000</cmmb:SharebasedCompensationResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000394"
      unitRef="usd">400000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000395"
      unitRef="usd">257000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000396"
      unitRef="usd">6334000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000397"
      unitRef="usd">4684000</us-gaap:ResearchAndDevelopmentExpense>
    <cmmb:GeneralAndAdministrativeDisclosureTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000417">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 10 - General and Administrative&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Salaries and related expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;943&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;334 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Professional services &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,695&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;828 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Share-based compensation &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,882&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;46 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Fees to Directors &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;244&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Insurance &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,024&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;6 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Rent and maintenance &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;29&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;24 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Other expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;216&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;50 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;6,033&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;1,288 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</cmmb:GeneralAndAdministrativeDisclosureTextBlock>
    <cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000416">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Salaries and related expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;943&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;334 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Professional services &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,695&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;828 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Share-based compensation &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,882&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;46 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Fees to Directors &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;244&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Insurance &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,024&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;6 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Rent and maintenance &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;29&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;24 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Other expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;216&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;50 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:70%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;6,033&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;1,288 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock>
    <us-gaap:SalariesAndWages
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000400"
      unitRef="usd">943000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000401"
      unitRef="usd">334000</us-gaap:SalariesAndWages>
    <us-gaap:ProfessionalFees
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000402"
      unitRef="usd">1695000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000403"
      unitRef="usd">828000</us-gaap:ProfessionalFees>
    <cmmb:ShareBasedCompensationGeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000404"
      unitRef="usd">1882000</cmmb:ShareBasedCompensationGeneralAndAdministrativeExpense>
    <cmmb:ShareBasedCompensationGeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000405"
      unitRef="usd">46000</cmmb:ShareBasedCompensationGeneralAndAdministrativeExpense>
    <us-gaap:NoninterestExpenseDirectorsFees
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000406"
      unitRef="usd">244000</us-gaap:NoninterestExpenseDirectorsFees>
    <us-gaap:NoninterestExpenseDirectorsFees
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000407"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GeneralInsuranceExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000408"
      unitRef="usd">1024000</us-gaap:GeneralInsuranceExpense>
    <us-gaap:GeneralInsuranceExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000409"
      unitRef="usd">6000</us-gaap:GeneralInsuranceExpense>
    <cmmb:RentAndMaintenanceGeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000410"
      unitRef="usd">29000</cmmb:RentAndMaintenanceGeneralAndAdministrativeExpense>
    <cmmb:RentAndMaintenanceGeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000411"
      unitRef="usd">24000</cmmb:RentAndMaintenanceGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000412"
      unitRef="usd">216000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000413"
      unitRef="usd">50000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000414"
      unitRef="usd">6033000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000415"
      unitRef="usd">1288000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000458">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 11 - Income Taxes&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Tax rates&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;Ordinary taxable income in Israel is subject to a corporate tax rate of 23%. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company&#x2019;s US subsidiary, Chemomab Therapeutics Inc. ("Chemomab Inc.) is taxed separately under the U.S. tax laws. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;Chemomab Inc. is subject to a federal flat tax rate of 21% and state tax as applicable. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;Capital gain is subject to capital gain tax according to the corporate tax rate in the year the assets are sold. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;B.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Tax assessments&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;As of December 31, 2021, the Company&#x2019;s tax reports through December 31, 2016 are considered closed to audit inspections by the Israeli Tax Authority (&#x201c;ITA&#x201d;) due to statute of limitation rules effective in Israel. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt;The Company has not yet been assessed by the ITA since inception. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;C.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Losses for tax purposes carried forward to future years&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;As of December 31, 2021, the Company and its subsidiaries had approximately $143 million (approximately $21 million as of December 31, 2020) of net operating loss carryforwards which are available to reduce future taxable income with no limitation on the period of use. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;21&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 11 - Income Taxes (cont&#x2019;d)&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;D.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Deferred taxes&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt; In respect of: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Net operating loss carry-forwards &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;33,396&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;4,874 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Share-based compensation expense &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,147&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;57 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Research and development costs &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,449&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;1,244 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Other &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;38&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;25 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Gross deferred tax assets &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;36,030&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;6,200 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Less - Valuation allowance &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;(&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;36,030&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(6,200) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Net deferred tax assets &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;The Company has established a valuation allowance to offset deferred tax assets on December 31, 2021 and 2020 due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. The net change in the total valuation allowance for the year ended at December 31, 2021 was an increase of approximately USD 2.6 million. &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;E.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Roll forward of valuation allowance&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Balance at January 1, 2020 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;$&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;4,248&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Currency transaction loss &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;583&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Income tax expense &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,369&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Balance at December 31, 2020 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;$&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;6,200&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Currency transaction loss &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2,425&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Tax assets acquired through merger &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;24,535&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Income tax expense &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2,870&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Balance at December 31, 2021 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;$&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;36,030&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;22&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 11 - Income Taxes (cont&#x2019;d)&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;F.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:28.31pt; "&gt;Reconciliation of theoretical income tax expense to actual income tax expense&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt; A reconciliation of the Company&#x2019;s theoretical income tax expense to actual income tax expense is as follows: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Loss before income taxes &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;(&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;12,478&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(5,951 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Statutory tax rate &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;23&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "&gt;&lt;span style="font-weight:bold; "&gt;%&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;23 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "&gt;% &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Theoretical tax benefit &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(&lt;span style="font-weight:bold; "&gt;2,870&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(1,369 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-10pt !important; padding-left:10pt !important; margin-bottom:0pt; "&gt;Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2,870&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;1,369 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Actual income tax expense &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;G.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:25.72pt; "&gt;Accounting for uncertainty in income taxes&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:72pt; margin-bottom:0pt; "&gt;For the year ended December 31, 2021, the Company did not have any unrecognized tax benefits and does not expect that the amount of unrecognized tax benefits will change significantly within the next 12 months. The Company&#x2019;s accounting policy is to accrue interest and penalties related to unrecognized tax benefits as a component of income tax expense. &lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-01to2021-12-31_country_IL"
      decimals="INF"
      id="Fact_0000000000418"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-01to2021-12-31_country_US_us-gaap_DomesticCountryMember"
      decimals="INF"
      id="Fact_0000000000419"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="AsOf2021-12-31_country_IL"
      decimals="-6"
      id="Fact_0000000000420"
      unitRef="usd">143000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="AsOf2020-12-31_country_IL"
      decimals="-6"
      id="Fact_0000000000421"
      unitRef="usd">21000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000436">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt; In respect of: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Net operating loss carry-forwards &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;33,396&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;4,874 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Share-based compensation expense &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,147&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;57 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Research and development costs &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,449&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;1,244 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Other &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;38&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;25 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Gross deferred tax assets &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;36,030&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;6,200 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Less - Valuation allowance &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;(&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;36,030&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(6,200) &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Net deferred tax assets &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000422"
      unitRef="usd">33396000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000423"
      unitRef="usd">4874000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000424"
      unitRef="usd">1147000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000425"
      unitRef="usd">57000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000426"
      unitRef="usd">1449000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000427"
      unitRef="usd">1244000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000428"
      unitRef="usd">38000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000429"
      unitRef="usd">25000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000430"
      unitRef="usd">36030000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000431"
      unitRef="usd">6200000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000432"
      unitRef="usd">36030000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000433"
      unitRef="usd">6200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2021-12-31"
      id="Fact_0000000000434"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="As_Of_12_31_2020"
      id="Fact_0000000000435"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="From2021-01-01to2021-12-31"
      decimals="-5"
      id="Fact_0000000000437"
      unitRef="usd">2600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000446">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;E.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Roll forward of valuation allowance&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Balance at January 1, 2020 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;$&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;4,248&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Currency transaction loss &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;583&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Income tax expense &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,369&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Balance at December 31, 2020 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;$&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;6,200&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Currency transaction loss &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2,425&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Tax assets acquired through merger &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;24,535&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Income tax expense &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2,870&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:83%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Balance at December 31, 2021 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;$&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;36,030&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="As_Of_12_31_2019"
      decimals="-3"
      id="Fact_0000000000438"
      unitRef="usd">4248000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <cmmb:CurrencyTransactionLossValuationAllowance
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000439"
      unitRef="usd">583000</cmmb:CurrencyTransactionLossValuationAllowance>
    <cmmb:IncomeTaxExpenseValuationAllowance
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000440"
      unitRef="usd">1369000</cmmb:IncomeTaxExpenseValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="As_Of_12_31_2020"
      decimals="-3"
      id="Fact_0000000000441"
      unitRef="usd">6200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <cmmb:CurrencyTransactionLossValuationAllowance
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000442"
      unitRef="usd">2425000</cmmb:CurrencyTransactionLossValuationAllowance>
    <cmmb:TaxAssetsAcquiredThroughMergerValuationAllowance
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000443"
      unitRef="usd">24535000</cmmb:TaxAssetsAcquiredThroughMergerValuationAllowance>
    <cmmb:IncomeTaxExpenseValuationAllowance
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000444"
      unitRef="usd">2870000</cmmb:IncomeTaxExpenseValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact_0000000000445"
      unitRef="usd">36030000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000457">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt; A reconciliation of the Company&#x2019;s theoretical income tax expense to actual income tax expense is as follows: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:72pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Loss before income taxes &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;(&lt;/span&gt;&lt;span style="font-weight:bold; "&gt;12,478&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(5,951 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Statutory tax rate &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;23&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "&gt;&lt;span style="font-weight:bold; "&gt;%&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;23 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1.5pt; "&gt;% &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Theoretical tax benefit &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(&lt;span style="font-weight:bold; "&gt;2,870&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;)&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;(1,369 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-10pt !important; padding-left:10pt !important; margin-bottom:0pt; "&gt;Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2,870&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;1,369 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Actual income tax expense &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;- &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000447"
      unitRef="usd">12478000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000448"
      unitRef="usd">5951000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000449"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="INF"
      id="Fact_0000000000450"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000451"
      unitRef="usd">-2870000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000452"
      unitRef="usd">-1369000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <cmmb:LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000453"
      unitRef="usd">-2870000</cmmb:LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded>
    <cmmb:LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000454"
      unitRef="usd">-1369000</cmmb:LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000455"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020"
      id="Fact_0000000000456"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000477">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 12 - Related Parties Balances and Transactions&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.28pt; "&gt;Balances with Related Parties:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt; The following Related Party payables are included in the consolidated Balance Sheets: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Employee and related expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;278&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;214 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Accrued expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;72&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;3 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;350&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;217 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;23&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 12 - Related Parties Balances and Transactions (cont'd)&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;B.&lt;/span&gt;&lt;span style="font-weight:bold; padding-left:26.83pt; "&gt;Transactions with Related Parties:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt; The following transactions with related parties are included in the consolidated Statements of Operations: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Salaries and related expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,255&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;605 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Share-based payments &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,775&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;91 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Professional Services &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;244&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;45 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Research and development &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;36&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;36 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;3,310&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;777 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <cmmb:ScheduleOfRelatedPartyPayablesTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000465">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt; The following Related Party payables are included in the consolidated Balance Sheets: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Employee and related expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;278&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;214 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Accrued expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;72&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;3 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;350&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;217 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</cmmb:ScheduleOfRelatedPartyPayablesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2021-12-31_custom_RelatedPartyMember"
      decimals="-3"
      id="Fact_0000000000459"
      unitRef="usd">278000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2020-12-31_custom_RelatedPartyMember"
      decimals="-3"
      id="Fact_0000000000460"
      unitRef="usd">214000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2021-12-31_custom_RelatedPartyMember"
      decimals="-3"
      id="Fact_0000000000461"
      unitRef="usd">72000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2020-12-31_custom_RelatedPartyMember"
      decimals="-3"
      id="Fact_0000000000462"
      unitRef="usd">3000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="AsOf2021-12-31_custom_RelatedPartyMember"
      decimals="-3"
      id="Fact_0000000000463"
      unitRef="usd">350000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="AsOf2020-12-31_custom_RelatedPartyMember"
      decimals="-3"
      id="Fact_0000000000464"
      unitRef="usd">217000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000476">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:72pt; margin-bottom:0pt; "&gt; The following transactions with related parties are included in the consolidated Statements of Operations: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31,&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;USD thousands&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Salaries and related expenses &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,255&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;605 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Share-based payments &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;1,775&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;91 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Professional Services &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;244&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;45 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Research and development &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;36&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;36 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;3,310&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;777 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000466"
      unitRef="usd">1255000</cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000467"
      unitRef="usd">605000</cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000468"
      unitRef="usd">1775000</cmmb:RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000469"
      unitRef="usd">91000</cmmb:RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000470"
      unitRef="usd">244000</cmmb:RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000471"
      unitRef="usd">45000</cmmb:RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000472"
      unitRef="usd">36000</cmmb:RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000473"
      unitRef="usd">36000</cmmb:RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyCosts
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000474"
      unitRef="usd">3310000</us-gaap:RelatedPartyCosts>
    <us-gaap:RelatedPartyCosts
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000475"
      unitRef="usd">777000</us-gaap:RelatedPartyCosts>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000488">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "&gt; &lt;span style="font-weight:bold; "&gt;Note 13 - Net Loss Per Share Attributable to Ordinary Shareholders&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "&gt;Basic net loss per share is computed by dividing the net loss available to common stockholders by the weighted-average number of ordinary shares outstanding. Diluted net loss per share is computed similarly to basic net loss per share except that the denominator is increased to include the number of additional ordinary shares that would have been outstanding if the potential ordinary shares had been issued and if the additional ordinary shares of were dilutive. Diluted net loss per share is the same as basic net loss per share of ordinary share, as the effect of potentially dilutive securities is antidilutive.&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "&gt; The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods presented: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;In USD thousands, except share and per &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;share data&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Numerator:&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Net loss &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;12,478&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;5,951 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Denominator:&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-10pt !important; padding-left:10pt !important; margin-bottom:0pt; "&gt;Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;207,468,650&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;136,755,498 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Net loss per share attributable to ordinary shareholders, basic and diluted &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;0.060&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;0.044 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/&gt; &lt;div&gt; &lt;div style="width:100%; clear:both;"&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; "&gt;F&#x2009;-&#x2009;24&lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/div&gt;&lt;hr style="border-top:1.5pt solid #000000;"/&gt;&lt;div style="page-break-after:always;"/&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div&gt;
&lt;table cellpadding="0" style="border-spacing:0; " width="100%"&gt; &lt;tbody&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;Chemomab Therapeutics Ltd. and its subsidiaries&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Notes to the Financial Statements as at December 31, 2021&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt; &lt;hr style="height:1.5pt; border-width:0; color:#000000; background-color:#000000; width:100%; margin-top:-1.34pt; margin-left:0pt; text-align:left; "/&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:100%; vertical-align:top; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160;&#x2009;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt; &lt;/table&gt; &lt;/div&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Note 13 - Net Loss Per Share Attributable to Ordinary Shareholders (cont'd)&lt;/span&gt; &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "&gt; The potential number of weighted-average ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented since including them would have been anti-dilutive are as follows: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Number of shares&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Outstanding options to purchase ordinary shares &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;27,003,260&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;10,455,580 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000484">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "&gt; The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods presented: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;In USD thousands, except share and per &lt;/span&gt;&lt;span style="font-weight:bold; "&gt;share data&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Numerator:&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Net loss &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;12,478&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;5,951 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Denominator:&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-10pt !important; padding-left:10pt !important; margin-bottom:0pt; "&gt;Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;207,468,650&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;136,755,498 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;&#160; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Net loss per share attributable to ordinary shareholders, basic and diluted &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;0.060&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:3px double #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;0.044 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact_0000000000478"
      unitRef="usd">-12478000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="-3"
      id="Fact_0000000000479"
      unitRef="usd">-5951000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000480"
      unitRef="Share">207468650</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="INF"
      id="Fact_0000000000481"
      unitRef="Share">136755498</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="Fact_0000000000482"
      unitRef="USDperShare">0.060</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="Duration_1_1_2020_To_12_31_2020"
      decimals="INF"
      id="Fact_0000000000483"
      unitRef="USDperShare">0.044</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="From2021-01-01to2021-12-31"
      id="Fact_0000000000487">
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; padding-left:36pt; margin-bottom:0pt; "&gt; The potential number of weighted-average ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented since including them would have been anti-dilutive are as follows: &lt;/p&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;div style="margin-left:36pt; "&gt;
&lt;table cellpadding="0" class="fin" style="border-spacing:0; " width="100%"&gt; &lt;thead&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Year ended&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;December 31&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="odd" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2021&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="2" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;2020&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr class="even" style=""&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td colspan="6" style="width:1%; border-bottom:1.5pt solid #000000; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;Number of shares&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/thead&gt; &lt;tbody&gt; &lt;tr class="odd" style="background-color:#CCEEFF; "&gt; &lt;td style="width:66%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "&gt;Outstanding options to purchase ordinary shares &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;&lt;span style="font-weight:bold; "&gt;27,003,260&lt;/span&gt; &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "/&gt; &lt;/td&gt; &lt;td style="width:14%; vertical-align:bottom; border-bottom:1.5pt solid #000000; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "&gt;10,455,580 &lt;/p&gt; &lt;/td&gt; &lt;td style="width:1%; vertical-align:bottom; "&gt;
&lt;p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact_0000000000485"
      unitRef="Share">27003260</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact_0000000000486"
      unitRef="Share">10455580</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact_0000000000378"
          xlink:label="Fact_0000000000378"
          xlink:type="locator"/>
        <link:footnote id="FN_621deee6493d5b6a527b092b" xlink:label="FN_621deee6493d5b6a527b092b" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="padding-left:8.34pt; ">Expected life for the periods presented was determined according to the simplified method since, at the date of </xhtml:span>grant, the Company did not have enough history to make an estimate. This method effectively assumes that exercise occurs over the period from vesting until expiration, and therefore the expected term is the midpoint between the service period and the contractual term of the award. The simplified method is applicable to service conditions and for performance conditions that are probable of achievement. If meeting the performance condition is not probable, the Company will use the awards&#x2019; contractual term if the service period is implied, or the simplified method, if the service period is explicitly stated.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000378"
          xlink:to="FN_621deee6493d5b6a527b092b"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000377"
          xlink:label="Fact_0000000000377"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000377"
          xlink:to="FN_621deee6493d5b6a527b092b"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000380"
          xlink:label="Fact_0000000000380"
          xlink:type="locator"/>
        <link:footnote id="FN_621deee6493d5b6a527b0925" xlink:label="FN_621deee6493d5b6a527b0925" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="padding-left:8.9pt; ">Expected volatility is based on historical volatility over the most recent period commensurate with the expected </xhtml:span>term of the option. As the Company has a short trading history for its ordinary shares, when the Company's trading period is shorter than the expected term, the expected volatility is derived from the average historical share volatilities of several unrelated public companies within the Company&#x2019;s industry that the Company considers to be comparable to its own business over a period equivalent to the option&#x2019;s expected term.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000380"
          xlink:to="FN_621deee6493d5b6a527b0925"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000379"
          xlink:label="Fact_0000000000379"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000379"
          xlink:to="FN_621deee6493d5b6a527b0925"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000382"
          xlink:label="Fact_0000000000382"
          xlink:type="locator"/>
        <link:footnote id="FN_621deee6493d5b6a527b0927" xlink:label="FN_621deee6493d5b6a527b0927" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="padding-left:8.34pt; ">The risk-free rate for the expected term of the options is based on the Black-Scholes option-pricing model on the </xhtml:span>yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000382"
          xlink:to="FN_621deee6493d5b6a527b0927"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000381"
          xlink:label="Fact_0000000000381"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000381"
          xlink:to="FN_621deee6493d5b6a527b0927"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000374"
          xlink:label="Fact_0000000000374"
          xlink:type="locator"/>
        <link:footnote id="FN_621deee6493d5b6a527b0929" xlink:label="FN_621deee6493d5b6a527b0929" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="padding-left:8.9pt; ">The weighted average share price is based on the Company&#x2019;s ordinary share valuation as at the grant date.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000374"
          xlink:to="FN_621deee6493d5b6a527b0929"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000373"
          xlink:label="Fact_0000000000373"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000373"
          xlink:to="FN_621deee6493d5b6a527b0929"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000091"
          xlink:label="Fact_0000000000091"
          xlink:type="locator"/>
        <link:footnote id="FN_6102973d32beaf4e6dd850f5" xlink:label="FN_6102973d32beaf4e6dd850f5" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1)</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000091"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000112"
          xlink:label="Fact_0000000000112"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000112"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000109"
          xlink:label="Fact_0000000000109"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000109"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000122"
          xlink:label="Fact_0000000000122"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000122"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000110"
          xlink:label="Fact_0000000000110"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000110"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000111"
          xlink:label="Fact_0000000000111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000111"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000123"
          xlink:label="Fact_0000000000123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000123"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000124"
          xlink:label="Fact_0000000000124"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000124"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000105"
          xlink:label="Fact_0000000000105"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000105"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000104"
          xlink:label="Fact_0000000000104"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000104"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000107"
          xlink:label="Fact_0000000000107"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000107"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000106"
          xlink:label="Fact_0000000000106"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000106"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000108"
          xlink:label="Fact_0000000000108"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000108"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000121"
          xlink:label="Fact_0000000000121"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000121"
          xlink:to="FN_6102973d32beaf4e6dd850f5"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0000000000022"
          xlink:label="Fact_0000000000022"
          xlink:type="locator"/>
        <link:footnote id="FN_621deee6493d5b6a527b0922" xlink:label="FN_621deee6493d5b6a527b0922" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Not for trading; only in connection with the registration of American Depository Shares.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0000000000022"
          xlink:to="FN_621deee6493d5b6a527b0922"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>92
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M +[?"/"M>S +['\76?\+4$L#!!0    ( ,6$?E0"@TS3;P(  ) &   8
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M!A@70/LKK7$W<5VI^PEE?P%02P,$%     @ Q81^5.OO8]C* P  'PL  !@
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M"JKCM@W9,H-<X'==!_72(_I-9)U/WUVE-_AJ]NXXD29Q92=(U!3Z&-54X0R
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M1Z,B9*9O_%Y W?IF6VBDUO7'FF8E&&= ^J6FE]P(SL$P?:>_ %!+ P04
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MPI( WL\,VJM^( /M)]_UWU!+ P04    " #%A'Y48UQ&5K,(  "'%P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6S56&UOVS@2_MY?0?BP!QMP_)8F
MZ38O@).TV"S:7I"T>Q\.]X&6QA8WDJ@EJ3B^7W_/D)0LITDV>[A;X(#MQJ(X
MPYEYGGFA3M;:W-F,R(F'(B_M:2]SKGH_'MLDHT+:D:ZHQ)NE-H5T>#2KL:T,
MR=0+%?EX-ID<C@NIRM[9B5^[-F<GNG:Y*NG:"%L7A32;<\KU^K0W[34+-VJ5
M.5X8GYU4<D6WY+Y5UP9/XU9+J@HJK=*E,+0\[<VG[\_?\GZ_X1=%:]OY+=B3
MA=9W_'"5GO8F;!#EE#C6(/'GGBXHSUD1S/@MZNRU1[)@]W>C_:/W';XLI*4+
MG?]=I2X[[;WKB926LL[=C5[_1-&? ]:7Z-SZ_XMUV'LPZXFDMDX741@6%*H,
M?^5#C$-'X-WD&8%9%)AYN\-!WLI+Z>39B=%K87@WM/$/[ZJ7AG&J9%!NG<%;
M!3EW=J&+0CE$V5DARU1<Z-*I<H5G\4G)A<J54V1/Q@YGL<0XB7K/@][9,WJG
M,_$9JC(K/I0II;L*QC"RM7366'H^>U'C)24CL3\=BMED-GU!WW[K^;[7M_]'
M/4_@L+A4-LFUK0V)?\P7UAG0YY\OG/JV/?6M/_7M?SW>+^KEW'UO*YG0:0_)
M:<G<4^_LBW8DCL2>>-VI8CX2'QZ2O+9(%+Q(D'LDYBM#Q**BGY$A5<JE([,G
M_OJ7=[/9Y-AE3VSU[Z;' W%5"N!&Q8(,<)L"O0M4%5W(A< VJ$N%*IT6\HGC
MULIE@M5_IE0E,A<W\$N:)!M"[=)(@%(G#@@-Q4\D<VR^A=M08\7'&D[JI9?^
M2OG>_%[=BUM=0^A.M?HNO FB'SUAH<;PH:AJ8VL),V#=.E-))A1,DE:L#%9A
MMS=/EH+:B.71!4@D9!PJ(IR[QR$H/U;T(8MR =S89_%DW 9X VTIL!&5=(S7
M4-R5>IV!90Q<970*IP.*K,)PU>$3;;WHG.\R9;!;&H]KN[&U?M<_5@;Y7U$I
MN\8C.$4X*5>@C_1E=%GG^498M(OGG!AM,<[@L^3UE/56<N,E/#I2E+K<0PG&
M@USDY,_AI02DP&&\U/%I2?"#M8F*#)8<.@8C+/-<S)TS:E$S*%=EH@ORL;8U
M,&,7?C_JPQ"!C)4M:X--9M=8HS<@&(=R:70AK,SQLY IB<6F8R4=B[X:B)MV
M-T[<-9<U?D'L@@9M&LIV#7^%N1VPD&$R1<" S3!P$NE?Q9<D$8.H(!77@3P[
MA[B0TX/AJT#KRX'X=GLIII,)%G5M.6YU!5K HD)9WZH9%3BY%I>F7HEY52$Z
M@3M-IGVYG&\3[5SI7*]\0K:N/B%S_JF5X;C1;[6Z1Q!!X"4_/NFH3P02WTK%
MW+@%@[DV:)UZO(-Y*9JJXOJ^<]K'KH6O\=@B0W)IA.R8_J)A7#EV?,#\P&/.
MJLZETV8#"-"*-LR"#[7!$.9MUB6)#$@8#UTT)]4YCK9_MEESJ^1(7,N-K]:1
MK7(%YJP0Z)A.I79B0:* (KR'=@[F?C>82)"GS1ERM;M7J7=5=G#^M3;*HH0'
MSE?1@' >G\5YJ4M4*5TFG)*+0-K9=Q"RP;X@<J@ ^2-B15<QK-X1MTN.(BP"
M47= &4.*8_%\8/^S*!W^B5$:P0,.0MNLFT$+IC6R5JQ1*X)@S"PN"J,W'SE5
M)M/CO?AW>O"F+29?45]D1;53B16?7#KR-%:.Z_/"JE1)@T+YAB<5VVK%C($I
M#''V*1O'%OSGOK?O33Q3_-%9IY_H,*=,CX[3P?]@]'ET0*=.-WZV<4W))NA@
M@% N]#WFF9:=.DEJ8T!#WSU(^=;$/8:'4Z:D+[:5[T#XO203%[VPP2"!FQ:#
M;LCCV^!RS%3O*RB26)-EZ$X<*H,KR%?DA)61.2V4@3J/FG@B;=:2"[D#T. =
MEZG8^$1_^L.@L0A43=!7K#!2,8?1/5OU/"TY;IF($;0\\FG(!D]_:!0AMB /
MQ:IMP K@MJL/^SW-V/=,Y]CL&>2EN\%[T7UT/(8<"'&N-=VMT#7#5DF5,B]S
MA9J1!E,P?,-@#UA$><> #@3"WTD35A6]4L;/B]8UI:+=.A0*QY8;-"/,.?P*
M#X)XMO2UXU%Y'4XZI6,DSCL3F1\))8]P2Y]E%)+1Q-':9TP*Q;FN J0/N/Z#
MMC43")#S9&0TBB8F0PN66FU"W-G5*VLDY4QU0Y (K<:_N)K'3+#!@D15\A&]
ME 6JG+IN.WALYRX@9[A>(E+[G@5Q@@ITB!93.R"+/BY(=T'1M]'M*/;( :<6
MKZ&=MUP*</*3[P5V2Z>^WU:A*O M!;!:QX9\NCK_V\V@$]14I1Z&*.C!B;K\
MO!A#T%3_#7&W)KX7?U_0PBR*7Y.1N%7,H_:8-H18UJ;2D?TN,[I>94_4[E:R
M]<B/,L/9[&C;6;H6#N-5QQ=Z".E5J?Y%:1B\33<'7B:,)?ML1WDT::*_)&W%
M]H39@@X*\#U@M#OD-M$L0!!55!K5M[FQH"R$7:&7<!XC&W$+2+*2I\P-5X6N
MM;KVP ?B E%_U,\URA>:RL'SM]7F6B)W;ZOH:5SU^6.!WEXLV>#;[IOM:!DR
M*@0=V[YOI8?_?ZT407RT<EG[MN0YV;![N,-.M"H$M^$.5C!MANSU&<I=<1MK
MVXY1L1 #03_@#0]^[(Q,_"_P?7JTY?NPN1\A'_+-B*.Z/;?EO3<G@/,*IE]Z
MVGP&'Q]Y1@^4^'LI,X9*L9#E'72 L\KS[LO5[;.#%SOH]W/9,9CC*&U%8\GB
MSQ'LX<%!I]K#$LC/0IZP/< *1_/>A M^3B$T3QG)1'(H]HZ>MW=V^.,VQGT_
M$C^H G"AI[ Q[P[;UX.V 2RHQ(73Z[ XS=.!UW.2MC,(A8CSBSD64A_FR(&P
M<YMOVYD)9/",/1R)IS[0C3L?1PLR*_\)F'L-(AB^D[:K[5?F>?BXNMT>/E%_
MEF:E4%MR6D)T,CHZZ(7O*LV#TY7_U+K0SNG"_\P(\[+A#7B_U# T/O ![;?W
MLW\#4$L#!!0    ( ,6$?E3\$+G&K D  #$9   9    >&PO=V]R:W-H965T
M<R]S:&5E=#$T+GAM;-U96V_<N!5^UZ\@IMBN#<BRI+EHG-@&QG:RFT63&'&R
MBZ+H RUQ9KB1Q E)S<3]]?T.*6DNOFRQ#T51!+$EDN?^G0OE\XW27\U2",N^
M5V5M+@9+:U>O3D]-OA05-Y%:B1H[<Z4K;O&J%Z=FI04O'%%5GJ9Q/#FMN*P'
ME^=N[59?GJO&EK(6MYJ9IJJX?K@2I=I<#))!M_!)+I:6%DXOSU=\(>Z$_;*Z
MU7@[[;D4LA*UD:IF6LPO!K/DU=6(SKL#OTJQ,3O/C"RY5^HKO;PK+@8Q*21*
MD5OBP/%K+:Y%61(CJ/&MY3GH11+A[G/'_:VS';;<<R.N5?F;+.SR8C =L$+,
M>5/:3VKSLVCM&1._7)7&_60;?W:8#5C>&*NJEA@:5++VO_GWU@\[!-/X&8*T
M)4B=WEZ0T_*&6WYYKM6&:3H-;O3@3'744$[6%)0[J[$K06<O[Y9<"W;-5]+R
M\OS4@B5MG.8M^94G3Y\A3U+V7M5V:=B;NA#%/H-3Z-(KE'8*7:4O<KP1><2&
M2<C2.$U>X#?L#1PZ?L/G#+0J_[I492&T^9&]^=9(^\ ^*"O8/V;WQFK XI\O
MB!GU8D9.S.C/^O%%<DJ]5V;%<W$Q0&X9H==B<.FTG+(3ML><S2+F<H=Q:SF2
MM&!6,4-'#/NH"UDCN;KW65DR-6=V*9@TIL%97A<,R6DL'F2]8.J HCU]K:H5
MKQ\8"2Z:$@^-72HM_R6*D*UY*0NL>98AFS<EWE9<>O:UJD^X,<(8?E^*B'T&
MOUX,,:R514(7 O4%!T)')&#*@3+@ST1MI2V]C:H6; V?>(YM3#N%#^U8\K5P
M&]KY"N1$ZD2MN+8RERN.=UE[@AXA%3()?C'A/K$6N4#Y8"NMYM(:K_/>B0.N
MM,?SO*F:$BMDGZZ)+]LL1;WG8EA9P).J7(LB8DG$?E6DP:&1AP:2@W:]X\RC
M.H>0HUI9(C/-?26MW8%(QQ#EG/'6FVG$;N1:%J(NS'_BVD/)G6^*CDGHC207
M<1@G\A(D!;M_<.RN%-<%\;Z1H+1*M]X$*FEUWI :I5AP A5?<UEZ&-W).H=K
MK6'TL**B'NXY<@EA!*U>("WV2D7L*F)O84B=DW>U<G+@[G<U^Z4!M-(X&8?L
M#IQ%=2^T>W>*?5#K[4K(KM$7%9!+/A D1M9P H>]"PU(8Q4UW"ZQO!:&S",<
M.!\NR%OD[4;3BY.*%92\CG\:[YGTH]GA(KX+G4LC/.XV7&M>VRZ25E%IR!6Z
M)4+'7<=3\^#M7_\RA=:O3]K?21;TZB/2FJ]$ ]0:]C<+[)&QY%_ !FPDUU*8
M@*J0(35):NL_B+JS@#49:RC&W&ZMZ(IWT,IDS]2Q(VAKZ4R2O2Z.GXS.P9&A
M"]9>A,YVX@$;]F/BJ\BJT3F@(0[CDS=:TXLK61@?MIX^@F<$=)F#%QLYH;L8
M.'L. NQW)=$&]8XD"CA1W-W.0M+$--RO;I82!4_:W;J,&N 2:NQ$ON</+2(>
MB?L3DGH>K;R)DP'_UNU\Y'Q",7XO]$+HD&K)>P[7,0(]!70_V_9,OQ/PIK3
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MWP-F_C/X]KC_8P*NC NZI)5B#M(8$^# ?ZGK7JQ:N8_B]\I:5;G'I> 8<.D
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MC])90F<PG;&MJ(0NH;/34 F$G,,3K0P#AH6C:3JC,QRG;&,+;:WLID"00F;
MPC!A83!AVT)HN+#3E?-,U18N[-"R,)ZR-&&?L: ,!MXD"%@TGK+)*(X3EHPF
M:?*WQODG8U&#/KCA-^2@E=A-R* =]LMU-U:_S;OE="OTH92&5[ G:' Y'7M<
M=P/?":@:-V0[A32R[EK0C@1M#>A]KZB9O6 =#%MW^0M02P,$%     @ Q81^
M5,!P!D:3 @  K 4  !D   !X;"]W;W)K<VAE971S+W-H965T,38N>&ULK53!
M;MLP#+WK*P2?V]J6'<\MD@!)TVX]= L:=,,P[*#83"S4EC));K*_'R6[7CJL
M 0;L8HD2W^,C97*\5_K)5 "6'II:FDE06;N["D-35-!P<Z%V(/%FHW3#+9IZ
M&YJ=!EYZ4%.'+(JRL.%"!M.Q/UOJZ5BUMA82EIJ:MFFX_CF'6NTG01R\'#R(
M;67=03@=[_@65F ?=TN-5CBPE*(!:8225,-F$LSBJWGJ_+W#9P%[<[2G+I.U
M4D_.N"LG0>0$00V%=0P<EV>XAKIV1"CC1\\9#"$=\'C_PG[K<\=<UMS M:J_
MB-)6DR /: D;WM;V0>T_0)_/R/$5JC;^2_>=;YH%M&B-54T/1@6-D-W*#WT=
MC@!Y] : ]0#F=7>!O,H%MWPZUFI/M?-&-K?QJ7HTBA/2/<K*:KP5B+/3]R!!
M\YIR6=)9B0&$L9J[2HU#B_S.*RQZKGG'Q=[@BAF]5])6AM[($LK7!"$*&]2Q
M%W5S=I)Q <4%3>(SRB(6G^!+AFP3SY?\<[;TYH#_N0'Z;;9V9X7]?B)>.L1+
M?;STOU3W--='98'&$3VG;[.2K\ U!5?]XRV6$9HU:%?*UX:KJ_M$Y'&UH+92
MK4%6\X>UXC77 HR/J*'F%DH*7<$,N4P3DB0I66JU >.Z%;49T,^BP-OX++L<
MD9SE9%5Q#>>NA4I:J,:AN>M,=,ES1M*,W +&L(HNA,:F5=H0EJ;DG-Q)TVHN
M"T#7B*4D(P\@K5?CYHX%Z2_9)?J33[;"Y 9U+,[(*"+9690D"&=Y_K=W#8\Z
MJ &]]7/"H,Q6VJZ9AM-A%,VZ#OSMWLVQ>ZZW0AI:PP:AT<6[44!U-QLZPZJ=
M[\>ULMC=?EOA. 7M'/!^H_"E>\,%& ;T]!=02P,$%     @ Q81^5'C'"$:'
M!P  ;1,  !D   !X;"]W;W)K<VAE971S+W-H965T,3<N>&ULS5A=;^.X%7W7
MKR#<G2(!'-N2["0SDP1PDLTVQ>SN8)+9/A1]H"7*8H<2M205)_WU/9>4/Q(K
MF;;[4@2()9'W^]QS*9VMM/EF2R$<>ZQ4;<\'I7/-A_'89J6HN!WI1M18*;2I
MN,.M68YM8P3/O5"EQLED<CRNN*P'%V?^V6=S<:9;IV0M/AMFVZKBYNE2*+TZ
M'\2#]8,O<EDZ>C"^.&OX4MP)][7Y;' WWFC)925J*W7-C"C.!_/XP^64]OL-
MOTFQLCO7C")9:/V-;F[S\\&$'!)*9(XT</P\B"NA%"F"&[]W.@<;DR2X>[W6
M?N-C1RP+;L655G^3N2O/!Z<#EHN"M\I]T:N_B"Z>&>G+M++^/UN%O6DZ8%EK
MG:XZ87A0R3K\\L<N#SL"IY-7!)).(/%^!T/>RVON^,69T2MF:#>TT84/U4O#
M.5E34>Z<P:J$G+NXK3-="7;/'X4]&SMHI.?CK).^#-+)*])QPG[6M2LM^['.
M1?Y<P1BN;/Q)UOY<)F]JO!;9B*7QD"63)'Y#7[J)+_7ZTN_&QZZES92VK1'L
M[_.%=0:(^,<;)J8;$U-O8OH_IO!-:6JZ#[;AF3@?H*NL, ]B</&+=H+%,3MB
MN\K9?.0#,=SAYE>3RQI]Q!Q_Y LEF Q;9<UNK>%",6G1:XM_ O_,:<99IDVC
M29A$O!:F"Y:D[Z"V%.Q*5PVOG_[\I],D/OEHV=<[$K<RE[ R9%>@ UWQ!>TU
MO!&MDYDE_T;L8+!9I/M#L@P3(F=6-)P,J2?6 B&&.1CZ.KH;>1<47]D1>R:[
MYW0A(,85*Q1WS_V.WS%>PX1;1\0MXTVC9$;I@%[>2 ?)):CIA=IL=\F+9D@.
M\KFD5?*Q)U>T%2M/@H<PN+7"P23P9+7*1^PRE(>>6POBPN+<DJL M:@6B'X-
M[*%7\#+AWI* 60BZTNAV6;X4C8^]O4R#%9$79)@@C1_*59M+!R]M$QC/LL63
MMQ/@(+US\]:5VDCWQ [(;C+Y>'L_]U?QQT.6MX(T44K;D&4E*V3*$ZAI%6 G
MBD)X)MT"[1E\6(DRU-HA3XXMA*B[?,#'M3OW<V8!5H]8T9!N%&O$/FG:R#!H
M?"::%A6@!QDW1D(<"RMN?*A%ZZB-J13_68X]4J2S6T1+:"YY3H@Q^E%6 :0_
MQ-,4-*L4!7SP8BV)-TN\U^;DD)[6"!Q#$Y@A/*$\(82GSG_+5J7,2E]'_L"E
M\LV+H%#-%DGI8GO1U2OI2J1UMQXZX!&6I,[)<&O%*+JA8D[BCT?=;Q)'_9W[
MR0&R?6F)B'WLNA%N0#)U)M$L=]1H =;4:6X_Y5%GD[W"7P? K>O@GA^RZQ%4
M%,(0C)W?<$N#WN,7\7R(=@T\O_'6*./1U[MK^*E;BU#LB[M?7JG$T;H449H.
MT_?'T71X>C*-[DK4Y(AF/-H*N,'1(V1:/-*UB.)A/#V)9B?1%Q U-U1$Y"\7
M#SC;-)09B%EGL6\Z?8__R70:_8HDFB@]C9)9]),A%_*=F#L2B=+CX22=1,=#
M'*:B3V@7I.XWKMI@GRN<G5 %$1VP;N=A=. W'_H@^U0>X>]VW7V>V5!-G-N4
M_!=?2$44 ,ST2 YQOJAQ(.L""DQ#J!44"B..L:S2P*B2WZ@Q7,EKW_*X<.!"
MU)M(S&/4D/-DB*SW& .PL4["B[5W(@^$@G.5;[VUTT%AK\OD42Y0I)Q\;INN
M-9:B]L4/<OV-E;=FG9S029:(+;0HD&0A("H:!9BTN03Y&8%"@%M%$*>F==(/
MG#E[V"\9N086>4 2<\IA_=T$_O>9VJ5> ?)>*(D3(;BMUR$TMBX*VP\;8I6]
MOO8PIVY;#PARL84NXS!  Y""1Y3*;9[A:2T*XI?"Z,H3S7?)D4QI#[0>[T*X
MI"-#RI:;F>PT3?.^8/TT64]MPD?>RUQL1916$R@0B/6C[SG[$[,DH^/U!!BQ
M'T?LBT9%UF,)$CT.1)=<>4=@]:^\;@E&W;"(?@#O)-/3Z*HU!"K@P'!03GA=
MH=1$L],TZAB4DK#EH?3X_:[FO4$$W8%+7M>=#*>@I/MMY7GV>RM]OKNS1R7,
M$MR53(>S=-;G1P+:G+SE1PP_.L+:FTO)_^U<ND%ET=W0KN2&/6 3'0L/85'N
MI<*?OS+7]B_.T1T]^O8/@'_ AO31%YJ 9__XZ*3#&-JW();:6D,1#E@,Y)R<
MT@2:#=_/8ES<^?.B#N\B_K <)6GT+OR[WPEJAQ.@*, '>@*>#Z/N!+BE (G"
MAA-A=V;J[7'JW0W%8F]G(9#./L5TL U&YZ\EU,_/GT#J>#-H:\]6Y,<NZ\GZ
M66K8S3[7?.=4FLO<,WK)<9ZF!VU-2%G6Q.W/&=2?-+0(9VOR,=L9%[PB'_T9
M\%4%?GQTM&DE=A0H2>U ;72V[(BT%H\.!<9THK?Z_O="OLU(H_&V]>1?]PB;
MF6D)+0XSTCKO,5+),<;AMA%X@0LO*F\$:?UK*N9M+4(\^X49L;YW]O'.)Q#/
M6_2A!X4G3\/7D,W3S;>D>?B$LMT>/D3]S,T2;U%,B0*BD]');,!,^+@3;IQN
M_ >5A79.5_ZR%!R')-J ]4*#9KH;,K#YPG;Q;U!+ P04    " #%A'Y4;-_[
MN$$#  #=!P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6RU56UOVS80
M_LY?<=" O0")]>HH\VP#=M)@ ]K-B-L-P[ /M'2VB%*B1E)Q_.][I!37;M<L
MV#! D.YX=\^]47?3O=+O385HX;&6C9D%E;7M) Q-46'-S4BUV)!DJW3-+;%Z
M%YI6(R^]42W#)(JNPIJ+)IA/_=E*SZ>JLU(TN-)@NKKF^K!$J?:S( Z>#N[%
MKK+N()Q/6[[#-=IW[4H3%QY12E%C8X1J0.-V%BSBR3)S^E[A5X%[<T*#RV2C
MU'O'_%3.@L@%A!(+ZQ X?1[P!J5T0!3&7P-F<'3I#$_I)_0[GSOELN$&;Y3\
M392VF@77 92XY9VT]VK_(P[YC!U>H:3Q;]CWNED20-$9J^K!F"*H1=-_^>-0
MAQ.#Z^@+!LE@D/BX>T<^REMN^7RJU1ZTTR8T1_A4O34%)QK7E+75)!5D9^?W
M*+G%$E9<6X$&EESRIB""-R6\U;PQW)?/3$-+[IQ16 S0RQXZ^0)TG, ;U=C*
MP*NFQ/(<(*0XC\$F3\$NDV<1;[$801I?0!(E\3-XZ3'YU..E+TC^<)8M_+'8
M&*N)^_,9/]G13^;]9/]'D9^'_EE9!*KT);S8"2Q&'X5[8:M/32?PMD+8*DE_
MK&AV<%ZFEA_X1CI<C2":0G;47"+ DE%!^$J*TNL/3F#M;J>9,&H?UAO4KH7G
MC.NG>T7LW?J6@%1G*&KS"?>J;J4Z(/J,]! 4/M)\,FA8DE^S),[8HBAT=RK(
M$Y:R=!R1-&=W7W]UG43Q#Y?#-TG9#<TY5?.-RUKS%CLK"@.O;3GRCH0U-+(V
M1I2":ZH.<R4W8)5/^$XTE*/@$M:6XJ%Q1>J<'@NG&?H;RP:?\&^:]BV5UGY3
M?@?+T;G@)1VTGQD\E:\='/]C,T_24UOXI:52>;@)^QVY!G2_^"GY7YN]IDIH
M,53BLV;'%\EXS*ZB,5M7%/JE&\PNF8./D,1Y/F;?QVREU1:-VR"N0Z@?1.&N
M2I:Q;,SNT5"\1>5=E/A &ZIU]BR]\L]%&D<LS_._FP#AR<BM4>_\8C%4LJZQ
M_?0]GAYWUZ(?V1_5^\7WANN=H+Y(W))I-,K' >A^F?2,5:T?X!ME:1UXLJ+]
MB]HID'RKZ#X-C'-PW.CS#U!+ P04    " #%A'Y4=F"B-6($  #&"P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6R]5EMOVS84?M>O(#Q@%T"Q+I9C
M-W,,Y-)@!=HT:-85P[ '2CRRB%"D2E)Q\N]W2,FRT\3)$'1[D4B)YSO?N?(L
MUDK?F K DKM:2',\JJQMCJ+(%!74U(Q5 Q+_E$K7U.)6KR+3:*#,"]4B2N/X
M,*HIEZ/EPG^[TLN%:JW@$JXT,6U=4WU_"D*MCT?)://A$U]5UGV(EHN&KN :
M[.?F2N,N&E 8KT$:KB314!Z/3I*CT\R=]P?^X+ V.VOB+,F5NG&;=^QX%#M"
M(*"P#H'BZQ;.0 @'A#2^]IBC0:43W%UOT"^\[6A+3@V<*?&%,UL=C^8CPJ"D
MK;"?U/HWZ.V9.KQ"">.?9-V=G<Y&I&B-574OC QJ+KLWO>O]L",PC_<(I+U
MZGEWBCS+<VKI<J'5FFAW&M'<PIOJI9$<ERXHUU;C7XYR=GF)<7^OC"%7H,EU
M1360$VLUSUM+<P'$*O)1,RXQ8-WO2@D&VBPBB]H=1E3TFDX[3>D>34E*/BAI
M*T/>2@;L(4"$M ?NZ8;[:?HLXCD48S))0I+&:?(,WF3PQ<3C3?;@O:5:<KG:
M]<5?)[FQ&E/G[V?PLP$_\_C9_^#K%S0I"R29D /R6IWDE!I>$(GBPHDW*&Z\
M.#>D4'736F DOR>,WW*47Q%;P?8XO:5<;!3@\1H+$'.YN-G HZ036/NJ 79
M;T%C$R"RK7-4I4JB-K2\6D.PHQA+I=,U)N=<> (O\#.\1AI:W#L:^3Z+X*Z
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MQ;G/+RL<M$&[ _B_5)@L_<8I&$;WY3]02P,$%     @ Q81^5 KB24S[%
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M5I&<L ,K)ZG\-%'YZ225?R/$B8/@*3 ;H^TD@'':_CA7>X /GDF>Q"J!1D)
M$?<A:4D4&V\I\X%Y)0<8G]6-(1IWGO804;TAE4"P0/$S*$^F8*?OF"&35/H^
M4>G[22I]=-!3BB78$A)B.\ >(]8TG'=S-0[JV-<L=JT.?J!H?!ODH2BZ;2>Z
MF&LK65M*!5M3<Q0)6 B7R'G ?-?>B""3JKJU4"[9'W@3"BAA64BRWF8PP2I2
M\2(<%RP((G.D7&>XH]H:BD]*3M#2BABKP%J855<12Z][1Y@98XJ&Z++L)(%U
M_FO0HSLV2^(&^7JE0*6XJ:XY;F(S1R3*B<';Z5HKLIK-C7]V\MT)W%M'&NQ/
M+B]//NAE0QL;.,9(\9/%^<F[SE$D#8$:,./DR<D'0Q?<-!2:V>W.-=<2/9XI
M^N2$*C 1]#E<LL)ZQ19#\!\CRLK$Y1G0":%=G/?)Y?FDN+W?@O>,(YU0-?7Z
M##PH WE'\\A)B./:_M-<?>$DCHU":(%@:_'D!ZC_49%WYIKR?]H.MML>]DB2
M].KJC;I\?#Z+P=Q D7Z,4$.$!V=&216X1?^P"W9*')=D#=:17I'"L33:NB3?
MUAJQZ1QG:.<X:I<0#'?5M=R1K/@=@GE*ZPC] A*!* B&,#P@WN"(+-"$M(_6
M;DPE 1;;,E*U+<E,AXQP27=0G"DXZR7;^1(.!%*B59;>CO#W'%-$H[N"'H10
M3O2?,) TLY43>^4CIJZ4[\CU9\I(SLS;TKBT69ACRED4X,@J^1F46-?VOP^O
MUF=.>.H#T)'K908!08HI0TP.NT;^N3/#1604<@(3#<AEP"RM@FR%-"WPE$C2
M*^S!Z2X_ADVO-U6%%3#&=-9;<MTAZ"*YLPTA)^;IK2G,=DF@8Y6$N4P?2%;K
M)B=5U7A8YKXH *JY\@L>?I'5F!9?\O%&NT)"G9($OVJ.^J]I4./Z_U?V]OT1
M;_LCU+&SA7Q'O9$?NJ.?X?@"B]PQB ,7!\/ANR52%520&B>NYH8R_NF08''1
MD_5BVKK6I)QD'/3M>-%C>OLX*3^0UF5@<[O9YP=L%/-5I.C!_X@9R#.<N^";
M8QR?RA]"2U;/6$PIS<HXUFU]>RQ;6D5'%HU(,#;8 NM X$U,>(.-9?/92S>A
M7G7E=)UDKCZ%.['9D M\#7K@?6G@<8G<*119QNH<!]%<51$DEZ:] 4Z3]1H<
MER <.5<2(HJ[Q+#2COW,*Q+NSB!/SW/N'"'@G]MG!V>%0 >2$'.X%1R#I%N@
M83H,R=Q7T,CZ@5VNHS %?H@9$ZX%7HFT\.U8U4I.\G+A3 "]HFQ[%(W@G,QM
MR_XA^M0(86DJ:Z[E*#^( +<-_5/9SZ:"VR!G!S<;_8NN< NH#4IX8(+XK"0%
M(8O-JGW1B1'TBE+^:VTK+EAP9D%1BQ0.S%KS X4B)7@S"\3 $4'FA3FZ$F&_
MI6R878&^97 D0N1I4'C(&#Q#V//'ON;P>N'"#,]GNTK7-5^F!6O7%CLEG)<"
M(1U().=X*]E,]MC9/9,>^$-JWW"!D2BH0UX:**DL%R .N1>557"&6),K]E&I
MR$6"[=%Q!?<YH+J<R&56Q"OE'YVDS%$N#@]EKQLB>43PFKD@>B/0:'D7,H:!
M00RNX*B(M@-EZK<&$> B8XV\=!7JKOWW1P62 "V-R!_9#U@?B?V2FHT<PL!B
M4!3C$7A#<G<A A$U]&I-#&K9(M)YC\ZAI<S^@$8ZO=>(*2?7MV46E],9ZR#(
MZDVDK4DRN^VQ>LPTU''?]^]S]16G<<#_%$$4+_X[+_Y9:-B;[+<4^%)81=^1
MWCA#F2MK9I-'<]ML$SL7UI1L ><EQ,ME9?T&#%(KI[<&?4ZVY@* [4':)"(7
M<,R!;2RI*84ML 9L)SH [3W05KO/!F4+U]K"[M %S)L.(= Q68X==I MUJI9
MBLA)K\ WG0L)C-DA&JVSZ G1K_BJUH8T:>R'E*8U-_4 $TJ:N_8;T&4_#,&V
MM72S6:^3\0WV99"!S1,AQ[CC8VF["!E:LFFPC)Q]<FD(-CXF2,0U"KOY!ZYF
MHKVBLU@)"2:%0F3#''0[JY(>YU.JSF4"Q1YR1M*#(KZ5'AY,IFT%X?G).Q#X
M?/'#6?B[.#]YLS';9JN7$"&G=Z:C$[SZT)(N@TNPS!32DNNRE!$:?_(+6D?1
M?+Y+RI(5F#7C=I")G(0S%2"H"W6F_ID^-&+J(!WE??656KNWZST\0&G%-1\F
M<T<"%[]A#H>@)/GQU Q$G9SL(HL7"@24-W^.#B.&7\/.@R^<74)*,1\QC';V
MRQ70@X+L-+$0<)%EDNA(7 C@$9L^!.GU898$N;<GV,VUWC/"Y<!*1+1)6AK4
MAJ/7LO6N:WTH%HC*]%Y2 N6F:M960L\Q"_5,?8!RJL4S];>N01S"$DDLZFKQ
MRH889./$1A#XK+"-9K3W7,\^(OA,C\!#5+![DHMY'#6+:QN"/ZX PU"$N]]!
MQ /.X?[S\'SQ3/VZA/N0^$WND1!-IB<0#5[Z3[ERLW^]F5IVB R=:[@H*$6*
M@8EUPRWAVY7R=FO1E4%6!E/+_9 CMQ>T+Y]1>M/TB ?\=*QHHTA%^]J6?B,(
M=3,XDN0MF<VOHB<J'*/DO$SD_/VP]L&A77&T0T*VD51PI^^ !I&OH9-<L+S\
M56QUN\Z466Z^H_CWEDN@(6[,D"^EIY@*J=)K">T1-DZL6)E=.;A_K#[R3M?W
M'%+?( 31@UX$1?!-CID/J"6*,.P9<3K4IY&M:"E%.X[5VI"!(>A(=Z#0!GP"
M@,"_T +\I:E3S6K?S) -(WL\%;OU$R^+Z9&7JPU)U)EH >J(Q(&C4R_3H,8#
MMO^8JV-''"]<^&,[X*OJ*"B3,Q1)KV%4GRR>DBF&C[_1K@P)-,DIR4M1D1:2
M*PL=; BH08-:I*@O0.U'X&NGDR$[K#'B&(:WA@:4"ITKUIJ69(J,"-\%LJ21
MWC=]VC&\+O=R4M\@ I'<^VC><@B!+6T=L)*V(A(7< AQ$>8B;#:V@K:^WL<<
MLX9E!UN#9O.PL1/J'A%/KAZ1'IET0J@6I+(0V3\7J,2Y+K+G,JN@2]N*L^Q4
MX#V\5E:?@#''P 2W/EMNJ;3@,-)NUC*$K7UYG)EWQJL3W\0=,XEB.A7ZC3HD
M6'U!(^-XO-.^BOJV*3Y3WBUTY0,EUJ2$OVKN#,PAH@%*U'5,2$JBBI0A;X@%
M>1<(''A=Z>+SV56Q:6 X!?(9W!G;CJ8D6WT@F[.LW1\<""7\9&\D,N#0[NF]
M-_>'P@0!Z-OVE;0L."0N+1<Z2L$7Z\COY/,<J$EPN$E&OU\]G6?V0V2+Z2FR
MGR!B/(]RYG=$NP;Z>*S4.VK OF'&[,-<_5/GJA2A2Z$C,-_W"4<8U4JMZ""4
M[[W3Q,/W==U<BY2_ZBA48Z]V#PM"\^K]^U=Q%HGM89^9S%"+L*VTS9NE5&U2
M42>B=6/)$'*EE0T/&)6$IL>2ZT0"B[E_ "^L9VB<3D% 9H>WS]8RMER.X>OQ
M\5^HTT]+3C_#MI@>8KM"$8[#?;KNJ&1\P_S:S^3:<KCJ8^=\IZ5:=15&FA</
M(W_[M6]R4_9!W\S4XOO'E^K>:;_I]/Z,"X_)6HP-M'$27K&;JSABXX&0ZBX%
M,C,VC#+H1/N?SB\OO^N+<7&UUQ29WJ$.5YJ0A-.O2[/1U4K<!053G: N0XD<
MIG[:\="WM*_C#!D2P+M4Q0W(<R\KIG*ZRE)IKH<.*^R<-!L(XIIL<31>9 A#
MR]P/2"[C6SGP.-.!($)$D^\5NHF1?'L8POY!:\AZL57C'D0(24*'F8572@PE
M3[<E1XY=N2B$H&$;-K>#L)'HO5@\9KR?/$'AL//X_.GJ[;#X_^7^(,DA6@"D
MK-7=M)KTTU2++XQ38;8"S;#H++-<=KR$]PTS5;_,U> <OW?0LZQ,D5<'V/+L
MFC852WRW_"/.UV9\+:: 2P8NB0XFHQG05 XS-0"&+SD'D>F-/GW@XG<_K;34
M]6=.M<7$8_XF5;RSCD8PK,/:B&V[/#3#6,E8N)%/EW%K,P(!G4@0.1J=A<$(
M4JH*^FYK$LEJ0)Z@D*SU0<""KGB3'[(?,) W(34DAW86AEG/Y(658D*B8@6$
M PA, :?YP-B11<JX"P%?^ :YKJ21<1?%I6N.K9W#YB\/="WZN;?%]. ;C_*,
M"_XW#+S]BM0> $/?\O=F9POU].'%;"#"64?&RMA&?S'.Z\/$D'3>S$Y&NG[[
M]=.@(L9+]IN>PX@YCE3U)9E!'39,%_<1LC-XA0BD%NC)TJ;(OQ]EXM%NZ<SN
M.H?9BN$E^_8:^ZX$*M5E5O8VI&2I1Y<5DR@R-B$I2%?@8MLV&P((9_W%"UX4
M^C8QED%<"M):LO\40$O2/<2PPP[+3:U"RE:D*DO4?FZXA7) K_&2]2B=;9UN
ME>9"]JD]I/% W_XRB12+R.9N!RV1.M,05]R)AP%00&<'2Z?=<,J#EPJ"?DHS
M)%7+'WT'I.&!]C'I>>YYO"D67F/J@Y0'W=R2I]M"M]5DXL*%+(DT'7W1@-$D
M(,:A6S'2E$3 :6Z-*ZP/67HX:J[^ 5"'E$7HF@:KPM94@6UB]75</*/AD6K$
M3'0L/D@7)/U4EZ&&$TH7*QDJ$5T(,JC7SL1V4KL9YES\'IPI ]8H),K4](Y8
M$IJ@(2;I*]5B"F2(_4R>MMET)^*UIDYU?E2GUE7<EGYDGDK=8Q9 HT0E*,^R
M@Y*>QJ':4!;)EN1]$I$$A&'BV&XE=,H*\K&C$Z@\+EP]S;+7G8(R8Z?FC@R*
M( 09DYZB1.M.<]IMV&G$>AZJ"ABVJY&2C+18+OY_MEAZY[+W V0OM/^CY0XL
M32X#JH<;\5A.6]WUQ:YVXYINO4$S;VC?HR$^,HFW)PHSBI$[&"V+T"W4.21.
M#C_=(X7M_'UFXTYR274O%(;O[PG?3&;L<$Y7T[FN98\6 H_>=EH./;C"W6>U
M3*1405Q%Q>PE>SCX\N5J5^[S,B>\&B&[O+3#M;!06)'9!&XC',SZ#4,L=D=2
MJ-^?F\UVKCLK8Z]6"I]7W;+E*./R\?G9@I*&./E*GXA:[6PX <LEA@4)Y*_7
MK&4S2'6*1V"I.?(BQSF0G7Z^D_6#<K1&)&PH%'LW'-0]D3^9H ?W?II^Z7#1
M3^0OOC22GUY_Y&"A]J0]Y?'Z]B2T\:#N(Z;UCYXB/9/T#7S"^+N(8BF99K$0
MOI_PAQ[\530]=YAG(M84<38JOD7&*_-WS/JQ.DHVLI>&!JA.DORB'R>_F!XG
M_U$[>%X/.5><:\"><4%_C.33T,9)_K>YFCB%W[(ME)E8,7Q702JD'(;>\ OB
MT"S(_]KL;22>=&V,FN;JK:TZ+!X<Q0NY$(?2R#7KF'39PBP1- H;X8=2-CMU
MD"K[Z6&4!DA5$+<D(&%'3&QE5BD%A_)K7@=N'5OWNU"BCH.3J2K)+6ENQX48
M"T47IEN*L\8DY4'V@OO6N#6_QL\OJ=:MO.N>ODW_5< K>4&^7R[_S\#/VE%&
M!^^_HJWG\R>/3BEAY%?WY8%L&K\NOVS:MMGRQXW1%%1@ ?V^:HBPX0$'I/]
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MP:SQL0+C _!\K;7;.YZ@?_ZF?P%02P,$%     @ QH1^5/=L*(=6 @  & 4
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MH2+-4AO%D42S"FQM@!>MDY)!'(9G@>*B\B>C]FQN)B/=H!05S VSC5+<O,Y
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M47?PV$T' #Q'C<-^;PZ9X]+P!H3IJ'AX-O1I2>?+J2MB<'1FM'E1B^+NZ+K
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MR<BCJNOQSC"R<7V528-=ZK8ECD50U@'OMU*:DV$#](-V_@=02P,$%     @
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M"$TN/O0C:MI=T!I.;\+\+;7#:0['"M<G&!^ ]RNMW=[P";J%//X#4$L#!!0
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M9_ WU%I%0^JJ+5RIJB:M?8G2=LT,SX') JZY:"P6\'V&GI+\O,,/)<)6">I
M"@O:S!JTACYJ6X*EX_PQCZSG470\)/$0CD=-/(P7A9U4BCI4BCFN%/+A/9 =
M5P79:S0H"?)R\!<R#>BJX'A)Z<0J(R^CX:.URZY[Q(,W$CYNK@E5-88XFA#P
M/L?:'G@1[0>6!?7%X+:I4#.K].7@M@MD,$S"\70V2,.7J7,D%?57>^63;V8L
M7K!O9+5#D(TG0<(\CM% 8T@;+CO]G+P_*U3XO>@4[30<3V;A)(T'P]$DG*9I
M.'XYZV/X/WS$%_$D=L_Q^$QMIWUMIS]<VP<98=7)>-O+N&G5N[G/14,YAU=:
M5:>]\-\ZX#PMUP&ULE1WG(FC=.Y/,WV:7ULR2[=(8#QPW3JN3_3,K^L4,%SF
M2&7F&/@6IME,\ZX1!93$'#)$FG 4W M/@@8=>+>F:WOS\[WVD+-6D<&[QAI+
M!>1XJ-H%;UQ(=:/SDN;CJ8*#9!K&\2A,J,B&<3BF"DYG\5.5%AV-,>K6G1_6
MAE1NI&TG6O^U_Q]8M6/PX7K[,_&6Z1TG7@*W9!I?3*DZ=#N@VXU5M1^*F;(T
M8OVRI'\:U.X"G6\5%4NW<0[ZOZ3EOU!+ P04    " #&A'Y4.7-R0$@#  "R
M"@  &0   'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6S-5MMN$S$0_9712DA%
M@NPE:9I6221(!%2BJ&H$/%0\.+N3K%5?%MM)&HF/9^QLMP&2I0^HXB59VS-G
MSIP97X8;;>YLB>C@7@IE1U'I7'41QS8O43+;T14J6EEH(YFCH5G&MC+(BN D
M19PE23^6C*MH/ QSUV8\U"LGN,)K W8E)3/;MRCT9A2ET</$#5^6SD_$XV'%
MECA#][FZ-C2*&Y2"2U26:P4&%Z/H37HQ2;O>(5A\X;BQ>]_@4YEK?><'E\4H
M2CPC%)@[#\'H;XT3%,(C$8_O-6C4Q/2.^]\/Z.]"\I3,G%F<:/&5%ZX<18,(
M"ERPE7 W>O,!ZX1./5ZNA0V_L*EMDPCRE75:UL[$0'*U^V?WM1![#MDQAZQV
MR'YS2'M''+JU0U NWC$+:4V98^.AT1LPWIK0_$?0)GA3-ESY,LZ<H55.?F[\
M'A4:)N!DBHYQ85\.8T>P?C'.:XBW.XCL",05,QU(^Z\@2[+4ELR@/0 R:0>9
M8DX@O0"2_.H>4TI-7EF35Q;PND?P;M ZL\K=RG"UA(FV#I@J@*;1K!%N/Y(]
M7#J4]EM+M&X3K1NB]8Y&6Z.Q"%2N_ YL);B#7"L_&=J=4<L>$G:'V@^H?L.M
MQ[UAO#Y I-<0Z;42N4*S1 -L:1!ILSGJ)E?"A/:^EFS^BC2 2VL8"@Z"2^ZP
M()ZR8FH;Y&&0$R+/F7AM'>UBF'/M,"\;H]LKE',T;9J=-E1/GZ%"_29:OU68
M3RO/&_0"M"FXHA,+=JU*9Q&=?Y:T(BWF6T!&Z;Z9SN"$J]KDX)[H_U$ZW[>'
M:G?64#Q[(D4?GEN[(D9>$CI]J1JJ\#JQA2,;5R+(4.I#U'9A!GO4TJPSZ!]F
M-VC8#?Z+SH(?X,]G"O6 #3/,J4G<%CYH4="6>DH7GC=IG3]#%Z;)XW&;M,HX
M\QU54AX^7(4F)RF]'%Q*+#AS*+:PT()N5V_06N?)7T*=)YTD>='&>N^22/^7
MXC?%+NMB^_V@\I(SI8&%X;Y6E>&:]H/>D^HI[9$^WB/I<UPDZ>--DK9?)?^T
M0=I#I4<;)-Y[4/C7'%WQ2ZXL"%P04M(YHZ/=[!Y(NX'357ACS+6C%TOX+.E1
MB<8;T/I"4\'K@7^V-,_4\4]02P,$%     @ QH1^5+2]$2)[ @  \P4  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL?519;Z,P$/XK%NI#*^V6(PE4
M%4%*K]T^;!LE[>ZS T.P:NS4-DG[[W=L",IN25[ UWS'V#/I3JHW70$8\E%S
MH:=>9<SFVO=U7D%-]:7<@,"=4JJ:&IRJM:\W"FCA@FKN1T$0^S5EPLM2MS97
M62H;PYF N2*ZJ6NJ/F^ R]W4"[W]PH*M*V,7_"S=T#4LP;QNY@IG?H]2L!J$
M9E(0!>74FX77-XD][P[\9K#3!V-BG:RD?+.3QV+J!580<,B-1:#XV\(M<&Z!
M4,9[A^GUE#;P<+Q'?W#>T<N*:KB5_ \K3#7UKCQ20$D;;A9R]Q,Z/Q.+ETNN
MW9?LNK.!1_)&&UEWP:B@9J+]TX\N#P<!47@D(.H"(J>[)7(J[ZBA6:KDCBA[
M&M'LP%EUT2B."7LI2Z-PEV&<R7Z  $4Y.5_B=1<-!R)+(O Q4*W!:,S:>\,4
M%,YZ03"/I@*F"&C#,">X5%*<;BEOX(*<WX&AC.L+<D:8("^5;#05A4Y]@UHM
MHY]WNFY:7=$17;^HNB1A_(U$012^+N_(^=G%OR@^.NWM1KW=R,&.CL ^S5Y>
M%_?D^8$\S^\7LY?'YZ?E"=A1#SMRL.,CL+=45P2-DMP. %.&"0%A!HVW4!,'
M96MFFT7C*$G][8" <2]@?%+ S-X6J8#C?4BL.60?HFY!X@/J, B"8>I)3STY
M23U7L*&L</8E/@[5/9TA_LD7_F@4#]/'/7U\VGF>JP:?(6=TQ3@S# :9XR_,
MW\/PZDC6DYX[.<G]9.MD7R#'72<#%Y[\;]L_J&';#K$ UDQHPJ'$L. RP7C5
MMIAV8N3&E?5*&FP2;EAA5P9E#^!^*:793VRGZ/M\]A=02P,$%     @ QH1^
M5+UBZRQJ @  P@4  !D   !X;"]W;W)K<VAE971S+W-H965T,S4N>&ULC53;
M;MLP#/T5PNB !-CB6](6A6,@EPW;0X>@6;>'80^*3=M"9<F3E*3]^TJRXV5=
M$NS%UH7G\) 4F>R%?%(5HH;GFG$U]2JMFSO?5UF%-5$CT2 W-X60-=%F*TM?
M-1))[D U\Z,@N/9K0KF7)NYL)=-$;#6C'%<2U+:NB7R9(Q/[J1=ZAX,'6E;:
M'OAITI 2UZ@?FY4T.[]GR6F-7%'!06(Q]6;AW6)B[9W!=XI[=;0&&\E&B">[
M^9)/O< *0H:9M@S$_':X0,8LD9'QN^/T>I<6>+P^L']RL9M8-D3A0K ?--?5
MU+OU(,>";)E^$/O/V,7C!&:"*?>%?6<;>)!ME19U!S8*:LK;/WGN\G $"*_/
M *(.$+T%C,\ X@X0NT!;92ZL)=$D3:38@[36ALTN7&X<VD1#N:WB6DMS2PU.
MI^NV>B *6-.2TX)FA&N899G8<DUY"2O!:$91P> KD9+8K ]AL$1-*%-#^ "/
MZR4,KH9P!93#MTIL%>&Y2GQMY%DG?M9)F;=2HC-2P@CN!=>5@H\\Q_QO M_$
MU0<7'8*;1Q<9EYB-( [?0Q1$X0E!B_^'!Q?DQ'VN8\<7G^$[E=2?LXW2TCSF
M7Q<<C'L'8^=@?,;!"F6&7)ONL_6L;3+9BWG4C5!4*S#%PU-EN4QZ.XKC=Q?$
M37IQDXL\:]RA)#Q#R(32)]]'2S!Q!';\[-(PO$[\W7')_K6YN>E-6F'^43O4
M*$LW)12XY+>/IS_M!]',]=^;\[D94.T\^4/33K=[(DO*%3 L#&4PNC&"9#LQ
MVHT6C6NZC="FA=VR,D,6I34P]X40^K"Q#OJQG;X"4$L#!!0    ( ,:$?E2*
MC>I7XP(  (L)   9    >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;+U6VT[C
M,!#]E5&DE4!"Y-)R55N)4M B+5)%M;L/:!_<9-)8^!)LA\+?[SAITRZ"E ?8
ME]9CSYPY<^QX/%AJ\V +1 ?/4B@[# KGRO,PM&F!DME#7:*BE5P;R1R99A':
MTB#+ZB IPB2*CD/)N I&@WIN:D8#73G!%4X-V$I*9E[&*/1R&,3!>N*.+PKG
M)\+1H&0+G*'[64X-66&+DG&)RG*MP& ^#"[B\W'<]P&UQR^.2[LU!E_*7.L'
M;]QDPR#RC%!@ZCP$H[\GO$0A/!+Q>%R!!FU.'[@]7J-?U\53,7-F\5*+WSQS
MQ3 X#2##G%7"W>GE=UP5=.3Q4BUL_0O+E6\40%I9I^4JF!A(KII_]KP2XB,!
MR2H@J7DWB6J6$^;8:&#T$HSW)C0_J$NMHXD<5WY79L[0*J<X-YHUNP$ZAQE?
M*)[SE"D'%VFJ*^6X6L!4"YYRM+ WHR.150*]\X52%1-@F*,5LB=(AR+ES$N]
M#WL3=(P+NS\('9'TJ<)T16C<$$K>(10G<*N5*RQ<J0RS?P%"JJXM,5F7.$XZ
M$2>8'D(O/H D2N(.O%XK6:_&Z[^#=ZEE63DT%NYO4<[1_.D [;>@_1JT]P[H
MU-"'9MS+ 4R%WP"F,KAZK'A)7X"#^Q_D#C<.I>U*=M0F.^JLX/7F95N;]]:.
M=:/U>H=1]*V#UG%+Z[@3Z >;:^*DZ3ANE;Y;XY,6_^3K-3YMDYU^JL;=:'&T
M0^.SEM99)]!U911WE<'7U>^6.8XV=TKT]4+'6U=8_*E2[X [V2%UG&R()=T'
M&JE?%%ID<"-+HY_0U_^A:R/>7$9Q[S]HO;FFXO[G:MT-1YH8< 6"+;2A.]5#
M>E-XY8 F).C& :WCU(0Q@\IB7@D0/,>U.]_(^U:5X59_E&@6]2O 0MWBFE;9
MSK8OC8NFOV[<FV?*+3,+KBP1S"DT.CRAN]$TG;\QG"[K;CO7CGIW/2SHM83&
M.]!ZKK5;&SY!^_X:_0502P,$%     @ QH1^5)O'S:U4 @  ^P8  !D   !X
M;"]W;W)K<VAE971S+W-H965T,S<N>&ULK95=;]L@%(;_"K)ZT4I;_!4[6>58
M6I--J]1J4;-N%],NB'T2HV)P@<3=OQ]@Q\I7HTS*C<V!\[Z<!V-(:BY>9 &@
MT%M)F1PYA5+5K>O*K( 2RQZO@.F1!1<E5CH42U=6 G!N125U \^+W1(3YJ2)
M[9N*-.$K10F#J4!R5998_+T#RNN1XSN;CB>R+)3I<-.DPDN8@7JNID)';N>2
MDQ*8))PA 8N1\]F_'0]-ODWX2:"66VUD2.:<OYC@/A\YGBD(*&3*.&#]6L,8
M*#5&NHS7UM/IIC3"[?;&_:MEURQS+&',Z2^2JV+D#!V4PP*OJ'KB]3=H>2+C
MEW$J[1/536ZL9\Q64O&R%>NX)*QYX[=V';8$?O\=0= *@G,%82L(+6A3F<6:
M8(731/ :"9.MW4S#KHU5:QK"S%><*:%'B=:I=(QE@3#+D6U\>5V1-:; E$37
M$U"84'F#/J+GV01=7]V@*T08^E'PE=02F;A*5V!\W*R=[:Z9+7AGM@ED/13Z
M'U#@!?X1^?A\N;<K=S5W!Q]T\('UZ_\O_#&RQBJR5N;?6*=^Y _CQ%UO QS)
M\N-!O\O:J3/LZ@Q/UGG_,$._'Z&<@_AS KO?V?4OA]U8Q3M _C[U8=*GZ#AR
MU-48G:S1[+@SD./.+KX<<GR([ W,AMMA/I+E1T%\''O0U3DX6>=W58#0_[T0
MP#("\IPU&';>P\NMP?!@'X=AM+\$ATE1N,?O;AU-YEIXQ&))F$04%EKD]09:
M+9JCM@D4K^QI->=*GWVV6>C;"81)T.,+SM4F, =@=]^E_P!02P,$%     @
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MW;"@-QBT#:#]E5*XF]@V[U_U]#]02P,$%     @ QH1^5+/VX\0[ P  F P
M !D   !X;"]W;W)K<VAE971S+W-H965T,SDN>&ULO5?13J- %/V5"?%!$Q4&
M"FU-VT3;-6NBFT;7]<'LPY3>MA.!P9FAU;_?&4!H"\5N$WUI&;CGWG//7$Z&
MWHKQ%[$ D.@M#"+1-Q92QA>F*?P%A$2<LQ@B]63&>$BD6O*Y*6(.9)J"PL"T
M+<LS0T(C8]!+[XWYH,<2&= (QAR)) P)?[^"@*WZ!C8^;MS3^4+J&^:@%Y,Y
M/(!\C,=<K<PBRY2&$ G*(L1AUC<N\<70MC0@C?A#8276KI%N9<+8BU[<3/N&
MI1E! +[4*8CZ6\(0@D!G4CQ>\Z1&45,#UZ\_LE^GS:MF)D3 D 5/="H7?:-C
MH"G,2!+(>[;Z"7E#KL[GLT"DOVB5Q7J.@?Q$2!;F8,4@I%'V3]YR(=8 N+4#
M8.< >U^ DP.<M-&,6=K6B$@RZ'&V0EQ'JVSZ(M4F1:MN:*2W\4%R]90JG!R,
MN9H(+M\1B:;HQVM"8[5'\A3]4A-T/ )):"!.T!EZ?!BAXZ,3=(1HA'XO6"(4
M0/1,J3CH3*:?U[O*ZMD[ZHW /T<./D6V9>,:^'!_N+4)-U7G1?MVT;Z=YG,^
M:?\4C0,2R4T5T/.M"D<W$D+QMZ&84Q1STF*M'<6&3,@ZQ3*4FZ+T:[<<M+Q6
MSURNRU*-L6VWB-F@TRKHM!KIW((0:F>)[R=A$A )4S7_R@M\2O0;5L<T2^BM
ML3C#5GN+:DU0VZFGZA94W4:JQ91FNW2YL4MJ5.NXNA4:CKM-M1J#7;N>JE=0
M]3[9Y#!.)'"!GN\@G !OFIQVD;3]]6/:*8IU#AK33D6LEK.E9S7$P?5R=@LR
MW48RUPF/J$PX;/?\N;C8*CW0^GIY\9KEXH,$SF'K\MG;$UL3@[UZB7%I@MAN
M=@(R89Q(QM__4^'2^;#S#0J7SH:;K6VGPE5O<BI66Q.$W>X.C4L'P\T6]@03
M026@$2S5V6E_B4O?P=XW2%PZ$FX?)G&[JEY%X<:834*E:^%FV[H%=9I;L&"*
M;L*8LR7HOO=R85R:$>Y^O<9VZ4NV=9#&.<RM-X%,XYJ8[?."N79LU&?V.\+G
M-!(H@)G"6.=M!>;9,3A;2!:G)\D)D^I<FEXNU*<#<!V@GL\8DQ\+?3@M/D8&
M_P!02P,$%     @ QH1^5'D3NW/_ P  '@X  !D   !X;"]W;W)K<VAE971S
M+W-H965T-# N>&ULM5?;;N,V$'W>?@6A;HL$R%HW7U/;0!([:8"D#3;=]F'1
M!UH:VT0DTDO2<0STXSND9,6.9=9-T1=;I.8<SAF..,/^2L@G-0?0Y"7/N!IX
M<ZT7Y[ZODCGD5#7$ CB^F0J94XU#.?/50@)-+2C/_"@(VGY.&?>&?3OW((=]
ML=09X_ @B5KF.97K2\C$:N"%WF;B,YO-M9GPA_T%G<$CZ"^+!XDCOV))60Y<
M,<&)A.G NPC/;\+8 *S%[PQ6:NN9&"D3(9[,X#8=>('Q"#)(M*&@^/<,5Y!E
MA@G]^%:2>M6:!KC]O&&_MN)1S(0JN!+9'RS5\X'7]4@*4[K,]&>Q^AE*02W#
MEXA,V5^R*FP[;8\D2Z5%7H+1@YSQXI^^E('8 D3A 4!4 J*W@.  ("X!\;&
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MO@;*EEIV+'5_X:"PH"/&_HMNS+J8)=1PUBIH!3)) %A))^ AN)8_F]:Y9.0
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MBM?JH;K^O&!+0=*9&#E2D=&03F@&OB@&1I:!;PD_!=![#9"+X)?I!)R\>-6
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M.10B907BL)E;]_ANA2,-J"3^2>$H.L](N[)F[*M^^3V96XYF!!G$4JN@ZN<
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MS.BBO*HI7Q0OS&W'$U>*9^8Q 1J#T!/P^X)SM7O1"]079I/_ %!+ P04
M" #&A'Y4<L<)Z>@"  !;"   &0   'AL+W=O<FMS:&5E=',O<VAE970T-RYX
M;6R5EM]OVC 0Q_\5*^I#*ZW-3Y)00:0"F[:':A6TV\.T!Y,<)*IC9[8#W7\_
MVPD9A1!M+V [=]_[W%WP,=DS_BIR (G>2D+%U,JEK.YM6Z0YE%C<L0JH>K)A
MO,12;?G6%A4'G!FGDMB>XX1VB0MJ)1-S]L23":LE*2@\<23JLL3\]PP(VT\M
MUSH<+(MM+O6!G4PJO(45R)?JB:N=W:ED10E4%(PB#INI]>#>S\?:WAA\*V O
MCM9(9[)F[%5OOF13R]% 0""56@&KKQW,@1 MI#!^M9I6%U(['J\/ZI],[BJ7
M-18P9^1[D<E\:L46RF"#:R*7;/\9VGQ&6B]E1)A/M&]M'0NEM9"L;)T505G0
MYAN_M74X<G##"PY>Z^"=.@07'/S6P3>)-F0FK066.)EPMD=<6RLUO3"U,=XJ
MFX+J+JXD5T\+Y2>3)0C /,T1IAE:P$ZUM5)-DNAZI5Z8K": V 9=LKI!UPN0
MN"#B!MVBE]4"75_=H"M44/2<LUHH<S&QI>+4T>RT99HU3-X%)M=#CXS*7*"/
M-(/LO8"M$NRR] Y9SKQ!Q06D=\AW/R#/\=P>H/F_NSL#.'Y7=-_H^?];]!\/
M:R&Y>K5_#D0)NBB!B1)<B#)G5*B7&5,I3"!1KU-55BW/>&];&KV1T=,__UWB
MQ^-@8N^.2]5CY$3CSN@=ZJA#'0VBKC#!O("&DP/!$C($;^JJ$M!+VLB%1Q!N
M%(]/2'N,W%'<3QIVI.$@Z5*W25/J&U("Q32%/L"P)_9I)7MLG+ ?+^KPHN%"
MYIC#K;[7,I2R4A<0Z^NR#S$Z#^]')XCG-G'03QAWA/$@X5>9 Q_L;7P6,W"<
M$ZYS&V\4]8.-.[#Q(-@SDYCT\8S/7OC0]T][>6X4A&>ELH_NZ1+XUHPOH1I5
M4]E<9MUI-R$?S& X.9^IR=D,NK\RS=A]Q'Q;4($(;)2D<Q<I)-Z,LF8C666F
MP9I)-5O,,E?3'[@V4,\WC,G#1@?H_D\D?P!02P,$%     @ QH1^5",205@O
M P  MPD  !D   !X;"]W;W)K<VAE971S+W-H965T-#@N>&ULE9;?3]LP$,?_
M%2O: TB#_&Q(45L)*&P\H"$*V\.T!S>Y-A:.W=ENR_[[V4X:2GYI>VEBY^Y[
MGSO7/D_V7+S*'$"AMX(R.75RI3:7KBO3' HLS_D&F/ZRXJ+ 2@_%VI4; 3BS
M3@5U \^+W0(3YLPF=NY1S"9\JRAA\"B0W!8%%G^N@?+]U/&=P\036>?*3+BS
MR0:O80'J9?,H],BM53)2 ).$,R1@-76N_,L;WSI8B^\$]O+H'9E4EIR_FL%]
M-G4\0P044F4DL'[LX 8H-4J:XW<EZM0QC>/Q^T']SB:ODUEB"3><_B"9RJ=.
MXJ ,5GA+U1/??X4JH9'12SF5]A?M*UO/0>E6*EY4SIJ@(*Q\XK>J$$<.?MSC
M$%0.0=,AZG$(*X?0)EJ2V;3F6.'91/ ]$L9:JYD76QOKK;,AS"SC0@G]E6@_
M-?L"# 2F"+,,764Z )%*8%-:=++0_YEL2P'Q%>JW.T4G<U"84'F*SM#+8HY.
M/IVB3X@P])SSK=0><N(JS6HBNFG%=5UR!3U<?H >.%.Y1+<L@^RC@*N3K#,-
M#IE>!X.*<TC/4>A_1H$7^!U -__N[@W@A'7A0ZL7_G_A;]_T)I6 ?EXMS5RJ
M?@W$B^IXD8T7]<1;8(H% 6D#"J!808:@C-2Y/J7<R,J9PV W&T?AQ-T=EZQM
M$X91;?.!<U1SC@8Y'P5?@32GA"Z.!+$C:3=?*1,?Q?;C\:@!V#9*@J0;,*X!
MX^%"YEC F3DZ,I3RPA00FQ.IBS%N,R9)T&!L&T5Q-^)%C7@QB'@'>IT51W,B
M]&G)16?]+EIA@RAJH V&,1WF4FYP"E-'MQ"S5N#,T,!_-:GYDT'^>R:W K,4
MNKB3=DV]H G>-NHIZ;A&&@\B/0%3=NN8UJB ]=&-VU4=-]@Z3'KVC.^]G^+>
M(-XWE8,8W,Z5P(>P?MQ ZS :>3UL1QW&'V1[Y@K33B2_=7S$7M@\8SJL_"!I
M;F+WJ 46(-;V9B#U!MTR5?:(>K:^?5S9GMN8OS:W$MM:WV7**\T#%FO")**P
MTI+>^85&$N4MH1PHOK&-=LF5;MOV-=<W*Q#&0']?<:X. Q.@OJO-_@)02P,$
M%     @ QH1^5$' ?_&6 @  10<  !D   !X;"]W;W)K<VAE971S+W-H965T
M-#DN>&ULM57;;MLP#/T5PNB %MCB6RYMX1AHDQ4KL !%LVX/Q1X4FXF%RI(G
M*7$+[.,GR8F7;8G7A^W%%B6>PT.1H)):R"=5(&IX+AE78Z_0NKKT?9456!+5
M$Q5R<[(4LB3:F'+EJTHBR1VH9'X4!$._))1[:>+V[F2:B+5FE..=!+4N2R)?
MKI&)>NR%WF[CGJX*;3?\-*G("N>H'ZH[:2R_9<EIB5Q1P4'B<NQ=A9>3"^OO
M'#Y3K-7>&FPF"R&>K'&;C[W "D*&F;8,Q/PV.$'&+)&1\6W+Z;4A+7!_O6._
M<;F;7!9$X42P+S37Q=@[]R#')5DS?2_J#[C-9V#Y,L&4^T+=^/9''F1KI46Y
M!1L%)>7-GSQO[V$/$ Z/ *(M(/H=T#\"B+> V"7:*'-I38DF:2)%#=)Z&S:[
M<'?CT"8;RFT5YUJ:4VIP.KWEF2@1/I%G5' Z14TH4V?P#A[F4S@].8,3H!QF
ME#%SZ2KQM8EID7ZVY;]N^*,C_&$$,\%UH> ]SS'_E< W8EO%T4[Q==3).,6L
M!W'X%J(@"@\(FKP>'G3(B=L+C!U?_]@%*DF0P>,,RP7*KQV,_9:Q[QCCOY8$
MIE1E3*BU1'C\:-S@5F.INH(,VB"#3MD3(2LAB4;0)HY;G!(%!"J4&7)]=JC4
MW911W N"-QW:AJVV8;<V4E%-&)C,E>G*C$CY8N95361^L ,;MH%CLU-KDX;]
M./$W^TWQIX]MGLT!E:-6Y:A3Y4-OWFO+#M_A!G.4Y%6=<-Z&./]_G7#1!KGX
M]YW031F%QSK!WYM4)<J5&^"FQ&+-=3.TVMWVC;ARH]'_Z=X\,#,B5Y0K8+@T
MT* W,L65S=!N#"TJ-_<60ILIZI:%>>=06@=SOA1"[PP;H'TYTQ]02P,$%
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M3%%9 _J^E-+L)C9 W9Y'?P%02P,$%     @ QH1^5'N&XU$_ P  [0@  !D
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #&A'Y45[4VB9\$  !*)0  #P
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M6?>YQ.034$L! A0#%     @ Q81^5 =!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #%A'Y4,N=R%N\
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M=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ Q81^5 *#3--O @
MD 8  !@              ("!VQ4  'AL+W=O<FMS:&5E=',O<VAE970S+GAM
M;%!+ 0(4 Q0    ( ,6$?E3K[V/8R@,  !\+   8              " @8 8
M  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " #%A'Y4[,+3
MER4%  "C%   &               @(& '   >&PO=V]R:W-H965T<R]S:&5E
M=#4N>&UL4$L! A0#%     @ Q81^5,0Q]V;B!0  U!<  !@
M ("!VR$  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( ,6$
M?E1W&_/%:PD  )D7   8              " @?,G  !X;"]W;W)K<VAE971S
M+W-H965T-RYX;6Q02P$"% ,4    " #%A'Y4=>D29[(3  #[.   &
M        @(&4,0  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%
M  @ Q81^5 7:D/D\ @  "@4  !@              ("!?$4  'AL+W=O<FMS
M:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( ,6$?E2"$UFE0 (  "L%   9
M              " @>Y'  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L!
M A0#%     @ Q81^5(;S\RR' @  B04  !D              ("!94H  'AL
M+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " #%A'Y4A!J2GH$%
M  #^#0  &0              @($C30  >&PO=V]R:W-H965T<R]S:&5E=#$R
M+GAM;%!+ 0(4 Q0    ( ,6$?E1C7$96LP@  (<7   9              "
M@=M2  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ Q81^
M5/P0N<:L"0  ,1D  !D              ("!Q5L  'AL+W=O<FMS:&5E=',O
M<VAE970Q-"YX;6Q02P$"% ,4    " #%A'Y4HTQY\WX"  "!!0  &0
M        @(&H90  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0
M   ( ,6$?E3 < 9&DP(  *P%   9              " @5UH  !X;"]W;W)K
M<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ Q81^5'C'"$:'!P  ;1,
M !D              ("!)VL  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q0
M2P$"% ,4    " #%A'Y4;-_[N$$#  #=!P  &0              @('E<@
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( ,6$?E1V8*(U
M8@0  ,8+   9              " @5UV  !X;"]W;W)K<VAE971S+W-H965T
M,3DN>&UL4$L! A0#%     @ Q81^5 KB24S[%   3$$  !D
M ("!]GH  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " #&
MA'Y4*N& 3K$"  "J!0  &0              @($HD   >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( ,:$?E3(DNY]?@(  %$%   9
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M970R-BYX;6Q02P$"% ,4    " #&A'Y4!*D))[H$  !O"P  &0
M    @(%^H   >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (
M ,:$?E1F<+G7B0(  '0%   9              " @6^E  !X;"]W;W)K<VAE
M971S+W-H965T,C@N>&UL4$L! A0#%     @ QH1^5**'5#R= @  G 4  !D
M             ("!+Z@  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"
M% ,4    " #&A'Y4$&CLM24$   D"@  &0              @($#JP  >&PO
M=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( ,:$?E3N32HM 0,
M $$'   9              " @5^O  !X;"]W;W)K<VAE971S+W-H965T,S$N
M>&UL4$L! A0#%     @ QH1^5"%DFR*1 P  ,0D  !D              ("!
ME[(  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " #&A'Y4
M.7-R0$@#  "R"@  &0              @(%?M@  >&PO=V]R:W-H965T<R]S
M:&5E=#,S+GAM;%!+ 0(4 Q0    ( ,:$?E2TO1$B>P(  /,%   9
M      " @=ZY  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%
M  @ QH1^5+UBZRQJ @  P@4  !D              ("!D+P  'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " #&A'Y4BHWJ5^,"  "+"0
M&0              @($QOP  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+
M 0(4 Q0    ( ,:$?E2;Q\VM5 (  /L&   9              " @4O"  !X
M;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ QH1^5.N*+*Y=
M @  X04  !D              ("!UL0  'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6Q02P$"% ,4    " #&A'Y4L_;CQ#L#  "8#   &0
M@(%JQP  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( ,:$
M?E1Y$[MS_P,  !X.   9              " @=S*  !X;"]W;W)K<VAE971S
M+W-H965T-# N>&UL4$L! A0#%     @ QH1^5.DU-D>7 @  <P8  !D
M         ("!$L\  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
M    " #&A'Y4C6?C,R0'  !,'   &0              @('@T0  >&PO=V]R
M:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( ,:$?E2>K)^WF@4   ,:
M   9              " @3O9  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL
M4$L! A0#%     @ QH1^5&[_;*72 @  M0@  !D              ("!#-\
M 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " #&A'Y4_U,1
MSP@$  "4#P  &0              @($5X@  >&PO=V]R:W-H965T<R]S:&5E
M=#0U+GAM;%!+ 0(4 Q0    ( ,:$?E2MRF7.^00  #P3   9
M  " @53F  !X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @
MQH1^5'+'">GH @  6P@  !D              ("!A.L  'AL+W=O<FMS:&5E
M=',O<VAE970T-RYX;6Q02P$"% ,4    " #&A'Y4(Q)!6"\#  "W"0  &0
M            @(&C[@  >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4
M Q0    ( ,:$?E1!P'_QE@(  $4'   9              " @0GR  !X;"]W
M;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ QH1^5'L/GWUQ P
M@@H  !D              ("!UO0  'AL+W=O<FMS:&5E=',O<VAE970U,"YX
M;6Q02P$"% ,4    " #&A'Y48AS0#.<"  "J!P  &0              @(%^
M^   >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( ,:$?E1[
MAN-1/P,  .T(   9              " @9S[  !X;"]W;W)K<VAE971S+W-H
M965T-3(N>&UL4$L! A0#%     @ QH1^5$(8\P"< @  [0<  !D
M     ("!$O\  'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4
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M   P%   #0              @ %+"P$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( ,:$?E27BKL<P    !,"   +              "  ;P. 0!?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( ,:$?E17M3:)GP0  $HE   /              "
M :4/ 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #&A'Y4##^0_.4!  !_
M(0  &@              @ %Q% $ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " #&A'Y4C^&W:=,!   V(0  $P              @ &.
L%@$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     0 !  '<1  "2& $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>90</ContextCount>
  <ElementCount>264</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>35</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00010 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00020 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00030 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00040 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00050 - Statement - Consolidated Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/StatementsOfChangesInEquity</Role>
      <ShortName>Consolidated Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00060 - Statement - Statements of Cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/StatementsOfCashFlows</Role>
      <ShortName>Statements of Cash flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00070 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00080 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00090 - Disclosure - Cash and Cash Equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/CashAndCashEquivalents</Role>
      <ShortName>Cash and Cash Equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00100 - Disclosure - Other Receivables and Prepaid Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/OtherReceivablesAndPrepaidExpenses</Role>
      <ShortName>Other Receivables and Prepaid Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00110 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00120 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00130 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/CommitmentsAndContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00140 - Disclosure - Share Capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/ShareCapital</Role>
      <ShortName>Share Capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00150 - Disclosure - Research and Development</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/ResearchAndDevelopment</Role>
      <ShortName>Research and Development</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00160 - Disclosure - General and Administrative</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/GeneralAndAdministrative</Role>
      <ShortName>General and Administrative</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00170 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00180 - Disclosure - Related Parties Balances and Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/RelatedPartiesBalancesAndTransactions</Role>
      <ShortName>Related Parties Balances and Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00190 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders</Role>
      <ShortName>Net Loss Per Share Attributable to Ordinary Shareholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00200 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://anchiano.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00210 - Disclosure - General (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/GeneralTables</Role>
      <ShortName>General (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anchiano.com/role/General</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00220 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anchiano.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00230 - Disclosure - Cash and Cash Equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/CashAndCashEquivalentsTables</Role>
      <ShortName>Cash and Cash Equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anchiano.com/role/CashAndCashEquivalents</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00240 - Disclosure - Other Receivables and Prepaid Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables</Role>
      <ShortName>Other Receivables and Prepaid Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anchiano.com/role/OtherReceivablesAndPrepaidExpenses</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00250 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anchiano.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00260 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anchiano.com/role/Leases</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00270 - Disclosure - Share Capital (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/ShareCapitalTables</Role>
      <ShortName>Share Capital (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anchiano.com/role/ShareCapital</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00280 - Disclosure - Research and Development (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/ResearchAndDevelopmentTables</Role>
      <ShortName>Research and Development (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anchiano.com/role/ResearchAndDevelopment</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00290 - Disclosure - General and Administrative (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/GeneralAndAdministrativeTables</Role>
      <ShortName>General and Administrative (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anchiano.com/role/GeneralAndAdministrative</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00300 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anchiano.com/role/IncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00310 - Disclosure - Related Parties Balances and Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables</Role>
      <ShortName>Related Parties Balances and Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anchiano.com/role/RelatedPartiesBalancesAndTransactions</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00320 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables</Role>
      <ShortName>Net Loss Per Share Attributable to Ordinary Shareholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00330 - Disclosure - General (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/GeneralDetails</Role>
      <ShortName>General (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/GeneralTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00340 - Disclosure - General (Schedule of net assets acquired based on their estimated fair value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails</Role>
      <ShortName>General (Schedule of net assets acquired based on their estimated fair value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/GeneralTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00350 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00360 - Disclosure - Summary of Significant Accounting Policies (Schedule of Annual rates of Depreciation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Schedule of Annual rates of Depreciation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00370 - Disclosure - Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/CashAndCashEquivalentsDetails</Role>
      <ShortName>Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/CashAndCashEquivalentsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00380 - Disclosure - Other Receivables and Prepaid Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails</Role>
      <ShortName>Other Receivables and Prepaid Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00390 - Disclosure - Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/PropertyAndEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00400 - Disclosure - Leases (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/LeasesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00410 - Disclosure - Leases (Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails</Role>
      <ShortName>Leases (Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/LeasesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00420 - Disclosure - Commitments and Contingent Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingent Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/CommitmentsAndContingentLiabilities</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00430 - Disclosure - Share Capital (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/ShareCapitalNarrativeDetails</Role>
      <ShortName>Share Capital (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/ShareCapitalTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00440 - Disclosure - Share Capital (Share-based compensation expenses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails</Role>
      <ShortName>Share Capital (Share-based compensation expenses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/ShareCapitalTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00450 - Disclosure - Share Capital (Summary of number and weighted average exercise prices of option) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails</Role>
      <ShortName>Share Capital (Summary of number and weighted average exercise prices of option) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/ShareCapitalTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00460 - Disclosure - Share Capital (Summary of assumptions used to calculate the fair value of the options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails</Role>
      <ShortName>Share Capital (Summary of assumptions used to calculate the fair value of the options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/ShareCapitalTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00470 - Disclosure - Research and Development (Schedule of Research and Development) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails</Role>
      <ShortName>Research and Development (Schedule of Research and Development) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/ResearchAndDevelopmentTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00480 - Disclosure - General and Administrative (Schedule of General and Administrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails</Role>
      <ShortName>General and Administrative (Schedule of General and Administrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/GeneralAndAdministrativeTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00490 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/IncomeTaxesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00500 - Disclosure - Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails</Role>
      <ShortName>Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/IncomeTaxesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00510 - Disclosure - Income Taxes (Schedule of Roll Forward of Valuation Allowance) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails</Role>
      <ShortName>Income Taxes (Schedule of Roll Forward of Valuation Allowance) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/IncomeTaxesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00520 - Disclosure - Income Taxes (Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes (Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/IncomeTaxesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00530 - Disclosure - Related Parties Balances and Transactions (Schedule of Related Party Payables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails</Role>
      <ShortName>Related Parties Balances and Transactions (Schedule of Related Party Payables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00540 - Disclosure - Related Parties Balances and Transactions (Schedule of Transaction With Related Parties) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails</Role>
      <ShortName>Related Parties Balances and Transactions (Schedule of Transaction With Related Parties) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00550 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Computation of Basic and Diluted Net Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Computation of Basic and Diluted Net Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="zk2227534.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00560 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Weighted Average Number of Shares) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Weighted Average Number of Shares) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="zk2227534.htm">zk2227534.htm</File>
    <File>cmmb-20211231.xsd</File>
    <File>cmmb-20211231_cal.xml</File>
    <File>cmmb-20211231_def.xml</File>
    <File>cmmb-20211231_lab.xml</File>
    <File>cmmb-20211231_pre.xml</File>
    <File>exhibit_10-10.htm</File>
    <File>exhibit_10-11.htm</File>
    <File>exhibit_10-2.htm</File>
    <File>exhibit_21-1.htm</File>
    <File>exhibit_23-1.htm</File>
    <File>exhibit_31-1.htm</File>
    <File>exhibit_31-2.htm</File>
    <File>exhibit_32-1.htm</File>
    <File>exhibit_32-2.htm</File>
    <File>exhibit_4-1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image0.jpg</File>
    <File>image00017.jpg</File>
    <File>image1.jpg</File>
    <File>image10.jpg</File>
    <File>image11.jpg</File>
    <File>image12.jpg</File>
    <File>image13.jpg</File>
    <File>image14.jpg</File>
    <File>image15.jpg</File>
    <File>image16.jpg</File>
    <File>image2.jpg</File>
    <File>image4.jpg</File>
    <File>image5.jpg</File>
    <File>image6.jpg</File>
    <File>image7.jpg</File>
    <File>image8.jpg</File>
    <File>image9.jpg</File>
    <File>kpmg.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="360">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>98
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "zk2227534.htm": {
   "axisCustom": 0,
   "axisStandard": 16,
   "contextCount": 90,
   "dts": {
    "calculationLink": {
     "local": [
      "cmmb-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cmmb-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "zk2227534.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cmmb-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cmmb-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cmmb-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 399,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 4,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 8
   },
   "keyCustom": 57,
   "keyStandard": 207,
   "memberCustom": 11,
   "memberStandard": 24,
   "nsprefix": "cmmb",
   "nsuri": "http://anchiano.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00010 - Document - Document and Entity Information",
     "role": "http://anchiano.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00100 - Disclosure - Other Receivables and Prepaid Expenses",
     "role": "http://anchiano.com/role/OtherReceivablesAndPrepaidExpenses",
     "shortName": "Other Receivables and Prepaid Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00110 - Disclosure - Property and Equipment, Net",
     "role": "http://anchiano.com/role/PropertyAndEquipmentNet",
     "shortName": "Property and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00120 - Disclosure - Leases",
     "role": "http://anchiano.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00130 - Disclosure - Commitments and Contingent Liabilities",
     "role": "http://anchiano.com/role/CommitmentsAndContingentLiabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00140 - Disclosure - Share Capital",
     "role": "http://anchiano.com/role/ShareCapital",
     "shortName": "Share Capital",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00150 - Disclosure - Research and Development",
     "role": "http://anchiano.com/role/ResearchAndDevelopment",
     "shortName": "Research and Development",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:GeneralAndAdministrativeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00160 - Disclosure - General and Administrative",
     "role": "http://anchiano.com/role/GeneralAndAdministrative",
     "shortName": "General and Administrative",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:GeneralAndAdministrativeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00170 - Disclosure - Income Taxes",
     "role": "http://anchiano.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00180 - Disclosure - Related Parties Balances and Transactions",
     "role": "http://anchiano.com/role/RelatedPartiesBalancesAndTransactions",
     "shortName": "Related Parties Balances and Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00190 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders",
     "role": "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders",
     "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00020 - Statement - Consolidated Balance Sheets",
     "role": "http://anchiano.com/role/StatementConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepositsAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00200 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00210 - Disclosure - General (Tables)",
     "role": "http://anchiano.com/role/GeneralTables",
     "shortName": "General (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00220 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00230 - Disclosure - Cash and Cash Equivalents (Tables)",
     "role": "http://anchiano.com/role/CashAndCashEquivalentsTables",
     "shortName": "Cash and Cash Equivalents (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00240 - Disclosure - Other Receivables and Prepaid Expenses (Tables)",
     "role": "http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables",
     "shortName": "Other Receivables and Prepaid Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00250 - Disclosure - Property and Equipment, Net (Tables)",
     "role": "http://anchiano.com/role/PropertyAndEquipmentNetTables",
     "shortName": "Property and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00260 - Disclosure - Leases (Tables)",
     "role": "http://anchiano.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00270 - Disclosure - Share Capital (Tables)",
     "role": "http://anchiano.com/role/ShareCapitalTables",
     "shortName": "Share Capital (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00280 - Disclosure - Research and Development (Tables)",
     "role": "http://anchiano.com/role/ResearchAndDevelopmentTables",
     "shortName": "Research and Development (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "cmmb:GeneralAndAdministrativeDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00290 - Disclosure - General and Administrative (Tables)",
     "role": "http://anchiano.com/role/GeneralAndAdministrativeTables",
     "shortName": "General and Administrative (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "cmmb:GeneralAndAdministrativeDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockNoParValue",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockNoParValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDperShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00030 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://anchiano.com/role/BalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockNoParValue",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockNoParValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDperShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00300 - Disclosure - Income Taxes (Tables)",
     "role": "http://anchiano.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:ScheduleOfRelatedPartyPayablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00310 - Disclosure - Related Parties Balances and Transactions (Tables)",
     "role": "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables",
     "shortName": "Related Parties Balances and Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cmmb:ScheduleOfRelatedPartyPayablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00320 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Tables)",
     "role": "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables",
     "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-03-14to2021-03-16",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00330 - Disclosure - General (Details)",
     "role": "http://anchiano.com/role/GeneralDetails",
     "shortName": "General (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-03-14to2021-03-16",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "As_Of_3_16_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00340 - Disclosure - General (Schedule of net assets acquired based on their estimated fair value) (Details)",
     "role": "http://anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails",
     "shortName": "General (Schedule of net assets acquired based on their estimated fair value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "As_Of_3_16_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "cmmb:SeverancePayPolicyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cmmb:PercentageOfMonthlyDepositsRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00350 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)",
     "role": "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "cmmb:SeverancePayPolicyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cmmb:PercentageOfMonthlyDepositsRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31_us-gaap_ComputerEquipmentMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00360 - Disclosure - Summary of Significant Accounting Policies (Schedule of Annual rates of Depreciation) (Details)",
     "role": "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails",
     "shortName": "Summary of Significant Accounting Policies (Schedule of Annual rates of Depreciation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31_us-gaap_ComputerEquipmentMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00370 - Disclosure - Cash and Cash Equivalents (Details)",
     "role": "http://anchiano.com/role/CashAndCashEquivalentsDetails",
     "shortName": "Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31_currency_ILS",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock",
       "cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cmmb:ReceivablesFromGovernmentInstitutions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00380 - Disclosure - Other Receivables and Prepaid Expenses (Details)",
     "role": "http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails",
     "shortName": "Other Receivables and Prepaid Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock",
       "cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cmmb:ReceivablesFromGovernmentInstitutions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00390 - Disclosure - Property and Equipment, Net (Details)",
     "role": "http://anchiano.com/role/PropertyAndEquipmentNetDetails",
     "shortName": "Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00040 - Statement - Consolidated Statements of Operations",
     "role": "http://anchiano.com/role/StatementsOfOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OperatingExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-10-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00400 - Disclosure - Leases (Narrative) (Details)",
     "role": "http://anchiano.com/role/LeasesNarrativeDetails",
     "shortName": "Leases (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-10-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00410 - Disclosure - Leases (Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases) (Details)",
     "role": "http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails",
     "shortName": "Leases (Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCommitmentsDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00420 - Disclosure - Commitments and Contingent Liabilities (Details)",
     "role": "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
     "shortName": "Commitments and Contingent Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCommitmentsDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unitRef": "Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00430 - Disclosure - Share Capital (Narrative) (Details)",
     "role": "http://anchiano.com/role/ShareCapitalNarrativeDetails",
     "shortName": "Share Capital (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31_custom_TwoThousandsFifteenMember",
      "decimals": "INF",
      "lang": null,
      "name": "cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Share",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00440 - Disclosure - Share Capital (Share-based compensation expenses) (Details)",
     "role": "http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails",
     "shortName": "Share Capital (Share-based compensation expenses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "As_Of_12_31_2020",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unitRef": "USDperShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00450 - Disclosure - Share Capital (Summary of number and weighted average exercise prices of option) (Details)",
     "role": "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails",
     "shortName": "Share Capital (Summary of number and weighted average exercise prices of option) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDperShare",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00460 - Disclosure - Share Capital (Summary of assumptions used to calculate the fair value of the options) (Details)",
     "role": "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails",
     "shortName": "Share Capital (Summary of assumptions used to calculate the fair value of the options) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cmmb:ConsultantsAndSubcontractorsExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00470 - Disclosure - Research and Development (Schedule of Research and Development) (Details)",
     "role": "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails",
     "shortName": "Research and Development (Schedule of Research and Development) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cmmb:ConsultantsAndSubcontractorsExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock",
       "cmmb:GeneralAndAdministrativeDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SalariesAndWages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00480 - Disclosure - General and Administrative (Schedule of General and Administrative) (Details)",
     "role": "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails",
     "shortName": "General and Administrative (Schedule of General and Administrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock",
       "cmmb:GeneralAndAdministrativeDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SalariesAndWages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31_country_IL",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00490 - Disclosure - Income Taxes (Details)",
     "role": "http://anchiano.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31_country_IL",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": null,
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "true"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00050 - Statement - Consolidated Statements of Changes in Equity",
     "role": "http://anchiano.com/role/StatementsOfChangesInEquity",
     "shortName": "Consolidated Statements of Changes in Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": null,
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "true"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00500 - Disclosure - Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details)",
     "role": "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails",
     "shortName": "Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "As_Of_12_31_2020",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00510 - Disclosure - Income Taxes (Schedule of Roll Forward of Valuation Allowance) (Details)",
     "role": "http://anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails",
     "shortName": "Income Taxes (Schedule of Roll Forward of Valuation Allowance) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "cmmb:CurrencyTransactionLossValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00520 - Disclosure - Income Taxes (Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense) (Details)",
     "role": "http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails",
     "shortName": "Income Taxes (Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00530 - Disclosure - Related Parties Balances and Transactions (Schedule of Related Party Payables) (Details)",
     "role": "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails",
     "shortName": "Related Parties Balances and Transactions (Schedule of Related Party Payables) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "cmmb:ScheduleOfRelatedPartyPayablesTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "AsOf2021-12-31_custom_RelatedPartyMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00540 - Disclosure - Related Parties Balances and Transactions (Schedule of Transaction With Related Parties) (Details)",
     "role": "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails",
     "shortName": "Related Parties Balances and Transactions (Schedule of Transaction With Related Parties) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00550 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Computation of Basic and Diluted Net Loss) (Details)",
     "role": "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails",
     "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Computation of Basic and Diluted Net Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDperShare",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31_us-gaap_EmployeeStockOptionMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00560 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Weighted Average Number of Shares) (Details)",
     "role": "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails",
     "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Weighted Average Number of Shares) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31_us-gaap_EmployeeStockOptionMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Share",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00060 - Statement - Statements of Cash flows",
     "role": "http://anchiano.com/role/StatementsOfCashFlows",
     "shortName": "Statements of Cash flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00070 - Disclosure - General",
     "role": "http://anchiano.com/role/General",
     "shortName": "General",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00080 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://anchiano.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00090 - Disclosure - Cash and Cash Equivalents",
     "role": "http://anchiano.com/role/CashAndCashEquivalents",
     "shortName": "Cash and Cash Equivalents",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227534.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 35,
   "tag": {
    "cmmb_AdditionalWorkOrderAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional work order amount.",
        "label": "Additional work order"
       }
      }
     },
     "localname": "AdditionalWorkOrderAmount",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_AggregateAmountCommitmentToPay": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount commitment to pay.",
        "label": "Aggregate amount commitment to pay"
       }
      }
     },
     "localname": "AggregateAmountCommitmentToPay",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_AggregateAmountOfCommitmentPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of commitment paid.",
        "label": "Aggregate amount of commitment paid"
       }
      }
     },
     "localname": "AggregateAmountOfCommitmentPaid",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_AmericanDepositarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares [Member]",
        "label": "American Depositary Shares [Member]"
       }
      }
     },
     "localname": "AmericanDepositarySharesMember",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_AnnualRatesOfDepreciation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual rates of depreciation.",
        "label": "AnnualRatesOfDepreciation",
        "verboseLabel": "Annual rates of depreciation"
       }
      }
     },
     "localname": "AnnualRatesOfDepreciation",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cmmb_AnnualRentAndManagementFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual rent and management fees.",
        "label": "Annual rent and management fees"
       }
      }
     },
     "localname": "AnnualRentAndManagementFees",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_AtmAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ATM agreement [Member]",
        "label": "ATM agreement [Member]"
       }
      }
     },
     "localname": "AtmAgreementMember",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_BankGuaranteesToPropertyOwner": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank guarantees to property owner.",
        "label": "Bank guarantees to property owner"
       }
      }
     },
     "localname": "BankGuaranteesToPropertyOwner",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of of asset held for sale recogized prior to the completion of merger.",
        "label": "Asset held for sale"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued liabilities to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_CapitalAdditionsOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "FDA or equivalent agency marketing approval [Member]",
        "label": "FDA or equivalent agency marketing approval [Member]"
       }
      }
     },
     "localname": "CapitalAdditionsOneMember",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_CashAcquiredInMerger": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash acquired in merger.",
        "label": "Cash acquired in Merger"
       }
      }
     },
     "localname": "CashAcquiredInMerger",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_ConsultantsAndSubcontractorsExpense": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ResearchAndDevelopmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consultants and subcontractors expenses.",
        "label": "Consultants and subcontractors"
       }
      }
     },
     "localname": "ConsultantsAndSubcontractorsExpense",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amounts of grants received from the IIA and recognized by the company, as of the balance sheet date.",
        "label": "Cumulative amounts of grants received"
       }
      }
     },
     "localname": "CumulativeAmountsOfGrantsReceivedAndRecognized",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_CurrencyTransactionLossValuationAllowance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance due to currency transaction loss.",
        "label": "Currency transaction loss"
       }
      }
     },
     "localname": "CurrencyTransactionLossValuationAllowance",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share Calculation Denominator For Basic Net Income Loss Per Share Abstract",
        "label": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cmmb_EarningsPerShareCalculationNumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share Calculation Numerator Abstract",
        "label": "Numerator:"
       }
      }
     },
     "localname": "EarningsPerShareCalculationNumeratorAbstract",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cmmb_EffectOfReverseCapitalizationTransaction": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of effect due reverse capitalization transaction.",
        "label": "Effect of reverse capitalization transaction"
       }
      }
     },
     "localname": "EffectOfReverseCapitalizationTransaction",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_EffectOfReverseCapitalizationTransactionShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares isued due to effect of reverse capitalization transaction.",
        "label": "Effect of reverse capitalization transaction (In shares)"
       }
      }
     },
     "localname": "EffectOfReverseCapitalizationTransactionShares",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_EstimatedFairValueOfNetAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated fair value of the net assets acquired.",
        "label": "Net acquired assets"
       }
      }
     },
     "localname": "EstimatedFairValueOfNetAssetsAcquired",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_FinanceIncomeExpensesNet": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of finance income earned and finance expenses incurred during the period.",
        "label": "Finance Income (Expenses), Net",
        "negatedLabel": "Financing expenses (income), net"
       }
      }
     },
     "localname": "FinanceIncomeExpensesNet",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_FormerChemomabSecurityHoldersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents former Chemomab security holders.",
        "label": "Former Chemomab Security Holders [Member]"
       }
      }
     },
     "localname": "FormerChemomabSecurityHoldersMember",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_GeneralAndAdministrativeDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of general and administrative expenses.",
        "label": "General and Administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeDisclosureTextBlock",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralAndAdministrative"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cmmb_GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Government-sponsored research and development"
       }
      }
     },
     "localname": "GovernmentsponsoredResearchAndDevelopmentPolicyTextBlock",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cmmb_IncomeTaxDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Disclosure [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureLineItems",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cmmb_IncomeTaxDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information pertaining to income taxes.",
        "label": "Income Tax Disclosure [Table]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTable",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cmmb_IncomeTaxExpenseValuationAllowance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance due to income tax expense.",
        "label": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseValuationAllowance",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_InvestorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investors [Member]",
        "label": "Investors [Member]"
       }
      }
     },
     "localname": "InvestorsMember",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment [Member]",
        "label": "Laboratory Equipment [Member]"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_LienOnBankDeposit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lien on bank deposit.",
        "label": "Lien on bank deposit"
       }
      }
     },
     "localname": "LienOnBankDeposit",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_LongtermLeaseDeposit": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term lease deposit.",
        "label": "Long-term lease deposit"
       }
      }
     },
     "localname": "LongtermLeaseDeposit",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents losses and benefits for tax purposes for the year, for which deferred taxes were not recorded.",
        "label": "Losses And Benefits For Tax Purposes For The Year For Which Deferred Taxes Were Not Recorded",
        "negatedLabel": "Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards"
       }
      }
     },
     "localname": "LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_MaximumPercentageOfPaymentsOfRoyalties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum percentage of royalties payable on the amount of the grant received (dollar linked), plus interest at annual rate based on LIBOR.",
        "label": "Maximum percentage of payments of royalties (as a percent)"
       }
      }
     },
     "localname": "MaximumPercentageOfPaymentsOfRoyalties",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents Merger Agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company inclued proposed merger of CMB Acquisition Ltd, wholly owned subsidiary of our company.",
        "label": "Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]"
       }
      }
     },
     "localname": "MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_NatureOfOperationsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "NATURE OF OPERATIONS"
       }
      }
     },
     "localname": "NatureOfOperationsDisclosureAbstract",
     "nsuri": "http://anchiano.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ADS issued and outstanding after the merger.",
        "label": "Number of ADS issued and outstanding after the merger"
       }
      }
     },
     "localname": "NumberOfAdsIssuedAndOutstandingAfterMerger",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_NumberOfAdssOptionsIssuableOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ADSs options issuable outstanding.",
        "label": "Number of ADSs options issuable outstanding"
       }
      }
     },
     "localname": "NumberOfAdssOptionsIssuableOutstanding",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_NumberOfAdssVestedAndExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ADSs vested and exercisable.",
        "label": "Number of ADSs vested and exercisable"
       }
      }
     },
     "localname": "NumberOfAdssVestedAndExercisable",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_NumberOfOrdinarySharesConsistedInDS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the number of ordinary shares consisted in one American depository share (ADS).",
        "label": "Number of ordinary shares represented by each ADS (in shares)"
       }
      }
     },
     "localname": "NumberOfOrdinarySharesConsistedInDS",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_NumberOfStockAdssResveredForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock option ADSs resvered for issuance.",
        "label": "Number of stock option ADSs reversed for issuance"
       }
      }
     },
     "localname": "NumberOfStockAdssResveredForIssuance",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_NumberOfWarrantsPurchaseUpAdss": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants purchase ADS's.",
        "label": "Number of warrants purchase ADS's"
       }
      }
     },
     "localname": "NumberOfWarrantsPurchaseUpAdss",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_OperatingRightofuseAssetsAndOperatingLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating right-of-use assets and operating lease liabilities.",
        "label": "Operating right-of-use assets and operating lease liabilities"
       }
      }
     },
     "localname": "OperatingRightofuseAssetsAndOperatingLeaseLiabilities",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary Shares, No Par Value Per Share [Member]",
        "label": "Ordinary Shares, No Par Value Per Share [Member]"
       }
      }
     },
     "localname": "OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other accounts receivable and prepaid expenses.",
        "label": "Other Receivables and Prepaid Expenses"
       }
      }
     },
     "localname": "OtherAccountsReceivableAndPrepaidExpensesTextBlock",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/OtherReceivablesAndPrepaidExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment on commencement of agreement.",
        "label": "Payment on commencement of agreement"
       }
      }
     },
     "localname": "PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_PaymentsForInvestmentInDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of payments for investm,ents in deposits.",
        "label": "Payments for Investment in Deposits",
        "negatedLabel": "Investment in deposits"
       }
      }
     },
     "localname": "PaymentsForInvestmentInDeposits",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_PercentageOfMonthlyDepositsRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of monthly deposits rate.",
        "label": "Percentage of monthly deposits rate"
       }
      }
     },
     "localname": "PercentageOfMonthlyDepositsRate",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of royalty payments on sale of product developed with funding received from the IIA.",
        "label": "Royalty payments on sale of product (as a percent)"
       }
      }
     },
     "localname": "PercentageOfRoyaltyPaymentsOnSaleOfProduct",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cmmb_ProceedsFromSaleOfAdss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of ADS's.",
        "label": "Proceeds from sale of ADS's"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAdss",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_ReceivablesFromGovernmentInstitutions": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government institutions.",
        "label": "Government institutions"
       }
      }
     },
     "localname": "ReceivablesFromGovernmentInstitutions",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_RelatedPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party [Member]",
        "label": "Related Party [Member]"
       }
      }
     },
     "localname": "RelatedPartyMember",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RelatedPartyCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party expenses related to professional services.",
        "label": "Professional Services"
       }
      }
     },
     "localname": "RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_RelatedPartyCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party expenses related to research and develeopment expense.",
        "label": "RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RelatedPartyCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party expenses related to salaries and related expenses.",
        "label": "RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty",
        "verboseLabel": "Salaries and related expenses"
       }
      }
     },
     "localname": "RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RelatedPartyCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party expenses related to share based payments.",
        "label": "Share-based payments"
       }
      }
     },
     "localname": "RelatedPartyTransactionSharebasedPaymentsFromTransactionsWithRelatedParty",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and administrative related rent and maintenance expenses.",
        "label": "RentAndMaintenanceGeneralAndAdministrativeExpense",
        "verboseLabel": "Rent and maintenance"
       }
      }
     },
     "localname": "RentAndMaintenanceGeneralAndAdministrativeExpense",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_RentAndMaintenanceResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ResearchAndDevelopmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development related rent and maintenance expenses.",
        "label": "Rent and maintenance"
       }
      }
     },
     "localname": "RentAndMaintenanceResearchAndDevelopmentExpense",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_SaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Sale Of Stock [Line Items]"
       }
      }
     },
     "localname": "SaleOfStockLineItems",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cmmb_SaleOfStockTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Sale Of Stock [Table]"
       }
      }
     },
     "localname": "SaleOfStockTable",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cmmb_SaleOfStocksPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by the company for each share of common stock issued or sold in the stock transaction.",
        "label": "Share price per share"
       }
      }
     },
     "localname": "SaleOfStocksPricePerShare",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the annual rate of Deprecation.",
        "label": "Schedule of Annual rate of Deprecation"
       }
      }
     },
     "localname": "ScheduleOfAnnualRateOfDeprecationTableTextBlock",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of general and administrative expenses.",
        "label": "Schedule of General and Administrative"
       }
      }
     },
     "localname": "ScheduleOfGeneralAndAdministrativeTableTextBlock",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralAndAdministrativeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of other accounts receivable and prepaid expenses.",
        "label": "Schedule of other accounts receivable and prepaid expenses"
       }
      }
     },
     "localname": "ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party payables.",
        "label": "Schedule of Related Party Payables"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyPayablesTableTextBlock",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of research and development expenses.",
        "label": "Schedule of Research and Development"
       }
      }
     },
     "localname": "ScheduleOfResearchAndDevelopmentTableTextBlock",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ResearchAndDevelopmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents security holders of Anchiano as of immediately prior to the merger.",
        "label": "Security holders of Anchiano as of immediately prior to the merger [Member]"
       }
      }
     },
     "localname": "SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_SeverancePayPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for severance pay.",
        "label": "Severance pay"
       }
      }
     },
     "localname": "SeverancePayPolicyPolicyTextBlock",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards granted during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants In Period, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and administrative related share-based compensation.",
        "label": "ShareBasedCompensationGeneralAndAdministrativeExpense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationGeneralAndAdministrativeExpense",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_SharebasedCompensationResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_ResearchAndDevelopmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development related share-based compensation.",
        "label": "SharebasedCompensationResearchAndDevelopmentExpense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "SharebasedCompensationResearchAndDevelopmentExpense",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_ShareholdingPercentageImmediatelyFollowingMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "shareholding percentage immediately following the merger.",
        "label": "Shareholding percentage immediately following the merger"
       }
      }
     },
     "localname": "ShareholdingPercentageImmediatelyFollowingMerger",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "it represents number of shares and warrants issued during period",
        "label": "Issuance of shares and warrants, net of issuance costs (In shares)"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodNewIssues",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Issuance of shares and warrants, net of issuance costs"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stocks of American Depository Shares (\"ADS\") issued during the period.",
        "label": "Number of ADSs issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodAmericanDepositorySharesNewIssues",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options acquired, including both vested and non-vested options.",
        "label": "Acquired in Merger"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "StockIssuedDuringPeriodSharesStockOptionsExercised1",
        "negatedLabel": "Exercise"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised1",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance due to tax assets acquired through merger.",
        "label": "Tax assets acquired through merger"
       }
      }
     },
     "localname": "TaxAssetsAcquiredThroughMergerValuationAllowance",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_TwoThousandsFifteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 plan [Member]",
        "label": "2015 plan [Member]"
       }
      }
     },
     "localname": "TwoThousandsFifteenMember",
     "nsuri": "http://anchiano.com/20211231",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel [Member]"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U.S. [Member]"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://anchiano.com/role/CashAndCashEquivalentsDetails",
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://anchiano.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro [Member]"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_ILS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ILS [Member]"
       }
      }
     },
     "localname": "ILS",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://anchiano.com/role/CashAndCashEquivalentsDetails",
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://anchiano.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "USD [Member]"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://anchiano.com/role/CashAndCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_XXX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other currencies [Member]"
       }
      }
     },
     "localname": "XXX",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://anchiano.com/role/CashAndCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r366",
      "r367",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm Id"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r366",
      "r367",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r366",
      "r367",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r366",
      "r367",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well Known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r366",
      "r367",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Name of Exchange on which Security is Registered"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CashAndCashEquivalentsDetails",
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://anchiano.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r167",
      "r170",
      "r182",
      "r185",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r333",
      "r335",
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r167",
      "r170",
      "r182",
      "r185",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r333",
      "r335",
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r167",
      "r170",
      "r179",
      "r182",
      "r185",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r333",
      "r335",
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r167",
      "r170",
      "r179",
      "r182",
      "r185",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r333",
      "r335",
      "r359",
      "r360"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r88",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r88",
      "r92",
      "r183"
     ],
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r127",
      "r128",
      "r177",
      "r178",
      "r334",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358"
     ],
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r127",
      "r128",
      "r177",
      "r178",
      "r334",
      "r343",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r88",
      "r92",
      "r152",
      "r183",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r129",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r8",
      "r38"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Trade payables"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DueToRelatedPartiesCurrent",
       "weight": 1.0
      },
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails",
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r316",
      "r329"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties.",
        "label": "Recognized liability for royalties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r36",
      "r138"
     ],
     "calculation": {
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less - accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r26",
      "r209",
      "r289"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r80",
      "r81",
      "r82",
      "r206",
      "r207",
      "r208",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid In Capital [Member]",
        "verboseLabel": "Additional paid in capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r166",
      "r173",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Exercise of warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r187",
      "r203",
      "r211"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based compensation expenses"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Outstanding options to purchase ordinary shares"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r75",
      "r119",
      "r121",
      "r125",
      "r131",
      "r153",
      "r154",
      "r155",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r164",
      "r165",
      "r247",
      "r252",
      "r258",
      "r287",
      "r289",
      "r314",
      "r324"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r6",
      "r44",
      "r75",
      "r131",
      "r153",
      "r154",
      "r155",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r164",
      "r165",
      "r247",
      "r252",
      "r258",
      "r287",
      "r289"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r75",
      "r131",
      "r153",
      "r154",
      "r155",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r164",
      "r165",
      "r247",
      "r252",
      "r258",
      "r287"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r189",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r181",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r181",
      "r184",
      "r241",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Prepaid and other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalAdditionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual obligation to increase property, plant and equipment either through construction or future purchases.",
        "label": "New Drug Application and Biological License Application [Member]"
       }
      }
     },
     "localname": "CapitalAdditionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r33",
      "r66"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents",
        "verboseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CashAndCashEquivalentsDetails",
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for cash and cash equivalent footnotes,  which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CashAndCashEquivalents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r12",
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r12",
      "r67",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "verboseLabel": "Restricted cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r61",
      "r66",
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of the year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of the year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r61",
      "r259"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r74",
      "r75",
      "r93",
      "r94",
      "r95",
      "r97",
      "r99",
      "r105",
      "r106",
      "r107",
      "r131",
      "r153",
      "r158",
      "r159",
      "r160",
      "r164",
      "r165",
      "r168",
      "r169",
      "r171",
      "r172",
      "r258",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r42",
      "r151",
      "r317",
      "r328"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and contingent liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments and Contingent Liabilities"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r80",
      "r81",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "verboseLabel": "Ordinary shares [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "Common Stock, No Par Value"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25",
      "r289"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Ordinary Shares no par value - Authorized: 650,000,000 shares as of December 31, 2021 and 500,000,000 shares as of December 31, 2020; Issued and outstanding: 228,090,300 shares at December 31, 2021 and 9,274,838 shares at December 31, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred taxes"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computers [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r111",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration of credit risks"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r73",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentInterestRateIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental percentage increase (decrease) in the stated rate on a debt instrument.",
        "label": "Incremental borrowing rate based on credit rating"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r222"
     ],
     "calculation": {
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r228",
      "r229"
     ],
     "calculation": {
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Research and development costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r228",
      "r229"
     ],
     "calculation": {
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Net operating loss carry-forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r228",
      "r229"
     ],
     "calculation": {
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r228",
      "r229"
     ],
     "calculation": {
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Share-based compensation expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r223"
     ],
     "calculation": {
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less - valuation allowance",
        "periodEndLabel": "Balance at December 31",
        "periodStartLabel": "Balance at January 1"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails",
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.",
        "label": "Short-term bank deposit"
       }
      }
     },
     "localname": "DepositsAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.",
        "label": "Long-term deposits"
       }
      }
     },
     "localname": "DepositsAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r64",
      "r136"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Federal [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r38",
      "r78",
      "r156",
      "r158",
      "r159",
      "r163",
      "r164",
      "r165",
      "r281"
     ],
     "calculation": {
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Related Parties, Current",
        "totalLabel": "Related Party Payables"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Basic and diluted loss per Ordinary Share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r100",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings per ordinary share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Net Loss Per Share Attributable to Ordinary Shareholders"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Statutory tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r76",
      "r217",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Corporate tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DueToRelatedPartiesCurrent",
       "weight": 1.0
      },
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails",
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Stock Options [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r48",
      "r49",
      "r50",
      "r80",
      "r81",
      "r82",
      "r84",
      "r89",
      "r91",
      "r104",
      "r132",
      "r173",
      "r174",
      "r206",
      "r207",
      "r208",
      "r231",
      "r232",
      "r256",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r336",
      "r337",
      "r338",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Functional currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Equipment [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://anchiano.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails",
      "http://anchiano.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Abstract]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and administrative [Member]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralInsuranceExpense": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales).",
        "label": "Insurance"
       }
      }
     },
     "localname": "GeneralInsuranceExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r135",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r51",
      "r119",
      "r120",
      "r123",
      "r124",
      "r126",
      "r312",
      "r318",
      "r321",
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "negatedLabel": "Loss before income tax"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.",
        "label": "Net loss per share attributable to ordinary shareholders, basic and diluted"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicAndDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r140",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r76",
      "r218",
      "r220",
      "r226",
      "r233",
      "r236",
      "r238",
      "r239",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r77",
      "r90",
      "r91",
      "r118",
      "r216",
      "r234",
      "r237",
      "r332"
     ],
     "calculation": {
      "http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "totalLabel": "Actual income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Theoretical tax benefit on the above amount Decrease (increase) in tax refund resulting from:"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r47",
      "r214",
      "r215",
      "r220",
      "r221",
      "r225",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r217"
     ],
     "calculation": {
      "http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Theoretical tax benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Change in trade payables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Change in accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Change in employees and related expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r63",
      "r273"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Change in leases"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Change in other receivables and prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseAgreementsMember": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual agreement that stipulates the lessee pay the lessor for use of an asset.",
        "label": "2020 Lien [Member]"
       }
      }
     },
     "localname": "LeaseAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseExpirationDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
        "label": "Lease expiry date"
       }
      }
     },
     "localname": "LeaseExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee Disclosure [Abstract]"
       }
      }
     },
     "localname": "LesseeDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "verboseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r275"
     ],
     "calculation": {
      "http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r275"
     ],
     "calculation": {
      "http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r275"
     ],
     "calculation": {
      "http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r275"
     ],
     "calculation": {
      "http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest:"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r39",
      "r75",
      "r122",
      "r131",
      "r153",
      "r154",
      "r155",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r164",
      "r165",
      "r248",
      "r252",
      "r253",
      "r258",
      "r287",
      "r288"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r30",
      "r75",
      "r131",
      "r258",
      "r289",
      "r315",
      "r326"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r68",
      "r69",
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities assumed, net of non-cash assets received in Merger"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r41",
      "r75",
      "r131",
      "r153",
      "r154",
      "r155",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r164",
      "r165",
      "r248",
      "r252",
      "r253",
      "r258",
      "r287",
      "r288",
      "r289"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r11",
      "r21",
      "r22",
      "r75",
      "r131",
      "r153",
      "r154",
      "r155",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r164",
      "r165",
      "r248",
      "r252",
      "r253",
      "r258",
      "r287",
      "r288"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.",
        "label": "Payment for licensed agreement"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of items purchased under a long-term purchase commitment.",
        "label": "Category of Item Purchased [Axis]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment."
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the terms of a significant arrangement with a supplier (excluding an unconditional purchase obligation) to acquire goods or services over a period of time beyond one year or the normal operating cycle, if longer, which may include identification of the goods or services to be purchased, pricing, effects on pricing of failing to reach minimum quantities required to be purchased, cancellation rights, and termination provisions.",
        "label": "Description of application payment for licensed product"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r108",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "General"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/General"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r61",
      "r62",
      "r65"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r45",
      "r46",
      "r50",
      "r52",
      "r65",
      "r75",
      "r83",
      "r85",
      "r86",
      "r87",
      "r88",
      "r90",
      "r91",
      "r96",
      "r119",
      "r120",
      "r123",
      "r124",
      "r126",
      "r131",
      "r153",
      "r154",
      "r155",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r164",
      "r165",
      "r257",
      "r258",
      "r319",
      "r330"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss for the year",
        "negatedLabel": "Net loss",
        "negatedTotalLabel": "Net loss for the year"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails",
      "http://anchiano.com/role/StatementsOfChangesInEquity",
      "http://anchiano.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant non- cash transaction:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoninterestExpenseDirectorsFees": {
     "auth_ref": [
      "r320"
     ],
     "calculation": {
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noninterest expense related to directors' fees which are fees paid by an Entity to its directors. Directors' fees may be paid in addition to salary and other benefits.",
        "label": "Fees to Directors"
       }
      }
     },
     "localname": "NoninterestExpenseDirectorsFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OfficersCompensation": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ResearchAndDevelopmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.",
        "label": "Salaries and related expenses"
       }
      }
     },
     "localname": "OfficersCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://anchiano.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Decrease in the carrying amount of the right-of-use asset due to impairment"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Present value of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r269"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r269"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Non-current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the nature and terms of commitment.",
        "label": "Decsription of occurrence for payments"
       }
      }
     },
     "localname": "OtherCommitmentsDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative expense classified as other.",
        "label": "Other General and Administrative Expense",
        "verboseLabel": "Other expenses"
       }
      }
     },
     "localname": "OtherGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_ResearchAndDevelopmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other research and development expense.",
        "label": "Other expenses"
       }
      }
     },
     "localname": "OtherResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r189",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred shares par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r24",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r31",
      "r32"
     ],
     "calculation": {
      "http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Other receivables and prepaid expenses",
        "totalLabel": "Other accounts receivable and prepaid expenses, Total"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails",
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r3",
      "r5",
      "r133",
      "r134"
     ],
     "calculation": {
      "http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseNoncurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.",
        "label": "Long-term prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "The Private Placement [Member]"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.",
        "label": "Proceeds from preferred shares"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "verboseLabel": "Exercise of warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "verboseLabel": "Issuance of shares and warrants, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale of other assets recognized in investing activities.",
        "label": "Sale of asset held for sale"
       }
      }
     },
     "localname": "ProceedsFromSaleOfOtherAssetsInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r59",
      "r205"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Exercise of options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from exercise of warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r341",
      "r342"
     ],
     "calculation": {
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional services"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r45",
      "r46",
      "r50",
      "r60",
      "r75",
      "r83",
      "r90",
      "r91",
      "r119",
      "r120",
      "r123",
      "r124",
      "r126",
      "r131",
      "r153",
      "r154",
      "r155",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r164",
      "r165",
      "r246",
      "r250",
      "r251",
      "r254",
      "r255",
      "r257",
      "r258",
      "r321"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "verboseLabel": "Net loss for the year"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r36",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]",
        "verboseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r142",
      "r347",
      "r348",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r35",
      "r137"
     ],
     "calculation": {
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r16",
      "r17",
      "r139",
      "r289",
      "r322",
      "r327"
     ],
     "calculation": {
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net",
        "totalLabel": "Property Plant And Equipment Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r34",
      "r139",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost.",
        "label": "Annual rates of depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentSalvageValuePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r16",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule of Property And Equpment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r16",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyCosts": {
     "auth_ref": [
      "r54",
      "r78",
      "r156",
      "r158",
      "r159",
      "r163",
      "r164",
      "r165"
     ],
     "calculation": {
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.",
        "label": "Related Party Costs",
        "totalLabel": "Total related party expenses"
       }
      }
     },
     "localname": "RelatedPartyCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r180",
      "r280",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r180",
      "r280",
      "r284",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r278",
      "r279",
      "r281",
      "r285",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Parties Balances and Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r213",
      "r298",
      "r361"
     ],
     "calculation": {
      "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://anchiano.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails",
      "http://anchiano.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and development expenses [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.",
        "label": "Research and Development"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ResearchAndDevelopment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r7",
      "r20",
      "r71",
      "r345"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedInvestments": {
     "auth_ref": [
      "r344",
      "r346"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not defined as or included in marketable (debt, equity, or other) securities whose use is restricted in whole or in part, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet.",
        "label": "Bank restricted deposit"
       }
      }
     },
     "localname": "RestrictedInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r27",
      "r174",
      "r209",
      "r289",
      "r325",
      "r339",
      "r340"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r80",
      "r81",
      "r82",
      "r84",
      "r89",
      "r91",
      "r132",
      "r206",
      "r207",
      "r208",
      "r231",
      "r232",
      "r256",
      "r336",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "verboseLabel": "Accumulated deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r274",
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-use asset recognized with corresponding lease liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royality expenses"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalariesAndWages": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.",
        "label": "Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold",
        "verboseLabel": "Salaries and related expenses"
       }
      }
     },
     "localname": "SalariesAndWages",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Weighted Average Number of Shares Excluded From Computation of Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of components of cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CashAndCashEquivalentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Summary of the effect of share-based compensation on the statements of operations"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Significant Components of the Company's Deferred Tax Asset"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Computation of Basic and Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r187",
      "r202",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r36",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of net assets acquired based on their estimated fair value"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r282",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of Transaction With Related Parties"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r189",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Summary of assumptions used to calculate the fair value of the options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in stock options.",
        "label": "Summary of number and weighted average exercise prices of option"
       }
      }
     },
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series C preferred stock or outstanding series C preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series C Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Exercise price (in U.S. dollar)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Risk-free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life in Years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Options to purchase ADS cancelled",
        "negatedLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails",
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r193",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at the end",
        "periodStartLabel": "Outstanding at the beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in the weighted average exercise price of options outstanding.",
        "label": "Weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Number of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at the end",
        "periodStartLabel": "Outstanding at the beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r186",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Exercise"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r189",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Weighted average share price (in U.S. dollar)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r199",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected life of options (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r176",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Share Capital"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapital"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/BalanceSheetsParenthetical",
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r72",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Website Development [Member]"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r74",
      "r75",
      "r93",
      "r94",
      "r95",
      "r97",
      "r99",
      "r105",
      "r106",
      "r107",
      "r131",
      "r153",
      "r158",
      "r159",
      "r160",
      "r164",
      "r165",
      "r168",
      "r169",
      "r171",
      "r172",
      "r173",
      "r258",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r43",
      "r48",
      "r49",
      "r50",
      "r80",
      "r81",
      "r82",
      "r84",
      "r89",
      "r91",
      "r104",
      "r132",
      "r173",
      "r174",
      "r206",
      "r207",
      "r208",
      "r231",
      "r232",
      "r256",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r336",
      "r337",
      "r338",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CashAndCashEquivalentsDetails",
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails",
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r80",
      "r81",
      "r82",
      "r104",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/CashAndCashEquivalentsDetails",
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails",
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r24",
      "r25",
      "r173",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Issuance of shares (In shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r25",
      "r173",
      "r174",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Exercise of Options, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r24",
      "r25",
      "r173",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Issuance of shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r24",
      "r25",
      "r174",
      "r188",
      "r196"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r43",
      "r173",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Exercise of Options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r25",
      "r28",
      "r29",
      "r75",
      "r130",
      "r131",
      "r258",
      "r289"
     ],
     "calculation": {
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets",
      "http://anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Reverse stock split conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/GeneralDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Schedule of Roll Forward of Valuation Allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Capital losses carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r109",
      "r110",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Net change in the total valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted average number of Ordinary Shares outstanding, basic, and diluted",
        "verboseLabel": "Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails",
      "http://anchiano.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.14)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "730",
   "Topic": "985",
   "URI": "http://asc.fasb.org/subtopic&trid=2197926"
  },
  "r363": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r364": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r365": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r366": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r367": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r368": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r369": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r371": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r372": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r373": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>99
<FILENAME>0001178913-22-001304-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-22-001304-xbrl.zip
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M1N6)W_=N=D$S#V[V93$KTP'WN=_E;H*ADM$</-\NM6ECX*7PHU&76*A/<P[
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MA=?V*+Z%\ "-56^,Y5;<8QHV6^M2]L9<S^PL'X=P]"UEOTU82)BVQK:SF>8
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M=.G=KAYO%7\7&K<LL?. ;AYL-']F35? 76+_UKW^=TB'/87&HN'*DO85NY@
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M(Y3W!%-S\:/*@4UR,<]#]G"0]P'MD6AJKI]T.K83]'^A'Q=8?O(F"-DQB0_
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MI\.!UAOV!EK?ZF!#[QF#WM"02SN4=!\H)\EZE<O?+AD;K-3J/_X?4$L#!!0
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M]E#<\FF=.6C6IHE>TA\PN<:K*+LA/(*'"4Z,XJJ&W?@(HQGR)XVGM?0GB/>
M6!?@=NX["2=(:R=0<8#-3I8SX?,>QUM"A_/N_>-#6BEO3@Z:NL298)Q]++'?
MPRVW=^_?/+Y%#85GO,@F^! 3\KF=2>X/)(*J#_>[]6,QF/7.\ _;N91X?X0#
M<?._(][ LY2%TWDH8LE,SJS7%Y_C)SIK6+.^")O[T._>>/M"AU^#BC?-4)&C
MEZ<T?FK5':5E9\4(1/E%4A ; +$ 9G5.?L%9]I]Y\9+?XZBDGE%R599;@V,6
M&9U[]T/.@<3?  +$*%!#@CA-$-Z%1B(B=T(KC%DA])<BV^9P(14R$X@JW53<
MWCUDAB.60*5MB'C+(  BF6\1,*13/>_E-)X S?.28-6KHDJ9AJPD\W!5339^
MV8VU.G.])4"<(@BTJ(4AO+^FD</,FV6Z=$=QE3YCJ*E5C\5@<RPD\[$9EHQ?
MNOEMV_,B8C5%$-A1"T.\L57+8?;<1'(657A5&)RY'+;VDZ'8':TB29&@IET0
ML!#.LRQ543#%LX+@?AUEV8=MF>:XU*\YAZW=@Z _6@D(6#/4M L"!,)Y%H%
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M88IVZ:/E>$0&X<5RB>/J9GF'Z0:RQ/5WTG\PA^&!?JR,8H5O:=>'*^#9<C8
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MH7!9$)RN\K,M(3B/#_<D><+^F?&J&G96:GR_K@%VS STL7BYS1EEE*&X[B\
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M= -%_\'.=HD#0):)4(26UD >'F_.V,%+1^W[%HT>9.W%K W=V!7-K9D2B ,
MF:%T])=F0H#:??R$DVV&;Y9W[8/45PD$V)9I<^Z^B/^^3:GS03=^PV=S'^!V
MDW'1OXF_YKPFX.2S-=CZU5_@89VJ>7 YJCM%/#),O=SJ":>DO9V1H&5[K!.
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MG=7*3_C1+>>U=_(&OO>661NT_R3:?[.9G?V%(ERR(K2=SZ#F.\'8JUF546;
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MD<E-<Q<>]61=TP_]Z9_H/^A_(>O@3_\/4$L#!!0    ( ,:$?E2WP%K&I34
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MDR!@P,;Y?[AJAUJJZMHX2U,M !"*!@@8R"0\:D#1T2Y1= 2C:("@04G"$WZ
M@MZ1)]GW9U4+U^DI*@\A9X"H05F^;,H$,Y,_[CPM:[4AG P0,R@)=TWBQ O_
M'WX K>YJ&[G.SQ8$$)8&""-P9YY0Y&EX*3WF(!-E-2'8#Q CN"3\N]V"1/H8
M0>51!SFHJ@OA8; @04&5<_8#HI=H[H53FNVB$44!*'@ [,9!_LQ@LB1UXQ;Y
MXKCKX=']'4Z4B;B51QWDJ*HNA(<!8@9WU..E?V]7RWL2*D@H/^<@ UN*0N ?
M( :PMHNS9U^42-4,9;6/.TA&O=H03@;;]/] 8?B_$=M,W2(O9G-C<!''*2",
M)FOG($L:("!T#18 ^(.$;)OE4?&M@ZIR!NJ?=Y:>BN(06@;;^N<I)]DW0#[\
M,F25&1W*9LZ2)(,!PM5@(8&+B"T3^3'(1\0+V><R Q;6M<V<Y4H& X2K 0(#
MFR^Z],1+T)P (FKEIYUE9DMI""&#913<+KTP_)K&3)-8/[Z5GW:6D"VE(80,
M%C8X8UO@.1MJ?Z?D*5GD]1VTQ-2W<I8@"0B@;-S!B'K>Y IE279ZEJI-W*6H
M1GT(/P/$!B[\&9VD 69]39($Q1FJFD,#BD8.<J2" ,+28&D$MPNV38..<J6'
M'62E3F4(&X,%#Z[3^Q#[YR'Q].OGXK/.<E%2&$+%8($!7H*0YVP1_\_L\.DT
M3?C=8SP8J-^'JAH[2Y8:$@A[ \0/\E%7$Q M/N4@'R4E(< /$ S(9>)?!;DH
M>O!?GG27@(VR$!(&V.7G<IUCNKQ0K8?+S[E+P%I1"/SK/?W?WVW73NJ\H!+@
M/L(QZ^1,9^<X8K)@+[PFV19"4WG)J(LQ*LGD)>9A6FP];$%)#!-JZHK);*O?
M\XG^MCSEP5$CNK;;6,!:O=')^:FH;7%EIMHZ^9/DQ*-TQ=9[H@J+AC=8'];P
M*#'*VMI-,'3Z+AS0G-Z\X%%<TEQ#9WT;%^F3:-]WL8'F=)7O?6"6)^Z&,"$/
MTH.+5(*0Z;M,04?3H<DTZ"19YK3\^I[_/B^N?9GA(M5 B)^0Q O%DR,2>D4B
MO\$2IZ:9-33#^:U3ON^R!UW-A!O9C2;#0C-K")/;H'Y*+,+0=WF$KF9%,'72
M9HY2)X>A[]()S:F[04PO["=(K*'!U$F;.4J='(:^RRVT\;KLJJ_KT,LJA=?<
M-2_U/$531RE4PV%QU>SR16 WO/#\=/:=K:$Y"!HBU6T=95(#2._%&KI;=!HN
M-ETEK-%:A5=H<'%+ >+4'B;A_(&+-KC%6N&J0C8KB(_F^74??(9(5L"-(;@;
M"YAO^Q$##EGO-20ZX=WL*X>BH07<FIJSAM]&7T):98^T&'^S"X_C_)(K?B 0
M 2-VBI9V<6H2Q%/!T7NMBE8TTI3-'16E]21*VKE,H0R*WLM8-"?P;/D0DA5"
M^3UKQD3JVSM+* ":WFMD=+4370N_@K&J:>PLI3I0>J^UT>42R'CIXRYO#7V/
MU\YP=H-C_+E+W=8N[KM8[C;\)-:ND$?G S(XP*1O;Q?%;>*$M>CT7B6D8[=M
MXJY.<RA! 5A)Q*V!FA_;P,E29*A%P0F)N.VBR&>ZZQ+X%"WM8K_Q(*T$I_=*
M)9VX,=QY=X6TDO+ NB5N^6P5EXO(#U-^TNJ:EP)AM)6NE>:#&+-=)CJ392Y*
M4: 8NAKK^&4[8F1=4]![S99V,T1^L ^4U[W]N 6,]^,PLAFC#%;O%5Y:!#V#
M &=R77LXN(A.O ><>+*"?;I6KXIG*72]UX]IDU:5>#A"P9E'(Z9N//']=)F*
MF. IFF$?ZQ.LM!V\*B.  -I[^9HNEQ'&2X'7Q7<=8,"J-VXM,'4KI)9I"398
M3<<[#0E,P)H[+:UC@#/+I>/)UP+E!4JPS[3:GU7N:[F]N=$>ON8NM+' R]HF
M_4C L/8 <Z4(RB1-%DRVOS:.IJ>PTG*WB*P"8_%!YVVQ19EB8R[S5KO(XQH0
M>T\S0PLTR9_? =X:EF0:H2A*/)WEW]!(-$HA%'XMXQ*]R -<3\A:C?J%-C_U
M!:U\(F]G@0=H:%%^BZWB8.T*XH8!S,#A!21.T2,*B3@NE"N@C<^HVEK H=8P
M)<?@5(C8NWCX'45,W9#)/0F6.!*W\_("X# R=:U=I5.+BKTKB8J^IN.ILZ35
M: Y;/@P4]_*7RWO!VN%1SAG_S<]LJ82RJ6,MNOPDJKJ-!=P9S($:_6%%3Z#L
M'6?L16@N$HQ'BULRU3)=+XFT7G[]LVZ1*]&WVY(I95+OQHU(KS^Q7",JMC)?
MO1C[?$6 PS31;LAUK=UD7XN)O755?B!^@!H%DT<VK\SS*R*G,Z%&89-JQG+#
M3MTDORF"!@5;!M[UGXA+V^*+*/]X,NYWA<9G<F%]C/.]-Y?LCG\(A:J1/6R!
MDQB14__YMJR_Q>4W7D3-M./W$9!(I*$^8]W"1MW6)B)+=JADK!X&>[?^A3#Y
M-Z2X[5G^O$T\J8Q0\Y%@K3V,*L/=(IOZ[DF,1BR^49\%!J)<W=9E^C6HP.([
MKIG"=BX8R 8DC5PF7X9#+^&BT5G?0N>4+)GRNLUH;1N7.9>@8&]AW1=-+[=O
MDM"MJ38-;"(,OI J* P\=[S/3&W/3\7,.LPN-5\V/8@+ 9EP-!GQ#--.967
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M9?P5T-QA!N$0]3 7:QB;!/%%'*>B6M0T3>+$B_AP,YDE?(6@&Y(->MD5_B"
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M0KD2E]B[Y]>4LN5MEK2A6Q7JVUM .=2J:\-\>H"L_>(Q\7V:-B!5WLYQ,A6
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M.H4MSLIL.2Z!BCEV\PZ;K*!BS#U,Y@;5'A4;J[^_X_+QY(-__']02P,$%
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MD>,;B '^, *M(NPEAT,1+-P[_S2!_=4%+$REDT0#S9MC]WO"H!!>$!4V^\>
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M WXX0>BO.PP3!N->;%CX.>+US=3:3V9K'T@XF>S9D9#!\W)1CMG!Y(27H%\
MSW.RKF]"65W\J4>#^ ;TK-.3(_B]8'>'']%*FS'IPEMB"+.^"1L<W.750'0[
M<,M#["I!;>2MYVZ5V(+)Z0X,G]&4,W-447GUTSX:B:+9G.%)!:^>-":5Y>)*
M>"=P/B&#\NXM%/S'M?]'.@\VMU=Y4Z3/S82,2D^$DR7-!\OE_29E-!LPJ(]F
M0F!&HN6,CAK*B1D)F)I5H MCF*S?$)64DK@#>%8TH\](E6)V4=^R&8X@DFE
MEP@9K1CZ-;K_%*AE#;8P[(?SODF!UWXVW!@_V!X:;U4!GI$UAIN[-'YSD\L2
MQ$?P A;.\QSIP%!V"]M25<%&(A"=J<V5L,=(%4ZDJ_8TUN$+Q0?IMN1..I0Z
MS!Z'&&$+X0]VCR9AJ4P'<@_XV4\N_>Z2T_#;E9NFF'(S?USO!LM^2PI)5)%
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MGEO8+->591KTZ*1+&&#<"6!+(68*/+6N&AFQW77A5G)T[Y1X\]R]^:18MRN
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M*&);W!;J)9$[# X3>DI7"2Q)<A-EH5(6/%,L^3:(:5?=<MBP4V;CLX8*B=F
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MJ8$K-7=97-8BD97H'&IYH[B*VNA^^S".G5$618\PER=<)14)XK;$MR O5+'
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M?WWS^:(M;^@?ZWY3PS_^/U!+ P04    " #&A'Y4WNI=,RM   "$*P$ $0
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M0O.@F:7$V4TT\@YDM1=;")7Q'\YD0DAOKV%O+:7I6V-WN(:S'I![9(8D=C;
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M$94-52P=G[P8*E3TQ,E"&IMW=PEW"0$;>QE7[]7M8-0^HZ#EH/*[;_76+>Y
MP&W;XV_<'N^G'<+$]>4+UQ!&MTG^4+B^P]!:V:V<@()SO((?Z%E9P&]UV9-
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M==VAZ@,[97WR$6Z1MJQ9CY6KJ15R3*8I"?-V,0!]EA('H*0-9JA)P=R0V2^
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M[OH?= :@MN6*T%+[#YL7W1Y_>>UV.$"6!@Y%=H8% (/J#/* /3O6^4*QC\6
M")-<E_DDF3/36D. S\1'27V@ TLKV&BW'5$ L@PX.?T=SBOO.A)_ :9L<J!%
MT[8#I^S8!S[0V7SV^_Q+^'UVO8EP$;'0[;#HQY?027UD=)SM49L+>!&71<4<
MQ<X^7%*QW5JT^RV%L*:=%];I.G3&HD84DW0 $G_2]%7/#'9B@OLP@$^(85Z"
MS *U1&]GBF=.Z#IVAV2C#U3B\OQ:-GGZ<7;EL$7%E>VRLJI0.2(.:>N+PJ?>
M?7?(^SP+SDO%*DNJS H;3]KX..1<\O'PR0BH+A5)L&7PK#$@&B\\CG&%>FP=
M) MD'$ATG'3?:)O!6K/QF,G)S,@O(]FL=K>U+>EJ">,8=@AZV^G)$8P@GL+#
M3XSB)I0_OU:,R%;7_KJ#J;T<"*H+)KV/MB4@T7P-[5")ZY@\= ^FC Z>T>9!
M/57]OD]J7U'-SE"PP08D%4^EW]B2Y G?HD#)^2[GRN7(O3<B+@A7W3'!L7?1
MGH?,2A^'(F(\%]Z;=SN<Z$Q@6I_4L<"Y!*3=4#%R"[? W,<<#1_#V4 U:>.4
M&NU]<WD=_8W8*V;F]0VK[>B,,C5P%\$ YT._0O<!A9F9I\T-V_%\AU*.<\U8
M9)8?[$;%%U><W@CXPZM>&'?5R<SQ&T@."JR<ZG(M?)Z#)?"."LO6$@%I364N
M!8A)S'&TO\$-QU*LO@(M#4R&J/61^Q/D\"A<)GQ@^WP2>LQX*G?DB?O-9K=>
M<&609FD/*\0538OR[6ZW]XF2":JC*'Q.4 %VJ[/\COW:E*6><'S^+N[C]^/\
M=)+30YO5\&.G)Z=?2O:E##CE">6-\,"'L6S\@ B(AQ'P(4:5H*J=!R,30&XO
M'-HKL\FEM4>B+T*P>5HJXHO\7OA+9*6B\74T]7:[VDZJ<K"7VRVZ?1#)$B &
M-0#0Y>K)ZWBX,3B4\Z34Q@@TR%6NGKG(8PI29V%S><P1%-7-U1V\2?MG5&JH
MW!.%6!RSS57<\3('"38V&O2U];CL&&GKM7=^7Z(9XY!#!%20ASPBXK[I72$N
MNVM4EI *YO-.CM_! 'DJ._YV@1BO_JIQY3]=R<*SDQ-?LW!\% &.5F5#^\3*
MQE-X)!.V^.0_0X+^A[N&TINT2^+/*&7@R_N3W3CVJ]YUFWY;!^6ANY,Z.^46
M0X8B-EWFI+:W6BH:,=-1EVZV]ZUC5IUKW),';Z8S!!.CO"N#>T%O31?"19TE
M_J;+XB$GC4T^1C_\P:G,EOZ"-J+M24A5#T/I(AC/\4*Y@!::MV_+]; >OQ_&
MN<TATSX8,F]LJT'[;AO0E48%3B.U*Z8\A=N\VY5H1+LMY\)HG:6,V*4_=/!-
MNX.Z8HNJ[-B5;[.#K^VV"P$%I*+Y6J0*S4C,;!PT#_4X27E39)6P=:*BB($B
M* GGN4[+P=JS><$U 3+L7XQ/ 9=#Q_# !<BJ8;V!1]=JS]D.79480;T5H_CR
M)*@:DMEFB)%IJ^_5K;C(?C:6/6%D <PX%E73.4<MEDSK\H7M_ ';C/>!^JCF
M;56:]C93/<[2[0GWD2ZW21/;)^C\[LR9P-*;UJQ+H*]%TVW)KAJE]Z0N9EAQ
M@(L@Z.K,]$[!%U6Y*DO%;@RP"*@$0%R2900PU*4U7&:;7"\]S1'&"=U'5&P?
MDW:XP@69+7#XU;4MPP_, GXAV&7' 66R35)%$1;(;T!5FNF\LY@O?P3[>^_@
M_9A>4C:"TLGQ5RY?YK*^TH2B2G7.5&'&V%2=X0>^U*4DMKE'J6JGS@K:6K[3
M>M4FJG=*6./A!^'JN^UFX@)BP8SF"*1.[O;Y0.^MBI>[.IFB"9@JWW2J4;2%
M8[C2"!.!?Y4$[,QUG2JXKQ-,#-1@?YP!9M44*4'O\] HL9!(*3+V';B#O&;D
M>I6\0Q4$TRDN6[H;?H496_F\P6_ML!++10KO<VAB;P;\OSZB@AKP@-I*FTN'
M*A(<:49'R@N,]202]E'>9>TN4Y=C.4:08\50N3(O87*>WPAMS4;W=&P_?THL
MZ/)67=H.S@_Q0+=G-H5>P+(3!Q+A@NC"!_<9/PPJ^')K/U?XFK[@"I$OG5?L
MB&]K1P6-I>(N98E^#*C0=,OBFT[ %FG^<>^-;!9 _1V5Y+6=:JBHTMO4KB)T
M0#=DC-#DZNX%+1)M<P=/Z-SE8?*8N"JS/RZY!S<?DNXJ_)'/ZYNS/<[KX.FM
M+LS35)TGXJU3?3RIO)@VG[B@-J9B8LJY^,-1@1K9J#><DD*'[WY<G14SW#)
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M_"D%@;% L?$^JTF"E.E@=XUOC/MVA:^O0>C#V\#6@ZO"'4[BY1@TT]L(YX;
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M0U>;^2(6*O(].V;<];C@+,+XF.,J)M4#G?-'@J['U-2FLW41":@T;(@Q'4X
MQN _<X75&K':A/<!'&)N5@>'DPATCPB4XS[%%B2?H2QK2@U[23MCBWGTQ#I,
M?\$46)L5@% W2(/%Q:U&$[1\*XY%<OT!8X@;4@J;0X=%>)KG!Z8<2\7@,55A
MCFH+\C36#>JR=6)W#WJ=S0^?S<%MINDG59E?M.A9J!L #"1:K;<)ZM4;4RP.
M^U.J=29:^[_/]<< "UCWEQI"%VV9OT20O0&A"B*,2O/T+69>_9RF/Y-B<%^7
MQ!&A^&=6V1VJ]7)/$$0MXG[09.(G1P7D"9?%*K'C(+ 9XV%D@R03MF/[,;>5
MLI]E8GYTW(GYKW0IS7#=6E=44?0V^2]=['(\</+D=U @4A5R.XU5:+/$BQ,9
M,\>S/>:"\1W&I]Q[+3JJG/U)BWC3^[U:&]O:%+CUK2G02L6HZWI35EA);X%U
MVQ(BTC#;VL9=_=&H"^-ZOKGXQRY7:XL 6L/HU#!J14%EAV 5EQ6:E]/QPBFD
MKW9F,]JP5W#PU9!!QSS$0NLW< 28P_!EMLQ,2(?T4$VY..<%U4645IH5<+F,
M*/5ERX1!*A9H0]N\(3VQT[Q0:]:J8DIDLSL\LOO)*4B%[P8R))3H28^&%$%G
M3>P+\QVP,]_!F>_@LZ6N&\C "]TH9M(!J>O$4>1R3PK/2T(1!Z=<*1<]R5CA
M@R%C3K*:.CF.205J'P/3=M.6GC=(%]4Z-S:5NJI5,^!&F K-@6#0C5YVQ,U0
ML-W%C&1=<$RJRM*V^HZ.S_G-HCV/BOPOR:],Q'1I5N.(L)G* EW;Q!)8%#I"
MJ&4N^23*28>6GL*=!*? BGEXV$+=Y+?6BNX\YZ8:=J5"W\6VN*NUU70:)IVN
M*(?C1B%?04V.,2I"S$AM(-JNK'XWY"QL?2&?P(:@W2Y$A]"]@V$@ 1DCUMLU
M\ALI&'8N#8O6&E8FKIBUTCY\Y!QKC#IF,D%V5]D%W@O#"\6MA3H<#&Q&[ZA4
MF5YVPT0U8IMSNDE+:Z ]8[<S=]#JTZ+-HB.J J(EVUD*W0+992ZTWA06GHG*
ME,@JL5W7C7&O\?K^2W4\T1?J>GD]9,&8/KD)^L)&14T6&1J1-LI$@@?,U]TJ
MZE31 3<X!CF&YY?5DA?9OUI54%]N?(NU@AUI.$P$["G-IF4"8=J==[FX_W,B
MDJP!!E(]-V,D>$%,64BNIDF]W^]T8M.6N26W5:O,3S?PX ;Z;=>#PE\=BD*-
MM!YP5IP[*1VZCUOL<%M*$?& V:!41($,G22R4^4$:7C:%ORQ!LVU7* ?*9+<
MJ@>S47*PY-NNST0TB?RU+<EM01TI^7CC#[D"$0$ND+*H:[XV19$$@0<>F^O(
MSB459.V)P<]Z&BYTN(FB51IR,%:44->;*V3+!16#U_5VO=?E@(](%O9-5JM6
M/+9TB#LW/*/3 3E!/":<(!2.2 6+?9M' 3KLO2#E+)5"G#0Z'5/0&95@XQW;
MW>&Z,<H=?+-=0/)^G*UC->B\GP_(U.A+D2@G\1TAF&(^=^Q$2NXG3L@])WR>
MS3?B4XVX_47;>\>S?QXK?$]?9L0F#">'UY&/.^81E]QWV^]G8+ E0N*F\=SK
MMR<7TG>E"VJ!8,R!_^U(Q(I%,?S+F>=XL7W*KM'XJ *2U*%MV-RB=UZDVG,Q
MHTC,-7B<\PQ.-A)RHPX;J!G_XZ?U;J3=..K<N.A<N0.M96=\<!X6@<+<J>V0
MB7U7K;DTG5+HFEW,T63 +2STZZ*GY84EU897E!/,\Q>=:VI;9,W4!=S/:N^G
M;,TZ<D3.-NB>BZ[.E:C=8^KAZ1>ZR[<$$[-2Y!RK;G6S[[/F=D _D?+C( IX
M*&V714[, 543)5Q'NK8GV .+78\$6(\IYH3;7$=^YBPQZLHQXR6:W[AM"O#0
MI=+64*0FN+"$'XJQ VFN:0GZ=-0'H> BN' 1">>=1'W_E!W2Y3->'! O4E>%
MRN=V%$NF$H .%?E.D@!J))*?=+E ?%1^94V*_X$BCSN ,4PYHO(A[$K34\T/
M-;C% \%E"A0/P)HAN+AG<'EZ6>QD\)ZB.>M[OL>"4/$TE"RV4\X3$:=A&@7,
MC[WX@1Q'1X*B1^?_OI>]BO9@JU=A,Q+3(H)LO;7B6%Z$BWJ/;8SV7;VEGQ$@
M9U)&^$["3UL?-"C7MZ)KU^()P+DI'_WXG=LQ#SMLT@/C \S9O0](*MJYB,DP
MZGJMSQC&NAB)>I:-#=[CP?,G#W-Q))5(O2 %S9"%MHQ2QT_31/H\D5$</6*'
MC&<(<P\E<GNJ,)>CLVF8U83.J-:SM8N!@WX <UAHVO@6I-_IY ;4YM9EI;2^
MZ&E];G+Q*<89;77J/)NZG=1[GF]'/79@"'W]@>ZY.$+ 3\D[ZV[[SRU'+5;W
MB\1CJ!.P^5E4&3:ZY$<$4$\S6=\_)^N?D_4_6[8EL0@].W 2Y;G,44YLAQXH
M\=Q-9>JSY)19:>('<P0^5=EVM^/4R(O/<8O.^4&1H0K.FJ&D><)>B@=/\W/'
M X\',;-%#)"@& N#R$U!^W65QUUEQ\YIX\%#N\H]53S8ZQB]OU_T\Z!CB@AW
M.SU[)#E#QQ.$CC!EG@^FL1LZ$9C)7LQ4J-+4CF08BLA7SS)[SK&/.WWN+88N
M],KK>%:>QCXZ <<2,E($PO%<%7"F(C^1B4Q5*CT6B]3U3MFQ!/ONF/+!OMM^
M_[NI Z1MAJ&B:VO$9:9[(,^3EF$MGCE=RV=._!549*L;>IO?#AME6QT+UVQ/
M\%'AJB[=JZ>U>YCQA!1KNG>EOCC5J6A#0G?4IK[-;9K6)H=Q#?SJ8&^#N$9!
MOFDK!\=UD(/!#UN #PIET;^EFV->4LDGS@9\ASI&V<Y!KX-T[J[>-3;7(OM>
M^:GDSF_Y1(;7QJ$MNIO..L\&L=B!$VUF=)>+8<B#7/X]J9G.O>-4MFN\?\/(
M0E_+A+QE/_.;3TOZ,TMR.C=6NT9'^8"ZE3@MJ=%2WJNNS18SW16BMEY-KBQX
MT996+#37J&D?CXSPO-+UU#@=1%??Y2"2'MM..[I$E:X>,Z,W)V" I2S:TC)K
MSUSH@=R34JX-/SG>M0='Y^7-D]%*3T":VH[@G(%$M2.;)4$$/WBA%XK$2WW/
ML_W3EJ;'E 2(TM20--TM3;EA60#)4FV)G'.F:E-'>[#7,]5/ZG?:@]WHMST2
MF,#/KD]+CF+('Y-+QRJ(IO/R:7)I_'+WBJ'A87O]CY\LALZ0?;B6BLR/0]<+
M62)\%C&!"9B^9W.5AJ$-K_NT(?N8\C !LG_K:/!?6+\-"? ?Q2+*A@0"8]+]
M7>W_,_CW._29EP?/0 #LJKA/SC#IE\K'9,#@R*07 VV'@-GN!G4)RP9?54?9
MM+L\A@T;: 6NP51H\$+:GC@+FYW/3U[8N#*4V/\N<L* 13**>23C. @]*83R
MPT?,5CVDF'BHE^R9^*='D/:;$AB*NK4N#)#\F/,;3.QH@>&\FPZVFY02L2-$
M'"6^9*GC<64'3A#%@8B5D/*4.\+!GCPFW_6;B6;%BY:/$(VO2M4-2%--&3=I
M1+D;"<;M:Z55N=ZGUN&=M" ?$2SOJG"#&/25SDP<^/6F7-!\3?2)7;LB4AU&
M!VHYCDH!QK-ORFTNK16V\TF4*C2YRZA;7$^2W#V^)O4S\R'[QA6F<L@2.<_6
M2.:TYE(-\\''K%4US%)!V><P,15V<9L^^IBD+LVHOT=;%-3>?W:$9W7CD/W>
MW#1U%5=Q&K!$)C%S>!"%J4B=V'/D*1?' $ >DSORE[)!4P)#6K+=E1R9W&L*
M7&@FR0'65*T:TUD1 )1@CBZ7JE*RYZ]O=[DFT'QYWKL')((*$H?[3B28P^)4
M)6$<>V$2"=M6OHH?V'KE*'IGT]Y]J'KS%)MG_S&2Y@-U!D5UY].06]T?K&?1
MI5W>TQL/+T&,Q+!Q"1&PN?:WH,"<M^_A>!G]2#J>R[V(2::\B(>^XL)1J5*1
M<-,'\C(>S_9]J/!]JMMW3_G2:LRQ36IXZS'0#=X4KM9N-Y-#&>P0G7FB;0"0
MS-@EIJXS6/,+_*P; O*<4E=F&&-!U*]5A4B0$^5KKI;T4:&)DP&NG)7PPR%!
M9#/ @32(69HR+Y'<B9.(PU<RC!,6G'2 R3FJ !,HX2O=+T$W1>]R<1S @*I$
M N=:>QXPDJ$C+/->1$I)T]V2M0V/M&2H"BQ!E.,M9%8O2RQ$6^JF%24%%@@F
MR$$P1809-P=8_^^SJC&92;T6 <;_MLH:#)K H"C=G<.7V*&T(3[ZIC(\M(:5
M&H9V1'CR-"LM@W.EY=.OM/S,I7.@<,9/?6_3U]I=^0-Y%8<:S,G1R'A.XMN.
MG]A>DK+4C2(>A3*-79#=4B;JF1:./%3)?B:!N7-/TZ\4Q8;=(ED@(L>-61!X
M,0NY2@/FIJD3"'7*3)?.PQU33U&CQ1VF8UHFP#5R(F/JT#TH:P?$1IC(:O+6
ML=57 0HP*)1U5F,IA4Z&02N8*C;R6])NNSJ.J4H[8/I%=1JNV1K:K0-\D.32
M99[.$/#1;2G!AF>CPI%$T95*2Q4K4VBJ=&]6\LTEJKG!R-S=35HSU =5W=3]
MX_6-T?I?#HBLNH0?4)<JA9Q3Q/M+3U!.9Z%N*E4LX:IZ'(.B%// ZQ*&U669
MS;P=XWG 05$;&^H8UJ9987<MZNLZ7 14[U);,#B\_1:,@4I'5V'2&JK4A05$
M3"]435LO3)LLO%)!-]<93#H>FVTR*A7"?KBY7A\T4S@@4 ]IGN V8'PL,[$3
M@LUY<0XI'I*(2MA^F-@V2\.0Q:F3N'8H_=A-;.D&W'[$CO#/$?N/*:1X-_93
M3=Z8D!UW, ):89INHM]RW >; ,TJJ0RO:Z&G_2 S +.838PT^0U5)C##@*X(
M1_[V^S_(4S&D!:B;4KPCTG;3+GI2*C60'GVCS+:2JT4J*B;$6J^<8Y_*+M-T
MNY$ZQ0'=.0U,(N5.P+]G,#H@^6?H2B9<)IS(9V"\12R-(A:+R/5A#0:GS!0"
M8'1,KM57H$&.(*+;H2/^NQGUYF*0R=ZV6J!<JKUUFY==*SX $B+?5&T6^A2,
MC,Z#:J)N&$SJ%/FU\'<; (>R&2I\O7[6,NZ9)L6[([^V_E$0$^ @?M3WX",5
MNHL6F0KD9:5TV%C7IPX.&&$W8=I#&H$MIL]/4U_OF?G!Q!=E<:4;*<(E909:
M7U-V7<E(:^PSVV -+/#"4C.?DCK)S?22J[H!3.!PBGO%6OT2R[_;"PQ$@&[)
MH3Y@+*S&=H>9(&]W*X'N65,[M7%VE%#3J5CGV9 5@9<CI=XD^W4WRFJ1EW6?
M8F/L$1VP'UH!9S%RN*I=Y;IAG"H5.P%+A1TSU_5$&L;2%C**3KDE$HB18R*1
M1C%B8*G=H$VGYK9V;;=9[P$%$TU1%SCI.U!3:.H'2]%Z0RW==36?@L@KNA/L
MAOQV,>Y O1CDX74U3W>B-M*TOE.ZL72FJX@(I#49AW[*.;]+-RETX.31'K,4
MZZPD'P[=TC@1?NPX#K:$#>T@\J)(^(GK1=B_.GW$/B.'Q*6'*K?/)+3Q5U60
M_^ROVTPJO%7?M.VO5)(*F_05;>3S3CK83G)B-[2%D"&3@B6.$TG7B5C D38+
M=E-PRGJ"=T)QCYV"ZQTG$(EZTB"D:10(ELRHKX/L+#_>"GY3?;-C70P[ "FY
MU?*<:GC;)(>%*=_I*+#4![27%)U"S.B=&K" 1ZG UL!<G@JIC%H#KVOP4*EZ
M@[I!DN4Z"VA?3?%9B!_0[2Z3T+=5FL8J8F"9Q$&2*-L)51 K7[HG7<GC'97;
M_<UN'',_$@U<7XK/M>-:W+^W@D8U,@OD+E$VN?&Y<=MHK]*XWPU* -WP9K?A
MQ&+(>C;W'!,N@Y?617:IS1)$(V-SM#P49'LYW_H=VX$.*PB^R1K,2AS'A:E'
M1;HE ,[R+<X6M49MJRC1C8_GT%0NC%MF)^BP7&+N9:.^M?2VN,AF!DBOP-Q>
MVX S7C'W,X=]D9)S#Z 93C+^MY%]6&9%HYD*\378UP^>I^DD#.YOO%;Z]I='
M) B>1PK?ZSZ%[[>.F9)>]Q\$'%VX_W=5O4>?YZNJPJ(A*L ]N=R^.$R%'SI1
MS. _P15/4B7<B$F/)V%BR^=I #_4+?=,#.!7\CUJO-+ZI43GF?4K^?_/0/,%
M-8\1\95A#MC7;;1H$ZRRVM#BOUA1VD\!=HB)J0VDRZ([@NH'LF1+"-4*]4D0
M?EGRG+RE_7L=D0JW>LN(QG<XC)ZNUQA&A5Y$*/+& +G=D%\T^V!=!)?(L-2L
M '[D%NF&3>QFUO9IO9Q#;@E4GXQ0'?,ZY!TW Z5PF2.0NZ+OE-6&$?NGZ!]^
MK]YD6@MRO5?:I\2AE7J$IK![V)^P]=K2<U.6%EF)[2'PILH;_'HQ:*LPKSYJ
MA;%!3S.H'&6G.NKC[J:A,O-&KPBG;OP$0[)H+(9-\JRFRAK2*,>G=L] LTO2
MCC@KKA]3QCW-HI#P7!3R](M"GKQZ%$3*47$<\23R66!+'H2!PQ([$B*1*GI$
MK^8AU:.']H1\-NH1WH@P\*P9?37-:!@![5](GZHRIUT,/1EEU<92][@+QL[A
M'<7@D=6M>VI9O7;U-36E?A8&BM]^3>FD(-T.TR"*L= \#ID;>UR$BB7P@W2]
M((B>J<7[T%:(SP;2.S"YPZGS@R&1/>/]P?&^?S_5^/T,;,IZP/*+V3[\UH#I
M;%[,H.H^1WYB=;V\QMR=0O*F')+N]48.7-$TM'E35USE&9R9(,4'OZDO*1%2
M8W%;<T4]W'7;>331.C)B^.N=:OKDI-,"2!FFG+F>[X8\9;[K<OALQS'V59>I
MD,^TW/>AO2&?"4#^4A97Y(IHE%Y_E ES!L(O"(3_V)3%U&6F\[@[\!LF!8[@
M;#''I ]'[273QR1QH=]OVSN%6HQU>8C].Z7*P;3"3&O*O="GD28ZS-+4#3\M
M"8",61>]8DZ%.I0<KE,>\4&0\E1W'&MUT]T!#1+&!3G43'*CCJ#2=)C2@8Z6
MG2*?^QUA9!1@C<&@5G6]S9L,IM)<_T;E<.*%XUZVC6'^&$8HYZ*W.FS\(=,^
MQ8'';'\V![4[F[1D,^KWP*MGFECMS,QIB0_7DUPZ OZV'28#/TYE@BJWYT?*
M=Q^3>/J0XB,Z&O$!6/RQ]@X_9^NL,5PGIK$#K<F/MX7X]'@K7?\LI[YT9_D2
MLQH0F9 ^<XL*=*]_:Y6YRU5A5TZHDU6,B- =H7=!<0?.[PYK#-%\H+WO@?6B
MN;U*RVUE7;CL4HNCO%N69LAC(K'(DB5, 8X'A>VM+K.=,SBZD(^^C/8OB17?
M-%2:E>H+_XK5"-,.(*= @O27 0G2![$%P:+9#M[ ;*V++EV2YO1-46_)^#JY
MS(G0=U,WXD*)Q&5>)'@@0I>E(8OBQ.?I,Y5S\='(N?GDH'X]GV7.%Y0YKS';
M#_%!$9'Z3Z:JE;[:[P7_ .93TT;B==";)!!ZQ"L="NC=V7G&*0O[EHZ1?,V7
MRNCIM?KG%O.[22/O7RA&7_LD1+EM;G55<Z46K3\=<_RPXA:FQT0K*)X_XY Z
M+:5>V&&J9!@*Q0*FPB!A,E01$[9@MJOD QF;OS+8N?9Q@UTGFXVD'DGOXX&_
M)[]YW#CU'18[KBUC)A)L<*:BQ Y=I51BQZ=<&@5;\)A*HT9.O<QLN%ORZO7$
M#K,RL/YT";30PA&D8B\*1WF!^@^6.X%$U!EK1M+V7,A:%+;BV511SB0U\GJ4
M*(='F>?#NW;<&BWMFZF1EJ; 2S]TS^$& GVO:[2+K4]#\1S?=:[#[&V7R..B
M5W[R2,9#F0@G$$(& >/2CCWE!($7VI[#F'A,F^<Y(MDQ55IU>Y5BI6V8MP.Q
MEL"1&!TFI(X]&F6= H+=9>_I1#2D[[WRHOTP;0O)=CV0WS#=[3MW+ZSE;5G0
MN6O3 =$C89'#!0^3)$V9\ABW11)Z*O+=.'+40ZEDCJ+M"Z''L75M(G\M2NL>
M$8SM3<"PSX,,R@1OT"V;6O_3M^%=YKEN,6GY?1/GJ7)@4C:0.]4X)W5Z/@8S
MIQ"A6SIH3A9SN2G:W$TA0[AW!H[# 8<C112DRK658GZ2<)\Y,K$%CYQ8 7*<
M.G <6[^HZ6XD\^,&UB/^V\PC2T?54*EUMEV3;43N/C*D:H,@E2K4#;9<;7,5
M)DQ_4ZC84]USP9%7(DM'"6MDD@US'BY'!'<=PT5?.U1OUYHI&A /^25H&YJ4
M LQ-V"'4 ENN1.0T;'JU*#?DY*1^E>C_[(BM-1P.TC;T;\R-=^"N4FD.*E,]
M-P=B6U5HV]UQS:P90/D:T5NWU^)I2C;>#&#KMCSF[>$+KE5#++7M*\UV\NZ>
M,\8^S2*IZ%PD=2Z2^OP:<D>&J73B.)(ILX,@L5,W<E@0.3*V 0!.VRMP3$S#
ME/(XKGG17.;W),R]I]S\2*/Z'0\G8J,NL^5MS[AJ2S3L;<NX'8'WZ0Z)W[;%
MU=LTO<L=T5<U(;.+=1%>MAR\7<9@S=>]^=,&-2G_I'.6+,[NB:_3E3;D-D]C
MKA+/9CP*."@J'D_=U)5"2O>4N](2C)W=$X=W3YS=$$\((%(>BS2*XC!P)'/#
M,(F=(/%$PKEP8N^A'16.!R".S0TQEOBGZH28[033^B&TYZ'+I*6P[\9,U^=X
M**93,'X5(W?%V3]Q$N"K/.;94@2V%R@F1!*[(G4#X7M1)"5\=]I&YC'U(1@E
MT1!P8O78K@F'/6K,_BVQ#B[?2M7C3%H.4T0WVZK>FAH[9'+$KGSP90(7TMVZ
M#+U4W]][BD!GF^RKN):4XH'G"=CRG'DJ2%+?]7CL)5S9G,4/W/7'HG*QH[/)
M/AKY&1 -M$K6/C7J+KWI#K5INO$?3XOJM:8A'&F=Z2XH^I+!GHGVM!/[Z:ZY
M&&E37:7569EZ_&#/H=IH]&5>PY),:XM.WA]7^ 7UW$*6I#(_N?HN&2:^M"-;
M)#9CTD[C( [CQ(YM.W%4&#]B,]=#"HV'"HRG5_*@!4;/[MV5>IH<YP']^VQ.
M<WU/]_^%<>Z/Z4$7IHV@Z8VXT_R/&&"[XM,^P=GD3@MD-#!\ 0/"G+*:$DK4
MNFC:Q!EP:^I/Y1PG@?Y5%P/9V<,F:-%>80%"#8SWP?!:BG?-3$\#W$4"?7H_
M\3V_V8#]8LJD,)V?CEBA[IX8\]$K+/R"=Z-0GA!K7-\170L:ZX;?GC7P \)@
M)#W.E. !"Y@?1!%SO$BHQ.-^Q-/ /66[VSFJXI57 I;=@,MDP+I<;AN,]Q+7
M8ML?]*[NU-^>-^CAJLM$$BK%5.ISESE!$*<BE&$DP4"6<6R?<H-.V*#'5)/Q
MN@\BF-:<7?/>CKQIM!F[#BC5;BKA3%6$9ON8,K26!?(KZ4R&0;?-.86G;1>S
MEQ3K'+$\,'UU$KJ>B *1@O!.;1ZK,&1Q9 <B5%Z4GC@V'%=FEF9+'CK()MS*
MY#HBNF#=+ZFE5#-6 S7E,P9+K]S?:UM3-E5K=7S4H!IPN<XP=1N^*9U==6W]
M!3'I?9GI-L-P5UEND[9G%K_C2EVIZ[BK@_8ACAHJ$+GSE*%Z[*,S'$.UY3 Z
MW/$G+$$+*]GN.,\&):Y=O-@T250-HFVS&C4)B^ZF'CHCY1=$2M]QE1)>:/NI
MS6PFH\01J0KC,+$#R8-'; 3\')'RF,*+K]#YL@(P*K;:A8W-Z71ZEVOW&5S[
M><Q,?[<A*26Z8CJ/S@S!C6FKON)%1V\_4ZGO8@+9X%+FT"."@>?A&/];[QC7
M_*'P+G[J2HJ'4:7'=HH_N?F![9+GN\8#$@EJ\:]:?M>U6B=H1,QU-"C:/4,[
M+U48)6LXC+'JS8S_Z=L+&)B.SIFO ,+I.]/=NU_P8L6S2C?E)<?D='QM&OG@
MSEWXSPQTE6WVC21<^'!CK1?,7&!X\[L>R/'U V4->CD3A>J4 +C0W4&[\)QA
M)>Q:F \O?U-N<],KN?4T]Y- ,X4 -E!Q+EMEH^,ZK%2J*D7=XGI.Q[G9>$I$
MAU^HW"D^ESN=RYT>H2=4E,1)FOI^Y#$_3I-4.M+S8J:4RY+$>9Z!P8<:PT\U
M,#CJG;,G*Q^3RRJT'CO"$,JGQ:"<3N4P"2)$9(@I$]@"L$LW0=BE#D1D3'85
M/OHF,QEDOZGE-C>-,"Y^VR*3$7S%30>C:;Z*9BXAZJ:ZTRO-<%ME!"2<'P;V
M%>BM-F7*<,!\.4Z H:%,[JU EJ0D"'[5>2?]@7]4W% \_=Z4XAW<4^CXW]MM
M@\DL.!3=7&/GYF225_V-IL]O-(-VC,1-C_4/)+*0<_YX]-PGCV&QRSRI$MM+
M.6-2Q3'S?2>5TG$=%B0\?)X8=CQM?[&A1X.0TH7==%E!^3ZKVRX,K=_(==O6
M\K!KJ?T\JJO#(LW675;OI!]09I:J:^U$:V&0%&?DC:MV?%I#JCC>_W2S*F%_
MOU/8JF);9/_<JKNZJYGQM&=W>#S"; ,7,DM)@6UZ\WD*[<0/2Q;VF/BI2P31
M!5O=^6O^(5MOUX!$H-LT>'IYTY4P]+-ZQJ,#ZE0J#NS$=0,W9$Q)SD48!(E4
M8<+"(/0>,<O@D'AT/'TV#:/SR.[7IN-^^]NZF+B][F>U3_.W]K8MG$+3R)>W
M0#\^V>[KA65?L\ZO!^I;A0"XR9J>_LG@$O)A<F+@O 4HR;>-#I2 ]3XHUVS/
MT:U=J#'!O1[LWL]UQX,XU_;X0:9S\&C/=<:^PX4>[,"+A>.G:1"R()8\"(1P
M(MMWO5C%?OH\L>]X&E)J'ZC!,NJ(U:9?T XV*4]WVH4[B-"U[;(V.3<)^_H.
ME<HI%;)K/JA;EV! $)/DIQO^5=L#-S<5EQW6#'(U[EE/OB 5SEJ7LF,)K[L*
M!?.45--0$S5Q9_%VDV)8?T>/MA@Q_:)E/>@+W YKO@/DV(3]>8=S_XQ*7Q"5
MG,@-/-MSI!.X3 0LXLR7V-'+1:W,?IZ=S]WCZ0*)]/[=7EITX9>/JA_#P$RE
MLG6RK6K5IFRKUN&TI]\=J")I6:W;7 SX*MLAX)7;(ZOF>?);U0N1LL83GLMB
M%L<!3Y0?II$3Q:'@OGJFE2K'U'%OQR%-L;L^(:B^M+ OVXX3XF^:?GO4TJSW
M<:#3!>M#%,K/W7S.(]J"3RXN/M]OI<\;^'M6(T#P0I7;^N1*YQ(F.5,)_(]M
M 5R1\(#[0MC"24%[<.3S!*3C:8U&WN45&@;D#^X2#H<M?$$G(!VA:TULVF_=
M(Y%\8;4^(O@X"*T9NCNX887-&"LBS+D=3X)E5?A\>.RFRMYGN>JZ>DVUD:P:
MIJ""O0#GF'*Y'7]S@2W"NF<R1D;/,@C?=9WL881C!W/5Y\6::="NGFOK=XIX
MX7B-E=:.>& -+K%:N]CIWZ(OP?/ITP\;2+==50:U-K7"AO7-1)KP8?DNI4Y0
M"(^H&74_EK[UBJD9AY>2;3*C]I'=MN^AM8NKUR$GQ>\%U@?@^(K\EEYJ:QVW
M&2B+21-.5<'DUUFS&R"5F$.3MPUF9E:E<9WIU!ST7FV;55D!6M%;%:B64J>X
M>EMOB#5D_%  EN^P;MZLPW:PV=G;=4A/OR-<.Q2">4' A"=B.PK3,% )\]*4
M2_]9R@;O>#K)??/]J\)ZL^[*;4WYKPD<_M&Z>EZ/2GWOF_3:I@!,B3I>OUWT
M[:7V<8"UB0.=NVF(E=6>?(P^F=Z"YVI[RWS"X[4,LFM%?CI+C$Z8&\N^^: 1
M]0F%NB6S*.MF(JT&A)/DN]L)=)BX)0@QNHS5W)36A7LY:K"L,Y,SU?OE6IE\
M!KL#,D;*(+:#0$1V:C,I190ZKNMSX0#P>1Y_GJY][Y@X)-X,^0ZT0@-'#;*8
MB*4&N](A^M#^GM%&Y\@E^@99.UVS1EH)6?CDF..88#;=[.-2+"YU^?5.^=&(
M-$V?H[?]QQX'M74DJ\[2^>,-LE(V!Y>9&*9SC)Y#0V%?V834$MF3Z<XW9U3O
M7VE?(/_X?\W]^6JCL0!ZGZ';!3UIO5T GZ2JX5:@%-1ECIPA;1*],3F&!JNE
MT^6++M ]R*9"346AW*;%WA@]8VP4&CN/^%O!CAPE>([LPJ'BT][\!)+K'?NK
MK>8!F*RP73C<Y\_?Z/M,\N1?T@KXUC)9\VWB/B;'PPK*0"/-P4CL?J]3_:>_
M[ 9M#[/F4_HSFS7?_LJ4"Z#&\!*-U[+[JM)7I.]P=\Z^^O;3=R^24M[2AU6S
MSN'#_P=02P,$%     @ QH1^5%.[=,2S P  U!8  !    !E>&AI8FET7S(Q
M+3$N:'1M[5AMC]I&$/Y>*?]AZHBFE;"Q#3X,!J0V%T5I3TETS:=^V_6N\:K&
M:ZW7X2Z_ONLW,!@B#@<2G6HAM"]C=N:99V:6F85R%4$J'R,ZUP(>2SU *Q8]
M3N'5)[:B*;RG:[CG*Q2_ZA<+_90*%GA0R*;L"YV"92;2 TD?I(XBMHRG$-%
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M]A7WS_E0>S&(\ZO# _VIOKDH_].!_P-02P,$%     @ QH1^5-MS@KG\"0
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M\]&8/1T?ZOOQYJ&ZZ?]?4$L#!!0    ( ,:$?E2O\!1MF00  )P5   0
M97AH:6)I=%\S,BTQ+FAT;>U866_;1A!^+]#_,%70Q@9$B:0.Z[( 6J(3H;8E
M2'*1]FW)78J+DEQFN;2E_/H.J8NPG3AV9=A%PQ?M,<<WQ^Z,MN>K,.C__!-
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MW['N/7*]SCO6SHG;4:^:O63F@\V;[#]02P,$%     @ QH1^5.3*)#B!!
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MLM$3DGV.7B>TH8I\GHL12$8,:0FAV >3S1#!@?N7E+H(DM']S8*8?(,7<C_
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MT%M?-#_XW!&OTRMB*P8SPL5AA3NV+H6G[B>/].+)7 6ND>IJ4%?*,?K=G9$
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MPI*I85+P@/@F^PW&+64@A)MGZ="?E'].,C(U2\Q@Y919!8 )KFX?B/5AHD>
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M34I)%Q6,PQ'8(()\OK:%HW3[H0-.?6J)8._!.*WO':G@[*B'&6[4N0 (FC0
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MQ53GEG..T63JO@+=GW$0]=KAOKBC$&Y/T,1LC3T3M 1$.%LYF(I4J^BR>(3
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M>*E^6 X!]4/#2B7)'EZC _$@$K-:.4V32MTR#:=PO&GH9'?1BUE>R]MR3IQ
M:7,O#\8-)'+OG,26$6NCOB+*55>@:KD*-6LD.76$SBB6.)\+5#OVY?&\)!R8
MT\.#$7S=E0S?*Z^,CR GQ5#$N.FF#:;+X&+#U8U%A.-P08\%*G.BFHB2L?0Y
M69W*YW7U;CV]G\\XS8;[ZF%:&6CQU !E$%\+5).@U^60/ .2$'W;JOI NA!E
M]PO>?NEE'L]6+0Y0:XA]CQV +3ZOUPTC./-I["P]1!+N-I+P(^WRO://:.R
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M(N1 J*HGD[72'[,-HXKQ@=1TF(3JRM#'79)HC[WS7II@1@ZO(/:87X9?H'[
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MFC=ZWO6?!$N1UI:A$5"%;O$&W.98?N5D5",); PO(I''^C1RK0E2%X1#H8@
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MF,@OD^"0D)"0DY$S4% PB%QGN2[R/WUAO@!4Q'@2!+EX.#< 7"H</"H<3"?
M#@ X!#A_NH _7SBX>/@$A$3$)*1DV '55P%<'#P\7'P\ @)\?&QO +8?P*<B
MH+Y^1X'PFK8ET0TW&I&7\=G$G/<KVVAU1O:Y1)^Z!Y.0TM$S,#)QW^3AO<4G
M)GY70E)*6O&!DK**JMK#Q[IZ^@:&1L96UL]L;.WL'3P\O;Q]("]\0T+#PB->
M148E)+Y)2DYY^RXU)S<OOZ#P0U'QI\]5U36U=?4-[1V=7=T]O7U?1\?&)R:G
MIK_/+*_ 5]?6?VQL;B$.#H^.3TZ19^>_R(4#X.'\Y?H/Y:+"RH6+CX^'3_2+
M7#BX/K\,H,(GN'Z'D%I!F\C2[=H-D9?$-/?CLRO;2#A%=?9IG[J/D-)QB2US
M(WX1[4^2_7N"!?\_DNRO@OU-KAF ' \'JSP\*@ $G)[SY@21_C/B3Y]H\EIN
MOJ+E1Z&N<R"DA=NWJCJ-;^U>K&0TXF^4#0F;D176B5I18KRSE N?<@3<]N29
MQ;25 )I_0/J5Z],_T+YJ&" [];->*10^C0&FC$!'=TO$%I:"H_A!1E-B>U>F
M+VMUZPX$^T,7*]\G#ELJR!;A9"LIVOL07*;1>P^UD,"-./VIZE5[)66.BCX
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M+.Q0!V Q)XH7^(^HH ]=UA*>KI%X^1@#--CA\H.0![48H-P15>P;/(26<<8
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M2+"(Y)\JF/^AXG _07LUH>=P]D/?SWJ)Z/L>6!/XM:#8"?=?6?7?((SZWYJ
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MAAJGC>T@SG*+]M>C+NV)*AA9GV<&V[!5<L OMFEVQU5(O&^.:*#7//T*<.
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M@N<S# <$9\#PP][  8(U@5>7\C"FNJ@@H=+UP+%\\FL10I%X @>DZ#Z&7>7
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M.%LYVGMRX;\S\%I'=T9VU1X81V&=\C29%]F^I7NCZZ3Q_.ZHVD==!I<YP;:
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M#34#6SP*3_WBQ9A_0YT,9ZEVWMAHF!86Q81\S?'V0QGDV9.Y>0=BL)6[_H$
MRM./U2,^>-[1THH//D=%TM'?HEE;P;:'<D/I*H/O6>-\BA>/^)PM'E'WGH>(
MB JCK5%Z<:<<9?J!<_FUF::_=R?+!.VDZ4N<P&IO]Y-8 ASI2*:),0D&3 _4
M8UP&]K>[<[%52:H]5E969,PMM4+E;A5$=QY8+UO(K[Z ;EFUGI&S!\E*ZR<S
M4N$KP@K(-1<\#X7(K5Z6-]26N'CRY>W,!J \IA"5R,'C:"_-UVT>F-E4CWXR
MJR0U^1:&."KW*DL]1;RNC?C-XUCE@>WI2WJ1_= 4BEV;,5/"371YV&>Z+WFD
MG/&]R:'/7>7S]+T_KL,!PQP\'<.K5QA@=Z--]4-VM <[/>6-%U%#)2QP0&T_
M&9*\-'I.+DF3FVV1[  ACCNX#CW%DZ<P&5MV[@H&2['WF=4:$V!DI!R!@O(L
MSS0X>95\4="Y\M>.S\/'\<Q$#S "RU-PV<=B7-_DR6 ILW>L7KN6))UD?,B'
M_3NRC[OB@96S[HXL%LI]SWD$9% /Y>L?VSK;FSV*GW(W>(N*]*;[ U0, ZD7
M/V'#& 7++'W+P5N+F5*SX34J8E6D\ 5+OM/&@R@++4W=S,@N4Q<>!GD'B_)I
M/!-3Q_KF(+J^E)R9S=B2*:TGQO&/?9%L'=<?5D35(A:GHPG)5X\R&Y65O>YB
M#P2@SZT-J%= C%I*W!R?7O)V7G=N,.MJLC6<4"''W-\I\L^FOX?A3'NU/;'5
M+[).GUZ,013LK$_E _Q\;*ZPHM-OEQY$[[OQGSV:6X7*+%Z);BE_''?B60Q6
M+54F[WIQN/;Z4+%DN$&POB8L/0BP:C &U648;*/Q6WZ%W_)Y*O%Y/ML(@-7G
MG<V6;&UT!Z]+9J3I$ E/>I1L2X"ITFVVY(YRVT%A4O*T19)SJ#M9*[^Y.G:'
MITN:[^>#&[A&//>2,@^F*HJ=>KKJW+,L%5L2N!FIPZ2X,-XE$!+VR<LUU]#1
M @I3<#5U+ 7Q1QG 1D=,-!5NR[*?;)YQ$_&KE>,B2,B4FSO1T\N\11B:O!]Y
M%RDB%4LG*T208;\WV+R"F)_X7=GSYJ']V<)G[%019!@T-I[JCF( (S?M)]8W
MA5^V:WIMA925=O/RASBT>AHO[^=_V'!]<X"^I6)N;T*=&,%0&\A$&L62>+P7
MHB[QAW)Q]'/  4#+'XK7]"SNH6RPS,T)L]%_EIMY$07H7D!]$>5Q$*Z;<M?*
MAVHDIZ;BX'9 !<:-E]2BHI+R)DCWCE<"! I0VLB1QM(/2).I]Y.66KR6SRJV
MA>?L_5[Z*">B!GSJ[+.T186*U([L.%L)*'59EX=RSDEI BCTS=?\!OS"^R+(
MWNU69FX,O2XNEZ'7O-,IM8MU%RAJ%0N)7)+9(6EVF0I[X_'Z<";_;J22<*=J
M.!&B"^DXQ?YR,Z]Z<-F5A,9X1LSI%YGT%/;"*FY4[=5[4:ZNQV"A(%[5[,#]
M9?GA0H6L.H(@3)SH[DXIFG&J :0,"W4,^[2)61UN5BEKTBB>3UUT=P5?)E@5
M61",WY[K5RFI2G0.(WGELCQ!.A[G)3E29-T =/-H1GI(MJ)X7O7<!CG87W#R
M'@PO-,]-6;GJ0X4LY:=87I,5]*)*B[R[A,LCI([)CM.X"#N5!*<NT2)HO3.8
M/7S6_E01])+>N.0YD<-C48RBW4N[VAJVC"O5@5?/'](RI>P!'(2(#_6#6/7+
MP_U6JJCG%2E"7I$;Q6*MY:05!>RUQ#1BU)$4;A(_'2Z_G/9W7_6*DFI?X,.J
MB@=LKXZSOV86[.#,,R$;Y#XD7[RY=C7SI9B-CL+5(#^#*MKWEEM1X((W4!&B
MZ5RDTT&Y*8MZ5 @S\LI",3#BYIGND_ HR1$#N]4N]&AJL<G:6SNN[C 'Q' T
MH4",#8"[08 3&5E'R<;$)K-\C9FGO!UHS7P^PN-"9+ R'RHIXZFBA*NW]SL_
M8N>D)*6NV<[WN1^WV?G<36B.W(IW#LA)E<^V&MO-C^*KUJ3J('D7WBW%0^KA
MJ/4!#NAJEH<#=$"GOJD84@VCQ[V/<AM'K!E1#M/=Q_BO6"T_X[0X(O<BYC$\
M92TFN:U\?+].IBU>I88YS/8D''/=87-*H,?$1$KWB<$"NH0H$B'W:;',/N4Z
MJYL%L"7W8)(]1).J[]BQ"RWQD'O7K8,=8?CWQ:\B"2PU8LB#FRSL#1TJ:K)>
M-3@7?F:MW@7#NI8YI#@:B?)?9^U[L4IS6T0KAQK9\/J*& @4%*5'D*Z]J1-P
M+IJ<F)G2>9!<\FS)REW^\XN2HX=P@/$5GU/^&S"D5T6,V6\Q2K'E:7RB%8G]
MR T4A!U=9UR$+K>*?HTJ[]MG\L-B*Z?J>EX##%O ?4R[WK O8$TK/<JJ^@#Z
MXKM25C<YR1USGUPB%0UV%84% 8Y>*[=9+TF5A\HTVWHR&&<%H8GBA<T*"-/$
M"DR?J\OBXKAER"4/MR:3<]K=5BH1F.KZXKF*0;A40TQ[L]]+>7]8 H2N6^2?
MGG,:V[.R] QCCNBR-RQN2S<Y,E-CW<-CTN)TZ0X"XP<6_N1ZJ8+CGZ6GXE(?
MXEA1\F(9RPA-G-4P%*'!%KHV</1B]-5PSZMG*Z[DGJH\H'?("$ZO5848@GGI
M4<!"B&97U[KG +=QOZ"\\?QB& [86[YNXZU?V80?D28WYQB]2:^UA:A.S4.O
M+." LP,X !(DM*AN!3HZR8$#YCO@@"7:BUG@%PQ#Y9+60=U**-V.+<RG# ZX
MA, !4#'@]W!QO:_!(GW(FU@R+YJ&X;E4P@%"6J K* AV/_QG@PA62IS[3:AL
MV[.K6\,!R+7:<$ *6 @&^X$DB9^/HIT!;=JF<^&.IZ^  _QUP7! _U@*'/!#
M8-;KC)^- QZ$&9SB\9'*XDV#FHNNO:*UK6N!;[S>XUH5_VF@L6N+Y)$G<E(8
M==!.X\_(_N>1MIQ [P7\Y3IPQ%SF?T;X/PUU4B/TF?R7^8O1?&6M$NV<L\\&
M*_D9*RP(6A@M-:+$:CZTY!K& 1NA-Y)^!6?B_UV<_Y*)/\[?21\B*\4GAQRC
M 5@RI))7C0L_L6*]:,*+>6Q2A$ +1"FT]>=!^2^1^ _Q-VKX^#))Z91/1C(D
M6M(.L+/K?<M3/8"?Q7JQA['@#=,*L"&!S#LP-:.%G+!B?S5FM#76 6->-JRA
M94#MQ-VM3CO_G&(?9F:-3)I\7$FO >IX"PH_XC M^/I4I;<F_7N#4_[4^4&/
M9N5;R'G#->NJ!Z"RJ"Z5V$2(7 ]*R#UIZ3YA9-/MO>*_[?1PK_A$NRG74GU3
MR6SZT)^&@6=E93F9UZEH+$C8W0F(4:>YV%/[;C_E->-"25(EX:X$_49[.^)R
M51-'WI+\;2NMM1>%9:XC!E4CSZIP9.WM/N=?3VPV K\-X(=CS=-KU\:Y_U;+
M$O".YOJ9H[LZ?DG':C_A#-ZH2S(Z*X;@.W_;Q<8W6(_)PJ$/.*5,?>^]E:A1
MJ.IPZO,^,YNK)P\"+$)=%V8E6O<R2.B#32Y12J7-3&^55F8CP#:V='W2C&[G
MY.AHS.29,U&R5)'9B7.?%; K($47MX03:$[TITU PB;,'4OFPC(%,11#<X#"
MG\B]K:[Q>R4'!TCL>S=$+B9)63/?B_[,A9UZ7XUGMLI@WX&/U,!#75<,X%Z?
M\X)?(@\2WZ)Q(%=L)C2AJ455'A[3U(FXHX-Z-%>6L>^3VHB;>< 3/[[-2#Y(
M_N6(;=5_HY), NPRHH!T"VQ.+E!=VQ L-[Y].\Y!^[DZ%K03/.KXX52P\9TU
MA+FY9Y$,Z5)H!VC^;H6UYYYN:@G  $,84!3T?9SD-S=X1Z\]HHA$.."D7>C+
MB6D"X+?JZ*FHZQ]L</T0A*8T\O51&/W'Q"79/\9:#OQF')=L])4R'%!C,?+W
M9%N^]TM_B(L$77QI[,[)9?@I:F[=X/<$C7Y3]5K@FZ"Y.W>O+2^5E-T@9TZA
M$RG8>LZ_$6OVS]$"?R#&[$^]C/^*R/TK(O>OB-R_(G+_965QE![6:A0;34^R
M!5-?ZO2"\W'@T29H;R&CK^K:.+O6X*!;? C/@HK7=$#]U^NS\64X[S+,6_X*
MBJN!@JL*^K'A_H_7TC]I_"(,_!MM>/H_-<F=.Z 7*9<0V@_XM/FP'QM'14)K
M(]<F7Y.8;XF8^M>61)(]'""8 X,A,]P*HFO\VN+?"C\_$3K;5S1@4%2%_MCX
MBF@P(.8;24^SH.I!0+'1< ]SK,-8XLG[L;_"6+K8+P(UC/F?P^P_P- GW]H!
MN531W@VF^"LE;Q!TEU_$-L% [^2_XA/PZE=&)/K3B\%/ULO3KZ\ISLCP5+SE
M*%%06-DCM1=[I?FC+9,?*</M#ZB@LB;DZV"' _XU/2U_FHG\59;\?=]4^'&(
M[+K2<^N$9[<Q^-KP$4Y_VC]/I*<T_3,IK'MHQ1 J7R33Z?^(*/O]7T&DY\\S
MP7]H$GZR&562_S$T'7V<*6?T[4JZ+$+\.73N- K\Y7_8CZI29H?C^*TAZ*Y!
MKC_AP?KGH>9/,PG87S<RT3ZIF-$;T[%Z=JXODBV_HL>1&_G+-)C\G^+#?P!M
MNF^JHF=]155!5XKMR0MP=SC'';ZF-;M/:8Q/>H[_D X3240- 4H_!)3]C^;$
MO_<[B[C_E8+SC]GS?\84G+_O1W]M57=<RTS11]"Z];4[%0[U!%YLT< "1DT3
M9C 5-=&6K,GX16M0](R4#2.1WD*AM0VGG,=$6UJM_DKRPJP6@#(UI !^_6Q(
M"=.\G(P_?A\6= 4E<0W1()E;$#;:^#^:(29H"R9 _??IU/KI.1=AX*OOT@D:
MD8"MPU0N?E,V'OY=Q'C_(7(#B&K?[->W4J!NT]=(<L!4!5!_EU1\X_#FY#(+
M+;<O_^"6IR$P_%W$LO\A<7^XT ?8\'H%*,*$/H_&?_-H:R?R6ZOR7_V^<UNN
M5<;\R;5/.6X.!QRSR-J@EOY70/^3Y_Z-?!5\)WK7[CNYS+4DT-RUON8Z''#J
MIUZ8'%"GW$8\VAC8P!ZJMLEC''!GW*$5P>A]T$$4DL<NE.V 1.9 +_O".REK
M1:E0EFGCG>@")A_+2282WX* F=ZX%\\2"]Z,A3?.S><;UMB %9Q.%+]$A"@T
M"PA7!XZ^&X;"*(?FJ\IXU[@O26DR!]7< (246HB:>I,\Y&1<:*L.U%7P]L Y
M:SX0J@PV5Y/LL067R6.'!3)'".V!FWUYKU#::T9C6Z;W<*Q<;^Q*/3@L3&=)
MO^$!ND-$U+]0'C''>F!,K+05V$:,.'GC<192^&=D^W; ;.2,3?]RF_,<P[Y7
M*90C^,DP;A='5/M!:KLQ_5DC3I1/>9N%X/U]ZY@X6R.PF[C^CKF"!!TX'8<2
MG:T+B8:(!Y@$<":G.VC;ASAGNP5*Q&Z7ZO0%+:0W<'OW'-V$RHQ/%4.4%0X"
M*@NR\W+;\)+]V1^D59"X)EZ-\=ML[ J^>W'P@'%XT2?&V@D.V(;H;?+<*IK-
M9NQ<>2G@8#58!CPG<.J_. Z& X1Q$3)^[;3NN^/,@F\/(=@G?O, IG37F>]V
M^7N4K6?2F(!W[LM;6GBK>(.B07F>]2'YLJW'[\L%^!\3<HU]\@<>3H+:4Z[R
MKE=C_U7Q%4S_H)@MO?(BT3/NTG7BN']'5@@&V@'M'<(!H<"I>! 4#IBZWHE7
MX0#B(U[:ZVZ!E=[A3V$CPW# &FP<!@<P0P9_!BP\KZ/*\_^/L#AEE>59/A",
MS6) *ZY[<7SM924KU_1\0:V^ E$\U8_NH&,L^SO@XW&#$J.4,P*UVQYFI]DI
M<(#0:>/9.:@]_%O@[DFXWG("+=,-'=D@2PLXX @.L+JVH6*AYO\$:V3Y+UB_
M#LN2I%ZNJ7!-M;Z"JOT3 MU1QUC=ER#!//+%G7FCH8Q1]@-B/V_K 5"/R;4X
MN'X+OJXO2##G;]V&A<JOW>IS.*#\VLSL@;%_/X#5Y_6,3?M=\ME3 ;9+9?EK
M8_=2_Q+:N"SQ%[ _);!!AG)ZQ-)0K=-)R?[;JB>")T;?OJ1G)@94";<[W2O9
M2/E>5WR/ \<7)\43[C,,FTORN&^51<;/@2G_]P/;Q-*;TA'LM$F+/$C*NT=S
MG+?5O10C^4#SF4/4P^X/.[J[@442^6*K7:]J1(Z8S^K;C+31%XK*Q2/RLS(X
MUM.#OG#\+YK.A:&>K6IZP)?XU=B] BWG+J<#U!NFMF+ ,5^.]2+)/QZ"G8I>
M%,0;$K3*R&\9V\"=T/)AX@NM7WB%>QV!, K3C,ML6!G"Z*"8HP_-06A*(&44
MA_^>[1@EUZ0A?SYZT5I2\"X(09CL 9Y>\]9.C3-XKC?9ZR'3S)K- CH;9)P9
M#KB;G>9F5CU8QV6?:Q%12ZD;_#:DJVPQQ-S=<+RJ%^""J^8<4YNC;ZZXQ3*3
MKU'F8QCUN-* [+$'I@.:\;H>:[#^^-KPSK9IV"RC_V<N5FBV"6,9YOM.Y8GH
M_BR T_$?<"^K@%A>DM6#7DH7>#F!62-FR(4-*BMLJZZDM*)NP.ZR.I:E7FW=
MAOBYR^;Q&B4)+.<8APG'",[#X'[!^CR$,46=M5<G\EB6"G,5C5D2!H,]%8"X
M\_$&!SG[#@%T*Z[%M1 .#/R6W'HHYV""!1Y.IQH1DH!#QY OG]9/T]:/.;NI
MQHO7VQ=I6AG;B?0.Q<E&W*VS[[8<FS"QDYJ/OV.N[GI,+#$X?VI>,BX&;SWG
MI(-PF5_-_X]\DM.<&JLT2K4H]@912+Y SL]@I"0/RJCF\+^>!ZXW*_J"&(@Z
M),K=<<SI4M(7[R_\=A*';A:E?_SWPF\!6[F%?'N8Y2$U]P6" T:IL7 CF\L0
MBW:%^R0W0F <U<*W\#[/0H*UN92I8Q=E$JHH7,3C/=]6SHDT38"C6N:#A@8X
MIFTQ-UX>SO$\H]O!_=!=Y98DAQRY)4S\5IUK"0X@$%O49H_02NB)[;F#+_M>
M)+1/#AW02<9#I2Z>X^"WR2:,\JT!J*>H5ZRGJ%LE5'[(LW6,3*=M3K[YA9NR
M_9R0ME^Z,F^#@%A&G,9M^C,2N29-S@B&UK:#U'2>?U*1V:#6 ,3GT)I]WM;_
M_AU]=+EMC.:/YDI*$\16=NE!=*]PU1)Y)>+29?+8IV]PXG&:N8J,"V:7TJE$
M3UAS5"F*X8DBTQ9,F;QR/:ISF.UXGI]0*00:4;)^X,)>M*V8_BZ T%<$<$*V
M\?#U5U^I(-XTB3K'K>+@@QX7&W 1]TJI&>4N%D6]3+ICK<%-&R$<Y;[J:H_P
M=U.KR'16VA;,3!F5KVX<DJ(>DY^8*0_9L.>$FIE/?T8,?96<HD#[17UU$]^E
M6C3HNJO4GAGF=+N>*%O(BXYEV;+R9Q3I8 TMQM7#Z2Y>872'G8%GZ=5O#*JC
MJ-Z9J#R[62Q^EKYY2E96C8>K^/3:2<O/>D_W4B,1P#=P0U%;?M%:C#$DIYNA
MH*H5R"#TU*<\6)FH71^%)%C;'\]1?IC)F2?$95-03_/] O-8H:46VESLC5XV
MT4YMV\Y9. #S(4^;H/8F:=$XZSK8"H@^/]],+2:Y;%LS1&IS84!<G&>A3JR3
M&WN;K<Y$FM/QRESU_CS=WP@FIMM-R.K/[QL45I0N6M*)$!*V;$];O)SEG>^/
M[HFB&,UX9G_2B7L-7.T$7=TJ3D513)-"#(\*4\J1]S$R060?GH2'L(28H'GR
MW62BV^./RP,<_9[^8-UG(XCQ<D]9*%$1N1KD"TB!O64>!\M6,%*GD<R@^BRJ
M)X. &TI?HJ5.B(,MOW#@JH'G _<8"F^M]&+*L?HFM0C6/0ND2GI/-=>NBJL6
M;T%2QL/!F6"N-E6R?3GS8EQH#9>'=O<N5TF<&*[J'=H\ZW2<F0X<R9) @ZSI
M],N1&O]\S3E^K!F&S:KS$7OIOW%<+8CN)/25NLLXFY0[Z6V\3K5-.* 8,C E
MO8U=+1Y$)WDOZHM3 "XS92)=V/&=L""O07X<?E:THD KU+7;<<*W<)7R2S^H
M(I:2 OB&$6CS=AFIRZHYSY I(XSN?>#N'\H9V7[V(8DR:)<OHJ?JH\OIIJ5[
M3+)1*>W@WV3U%S84+Z4NQ (&.24Q'C6RO+=*-P?8!1P$E)B9GCX8PH@#U>_2
MZ]45/31^J1I#\_!^8@'ZZ-RZQXI'II[.>YE,("L<X#FCGJ(7R%Q/%I;OS/RW
MW?!WY"WY;]D)E[J#4T*XJW2;QZ7F;4@@,H)$@0WH]&5%^JT-P!&F<CY&U\?)
MA.7:'"S;[X%,;N$/2,CXEK>F<P&;]&\.F)+PBY>U!7A!)ZZ\LB/&%\;9&(MC
M12)@2(UF1I \4L<=QL"X<NY)%;-<@/$5W>Q8@BM-F-..U/W>3$Y',:J$0-3/
MF:AF N&6@,Y!J-PI"(.):<^]<>C=#HWH)".K5[[0@C[SFN84T]L+H2 HBS4/
M]<;Q95R11F(T?41O_\CR?H%'X"O;M8,55\R#-!T9LIVI@/^OO>\.BW)9\GX)
M DJ2#!(5) I(SL$ B A#DAP%)0Q#SB"#H" 904 )0\XPY"Q!,B@Y#)*3Y"AI
M2,.'>Y*>O?>><^_N?KMGUS_J>=X7WNZNKJFNKJZN_C4&7S..2O"\CW-DF^5H
M[0 W\_9"5+8<@=5T::P(T[BDAI61B8B$V"7 ;KO"OS7W](V-X3K,Y57)6O^<
ME_.<\[C39KS*W+TY.GS$=9P4V2(G[M![P+390.1A[!('2PNYYI6P%V4*'%HG
M'P+68<(#MM1O0K% I&B8!-O(2R*,QZL9Z.\.ON1PHZ7(32M2J=SVM<J3WA-/
M'"[CK]'POUU<6B5-RQG!=CG<[1(:6:=6TVP/WDAYD''J^VQ=V8^<W/BCK8RW
MY=%ZOS@OE@&@K5-R10K-L@@!L.,0UR.M3_8U0HYMF<QIY7.S74OTNSCG/[/L
ME:&M\I>C6,\N!!<?(J@LS%X[NE%^?KG?T3;ST+A_DV26=CBK=[93481!VX5
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M-J[,3K87!;Q)C &O"^]B^X99+HCCS\1-46H;6GQ9Z1]=UA@X#,,S89:GWFW
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M7@.B62Q0:@R59TD_,-R:^9C_A6UIU'6PC'7:_J[)#>0N69]."(=R767_@%*
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M^E)$#V>V\51=@PT>4'$V4B*"H^@R(AX*#1^-0]H>Z>I^M;SCU\9:]EUO??3
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M7N3Z7O;.+S7Q_(4%LO(KEDS&KS\QNYBOP[Z%RPU=9YJ94+NP='*B1_1[1&=
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MZP0I,3NZ]ZQ--4%7WTSC[76>6XG/XHI6=5>191FNUGOQR]';0!$'4>)$C%1
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MEP@E.;IXA)/-3!<4M$67F+9<'4\>FY[<\0:]KX*SC6/@U:!S7A (W35,;5O
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MJE#_O%ZJZ$/;TJ:^6G WT/="L:!NK*>8H-)M&37&- II2SSQ!?U<J.17G\5
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M@BVK]HL6#J7)^NX*3+YM/>UJ1Y2$I&#<C].YY-/_Y3V\QSRNH)979"[22DN
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M'[^@1\X4RP8] /3SWHI2CB';S64U#\!4#2CX6.H=?3][XQY9YZ1. C\''/H
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MYKJB1-3$0O8-Q%#L"L^5.G\XP@'899[<M[+4>YE3"[&$B(C2Y'F\J4B/>NK
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M?M0DLF;D_7GPE,0'[F??51]H%KC0/ 9 ,J<DA<@'2H8\GW[G.5?A]YQZVF?
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M #?>K!J.53$7>A,( Y4.Y+/.LWML>M8<X]35K>J>Q/-#&.KT#;;UBP%Y2!Y
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M-<EH5>1LDS=+;6S3J(-XW!7!SM8<YD8$D>VXDK335V"*B*LWM:,D[4-=?GA
MP)5/-!D'-4Z@%#]JY^ULBYZ883CSVVQPL5$*JZ?A>0>=&<OX=#.?Z_B,0SVX
M5&7PJE*XY<UEB5?)&@/F.MYLJT)3S.0HX)5>E,%=A-X<69BG?:3#5&/9"&K'
M1T(1RDG]OM.,)Z_XWV>+]_\_N..*;^V&05A=^SY-C(,7)]C=*><?MA=0 4_<
MTR&.UFL^X,]J^;IK]V!PL()'B*-Q"[_B#\#1UC,ONVNBS*7@J(Y_.BY5X;W=
M=JW'7+:W''FK+I-ERM>4^A=>QLEJ@L5^;1=%3BBX!ICDU.B>H>"@KI:+]J,N
M4I%,&S7O2$_M>L?]RSY9'SV11(W?,])]'_5(#7ANT'J4$X.!][-/<P@JG'YE
MYE9Y[V'8#@+>G1"]2M])P*[5.=V3YF>0#JK+^C98\>4((1 RYFCE >Z]1#9Y
M:W[HXJEZMOV07ND<)/YAX7L]'[D$SZSJ0=V'I:+"-5X<.Y>'ZL*UKAPSL9C=
M/?G2)Z7@SW7KQ_KS+D#T<#NUG06RR+'@J.GC,X74@I82>:/X8U;I)1[BE"_G
M"2=WGD_EP#'4)U SF;2-]\W%?P#U7SWJ=.Z)59YSI5ELSR(VQH5M$LTC](=<
ME_AHZ\,=^M-X<(B9.):%&5'+9T&^H6*]^K^G^F4=BXSDTX*;S=3Q'YJ'*XLO
MKPJ/X"LY+<P$I(*_'+/Z%Z.%]*>/<$7CDUG>TO>E7C8#RP@,^%XJJDE8=J>"
M\0:\5A\<;>M?D#X<"^Q*OGG1:,4I==#?,D$:763:1NFIQ>]4G3^K^LCG'5?5
MP0+QX\</><IURZI9?-[_*E_85S26Y"E_?NSS^YAG=OFF#E@+M9'$=N=-!<$;
MKV#4HZ4B)EM&SEZ%?P#PAM?'0(03LH^^-<@G?#:## _47 NUOJUHO'(,JO^G
MMD'P#U>PW_-N)]-5#.)&#R]O99-O+".^3EI)EO+F.-'WTT_O,3C6'.BI=II!
M.'L6/450S=;-%N?EG_/]6#@U7<QZZ^5YH_(F]M6AX'#PW_9+_P[:6Y<#NF<^
MF3\C:"DLJFQV]NX/@&SM\T-2P:K$,T3(LR63/=IB3"@WB[C3NBZ$&>JV&6@O
M)9?OP#U//0E3]RA_O'E"61"_2;T2&#Y/=T9U5G(_7.KW]HO7H<%R<..O%I>H
MZ-5.BV]91-GCYK/GYV>_1]EMXE*/**$,Y)G GWR<M0VN544[3T"C O6K>GZ_
M QQ ^^;IDE?W+BG=C'#C4A>)^;WW*>.[TH<5.Q7C,?Q>H&Z!\B_GEF:J6PT^
MU^W\F+!>L[ITHO#1SA_&F'?J-L-/<U*Y%XZ5V< _2SQ#=ID%S'\IC:KU7/=#
M^-]-+^M,&SQ<R%SPY7^V^^)MDP@OBQI>:@EC5TZJ@HYR-@QUDE_,(J2N%..U
M;WZE0&>IM7X5VR@QC<&T!?EPLBCJB<8V,>K4T>W6O)(Q28U!, ?R)\[*D;HG
MB5@>/SM*#/FB@;H3N2L<1-3Z=HR@$T4RE_#Z:U5_A3^;4"].;B-4\0S]'&-2
MT'-[O7D!*PB+1W$YMO+PEDKY[\'EI^ZD?Z?^-D*.LHE.M/^<EV)Z*/]C E;C
M6JUG^V&6D2<)?$E\H2*"QM@6*@,;YP\2+H6*Z(0(W5XS)%M9(UWA4H,!B5&*
M.53SK35RF?:=']WH$P^RK^:T%0&Q'<^IH0-G8[!6IAC>^P(+^\A6%X]MY5H)
MQB(X(U(]P-2U"&B0$,BS)Z[+G?2Y$8A 34]YS6?;!1:AIJ;;!([K,[5W+#O2
M<S$UO/ULS7RS*DUYFI03RWUB^^9>G;GX@*+Y][R6*Q-J/)CRSMNP _T?>]#D
M_X.PZ6/T O_@P4E)X[NP<+21AQLA?:EC/ARE<E>0%O#[5J@]@78-#-,_CCO?
MF4KQK9#A:1H9/TH=0V@D*QE+KR+G"N1Y+4AZI@P#IN.RQ.8J"62KD:]Y5Y2"
M+IVV*H3WB<RE*V3, ",R:HES"8YJLG,8<&B?N2-?P!3I?67_V;R03 =5_;7$
MNK?\L;-E4*"-J#ROKLJH\B]D:VU+_6<TR4>,D @*.D6AA3!+T<'WF)J)J^N=
M C/7%Z%X:,+ACO"XNH\%H:\OX+J0D6X,KX5]YJ^X_.]EVAZK,?J?0;Q>;PFD
M,8'WS=L=JSL+]#2!-B)>J4S[_6KZ:W6?T4:B?4GY[2R+_%F[=:?J$+J(6T7B
MCU+[Q,R\=&3IPE1UUY)O.!%9MQH#T[QNKP;OE$%<?1$48$_*"3E4$4^]]4BZ
M$+J@O]JG[/,%S+T' S-_I33UP>C5XBYNY>QB;UM/-215_#482>61]T5)WK2N
M_,$O,)#$Y^!]J97(?Y5XZ+L-@MUO"?#OW-<G=:R=%WS7D]?CMBI&E)?:9[I$
M# )B)++?VM?B*K%T$C;+%3JX<R&AHE&S_N@9KRZ "1XUTV9_GP,:WH]Q4-Y:
MCOG4W_N<O8K+7P7"TR\/CY_^:24421YBR7COJRKS-U:66+*LM'*A9^QK,1[(
M@B5,SA.9WU[G'0UNK7PY?;6U_+F.QN #:[7X*Q/ZP/OX?X7^5IR"G-0\>-B@
M'AFKCC>G$T;7^[J);7>ACO<</,2ZZ]5Y!874WD@13!5'K2F4/?M8^M*3__UX
M"&I+XA%Q"U4UX4_^B2)3<?O)_F%INS&^FEHQ!]J*_5>/O-KOVWPW8%F8#\NY
M_X%OWY!])9JB6_HIH^%GUX>"#IH._F'X^#]+J5&;+*GY;&79DL1B;N-7I<;W
M:/U+]@9G>,77A781B0PL77GZ4,^J3)0G#O*XC;]HFUWT=6KZQBI90$G$>PK=
M[,UV,8VII"E6P+Y%*E]!M-(;7;:^)MVI0EHT"8DN<L,9W2L(SMQ-((:"]9[<
M/A<9>&!=R-] _4P=$U]"K:>ISN*+PO-RG#2I*%.1$12[L7;=AXPN\9-Z1ZGN
M\,CT!/]: JSD53]JX'CDC5#]5?7)LVT"?X<ZO*6GZ#N/3%UW,@L8V Q]$>3<
M_+ENJVP(WT>_"NLR:1)=-M3]IN#WW#LY# WQNQ0CBCG;,<FIADJ^F)2\CPA/
M9#=]SQL'.Y!QRA\ 'FOSWSI0SW+&R+2U)X7<BM/-<?2O[H:4JP2%AEBLY%5]
M:. 87_E[[<KMU[&:[S=U^<8I,4=%+RR6\ZK"J[E>[[ L4SJ<3%7=ZDY^\TS_
M2E\\"#Y$P O!NNJ:V)@DW([#?3F2>9-"LII7%5?+]=+,][*MP#T3+72K;<[2
M5%P)4K%L1'L%33K$?^=0%!1:]V&9TD?C+ULC?M7\DORF?%G7_86+YR]C[OVM
MHR+C]!J=ORZ%MY_(%0]]3\9-RA'_;2WM[,XXK^+<K<)YW;>QB5C9<!QE_+&?
MR) >]>@0/PF<,L@SX9#R#\#S?;CKI,GS9<I+-8_9@OZ5W00&+R/6V9U^7A4)
M/\30/W6-Z-)[_\S"/078"+46PNZ5;E9 B]T.>P&P21W.H8>G1!G"\J0 P7^>
MU?\7 ___Z( 24> #-0T 0EU%"T^"%D4=S")5B(44M9:25/<Z6!Q,*/X!"-[[
M5A9COJ#]>*2&]J/$[FOAME3L'2/VS_"*UE,P">9I]/5\]G?D+Z[F =9OE@;[
M\HM9!79+?6>#Z3;?9ZX 2L)\=UQ5/O-)%SDDTV(7NGJ^W4DG!^V8S+4]NY^B
MN',B_6/.V0C:Y^[$6[[$M3I.W<C'8'M%_W;0.<)M#&L*3]?9XJR^*/],GK'P
M CD=X$6S'"YC)%;8BI,XY\C,8VUH,N_A\#*= I]$%/XQ[4"%&R@VU\[>[3LE
MYY@U3VT&P["WY>6]'2X>*($GEM'C_5-:'4172&OC6DJ^<<NP;#?BW+]-*W<T
M)=U9KFT_I&I#9:O$A,0#_%)BHZ^-!.=#CT\8I$%?L0T9JO@E6A"/LD]2=_=\
MX(_GNZH@BIU2E]@$3U[87@(UNA:)!]0A"3!$\92X?KJE<-;_VM6"=(99GTI+
M2-@=V&Z%:6B,H)2:FGG(J?-="H^?:=J;XKB>*?M_MD_H!5K)$/EP\J=JOH%Y
M:@I_!#&Z4D=P=7RSI 5[23C2/+^(3R 0=Q;36.@IRT+&+"U7]9V:IK=TBEQ[
M"-LSO97LXSUQ'VW2\V71-R.6>N'\A4"\LE"9__I=4SD+Q7/5@I[R3(ZY#Q'8
M==WI[@^XR">"%3%J"E\W,]D@6T,K8OIM7,+NJE@WHRQ3?-3#X?@-M-*1F=X#
MUMT<3J3+Q\VJ<U+_W4M">I.A8T8CS?X8H8)9^@GH65C,A%@-<DS\>3I^? V!
M,P4R3*UEE<9NZ] (ZWW'2N,$#&2YU',=<S(5/_=:-HG?Y.V8H*;BS:[W=_'$
M?2.2Z&N3B +4M3CQ;8GG+'Z6,90-NKLT])&DK.EF=CCZ<VZ\G\>X/(P8.&WP
M3:V!+Q_S(I[JT=+/]@^MXV;3@9Z >V3-"N? !Y?6]\8<][1B? O@GUB_01TZ
MJD;*(?N0>W\ M5LVP4Z*+^BQHOSX_9:.;G(ULG-OUXJM,Q7W(31:F?3O>TL.
M'>EH<>D'9NLQYCK65N9,>/K3$M>$.(HA!S!0@8R3]^C]Z;MQI/JM\X)3K$90
M[D/#BK:GE:QZW6!@8=ICLD6,I,H>QV;IVJ$CHVEDN-2QQ<'W4I^VLR$K^V"9
MRJH^F43-&YSF?B>7@G5XC"RCE?Y8$8G+#G]H=SU WJN :3_9[%>&J^&J]N]I
MHN971$5"[41)Q(( 3;#ZHU'692.C):K.%Q;M>Y' 9(K$[X9&\UC6;CRN8)GY
M:1N?0RU-"1OF^D0[+!WK-XYKIZZ7P6K+-MV!/#AG^RJ<WPA+=FI4(2 0^,81
M]?*LF_J%,1@(<83)3L]K0?@NP,!LKQZN^*.>49@N!*R5]<8Z\U=&:CX4H&,I
M39-8-\-5QX,F^7+44_0'X%"X8GC @Q.Z/\#S>TQSL>Q<!P]_.@&E7Y1+6S:C
M@T=1Q$I;8"D-+#L/#Q;+43>2'GUX(PL*,_.*O=*4C<K:.@E_93O7F]+:;];7
M(7@9UOM\JJ0>S0&?A%*S_\>'N/GB %W51"7H+??KV1(!S'A&_T='/[B@_\$^
M0L^6_E:'_YG2!=S@[$[: BD=31X)QO6#Y7U-#NZ5O5>*Y0P!/H#S2N$/\P[9
MC\'9'?4S+S'K>XR;37=[+;(<4.<\4Q.C'3OQ"EM?=II+:_H%>X*S9BI>;KA3
M8DV'L**?B+Z\Y;21G*3LLE%$13[\\A;V3,Y>X4[Y;-]!(P/1CW<)6HGH?9T5
MC<KLU'3Q&K:?P2@GM:,/PKV/_1<8!/!U5CV,.)I'&!"FGBQ/M*,RQU:,*BPI
M? 1<;B8\UEIC"?203*T91+O'7A/[R88G-.I&0U2]'H8A=:;'J,"?OCS"774(
MU%DE\:%H:/'/0/AT!<<W5J,+ZET#I/83@\'/><@1]+\E9U&^"L&1KN ;GAG#
M$^?2J=O<8[ZH]VJMH TP8DITJXN3JK@6U7>503K+, ?8@:!8L:9KQ%HK0W0&
M1SVL&Z!27#2EF]'R:TNW-\_-_6C;.J%>^H4-Y_M#+4^#K&^6/NF!H,</4_6-
M7,6+=X.5]]>*'T10^ZM 26#]I^'+D1$IOH%\Z^$/:-9&;3QIZH*J;.3$7'],
M/]I@@7@R(I\(61[HECO 0;T>9RZM,X]>?M>#%_WN>2RR2Z43U"40KGDS( Y,
M]/7@RF0>EFKK[,XBZJ8826>!PSH08R+/0LA0#<.A#W_!7/AXXU1P@D6\F@L[
MM#.)IE\IVG\U<R-!6 K6HY9(>/)^?W3;7%C1(> L*!LLE%Y,Z[5^8B,X^ZVB
M6]PQ^^)S@XRMCWL*([(R( _J/7&L, ,<[-U0]\K29IKD0,3,R-RL0NGS^._*
MSEO"<P5K<6RYJ?%;@6>/^YE/Y'E :0T4'3GISJK(T3,A>G>=6@#<>AF:O?F)
MQLA08LX4IJM(.R[GBR;SV=))6E99CL\@*LO3Y#RBI-'C+VZ9R&T>2NNOURSZ
M+&*22X1  3;91)><-&ZTQ)2*2H;%-HQ:S6,I>1<N1XV8:=XP]=9"&,5%5EIM
MRRB,%VG-$V,49(Q=:!+!3P @755TS[<HL1@?-+E<0W43"K&79CA.5^%V5*?R
MP9=7\ ([M*44MRD<[-+OH?-QHR>JM@T%V!5X<79%N!"R+&%^-%G_VV#;OI5A
MG5S9"XV_'*\62D[23TR>PQ7,8A\NJT0\3CULWB\*+S]+(\R^6%]>%"",V2VQ
MA)VN5!]I8P V3@5#!$F>\F6X)@Q11+6)EJ/8F+13:L%6A?I[E[BO'=U78:#H
M0 [SGQ^'*72ODU5\:)N83BV'81[)PWI_ "]Z"&C19*[\X+2!\, BZDB-I:<W
M:'P-U!?SQT8L+Y'6WU^#G:O'YX*IGLQP-S<:)<DW5TQT,SD1!]B&RY?BJ5:!
MYH(Y\Q*LB,3^X< @%U00\!>!_9>#.']+73.<H,R4;@J#I6^^7/0C&S'!?)AO
M+.(QAA5\9>A8?YZ\@A?_T>=(-)UMDK4*9=QHT4"/.#(G+H$B5MT.68]O52QF
MT3=Z(PV3?'N'$!KJ!:Q*8;B#,X5:(P5XC=;EHEBIR-X<EHJX*,2KDD2*\K%[
M4&@N]\D[M3C18*IWL:_K3(2>%8I13.4F'7#&O_1 EJ+:L4?BI>1ST42["=+@
M>D!+A/VO+;<*XT"M=9])MM]>$9X;06J&'!?%N-5OURRL9@1+S2(6=[':[2+W
M:G@Q<4XL"AR:1Y] ND&.RV+'E+R/S 1$/^]KKOC:4#-8<,";,X"Z0OE.HW5J
MK>UB*L:"E\5M?>LQ'EIB;#%)@-(MW7I19TJA+QK3Q&GCJ\7@QLPIS#=CUZ-3
MP[Y<)]L%#LNU3+2O0%IG\9228*A4@:^%ZS@UCI/D\J5?="(TN!T*<:5R/>Z&
M?=%]4KP\<D,)4;G*ZQ)(D^[CO2!)I^AKML?)C=8)->H:(-^"AEODY3LF4B&$
M<7(M'R^.X99JSR70>/(ZX2=2^Y[0%@KENFK)?;R>QIFEILL6;HTF,; ^HY$B
MXP5:(\-5IR161@"%F.T'G1X0K$E>GM]6I-T"4"?ZQL&EC(?[$#)LBA\N1<V\
MHYCTLKCW5W-@MO7)^:@PMQ%WA4R^:%\^9W#QW!F!2^DG%.2VL>,DP4BG =R/
MN('BHSC1#HJ/RCU2P0<G2;;)SID]%$8G#^Y/U+&+PWO<6-7<)<45+#"IF_D8
MNRL%_NA-_!5+BM/,M=5*6\2<"K(0>%4-#'2D/)$.FJURPP ]NHS60Z5*?#UZ
ME4Y"/'N(HH_Y?^+2.P*E$-F.X4;KP5+%*&^0D _2R_<N2\NG22MN 0^U(G:4
MC4:D: ]0PSPCLZK\UMS,IEW4M#+ML#!XTH,D@FA+?&(P9%30R.^-I2:Q+P,)
M/PZLBD93N;UV*O^ARH? X"*.SWNAI*P<N)L)(EP95R+*W<+4+,OLB,@%JF,-
M8D,P=GA"IY:TV09IF/90[JXC@%<@ZU0-378NQL.8I6]CZ]:RB"9\2&Y6*3X6
M^Y:N\)D::TP'/*WU%-;0=,=G2T*5<G%!:2>"#5/^CLEZ:1?/3<0SP+XN/]66
M3A^EB=<OPNKQ.,E_:D(%C*1!QC2?%Y5PZ/RKS.E?T-.;? (4T<@(H0KD4ZM$
MY/!6[VOQF#-[;):%9-Y#;M@P9'UR0!VTZ=".7(_QH^J[PM;:S1CH1%^X8@(/
MZ-AYCXTVN$>**\WQ6S<'8$7AB%!-3:96GU%%DK<YM!5EAD-QO"I)=X[C/=0Y
MLS>FJ0O!#Q35AL]<>ZT;B1F/&NP5_(KOI^:_PWM9L2A\C6M=?9) (%5A<4X9
MU>K@31N?QL17,7-:RU1 9:JC[/Z3+=G,B)YSIC9TLD$AM5=/*='(;I2),R"%
M+X*N\ODTD$:%W,+XX<8QB5)PRZ=X74MG&#LDO]YOULQYB?W6S0_\V]Q\H,FG
MN5X;IXVH3_8H*OX%$=$X?FOSIOL E8W7]?$O=OW">'OMOR?<SWPR7'M:U HJ
MC#N94[JVT_\^T_=RO@G[7+DJ^,7<EL?YJ*QA&]ROB[=@8BSG^(Z_L'CKE?$]
MR7R$V]TD#@&GBDKDEZ5]FY=W]/PW$Y@N);^IJ+Y [GE;OE:7-4B26.GQ*ICV
M/HPN[AYFGKU DT51.=PNB-K"QM5VZN,I!ITRZYX+7^'4U/T!4!\\3+>FJQ@J
MD?> ,/6DJQ31@8]^ODM';=>WSM?KG)XMC/&S:YV^+IU_9I!6 /VUR0.:4%@G
MDERTX+TJ8X,,-VM!W7VG?C7L<*R'90?/OM=^UC;EM0.S?A "8?)(_!9C@&CM
M:4VQ;W8!]8H=W#UIBG]1_%-W,V"9V&5.V*\B+EB'0)?I7,-G8,-\JJ*T;TM.
MXF7H]V3CIO2QM-7)CS=-V+VNEI/<5T0KD &P1R*$:2"6  H>-$T/YH]L.W4Y
MIV]<3*(TEAKC+YW^PM4<*5X2QX/C4D;WC<,YT$GE)#_E]7%8(#^[6>8:C6+_
M5-EGD3J=9HZ<"H";*M=DZO;T1N+[UR^0NT+>F2^:[ S'2,W#3#,_">CC$@$^
M ^@.%36RYA_ *S6N2,J;<*KKM1DM30^(<913N2L _A1VBH,8$EIW>&;57% =
M&^G])0_3;R]1F^LZ-*>%.^-F@&.FRYF >:S3^_(I2R5ZZ'*BX1?.,T3=]@1^
MRP!#.X\6PN1'X/! S(@($LGDDOWS8QP033IO+4-DK3*RP%9=KVFOKHI3NB>1
MX[O)4%SQ<V!SL!?@_591WDGZ??[S%/NVDT?T!YHOJ^N;B;0QWIYPC30X.[ I
M9C-8<L/'>YA$?P'TS!NQ):@G6U%MELSLO]DBR&*>KJO]WKW3"TWV-NKIT#>=
MGB^\U^'\T?,_]4L<:X3#%VKBOI>T\6Z^&[6T6'E2RSP#7%(PE"J>'""0Z(6_
M?M!>FYK?&.'']):>/,JM\@]@ZPQT;T:'P#ZY537&0SOI[$X<4Z=$5!F<W-%F
MUUSHJE_1 HPZR0WTD?N^)):= CS$V7UX$T,JZR%?ECTQ]9S7LG:J]L*-VM+4
M">[&:*IW>^,YUW(PUEJ_9QI2:3;";Y97^[&[N<B82T<M6/$YM+/*>8" &,(D
M[9&3L8EY+/(12_";DG^?:UF TUB.?OGW?!+3HU$0-Q@XH7)4%**MIS)8*=)Z
MVH>M/0Z=:-DKII[Y[+^Z>O @AT))'@KP6@37=;56.78S\0 =1?[:N(ZX#4>>
M7&D"$%?;U_W(>HRA^>ZO4]HR?Q.<VW#$Z?]$.**K<1252E?B)+KR*8X'].:4
MN>15#>U6;%P@/X-&S0?4WDBB!0Z\><9V>NZ3WQ2K\[E$KM/<Z-VSAAP,0#=\
M=5[35GH%ZCGA:/SX.N/+1XG/]X'':FS:)_%#V5WVK'7)-W)%TKV(88P%YN,C
M!3'+/2V1W@=I[WV0OB"\\FT95^E5Y Z+4FM UD;GJ+]R@U0!3WX>T>/JMTQO
M<A;S1,VER@F]EC-.4F)[[%N_XLOH:_!H^2"%9&EKEE66G(K'CHRYN3*])'#=
M<N@J599$8@R45NEJZW3>C 24J7),Z^(CD+MLTU_89PPV+G?;J6#$,7I^JEG'
M=#]T/3+,8O0EDMX22&'MI_J^.CF-5#9*?,88Q-SE[= #)>0_4E.T$;J4)D43
MD?G,4Y%6?)_S!0=F5JIWRE&H;O=G'=']T&]RM=]4M%>ZK:?#JS@XU-AY[@J?
MO(RQ 8]SR>W!QJ>BW\;\5)D3$$8T- T<?0FJ6TD-;*Y4NE52_U7QM_=AC]2$
M:$3D2H)JF=Q]K9LKZ.?.!#479R_3OEA>G_>#!7BDB<3."_&9\TFF3*MU;B56
MF8E[6MU$:$FNL,=1JXUNX TBF_N01VJ X?8XY6F5OT08X.;;S8/&??!)R1@;
M1GT-&/F=1WR*S?'NM4P" +(C8Q'PO75'W/PMB<^*BA9W>>4R_@":'O%!7EB4
M_P$L#@%DJTT:AE_68G6K4<>7);2=O3@<+%V\R'[YLD#T K:7L]J4WKV=2FC;
MV;XU/-;$JKC Q(8)K.M>/0[G=[]$LV5MU7O.41P0EV _K[O"IXEX&8L+KRE
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M"<]^09S3DQN\X>>4V!!\..[<YSRB#^/D),S@ME^8U6I^,ZRK2"'D#$4<8(S
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M#\+$E..;(LZP0R9[%.&(EFTJ>S^T'C5*'%"Z]YS7NJY=VK_4>,YBYH8)$B8
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M4P' J _7R52G);'4;7\V_&>;A'3HFEE'PXJ%^$P"VFO1'["O .&<C)%1(LO
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M@&2=;9:PDV*YL&UI;O-G!0YT#7-;TIX>B"JQ1U%+(MKF\"0_FX.\KP!QP=
M%)Y%CV3]>P&T(-,J+.X+#GQVFH-]/N7IM^+M!"/099Q>?!;W9N+<_1K^BB,G
M'O6?[0CH4EPO/KN8"9[V 8;2P'T,?E\RG*;(64T3@V_!<,O,8)@TJGU4$#WN
MY[R_,:8T>A^#F.8%N3XD6+XVWM>+"D[2']C=A:B] M!@\(<N8:<L+&J=\A(Z
M8M3G-[_^9D!N%KB\:!&*0K7KQ/H=-4,P:H:GUS-$H698_L'>\3?.E)9QXH[;
M401*'URFY'!ALURC(:JKV+5=5@^$NPZ@<*.D*2XS0&[55RY7%]*KK?/ Z?1
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MA$H/Q5E.#PG+'A]6?]/;CWV!I G?7Q:E &XU_YSL)!)GPL);X9OCC:T8Y2L
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MHE3[XU6B*AH27<;6)"6.S814#3;SAT(ERR^8E5);3*L\!LQ1T0'QG[TG_+/
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MHE<1H!'V^ .LABS;U5I3+T^*#$6%(]?O ^4@.[@0Y03DW7=V;USM6%#"]L/
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M/0 [)7+\(63#&-%5 O<3E&D.BW-E-"W5QIB63L*/[8BMR![N??]9Y[2X@P!
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M0\,A.E&("Y?*@D-'*.&K3FD<G5%@I"Y-NS^JDZDG]\S F!KCX(L<H!49$ F
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MQE5DHA*+TEAKXK]JI[1Y^%;+Q:PB*2)2._BH@K]Y$?^ ^8:_6ZY$YM9B;S$
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MQ[+)5%].Z^26%<R<D,,@OGN>'1<,@,)1N:D"D3HK= @K"2:H(#878Y43'!$
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M1G95+_J<]:@'$57VM^G2/&H\AB4;2.@/H4 5BJ* N[4$.;2H;H *#VA&HI/
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M.WS4EGC+UMFX,D*L'T6\J UP=8P-S)TOW7,:0KN EB9O>]JM5X+C@C16CA=
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MHD9G7K88_R,"!/?/#XQNGW(L'X0J I-3EI.-*:7F55'>U0_7'E!!8*Y?\RY
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M$.@JU_FI)HY#ED3+90G9&E"H:<<6';K:ZNC ?"O%*,J_'U8$F]"7,AUQE\(
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MT4OJ7[OV:4-E>U]-JF!.0\V\7#I@K)VI>)B'/;?CN81M1B8O(!N8;E6KQ_@
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M_7'C34"\)_+T\ )8^(;9\8KAZ;NO#Y^G73A;9:F':NKJ_N=<=OW?!_J73D@
M<' @UUZJYP=6JY-:6(#R3%B$,>9W!_H3_>*6_9.C02UP8]%>M%4_TWB=;)'"
MZT!\^7=N$D^F#TKS.D\REG4&FG-@ZL#WN9^6V4GA=@-N RG]61=^$FN6N-\
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MPR0B(<PKSLG'S_O'" HV-C;N0UPR/#PRWJ=43WG_T]?]5X#P 3H?5@ :"AV
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M^[S78M[N7:%MO[GTB.RB.NVQ[$:4XCC3>F *J=C CI84U/29@E?\:#OJ]L@
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MWX"JWQ^9Z\WC^F\B*T'(=N?\T^Y?;P;^='F6S_^DU*"2=>P\&E\_%./L/)I
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MWB<("IPG%ZZ$=;O><;5..Q8&"?"O,XG=USJ%34"'"0_,YD_&^DF&2JMC)R.
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M#!=T?&)67PV&E9V2 "<),_U?89K=+MIE6G@'3'2482RJ^4YP]?R*<71FAVF
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M*W(KYY">T0V?>?QRB:BS@*26&BN2[;97GPVH4^LH-ZT(NRWHDYMX]*T3DE=
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MN)_%",53^V=\S_H<J#U04VW^RZ8IP^);6/]9;5FMT&1FCP @5$FFO'LYV>O
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M-?-]+2):81ZRT."7ALD80;P6"1\"HQNZ7WWID#*FH%UBV*K]+2Q^S"#-@(S
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MW__!VEL&M?VUW<(!"K04J4"18@6*%B@2'(H4UT!Q+5 L>-! \2(AN+0$=TV
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M?R:A_K:_ <P!_Z!\$ ;IMY !-@GMS4HT]?9?+!F"H=[=5_B3MB$('83X#8?
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M2_OD:&,5R0UD;0EBIAU$NNR+4U<RGM3CO38+S$\I,^T]*]BJ=7[*MUBF7@>
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M>62>\%R+5H(6/M+A@5^WR9$$,2"L\RNE!=W#BG0AXU?*V_H,Q.APQ67(GVC
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M#&'V3LMCIE3M@2ZS ?(??PMK<6GH)D_'5GYFT;1FZ&#FI"@J2.SGPYTH+&A
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MJVP1C>Z6_KM75ELZ> ;D&QQ>NA! "G&AXV$0\'+>"!&6519.XY@CKPC,-&Y
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M"5^NL:+:;X+H[<Q4,UGQM +'D[(G5T>>M)O'<4KE(@?-@/;O3&?>RZ$A+P#
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M\^'/!S-_3?VG9L5#@CPG'<9Y[1+R*%>.#GX-L*<.(>91,!_GLSX# WSZ0%+
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M_*BA(DS=0X[3K_F>I6_Z3M[<Z!XWEQG>4CV(XR="%->-CZ"R&TI^.,LOAS<
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MW4+T-(VDY[P*;=_@$A/@5QVN2A?I7$\?R)R##8*Y)1AQE:GK)Z-1&<PZ_/"
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MV*R.9CK7[>83G0-&\^(DC:Z-I(N^?N\JNJI#6;V\<8\J/%:S;5JOF958F,6
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M8PK7T/D0@VG5^1JJSLJ@OZJV6K%Y\-IF+("O@"P#RLK;'!YP#G!%ZGR)#?+
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MCM:.-O-_L?L8]]=/Q=&W%,YX<(ABX9ZYA/MH#I9 ^RX]!WE(L!5</Q3/?EA
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M#]OAHUOPNBM0N>GTL>FQD\WS]3G;0I]H%4>!I!L^W/FIB>,PO:]:B6F%<P8
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M2H =;+X"DB6_XC/%1\FGFW!'P"SD9/@GA<'KY,AQ.0."[5@-.BE0*<\6N#1
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M-!YTGUS#\Z^F:^?4E$94C*HRU0L&;-L6>:U^_NQYE;&.P_],%M*A*#$D&=:
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MS<ETEV,K+X6L6D M1;8N&(W(2$ 1!H<^&SEJ10C%7)Q+-9^*G[$W+J04K'
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M*90)-1*<1=Y2X)_<'TM#<L4,/'^15R3[[J+Q57!0O[Z*10'Y>U5T%]@THW9
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M5H!R&U!;[Q@$NIZ]1DC;;EE^R6V1MUG^/UJ\^O_3#T,B65I>44B]DOTU>W%
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M19>\15(%K1\O_$QIC!%)GPCO"C9N&@[C9I+C,EMI<)$GYY1$3;#LY.H /.Z
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MH,YJ:6NINJXVT==\ SRDV_IY:2<M0LY)I:4(5\*>7AP+L<VZZQ"PU!=PLXK
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MPULX&?E-/+_HJ<J+>HS T[TBNP/*TD(ILU'S%[8*',R(W'LT4&M1PAM8L%A
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M">9)+':B6(4I>'IX2^=8F;*A$#7#3S"&V=,K=5U52@2Q(FCPM-OH:A&]WV'
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M-?@:C9Y,Q5HY>Y\H@, K#@M3<ZI"3194TS)5!NGSQ8E^6:RV&0'YHV2!8F$
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MF]IX8Q3\-!JEQ0B.+#J7*9Q1)\3$_V+:M:,O6K*L8E2@T[KOCPR8\!=:.BK
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M'1=X\H.3]ZJW&E<5?=.2H#++I6W.-T6_8 L5V%+)BU"]@.J_5;WFG_P_04B
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MH"6:'OM$X[@0J<%S19;I*.G!/]T6P?AC"]]S74^F:O8PQ/>)'W*.;9-+9V_
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M"T( 0Q/HC$U=)J5 I]/LC/1.CSSVZ51:@AS[H@JTO=M#QK+[W\LM7]D4Y89
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M! K 1>\TO2\&N7/9)Q&4#:%_NG7%MWS)0TRY'([[R:;(VV/80%XS66JP;J4
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MG'[*)TV7^!M:T,P=^YE?I__.SL0C8:^G!Q?453PB3;IG:\>CJ;4-90O\',"
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MSL6MG8 3*V<SRWQHA?_? =JY10:&>E;:0F0.Q5.$]UVBHM'-JIE_EKYDV'A
M.FY?[>YCEC/DF*]#?5F%WE]+A+'8,\223S,5ALAL,G0LQNV/XKU\>FD6MA+
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MZ1T-M#&!/X0\F]\37=>XS3!MYV,.$MPNGF>M+VP>F5&EUTNC@NBTNJD(':(
M"<F5"=8_X*=*>*"!@QA)3(^' H;]5%# M_<H@$H3[A<R'UC:F$]FYH_9=^@G
M"D#_7&#I=NH%!9RX1S,E!C=ZEXU1K#>P=\$-F[2-J)I#O"C!V2[M^AW3%J=8
M_N+M\@?[8>GRE5Y^[ZQ(N(@2(S'%L$2=O+3+MN"]9*E@FEIZRS@SM#SD>;=Q
M5XM7\VB36)Z^3]8.;+*2Y)Z__BX+^DF9W\@3V2<5=[\/=]PWC"OO58_&LKQU
M\IO+\2IE1X _,N2M!,\Y)JB64<-_2MZ3%!FVK\;],*6"'"&$SLI]CKM>/\L
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M-HMY\!#M<G#7; ,K<M-7H7A!)LG;' -($<B9UD%/Q1C_1_S&N4SW#Z[=S^X
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M-49^[K.\!I39[1]X^9*N+9(?XUZJ$K3!]F];XA,D[=F#Z>8?=\=]PT[O/LS
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MO1J,<7%G2#4@C3IJ?O124]M7-VDS<%$/.!X2Y3G?3#\;SAZ,0'JR7!]S#*
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M\F=!\;MA$@K"&(/;3YSDXAO3MD@ EPS3 =F MUB&GJAX3&8W,,>[38W-020
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MX#8UX1UGO#95 $X2'@\:W./._ VC>4=XNLKQO2_D'J [H?<0['G>-G#?R\%
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M^_+?7M4#P=GU#P?<!K0(',@I. )NS)M=XYUE/OIZ_P9T%.'/PW7)C00TLEX
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M#N/V4/H2T'L<0?NFI/?R*-V6O"W+%%>,Z\MJ@ML@0#TKE#PB"&X-2DFZB"R
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MRM[*(D2!,8J]#5JE!;=$?Y)E^+_>+^@EYCGQ4FCG[;OONH-3OQ6GU9,,"H4
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MB$JRG93X+IRICOF4SY+!L\63ET^KL$_'ML'TZ(U=G1J19,I&1MK&Z@9%+Y!
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M-*%6(?'Q>F]MZ'T6BWT2ENVWP81ZFO$B9R6<$PP"_7-BYKE-K:G!E@:.6H\
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ME25P9-5C)$7-*7!9G%\ZT[(X*'E5GV'PYJ .?U2CM9'M+=K2F'O_D.(^&AO
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MRJ.6&3?Q63&2'QU7=W?O["D$M0PHOK]XOB]#+MS=A9,<?3*?]3PKWK))X+2
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M+$H*?9V%9);6_DV^R?D18< Y8&]]TR(A,JX M/N<_UCO['[3J-S-UHWFVBT
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MJ_R2A(S[Q7*@J&^;$<V7-A_C2?L#]E*3N5H@K*>^D_ P>,M I@-%L+UW*NJ
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M0^Y^F7"*FMX&(9M42)TO@G.X+FKZ%_9Z5ZYU>+7(Q::-?TM2I?^UAI*$INH
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M.;.4//O+;4:==?A:)"HPAL@_T0ZUM'5:+!S!MSW-$RM["_!\UOM=$+OP9QV
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MOFG\[6RDAW:?($=0A1865U?+^G</S^5G!F,E/(>OAG=T!YBT%'?)K/9?<T4
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M-_E%*>KZW;Y;L7"&13O5.GMDH6@F;W/)DC5N81NE=JH5C=I/6F+*YBJVAD=
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M^5I7?=@Q8;)] $CM9B(SQC>9P&:8<X,^>P7)(LX1M-Z\-&X(2W(O&%42@NP
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M!TJ-1I91G&37V'Q>VODW#)JG/E/9IJ>H(8GO&D*>X1D+-KN1FP) @$/+O @
M\U_]5%W_D6J,HZ*?<,'DE-(? 0;TCX"):,-H0^=_/B*.[&UU:@.3S^J$'YN%
M)SO=>_;_P#< CG^8(!#^1=Q%>';H(W4O[/<] $Z4C**AP0#@X6_%IYBW/AP"
MKZUEWYU%/@*DAPT(G3N?BVTV>7R$M<&3Z\3762G%WTFSBUG@]\24OS=/_ODP
M!R.[%@SUN$F%=>+?\GBY>L3^VGL$4(J^A!.87IBBX9+:?W\G9#>O6>B87"9O
M'T_O *B4:_Z)#'>YW/ 3IA#><&;G&R8$2+>7C;-([S-E\H2%:IUX/?K7TN*B
M&1J78S=N%(S+UL"B]!(9CY:,,A9/N_)2S3>KIGL&R !O@].W,'F+/Y1@!NZ]
M4+]O([.UDX?PI_2\QQN%-FC.>JKZMA1[D&=Z,4E#S%)O%-D^H;FY96'1T('D
MF?73)W/Z<O"P+8_E-2**SW4/<@*^-.K[(-.+6#F]XM]4'SA^S_'NND+ )[\U
MI9R7-,R@(0;GT^3)N.QK%$M+'>)G0XM7W E<GE'Z3AZ5J8KC8$^IDJ+R.[^>
M1*]J=WIQ"0:"J_BB;X0#ET7T"'N)\U\4['<J>'0+^0W5[-/V []7RY?\?+8S
M-<5Q!LV!_XIK?;/Y]4R&7#W(UZSY[+OJH;:FEX?AC/O\F-2NTH_/21_F!HJD
ME%DCJUT_"F]>%8,M7G^XVE.=4<9EY<HDML[V&^W3O?K4:E[\ !*@!B%EH8N>
MO>I&G:+LSP1;J>_/<E#D:&J0I14X/.$HX<E6R-!.9SS:R#=)%EGDMK^;:_:R
M0BY!2XT?HZ;CC*+(W_6:%I1GWO#222: 3"_J&O08DTD[7Y<P,47I_O(E> 0,
M*HW['6S91%=.KLE1G=2Z4&O##&6X$:X,"%157OT>N=GORSBX]K/CQ>Y,!T>+
MY874UP3%9I^B=ZL^H]9BP7[/VM@*]O L4TE'OW$8L.9[;)J8,FSM6 UL&-;[
MY5K>E4?2YQ>^7Q;$9-'7*PC"$7]/VI>J?(*=7M)CPQ8;RF8_B,(((L9[X_6,
M$P38ET!Z(DBJ*Q&%Z7*H\#>Y,Z5Z/OP-_O (A76%0U>KM*J8)AX!F]O";Q\!
M'R1A#MIE<-"*>R_O]UT(?J3RJQ_S-? D=EX=)C%/]>":>*N".GKQQUK[)X.>
M\W^JKP-\C.%K !7Y-%:U'0(C75G:NTZ<UR^(1P:A8_ /1ZW&V/2PVG;0[_,^
M,Y18;Y<9RN)\83=-CXID]A%T515C="9?SW&WAP,+88DY 4,C=)4?@/#HFA-A
MB2UTS[*>^H#E#J<0/*#\Q+<WZ9QO.<*/R?L7)MW 3//+^>.S11-2_N?VOZHB
MC"YX5AX!JS/68E\[F/S&9_W@>5ZG#&*9U^7@BSXM;&I\JBT+X>E\ML_'1(-Y
MRG.1(#WD/(7_&=*17I5>(;;9N9M].2)V97TG'?<_WV--2$ TKIO_LHVSM[QO
MJ#]7PG10V)TG[1& KA36TM:B 8KB-)(6?S7DAA^?G2KF=3+".ZG<IDRP8LWF
M4&$NTN;81^SDT)61X4(A!;#5LBN;$2NTTK(K%9O.@/T-0T_<3'Q10B5PZ[<B
M \^DTK&S!!V2!23&6-$Q6*!",H2NBOA>%P]N)+ZS<9RHG+J;6+P?!PN,5:"$
M-KD"9+^+N4ST,Q(TC8E"(0AIWXMVK,@![>@,[;)6.*H1S\9Y$;I<Q=[*2!>P
M#,CS#\@3(^R)]S-57,OMG!!L&<7QKB)0W$7P3@EB,T3ARRENIXH6^5>WBUAQ
M#1XJC +5GZZ=]%"F%1%11+PC=P&[':K*.<0_ PN(!@:%) )?2!QK;CD3?'>\
MCID<$14*,HTZ\R08[$Z0Q)!!99@'2?7IZJ9P*:)B)>0V[4H)12$>R*U$Z!9)
MF, 1]^\6"/W+L$> 4FQ,2 OI00^4=?UW-P14NQ3*.TUIR]6;.J\P@CL_R!5
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MZ>2.%_RR:X=:#T+.E_$OSJ=0XT\$A&EM@5Z_17JAL(C?/;'?RU@''G8@'MT
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MO,<GNK[E(4,RIJ;:7)RA;+@?5Y5XJ!O%, FEG0<!*\Z[J%U+Z&J5P(YQBC3
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M1&0KNP^#+(8N:35:)]*[FVJ;#X'A;@^7)GF^G#XJ8$L:;E\K1+N']:TRBI+
M>%2S^L2?7Q/[[(K"-ZO3<SB*3UP( !L-,Z:<=(]L]7]N%6%PA[?TP/(#(7J3
MX2/).8MT<#-<!RA66[UCLS90)N])U9_&F; ?,O+#Z27,N-;) :, &Z/M*9$<
M9TD$@"9$48+Z::FB>X[7D&YSXV1=254]!<'9E6^I0ITR:1GL&-W(LVO(AJV#
M0M<[YRW=(.V7 8SRJHZQDTH%K>0KY8:F."]<5LGW"-M=EP*N"I>\/*;NLB@
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MVMXG^9WTRA3L(SL83%2E ?3B?SLTW*;0GK?/SGDU.?F_S2+]'PIHOV_293<
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ME%4$##L;HB9N0G5-N694;F(YSMM)U5MOX^*DM8\*PZX5,4WV&VW51#K['&\
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MJC[7N&"#P7^&BHL):N415S;+, 9$K_94CK$X]DY$[E!CWB>#S!LR)8&7UEP
M=QN6U9TV5/_K/>?Y[V5KFSA.+$GE61J1(G<U_L0D_:_ZG_XSE*YL3.M:)_=\
MCU?]@Y!]J<?_?(S__:J;T58T_NS\?Y7Z?[]ZI,^H/ZWXGZ$V"%0JM;T"^E*G
M_;FO^3K[IQ/^O #Y7/X6C_W3Z:\]_RZI?S[]M6O#A46;@9[K__/I;Z;]EO-
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M[8"A[*L,KN%?-L%01O15GGV:]T F4N,CA>J#,E*_"K$NJ;Y=8BG5')GM^OW
MKNZFNNB%N3_J6/J=3?XIJ#CL>GQP;J/,7]A\L;E$L.* U7'-K=LKH&@E-97?
M+BPQ"#\/\!<OI\_A:AL+FWWE,"S+>%KM  ,Y3@<&2K8[6LG@ K(.)5XWP)0J
MU;8F?'=FI)\GLZ=)OS?C@:^:"WVNV_?)0#RO+^O7YY#GKH0(\@ <BFY^>?ND
M6F69;NW_G]CU7Q 5W@1S>%S*=IUUD/1*=X9DP^AS7K"&B[ET)DW-/5?I\,N2
MB:,]POSB-3BV>>>E8$3<H@F"3#= U(+K"D4I>WB_9SO<D2?>7*SK)6!7FT>U
MME%C[26E+EF6S<HI_0V_J!^=J3,R@,W44=LDA):\ 8P;*=2( >T\VA>=$*_$
M3R!40Q13VZC].#Y%,!S80K([Y)+-&Y)3.#CD//Y$;(-5W8%,K[#IP?7:Z":_
MS?=%3Y$NJC.:%'B B<R\9MH59,H.Q@]/BZYR>$IN"5O)*N8M6+$-'="[Z=N=
MZ)M8[3QGPV\&_&-S88HZ;\4ED!PTY;*GSH7$2!DU/[1E*"9]&KIH)LG3KJ;$
M5=1LQSK#!LWH=?#E4')TO;EX9SU*WN.73@D6$*\EVI4 EJVXH<)*]K<AOK1+
MBSU+ 8=A&RU<V%ODY'[RM/46@R"1GU.59]]XHU$M"OMAR'ME.21*?0/&DXM,
MR9JY'3/#1D$B=O],U?^"\&)W/6(S^QQ)OU+C/,[(_N%I BUPYMQ#JUPNFSUT
M*Y7FET-<JN;4R_I Z0".ENYXE<\):SO?,O-<&>^/.MZ>@9LA5L:"9,WBC5K?
MG+SD"[J"F8E,OKY[-:?Q0P'VX]V3:!F[XD)LD:U (O?MQVM6#^XY(P'OFHQW
MR/>)?9DT1R([@>3N<WTS?E<K6PYCTPKCR@0UVE]+NU\X.PK3/\6$.]+5$OOG
M@T.11/O.[RPYEY,(AU6RRK71P\A5>V&>%CJ\EB?U9NE6>K&/JDA[@K@Y*@(W
MSEH<DT>0OB\ZM&_)3"QS)*"W'()DP7;N'HGQ'V2XI<D+&:1T>5N=:(-D:T@J
M"[ZZJ<:^%(E:?C_J65"2-$)9-P0'@N:>:\Z4V72?HS9%>^]'\Y9X*RB;3(?Y
MV4S,H.;H5G[:80])&Z,<4IOE!_5:"'_!HJ-0O'./$NZS)W/6%U7[DVD^+/G,
MGY+91<L]EDB?!08=6@4=Y3:-Y=SG'%1QLVB3H*$\\.P<\DY"4?L-DAP.^5,^
M7]ZQ<=Q@UL&%_W/'ZZ!:,H%*F!9#29U4!D>,J ,+%R_K_3.L=P^+VG%LC8/F
M3L>>HQ7:+"H:\WP#/GHX\=O8S.O@A?XA'4UV\E=-0+;$PK(=]G: V=QG(OI:
MSW8ZZM(0+9W$8\1-<$X++*#%NNS<NUW <-7#\MMHE<C7]\%?C>;5VJ]IUT,G
M%QL#U\Y*YZ)\K3ICL'+5&=?Y9S;6P:"5SS_/?[U/K[I^GC:KU0Q^'YIVL.6P
MW><GD=\3Y)\HQ^/KY:OA?.8>\QM!#M[',85KWTI3E:V9.YU%J3JV&#'O')4-
M,]R=6M0<52B)D3=_T45] [SJ_*:#/\S(,K%'AMBJ4IN>RAD]VAZ0*NP<X! C
MR\^=2) M&X@\,'3>N7Q'$;*2 IQ_;&L86]AT<8KG@^Y9#(L!#AM6X3ZC:D\C
M^GOIG[<$53<\?ID00@X&F9G6/W(0M?[>5IYVS>8P)MVE*/7ZE\/D-0ML4?D3
MUV-!Z%%Y^@+'Y/J'JKOM$-#'EZ6+?&UGOU]?'_E^["35\DVPV.W=<NADKQ"=
MII8IF;V^<^NK.(+<HX:]0UA_XF[K5NC? 9- E<%!6'<*R<=FP_XUEVR]FD/A
M)U1DM45N?SVG4/.]=[J\3"$6^9U+G;L7*\&=-F--GF;H]/42GP+?\J%M"\.1
M3H=M+]E1Z=+.<I&.[;M8PVAC!E+ 5ZRS6<L^DF>WMT#?<H'F:BP3MI\9UN84
M'J-^ G5Q(J\!#"=JJ$L1 L-XO'W2S]!TO]90P;^UZ8U&NOPUE\9M9SC(I&C/
MIKC7)T0,;TL\L6H&['Z8.TC6C#^B':J)L='M%"W/^XKD3!/T33EG:V=DJ/3G
MH(I;,(F=@/>CK\/MZ1VM:W6#O^O@407[!?S69JC>519?G:[[OMCK>;M2W#%Z
M$MTEW)Q1IR!D+N)/M3][MOL2_Q.'UZX=]C>!LNR:R*9(L$_*DK0:FHQ4_$$G
M3\6QR*A73X_O%7].\-<*!B6OZA\D1X^^V-NF]^%+IP"=:.VN]\U*EO?XP">4
M3"'.&QG+Q,/S&>O%7O&=3#,>@W2XH8I+R<D+O6\N#4!'1D%JXVSL&_!)D9CE
M-N7X6[*)%5"2F6'[P__>M$4:6!>0B&J]3>$BU(OTU;_J.3=^YZ>Z</&C)TB:
M:C!#:N.W&KXG[&=IC=6M7NI;(\Q6/=G[5TUWMB(YF+JMY+VLVAL,%T+J(QEE
MN+ [IPW1BH$#79E(H\9)/[4URB240FN4/T2:..^^:N_:8TS2"JFN<]]DIX@,
MWH0R<2UHOF;_T6*MY3M=Z2=*6GF_HXZ<<F9NSN)SA VI9?#^G$=?(?9WD=2#
M%_DA=$S\?M,KFK#?!R9V2?K5F:8G/ZB=KP<L6A?*/UVJVM+6SYU401G#]Z<[
MCZM&6JX,VX_*%= OPB&\_D2/F<,$E[W8*%&+]#? VS ]W*2]CH9'"U(]'SV0
MX*RO%$. ]R_)P7.GLFV24 ,Y&RM5+R8C?T4%G;TDUB:PG_CTO?H#6K:T5;1E
M7I;ICU,W%;PGQG:8BM9@OW*+T_WTV4GQ\2+#_E'A[_R0!S]"O<,C CA^L%$C
MGTD%]YH.53:B+3_CH.]*(,BJ4$QAAU.U"S:TW+VPWSM$]H<+'I!%**G9[.QI
MQN+]0^2<RV*]/TM>O$7DR#0$=$05]IJC83SH^4B_)1M:]/;KQV;STY^]=('Q
MGN%&WE[9>\C>X]S6A2% []2CS&F_H-EWS,NG9UOMOK1\<G2N<<BEE.O'S"A_
M*NSXK-N2J"!9_]/WN:;?^_R2.PYF"T_I-+XT3K ^_B#(F3)^&O<;@FR<*O:3
M([\J().QP_[I2TY@3S'#EE?YIG:LZ:1WJLCAV8.'@@A&WFD^S\ 7^8&-EOIH
M)L^9?$QH/=L59WSYL/@$=A*#XT4K-4"PEL'?%NU53C\:PJ"]?GWEK[^D(_=Y
M96X3RJB"EFL_GGKUYN4M/?RGEH\1U5.2#8 J\W3KI;[KY[1SXS??R84M=:\G
M 7_R92/)C#2CP-35/4M>]!V%. ;KQS9Z8";U$V<LL] ONELU5AAE[MB./:\C
M$,/D8^F190;TEX\.HA+E3]$"GROL[C,[>4P/-CB5B+XO%->OQBO;UD$[STG+
MCE:M)AXAR-@L)JR,)K[8UHY8#NQO=%8@JX63KYTDNKT+@@^5)LL'&C;6A_PY
MEX?X^4IUL5:P@L18+"JX#L'G^%C_^K[C?R?<R!/ML71-#!D30 <J/0G/)_H9
M:P8OA;]N/SHJ*U@1W=MABS%=;6&X2_L54VC)EHU&OYS>-*UYM_R[9\9MTTRS
MXT]XN3<=GZ^A^"14Y'=/K:=;D4.5@GGE[J9E$?I1M_#F@33!*7YTS2HM60ZV
M X=#3KOC-_RR4[&.?=E@ECB^"BOU@_M4=LX%EOVL J,-S3F=UX*C+]UO@/N#
MNKW(5ZVW:I <UY/7@VWU".(;@+@F"8X;E7E4[E,5/U1K-*)K1>-E8UI?-9D5
M14=DVE*WW[U4-[ID'6!=#:K3PG,8D;T'R[0=^Y[S!-68KJQ/FA!-SFP\W'KK
M4I&_4XU8[BLY$G#A7G>@;;@[@#6Y=>=40 *B.L-Z!C\WSO32NP&T0Y8971^0
M^D9E1A[>*>#39-UOJ08=7!W%VYW_\J;N-/X6@(/&6C!5)+L.(JM!R5&\IN--
MU^BWD]^HT=[?Z])O+^2IND2<?\.?-$^[96_%;&046NC_9<9* E7SFPX.J/:S
M9JH"_S@(^%?$F&%%0:G$G[>B3*JG%;WU0QTX"^RFD9SI1?JT=N"Z2*Y.QY_F
MR,VI,-9L,Q&(G6TW!,FLNE/2_\9Y]^ZP"'^!\NMIE=$%;M6M[Z@@Z5J4<NT7
MM:?DVXOU3.&FZEL-\7>!M9),])<J_L7\4\<0&#GQ:?3*PU0_1R7 GQAY^I+M
MFZT2MI3#1N/%X\,HM611O/-? BWW%LUGDV<5^X[*\(TFUEH^5#&>(<@1+?3;
MU\\B=:M6,WV.DON\)IN5_%+W;P#S%!DC C&7E/.R#LU9/Z? !BZLS @!W+)/
M;&\BB<YB>B7;6YN$=D>&X,<W ).# ]E'R-/Z]CTK_A_S0VZ%?3.<I"G B56X
M)1W578K![]V::-[.HGN(WT%]E!L!C.BU]5C'S_C,1/%6Z*.A2Q,!;<9J4'"6
MMD BBF R%1#QEUO6M'?>L=&985'R"Q/!>PG5Z&WV#>^4NY5#B3$\$O =HC0=
M=I&6#RZ! /J/.R+CM4HMW'8L'_EG2G0#DH&WS.3%DOY4_7(H!MBPV8MY _2V
MI3&*2UIK-I5:T49D&*;KE2T^DME(C<"2BC#N*;E/)V;\S<<JXE?2,#.-/)'4
M=+_-!73+AN; S0*96 #/C?)#?._%[&%K6FJ=7RT;ALL>%1:PB2RU@+^@>6 N
M5X6B@P>6VPZ-O_H;]VQ2@!1XS/J"^LP.%%SCVC$$SW"Q$KG4\[;4H]](.=?7
M-W)09MA>OP'@%=*NMU5\@ U9QLT IUIB\:_K+95CCLNUU3$#.K*Z5FQ>Y(8.
M+V'\&T2D_E99L ^+L\IL3[1F@;G\I&ZQ] D4:!M*1*;D/=W%W$/5F^?#U4:Y
MT7I+;D(.4XAXP^=V&.]]]QXPUBWS4E!#)JE.9V_DN4W9QE#:!OHT[ZE4/%K@
M;FK/C N2]1U]7C=V5/,N.9+VG*F3]L>G@MN[9'>FFN[T&#W8/+^L5!8$%55;
M4<W/M8WNL46^1I#N,3BX+OX8<(SYH"64XOS&CQ=R7/EU((-PTWSH37_)]IF3
M)^W)#4"R:64]NGK/)4'N:Y"L"QH2:#NY^O989"N3X*,KMJ75ROP-T*$I*M=L
MF;GOZ_D1RKAS)P*!&Z57/_UR9YCFXT&QZ<\F21MB\[U>&%K&E8G2>R?H^P@8
MM*N),C.TF)L^*-H1F?/-^?WY<GN#[05J/4;<SUAEV=?Y=F[)>EB/-Z:L5R&K
MIP1_B=5PW2(U''W;T2U] [1&.R@'2<A1M\7:DW^V@9^]Z>JZ >S)3TJVM&FQ
MW#^>&P\$<.B)L%P? 3X?.YV;R9<M5S@OO3-/'#I;Z/Q_!A*=<-)4]UY 0,N9
MM_/<< 8R>/O]I C\U0B9>BT[T0*3W:7E,:;H/?)'57K0P%8HD_&IK(C%77KR
MY=(]&D6ZV8$Z#Y&<I1/2[,Z1_2G\F/MO;ZD2_K+#7K]ZZI?NH2#I5&Y_:N&^
M@[4T_=XBK'G:G,QU<K>5Y+ W9$%+2@>_I"?$!!H (QZP6ZF*AZW :XEV(HG@
M-\"U].JY#OY0*P6[L^2S$9I2.:PB,>[K(\?+AS= S+N6FJ@EBQ_V&H$^0;+9
M^Z<]'YG&:AQX.\^N!V)D$TO^VP\Z,#O&'^IH\G</EK[*UNR2/,CUF<[T*F_O
M-%Q<Q(3EUK )V>*9ZR-_N:4/5(]T9'@'#P/#K)XWWW\SU>PK/QY8M7-73AY*
M)_(.%7.&/72(;,@I,?7_TH\Z H-^<[[7/O?+W#/VWE]4853MI3=:;-UOL] :
M Z6E3:LLR^%$"=V)3@"-.7CP>^<#5'+\?I,K%K2_IXWL<53L9!./QA2R@;<O
M(HU94/=QYK:*?^FZ^A=B=P?0G<;1$0?5V@J0^QP_77E)NG.6(KTRVX2Z6&93
MX85H*&O;&/1V7+1D_#EB]Y$.X/R<H6'V0$RF6/M6C[.?#"_/;^,:MY:[I][\
M:5FYL3$R0SXFHQ\OI.<8Y<$@]%3%"_ZRPE]+P2W-)<M[$>XE%J*0C(>DT4<E
M*.W06*LJR>#X$<JO<WX\&;R?W[.%CMA J62YO**'':!\,R8K-5[7X<+:R)Y!
M.7ASR\$RMY?R&4W=+BPZ<__32^>D)Y*TP*X?AR$$?;WFM=?5F"295HQ/([)G
MJAQZ;.;"](7W/5J[LZ+8O"EY&\JHO8_VM+0]GQ[S,6=T^G!GPCC#RWBY;?S%
M0O31MN1K1$TM!<:!@OP>CUG>>FS4M-<Q.[>9DO9L&! Y8H)?WKO;2D."ZVUX
M [2OW4G2DDT 83:ZO7<]D^ Q@L,_3-?\_#T9NA.&Z&QOP?BIE@>GM*\K;@#)
M3>=+TN,HH0]Q:F#00=C'&X!%^Y3!WV*)_ RD<EC.5W'Z>&W1.UG.5^37(AW&
M[NYKX9CR-^W2PII%_+ <;]R\[$O!5?'YQYX :MIY6]H#+UE*@O*NNCTH0V_G
MYJRJ#I/ZUJ7:L^,=(52/*Z]4)RW3L2G7(>6HA1IME^<'_&; +WUEA#Q=8#E-
MX(&;>7I4U_CGVM7UYG#4:M)O%SINV<GUQ3MC&1LF,:OWU!#D5J>Z66=64F7"
MEC-@:Y&V,N,.'Y.*+XJU],:&31M@X'_T=UB'J_'# GVKW<P\P&\:G?5EZR&Y
MZ>HUO>TV[U%9[PIEZ%I/KH9@%<DQY="E]-@>8C(QM_:5\+P._GC*+=:9@(0=
M-SW:UR42XJC4'"HSJ/H2JNX&B)@VUBR0[(K\$S,B+C4F6ZN/6 VKAEPE/=[Y
M>ZWT1;V33<R3_51DN?6H95&!V)-RIY7\4FC56T\3^"D)!WZ;-/&69S^1Y]PV
M%/#C17)QF# QGI5_IM*N)L*/9;HZ>)PR'/-2IIX8R_T7%_9*8-50/HS@-[=>
M?O/%<NM[THU$1RMQZFUS\BXFD@7B*4&S"II?/.%!/04Y6[Y#36E,ZL Y<7?*
MULSF[[)?MVM^;T34$!XQ:#W32*OQ$8L4\<>D=69Y3K:QNF9\^9;Z2;%'CJ><
M=0B2!>&.!N1W<K" RF=D_+*FC_BU"?N5PT]GG)^?Y[X7)BVX1:,:5@IF;:X>
M!IX, 7YNWLL6!LICVMB1/O"1,0$SK=;9']QX+95HV?<X#8Z+YL3I!=24OX=;
M$3"*K=_5'B.UGM28K![3^5+)Z7#R7E6WYU9.83GAZ0NW0!M8;).6;,U.DGY3
M!?<3927 XK_RRU[9_9[5]T:]>1Z)X>7VF;.W$H\1Y+&76H,B<= -D:T; -\V
MM@QXJK?-1-P]>0.DUS9[R.+O%QQ#@G9ZN+!;&S[VUPKX$F%BZS6K;6@B;7/#
M;_)JL^0K)6_M]]=,Z:KQ_?T(\LQ?R+6IUTI&.+LBOUH83G4=?(D@VY$QZHW+
MK6&$-J_I!YM)?2FCLLW,LGF"@Z&,#C< D;'Z=O<K1KE37^>L]H89MVY_;O->
MN+1TRN ]$^QNP"]UN9^VT^I=*L8Z<HC3;$+W;N,/KS)J-J;EB((FI">I-VK<
MSU^$Y(;Q-R:[8$*-,9JS6Z^E@)VB@DOSV2EY9TGY?/IV6LHA@_.R\=Q>9#@G
M1\,>R(M"6H;CEPXNL=4;'\?1\ ] 0$)M()Y[][N(]K9R4P 4Q,V@R/V'Q6]0
M&*W< +86JJS:B;"8MS4OQITI%2D.C,<"N/8-3$OU1$?C+6TSB4B,4]OD?"&@
M7[(D+6(IZA(2?649]2-$]IP:XWILWXU5H+@L.ITX>J-0FM_V@FH<O]]GYKE>
M\XZ_[*YZ9N"R:=%M[9!B-8=ZADDS!YI-%$RT?"_H/(U'SSD285]<* WEN'8L
M/:DZD2W,5.;[;I;E!8_]DQ:H9' !:9-NFOE"X<,2[HR$<RX@7TBFZ% '1Y,Z
M4=!A4);%"P*KJ&*U71EKULN) R>J/L.7K0:A,W(05C^->QZ^"RG:AF]?,J')
M4.V)'*[ 2KSE<ODISYS1N^D!';/9I@&=4W&V#]6VD1D3H(7OE\KCN=6D]SK"
M>I$/G".F@&4!JH-R:28B)Z ML7=%3VD_/U#P#N_1$8)<;<S/_#5QWD/'HE),
M*'A0.Z/&,%5Z^J+=:B:5NH+=9VHZPAU4)/_YW#I(]FFEVPU *,YY,7GH_%8[
MM6#GR'0YY_19E?$!>K%9I?-<[MB/!9,D^V59?TIKRHY83BZ76A*'R6?4E5<V
MJ2VO3CHN/L 76:VU(M MJPV^?(P@LUI>3QB'Q:H.M(L<VGY&?HEN"QR1VS3_
M$7I)S!@7\9V&<F9A]NS+2Z9B5)"L'+H=O^O@SM76X8^WE:'RE?EH_(Z]'7Y+
MM<_>(M^]V-HZ%72AC&^<P]\Z45INJ(<L5_:U)EI$25=WRP8)MU8RS]1:7QNR
MTSH*^D]:?2T;A1( NL&/E,"@0:_)+YODA^5)EQH7-9AMG/\+%*G<A7)W]A'E
M2DIY)WFUQ5[[=@I@%=;E%+Y?_EHW&3@NE]PO>',#5,+%\GRD_9@90X*D+WI3
MA!<WQWCR77DW?!=8MU4GL"/Z0%563Q=,\P:?/98O(^^RQ F[ 5P(\# *@N^7
M=U%6U403YLT%1VM:>UWTJ 5<O%Q=R%0T+@\ ]]WCB^S\:<_7<EMZK$1]\)5O
M"H#R8\E9@-&.]8W&Y1YU^PLO1]W_);HEN@(?V/\1O#1F2 =;]35VBJ" 8E,C
M\ TM%*^E<V\ C]**MD).?3Z2ENP@V>>G868[POZ:MJ?@S_68O5VS<]<U]O5$
MXK!D2M[R7GC@3&6)31:"W !3PEV&K)P;(77'LRY$4@H0); N.. /;NL5+_@&
M4@+K_+>)IJW1EK!6=A#K731WG[P>@*]NR@7DT&3#@2A$5$,AI.0VYX(.]Z$.
M2)YF&V,G.GFZUSJP^ZST*P.4SY-5AP#6A^].#(CBX%R@4OB",DRN2H'.HSTE
MY<,A H>K5%!)K"_F(CM1'C_%'V V9, 5R5;>0HS_1!!,44]G!^OI*@'40\K?
ME!<,#!)T<!06649QI7MR;>CU"Q$$H=705>8BK%!JK"0XX,!:JYOR(O:N6[5!
M#9TM_3<\T:J2LD2:)Y_:=BQU459PQ\:=,5'\[\;E,$E7*Q8C\VG<(C_QL*VE
MUC@)3+#&G3QR6/#XZ1<GR+]IV;B_U\&N2#D8N[3O33EE9T56?6&T(%,G?ERV
M.-8SVX_S"F$(!O$)$J ,=2.)/AF#=R<65L01^/_J0<)_4D#Q@5FS5J*;64:R
MJ*RJ_;6HTM2X!= QY1<??:A4(: :2T4DR)-^G(J[ZFL+_6':Y&,@<:\0&T^.
M\#M?<,OPIY$\)[,9>:<@]J<NF_J%XNOI4!(>M3PNZB>1XX4(DNUTVJ_;'*J4
M,77%.J?6'=QB_ WD';5%A-V ]=#R (V69@-3Q_M ,A.S+VNUT(#$:CI())DX
M D\1YU49!91QDE^9SADOEX$+%-=5F65$@_=YM^G^TU?=496W_4L"X$!_Q;<=
MOFE"HIB.ZB^E-L'PN)0N3!E-6:657T2-2O_7JQ(6'1^XJ<)W!,%0DTHQD6O7
M'S][)9&'P$K>[[D!O.4+1J$4I4+E2EBY?X[:"/"1_& 016UD6B)XF8@,CG%9
M'.7%!ZX&^E,BEF_ 6W^E<A!1&#5K]@5$8KA=7Q=*4 Q^0J(W^H\W)]YB2>1E
M!S'/,%[NT!3UJFOF0/[]Z9$^+3BPZ2_?;1FB.L%E>A$1"!39(?!"#7]RJX=M
M*[Z@US>@F JB6U5)VZ%DUFG&Y0<#F#'SJ=DX=^%Q< ":I0SD_:$016U$6@)-
M03'/(77!OX=, )6!"3M32'#QF'*!WM^^KP0^YT)@I>B:%6(Z4M#9I183W5V\
M]S/(X"WJ@Z@="(J=QX]AL%HPW)0+"RNV8DU)7)[Z9W;N++<=2!#HX6K#X+F#
M8<__W)M6_Y3\'9HAR?_$>2C!$$8IP="\/]\;E=TP88?(:30-XZ)8<*[_>8FW
M^S/]/^VI1Y&"T3+0C5$A%B7.^C_5E,L&J=;! F%4^J]/]*'POS[&OR X;!#<
M/\'R7SFJ=A#%5=DHW+++W)T2Z3G@Q/F&-Y+1NIAW\'&J\K;8TY/BIW2@DT)L
MU<&6ZA\R_@YB-D7#6PJ1\[L(4CD9?[N#Z:G*MTY:8CHVKUP:@B"SRRJ*T'H-
MVYKGU,GDS;H0[0D1P $Y%C^A?WEX??2D6$+.:Z)#C#AJ E0ZS86_"";.[5VD
MC$#77?,XQ[-L>"-(NQL4O)_*-VA^)S4),(AJLX%&*XGSV6&[SQ?2TQK6*TB(
MO*^8L*T1W!M91)#NR<@UJV1D+I9R"*@L0A M\TX04/WQV^O]G!W"JV43'+7,
M)KNNUD4(J/6OFR/:>T9X[-?HO -ZEW@HW0\[[3TBZ</K_3*_LW1/6AWV'D]:
M?)O /X^JS-ZYZ/@LS'+-IKRQ63?ZI.+O 7:$;@"OOX;(Z4\X:/K&AJ#"=-84
MPWR87]!0G4:)#;O]7OU&>RB)UQ@5&&'P0B>"O(472_4YFU247M)80,O3PG6&
M3Y,".11R?@;;[E&CH2XZ[=S.1P4'R$:[-)60L[P1!&1H1,;?GK0#=!)JF^ R
M/ZE&$HRNF^2&<3@CQ^X,$'G.ZLMY&1'E?%XN*JW$CNI)[QI^\]>R]*[RY?:(
MUB_K UOLN+F8_$9=TCEG;:[W<R\T A<IAW 36R._/<PY':*J8Q#[<_]O,,8"
M0US7;&H-EHU#HOCZQ\DW0!/7A4*@ES$?K5[ 69'\AT@G2'DA ^?_\H3$VL#5
M@7*_<7I/,@/3+-OU?KY_D9C_LOD-L&=U&B5>&AR 1I"N-\A?*GS<T=T97C:?
MWA,^B6)JOD8CR&*=OMT MPK^7JH0Y\D0=6+=HAUVKD-=KS*XU2'&R9-H7<.U
MP!C2N?XF?3VQ;>ONKNPOK@O3%W2AKC= LU.T_9(J/L:>8S5CY"BP?YDT9M[1
M [D6^\9GPYXI8M@%9KDR)KK'U0M1'?63:N3H%,]$S"14V B':J8N[H!)1N$Z
M8TF;^(OU& $=V;/L)>>K&KDF;B74G9-0-XVX.R=#'.P]8K2.9.EE*[\Z/NZX
MK&"62?EL=SVAE^NL-@7J7N))L]7Q85&9?)%R0%AM9DBEQ7S%)1__\7$71M$.
MJ]B8[M@-,:VZN[%S=%&\Q]BE86CV:Q:C8!Q;8VYG^N+.=9&QV8U^FBQSPI_9
M\"<LXH6#"/UT-4HMC0T:!+&LZ_GH7Q;@Y?$?&"U.CC;RVX6 OIUM7FWI/CB?
M>OA*;2'J$6LE)\;Q.3[A^[Q=9!:?YV7(?]JS%3RF>( ' 8WRCXFAB;P^J6V;
M'U)\U5X4*2$1 -M^PPM;WM;MEV2^F-0S$HI\7B7 ,)>C@S>VP++5D7D<\6>^
ME(<)F4TPO4H;NB' G<DNYJ(CIKH7X],;>U11/0GL]<,K4 :J/Z;^0R%CZ7YN
M#(GK_>OF[;"?E7U@:M:B(E!9I'Q3@[&0>F/[14^06!.&ZW^-4R':&+DK<J<T
M78P66'#(Q0\#+[]ZBS':>>Z;$MITMOBR+6#N3L%)*">&Q921H_T3$OFW=GYC
M8%=.JY*3_F/@-=4"W"@YF\+A<V#^CW/J_B%CJ4PEHR>MXKK[O#V,-[7U#Y<=
M+)3Q%RE#W\DUP3C5 EOL(W\F;3V0W<^[4'^!,<SH/;DNF)6 T8I+;MN//Z0
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M-.)3 H_?N4#I&J>GHK:WS<\FJ!D/257AP)^1!9:W37C]3#9$[L_Y;YH;BV*
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M.X4<\QP<05BH%1J05:A)?B(2S=)BG?%7KPIUU^*<JNP8^>L_6$8!/0>TLRP
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M6W:VF!, S4IRQ8^B0S4Z@Z]SLV1$'1GK#)NTR_7>B"3>Y7^-N&K3?J=?E(S
MYGMN30'EPQ75#I?FS$/&R.)_9G5-;FJ_N(OS$^7'P8?>O%&]J#_D9Q2GI'S
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MAS.5!O4;,\J_6WU[!IU;Q]^XXRH&9MXL;:<A1%<PTM9D 9Y BOUK4JY@#N$
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MA5L7^(!B%A3R,ZW4;,<FCVF @Y$YPR+NNDR_]>1TAF_(J)K82@]\A;QZK5O
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M(P:1#X\6O".?95-8&%K/Y>8YLU">L][ AL^\26%^G'U%O*2Y+(_.DRK'92=
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M\V6.U)"&JM@EEBG=,K!#:T[BL!U[(GP"A'L2[6T<'05(F_,*QK!S\$_)>71
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MR:+672:[F>C]T'\!/4CZ@_]A/I%X^?&"[B\]_XF@CN3(!S$$ /R[$\K4Z=%
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M30:-]<DG3!33:,&)0J\I%7M\'&*)WGRWH6 )9S48-F4HRV,H*G%IP;;?4S'
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M=Y7K=1(D"6OR6-93:?F=B6SLCL=8ZF/?S-M7.&Q'5O.+JE?B6E79G6)AH-Q
M5]\+ZXW/>HQGEQ2(+;*:[M\RY%[BKQL%$9J%.PA%YS*9LUU#ZH.&Z]2*R)40
MN0MH^A_WS=7<Q<98CPWJF207WF;X!BC:T*"Y4/>\@JAC!Y[Y,7XNYJ27DO7
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MCK"9XP ^_!>@;P,]!:N>']"'-DK6#)B"GO3R<.&02ONWP!SJ0P$=CB*2Z<B
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M>^NNL=[<J/WY:K;\T?\K,/2?CD5]ZF]=XL)_C>G'N&T Z?*S70<T)2WP*SN
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MT:_U:P+QSBT27^N^1:@HFPV9-)A6U>\X<7:3X3U^)MMG"(/QS/C>+^4E*VC
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M(3Y=NX!!LL*[R@VYIV&?NNZI3=QU+ PR:''5OIV1@I51>$WTOPMNJFE&B\O
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M5_-.G>6AR+M/'27/%F'INA1M+\[ )S$8;B.D^^.1DD3M&[[%.7%5"OW&?D!
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M 0()'4JHK0M/9@WL$\PS*EO'C5FATF&P%?&-BB9A'07XWU6WTD>S<03K:^C
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MYBLD4ZOSA)^POJ?\8.6!G;73A@L9IJ(85H O9P87G;-UB/\LN3-N>8UJN-(
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MK_5_=9?Q:B<"*'C-7RQL_,8D;KEV7HL4-;"$X9#1OE4_$$0Q!KB!5RE2R9J
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MX;"9]\0C\>'&2EEA#@L\M]C+M"A33T/%;Y*PHX5F.SX> RL5D*$8&#RI2.C
MS#O?;_2X0;7TJ2.;]H3-J@S;-X/GT(KV.#MN/FA+Y=,%.*DWC%9P,TP%8'VB
M,]4\[2Q*GL19@WJ]F_TJ8JHZHBXF=R >60H,3]4#5W9!8WT0J83S?1NA54Y(
M!V7&P>#OR)[9ZC6D,L$NQ;5V7S6@!4Z.@CNH1.ITV7$%2V6)P1&CI"A9K*1
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M3/XLB."3/%D(A\\D9ZW@=,[^3'KFVG ZYP-K.:IJ]O]_&(W A%5R<\WG-GZ
MAM7R&'\H&KCM<EE]GT?<Y#//C5LCKVV>^*Y@12O<[?5UJ4<FJ3<3ZT!BS7L=
MFY8;(44YA,P"HZ*[EOZKG=P_W/S>K93H()YI61R0_D&CH7>AS]L<)^ Y+]W
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M54DC$@6V[+1[B1&<PZ0\&QPC]NQLWS^9%8^=.B\$'-0\]"XE%P>HZW^E'[$
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M#GT*LVX&;K18'+;90'F=,#6T$8ZTQ-*,/6.='C4/7R=57U<3)4(S/N-(^M>
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M;%2W71[(^WI).FO9\R7]P#!GW><H_@16"N\.OWXPQNE8)RYNW!:LW_LA%2G
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MS][_X^Y3UY_POWVSJ1"E'C>1XCAHEFX1_AX-H)L9EK]_PX;S1C*8D>3^E7,
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MFDE%IC%7G'R<&-8-4=P4J^B9)<9& G'UC9%W,*O6@0)-V5+9LMXVE>K;*[8
MZ9S)6,[A8U_!V+1T0:@/A6K<JT5_*)SY7(,&0!1S\(99]I]6TYXI:L$B.%%1
MO+:SC<>O')\OQ&^08:])":9EO<DLN  5);?4:(;U=+.EM5M*V2&V-U 9J+I
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M1MTS#(O1NK%L^4H.ZR^Z;/*B@7O5XN%UR#<RY%O;DNW':%E^_$Q>\$1F.F,
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M^0-4J>>;K]/2X7M?:I>10@!;^O'IK-ITED1>KU0<4QX1I\S>51#7OQ1L8=P
M+>\-+V&)[3:'K(NT_E!+P0V^#0I9K[)1E+<ZM$]:J6$);]A6E&C"T!'SC(H"
M5+T56@<7#F]4=_T@T8^Y#A55G*P("C]!4C L;>Y232$Q=E S9VK,V,V/;QA<
M&M5#<8;&_U)#'3G+$^D,970B!0=;E /C@P\V7UB7AGHRI*G6.M?B&?*D.$^
M7=RIC9I"DNY/TB5&SHX6GZ[+,YQ^BS%6\)<J\LESV3@GMP\OY!Y-U9>9K;G'
M78+N)RB9,.4((J?R6^V>VR^]Z.WPS7&6],R0=(]U;-.67F%).O>+"W.@P"(Q
M+:$P>ZNRW&W$9!INZ YD\O:K?H%\QS[/"JZ98KY9\L[I1IK-% I -A,ISEN>
MV-_3H= >5QHC(ZP&M2AJBSFJ:&0OU;MO<2MS.GS<JP+RD"?7^;\2)*_3XZ.C
M]XS<E#2B29P8IER-VR8V<RMW]=R+Q"7>QCZ4H%Z(Q(?T8Y9YS([=?=WJW+^
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M+=R6=/2!SR]8L$M1DRE7%RD+^@%542Z1NU(BQ<_-LWO=!*P%+JJ\F7"T*9#
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M'V'O %;P0;URV>@CV4+'M$"H^[@[^L[ ^&-"V66(5.BNRU-2SKYOW\HBTD/
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MO@Y[F_T01Y=Q"JBU?^R9K)4F%X<QBSLL/Y([^FS^(V!JM!WY>-G@9DU$4@/
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M+"^Q2[@;P.%:T[$W=3FC&E6IW.U,6"X=!8W0A/X57GBNAMEHO7,"JS":]"E
MA20T._E5H*I,TZZ0+]_2-&+G(DS5+!Q ;^/TBNA_3,D"%#10<OYJV%;=VF(
M3PO=5Z4T\(%X "FR,"F<&Y+_%I4E4:,PL0T[S"M1VF5]_+XNP4T_&7;)2;A+
MT0(>3%-<1(>9PCOC=*L8^+/PCSDPO ()A@D#XOT=@>K2A, T*2VFD*:!U0@1
M6AM"XQT(K^& ";'=+F#[]G6!#R@YGI5T]*CO]4R$I=K3V[?<!$W**F8K1YX7
M:7;!?>_Q@0^7>"W!]8UAQ5K'Z**NPN<O'=:8P14JNK5/U*U@\=/+G*J7XTV)
MICL+ DS'EV0B+\<O??6%*0?CQQSWP%BK\%BN94E&HU/C=??.AB\/,OY.CQ^Q
MY!HK9E8=0-;NWBY4ZQI0<M'CN;P 5J#<2"(=S?5.CF&S1JY-_"Z#NA0-KTPD
M'T3_(:AU_G%3\.2O\(2FPINU"M"QGK_S?WU>Z* B:C>S3R2^'=[;XW9:O"_?
M"/0>B[2Z#A"J)T-).S#OL\ UQ2NJ^X9?)AFO'/_M4K)&RM6<4=!\Z,1Z7,)A
M-K3B]X3YPE/4(>""4X-SI=E[M_=]%B!=Q75X#5S%(S6"<(P>_Q!973H+WU;-
MO4_ZT%-^N20T1Z/9+:]I3WP^-JPH- T//T<Y7/7\U:G-89H+?M]YX:&QLF['
M)$TK]UW*%/\!B0B]S>1*$XQA1QURFLG'D^S'R@M!70)M<G_U[I%*R[&;U7;/
MOZKL%YIEN@:?>H0XZ@_J7 R((#[<$2X/H*"U'XQP5_MTS6^:HGE:I/6/^6!.
M=Q]MZ? [(DMR:=QOP%+K:1N<<S*Z4&!!3P9YZ"F/A>.1O#RCH5T&[Y;GF6$M
M:!60_IKX@KGC\HJ/B\37@/3B-3,.-"4DE98P\VSH#O:A"X"[H.OOCPY87=4^
M-[D,%L'- S\,JCZ?-6^N)C?'9(]FX I:.5LNQ1??:R160NR[(4!BO;W-LC)%
M<O053"]#6B10=JH] .>F4]"[65C8'2<.^MMB4%1NP/Z'M"9C!M&)#R$\>9HI
M@E?^P.YM'1J=J;R7*G),LHQ$+7H.-0E]&^$:O2!#,+OY;9&',I*G:6F=[<?T
M,<-)]X]N99?(W%YH1*0G?61;2J_3! .6WP\Z"8#9(V5< ,'K32GG"DL:WX:L
M3W)<M6J+U' (R7LC-(K0*P.#A/ >=Y&GGF>.>DS!$ZR<T%&167;Z\D<;LM#&
M82UPNQ V,,;#Z,UICU3U!$!#TP8R:N__:#$X"_V(RD@("WE+O%Q_?7PM^O%?
MVX7?7QT/OD%A"_[N3FG9ZZOZ=,L_[B]P_/]6 5D?^;;MCGCQI]\=TR.*U^^<
M\^F1%ETXMI\E?3Y>)_#\DZLB_^1-$E4K?%?NE]IAVT#J<!X2(LV];-%A"7^Y
MD[+%M0H5>+G !T8_;0.=2-3T_L0D1TA 01'2"S',"47KU9GJ,?=Z@R:T#LA]
MB'$L2?\![LG>K.$&YFEUL;REE%[18CYEJ0 <W?9H?H#TT]M>!;Z"!FC&HUIY
M9PR@74TCY4SY)S$UM;!/N(54!70A9,73!LK7C.^9<N)TF930KSRWTV.G=IE7
MQBRV,_F%KY+$X]E%889O8&.5$#Y!09=7FK" &"HKVIO9O/(@^<[OFW;7:%FO
M UQ_15@@L@]M$E86CP;KJ1*^ZHJ<00O,8N3SWH?,8,',/;@_A8PZ+EV_5-3*
MU#UO5>A@@.1J/*Q@X'-4PM7'@0R&A.+.60SLKK]J80&\E3[%&I4O;QR$-V"U
M>RC^@QWHX V0-C[N ;B6O?YTG*3J)#QP/>M5I([N KRN[1,&F^T_7Y"W?]M#
M\DC-*:'-C ^4HZ=EW)XUG]/VR2^7J0IW>PX)>[>(TP[L=R4X%$E?\3<9T &2
MPT*'GW]D$"9L#W80S+,5&DK%HXO>S^]5D =('ZJ^\@NH8@UI]NU^'"/F9N&6
MC=W7'5W1\J"_JD+';H4E-:/@675KN/-KPMTZEU8D0"(3)K3DE1_)O+*-)0E)
M.0]]KIGIBIT5U\UI(L<94HVNJGS7&!HW"*Z:C%<FC4Y GX$Y1E]XW9<Z7T07
M>PL/./%:$=;D%]&)KC/D$U>J6=T'RQ9"H=\_GWX%/[!A*CN^KMV+_7][3,OX
M0Q\*MFREG#TD+)//Z#F=.YQB812VGWA7$^\O^=41C[!HP<A].#U8-%5>MX-Z
MW@><*W*%K',<H/W?FV_9+@;J+@7.0C9XYMUAO>'D%X;.P;Z-EBF6VK9@(,/G
MO"S[LBS 2>2@2-?,%-C%PR>G<MOAM+!^&>9F+2# N*]JF[+O%,>ZI$A\6[U[
M#0]U<\$J//XYEC;EQ/L7T!ZHT>L6)V_'T0NHU14X;W"<EL1\9<8"O>0,9(.?
M3Q$>;M]ZTI%&!#;I'V!GKZL8YO88JW#SO)4-Y7"'P$ED9(C\/JQO51*8,,N\
MMN-6/(#*H^)M30H?', $?(-L5"FO?Y=&EO1B3N^DB@6F,I2F=2]HCY-@NXZ8
M]B2V V T^PDWB!,SWWSR%3T:HT%02:4O(3-Y@_&:Z5E#\H6^X0ZL&);S.2EC
M%'*V2ID 9GP?>ADTR6\3 =!U0>'':P]*+_UJ,<^H4GUCA^1?4^;&KG.FKU$!
MC.*MY#HX;*R(QZ,5^Y?<!RPW\?1HSV##]0N0-?$M'*MD"=4;*RX/@C-498$X
M=C-E>WG,Q 9W%"5PWM)H"V-7'JI>61A\$3B%6F@\]',LBL'<IV%W!**S%B+U
M.L,]]?8Z-S\3U"8+J'&XNONA?[(5YV(LIOG!18C>R5=G(@I:,,ZZ[85=4 O%
MX6=ZCT,]+YL@]K=(*SJ3RD@Z:?M%%8;!(0B?JY]/5ZG?/P#RR8KV,\*^XL2$
M3J#G;YRA7AX>*3>/3*;BFQ[968RSRW2Q&DXG#03Z%MQ8,Y<)$D]TRZ;4.OUV
M"'%/BY9/"N*<2_&L8<O[D:.K2IE?+Q+482?R2+\X8=7N+,1A(&,+J_K@^<=[
MFW*<#FF?JJ"_4W6IKUO1?D:.$%B<SQQ.=[/2WUG'HJ TVL>*(K)%1I3';:+^
M/-?(E:D:R+K 8_IDZNUG0'-G,5L)4#)2D]B3[=8/9*P$Q7Q#+F*M_HHOC(6(
MY6[[J##39D@-;?!I6ROOJAHW0=!B0/\22F0T<9RSP<6Z"[1V.G&MO&%V#NI4
MW*-K5#Q:YHN\_7&?5;$* C+0383;:[4$V\/+W2RA.WWU'3'WFNX!W_NH +]:
M0$(::3INLI/[=I4W+N)GDQ>X\D98$;Y.7 ;]&N\08V )Z@]TD>@&G1C6HOP(
M,?]1$.]E!/Q(1O7&ZR-GZH1F<(F3"C-#I0.6_2E )VK\P991YM.BQ#?VC]W
MI11TRCQM7C$OC]X]T7)T^0C+L S-KXXM7,C%UBV[XO*+6NL/'C:)!87:"-,8
M8M7)S"4_L_'?E&M]IYY(MIO8?MP1?L\<9<5Y_N9;_,X2PYSJ^\>O&GR0EKMM
MA@!U#N#PF<5?!>F@*UZ&TJ>-8U5K)Y<"=?3DNUN178NXYL2I4LR.$\V94QV6
MVV'L8VF<L5#.FEU&K>-+9%6:-;Q\,4#3;[XXI(MSS6F^_$@YM,?;?-MT<+^X
M*'_*VP3=5-"LO>BYT]MVUR#\H_R2FR#$+H.KPB1'JKP8*=O8U8E2,/CP()<=
MG_AF$>-#RE95.=,25L&NC)?((PVLE'_#$+UP.S4UCN.*1+@YQXYCV3<?2QT0
M?&[@EE,^  EN%'J)V&6[I0&  2M'PA1'4<SV1206TCNUIH;-6'>![9JD=\B9
MVYO7"9\^'0_+ZS_:=N=T[.#Q0Q>!WW(1PWZ08=R4UQ9XO7=,@/93<?\$.K8I
M#6Z61(3>X^@<;_SO**UAFP5BRZP6+""I$K]!S,W7S+Q\Y[#*_8,8AWMS(G_:
M5SZQ'Y&J4Q#OH[;CQ/!>1[.S,K^2L<K+)SMI;K*+;C* >6GN5#8@&OIMO_CV
M/*MMR;^R=VZ]5MXW_ I+TO;)G[1CP6D)G4+%;KFS/][P'&PR>JE P_67K#4\
M8R8;5NM454S%4I@>9'%A]P)\A;UAF%DK<)/E*FOXRX)B#N5Y=5W#*!^>![B]
MW_F(@KN _%JCF,J1[],5FMGZ28,OL];$C=9U!58E31K E_>])ICMI[.*\A'J
M_/OGX\TN53=^*[O4%+-PMJW7,P2OH-LO>/+T=G5QXJ0UM+TL2@_'4CMCT6@K
M6)PJ.W*MXZB)V$SSF0QSA%TZM&V3\-1PV.LA? $XM(-Z UBJ-32D8:HPQGCX
M@<"6IBI>ND04PJ$&\7\L^)^AVKBH;OLD+MLJ0%V\XBQ<JP;QF]B:*J'/X94V
M:B*'3E"_<,;;N39!@5+Q.!4/KAU*Y4$*FD]N<,S8S=O>V^P()YY<%^QVVR28
M]7UO-J[^<U+&,5PO3YAG[_C*A]J9-+*^;-&O]L&MIS5;!?4+-+YO_-!5+S^#
M^*1F!HM":/)R67G-=3M%$%=E< 8#H5?T<]'>RZHBXV1G"?!'ZR=TW^1[:_+1
M!^@:<:$I8?A82VB-? ILJLS=(,Z:+K=1.W3=)L!FVVT."EV]<R0WA()Y4=#\
M,7)E9(L"_OT,P#S+?<DO?[!%L4B<OYWL_-GYU:,"$HTEO6E&09^)/JSEW>MF
M?R*ONNB=.C6,?739_A?B?;A6MTF'FHH!X;]IT0>L_S4M6L/_HP[1^>'EN37Z
MIU3M<E$RM59GUF"QX,^&#U4$CWCL!"7@:I:DG,*<R6+G//!(Z64ZG5!R"LP0
MNGSFN%V8\#5A7%\,A& SJSQ)*/-B=F,/#)7WEHICK%(E95E#81T DQ)6<#E"
M[Q%2D,N(IFG[J= ]_. 57UCB3Q,4E+(;B5.8;.4QGN>0S5/K)OSC^I7_7E<Y
M6S.:%,R*OO%);=L8#*42Z U6*1EA-N8&]F16*>DF-5\TS0X,'01S]J\1@7+@
M+;=\<IZ[#S!3P5A#:42CY\O\9'2?A!4Z=H((!-@5#&L'4O#6T84L)H"$];8O
M)-.+;[;/]UC*A9!%T$BH[CTD;_H6DZ;7S9:V&1&!&PD;P-=)HU7* J.5P,[%
M*68C/6!BGK;GZV.);E9:[2Z1_C]"ESA%E[1UGG8)LZC"0*#B.I1_Z7.6>!DI
M/)3/'XP@Z.H7.^.KX3/0#^6ZG'Z][B*1=TD[R-J!U,I1.&;*U2^ ^O7& P;A
M2OEWCC4Z7R\7H8[HCS&W4_'6D=(VL,A%Z5)YR0C++D-XX&^NB@JX-E)'GTIX
M1$:+Z/[I'(4CQ9G 2F]KAS@5UVB^_S51W#60:QCG,RG?5:*NGZE<V7\_X:\6
M"XA$XXZDLTY@[QMZ^Z_^,6](3PK=ZU42YE:R*3.R##U38K!XI+V\+_/A45]$
M)>6DNXOW;T>?2V="3LVI\>Y8]D_,OTSQH>JE/'_6DO3$VL(]Y*2D:2TX1=_'
M6^O=)KTHGP LMKPD\9I>P?4E9M40O<T=P7=^]<T#3N>(?8X01]K']_SS-?QC
M57*8-Y/X<^P\(M_[K-M_'\9>*)P(LR6WNRW6K<@73EJ7QZ%=Z@?JV\:]Z56V
M\TP?9_S.J=+);E;T/=^$-(MKB-C"EA/FPF.*T?G[^QSO+06&6O!K09,8921G
M%X0SF^V?0I4\4^(U 56CYS8$._P)[K4E1?1]%^RY!LX$/Z//4-F'^'#P;1\#
M;[39_BZ.<9 3[X8"O;#)F6]27?9TG?_RG8^21XJ(&15]]F#T6H#VU1_87#JU
M4+_$T^ R4%O,HM!3'L]<?>86+QZJ1-.W*F7-%_C5M10KD^ZTV]UO2MHW@X\'
MP&$#5J<BU,6C^_J.NDA//L(TAZ7#G\K-</?[>!5XHU=I3U)Y=D2NIU69;B/.
M;Y=I27(_K[D&B5#/HNO0Z^$<'5^LS;?1:4)9YSS?XUW=LW<$D]+\?0/@X5!_
M\:YHBM]"FLFEG /A7LCZ,(ZO"BAT)$*=\.FR[4@799?'R1)$FI$'O>'*#5&<
M!901F@+ZONT?O&!\[,;R"J[)A*N:9=#+M;BNS^?52^G?ZNY5F,1]^:SD\6HS
MA)<DG2 R!P6.T&\)@20,BQ*F#!/7I$X&:-A=<;%P/VSP;(%[!%907H7:S3QU
MFR-NBO=.6Q>8,V(1>O<&+)4O*ST3]%@1C:.$GMEX+Q3"3ZW3CBH9MA_AN 3!
MG^T]?/PR\;BJ#$=AECZG1M.2*?0*&-S^-!')6XZ2!L^[%Y2%^]F/L0AZGB>B
MH?SO5ST^=L\":7:0&<'M*VQ4$NF#?#!9M$H)L-OM&@Q7;+PN$U<\ )G%;L^!
M;N/?*Z]V!S[5T'42H37?BAS>W-2<99?.1RNI)X\*U3,$WNM@Y<#3O,]3_JV(
MEX+YQW]HW)IZ?=R463WA9=N\>?*/M%LG2M.04W.[_UM.]+@&PGI]*N6/E--7
MAP-G3JO--Z?#+HF\9 5ER"0I][3H^D*-P25BX,8IO_?Q,"%:']Y V//(),]?
MS]T&62,2(JKN^#'4)>"2D6SS3.[^Q[<$^ZY8($RVDI_(3*EL7I?3I# S7J1R
M/]AC-.3#=-BE9V6'V61T+[ %_(PUS^:PFRT'$1;AQ(E+)2R\K5N=?Q:^P 6_
MTW1;#PDU&$Z&)UFT.,#UL_!YO9BD6<E69<)KT#Y#;V4U(EG,\,CRB6B&7BK2
M :KV3*Z+&]LW7\I8P]T3N5P^6M2N(_0!YN*S<\5E,O4X3EP_ET O=?#%J+W1
MSK>"T7'0)7<GI-#R>(N7;;_KJ\ ^H85R3H)O23L7^?!5()_#T=>(77:6>-IO
M "<@\[S 2LM6&(=%!.GL=%:[.7&6)V\5.J-?PA K6S1:0PB^(E1G24!/?,))
M(O#O-G^.#\E9<LT"R:E2(,O\F!Y^,R7+0P=QW>D\;7;S:H;(ZV7 +KD&*[LG
MDJ\4^FD'%YPT:SNM!O[T#9S%3/;(PL?57X,PM'%HSEF0W0+/DE@@/7(@Y;&-
M9I9T=,*I2I-"/V^8T[;]9%J5 _3C9!-VE]&*]T7RP*2L9O_(#7;SAB[O"^C[
MI:IYCL:C[(#)<6"56)J_J=F_>/A%"NEY\XRE^0DO"S>87[.TNJW',J87S/-3
MGB() YT)%R,D+QAG:P2AT:.Y"ZO60_ 3)J"N-P=C9<>7K_SBAR5NGYBKNTJU
MO-T>^+\^/I4OJ/[5\'I;W:UU^O+&CHV8UD3_'0=;%Y-2L5;=J-I'B#V3P'?Q
M,UF5KT9QZ[7+!E!'J SW $!*/5!MCH)?F)LO0G\*M&9[R[?:R\,\BA@$Z#0#
M:YQY@O3VOI71Q)9"(](!9TZ4*G<)C:/&:#Z9BZBI9_TSU?LHH7*XKX+&YE5+
MK4OC@IZ:OE]Z*>SD.,T+=-1BX#@[3@W0SWM Q<H_T,RA=3(('M=KDVNF:+OU
M,^%$5['R O-$UMDJI2DEX^0LO)8^%R)7L Z@3ZRY)Y%0VT>NMCDMH52[M<6E
MMN,,[)8%?2*7B]*VCR[3=QU"P2WELW=$J_*/7N3Z=Q/I>?0AV%9'_!P1L;.(
M31HU6Q'3_EO<V\F(YHQ":\^XC]# +^@A@?:')9\(_XPOH;2+=V!B,5G:;*A[
M!$'>Q)<:!8GA&07[WFU12O *L)QG;5UO(+_\#EIYJIG887(K/'V5&PGN-LRY
MV<X*OEH@O67C)M.(LRUT?E7$D!2X2+,"S_,-:)634)=HSI@+ 9R]4>4?I^\L
MSBYAQM\*OV&DEFX& /-@_4+%ZS(,[!9UGX+OBY%;170?TPY'=@=?KL$=_BY*
MG*-PMCI9 X"L;)[R$SC:./%8J090AP/NMC#<09?@B_,RC,Y(93_9I"#&L[]1
M]:2F"L)[V!MQ7#IG:'7[)=<@((:A+?1*>1)RLBUIOI;^5O?>Z3A[J-<#!:W,
M^CMM5^!]7@E(T,&_3Y3=OU=SEL*D.V0H/W L0YJT6SRDX\1-J0:N5L6WN4(]
MP>YSAXS,8CJ4!W^B[CH.:=>0VT<Z#'M_N8T\XA3$OWR IN(EOR%G6K+ D($G
M'QI%E![O0<S8BF;Z6L3[@4S9B<3$@3&SJRV/U:*P5#7"$M[4>+8CLF"X2>UJ
MB\G#'0CKQ%Y,HX6!94?/497DF=+UNJ+GWH$/K,E3-"(-#J[0K:VWVJC5'5(#
ME_65H07;-5KY+Y]3"8>3IO$>Q MT9WH6NCV#G[,B<B0-MI@KXOO>S!3I5M ?
M-D&7@E8+ST)>13=;9Q<TOSM!"54D=MB XEIRHRJV08)W=O^LV[03__G4&1>C
MI\L/A^7#)<GN]3N5)NDX^:)B:&.V\<CJ&<AP,9#^HHP1D#?#S4GI591LW_7E
M&B9B:3%("2/UTLJ4H<R0#ZG!6??)0>K-()4BS,AV516(=.<>7&A(F8H(ZUI4
M$GKS0$J<?+F?\-0$;14D?^?B['8QTS0T8989;?SP6O2J5;0OID3.!UJ1G$)R
MN7S?7C6JT*KAU6Q5XUY32# ^+ZHWO'QYMU$S<GJXO>7G !G;*=\GUZ@OE9="
MTNY<T&!M_MP<0JFIU?3\LII!C@O]7SD2;Y(#U.RW>$25''LW?U_K*6OE,)T4
M'02LSIX1T"[@Z;_[./$8L<R7'DM](H_>%G]1+VA;9("M5P+9W\8[('N*^0X6
M>O4VZD-$3+WJ"P>E<"?3@E)AD:D37 RM#MU9W\\/#*G3_40Q'T:XQKZ;&$[3
M-CG)F*]DK6"?L'YT6(:)#H?J>%<W:Y(:@D-(>ZVLKDP^)#,K+UQ9Q<@M^A]5
M8(7L/;K7R<"JRR=DME'A@%F<+U*@=']CYMY<6YD^0%+349X:#U=*6>K4?JBD
M96O!)=C?2 HX>OE&RRZ]?:Y5R4JV#IH!IG:W&DV2,V78X<MQ]VM,X8PL-=0L
M!(=_Q?X8\Y9-FN2/;1. /'Y^R&OS0GY[</S Q<!3,VTC/<O6MS]/N4Y9WRD:
M)'@^NI('VFMWJ#WH+L8%$I2B?VO#O'4R3)$5=HK\B__:H)ZA0U]H$ F.= _"
M-Q)2^;WAI0#GUY6F0U>&/%(H[JYDO%8[!5L0L%?@3_J=C-ES!H>_<&*&A<NB
M*_:5K5+P^2+]8%S1&#_,# ^CG]C=:(M]8Q"GM30Q=,2PS)"DF470.]EU$;/E
M>J_""JC2"S/9J;L88@4F :4Y :-')38_B:;)+?HI/X6J,#.[9'X/&/0SU&A#
M&".:M56#H%AH>N[AJ*OC Z1M@QA'RI*G]A@-J,W $Q,!C"QQ[J*_1]90LO07
MM)9=>N$"<IQ!P3H:Q/>">ZE$\RV2M@$6\;G,I E"::XXNREM/L?AU9-8H,ZB
M_W7XIL0N"),)EW?!'H II'$2\,6'],X$-N=W6@Z07KI!<YT&X_'2]9UM.IL$
M% +:!1PH,^:SCRZBP+4Y6>O5EY8\)L#M^3 Z28A,-#60@8F-"L<TC#3C'8PD
M;8-NEE;ZW%UZND+8EDWII:?DF3*5W=N9VY19+_*_\.?^!<3</.YS75=H'.E,
M5[;_A G&WRM75F %7_KPC OW_49XFB=SWW^E-1;,B<&-W; ^G#V5O]M4W5Z<
M'TDE7)*O8+ M_0^D[*3T0$-@TA"::6\@Z2!NI/+I7)8O=V_0Z@P-*'YO]X R
M5N0SU>*2N!0 _H2ZH$$O.I;,_T>DGY]10T;PYTU;X'O""T&]\#QQ?N_S2Z,2
MJF3 ^0MG*[82,0\OC%A\W?C[_5\?\I)WF7Z=:?^Y^R?VS@=]%N+_@E@S\O\)
M8@W![."/TVW20\/,MRV'-OX%7"6/3'RH"@:;,D^XX.6*1,;3TV$Z$^NF]]X^
M:MD#=14G]IH4JK.8QQAEJ$__T?:R#U6\W"N?<V2I+D"]#HH\X6VA;L\$> .8
MY18@(%&%>6_/HWA =HD!U(/,O/GP"WS*4M[T$][J)%E<1(//):ACY;^='F^T
M3](,P"0_H2.CF("H:!^HY2?W.2S@;JX0;3L9K]4*7UZ7@WD#GXXB#: ^QQH/
M7+>4"S/@&Z<3 G6X$,.L(85Q\/S-P:32\\O-%??(*#EC*L&^55(N)V;14JN4
M(PN:RV!CWEZCRC3 -IG_V:H7#[B6YR>8 (;-#H11)P3[@AEK6B %-+R1><RZ
M;G"Q4+#Z/ TRVHO03GK&=?F4REM:&*-IS52TQ@*_ -2NQ W$R9_J6@R(DF&J
M#)O3A0!;2V"",N>4 7_,8;Y<6ZNF\0"8<VKR< $,K;RD7)3S"][:BW%@S!=&
M1.Z9$CC<L4?[4"64\1;;U@+?> ;?9*NGH%1S5GY3LB)T"C9LULY%.9)I<C[*
ME,#:1+!H-^C2\UP? )C+,36AZ4J6Q;.,K[562U5#"K"?'YQ<T[C(I.85FJ6<
M?#;Z"$'0;H_2>/M8DJ/@,P1]ENT19793W^>/_-O/C$7A&H&P>OJ?I^T@2793
M__1^O1KO?0Z2VG#C 4'DY=B=;$\?0]A$SYR];$XE+&L;&E)?NS(O\%'"N//M
MMG/L^(F[;;O@Z_4A._H^';]Z/^^27$3,M;,&;8@WXY!NZ]LE3A\BF(7K7$Y2
M&>>AG=-O6G+MS 7DG1N_ 1XA1 >5,LL2*0_I0SXRH7NQ/GT+EJ[<GJP1%_N'
M+HJQR=\$]^]""/GV_0+ A.6?-6WLYY,"_M%CB*1H 18:E@3-Y]R.V*CE:V9R
M#R=G(@Y<!^)WP%S+M@)*#J-Q*,ZD/#]=$*(,K?:E4F>Y^CM[V,Y8,&%KZ,L!
M W%>#P_!)1)F!D#RY!YUR+KH@ 'TVTQ.-A4;1@<O&Z%ZS=G)RM#<;)'CWJN'
MX4$>T.JI%*OV S?Z&D&=(,65?$@JSZ7(,TU%/7XF2&<#49[H-U]C/.,F*YA_
MIOHO(+]<7_G^]17I]/!HS,[T^?(=;)158?2)6ZE?ZRP'78<NO#H5"!WO@-(8
M,PW[3C/F^1<CK]WJ("3BG?B?E70%)]UZ[;+%U>>(])(2M)8>VB;45S[J5OCP
MX\@OM*Q0U^>[R!N-B)]S1GLP[_.%X *8A6$+67X)O!AT_8UG#%/^KB<FTE4;
MC7:CXE8-><SQ\Z?E$Q!-MVYP+7N3FE_2DJ$? //\4/6"=:Q'"4N<G"&(BMIA
M45":YYO48@30A#Z!BHQ'H\ 0J87N?,.T+=_,/?0F!_U;VL$3915I+W/-6UZ5
M)L>SZW?"#QGWU_OP$EN/GE3<N%,\,JRK_*MLX&@/\=NU>,DO\5AU\'K]X[U,
M^W&/#FOG /KOX:3V8N]/.("P[I@%O\%1,Q[1')I0%#;S2/TF7'$L_ABP?/1M
M\ FH04@KR#P+=T_3VS,-U*?!2K+S1>B$W]X G8T%]AS_H1=&].?ME\"_>.-6
MAZ]96DF/N2/\RLBFJ""$BU7>?#8XI*].C!9U<:7^^&D'%4RYW4Q]0Z:38 16
M '53+Y86VOT.7YKM"#MI+$@^0CGJ]@*"WM^+D;DZ[!;-M$45CMZI>5:S4]ZZ
M[K(H>/F_?SD6F&"D9;+>M\@3<XY[/EPEC_42CI?U;M9$_'Y7^MJ-$F\U;Y+]
MC^1BAQ&.258 +1RF_.F\O0<*5%_! (0*VX?$AG.T+9F=\<F_;Q'3FM3<Z=,;
MCU(Z% N?SKDRZJ'1^I4'&PS/L@1>RKZ&.)9WP;O_B^"Y#9+3&4X\Z(S_LTK1
M<E,RI/Q=VJE "9HF1%I'GI7Y6[A!>XO\>Z9* 9]]G!8#P9]P*R,W&N4+?_YL
MQY+'*@J@RE#5W[>:$"G'F&<>&RGOOET"OWTEVZC'37:PF46$;U5"8UO1 7%)
MHLH[6?!0^1/-+''.CJD:P)UXUZ'\O(38L1K7\V-_A!^OPEM7@WMG S?%6O9,
M*FTR;B\#/LC%]..*<H7&9A9[KEKL$>(O@ >I1$NWN#^KA+/ 9P726!8>@KMG
M/!J!CTSGY8I<=!</5P=%(3F1+GC#YIM"Q:8?<KWAQ)U4B12Z &\/%M\#;3$6
MVKD9+ (+?;0T2S^J>FZ) 1L7R;%&-Z"V*(3N=8;Q/?BD@IA[:@%8@9*Y'_9H
MP^[H.*R7OQBTZNY4FS &'8U./E@ZTB5#3[#P=42NG\:V9KQ.00L,I9PE]9=S
M';)6U[488Z,4Z%@ <,O5+8?M\R3CH8KGI.V[[Y!L_VQ>WO[2?L"%T.,2'"D?
MCZHZ6_U1_33@]V::.B702-/;2/\BW)@Q"]]P'V,")O'9!:6V<:<M>T&Z[E,-
M"0;Q4/)4V7.O8Q<]Q<PC:3R8[F* H?3ZNXXK#]75GW8H^,P81RBS:?X:Z9N.
M,+5/U6T+KQ'O;],_.GG\C[T^U)PO;CZ>0>Q]^>;.W_]WN7"^=&TA#)0X4*<4
M<3*Z#%_3)42W@7K>O/=-]/W8R0,NP'^1.&+/-VHUKGA0%Q>R+I!?<=\7=\WM
MO?9L!X0+:1(!7.]XV^_-$(10T(MT0'3!-^Z6^ *AX9L #SM+7&#(I#L86:5B
M-YW*^P6?484PSX3+J=4SU=;HWHK2F[T&,EI/A%H(CB&V-65B.70 ]9XKX9I)
MS:K(55TM44[?&,@O_6)$*$MIXPXIV^58[:/0;V8C-#7):*53G8L!M1\M.I1=
ML0I.-?JMW.V/<QR8@ +T0\8"0LLL)(<R4C&WP 0<*?C5O( 3YYUX6M0E0VF$
M="T&KCY8BRFO<Y_G]&]4*=N)LWN@8!UQ2=K!<,#IK:@(W;?&#%7$RWL?0IFM
M_L,CLH+KWH!T<@*5X/)LEU>/3)WX7^PV$.82.LHH0@Q: %;I^.6V ]TZU1)Y
M,^SGO@1_"_G"!J3YA]-&$.Q=YNF#&;>[HEK'?:;6ST\U__E3\!YV\&N+Q3G\
MS^72GW\=Z# R.=6+P3Z)A6_\%NY@,"4%=+8+.)'2AC]+)PI*Y0R,@5\B< \8
M0[M,M[5WV#@);<147"YSFT9K+9&N\F*$06&ZDQGV?N,@&T="VMP,$_JPQVJ&
MJZ#@Q"NUQB#GQ(41O]D5%OZ(OJ&_B7NG1TX(,&:C.$P305<MJ]$ZAV#>Z'>E
MZ$A'5<_1BXCWNW(3C,(TJJ^5$T?:ZW_;,&GG'V>!AF^Z(5J!'WR0H%?[&=K/
M3W_;'S%^JL":^[IO?X2LY_3+QK:_,2.FV^Y)6[]1F%'*[+K3.ES8;9,%Q"D@
M45%"SIL1!*2X=\)WE3]Z+C<]?"S2JTUDYZ<[7L)\=%JN+U[MU/2_@/WP@_-"
MIWPEU397O$\B_04=NR576 2#@ /7J?,W'?6_"MP$OXZZ:1B=(*,#+JD8D.2G
MYSE0NC]AUVW^(+SAIZ &7DU!'5' :F[%009W?(KFIW&F?+X4 &W@L*')9/KU
M\-TM\ /P<I/L0A+'^IJ9YK!.SWWU:(XI_!FS.2*!4-P72\>I/M)_0&@R$0P<
MS;</B5[?Y:OC&%ZT?]4J)Y_ ?/6H?,_UPC&/2_2'5F)A"X6)7+9<LQ>:$\W@
M=P(L=6<J'Y@Z\4!N<H*8\'NQJK#@N39+2JCN#FJ]:X8NW!M8!"[B%4)"F_T5
MB>8/EKXL#4"3]KHD\UH";K<=C<G<787P7KV%\-4]MQH?2GZDG+]\,-3'S"83
M*>A3^GTC^.2^%%YV.R]>SZ:O'4(T(+V#3=7W"'VV"1QUICCY>=!/ 0H6NK5Y
M9@2'G1D\3Z_<;#K1@IKRXXD> 1U>N  4GQNP\@F8M#+)(S5B+D.*ECS<ZZ W
M"G-%<85'HHOU3=L1/H+[[<=R=7M!&&O7ERFGPS-N9M1E@0TMVW6C75)Q=/(%
M"Y,*0W*_@+9Q>SZ%&)I8 ZYZN*EWD(+Q\04Y_A^ZWCPJZ>W_'@9QGDM,G,=4
MM$P4!QP*-1%1'' JLC(M$TH3*4T:KD-:DI)C*9)A,CAA6FJ:>=,4AVZH(9HY
M= T-(],&-6_3_3SV^:[?\ZSUK._O#Q:P8,%YPSEG[WW.?NUC>M\,4:=-PC2,
MPL4=NJQ7NYM=9T*6MLA8+>:F1PCUNA'*USO$=(3X[!AJ?++A\/[>%#4=N$]?
MW9%6?KY[A(6&1)4N+$BI 3?U\[\\;;*!?].'B]5)/J8R)9V@:QH">'Y8J4'(
M+'6T#GWUGP;.IW>_YIM.&CO;LC_-F^&7[Q;]%;[RN_[T?Q:,+VOEK?K\%JG&
M#5785)W_8NF3L -1SC6=^356"&Y142!@@_MKU7;T9N-J0?]73MD@I>0,46:!
M9Q$R9N,;O<E9\22@"/;'JYM)P1; B!_CN1<F9'R>K>H*5'J9H&7TH+"@;ZSP
MB\T^NZJ" 6A_SMW>6/ORCQC4>PV/L;U$.\LN97EY*(R:;%CWO!RL>/T,0H"I
M5_-ME; C+$B!\ATK6!5J"6'$VK:];/!8.5Q[#I>X  =VL0'%$!V#T'Q<LR>T
M&KT<N,O_X=N1A B!R=#WL#\W,;*&G]%_4=U(:*^/06(OFF-HT2-6+U^YDY5!
MI(G$L*"OG/M%R*&O9/HEN]>.2%T.( AEL[L#_M6P[DX:SZ1Y=8[ 2OJ([BFB
M^\J.V2K12%[1.$TRU=X/[T837_LAR8*B_.!/+K!MU6"99/X6W8U6MXX'A/2_
M.%"MP/,,?TA1'!8@PND)6 VE*NA]RV>DTZKAVP-HK6,'O&^_MTKDW'F2/W%P
MMH0?4;!]E[PL;D>OF'GX>8>VF6G8*+S)\CJ,YAA4E!:2E\D8SV/Q+RG/I/,Q
M\B]0\T'65HFF:B<^TG-N6;(0'F-UCS+,DW8P/T8N7A,W?$-E9D;;D0-!:91T
M;SDXR$<+@.#[;Y[G /SY_F^-\;X6EN["7V^"PGL7A?>_AQE>2PZ(O?TLK,]F
MW"BB6HGC?A[D="3L44DQ&;?K1&==A[C-^A$,_JX7W_U6!D:-\VT-N7YS6HOP
M'\"R;]KTON_51_Z(804?R:S9DA+MN4OR)B_O4FT[%OY7+]1[X_<"DE[QO]^[
MKO\'L!'?<2GPSCZJF-?Y$LEMK2J=9YWCK)J0@E31P\O1*>X+S2NL\$ EC[ ^
MF,=X!FO R6L%E]33N^RU)9SKEKUV[6TEB\YR=HR"WXZ^06ZW_0IV#-M[.P'R
M<3+#P)%><LS<"3)"^'$-PH2HTDI3L. TIIOZ='^()A5$=X$Q%<Y)@R(V:C,1
M8I;&H">Q*</?+2S$R55FCJ >Q;:4O5WK:;/[ \'%.0'X)BB]#F@2$TX<[#;7
MFB[4B$&+JTTD#,,\<96.N17/*6:;_Y'6J^2S-;_>AS(^"V]G)*# C^,4>(B\
M06T=! LTX4E F_P("[!GS:)9O\U7QQ1<F3#P2<88(#PSM/!5G>XO@MN83'TQ
M]*I^RVM6]%>.VUK5.D 2A*AM)Z\$J0[R3"V,B2Q3S/??_AGO5]* KAL4PP$7
M[NO??JW;+WGP)8.S+%#*A1"'X&Z(%=M.",VP-R&'S-_\V@"ZT^W_\ XQ4L9X
MUYTN=,@-WD&IL###KUOO6@;4,^'+S-X)N[Z -2!RZ&EF$,BRYN(2%31_02CC
MS<*%>?3]#*_8V5T+C-82%FP!K5J5Z*U4 ' *WV1-DU=PH4C5$^N<"VG<]E61
MS:9G@LHV>W.>*RC_:QTF.W1^R; 6Z+;.75EX754GQ<7$O<ZP/?M#-*GPJ:X"
M(<DG40,5Q75$!^4[-V^/3*<"8AT%V_>L/IBNS-_@/!,\,*QCUSKZH78__KW#
MZO$-Y/0TX<[YJ+13OYU-5SU^>L72?T%]S=>;\DZ3:XI?]L[QR?R&ZL] ]XXF
MPH,97GK90W?I;J5"K<G256WPY1,8GY4E=FQ2CG[%^<8?I1X+O",H<VIDP8'C
M0KA]GT/'W*'(@B]4-DGFHW;J!!(0IA1]?U&+;[<WFM9F4*/PEFNWTJK;E7O4
M0W@SQFU,@V=EL2;,M 0RUN&?_KYMSSC+7AG$!RJY?!>>=#*:]"0\4T]GIJ8:
M!]I1E$L(@^ 7Q@)D;JZGU.O,4\XV.\06=K(=&NWCJ]"#W2AR%73F?#6U_T1S
M.K=68'JCBC!E$LJ\5;Z-FC0?Y"YT7A"6)"$^!A*6F1P/:M/GF+6P,TFE]>SO
MXYU$7^?L9'$-S=*OH<38EAWAHCP(6/,=3/FY'RRIF?:1U"FQU %2?*AFR Z.
M>S3@(BEP6.#YT+A36&9NL18TK?7,L5;2$#Q.;TE.3;;=2X"H/L&  _S55+W$
M')6.R/TO*X]_"]8^MN=RZ*A3)%1/UQ?B2=3)G"GCH :.TAN_\77H>LW:B@E_
M;L"?6;QQ>Y$L">/[*1ZH)(='1XK:])J-G1 I&DXVP2I61X@,X=: *-%JJ8'L
M<N6Z]C0.-;TZ+PA,"J"I603X%EXB* WBF^X;K1<'9_I>N8L9EZL-?%/@\]@3
MEF% A=OP1<<>.EDX9LQ.R);DA]>R&&/E!QXOHE]QW$R/R*&Z,NMHB@L\V^)U
MFR(:])F^QWC%)0(0ONHC*H2:E;]#BJM4XJC8?M%LL<G4\B3C*(V D2$\W;7!
M9<*C$%MZ\CS.3WO/32!WI4=<LMW7&^*LYIEINQ;V*GUX&7/'12VXFE"*WU-I
MQD$-]=19!IZM_[STA[:+B-MR?(\N7 8BOE7\>'P;&NX@9T/FFZLJ0YK/$,.&
MQ _>XTS_M9%>=+_CW#F?]<A8PR#@<&DC.=+]P+\K>VNNKXK*WOU_.O7[D[##
M.;]U*JT>@6@\51DZVP=8FF:#A#6C@DP<C1%5N7ODGP]@)D5X/(T;$G&EMR:)
M$CI"T+TF1:H\?$@YS*:,1_RBC+_Z1W([(] 9FJ\D17T=;9/KALKEX,BT#2C*
MK-H@A3)^,^YU5J-[(:&OJDPI?G?07^JE!R)W*BB\9CQ'2JIU/3;K +LGRSM1
MN7^%]WP/<XX9;Y'Z]N]+-G]="OT8FJ+FBN#LGFKD?N*H?F7;$7+R/$*4B%#+
M4F/\^<"F8/PQG-K.VM/NA&6D0IO-ZD_HH&?=ADK1O"1+<=G/O6[04WK-5Z%.
M&N3Q:SJ(M.)_NQL*&"],L"A"OTJZ30 <VZS+N.-\J:YG/,6?F[->G5%0[,K)
MV<</0H S2B8SUW4,0F#3%6LGIZOD3.5?H&?\\&%5HKDKO]['@.2S]G6A8/XE
MTUF1BR=3SR]CM)]06: G%!KN*;TE(;1W6!IDIS%77Q67].U16'Y]3;:?]?"-
M??@&!\UTKDK.*)Y&>("9A!ZX"'M@1 E;:ENU:75TO>P6<8ONX[L!S'3^'"RK
MWLHH*L'"\^(>/]5HD[M^EG/%XD=X)DE846FVM'?]S1TQ5WL5&GZ29YE)M,^^
M043VA_\#J7V%$&?ES'7$EH71",XQQ\^QY5J0VQ[%24/N+ZV*!(\_$63THF0,
M6:&=5_'E--=EK-*O]_B;U.<?EX/]8A%.CLR9B*_ME_$G9%_-\/TT=Z77_6P_
MAK,X1!DSW;%='NNA>I9K./65(RDR]+K*]GYEH%=:,EU]D1Z0<J_:L_B.J]Y'
M^)D-[PY;L]=):FGT/=^K#Z^[N)YRKP2'^J8RJO^7<Z+EU)#_KG848#\[VSX4
MH6*=^H@^FQ.#A\CU><%I!K@S\.K4?.'*K&-TX+K95=LE'MJXN3;=(ZRTD.1O
MNHH=9\NEJ0K/ZM8\WUNJ5! ^+&&DN(+3JT1G1HFRGB$;X/QRA).'*E!2C%,)
MD;4)QIRS:7K_1QERVXNBX.,]XNKCG@DR$7WGZI"0^OK^SV$*KGP 5#\8'&,4
MC$\XK:=R7%*N/ONZ-,FJEATI?S5F2P#;T$3YMZ4MPZVBG(?DH$F9'1:??ING
M2G^*3B8,6&\ !A#:9E\0M2YEGM!_"0.DH"&%9@6>LHVQ?>> 3;@5^(!<K!\F
M7N'(^E=7;24K!#O&>/.1,(Z1RHK?6UK=P4>#K%<"N?(FXT\7)1FFQT?Q";/J
M,/Y!6[IS1K>US,[3(4%86'EV#]?4$\WTRH)>88BY;_CV7%=N\]"CL^Q!W3J/
MYE:66B='+M6JVVZ!>O3/A!%7_AX3/58V;E5<L4FX(JG*EXNW$%Y=D*] ]ZR(
M"[>O@JHY9R0-Z?E7)S/Z&>/-.A%KDT7E(M*)[Z(K\['%,CH69SDK"TZ6UKWK
MU9F:<M]%&3$X,14)$4"XMK$E^[9HB3TAF7#P04!7?@@(=<F:[VK86K$$5TU2
M TM.BRY\X\N@B_P-K9<0U8<,Z_[YB#3-]U_&]G(=3[;I=_ !SM3H$.B4?*&[
M"'?GEK:CJ@AG8&=3^%T/;^*>:]O5^A\ SO;JV @DBDS\(\7VSSS)R]FJ+<PE
M8?_H.M1-.]?Y;/EO2N<'5<G#G\@IXI++Q5?W'-J7J@-BS^YMY1S^>P_Q:NK[
MLS&2%C?-QBMG.>YET:+[SUL^A[\MM!]B"JWS%NUF)[I2/2+@N"7VT;QDMQ"7
M:@1[=XZX_) \@]MMJ]M&JH@3X7)CD_VT[?MPI>#AEAU_8X FX_^N[%_J!EE&
M*?#VUML=F"CUB"UK,^3;13%9:XJ2WPXUE :\?T_YH1*_<L& M1E=GQ&;6:PN
M!__3#>>XC>\"D60801[B=4=@:%X1QGX0?&5HLV@ &F 0SPA7]LF SEZY]LV*
M'7B%)IIP,M,<E"\3Q+;:S (&Y1OT=QXM-R*^?0J8U4.C%K+#KU-73SI>*01%
M+20/(>HWVTW:/U$B%+H34"^F6]&<HA?>X<H7B_<WW.YS&F[OW!4']*_5P3WJ
MN'B:^,),WWG/1^\GSX@W*G?_/03D'V@3'G]L>L?LX8?6B&Q9JA!F535H!T\_
MG#E-'"?(6_?R4X?/Z''GM&\T1EML,P#NO[L3)S%PO18C*@::U)M.O]U4'LMR
M-I&QK<+O8 TM7 $) IQ820PCXF 1W\RG[3[V)&EVY) 9I_'7=5M!M(W;F'$[
M-+NE;'<-=#X,9QG&B'Q@O\XY;52J18;-)"SQ(F>%[;;>XK\OQ%?*-4=**GW-
MJ@:#LFKLYFQ1;R8<F!$)IG];DG!_Z2MK#3>\R%<N2\S09;^BV23%#ZQ-X?)I
M1"2 N=!F^V#'D+_%FC^U\!XEN)MOFT&=J\/D'\?%*8!_QH0XV)%Q\I[O!M(Y
M#TC4V 05@\]!PR!JOHN3Y8?0E!T+2A9C0/#J8V%V%]4./UOP+3HBV;G=]T"*
MUX"-1Z(D*T^G;/@NHZ%, *?J6B0RUFOT*;C5)0@[+I,N2(KR0CAUO?D4^'AR
M>WMZT]6^)8?UIF=^N\-:KATC8OZ/(ZIJT45A$]6Q<C#/RFDJ^G>4Z\ I!8N7
MGF2*?@5H9WUL*I7JPM]UG_2[=%&1![)@C#^DYQWR&%^C1T$^]0NK&+@]@;&W
M()P=YL,"CXMS!-Y+>%72A1!W=82!>FG+!ENM*!\7PX7+]U60L>&QZ=IFC+7@
M/8,8N51[J&$=28J.]X1Y=QK6JA37&DJ_U5+6@J+I<JG0. :N(9$-:K<^T5,C
MNNE4Z3$>7C)96#="^$L ?]I'0[-"LX/G,JE)"5XI)\S!+%#(\6P<Z%$)4&5;
M#VO[-A]G5TX<7:NCPJK;*6^+@MZ6]B=Q9"_\P[=4DGIM31=Q;?9Z#FK^FU?A
M,9?>GW*^5 O4)0DS9@AIGZGY##T :?%%EML8MQM1F<R4'S]X38IQI),@-<A.
MS:+,$6M"^8:VI1RL5"\*,L=_]&*3$LH@81T2P4WNH( ;/!7+_P"Z(U[=?\64
M3X7(MZ$2IRKN[AD+QQ[_E<D[A<X++8IJMTG5KB\8^GI-\N3!'$JLMO\3Y67
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M1RE'NX0%E9UPU0331R^J2-.,$.7\,0M7QEGV_ U* G@CE*YP2DU9 5\"H*(
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M(]]8$9:W6Y?@_UIWJ'G"0HVZB5&X/IEJQ?"U@!#C!_GCNFH85UUX3B8'9[O
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M0"F#1<$9I++#ILM*@45(HLD69VF6IP?#WR[Q F)R%PQP\^J$14JX8[$">&+
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M02+%+>5K$^F"AY\%![ GK]GV?HHQM[*:(5R^JMW_%H_2?/B9Z-O&H<M<_J@
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M"E;+5X3X?+3O/V71EHHY^YBL_ >$X?;U@21XM?9AW'M2,I4\UVEJJD1-[D/
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M-[XADO9A$*3#T,ZJH;"=1L8:TKG1535JD_KR&#9P*HJ]'J'90,<GY%D"! ;
M?XR7!0_6>0PH3>K3AINW)QSL<JF)I\H-JO1,S656[R>&'>"_K"75N>&AW$'_
M'),<DJ=.0G]\FQ?*"AGN'K_"&H)G:4-F40P/"%*#$?R> =L'+I$</J7= *FU
M?*OG\17^DXG5Q .6<EQ_^RHE,VA/S-B3D#^@_,O,%Y^&:XIPX@G@V&NFEVK
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M#]=&+'<>_ZG_TIO#"F84C-_?2]PK0VT3W1Z"4=2=,U+M+6C1[M+VS&A'JZZ
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MD?IC&7VS#220'*?YJ#U"[W\0;R8R>YA0L";SA )_*/=_S(C(4&EG$'#<6_!
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MUI (GP]?JJEMH<\T_6XHK(1RB5)VU)8X>=!D.)AB_$K].E\8V[2%J[6%RJI
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MRS7:*E%>@X>\\J<J5+/7F]N0L*YO9U:5Y]DT9'6LN><T.F+6!A5UE^^_[WM
M3VH]6##/#HGU,GNK&V5)IYE<XZ>H_]#006$1V5'MJ!K.><D +.";._Q L3R_
MY1Z!4ZHMV 5; 2\(2\+4GQ_,T2IB87W?G!P4?F'*_V1NAJ@PO[37GN\9 OI\
M+G$"F?"^@*>M'N50&):CW5EIK\%)=A_=99GG64<"JDJ=/T4L[OPTL@)/.3:/
M0;LY/X1E>94-J8$5:QIH/X'GOJ$FR!0>KVW@#0!_E;@/S8T/B8-///A?UW_G
M^KI#I;GWZ=A>L]JG-KBB1Y+^H32V-:X/&Z%;\SDFB^K;5Y:L9[%LWJW=!#7V
MP@UFSU4B/-SD/6EU_[CR=;I7>H;=;YD2HSM1,3]9-R6I"Q\=Q+ZS5;KW<^14
M:KLXX70"GR)J%.4<>6L[3D]W<4;<S-Z4K9M1-;Z(1<&EX;D,=?>:\(''.=2J
MC)H1U9:5V>+ Q<BQE-DG7EN1D]F?GW%3MXX),B,"(GI-CLZ*4K;5/O_S@6VP
M:('Q.,$^[;<BX7J[9*.URN4HVO^/1[H! B!9^=I9ZNWTB,9D.^&'=*Z"/B*O
MQ=6%,!_$L&Z1G?CI%K:R$.&T5Q:-#:+'@ZIE;Y54/<N6X%DU')>27'(/ZN=P
MW:".#RIKD[7CNF)E>SK4A-TEGF6ST-->0:IMHZT^OOM&L1$(_UWQ8#YYV(M+
MO*1X-RG09!EYY=TW@DV,3^EGX*WDYW'!5B_TP1>/2CH- A&9S3G\*M!)(9&=
M'F.[6!3:R8WWRCE+'6$^>EW+DX?R >( ?PZ?5_U"L5F9>HE!!<4XO?*B2W&!
MEL1B1R)OD57B6;_2G\##AMV:=':-DM:F>@.NC_*Q,L/@XSH^9#J!4<+@+&KP
MUY( ^0>7$!G26W_NO"1=N<.A%^EC[#5%P(FT3R\5[JE<=W9<!IE[O^"1QRO!
M=V_OA:UD\[TIR*X77=('/^AD*',317YQTTLQX)=,'8.\0+.8F2TSI8B=+%J_
M8@SQR;5*#$2#R&^WJN4W7+*2W&C/2](#'2Y:6)'<R4I9-+97'BC[WI$])--0
M\'9Y_J4#/) C?;-.6&+&[>32,,RU9(^\.R=S(JF6X*YBQRYIP\IK/>I29#OY
M]Z(J\9E0OOC.?H5!GF.KCS38AEL+$V1'Q\L8/: ;N[$L%P_NDY(H@+3DT518
M'AXS99FNAF0\MME7,>6T@@3&47%7B:SJA*R:_H(=[Y5F)Q?,TL9?KS5.=13+
M"02#D"B)Z?K+0E)FGJ#/V,<S%1YI;E,3-N0Q81L4H+@<'O"UXA9 T=YTZ^1M
MOL2+2W$QV0]F97]XI1&20\K<!&6:I\%VP(RI:LF+!L"'&UI%3A4KD%MQ=5^Z
M7[\ ?"--3U[N?,^D?;\H!,-EW(/7L#M7=>E(P^$[G33+XKNWP2[GD[0;012\
MST\M#\8RQ=Y!F%,UH]^"@\C%6FUS*<9^[?V,L30"2]:10XW7U\.@R5.S'4F)
M5>CJY&T51/8CJD+C9EE[#K8\^I4V4'487U193RQ='T"DE$!RKW_C>Y\&7E40
MM(B'F%)A/](Y-R3A_3#>MCR>!=DQYX$IM[64$&]6F'Q>!OF\H6:H]FSHTQXK
MY$ ']B_']QMZG;..Z&2Z0NTT>;GW*%'T2^F[NHQ.X'8 L^H 3\EG!F()PSF'
M.6AQ@X,]8J1U'@U]L(VZTIGP2T,T2*)S6JI^LNN!P*0I:!O9+@%"SBNF.*VJ
MO&Y-2?0JZ0I*2R:L.[,;2S, >IG&.M[U/DB[X,G]*=,I[%E][*'A4M+Y8+32
M@/2PFH3?R<L2,5.YR)$ECH$"9+6L/1"WI*^\;OSY#E*J83)W+'?#))5P*]X#
M6;N/W2O=,%G7R^.4K.S>,(C4#6_J]EER@Y541M='^_SR.![VHFV6*INR'TM[
M*ZORKQ_(T)AI]"[IF9SLL$WB3DC_U2E[I7Y.-Z>_[I(G6_]UZQN.3Q'82DT_
MIT5U<,QDTYDJ)#>A8"7W."+Z'1X&RO5BAMBM](!Q_QWK#U8P,8,PU@7WRUS/
MB6LDO/S>?YDJD&RE1_/_] T8MATIQ40:_TD%"RSP0^*&Z44AORY].,6:NT_D
M%M>%HE&;5XFN83D=V<XE<=P>.BW&R39&=S/0E?&'MDA=K6LM7]ZMB"M*K!KQ
M8P+?V@)^2W7#M8L,84D+YU[(?60=PY7$9XN^><H@#.BIATDQS:6"?8H8."<5
MTU]I:3+IUS_I:RPYM?5  E+<4\QUDD\D?:SR^$M%,&>/\K0.TBH#W3_K!6/:
M0$XQTWFM0=C-IU9/F>C@1Z40V@\,1=^H4 8IKIL ^)=2-<MK*:/OWGT2H&-%
M5%6(R:^R#UP,8BO(VK"^YB"W87//>6G$Y8+@BT!3>^58JD)-UX(Y%AY?TL&#
MB;^F\G56UVYW,W*,E$E J&]G6>D))_Z_LM)N'?:_M]2XWD ^06USG,EG,TH1
MB\X!%!P44?EUTEL]<E3&S:]5=+;JJI"@\2S3CT%H ,+UJDM61>6OO6HM\AY'
M+?@&>9*WL#]Y)+5B()A4]]AI)*[O3!9L5+_?%2_K4UXW/QW^^A7K215G@-50
MV%E.M>(3G'25#=8BRT7N56-Y%M(+8K*4F!4<?^G*C&--3HI[8-TN';#TZ 5P
M4!8BNN,M_%/L5W5IR6 +JP%P(]-RX=3V5[SJ1L=5E^P7J>UD[R4!2A-ML*'K
MTAM4[-3)^I4+(&@GMI>NJ+UWG936$,#B"XF,'*D;4)?\IN<T=*-U$;+7UJ-<
M/?"E+)YH(>EJ?=36MV[^*U1?X=9A*1"MK:"[T;H".?_Y8=.Z#> 3M"X>Y50<
MM#D5T1UIG3\84V_@,W<\G(R.M TJOB][4I5L*?MZODTJ8Q5E%3>!_1C7[-^T
M;NK;&E8Y6\^S;B#YZ=VN^JK )CW>FKM?-*BITLI4 #L<W;6"U=O_?<.E_B::
M%6^07(@%/0F#3!X4$/@V\T"CEZXUX191"&H+G>VSDIG]"E./M+VPMX\K>%'V
M\>'RTXY!Y=*-Z47%%QOZ4:0E[:!UA*9&,"E]3:EO$-8?.#B6?@'YH#C83%%
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M"L5AL6*2O+UJO&AHE=).*06.= WBN96(-/SQ8VBZ0$-@AOF9')@^DNS>1$0
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M3\/V+&96_ZR2>#TC;3UA-6O_A3A^ X2JI040T.,/_ACTHOSV6;,\%]WQR)_
M*-/S*!:6SU[1Y:EZ8RCZ!+54.U.#.S)3DL5EI/1BFM(5C I4AD+H<V9>13)5
MA"FE"DH?UB$KD_WP/'DG\\B9FY/RRI].] ,?&'H2[$WF-]Q?7'\3O%=C/J_V
MKJ<=,98N(#$0-1K$6^X3F8@]].S#*RW?4N&=W_"_@#"/'$O!O;JXGU.]8OHN
M@+PN6?DV5V2>AHD0::^JS^R@MVZ.J\!Z(@'F82,5^8E,1Y#.N[W\#(I$Q!!W
M#3K>N8]2$^90ORO6R[]6U.\VX#\8F.<]UI(ON&="J0D=MQ!.\&A6C9WY0%6)
MKGF6WRSCO5S&6Y-)?5BEF"_WG&THTFH6>3.1&DDK3X4K;#,?!$[O(MDFA@O@
M$9UE5N8+[/4BRR\W](09(O_*F:"5Z)*UIJ<,)+PH^O='$R0]?VFJD35\[5).
M.MHZ-0*GPXDTI[#'&WH,:ZE9:;U+^.OP[G^!3NXU52L]D4<;)GJ7J:FT2W+B
M_H'29]K^'V\D%EXW.1/BASEGU:><%?7<997G.7&Z?%@:K SP S I)[/MW*L-
M+<R&GCQ+&51/)1-R1KS6W/_9&0I0\3\ ZZ_&T==<]\PH1:P*X]S/NC7V"I[O
MT,)]J_)QBL]%A8F1-C'L/%RERE#K;A9:/58.N&$W K,GYL1/>2V[1^0YJK.@
M7P8"[6]*390O-8@[C0ZH?283[4F9U)+L=V/VA)3+P$ BMWAV/?4=>GCIJ[TR
M,%],%O+:E^*X8TMFH6\+V-[U5<NN"_RQ+PW;HBM*T[K1K A= 5HC,O*I([VB
M%"_ %H0*51TQH3*'9IC2*8GG7/E98?C.X_F9N\"NT:KB9X,6QP@R0T=NJ(<.
MNT**?K<9V3A$7K68?_1$0\<LWY6D!YH$9L\8BI&*KP"JKKQ(CI:2'&$V-7PN
MGX95.IF,<)(%IY(!DV<!F&:O]-ZJ<5=@!1IZNT]17*F?-IA((YV\7#B T$\[
M)VCL-8\*&^)\QQ;FE2CA#YY/DK=2G5NNN";*.8%Q2[!"^RM*S+KB[6.S1B#?
M7EV@%'>#>PU@(&]DF(CA8^[BQ\#=P7DS?CBCZL5%.I2^E!$KPA>]:X/T9.@M
M#SW=BD8$A(N4T%]C]31[7E!FBTG6JB^[-6DO1P-3[)+I'^NRW=1<_'*:[5'4
M>L;$WL?6C@D3\Q*#D[SI)U\C'_S^3/Z\BZ*X;[VHBX(FP5E%"I1I)I]/IXL*
M18[4)6%=FLH\46\-BZP7T*J"QJZND9\Q<DR6#&6>*>U9I3S]M,)1R%!)[* (
MAI:Z,"U_,OE@#^NB5$0W-S="=K-D@?L ,,I$U?*BR"$:^7Y)>A3,<CI:DE?4
M/?L MXO,5,M<-TJ5U]9E;9/O4;/!#\Z;0H:>;/?+LDS:\1#!2C J9M$,,_75
M;_L8?S)#3>?R0^4*OK'TH;S[(CW<1?LG\"]'9U1@$1M)8&8619/]4/D@3U(I
M[I'<%CSO&SEEU4#;*)Y3<M7\>_"ZX6S6"+4:B-?W?ED.=[_"\0@5>CC!XC0K
MBD255PI<["0*JZ4AJ)*G$HP-@.S]JIJRDHY/$NC#.:;# SPFQCG#TWDW'JC^
M 0@L-VW3XON;)4N:SC.]WW;:H$L,Z V8"L=_7/X-W_FNT.$&+E)V/0=WA>>8
M5(Q?;NKCF'99E3.[([(A>'_AM1I;GW@:CU4?QRC5#AN<:EF#_Q9D(V"J@<=#
MJ]8\.:5TMG4=FNVQ_5NNC,=IO*CG0/38\ASE7^EIC.<,O#3!QY:TG@$E<P8%
MB/;2\LO%E@-TT>NH)O*,FEW.%[7DA:;8)\VCY!MLV+<6H(4X=0^2NWIS+TLP
M=%QF+FJE95AXUV* *]VWXA_'\/FM;QHERQ@BP"P W)-TDG*_$E1AUSIY;I0G
M[>P":"0H2$I':]VPQ4'%>@2T3:1M-]:Z$-B#EW21TBBRZ3OP:3*BPF ]B3H?
MGO1A6 -_Y#_9+[K >]/#UD=6[;,M!]!R5&)G01K55Z_E$6%V]:EL* A<W=*R
M^0:.22#;;:4^-N5,XBR-:K&Z,TA5T5R_?P5(<\LEK%#L-4WF6*7+ ,DQ45WO
MOH[X\%-%]&GPAD0;8IKCC9[0'D\-[)U'YDJ]\V@(NY@2?;KTG?.Y]S.&I]:H
M#=L/M"WS7\M2T5?4F(];WG=BA[T-/AK %.QEE;A?CVQX[#U#_="W"(I:)$CX
M;'!4X1H* T'C_(9KP29!@S/W\-?GW]8@K!7Z[5KZ;(EWFL1<PGK-]'Q#VJ.;
M-DW1P-3R6TU</ <8!:RH^)O-TCZ!Y9J*RW:EV3<*HJ!MR*>TK:(?03;/9<G]
M*E=2P3]NR#+STWUYNE_*/\2SYAO*-1LW+A_!=[XU?FA<U[/PC6SDD,G/6YOZ
M2KB5%:SGSI#9HYFN(@$%F\^/C)"-:#RU!^EB)@HF*?9W["ZRTF),]5&75(>#
MYHV*=,?C32RUEM(4U45O_A->OQ^'+!J9L0L_\D+3T4I$PFZ+\W]WSS#1$XX#
M_6.R.$&+/E*RM.VOW#3\>L"L)$E,#X0EBW#!U)K$Q$Q]9A.*W WIF&7^LT-S
MA(MHVF0N\Y=SO&_C *6]R;P91 _B=3,R,93<-&2SMC(QU;'FA?D62(JI#!M-
MHL'/)<NLK4E>Y6=UT/W?K6N9G6)/LZA65#IN)$NEY<@7&K=4G8'HB&!D6>;;
M-EY5'A,/6U-)C7JIM'E*>?IS^GI#5EV[ PGWSW+!%ANF:F^E+#5@*K1=T='@
MI7;38[);.K/PF<A>>'Y]PSKQ*-BF-'C9+NZ'.AQ0V7%U#%U* WQ&)J%,Z:E2
MX:>S!&)9\!A&9Y%2%M\-?ZP614[ @8%,+Q9PYY%/;O-F2@04R8HE"*:HJ.CN
MTFS<U%J.SRS0AV_7*NV53RD3U9YSB>(-Y8V7>NJU@T+13*]>B/&F^AS4B^M>
MFO;"Y^TH6':WV&&_[E(9LC4>!9HR)I7M88%)S/TZGW8]"HQFD'KGT*BH\VX]
M%@CGMA.?NP_!P3M#-( 5(+X'\I)+?;7IDT=\W>>@QKWRZT'1E?IJ)+1?/R,7
M1S$#:.1R&AJ:7%[;5_[S9ZG#;@O:=J*QQ^IFO(%+MO.2?4PI:N5>"#8ECZZZ
MQ3F\;:?"7\'6Z^YB\6Q)(%)WW9(84,N;'HG,NIV&T+^4IG6^ZZ!\>]?FT1Q4
M!>6E]O:V?^MRYKTM<LI!G2F_@MY'G[1[]),EW>/T8]@512JQ3VFZ%O?UZE7Z
MA?X 2B7Q*I])=$*PD1H>?_^W3+519PI92ZGBH/WZ.ZIQ']- %_#Z#Z#&<UW;
M-1=X-,YU1=7F3NHD!?Q;_&YD[2<*%L2*EQ/,!?X,+_87<9,GJH*\2OLFF8W;
MLTWSF>COP4(UC>^UJ1:HKU^'2/(H8\]W@^GI@54H)BYNX$8K:Z13$*UJW3Z&
M>N-("]L#$3<$+G.K63<RV/M)\M!/YE:2KCI9-S+1 30(*3W GX<;VDO!.FX*
M]53A&A2F$-449NEN,"N(U*XG 45>U$X-7#>5[MO']JVO&GY9Y%^=-C4[ZQ!P
M =C V-],F.'30+3DG;DHTA[DT38%=^ZN0@\6DI8+V8S4+Z;BG)5?UW916#57
MGC)4L2UJ'(R%F;4NO$R-R2*9*\SF/>E=T<BZ>#PR$01^N>I$]_KL_HP,5!0T
M:B'O8E:/ "$_UCA0??41>H0J]& /=^9-OBA#1M!><?3\WQF)X&_QA@ZIX*+O
M<E<E)E^F*IA,",)"E8F,"(;$W&7J%@N6LQ])4XW\+NI'J_)9TW<W517W! <A
M)6MTM:HU.76\M_8^4J'Q_K91$[3$JNY(7L"*&KN_'^6#M7R\L[9:QL:M4)(C
MO.[))T"DW2.%'DU)[7Y P(U]OZL?&+R[.F$4H&M&=**UG^SU#L=JYG<$0"?Q
M_YK$Z6$RNWY]]D6)=MY$%%0FJ]H!0K7L(M%J)MV3X?0QD"VU7%NQO>DR<7&^
M-*7JWH)@XO)8_@,>UN3;MIH7#O6C6)E='(T*KYD_&J+K>2A[R?'9HV<G,$K-
M/%]#Y.)OKN(^S-,++XX>1ZZGQVS5 TS^7B%[^D11.@A7)*H6:7OS*96@C'H@
MTC\&9KMJAE1%-L[8;/Y\=.[V055\1'6*_\RWY&P,]"IL!COT$4W^9:%(7&TN
M'ODFK[SI[)>],/W.B==N#?*T1T(@:V=>'_RL2V+LC:+TO/_[@B247OGTJ'A6
M_!N.0L^8!F,&Q0>4DLX%D=]%F9.O?UZUE?#W-9Y_ZZ@:R32_>8_Q9=.ZN62Y
MT&B-QFAP7/ ME>4_@%<< MFADPIBO](@OWKU/F;U:#O+&=C89KSWR<<5W%9/
M,0J-EQ5+WN>X]W[_EV)^^>!!94&'4,.86-IL<]&SMN0/UB_4UW KSQ>9#Q"_
M"Z/6#65"DQ?Q?J\OORZ].=6(9U;^.",B"+MO1;=!PM;7BYS>V&BT"]:WMO>N
M6@U=^:5LR%^Y] 82-%_)K[$J/&(#NE]^.E8KYQ9I?Z'F2[Z!ON!!!&9^R"Z@
ME5JN:=T.?^?KSK$=L\,GK^L;]-G(?L*S&X#]?E]G6;MBPF/X@"HY:U_V*I.D
M$N0+WWFKQ^^67\:+Q #ZM<762H&#:J :7ZF?WX[RZ%!/CDRTK>%=!W@;*B 5
MJ:G%%_]\K@#74)SYV93D8\;^BW15B!SCQ<<A<A_3AR :E2J+V>8%B?"LFW1I
M&EO-YD&D=K6+PX$TF89)!*YZ_E7)(EI(EI567M(+\="1_G.W+64Q<C6"ZI7]
M\ESG+3#];/_DDU!F2B/,D)N/>LM"RUL6QS TR+L99$O)OU=ESTP+]5F(V=3[
MEW!W64;D(5+;(/(<D)!%^+?5T_\P8?Y:'?W+GB$C,W^\]>(P,6K:-:&.M)W1
M%[W\ANI6I%Z+MH)W4Z4CU1 [DE;TP@)2B[BI75I_F9H)?E &=;@-O?E4"Z,9
M;CUR^3D3##%2R5/Y?["".A 2<Y6/5%$[0W0:4VYQMR&[>9/:I%P9T4_9N:FQ
M_&8ZI6ARU2"'11"]1)LA*Z2_XSK<QA-")002C&0Z_6&=EB\P*JY@>,=GY*!I
MPYY^IB<208RWV"PT3A=H W]">J3&$+;:RCU &IO\\/?<N*)-\YYSD22J:>M4
M0ER >L7\-05K^6G_0835ID[M)R3#"D28 L+X5[Q+K;>A9G: 9J09ZS2>*IAK
MY^SC$F?Z32OJ$=Q.ED76&W3/"^B4]XKL194X:#05W3-%.9Q++Z]2!'4^N\H)
MD/$'*6(T/J)CZ$_6_'0>A9W*F)Y/*-^$9*M !P-1NCS')0X^325*Z2$\U_U6
M=Z">O=ACXJWSV?W4W)T%\)HI$2]U>=.69D>?(\7XBL/$2Z-QHE@;CB^MG(G1
MN@X.Z)3I! >N4Q&^NHX&?+!*#N%.R]T;L.ZF'(,LYA[4ZK<ADK3UR4^\6.9U
MOHJ%*KUR@D(WL85\$4:HX2.5D*],^XFJH?I*0VO2'+;V7S7(USBJV3N#*O=7
M^'T__9;PO6*'^&$6"HO!YDZ8Z0J/M./VKX'CW%/A?4)"4:17@_,ZWFK%7O)'
M<R'E:1SNGH/]ZZ8YLJ,WQ?0Z!99++-6FR1L7>S6RN2WR?HU\-TDM,\,& T0(
MOJJ&"\-V!-^'L1?=+9T+*:''-GLN6UZ<QU;\G0LK?P NL_6L4*A3&@6GR.TR
M^OW]_#4/3WH.<24!<MXG;U)N\3&YK.+&96Z1'%3I>62&O=JH'%=CV1Q49PO^
M'NO5,Z0Z,@X8 :Q 3EH7XM-<"*T"DE.]6 9=[[%,JKYX\U-0&"[QJ&[5?%"Y
M M [3<O='7UL?5<"9=5'0XIC>3^6*PIIB1#/?[601Z\%CY(17BDTEC\>@HA>
M1.DF#ZT9 /,C^FG8%H%(!91S&1Q8*2=)!T&:7EA^F6J$F>H&/[EG93BQ@.8"
MC1BNK.MU>KHQ>=L>5#"MI!G[S\*G&;H5^B5,21LKP+R!Z,I''Q:! Z?DG0[9
M:'A^@+Q-''PUE3*V83&UFV FRIP&LZ=J]<J;@?^RT"#/=!#/G =1@4,8Y)'?
M0*FD(CP&+A 2&<^,YC;*-XC\(QC%Y"88Z:/=3:N*='/-BK*F*!?[R]<F"-6\
M?_^><[EQ1VZA19 UMERQ_PE8QJSR;_N6M!;2T #G*^)0=#]\Z\GZN,8)Q$:@
M6A$0'O=J)'_QF]Y@GA@WFIOQZ0_>A_/)TN.#8T!;OW/7QLUROO9B4[FV#I[^
M'A.33B^RI*]CT?<IW_CZN2'E#Z"UB)SU;PJ5<F"FS\)F4Y9A-M4M2:/AB.%]
MWCG1QR^54U]Y.:Y3R*OIQ-LJ*A;TGB7&.?OQHKK.K9_S;+?+?TT4L9J2?G*N
M]8EQ'R4ZFO-Q? P7V<81+LHOZ85,K$#^GK,77K4L4*Y(,TZI(R!]3!\KT[W!
MDA\T,:U@?<HD9^O[OD8D6':S,%9-YXGB'\9>NWP/]F#[:0G1&_XY%.!KA&%0
M5I3A[?,)5!G+\<S[2*OK5\W'S>1/O!_Y.?WH@D-J]M)Q_?=;W,*;SI#5&5X=
M7H%GGC57UJZ]WZVNO32;)ME<'W!]\EOZ*ZH4A).K^DR.PW[EOO[P0T4US=KL
M='W'MDB]EYTHCKO[M0RO7Q05BOX:78.)XU@*F_*+RE]>\Z8I(=\^CY@3*&D]
MC?'/B[0W/UA8XY$+CG="#S[++*A'VSY!UF'O=M%%5XKE5:<4[%%_^C5$;YP3
M775W0&6A6<0_U=.LY>+AP[F5P_4;'[[D.UQC67X];BGOF[D[NN[W;H95OGG<
MYJ*]-$.#RHF4ES(WI<*O]$JP>88M#(VMN'QM^0;-&$%FXK;\1K_]CNY2FG\V
MZ'G>HA)FB&R>Y/R@QY=PP_A-R=I7.%K8']<8OG*M"4K"?Q\WH\.4JGF]"F0T
MT!U=BJZC'SR+>0W?>HT4"_R?F]P$[.A=+E&A=U.U8T]]+%9:08JN-A'_//J]
M_:=O&J$Q<T/Y[J+BB&X8=S)U1+7RS5N9F<C>U@X',9]/GARXU_1BXZC#*MNH
M:-LLP86JY!!9:2B^OOV2:<2&Y6!_M[KO"U+(E6E91_Q]J,9Z^<<##DQI<="$
MF$X-?M69-N&,P>DTLHT-:?3SUE/A+O-^?MSLR4P#'QPR-FW]C7]6;3D]?I+N
M^[EV;U/V^_ROL3^ QWO9C<]H6T:5Z&4&,$[SO?TPI):>VXM3+^5CVU[9&.U^
MDS@LN^W7\U;Z1P]LJ.>=%A5E&E?$2[K].,LA8TJ0-H0AE1Z0]YQB6C_2RC 0
M34KVRGM\9B&SZL7_^7TF>!FOYQ:X1,S@JT;6R303'(2T&BN_F8 %/LS:MC[+
M$E;D;J)W^>_8S"2)+:+%8$LR='AADD7G@+Q@'[;_/#XG[VK17CZSJ"^_0PB6
MPC4MF1RWA!G% V?Q3*;!9H"V"K /AO/"MI&^'I@HSP!7(,I((!@]&8_*H9F&
ME K;H>=6?RWD,UO^5P  SHRMB,5JO+AQG'-L28]&K'#=C5YKV(I?MZN_=_C[
MGNFHZ_RQ?:G)_+7TTXFRVH]4>[BK2A5;\LBRQ@3-Z^"9BJ*PLO+E<MW<I9XV
MI?_%V'N&-?5UZ]X!!!0IEB!%FH!44>F]"X30$VHHTJ2$WB&(@@A(I'="AR00
M("!"Z"A%>@\0.DKO( *B8'GY/_OLYYQ]O6?OZWS(-=>U5CZLE3+OWQCS'F-*
MCR*]J@FRU'Z0:(./:\.B(:NDO 2?N;PZ&I6K(;T8906B ,OY1#N+1%8$ SS0
M;Q3#'<> "&8SKBE27<&HSV5%1AKL=XOTR.HIQ.4B)E2Z%<-<WF4-!7PO[?VU
MK<*9IR3YL]Q"+O%I>@UT4[@ '/%C(S^^CX- SE:">MF H0"P,JBX+A2%.F69
M;9+GRZT2),)^C='JQY_@Q)-5C53:,=Z(+>G?*#6QR_#EN0-WUEW"O=GWJ8E+
MO^'/V!R(>>OKL:7AE%(#WX3DGL^7!RR+[D/V($(L2L;N"*B&^?$AHQN6!?9X
MD5XX/A/BAN8)@A7TT&\:^\P'V*NG[UH287D^T9&L$V(;,8EGX><FQ2^L)L'2
MA$!7NQZY3(F^P?X&=CW_DJZ_ ->;ZPB3IPP6,6EWV'?'3 7L&]2346L9&]'&
M<@CS[8M@-M-G&7<NJA$ME9^!<5$*9H\XL%=^THVX"?*8\S1+%XF.@C]Z*&=E
MGU8)5I]%<?UVPXX[W=)("2;'>#Z3X1L\8ZH@W^=GKIP]Q7!*'?V<EE\9-I]?
M%"OQKQ)Z>0.T0"599SNB+2P^@S\D/N-\O($^]NYI'>TZOVC=JES<;<[?"LL<
M@L[E%A.OL]?'<P6341'<,K_F=:!F_*PU0B86,BHO@]WSZ$L%_]=@V'!_SR>3
M\^CKU)V081WE7\\E'],2$#=^Z,[0,Y#RSA*)F5[;^A2H?'31I^?A$V/'2*JK
MW4)(K#P5@IB0=N,RVHQ(T'])$_@2F45/IQT1![G1M&:<_244*FJPNH[NX3O,
M4:K;\ZN/H^M)F#T$M\M(#X3A2EXQX&4<@)^?>J8!]C^+ G,^6!'+5B4:F0NI
M_&5.,?Q70B&!?&D)P E6UEY^"8H>07,_31FT:-,*JI<S'M093@9L=X;K+3BA
MN3RP'NR"173\"@CB2_ +^8E0(IGB;[C4Q0]<@M!#/,K%,6138NA;V(YZ_(]]
M71X\Y+::<QP":@ +9J, J2P:@P:B<C9&,09&Z2QHB7O*EZK>M H\D.5(^[P\
M_)C[[*3PJQ*!1P"X8$+9DZ!%S&G)G1@%9K$47MW6'EW6-TIRX4G6?1*"K=DW
M\&K3LVN7$.F):(ZT#HKY.,FZ9GD8\:\C23_[FT926\7(M0?"%#V@IUUF*B\#
M&W:B:SP?^L_:\\A' 7R7KC3'^W?']E%J(3J/8IE@D]J<,DD<2H14R>Z#U!='
M3ZY:K2+'QNP*C*>E1THIJ%& 4YU[;P6HBVGRLV_MQYJ-V1?\UY:6%JOV'L]-
MV&>7U1PDGVJ\ADM)!]VFFS<8M#:(\Z<H_S4@>XH>.Z%P+M$C8WM72/.'BM+S
M0.OK]ZJ#ID,&5\U.;>;$-FNZ?V$^3]A<E*\V[KZ\O<.6D+##!\6ENC$QF0Z&
M?6.O!^I#;#0M/#]]/3#YSQ+H-M^5DU82UAYWUZBPEU=5!*WUDK*:RY\U,8[N
MPF)R+52W89WTYSDSW4<<]9^='4TW&D/X0WRU*YI+)*9YG9$1(@R9UF,)T5\)
M<8<YPQP;S;LZ@6&/.>'KLU(+Q1?3H8ZO%-ENR2''N\W'V5X$+M[<MKX?M8N-
M?TR=/S4"BMD?/L5;/M;+?;OCQJ)!8YG'&?.0P]^[5Y*^]*Y6<"_!8'DKOEE4
M<6>IB*&@,8+8E#(Y,)?MT]#?G'V_7\KW%L(XJ;>)QN3N:]$.WA>$.E,,S^#!
M^K/IF<@.Q Y^D]=!L2*/)*+7]A>0\X?D]M1@*../,R'P?I'+]DD[)ZJTC((6
MS7'JUN4\DCI8&HQB$#)1FAKYW'I'J"21*TPHK_U!*2/WVI/(B\[\_F_V#3HJ
M!E A2J'39TS/B#+[1D,*]<.Z<7<IVM210KK;_HNJ:)3,VP"9:A5"Q(O!.%^-
MD(=Y]Q(-X_N786VWV . /4T7O8S#$+Y;L9C[F9EDWK*5TI/9#U^'5KR[[_1>
MYD#<"DBJ/,\_&F-==^^<RZLJ>)1-Y3?76MVS_K%>FW.I6F_B91#<;]O&>>4]
MWQ3ZNR1!T:(<EE9YP,JOCCJ4P$4-C>>WFN5FR%PQLURN6&RXB9.L*RE<2_A-
M)2/9'UP-O1!+HT-NL^YY+,B;I0=/&(I]3J/^4<'<LZ?-]J<DB&?(BD/8JQ,1
M%RN@Z8EMVIY8 TRUB<2W$1M4K2&O)%X;&+&^.M08A8TSW74804RCE!K>?Q-M
M:0OX?K:R<35<,MX\M!@E=]=B]C/>LTOLBREC+J6AI)S.9VX5]+306R>%4NV\
M091O@E!>>CN*R\\LAKL6/C0  FM>U-6Q/KE9[P/*ID:%?A6DEK0F[]J>#(=,
MTOV7<@J)GE*4*_9-4@^& LFP!+R-+-:BKTL\<]40 8U%8B3]&B>V"NU4+F44
M)K#_C[@?:L&I"R'CVB" ?TD;\#*ROHR_R6G^NWH0Z;R3'0$R!C#L?W6:3\E(
MB7A<.*Z*O?)\)3,7&0 \$'[CLJ]:HF"H?9NV3<B9+U?C>G]A#@,L@ N#D[3\
M/^_T__>Z%/3,<^CVO]0=$/(!7U#W[A!5&7YD>JKO93YE+"-3#<[H\64K/)#D
M5Z#Q0J0J')R6AR;)_R@W5((:318>%8"I^*U>$.YKTM.'P?5/LA@X@]AW=-F;
ML,Y)4P*RS*>XVS.JW4JI$W.Y,IND:%X!3FF"PN\YC1.,HCAD6(KM8V >IX@>
MI]!O5WME25"5_B\^>2)5)[0@&17;Q(SET^$ IT)*Z/-V)+CXA&Y+S2K5*>J\
M]GR;(LBOB(NYUPVJ8A=5T1LM  ^GRJ34!Y(+0+ME<OF$>+UR.-(%4Y)YO#^<
M%/J@V(/\H%<^^1_HIC8QP=W(M1BY6'X)#LA(BCD8.5+P0LES5[!/VY"."3SR
M.)[RQS=GN( +1Z@*A8M$*M1#S>&F;6VL;A'.]9J=7EK<S7WC'$/S&S62,<JQ
MMT=F&TW'WDH9UF_>7QD611VA>Z&H3;I4#P"]6\NT%P\*\,N_RE0X3<P!N8VL
MF;TKX:C#$A-=//7X=0%L/E5/>C2*T0#2\&?$BD.FW)=3)#Z>XT &B9QNG#)0
M63 KF+.Y\9.JJK^,TR9-4R1++X\*Y[/ANEX[[.WJO[)WW./F0Q"5_)B.ZDZ9
M1&>?;L3HIL-ZUO'+CAT*TW9HN#!==O\FXZ8HV%[2V\T&YDX7=V2AEMKD78;B
M7+&L;VI-CO@RS5O!(TM-:N!W>,Q[;,+S)B2GQGH,4]0%>_']U391L:VS'L%Z
M8NGV%R"OWZ&P7ZV8Y*[662>QZ !_\S;4V"0J&<T^OI]/R3OWT*VN2KA=[T,'
M<Q#CW'2\46AGQK*A]5] F1?&P-":<T&:B/%4EQF,^)/4DZQ)J?3"DQD!U>*7
M_$P7M]15 Q8 EE03HQJ3"EF#CHSR_]05'B.];.F]+V-V\LSS2>!= QC"<:Q-
M5-^&'FY!&[*M'=DM*,,)"_2E)EQUT7==M)Q+^'E:Z-,M&CLL2(U\^A+LC6[7
MGXR=0 4 PUTY'Y=04Y^40CQ'EU7&<O0I[RVWX2Y:)BSS!<@:OTR$ +^&GD.D
MG^*O7ME(Q2O_\-G6HZ:6:%?7[86%H!4%5!Y'UF=#-A/QFITXLCOT=#ST0@8(
M!@/\XWN;P!B)OP OL/JNRHW< _0I3A&79[EM_%HK$D36#0[F7TJB%S5FU[SA
MHVO7A]/>E)@^/45?"5Z;,%@\PX5"&:@E %.[^^#VC42XCX(S$>=^Y0FKKH_!
MV2DV7P9G&?O&+-G:*^8O8%+2]_4WN@ $]7E&I>A=)@HX4J!*K3/[H4)M"T8)
M!W__D_5Y"H(&L"XI+^]:]9:29=B2:#I'M&X'^%BE][2\7XY5U-.<VP8T\H4K
MJBW]D45?+46UV;@M>]A5!5#RYCJUW:-?IR;]EST4J(571=PN^+KS#(:WC7])
MK]SY.(%.3P1_.AKJV?QTS?[%[D,?HZV!!Q(7K[<$*,;\*]:;'Y"MF6*\7U U
MIX3N%L[.R9F%_&NZNF$C-6_!4%C.^HS8RN54Z<90J]UH-TOGDW]WDL.>27%G
MI0IB)K?;^K.0I-10=E4$F='+V"04R;&Z;>.U6M%T+ZK^W'2R)%"F%_+>[>E'
MX98V&YZ16/0IXT9@\^OH96W^:LFM0&FRDX7-/ )I>Y9=H9F-L,F$9H 1;OSN
MYS5QAM[?'K4B=7?7( >]V<N+!T$=W]0_]_XY#0CRNQXF"Y4<FMO<!UO6X-EM
M?$D[3*2ZSZK'0-%FZ],*EQ:'7KQ3NY**GHOG/!DW]DF;?B_HM?:M"-, F>XZ
MWO,I UJ=-J8 @Q6+:&*Y&VKI-';'81L#\TOMADZ!WQ86)L!SK G-&=2H_N9)
M#DN,O=LS=DVCHZB"3-J'U$NE+DG.X/X3?/7-^;!2K09O,372BZQHD0<,\,]%
M1A(*]WM*(F%_A,,E8D\J#1@:TG'3VBL:BY[5?X;]E-^TD6*$A3Q O\OY4U$H
MA^;[O7;&5*N"56]J16OI]I'WKH IP7WJT%^M(#3$H8G7W$+<E&Y79(A'D=GT
MQ3=>"9 ?K\>6FZ!PD6317K/'6-@#4>4N"\-/O-DS")))5>G:5A=J[.NOZ V2
MUDZ0&2,(KO40F^MWI3ZGH%EX."#P.$#V[N2T%T[7 [\^RL*X.0%R;(/N3.$E
M[5,F">S1/VH3$7IB?E3%%?G1S0+XP%G/7OCZ.P<2TX3D.+^_]-W\B"L7^^RQ
M^S;/5@#W)V<V2\R\@.O^VXF$D,73_I3?WT(G->42TY .V>23.Z*1^\9!=YJ_
MX[F4@X8#S,LJF,\@-[TY+[#-APQPNSBP99OO7)PMGX;S=G-J!P+)@.BI^M1W
M+FZ0[J0!^%[I!00_^/-\I>0K87[0,ZXWUY3I4YY*-QE-J)D"#R[7M-1N.4_;
MDXO">\W,["Y%CUO7\^M53;9QB[LSE54*?5.UI/<5=+J;%-H)@N+#?$&L2+.9
MIDIWOWF(+QGZ EN&7SGHD!0;86\>=S(3]$5JR ()Y/^EI'_B/W+NK^(<)\PG
M8L".19-0,OGM$^1_O*'0D/Q[<<*DX6-@X.5 "P,+NEX*?B2&?0OPOTJ3_J>\
MNZ) H=D=I" =Q9V4C)RE"%&7[DM>F+L\[YK2/IX@<*A:J/XT0HV6EB@M@D2<
M%%+3P#SDDEW^Y]SZQ\F/_YE;5PE9*FML]L)#-38E@TS^ A+K.4ZA6&$BIB8W
M)JAT->]#VHB&<B[%4LY"BA&$K$?1-78:E1S27PZ8OY1TN0GS7&28@2%G0N!D
MH:TSL9AE/O]48%L[%D]=]MMUIVF56,)& =%*$H=T<J_F$O/3LN3;<+T'K"E+
MG:N")\4WCXEQ>T#<M[4Q</RX,X63$&,'_URY3E"=@R3KPNVQR84IJ#O*,AX?
M#D=/Y+5/4LZ6<IT3%W F5XA-K?<<].>V0FQ388$3/(^6&#]9/V7FV=7,J?8,
M:VF9\&D$Y\TN"5,[C(*#,B(W^C;>::)O*7:7UTQ/!"[^!>"=!SZ5L<,\%)P*
M&UM C0^$6=DM+,3NHC8#]I^M7(DN28]?/L^K9'IS&-Z%^E"%YKCDY+<K++S-
M][).3ZOPA/;(0\BZ>X&SD_^H$/]PH^E#0AF^U?%@WSS5K:6 K(*ZF[4D1\WX
M&#FNFG<363,&<[LFX]ZX@K8\/:YIP8=HYN'U4_=YOZ"6WIIZ2=^O,)]HRL^4
MBP\RO*G6+@T_;I(T=2N>W7+3@DVB7/JHFK+&WZ:$N6&!E:_0*5JJ(>6U<U&C
M\+Z&%B\)HN]G073" WW%8=U5^VWCIJVE.W%ZU*BE]*$?([9>S]\%=WMMFVF[
M8K_Z=/O(31X&!(].H[*$:V'IMS0L)?IQGL;5^B<990,:5ADB77PM)90.2 Q4
M:?9JIF0)=XS5Y%TULEV(IWSXOEZ7>K2)I? @$Q>"Y/XU6>RWF^VWA>_ETT9Q
M.&"1 11D_)YS/0+.BOL4K PC?'R\7_D5Q&NF)1*'D7\_Q+-/-DTL&XB>V_99
MF!I6V$^NW34Y['/#].+]2#!VX+K#T@?6OJ?@Q&WK4V].VDQ6"8N3JO-6FCG=
MJ9:WAM8,E_!06C[]^B?_MF'#S7Y=9:(YD?M[L=^?I,E8U&%,IV.OPRO7F2^A
M1&F"D"-1]\87\5[,0R7WL9*V1VW0&QO,W0*7G"?+G>8L2<%6DCMQ=&R?I?1;
MGA^O<_] ^?**3X*BJ_@K0<0&ZD;C_C:82M^56O>LU%^FL(;!"C$1 XQ,1<$R
MR/2-4O4P+%3AM-# U:/2:A']7JJW<6\>P:V"T/S Y6%V@.<"K5&#<I2P,Y ^
M#9"U46*7(*3O"Q>\UGWGBJQF"#J@EZ-."V7:+R'2'A<'<9"HSA>D4BW7I=K?
M!'K\%@SI<0T3"G_K)7N*7<TUCA.2ZML(YYE?2JIB(.7.C@+IC3>B"K,ZFWX)
M-FY*'/CIR1XKEG]Z7#V,O-IW#LG]DG^RSBE"P<-#GJ7INC\-7/+1O=*+<&5;
M)>6!R$;T),@9MQ0%64*)-;+ @FY(G3VKV29Y\S# _DX5-.^4Y/)TA\[NS4QC
MSN64X'N'$?:'S,?IB..U":KBQ5!]E5F5 ,6;S,XQ'=%^-E:?KY@FZY8HX[:/
M;3HI-S@(#/.G[,-=_H5T^TQ=23-#[*!=ZU>T7(R=+DP-*?VQJKO6DQ:B56$"
M9/]ITZ+&<,D".=*0C^O(UC^(110>N0?A_^"A5#78:3L7=.S50;.B'Q^U_HS5
MV9=LG%;+U7^U^NP!T>YQH6CZ*MF0Z3YQ<Q"Y?_N 9!-K^Z#2(9$M A87B 0$
MW)/![%N<1WUIL!4GO::07/T+N"5?\J>CZGH'H'7/0-^MGN3X>;DE^C1N^MJ7
MG/"HMEI+J&;=^&=KJTJ?/7[4\>>[91D+!? ITFF!T.:AF2S^Z?46-?%<Y&[1
M77%0+S0\09SM8WP@XLG:G/NHJE57]W&B@V6S,D11(V#4V,M.+1(7.2\YN?2$
M4Q_ L%Q)YE6_QXG8>=[V75G5:E?%0#TZYX:N$D&^0);*-2#'/J6"?J/X_4LQ
M(R:,)+>%.'\FE?Q&*;54-'YQEI/W,:/606>_7DM"KWJA]9N2'KBUS>;0&FIC
M[^& 3H,BG?GDH7=D/N'.Y"45A?'Y(?N>;RJ=HLN=9<JGDWZ:5)HO^,LQ2#ZL
M"TC$F52>&K%GP4I*GWI8\/!7,SII_S'\D&Y@JQ'_D+L!'K9;3IH>FN@X@;43
MO;]%6C\8W)P#?J]RE1<WKI-Y:2+1'BZ#O_9@8$&:G<ZDT3K%M"8Y5?VA5/2P
M2///&$9@84L4/DSH4RT%\OYC'2CW!GDBZBU;W+3!2ZQ/KBG[\,?4R"UX"+)&
MI'M"J_3U*&*W];8O=CPR2+)]4>I'A4/77.+,*H_$[P(QOKD\SK>>Z;?A^82N
M>4ZQ ]&MJ=+*I[\_&))M&Y_,,,QG[AJN#D@DG#RA>].^;_7LE_WU_8V6-WV6
M 0;P#04-UW!'<HP.9$_/\_D%]?5M*\K?Z.0=R.W<V];U;Z5FP!PKV7[HZRT9
MML(NE E*PE+N4K(5[C&<X"WLA ::\LV^Q9VCV+S,I0;=H/>/#S-%'U<A1J8^
MF\0Q')H%^& R%(78'ZGW8)FKU<U-4AZGRA\R,-1:AH>*>/]1:I8VH[H1PMU&
M):-0QISPF+ V]WLTN^J;+Y6&D(Y:,?(/2_K>H>'M"-29!_U7/7BI8D5'B4>F
MD!:+Y"X'0XN8&B[_57&EAN3DB3FGKXF(FG5R;2"CTP*C[H4)^[.K-4G33',R
M^$ _D?(_/S.#$.-U4U3&MZV,'Q _]XD%PTDTXWVM9W@K"3F@A.(=XKJ3$9)@
M+G<]!<!/\#(37]@,C0(:@53_SR4&5^#X+1[^#> >T0/3:P OHJ=H$P$:QPDH
M"J!YD !#/PTNYDN":"LK(0"1]">!)6R7%$'F4IP2\5;C'J;P"@8-K/L?-XF#
M& H4JHUKJQ0"B)!Q714!"7\@1;+*'CM.4(X-(M@O80Y9, PI2A $=#E%LV#O
M72MBNXUT;Z6=L&.6/2UN3W9H$Q%]^E!#"?WN?^S4\U_K!LO_ OI4\J>,\^%+
MY<H3H'+UU)-J<&:G4[\!5RBTA^ZQMQ*!UZV7F!O+026#HP:[K!V47LI9V752
MP90609R@&,QRBK,%/=8 R4 $DZOAP2Q7SHW?J3"S,8Q@857EZF'P@4>,=.EN
M# #&,VPH=#K!9?YXE92^9[@<GZZV<VIOW;2!UUVR<@\3?CUUJOY],:(YUW#8
M=4)JK5%,2G6E:G8MP4VND^+^.S]3T[4G,Z/@Z$#-C"C\X'<,Q^E#=)'=L)U6
M6(N143[>\NPOH+66>LRD1RZVRL0OAG1 TZZB,"V/_2QG\\HRCI3?>)$='4I2
MN(-FGQK#+?2/0O&M4_6S7Q<U_'A,TM$7BT+R/V>>7/Z<:@NI-Y0(-@-=)LFS
MVXA:>4H1[17%ST[\DV;2F"&'5D#^Z20<;6U!BX!\A[&6(WOYL59951&CB.G6
M*4X%28?K#L#94XD&&LM$,(\V,QB\/G/*]$!L<<<#LJ8'Z%]E?*5MRG:&%W[-
M-Q,F_/29'>X"^\1G!:*%MZ)O/T5'B;U(Y]$Z=BI_+'/? G=3NUE]%&R(+,'H
MO,]^A/?OD6.9POM2A'\YAR;'9*-4<B)*-<@63\HJ]#<FX:P%KB]KW:$6&P\^
MP/":K1/WVY^;&B_;5Y@&CH'&:++;!80 WG!O7\)87H*6U("OX*-><)[#3\7M
MR&Q1T^F[?MI]Z=1\QOZ]DK 7Z<7;26X/MY;#3TJOL0ZPE27*0(28,_VS]_4#
M-Y4((N^]W;2EG(K-GBZV.+29>L-V%,ZG2%9]!AA5[A5_I=.X]!6W.Z&?NY+C
M^1009GY66EW5/RDT3JI66FFU>D;2#A@II_]C^6)LB.ZDLIB:TV>X [C>+I'*
M<!(M09:*/+GW-1OD?6A@!54[UJ= )8O$^*"\UWU 5-I%P2S8[\Q'B0,)RG+D
MOTJ7PL5_0"P!)1C9,%?187DV>TS*3&!I-=B%A6<NDSUL2XU#T&]$L%RFA%/*
M-2V&0M\F.HM*7$<[+E!S7']5=E^W%W ^<=0SIT)1=%K43&-ENTG,:TC$ ^J%
M9#N&E:3ZNF_Q!1=+M ]3\BF^ Z&W48%+2_]XYW35 K&VGCC1B *8E)_*3?^5
M@@[R^+S?@D _%5J?86D">#?9B!5-SA: ?HJ R'0S;^\;B\:%=$O6H$PO[^-J
M?S<Y2R_8=5>?9V.83^YB0J5G-567&]-+GK6:.V7U1#U9GUW@>D,BC'R-$WY%
M-(J?95@A03!K7T^TF#ND6_:H#I+U<U&O)_@4*T^WJ^>@W[.D*%@4) 6'3IJ2
M:QY9FT;^P52DSU^T"U>.]=R3C I[:XFZ! 7?-$:ZB<K O=$Q&M3[YUK2R<4&
M7#+MA;24C74%AO,1I&;&"9$\Z2MLR&^#=Z<OP,.IK_RL3ZM:BP4Z%$% L@H/
M;/>569-NUX@(I+NCF# B;F+KWTTJ&, :LC H,>(LN) V\<;2_:K\(1!5$R6I
MDS\[N5MK]>*G[D>[UP6B3=VVBE&',ZMW]4$;X8H&ZA\N/-Y_"#6MH$5N*-P#
MUIA3)MWPL98+6W(A:WGW>EJVK*FQU80MPO+,G;O!P7S.46W#E;V%]<:M'5PB
M[<(CM%-K15=#@7->ILS:=+4;2+G&T_"E]W3,_.&KGVWBUD!$SKCD<VTIQP4&
M>*>T[M>;VS"Y$I:54<3@-W!O7]463XV&U=LK<:2$1/YS;5BT0$0B*M- +?,)
MJ6&,K])3^T^;6\G;/PK*-.N.66$X3;>*VJZ9F_M6Q_>86:,^YK]>/2!)%;CO
MECE[(7:[/^B0RQ&[2GO9<KX*<]A]2]&#L\[0!E9YNOFU-6ZYO<OD,&-,?R"Z
MEFJ*\9E9;\U 6L_LP-/W$A]T//:F"_"%";]2*5>>+7=<T)!_%4N?YPZFXB[;
M=7 ,-S/QHM%LW+?:?./P>T/#ZEF1!]MZAEY7*.ODSL*$?ZBX1(+*,*R-$!IT
M)8[<36>AGP>J==>F65YK\?8FZ5U=.@<(OA!)T\B^F^\%#:C1VS\#][+K/5N<
M3>4376I^4WS7'(6__[[U[2D.<J\76F"M<$"KX>5*^F,C4P&%%4<@,X T=;FO
M^F\N:+4Z, ZYC6457Z'9#183J"RX.>\9_L6(!<Y?TXE;RL)HB19Q8VZ("?8=
MZ@E=]ZCJZ^=U.F%Q7T?S-=0%ZRQZ\F <S>?%=8,/K1.RG==[6]A6FG9 F*80
M3!>9R2FH]<+A!.NE[-JQ;<9G/;8Z]^[MY#C;ZV?X=:Y 25\14,^G5!*VJ9[L
M/*!2OGV\;Z:J49$,!8LNVH2]&X5OUKFEG$6]G,/1QHTS*J5315ZGLU-ENZV>
M*IX1X_>=KB^^H0Q7./'Z2=^=9H;WU3,.7'[UN?5-A.VYIAW]#:;)CK9FT1GY
MT)LVTCC04V-G)6S;2VN#1P9VI]7LDY-ER;U6TR;L\43V*_GNNPD];5H=*A55
M;@-UC&)+7(K#H=31R?9)9'/IEK>EB[8-O_0(13>J3.27-F2%V-X>=OJ1X%$?
M)SYIEE_\,T&B<H1JV.01K\/BI<+.%;N%8WJIWE4YN]PQ8^Q:^)'B0N"29O,\
MK>IEIY_!,Q37<6$?#_AU>YI1?J&#[I,&,T89EZ8I]48$?UT"B/&-_\POW,.R
MAF!1+K%T_$@C(FI10ZXL^9_-7 GW*8&&B/_@E'_R(1 !^3&!XG#ZDSHCE4_
MH.*$DZN"KI>GKG3_AU/Q_TX?>67#P+1^)@EG)!@&  L4CG$I!V;%_^,(,"[-
M',0B-;KB9[%AI/,I@6K&=0K)L'?&K&1%UZ$1JQ(" QM9(V3=%""W7Z/UN534
MQ$S KTG9SMLJ$JK7-P(KTK/=N*0?"NNG7LX9@O\M_$#O_P48_U/=9?"OZB[E
M*7HO\RF.F%T8:Q:GEZ1&3?,_ML2T!MZG.5]Q9-VB/@V2W+8;N(-[AIO(9#TI
M460J<Q$@[73-@1C%QFIEIX6GO<;C0"K(94-,& +@^D(LAF9VD**5K*N\-&D
M.J?!E'=M1R!+:J6T=?8MX32^5W?6/?3JS6O/D<?*@H>2D1U<D@B;ZLA21O;
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M_JWKNN:<"\K8$A>J!J=L'J,0+S4GV \8NP!G]N1*\L3WAIL]RNI.%^S@,!_
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M/WQK(J)O9Z(BV;9Y&OAE0HGN]]C?2)HW9[XOSAI\Y\Y:LJ6*TNFUI;_U$__
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MJ>)N?-]7.W$FHR,,2+T0/<? ;U?$L^U9-;P[],GEO=J<<=P:$JD.&PPQ]=P
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M640_8)3V5990A1SJDJCL[E87BA;W-.3(7,/58AOI:&/.Y=,"GC:OYV<>HTJ
M(*21^N/WOK\S[ PEX49,GSHEA2B?$$T".K)>?]XN[\[0CRKKWFY/2']4'Y3J
M+]W,%7D 9@RP_L-H2!3(<1BX*&?(3NX7\F4S?Q#PKEJ. ^0&"VB,;!6Z\W+/
MG:Y!(\%+'?/UB1;_L-Q0X"N';OO;&G?)E !U3<I-@][XY7^.T:=/_WM"5E</
M%G=BIN80F32M^4A* O_O4-Y_\AF.\<LSES5G9\9F#S4?B;GQF6B;J,HQ#'D*
MBM*;Z':9SI JSDSKHM@H(@>.7$$AZ?2W'9K&2D36^ZX& WU5O;]E)LVFU!-1
MW8M+*R-<$U_ 1$TEFN".HOJ>U/PWT/WS9 T;$JE,"U,9X1<*C-+[20$8X3M0
M\IDTO_(ZG%]:H43IO6?/3 GW NJ#E.#+[BR:,K$;SX<Q=F.M]/ U7ZO%CHC1
M^7+>V!W&FOUMQ>C8743%E"=N4+5ML6\'?$8S>V\6N!BD.]KJLQ+C?J%MD-OC
M"8<@HUF:GI[Z]1YVDJ]BL77;LH_,SX$3"'1UZS];:AJ:2?%LK^@EZWZ#3QG(
MARCL\(*MN[%1A'EC!.UA[=A*I[8FLE"=)NM0B7RZLDD(EOHYIR#3/X+SY'^-
MIZD25M'AT'13^?#Q1ZVNLSHY'7Q&4@IAEM3?-L)<2\RQYJ-)N9A:T6KJ/#!Y
M F"-AMITE2_#Z;F4:H7X)AFH?#D5"6$2[D2/G L6T?@TKQ%HRIHAG;($M!8R
MNC.32!_EB(+ERR&)'QGD3D"+=\G-;,?OO*+-MAISXC+_5%/'6_]U-FH$=0"(
M^UJ3IN=KVSRQOYFSDQ__'8FJP158V-[YE7I1I]#Y*UA&>"!>@LV\<+O_?\HQ
M_T],8/4LWU\2\)H>R3J0^T\:(>_XGNYY@ZCY87;"16/$OJDU6;]@&,6(EHQU
M%/N]U4;H<NQGU/@[X86:]$V[;"6:#;:B^[:".T"?88M,.>!P_Z>"%M2;<CB%
M44LJ']%;S/Q<(>J%7>X?VV\PJT#AYA-=G_< ^_<-4MD?S)3W.JW%FT1/&?C6
M7/KOV@)XA8!#07'/>QCKF:K-_1(2F8S%A /"?YF[=?_)^GPK#&+#6S8D#]7(
M7\SB6I8"Y<I?HA-:;M->8),*Y\_=,Y2$7+Y(*A+\O5#U]!PJ96[\QYK,W'!S
M^0-3OI>/P Y@O4I'/KWEAPW"55<;6*T?2ZB6ZK!O)&Y9<;=Z442K9-4&0-2C
M#MY%S*=RP7<<@BDOIM)1&UE8);D/*^+'S^:W6F8*/'O7@+ZFS@LC&^:'-E[R
M#0Z^N/OV&A1^*X^BQJ5,;9O=ZA1633,VS6#+(RYVQ*\WM4,\<Q.XWIU7V68^
M>1JCZH*C8YA1@.$>/':X3<>)51$TYVE8,>10((9*+&I:]&2"'<)_I>KE2+^M
MXAJFL8[B&<;HC:Z7](T?=G\FU%E0=U>!J,QTF)L8"E]CVI6<EKR_S^F73W!Z
M5,X)IG?G*F.QU0]B/H!]TDVFB]!XZJ_'' A4?XND*W*MK6#2@#/K*D9<E9U(
MGS[-.+5.'.0]W[.:^UH[?NNB$77F[B/>Z/D]4TCYHE\AE^&SVIDP/U5MTH#W
M:*U"UJ?7)*'$E!S9X=L68S9Y;AH\R@Z-@)JV5AK//,:D^-LMY\!YM].X#OOG
M)@(.6YQNR^-XZ1AQ*HDQ('\!FI1I79&(.] B2<)_%>8OUCE /0*434&9CK@L
MDKWGS?P!_AFL'DE+$U(S]>.W >1[-K[.!7]H4L=;+1H;N]_<%EMZ;OLH&*O,
M,V7^P%'FY!RSSU;R+Q%;)Q>FK[O@@+2&@CV*C^#(60'YB\;Y,'Z1K-2"/3/Y
M]]2I?Z#FK4E-#!GXJ')E%YXF+1^L+B_W[_UU,N7LL!X:^AOO?LZ^.C@"H5EP
MFHE=E6&ELWC'!DY\QJ;V"/1Q&;UC,Q5.3YSZFA!TULE?.2:'\>DV(=QO)8.1
ML/D:/MP?:9"(I$)EB&($'XJ7TN7-\CSMY;O ,-"K5MH6Q=R>@ /SPWY7$C+$
MX_9L+CY-Y+)SGL]T9?DKT&]X:EH4OZC+@*6-0N^@WA,?)PDN7U:D=_@-9P_U
M$NEEG[]!F[#.C">?S9'7[\_\:,"^@6*JX:U,W*@>;KW=V6R->:*_RUF^ZGK7
MQZ5.5P>%;:Q7I:2.[HD5%6G.#D<;#B9HQ6H2)YUR\%92YO93=O!D_(5%,G4=
M6!FY]]QE\$7 '+!N[:.WXIU"ER)!VR+F/,'!-/BWV\D+2HB.%F+<?*[H+^#V
M-O];>'MNZQ"I37%V/:;8#ZIM%KA.]LB?YFTCQ!S/N:[F S*#;:4GC%4F!^J>
M$=3RL[6T)'=@)P9X'MP Y7/P"HDW$B%V&FW+^5%=CK#UZ&O+-S8!Y,H ?K+0
M7!:^\PS7S?="4.S;6*9-*QHSU7(36U7YY9ON@6[MVH-$EGV 7%BCA/%*FSQ9
MHW1]HQ%V&\#DT(TYRH\?P_!$2R0AT[3NGEJ,Z^=]?B'\@(;[LWDM.N4&;,GR
MSV$;=4V#=CAMQ/X3=1RX72""4@]/,-L2QNJ-D]7EL!/W>%D4Z24CSF6Q1M3K
MJB<:\Z8T^K?&F6JR-+".8CKL%D;M'LPXF6]FO8S%,QSGFN21=<"W,C&^^+G6
M7X+,LT[*I9"H]B3'D?[0J_=O?E!T3D%N*GX!1K7L:E/<LS&*=T)8-T__G',R
M7!GN#E>[%Q[:?N?S7!H<X=;VA+B/VP-CK>XHA*7TJY2_7U:EK^' _'P=X5^8
ML"](CJL\I1G-SRT66J1+X.N:0ST00-ODJCI*W>T/KT.USVXWGT8KDMW]3$UR
M^5H^V:BFVOR%+\7+8V3&?XL97_KL__FMR(JW:WQQHD0>PR492RC(53A=-Q[2
MVL$?W)4V>"ORC!TBY?\9I_N%FN-GR%Q54!O45IALV9.C+IT3R+\\L%J,)YW[
M_AA48#C+BW30O;W:4WP1_:5(_UIKS&G$Q/K-T#^$O#?T#R&?KWV_,/J'D+4\
MWK!V5CT\M^#$DP+7?H7JGC<])8@190#[B($WBNYHY40[><Q:<$^%9G%L1Z6?
M<<#CSCMT#;"E509CJCWS\E2<IA>\T/H4.L91D.N4I^!*Q!B4]-*8Y36_,F_[
MD/C(W;P:XRU87\H/D(5B[VNF*5J<&W0(Z_+<UXY>;$\4/72PW(\:7R@78'=H
M$WDDA3@1?\+:6[/GK/M,8;IBWOVE>$IVA0M5Z(BV/S_USDR]5<0%@NG;Y\SS
MAJ*'O\$@I^GV#M'A.V+A>\FQV:CZT8+LO(!:-Q_F:W-W5XY/!PE/9R2%T>OI
M@?=#P<BEX.22D+"."&_*AP$HE^3"R7@C5#HIWJ)?9C*BY.[S0CRTG4(OFF/_
M=^6J13M<D17++:7J,=3?E<H^NQ!I<F1Q_%@V#?;CDQ4Z7"N^,A,1>0!Y_H)W
M!&UV]T>)[!7,,4R" 1^;UB1^;0A0DV&^?6#I^7+6&UHSGZV<+8F7]P.L)3=_
M/*]I=\SCF[R"_U[F,1^YJN50H!-"&ZD:*J9-6*1U=&CW^SU8M!YN679\A<T7
M4;9K?;C:Z_&L="J2>6(:O%I%'U+X9HFB2N[=WI#S?MQ8@;_DNT3[<%;T*7T8
M4CMDFL[/J&+<4__.:0=F:?+2PTD @^F3"2M?.*\]4^V%T*<,%S" J_5?K$F;
M6E0PYW!]]J]]X)'H]B?[I6&F?Q7=<YMOVAJ6S<WV:?A-\C/JBLSM[:9J0"HT
MRL9]5#W88S+$J?*8QM0@7_Z\^H=U*4XO0+!!BM* X 7XE%3=H".?^?&\.G6E
M:!B;E!#*COY3_-&WEYT<%/NV>P6Y?RP*#DI<KWWGA65V+&U@2-"6"@IKZ6AT
M8RH/C9&K[1ETXEB]>/GA_NL><V!MNI1"2:MHS_TDE^[>,8U @_"#<N+):^,H
M.OAG_]N_O[DJ@7CL1C#?M3Z#;O'.](Q__D6V5&J/#LS>F?N>(O1+;5J3,?^_
M\2AZ9KH&.;+]HOSRZ"J5=G)-KDH)MW+D3:$]XTX#\_GU/ A_5,QN.\$3]OV'
MMPG=&Q4^I1\,[V^Q8%I SN/K:7"(U9L@I@979+GCX&?"IU_E>=RZZ^D@?BT)
ME0/=\B$7-M +3H%X70GR[L;U?55VD84FI3?]UX:E9O(?P.W$JG-'_ B3#]^S
MI#G0EQB_+*8GYEYDB?X"C,H%PN^_4X"QO'Y>@FX!!5V,7)X 5K;/&_)[X/5N
MFN$0XI,X0*3O2[XYWG4EG0_>[:R[SH5<3^9$:^<+]@*G1^4^F%SV1/I!)O76
M9K&,63$X7R*1FWM!JX@[ZB\)3.Y'[;*?F/?4D>VK^@:]+8,[PF?*NV?[@$+\
M<AS .#W+Y*/-$E5EA **."O %.#SV(!:WSK\6)=C=Z#S6UE88(-C8^S<U(BK
M+*15%IIB&3;CJ%0[G'_WS&D2+>-RSQ!W9'LO.9DGQ>Y7(@)+CMR3MC\O+?6U
MF2A7G@ZV#7SM\/LS)59A4MUZ@357_]+M+5";>QCA:A?]2M-9FY.KT;_%KVC4
M=GQ0I5)M(JXXZY3S0F F7=DHEXB:6AFL6CMX ?.<$[]C/C,21W-BIGO7C;3.
M]/YT_JV1%W6 I'L'H*" ,3-MIN :+^.NV:*N\RI^DRN+DL>8JL-)ALR'JC%6
M$["OJ07%!.$[8C"RS_</++BPZ;-!OFYIGR&6@-2O$U!3)4 S6;=K]Z9#A&1.
MK;<+P?X_G@S*M5(N[TNG7Q*:,>+ _W&.M/5EG1=:(5_V/V.D)=]C7[1B?0_R
MY1OH[@UXYH?OHWL<[LR541XSCFLIINJ%W0U."3H"J>;".]W#^DK@NKM^JI9E
M2I$J(-^$EY>V#M(3\HT=^T<&(%PP]E?U=8@D78AQ\G1[@^/\.OZ>NTG"D>5B
M<4\L6>EY?6_BR6-=HX+OB-0"8UA^+ AQB[U59^'/$IG9&5@9'23F27JS1K+H
M-^@>-TPR%*(AA,4D8CQN?TW*QE#_^8YR^T$=.MOI$HZ=971,,>UEG.6I;5GT
MAIHVXG&F&4\*"?PN2P#,)@HEI.P>8EHO3[E8<1N[Q\CD)O**?[\F(A C<5UH
MYFB_?EZYDIADYC0C<!P155 U\!'I.Y9U^P#4;F#CN(KNS:J L<U-%I@@T>[Z
M5]7[]!X=Y$#.G,"!V=5FA%G/GSV:0_>@BUKOLL2OC2G?" &Q]8 ^ <.+]GMC
M,I*Z@=KFD%A>8I5]GD,%(!8'+W_NX[;-00=G3\H0OF&?APKRK)AI&'R1R?8Q
MK+O&R5U':!W4A$)ZKV9G)^WPNZG2H2HX#CS?OTV[*?R0;BF\[*:VWCYOY+/G
M-@0!A]VZ?*_R]GH=CCKA#5TW]*)F(/$PTM![IML#>JHY-BR'>7V,6S854JW*
M6?2>J4(]Y&+MKYY@I4>PF>-)"DN5=IVN@;Z!6B544?#SS&V;:XB$8_"6H/P!
M5,BWM_"B?E%:!UW3(I6FB!KJ_^%]9"NU\./30\;(.O56FQ!4K6Z54%M)%U96
M<A.<),&F[PDG8'M2L(\V0]>Y(&8AS!="T(_;3#_G[-&&7-BQ\T:$?LOU @<"
M#*.X1X'SQ:T4F9MF,5\?M/%=1VX  Y14V'BZZVT\4P,;A+<<EXK/I5T?^K<%
M&O;??2. :<CJM2)M-(BJK5>D[H7Y?&"9!,: 8L*-C+[.XYJ!4Q"E+XX%%,"I
MN7PS7\M#1O8-\<Z9RIH=N9A4K-XRRXC]XY-Y,X\Y+R!P39;BYVS$WE"@NF7>
M*-TJ3KXDYK(*B?BF4JLAJJN>O-0/?Y]F6DOQ0P63]<7-2RWC$26E].?@G_C@
MT6K2G^8R,KK%,,N3JH#)!@7NG"%7[IJ485Y>8F%TY)$^/Z/OGCGG[WNG769(
M+[7R9+"B.2MR_8MC-&JTAT"XSQ;'>?%I?^#1;2;RJXN*]%QFVZ)*2.349\)0
MC^4&Q1Q;F3U;GE0QUM<,'Q8?<:4*4ML?&N<?VNYD=V1A3.0OS5SVHD1N^',X
M%Q01["8ME18[8A3OL=F<I]?RB1\)8+TCN(G1&66U63_'O*]Z0N>>AG(7FTSX
M("QG\$0+4TW8V8O!G_B[T;?7FT0BH'A%C5?] <,9.ALYW*L?1DZ6'>H3'[9B
MLN/LX$IBXG/<1@WN!_5U+DA%ZF$3A:\$E(LY*O;9?%7KV8 [RH1SGO"FWX@*
MNX_1"*JW("0LX 6AL9JK?0%H0'?D>;4K0O@O20@6)<<-WKPK,!FM.?6-%>O8
M\O9,PMQ?\*IQOP:E9#%^P.7 &OGA-ZQEI)W4],;')JP-VLEWC#9;6>6&B&Z'
MTJ#IQ#N]5#/HO27*#L:)!>_$%E3?@) GUR)YB$6%)[TQ''?(>QA\69N4'!QL
MDLM0*@K<9*[QR&H3/T?G1B9-MU"MI$3MF7JCEC--4P &WJ.-:I_SUJ07CA<V
M+,;V]/.(PS%#Z^,+:/VLA2'G& >DB@ P@CA=0A(-KG3E$YDY9F84D25U?'<$
MN5F0M8(<+Y9B6%("Z:=]Q@*6E?>H+FJ3QX:@74F8/6-W^0FA(52O30;#V?W
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M?ZAN6UQ!DL//%=#X:&ZT'V=C)0D!^M>=\<&E%KLAHGPEZE"(5/"K:(N*)'J
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M\V"DBRK\(/%E+8L B.L[K9_,U50*J +(R*HF0,SQ81'S6L0NKV3]2'YBDI"
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M.SZ>):Y55&-%#\]YDBG$Z\$U4(:2$BAKG%Q,2&O!B$4W1J18U 1M.Z1$+BI
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M'@TA7B6$:0Q!O,ESWW1'OUEN[0PDJ=F7F1>T4(WTGN_L7K^HABA*-/V4I-5
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M;&SPK^U(?9NX!):,#<+9,UF2H/,WAK*HD,Y:\4;D7&,&&R_O3T,U)5B'F!R
M2].?YJ<N$Y7:&,*[Q_+UJUA ]Z4QYIF9/-V4V/WW^F]0$F(??=NF=S-^+BR$
M9,R*QQV!?\N^\5G/L%UIW/<>&6CP+\ @YJ1U(I-NH*8>F2-Q'.P-:2?49P ]
M\4?[LAQ((AN.(352N"L0]:QNZ+87$)%O484#YF+K2VH@*0RX&"=W-.#CMGTD
M5KWVA2@YSL=LM$XL48]CPLRM[J5PGCRPYM V^*T+T]91'79 ::; ?$72G>.
M)/NQ;:KL'[( TE"--]-C.R'O"UJ15SKT-PGI9BL:UJ*B*4)71(S]*[P0O;_U
M59B;?.WK?Z]]W2[-YNS)N;![4$@O1? ALGB0,68 VDBGQQD*/JY.,+O0(<[K
MOS>T\F]">K@S;Q2VY;H!##;-.NYLB-+](%5&RS[V5$EWW5"3EN-.9RE@A'@N
MT6JX&00(3A4&I,7YVIB]J@\COBQ'DJ?&$<R^"33LFVMVQ\:/6WIB^K_KE*O!
M^X)7:GM;NT^+-\3A>D=[MI.TO:;<AIK!H<AW_GA7VWG;T9S5,3$O6%CQ7@N3
MK?YU9SZB;%)Z]6%(&N1Y5,#*&IN63PB6:  9JE>]10(+V/+[((?X?F@#*,ON
M7++=;')89T:A7&.F87W^S1;%CMNJM?26M9C.-58VM O12UTX=.Y=FE@T>F-B
M[$FC7';3^XL>8/_.5JKF.]^W"I#2\Z-74S? GIO+UW 7OCT+?9"U;T(ZT+I0
M\6UURA?M<8/TB*!1XPH 0S*,H:G#P84[_6.J7%9!:!?GLB-[Y(/E];<KF/K9
M@K!!"YJ)*(:@@UV#:0>*GU]K[.2B7+C/9*52)NK72Q&IUO>17&-C"/6C$:B7
M_4KEMKN+_V<4%D$G,MQZTEG."C+69](,3E'(1U1U6*DMO+/ [(.SYS2!BUXR
MPAUMM+<-3FQ9FAL%KQH^Q']MM\EX>7!>_YW=9M?J@-^27*A)W964^JINF]RW
M>\$VO]X?M#]D,61+S!D2>#\]8IX@1HJ$-_#KBHR)>;KJ!SV8PK#,W4JYRYY_
M A&^<%\T#PQ)!V=( .G&V)PO<X11DS>#I?=73G+\ ZM3&M6\?H0AHXCO=9B)
M"ZW=;Z^1^(Q4-^H'Z8=K KZHSPB/9^\&JU>69#<YB=,>MWB_8/@T)@(*Q#^M
M3M"LU4K,&LPJ_\)B3U=U?53._/3=+^[Y*!)I/5BDC)6_F.>ZMI_%D,9O!:&A
M1AF\/F.XZ2$FY3HP +4(RWWETY*3ZX\Z>WK[S4#VE253LW6.W$I'[9WR04Y+
M&6%'TJ:&Y@-YN3+LS:_%&> HH6"YFV4U3UD,2'^YVY*-6,7)3#)[,[[N528Y
M\$"__S9<E6V> ?,G[3VD@O8U3)_I;T@5.6(&L<&][9K'RSV?@_XA>VQ"-0FE
MN%J>[;]NT$,2;AUB-;J#@EE()C'^\<4=2G<WWK+\-V"N+!9/^#H1$K$*>MWZ
M^:/L\1Q,;_*FKA?A1N.?AARI5G.CYJSKKYU17*_/,BF@R;B%[M_BJMRK+GX2
M]QX0,^0 P[]D=O1C*6 W_K635=<CJFP*_Y#A$8FA;>5'KO\R_^YOZ.8R9KMS
MKN)?J-/UG@E/J][!;09G"#(D*<Z4++X9Z/@#1+4W6_.Q'B#T$.:U=&,*8Y(2
M6@CH?G,_V6GUF[GWHK(W]'W=[?E\IYJUIJ"YIR4AW$2MR_-(TUUH"R/KN-Y
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MQCYHQL4]M-LA^R<'>CI?PRW%K,$"UP;%T.G3ME=;I>*SA$8A)Q>T0L@QR>+
M4,!H(ZCBGN%+2CG\O?G8,)_9-=((]/W.6@!:89);+_(,DRP8_K2@S+HMTK0'
M%:OW+DXU& \E:.D5[B+])*[N5-CMM=ER2^&]=R2$<'2YJ)59Y>R1-_?UMJ5C
M$W'0C[-K*XWU,L)35B-_&[+1+R32Z-(^'ZT*&=^LVF'Z4PQV.:UT,C9)67M
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MG?H56A,C*U&LUFQKNW@^$/UD8ON] B)<\]/TT'=4=77#<' "+E= R(@>)-#
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M+5<>7-$XF>)K[FV'/(1V=:5WI#8 /P$_(DA[]-KPUX.X7MI8SB+@K'?;HPM
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MD)C>!.IJZE&O71,M/8$*-UF#C(U[KO32BPO-$44%S,-3$U;%;&FMK[FBYSR
M72-,VXWH+$.>)"_JZ=)+C!])V\'D4Z)W/K-(_\A6H<GHA4EH+8@3_GA?WT/@
MF :ZDF(YPM>XUKD29FKN54=JU69=B?GS4\<JZL"&_[#4N]Y*]A4>N%I[+#6$
MVJK.+^\4U:UH2U;6G]'>^BSR"H_!0!/IG'V.: =F'T_6/.#*;EDK*)%9Y*<I
MK8<5<.$4O.?D\]T^ZS2;FY:]'ZX!\-A82"F )VX:R9V5>]L\U$/R^*%0XJNZ
M2 *[A![#P(2XA('S6>U90O)XMQ3H">,;814S:,3JV3N)0;2=D^:[]#B,+I>3
M./AHZP.%LM GR3M-',6DQ$S/@VAS4R.7Y?5%[,&?]T!SF?,U7*V*W<UR=X*4
MIB[(,TS9,,SB0_92]9B=,"]+VAW$^;]F/9:LH+>=H?1[T"+JF]Q6#E+HSFTA
MNHZ>O6!C4] LOV]ZCC(5A:\LUUT/<2Z;AWESXERO?_DDC@\]8J)"['Y><LJU
MF2O^B?QA_8G649YJ2(_B-#[6J^+?X&!>$64*+5S4B%Q@/G[E\/S.?Q]9'QRB
M/".#"Y>1&JQ0BN/(A!-6\>ROS_HHG #Q01'/+3^H>AZP;;4K>< 6XY*YVW9I
M W&J7U-/@VQ[J2@"N>YTY*P;)%<]]H/N4+S'XAC&]H.1>8-4<!-JK:[(&5^$
M*];#[0_@5;;%BW\H4E\,XCQ>_/CV3L_V>3!6JL9 V7PN_?-S53D.U]XWETIC
MNO>)%C21E>U91L+5B4VSSS><$HI='N,#0_RIFC5/H6@?CP2$.>J-Y% J[%OO
M9+>[TPN S*?BCK5F41^^A)O4]79,&UI"A>?)M.@S8*O:$WQ-*6I#\=><+4-E
MVN#==KTMD=G1Q""WE=W;5LAV.D-,IA2QM6"X_@4;=6N0#FCD!NW)G5MPC=WK
MDBO6@)U?;[WQZC9X;E?[DIZ D)+NZ'30SU<_?$>'>OE/[9QI  F.1W"IZPA4
M?\%A2L64P!7=+- )$F-'E&+(+JC9W&9Z""61ENF5"Q;K;IS)Z<?H^K0Q9 TY
M^/AB"*5-:6/HM@B/7\W975J<&/]]_5K]//^^;*L*)H]O@QD&K1P7S&]\VQQ5
MUO#),4V<N)FH#FEC\9)(MKH?2ZT-'9"BXEQ>(ZPJ.N-&X)/HA<>$.NWK^0G*
M<,.G:3>48\PH[S7MP[FJ:YN8UVZ]IT&V8ST[9T<XVH19OCS-168>O'N<,X2W
MHN>HE)1<'HYKPM5NC7,;NNI?LQ[A"'2R<$C(<R/@'C6.Q><><>%E4KU=2_C"
M2V<?7!#V 4V56J+I;QETJ\]YM/X6N# N/WU"W ^NO@N23DSSYG KPUV6W=.P
MYL04FQ%'AM?46%.!;M>(<KM"HG8N,:,,G;6>A_U)6W7\S[O]O#-5,^2OH]5&
M*[40M,EG\>NBC,IPY8;@9<$I$&2"<=H8S\UZ5J/+9+/(X>]G-;L2&QT VKEO
M_RYG".?J,3W61OW@0_+>@'$$RQ<=C$(,VKJ))T4*97"+!JC10OT@?%2=0>CW
MW?VT:X02$6O^M9IXBA NDI[M3;BZT.X"Y(R#(<!6"53:G'1OL?,JL^^+$[DF
M1\OR.<TAB3] D2[R)8MOZ0^4K9U.KN&HDQ\@1BE9>8BF]WY&]T%T<3F:9PUK
M17 1E8P]J\_3X['7#&!YFK>5] N2?? M-8DXR1O&%56NQY_$:!TT\E(M4F8E
MM+ZMXW'G1Y!O.5+HYG]K5.X2Q?]E&4;TYCKI#SKTTJT%2Z X!98=LT\WD[6K
M5"I%AV1O&H=;9/T\_[:9J611NZJ[J3:TV.,V" J],"B]J$<*6Q>UKI?%W?Q#
M#ILSK'@DL;W8.>;7(Y1"(N^8L'X=.12N]UE1^/:I^9,WW9+TU;9E&1<>XLIC
MKTP/(6VKF-B_! RW*V8%=B(D685I,S8ND8E6BYY_ \,")CSB)S>G8#,85L-=
MX!KC4BVGQTSM\8EQQU>IQ;H!.8?&(+1KHL/WO@5Z5[C;EIFPFL\*)TGM@)XL
MH6:O[9/;=KU"==- :L_"R_Y)F:%%GYH8M5!.^28_T1%TTV_'(ESB9BAK.J$T
M/V3!ZPCYKI3QNHQ'BPQ>!)81?ZB7"MT"SG:0^[";]>V4JRWB:U*B<FDK28K!
M2Y+(7=[$<9WA QMB&FLU:,<V)?E.@?O$W/76XD_+8V2G?RBTZA'$RY=G$\'L
M16@4?07>WW^IU>P5$)6NLW]ZW.#V=L<24<QRX+<'[9(3]4)6U4*E<_6TG4!/
MHX/$M2>0Z>26GDS^*5XD&<G3-DK/YWM[&R"A.3P%=TZ.&@)ZB9**I5)QVD%C
M?HO8I6&9J%5\AN0[M8.O^F'*JZ1T)T2+/-M6_>XN8>?*HA8P]FUIO8<[64T+
M77"?84)FEE &U_3VL["[?B+>:X=\OS^I8"[KR"]\>S9-F[4*I>;MMU@8Z3>@
M]<TR- OY5GPIAA6HU-R012K@''JHE\F_[HV8<0ILE;)3>ZR2CSEW)W1@+TWR
MGU_4EV@T/88S@IHFP/--?TJR.(*QG&9SHUE^=J_3:FV<\ $(?$F1__64V/(+
MN16UOD3*1IL4H4.T6^?KZWAIC"I]UT8 ,N>E1H83<P#,>1N=>D-@E6.=NKH]
MWLZ +@ YT]G^9XH2;T%PD!@1B'#O>Q,@S9W@Y%6!A]:FO?I1!QW)^/ O97[T
M_X2._P]J/^<,Z!H.4+B]6(RU'95'BQ*3@6^#^C%5ZK?94USHO+\@0-91FUU5
ME3Z(_8^]+LM4&MSP (A:2^,%5BNF$K@W@V!K87'OF5ZJRZ[.HU^PE\,MB"*I
M:SQVZW[RHDA-=A]+(<DRJ*J@T'.W83E<8C:M;$I>_6.;#NX\2JL1&P+MX0<8
M:G:\.\3O#*N1GK\KF;+N!Q3M<2XD*M^!Y+!)&S>RL.U U&,,:*-^LM9>%$+,
MBDX5/0BFQ%E-*R9T5W0>D6R<^7:U*,0SQ!O+AW@Z[R1[V+N3]O3D-?!!GURU
M@$8I 5K@X?AGF=?UBS#[U]&#(9SGV).7:K]HQS.61]>Y\"0:YU#+Z,)$<L;U
MU^P$2\KG.GM6/-1O*<@3E645 PZFN\$.7P^9<XS%;,+(49=K-R!>1)''(LJP
M@\K\5(]]0?Y \PBRO,R[4039M8HQY?GS-5R^4@&V.-MUBS$$II<"8VJ1R3 8
M;P:C9.A_@JV3^L7ND['0K5O(XL&2()H";H?5PGQ:V@U]"6&D)1$](<']B%3Q
M&B^14]W6ZBVS)CE]>+[5[% RVK&WVAY%[[G>"1A?_C2FHNUD>.@'AA:=O>&?
M+.G&.#:Y/!#3.4"U?TWLW[CT# -'Z(9W9QX&0)]%UQIGUR;0O8;6KH034/E2
MY KW$7]X$::E6?K/FJ()D\-9?8:U2_%0C5R]^^^4=]"]TW(Q;LK%]JBMM0J/
M0L\'V+/;7-2[.]GJI;GMT*D?+"CR<6B=Q&J#A\]Y\I.HB^S0NO0QFJ.[-H 2
MWCZAJN@^P\')P<3'HH&[L-[W$B]NFVE[SG7[BQJ^(_@KHB+*6>IRFWWRC:O@
M.S]<62)AU:WR%4>*=Y<U:'C2F$9:"2-/ UH(6>*3PM)X8%:HWJS '$A]4LVQ
MIM/N3:T!P_/3&F5D=+W.I(%2$%J$G\< J/4VJ3B+.#HRX,8B3^B<82J[Q@FK
M.H7[,;T= 5SKN6;N5J7 ]G$D%=IV&#!9E+[WCCYSC. $/<(D?>>PEA[>:ZD/
M]7X9]/=I'0(5VY3U\) TBJZ]O:A[6MDNX8;2A;T)ECLR7<E;3T6VOPQO<\4^
M0+.;/V(_<_B>,>-/6'_I@-(V(_S8,Q=)%/Y"'I<XZ2#@ASULDATO.W<T*GE^
MD+%]"K05@0S[I(%[C:<%Z:!+%6]ZEUAA:QF0>([4(OJ3F$B20]L08O2-F8\D
M GRUH_$Z!GOU<DPWY4R(QS7IV-L%7<PH(@Q&277"SEIB6*450HAQ'3G!=2D+
MG+4O4_/3(;>114\D2VU)*A-9>8.I 4+G1WKC:?54DHK9KG7WVV^,/D6PPZYG
M$AM50K-[=[T<G[=]$57W#N#ZY?QE);D\Q?H6@-OM6+>V8OF"K@1*MN9I7 >\
MV/]KD*_\3820>OTNE9;S$V+ZL,P:ZF,D3S:R+>;4C^<:V-MI:4(M5\7XQJS/
MT8S7Q79I=:D>BYLYGJ;7%THZW%N)_H%:*H'J.CQB7P/JLM6W;_?"V9VLB\AO
M)360"_6%NS]N#DW,KO9\&#(_+J=4?I)I[6A)4VX^8:;,8&O+9L2.T<:4#_HO
M_X''X]]EF"8/%@0%\#"%<)C7,I%KM&7>M00_/*OWC@ ?UGBVA6)WF#Q4*8IA
M$\693[@+I&=TYW6^>G@ST$#+,%#6>JD4X>JF=L;EH@\MO[4;^RBP6R$FQ36*
M\,?93[W/*OPDNB3>^%,YKK@*FE^!NV]="/^;5FRB]V:R20F;&NI1IM%4+::&
M,I>^BN#$H!/VYDWB'&H\U(2&^<J([I[&L-.76=4%-F!Y0OB<9KXKZQ>24ZPG
M,N4I88/X74W_0)K5;G)3^/7X/%!BM6V>*QL1QMLCHVA./G\5>?A^#\1Z-1@D
MO,"&,G>IMC_#!+$/,6B*Y#PV\OWD)#W6?F(_C'.YQPHACLK)"N_8K7\?^ZMZ
M;!%#>?(*>%A"MZ0 _R.<4^F9)!'08_R\'"E,.4Y;AI42*!"TZ\"<69C8GGLK
M:U*$TI,K:H?\Q.B<\+IEB\N[]_?XWF>FA=:G''\0<'F@%3#A_FU:'1Z07/Y:
M89AZGO>%)O/O %3T)(:GIA8]]#]S;I^4IZ4C*8X?/MAUT_G1*JO\AOSK)=X0
MI3O$"\S\06F4\@\%V.[8*<KRQ.-DZ(;I#;D!"L1J,D+<DV"Z#"D*L&/43NEG
M''PJ7%5ZVRM\;>X'!F'Y#X7&BRKPG)97YQD&X?,;44.HJ641,YIG_46[797M
MIM:!NYKZ>9:Y8]/;<D?N+:&]VD=S?CSG\TC7H )1MO$R_5[*F[8C)S6E\21D
M#3LVG[K+E%PT)=\30/_]1B3 ,/+12Z=_?3M\T7C267-2'LN/U)41!/7C0$TA
MTGQ)]44]#*01/=;*92Y#!'<K?8WG$&R07> T7!P$J722\>>ZGSYK;; =UQ"4
M_WM"0<K.Q:.T0/_;QBU2BUV!"UO&!*"+=K#%8,3;-6?L4@NM6^/C_R4$ESCF
M(WI1NU7BP^B>P-.9#&I2DSH'J^Y!#E\<*(0)(&A=/BG.I%[ 8K 'O>E=CFBQ
MZG2+IX%+XF*GG9Q[ZI#9=BK/8/2&*O,E%[Y&8 07Q><&P-J]_C?\YVO91"R.
M^:X&+^ZZ-@OMFT?L5@>.JVQQ[AXY4!? CV\CO^V7FW2^7ZL=8!^@UH:BY!>!
ME2NC2*+7:1^((Z1N6O\="N5P'B. &>RSO@9RTFH5D7[EL&*)R'P0.BA<DTR1
MJD*:@C7F4\HHF.3ST2K];/]%FR-XPR]@V=0]6O7M,OC!2#CZ>BJ4+**9"*%[
MJ7N*+C$3%J-R-O1U\OWX;TIT3;3"(,RL0#*_N]+6(?^$W'7E]1R(9OLF/"6=
MW^EKK+?0WB=D%3 HS&6=W[%<A6O*V6@\J\7.L=J<8>8$.=)RAR<<U0,UACB3
MX:PH38820P^QC[>_>^2VX>YI1>P%CU3XTZ4;]J3(5[U_M%:@66VB(<H*C9XD
MR]+^S98YR(U2!!?9#2L)C4T!,H4V6X+%<.IA8+GMCXP[AHUFHOG&#D;NC=UQ
M(/5YJN 3AEVD+I*^#Z_<[/UEUKE]Y;'>76E3I;M;K2R,0+2/*3B(-4FBG@;F
ME;QPG&_\7%C#Q<O@G?AHWQ-8&,:GT/";$.Y3#/XZI#7$)\X#YPANI9.7[3C'
M3M@YG;\I/076V.>=W*ERT67K("X8!Z.+/[7T?:?+B0K8L=WT?W6OA:7I"24^
M*'O;.""EYC\-W_]3GQ);EIF)S",:STG/,/'NOLJ*:OQ9$WGWHM+^ONB..:-D
MN&H@-]X[S")I=_9/^9]4Z*DXZRZWH] =^0:9)+8&R; YER??$,PYT5V(DM:Z
M=73]*I!Q2;RQWGMQUGGT9WU,Y9\/J3!"17/3G"'SUF7EBCF>3]1=T]V>_<V!
M[///>OW>@:O#0]/>30&-Q7& N?L4E'LV5/GNXO,I!9BZEBZI6+8=ZU.YW6<O
MNP/$#X>QEC42RVZKK2\"F.A5SYTG7)Q>*M.U_#V?52%!^T.\I[Z3YIF!&,$#
M@_8D3>Y_*& Y\1$4WP/ _,8RB'=BGZ6NEV<\3>P!J7E_\GE/9]R>]DGGK%KS
M:N$U1E*U'27&9]*7*7Y:%1,^WPZJC@L!.A*>\O#4BR3P!2RV\0 )/QU]%\/[
MQFP:XN?K_:R+&1V]]/ZA> G*G!Y3]P:<)%*N=O:ZSJNK+(?45XJG"];#/V5$
MR<'B,<W)MH#K2ULY]BH$N5VXN,&[CWSV9X :[O&ZU3/0/(&NX[+$?:A*1C"
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MY5CZJU9R-<#+Z;,2S>/\RL$(3%/]_:^S;KJI.[8D%]&IPD_AGD+%E5>B?+_
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MCT%.B25",B,[U@-%$FXZB8!E%^L,31,O-C/'X.^"7>9#/&HO@7US$L-Q%&X
MKZR%A,V'G1:!>]*A:NGD$F8NI]PA@/= > $1M$R47V S_"9Y8H24?9%;3'KU
MM-&J!F<8R7#)RTMN/@MKX)$VR@=&;P<PGXFV\*6^!3W2C'E=%]S8&O]PL2B
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M9SFO&;G]Y=A$(%!F#*__Y#'<L7)-*KGIM%"7R/-GJQ!!NI?Z"'O$$S_MK1B
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M&A?.^7'+GHWH.>G5<!(*\T^(MS3MX6["E07AEJ.:<SV^7<Z?_;1S^_<S"_\
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MX<8K/X@@J41C134T:[/JQIJH$D)GBQ_';'T\C%_289!;U"*""_F-L!6KTB&
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M?' W&-[ 9#^(KHE-ZL&K"4@>J\/*)I^FM+ZRRRK7/>*+3R.56_$"O0 F4Z6
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M:1W&E%7=&Y]3N"XT].4 =%7C>;R_(R")-_\+EP,*L6NW%'1L$I4AZ*D:A4W
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M">/./V4@W!Y&&(_4;[JE5%RD7(6]D2F1U:*T&Z;AHWX*LPR>P^A$G68AK-L
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M\2K3Q=75ZWR.( RPUT:PUUQ\8Y"/^6X]MU9*672,IC:I#(E@"O?$B"%>Y)"
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MGW>$SVDVKM3.WI%N[D4;6Y 7W--8*D7V,QK!+^AC?U,DWCJ^C,"*.G^8VA_
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M\TGR>M#2  VN!M$(3M&]$"N3LF?3+@GI84W MVK,AE(ABD""B/]LN_6_Y4R
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M2KZ:9/[9RHNHZ@+8LA6UW9EV\"):] ?@OI!@YZLE% FEQPL.=),@6\>__+C
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M 1QLM\ZV9%]JD'N;A[ >+,7KXPGKLHEYKUF; CMU-_)ZDFL[$*CBEG/MXNU
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M7OK;N[MW]^S>W[U[]_UO)^<Y)YGOG)GYS,?FF>^<W,W?K0/(-%3450 8&!B
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M:*<]O@HN7%G^@(W>(AT'-_RQ04CZ;+V9GJ6Q34*-"J3QXGG5B)C.'+8N'FN
MRY4=%,M#5" @ZE-%G"MNUUN/B1"-X_R8J]=U7Z!N39=?1PS1-+$]'2P-#8DO
MD@O(88"2#4V\F6L#]B.5Z[FI%C$6VRFKN'%0S#7KU+NL54^$ >R\1S<N;#$4
MUW12A#B:'?F4#;;]0_Y^6Z433R37!6#:4]H 7?LJ7QC9]=X!+DZN(4H;:JZU
MRCN] .? 5SF(Z/D 4,KU$QV)GHJ@O;G;QTI?NJO#%MLB-MZ%"U%4I$7  %=X
M/7&-*NR+'5Z?]5=EL&XJKB1Z1 HFAJ0VJ8YG<ZA#8I2&OKL4D!:+4?*^+K@R
ME%Y%W.1BR9>836X*+_*P(SWS@)_S-K62GQ77,I5C)3=?E'V_CV2_S<JB K5N
M:A\$GB)RO(6((*X^PS5?+#3.=**DG0]*H''IC_Z,XU4D*OMN]Q8/B\#.@'^*
M=NY3H@7+FZR?]EC=]5H^F]K'%(]Z;$Z*9X"5<0/=:M47T!.6*&:JS[.O4[85
MM(/X(7_SX]1^GAH;%M9D*+"#>/3S3KPT(X@5W< $2P\\!7IN,!V;U*=@);H;
M!@-%9:^Y9T.E\\/)]^M=2_Q_%=T!F"GN *WFZH=J3^J=5S/VP%G7$5OW83-4
MSAJ]/8*BC;X1J^S@G1S:,4KCNYG!+?==?X)F-+X#Y&7LC.^X[S)3$>VEUNKB
MLG0[>SK73PCW];(UA]"N,ED;DV/ER%H[+'Z:..6?[W:F>_3R#H#;<[75]JO;
MC10FB)-$ZY!O,_$XFW:4?_*6*O]$K2-CY!K4:!+$/ FD9:=J/2R07]@<>Z&/
M-6=?"'W]3P,22I[^*ICJ8 ;%0C^F@3V\%A;;8MQ1VH[:\;3YFP3:N-=] A=\
MKF#G L^\H[I4K.,%L.0\+F(INN%=@_(_"A#:$QNW,X?+>K5][ AN-/+$/SK&
M6FU),AE4@KR8D!%XN.T@/(['$E+47;+ZXD\8QQP&2C-^N)5$Z@ D"&0R,9_A
MU P:;6TU<FDM6ENH\C!C)PD8QWN[H4DS<S(9K[Z8D7M/&-,VI8JX 7+RX-U;
MJDN/)6D2[>[KRB0TO7@&ZD/9GX(.SXMQO*)K_8Z5#<E<D]\$J(Z'.UIR<&ZI
M[]/,C]$$CG),C:'JF>M6K?=T1%HO:I+W[+1?#&-/5_7'<YK)W-:M7OYM1GV>
M3:Y0]M?LG .]OF.](0^CZU('3&25WZX*HRG!+GD7R;B <T3.[^U6-%?32Y%=
M+8!7/J&,V)OIHG;^9="D\".UKDVD>SYIFUR+3Q+SR>(ZR<RR.PRP><O.ED2D
M%38_-WI+\K3-*.YV)8@*36G7+1I$'/AC?<9RD_8.L'9;CW'JDIXM0!92QW=C
M./5E<U;^7-FD@$2SYY;[ML](:L=4J['70GIS:"SPY>]8\)L?ZR&?/TJ=(*B1
MAPW-3&>_.=&MDZ%RA8>W<"#$X@GS3!T-9I-%-'6CT:+/4L:CS?:WSN?V6-MW
M@(1KLT]4VWG,:-F^; <.X4JF;D:"$YWX;N^CJ%^.\E',9'4SU2MP=NS-I@)2
M(8ECTSUW=;X:G..1(($-_O2FP[,9=C;I8Y98.6KD!*.Z4YC:=I@)RP,D+WP?
M;IV<2DG&@Q6/[C&14:6[ Y2&M^]UW@&.\!KO !YM0OWY1T^Z[P!F. &(<#)X
M@HO..0_6QQG?R5_RR\"CJK4O:.]!YB/0C'3C=3@\Y+ZJ_%+&02Y@Z'X'!>J%
MJ2X\=K;#^H3;KO1U<3")^$$<"3O["=RSKX'+@MA$&N[6#&?01O//]\S>VDKV
MB2H\_&I]4[T)^3KM B2-<8[,&.S#4Z%"'OY:U/Q"MFQ:\\TI9X:%_J.9_:>?
M+%?C> W7LG&WO#]9YD$.IA;=<_+W&_#V&O[Z_^G-U/\";=F;&'> Y]?\LY!O
M<J(N?WB6[C.GT@8I/@OY+@6/[%X)FK2;O:B3>T"2KI(%S[4 .?U&M(;Q''X'
MZ&^Y>=<2\"C%L^&=:-J%<>5^1X#!M8P>.CX*J<*,'+N6IE!'X:\R&S8ZSES4
MC)S1=I\5J&1][1\>Y%\NNP/H<?\I;2/<$"R#.//]=B,. $-\&AW85-9S2T/E
M_"X20U N=X#?(>"Y"(T_;]]M KS ?1>)FW\LOZS=(G_>XB,U$40%EOEI5_K3
MI$*'9RU> @X;W+3%)FD(W_;6<$@VNIM)OM?@P<7W.;W#K@GX*?)#GZ=*I[/O
M9(_Q18BM,'3A0JU_'PUU[>54J^]3-)*CX+N!BJY!7P?H_N1G[\F,.M?TC78W
MP2I19:N*JQ_'&\EC.Y1!J:9Y6@._$N,D5C1<2G%U5*.IT_"G5L+C46UT8N=W
M@'>SPHT_5A2HKY^N?[KWB/O&$1:*/V=+9R<H[P!>+YGX54.5&+-5U@L;TW%H
M*3&24!]S<=<#0$,4@F.T_?F7.S>0/6*7A^XE0[1T'*"A/.':+ TTQ: AG$6,
MZ$JGZQV3^&/&Z_ 6^J.DZ&#!!@A5HI_*NO  ?,N":F="NDBC("]GG/K)[:.!
M1LWW(9_-)=;5KI?V,DZMS:LWL^==Q3[!N+"=$0(7GFS$X)?6,R, Y<TXTOT#
M\TE3ZVW<^C835,*55FY+@T>!471OKNPB+5="\$_<MDA7[B_3SNL>VK.8X4X!
M>&'[HJ5FVJ#?K,#N'402C49'ZER]KZ>6B3S!TXP^*P3UE,8=H,M./&2[&DO6
MI$]Z>=$UVGE80QN$](MLC!<"H^54?[3SK_5'5WM74^#D8A$C582BKO35& ;,
M2?SU=ZG% IE\S\%.VNOAJO[3:(R^?*$_466U-=%:H6P *F4;R.*/5/ 0PS?1
M>X6,S=+)R63?W 'V+%1WN.E9KO&N0",M00<M%UL.FL21=X#J(-*"79\YL#U4
M ON@],'E&@K WE/'<G;_)""ZVS?ZFMU=+@"4>JTW91.A&Y#09+8PXB-/(F,,
MP4U@I!C$P"IU8*W+[VV-7VP)F,E_5Q[<2W<%XD7SOXK6;;+?<%L _K0@J'KA
MS^$RM/-"]>/NAS\,UI,=%F@%^<,<SYO=*Y#!K, C(R@(@.IP0FLMDVXF";]R
M6ID-E0L]9*'G"\+QSNCQ97F)E+92@8N&F=756*;\I[>*_P/^<?1=GZ^1^>')
MRD-2/046\4#]@0[&$"J?-2*! [BS-2E%6B*J\N*\VS7 HZHV[=@?]')=EG9G
M%OW#S5V!J<I(_#"GV%$NO*;MM8]#4M@U5XOCP)Q3[X]L5KI++4#@IYMRL=]4
M0_PD$J#*I4"]!N1$E[C<+_XD-&EXL;.1.@6;1Q!?JJ_&EBZ[?3:+!J G=?M/
M0*^.1]S19]OV$&WTD\/5Y,@K#-T+I8WOY-*#Z(WV7J]@KD,G48=2H"E:@;82
M'3ZK& %=OW;?-'%V7/B8@+NY8WR^2M+<V,+/J-4HES'A&[*!6FU!]MBA*3&^
M'&9I)ANK2F&3\"]&*[XR9QHOG-C/I.T$&)W^ITF..PN9"Z9](V'2!B+W^BFB
M-*M:],FMJ(66[^<7-(M.E?&I_-M+:]C#61[2S]8")D.?KFBBJ@B++PF"K=XC
M."0H+B)ZR&N7O^8UH XS9H9_)CUT'BOQ?_ONEG'IV<3H3RPA61X,K@D+G<.!
M1];"<PD[X!8'_^^E&QX2YXA*(:_WO\3NZ61*IRDH\F*H$Y.PFX/\8=-VF )5
MH.JF"4,UT%HMZZG[9-F%(O<BD.X5$29$A!1;TYV:F6O='Q1RN-2MJM%LI8N0
M2\>@Z:U^,E166?Z=:&ZL>S3SQM*6 [>/?T^>8;[7LT1]R_H= O:X"KN#UT8O
MF:. U/?"LI0!HE;,7H[0AWMVB?,[%RLH?%TR8P*HAHM 8&CNV,V)UW8A&KL,
MOV!':S&S#U<6Z_K>W;/>(9F 3;73DJ.IVFIY3-\S)D':@M<B3_AQY7%-QUB%
M"(-?BLD1-87_T.A9OC>)LQOOZ-A X:U'HT9MF)/H-@%4UZ\'@+F)/,I:RP(.
M"D')?F"G[U2G\+)I>Y=JIEQXJ.CI6"S:PKZ44EZ</_W"E_F\3V_Y"<=#_5>^
M7 ZNSX4>.HV5!)"^D\%S+JDSQ<'H1P+\*5\_=L0KX4@N+B(I2/)W6[?*#.5E
MXAI(?(%_:3BQI.32E("99&DP29ZB\*",K<T3-95"6=B>3 3*#E2<R-9577RW
M%2KS96,NWFK<^7O"U1:RS1)-3_QL4,T0\Y55L\7%\U\?,\*[YKDGZQ^WD0M\
MW^6,K?W%@P7:$$C/$CP.51AU_-(7=?3;\MN.>>-Z/F%OX:*S<I]JB8<\9:#X
M8NYD1GSCA@)C=/<88W?A8O(\(ZAX(?!YA%%#!HB)OY_C,'*DCIQ18 SIE4<X
M[E*XRI$0%62/E8LN^=8T9_GZ[U[5_G#Q]V$EIOR/##=S]L.<I'*3EAZ=87Q4
MNX7B5%L"T7,0=BD/U@\+6I,!Y^KEC&]#]"<L8>-^676B\&!DT28I+D.N8JX5
MMZ<_Z,WA9M=>4<(?\;0#K0*II/B$/TV&7M@@Q<,Z!6<VV@.=B_R/P"OE'Q]=
M HP0H?41EA!F$!YEZ._R?\\A>+><A%T\J'DNZUI[@L& SE#@0A<O/5 8;1/,
MDJK([;G:FD]^K1>E2<>N-"0HB7AJ@6^FR$\5V7)EU/!A?0&)GV$76YN'"I5:
M(UD8@U]$CSV-.18UST=S+:H%2KC2VSAKNYO915YC.)14J)5C>>^8W+(=+DO#
M\ZS=2&90H7)NA]2MKH5KW\[5&/)0"-\_O6>P97ZJ-HT')U00P\,7F5?OPGD2
M)U<BM6BZCSDL%]GS2P .UXP)"=UVDFR5UQ93Q!7(3MHQ*?C4QM:[*^<-G <L
M&M&;RCEV*LM!/%C;*YRVTW"V:/='3U =]8><,<C#$P(0-H:%5."3*8KS'F9C
M.HS*W6J1>? "AX(;#L"L7+#DR-+VA$H6U)8T'):U&"KG>/$199=YJ_G2>K96
MAO"3LF7@Y]&/M7MF.O'7K *K[1SA;(IR&1&DD;\.UAR[YJ]T\2KGK_7J)2".
MH:0E;WFK*AW6( ?Q<V.+;Z,$TW2-X[5RKD"UO:X\A[5)#BN)Z7WN>3(7L=B9
M(L9$-M]!2?;^*&-(I9<JQF<SE^:-@,H1Q=C8&.[)STN=QP7+K$XWO _.A0@N
M9@6T:6>" /!?4F_[6Q?;+#KI'Y\EAC]_1 H^B]%]K"%;CI'D2MQY@\*]@D;_
M8?O&>(E_^7)<6%.!3)72+;"V'&NQE)L0]JQ9JL0RHQ<0>(ZN<VZ!DDG3(P[W
M^MP=J%V_8&&V"L6:TTM7M8937_,/CD6Y/OY^M!G9T,C$@Z73;RX9UT/AIQ=_
M!L_>H"I2?./-BNVB#V%Y=A%R]BEE*_[([QO"9KQ-E"2E3$2E:;D>X_@.T$.8
M+V1J+'S. ESV?8N*;"_-)^*F>]FKC[[G1QS-+4*,S[^?4?63XJ_TT#AI7>JR
M+^U?.U,CRY;Y0MSFPL:$0^C4%/:$3A&ZAW+1,KH:=:QT!K.?D\+'SHYU?N1_
MR4LGVC_E)VWPE184C;D#E 1.57'4[!V0?;M$7\W-&RUZ=(37D$\(F_/"?2D'
MX!^,V((#3\X+2!HWX'%G08_-1(X&<FZIME9E6[%Z!$-#6$X1!=>BI7&RF)(-
MZP?].^8FFZ1XV=6O1FO3,L=T_ $GI-$A$M&O72W-JCT[2&K_4$<2/7\=9D;U
M3U/4(X3(1;6CR^-17%^$=E6NM7+<RR2G"+$'EUQ=1\[T9_JM43J.GSV#WL+5
M:J."M?E7X7)4#L??7A5L+Q;775B4+0PR&=HPGI05T+(0R7!SP>0F^+;=QH"Y
M:$]MOX/$3M\3A%WMU&9=J$KH:X+AV4 )7'C)&\"XZ \!BK--M9R;#>@)"\Y%
MA;$W+U;FHZNY0O7#,FT/[:^7AE<6W29,TNO?H*(G!:2<Z.KTK,9@QX@A4%6@
M?)U]FTQ8]&&(QG3SX<OJ 8QTMR#^$*TI]JF#YSR26)1>Y,>D/;FX!BA>.P(W
MD\G6L4A__F>UPR!&4!&$F:!^QE9$K2#M  R6C]Z8M"3OP\5AS3-!:PRJ%P05
M3-\!" 7,&>R_8H.*]I@9(UX^JP-X:A9=^!#S N(QH("549PG1 T.W]T5: L(
M8)'-S0WV-Y!WS 2N!Y$M2^/;)?ZR7'@E ! RYBOFIWT^RX$1R7@HH/=)$Q71
M$U6J'RSDUV2+K< >S7C/3L2K<I?7)C%@<49ZA4#HT-N-UI&2' #DF0#X^-7T
M0=?3T =CP%\P1'<<D[;^KR*.*T/PV^ZGA/BSS_62@_CJF88)#Z0M-[96U;GD
M3KM]:30^>#<ZD4G,C1O\3-%R^$XF'&_D\F']CYF<)QO/@-2..O[GAWTPG<43
MF8,!0P3N>* \QRW':'=DVF0'O&UJ<G>^JSM<V/0@*<QI_]>BMUY3SDD!N<.!
MS!<"O]>O8VHM9(T=4I-HU"[D]R"[XDBC^B<^[%3#JNN0Y^T2&"HHS\EDAA:"
M@XEU@P6()A53&]L#(^%Q@LS[A&O<EJW.,*$5.+=)2J'MK;YAY&0#O?+XM>!B
M9>.R2=5I?OVDIKW=+U?EU7UP&B$7V_%U>;+ +86PN#!#:,H5/O)8S9F#W $(
MBK27$B*.JK7P.JG].=?R*4*#T^?I6"@"Y6\^%=<J7];NF&-]7[7/XI20Q.SX
MTEJKV213RFC5M'0'B)J5J,MZ0R<W'7J8@*74@B:I*&DDT_&_TNGVMS@3C*])
M^4:EHW2H59K D\I)QSPS(V.9YOPW[&#U>)KLN=)G]LOR#PM>_VD=J]_X;*$-
MD2>I0D*ZW=D2^A<KA+I&9 U<)BX-J,NR+@C-8/P_#^8;':^XM;)&&HS.X/+:
M%Z[6EEZ?"^.3' ^J"TQ\NTBFO>AD*?74_BF=_O<BL1#*@UFU&/@PYUOH=/*2
M*J"+API("3 P5B(BURX,Y5$O!FLLP3@Y_AC@QMJ0/.>_-(I@)'@I18E!)%[[
M[ D41TY-_V4W$305"A@)(AE461[_)*^1QR2]2GIJCV-2&$I&Y%7R[TC1_PPV
M*570EU&*%0*%"\T#L7YGU?36XL0 .WBT3;1;I.=)Y7A7"M$CS#PMOGA=N? \
M9<.F*6>XMDV\Q&PU/1A;UXQY0OKYEPQUJO@GC'VA07S=PK@YTKIXA&B2X_U%
M2/PI&$V*O9"KU#,IMWQ]>D(3)\9:I5AS3C5V8="I9S\W(HG%L17ZM)U+B%LG
M01;'K%0EFTRHA)]1%ZL"V?N.AIWBD3RX1MKVWE)IGM6:)R-^:-[$OLFYO%^I
M#,I0*"U[F'CAN@'7YZB0CH(9*&]8#@P(DSN-5;QZ>9)@;<K36?:O7D0JRA:#
M6/8HZ3\DXK#E0 &CTE2Q4D>@HT_L$P?L4J_2@ZF"H0 KE=IXGEY%=TN<@>$8
MTMEJ/06ZZH\+$J] 1V7=18N*MW!.EDB+PE!>]5(3#47[K_U(8S6]AX[Q!/<:
M*A/,=A9]LXD]7;/8^U?/LI081@$\\*3?NN*RCFK.1:&6E  ^QW]VG_?%..:$
M,FL!3L4YM=OR':!*-QAIE0P#C$@3Q\KOWL^BMVBARR.%YYKOH@"&XTZ%282A
MH?!:\;>FFA86S\"]-?V!<7+O:-.;E=.2)PW"[]>-7]F.N/EQ# :"\V+.GT6-
M'&$*JI7@4T6ZR0D>PO:ZK4EXL 9N"5\US<G,,CZTT.3I['6[)3LT]"=\#,6%
M-!=@)L?'TX-Y,.-;M*K&VC?U@S-HSH@3/;\C?H!5XM$*IF-F% /:SS4O#>\
MUDEV6?7.)Y52A6&FH\X4 ]E<G&.3$1\7R&]+0O@F1C##ELNH/[BZWL*?R(57
M%_QWU>@SXP 49=,E6/;(Z$L7B2,8WX/D-28-8-X @[@7#=&_5'!E*U8G&ID^
MV1<0&.QDSN&)J)!.&W(_JY4_Z@WAFY+EA2Z(88")Q1?7;DQ?ZWHM!2TU$,T,
M\F!RQ/,L)?+A30D4!XW0<E55OOET NA)L-:"/N%K:PEJ&\E2T+KW(3I*30H<
MQ5#>DW_/M2C]APJ$+]QT-((H 1$E O<47!T*YFG"ARHLHW*U"(]M_W%/D0#C
M[Q7YU,R,3EY1377H:[HB,6N8L 9J&LQ37+A)#>4IQ;2-GX **R"IH;S$7'T"
ME)WV>&(6BO,^#@[",#!9>)H8O;!6#/@% :\#$<_?,_%WJ,R4*&4 X+O^)$]G
MR7\)+>\55V!!W&" AIX*3Q\.!S^N?2D4_):J7T^-UY[GW_3X8@$H%M9J7&B]
M_L,P!2E*..:$FK94,1$Q#<:TGCI,\*_]25+^PH"!8VKV8!XMC4H*^W+W(RHJ
M4[X+F\WH!/,)\^6==%B=BYF1=/\L_6T!UMJ<C?OX*HAR96]/L\E_"L.^- JO
MG6L7SW(D\80D?>J8P&U=E]6^]!?=GO;]W"W=2+G2);FK^4-W>4N:B]>T-VNN
M^.3%7/H<7TRXXU#:)L- ]SW\UEO6:PZR;R(I_-"FU^0_N<44/?%B&<_?K'LV
M\77-+I]XLI"_'ML5]"TA:6&1'>%JNF0_&'3__4.;_^1OYOI?X=WE?Z=FUA4'
M[9K06I9U4,):??\_GKX <TA.PKXRV=_W_+?!6W>%*H&_,JAO$0"").@*GH@U
M,]<#K.)1,!M=/[;DNCQ/A7UU96$;YOK6Z&K,&C+>KO=JLCM*0M58-2*X>\\*
MS--=+<"*;'DG#]PEBP#3RMW,]8?=3/9-^_T3ZGF\$IX:J)I=7I["=0'6HD?>
M8I.# >-8O92=@WAZFNU!RD^8E"5\3PM:PF;O;4C4M\]3C5/??_PIA7<Q%N6:
ML.=L$M#S/!+#\D3?Q0(L@;4:1JC,Y2!! /"F8GDO.IM2JJLP@O69LS"93,6>
MFY+@K\3"L]E;\/L>2$M*HY@\U=[H+>LK6IX82,1[E]E&=75-J,/ @N\H]:GU
M5I/O!WU/4OB>0U^2+>>!&$[DOXI(&,28$;/QZWKNA&H.6 0.R5BSX55R85H4
M0N7%QS2R#G'IJ=DJIZ=%_E?09_9ZRERGIY1^<;L\A(2:6LND_I#!RM6PDD^<
M*I;Z'LH\*>XY4&RH#AC/LO/U:P.5M_J_+?34S(*4,5G4M2BP5I.$/>/'J:U;
M)]3OM>V"O4XOR!6M/TD %L3'OP]N7(=X7'$)K-.&P8Y74X$;K70%@54PJ,O]
M>*X6>@K1>EJK'859;OVXH408*@XEGUK#SPM\.$8 6T6K1>T,,P%0VE>9R=9B
M8\ @!R6A\H+'<E#+%%5_W;W$>IS(3LHY;LJ#[MGWOSH*0VM._]3;%HE4E'_7
M_X27,T[-49C=Y#_1YC_.3U((,\6831NFW?OK#G;OA7/&.4R]*7'NC6>U/>;O
M"F!+_YU0V;]<2??7GU @>G%>LLI'V!J&_7@UO'D*11XMOU*\X!YAI_U&UUT'
M#[I!T_M,,SGO='9AY7*"]Y02+D%(4UZ^^$(?WU,3]BU17[_3X$7HRZ?9"14Z
M)9::""O]CJA$CW1![]??;9-KX/:^"<^\RPO09'E6'>GBC/&[7XN714UGUF(R
M%W!UP,VENU8G+KCONE.R.4.+W/H@.3/ "?LEQY&\4L'JF6A_T^XSE[[9=66N
M=1S;Y=5+,A=XL"ME9'*)G+N':!T%EO:(^]DM.\D\5^,!(M,&3\S\1X"X_59R
M$Q8P]VWPH_B<6>Q5+H8&+.TS4MO1=AOBR?1D_DSDG*>^%B+2R;!!4-6S!$^L
MF6JT%QY%F80(77+TVY=_PUZXS"OSU72XXQ%^K^(= )]VE/=39KFX=\?K DG@
M4&D3?147G&>;]/5HM%M!#=S?S%XELIU?Z)9BQL$G8&JKJ3WNZ4.V"!UL:^#
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M194_Z)6\;P05<>O[05[J3,5&CBES4U:V"CGW>GKHV;H)F-IZ,=WE65A8!>3
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M*O7^?F#'G&,*R,IWZCR=(T5?8$<LOE.J$,B2_G3V<L]M=@Y0POTW1U)^5\>
M./=Z4RJ6+M[Y92\+4ZDEF4!MK))[L(C--U1D:'9$=%PPF3V7IQ.1IW;P7V"*
MK2+X=33)STKU0Q.IKJK.Q7-73*U;8YR37,VD$6]W^@+M[9.SZ'3ECI2W]*E;
MU!K]Z)G9Q7@N_%+BG-J&Z^@-:AL<Y(PS%-%1B4.%G6T7'+E']IO%YD%E3?5C
MJR\RRU2"(2&I'H99-_?LV=NS7WL]#TY9,"UKQK5(BIB)*CO(-A'FGTG[KHX
M*&L2';(K-"?@)JQ"Z<Z-%1K;2,*9YJ_Y&I::3-HL.NI:0AA.7+VNO:[X*7&F
M:7^:+M$Y&-'%RY(XW$0VHVK<B]Y^)-P:XL711O='+)3#79].^:[%=*>N:<UJ
M57^\ +*I@3S (?6.%<YS\ZB,Z2:/E1E,,E!JR.?K=#3#%O9!]KBM#-LFZ&,U
MS/_.+7I',<&T:_X=,5GB-<7#4A.OCE_49.:4%4Z;UNJ&WT?^N$ZB/<X'O#]A
M2R%=K)+&S-N_([:;3E((]C,\+H@KR-&V#QLNS=Z]H2HP+UMR!ITBLEH]-:UM
M(YPB.^_-\5FQ4>.3$LSM^\_D3/7#U.A[QH9O1%Z"T^I?7P)=>5Y76\RZ2Y.O
M6Q*!W@OW@OR<#4C&!2/\:07$B! N$[JH!=MP0?"O"&N!:F=3+Q_^E<KKUL_R
M-KZ'O=5K2'Y893]M6M18&;6 (;^N=ZJ.J$TX3\KZ+OA\(#*$AB7FR([/-PCZ
M7_#-$:W(N"ACB/;K]?OJ'(4X*RKA]:GVX,/N<[UK9'N&U[ 71LLX^)W^ML*%
M/T^#:<[JW9MI^FFA[6=#,Y-OC#WST]&-/&3*2X>_Z<ZTE6WP%1CU()1@.OD8
MPZ!T]0IY-)XQ8/KX< /B]M5YXY17ZG7CN"$ '9.Y*)Q/R"O;;[_7<$F*0I^=
M;1WZ5_GDR)XFA3085\M:3XBHC4)^'O$*[>1YO?OS.9G S'7_D1#\ SYV#/<Y
MA0?"N9%\4THV!CGMHQE>,G[_9GUG)_GOM2;S>)!A=&QSD_STK;VV[1^@56_\
M04@ DW>-MSFG<C7A+&DH,MY!_FDK*H&*--@P+;K#B9+4^7-;K2'2"EM_TRLD
M+%C+OU:428;64I]]8S-[( #=./'$> =0[]U F\+Z!<3.&JNL!MN6/-2[#I$%
M?.M(?ZYJ>7&_'2:_F)B-'$J;V2 ^C2B>E4.T3#_)RH)&O/&H[ZLWK/[3P$3K
MYS5SNTB:<VLVU)AV"^^;=&;!MH63^;C^"&DK[X%Z?\<D*8,Q.&!WX<[^ T5%
M8MCCW1H;^C%R+,#- D_"2+E3Q2)FBZS@+YAGWC/EY&7DA0X"Z:TSQK<%ZF"4
M!>.[0QN<7#XT:UC7.89/?B"BS>[5]9,'\S\WL]94SP> ;,D+_8#1XODHSM$2
M]""L)VZR^$=P*0S^1TM&)D!E5D\J!!RF+[-U5>\V)9 9TZ#L6)$&T*!T>L4Z
MWX<J\V"Y"4DB"9NV=V)F\.ARF^?6?+G_S<S9NTJHK7&EHJE,>KF-,J2FFA@$
ME'IL>.>-N%BQA&?IO#"S$DK-T\S.JM?' YNX64_\D:R5;!-=2X],Z^L+V,U$
ME;V!.^E".HJ'5^KWK/_8G$IVV(P T&DYOUA@Y*2\X6<)JA#67\%]3\GRI<8A
MG9)5"Q(?//30JZ9ZIJVB5I1L=P<1MV R* '9^YT81DIT4<?J/FL^9;O' _Z2
MI^ 64N<2!&ENB)I=2C2:H1U0Q.B(<V:W3'YQ,N1)\ )9FY\H.4>@ZU$T(UGB
M_>R)L3'F<QBW3)TQ8YMFN(/K+>S]6R^J5X)+YXJ$5E,)9E/(LYY@VWSCKL^Q
MI)Y;FG9[]O2(D,W X%/$DHJ GI>G%C?<1ZH@"%L.#Q9";P4R;"JB7]_>>\NH
MEJ>]PW8U33;6<+/^RM7A9[1$VDMSI!69:9JW$_W38>5:UF@]AU-<6]=FL[QC
MKLU&]?\-B\?#U958JF ^\>S15F$"K\SZ<;%NMH-_LF1U1RN00W#A:?E>$SPA
M-]"V#9.3Z7&D4\A<JFO0R)P<7B/N?V=-*]#+=SKFM<%F>7N>\,^8>H^5VMJ]
MR'2RR_4KS.M^2T[/QVGG2'L*=V"L4>8,G#ACM2C K5*PYT/:*X773 7RTPFW
MG63RA@T190;#V]+I$6RA\GE# <>JJ64DVM61=.D=M*YO0Q*'&&Q\7FH^E,W^
MHF;"#37*E=I2@OB?BX4C\^&PGJI'D\WB0!!BRQ.1;*V#U=K^CM >U=^5=9H?
M3JDX0VZPSF..(WB-0W LK[VD6<^(7B/5 UY:1X.B/G<-G[D-5&*KN'O59&V#
M'*2[K'9B'>8)B'WBG',&,*-TVF5.IN]'O5V=TNKB07N'UC*3,H)(DC,/6.YT
MP8<0^/7NN(74P&5NK M%(93MQXKL>(Z*DN]GX22;[@6(\"P\XIH,#%B\?@8U
MIATW/^[=2(O]J..WCT3TP3/3M)_OW?M]O/(>2LR*.+D_NK6!L5TD^MT^$D!P
MBXN3V4-GI')$&WS+$X_8[4.KW^XQ+MFF:ZWAFOS6?W,U9")8+#YJ 4W31Q4'
M'C@_TM\CPFRUN76[R(3?0VX??7MD+::]]J0\EEU4OEO)+0L(+13K0E\R>."M
M86NSZZD";"G[477=!6DL ^8]7:?EDE!!Q@_SJ6A5;]@2R&@G?H<WHO%>#]K.
MV.CGP[ %24K_KS09Y05XC4W_=[HA-EY(JP24G#2$U%8^,;H[&#@ ZV\9XINO
MVPJ(+<U!>8YO!9MY"0FOGFC_2^/$\\U/"6UWJ#:C'#S^R/K&M7KAS2Q(?6C)
M&17A=(%,^_F+AM[ [M*+L F[-D4P_762$X)US\.<0Q%4*Q__/3=QY6]%J'.D
MY:/TDTVE/3/O%OL;8WJ,QD+M5U2M8HI52WX5\K[8I^)WZ%4AH U)AZT<_EBB
MSQZX23PWD&C_A,NN<!ZI>K9GML1:DL)+HQ4U32G^3H2O^+>Z:Y0"6YMG79JQ
MGS@V6AZYQ,/+9]'"2184X9G\(_.7F_C(H87S =?3^Z-XRI*W9T'D!B$Y:D3J
M$:>'JD=N G>/WGG)0SQK\( 7_T9 :3P>O1FO$CV6INUJM"NE;[F6S%9"O,2!
M6WC",-9E_KC'G <.=^8?&)JA-JLM<5%1R5EF;X.-$0K2%\:*1<ZPG;@CA(GX
M<9>$-/1:)M(_?CM-7V>6".6O[#;99WE'_7ZMZ/YJ[8+FXEGI_U/!UHSZ+7ZP
MOY[[#<:5O@<:9BOK51]9OAS5#WYLW=4E$WK,QAA_NF;(FOM+? @/M#]3X]A/
M-V_MN,<2"W:C>@0:^1$,3ND'?$$N?)QW29,]N^7MY?'U)X*K/U'@^4! ]A[C
MZXC<"5DH%_K/ H3;1? MO/H;+F^2Z>?"^\A,0E"%VNT^S1N#Z\B]S9EIJL^(
M'AY#KJ\6[0?WUQ0K=E0;<,>>*TLT+/:AF/O0:<UA&Z[SVXT%?^*=(V]M^&/X
M(FP\!>0._35]V_@GY-5=19H 3F;??DZ6%%_5[Q2H?]T!N,$"QWQ&#V73Q%%A
MV+G1]H^_@1'.GCP0RYI]Y\&@'NU@I'O%BGW;XTU0]U0U0;UG;V!Q%(Q-UKP6
M2)%?FQ^ 3><2GN,Y0/O*[L@"F;XZ3'A_I)MT?  =_-FY;*IAET!62ZJ],PG=
M*5EYCT,)$SR>)S9L4HA6T5_32!(W&3[T=IW(#D##&;6&?S+#*!L$Z8F@5]"9
M=TDRD.*YQ:3!W2)(YSW8*# ?,9UUHGJ!B1\EZ_2XBOX4MTLLLRWRDQ$EO,^L
M9= X;^XB# 3?P_GNL+R%.1U!$*\?A8\Y&,=A>XXZ@M\.QIP%H4T\/A^A"IA>
MH$._W[[;'FN:_<PUZO-+[(O=6W=5E.KMBF?JBA1]GQ,'EO+9EJ,H\<I+\W(U
M22/ 4Q+@)!=0W_NS(:W .*BD)I:*\,Z>;SY_P^OVN!MOHU;OJ>S>"X!4I8^C
M4_%+K&^APQ=+>HTY9B1N7/F[0\*EIFPCE1*EHVW+#I:TG<$$)^#F*MFC5A.H
MJQ\:CY478;SW )5\B@!*/'4H\^/7MR&^3?#IT33$3XRK\9+:I!I1%A9N:-Z9
M0PFU$L":QS,+?<!.[U\&]L?DA*&BX$K'RU<P$Z QL3AK97%6DCUD9 C0Z.NA
M\!7,OHQ6"]"@QLD!M[.,]%8HS1E**X0Z$]+C;\P&?<E.3Q6?(XZK9]<_Q&:6
M A,6SM^WCE\WG)N3S2^1]RS1WLI,G 2]#P2VCZY\@]?,M(MDJ8V7P. ?F>5G
M<4]>Y0AH6PCU,%O9HJ_K\MQ*PC*WK,J&$5W)>U>DV8PZ=:)])_[UP^3T(K:!
M%SVI-A<V)].S*5\7:-J7#F;TTVY;V*PZ:#7(G+470\RCJY)\\D+M"5NS<S-B
MDC?\,$0B,L9&@<ESF;D<#?1?Y<WZ1JO+VTF,R.&D9&N8>X4[\C0O5>MFD_'_
MG9N>@+ARAZ^2'R)X&^MHK2/JO#9RJMI%B1ZMJ1THP7=:]1'.X#]7W\3$.?Q0
MV,21"$H,.%,9&US3MO% ?![<QI'HB;9%DX8$_U]R-<I8-W[2%@K,9/#1KRL=
MT';(HZ%.0#Y;9WP.W1_>JG\%-_>[-R(">IOL1_E'K-(.C-K*PF;7K]V4^ZE;
M5X?E[F<*@N?-AW94C&L/$8>@,V(E5O5"A$'[EG3+)T<.QNA/:8O,YO8#YQZ&
MU9F1=Y$$P58)P[3/[7KG]:U;AX99X@37!X-BOUY^;\4C82]*5]J<$5XST$I5
M[:WM5"]OZ,ZB?<I%PU6E>!C8B+VMK44\4(]2;UR:7'WP=L,^>PWG#W*+BBY+
MR]W.6["$MM#PH_KJ'61+MC;B@W]+FC1\CL8?#G0B#UZWSZQ1+<=%Z'U *BE0
M>S^Z&*ND,AML:[:J#8F\+$%)KBQKT.7;8@T;P^AY@9.J+*]5\PMSBB&!42_T
MG&NQWKQ,UB:SJ@=F4ZQ W$O$1-ZUF\-H-4?*U]7'G ,>4*U M0D>WO:E?<M(
M]L.,-CH02<LM:\EMLSK8TA?K9&1=%XI-6Z;=$Q33^55Y%X+_K;8.=/"(J8\
M"R"V_)I8]P\$M\"7[R6DEV,R$1):U<'!]G-_CA[^R]TA!4J_)UYA:B+ VR]S
ME.C:+*[C"2QXSJKYT7=LUFE%FA]7P/SP\NZY_U"U?95@AIVMATD^FJO_3.I9
MJ\K/.%HM1IB(@*!^1KA_4C+ ^P8-:\*R#[76"#\!_"[,6L:?'X^'9$GE\O]>
M%EHI]1Z,G(/@GWKBW?ARD?[N^ XKP3>PJ+.=/D+$)A)C5^++B;/@%')=0&)#
M:@7D_K*RR;Y9PY8W+=]P2ZG;[%'Q\C@7M5,R>5M%*(H\@[)[^WP+T@FT79C^
M=W9S"NF=SZ[E'KS5HMBX]^!C8.853/20TW4%G*54B1<4HS0,*+&?K+XB;O^Z
M17F@Q;OT_ "JH,"PI+11WG8Z3G@--;ZSA*<&K3PT!J&0JZVT#OC2-4&'*G Z
M6:(JQ>\YTBA^W';'X]W#!GJ3+V<[:#@LU<^%FO5VE#5;P4^-8**P8FNG'>-R
MM.@=#X=V0X6\8*2>,,/O-HU6 4*LUZ>*+Y2?XA'5.HJ3<K^M'):J2.\4ZF&]
ML@&L778OLH#V&<"T&))*R3Q>ON&]&QE]9B7G"2HOVA ;RO@$?O5VR6BC[$.$
M5*_Y" B[3E3+5,_T%O142TLP_#CP>0"/#C-_GP.F+2WBFL#0AAA04>.2ITX;
M_901HC7.;._.-"IB9.\ZCN "U( 3*6A_REMFX1Z7XU7AE+? %)+<\VV"-J5"
MUX&3YS+YQ9/9272D9"-]W*O<K8R^0._HX0=^32;?_M3  [N:485HW;F%6Y7-
MU0\-,M/:*WEFZE#'$\'T%M.D "<O5)$/U!C/RQ@FD[XJ'PU,(I2P_HA_.F %
MO]F&:O>7D3ZQQG(#0@33*M"+OO+#8RN6H=1KMD/5L-(W[S^6[W1^*!#P_;2)
M_%CVNO+4V&+AF(\G7Q%04K,_UH'9ARBC0V _8BW)>G2MSJLOW@3'FGT1Q+>M
M:PB YO:0-O$#MOF,B*(TM13(MZ_2$27[=M'7"JX1X9^/%QQM?^=.V^E2F2S5
M8-G>B\7 ?7!B9Z[IT/&YRQ6E6[2/DDY*Z9]S-G1JP!.U1JPLCD/X>-M.+ULP
M'\<@]BSV@P4#GK>>'(6*!Q#J"4/6:[I M)U0=XTS/4 ^NSXA@:/V11R738$H
MT7(*M:)UQ@2SQ_+ES:T2TH_ 1NI']HQD;O@ARUH/_^,6=:UOP Q2&2(*/1U,
ME%>V)/5?+B3F"7[U!"!/B^:>(T+D\SF6VX] E7"OC&8P!Y&KY)8^1]ZEI']^
MW2.,0CGO0-B]L.^2C2Q[]C&M>92#&U48+R&BG_%Z583(2G!ODV[BOZ/H.!<O
MI(7=LYOV/.!#0T1)YJ2%_J%2_*'E6V?+;]+FQR,HSC<IOV':/BFS>I8C=6MN
M)N>B^^P=;4:L\B+-39+?'=O=.EEHIAN[YYO8[)JU1@#;R-3B!<CRV^PS\'1\
MS;<$RRE5A8"/SS6'>*R0*?J1RT',H%'[-</JO98W 8$F,Q=)(LZ&X%0 G'<P
MOQ;=23-@5P#\4\L#-BYM87$H&M2V((5:M+S:_@![ZW.EH+IEFL$R8(,P1WSU
M]<=0,D(GX/51V?XU23SK+6;SB^29P8UFUS?>IJ/P_)F+W2K"C0E9!Y.+7 4Q
MHI9.T/2B\7+'@&J*)$B=1BYE21' +L3/OOW=?%5_ZQ,4Y4R3;4->W8@NJ03_
M_"O:4M'EUAC)6*E?FDO4KY,<^ &^J%W2EU6?EH] J5GI>P9W! 1#[;3<4)&\
MQ; 'W-$JUL,!M1RHIS?M>^9CO)GT -,Z]T !*Y\KYRMF0FIGI*0')$/1:1YL
MYMK2_S_7+EK48N:\KYP9W6&/!R4G/M$#JD-%$?S]&QV^=M < W,F[6>E\>>N
M8<$5:^#OUU;T[<_1:L:N<3)4C=!H?/&_B/O2* >H;5J5B[,F&.(9@G9]K=<,
M[U+?:(1!H\@M+TN!KNHEKK@;-8TO2@-P1L%$E4SN,T!(HWPG]\APXQ42V.FN
M_?R'$WASS'6MAYI=WV5"UR <H#_"XUX3J[Q"-S((JVFKU@-=SQ:A[J%UL>8$
M3,#7WTC0&R249^6.=3+18F[NBOL:+$SB@M2 V3.AWEE?M2=N8M:9"_UC5ZP(
MWG4EI-K[M0J+Q[C,-3Q(G]W.*1\C?KM'56)Y+AP5;7'JM6WS2<5;NXM1I0OI
MR!WS77B35-+@=217ZG))J9R5&NAD"C"&%S63,$M'D ZYXZ KKJ39[6<BY>CW
MLK\MYNY$WJ)XO-F_9Q184E.;=^DK3DTE@+AC('R9Z94YT=L<@>:%ZI6W^^>$
M-*G.OM0/N$K R#K8XQFCJ9OLTV#YST\=5CY-^]_9;_7C\>@*]:I]$T=3'7B5
MQ[+74:CH2JIIFR^$4,T86OST;]$%M[\XN2TF((PV]!=99$GF2K?(TP_XZHG,
M/V*Z1,0G>WF/'NK#ZQ-=%TT?6'NM.#IFJ,%N#S,$1"3/(29GA O]1QYLRJ&L
MS)=03XPTJ[#S '<6CWJ'M1C?WAW 9*_J%Y^U:X->7I9I";6"74=7$.X-N[[M
M=N<%+=>0FGZZI_) >FN<81(CPT[MW;39$ )&JK]0#3[E_+K9YGEGC/'T>7LJ
MC4LU:8-Z_NU%K>^M Q<5-6O/;#_OSL$JW'>64G@.GI!%?GE&JIA_5$50!*DQ
M*H$(0;?Q7:]STT% @8$@U Y_W9YT-[P#T?/2[46RJ" BRP/EMZ1JH9Q!#V!J
M%HB*LR@CT>6&!^"OV?!A9T%M]@9IGQO^7D>NO)64T+]&[AAN1+[*:E[N['QK
M#%ONVR[CJ//':*/<LA'*K*OGCX5OUIH.\R 7F^?*<Z[%V*=5OI*J&0PF*M]T
M?RLSRFR0,YKCAU492S'T6S:%K8?>-"[I8U?;C^+UV^X#4II5M0-E.Q159]GN
M0KG!OPHZG!XI3;+MR=68?DE3(2DD;$;PL-,COLPW"<;3JBNG6+9TFVLZA-C5
M)Y;J HK^EA?>SB95I1O!*]Q"5<_,>O*6Y*_-U&H92L5^-HX,2(']*_*7*GD8
M<5-@K?V<484R]@A0WKC4H-[/-#?C(04.4^QY]6>5%P'W[\V;D6@@(BG\&O)U
MTQ_5X;/GMZ_'T[H#JACVL6/!92F!%A9,.5C"IT5S;;8;XM5GM&^RP?O5NXPW
M&6?B%8\CUMI\I"@/M=U-O7Q1A<S0@R;6-1["<_NPII>"075!:HUB O-E&(\E
MAQ[L1#B/!_:1O^.1#"H2'-I3EZ6V92D4EK#-*ZK\%]G24V;[,QOX]"GTO%%(
M;_V:.@\DUZLS,RW4_KMC4<VXT!OY*"M]4,O.QD.7G_[(U@N73UM<,\,B((9O
M5964:H_ TX* _%)A>V2E</$TL N\%Z\HVTQRK'[1>%=*6RYT.MTU=>ZA[+!F
M:7RK)RY/S,KM%&ZR8<L*?A"(Q-96*:0Q5%$##;W"%,I=C4SY'PS-H-2&2I0W
M6QHM!CBL;8:?&F#]JYDE1M("D6DUK"UEG>-AI(9:3NK61WZ#];G0?I)(EHBH
M[(!4G&P$X15]CW?]'83)+O9>/%E7$A'_VU#>$+F+N:#%OI%A*08S(-.7[1N1
MD;QR/XM.E7YGZ&TBIJ<QZ@$ID=:^MF".UA+XM4<U^.A/7'G^@JC(=\)*O<]H
M0CT^Y (=I4<&S+ZM5<V,WN8S#LTW8GTD'3FCA&R;VKJ0I'Y&IPXS98;]T_[:
M[OK?SG?OA!_P*C?7WRTI^C+NP'J*QTFJMK(O\"Y?+(CQ'YJQV*TXT.9R@1$/
M(AZ$MQ(#GE/*]38OQ5H=[ ; 5VZ?$ I<E$>^@GG4FXIH%=[KQ@&" <%V^5!G
M.Y<WYL$U+.;:3^E@WE1V.OMP-"E7NT6@'K #OCRSV4_FK_\$FG6"40PU>0D#
M%FY!'^"5!7;>4J XJE)L(WI2^#T'?F3L5H)!)M=/]_^V.=\P$G!&:%CP%J.2
MDW2?6O'IX R[2(_#MXO&GM$=-7CMS*%SWE*6)JVN4.(L9?7&"1D)!IU*['<&
M*XOOU-6? _7.MX3-F*+ARM$6%F,?4ZQD]K-D&YHBO2]DLWRASTI%Y\J\KWN5
MW1T"T,55C0&3KBFJSCMH$G<R!9U?4/#M*@-X,Y3ZP#-R!]K=+8PK1%@T#*\*
MENJ"M1K5\C+"H/LL,G^_VT+[M],LD:-V'*)883M<]UL2K45EM2GC17?5-^RH
MH> '+5GJQT!D^P+&^/<SP@,>:[%;9KJ-GW!G;53)/\%/6FK6>=]L IZ\.96A
M#]"!FYHYR;#3=U3O&_E5EV]%07[K8908'5;L[AFK+RH!AO<O4^%A,W4GR+0%
MVXYL%ODP1$<;3B%,$@[6OC/>36/[B^VK0\8*J?^*>G]Y3 3KXCWM,V<35EY$
MWEV=;>KG&G%Y9;\ "4759G?PS>\H9_>T#SXCFM+^F86F_D0MC>Z) /-%2!PP
M6CP/1*L*_MU8?&@0/EDMA&%T^O;G'6R_ZJHQ=4@1R#<+Z]V\;HVLK?T/U5#'
M@#UZ4OSU_];(=P#$'T5B7L?,!KMGQ*!7DKEY$]J\TOK[<%U;'N'W==(?;G?]
MZ('C%&)\V[JP$5P.W5SQNE>-Y?EV.;UOHJS0S# Y?^Y\4+0N15#!X.POU!9S
MP>;N^@;N?>RX_2UJ-KZ P(QHI(E+?%?^T+A/\-;<K.3']G+?RK*Z#Y^;:#R;
MT2?T=G5K6),!A=$TOP,#).OB<$/8M(&@:BECI$Y+C6A< =/\Z*+M3:$,U_)Z
MKL9R0/<KOVOH,6.0D>XVKWB6QK82&6AGDCN7^>!3^<WQ+9#=ZS83$Y7Y0)D<
M^UM[W1J^;-4&=_15YY7:XPR?A?!L%&0;H>%N_O>H"P,K<0%1X-)TMA:]H%HV
MIS'Q+F<N8[8CYZDYV[$]NP0SVF7ACJH>I-C$5_7&A7OO[!(L1ZJ"R:?"<WZ6
MDY)I%Y&]+.M,;& >FJ-W-".8&D6+!5/'P<9GEKX\N.Y^5EHW*)08]1LK EI<
MV1L)9SJ51:9KM<9+JC\<8O,3LA@>Y.,H%<6WR"&R=%2+BQ?,-[B_M(D]0XEJ
MCOGOO.9EY!H,GS.$R)M2]()HK3L_WH.^"=D#"^KDW>VP@-KH//$[GWD4%'?0
M9D2E2JHI<G^439%6!( I*]%57,MI;K'Z?CJ'EMB1+!VIVCP?L0:< I]5[WU"
M7=[A9("&VIX?_Y)RYTQ+@#;19)'(/YP+JO@/566K@KW594?I5-X^K0:3]?!5
MK0L9^.P_5"[=%M'PL-]<*4 \1CSGTE#"0VO.6@5^%8<HG6>=&LA;G]W&Z;@,
M 7*?U#6OBN/1<$9=HD75!<KNM^A8Q+LS4O+=,']#E*:OM3HG/V$OEVSQM?BN
MV4"G5MIGK,]#VQ4@>,0+5,_ PIV)!]!NMY&==]"AQ%HM3U^*E"R",L9]4)/:
M26,.9"OHC.YNJPGGRV5(5I7-[/X7VA3KR3RL8GVWT'WE'S;;9?<)><W\]Y!@
M[(&EULTL%UK;X5-JM$[K#:9]!=85C_*:UK[.>C*T60VN??)OJOKF1EM9Q_,7
MEC^\BZH#!=M>/U521%_'2_=^>&,XAF@+,2"[Q-B,YFUZ3\#*/P2*"&X@JZLZ
MR)'6]:A-%DH"'""(4IZT>-9!2P LVL"^%0,^-3UAWWJB7IN\YUM%ED4DU!/E
M4%$>12%M=?RX_.J(H7=8SEIW>L4F;8N )[F!JHB#-<$*A'A:("-;NQF0X7FF
M+3)M>-W#61%0+?".$Q17OR(Q.ERK5)?9([BL^#L_[?B;N"C/@GO%$K:;JG2C
M&76>(16^^0&.2=]*LHH$WVM!+?/0&2N6M"=Z^1E[!C^I=%<I?UT=D9!X>R"Z
MP_,$4O?X9^"!_7%+^8"B#,LDM+S_?1^^8F-&[I@6YOC<5? 7!%@QBLL7?AS)
M19YKTEWZ=0% A4F)G=EO=%O?7V8;N@_MFWFI$."^FNW J=/1(<+)B6X,8?].
M32\GBY4:<%!Y=GK#D_,7J7BF+'W4C$X\!?DN)I%7/"??9#*3U.;O<+WBI#[R
M1KAQ)KA83LD%UE,)<#@:,.^82\$+ Y0:$M4X8S C.R:?T;NIG:!W3+!Y2MZ,
M-H66\E]9(^ GZ-[;>/%PQ&:Q>7;I,05K>UE##JI_]@G LWDG[\1VY%+Q) (@
M],[@<40C>]C!G4'Q=Q"G#V1C&'#+W=N_'C5M"8W&I>/3@"4S#Q18_5Q+X>'V
M[EPA[]X7 49WPP_3(&OU]HF\+?@T405?GEN;( =KEX]6/,$.Q181)+>/U0%0
M8KL%S,!JBX(QU1CH,<[M4'C\CG< MHL,ZJ_JW$).SARFS0N&82JN+]U?MUVQ
M%JJ.-P"S?*I;[V0*-,UD: BVQ33=_L9HZ '9]6ETLY!X(4AR<?SIG:]8E6X;
MAZ=YL+F6I8>!3.7].X2F&3]WV*]LJ0OM43>\L@.-JRUS4KD.PK*4O6?#Y+>[
M9!GNZOMD)@5]XD%.=+T67W500<A%U2!?ZG^BPR;-CI5']9-5[!<K1:C;SGE9
MKGR)_O!.!/IMQ6/!6SOGT0&](>$X6BM4<%";U2Z$/;B].HW<R-BUXM#*JH?6
MO\@.*;#,-)EA81QQ32$9 Y.TJ^N\+^&\$S=XK*,CO\GY^B5P-"HLT)'7"^'L
M7MN$G)&WP?KHVX;U"=X,EPL?O%U3%FIV\U^%MKZ-P#SY/#49OCW\&%AM+4^S
MM2LN\>SP7/G>'@E)IR3<2H<J!3M\0HU]8;E^72!](C?1W%-?KHP).[(J0&QD
M+MHF>KYG&3Y*G7>XT&']^>;,-(<LW;*@ZR*0ZY0"?IHH$==/,+?=VQ ;Z9T0
M7X&@0_I4*05!/4M=Z\G!\%I<--"#;BV(T:T1BTL72"L#TZ5OW'0\&W7MA06"
M/26.B]2X9 >>5."=I\7HZ^KA]3[!<6SF1O]W1Q8Q5( H#?W O=>>+8(\$%[W
M:SU_UW= \S\P*Y.UQ1#F*IBQ?YADXBY<[#C4/ S*ZU=R)\V<$T"?*)<I**RW
M0+E )P,#]D5.(,(:,K[\%8/%OW8#R,_2W:ARSFO@047;X@FQT,B+]"5?I/6!
M#5AJDKY 6W^:4Z1!^N@Y<O!EECHQ'/FD-=6/#0\:@C$=F["1FA+0# B.><XY
MB&X9V4 H&02QC'&/R>=!ZKG9V4B7SM_L/C.%\L6S)!,FEKU->7=]PC$S2_*?
MKYTWX+[3_VR!WGAB,/JY'I@I)SX<I(0"'@$GHGOA%?3\&50:1"OP.^'IOI5%
M4[;&E!C([58[-I$L\<NV@&8\;!S_&MLQ:5#Y8C])[C;-CDK'5R1Z4Z]2+^<!
M#VEY(N_.UG_%+NUL"4R3V16,BO-8G= U3=22I_ :AT>R'AOA!7@@*O5[7US5
M/X6@F6_#GKR,%U8<8K.91E__+JN@,=,BD>SOA Y#UN1)Y0L@Q_X-LX]U7%99
M<4DMVZ*^,:3,VS7ZM_&4YC+BFJ<,IB\!):B#@;FZVF##+B0KD6?Z77U%LU[%
MF69:[K#MOLEL<#'$#%D'=WAW6:F9W28K6%C3\SAVK1/H '+%L<HLJ%0WC*&R
M3#DQN%]'+MC%*HM;DW8"8GY.1Z^@I>*S0/J55:"*H>63VFP[9!;*_*+NH:T7
MS$8YV1[1%/[[3UI%F\#'QXO?8"K&9H;"'+/2V^$$S2L3?M]/@38S [A#.@SF
MU]=@//+KA8/Q^L=!9JBN-2@D3/[;@_9AWH;+]VQ!@]9O0 E57^0NU52LBPR7
M'G1;_1>G.4@F%/+>K7SQT5@ [N$SFK2WE88%1'R!WC  *JDMG.^W3HK-.Z8D
MN6M/5@<]$2;(--Y(#0EOPMW%=Z"$6N]%X</++\5OUW]2/Y7\NF8*/0GYX=J!
MXV'*S8]:_\ZSGA..YO9F>L_W!6;:TG/2PD:"^TNI#X%TK;"&N1:-,Q@'1^XT
M7<4Z-#<Q.GWP157,[KOI/,6@&WOF!^'F*F4<7TDH<B3TLYN%$J!_'W__XP.>
MK_/2O5]<L;-K-]'J9K*(R;P5(9+>)NA]F1/ N>H"3302UVQ]JU3OKV5XNNMG
M(_%*\Y!&;A7*?UG%;/!Y%AN=<@\T T3/"602@<6MTZ7.W^2X"OW>@R+]X@+0
M;LE? ,07L09V(6?Y]93:;_/+G.RRY/;X=\:KO.3SZAJ=H/9?>[K 6Z(5,;0>
M^^.O1GLC2;G6G7C6<KH<1-I.'CPUZ'NK  ]).SXS5-PO6[AK^:_DDRE8Y\^P
M+R( 9LOYOF'*VJ-6=:U;HUG:!7>4%XSK/V<_[ 6DTQ77+2?59*Z1O<9B^-:<
M![MZ[CFD<4=C5C8((T<9-1J< 'VP]E,I+Z^-1K9)_72'=RG'#9!_PO&BRQ2,
MD)][BB\%U5?SH>J]? 2*/-?;*PQ?_M'*J27F@QR>NPB8Q7"_]?X/U;>DO[E<
M1J5*&+@EV+#:\05(WPNN+U!]5H'DH5)@L;88I+ ZZ-.@(<V,G:J4SI-,M/IF
MM048Y $NC'S6ZZ[4>^)PU-ZB5LNQ!2FR'Y2D2#&_),4E)!;>>ZXFGB5=\L1E
MK:VVT$."GA.UQ.F;0?L5$7V2.$C:@CSIS'887]HSU!ADY)I9Z1Y)'6Q#>N!?
M9I.*+DL2J L#&'H- XGLRA5HUIUL(3+-"%U)8'D+_KJDWVY>2[?H3<",4$H0
M9D(4%V_9Z$J4N_*5/]CY2N,0 NV&W(DCZC;]" 7+\E]@-,6JL,6UJE;8NG+%
M,<NJN1HGX/:!&=FX]?$XO+3(*D)H,1@J;?QA1<H;.5)[%]WZ(04#%YOV).%=
MMQMPIA/C<Q8.V)[_4 %*2L;GP#NF.QK^HAS4F"2!$MF!H-];A.@?((7E;1SW
M8^_%44>=\TZWH,\.5AX=IG=N^JYFL *?=UL+TH\]V&BC"-ATT).*;HC,E5<E
M71<V*@4^V[>QX&V(2GYT>$#WZ<A^RW>GD35JUFB>B][11N06.L9!OC""KRQ6
MM1C"#2]/7J+QZ.20_**KT<XGADOE!C^"(0V[XE,";?EI?$.2'YR AY(*5P1N
M\20?="ROE<MF61S[&E\/(F/FC^Q7Y[N_$8 9P ^XEO3#@S.F7-K!7(85-[/C
M:7&47\!WF,QR]"6HR;5!-TAGL]@Z^K5>VI?C3*(K6?V2F$N/C$_-K<*DI=O-
MH<O;G!_?!(R^ "_Y8ST#9!2L4PW6#.L(=%7?LEY[.K2HNDU3GI6[E^^B@QG?
MW>B@FOOB95>@X7B1&<71K>TSG\@K6=;[_%-E?5:M2WQ3[>W$B7O%$([O5;*M
MKM<AH?!7> @SB\!,\T6TH*ZLD<K\;EJ=P<3X3F7!T,.1C:K9&QUS-TP(]5(2
M0_FEE,J9<KC*1SD:4KXE^%R^J5TW2R*7:)XU.8);I.?OLE/X[= Q7"<5DA/D
M/>+UG--V/\+G#-V^U6/[[>_,"MRPC815U5\?UYD117VYM8?VKP=F1$Y?L\Y#
M\JW64$OF/\D-J]\;DN_;@P!=1_+_=]1S/6F-X,0N=:!/CPVUP;QV>J=_ET8+
M5/Z]%"C4")HV4Q)&%WF\E6R:0RP3FFW<9)D&VZJ+CH+>J 3JW]?B2EXJ_"Z2
MG\??M.STS*S^P"Y/F7IUN?@* /5GN T6M):]::R&F*[/6AW]9=W$Z"14/,ZS
MB5R8"<G-&C1];@]NG:Q9NT,XL!T>>E_8'JE-JF0D$C3>ZJ'0*J9>:[K/^T)0
MO*S[AM4KP:<+6DSU9XG_H;JE_Z&<5T[4T2 /8B#X3P"JL/[J4^LSZ4QD(\;[
M"]S+C3<-;F1'UVPSZ3X O5ULX:A ULO9H>OT5:TF-UP ,H,K8X"*U;/^7!.;
MS_>0U(<'7&O<7F?M#/.<YQ<!;L#>>BQWNLP(;P2(-_?,OC:GKZQ,J7#H0+I"
M_H[SK.1A=1Y3! ?ZZ9TECO0">DM(B%X_Z2L+.=.K?_JK5RC__6-*9W*1MY2E
M3S20:?<O\B\N[0)?"[.#2*IOM0OK,:)K!,\Q,"6HI-LP\Q@8^_1.1+[PG1=U
MZ$K]HD !8:2T7B7&,2([RQ1@:?A^O%CX%71J08Z(BS<G6GT[*I#B;<A$,19]
MS81FT<,^XS]2.Q2>V)&SZ/ZNO4"!9CY/=M9]*:_X?I).1!5UY8N:FP+\CL^7
M-5T %A/WVT^]?!(^U/BP*!;?CUQZ<=LN7Z"LGFM (-!RN-?75K?:F.@,GEU)
M++ N^#0!8U1^K.51DYNG1!U+*B$*M<")YBQ\\[&AG!$W3:%3'=%O&"[J#WW!
M-DNI[(2TPX$D05W.QGMAI_8-AT<D-/$&6/'(PLX@L_XZ0K+.F+-%77+JA&>C
MHOVC%6&SI1$OT?IA*G*F*6'>13;*H\G-,XHKVZ%HS*PN"NQ7!!L)&N_K@;00
MO*08=&L"'8S1[;[W"VZ, %)&?,H5&:2MJW$R#Q:5&HU2_,+>1"Z8UNPBOB4\
MGP-[.V2*Y^GRO%M.T3?*6SVA/VZ$.\Q:R'\NO8@RG,V[;9WQRUKP3AY><:$=
M.9M/E+C!>868_<XSS/9&!\ZEDBZU\KBR?K&ZO-Q7/+F8:[X[.;3FJR(F:"F9
M2 '77F:&GC*J)/48G3S:^1ILXMOOBTY$F6='\#=R.YT77T/FR9]STY4:XTZ!
M?/_NI)@ IUBGA//T.38ZB!I@_5&:M7?!HP9ZNW_N1MP"I/S=O^ 8=KL>"<EY
M86?H1M"E]("OX1ZK-1K:G,*/#;79S/ZGA-4Y?JV>DLD$$1Z(0-7^4]^.Y\5G
M=O]$WXW!_D-EL/%'^;T'4M,T<D+7'5"^V]S GZ;4R-LH-?JZW96,O:2J:,F4
M!4<FOD$$/C"KE6-!CA3&" !H1X_QV7L6'V^;113-9UP! L4$)OY<)ECEBZ3,
M+?PJW9T/MRX)-_XMV]WW$41<HOO0=;K<@I97KJ^::#19;$GB"*W?+F8-G&GL
M=M1NJ#L4;[=@=V%\5IK@YHH>V7+W1\O/+"&#]#;*&%X>@JND'J:T;"+,(6SM
M8OM<.69BB0&?6^3*SF#+R[G"]?M9G""Z!]^1L]]^T.W>VM7G.5.[=5MO;<5=
MVS;^>N++2NIDIPLJJT^!B-%*W!!#$>_I1H/#GV'UQJ@7 Y#,B &/0I:5K1,W
MN'=X]AOQ^?B/-^RE&Y7SBBYS!4@=T9ID.^![28U!V&;Y0LCT'.SJHT]2=]LI
M2:K04X2LQ52(5N-;GFS[NT._AI>0VS(I:(C*R-*+_W7A*S=D_W6C PBL[9K/
M%Q$(#7TB^O-:NBH7)23*/>WO#;4]IW*T',%.S6"4S=!-\0AL%?NI@40L,(NR
MKG; ,FS4E0SY<C3@;\7H\Z.RK4!TP-LL>_I,0,O,[^P5#W1N!=H_XRKI,]I2
M&H2'0_6E:L4U!KV:I_A/QUB5 "@+3Q_^1!^WK/,,?<4&<B>'0>8@,VAJ+_(E
M.%Z3 ZR#8?=T)WI-+W#[L)O^+;_5WYTA/F;;4Y''8\W+P*V2\@NY!V)%^S!S
M\K?IY1U..%3E470T^V/LCVLIJ')^0?DHB+6@DQN=??1^7RGO%9^',C)HT;BR
M^AOE?2"HHFVKV'JNF.S8>C>%:^I;_R+>:@@6UE3]\DAQ'\:J5$4.$_MB()S(
M0L*>PU]LX:_EW+4)D^9.ZJY0!L^_2_4/W_KZU6P^T5]3:=T.OO')I7T[X4A>
MR1%+5TNG6PAI'W)JC1,NSUA6C#89/:&]DVFC:_#QG\S\_IG-X$GW1JO_1BK;
MT:#7<E#9<<2YLL^_ 'J0X&56WR-B,<28YW7/FH[XP" 2+^T/\-I+S1Q=?V8[
MX.WU7G7,^@0=UVXD.G5L+<QSU=#BR[M]2COM]K\',AL#+0V,']<P'ZU)UCY0
MQCY!B%KYXL\K1P\5"F:(K>*"L!=IR(ZS_P5.M9C=7+K!-Q_6;L>3'E"!$$O\
MO]GMB=T@2@I[45<?=92ROG-SZ?X7?4OOPI)?9 QYGC<HCDKB?GV#Z"YKHW\N
M>WZ>*?D9.?WLV!N@*15H8BL[X+9DHJ-#\%J0'W_C05B4F_6]R=0!6,FJ.N)O
M"[7179J8M@PV"(9K(?-(2^BD!QXEM41&5,0PE16U0MCI3TJ#D_IW,8U26+;R
M9OV3:E1^MH__@-?N9[O$\"!X!F+USQ_6"-#N*][4YVV]0P:O:D#1JZE Q25+
M.HPK=05K7 .>"]'W0#-RQHL2[M.SC/"[0==R#,J-^S0)Q=-5M&E"LV[+YGRW
M+3H2O:M(-*SJ'Z/;7&#[ZV$NT=52;*T'LG[GP]\TOI<VX.MH6)L/V^%$OV9<
M;/Y9Q>LM^=91_I#&[E+#A>J:U=M(28;7K.3:S#<JD(?5&G+W?(9O<&(V^YWV
MAWK<O>7W#T1H%,N/[[PZ6JJMW3<;IM;[\K@&;CFTE2YQ@3&QN$3&%A??!9_X
M#>/ POD*FCF 8Y /G_%$9;;-/:C[>+YV6"EV=D]YW.=E*ZU]>*K[F4&:=XA<
M%V&2O,MZ(^@N9<#]BU8H7(SC :36F\C3>*4+RF_:T]1>:225OHLR-!BZ[76F
MN>;/WQY?Y\'-V0HW;]>Z?!!(;OX/5:M;_->/BE5>V^-^NZ=#/%^SB0H.<[TN
MB!62+\%KY\1\S79$XH.G8O46.ZYF(.>N@_<*-?S)QNCI7#[5&R#ZVX9$F &'
M-=K!)0K\.67:ET'I/2A-RR1W)T,B0;@-2P34=*XE02K]V^S]KM /ZW3%.*F3
M2\RG$OKR-$7[@VZMSDDXQ].(T@0 $/XD[C>Z +\SR]_:R=?V-'*U(SC:]D]_
M^K(JJ-%:-2,OI'((BD1K7%+57+Z: L15$H'NR+CVJ<ICW15\\]WE:^DQEWI-
M(L.BJALI%%.]C1NUZ_KS.$#,[Q:] 92&SVT07D(2U*$?/;(>K/-[I1X(7I]%
M>A4F30*,5ZJ9'(R(PC97,N,1:F*A0O (ZXVO=ZVECLBD+99B&@C9/+*E-E /
MEZ!ZMD+VO9Z-V-J:/3;N:T<$(L_M)%7<;)_DOF_4Y3%X9:Z_4K!</K+4V"<Z
MY J-+!E/AS4PPXCPU&P>IHMRO_B+'-=RU.J02(A%2UN/-\V;0.217#O!VNQG
MXR6[^9!/H7EQ)/@=K/*-&(>!CD?MM0X\N0^DJSN[QHTZV@1-Z7. A!KJ7N56
M\:ZF;)U+#=XPB&:#0)5LS+79/HDKF0Y[7_!T8\2DAX(+/NA#=S-G.GS#3N'P
M?U62D3Z]03K 2557SSY%@+R:.".G^?X'[UZ8+6;8*6=!I5:@^\<.VMO>SS W
MY:I!97:JS6_A[CB]$!PS>[XXSEWE&&C#CL*U^#\(A#SX+GY_%:%C,=?V&GX]
MF)KJ4^,O]]5B=0;$6.?K=O5Q9EAC]5[62M[#=&@L9V53]T=<UM+;S)GN?[_8
MLLY>*1)A^X]'7#1E^6 <J#\_"MN(YE85CXD^,=29R#SX)BM#*3;M4@J/4.#Q
M:#I@KU$4>'#9J),%7#&9.4..=124J3#+?0_0S$PA!1L,6F:N)6P!=[7^Y:M^
M8L@P#LGK?#:]?$(.TN82!,HUYIXX)EP*_K[UI[):A2;+Z$Q1LOJW+1.3+%1Y
MG%LBH_\)K,BV4,)-@NK J*6#"R-0=2GGOWI7^V/>G?("Q-[&0N4;O_ &EA>!
MZ?QU\%\\S4M;TGL6F*">B7@G%JCCH.O:S8&@\$G?RSP!P"@YXG+!E[!\'XK<
M\/16<+NH@:;B0-KY9*%Q+>'V\AE,3O0L(K_O9A[X.?*((CW@V^6UMZ=??B8;
M&^_4NGJ4L5&;NYX5_0=LTO2TJ.&QHU+],Y^\WR/U+:U07DI&7I/?S4&OSOCI
MFN48Y-8AR/6ZLT>M<J;WR\-OXK]XCMDS[R<>FO-[)+Z<M_O<GT#MU(-,MU@
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M]F$?A\F<.%Y+!FFV*-IOM3O<-E-V1RC]G2+GA0F#=CAR QTDXX:-3X]9]R0
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M+TUH6>T#OJ^8BA.!6ND&JH@/GS.5,T$L%5>P=>3EMV5A'NBWFKNR'%!3Y5'
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MZ]8@S8Y*@R9\ES&]%!)RC+H7(J2J_0@ZPA-+R-KR29D6>^)\' KN+.CI9XC
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ME;RG\WY9'7*S%_IT]NGQQ[QUB07,L= ;86")2Y*4V[6%)CZ>UP!:2Z ]A9)
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M,HHW.DIIY21?3/8 FK_WY%G"\)2KUBPXZ9I+Z<&P)B^T,&Y'. 5HN\P?0!@
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M'U.[HU>VGRCR0BWP/*#;Q-]:(LAPK-'%: VT9P8EUAX\#*HV-A(L^53!C<;
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M][2@2/^KN=S"#G^\>?:,[G7J38E9DIMIR:5T_ W$SGVQBCMH\'1F8TO_SS+
MVU#NJ=.$;<')V,]<F$]'O(F/S?-"<8BONLC;RX&OH'RK0X(3'WWS[J,P_\&P
M0(3Y<7ZM=DB(+P_Q8Q,_:,M!_,=*.-J-9 [M&!T>L[:']F6/ZN->[CW+^-Z7
MV,)1M7P[:_^5LZO]_JKLS1RBO\&,I"C3^.EI\J-CU.?P2ETGOP$ ;6Y($7^:
M(@[9KR $5C'=L-A/_;"ZF !]^\ZI6="Z!1.AFB#8YE%9(Z,EU3S$1&G]\]A,
MZBG=OIB/7$82U\&3+YV6R;*P<W30H_OK'/V!AEBZFKM1>U7)WP00@?.53$TN
MG:5EQ4[_F8 \;6R[.'WB:LUN1,%""'\MC@.O+XGC4%I?_6BN\\>0&)2Z^'C%
MIHD0..17GG?/7B>W^'[B<)2LV5+5@##-(1HSQQ4H$2_.!U-1'56NB2">L"&_
M+_T34>W@J-9S*UK]0R8;TS79.U'P0)92=WN*<TA]8B3X;GV!(&033_SD6W;'
M]3 /7%;H4S=;2902"WT@%0;?"*$GO0=6^MP$;?V2K%MWD#FG;8(Y+/^D+8/=
M56S+_8')B<)H,#(C[QEWRC3Q$6)\<1XM(XI7_3RV##!N2/XN^D5J2Q:W>X=,
M\ G$S1VA;##FW<2Z#Z<+R.;E;4M #/RVKJN2G&7,Q]PVF3+&%2?W$,Z&I,O?
M SVYA'%O1<Z_>F>QD\P*[M?G.GVS&*A2R\OI+N]5V9UQ BB"?%TA 5'*%DU
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M&/LV(Z"MU;UZT@/N^US2RY&_HD:=(N>=]9,& ZF$6Q#/PQP-MLXB00I5/]=
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M8Z;ZC/MW:7L139P^<'@=Q*E?C01Y6-/>)S,V+[ZJ$2OQ#F_\WZGZ^V":7 !
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MU=.VE\Q7BG\CW_+SGV4WK[O; *U9N(E52%UB\LY9\LU@L"L%8O1"LIKN\PM
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M2](:>L7GJP@@-CB7&.&09HB1^^%,W:$% <\*)BX"@+F9$EIR[O:)3V!IW81
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M,(6[89G"DXRD!2<G 8$PM^G!C2Q'H[G.A4P7QDX4)QE'YK&5R_0 .HD0D&%
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M#H&U[Y&KQ8X5CIB9J4W4_^\*_Z]'&TE$D.S]MJ\<J[95T94UW.J.G--@@69
M+8;YE(1FNJM[G(:)<B<7K_U?6=VY!)9]/39O?-.F)2TWTW8J]K3]XQS;\AWQ
M*O)NS$6!>66^X*.HV95.2 \E9EODLCCIZD[2OR24'RW#^NY/:LQ/A?WS9:.L
MZDC+P(7;8Z;[';XE;K5^^!_1!NYXT_L47YXR!N6R;0SP^19;3UR=D(C(&$3G
MU:ZA_;G"L;(3__P#D@R_MPC!0,[>('MGN1_ D9.00H;.!+9UM-9P89D2]B[
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MFYWHIV@)T=73T#N0Q'E[3NG"4N]#FA3:U'5CNRAR4&XX[%/M0L@KW38.[1+
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MZ]?I85@$"]U/VG;E\H&O91/BON[O7R3K8U.%P]0&*X]03SR%Y.Y$F^P<[E*
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M7Y&>E:G?K>YKWSJ!D?P\[AZOR,S>DP<]XZSS*;G$9$I1(UH:%-#&_,0]9\F
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M>\_J"1J'54EPEN/M/.*(E7VW=\+LU,2;VO#SZG/"]#P*;,V-7ADB"5:&@=8
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MU26U"N*N%E@8.:1CK[Y(42VF)YQ0EB,Y^F]T:2C.3^*9L\B=[Y@66Z&-6NL
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MD&"901RB<B.^#7S63FC.LGF:]0'L:"AUDZ-^C5AB:6C NHQ)OCW+Y@?D;9Z
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M\6GS;CR4YGV;EI+'2TQK.[IC )KS9:XPQ%8;;BF.^_I[C*#+Z,GW8LN"3AL
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ME$717."CUP +81W69O'*SM[_Q==[!C6A?=&C*&)!05J0+M(A= @=I?=>$DI
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M4@YEX=>BK#M:-V9ZYH51L-Q&MM:XW)PC[W?:1>_;D62+;GIX:<3VK,N?3\J
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M7_Y\..G->H<%;VMK)\/OYF^/B1)#(V^B >688 4@Q!K_-N8Z<LL?W][U9\^
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MWVQ-A(*HBE.#K_X;$=T5,7S>3>.\YZ#:LE,+X2X$8"R1@O-PF==_8A0'#R!
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M)&9V!N1DXB/6\>%F?J0(9M;3SO=(PA=RTU7M#/OZA5HD $/EOIM:C0C.+ZH
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M]#9QO^6^ZR.$4PG&:T2?9J3?RQ Q?:6X?Z>?V>@LYZQW0:5P_"KWUCEXKC*
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MVRE>+Q7/MQ/.WNOMBF4&,S:_2%>$W<I7:H75YSH+:U7%6*BLXQ JD!_O'?6
MSG-*@4MUS<]LH@]!SM2YFW4HG :#O &KCE"JCF;V<EBDU1 5R?'M16AZ'P V
M6-EJ#D><N@D8E71%U',U-?(X@;XFTCUID'MGYR(E :=T+LF]5;RN<FAG#>;/
MEH18F?&PC_=_@&E]91^4306DRH:J9$QOOK)^/)%W99OJ8&KR#;$$F/_]A+J8
M''76P$(YG+\U<SG3%*>*.?H ^2RX+T(A^!_^2[7NV,:_CO;DO!T@'H#<RS3T
M^I(D0!MJ/;MAM*P,"/'<_(*N2F(D=RX)ZV/GM';-!ZE3'D5,#Z\I.,_W;QF\
MFVSHDJ*3ZJY,^ 3V)<VN1'DK\Q)WC'@$W4?)=%7,L\/2MFQK!/<&]22-XN5S
M)K7,Z<XU#?/Z839!@!61LR=(ID*$H]=NA-+QX4L_<&<6TLW?]&V]97.Z3W^S
M2\1_<U_V9/GC^ZE_J3;FWL1TB3Q=X&Q+6@$>S8?^CGPXB4<T#5OD2I0C*H3*
M$1+7 *#[ _Y5 2;I(BZ43HS978^W50$W:$!CF #0XEZE,&MU]?74K!&&]$>J
M,\#1@M1=HPQ5RPS)P62X%E:(I,PJ:4LU-1U:,WW]&]PRI-2YL"B\4C-FPW.@
MCKW0/95)Y9&47>SUK<HO?3KBC^!6$MR#NUJ,E@':;/-%?5[6<+-2AG>WBL_D
M"P,,/5<9B[-^Z<H:C)KH3Y::ZI,LVSXA6 V$VSL/@\'.+&WH9,N[ '?216-.
M:=0&<,P19NG0-Z*"?6OI75#W/3D ? F-?' Q/&SCY\4;(A4K]\P(!!UPSGR)
M0>=;BFEF9_BQVJ(,^X9$_UF27\B&U=X2S1?$OWCF$#>:'>"3ECNP570.3&;8
M>76^514;[DN@(-/S"HJSY<J0P8!];?[L%(F@G<V$SF"BZ_/^3;^%^0ZZM\)4
M-9.-Q_J9H=TW\QU'ZJI'/1;OXO7"7NI7$OY\<=DW+NI-(5KG-SQIU>I7)71'
MF*8$ND8_.0",K5-Q "D[H894@MD%'AK/@NT??JG_8[*.H!.-)NH'<V>; 8EA
M:)"[25-3G5^?^<]D)@O6]?.F 9+8EDY&Z8$4W[-POD@X<IK35]5%0,+XT$R;
ME4M*!?W29,N0_7+:]B5W7NV>I(_YKW+<CI+T;<.))<T>E!EL9*9>I%C.-M/&
MMX'1G)8D9^+\*. >Z5EQO!IXT0%@*D0+('IX(_V/Z?LYIG=#+Z:H[C!2;!,>
MKB8W%[I7T81ZW)8*]]Y$2&]F:T+Y;5+O%X1=X38>6 SBHI'N22[.M_)UBA]Y
MJ_T)[A_;ARAF/KV(U.*IU]"6U3<\T9[%I& TGQ$ZS"N=.\)E*F:Y&W<=WSI/
M*AW+A=4= _5TYMJVFE\G%V]5X]\P^G#4?63MT SC.89.J;?TSHEN=3R\"58=
MJKRDG"7O^T0R)?F]-\-#4.# [&CXKJUWAYJ@^E^A_Y/Z5(HR4/T?(1M?3M0C
M<1>7H'/7_;J/(X@; F.WVW&R,#IH**9-Q-[W.]GY._WO=?JMEF\/[PYU \1#
MO[KPV4Q9?!-EL;#;H4J3R[@(YWR;=P*YE)ZVU.52)PLWU.F:*$OY$J63:98M
MP#]0K,;_4C%YW+C]DL:RT+!]QHN@+W(K'=F  B>*G78#2FS;X_Y0C0[M.%K)
MQ?)G .@4SB7[BOW70!!3P2<%XU85N(R'>:E2([DW+^X;GR)B)C)]X6WIN^#6
M(T-6/<.OC<E)V @V!Z.^)-_LLU+F4-"'3X9E-8L*9J,1Y*MD]<K(:5:(KU!M
MI4CMY/&SQFR7^:;S HYPI3I4HD+._A>B/2'\H=QMA2]W[*$*>FZP?NZ"C !K
MDPK1_/X(Y.XR]XPO ';[R0\#'!63;=LO$2L$4GHJNMBK(]$FEOD<M*,95QT5
MG:A)=OQCY-"\T?TP;BFV1@/@^)<[4XZ%DBD;F7<R[W?7L,7K]>;PIB!9U/9.
ME*Z>X9 S^# YB-*C:/J1]3E F2AWW'MM4(K;5B"2:67>KA9HO];=9\=O$?*#
M%0$$_\$>A8"*BYQ-!DA.NX#6'?]]!TQ!3_)MGE)LK&U(TLTE&[$N3TR*W;3?
MJT&&NEJ9%S>,[O-/>M;FU_%\VE]&D1Y?!"W;&BZ/8[[$IY,"/LJ5',SGR*=Z
M-GDWS7F=W!KV?X1,-2(W9GH*M[Q2J;M6+KLT"F ^.H(D_2G-S-3*S>^LA?5M
M7EQ.AU#:!9WVK3EO&(PK[T,,]P6GS^LO4P"<TL?V;T-354%OL"'?U2C(IU%^
M]1@+L!]G+?W9['7*45_M8)C/EBSU]#KNK&L!TC'X!?@$PT3\1WE@2?NZ<6.^
MR JAMKXS$7PS7F#_8[R)3@N/(WED+X>!)X$?H7_S051WBL&!)/ ZW]-4LI%1
MF^+F5_X(2X.7CBYM_YBQ'W!*+*<@;F!\?P9^@7?]J']MJ"A5KPK*R7\CO4[5
MRBSQG<YSO[$VB0JQ^6TRZ=5Y#3SL=/B4'^NM_\ 27/N\&Q'?+O&U%;^LWC)?
M2^+!=VQ0.MAO^GTC<&2KBZ_O2\G)@Y\@( (_8O.Z)/HZ53?5'U(CEJ@YR+:N
MBNI[!4DZ[#8?.)C&+BNLK)4>[Z7<;Z1L9_^LDP_I:\]YD<[F\#BQ_:,3U/?G
M!S9"5:"1;D16"&^"6Z%&4([26_=D^&3[@B2'E30HI6_C>[&43)!&TGS1;KM*
M?3K+2^@%&E:MC<!17"$9-V#TJ5NO"])PM9KX.>)UW840/</3K5.1+NX#;__#
MTU@;Q@"$C$.*BMB==I&FVN*?BY(W\!;:HO7RRY@_V5%\>N [F,#;+;]6,^=;
MCF0%002:<-G"&5G4T*OC7 HN47PF7@ORX?7^E%/_W-2NHT[5,OVFL>#Y[GSP
M.)+\,M+:Q"$1C<XOEA3J^T@>?1(VHLA /GFV&4==7R0%#!G$>&*,-X\RPP]]
M\U7J%PZ]L*<LAQ#>Q-@>FXAH:%[2'[&/^*X-)VV0HA%<Y=NTIFU& &+B!8NN
M%+&U^,<S)[B]8]^HXC.P.-+_*"9]N5O)Y)]+2$\-1^;:$O_"D$ FQT*J"!4(
M7N>2X=\XL'Y+<,0:$<5+*^*!#S0-E1=UXZY=.+)*?=40$6><8/*TF\B6=T([
MP"+GWJ;[N)OD&Y:Z^9<RP.0L)?^P.]1"@U[MF=Z[0R;$1/-X<V>3<;-),Q-Y
MSIZ;<Z;0@P.7W%X_^GSHNPQ%I@_K\ Q%DQPHI6$Q#CUV+"4_UZ@209)2ABWY
MDNY8;W1[AT4 6Z'\UK),$Z^68#=%P^#-+>X3$;P=W9,5,94VW.I/)PSKYINP
M,E79_VSE^2[%;?)/XPQM5:]2=/S,&<\Y1F$4H=^KUJ ,XV:J7Y\QD%9[H?Y7
MUL@^21$1G0[%7,/\/>])FD1IEFZ=<#!:)Z+^;;=C;A4TL9X,+Y8"R]8)5K_^
M,PP1!!23_9)K5?8=Q-&PT9O$@(X$5U%!LH4K$>9AQ*GI9#F[HL!ZK@&[GAGR
MI';C&@E8-^'+O+P 8?F2$6FKA(*EP.6IO&6\MNY*92)>XYC[(Q%Y_59\, 53
M)[4_,+>/0OZU,NQL.)O0E)YHL-U,F<8BZ64V: FA.4\AX,0793D89AM+0C3!
M^0?&H<"S;FD961'K'*['KB?TL4%T26H-+<D>'(Z]/+^U1 7QC^3S#RXC?^6L
M7METE%4Q@O]'PNP3HI[_V_A_>1OA@N+M5^K,R]E3,RP;,<,NDH+9_U&9 ERJ
MXXSC$$&#R65__JO1M6@HJ;5\$"#I=][$_M@O3<C55@"O@7I\LX^OQG[X3L2,
M1=5LBC,IOY,AWF*"HISW?@OW6XB1<_+&+IC([/X:WW#AVK\/EH-%;BS8G+=3
ME_QX@]?2_6L/"VF_F8N9I>D-1:DFMRM7XK(37YAHAS)F*L_*@_N?2=ZY8W.+
M@?Q/3_?9:/UM=GNOC,5:\W9L?\_E-;"\FKC\H4&+9LW=];:44BC(E<OX'XFM
MC@9!B"05]60[FB]@,TK'F@&PZ.$I7H/+C#B\7UI^^3CWEO6+4Z5#1WP%3TN%
M0\'K)W^D^BH"W?(*R=>3/W>.,<+L#C>['G=>1PX965PK_?[.O2/MUO,'@:CM
M*G@N.'CZCEL6PH')[\W,>Y*;PGOX!%[:^R9!W:H>>#V'.@.03G&T)GP9W1O#
M?6I#K*BE&-KRIL970/<#%A:RKML6[W/1''TC=)MWD#VR#A>]4,WJ:FG@&K[$
MIPL"'O'G%FYW+! S73,?*1\M-+Q'5Y'6F3SHV\%"F4*G-@*TPW4>ELT&?DWI
M@RBX/3T;3;GW(-/X(HQ(&LIK5U\GQ$@W<]\X&HH@&T5OLG[$ W'1[:C+=S&+
MH&IY5PJ2YU-"&T^M2?S%J[7;F!!'IHR5*XW?!QX<*>LA28?A2?^]0&-PS4V]
M'/JSRJE_M-TK3N,SM 7)M)6S+N], SJ4WFM#1NX@>:]".2"YX'<NZ%.H7%S-
M:Q7H1-1A]G.-?<($/@I5U]'&$<BV7-G8F</SO7<#2++,KYSTP"T8BVK-[9L6
MOT@JG)&N\*:?H!J;S[2A9"@H1VQM3G^[T#R1:4'56SP:V'4TP7R:]TMBWL*?
MIX ,$AGFZKD7X)EBH>,@?G)Z=X5IZZ,;&\IUZR<J,8=I&+CFJZJ+NE]>,D+I
M+JS.G6Y-6RO+JB$?N3(5XKN=8(2GBD*\B-&?NH_ZD;W3]\./1IEU885!"G"@
M4U[6HD26'Q])V_5QR#5K@AY+@+T.S-K#::)ZYQ3\Z&LK4U_+@Y5O?!V@!B0C
M-UU6.FIZ$/E(AC#C7[GL831K!EO;OD^ZP"3=:N%7'N-(9P/S@EW>$LVX!?''
MX#!B\VO:,.88QF41Q),IX!EMJN9HR1-0@'&+#KOY_XHV]MC3_B/P-[M7=0MT
M.>-?Y_$_1,;O<<3_:R#/DZAY/UAY[3XB?+T]M>3> MSL)A$(GZ]4V6!__B2(
METN\QH*HE\PLI4.726T3Z+4*UU5>+\)=5"MH<"G\T[6.+)WZ=4CY<,&.U97<
M'U@P$3JL<;W^H])(^W$2AU"E1,@1*E2ICF$M#>C%GJXQLL\>_M_0C]WQ&9)$
MJ6Y5'_N\JMYJEW!MRS >1.*\N4.!#X,)^1=P U]/O\=AWHI:U5!F_)37B7._
M\A:J_VF,$.<^%]AN<V1==GS*KU(J-K3VP-5A]=-RC2L !ODX1>A]382/.;\8
MY%AX800SP[L:T13&2)9/Z!DYK$3@-E]42M0ZX=V>FEO#'R#DECPE2<* BM,H
MM<D%0J94&MA.V"M<PS-#,=6&!,@HD?7[:QE";;TL%)!):>"PC;]?RY&BD,$7
MQ57M>8./<[184&Z97,11*\_Q _/M94ZEDB5 LV_2_KY[/T_E;.69>)KIZ&(H
M-MYT\G=>4J3562>GJ#]XR3,6='A6USZL$J3<K;M67O!"P\1J6@'?%BUZ/]-R
M#UN^F7B.6O^G@W9, *T6:Y,WW:@O#&6Q/;2P,+A !2PL&2]>:VW0\7I)1P_T
M7-+_TI5@$+("3BSG'.('%;:R/2#FF^A()T_]+N5%IZ@E>>=/ <%;7TFY5*?@
MU@^O\Q]ML.<D/+<8?CTRZ=H4Y&U+^!!<>XZ16#*$;G4,^*[=?423'\D0_BS:
MTE#]EP^Q;<':O7E%<6^Q.Z7K-#7[B?[I!;+"6KK4<\#1VWE#CTN1SN]G#63W
M:F.9$W>X:6UV;VS-H&EL8%O:EQ%$2K?CVC&9V7!,U"CG9OX"';ET*4@AAI'<
M75X;7RE3IR&/U!_"J)B@KM\Q^,F:)PX-\3(<,8? ;F'O5_=+P?]2H>\:-ME@
M'I/3JNRQ/P_"OO^?3GA@G-?T()^KSW),%/N=&^)%4,ZF]=E#O]ZGYLP'+L!9
M+]O'L,94G^V7I;=P_U^R0S9Z,(^!@G'SYK.<;>$U;O,+?U,>LG+7$-8KQE,3
M]G["HC+Y-_FY07YE%&>]F(;94ZF!44I05\\DPW90P47K-(75#+QWSA>?/B*2
M#NW9W=*PT]=5P=P3)4X?R8A<Z12O[=J!4$[=?-W>=<T,%\J:V?&UY3V;\<NH
MS'9?3Z^/@P+Z?3!2XYQJTPX@!]]9=$2US3'=G^G?=DZ$DQ+%_4=VI?.%F+,'
M2"J0DH<:)I[];T!SV6G $G;'U_UYD;R#,"]VA]2[#] N&&C.03_UC<F:=P/W
MM#_(6BX]\3MY5<GK-&.58Y"T^-K$C^CU\1$, =;-=+VD](PD^KT,IXD]O\4=
M47KGSD=\V=K/J$&_\]R'^>'P&#EJC"0/[B=[JG*ISM*S>F/95)B([T5>M !:
MTJ^J.[/P R!P/FPU*EXHP(1:]_Z5&@>*]QVGSR5R N>)E5D0=0&*-_@R/&58
M_P_BS[T919 U:^J.HZCM+UT'CBS&:%) 0E$L/^"6(]^D4>K](NKDV5+%(X?W
M7CN*%Y.0.E'W5M>I\@]W) P'!H=&-H@]!G!<+88\6=&.7V0/JC?1G08[</+#
MP> W6,X[5:AL!!G#''(T/K=<:).IIGVC*--J<7WK9]-5=359>OWOH+ FA/W
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MWC<E @6>U68.41'2H_0A4\UY56<K;*/&[-Y]ZR \[64Y3.0](//$._+0E9M
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M%4#2I:#)L8*^_G;@%XM2N?)EJB2KS:"@ZYS2?%6S.6N1<-<IQG9K'\;ZIM1
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M<MNUJO0O*L]4RGS'A*H%^&J]Z@USQ)2M#[/:HXW<1]ERC0B1VC[8D9PN&04
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M>5*A=--K7P02\;K8A?2MB_)+:7^]//&ONM64BJ1.82Z^9HMB?WO-P(.7.V7
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MF^VP!?I=^]P*A?82ZB9TJL'05MM ! U)@DN9.(C2FVZ\<ONL3PW)'#%W9;M
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MYRP<K[+'FVOZ.2I-ZI8-\>57'1>T[M?O#<?$/6U"KUG?DHFH9#G@&G9V4KC
M-YVG;M)!IY I 78@WX(BK36=W ,7^X)R[*T UG=6HOT3^))X:\9RUT_(W>*]
M!8IC^>_!R8 G\XW^O<G973[8@^CR  EE==QUDYVNC]L0O1Q-(,E"4<7-02[R
M=)U)2,FJXQ0<HI CLZ]7<#7120*U/A:,5M&9!I8C+V<JH@,H*T5U60%6IB@S
M%P4/YVRDO(W\&%S^12BM3 Z3$KX'AF6V_VJ$ORV<>9F"=C95>'CQ%E##5AG
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M%[&++3#Y>T_J(N:U^LW(Y4@I_+3.?S]UB4)?3, _T_I'CW<"RG7B$?.$RP1
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MFGCO3O'L&G?.:B;\U)+C\=]3+D_YFCKC;8G.7,Y_(<_%>7[P3N!M!ZMXETK
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M+D.&/^O:]9P/KU:,YJM>RO-8O '4^ SYB=((:0J-]!T^V=+.NP3EW,,?UM/
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M?)81QIV),S.02..[&8\* 8]):<%I<Q@B\44N%?W1.D-<'JX'SWE %]V /[&
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MR@W;)EA[@U^37=T+MB3K]")]_E[E/L-V1LF)"'<<.NC9T#[*QNDVGA;&:#?
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MW"I\ UA\&D55/R*W\C5I7"J.>PD!XSXXU(G922*;T #[N> G+1F28@YW19C
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MKU1[2OEZ[I-!M+Z=,AC08O5X?A_FF;5+^NZJ8&J^?B7>/RUD;1,'CE2#;OM
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MMJ*%9?X</0WZ@Q 16\7JA/%]:SG]J3NXO#:Q'L&V6CM!AI^LD-:.(-F.$J4
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MCUN1@AQJ)FZ+W=]#*H% AE3FJZL"/6XKS(S\+J*K&\!WP+*V'$K'F,7[3'.
M':K%:BCK+]1*.8$U0PVXHK_"5%2WO K6-1^W?O:("C]:+W7 L\D7$B2E)-9]
MY[M=&]S^@LZ/90C\VF*&E=5UL)[!$LTCAL\CWFKTZHIJ,$?QH\' FPTR591@
M4"N9H2&AX,8Y1N#F;>K'X4[&P^5DW/T)9A8\^%Q;0;SE(SV)%POAZX^0MCG\
M'="<S >4G2X;<9"#PVIF1 6  R+0IC=LIO54,O>]/1I;&1[:'0PH" M<E'H$
ME E]^,'SN]53W?#[&#^D!)3\\6C;7+NN;3+ Y6B?P:)R@3?A,OQKI4H9M'
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M?Y(ITB,YM'?,;<VA57LP&ZJ-;C[U_O-]JT[_T]7WA^93@7W&0\H@66QVR;J
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M?KK S1_#%96";7T&$W[:?A?5"]E)S_6:DYE^-;]0R$N[=IQIK;P%@<N)<1N
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M43]R,+K;@1NSWD7LP2>TOX>LC50,^Z^Q-[_:9I^R6PK1HMYP"&EJJ#JU\X<
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MG<0>-]PU\5R0&>2*?#80WC22IU(O>_BT4^\N58#E_=HI*_;/^!*M.-TQD@C
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M!F.'3UM=L C F(D3_?'E ;?U5_4)V2IGWN70.U)0D /FOP-A^G^>S$L,N1@
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MQ=->A=?K7@,3*XM$]QL,)?1CZ&U7FZ9+VA)\2@^1G'6;=^LJTL74/%#SO#^
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M<31#INS@:HM-%TJHLLPW"5MJ>:#,I: LZE(]B<86I^#2D^7T+[TII>!YEG@
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M]5LW&&>Z5AP:%6T8H#+R?YN1I>>7?)EGYTV@(5\R?UBV!C==N1YMB<!I\YP
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M;=LXK*6WDHW_/7ZG[%P.>X!U[P.<VK:)/F(8A7M$AL.J&+[VD; &?TKFO:#
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M8&!\Y+;']OD[DY0EERZX069K*""V5HS<SGG?M:L'#5F<[Q5-G?'4'*LXD:*
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M-01?]CDTL1U@(NHO;A0/"#X0O67^,6;K[BPSU<-);RWB[Q=!!,Z.X"'GSHX
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MKM*,RD'1N5EQ=YBJ=Y;0:FJ]_H</&?HE?X:E,^_.C>..65.7+\&)EAFN/82
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MR];;:P5D<<I/!1S]L5/N8#P0/Y9_:?'7TF:Y#5EQ&@R*Q ,_N<<1*U5V>,
M<71;J7W^[#Z,)1L/;/3V9Z+M(&'8/ONK$AR*N8H+M6@C<$.U*M/#?KTHX^"#
MKQQW&)J-SST'%@V"./9!$Y^D>#C;)8OZ;E?<+'+[)N?>PG@B$RMV=9-"0ZTJ
M$[B?ZXO1#4,O\J\,1$] DNO[Q9G4/KV''4&WDNZ;,+^- ,7ZNJAKNBC=W$Z(
M_8'=:)/@];A,+X'X.^&!L="(UY[V%T9S<[N7B*+TY. 7COM+?59I+0R?G@^'
M3;YV<O+VZBKQO=R-6^3X9%.+#NT8SR&D2[2PUFK+>TF16;J%]+^/Q /!XW$&
M/[NWO!ML10Q?1*=17L8N&F8PC!^ALRCN_6Y[N WVM/WSB9.UG(O\CR]@L]\%
MUOG)73L:";D]9+3GS62HJ)(NP;E?8H);B4/L(S4;)P*>%=C!O>$,D:1,K8@]
M:@/FJ$#AKES7::I01S'H_2U)A;Z.[@A"'AH^BAW=YI6X/1/]5NZW<!SRDRX?
MAYMB5'[Y_0]TX9<_A8*EV>V?PL>U>LA1@JT-3OIO6I*E6%1@*T5ZH0(H#WG-
M1#+1HJJ=_M@NR5>2+&T&L&WON*5/'F3#U#4K"?W252(.;ALL)#M[ GA@>:&Y
MO/UE_[B%(H1231]=770)W^\'R>\,.*X;"[*[QP/6A(>=D'N5=\*%/DO3&!H@
MEU',<CVWN("*M&4T TNT.W11Z:I6D<Y7150EE^/49.0S!K&$[DN!#)[ULQ:N
MOJZUV?Q/+8G>*W.!ZCU*!CZ9LB$0%]9Q!2HCJK9/E=CCC1A:B$Y;.D6W#?RX
M8DL#!+)+PP-_]CL+')3?>"8:_[*;'73A60+]),V,*']:U_3S=AOG()+1Z5&[
M#>=G5$)4(-\K#9G* E2)<R5\\4"DS<T?'-1Y"F]$+!]*R-S<])X^:2S<?+0E
M,C59#X-+F^E/MQ-<9:5 &97:?*2)#]>26FFBLR]'$IPRHGF?R2Q&Z57(/'(.
M)GWWRG-'2B^I<)_L,GBN5D!+#AYH=,8#6??&/1F+U!,POA!Y;FW-++*BI;5+
M#8/L"+X6Z??_NP4GU'OX;R5FT>Q1"*Y>P""/X*]RLG ?#W2A!K"$9[H14"IL
MT P>:)9)?'P]@CO["WV3X%7&E]'' U!EF41?Z(>&V[F8[VT3^D]C79))GRG&
MWGX/D.5G,1Y#5=#>V/!SQ*6?,K:H5XI]$0_0;(,YNT[4BY.2'EK$=UI[\$\:
MI_%FM%-6;2W>-_ 5$S31RT^(4EZR2/.%^=U'D J5ZAUJ#4_+<\(<UH0DR)!E
MKL>XQ%\(.GZ:N<O2=ZD\J%SJ#C+5FKZ)C!!;^G4H>&8?\E$ RV/#6XRPK4L+
MX4=Z15&^IVP[F[BY/]<ZM]WI5WS8'B_6M,R\F%YL]NNTZS!?R!SLR5OE4;)Z
M::QYWD&OE9/^'9%Y;%D6V77"MRCNN;WM!;_]<JC#*79-],O+A06_(+IPJHX:
M;/?<H5QM\-# ;Y'?-9D_> FPVS)+:WLH1];?F94[S@,NL^<6=7O,EPFX6S=G
MD5)0 :DT2X:9)\O8HX)H7E+9&K/T4Z19>X%NZ<QP>BW-9E/FA_K+<O/+V,MB
MP=>3G['SXAY(["%J0DJ?5*BCYD^%6%ZH.RC'9BTE=_KY,2L/X6$QQX4RAAL/
M^/^^FXE96SQW*EU?W)N"+%ZK1%9:<QQ6QM3'N&."$@5#>1]]7:MMW':V2&(K
M\>V\%="$.JGU5T,[?H+^&"@T4)+"R25P%N99$8\P'4XW>$UC9C##)^?K;8?V
MKPY>KG5$.LEI!/!LCA#I:^Y_RT1=OI'-K#BS9,[T7[T45?J(6(%>!=J]&<B&
MYY#ZK;;>8JW&1#RPP#C&)?6"1T5]P@N)!@DI1G![.#P.'MF).U-IG<^<77D+
ME?XXYGP+$]'6!H9,[Z7$K"$9;47Z XDQXXV^3SOZYJ>G99-E;";G,Q;KCSI\
M,?;VC9X,[P94Z70'?ZPR#67]QZ,/Z3!]\!++PCF7270Z-->ZR5B]Y4K/&^0%
M>LXR4L45&W3%ATFN[Z(R]),RU(6C=N^[XOST6#Z2(_9_';.(/GNA+VT*J8?A
M >,)N5 >6;TH1SOPQ,R:>PE#G4CBWOTY)&/R^PY8,I^SZV+^Z(L)DKQ#@>H9
MUXT<_V.ZW;?O24'7?2=:\, 9P1;+\8',$;5I.)MOG*3'3(Z.M>A:Z83%P:3;
MH$;MLE[2*0L-ULIM0E^D*P^Y4I@G$I[&#>S3'W-E9*KL% <Q;)P[5=K\FAYP
MQ\5<_-%Z]*:=4J*9/8WYDB\)8^3.G+RDIJI29\YX0!%!O\P?)6L&Y3J &MN\
MX&7X>D?\M88V>-E!)U=[JF7ZR>!O0L5T<-!X=@.TX#<FOTN/F2'%\960IU\O
MO5P8@>QFS<E 'H7U)LOMG=UCVHJQQV>P'@Y6]F>[IGY.W41!N@/3*);[JQ<V
M9A(-C7--9CWGEG3.RW?C5C=-I(?J7OFAEL_Q /B7^<:A7&3T3.(>9#!ER<&M
MOR+QJTF)\^AV@-E2RZ*JOW)J]TSQ 2VK:J73#??!M=IM/!"Q+\L'2HIU]7Q[
MWWDZY8]]UZ2C3,&-2AP7@T9H@[3UP/</")#W.X;23##L$TMH@E&QPVI7?@$A
M4S.Q3*98&H]FM+A$)ZH:?BB8"SXHT)33TU1&K3C9GJ\FP7]V%2 EC+R(X"DM
M<I(A1Z5/#I<:$4AF)CZE&D2T9 _".K"93%VZIAA*\3AS/[\*P9_>LK*Y6>5^
M;ET=1!WIC%'<C?(/&CI)6#M?MD5B/"_M&D"\*N[Q:\I3K 8152;B"@?5I;,Q
MD8IHW>J"Q5JQVL7XWFD0$CM,=7,TRG,])F7 ?LUL*:$F:6F@+1E^S\.&PK/F
MO72-%O$ZF.6VX?>6IVQWN@V7:4)!$@,RX71]&&U5M.=IZ ]<[P2_>9G+]HH4
M;X?OLQ K*IE8/^ZA[,VZ"K#IN./FJ2?96!%O1)11(]0C"0&1;QK!JED58MP<
M+=I%<S3K'VL<5%1$)8)<D1,E;E\"#(*7FAO H/9D9(R A5O;&V!7 +X]>51T
MCSC464I@,=KO?OWGAX<_K,VX,QY%IZU0:5Y5/J^8%0L)6&QGF0.]%I:/^\@2
M25ISAM>4BQQFF-Z]R%>G.*CE"GS&)!,JY6JU%)HJ]@%5NFB"(G \,],59\#6
M3Y#^PB"UOW>5F1A-FIUY+5O8_?D3RT6<])I*:CUK@:Q\,8$!TQ'D*+R2G.DU
MEX$',,?2&F>"5_3-A!@77I*EDB@9#_-816 )2<>+M+X*"?BB@G#6XS5.#38+
M-Z=V'Z>\$RS)$5$@K^7W>J_,H#EZAXG/:/&DU-.99#KY79\C+@8/[#-G8G;Y
M?K&*?%&4I6>=^.;S#,<3^UDR,RS3)7A]+02$/A3"2;X\CUB)U+7M)P5/0T=W
MXCT<6AWGO\\&-5+@@7"_VA$I3G[AZBDH_7/AR[F2<_(@L=;-)Q48]HY[UT=W
MYA2SG)I<9=H0P3(+$MIZ0>RFQ@ZF(E7#[\R?JME^N_6+RSTS)>SR@'A;)\#,
M<ZG$3/V3B:6\JJJ_:!R_JPAJ]D-(DI1'*59,$*P94I7K?SIA&4*GGPHKY)M[
M G=\"@HQ'I,I]U!M5.HY;.K_CFU$>KMOA\3VUE2B3>=4Z7-@0[N"3A%)&73N
MU;=(&:OG?-;S)(J\IZ$G ZT\4%5K1=A-KHNMY\ZC-NB?BVH-KAC97-W[:S5N
M78QI;\B60GD]-GH]V;UR'7>\^DO B3_)M"I<FR;$I#B7^33HVH22;R)GVD(X
M^)$U(!)0UP(?E4KC, <FT]_QSJ=RLZP$S_5I0_@MB0?"[]4L Y[H1G;YC=H^
MR<YYS[T!?+'('42LP.S-#"%?2JSD;J4K,-4ZUT8Y].?P2#CW.2**F!Y6H6^,
MR*+Y[/2K8U@-&MI<8A/B<SY4,@TP^8\;L]"A.K.3SF-B7:UNQH4;GMZB4N2#
MN1YQH8L1U,^391C>L7VYEIO%P8QAP'W% U'V4K.L"V_#%2%[J84^?I0Z"\O%
MB7NNNNT6M/8Z6L."X^59GFAK$D%YA>R9GC=_= 4-3YR[3(JB6 8.2I>0NO"&
M(7V=*L.''Y8.-5]3H+I>W9Z FU;U8.6"N8,8BS6S"U^8ZP"!@X_$L;S5B4M4
M&,6FVY/SQ7*&OC&/+=\;U'N>,*:VZMB-YC)H1:>CFM;VH5KIAG+%I;7.U6U&
M2U_W[L\@?2P.C&A79NZR I()H:Q!GN,8]_8DTX<CT;,91Y-(C@C90W9(6*.K
M7CQFWF3_*+7(_N2.GLB+';8#'6P(ZSJOBSAH,Y.8]$#,->.I C855A*6NV/%
MG9/F6.F\A]BPD:?61RJ*.!9PU:GNPK<4]A$XQ73O#<B1J&F1J>Z__65@S=(5
M%'GP]#?B?:/9FJ]-QS?IL2);O<7@L_H1UPV17E'P/-E>"DRUD=<R?,>&W0Y$
MA[A@'4M'R^,4J2@A$_)7U#)7UO.74#".?6NX]J:CO_T(VXE0=!MZYJJ W-8\
M^?9RV&BJZ@"RK_Y4R"HJ4;]J&"*&!X!F],ZP@S3G6&E<2_7(1Q?"O33+PSD(
MV=$>F:FL^?Z%1GW=%R6B)\C9@3>BIBXG-/+[V<N:F2G0O7&MKH+7+UE*ES'C
M:^5K>*#U:_G!(8S?"'TY.[\<4;>OG4^F:L471/0ZK6 TW:8^]NF20?+2C+7A
MO1&YVHQAT<-7PRA6OR^T'\XFK*XH)?6D3U+S[&0]1?Z[N)>/T)D0='%F&,(*
M#WPD&W#J^Y;0WR^Y*S&P>*Y_>W^FYV2 ^J;:G,:4D37(S2M(O,^]/YJATYZZ
M,F2OJ5K2;J*$5-L]620559TLR22_5%)\+R<I-2A9 .M:KI?(B4QC5GE/J82@
M&_#Q?AVBAVD\N7"<>[4ZY4U.?5$:-@?%,AZ(%GE<*.VBM^%KFU?EITK8JUNQ
MT1/7YIT&1%ZA-NM_/T,8CV._%M3!%IETO'?=#\<*"W332M.2DB9W&M26_66H
MC+LLDH;GMF@ O3E!X8P4J8- X&&![17&!PUCR\/':H+K*G5?/]S[HTR4\7[E
MFB@R8LGYYV@>!N[)E+BBE]PG2F*5+D]PX/)(=DN<4>_DYX(SW?;=:C@XK]+\
M&;)L4NX=ZUO&@%]\,D6+BR0%C6-[WI!ZAWN7-M02/2W/N!P,C?;F5B'AB(.G
MMC(*>& H<<JGJ/.)Z9V7>@9O:VHS'XI;+G^8R6@[+'VZY(R-GJ8:@AQ9>32)
M[UMBTHQFP";\=\>;0ZG2BTD'.-PH_4>GOT?3Z3N(0'75*W/1)M2V..D:Q+C
M$7*><F[RMXM&DL&*:P^7&Y00*38]\<W65 !-&;>DZDSE$T,MJK)(HQV]G4&[
MXM)V?(HRS32NJ;-/2TQ,V-E-&0LIW)*=G<T?,_QQ5?9\W?[GMNB_D7_L-Q3K
M^N]A#A+V<1[C"[]I-158_VKFPP-_5'&35QRF7!</K''B@7>0$H.\YJMBZ'D
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MBPZ(U2]!Z:=\],3_)49(&PNCFW<US,\F[J.?XA11Q!N(<Y$Z,T8?8:RZP*Z
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MV2&G10\IGX5ZLI^E D?3_]'IC?\)X?O7L^J%?]\OX'FOJ4#[GK=!!GWAC@<
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MF$MUV9\)=1] 3(>]0ZW:CNT6W3V7.CY56X:L_2+H_ARS.-O;@2P.A-*X&GA
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MHT): :XUJL"2Q4@O\\6W=^)U=_*'6&FNUKV.Z3L+<2<:]=4SASP#KY5Y+Y\
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M&V3]7G4FFR;NU!&QXU?9V)=AS PJ<_%RC;+.4Q=D RFNUC7U;/B>E1T4.!Z
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M^/E?:>NAE<G/EU%25-.ZD'DKS/KQ,99+=:XP-<_D+#KF6R(/V#.%=DN_B?Q
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MD65R"%4ZX_ZZX"LX!JP^K@-D5=K/55<'MXVR ZUF\%01Y,XB].]Z2^HK0@M
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M[[&@.IF\A3])Q0YG^.JLW_XAS5[U@3/EAVZKPEG5%RT[O#6>%[ZK?YY45&$
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M0[\J3Y!>YY5O*SQF)"QL(KGR1\@ [;\26+XT$)H[H0F.:&*3TJ5#5H:>;3\
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M,(H./97<H@XZ9KSP*L4&K%FW$^JRW]R.9\6O(MU&KF-N_<.17/(#-MK@]F0
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MO K5B7;ACK&WM4BOV%=DD8?D:54)BLI(-@==.X8>,O/F147CX3%[%#*Y#),
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MDL&!@FQN% OK"X=,O$)RDTAA?^,? VD>7X:>/0*8\Z*0@/@(<N=!EF?#WI8
MSF0 [\Z3LS\E=2ZX:GH$>E@2*-L*V2H:.T[,8F24)ZILP7"E@M>9.1^@_?SN
M2'H+F"=FSH%Q149=-2[W8J*:1L1SBC%)2Y]'N8-,]:D[3G66R9L:X42@H@7#
MOE6K-YP-BV+GH^\Y-G.R2W(PVA"G-B8KSA>>QVIBA$\Q-)X\A9^>!<=N287+
MUOR)!M872<U&B\\FN\KE5O:D]8_'[J+%&!Z!RIY'8!SYX[%;9>&\-7_"TAY?
MO$![1G**N9J8OY05X"UPQ[1^+WXKX*GK5SY"<%'J)QV/659\L!O8R\JGF=J.
M#S%OAH0ZUJDDX_>14W^8PH)=5?8)N:3[[?*,,+8D+@:>R#.1H!>U,9."1?GU
MK^)*94MT05VREB]H6+N1[I_G8)#Y0D!Q/1&@LZ]RH)C8_0%CDABSI9--;$33
M&^CV'9T7F6C/R6Y=C<CPI +K#D7&B>?G56^7<B/T7NK0\Q\K6")6D3U+.D/U
M*-IC&@Q7:?[)DL7[;ED,[3\4#)26IV0#ZY:&ITI%!Q^!+.ND^#;02DX.QC*@
MUH35_TU[[L=@6W\&'/OP3=;\B/+&RC4^K_+-5OL-+B@*(T9,&TG7Y6+R+?I7
M#,0R),HP2B%-\3C_3;D9\?WTI]1(*H"A:59L4#3VAZ7#Q8B4"]9F!%_XQ@;[
M03#8RVFP^-SH!5]FQ=O\WB(%=V?1QA3"F([%C@WK,<#X1:*W)GM&K8>XCM8T
MPZUB+*C6]RZ<\.</"A;3GU1+85NV[QW%URQUG:84_.])&)_9XN ;M-42I9;M
M8A7IZ].)-F.$I+U:&,(,X)0M$%>!TT_LU5A[*:6]+O!&#\M TZ0/ITHS7;SY
M5+J_<B+BH76_GWU/Q(PE=+'P#N[7Z%"BE-)W/KF^K/.=>:#948*A0>13 *]+
M-NZ/_6N7A7U2GOOW]*>8V&O=18J_NH.8(6,1E:^FV5G/%(D4/\#JAB(4N[K)
MVB\E!1=E_=_GIZK8&N&Q64[EZZQ.'5#:,T3_YA=_-[":=3:&OJ<I)#C# WJ_
M1ZXP<%00'Q7VW%Q34)-TOQ<0[^5>U-])YZG7C+$6MG&[7;7$5CD4[4>I*YCE
MWR_)GUNX+U5'J-@\Y2NHR4H3$#2=]T_^= 5=%Y65FC*K:HE)47Q/&+M.2Z_B
MCI<PM_H(,"L"]2&N$3P86RO(FS&BF?O1/,-^)X*'#_>/P$L)RF1C&RKZ=%%-
M10[Y*?KI2A.5TT#FG@3$*5;O[ \?QT*_[1G9/<Q!G;>NVY07<))GA=T> ?<Z
M418.I=:Z"1&C"KV]CP75K2X-]2D6Z#7LB[AHAS@D.5@&##VO;QX,^&[Z%,75
M(D2Z$1L<=Z>^5*U&9DM#_2$+JE2RR1?"_9#;V_J#_I%Q4\%=;7E7% @<'^HK
M))V%)38!7?<8_>A\]B$6[4CQ>+3(M-"&BA;<WA($]3\0M$ 3">2*1B$Q.V%$
M_$3I99NII3-U\,=]I.CYA=\5CD##J" UNSA9_[%;=<7*PF'C5(J">U.J[Y"A
M6?\I];?70MC!Z<IHRV^+/?I[B?D.VHCY;JDI.-&[Z>8V@M4\R%5JHQ32N_2*
M35L4YA-RW!%.]!,Z-\=1M5P=Z^J2],67(OF<SQ!YAZ_4!TU7YUU_A)S:5WQ-
MG7*.Z=D,S,YY5G<^E^6/8Z/2QW5DRUQ\_DKQTZY:_@HFK=4 C75Y$57N<_'B
MG.=Y\-@"U\+7):9KC=M5)W>#KVR3I=Y<UI60?G8>(^TGI/6HNWD8-[)JH\ZZ
MZ;?_,*E4E2BK4OI%CR*N>(/75A+P$:_I> 2^>SS9(Z8LI$<@@5SA$:A0? 1R
MR8 P7>C9TML.+IM)'?(A)D*2A>;O@\(=G70"-$_78 K*.P"VLC-5L&:W/]0;
MJH-$D6=L9"E+"&?-=,==T^+[M_B?_6S"\K,Z>\K#A4!K"Y_H4I8*34YZ_J!,
M*G\^&P%L=X5BJ]V%^TNL9)4E?J1(NB6AB&48!S\0OGW CY$Z&^2+R5'P_Q3[
M\>#U;]K3YP*O"$ZZ5Z*A5=/@>R5!.U8(BTZ1AW8@YJ]-[!]5.!\2]!E"V< )
M^6P%CT X+R7?S3C8&5:7;_)<<J\LH?/I%;AJJ>E>=7?68]DU^NPLV#1T]S*?
M(;F]#-$_'LV_J0\%W\YCFR>^W*)P->GVRYD6>E675+##7??#]2**:_+]%$^;
MQ<:=K+M?LM;:F0-Q$,_J/KC*'7&N&>^&#-@M_D\DGO\S^6>II?H?O+%3>L'_
M1%G_:PZHUM-9I=Y7/T ^_0#R+=1EW&B8HQ.]T75E-%S,C-&K.E$;\E'Y?WIL
MR\R>R_/<OO[^/J"&)P)BCEBQ['P=:,#F[,40>&:'^#'Q8? U-^=+I+@&&1R5
M%G^1]%U&H$)8IP52?153H.CNC-4BU:=BEM;%[KQG6UTAK@6I;[Y*R.]U1OHH
M>T&J-(C+.>J+!0CW9M%,V/LPE'2C5)JP5B(BOVN4L1 +0!RQ8J]T^'FEK-28
M:18/QNTG4(UNJ5 W4?=*+UH_(%<(ZQ+*K[:N<QJH^Z,QB8Q$;1HY!&=K%",\
M7MJ'=,%@/!R.T#\:&U+?EY]OQSGH G-4C.VUC8&N('1%,=BZ)+X^VZ\/I=LY
MCF_J]P=*( Y_-_G=_Z')Y][-(FZ54W,@6#*@:_J^GJ1QBECG<2V_N0TKG(&0
M&_"O*WZ=3615:<O:W6KLRN7H4S;IXSZ2(-,4HV^T,V3CUIXT4FQH4(..;+,.
ML@O%=&#B[3X"T)'6CZHS;!5JE,+OO/]4;"57X-,;?<Y(]#@[*V>SN)G5A6N%
M_0$OA%>8UV4L?3AN,(_E?#-(R9UANJMRWV*3_E!I5[I_LIN@\PN?W*I(&^.U
MV+7IX*@W%2.B\P<X<E\>UIGL!P]>!5JD.@>N> 7,"@JG(.'U&A_*<MOZB]L*
ME]^)2X<%*U]FT][<]?]&BPW.V<H]_KC0'BDB TU2%FTD6A<L2LC,1]"V=/XB
MXT7]OG;53FJ4C=T6S3XW%LYA(1.XB#KX118U28*X1=R[J-QK<T*7[9O;Y2E&
MV"D&JCD #A,52T9NCSB/.E?(%.Y^,5(TX$QQ8D"OM'^_&I;AY3QB-@]3]%UK
M)]/3"[7.GV:78CXW#=F [^JE4T><\8]_GMO33-D24*5B,E>W&B"A"?+85$&5
MU<<PM-E8%YVNVBGA&30N3AAT(\8[$N=SE!@\,#@6)"4<6G@$!A5;'H$J??\;
MSG'D3'9O>1&=BF["\-"]5\&C#?@OMLW1*%Q(=OMUM^[HRFT<KSR-)\_XIT5*
M"D_-;$-"WA(S6"UE]B-Y.T/KP$;_0")'\6:O&CA_@!S?ZBX9+L!&"$YJ64^0
M6 LB,+FGW<8@@,/<52SY/?:12BP:OIXD[9C=RV[Z<"[U[/VC*PU%CI[+IBE=
M!9.?\J^^YGC..@C]S.T?)I0;6MVT1$S0T96_U?RQ?J_)>A\+W[P5=G,L5J^Z
M8+C6>KM&@_J5)QKGVC7N6@59OD79W<G?V39W9ZS$-_FN<<LV))37_S#(N2'V
M3F.)V#!.Z_8#CL.K@O,RY(:Z5.3XK*]XG:C5Y<H8>WQ>;Z;/GAPYBU[#D7GJ
MY>&+$5E!+:3S$7&I-%XC<IL;T _/%"8'RN(TOS\5V$I3*Y1/=Y;4#P_**^ C
M4F7M1;Y'I3[E6</;U94;E02V']T($FW<UZO=5]G/PH"^CF5ZF<+BN9:%ACI"
M$(BM_@C$6'@0ZT^Q^8A!Z[7J+FJE1<J'1 (QF#Z]Q3RGK#U0F:.&6+5QSWP:
MFSL26:FMM\0@5>N>R_XM08D=X\16&<0SF -.W-.H#?O\)AX#/\>5'D&%(0*"
M8;LOQQN#5OZR.?XMP;Y+8N#+G7* 9%1TGVI#O;'JN#Z$;:.%B.C2J9>R=POE
MDQ$KQ3,/I)NL9 4# SXVA;>A4SHMT_;BX%5KI-10LQCGZ'@Q#?JS(VB T(AL
M#[&J35RAM:YZ>LBT:GF2A7D('5:&3W_)1@Z!?)DMHE1SDR_NPK(4]DOO;^9T
MI(LDKHA3I,60,BRB;973_!F9S)*^ ,]Q ]8O=GN(B)W4JAH\=DJGZE.\"X+V
MIM-$TSPJRUV!FCZ%3OVD5,M@!(Y@5TJ+2[FJ6[N $[)%SA;;UJ.7?]YOB-S;
MEE18=I)E1C\031[\; FLP =B<.,=D%S)O68_>*F@TEEN8"EHUG+OBE&D[ ]9
MR+L;L-J4XTC3/YD"+]-TU\IH^W-O5?:(G$6#;]>6+SY4/<^^31-<](;WT^VJ
M^8@#'DKL0F/\#]$VE@'^FR^*_>?>^V\Q(BK+P[$J"O)&BN5 -FQIDUN"RIPU
MOJM.T%HZN&:9JSU'><L;)[YTF=_)%:KTKN=XYV*+ISHI?,Y[5!3PS(*JU]:N
M&,D2XN%K'G=>?KR0_*NR=T8X>HKLN0X(H<@Z+Q,E*J+SD-W.1Z4!33AJ^._L
MCBF;)MHTNI37P\L6?<'5 OL-5 )E&/[^_*%'^5 >,P6//VG''/QI?5/QCCD5
MLGY>L^)8H(ZKCV6_QIM\2PH;8_DHRLT#*7Q1;'.:IO]PW+WP8N.@R8CA'=3>
M1 JLBI55'0',]_'?<H2)T+UJ>;9,W%YK]I7O(" X,.OJ')3&SJ;5;RBUNW84
MFFZFE\T3I.7'9[<[FP'%NKR+%,-X2IZ&..Y1('K_JI@ !;FVAK2-4%YS.R:+
M& >DSV17"/;/ D/(/3>RWB3:YHR?MQ\X^Q+4/0(6C;4-5J^B_ XS22BPGU^4
M&^'L$;F)O82_@BQ-<WZ8_2DMK\]DSLPIXS7M]7O:CQ"NNZ\<:.G_>4+Y$3 P
M51OPR_<!([2:@^[;>\A"?V UO-$N16,7&:U8/$"D#/N8W04IRSYVRV9+"4@R
M8.?@,*@X%%]VSO!#?-:$_O\J./C/L(SI'T6W<#\":#)1%^K?I)U>7,<W^RZN
M1E.;IN^49<#-ZR->14(=L/7SG=^-;.5QWJ\*]&,^%Q5>CZ<(J8P2D5T=9/LC
MHO#)HH::WATM:(XJ6L!>F(+,O:<8B=OJ@;G*V*T&:T_L$I[[8'I2N+)C* 1W
M2+ L[[<UMR8/8T>GR$KK2I3O%'%D <^"]71:B)T+4O ZL2KPOM\O!3/+WR$#
MC@]O&JE8X1:!>0MU^YYT\ADE?YXB&O$@S =>XAXVOO79G@M8,C3SU58$@5P0
MCYN&B@"SW&_/;=$]Y:\PLU3BU/3AS:H(9/"[FU7+$P39#0.E9O$8D*NUGDQM
M;6N5*[G:IYS<?O&>UOLQ76#LV+4HV%4.0CAIDHPU3"O\0SZSGMF;8AMU^L5"
MP9=E[./EI-*K=IWJ5O"I'2CJ6GY+Z*#G.T40V@:TJ?W9E;+:)$3OP%1=CFVK
M4:W,#H'D0]W&5(  "9 ^] A\=>Y=IH0;YA9;:4(O'9=J*2>% A#Y_N!J4P3O
M2N#>*3?RL>3M\#V8Z7KU8<B2TE<A,<=ZK2).G_,&@MHB-F%#:R ZK>JV((EE
MLTA'B:/+N)$,EU[W98;CV+QU-@;%IM/U,#VPA';P5]-.&KPI)$?_>U=#ELJ(
M+S\7^+*+I)S 2]Q,XOJH=(\ 90YF=D3]1WTK0\IF8]-T"3.!U3+"CW=[U"0>
M+(J3(M14>2\^S.X-6*0M9O/4JTGN#HZXB..+B);N7S1]L:YKM_(P&,YNT>B3
M>(!3)>=M&-#>:AU[:VMW;BVF1/]9+AL_':1107UIO3I$_@B$U=IJU>@KEK36
MCM:*Y!^@8\_T.X50^K]O7Q6.L+BR+NVG2]'V.8NF7GLRXGYFL[(F!8;=Q_NW
MS').WA?$4;^6VWV"@%&G%6A-"^7:@=;[8\V2HF78M=9'<*' 7:_=?#3" +TK
M 4+PZH]K<'LH[/QW8\_$^P5LL5WF'.INP1(1O-5,#J-QZH\S/OM141'Z**=R
M+,'1MXE?/$%Q*%?O3U:ZA+(2RA=^.+O3F6*7.ZICWN7'YIV5@[CEX)<AIJG*
M4VP']@>D0RRU%019J]S/_L( G-FQ?*B?.!O@N95XQ\D^LQ2=M9G]Q383/O;5
M LY*-$O$7:X%_?K]$A\1,3@Z-HPNV  E.OVKEW337@U]ZH)\6E*AO"@GZF=-
MG$C0G3[':O/Q)OQ[BFC-0C/'\!<EQT67P^<\""&%5_LZ$ZZ,+I5$<]^'OS(O
M%@,W9AN_30Z%O&>4R3S;:*XBBCS\K)>%\6J9BTIHJL7U'47%A9+O.-;'B/;J
M:JZ2[0[8V'X(XY:P8G.A3'JMNHIH9D??49<8[A,U7830@LX0)&.^LQ^TNP1Y
M7-# (X&YR1:,W!U8N5=,-#[]1*X&UDOS[>C34:>L^_W$X_:[Y /;7?Z'KY#Q
M'7R/Y6VMF/,!-KO/IIJ+"<FOW\8*$1T=,J<$KXUH#JV+E93IZ_ZISI#_/;3%
MM)2"Y(CM_>3,<(A*BO:RV*<=6F0M?8O?D::0V'6^Y%Q$_+6*\ C,@BJ1]#&,
MJ(:PDVV]41+<OGIJ,4NJ$=.)>N%*;.>"%.(P/)*Z_6B;9GS8:1J#=A(O)JM(
M!D>QY4A0<Y&H5@R#NVNNVK;N?\\>_#E@>V?&RAFOW2:#H[E!>K0<(/) 2=KR
M%DZG.[E\J.>M\\J3 8_*3,,D<'<Z>$07WAH^^4+Z."N;IWK^P^_%QD$+RXY1
M8( BP_^\+&?<1[!TWD=VAM<VRB"%.T*DT:=7N*8C%F',X?TXO/^K&?P5F)A(
MK5PWI&3X<T] =P67$,4)SM56@* _F0?Y^W$1@::4[Y:A6[!W0VEH'$G1MQ2K
M\$CW\%D=N&QW#-7%LB [Z9=9N8S:A.2EP-E<\1BA1T &?AE)$_9AQA0" <M@
MGJ(:95,.J,F?]P$5V6I5LV!%<D7(<8TD%ZQB\%,VXC )B<A&QN8YI15BPO'G
M-LR6F7*^N9$BF_'Z7W$L/%_:WDPGC?DXC8&4O1^!5WT+.^TWC--U?B3PU_4;
M&(H.^K6U4]#YY.\2W5QV@I2D-<[329.5BU?.&DGKY623NMO**MS\WUO\_L2F
MC1G9 +]]-"Q@EK'VKM2XULY&UL[U X-TC N!T9RBLI?RA,M7A"+"]S^<.<*B
MPG]_XZG^I70U*O Q:SDCZVX&2]>(2M;;$[DPLVB/S*=\6?5;A1150-!0=@]9
M]?$CT%7O1U;=Y+VE##;@2J*PBP^PI)K?/+O(P>[[7T!JA7[I2_,(5 QI,O_C
M7^:_=QO^JU2K_:\*[D<)[9^13/_$JQ)H'DN=M*CTD_]:R#=3P<A*$RL,!]FM
M)NJ\#&)<MEBBHP7T;Q*%LD$*TH T(1A7GC5!DL*!Q3XA 6#WE3^TB?)P?NN)
M&9-G/?S'G8BO6%ZLL==Z0@(KEB>2-Y9'79I$0S4 M:J0#=2DW_JK$W]1*,13
M"FL854)9C5F7\1GIYX.B+*:MNE#Y7/I>NAS6M'WPQ1USQ#$T:%@'K,B3^$4>
MK.3_?OIG (O.;IW0EZ:Y>3U8F* )TOL?;0T4T_5$QP82X_K=%./M6!21I'I[
M6/)/.HJ"6F=J]18E"<8Y@5Y:E(^Q&51,R 55#7J!#KAI+X9T^+ Z_9MP]+W5
MIU60U/3TAD0^#B(I\PB>Y)LA)XE04,U?%!K,S:_TT+9 @K8XOQ!9=4??8VG_
M#*"M@]37?GUKBZ3RKA6?'CWOF)!P*\VD^.#6+@8R.M:\W5,95RBM^Z0II=A
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MP,(,;Z:P=!TQ6<RB&SPI9"E1^Q9A\(Y9E,%HBG<F&;Q0*?!.(OZS.;/RAU
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M2/#L6178/_SF-:1$V@33O5J1:8'Z!VXWM?*W;&@A?"S$ JZ4ANDV5:Y%=&B
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MQFAWHBCE&JUSIF7<QLE\Q:IC/F9-3\DIFOC$O<OL,&*HVN_\!$JM&&!T4V!
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MK37\=47*)U#>N514<2@L:35S!__-25Z7WB&$"RI* *#Q9U6)!!3\VBBWIW1
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M#H=B=MOSW=+"9HKKV*645@G.N=_;@;_G[&M]OXFU$5!4Q'-A4VM>_M^0)[
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M.F9@_) ?F7?!9OG<)BU#TV@:WM>E+_$Y]+%N?9O^++8--&O@1<ZG-\U4@#N
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MG^ S'2RF2VQ4PN\3D P46035D=W##B<U5HG^'[0BEQ4RV6%:K4]?G3KLFIY
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M2<.S9^QXBCQ#>9Y GM$"KA5)0NT79HRUJF./=,?AK/819*")DI=/<N];3$)
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M-CX>?4C6;*\A+0?GY%'%1G!XK[$;PEI5>5I5?<*&+8G(/E)],BY.A)#-5/Y
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M.5GY-P$;%^C&V-]>E>GO&5_C!;!#^P*P\Z_2+NYY3YR,DQ7^JH FNR\E(=F
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M_5(&V";;$DH329]X*!B.+SV1LM&(]&+.<O8[ZOX>10$[(UOOJX^.GI/E% ]
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M/H:BADA\?5)X^U1.$I 4JB9\'^: [!AHOTLM.J?E3"74728GB8<DM28Q!CW
MZ!Q*-N7L+HW5+>'9E++:['Q>0?\[W*:;J$!%%*^LVIMER$D(FFJ.W%T:(UJ\
ME(3_B=2">58J&'65O?GJQ2O2N8FUHLLBBRQ4EOVRMZLGY<P??X:3[:>PK@G7
M<?94SZ$BOR9EM+CUE]=]K;(1R^JZ[!"SHU&8A1H[N\CXU3P2-=:R<E.F$"3,
M2RRD*+3[7_]1U.Q:_X7O%A\CJ1@/HW.0FIH4^3,]7M? _+5-@U%S8S^1:$H
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M&9HPN\#,_%?MET]_&-(^LC+H_,MDA/\O4GG_A[1_"_C\6\#GWP(^_Q;P^;>
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ML&JQ.Q'NTKPT4(0C;!;<T'W4P &M2W/-K\9K#&%7E,:,-^5TKK?<!PW!(@Q
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M-2N!C1-TIU!T:-X%PQ&_/8!?XU:RDX"+>LA%*F>)VJ-=H$9W1.O+,JH0*9'
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MY@5K7TR >H)T]15-OX3P?@"LLL19&:0J$6U*Q'K!N>M7"I]?[^" =]+-E#T
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MJZ9B;/V;;D\/-/QW7\4ZI3+_=,5T&EBZG:1IZ6O>L?273]@#LA;9A[&LF (
M+W!ZYTWA*]B_,GQM'G8K#:%CMV,@BO1+C[KO8RCO>HNX&1.93[PJTSE2NGTO
M_-IZ5KZ%45Y[;8VXW982L6=^E(<HR=LEB5C\-L5-J/D7@<(FJO;%>KD>)CTH
M;93EN^&76I@/ RS&+"TD:I!4XC-D,HURA1RE8,4@<RWJ"K?&\'KM3M+$2^*H
M8<^#VBTANFII%KVX>..[XE[D]TO*J#+-R"V-*6%B0QV#'5AO83MJF$DTJ^5/
M(E.B];7RNBQT2A"8H;_# \W *DZO3M/"9DT;%:=P/081!__@Q>1>>BM=8NEC
M9*$BVP6>+X?Q7I/L-I/^7M!"2/':PO-AW^2W3'I4*C/%]1X W^JF=\-=UYV=
MDT$3V#T_/L=J::M7O:)"#J>@!U')5SX @3?=]7Z3M(G[4RNA71'A]!^+<T?<
M>.^KK2ZH5AZ B+,KSJ)\@FDDN2YX&G2?_28RT+S)PL BX]617>B!2P3!KZ7?
M\PD#%D&AP7P,ZNY$5/Z\]VH]G';8X+E.C=F,JH+:3&,;O\J);(8" 5%;6;JB
M'5&4#N*#FG*2G7LR[12!3\;(H%9SP<KS7SN(ZVD5HZ,YL?$:4KEMX3&36IL5
MDVCV2O+G1/ON:^2,5-W-1)-Y4W O\9P.LPSLAC4]@J>*ZK[W;^4]U:ZEOS::
M%EO5UIZ"P;_GW'WGY8_JC3B&>*(?L1XFI#,ED%^S$_SV@,==F=JV54JV+>.I
M2'L"_/AEY\O=E,8>FS)6XQ\8<X+H$+>)2RZW#G[\H=QCU3%MY_ZO9VL;SZE/
MM#I]!=*,\99PP)ZJ1RVA'Z=O><R91M]W#];"PBL,E=\] &@^(4=9J%Z>G-?=
M$<Y+&$P1&!G&JD6_^BD4A4*4NJ=RCLO]2[W>?I_;G9689E-"[_M>G2QT].N"
M#Y1GB6@0G:B1*Q/IU*&ISMGEDHJ=TKJ0R5,4FW6(FXF\->9*+AE>HR3M?)9(
M&WC!QA@2*TL%GHB)28/9>J"G $UK&%(*NBL:Z=X\U[]-PG]VL?]BI3O%'T5X
MWLO&M]R!14ZXL+XTTE#? U$2XRWN7(52X2]A U3E%72T/[TI#KLBLJ+0VW-D
M,=6S"1-Q&HVPMP0SV#E:*6.RGC?CS;9[Y^RY)K[0(0ZE*J0VP?_HCA^VDHFY
MXY$85</,LCO?E$;AEN O132[C"DV_'Y/F,#2[5J_MHC\/.UB8"Q_B9N]H0)3
M9ECEK)2OM%%\181\R2I!AW,VD ?CKP]DGY=+TA<T>5\=#P(>&:D%.CO<.%J_
MNXQA7[!#M6K9G29.%XO F6HD/,&'Y7[MW3@XCZ$";#@1FOJNH:5Y=/GG1)EP
MK_--6+L_=T0WN7>EGETGWJ0=O-1Y@;_M9)7;F&D0G:F_^\5S$'GO;2'HV]%0
M]LJ>W3-K IV(DVY/'U14(]>NT1.R(*I#)WWS-GU-.#]^5PH\L3K.$>N",G,3
M:TN76QCIZ$S'N]&-1(]=,88^II?/K)NNO,QQ5CBN$&R\^KG?.G^!G&$EW.?3
MNT&27*.0P7![>Z&?6>@A8Q"8,,,NO],PD\;I^WO(MQDF7]LY1#3_N)=A]AR"
MIV-6[UJ\G\A+!B3\ON(SA3>JR% ].:G\Q&L$#.))$]&GPY;X&8Z&S <B^OPI
M]5A$;H(+0U?6DQ&M)%[2!H[.M.)C- T*!=RZ,)V;F!Z <?,'8$12]_@!N(VS
M-BRE[$L]5E)LGN <Y&(JA;)HTWQJ(TKN"\>LP[?N)B!,A&#!'U-YNI1E(B<\
MAP0COV%0"K#)+(AO[GETHF![XIG8<L,A1TK,CO/A+TV46N ^GM"W\8WU:@2[
MNXOV ;7_[W#N8Z8DG*W-3R*X(GJ;#7*, GD([0ONVB1]B'F].RU'BRL6J<?6
M;+$7<T7C^!EISZ$-76T,5.YI"GM@1,D0!O#1BX5=&U&@.9Z@88%#&C!?$H2R
MYV\U'49SQ(%(D#T'N;F[5TLS-Q4LS/.N'Y^Z+E]LIB\SOU6N.JZM=' Q<D%F
M9TJE3B!0_]R#VDJ%$MI?47F,%2"H[>Z8@CZ;,MBDJC69^JI6W!98O@X0):Z7
M7,B+ZK!&&5EIK*Y)D8C(_KE2,<^ZZRAP8@U9M;N-J"<<A9R9BKOE@6,ONW6$
M:PHMH6&<E7%D+_1T<RI6>HA06H2;9\JPOGB897NN1A!8RY&F?LD%>7:BL1IF
M"D;S9F&]+Q=$-#T K\^C[KP?@/T(@Q ]NDX!M 7Q=U61?6.>B;KI Q5=>GXU
M/W_A(<7D5([XT+834XN7Z%"=_9K7%+G&S1RJ*E^Z\50Y=H6EC\SJWF6 (OD$
M'K/DI<M)&\2AY(39F#.SM *LSG./2XT1W33=1UGL%_%RU%2BXM'Y9$B;YQ[D
MA[S=P60>6,*D-U849*>WC"DT"- %NA!S9@81NHWX;;:9F@R;]0#W9C\:<98;
M*/$L$_FAY5P#5;(<K^/C4+)HONXJ*CAGH(]L9JZLSRKFVG&5*(YE:QLS]&>$
MH)Q"W=Y#B,!X>I:5%C80VP.32)E<-[VS'L:997M[BR>&3Y0<LL&[#T#[)_/8
M86<_]0;V$]*9^+THJ\'1LYKCZ2@N[DG:;^T$%VW<F" ;=0I?K U].K_&M\6T
M/UU6%6S?TJYZ=_%&Z56NQ\Q% GN#QOUYB+#6#(Z?$YQ-[+HWNK$W$C):^,;I
M!78,8MV<2%*7$E&/</)E=2H1;8*< ]-;[)@?*G+>2\,BZ7J(Y!+.^S?58U =
MHP)1G(U(RL:-*&K,P#6_3 _=")Z.RT6A,2X;)3EG;>JOE4\(M;!YI*BR#QP]
M[T%.W<($DW13-H*2V5D)NTNVB*I>!L=2(6_4:^7_QMY;AL7U;'FC#4V0H$$"
M! \$"(T$=PO!W=VU<7<G0' +$*PA$-R#6W +[M*XNSL-7'+>^<\Y]\Z9>9X[
M[\Q[Y\/]4!]V/]55J_9>:]6NM=;^_9!02A9VX@; +JM>)$H=1_@#A.)(HT$-
MT7YR5D4W.?8S>F]&RX@!9QD'2$)20"V4=3("W6K7Z<=7283]G=(L]?).?0J"
M//KAJ2Y7.7F[ Z:F#H[]H-=8GX;5 V;@_=_>!)@7++I3RG" Z6/%"JY1R 09
MVP/%[3%OIC%#*$XX2AD^LXHZ&!?T[$C$*QG7&T)I*!&N;CU7S)I:C!5GV&QP
M9)*EQH=V553K0PT9<RQVD+A'*LNP[R6GO8W7B#373P9VX30\SGF^+@Z[80OU
MWZ$] 80P)M9L&F57TI(-ST6H;"&]KH)Q[/DKT)#&$]=$D+F@N<KV0V;RG1I3
M-VBR]B2@EN8Z6?DM[162@V 6;#_KI"4!O(0_86-"X!S@AN9,91(S.(K8\E_)
MNUX!T\VW?%,>4E9RT>_=E PDXUAL(U7G_PEB7=T*+K;@81NUC*IN;LH.<K>C
M-X:($T,Z[T:1]$5Q%9!(K)S*;R!>NR7L%M7%TE;)M5&OI\S<0%-I#NN09X4I
MURK,WS_,8V]N/  [O_NMVVW1\#XZ&$/,:5=!SUU/I35-8?22VWF@$.K=AR6)
MEC_Y?4>^H-";LU1WC\G/N% $5ROX<S:W=[P4%R5=)S_KKA"!*)\<GP:;_HV4
M/OCGO7K:%;+3]=5ACZ#6#G5#X\EQR-'1)>B\0/IELB8:B)!JA6[5?1^V%_&O
MZ$4*[HUK1^?J$VQIJ)AU;-9,MA3GGPR*TLGI'3]HU_(JO!A!MO2,6FR92OH)
MK0%)(GUS??&;:R$?^'S:P$M;YW=3'V?WHLP?>(PA9G!RPN@6, +1VDKTK4 2
M<?3WIGT_5$RQDQ ZWWOEWJ,-UTG3FM$P)_@S!_7XH(/W['N=UEL$4%38',$S
MR'N>6%*!M,#<$(LC\FB+;VR.M*:&HT%][-U@7\K)2S(2#Q#78V_RL ;E;"MG
MLK^^*VO@W/%\\;SE]1OQSS7H9 X\&5^? '-7<VU,S8^[H2M.3P"X8M<[9T_Q
MB&9N0]*7[?DRG]>/25G\<!*$2+Y3J,3; _JI*_C8BQ8L:]U2NP=7Z4T2?PT0
MO5"-IEIWX'>4H-HX5;^\?<.$L>=(T?FNI 2S7EGCSK+(F_DS(_-#DCSI:8(0
MD:,5CPH3MG2A9HX44*R4)W#E@A+B)-<XY;Q/J,0[]'%Z27Q3#9R(Z@/'_GL'
M0CQN>H+&Q!^)(\N?=)TJT2D9WT#&O&&<=='-%.1,PGC=[IJ@IRGBQ#YH/ICD
MC+&-4$ 40PX $.R& W;9^X\HQO*3AL_&QPWPK:_%7S%*[/DEZH*5"-"J)+Z$
M-Y@;!Y/>7I1S>)#*!]*;.':+M<EG90)\ 2^79U9UE;NU7B>X<FI\VVB(I[PV
M,P5:"&2Y= .<73W+,@I8&1(?2@=H!Y#-U'MG$..WU2:L\S48:U EJ.V:B*OH
M*N_@+2GR=N]TG'0U=FLK!BM??3-4H0<,<Y%VU.MC:.OI64BZT 33NX@W,]#7
MN>&#?RE)'B@<]LJ81RH@@=<DCTNKWY<[S[F.V(1=':*]$]W\NN%,R1?YIL70
MZW5./G2IS<^%S^KM]FCD-&>P\_X#;Z>L<2'YQQCR<$'60>BK#<:CFWX\_,X9
M\Q.QS/IMNV\Y.R3^61B0_R2VY/^K]E= K/A?>6S8ZUG^%%_]O5? ,;D8M-7)
MDW:(9KY]]]F=77?S?F@P"B^_^OX$X*-Y K2:Q=1@WJX*/MRS::#L,BL\%/B-
MH#P!CN=^W"L\ 2 X3X#E*E'_K^$R*GY@LO,.O_LKL,"XX/;GYY&.(@ /U39Y
M/CF/W^2? +Y#9!9/@+P_?VBD!]:.U:9=Q=P9_ADW\V^_^_T9QW>>8T)@[ D@
M0_VWF:O])E!:C^>RVP1MB,#_VDU\7G#W\_+UP9@!66U4]<B_=,HY)+OHL+N_
MLJC A(K-F__5Y\\DG'^$1SK,L6']J\^]^,.'M,>'5'K@U5AMRE]]_D@J^T?2
MUW#W%E"9OSK]7:"_+TCV[POZ_P7_GRNX]+_HV)^?&>=C_@CC=W_]M^4\*^CS
M>MYU<[T,/:1\=/]?&OHO*FQ1@3,^269)=M[SY^(?%;U25/WOE^+SH;"3S#^+
M>A%.5]DL?)V3Z%NHU,VG[%=L[],T7H']-RJ,WD>^B=-'L^=-^Z]8F^P1\G^4
MK772&OD<DK.&2N(X?'V@7MN+MJ1V2G?W*FXV[H)]?.R_+UOKI-7[6:QA#<0@
M=G7MDY'_WHQB!=+  /$ U@F'[UK\^U09H,6+H,<F!HVBO[()[__&@?5WN Q5
MH[^C:,C"&?U#*2X2VQW9E\_1###-MQ_E5$TJH\44(6E5(VL@:=$QBC'#-.OQ
M!1T=P13^KEXF2C\A7HRI/Q (&40"[]\L9XZ/'/R2&[FZMEW,["3(D1\;@E06
M6BHM>$SH_01PV+S*CGQ!G'ZW_0=K@]7E\"V_FUBF?+S(JUCX>+CX2 P18\KO
M>7[&?7=3T?D,HV"&TE1$15*$X IIE_5\.<_+4BU:8&;C26[-3$1IS=77D. /
MHS9];H!@1Z=)X*XZ(YN?8)>K9UUFW<%H/WYB%6^=<?IVI/%X#6T6\G8PH\UF
MH/"WC8^1_%_:R[0[3ON90HZ].9W(I9L8KJ(=AGN0C-='@WK'&^=I@0*=TO?X
MH2OCL,-'U?J@(6CD:>2ZX'1:UJ[^;"I>6<JVQ]+'Q',.F\5X>9ETE\M2.EK@
MMS]%,X^T(2?+T,9XW[&-YT/JLV&XN:U.5[-GP#/HVOS0#K.QLR'R:1G46 @E
MX"-%YN^V&A,BN%-+*]%:8$M-:K2;,)N*U*(B)SLF-DFX<](<6-5^$)!4_SCS
M8^+PG>,3P,S+-$,Q1C>%TN*J+"\<L.T2D1:%VN&$8D?5TOK5XT,3N5J2^JJ0
M8J]O4$4I.E#F#4> :?Z)%G)@ PFTF&PP=?Q_!#T+5FQ6O#V2LBK :R)>"GH%
M+'X"7!9>>SB1U ON8PY=X!D    #C*]=;\7BREY]C#&4RPX7^?^<<>8?6XBV
MQ>8VD8ZSZ4IX:CB@%*WLIP?.NM])W77HS51JX!'+29+^KTR6S%QN1DH3-7I$
M(:X\(/V_Y;?%Y6]_8;I_=YD9ZES[JX5> :O@"\MP;T6IU":?SVI3)K:%)%Z*
M?HUV_U8V<YLO,@C2FSD>2R!YJO,]6KL<4U?$G.+6#-O<;10/\.BR4RFYU1%O
M;;+TO;9.=<3X6,\FY^;1AZHSYR9?)G[&"+EK21,0T/;.*\8%5L3T992$26^<
M3]$\L.DKMW(GWJ8?>Q^,%CAI4<YP$^3H+;*&COJQQDC)X&<5IO@*6;NP8)3B
MC3\IM"N)0RL4:GP"<W@K5KMAX/_!(?-KA4!+ 7 6]*:SJU8KY@M3M9=+[) 9
M*]4W(DQR+.YA8:[=V1G^E0=,,0X>_S'V^_Y#6\I7!]@V\0OIFY4!(?S12XO[
M7TY:/UNS+^/NS;LL7$OC??>)(BHPZSS<2.1_'GG!HOS#37#A2-8L6("DHC%^
M::'CM6;5^5<=VGZRCW(\,\P%0]\M!,U:3_):/1C.^O@FXPA%HN4\%)@A'YRF
M_?GGP\]&PI*/!>)6%\7H>RD3>/Q^2A7BB7=#L#*E1[-/T5)K!N]2G%FK. GM
MCN+ZVI\ ;_WY0[*:[\5G;07ZJPX%M#UX'X]@#IG6,U_K@FUAPBMS?-*%>S-*
MR_3H;!(.E8J\QI/!PV(\U\<U*T-R^THW-H4^96J)I=,6B0L;AV?M@$SK423)
M5<$;B=8JJF?/D#!PKY[JW=+$6D=RY3!=M_^[^44A1\S)N?8D%I *NXJ<G]-:
M@?4F3A7&^3P1.*^_U/*N9@PB26@T+]S#FWY_1; K1-JDH4=[JIH<7)*3NJFG
M:4HE^M+%VH7[@,?I6/W"AO>>4J*V@A-;AT 9G/31L7<FWN'B4">_2QYU>5]Q
M;GG7DJJQBN9#NFD ^89Y9""/VQ! O>H&,KX,A>K=>)Y!#^E?ORVO;Z !PB7Z
M-,UDS<!]AXEJ1^Q<M&+-L@?O&GR?D_BX^!,3=/>()]YS?1=2N0YB0M72K:EI
M"CZ7(K9EB'>*SF*RTP)<S*]4D[W:JVM]=2E+O;;O$PDOS\C$(+;P 1C+NCQ=
M=N.W^E >ZO+Y5\VD;0;>RVI&>\(8IT@3+RPO3W7^5;];T/S,N-T#BL4??<1N
MF&9[ N"X9U_<)*O55T\8FFF[&ZJ1KU8@P87*279;N>.H2S,12F>#[S[/S//U
MR2 JB(WCNWU$Y WR9Q4B+1=U'W3UA)2>(NF-.]\?5^8.EMF^ V:$+R+R]QW1
M;8<E77?,FR6L\C/>=NHTL27$Q*4Y&3 AK)BD/PA4P^VKJ,>Y1[0[WG!*RMI)
M394%3S)F&\DMSG'U];8:0VK<NN^6BHN\^<9KB/0YN+:?3;HGE!(!S2DZ7$(P
M%^ 9[*3T!.A0?P*@5/OJ)SP!D!_'FGA9KSV> %:\K6CJ%"M1K)W*>ZYNGG(U
M/G@;QL[3RA7*-"2(@+X1_IM]^98G0/RZS87^ ^[?[@+>J4X$9TP9^>FGQL]:
MML<+'@B&ZD T. 3C&2#[#@1EHOH>G5HY=V_<DB.^_]M K??WF*;HWH85EUTA
M$O;_!@;)_U2<HWAI"0J>=M1=DHEM)QC@A;P0R;7B\6VPL*V&)D*PNB4!@9C?
M$>!IX2__3(*W97&<ZWYUK86V;&XC<L!)C@'?^%[MJO/E(4R\L#8N:U&WIRD?
M]2<>D/>'+:ZOB0)B*5XG3+#RL<_'<6BA2IC/<.':COZU( 3,EL'YB./^;NJR
M@3J^ TQH0Z^D)C'-SH4&E1C QO0[ 9 ,X<7\N#&6&CV"^'"\-UA*TV)F_4GJ
ME/$#8I5TTONYFL&HXVKOL=TLHSQ?:4L<"2Z:YY40:9"HPRC5$NXI>U(FR>#Y
M[INDC7#N](:Z.#$A)8]Y<<L#"T!!5D/@!G>@^^:K!O&S!8YI$N'>C_R@%S!S
MTZO"[-J*R6.*X"MI%RMKO7>&D^;<7,?^5J!.M]<_;_2[DAFHHBQFDI7PZZR9
M9;,VY<MX%) <1(WF]SQ=4U9Y>;=352JUW7\_VP3;9RR.H.@2GR)4._QY:2_T
MFJF0W/R462H6/:@'F)(T'$->H!<7;G1,)RE_K;A8$%][]W2W[ES["Y6YQ'>E
M\?1(EHV8KTXC)%;Y->D+\[W<(1K29<>,"L#R2@#$ MX2A-;_!^J[HTOK^'!Y
M;C/PB%0\N96$YVAD-3Q0GE C(B)-VXOAX]'>O%FXA$W64B=9]PR<O'5<.BDM
M,">[BDW7=4(G1+U.<BT)?XX-_]5!//6%H>;Q.B]3C2Q>34B^!QK33^UB;:-3
M$$8.=W^O-U"(:%2GW9&XG<_QRT+.K2V1%4;6^G?21 :'7Z\F;59'+P\EF)/F
MF([,![V3%( .-^K*ICYX5VDO8%)K[]<T53X0^5/RW8^^2 6!Y$Y?1.=D15G@
M!XZ@=0T#Z'!CG0)]Z!(S(U9^-81P.4<9]Z7X1^^6(G\)&JM*#QC144 2%37>
M@U#53#!.#]D<'=N]/.:X<O"(+GY8[P/XR$KG[->FC@^2:WZ'P+^V\OKR6_(5
M7U3GDC_;'BVC00.& 83[DZTBK Z])E3!831&JMV/<,ZGR**TA)VWS] G?E$+
MBA^FX4(X+,>[\J9\13*G_N=4?G!G-W4A;P[&9V(L"V!Q=O@Y&;KNR.K^N@\H
M:=P%-)?U#1(K0T6A/?NJ_<Z'%CA14&;737:&<[+\\#GTT7_*J?M-9*I9$%\2
M;''@"\-7%Q;N^=81P6" M:).<M!JPL?&EI.%,[LS^ 5HY2.57\LMEV"&VDP2
M5.&T^HU> V]O+G_>#<6YC,,(XP%6UZMXQ ^LL%O 84&)#:AC7BW,=>:--4M[
M@U2UD;D)-_DVF 8"XNSP.R,]%7_PBWE ].=I!'T]]8,%-S,_ 0S?/8HU-@)H
MR]0[NO8:\TK+I8!VW^:U($V&(M"]A51'][V>-4R. ;DI.WL-B=IIZ. G[ ^]
M7".$;53KN'"3BCJCI[_2^% 8,ZP*++63G4HS&ISP]<BH .Y\+C"Z":LWON6K
MV@,W&YD'V80(WQ'[E0%'Q!>&?_ [&6H+\W9]<:I;XSV,*[4M?O-MLV )M7'M
M+4O9IJV93MHI0>_)-&HP4#1M;5S%'(X3HC-V@([A':VGJJ49![7VFI9O/I^L
M#VL3\(V ^('$ 9FV->29LJ=^H4=&D<DA"J-]\11J8;U&F&)(B'_@3\F0+%GW
M!$@B#FT:C^;FYYW2XW<<$H[$,->U)__KBJ#@-,X+RJL_/=:8_3]XBI6GK/%5
MQFU+2$7>+'P:2P92F1BS@3@+TL 6.MG-3#V_4((ZDI*J1+W>M6?\CMW!)R L
MZ^Q8QB@M861;M'%!T9QZ;4?;PWS.)+.]U&0>G/O&,K]ZV49P)?U#]W2BN/S<
M7JF/%RSF4W;]D/A::*CS?5Z=6D,3G?V(M7^9[X_(1[R://=,V6GG_O+JZ?C]
M?IUFY/JOQ.9$<MS\#>V791Z&>SU\XQ$2N]%OO^8.$%(/I8(@)\N1U2.XD@YX
MJ2.X%0 M[BF56*](G(F[\ BYTYZ48O> "R\BK_[<C^UY*OJT+_;F%M/-HS.Z
M,8(_S5O9M!N]?S[\W!/U^YF^6Y_K=0/JBK&<E/@WQK@,BVJ4"XPG=+:>5!T+
M##<F7V6QX"\I]R&1,1/P-EV7)7>1,HQ[LQ4Q;1FS1O4C2#?,>JYGD2G1Y0L7
MTK9SS#>PG:*T#]M0943]!B6->OOEW$0HO.:H7.SEA5<U_6+@S^*A) 1S4-I_
MY!KSYA:<.\J-UTZ''VW[GB*\FQZ+M)V:63RUO;'I!MIG:^"^38R.+]*U3/7Y
M.M;IYF-C1Y_I\"Y%,:T. +$B$SKMB5CC_C4"IH_368E#V*_YABF#C3G!7<;Y
M)]TVC_DGW0861WVO>N4T^KN6CCGG$+SG68HGK3I5XJS]NGF2\36!<(\\5:80
M$M4,R.Y4O3-AX4NZGE#^H]8 %O0)$!WO)_4;EVY29S3"8CKO;2+G #?5\%)X
ML5.AIN9N:<&(TYNY(CM6<SJ5"TH2)RB)573"6D]@RML))?=.&VQZ4$U,K8:B
M7+!6)H(M'C-N(<RQ<G%,Q_ F,;<L^>''O&T1@TPV^18NH!+A]/Q\=$;1L%#;
M4DN%)Q+-=X3>UX"A'?C+IQLG1^GEF1HQ:*+@$-]Q$6_XQJE'RR_LR):BHJY)
M$3[$XYTH:G\;$$U.GK])75292RJ]P:3D=[#$9 P;R:BB*-Z+X/\N-NM_:$B*
M.M??.B,ORD+^L%M_^N?LUO*.L>K<:P/'6+MC6@L6'-*NP \0#MT%AV@XI)E<
M9V<E8#][ Y_J>F[M!+33QJCRUSG;3G_T!U\S8+0G&@14>XH4&G_<]A-,4<?>
MTG@KM^@FQB48S7PS(ZV3',$FB&VE_I:$535D0C:>C-%]-F/0T2F220:+)QRP
MX?MZ=JC02MD*7Y]GKJWVI/+ -9C@CO;!JN"4HZYX7G_(9 G7QEC612D8MU:.
M>P&^SOL*KV&U'!-Z8R46W8'$0IR<I/1!=T0Y>A'06V,UBI0&XSFYRC$MV7M3
M,Q2T.UWU7<(F_8QEK@>3"V"<J358%]HE@'D**71##'8HZ'0=J<Q6HU/-M.=6
ML/<1+M?.]N>[[M$CGFH6R0=K==<4E>7:!N16&V'J$*.=2/ W;9\455HU=NW4
M[IX<JNU$$II\+O&XW$0B.Z&[^$T+'/Y%N^M6-\VCXOH:9V2SZ4C;7?J @&!5
M'+ZFV<?<Q6/%M:ZF-M6C3O2^/H=^X14$B7UF3(@8DF'NF(GZV'=USC!RY1VV
M\97B&L\:O<7I4.,1<<+ND ]8HJTSI]/)%\71]R,L,8VY@ #!Y%PO3!3@41?(
MQ^_AL&)C+/6K#O);.D6#)A.'XKXX*&C21!4=5>'4+JB4:IRHTPV_@(H!IZ=$
MU6EF2T&8Y)[4:IHVZR4/V\P,CVCS?#KJB_5"ED\M^ D!DU?=!C?%JJ<""7X(
MC0+?F XB_5J$@K]QR,OFN\FXOFU\7F$_4XFW^/JA67_9A=@$0VDTJ:9J7&T\
MRF:%=CX X[)X71]S'\L]::*KD1YQ<Q7UUSM" W5H(8)#+_O.I (2699[0I=G
M3SFQNAY)@OQ/56/Z*A"\'%?/"N_]F[Z3K10_I&Y^O3,KHF^')M@'*6L&44DZ
MAI5!>C'/2_TT3UJ^BHFCIP>UL"K9K9.1$$J;<W1$^BA,V&,O3)8OOQJQ?RBM
M;)[6 ?ZA3?4I3)>9PCL@(%$YTKS&%5<!*=W=2:8U: U2[L$>->CZ$\55YO2#
MV #CA]GVYVT%RYO)IX0!DI_K/3,M_N4,SC ]D+5'^'"I*9P6^)L]X@F ?]/1
MPT_T^&K.NI,G)2].$Z_RJ W .D+(IZ[HZB*/=.,E735^D5/4C8W;H(+DP.\(
M&%'2KBS[%0XXX^<5G:QI)9JSC'5WE,681M*D1GL9J++]?/SGPWAAN;B;?'@:
MO71K;2O[#<@)3WW6>]1W/]NK=>%)"QR!B93N'3JYY>N[O[^45C@@3V(W>GG%
M!S)X0&9GZA3$W.-A"#Z8_\Q@:ZLK8U^Y <"DF>#>\0$U_??$=/X385)$_2_.
M7-ZB.;+Y\I1=/PU"Y8K:-HC=BO2P3WZ0XE:F(A^]6=-,9XO'F\?@ ; XW,Z(
M_*] KH,"&%S*%.E\W6/6V($SUUQ#YP<,+_YA*;^V*"):DR+Y."!?O0S/=3[Y
M5?1NXW79_'S'_+!72E:$23*+1P))UY$U',33'DDJ>D"R<N*(\8B!8?J][<8Y
MC8'DTE+SQ9ZG B)^Z#J.E2_HRX57KO)-#QT30*\;(]:9<%:\8'><S[&C%R&J
M*X0T!]*Z!GIV<Z761XQE#&MS#!-AU#9=1P;,$'EB3U59]4XMCMJ]NZC/3A+-
M*'"T3P#9W\(/%D!E^\4Z2E?6\"UOU"< N7;K/;*.WXY+_H\;)\G15/$)ZVFD
MKX90+V;;!XT$S3-WU$ZE :J8?.QQ;K<G@$0R0D*\0Q,NG+A20XS.Z72<J=&:
MQL6T5T0#3N)',3RG?<CRJJ[I?-^T<HGF.9HU/FG]6D[%A'5UDZ&=L15>LTA&
M91F+CWSA-;NE/W<FW  2C,(51*CZH9BJ\[LXFIOYZ#7,"E_$W>1$/!RR# XN
M8WJ)MUMG1W!5%KW?OD36\LMK[J)OWLUF6(2E.%--P=[OE7KV6/6-]='AVUJ5
MNB9S<(X:.;-AR'$OZ;<L##(-;*:@9C+.>=F:9B7M%!IDXD^NWF7"ZX"[N^FI
MZ^!+=+DYRM;33U7:2)I"]_12*$CDFT*"I<Y6^9IEJ8UN<V,ET\Q8P3V;\X@
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M,1@[7;O[6;]]IUL"/*(!OYP$\#S_QJGGC7GX&Y5*?!0J$:<?8RL!^[$2#Q9
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ML>K:OLK #]'/0AY/S:WI##X&$]SF2R(-'<.Y!%(-^>\9X[T2U>:3GB<3JV$
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M%,Y(WV5VG'=$]KK>D<D)//L"XL*]0VWN^)(EL7;CY@X-T/V%- HO,.A#*\N
M2=CJI9JQ?R3 Q%$8XU-\O52^8"N46.->7:E2#:FV"'6/;PR*[R6C\IZFYMIO
M.SD<*L^0L_M84_.LLR9@/XB=/[;.P,EG,IW$D"NZ8?5+)Y]RM=XK>;(!7K;
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MDTLD\9RD>CG4C7&M11NJSYSJD[MDM#C[&BHVO%F8# HUS#C!?SVL?W#6@O,
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MHKP^TIK4AF;C[BAU0P)/JI/6T_'K;;Y860O\@38KSTY^-HB:=YK=P%MKXHL
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M9OTQZ&-)#/*HV.NA5F\2LS:M#5U-$4ADH32DEM6F^413A=)]E7VOK'A7/_\
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M0<L9UFYF=?!BCO7': :.X]@LE*8F-;%T;WI$3;">1=C3;)@IA8X<4$>-*?D
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MK+H4+VJ]'')V# !?W>!\JYX+I# =6GI7$\&3T1*V^H2^6QT4._M7ITQQT^#
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MT*+[2/N-INY0AHHE=#C*\J2O:N1PE810O!RN!WKB?ZD]O&L4M!*#51-:5<@
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M$&Z:-,P3:43UYD2#;=8E\/R*=91.+O(A:\F('Z\N*,/@X_U.$9H,#KU8TO4
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M+31S<%PD2;GCFD\Z]G[\79YNB-<'&C!#FE4M ]RK1!6D7W<%=?'+@U"X'N/
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M=AF+2\UK\AZFU!\2GE8$(J<V/7:X<-#U,=^^^IF4H9U]E3(ZU[57+:G4D6:
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M#PAL&G_8\T5P^3RDD)HZ8@FJLO9[H(_NA>[E6EMC%J(QS%B =+T@YTGNT3L
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M5.%Z;-WR(F1[<T&NEC7X2]<3CUF/MF4%-//[@C&_?T>._\=[\U>_4F>J!\.
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M0/QY_(*UA*I&]SFX_+]??<B5R!(P#J:U@F7#*&M=6K$U=XH0ZCQ64A="11Q
M+WJI:$LPK16%B!0W.?/$8J6;$S<4WK]QJUY+FE_;R.]BG2-CY/#&-/KQR25_
MNS8^W[$F@4LT<S57[+70.<?8B!#1;$TXJ%A3U))/DE2Q+Z;TL]"ZG- :.3U'
M"NZ4]GN\.DNCF(=ORX;04=RGW9#? UFU5!10G1/9<7=<9RM[6>MJ S,4HZO?
M;4MTZ^?2&X[L+4\QN[AXR'9V2#\IH+) '[LOW*F%IX#J6I Y9S4VW<_7!S;E
M3F4E CPEBQ!>/<[=(<:,J"5]LV6B:<B7D4I 3RT^H:&6@H?P+L]=C4SPC*^>
M0U;K2J+"F"#!3%1)[#4J8%->:^E_8008DP5DG5T&R7-+J'OF_EI61:\;QC]V
M!#,K5FGN$[Y/8G>?]*W$2^6PKF%\L"AW^XEE8BQS=R(-5@76W/#AQ/"($&&#
M64+QG)[';.1'XJM7#QZ#,]_6GU*;) ;\$\^D+Q)-+$]4HR]P=:!;)%0\)']1
MKOE*J%MI8GQ$B'3@(-@%+/ZF;JRD24SSI\/7K,J''_:_8 [Z..W)U![> 3[N
M@59K:X_>LK83![[590(H )=5X<]A!)I(4$F:G%"K(BS9+G23)KL.F).1"-(3
M+Z6-#NVVR V=G=LNI+43@J7@C/J.?8\OOS"$,G9?JS /=I[9/*M\BNQH+^8Y
M)2P*<!IS=]T^$(.''!PB[)-NK$-G 5@8[["$J-QT'))A^%X=O.)G9\%.N9<P
M\93:\R0N8PQLF4AYK;%,_]<N*8\$M!A=M3\QE3)I^S3_$+(-6T4+^(965XCC
M;K3_\VQV0V=27TE;'5?DT5PQ:S 9D?\@A$]=6A1@9$U.SANXRQL>!VWPS7E$
M. EAQR+"/JQ()52:VR+^6M92,UZ=Y3G%2C@26-%5#G=J 2=3]7O:*@IH0*Y
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MC2F,_5EX^=V[N8CF3:3JIJ::L;W4G_ONRX&")SW3\-5IB'"3N'.SLFS\J79
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M55OPW'W:X#V %$O>LQ[[)HXO[1J%!1:6CJY^/CF50(SY@[ACLGQ(<#-+(XE
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M_Z7A\/(9TK?5TA7%&T%1_4?/50'5'9V1!8OBQXA?#V]5G5/$K=ZE2'DO>X4
M1D#&\A,WC!Y^I+&WGT6>?7XVPV! UIX:1@^JEN62/DS)N8GM)PN9$U/<X(EZ
MCXK0K7:ESI<'X.=:-4 %CK$ H0B*>A6B*ZW(0XY"%1':3JP">)=^]()MPVC2
MN1=?74C&:V#=DTPB[]6TDW2CD[W65O,\I>\ ^%HSB_WF*/$9^?)8_.OE 3^.
M*X=9>XC.=K23@A!Z-O($K(>:6$T+A@3+[= ^4I?71\#44N>U.M;6#B\-Y![
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M9 ?-=#$Q'1<1D: #Q!B X<5"=[5.O&*:1"4\27I%<G__[-YTC%!+:UK55EP
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MS;;4N[HXG4JD/3DSUZFL!"R!U.3]$HR/=WL+R:+B&\<[C_3TX8M>S)5O9[H
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M---WN\_ U%?J@*EY7J8!WQ1+WK#!TW!N2B'\PDJD9B W:]A[7DZAP8>B49[
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M7Y6Q.='&[]1GF>Z\7F.3/3?SRM@?(W!;\U<Z?JV O.QOQ.Y/?4@]HL;!E&
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MO&<.[U!90-K)ZF@D6,9X$\F:7N_^<FEH1X;.U&.@:!R"P?]2%\T=="-'G@L
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M1?+KJ>Z>A(T^FJG;J@O^J@.3SLH-SJ^N*2,BYB]#SQFNK9]H*Q"K11^GNT=
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MKI!>F3$LG5)3R8*JP185.X.]1!4;+[X]LF'C8U37"C,+X\+X7A5I[;BQX'!
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MM=\"W9_5H#CU-N77J<O0.?.Y.AR9F*CD&?7/=?$.Z\^741MUXSOZQXB2\'X
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M#'V&06NCI@1\[\)+6HK'Y) /F!;:EE=Z[AQREHM71<9&O>/>A^X+$W!^?U9
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MQ!3YT^Z.M&ZJ*0-":K8;X6JL[YZJQ1ENJ&??TZ\< AP3 :]^5N>H%KDL&EZ
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MEIA[_1T8;Z57H^);EGJ['_-RVC<?]B+,"43Q=Z?BE.$X-Y]N=%C66Z_.JAZ
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M]!2&8X1&2U/N*Y>/0<$GAP2\3CLOQXN/8#HPM(Y>]>+UJBFG8H)AF[=[_UH
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MD2;1 ?7MD)8?G4\8&&T<\(,F/#VNA<7,E"YQ&]:AF^Z+=RPZ4\D_^;EYG"'
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MIA]<4! M/?=Y53FW>#2GEK%YQ_HT*7W6@HWHJPKW(CD _1?9#/^WB(ES\Q^
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M3,&-0->156.2J 3O!Y29Y5U'X,8^6C(L(8VX*B-0'_9":U)V$6MP1\\#,@S
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MU_E?]/!5Q>!9M)* SVZ;B75]2^94QRG;<S!_G_ P0W%Z/RE'_E#IA"BQ!CA
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M^@N^!? #DGBDY3$SJY^7.3OM=)-_]K[1/EI<[L'\\!_@SN_" K(@^I2A!L\
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ME$,"XX_DW9.[2@1\-1'7>M9"1\S&(ZORC+FLGHI+F6_=*A]-+:06XG'ZR,N
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M<4/[&N3[?+N!!]. J>%:&+4(+XD4Q/'^/J$9:3'@MA!N5_M\RUZP@:#?KR^
M<DFL+E\==B+0Z]9*4TTO^:BD>M5,N\W=6WI$-W)*SVR[Q3'*/O,=SQ^ DV9'
MGC&)JI](W4M+\T$.O:/1P9%[][,[$@QU1N$T*Q"Y&G71+_??WQE@;T/YFP>0
MTK?G$+V;UE%M<,5>%/D#O!+[U?+D[16-L?#,7/5Y6+\ I.&SB/Q*XBF2J7<Z
ML(4J+NF-Z_TY6?E3EMS#4X>)< :&WJ*[JC!@:_7HM/A[W]Y'^JYY7=FI_C_
M)[M2]F+>GY\(%(U2P;E?9RVNS'-#I=:9/L$/D?D,&[%EH]QQO;L2ES#@ W\*
MQUNTG)MJQJ"4REC$<.B;90J/DYTP_U2&4;3%,1-!<"31 96U=Y*6+[K)Y8<[
M*9DY.@BC"58S8EI:8XJ!DYJ\P.R]G'$#X7B=BKSMI-SUM (_[!8?@0RT&1:H
MEUK/%ZDWF-#;U[<Y%?#FQR+X: 4>.6OE]^KAMV[9\#9,^N<WE(/D1]F;P7^
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MAWN "QLA(DBIX9_XI@?^"OXBY*M8VR=DRH9Q'+5?91A^M3;V+4N2MDC!YGY
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M_E'Z?Y#5Y;_Q7PMH=W_^+U!+ P04    " #&A'Y49^0)FXXV @ 47@( "@
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M>1R^EZ/[!:QE),),7^*^_/@6\!E\;8<5?V;/.KEZ2%DVU7T64JKD[;7/*VP
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M4DY52#?(/$K_PZ!&G1P5PM'_B52]^2DHIL<B3=$.Z^.93G9^R=-+%!V--R*
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MP-%G%HMGQ^#KZ,Q]:>JU+FA4)<'E]W+M,_!2@A^ODLF>V!@QXSMN>C&U1T\
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MX?PP"/I]@>B.$*$KHVGLE7P\*U8<!@*<?*JY[\@5.1S\?8/SN^=A#'W_S7$
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M;.@;K/W28Q2^=Y[?\KGF7$YE;NT/;-;)9/)XSY=BJ(H-N:&O*!-] >S,W .
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MZ#AK9R!1[,1)DBZ3,%*HF%9P"-8>$^^7+W[D7W7NJ92TY+#N[8// ,[]S,\
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MEH'K[ *P<S(0,ZHTOU3%]6,/G*7KQ\H+?H.MQX<OQK1)5[-*3@9_*:B68,\
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M3E;,^/:,0 ]:2]H!_CRO_M&@+WW\!I(O,%+U>]2JFWAUR ? LP> [0Z=^@[
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MQ$E5\\F6/K)VR6N\E99Q[I?Y::7[SQ]I7E[4GC_7?A1'K]=4:0U[=VV.ZJ8
M1VX#E.^WR_G$5PY,C\_,WOH<K;23_M+@^RUT!CF24*.Y"1'Y%^C<R?:H+BVZ
M3#R-PRC >$$=:^?C'?[)BKL\/]R344W<<DZ^V5N5RQ'_4>\NFU!Z>9MYL\>C
M61-[;Q^-;0I@A0B 08N%K]SY]1'[<JE#K/ZCN"T<]3J1@3;9 JUBHX].]7S2
M.7!RD!"'T5 /:6H!/3&C!"'_&J;/QJ./,LC! BWQAEV;90@E9E)6.VP(^^<.
M1UVAI"\,7#G)6#91OVK1C_;Q')3G.39"Z37?'W]O1&IE:CZ^1$&X66IMSB"
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M\Q:_2].N\:E3C(1V@[A0+M("QI\PHZLO=73 -EY46AFR.JM1I)6P,IO?U_H
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M\9Y&+8F]WW\FXQRAF9#BY[:>R*]MH+SY 4Q7Y?'U"PHRX=R6_J@0/5WHJ3V
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M_UAGK^"KWWF- SOZN"GWP?Z>O#'NAOI-Z6\.*1JIM *1TPH7W-TAOJ+B?7F
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M[%_Z?D]6^@#HO)X@Y!^M?3UP5B7^ /BT(W5P7Q_9GQ ><XH;)S=0_   ^CT
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M91I*GM'4-Q]V6&H_6K<ORH4BD5X<OKDW^#1]BL(P2W4H=$4]\C?H/WGM"4P
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M7R0T"\^!"^J=;1$BZ2>4)?JCZL<6_2$WK?XO2(XN%G:'9[3CEK!V,O_67[]
M'VLU]0)HER*Q56ZH9H9)Z,A;/IQ/!C.?"Z:$TT@[="J,CK\[EX\HN+) VE*'
M^W0!F8BF/S&.9Q^OJV"+'[KWF7N2W2%VR=]AN!^]R%/+)TD5C(A:UE*=4AV
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MP/MP^@N&[:L-:0=TCY;6%ZTTKQ)$/JB'D2&W=!F/F'H19I7:3&E[ @EALRK
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M3SO? I3,5F/]IZ!;W[,&0.B_ -.XH<8N#E"#4Y.EJO]:*X2:7_V\JN7@N:I
M #TFM_P;DAH%?S5.)]$SC8U@O7 -ESPVEOSR;:KXN<V^PQAVV4/C'*VDT?)T
M./,"C<WSMJUXGM4MP.P2GW+_MW5@'GPVS839)7WAPX7"!)OK'>U!&&XBZOU=
M7V082"Y1[S_];ZQSO]3^BW;^#7)K+EJ8TJ$?)-O^SSI?0*2REII6YZM$A)!4
M"79@/4W8.3.(I/I/&6A=L,,+4H[3VA,VGIGL(']17!]NR'4L%P9J?'+;QV#J
MF#QF06KQ^*=)/V=V,"_$HYE?*\@K#(^U16TA?-KGW<L?WW*#2J-W^(%%F!8I
MVBB0#Y>4'^JC[RBPA(%]7LT[F#*NLES&XSK-PBQ@K4DF+XN1)N'RGRKYFM0=
M4*]#O%T_J;,F1Q).I)/'"-ET5E)<((_VT'5+#*D)OB+>5#ZG'_):>6KA0EJF
MNILFWY2T62]SNSI3+UA4$_KN^_$FR[[NIANN9#CQ;"W!+S%ONDSHJV1S2[G<
MD<\")R:,I$_''^^"<>E*9HB[ERM(%(J;?2,@K3[80]2"Q_XQT8G0B.OP=G@:
M_X$,[_GB=ZH,;CT(!(C(A&7'/QK_E&^%2[^_#ID!+F8VKMQ:Z5,K_<(='V*C
M+X%[BL:+%E8%F3NO*9ND]Z^4;<)\O'^MJ#EB9&EG%DR_!7MEAL_!BKSZ 0%K
MC6)N%&PJNQ]<L[^!GD;_1NX$<8A,S+I$=% &AWYL\K0@#8U<JLLI3<K4+U4S
M;J91!S#7&%RWFFM[5VN&3K>["U(:@<0-;,/G*-QRI4V@;S_4!U7PA3T4*$L+
M24ZTD;.(@*=_9LZQ>;:)IW[)<SLO"7]PIH?[(ILT8$^O5R'"N=FRNO5]Z )=
M9]Y"NRN)#NE[(9G\_<MO9*%'*5%;-6+792;!C(2WLC:1;G3%I(*#\J7-7NIB
M?^$+8@W1G0,:OKBDBQEPBQ4>._+FXENB=URWFW41KX529 D*A,6N_('5^D+\
MM;075]69+$Q7:,TC]3=S$F];LP0 ;K-#/TWZWK\R+\!(?QR*LL:IC_69LOZW
MJ"*D'4&1:'+/1=F&O!+\2?(K9C>[@33A! )"^?**]EIF13U,:LT>X29<BR_U
M>$\39AVAI_J2$^.EJTU>L-D U'DLX"?G&S;O4P3VT.9[B1:6-UA]@JU[.IE"
MP+5ASV,W.0&P[2>%^=3=AVMZ-2]OA8(L]'F'D8WOL3*E]=4Z!E]-#3JX1H79
M,GX0HNBT3"WSYL^3,<N-4:'S>7M+KN!'/YB!1\\'V'&O+2D:T-)]BIS.+C5F
M5R(Y?;^4/@'-?MN4HOTAI.]$.==^T<G7:3/?%ZY*6>V7$):"GMS3J#".37#)
MND?*@.H$ARACGZ^.!0J7'&PE;6)#NLXFD^UW+<S$,L(L!/12K]??]#V%?SJV
MJ;A^CN]2S<0[*OX%I"(F_P(PCMD;==>_GI7)&.INTYMK//J'X G^GYHM:R^=
M_H O_'7)*^O?" #^R:&['W5._TL;0MG44%.V&MSQDDB8YC,VG0 ]Z_KOS=N%
M5(HJ/&>PG:#0)W&%:6QNU 7$GF]@M@G46:V4JJ_*$YA/$LR(?[V 0A%4/TP+
M_UG*[R^FY4-7E  GT[OV"'C."8M(8&FHC6G Z3AI1\!K7N/IY#)"<!I4<#Q&
M$-DF*OQ)GL%00S.KE,M^IH6KA;?#4(R^*.?FOP+A@\1WWY<^I^JG-0JH_52]
M4**?RE/Y7?O6H_' W<Z*=?V"K3SI9\(5^I-6RRI96I@9J<&D[L@@_0Q=\3H5
MAFQ-Z"; 4B9JUB6=<["V21_20&_Z.))@&J4GW*1^:*?8PS&"@)*_N,!TNBO/
MK&S1P*5-176\6@1J\ZB;XT,WRP/Q>03=EJ/1J5IS30,(E$PN<P73T&;-2#[^
MK8!U:S/49;-ZR>[S2#[HX)'](^2+7L1B'Z&.=L)YE2NQ?3DSA;%NKT<4BOQD
M(QWQ-N%H .;>OD'H\;Z4Z%O'/04UV@&^Z<=&<Q.4ZK]ZE\_LZ98>N(]0G(&F
M^:.5'_<)B&1O]CC]M@9WW8XBTJ:-= .,4T)BTV9U-&])?I@@#I]MCWGLS;O@
M9#5#:E%RYF?B]_#)CSX&BGR%;?]GZ3800+#66D,G=P^&QK :O75%.L_V_6KW
MX90+!64U/Z+)9_7-H\Y,(#,V-TI-U:(=U)'YY+UUA=X<2ICDOD0;*#'*L1!V
M!+-JZ]#X'CY]A!H.Q<0,FD6^JE$T<M2DN6@0S.I)D:^6!K!M5==#D$\!%L26
M1.EC:G!:I!<['MTIVI*T^FD:NS-'N'KCC$7'F*F=B*0DM=2I-B6!YN:PR\@4
M)07Q)KN"$+34H>..F6#E6."\N4+S9B78;M/XX#'#R&\W1PB9$JZ!;9+ ^I%Q
M]?V:% KV@@SB(6?CQN66*T$&61T1VF:2=%8]8K3=4]YH@O6YOP!J6CHI)&ZV
M6#U!OU9,Y=+$ZJ5,KIXQ.Z5,M9X1[EQV&#!8_=N*=WB(H?B(%S+EYK%00U>G
M8>[P%U#I(D1W^"P2*@X)(:E,__ MR<[W/4O-9=,81XL@RBZ)(:PVU4;P?NKA
M/:0PWKA+A!9-;8WP:.-_V@__BNUY=*\!_]F.+75,(*;(L^=$H<EA+6-_,"\L
M FYHK!,M(;F4%UA]X/]43-=M27L1YGWR30'EQ?,@'5'SZF>FOM=0DNF7=.04
MINVAKBZ<[-)4X5?F2X-8C:$Q.EH4>T0'##/7^*X-URYQY 2#3LD%%E']9@FN
MM."H0)GP$H>P3^NK9]\KY7A,JQNT/%UF,PJP6'G"4FG)NVL5YW_VY C^N(6.
M1OAB=7B 2Z !Y'/V<%]]JO*;?-ES2:.H)G%CW7G>T?XP7/!#>L'?FA'PPB !
M?6-7]@>NJN7-L=(<C-*>&GYWE1'"L.CY/[95>V\9DL.Q>069#;:_\]X.%9)1
MLT//UD%4-8&TAH1]T)45OR9YY7GI:E\D90R*)/512(]>^U65S&#!YH_M72M'
M)D9$.[[5E+R;41T27#'IO=C6\,0EACT*LMTM2A3+L(:72TB29]BYXXU(WXCP
M(G)UK)'Y:5,.+VQ^WK174<602Z'ZRC(IDV\F1+H7>ZPNQ?:3W0@U!IE9?(N@
M1D&P\>XZW,&5CSZX1?YF3>6@RUP\MA;/X:&#NJ8'"S?5]MI]H380Y2ET3_TL
M_.?; T3_C&UC6"*<=QT?E1LZJY12SSX')M]@IDV?;O(S,Z1%Z^J7)NV^'Q?J
M( UH:IYU#ESRG_ZRTRS@LR<O@'WEQV>8X'OLT)=CAS*[ZGM$+WZXTO\VN,K'
MY0R1;# =9"H:LVM]H!ZK*S8C(Z;;+"[#IGEB6R#0) 7]G*(H%DCY(LV)PIK2
M^\FE]LW=;B%MY_63JQ>9:M_1 S91I6S9TRT3Y'\! QN$MQ<_3WD:P;8O="R(
ML4/@8=QA++"*I*CEW9CUM_H H25A#*JQ)I!@S$NZNBEE2Q;^FCSE$0MPHHO%
M-O(8-+?L96[I8@^DS_Y'A.1(G:K$)HX&4!J57"DNJ5X[00O*(Y[>P75"T;H.
MFM83)S;U:ZEB)741Y>U?*87UYMR<J.1PWE/,7_FAO*=)QG(Z'>E^:ZACQEU1
MIX1WRF3;@=L2:16X*KJ)IY-H3NU]!Z:"X;8 2%TLE<L_?!"K==NI9S#%XNL0
M'0PB0OX4\]7J2CB#-!UG\S36\G-3("WN9V/((\46 \9%!MNUJAKEC@A?UIG,
MRLF[*-JDOOIDB@3?D.V@>$:"ER([(O7RD9-3AVHSH2"NV,"AOOEQ*DD'7*[G
MML,6XD/4/-C^L"DA:JGN>$/]T)"P8M$JS(IP^X6I 2W_AP$QUF38F$;6)JKM
MV-)Z8R/)JRDR-:^V"&[SVR8=QEAQB.5-F/^\I\^Z&H<)::KQ9G3Q-QO1_18'
M,%0F^^8O9+.%<WS'K1]\.]>&&UFW:!G!3>!IB+V7&\SH<53I=PT:J/9-"%FI
M@$K.3<5T#M^C/U7/TLT&2REPV9,9"DT- C5J_D_Q9PCON**JE$&C&N_;O [H
MH@-J # OMLF6+"ZS!/,C6\O-C5)YW'($.?%)S9K+H=ZHXQ&]G.</2(*O ;UP
M<($?U_"!( >QI&+9&%QF]X[S>EOLX[;DT'/=B*&^D+^ 6-&"-2 ?)V:Y[PDA
MT"=^CY?7MT*/O#$32J,&#+Y/$H"XG^V:<=+J,ZG&.O5_4+RUWWN11*(?N(I?
M<O_3M=#N2!I&/"Y,J8T(BEYNBA!QP4X\Q-I**"&,*H]"$OL6':Q#?D0$CWZ"
M-NLYCCA&O"3\"_ 2";BJF0KTI@3&7"S;E7@VF/#&QS74/.S:&::2K[X-GKC&
M];4FML_1C;^.4&)2C^J#Q%T9,6+XXNU-,C_YLSS=75!,:,WDTV)!6SN+57^F
MRJSE%ZO*.3-M:ERN_I+:QU,<P,DW\[%HG1,C'L62R "N1QV&]]:?$KO8C5;_
M!8B)ERPL8Y,EMZQ"7V33U6'L[1CUU<A\DTB7^$BQQ9MA]+6'I;$;0Q,"* ?M
M4X/$7;#T\N,N0I0>GW"*)"_&XE&*3M4 ??Q#VG20W[=059.W-@R![A'V4F\/
M*1TZODD(^1F42K'=EXW8L"EG=[,2L$X,L'YFF= TFC##;$AHG&^C)DJB=%J!
M"F8-><K\$/*U(8#=?H1*J(,Y'KUS*CJ+KWKV+.3W<[,P2XR$K\R%T-IG(PL=
M^-D.<U7:K'M=W"-P+Q/W?!FP'CI.&GI&'2>63 NQ0:EW&@7H1Z/F&LC:=&AJ
M='"8LD0''4NL>DV?")$=:#=+UQZ]7Z C1P%&!NC3.,V5_E]\O6<X7.';[BU:
M=)$8G6C1!M%&#1&]=X-1HX71>TM!M(S>&:)W9J(-1DF(7@9A9G2B1"_10]K.
M\W_>8[_'/HZ]GP_WE_5A?;G7NL_?>:UKG9=B@I.&S+L]>'!7>(Z89!,1874[
ML%NFTO<O =VE2D[S4/);F,6T:ULRHO)H9CV*>,Y)@'3.]^(#[7? !$)(LNG
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MO6I88=FK+,A<321_;P-5KBV7]=6G4$ZB<"X65IN.21_Z@7I_G-(_Z+(K?5:
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M/ZW_.T%NXG<@.>T>OE%9ER7DJX7RQOB<2 J/W[,&_ZF@/U]]\P$07TMT]>,
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M;;:&9?Q:+"6C'CXW(;#QRT?<=BK5O)2ZO^ \S=AH #_(\:MCOJ=TC[[?^6-
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M9V7\/0ION7LZ6<<$:T7ZQ*,]" 4A&]> 6;52K]X3&%&IRC=MD&AAA1Q&,3.
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MUSR6^V&[:]^4<! \20IG;X"NGRSEB0K#9ODW#*=L@'&??-.@H$\>CHQ7(0H
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MEN'9]7,V<62.2)0RP)WYDC>$[K-V';ELAH&0OJXOZM7'[-R*>&]K/(+\V,/
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MA\[*$DG7*ZQ;P0)D.P#7(]W/RH@[]S49&.J_,G!BH[;AE9D%>,XW@& 67A%
M=QA[K;?4MXRM-@5\P[T&8P'V6.[TY]-,'1=(0R-T!G,C;?A!EHN64O:81]J&
MD2;"+9;[*E4N.\ZC+EV<:;C2;U$H*V@*$2RA\U%S73O#>?G5+_.7L6^@1:H9
M^B]6EH4$=^"O2*$#Z[DI6=?\3$=6BR[#^;2@"E_3U0QF0JK1*1WKKPSSV1>5
MN>2D$=C[VMO6CLE1GF&K92V_>_)>,",>Y>5Q6QQ9AX#I)$XX7=%=VPN<ZH?N
M;8_0JP-CMR^?1U!,Y;5SSK:&45IS^N@TA= <>M4([U0FQ/&&U-\Z-A>BM$7:
MF/V%7$._IGZOTL5VGL7UUCAGCF_A T-*J]BNZQFGME5TPDTI[R<V_B(RKXSL
M7JI+*7HDF?QOV\HMLR+UQ;C:$BF$YI/2HXQ]DXMPKI1Y[?Y0NZ\7V.AC3LYK
MI'^$\EG@/POP[?/(H!G.+.9!IDG?/_^MPM7&=('T #^JMD<$2<I:-MG@SDXR
ME2YF.IG#A46:_[D)CN\*DQV7"*#7H!C4O'5-*$,!Q\LH;*G^;3%',=:RJ7#D
M3R^VA1.&B3R E5>X.&6&V.#?66K@1JRX>19+6MLMYRK)OJ506]G<@;D_P,80
M>FM6&N$?+:'5/6,HSUEV0!;G_"[T,T2%8MWM:OBC5D+99\\7BUV<R8EAQ>8#
M#&]$.-V^@6R5!X$DBGNW@ -MOU%D@"GZL0+5-<*0QAFC2GP8[E)+3?.JKB+3
MTQ6C[<['-8QZ 37QW )[^,UG'M5W95J4I+](@&V\^,AM0!TH#YC+$].7J4GT
MJN;*$V?#O3-2I1N$I-&*^YE_Z#N;5!3DE;ROV]O\%3[;XB=$9&-7+I7X)LI6
M*6[""XNZXV^%5/O'C&"^;+LE;O21G6O*35Y@9:(1*0%YQ?#]HA[I^8Y+I)>H
M?0@I"F3U\C#*ZCNDB3?=JMWAA?5Z ?Y<&1.>7.\=:X@*HXW;".J2VX-?%E#=
M4!;K=$CR)='2OQG&/H1X[$S$?Z]]HIO:VE\,T1CZX?&,_5'[;>E_34_Z[P[S
MIDOZY1U%H&,+B(W82?D+1FN)?QA:';K 7'OL;Y-N7F7BN%W1XJ26]JOD8M!;
MU[>NQP,^:S]N;-C5K7BGQ)KE?"*CBKP!GT:UT3*X&2(5]O,<YH "?%O= 5$U
MJ%*9!'1)I7(?VWQI87$9,3PV.$;9$T<+VBGKQ.Z9"+ .BF<_B3;P,QVB\H 0
M H:@R;-U;!0JO)-;4^&F V$UB+5P;.;[)G-^!V?&PJ7MC.7CA#O&8S_7![6?
M7W\/-^O1T)589T!6U-)31&S43TI:M0=T0Q4%Q1FW<R?2_0[T<0"(U*TYI4(J
M"*THY+% TP=_@'7]7WR]950;3O0MBA0IQ4MP*%;<(11WE^()!"DN08-+*=9"
M">XEN$M(T."T4!R*!1*<MD!Q:8O5>_O[W[?6?1_>?1]FS=>96;/.V7MF[W/L
M4_O<B>N@'-#EF)17U*F@"K;5<L..6&8_GJ!HL4=-#RSG4'_L%$QKP9ALN\03
M,,I5PAF6:6DC/'\O*\;;'BO@4+>.U&>F0"*'4SL@G.PP/J.RSC./S:(IHE2H
M>2I#I$-5T</J^]A.T;.4+"(1VV;==SNE[RY<RZS7BV.$FS]E>6*@1O[;,(+P
MAE"1F()IV*P2]:W04:&'4,ILE,"+4#6UH+8C1^-VAF#X\2_>J,5W:RHF!/.0
M#./]IFTA"NC@X%>Y;>BG$=&TG@N-(LAPD4PY9-T 1LC?OD8D/V83IN;I:TTD
M8A"B?.I1L$MO5PX9RP$Q6==2#H]32<D4+W.[9[6BSB@TG<RV\SG.VGL$&/HB
M)%NOFM@\E78!H9LS)T8?[=I9M#AQR)U[SL&$NX-.1UF#@Q/$<&/C:T&Y*0)>
M;(>$)97ED<P^+1NVX(L6/=2OX=TY[NX#H,TD2\/05.4YAQ[IAO&E6H10NZ>R
M)47V+'G5\D30%W,[!0,=57Y294X,\=.6;$TBW(?["?65:*;1J!!8M:K2BA_+
M>_OW\"I7K]7Z&/7ZCQR-/#_ %<B$$G#A83BGEJ  XNJ>T*])JY]F<<AF?=>7
MB _BUW*V&V2#87_X8[J>AK:(]HG?4F5""D1*/?*;VGP9?_NTMO=<6@4[/G&:
MR\ <LLK60_<+S4LY9Q?*:V&J?!U\;43]#6NVZH!L%(3, K:>/AJ)Z7S\<ALC
M/Y!S9]S'W5>O*$Y$ MSI]>H#S"HIV0Z:8>.&'WRQ9!0RL,+&)NDOTK"PF(I$
ML(I4#N[<S"<EX[M^W?T?S4K^_#?4\ +!+3IY:.3/0]K?PI0U80S_HV&Y/_&E
MH]D]&AQN/P'_:.O,<BKH:E<R\:)X+Q3J$)DFT^!X39K^RL-Y ZC:5^==S=-V
M[-MUC\@VR$>GXQ-BKIV-B13#3 R=A4PX0?*Q#JG6 <P&=#S5.0&;78K+L)S/
M3@L/>SZ53W?N+3W#/AU<^P[-J+,5(W?L=$MG,?UBMIVH7]W2T]]M=3(;8+>1
MM\C%?&;_+K[<_[P(?>3ZY%0?=F1P'-<8\#SM -OF:7+9=HMB$2?Z5;',KS)4
M#DFR<!^4H+K?>%5?02MS_\3L:/)P ION$9I"NK3^G%_Q_#*$DO#,?D:FGS8&
M.C8X5<R%*/+[$PA[_-$%E2=Q,\K1X6#R2T>V8&T%8+@NB$O\ 6K.'7O8IJDK
M5*&@(C+WTVO.1W,?^-/6\P1\*E;]T\E)OOFW:]#[5HAW#A3"TTX@G-3V(/^>
M%')=2*P3"/H2W Q28(#K\7X$7 +[6\;K<15",&[B08&XH1C'CYDP"&+4YV#J
MNKEN)B7_X\_NI(])T2LQ#/LZCC[SS95"L"RE%1^/G^;!1V:O9+S-) &S)\<D
MV/B%%9T[0RCGDVS&/+5:'_JG<_?LO;EZJ!X8'@ZP-#-F<V?WE4-J&VQ_U_'+
M3XVY>!NI9'0P[XE[]935UT04 ;*+_A'+GW+?+^'GY[CSJZ\C92+E1CS4Y/N5
MM_>\7.;#\#-MCZ4</%^<EUF39$+W D[YHZL(Y&?#.#FZO;CL,V"@YS=")P6Q
MWCV^&5<;(AH4\?"MGGA'31/PU_% $>O65+G';0DF7FN.>K(O@A=65,*%$AAY
ML6V=Z8$/OX,#=JZK=@^CTM*[E'^"M)<2^67 )EA["%&RFEAPKO%,2,6/Y4ZQ
MZ?7K?N-D8@S,9=SK8)(,%16MWM$P7VM5J)\9%@:GO1$^I!'>(%A#K;BX[",A
M&\TB\2".//2B0:(HI"^? $<51GLSX4=QFEF&<[$W89K5/31@OTYOU-W4<>S-
M(A]RQ, ^6*>*V"K9OQNZ:M)T3W4=^(#=&F5B4UIRLGB.*-)#? ,&.)]KW!&U
M P:YMBM'6Q]66&>JXHHC5N6;-UB*>0J?@A@[B$?7B#$A67Z7I#'0NM=MD28G
M<'VO_2LJC=WE7<V(V7"FCKMLF89?OXG?86WJBB#M-_+Y&'1,."L)%%U[C64(
M0=UU=?K91*4J:B\$Q,#H7P4I+A$E3(>YM%]3O:-R]&T<TX-1?SMV>_Y.GW [
M&,1H$I>KOW@*3;@48M2K)==/LONTK0&,-7P5>7+N\[Q_T+W?O'P'W6&4];VU
MW-Z:6V6Z3.DO0=;OS&5P_3<?-2?3BA:)+XMS@_7_ ^K5=H?5MA@6J8I#S'6D
M->&"%43_ET%1^+GY,P-T9%GVLR^%X*%(T%=SRNCB6CV*VF46]D1U3K9HDH.;
M&:W$3TD[@X4CH"H.87J]V:Z.:Q-&_-:?A0]$IK7^1SFZ?G1FGTD([)X,0 W5
M_VMV]&9+]O@?KE\@Y5C]_6W,!:KP\VD$:NHO 3[8EBF.0U,9ZVI7(-<U?&0Q
M-AJ)?&WXNU 59QE/Q\#X<AQB&"VF*$HR5=]F(5^CQL-18AW)\WX8^4XMW&S/
MC)&[NYM.#@;N$_?.C(N#9_<F9AJF2 IN.C3(NQI1)FB,!2&V*Q8>DT;C"UX\
MZW"Z;R+%-INE"[7B*D>DW/RJ"6EZ]&B*'4Y8'PBT\WJYTW27O,&UGUZ"#!Y%
M"\D_E;.QL(VLSQNUY?"NCK><2#)F18V"-\.<EB6RY)$2<:MU+RB]W'G4N)A'
M7!'-2R1^K_-KN6T^'F![?I8:,'XI5#DF#85^J!AS.5Z(S*BAOG:9/IC5F(>V
M\;EHS%H9!%CDU_!(DB/;YU;'I)A8ZOKV6-GHM>&U'USMY^K<Z+/G1%!M!$-#
M>/]*-_8<$I(-S8ST-TZD?7?(PC%F2ZA1\STXWJ)66G$Q**KH]IVU_ID5?:!B
MF3 >*5TC(( X\$>_U>AA+9@V7ACH,V?9[S4SF;TDG >J;"T!>[BNJS7B$6>E
M$PQDELWMHZ!#I1W,&<^EQI:-.;W;NB+%X>FDS5\""MH-X6U-!O##QADN>1;T
M]%42.U@MTGO?;0?!]VFW+\3?)%11*Z9I\WR_-_4$;#MD[O HF==-G0U?:+ZZ
M9*?]W'],WEBFDS77/$NW) H$[&R^U<*B=X#^UJ_G;$*;%1Z6TK"@VUQ 7?L-
M)BZH20 31YJ=+5]D$*X[BYL38XUZ;A]OL,_N\MP <NPB/^OY7=?SR&);;38S
MZDWM$%L!4C^,A:/-; #T/) P$:2,.5LO8R+MU*=8$7S,U-; N#H:6)T(>4%,
MA\B=LNBMR^8/XJ9"Y-O=#EG-57"/F7GCA:3'&T7N^GO/21'R],HI75N@L'VN
MT??7RGP0\GY&00O6LSTN][ =P&6/+GF4U_#7^+HGZ@\[)Z+B.1]%WBN>8+YP
MD$A"3;_6/S,*KHNM4YB(6L>>:<OOU+9UN%#&PZN;B7CF,=#Q:B(D=.'BWXU\
MT9.IE&.YGQ7C4_]Y5^I!>G!A&%H\@N.D]?-6F]4=^(*>1NZX5^\3:=()>TNT
MJH64$=.<I+?*1'#*0)O'X)Q(U)0V8T4XLIO1T/^12\?%0]HV<XMA%L6=\_22
M4+3;/ ^:)*2PO;F-#C'^4^Y($:9?HT$A^T[&SFQ=, UFOKYQ1X&GA92%J"-G
MV8\5\C#KOC]1_\_0#?I,Z+XL<SS7"BB10K@JS78FHEH-FGABDJOTL5'9Y!\*
MOZ[Q#4C"T"VN_\^/?1GRWXP$N!03-*NX.#/[XC_!_@B73Z=_T?>J96O&?K#J
M&/F*%T\/W3>6]JDNRIVNL1#4>S6/ 4DSE<8C+P5I_0%YU/R_O&U #Z2ET["V
M.3;[&(%N*FA-E#5S'B^KJW9:M7=ST3OX&HJIQ\KI[HFYHP'U8H(" WZW=89)
MF@;1248IPK-^+%]#86H)N>\XBJZ613,!\]\LSJ."?SQ/8\<G/)G(ZCVQ_9'W
MTF"XXAZK#V.:!VKKD@905+]957$'=].;WC,K*:1KX(<)>[BQA/+0"TSXE?8%
MO-.7]@XL^XJQA*,:6-K4\)54$7<D7LU+@&-+NM05LJ&<%7U3HC?H Q7Y63M1
MJU._X9=58GTR>:OWS;)UL; >;8!$( "+:+4M('59/TO'"?C:B3HQ2.^6BE\6
MH_Q3*\W$4_X6^ *Y$6E90K']N3_>3_7B@K46[?N(W:K.*Y63V8.RJD^IYT[.
MI?U?@F3#% :P)=?O3]#\H4:2@I6M#!'U(>6^SC:)-:WP2DLA>%G-Y%M&VQY7
M>&WS6GG'!XKCL9ZY?^3MS/KCN/"KQ;U<W47C("7\7*%$UB,*X E/#E'U((@%
M3G?5V/.CU*&@]>D82?_*$\^(AQ0&+0^Z!]U[':-7(NN?Q+/NW=0'^88KC<1!
MWZ)/PII%1'"Y["L:_M-3F1!Q$?;K/25V1,:V5@D(74O#!Y^.C\42-&FO?]H?
MSD3 ]6RJ9D4/_-S?&VOS=]Y?T=S8G!"-MEF&;?#*68%%UQ-K5N=9T/5:A?/C
M,4*4JQB/- +A7=6]A@1"1)K4IH[^RX=SYT+3=66-.<$6X^5"LT;NM*>;.[41
M\A\LZD@-D'3MK6/Z:#?I=F,5P:Q+"-BL03,:;U1VMTGG_GHK?=I54]0I4<0K
M0E-;R5Z G/)A9&V@\A>G I&=?Z@EO$_(E2+QR,KNL5:@':"M7NM3EY*U/64+
MG>Y7K7A[R%'ZOI+DSJ":&8:^WG#R]5*.B)Z3PH;%+7%"MQ=^-R#0IQ.[\-TI
MT_"2K_0O09<MF<FW%H=%YP?NFM%P6J8S/JYT'/";+;>:88O\ZH@?VRV:BD@:
MY1=N-'EAYM/G?\@2=V;7JLEHC2SL.I+EBX)[>7UE:'>6VPQ'3YBT2=D@=XKY
M$4SF[##$T5@??]&8I.?#G4*U5:?H%=L/ =^)M:[0>F-\L1Z[VWT7Q'\)_GMU
M-]J<TWNBPV"F#E;9T1%C'@L!IJ,)7 ZPN:L-YS"YQK;5G[@1IA+IK2;R<;X
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M:GYO<WV0*0!&SU4$,8BX1OW4GU;O.8'7^ODS)SG;T38]'_/*0NO<5>I%BFT
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MFYMQ+?:KOU,DOOPCD.3HDW[3;?N#4Z/X/U,UXQD">H4SW<4/MH%%C<;S0L
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M)FDDZC?/84XU,*!7K!2IR?_2(VN(45JER2B2V Y- Y1%_JRTE;93,&J0FSP
MC'U+>B ;)[*(D9<;ZZ'&C#M .L\W0X!,RST=<?V8-19Y]-,#,<0%QH[GI:X(
MO"^N)AD.!MJ1Q(].QYPT8UXEU/4: 7G<?ZP8T-RQ[)4(;EZ2F)ZL!JZOVP=T
MD2FO%-AMO3S/\^A'\7QW!-KC)BRH%#3"FR[1J]^0;X04 )2I/3LH*?:MD]9?
M)T:/U7@0J$:-^!*K'YZ?$PTU%A:64^!+@5<M2KTX-R9JZ0C@85\=ZPPG[A,D
M@:$GZR?^$0NF%CI6.^Q_?8A0:IXD;Z%K*]/NW57QP?_B#7XM48+CE@M]9.[_
M\K=(?O_SYM\B&+^6!YSYB0T0^C6B!% =EQ^:Q* 42Y%AL\:&>&J?MM2FWU5!
MB #QB>O(J/4W6A'3R(Y[=&;N(_(?^BZWOY5"!!2^((VW[W[P3J%V*PU+Q,AM
M,N=%).@F?(;(YA-]#!5@,^4XUB;FR1^7/GXBSJ^*FS%JE"KWC\;_Z>#*(+Y"
M,RIE_4A(^TL X!_O4MI@F5AE*;E\W-%+_XALT/F]8VHT3U.TQ;>@\#*Q/U?V
M+$O'3X_0>O;@'&@M_GOFORWY9YSP0RY_0R:D.UP';2G?]5&N6[1=M]A\?O0K
MWND'N'A[XW31*GM[\,$PV9^'M)G0PE[*D\,J^%V*O5_.MPP_P+;V\ZF\$E!]
M#L+_*CW.R_7VBALF0A19 987-J#OT2G$8<!EKX]/"X )F]M*;- *B%(4Q0'N
MZ:R&^Q6P=Y_F].A9?KKG.]&#!B#FBJ[RV;@-.6=^L5.M. &PFEBTS>FZX5=I
M[IY9G-?0<OO[L,Z'O3KLK+-OWL%8F"Y 1HZ]CPUF+8DD %L/.L27ME&Z,[]3
M[G'6@.10??LD')%(F2)>K+-C!$-!G)%G&&]V.Y3*\#.OT+RE;;!R T/:5ZB8
MU?3BJ*X71%+QM_1WWE2^:X:-W\8D:D#8_E>OYTX>I:&AO!7$*L)N&.*ZI5"N
M+UUVB#8@]I5MRGY//TM=AG%P&KXSQXB?Z("TPB-N.9A8".BX??3T@XPMTS-?
MKL]03!I69?($[J)[-GN^448C6V".&CN_:?9ID3UF'A[S.:JIJ4 @\UTA?UP#
M"*P/A0=/__B_4C@ R-6].!T!:1D:L]$X&\!'_Q)0&RC^GD2_M[@S.;+=,Y_,
M116UASB7^.SA&[4L*S]HJO9%IPQ@0W'0N6;K;Q6]$MT"^;X0<BB2C.GVNE!X
M,&:VZ'4A%A\!/@)5ZA@4%-=,O-X0:*WIS9V>4FD,O2]ZW-;<U:Q7&ZB8E^ES
MK_T&O;/M'.SR77E% KW^EZ!"'S8+[>+K_K!E-T?>_BCJY/Q *6.^WQ%8=4SE
M'H8L<5II.EJ!;=N(>(KJ<&]HJ=I-,/G>E6_R!'NA>USQS>\U02 GD;R!_)P/
M!_@BLC:OE=1(CXJ24LSDMR1Z]RS"[:(/9^"G9;;^"9T8IQR9!Y":T?X20'KE
MSV>P7]8GK&[R;0_.5]CJCT:W_(D'HP#-FDIF*HW=SB6_*K[_U]ER"46J16>-
M=OE+H,]\C4J-N-$HA])FZ(UW1'I9Q_8[QM;I?K5/XAT,*Q/= HXKN;2'(*G0
MU$HXDHR,R=C*,]5\PVCR;8=1BN5T.1V;VQ7DO1)$3CK21!'815GAT='2&9K=
MG;^'P"^@<XX!]@? RG!Z"E/-M'XJ>BFBTFKYIJBYDH+%9 )JG\JN@21)AM:=
M]@$3GAGOGQV(2>/ZFJU*I^=7Z%YGN)$_;+*%MZT?P;9##4-<"8:J%*3F+EL+
M--+_B]< ;\,5[[8HC$]$K(:I2+ @\KXL.#=!7QZX>#3#;O;!M1::;7)HP?B6
MQ9K!>I>I@%#VDO$D7_6:OT8;]B%TC-^CK [P>]$V+'',G-JVT3]<B5$V:]=3
MQ9N[CN2U+RCT=VNVP9@=0KT>)6?!US5Y8E4*[ZH7YEX+'@N#"$Q7J^;/#@C,
MSRFMZ-679HM9/CSW)9O!317?\G+F(UH6<.6RBO&()'(XD]^!*B9P=AJ>DL5%
MAJ_P5HNJB,(>J];3[,86C\I%_A^3+<4E#5M:1,+$?]5LE/X2</XC D;!<KZ+
M.@#M%__5EOG_&D%E\KY>[?$.#D&.L@=&N2J"1*;$]_\2D!_?MX]-#> KM(P.
MF3JH#5.E"<T<:0H>%\FF3=<:;^?^%*Q.]]Z[:DD]:9<Y&-]O2C'S^JWH7X*P
MCE^N_ET_^& 9<;C,NZI^KL38^ TM=%46*^3._VFJ--*_XPP??_-OS=].7':+
M(IN+?]WKY(^32/Q*D6"_R_!MSZ(4ZA"?4WL.$1F"#==:J"[!77^ECX&DI6<0
M#D9V'.R!(GJ(FB_"DSB/.=^-M#*<[I\ 4:FZY]FIP3'M'PN5B<W'8@O'?:AO
M+GX_G(O&18C/ERA<6 V7O?#C_]9Q9N0[VN_9UO3#+J#[@6$KTXRH-WF9SPN=
M<>CS;@U75\3<\H6A/@&P5&6#>8X*0GKNM[8=F<QR 3&ZC4?K&>>_FU8Y01I_
M8/45<XE4/?/<:J,KL>[BPT5:!G(MZ_L$E_LDVR)=L+HA+,W?*^XIH.[Q]!+5
M*!;BDWL$ZQ$A$9O0TJ& 8FR'N_UT_[)I&9/*B3??[VFZ33!=Q,7-\)_KT()V
MCS69(Q-B]PN9>_;E*>)\!/%E^4OB!F/N/@6:^E,3T)H4/=XZ.R V9V0P-.IQ
M5M/0&0"LV6F5WDU]C8,("S9&%X!Z>5;].$02OS!4?G)%G(7V2K'1K0#V?XST
M;H[7_8C'?.R8_@%^PI8M@8$YL@E,:SD4ZFN%UTF-S>C'")=^6DP)I'*@3%#.
MG77:EC&2(J[ST38H;+3O:!0#_0(H&2F/8#NNW[;922CCWB2?%-6[0K2-3VKC
M/5W[,=I="7PN),9+5<:ZT;AZPK/5EEIZXO(<UWT_E(BZ-A_><OR]KZ/\K']2
MAHAK[GJ;.PNX^=[>BD*C/JDF'EVMMBWL0TRC_$U%V)=H57>>RT6D,?6/RML,
M3+$?D1:S 'P)^Y<@)HSIFX\.'5/SV66"'A#)[F8Q1E'SZ@ST5A#@E5NZ[$]I
M,H%R/LYE>ZZN,.;CHQ^D?]U<JLK?DX>DSJ]7;Q/+"M&P^Q$I@-+L<F: @?UX
MR:D,'L9 -+-IE>"H*FZOM4R4[3+3NYWRVG&>;E\L1UHL[39;J!,-]*/)<G>X
M4B07XGC PJB#Y*HYALQ$VK#Y9+N1WGP XU4I /AWIGGJN%CP4ERW+S6NN&:?
MQ=K+US.:E)$+ZI8+&S,WD/*H*U#*XS#QF!Z<>>9XJ]" 9OCN%D51(+0KD" <
M2>>H*B3Y5=YH\ 3V;46CYESJ\LBZY8P,0<YQ C;53B>-$38KDENREM#(6)O'
M0#\:,#<I5CW[%'<N//21R2SK2=/>-?HU7O-S$G!2I9I*Y['2BJO7JS@:J 1L
MM3(VT Q14;MOCRLU,2@&A!MW4I%/UAAM)MQQS\RV;9]6Q5LACCVZK)[O]!BM
MP:%I2AZE244]"TDOZ<QKV*^0BK$7+O8_K.-9D7+0J+PN)N-8<=_H%3_?M91G
M^<.VTU7_-2K>F>J@_RTHDSW_K:(<HW%=D_7K\](O8[)UIQ]8R>\?D8<&BY#_
M$0FU_>_? GVB7E1L&'XL!)..'$?=]T3QD\FXP\;'@<6-C$QW6HR7_#D^]BE%
M6=?K%"PHG&AX=7N%0\1]'K\/XE;%Y?K\05F!M=N:UH0NX(0=Q49U=D<R)^#]
M 0G?7;416["\71TO/CGK928VON1LX%QB[VK+X45B4NIGM!5/Y#L]>_QY,?>1
M.B.:9\;_JBDS^%//'7Q_A52N?5T+KYXXZ'G<=G>1FU,PJ-9DEZ@W1OQ69.H
MB#OZRI=&S$JP?UZZ,[ V)_Q0"=US OFQ3-[M7M N^]D-1U261X[+D L=!D"^
MO]7KQG9O;UDHP_<P8&<ISBM*H^2 CC3+*XD"6_(3>- +'XUR0V65I+ZB:(H8
MLH6DR"=G8M>--_[/VTZ%OFI2C91'13!W945;4(UHYCZ[O@(*O*05+Y)3Z[=2
M5K8Q$(_QT;,GZ2R:^G/&79WRN:GP58L+;N7]$>'XV2"R_+,R]U;*G]]1B6O(
M]=P,F.&*JW+=5V(_;@+KD%P!Q.& AO>G GFT^7L75KSX)%EQE< Z#6#)*_?I
M"6(7T&V .))M'!@<P!<NZ%4?A9/L442!-;J#*/:NBJQ>.$4"\9K'+O:(:>T9
ME[IJTL-_U-K;B6-O$MUE3<\OG <:O@?#5V907LY&38I'H"EN)CM***X#Z->[
MG>UC;YX=*' <V]8_TDJ'+U9GT2OAF[)XYJ.PRZ(Y#'R$V#;ECPDRFG<LRXYR
M#EWZ2N]9<^<;@=E"-'I)FVVV.L%0PIU.X]PUE/CS!@7D<2\+VE*]_U*3R*<M
M7:^ RN&*+K]I5#GMM@GO@]$5OJF\%!<>S"+Y8FC!\G!-C)2F-G+[=5,.;'.E
M=IN+]D%M9.Q+VX'=<LC8N1+ 5^SI%*'Y]N ]+1IH(B:H['Z*_T/N09]%UD7G
MY[1*UF(IT6R,8%6G86#,&5X''6Z2E3Q\C48\(H$6[,D4XT1O>M=%I!^N;YB$
M,86]U9\:"[JEBPRW&>/0?=4?;9E,S%"37G95_=O1.YW2.?NQT,\^W9\85^))
M!GO%/-O)G0*Y$_/-7YVK4R)C4G7&U>\$UDN*[AQ@Q.H8NOX(ZPD;;)C#ZH*W
M><O]^H/7!];9MKJ+4PYQV]^0@2]>Y^_=RLA:RJEX2]\J&17OPOS5%7;Z_A*0
M#O\EH*^:0/O,R_*L2+H/^BPK [M$J/*R9'1CO]WR]&Y, OXM/^>C@06)\Q0;
M<'P3!A&CM,U'CWSRHH@YZ?S\2%%9S7#_J3GC+ %LNR_@?WMY:6 R_Q7GH07D
MHC4?=L96HJ!S.!MR?94Q(5_Y\XBKQ1B$=\IN+CC$[E-(($V49PIX)L.B5!\X
M&V$1B; E/K@ *T85E\4M9?O/G%B?99[;4/B.OJ3!YIK.#.&0J_2,]Q(*G95
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MIYO/'_I_\Z\\1WPL"3-U#Q%4PP_#YV)A1L[(F0?IRQ)WKD -A60*#%$08*\
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MMQ8=T+(AT\DFU''JP?JP!'Z Y^\L(QSY!W/]79)/M1$.7#W>?H4@TS_\3@H
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M7NTWHQ4+<H3 )9B"57B3H+K6B)6:3" /?W*Z7*CB8MBFXP_B#Y?_U*+@O;)
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M3BYIBO-\'J5#$ 0OO4^>]4F7_?Z>OZL-+4=9JJ%F<A:IM$/)ZMH)N'OK1HZ
M[!2JN(23AF,O"RZH2)!GM$LGG7:P(Y2,>7Y0K/&85T=J.[4+W*W#@*<D\>$2
M>U7/ MXVJLHBU>9&=FKA3)"A?+]AA=&96^A^^#N$I8F@_TIK$TB(UIPCD=L(
M^@U+^Y/;8"U./I .,@J[_/BE"CL3+-S)==V8W-K6H0P9PRX8Y:?4-AY,FYP9
MI.B)/Q1AC/_L16SYS5^$3!GX\EQYV659&='QYM?PP7S?[0AO8U4$+(57_D-
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M>JZ)C9^WSM@3$WFOZM4C:,6"S)4DRQA8C(REZ7;4-)*RMRQJB@Y<NPUZ^)$
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M_<JRP1=\WO?-P15:%L;F8*4%+^F@8Z_Y]"+].W&X-1J^VYB\UJ O@@T/2<L
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MAS* N2N'R_0+A.NYR%&*XYL !1^#&(LE*5=3A%#AND5>2.=EKW:DK51J[YC
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MJ+S]U[N@*^DWF*B/G"F8X"]>]TL4:6B$!FYGLH/\+NSZX7+K]6;0EM/MK]M
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MTRRHE/.CT]-6>/ _9@__KZ,KXG]5\'!2@?+>^%7I_@&6N7&Y^.>?E7S:G',
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M%O"QP<54 89\^$"P7Z>0'696@&<$W2*Y7Q*-&:>WC8$Z'IZ)Q_TD0WR0)O?
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ME)G6V"UIY_IKM*"XY/C!3N%E? ;!L7FI.^3]R,^NF4TV:-4HS&C++AU(Y-)
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MKZP+]()X9-2I)H@7)AKUPLI(F5*IYCGX5>KW$BFIO[J54RYZ*H:[!!0R*4G
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M'Q DZ9/OIV,B6954+OE.UMNRX]S5/QV!G,NX/[NCW]E'<6M=3/P$A5"9)OR
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M 'W*8;UCJ"'4D'T*H\_Z3L*J%&C.(CE#5[3=H319+.3[T"+*=6['\,F+';^
M6$A"N%!H":C071+YI0>Z@U:CW,V_F3\FE0*"+;0E!TOAW+C#^@W+&ND2DXJ_
M%XYM<@VV@>[@3@XZVTVZ/AY^S=^'%@%JT?]*^/G?@D#JHS1(_;]]_-GL_U?@
M)*)  1UN]1"ZTP-:RAF11L<&Y^^)QK.)[H,UOQDP3)L*FSS>B<MA!$7HT)0
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MF;-J9O6#;D;@.?(3,?C\.@R@OBU<F?#>6X UTFY1]&6AO9:^IMVC E.O6A<
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M(G3LUXKUO-,3'1S6E&"0L7'T 9.=L$/Y^WS6<GD\LM]^6S7S,58)[?BJHS^
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M[BD329%MIFQZ&KLO^F&JNO>;V'HY\!J'>S1P$-\3OH>T:*B6;N_)YR$4)I7
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MI%O[*5W;=+2*L<J&QD2K@F;MA(MWEW8G]V ]W?R#)][+T9Y47B[@R+1L]$L
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M"'_\ JXJJAD"\<&\!J187BQL'1?&=F!:BUU$2"WL(L-L.IHF&H)_X?I:6.Q
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ML73D<?"A^D;-_].M]G^YU7-#P?]@/_C_C2&6K$H-W>R?>O!W(1?!\5]_)=1
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MT>&'3F/L3ONH5X]6=CY3,,X-?- 4Y,0ZW07/88HADOJ)3364"_?I"7KZH1L
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M1Y)^MMB<!;+G(BKI"\3^^V?<OT&^4Q)0IWMW+>L_?K/H?P;A$6JAK5C7B!C
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MD<T(-$C(1]RSV.D&,+J8FM&D+"/_) W==ZT:T30HL3QX>'!FKT:6EWU HA"
M)ANI>S"%>M[O>RU\%-,1M4Y"L%8Y(W/ JTXS>\(''COI1Y)V'VEI%C^I7FO:
M$==5EH[V=Y?<^7(XB*LU%]HB= ,@:6X L+Q+Z6=&]5>R;PS=\S-U%%0_>(AQ
M">M 4LI8M=E.*OG%ZXT$$),-C7QP#?E5L>*J.%<E3-\[:!?L/5RTY)[C **
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MV*5JF%-A;94U8EG]0Y!(STM/.W[2@U[_$\ G^DEXM,B>WJZ[U7OU?'@HO]1
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M5[VK,UIW!%5SZNF-03ZO<&C&08#, J:*T&,\@,5QJV1OTRCA;=/#VS,G=4Z
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M,;WY)E&DHX[///H U:D8@#N<.BZTO@J_SYD3K<!^<P#V4_ [Q@'Y_.QN\U]
M**0U5RC77NL24X]T?&,_^?NS&E?7I[^ 'W=%_P)6@=D8 =]FV/IM[E,CF[^
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MB8P'8^*"F$A&K^ K8PO\7L^!0?8"Z>,S;Y[5T,H9GHFC#(+ M>A'N\M-SEB
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MRDA32RXJ2J-!JQ)I4NLO.A#I].H<7^+20%7OS @S) O K>6TW.#EN)2N!D.
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MB%_/$T*S_CSR_59")]Y/('HN9A0AVG,^2KM$F5XB,D[0IGSNA"[T3>;4/T>
M4/+QH=LO=5GDV6O+3S,VGKE%97^$.Q8G46M?OL<&18&X]W/R+TIN&YV<_@4D
M*:D>S\FU!9].)I*!N5+]&SQ.&9XG="B[A56]5[&6+Z'^<[\S0;]\)0V'+M>!
MK0(BH*PUVO+MADN'=KZ)YULI_Z8L)R/V1]1@E[UVP=N;CWGZ5]DQ\EQ;Z"^
MZG'X3H_9QA_ES9\FY/I[\_?D.6L__/(,2;4L4S]WZ]DUEV_SK8@\)+8$$".+
MNSJC%1T2PR-L:6=I-V#?QQ N"1),)/;//BF\30.2L0Z&/Y1PN6%"89S$49DE
MQ)7='PI1;;7M\'DZOQ):OJF5NV_[O/^,+2S@]Z8:YR]9/XR:-W#\ZD*BB*T=
MX->RX-0#RCF]^B=,W#9_SZIQ^9X@_JCX/%\'S_]2>UGP<#N*YB]@>&WX>JCK
M.1>/K S@*\#FP84)/\T\-X=J=A!;FA3"N=>9S01S^R5MZQ_NRWA X#NNIM0O
M9?YE&78WVS2V!#&3M([[$L7P19_7))\=6(Q_&8HF7CMUJ@LE?F#>XHC$C?]R
MF+S MET3VWQUN6ZT#5\*DCK0K/6-L)X8]]B<B@Y(Q:\@M[J5!#S^V!+6UK('
MQO-O3-TP&1;)^*P[Z+;M'60A=:%\V#$CT[Q-.[;<(0[TE'[6%:CVQX)D#W7_
MJ&=5\*YG+Q9QU6_C",V[@ES8/51KHTTI^KX_*K5JG<CQ0I LR7G[8.3=]SWF
MC=/C8KWSP^F_ ,:Y8</Y/>;BTR/NF6@!S,KV?4-/RUL[)+0&K<**A3U3'\ Q
MS_U:Z%'KW=E1\,T@S[2=G8[RP$=,8L<Q9M*VO[8:P>"!K?>P] 1@0;"LEO.Q
M-O^LG"\<%\(%128LK[W<UW$AG!X_^7^8>\^@)MN_6Y2NHH"42%>D"@&4$HI4
MI?<>2"C22R@:>E40I81>A=!["0DU="QTA- 3.DJ (%VJ NIS?,[L<^:<]S][
M]LSYL-_S87VY/UXS]V^M]9OK6BL%NN??KIWD>=.HV;N/MXO[,5VU7'6#4NR%
M%@ V+4EGL.%\BF+4:&U]+9GQS>K-;<\GG#>0E3E+ILV.S-9E@HE)L$-:5="6
M,G^S;" N*G_. ?4N:*@';* R$4OEBOG:JF@!.+UJB.5#[GGY+#ZY2^<</&3D
M::L-8".;*EU)VBD_K4V8-2A<6-O6:5$U@DUU\7\ 3/P,W0BY@?.G_[0,?B=X
MF91$+^G)!^EF?-H'FMRGX(U 3?PR>6'<CG.2TELF@12(TQG(U].'8B-U>34)
MZ7[Z3>W*/E*K'6XE[ON.G-/-AZ+ZZ1NTDS-6BJK@ED#'IW(U&OE#YR&,I_LV
M Y<L';P]+J<?EC/:L"'C;:Y./4[)9W7LDK-Y?>F9G8G,JSV%^#8KH2OLVJ6:
M]_O$L#GL=E5$HM-OY%1ZLEJ_2?J89UQF9[J4718&F@TFMNMUF?(KFJJ.S1?,
MP'&.HCCQ^H;"LP^/+R32(X %,]<*B+>5=J8EO7X\HQQT;+RG._@S-]2I^:,<
ML=.(?N@\0E8H);M[EVCPO?V9F)$:6&?XI^.G ^R;K"@>Y(\(F?DGM-1LQ.ZE
M3S*PU"$@O>>,0U<B#]EYC8NUFJD0VX#B!M9-X..X'_@E =$A6#!DWQ$/,52M
M8]^3U*%H(<WRB27.QO.;BE%JK]7O%3C+X=1<T_E'TT/G+"-N>0TAQO7L^:GH
M3P^+N05S[Q^_$\)ZQ,? K0ANCK3YNN'C+9&SD@X&#CN6>2PGEAOO?KAMVV1W
M!&"-0*5!_)_QST=I.%$Y[4N*#Y=GY]H$CJ4LO+/RHE>S1AJ'#9@75G-IM'!V
MF]]_0,&-R3(^P?42A--L=\K2$W"X4&UK00B7SSS9] K#\*6C9)/F]0/A6^$$
MHUBL^H=64W0AT"O5X,Z=L5JGBYIFC4S0<XK42'."#Y_7!DC.2*ZZCE=AT!-V
M_@6N:![8VF7%95YNL>>^I/46X,16I5XL!CQ%Q<MR%&<@D<CHS9*<OPRB_1+J
MY8:,.B 3$DR7[Y,CF]$W<E+W+TWUKRA._:]-8-48^;C9EG\#'NE]-I6=3'H#
ML;9=E(+-)S%5CE.E7/N[YI@15X#B\V.S\*9]?>^T"X&2NK"/3OR6D%OWA'@;
M0&'@$QU*A/CUX?@+Z>_*7K-4++"&-X *^$"<^>%P]4&3&0!NR5N*Y-5PX5/W
M924,:BF:(R-B>1BM#1PAEQ9=UF)-]")<3U*PC>8F6:A"T])3U',V=8"=6=;'
MDOLVHWF_@P>\MR\6?H*?Q.5*0<^%8"=0:U5AF+LV;"U +J7(+CHBAJ9#X<KV
MV)F6K*J\%S)$Z IFR(#=.,4$:;?V.2=GH5Z%IBWM74LSC81,Y"^]M<BEGP&?
M-FXM95?:/M#P(KR;-."RJ[F_^AEHW5>M+P]*>'GK7>(UM/\BEYUMB?*LW_7H
M?J:76W?QGVPSNI'[H+83<HH.SAP]9]IQ_2GVSV_S>%OV)Z-T/%SG-\")@?V!
MU6$<8@@Z]L !V/;YQ@,J$^H2R0W$8EO+)RZP*:.G462]')JBO3S*PMQTA(<B
M_:D7BUD\,9?S=4M>!YJH<2;(+?([K98\1@2/6GL+BT^;M0I$/[$BF";2$K2&
M:S5]U3.'6/8F0XV?@$V?6HC](M8;=IA!KN@O\W;,=5YO&L#_\,7MA^YGAA>]
M]8.>*DQ%LB@E&(X=+Z 3#&9ZK&0^='&!45:I&VFK!>?A]%GYK:">1':QU^)P
M"*OOWC NP#*-G!&C9JQY(E>7H!F>GI^/+/\@?8%B'NR'FPPP@DFOG?V1.H.+
M>Z+'.^T8H(&7).*@Y>TR#:SLOM4W41H\.YHUXP:BC'74$&D'5#\5R"IWZIY5
M&4)"^ &4N@ _<RK+)G)SZH]"[-78FP-G=<,^S4)07.)<B*\$LOH8, &ZEY>]
M:[*L4N%JRM5<L (;@P31-*EQ$="YG)H> ^EG2C=[U1@M(395;S[@YRQM&>=[
MK=^RF)AK_[>I)5NU/XKEEQ:U]:%2'CSGQ?24?1\$N^ZKK&+:^H4",W^>8@QG
M(]Z9!RFZH,IGB_8YI!@G6,@'OKU#44^9PK,Q.Z0+5J.50I2=BG3&THY>)+RS
M<T7+..-*\-&-\0>4"9[@CJ-I?1K-G6_=KC)VBPP5D.\'[[:^"(P^E*_^Y4?9
M6N/%PD7Q@++$PTZ)ENG#2NUCSR&E8:9[R-:RUB_%ZM>WO%_L*K8N[A2/+T_2
MU"-X7[.O#\JC%A^,\3VO\%V5Z$#J5<LX'P/KOI<;GM?:!!;3@T.0*JR"H3[U
MMBU=FJTI16N C=#?=6G!*6,6<C2=:"GCU-[BC(_%]/4FN79,Y/MV0D24_66)
MB++77*V6%"[5SX:^S/7'70%SD< ,54"XU,M+?T13OO-<HX?ET?*2(&%<([@J
M:=]ENBIZV&S\L:7;5X7MRF10AM(#RL:CQ^S2(>8! R_L;N=;V0SSRXU:5CQ3
MVUK*5!H(48G/MA6_"$]5%5N,5'($?AM[TA: "1LRO:'X\(76#P,GZ(YIP6-)
MOWR+@I#5K5[F,R%O,G@1S:OUG?7?Z[83R=HR5IB':]1=?7Z^$.V+I( _(,LP
M&W)5#N5K_Y"E6F'\B$P2/?&1WWH[C:CX!'/( 4:#@:ZO<FX1(Q\&NU[0%# Q
M#P,F$\J=$N<RMUEGU/PV_:)L#="_DH)1&0BRD\-$OC^"V4._&VVI)G.[&7S(
M_M#V_6RFQ+V"F3.?T.ZWY*DH]-[FHX]7Y1IZVQV7ZY@:V3]7DF#M&&<H7\_6
M74CLZY_JCWKMLV\7LYCXWIQ-*/4!97.RG$,B8Z*%0A[0LW)Y'J1+VGE2"4S<
M CS]8ISQ65XP4EZ%DV'O:ECC [O#=-<^D^MS!O7]6?2+RSVZZI5![7$V2P^R
M*\$HCL)'#RAY]750P+"Y$.\_)<I9'Q==/<\<AG%!YW]],.NV*A-!IKH?",8Y
M[\3G("NM =SC@L=.V9AG9HY/,.EGAB2,SYF.DTU&: &C?,BG%;T;(!B)AP,E
M3EZ773>]_NN#1"/T3K9:L@BG^C*Q;;^$C';J/D-+LTDR,)0@2FZ^;PS&=B9.
M9O6/F@S*3&XCTH*E+U@WT8YQ'1!.4DU>#@[LPX%6EQ6P2M3K>BYQ&80ZE['G
M&48Y+DOY@7^5<$%8J%/N_4QP?>UJ_]@RQV/.&W!PXX_(V8=[#!*%W5#O23OF
M&1(JFB7EQ7?<ZJX_J4ONGA_M\>%U.Y0:QP&I1P37]H 7ZRR&RU;I4-$]>75G
M\*<O=2@'DR5-QP<FJWBQ'&)S]ELQ!J[4VV@DVM5Z_)>GI6F;Q+ J]PXV\U[W
M1A & O-DQDSI]$;;MA:1!=H!DZ8S'T /3Z5OL2#C2J<:O%B6_/?M;(E==,T=
M%#T%3R_8SNL5CT"U(\ CZZ&G/B$OBS@%CMT(/2A5$I[\M/Y1<G_%\6V%N:IO
MZRZ=## O=61!0YH1H']'1L%YVR[FJS;<YJ#9G24#X2P3DA+W"GYC?\#AI^E*
MU=Q4XZ#GL\&FMP:UL,.^77*!9=^TU9;XW%W^F[;L5^%91([-4;L=T_ORY*C%
M[J=_-+._O@KLEF3>VCEQN\(;T'$/)O!"MSWGHRS19TG345T]OFV6,3>5BL_K
M?BN8!.8X%V(SEJ>'T$-!G3Q/:H,ZTY*E3L"!!;YVC!F+30%YE6 'I#@=*PUF
M\*\?"'Q</"1FY]66]*$^=#K%Q-F0#IA,4.@(8%NX@%EAB*+R]0KO("_^[3Y*
M,'!)2,2RWG0/?>-78Q)M!-$\P(YN+Z:F:4);3,_"EWU*)*Q6@\:TMFWL.KD.
M!@),QC'M.+<=< *O&\"F%SLA=^SLT: !@\ZWGA&Q[PR?R<JAPSRI;N33BX1@
M.37#D>&^BVNQL.,/M]E%04^=OE+:#0C3TL[E!V/Z%;IST#P:=1-/?AK5M9R7
M:R\3>QQ9EQ?VGST.5YA5'GB4^'<238*940ME6]6H91R2;AK)P'*-^O&LIBHY
M*0-*IT2CBYAM'*S%DN6P*DZZD3<B<4V+G>(EQ%1?/).N!*&@VPUM*E Z"+?P
M>98LO/_@)@&E&)5YHJLOZK)B^!$9\&9L&@/KF:).,JAZ> A.=^#WW_Y!_1A9
M],(,I?;HO^JM2KT?=,JY#Y>ER6.#0T"Y&>];GJ> "N<'(.K5_Y#) ,%X2F)#
M6O+EZHRR@[8K0I,"#[RR")XGMFCIOO[FRF=J,$Y[*99^#ZU&$^38@M7^XX<H
M8[*?:=1N8[NH_?3FMHB<ANT39 *K+W6KC1N ]VG)@%*R".CY*D*'?OT@AJEY
M4,\1ZZ-I;$%6!#)5EY']S.WQJ=6\WT'DS;0W"#S)"I]NW:D^7[LR'UY*,N)P
M51562E"7R2:R.&K!UL^L2;+[;(JN707JZ)Y&)4G@F&O&.($M@-3PW#3WVRJ[
M+8&J2#?6ZD+-L?YGH!(2?@GVP?A:@TKGP?* E+'W*M"=_50-Y[[%!M'2E>J7
MH$F;(A$FI5KQ._*HRB]\E)!558\0U#M3\OLD%*IZ2UI,5WV;Q<,T,I:M;BFA
MH8=.DK#7M0YZ:&XQGKU*_5$.+8<'R-?M"M$\\O#Q:>6BA+3<-)W*%U:<9=*W
M^NXI0OQQ+1HLMLG$0T+2/'N+LW)*E;!P9 /XD'<3TJ2X<@>LXE)[4[6BS33S
M$9,1=&'LVH.>@2O'U'ZIO]H'GB_D#PJG\=LXX52P($V/W[6)4+Z S[/*QBBK
MZGP_,WN>;W1.SP9ZDKRUY6IE&3>8U<2DLMJQQJ$6-W@!'X+8R0C E'Q2LZ>:
M^H&3G;IN&H)TL"]I!%@T8'. R-[YV*:+^P9+UMIS$^*MU7O>>&EI#<JQ& 8D
M!5VWF6GXG,T3;QXV5^(^>BSV(EM$<?-R[E7%FJ/9_M/)##<Y )AH6TQZ-V'[
M\^]O8RE2_)40GZ[I([F%1 ? 6R7](*-!N4;2[_Q<*7$RH,:D:MO&C&A];%J"
MA<Z2?RS(9Y2]AK'R#3&K20LDJDVGPV^'SULN_VQ2/X&S>]N:9BSYMFR,M@,G
MT"XUH\AU58IYW_Z,0N\]GRW>O\\)^=^KM,S]Q+_EA)EGOG$VOE;X,XTN+P3Q
M&+DTE;+D[R4K#V!%['7/:[$$A^>@"2)DH^^_[^3JYX5RX8T:<QMO<-$>;K0R
M"1EBGRH]$*UH5+W];=%QJ9=>Y'USN=CFM+S-U[DGM"&>K87?8^0'R,QB)F\*
M)'!3PY&%R<PF)T]/0=]@[6QUNUWD4G\)GVBMR?&F>JSC$Z9/?P8\34WFA,B>
M,V*\FU7.>A-!MAD00>?JI[SJ*7C3B7E_*/30-4Y1 P[1,KCK"E=EG(>&=PP8
MOU,W0XDNA7)LV\>.&@OK\XQTL9 /!Q?UU51G"CQ9,@L.TKDC7BPN8:L_&<LM
MG+IT_8M<\<U;'8#AGQGJUB.46>/ QMJYVS>T=,G6OC:(E(KZHW.]PE>XO_)5
MHP5F(L.)Z(17*]X#9+ZKS%.6!NE/6=D%L6=H15NUUU+0P',BWW1%MM(N@FQB
M2DP#W?I1PFAV[^V8=UJAR*E.(]S((8LW4G&EI9[W*.=AZ%1CJPH,/!3ZK6(F
M>MA0V*&!L5VNF/[9 /+!!^0=8#ZC[=T\5]YIIUAN:NO.%J:LX6VP8XKS$W?*
MB;-GM_B1L8N!MZ*1C73)YQI\!W,NH(;4NR(MT&#P^ ,*UB8&^YID_,2R-9N.
M,;"5,>6AMYN-!U'KK^ MFCEM?+&6XP_R[*_:0QI;[ $#IV>M:^3J5!B%.]X,
MJ;+_87VSK,[/V^7>;@R\U@<NU*B4L*5--*:L?7L<S8XZ*PC_J5F3/:#EESA;
MTB<#+.AINZ\S$# SM/5W2(R*#@9C=%!YZB=7+7R*8!_Z/UGX9Q"'N $W.I6M
M;0@:)\L[LRX0"YA\6GY;N!7Z<I(>:"(643MS[PG?9V(+CP^U%O=[+=U4\<_E
M\2X_QS5A3Q< 8*&:W :@<QSPPQ<4^+>(6"X)W7>7&02F4F&KFN!%?Q#"RJCD
MW(-M@2+,>\=R*P3LWU<!B1LG!8VXD+O-]MOW[:OJ*T)/%]Z_LL'KU=^\F3D^
M,9U/=:;XH[?M6"VP>H',LM6]35A4[X0^:_-Q=J)_C.3;P;_^U(Z7OS8;[>,6
M=K>W_>. .;[X1'2"NWK*1V/9<QSV^S2L!&@B "\;!H7=%E ,JHO[>OUL+CCF
MH;C9@._&KS,</RRWN:(HG_;@M"8;9.<Y@78^S@1Y0G>NK.CPUZ?/E>[7OQZ8
MP_IVYF^+HM-%ZCH_'/AU87UED4=7$%M\G4;'3)\'IS9G,G9V^Z<YY:1E@=6N
M0H7%RNQ<6)4V%/#<Q-*14[S\R[:UG\DNXO5GK>&OYO1_;+IP#L$)D)MNO#[[
MYFET.R$/X\6A.Q=E7&NHJ7!*C\U/G&G;=F%5UMQ:X/#$7_B]EW>;[F372B32
MMN@)'MGT72D_*5JK9YJ)][9[_@.%#[?U5Z?OV+<+6%MZIF*6N=XC3W=KUMD+
M4(M\P>MR21BL=S7UE3#Q(.3F!A]"FJT*8MX5\4< I2!/];@L#2H6_FS %ZMA
MYQ"Q 1W]-8I4O,PZHD>I<E#1 L*W*.)#H]'_1D<',,J'2 ]N6J@FB)[HTZ<8
MS$)425@SXU=2\J"Q[5K]'$QGGX'D5^([4X,>\:,-2GFT=3QY0H:Y??.5=,@@
M4-9LMCN+3TFX52SAZMVKOR>2>7V<#@ZL<_ESYK7P["(A<1;=9[HR&PO'^$';
M3M!6Z\AO!4&)^)MQX1^=AJ!X2<A6:,2HQR6"O@@4MA4+<@"]40N"?4]A@OY&
M'%G=\K-]]QK;N\DK-HWMH+,M'&][]1"*T/L0.F@]M;DE/170'5 ^S^^>5R?C
M9W"E,^X'>?W"&JW-3W565[B)G%K)#Z@!'PJA'167%&9>XI//+%G2L&)?>M3.
M,0R@S!_V&#^3BDF>$^,%DW@?2--O3TO]3SQS0'@@RQ:HN=3NN0M[":TU=^GO
M*3T#0^,(87SC?\8W^+U"@02T'HRY1LKO]J5[RH8\1,R^9Q-L.E\[,8?PIB#;
MI)L''**A2.<LT4J,3\; $_F[.M5CJV=4S2YP[3RV=_$]22:,:RC3S1"<\4MA
MM"ZC(2<%AC+*8LUV"^1?-:I&_T8K39^2A).7#S?[O'9D&I4RODE"5?\^$%FP
M19DG>&> W/4#/M$":<Z]9&E:#EU[,Y"DK;SPG(E0<CXP_@<Y] 5#/L?GF4%5
M=/4<E;E.=EH*,:]>\ O[OMVK"E*$DQ"A\P.741./E,V76">:HV>K'>5G8EZA
M[]^Q)8_>Q;]%_RHG_([_ATS]%Q Y]XR$+FL$^JD8ILA:UY+J!8<GIHMGKAV2
M5Y]M/RHWGM+?\/&)S^JH3;<#<,,48I0]+827-FNN'^C^<)F -KL(GU [ ;GQ
M:'N%*;&$M+DGODSS7'A.U,K'?(+2>,6FX#)>X+UD/73PJ0:I^Z&@E'6G3<7G
M:!M<+6OXG$FE1DNTC@*E;*83(!"O":M-Q,"TG1?QI5YCL_[D4@:QZ$=Z'1)/
M9=AH%Q7H.$QN$5OK)LC HEH5SR%5!Y]J]>,/[ PSB1ZH:<0M9S&^6P@/+P[?
M?,3MVPVXIT=;B([6LH"/.!EI^R^?/A$[NEH>Z& (Q(<2!GZ/*]Y/!M<MU#YR
M?IY>NQY"JGP7LV02A<CC$(O1NRUL,UA981-E:UV4W5#_=;5_4HII+.WQ;\_6
MMG<N346PC?3[7,57A&.#JTBIQ8H228\SNECY.A1.>[B*5+>O^[TL#?GY"O)2
MRCS^X=)*ACRI?E3F&]PJ]1>ZLSY>,NNY_0-<WRQA>I\W77U8L"9>9@015? V
MXYJJ'U3PD1D(M_T.XF(SIWJ\G_"])IT]SW?-"C&&W+W&7O5L>2T%E'Z<+5^C
M9QQ:V/.=9'#$<0H[48G1>H0\_;R=/*381ON@M/H_MJ'_&T$14^%]'G>$J'%S
MVF@GMFKC9-UQ9'+TU&PL+<:4,K\6J@(KRI4>D)=T5!'++/K,,\D<_WVKZI-U
M)Z3&.LUDCQ3)SRWL<4T7^G_?#7ST_[PHJ$_K(.=EGL7^+$^:K YNR"U<UU%%
M3TTF=G];3SO4F HH^ P@0ZW:2-3'(\B>*IM!9&5>.MT%VIQ6O[AI3 5^="%!
M1$^31^FI4KO A#9A^+HDO0.0^CG'HXQ#I'7.R1W8@R\_8G<MK4+2B!T;2:5G
M\IXH6UR^^0V7[&U;EM9"O(U:PVG='BR.I[4W6>05\!H )DU,&\*94S(ITM;+
M#8'\%"T\!M<LF*R=>'Q$?!=J&W_E6V2R8^)REY%\&8C.?'&1?(\6$GK0%[9?
M?7#_]Z+$>;W27+G@]GOLMQ^,)+Y3S#WCF<0?7A*KI=J6P&^!A3 :WLYJ-,V8
M$]9L6O0/[NXTT.-%:5RTVTWB/IN!ZT_H,6O@]'.*4]+[.+PC\Q)@('@+\4MY
M,##SH9JY>MIL\,/^NPX68I=SU9K4 ^WA9X 3GX27B[;#5&G1=GW%/RM<6]6_
M+!$R..X?*16-#0&VVLC*JW;MBFIUQ6=_X."RE\__?DS0C-]Q A'F&RV([WGM
MI5:+PF[$TSD"T^24S[@J? *E[.XU!^S;N*Q\DBW?ZGE>QEY,N=@@OC_<(8B^
M;S?P6_);WGQ,V%S[SY<,CW$,5Z UI$&C;&-;2;WG]$/"^( D_!A?RO_Y#V\^
MA(]K';!Q^;[=1SR\>,406'E4%$<5HT%G0Y/G>OGV>.0OC7HZLB_]U-/Z_2VG
MWLYS"ATS)N 2_'+LB5=^('K><>Q,Y]:ZHG-.T@36]SUUPCB>_^[9?/"&E^9=
M_&BXXD6 !T./C.GR J%E>5D6\,QHYG6['"8%^C$0]KFEG1PEZ,%<UO*$16W;
MXM"['V$HS/3-FQ+D_BA=9'S=32C$;9;8(%[VB;=+2>,IT)(S]&=@S8X"FZ51
M2YI^FS<.$?#YN2/,6WF^.5EX6=0?>K>(I$O_>*[*@^/1L47KG-#:Z OVX'JC
M&=TZ,N/YW+%=^._L.^O%]<($$,5T)ZDG;,"S4VBH(CBFF5$O5ODTCZ)V)?6W
MYW/#V8;/4C:YCO2PLS>Q8W8>]$-54 .2)IV5E>]%G?==[YW23NUW"(+HN!;Y
MNK7M4.!C2]FU"/7%'2HW-M!J,.9+N#A\L1MY@^Y]Y>\.-//DA&N8P?N.'M45
M*"-,Y2%T3;I*\ND]4)-XX$.HI1A?L;>1QS@L&*34[V<3O7)'#J<,7&??-5ZM
M: FBV7T5FFR=^!"ZA3Y3ZD,K'QK?O..GTVC5"*^]<,;LU('0'P9L"LXK<HUP
M%H3O'T)QC?,[XMBZ?\@ _G]8/IRXIB"/.UR$N.:"OL8*$N\?6M P0>^NW1C3
M.ZV:??&JVJA"Q_;!YG_6M_K%Q=? .*-R_KW;TK29Y':'A+$3Y\*S*YL@*W&.
MF+MN.$2/MVPF4)A^F]IV3U@RZ2'6K<<J9<N&H!XB!&CV:D>4ZP PS+Q-@BHR
M0-C7KQR#N2]]8=E1S@8>BQC<<85%J\VMV1F9S9H. 9=P'63>2VN0?E$10-I-
MB"5VLO.9+]BY_JK/<G@QZQV\C]E<T&16H)?1YK)U^Q7'[(<,'H)MT\&[HPIX
MI3^8\CJ=QT5."NCIB&^DQ6C6\;[5%=@O4.QNQ'K>RD_VO\= 9_/R#,9P1R5/
MF/U0__ND<BB"E+W9P^ ZPQE1M&9S&,=*]Y-PGAZX\ >0A*[/^8<LR;]O[;Z/
M18-!8TPM].,) &5'N+=,;A[ ULX;\WDEG[M?10'L/'KBV)F'LBW/!^O-'X03
MR_DZ$GD5:C_C-L0\N%6N6P-BJ[G?($RE7<)0T7R%L(,"\C0_2.L1NS.F3;=Q
MB8W8',:4 /5.MH+;<F/?C\&-YU5OGZ(U;,QE&)ZZSVQ6YIPCTS@ITO) 'JF&
M98RD-&LAZ2]2/X)+Q;/JK)*N"XQ0=([2>P_ )\6Y(CSK9R8NY5 =4N)1!DZ(
M8!)RG;=Z(,OVHJ;4"_'V':FFS(;6T2O-6C#O_CI+;?=D;XPI\-&^5>B850KH
MO25R#%_VY8Z(*%3.PW&4E..X#L*<%\GJ.D'7X(CTP\G^01U QLLE'4RRGG<N
M:'A7RBN0!53BD=-F^=[FHUL/#&(;4I,X)^:KG^&VVBK=:TZK*FMAE(/LT^PC
M$,K$B1HN_/P]IA2G6B+"JX&<WDJ\\Y'X0*-5UYQ+YNXB,9-=05A?=&M)G*N^
M^3P32/HP6]4ST..5WT^P0$X?+2'-C_'2O$%^=R1H6.,)AS.^!CV!-! U<7@K
M_>9<R6BMR>MUCV#WCS4BD>-49,'+;_1%*4(X_;^]2OG_(P2%W4LC*:?+*$DU
M_R,XHJ[ Z+<U&.L"<_KA#1EVWU3SSOP-VPLBH_=\_.PL=E=?\C90)HG8 D*N
M:=<V:=^H%?2]!M7("W#AA[H<R5$"J-I49:$5HDOR.)>)B).S\J@>@W_(L"G0
MX(@^T/A04'>RI^,-*3;T[7)]36L03"2*!M;_5U9%94PVR4/3^6*JIS/S09ZW
M'\I32T"^V(\M'8&G?CC6B]2_FT'F,B5ZW-:<IW@7J&'@7R0+L)2K03QPC@VB
M:<!&"/N4VK/RI^@N&^MG.3B:OG0P3\U=@WYYN_G:=*?<#QEKU!,A'3FF"5P,
MZ!$!5FN;LP^$V'U8R^V32-*^I.40<EQ6%GWZR,9\W2IYSY[1#@ZOM+.6&'%
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MP/962>1]AW"";M:0,3#I>V&)P,!R5(JF-/DVV89K=MD;DH2I,5FHN9I"=79
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M6Y#SQ@IP1;8EN>X3.I5DI#\.P(/>&7$-U4.W_:W3CS >S*3 V[<8$<V^5TX
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MI)7.!1.B7Y52N?*Q8H/7W"8(2:E$\US<W<F5 %&=T/<E9"ONV.)W=<(5GU1
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M6NV9UWH%(QF5\7]84R4/^(D<UE#]^57Q+Q'=&Z^4QA=-_2M_VI5?,X-W$GG
MR9N!)=0&'XC&>LEW;4MD*<Z5J$5 ,;N(BRJ/IIW%**"M;,V8.1"]Y_.H6Y1#
M\ >FMHZC<]\Z%04#C7<&3)"54)-^<>NQ(3<9VCN^<2AN@J2]M"8N[%9=#U:]
M7+&-7;\<[VV8-"3^"R";O\GH9&S?D'\<=P3X<ZCTX81XQMX]L.;&G>:&YXKS
M" $X2XL5#^D:'XKL@\V$>W@+^1LO##/N]).91L*6_\TU_41;ABL&_C8D%5VS
MF*CT;0D S-6N+(K^< @O?],@_=.X].#)#>(25LEIEW4[J/Q N$R.ADTS;R/
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ML @X.U1Y7^\5.-3C@M%^FG:H7&4VH0##]$XSK7ML06$VXB^9L0![5XA%RSM
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MJJWW.U!/\^*3Z27^21=AX.S._)/#>+=*B01H_QT=YS:XUOYOJ4Y1W(+'=Y+
MLOA 7";BC%E:=DCKQHAJ,_3'2@S&VR0(VK]18RGW_85+?E,;^;I#Q8,AJ#VR
M04%AVUP^[ >(8R1<]%FCSC0/[J5<HHP_U5>FGWMI=WL"AW:^.Z8>FA@7[A2M
MT"/LQ%!%B')^OFFN_RHL4?(2(P."526O:Q4X,W,E^L-PM&LT#G6E,<$/X6A?
M-HX>[HK"8:NR']I>3'6,TMC!PQB0Q4A]"[VX&8(S+^IBH %<ZO'\4 %O+;O
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MV2&@@E"&880SN$#0K)"E@+PB&'FW92*U7G96#M5OED2IJK"4&5ZOZ.I0GFQ
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M S$433HNG$,@>1&3-2YK0RU)P6BNZ4#U)<@J  X/V*:Z3N.R-5XB0T?QFG:
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MI*Y%D@[DF5<,[OFM[-#>'N/\L[,YE%5MS%9ISHG0//S!51#"_& GU.7YZKW
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MR/MI7O9-M*CZR6ID&\5%^*>IE-P^($5\-$\&S_Q< 1EK> ")A5IU%FI'=H
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M7#\> /WNNTOCK>I<9\+U35S_6-5U(*ZN^-.'<V@,&?TPCEHWZX7WWNAXOXC
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M>>?=/)&CSA/#'AZ%O[^S4+-*:%&$F#LYM=,7UJ14519P";;IK(E!KANZ#,B
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MF3IJ=+L#":8MLJ#0@.8#.JLXF;DY; 1X:$;D2 !F1#C&Z>@4;?JWU07O/(]
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MB7[./G^A56]E-[NBZ=B@ (,VJLQ@AFT;< 4SL0H8'CJQ24]M<X*5WGT*4GF
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M\T)_YV9+<Q7JUV4^:I;I<:IU3]<,;L%J/O)RN$**?ROB&'<8AK1E:Q_%XT5
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M!41YUQ 0$-+X+FT*%37LQRJUN$%)!"=W-A%HRX-,1^CET#9.>W:_9;0YH8A
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M54RM?_='R&M^A[>BB-5;E3+A2?/?^O"=QL'7C#V5XUV U)^6N>>7%%^ZP(F
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M8-.=CZB'JIC66\N3E]V_V7A>C#P6^>QZ=-OKZ'U7\(JL>ZJF_RWH=\DPGI6
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M3PJ7+".V?_:?F[GH;/K887\^P4W;#K#00H3X?#C'05V5PVF2AMSRMJH9(D&
M8TV7G759;) L2Y6SMB!+]>+FGC$URN>#0FB%DQ)-AHR4IJDTPDS+7["59Y6E
M2C%Q<PUSN%:CB"6YX.[N7NO/KFKDQ'%$OL-,"![W"0J64H/<92P=H'?M:"K@
M_B[J1/V;N[:M72E/SLAF>"PO/YW4*5M.(SU(=3YGLR?B[27)7)G2[ZJ406;R
M*;H7F(1$\PPU.:P.7_J1#C-II\/]&8X[,R1\%"G#6V$?]Z"?YZVJU1@^DZIY
M+1UA-5!;6:O)2T5"4?GU#8&C 0] 1C=N\-3IT7]&5KR+9WT?1J#M5[0(5:BQ
MBZR2XF[@:&3L!&M^<'>Q<63L*_.4^".H8HI[E4#"E28!)/5I:2B56CG,')7L
MA"J-'X]2U>C>IRKVLDKQ2A;)'!;3!MY#J9U5 Q,4)^T*IDOFWC69Z3\:M@Q0
MK<B'IR*S'[29A7U?AI8-64W8^5(5)V6$E8B76_%EK;7Y..@RF\?:OX0?V&P%
M1:A-%-#<\+#]OJ+EF;+ND.X0]OW7'0X/Y.G]B;Q;<,__7\I2_&<#QF!Z7\-E
ML2<3;<H,]A?"2Q.^!&T$#>QE3 J=>:KYLK0,1*X:NA5!-_W6 \W<NF>)L&P;
MVY,IYW6<I0RI?O?F9*4]2L_GQS?$0JM"RY^]**BM$/NOJ".Q&Z#M[GOMM(G$
MT&7LH#;';/$Y]#2M#"2Z%'7+LN4)U''&J*OJAN@BLJMBL W<_*B8T3:P4M\C
M9;1BO_W>H_!8Z\9%OP_[]H25@FN+#58+N,KSHY2I0[CD@-A^_CXU15<P%Q/>
MJ84']4LU(O-XUK)DI\AH-;M:9Z\6XDVQ8Q7^+6(<4Y8@K?8DZS5&S&+&32 @
M&]_C1LVY5XG/@583W31B+#+U<E2D)34"'4?Z5E3&R5!N(T4M# 4IN-2JE8,T
M,5A5R_WLYFW7T,.49LL6]FG8K4^^FD,E]89'FS6Z?HL5896YI9SZ%#/E<.WP
MP<O:6WH5'$[\ V=809T(^]X?M:-R&MC,E3RPM$&/#QQ%.JP#Y,AA$"LQ7&.P
MS&D_Y'!/R3>!NL!?/F,A%* %F]N.5)TY.MU^LHB5+DGC5F)&P8_JM&]^O9!!
M4/_YFS)R2=O2/>;/?T?8Q_>\,TG2JHO( VE)4[N@JNLZS.L!C5SL+Q1R3+ "
M>JI8$@HMWSAK$<&S;_K=>RWW65FC!]"@177^?(!(*/:&7\GF]U&A3LZ_N>[_
MT=YY!37!=GD<052J!8(40:63""\M"-*5&GI)@%!4>A(Z2%.0*A!ZE]!+0DFA
M!@@J M(A"*%7I7<5*;ZHZ+I[^^[E[GR[,]_%[^ZY>&;./,__G#-G_L?=2TO/
M!.LW!9>1\P(MM>V*O\XR,YVQWB96]C. L0+,T^HHL1&0JX1B+TIY1WGFQ:_;
M@E=0.>XPT/"T5>!,*K@7&:1FU[T1USJNP-@510<N]Y32V&@-)JO2Z&S?!'SW
M^/7HQH3,PK;GV^"/O-'P\<DRIY1)M<+A(0QM8H6-Z;LE^XF*&ZSQZYH7*.N5
M'PGVYOK#"/K)3H<.PTIZ,IIEH18AH0.HE1S9TGB/[-?+"^G1<U;LQ#L*.3J$
MUCTZ]=/61=W,\U,D/HU7T!TG0UP$8Q-#+'SAR<'=GE07C;@11< SK3#QA9R!
MJXU3911C68EN -CQDF$WO;B!Z9UM;,YM>ZYBG_D(<)XW?=D*2:M+Z?K%-^X)
ME#GX/+';">PIKS>SZ5X#UYJ%;K3E/^.D0J/6%>_ 9L/-+,'ZW+J1MI^38*I'
MFIVX!%=P.<<MT9;5=_=UR8X$1R5%HFV@LJ\1D7%T];49C@F:,F?";!,B5\F_
MBYW<[TZW#)4LT;=<J<A)6;EY##JJ'!?\30=["PDS^\><NQEUV+7BOW:DNC/(
M/ZO5'AV6SSNMW@O"263EI>FPB6N<(6W&$56 $S+C@CZQ=V[H)2=RZ1DW'K@A
MQ=0CJIC6$22 _)"EL 8+$,9/$>L_1" 8^PW=:#F*?B$ G.0$3?_"2%25O=ZS
M.B'";LSIKGY"+[ I?1-ST2_-SM*/'=AIYUI#.>TO][WK5X''Q%R&MPYAJGV8
M ZK<P[6<#RUNK^"3BI#!O_;I[X@HY2;1-&21N@"-^/MN&*O$T"*)+?(CG<"C
MLDY7O[M3K5D%YC/T)$:/#[;.'.A:A.>+BYS1I:.(G^)$V7#X2",W/2G*!*"?
MD*$S"WZ<)7MH>4BNZ<O[2EO(SQ8Q5-4*!KL:AU0Q'V TBLK<T(^-_8TU,\UK
MG,<I03Q7>N"7T]&D543/;<>R2"YG!A=_3", UN-UF@<9F'A\*.B-U;>_+#TM
M==/?"3Q\FL&C/.U9@]C0YULGQ!^].%3;-V O;\I"R*3;DW+=6EG1P[2F+JS.
MW-Z^Q\^JB94TF;I9TIYC+1$3V5%ZW1OL)<L\7I>GOS_!3/@H:5=X@!G"/,SG
MO+V'M%%415E[.I/@+%$$1@]=OT!V9!I7WH4=IZ0;IAD75)$>].[GXZ>DE7"M
M])5IL9!AS/-B'IRHG2X?4L%'OR8\_"+<NS!S*LTZKQ=>DBZ-##BMWN>RDO\F
MT'/Q5!M(]P[,/Z+9(TE1W2%="C'!X+YV.K@_[J^LG\N^8\3=4A_16R7X\SCT
M(,')5)-'#"PBF0P*X&.T>-UDPX>%)QST*"93#4THY&60[S4!$)%P^3)N@OB]
M7/1?,B;XO\"5_]QQ0?AEZ7=CNE0@>Z-=Y3<=5$34TN1FZP1K+KO<$F$[XU,Q
M\;%1=MMSHCNB83^+-XMJ-O;0*%[O/7*5E/J9^\>TYE,U1S%5_,N\;TJE65&B
MI[MOOG0NHV+(]VF1Z*.;[#WU,&SR7FAXVF\ZP6G-;RL]?FW.^5 4MCD- -!/
M&YZ?=Z@$1/NB-C)D[&-I##S@&*'AN%WMCNY4K0M&\RAC-I4'*2 (@*=:F X*
MBH2^N Y(?)9_:)N1 A+]\HC#H*KMQ@NL^FR#G-UONI/T0YFB8__NQNPL]"8A
MZ_W=54,'7=_R!2X7CVE[P$9_8]%D'R(]Q+>:*%&KH*.#:"D1=@GN@WX06)AF
M>RRZ2UTZKEY1&J9L- 94);RT_ 1-:5?NRNEV(_O?*ZKQ7"CX1HK]*#A3C/SX
MY$2D_TA^_.8#F*3U<-ZBI=?\2$Z]QR=(&H6(AQ[BX*6\]^PIL(N .5O[T\!E
M?^LO-J=F(">R\#<!\V/"S$B:_<8L9=\N[$#6^ .<UM!V6"8D/WOGFYKO5,..
M*AJ6HX:X8:7MLOSQ;T^R6G+EIW0=4..+X?L1CLV5UYR'"]4-KWQT)+W'L<3,
MHT=3I-EL-,X1>454C<V.M%O4 ZOM>F\#)G>,Z3/MC"N#[UXMRGXOR4PI1>I>
M:.)Z)LU#<A@W/8W::(H=<3'#1(3F6WF_E-MW\"4NKFSG@A<?4AM&;R(//2U/
M<ST0 ">@D4:/7[GJ[NA/"9G6>0<4N#YC6XV\$\[<>$N,\](^46CFXV3A_8='
M@6I1!4XS>01[^*'+JZ23BO(JN^7C5R6']S;?/"+6%HM!7/'/\RLWW[AOE8\
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M]>0S &XT?.*IF3^MWE(NLTT(IKKH=9/=;RXQD[X\F]2[RV*YI$F4@DHT2P<
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MT] )UX<,U@ZLSC]BMH^*4<Y[(90)=8W9Q'J&",E/M5R(H,3RUR_( G<[X_L
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M@6W7%V]&!'B6H,>-->]G(>AH72.P:#4LX*>4WP>]M9B'!4 ;1GK5D#* )X\
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M513-;""1'E_;&+7BWS$?OEN\0P*X%\/UC7GP=&H#_8,W7--G,33H8',O?59
M7 EJSL\KCV#N'XCWUM71\@ID?7$BM2U\#7%"7()04^CAYP7%SFE;OJ).$PD:
M0?.@G4JX#Y=EZ,79\? SX09[\'.*'-/2R^,<"$XLN\(S(C^2AHP))/+D<^/I
MUK3R^P@P-:HGTI8:MER0.P\=][R>>;C^%L\,(8 )LI_UQ\[=%:^<UI.9IDI0
MBRBE=ZZ'\W,WS0L!YP_\/%8[>.8% A>MXMU>3;_67Q)!  R:4H^G>0#+[[.C
M^H"K-]_4/IR?9N_,QW[E:5D (XZ[8%6OW)O68_H\SE2.RRI-J+YA3I67-SZ?
M*)SH][6/Z\IJVHM]EL<Y98 MH2#_\>FO%HDF9ZA*02=F4^Z)9W]91U+^^CSV
MYE.6?MK#838)A2P!?W':*YJ>M3L7//F*: :@;.C&M\:M6TCX+L.4$89Z;Y?G
MA5=-:Z<:/=CD]TH0GY T P9_"07_[6#5#+ XH_S18FKT^;2< 9Z1?2:_UPH;
MI3R*O,)QZ17#:5<Q/)XQ2BLO<U0]JCS]SOCUNUX6MFZ/U+\\H>>Q 8;5XF$0
M&EQTM7(DP$-.SA9'$/#@HGP%MI0L8T T@ @>&XR(W2NUS7(ZU:3/S%))!.Z
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M\/S"9L#@SXU]*4"5.2^[(6 C#B*G89C$5?]J%_7?@R@,[Q'@CR44Z9V<N$8
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M-(.[+,1 7B(\O<)<;/% LM<36AMSIG5Y%Y2Z8,OW^-$)5/B\^]/X[; 9Q)<
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ME@2!3S/S>75KF<.;S#$\6D3 ZUNVD/;SHIL_2E0-^\%NPC,::U[$H-,=V R
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M>EDKF'93I:8+6CUKU('Z-1B7^E*+8-6(@/GJ.VK]W'(4;^I"$]7,=.KHXOT
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M=K=KJC%3/<:#$%TDYAQ=]&.N(( I25G53'6@,/N850U#1HZDNRR:3FP#]VC
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M!O[X,/T-0J;UI',MVPU1D>-@RBT7?4XK7)$&?4IFC=PX)EBK2M+?V==PRXY
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M%9^J%)_V?N:O,*&AZ/*P.OQ*S*GW0J#!KN@ZP& 1HU.3@ $"6CM=X4NGN?B
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MEC3B0S>S=>G*^6EAX//TNKVAZC%A%--N]XIF$ =X[)11UO<@I$!A@%ZB0ZU
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M!(S+"FX##N=Y'M:@ZVMT_#)5O_&8)LR *';YX!+.&1:RG%ONQ]GGS7#FMA:
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M(("?V=C394Z*"9>K"BD3H^9=Z%_9CV?1^E]=)^"QA7=T(0C"E!H.0*H+CCI
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MDPC7:)&DP*K^XNZ+<T&6A\)$1SC0[_?VE?4P./('GO(Y@#C\PEPI9;S3]5)
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M\-37X8>)X1\R>/Q=?M9_6*O\NT\,C!-\Y2\2!<=4_LN<$YKSJHX^;3I(@!S
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M1SBP PEH1(_L%O/[D97J8>/OF07%6K''_E$145&JIQ%/"4XI >S#01IJ_\Q
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M$$*N*J=5*<]O47N!.-]AEV]J2@PYF]Q.H__1S::&RD:GC\'P3Z?C5D_02RL
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M]V:\R<;>7OSNXO+QSC*>QM?TQHB)X?$[ V[F;#;\T:/H0X<7NYB,ZP_WDK'
M5(<L60=+IMQ,V/E\W698BH $"/_$>D9G'5+FR-V7B:?=$79BT?8=S;?6$\UP
M4(P#&E\R"4Q[F&9P6)F=Z1>]8_5#@[,0VS)N]8[;AQ7BN'NV)#UR[QP2.#D<
M):?T)W0%:3!<ZLLW%.H=+";>TS7,EX\F@#Z(#L?:N;S*X"J>J4&W;HRT')<7
M(O #$PCTS)GID:"ZX,@ W7L-1\EZ0"I?TN"Y3N'EZZ.D+W<%GM_T&I]Q6/R$
M!3I+0EW2>^EE\G6Z<SY;$Q?I+5[)X!D,M;KW#D90CSL(P!% >(PNOQ"6R;"R
M\_&GNZ>\\/O32TT2;\&NKQ3D1]G('%_:SXKNK;Q2QAH-A]HD).G]>5IB?S].
M,E:;7/;T5+I,1&H=YGC-'5WF.DF#B6ZGFU50SLR7KRR?KD*U G(UKG_(#,4!
ME#EM1R*QJ?R.S)QIHS; H/TK?H0 ')A3GM"6,]8<!1GA8<Z.,_'XNI]Q!/O:
MR[>L^3V,T7'?:I0T!RO$M5=)&*;<9A).O*HZ!!\I7PSE;!%QN0+GQ0CP"*%9
MORL3_N-SYO\P\ 2C!1PBE/$LV^@:1E+J?F19I$)^0RDZM=E2,R[M24]Y']TB
MG\)=WT(BPY=J%U=^3H-/",B4#8^W"QM-GR;1GY"MO!K ,=P@+CQ?OZ<$3A!^
MG0Y\2*F>:_0/JXWBPBV;3MA<6CBP[00:B3<'9].7GIK@EO'B(N\5V;<Z]%>*
M+%HY\ R[H;E^ES"[2P%OR^KLEU4<W^3YIX:49$,W[V'DPV:,],ZZ5FQ_B;')
M&'RPM<V\G\5(Y(/+[,FR^=FL%W8?);B#O29X]\5^G._*]\<"DW?I'WD3?C\:
MK(Z" +5Y:Q2_\T;OQR5-A5/SLG0EO&P(*&A]XKLEW>&&E^][Z:XLV&2+=M63
MG&+#L*/'BQ]_:XRF,-]R(I1A;!PQXBW=>"866B<)EL,A#N=D#B2;Y1].@ TI
M\GU48N^'#:IX%MT$5>$?9CJN<Q*-9[9KP&5,5&IYRC]R8A\LS.S9T.UL\6-V
MTFCT?NB7*8=OZ1*H*+J#?:O\RF9(!0Y-Z=G2E=X24.D11,6Q=-<TU+^\7-N?
M(S*F?Z17BR6JVT@&';Y4E$Z:^\%@N7L=*X>&O'> CQ&P<)%[C.%/J2ZWKJ'S
M_181:"SO__I1YLQ7D4]BH4Y"*BLB-L>&R!*&GH*V6W8X8&)+/U^?.3;[C-_V
MXL&ABCGF28GZHOO?3E8=JQ&9P9DF"ED5H"2MPN.R&TZ?X#E'P2CDM:_U/E.H
MUZL6-7E!=V:0H;#=C$'[/PX7K KJ7>D:CM&$! R_UV20FANO2$?X)X>TRLB>
M6RLMZ\4QGB+Q2KY%K) /6TJF?H%OOYH17'B<(M=#G(]J1U]T=RKA) .:-4*H
M/ZP#%)Z^V[5\AC?YN]/%;N_G9IMR*GUPZ-O 2^ZV-7>[7MD'.W55[[^@GY$O
MY=N(??NJE&]-_L-J"!2#N/X%R>,B>GP"^<<M,TCF]=$PO2QI;6")Y0'[##,1
M#<@KF,X'-6[IX8[XTL0.W8CKX=J.;&+NG#)_Q1H3CDU1GD'RMG/6'?0W[AP9
M2@_?-AJC$ S)@,P?5P[T.AMX)K7M/$]BY)N'3/,52I/2'6 WW[+KBMV-C/9;
M+-%;OYOMUVL5;2;?97W<3Y%36&:[#_!P=T6ECJ7RUIB]E>!$E&N!SD2GH8BO
MO1E_FD3-@;IW(3?J%-@PTG]=WR &?A>U>JAZ16$*5_T3F$_ZHNX1M;(LU3L7
MFMA;S5)_GH;EV.=BFR(<L"QVZ$KSS<'+*9*QYM^8;EZO7(H8F^ONSKBQ6G0P
M?5@&%CN_"*&-+3RWU,:09=C[*&@R"#A.5?U"^YK 2<S?*E.HT;!QIZS2\[;\
M<N%;6/-ZX;L^2R5.#CR+S/R-K40S'\LE7-L"4\:3R$S>4HTW"3NF%5Z\2A&P
M3^L$XG#'01E>6SR3$OVY\XP*;)6%*\WK<A)ER-0I:R55)/,_NV(!KP?!,0S[
M+*]QU/+Y*I$1>Y61>QG/PMX5,[,2>7"ER&"^W?ZYRK>^0J7+)*TMY<5HD5>4
MP4.?&P 0-H/_JM^F=/D1&S>)@-_+*"E!K"J' I/=NIVA6_"#V-N.^GPW7#^M
M]IDKLMWJO>/0CU%XT;6&S-PP&29<(OT$'IHH=J$,:"@4KKWA54%? ,'ZD/7K
M1-3,N,A[J<W/O/,OQHC^#9G[.T:AA;V+/.J:0REW:CR0/*UALY$)GP1+O2I&
MP1%ZPTZC,JC/682$XH!;?[RQ9W141U<!3B/TY?K%_O@1Q5,+IQ:F3A[2@P[5
MN$\?=:XUN[^.>]-C(2$^' 0X3OEW1MCG92ZF$WV53&);#-XM6:UL/+5!*/41
M%9B8:KZJ9ETV8"A^]D%HA74#R[=B^!.H%/Y3ES[XX=BXP-1.ZA!P^^QTXTTK
M+&RHR4*7[5:--Q<PLL5> "*4N-VG;OWH:C71+.)!;;W]N<&\M>V3%X\5,EW=
MTB(]<A)_)=.'Y"T>/!#F\^RMT*13YHS5P[?3U%-1]$Z%4[_;"V$4S*$%S;$#
M.)LN[F^3(%Q^W+HY).2<9:+:56P\T9M9XNNJP2GP?"LDFWQJ<EVF#]<_'U^4
M,EC!&KF$Y.Y^FJ.[71S>]"._I\"27&JU819'=BYV8LP15UVR(1*$+']CH&#$
MX+7U_UF?XH]T@C"#9"V%EK78C=^K;JPK"^GE6NH[G'961:1CKL<K[FT7DUL_
M](4X<5ABX$<V*^2KT!AJQ@A2_UM&C5;_WG,ROQ+4ZKK9HRUD6G!6]ZNNJ='J
MM"&F.U'!/>=R!5F!UGO?RE-OK$A-00N=FH./]7XX_3332+;(&!QZ+]'C?^(S
MO?B8E,V*]&=M!9/.67W'>^-IQ3H/9W'  I.#GDBV#4RIP8FRQ<"I?\ B;,**
M;K)5O/Q.[EO9(KWYE-<Q@YN>_+2,0)^A-HH:LY(:J(:VGH/ZA(_:Q,48GQ-7
M+$*TU2? NER"S]T<SJK=X4K4>:*:Q_3UIN/KHD_5_0@)%YE&BP\+:@4;0?69
MCX1&1H8PQS(BMV[$A.O&S_B^*1*<-TTYM2.P0XG7&RHG^U?RZJ'^O*B/IAXY
MN^$XSJ=;U31Q-$1X4/$0GZ1N9_BV],TQF_!<C2K=2FCU]>#X=ULB)4XZ(O/-
M41WGME'0J/50CK!WI@4,YHU+12X=?ATNKZ>>[%P:Z9?O&*GH$7TB=/PBRY1-
M:79495#EQO$=$XC][[,X22\33R_3QWG%T,9K>-/K]ILK? TB[54]+,.;/N4E
M)H9I3PSH<L6,.M[,5]DIZL.:UO5J';G:._=/&:\W6-Z7EW4XB%QB8[)?YQH:
MW==^^3 9".!&WS$<%[:EY*N\JPVO@-DJSB'V7G3]9W'ON][Z+D[7<]4J19JY
M^_? AH\)5%6''8A!<O$>B+"_RPZC>!>0:;Y-;UQW&^8@*BX#@Y2$Z+@_+ZZ<
MJ[?SC?GH+Y]IVLPL<L'DY:9>ZD),-T8Q9(&[HNI!<<ODRESX(B?B!MEOMOC9
M^[-YN=]3GFV+=&Z)VJ[R*-A!62'MS'',).^_Q)YZFO7R9 I6?0+)S1Z=_%N3
MYABLT1?!&7AQT2ZG<*YA5=?CT VK 5.E,(0'4VMR\VTUP%]>=<UI.1=9K]K$
M*&S;!,+A[\%M?+*D+?RF--4 C^#SRC^!?5O9L-:)=O;YZ7"*W.26+J2B/3/R
MX&B)9SY/I7S,X:YS2%YW7!;YK([>]ZG.:CC+JI5&EQ/9H?VZM29>E53FU(VX
M$%(RT59X[BZ>2>ZO/'S[74E[09\WTI?R%KJ>_^78+&Z)!38AZC6D8UYVE+2"
M9ZZD8QKLUY@WDQY(=9V5^0DDW*MLLN57.SR\[G;Y%4?Q^9ZC/.7-L4B>1U/:
M3'O1N'Y-2TML1EZ.$WO3C-E]LDFG26D^'$0,P?DE/\7C-<Z>CAE#1$\RL0!(
M-M//GM#E61E)"EXHU#%O)\2:'W560$&[M@24._B5IGM4NRM:&3,T;+F>-[!5
MGEW^ET2#L<AW4_343653X4*\I*TX3S=&QDEUE>CDY?/\[">3 #/.=(OGG=*'
MK0L"X:R0TW]UCB6+$!NV VT,,;ZK^A(+&3\!Q^(MN53U[",;N/'  #M^O>MJ
MIQ(*0@Y:Z H\.R:7R@0$\"2>=]L6IF"+[*M<'ODSOJ#N?6KM'=6&3&CU/K2@
M Y0])5V.4Q_3<WEVE(09QJWJQ&S>X^T:"1;3PDVGYS:@H&:UA^),!6J$])NM
M'&X[?_2NL W#3B^$8JD(-?/KW/<)ZON]3DP?U/P2HT3KK$3L\LVR>R!#FPZI
M7G4CKGAFB;&1&.Y56'YF\,[LR0OB.2M!BFHO^O/<Z2SF[Q80Y1*-ZP'_3/[#
M&COCN>C[XEB%W.6_1$_-<8+S::=M]U:NF!G2+;_'S)(@M;X*-%.1Y7E*K"?V
MR^M&=Y4.!IA%6-CSP\R&%#+Z$ $FR8S UW7?+]7GF+S2*T(@M6V^WJRVD69&
M<( '30W0HDH!E: R!?=6&-TWK@"'1BP0\Y*DG"_I,[:(5LM>X"5;VIQ]0"@V
MR)#Z<)+L,AAQ%^FN"ZAFX3N]WA]3."8U,2^6>.2ALLVY0?/9C,ZOY?P"-??J
M>W6N6A(!:VZLA=HFZ9]?[OY'Z1Y5X6M7#=U8@:40/A_0%X=$D7&=6<,X0*@O
M]QSR;Y7/H6[%$@)AFA9&V_TF4S[9@/YL.(%PNXSU8/<W0TU@-+21^MS[7RRE
M%+F.Z]8+XBNLBY+(93RS&HFGYW39+3U_,UT'X'87/Y0C=QXRH8>GG=-1!YW=
ME!P"#>C^&E(7I/>A]2\:*N,/BJ3 =7)^? _ABKC<;K0HTU"K_5![7 \^L,(*
M>9B.?G#CT#' L4>>2R^J_@+GZ)](N!NY5$/X9F@/C[J(I/ISMOW"=QM&R8ZQ
MH3JAW1AQ*=$3KH5&*IC!$LOVLTWQ0?1"OLO9?_-TS2-P.)GL';U59L3-Y+L3
MW.$S2.Z6XO3M%_WPU>OP>N..0*55<_6C0(#9-;<)]?8>5J I]CJ2MRZ31^99
M#9R;\5^*U[[?9-:%S>_2$P?8+4]\&ZU; S\'%/NH3<XPFKHV]]?8MEERM\NS
M*5[X@^:(^ZEC'^%R8P0G#:Z&9R;7TG2B4;_>T/A5*4ZUB5!_8L" SBG_>BJ;
MJ8'CL6.L9=QP6.!RYB0)@)%E;I%2<@-^\7F_-KR>!VP#@PXPH)5\=_I^+B>,
MVW3RO@DSTV76=(S$%>T'A8'DVZ7\R/MY%XP7-/_VRHVJR=D"?MP-=WR,V1)9
MT!^(LCO _-'D_&K^T<?T$H[MA'$X0,@DX&EW;3"$$6\<8,PC[95ME!H'43YC
M:-UD2#:H:,^(7W/FW#!=LQ"'TZ2DE+^\#^?(#R<<'TUD!3((_TH@! V)N0>)
MG29Q]S"2+F?>&;M^L;@\A/-%#+B#4^^OL9$.4;P0LYWU4TA.KE<)+R,^A)EX
MUC"Y$)B>,P>)9,MDUC(0@).%732[D95)1EY[!A$M:!,SQP'1TB=@S9/^@KVN
MTLZM4IUK60M5!,"0,EV?><PM6GA^L],AV2B4NM0(^EO:U'MJL:PD ZB3Q,8;
M5XXC%:.EYT#PLK5&'Q!]IGL[48N2T)&"-QWCK <%Q?"O%VX@^\AJ)V]2>U,S
MCH#$.UP]7M'/SDJVU&5_\F&T[%S]>8PP.J&.TFX'Y<@G7<,"%R@4%@N+7\\Y
ML5A0KS9=V+1U.V0D:5Y$$'J!\EXA?ES"TC,!;F7]/(NN/GEV:=I3+AF+0P>,
M 04AI6@,WW_)7 4AV; W@>I5IDQT]@(,%@;GD(2_6[MI[TY&X8&5OU^N4U:7
MI2Z51J,0)'#29%*@NO(XXT9_P!LMJ2FWDKF9A>'#J: SQ[#TYR+;H"7UQZ<T
M'-5D$<"2)MJC_C0@(%3W..&O$=;;D4SU/+FZIP$XWL@(^S<^/Y<:ST3G/0R-
MI%8OZ.4?+>7)_;=1$__-7F5[+S@2K'$D QKOW1LQ?[UCA)JC+M8>H"3\W?:6
M'-8"#LE*Y*8NPO;B_(TKC3U +_+94F*G\9T/&H;((_:A%QD$$6S[W%&0[5P&
MBYNX\DFA#^X2<(@:32B(9\>G=/[V]*Z +#X:#5K.<]1EV)0<ZO*P#^'WC30(
M? 8L+NA(]?CVT?%,_/-._0HT@P5<)774:/XVYD-26T<. NC04>,9!V9V5[&]
M?A\RJAS39H"ZL(WFVNU;0@'&ET<,:+!6'<ID;@<B< %AGY0J= [)0N;,&D.P
M$ &Y6'D*%&=E0+.&;Z<NI?Z%2ZI(_$HFG@[Q9 AKB 0FE"? #AR?^/U"<,JX
M K6S]0+BZ$X#J"[KY#]9NOEGZ>+?C=MNXOCW]B8O4,.2/(CFK>C3MV8KD7!M
M8"%ZWKFE7^KK@UV1#1D\@6.U>SO,"AGO#;FO6S_46$5TWJY&?)'V*9*8G_81
M-+V?/(#]>N_'3^"EQ<D^/E;(M]@[?3-6A,8'M&;N&M6!V3Q..?'%Z+FR:D;+
MYOQOL"NJ1X^^4 $-U+<$)_O%:8TJV<(']/N+$/,$8J?%"T[)2+,L?P/H@CI\
M3@>Y'WON[^5B=^GAR=_/J3VQ$/J/KAS\_TG4$+?=>#K7^)2\KTDZYQ]YPS(N
M*XHT44XUKND"?O%C#UV-OK?O/WY>Q.9M_=H1E<B1R)Y4].KHT*C[L%*U5,<5
MBR1K"7;#2!RP8GW,4#KARQ(NK)XKM\/9%'E+]\8ZE_'IT*\!76+8LU/9EG<4
M+%DA'T'G/<B[Y_:)9/L:'96: +*B[+%<V+"_8MBIV1=QY(#S=V^N!BF>XN=@
MA>21)E%3>O_:!/@O)%H$Z1^@MH:_A=[ROXWID +.1%H%H93<Y>[-[ DDAT5J
MP9FEI6LO3BS(^GG/;CM!&];<3S>9*#@QZ$1/]%F-L4*F#"95D*^E+3JBEMCF
M')>:7$>PJ!A<59*Y9-8<];*YA!>/FPMWX;P2%S%[_<[7K\Y]-CY#^5/A75LY
MGQ:=C-^>3[SFZ=.R'\]B<6?6(,C1\?;7PXP.E.Q_TPTH*R@RF*.L_Z SNTFZ
M5.[OXA#_3R8CZB.4Z._ZE%<W%Z+&/@=:7^#[,7%%XR< #1(9$^.PB$ACURMO
MG8-#<^>]JU_ZSU0?\R>BX4KS"3H_ 6L1I3<;PKU3CW1?<EB\'A7V+3324_)#
M\B:>="6U;O)17OFUSYEV-%J4[83X^_>T1=V*<KAKFY)&>65_(Z;:)8_CC2 9
M-+W[Y"]X\7R=G*3S&O"P\1E /'%>8L4N7UQ"LO#\:Y&N_J?3T]&$QYA#*P5*
M,&XT]64HCQI;W_P4T9U[&'ECM1^%V4!(LZJUS:OR=M'UN4O5? Y.9V))F=!1
MKF\+@:83F77\_&%(]BW:IQWOU_)"6+\T=\Q\^@D<L"]8Y]K8Y\PA&4HV7,]
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MF-*& W,Z_SL0Z-]/1UF?C*: 0T"UU0_MN7YW_I$G^Z^F$S*$3/DV&HH]ULD
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ME>RF-P'*H'<F*!R&.,EZ@/YQ')<D<G^R87*'O@#F')(EHU30PN8V.%W(@HZ
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M]&)8^L@ VI$KHI>DV_KQ4V&S]A.R?=&,E48DUZE2TN>H^GIO7MZQBU<(@&G
MEE5+YG:[^?-)47G7S^..A43^+_WD+SXPNH1K'9G>*WC:(&N*@YX;)8GNS2;2
MO_7UESBO6<?+#VH1D"^7^]A+/<:%[S9DV978MZH:3O1HEAG=]OMR>>T%^W/W
M&DGD(;'[-RSQ]+=T4>_SY-]!S=D2:%R(+T^9K'UW?B2Y$(;DJ0FS[^0SM,K*
M(F^3:LV4TZU$ZS$W9'\X"1@?[K8,(0#G1;6()Z[IG3-_[(O5$J!S=T?+(]^(
M9B[6B/"_G3\6;S0LB("\S/WZ'K$ZTZI=8IN',&,YK$!G7E,:+4M<8^Z*R!/[
M/'LQM^XE*\3%J\<I/7,!1TFZA"*^#>NND#WA16.@,*4>1,Y\%Q"+W">O#']E
MV+(_7QJW' EP#N4R*7DJ7KWRA%%4-/#]N>,@?EK;:]%WX!Z/&?HR2LOC"KI3
M+WT 9*3LKMR]]OQEH+LNX-6KUICF5"45G\]R?N3$SHK.8+B8@X&CPXUQNPXO
MP*"JF&VM:9A2&6'V$T".;9:V3+)KB?8*I[I9B@G&$%PG%ML89',F7>C:@073
M;T;VI1=]8!^O6!4,)G,G=Q>F!C8-,2&9PR_YWO0^BL5-;F<]J!W#-O2$N.5L
M);N9+5,>6Q:': ,U@\\#YW6]C:+:XE=@S:@DNJ8#U@;33, MX\OWMU1:K3\$
MECD&L57H_F9G+5/X0M$Y<;L7&)%BTNTQ6/S1@-ZH2M#4G"W5L;Z$G?OX$W D
MZIQL>;0$NJ4WB,W("@6Z4Y6?*QZI9ROD69L>9HX9A5-/]=IX)YHHNOU0;6/0
MZZU2AD>FKOA/F7X&9&>L7A4G='.KK2GG%!:>"LIA<03&T[L^?UCJ[+&\]H7H
MPZ>]%"5D/@O3M[,)JYK>,'1]P@KY,-6;T=N'J9$VT\#W)^5?C+4R?35QOGO2
MPYHE[&N2E0'4ZT+WIC%^VK%:+M]2(T$FNR]NIR,QA.BQ(_RHT3'P(05SOB&K
MHVS>(]K1KJ"DOD0J8G",)4LV<<XYQ^4E@ICZ%,^<IE=Y]M0U_TL\-H.9]X>[
M<R9ZQ@42Q+^.P?ROL[#I$P&S>S/X!QHY^:L6N=]*I!(#2NV0"L)Y[ \"^SLA
MW5JY,!4/J[[1UR?[;#VZL\W01)YP6_.RU314VB@G M(_;F8_V>'A;^I=XFN7
M>%5A<O4N5-FU-M),(5?K)W"TP4SI+(K&OMHWSD$>ZRGM>LROA4F@Z#L\W%YQ
M1G/'@&)W8[,3PC.:5Z>&]._(>HV:B:EQ8AW5(9 =;8YOGE'MQW!Z%$B1:,>(
M!F7=F3%/EL(NR:MSGJ<;-R5.F%Y87@FJ'L)(D?PBOM(KEAI;=G.US(5U=DSK
M/]*2O]HC/>1W)U:(83T'ZC 3Y=TL)I4/^W'O-/G:>F!F0H5_<9X,,A1.,_?%
M9BA8TD@WEW3,6+&+[=XUM,;3[I(5[Y_  ^S=B4J,5%3']!$SK2R=T5J6TFL<
M[)OLP;+Y.[Q![2\V&(&O-G$;5R?T_^\O/?VW+V51*/:8PZ\F-LSH"!.O%RXY
M'I68KQVJZL=CG_%@53V7(,U>>&;A?O;2!1IXDY%35<S!,N=7&3!#TOW^!=<+
MV/;-/ #/S#A<9_3^@I)\<L^E]$_'CGFI3XL8^DW"%5!0W,+IXG+G:Z0S+JSH
M$XP_ 2;K<I)YBZX"JP9;JS*2VSQ\.G$=&MGI/Y-O14:?=/@N*]7UGI"YZ'?'
M0R_V8E3=;3D#AGT)%S=^ D\?#M9;SV]'J.58*\J5.>7K<DFED1ME<J]V9(1^
M?3B$9]9YMY#T)+!T"D?83A),A"9OW:Y"+^>,!L;HRUT/H!G"R$S=";C_6V#R
MI13A-X]'SS>J6I\<7Q!J$?8M,#V+G$!RF"8XRQN>Z;N?KWC\1ZR]'+9;YVHL
M9_'[K*_FA/=T.=#X^;Z,^AQ)[F$8<2A U<W^TS)1Q)+VY9/GN;,GV!D-J]H8
MCF:%8]_@9;]K%M0(OYE.-6SZ^JXGB/<A5RQ6-:.Q"H]G5A$]C4,+-/;#\NU0
M=NWV$3P6E;#G:M;EN6SOV4ZF1 &VGRP.VTD,YQV^+'>C^(6#D5RQ5%^C<W&N
MX3=LSL9OUV?K 7?>4\72M]OC@KK)9@'2.IVNM]BJLCOX8PX=7D,79;R;JZ+!
MR$31O$]/,C@5M-7N<W5, _5CL^N+:F:CJR5TSBM;,?[8VQ*><>B]\P>?6[JM
MJ:'JCWVL9_8W,_!\\D%XF'#&W\I-<1#)G1:^W%W:*> N5^;X$_C\9#VR]0NL
MK?YJ3/%5N8Y7[VY?D:P!C+JO2G-Y0+9[1Q'C(U@HBP*3#Q/'8P%5DV&*G6D?
M%A@6/1%@GBF_U8CHT]!R&CEB)S]:I=X^;)=LTIS5P/\%++#\I#K!A#^;%1>5
MI!-8D+%^U^M!9L/#<O^.)%UUET_X@UI$_=7X_! O)XDI/8<NA\!;:MXAUTUC
MK$ 9DB(M.S@T6@!#SM<"3&U;+<I<<)Y)VX3"!X@GGQYK^)?PXN[OP[,HM"\/
M9W^LC2;B)N<&EP9*CWM*I7OZ?GYYK2!)ZE,$" SONF8B$[YH$#QZ@S)ZR?P>
M9)\2RS-I0LMYWSZ?&Y/!,UJ81%73Z#KV%6[*AN=UV!9?/G:R(.[@W2 4M'76
MLR?@Y+FM2\].)\F;.CVL%,F2<W9.<M/;I FL#NH%AL7.V"AH?.2-/[-0W:!8
M;69^'O>X;$A8BC+<JA<'B?=!76_K.M<DI=*X=OT$K#OI!JJZL,L$?2[#M1ZX
MQ;X1&$5LAK=01/1_*T&=2.3/+<PEW1]Q&6%&3V1EJJ*XN8"E'YX3I[MN>+7L
M(Q(%ZBEUUQ7(GKF9OYT6"XTU;KP:HU[+#-K+#JYJ,?JK3K%R=ED9HQM2_@<-
M[M+Z]\@6Y930)4XAN1]&'& MY6SA-DOW]=E11N^,%TGZO2;-\4=MB)CEH<7O
M%\1H@"(;\LY;0,LPSLL1._3F7O0'!JFN/HLS ZXSAJ7IU?2*G9"QF_;3]_?)
M7YH*4DB"PKI_ G9JC319NE+\LJ D$J*&)$"10YP7%4BHC5[I3.$5\'9F=KS4
M09&I?BZ#9W;0B7A_K4!$NCY!WXN9OVFLU#M,]S?G#0J9H"'G3@?8^>KU#79@
MRX)G'!S%9;HX&YQ>E);HH#X05<\G<E-N\N. 88%BIRH'*^\<DJ6J SPR^E[5
MD^5W49KUZI6_!=MO&=#K%1U^^NS&M(CTI>?H:;OC'I658R_,K'@[OST_<_]0
M-!W@_F+BSF=(M#>E+/7;YYA".3.K;J'O,YGGX;:?L<!W45;8XOV<S/"F\HG^
MROO+3RBZRSJ$1I&1-OICJJ--4=&W$]^QN2BFT82V=6^@Q_,;'1-TI'"G57LQ
MDH%2^V^WHG-*I]R#;:<L;UD2*P<,W9Q?"D/PS$<.^/$9F,K6>W'%G5Y."2OL
M+>:-Y[Y9SJQFY6NJ6<;[!,\B\O!BS.'XDF8SU>S/SR^O3UASMJ<+XG/3GVNN
M0PF &ZX;MV0S"RU58Q6[>=C&#]:GE7V*6(X-748EE0*VZ\$"1^])]80F7[I@
MK2#Z:L::6Q3PD.ZN7WG<U7;\"XH!GQ448W,%L9*[$">"Y-:X;XO^<F!*CU3B
M=7DI-9ZBGY7YXCHVY<PA0 $.Y3<NDYP0X2A4[- ,$/H\KR%;I'W^P]MF!3JS
M1.THJN[V*GS2(VVDJ>Z;-Y%99;T\[E3]LH/R]?]K[EJ#FKBB\"[!A$8(H@L"
M)JC@Q,4:E1HU$-"E"B8(2D(!BX^14&W6UPPJ(""Z&!7=*J*!QL&@*R$FD49%
M 2V*-59 1Z.2X"LHOFHA4,0*@EJUO4M_]+_3F?;'/7ONO6?/.??>V=VYL]^W
M6\N2Q<9%>%]+JX?6O=M<JK@PGM=E;$D5Z*O33-[CDF+X O+,Q%3[&BA[SVNU
MNKI=M636=O/U*8_O:.O"U\V4>&?>N2K0/*<XHQ8JZHH/?'P=.:ETX/<UEE#S
MJLK$L[<7SABHU-7:@[;#%YT85U"COE\9=3,\\:RPOW#XY>24=W/62<^YZ,/6
M9>>&8 &XP9G@$?-M^Y!*0VZTSQMS1_7.9XJ+G)66JJ3%"D*4>S Z4Y9DL/LZ
M@QC:N[(/)7X1QU:<3O L*409&KNPWT>^59RX:MX6?L^^)=HDG+M:5Y\8EI)]
MK@KSF7AERDMQ<M")KZM^FNJ9TAVT;<Z1J.2S=MOC]Y? <^; 4J7ZA,O.?0ZO
MD>')21N,C2,1DZYQSSD$OL[77@O3)K9>DRMVIQTQ]Y]:$++1*8_8+PIH@1N[
MPA8M&'XAC'UX[N7,"S+>D(RI"RMVG6P)P4,N2\$]^^#TW9V7<^X*CCE?]#YC
MF7.(JBCYA H'(J]]-01*?Q>G:KW?6WI&H+I!]39D5#EE/^1BWH%.H\Z7XO#;
M1M;6\? !'\&T2]+"M\?KX@*GY]TS[)D&<3=0[ #9QRNO.N.8([S4$5V25K1@
M^4PWGV&2'FQ$OR&!%9/WW^,)_NU2YL0-*@QRQEK&M13HP545_2,[4L^XHVG3
M@&UV<;7B>V)46VGG@A@UM]E!!.T<-@67A%I%ZR,IUZY8RT-Y7O,\!^$GW1H7
MGM' \X"FJ,BLU0FGK?POE+!^XU&1N''"VKXR%":\KNI&3\?;2Q<OBV=$9\FY
M+ZPSBTAH!6?]_'9$9]/40%.1 GY%=[2(8L+YF#6\CW)G0VGK)7#/ B>($+1,
M:;DOEV'N8Q[+5+6'T)LBRJU%4:PBL[G-;<0H1[Y6_HRO 7:+M;<B#?G5\1%*
M>!LW_<OVM1Y2AQJ!_4W(1[Q)SS/"E4TI."M#M*E)>)9B[NN566=Q;1N$D(WC
MP#RDCY  %*:XM\1V8P,D[#M:E-X@;2-0%Y&%AUMM6F4#%!W92K++:OCH>&V\
MJV14>$O!T6!EDQ#FV.M.GI>F"1RIS(W'=W)PW\\S_"C/B2=?=C](V?'*X'<B
M]M1L7MV.WR:DNN=ED@D=*+RHY&EYHLB4XRY[A(#P0X)9:T09%3TDM)>I82&]
M%CWEQI,V!F/BD 1%81\\7-5V"+;.W$_XMSSP+]I=ZHG ?LQB=W;>6+!.!X2C
M8S+XH58H)+^U01C<FB"_Y;I21+G[;]ZH,U),$;^$9GFI, ^+E<^)HQ$2@98C
M\%4PS?INS*,"LG=0S")<K#C<!A8EU96=*3)DE!-C[V7)C:&FW&82^LY5$C?+
M+++!))2F(C&#]R2T$741^O++5/,9]2Y$T/((4W8KF>>Z'N/^?&_>AZ/?,/;<
M;B[:1$68&I*/!S\TPKN*0G6L/+%Y<CTT@U4:'ZSLP88].87?$YG2I9C7LE_D
M)6^/S=]:6$[XYI!+W^H;)D>"5HU5>B@=\]5Q?R6"+#=61MJ*=Y/04R)PC#HF
MTC$!0RFWDQ*]7RM9Q(Y==HN!<.W..+#$]5&^3S6^>@0.X. 2D>%9*0I77C38
M_\<XM$\M"0$D"C\T=@/UT1/A<R<X9E7T -DYVP9Z1NIY'>4$TXEUH.6$Y],C
M=6"7PWACHM&![[\*J)9A4%=,CHPFF="XE/K)*]'!;U/ 'CQC.<&8"ZI0?SG-
MDSG<1/N<WP?.J!B= RP6Z8?2[X\X+6Q@TT=]<* 4L\E6!JS8T9W_!'.A6\J<
MP'+8($,HV#RP'8EW&=#5@Q3:U$ R"F+P/X!?AGR+-^C9>U[Y,0REX#IR*6B$
M:3L76T"Q#!LJ>8C2\3A 9^6DH#29$/BV#^#)+YJC() PS9("VHP: 1(/*?M
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M\KS<(J"51?#>O(VH?X[SD&9%N:3VKFZ9-@[J5_50[)4N5"W6QI(H9N+2_N;
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MIHZ]!GR@U+NZO[AWQ$$.,'\PNQF=_GPDK5AWV',(+7T2*\YD=9702!7 _;)
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MB@!FW8?20C&N(Q*Z6NT8JG&IH'<^%*YV"L6[S]BHR6X^-R_:EN*DL/B2Q!Y
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MA4I'H3I-/@5_-56>!K]W_!<SUM$A*TS+S_7%D+4A!3<[=]-W$R+PX-6IS@+
MZV<//_\=$53X=NCDY@5UXMG.L>NAGY8\!?< QSYEY^8/M)/G0OSZ/3MU-RUL
MZ2BJA [LPRUAC#'JG;I=H5)Q&*-;[KH2ZSVL"KXX(-5=ZY,<+F %?]2(2J*5
M*J9:6V[.0 Z,!<[<$E%@[%)8,B#!@*<;GCK#TKZ=SKZ<.(!?2E] 5MJ;8IXR
MVF$ 4/8.26T*+V=7"AQ)===)3C9)YH]G#)9&@]XT4R]AF"EU!*S@P%^3C5IY
MZ4TTI-T'GC"L.<*IXF.CG3*+I $OKISK$P3>JTF?E7-!<2'/"/O:HYXBNEAT
M..GK]>^Z=(8YH17_PSV\]:M[R+EZY@^@![\70.1*-J>=LI% 0QK%<EKUJYO"
M[IX/2A7?F*Q+T/G[D7Q6D8WS]$'_T2Y1/];0(B\-DF%G]*6#JYO^XUKG*S/Z
M^X'-\7\,G."8_K3OB*)T<06ES[J#W_F#^V^S<6+OFYO2%KB+UD*X4Q=4'>-4
M1V2 M2(\?C%-1O5^A('3>=]TK0)P&,&I$O";1$MZ:DM:#CU.7\4!T<MHU\EH
MO0"3V$X8D'4=ZS:"&T\5T5[&T0@=21K$T+41'_.Z#Z Y*+UQER"B>E*Q"]*^
M@*2GI16I\\58C=K5 NX$ ,&9G9883SE-?O(AP#<M!)$..[S4$_IHI _ V4_>
M5NSQX!FBU&$$T'YU:G)X&.V7)0_'7!8(6,QAB=76P@O*\QJ!!C$^<LW"<J0"
M+A+?-)5\73^18F[A6BB4$:.?)CY2&S&6&O+2?[E(2F Q-1%"5!Q"9-1XOO_I
MS^/?0I9=*!:P$$WM5S*\CF\O\P=4+:*'6U WVVETSL<M(/G$! ][RUB?/-\X
M.371XA(_$'CSBOWDZ7A:/G\<<Q=OMU7J Y*UJLD1Q 1-9ZVW]MC@$33?K^GJ
MX*,WBZ50]$M!ELTFV>G'*DSOR,R<E.*!&EL)YV2><>,WR11&2TFG<;1MWBL_
MO%*D79+6>4_&7Z:VY-!FRR@P6:NEXQUP60-PI*B6XL$(&/#JQ:ERY7PV72N;
MRK6\R,X(ZCZ4N>R)H&GPGW9A\TLE;?=,PF^DD;UYH9%XUG#L^NU/9:Y']P"_
M_I!:4YN0UKXGN^3<X(3E^%U8X,==P?HIC*LOKU%07J- E",2O82A>SNLMCJ'
M;"4A 3FY]!@YO-RV$Z06$/#JB<,P4TPDRE=?K+L<%XY4*UNGC #V .>45"DM
MSM7LM54<N$AZU(.RDYU:8\03,;(M<GX*8QS=USNO#5:,%E&;@NU/0U"N#I)7
M=(1 8!0&R1&(.L42(Y?YM4MYQD"Q"S"@:"$68N/42C'DX&#ISZNY"YVZ%$(Z
MX* J[/)>A2MY1O6.WW9-C/.J^-UZ)GB,[I+['@":&36O\?6BN"NMA3^;N_\M
MWF=JOWDG2O]"T:M5LU8\X =OYDC5(T](,0>8LV=_'GEO??:=%=JEKT:-J63S
MV8/DR^6HXJ",:3W[PM,+PTB>8 $R?#4Z=H)MB;KH5$U78: ZD>>)F2; -E(5
MPYP7?2E1O +4;+V(N[?^*#CII2>2%Q)QPK5$@/V)O<_QG,JB3&G_W6Z'@GD;
M<Z*+GI^W.5;)_VF1^F+ JYGC%FB%X[^J./<4O0O5N);2\SMHF6HY88Y6*W<;
MK3R=@NQR\?B"B2D,X/JRSJZ/0:13.;]+Z9A\1:\Z]^B-Y>JMN2Y7H]'-P>SI
M ;UKSD+&&* W6SOIKLBR$6W@0+6=P^KSG6-UO7Q!<ZZD[YZ1#K6MZ@!:@?NG
M#VB_F]0.=\2<6OV[+OYJP(TPE4M"5Z/4UYQ=7KO:=ZY%G5&>FW':AA,,B>R:
MB*T<:?"<MJ2ALJC^/=CW,&#FPZ \>;%YS7H$ESPN>MD#6BIX-!4!;+4D:SI!
M(1C.32.JH*\B[TFP\,ON:DH4OF(K&]IG'16KM4Q5\5H ;O#=%VHQM "1L(#*
M/+T$ ;A> &SV@"1*)N.9/?<K0W QS2.;A2#>@/UDW*]S#NCHY32_+ATXQK15
M][((%^QS;;.(2CQ+:#-P4JY9=@=KXD<JX"0I4VB-EH/]BRI3W3C[NGGTVS67
M]Z]Y0MHH=IWLKZ26OC]/UZ(<_K-5Z]]22QAY(Y9])<\1!^58#\UN=W.?R@XV
M315]5[AM?*OCR,:NC>@,X;IF:9_1_?HWA2=M(X8XGKP[,YZF"WS;@;>0SMTI
M3V^GQV?Z3;]WB;.13"ETZ9()H7)Z:LP:>;U4+3=0H;<#>Y>:]LQ^/G]P>U-$
M4]5D/X1ZL-K/^>.PTR\1/36#;UY#]'A6$C);QVS>4(LR7M$ ]'Y;Q#607YI0
M?9K$';><3S$019WHDY]?#F9' %Z_1AN$TG;T@D1YSNT!,:V; X0?D^'Q39__
MY-KU7:G,:NW]8G:12T''Q\A'KB^^JE^0KWRX!Y0X\TX^MPY=?4HQ&:W(/:\?
M);82SG]469'C[V/TR5+R*CA Y>&.E".B(22U'4< GFRD8H/@SRD0:0:HB5@5
M"XCR#_:A2NK%0N!8"OF E1R2=OOYR$,I+<JY0"=7]LY7QX70GF0 C %?ADA_
MKE4CX>5 0V@@P(0M#@/E0P#!T@ X&D&Y=(@%)&\."6SXX>$P7E,M94= 0)QD
M *<*BU[N?CN)9D[N#:7X1;$JNXI&PAH2]80 :*/IOE\D4,D;8%ZT+=VZ:LZ?
ML#_IW5L?J.4GXOBG-Q$U%36=G$N7GLQ?BKB"Y#6,K+'CCXJ'8Y?H=H]-:KY1
M=K%M'B#DSQDW;1RW9"^'-D2I6%[,.B[9",< Q$'BV>L+MUU>+8H_.#)8M'V[
MDFO!I+Q!7Q5\0/7X]+;4J*(R%:DC'.@##;;>A 4^ YG^"WW6<-^/$MS)V@-:
MM],L1M)VU(-$V?3 \W_F\!N2/99HX.7_.J'H$O_1'V'LBD#MI]LG%O4Z3MH+
MS'.CQ?1]XSP%]_-#X+5!8JKA&\^2BH/G 4^L6N*<+E0N_R-ZVE.;UL!QUIWB
M1[4ZRP)"R3U!)"S=%%\>BI=>%C@2MV!2O(S;KD6 M-NR4S5%=$@8"8JU+_&-
M&%<FXOEMJA9^8PT' 85BW#X1'RN9,/M+ \\D!F*J'"$##P-;L8"1/(&/V1&2
M;.(M1R$T"MG$1WMJJ4?WA2]%]]T K44[-9EXR<$DEG'46WU$21&5!5TZ$@90
M;VL&AV%LPJ137HV@N6Z%^&)6]H"[=MR&8S:JLA\[4:L"=\/W /O]S)#7;#T4
M)?'71L!*2:D5%#^:\0^PFN)WX7CIYD+)+>7C!'7/.(:K:*4 BXKH1LN8=V#%
MN>Z2'6?(RP>Q:RZ_! L.V9S.>MG(PY>C1-\483V NX>X:P#! P%KJUERL\?U
MK'45[Y\681]E($;=&O>7-+==W#+K*Y(Q*9>H*@SH@KPPUG+^YQ-<ORU"WG^%
M0FGEK^^WVE_C_J=.R8C;YXK]E RMCAC9GF>_A:?#/+^'IU'G!Y.MVB!K46<!
MJM>):0TQV#RRA!I!4'[4R&]&%X+J"@7-JRE7=_E-HA77<(![LXARWH$%)-=X
M%R WIVN $)+N7O*F''^;PPH0J.U-4<D^./#G4D4AKDS>JTGS0VCF'.6\^ML(
M,!C6VTJ%_@A]YY<#1G)2" D')"\B(*4(OADH;Q=@Z+K,+(=CWIE6*0&R5K-X
MO7&,WYRT"0!UJ#ZOAZ. Q&0JLAD01G)E4DAI,+J/2/O1A(KKKJD,Q0J#;NN&
MT),WH.W1_90])/<^=9!VP?M:X?4C^?!//9LCJ*BI+^M1M4(9ZEP^W)!^*GR/
MM=ZG4. ,V2'=AU.')YK2I7%6,S[F6E[%>9O]$KB9LWM GNY2&OOZ\/E>WA,L
M\I N<X3*,1?T'I#[^!L.ZF'+/*.U>Q$^87:CI)I'QY/:F>+],->Q>;_9 TX<
MW<Y_L0B)E!%S,97XV#);N8#DK]PWN"ZM#27[Z.JMYD^%7L1FIZV22M9P!\2V
M+]QT/UFOZ8F9%G(_>B4"]2WEZELOY3-B!6O86JA&I=/S3'@/6MS:6NSE(=?^
M#CV2GG:.Q"/)XZWWX1+#L;.BG?//;Q0NO$WTIDZ=1"LK-%I@MGB@%OV%GMJ]
ME\LT'*THGL2$)Q9(Q(C$'->4;*(';OYC5J.+F<N<S_UX[<K6 @<G2WU2@OSD
MGS([_^YWB_8'?_T:$>1U_)MU]^9DWT[&]_Q\WNC2J_.OOD\J[<QN6@0(R)@2
MK^:N9*9/WI'/VFIE#S@(\$Z5BJNG]H$[1.C>-O, WO+SNEK27G*X5'?->L&-
M&%C6?B:]770\$!$;JA>-V*KIB:-0F:M?*\HJ\/5R2KGIJV^3:#8YS@4DKZ=.
MGT,RLP8 _S1W)L;"L-: %LV6/OD0G+R:N<!K$M:!^ A.[W0VR/F>IE7+C/@(
M1#M1=!L/3Z94\1&(T3VC,VH2AS&L)@!R1>W:GN4P?$6FZDE'*GG-(VM%-NM.
M:5]2@T3;'%2K"*BU1JD4>)KN-_)GNIG+XN]\;R=BD"YMRNZ.&1C:GZU]OQ?F
M-:717\&\8<==% ;57I92/T<&L[^ZL&#_K>#I#@UP>9;;(,$=<8EH$M0,WQ8<
M4GU<]V4F$F5&TY+[;=:Q4A55OI)R\;W3E=!Q/&!O[90J4!9GAWS:H6"V^R!C
M9J#>RJ(I/TV7;%G@LV!4%T?_WA3[58F...-61!,V-2Y'T27-_<A8OE65&E=L
M%?TK&W]2#*O51>V;F2;J[LV _7KNZ]+\,S>CSY3+%:EWS4<>.ICOS4#P/Q3U
MC, ^FWC&5Q:/BD3E%SRW9\Y "Q#U.*I+KD4&OB^"]FV+$Z7[AK2Y&JZ7!H1C
M\S<N#:>*QO0I61\U+;G*NSJ#A"[:Y"CQG"CB?:IE-9@YSM+L'Q%1D+IVB>..
M]MLBH_/U," OV?,2]T=9UC,-K)Z8H:S#_!EHI2HQV8N74E*27%UR%HFZCV*%
M/:V/DG%WHKM[BDNR"7,Q*&#Z9ULFOP>Z%H@LM*A04\@W2-*,Q4HL46)_U8T3
M]#Z;ZIU4N@#"]Y#D70F3$4:K-M4A&1#Q=2)VS7CI@BRX4_=6,\A=.]C&N0T\
MK="E:@%,2;-$.P)'@Z69%;IH#9RT%Y @H5II]X&86@,A:8#7#NL6F!K_(R1"
M^Z9%.:]V:2AFU>G'GDA.7#.?7 XH%'D#S)>7DQHOD)A,BP XLU3""B 3DVAY
M @!>P<6N=VG*XQB3O].Z]H(:WTP="@T:Q+JWR.,B,6XC1#3SQKQA6[.P7+/L
M4%1]]&^9$[N_D'IJ[E[9>FY>%"C-V1-"OZ_%TZ/!0K49#TT&'P8(_K>^N^7_
M,LZO'-9/BG&N-.X42&*QM0"^!53?FY>YL,2LXORX&57CV>K&*CL"7 CAFUFX
MZ3XE["=/K SB@@\LV+&*@GA\<<Q+FHO]Y:L!'W4XVP7EFSUM&**.D D-A^NA
M-D^_63KF'Q12E+ R#U].?-#L:34ZAD4K7_;"9Y;"@ B\)W8@C!FW]0GD/"-R
M %(*W!IXS1$MK^X?!,5[Q<[,3="(=IEE-R_CZW&,Q9>S#IICIKX&RL#*-=X%
M[8B6U&<AH,[ +SW+N04';QH=*$ A3XDX?K=P16.^+V43T=Y_:6OG+OYU0E1V
M2"MIQQ'L\[/C^/]UI*,ISL[#'Q9NK]WW!,0(;@J#]OPP<5D7=E7V8XU(T(+I
MB.>/&63!5[;ZAJ,J#CE-];S>64 <00 5S]]_-N+PEHF'Y5!\<K(1,S/B_[/P
M)MFX L0YHR8_HVL@E[55 K"TPMA:(!8FMZ3T9PC 215;E%2+8L]49&_($(X&
M'(WJ8H9(5Y*D/]<2@.,Q%A ^)S6"[ (W !Q=TFM3Z0,/W?9P1]*]=7.V45O%
M\?(:4:JX?' \5<$D=D;KDUQZ-&67HOX'2!B5!9*N :TCB(X$+N#<")I1\#3H
MY,(=R%:M:OU[CO%=MY6 _,%=;M[]Q6M/%GZD&'?_BR4"V([\M6@1ADA[(_!T
MMNN&IVX!%O"&A8^:G@V3$T8+_',=:$G@R <AH5ENU?J7C*M.2>\O6BA.[IUY
M5I&>8K[ :P3.S:;+=(UD4D'3BSR?S3SA?HZ#A6VM=0K)VJW-*:NN1W%"PD/[
M>KI^7$[VG15)2'KVOS:49MF5.+RZUD>*'M6JL,<"O1G8J$K02LYO+21\/HT
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M8N-/LN,?BM9)(3@=R@12OJEC+I@L.=+W'SUZ_%W$UBCZI<5\5]\WB9IRI6P
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MGH/SQ*@YC^I>J![8-*":7\A!,6)X'V!O0'ZCG*9'=\O+ "27\>F]'1*^7R.
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M' 8/)3WG%6W>.N%DH!5D+?UY-4=4TXC"W+J>I%AI+O1DG.LD]J%D;A".6?>
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M1?[U>;OF.L&<!9D]7;?];_,LEW6 YPE\Q5SYH3[=I]^*D(K+F3S*.F>E\NQ
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MCPQ'G3,I8&ISV5_M>UH1ZM.^:OE0A%4(K2<.YY#)/$EB<L$E#DQ2*Q">S69
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M;L)[;)6D3JVP/@Y-H&9;-,N\1#!)[HO(7C%/R+^TYY=^!UM*[AV+ @*T??2
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M@3IJCJ;.FUU?S)WNRG;CZXV\-X"M*J,XQ)Q(=I)L18G#?$W475_=:6Q&-%=
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M'G$INJ[:O&3 ;]C/WBTPR5*AO=$_+H^=*]53+Y4\QZ@7N&JPKZ!*Q_[X3%(
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M/$Z[JK#7[%J+@%3R9LI  <K@VIMQ5JJ =5?[IEPH6U*_F_.,ULTCKH$J[-M
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M_.F(925^-7UNP-X@NL]Q4G/#^'2WS0.%VZL$%;Y++!PS$R5K03#3GJ+.9Y5
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M(G\9\85'E&Z-MR(VJ3/Q<"$4L* LM!JJ\[HCJ??BOL@^G!Q1L- VBR"\*,O
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M(-*X39>5&:G?KD)_;F4/$IBFD:I5@H)K>E'!>B5#$+VWB!EIP/75_3E40@4
MF&DXZ')%OY,-0K$89T,4L,@7+I^1%W_<H@PGNVKMQ%W^13_%N=F[-:H2ZI9K
M)G]A;_/M+3HBS5;4\\93Z&#PU\7' P\,IJ'DW@8!O6EHY^^V$6C@@4-CE: O
MZ"6!W03%YUYX!UY2 V2LM@%W_1'FSB)=B-;D8^X=G@L"RJ'2XBL[>?XO4[7]
MEB3^?\+_'OBO**E(MJ%8=A28[P^PX?3_">BV^_X#4$L#!!0    ( ,:$?E3K
MGR^SEZP! '/W 0 *    :6UA9V4Y+FIP9^RZ!U14W98NNHL@DI4D&92<1)+D
MI)(S"$B104DE27).@E D$4E%E)P1R1(%"@0D0Z%D"B2G(A:(<,O_]W3W/7WN
MN=W]WNGSQAM=CCG8[CWW7#-\:ZZYYMI77Z\6@1NJBBJ*  @$ BPP_X"K&> A
M</W:-;QKN-?Q\/#P\:\3$%$0$Q$2$M&0D9-2,- R,3+0TM,SL][E8+[#RT)/
MSRG*Q7M/0%A8F(E#7%I,4.JND+#@+R$@?'Q\(D(B:F)B:L';]+<%_]._JP[@
MYG4<(;P ;- = .LF"/LFZ*H;8 ( $"[HCQ_P^P?"PL;!O89W'9^ $,-0=P/
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MH-,/0&8ND&DGV0G9L39S=,O>S[(P&'#,'V'&?LM7^ Y2O9I^94H-2<RA,E$
M57N??S+H'=\5]>QF=ZDFKL?"#2GU<_5ZKL;8SF!IZT<U=1\^/-D)OB[-#:D
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M"L'^^8D&Q_&$:@'>K _DAC1Y<D>/1I\]^WYO-5B<"?^+-8IXNN_K9(5^3)9
M'<^IP\@H>$"[L9FI=_!NNH/S'F(]_MB6 H2HFF-2!>.I_O-ZN>6RY!LW-S^:
M5']<"1>KZ*_P<GE=3*)(%V>'O2+MW/4Q(K94Q95>G?+):U=3IE 99C-X"5O%
MEY?,RXEF:TAGXNG-:?]H>ONFE$J>[U? 37M=.QG.@\?+D+AL,'!>^9,%T2+
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ML4:Y0(&3'%S]ZZD445E'YYQ L=D<0]?-SR7%.=>D+*?L*:+(<CI*.'.NXW[
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M\]?M2\^VQ'LS%C*9]C\<9Y]M+V0J#U<%_NT88>ZE'^;]RQ4FF/]=C!]DOV/
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MO,?1;RI[150@UE\\:'0JOQ8C2]X(J8D.\P@<%Y($$1B(0D=<-Y1)[+54@9R
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M/OJCA! -VJ%'T!XQ^+]826U_ [KK_^X9'?_3?:%]<2BRQ7/N#M]OP&MJT&^
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M, L.?RICI4<@(5PF\@:"1$L+Z\C2N<D6\LE?61$37B]B >-\UR%DKI-5#>D
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M:^XWX!NG-TVL%]4\_6_V0 _Z]*4@LD(2+/<_178[SL*T0X\<@5%T^<B_8L6
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M95I^?$?KKJT)% AJ98BZAS,(*L3B'$(E?=\9@8(I0C<04KX8#@9)8-8LUF4
MK 42Z98O9.9@.H8Y,0<\WX$_EMK=S@](0&[?=/46?8G\S.AI)?:PG :OP4 E
MK>N=> $E<UW4":BR1P?0<6\7KY0[.*# 3&-R44YIS!E2'839)"R-R1D"ZF..
MI7(OIIW.-9>C?\B![R"(W6M()=NZWGK"$TRJT\6*-PDWD0R#?6B*80K48*(L
M-O!2/ZM+7_U4CI.D>>$L^99K@M(-;K.-66O&61I"5,YK?]FFAJ+$TC)>XWKD
M%Z;D%PM4LOG2L>&CIEV'-^_>'2UN)"I-QNE1\5>;>S]TB/>SP:\I8L<:GN9,
M.8\]E>,@<-;($4;B82/(C+4ZX:&<R-.W]+^RL3U8_A+]E2(#R]J0'7[[V5;3
MO%W4 CWS#',@-5G_+3[\/0.1>N7)7@W^UVDMY^%%QJ:UF9>/5O<^1=9S4,EY
M881@]PV&WP#>L8#7UCL]4: I,]4E2-/\ %T7R >LBSUMFJCG" E8S-/1AK3+
M%X\["@/SC,D<RA[+39OF)5XWE8_MP.N7&Z?H-\U']7UM%/2..W:3/>,LL^P7
MJC4/B3Z*HV*G:*L,4[6B9688-U>WW?N.31OS].RKK6\F0AI9;?:#WC)DSBQY
MH0T(9DS5O)[27L>WS;@:1MPP/7<D_0YW;,07)M72E6:;<W3;,J=0HUU%BT)T
MU186XCK(9 =;3OR:?NE3P??.YG[Z:"TK[AC;+\1-6Z(=C\M$>8+4^1;FTH @
MEX7F*GJ!)ZM(NCN(QD<#L/CXQZWI*>!^H:=\ERJ:[R"D="FW1-M>DA_,)C_;
M$&+Q73%^IS.]8I*L8;D ;%I,2=L[EJ-^C-$')'(KEL)1#NA>TA)916O**<=@
M[,&Z"2!P%^BT_6Y]UHJ6/!7"T 0P%[1 LB#*&N:ER@GJ96SP<SVV'Y?:+W-'
MB'#C! HI(2>YAZ3H.4J?SB]B?3&"G_798_3O&=)SF^8CA6_%BA!*YYAD!=@Y
M($&%IW-AC8L4N3=-'UN)1CW0%V<^A!:4KACZ=V#($01=EZ!]MAPWOZRWCWVO
M'&/2*[YK5NMI.OJJ-FT3TY<O>>6G^==JI**TLUB)W;7T*HTG2VPWXO@OZ%EW
MTU6^C&IQ*K HK^>,BM:D3QD=-QT:J92<4:;7:\+(,U_>L-@#I1GN\)ZL:N=0
MF*ZKXSYONA:U?NVLFM')=SNU7Y;2XX'/&O25"91;DY$$>]W&Y'RQG)19MV\:
M7#-;NS,&)9%HN_/U%GWRFEK7>:J6OUUJV#%!VJR_8;IGEU XJ.OUG)[@-YRT
MK@Y7&?M2.QA3/K^N'?DXFYY72YYTP\05LQ>=']NBF%-0I][9@IO=O"H]+1,Z
M"(?#E74GM!:JYZ:B.&C $F!_Z4F"_D*ZEJ%/0\K#6XZAN-VS]#TGX<[6.VB-
MM 5B\<!*N#:T;NBU632\S6A+N7<#Q/F-.*044%79=9FIAFT)%/CH)'9/W%:N
MCO>BN%B!UB&?\\\"KOPW]G5'KK?/M1JKZ6NRVJ'O_K>XLP;D\F#=E&6_O>*@
M]VZ\]>?;)8H$/R.&"%8!K_B< ;>V.Z]^@9\VC=A/%\/!<F>!=,:?GN6$A%10
M(H+O*^2ZC#>)/N"V3#^XWG71#.6[LMU52=VPKV31\J#S^ <A]V+;\3]55Z7_
M@9C[JWQX9]Y_E&,UWF];.@INJ_*I)T3_/X:P+6_\F4 H^P\)A.):(' ?<@20
M"SM"AB-9BU <T(8XYPX P-I\#SB./%8 7TPSP?V'D62U63<'$0?K*F,?NW\D
M='=^ TX02#1]2W+H8%)A^_\3O\: FBD >-NSV"$AI"V+XOC)R)K)J;X>%UMZ
MZP_G9+N1$SWLESO7/9-B5$>\!7;H&ZG4 %BB6#/+DN?/1P1/?G" -.M0:_4I
M@T2C!O/$0HZ:<[6XG9<3E>V]\0LQ ^/-RYG$B#(-T=^ "XN8<<?&,_\E1!V1
M2-KY(U51R>W&; 4-24.;]:5HXDT1B:9P\B"C8 6X:"02$+57Z$_E\>AC]  (
M89,\^D-/%M*W<RH-Q4RD0CJ8#(8N(-%='E3^BSFI.-L=#.C1PY,4[CE(\Z:6
ME@@'[T@D&[!Y"0B(:>>D"4N7@$( *^:L+2Q?I _$3S<.S-W1,T9)@PVCLA61
M'1]-W;$#1B! 7#5@A\JYH6V?]OU4N6GN+'9;[P0^Z15>D,;_*>+'SK'JIF*'
MZW23#6L?I=[3[_/H!^)G[Q]SQ]$I#8CT(0&GYR#MFI>AP$K5M9E[THMY]09%
M+99V9ZHNV,PG#S4%^"6 $5NH&5M%_4!2ENPM-C+D9MI&U50^6;EWQC^G#N;B
M+)NN'0BY+)20"\LU=2>K2KTI$0:V<4DK##]A- *=I$B$#>KM XIT2R;20W^*
M>I6?;%H2BC8\K28/= >NGWSX:I]H,M-V"TYT<0?BHWT4X2-E/:?7_5N?C.%K
M%U,^_BQ9X-ZQW2-_3<M!(T(#OE_[49!L3U!8'9-)T]E35+O->@?.QO.TMZ*)
M'B[[>"3#ZO6RZ-Z#J3,G$CVHT)[U-.Q!L6>LBN.*1<"I $W!@.JN=SE9 +&"
MY\T7#).'BI\^=LL[I6![Z>%LV>B54Z(U3J 6UR$A&5VB756JA+*8IDBY569%
M8-^[:Z(=EFV'_+,]H5O$2^ERY>UKTW?/0</DMVVMB#9J%-YBL1>_ 1[J=ZGN
MF*^(K><3I^]YN>,^0E1"-(S>O"FM6 5U[!?2"P-S9S.55_S N,)SJ13Z16@)
MM.SF=1T&Z,1\ _*=%6=+#1LCX?83W0=K-F-!,!N;\ YWMGL5=N*4F4]#C3C;
M0MCQ:EMRON$GRW:X0.[WL=+L.[6OJJ!LZ4+#+:SORH)=/NS0F[U'<#(NLDF4
M"**G&%05QF8[&L;47O_B'H?'RW4L2FIG@A#E+&?'RMK3#/VL_"N7,/.C#\\B
MM*B*M!$@X6TZ5J(]31!>^%JB9*+L@2@\K[S<3]W0"S5E2:=G7]/268Q5!IVL
M)#\0!,R//:@4D((K<?5W<Y9=PV*ED)1508\/U@^'_9TQ_4KH*7C-9(DG^)+?
M:%(W.D7!XDW1/<'#Z67"ZRXD7?><-3"FB,*8EC^2=N$EF:><-D'F(! I89Q\
MGPCA=9^(JH(\,RM&R^\POSX;.+6#<SR.D^<!32.- !3A=S:7HU*0AD(?0=/E
MEG3-4.HQ[ Y&)D:#CC;&1/JAA<[FL_FYKU7J7X[E5]$SJ[M;E]EV>YZ3!\Q6
MK5J" LJ6^''S\^D]\?B/YMNV=9I/<-22#)]5*]93_J^51JU(*L.!O!I#Q1'#
MC)T_R&=:,FZSD/$0V?O^"HH_/HH[/6()@X\]<BH>>":O-,Y^W%37_Z'N#=E0
M4DXI1,''21&^:EBGD&H"!X]M5']FKD$1B2A3>7.>5?V'B9-3^Y664@7UW06(
M75>&]6'M/%/=5AS..T6H_L+344KL*7^WX]Z(L5IP=PE+-L67?2+FU!N!,R^Y
M+8&5BE]R*_3<DD?+TK*^O3>;N)S\)6P$$5"0[96_6 ^7?%HZJP!GL7VJ''X&
M..Q1$UE*N4J\^./=;%.\48=Z:]2F7>YX\<:3/";&.MG'XF.O.P)0&Q5\06;9
MYKX5%3T1.*][T7DEU?XXWN*QP+E;WZ*J@^M'%+BKS+U/6H5*I%[K,U8,(;FL
M4Z=*!)W60M,RQ\47>6.?2EEWC]4'B.BA+F@OOR-F3(B] >1PN\6=6DUX2 9&
M,&R%^)9V_UH(I8;<>1&,A>N<=:TQK1*LHA9^)M%@]$KT/UG>3U>;P1O(F)LI
MJI>0<[*S+3REZ14'<:9AS>9GYK&X\8/X_<Y*/:= Y@BQWLN#9)VE$.?D\5[Y
MPK/:P]<@:\9\-C\QFMZ*EN07NFJX;Q\Z%)0/[\HUX!;>1^W5%"?[JIXM_D_U
MS>_'LRSQ_9FQ%GG_U=]+Y==X;-^BUVCN/]SY0[^"^2:&$X_,Y__BJ0R::!J[
M_F-OV.$AW_\05/Y',U@[Q%TH4VDV(^I2*D:^"XF>P6+- ,J:/,N;VN$F=&NZ
MJ1@3&G@ C'Q$]U-D*C7_RW8QP/E%PP>]5;&L+?9##*VULO+O-X-=%W8Q>%G.
M)JL6\(OP+&VNB5<XC&\_,U'HT7=Z>Z)SL29/E:/(BKUV2'EISMS:HX+/XP%G
M7WD"'Y@G=Y JRGJ:=4Q;I>\*+"=WEEV*DE(C/?[T\Z4N_E5<<2'I>C>O-'FT
MWOFX]C5$2W^<PY?3V.^%%4'[H8^\ [B6#F.N'D6796YLFT__!K0[.'O^%5T^
M^"NZG,U% \JF.>  E+"!N?B1@X"G*=!OY72^NN,8!1,ZRFEZ;EB"AQ*-NP!H
MY(6!9WD)Y\BQH0;,4O18P@#LOY5P#\Y$R1<>73625]Y) 8".5.Z*=O@ '19V
M#P-8T^T#JYY*&#FOQ4*[&4!3K_=H2E9I@.X>%H8=<MR@2*( !D%E=!B/-9S]
M[KL4(%VNZ?D8"L>53!4R>/31(^R.'LCO#*1B#3X:*P$V[#)4)%_):^/*L74V
M0F-@.\SH<].@PG/(^'6>,R(<>$C;;%F%",M9X'F*$ M8+\P"<D)A1PWHC#O#
MK/JJ&V4;B+^2R6WR@E\3$%0X9-[ HTG3V')#IC_,%@'=*!%\EZ$^1R$:=Y:)
MOAU(MV:>Q2CET>6A3)/XP!,T-J?:B?]U;6B(@Z 57"9(8&'0DIE)@R?GJ,M!
M?CC?-?J4"T^NE:M.YQZYRX&3=8-W"[4HE@_D'7#4P!_D>KO,E F'H$7/-"F-
M:92PSP>0XLS/?ZN-8A(JR7CI=YK9-/[=9UC#O>AYYHI &RHGB30QZD1FB$,M
M;9K8VD5%EYJ_(ZG="5SN*1E[EGP@V5< 5EY;"H;L)_CT0JD1E[8";TB\0,R3
M< FER4'*1D<YZ)P-=37^-:=_%OX&S(WU-7-J]XLEU*^?'O%@01[('U4[D@(?
MY1C%-&31<0+G%550!MN[I4NR<"'-S%8W$S*C].YRL21.%UCB.$9"6/%2<G3N
M/ST7RMRLW/U^V.EK96#_P@YLZCGN&_!C];GE:W=:?);&R'MG#')<L7R?*,Z/
M@ZP.^[J*@MR@0A5]@^=BKE8>7A077?*R>'#]-4-@AH\V&ZZ6GF#/6R MA!#+
MC1]M3"E+0!7GB]V!PV2[SOE:^TU"^,'+GMR:+'!SWLS+W2BI4-C7! 8D MGO
MD\ML7N3;X,[P<3%[B#1MW7:&:C;9YZF0C%(#2C"" ,=G4Z%4>OZ1ZT4&<"BT
MA&?EA.#PPT7<3?Q5&N=>@C@..Y\.+,1(^6*,@O'@L$6,XI#CXCV6#HJ0HBD:
M:SJ'N<0!VU2;Q]QX#(D"ZR> =11PH*B#$=YZ/95;ADS 1<=77 )-^2^/NR;J
M^7+PP\G5^<M*4SZ:;KVM=G'MJ#F7\P(3UTT5HK1$F*EJRNUB)Y4U6^D[RD3C
MFRO$JW&S)B7M'J3'4L(S-86Z[[H=VC7H6\B"@PO8+Z+L9%&I4 Q<./N\)!AG
M!9@V.!.E35 VJ?R65R$HY$&]S=\X]?R5?-6RNU7RW!>3.H4G:1E3A?3IW'-,
M_+G1=V'1\GTQ'[2ODOH^PEU\.2]YK!HJHLRMQX(EC;A*\>&=+W(QNP[GC%H"
M"J.OR#02?/.9FQ*-@]Q7&6Q&9&&5GC#17)*/9H 6^\ GBOU7V8WZ096L1@.5
MP"K01W$5G1^EK5GJ$KE/[DW4>M?/$A)4]H*&#T*L9[O(B\/RD]-&GF'.%]R]
MT&Z<GX5D;BMQC[L'X&4Z>W9PC>ZWC@?>:694'Q=<MB?T]<A>&.3$,?2IOSKD
MTYL>A0O6'T^2%DMYA%G#"'Q"3Y""B[]E]$E5#S6M=7^HW<UB5DKVB]"+UJF>
MBG^9"C,LO[9^1?Q+C&W>Z/Q3';G:LDE]@8:IO-%!T<.>[FP'%M+[9<^("\MU
MI=MY;<S]0S49DT;2+NZXQ8(-L- IGM(,:WME1?YMVY34VSW C2(]Y-W1*AG>
M!VO/GS2J.;%B+0N0M=D20;S-I"]CZ@W12H==K<O6W6:A.(\POI?A(J(*##7:
MF_:^6Z,ZB<(_R,MXGO<DQ-L9!5"XP'(QYO7 /]M/7"+7L'16R.CRLRW:\WOR
M*!A+7+<MZJQQ&LFJSKT?,.&Y.)E'#Q]O4[LKD(PAYIHP>7TD'I "#G0<#<.@
M\Y8/@UD[<1GII)=*\QOVY(UEJ>*HB_\(\GP7 ?Z*N;\!_7_6_*/[62W_YWE(
M=0=/6/_AL#>^OPY[.S)A'^WG3O]O)NS^_V["MOA;WUW^R+\;M=YM:HI#6 P!
M$HPBW2@C7RUHZ;'9A&\E%<"@0GJ@HS.0;BPUURF*G9/88GSXX,KW48G1()W?
M@"2\ P+PX^Q?-7'*_W]6Q['XS.',1+"JM-QNG=!AW73&2$!"2FL_3<M]M<_0
M%5+MGLFF:>TS^$H#4\;OECRSU6*O0*0W2D:S2F-?8P_M(:\;')JO*<R/5>(?
M/87<^&3[JL-]K/W4R^]Z*_!'7/L<)+_Q6=Y4>3HK]*9=0D$$V^XI0;L35&&Y
ML<+TA^0/WQB.B@(JN?X9/>YZUCT>.<\N.?0,NIUY&'\]<A/N+(7N0LIT(8,I
MW$Y9=,HTTEV<L MPA[AC8!@C$3K:*[I+0%\,E K@7 *Z0X)*, "9+H\^D;FM
MHU8?[?J2=I[EH^O0M'=($ 'T@;5"*(P),JH 9:2T+PX!I0 X9[$?!RF,4:=W
M,'1KJFO:0( [=G B :P)X-\E;";J&<5&(]OO9^%3@BN.7Y">!U6L;Q@,2W);
M.GOA12?ON,RQI:^C^RH?U[X NBAAKKMCAD?9!-+36/:RNSZ$$AN\V -\Z>2+
M8D.(<@V+Z =LOO79ZI\%,&ME1JNS?G72H6@]8UG!08X<QFPK<[@K94J/;DV+
M]G'5Z0IW<#)ZX-S!@0'*B$P?R ,89F'EC-;/!QU]%YFPA\9Z&D;0TL78^Y0-
MW7P9VCT5QX6"J9(:VL R@D6L<*C,6%IH$'[V,2![#H+_5=_FE&2F2ON2Z%/5
MUHSL0V%LOF=*H'CA,T;0+@]DX;7W=K)54=6>_37-<=Z>!7 .B'?/#N)%6TG1
M!<W%9\@%N'=7XX;WS7)ISU3A!0YBQO58)9=Q3=&9_6)?Q1M[21N\Z3D7<R]&
MS <1N>Q+6+>ZR?:IWD.:H:(PC]ZJK0I*F,,+=G%WJ=V:B^+-JCQH^^&MQWS.
M^<W@'E'1KK31[%79OTS-ELWC#WX->#VV4?@2;YQOOH,)#(&,7"GH\J"CZX=<
M\-7O(*@K#M"S"\M>N6GL#6*DC_!$B(ROA]52O;2M42!Q9I.\G,JVFO8=H^QG
M3A>+N/T\RD=W+_ LG@.;V91^2X] G0T=>&*@P[T+7%%L9=*P#S.W4V*1%LL1
MO=Y86^VY-A6-\>03K)6U>!6G?3G^*_.RERRGT$/M&*Q3<V?\U+@A7IT@K8WZ
MP"2NKK<M02D3C FI4G8YKLCD;&=Z+/F\;0;IQY*CPF(+6*FJYTR9,SAXL<6+
M*T#GGC 9#17U0?5:&I[KD%UZ85LU-L&%Z(UJY%D[?<%(]-5PMK90$39*RZ-B
M4[KXA<X672EO-O$K;!'HNEMIZU3THN.Z$K-I"$580[7\CEIL"(7S)\AC-KW#
M8!LGHT_A-CGFGFLZ%%0"B:*C'M_6GTB]$L6252(/)2B#V/<J==3RZUD\E(,)
MLZD:]#I,0+=<K%SRS/U7MR=FO)Z>7RJLRBX(QT:LWI"-ZSES<N<U4S42A'0*
M=$[UX69.WL";<%<LDJMN*W798I9EVQ44O:2%)NC$;,=''BC[0R?U8[R@ N3;
M:E7U*5[*8@6OI^[6;^E]41A[E(#(N__UQ#[ABS0#NJ[/2(?-9B.%[7TKIA$8
M$B>^8F3P1BB_-%P@H,-L(!^UL/@NL\>, NMDO:#(*Y*<];P7->=<^B8>-C+R
MI'>P8=V_/ @-GU7=GF?.;E5F8JL8//#6\/FR^=%KMAKQ8NQ[Y6L%^K&*B8J&
M6#FC4[YV-^&1RT+J*K=][:#P!7&C<"<LK,*STCL+)-O\:D'&5CR/\';J6/.:
MW7V9VU9?0F#44-F)^_XJ#N<OZ6U+VEE74CI(EE9-GM!LLX,' 9GLVU?S%Z\T
M\^B9MR71]<OVGRPE]55=\*YLUGZYSX?*->3O5EZ59)O4$A 02$A_[O'8U<GJ
M-->G-ECEHP*G1OX=VX;%U-O?OZH@ K4EN=S"^1"KA_(EFD&!^G,<5#1,.$\T
MC51@T/J+:M?KHT.!=@EGVIN&73A(>2_N4_L%0-*S>;$=PE-GQ_#S^W0WO[#@
M+LFAQ[4 UU4CJ3:HUT6._J8JZWEIQ>QLS#UK7YTJ)\U#SY+\T1M/GS)1+?4,
M!12H(-[1K8:/_:BJL.K0@!"'%[<:!K5_R*ZFIVN'\/C_.E>,$3WUS[9S15'\
ME^1E?@X[0!L?2];?.8\ZY<FJXJ+,$,%6&2OGY_RCM$WCY4:IYJRA#NI$E4$<
M9^&9&PP'<^:C2AIGZK<42@($+<F28K9"CX3NRT(I51Y7US6#4'[00H;_+(KC
MN/Y^TKD,#7^[CTXZ;R^CW(^\]?]\3J&&OZ_7?ZY4]S\'G\7R?8WP)9"CM;%Y
M-@&L#>R0B:$! S?L'W'AH\6TP"_UI)^H+"+N#W >$%@W!OP&O"9Z[9+RFR/_
MUBQ.>O'O#CWC5+SK2W&]YT_B)4J]B_"4X"KF!,^8D6<<E#"!)U!J@.4O\;JZ
M)@^[CEN;YMT)URSED^[Z?TL>>+*#VE?:,3OPGQ!_GL<I&#/1?JEC@[_6:NH\
M.6P4V78+;R^<*0:B^BM ,IZ^XAHY?7Z" #9B$:5>^+NCJO^7UA^&Z7CT+S6_
MI:%GU[?+:$@<_&L/%M][#DK3 "8R&'N=[E B P7?+8]72C;:-#WF?)2(JCB$
MQCA**)IHAQKY@$*H )J4< :B<6KY'G2^72)=2/GN=B8EDV-SN0-,H8J#?1XT
M.0GN LEWEN32.H_"_F$P6N<QK"_FR+9%$\0B78;"4,+2GZJ:^_,^?@4'L#VJ
M-;A;NI,8:I;+K'J_*Z2,X0TP>XX-<B+H6*C9%7?=HO?1YLEVX@M#:NX+\SYB
M!4^>Q<YPL\:8!YQ:D;P*8H6CV-U92Q?$ZB1^&:M\2BRJ?'#7=BQYB,2\R3]Z
M$E8<46UG3RF?VL!Z7>)ZQLOLIDBLSA $;\PEVS+DO;3I.P'E)&4'^(._3,VV
M;'V!UTH_RB.^KZP5X/$\O4=!K5Z_&_+-T/6Z.,7/B;T-R5;(]@VM$\R'L$>6
MR4:K(TLEH!3ZU-U">HQ''[)X76F/"@@JS5U,,[N=7\S;5"C&&@7BN(#^/[2]
M9UA3[;HN&D0!J2)$ 6DJTD*1$@A-*=)[#82 2B>A&$(-J"B"&IITB( (A)X
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M'5VR[3V O]7[NMW&JIP)JJ<^&BY2:.@)X951Y]4M/F_3R;40(UJML0G34V1
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MF2C;[[P9W%8OI^[,55PKOZ^W\Y@X2\ .$)0$*.MZ4GGV _OX*1HE,T3=2RD
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MN13*QNV0PNV0D&Z:@ 7 7?_2/&  @'7=2?:<PMQML\-S5/I1NSIH?9R'F_E
M5:4M'V0!^W[Y'K%:^PJ#O&-+.[!?75[P^UAQD2V@#<P]S#XXKC6G:/6S1/#
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MM_SI29=TP1J3W\/Q\8&0^9': MO.M[\!CZ"WS&3RE=Y/Q;=ZQG5LPM]W5;D
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MCU_)D[R/ZA(U<-2@_21*LT#7A'Y*JP\QD=GK]KB<[+UAY[&9J1=HQQF\GNK
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MG"(GF1X"\GW>>JL]X72QMA_-J2WUM,6L^4 = 2*ZY_J%S:=*1NS<#<>31V?
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M(7Y*P9HJ /"$ O$],[QF11?%::8ST8'EBWSRB;[Q76Y3:PK RH=4L)#E@H(
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M>2")VP\PH2O9@1]P<9 ER3 L8E3*VC/G*0 3LPMC&0=C_]QBW4R]>ALJ2*8
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M_&$&N_OY5FY[XLZF8^CY*+/*:/JU< 0P;R"Y2-.6WBV2CL39^B.A!;&6HI=
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MKMDX4XQ#K\H*][TD_#L18=S/=)GP[X1+NXGLYBUS&!/P30<Q2TV=49)YQU'
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MSSU)B_BA$[.3LYIMQ,'<7LG@F6]U<Q!=BZUM^>5-JU#[Y%W;_&&RM)#"2'G
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M/S_WB'##4 93KRO\?FOQ:G,"!$R2VH#E-^!XFHIE]=;DE"Y4C.$D+E?'S%^
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MM1.I&D?Q\P#J>H!O&=D7V1@?O,3TYT]VP62IG.F^G_'T*_A*QJ6HGW!Z:8\
MC%.[5PPR$8_.RNW>2DVYE.$4?0JG3^$,6!!!VL_6:HNPXYZ7EQ403YCV 6\7
M\*\,#T2;2_7 -'G?B#PL@2!Q3T[-!@)\8@T[G0+BZM+%MIP%D$ 0IMC$Z 'Q
M,SXS7ISZ#-T7BWG/M-0SL.R'1@#&^Q>-&52AUX.K'Q;&9AH!D\SR(@<+'I!2
MOEB<5Q3?;DK\A_C; QIV!+$9H(;E/:7$)IAB,L_&<C%\JWB$&HC76*M-F%6P
M/ON!IEX7P1ZA/P%^..1*7<4P326CQU6EG_0!^.]B:[L>N%:$VY:*/'FEOJ%;
M&V6[4G\%0'1'-;DRE RY,[\3X^7TOI_WP&Q!^A&LC#TK@Q:;6_6*K5A[(^+?
M:%#*83POH3E=%=5&VGV$*L'SBA%J0#C@&=_3QQK-/GB&T[KXS@>N&&F3KPHO
M3%\7O-\<9ZQ].;0*!R0=[,!I#($Z#PNT6E6?&J9JR8<_>59V74@]],DH"HY@
MS!ZBG@>Z9][;)J?&4ZQ;V%$QY.1)9DS1U/S&^Y#U%.2NN;9JIB=-R$-V?-QB
M@$PR L%H9D?UH ^ PVF0+%WFSG%JM[AO#*7'G0T7.QNFA#&AY+'E"]W+^9[W
MXJLTU,4+-;' I[\7(!P A_EO_P68W.]45H8NSS)8@3A=@W-J!QC-^0K(\I0S
MBM.RJ@ >"G7&:?HAB$T2>!5DV/'"\^MZL88*0%0]U6AAG3V""F^!D/J*%X?K
M+4CIHRJ9''O48N+3^W>W/MBWO6YK&)LL2ES@'34"@T#4@+XXB!0+M)B&2:H<
M2F^OBTO+2>BAEZ:5L? T9K3@UD7WV5-GG >N3YJD$W#R7?+@-CP>!82B,?0<
M[!4LHM.-+S73#HT59;$Z!0_8ZZ,?O0?SF1+8<2Q\>/GF#2]NIBO;][E4/XLR
M5"J_E(WT/X"IFX^=?H&IX?1VQM(<2%;.%(^>?WO&JFR4*R'NCT_<_?%Y'3M]
M+\S>:.I_I1[#H#?P0@VA@.>I/V6QYHP;A57-]Y2M4%*W7,9W][=[Z2HS#",W
M1TZE3C@^R?+>JBH#@EG*@'(-RZW,D_2ZYWKZ^JSO@8R]%?,X$7@V]P@2;Y$5
MTV'AQ2$2*$AODL$)?;_1 %= A]_# D]_<>!93QF(V5CBI%'_&<5DU028U'D&
M#5<F%G7E$WGQGP55B%\[A'3?'^6J<,#7XD_AHB!7R4-!IL<;S,C&#+VV%UQ@
M=9:]X;SWV,EP/NX/KQ/2$Q2OC-(8WR^H4>_QXHA'<5Q7X#]_+[,6K7C_\!--
MYQ3?BG RZ4?0_\A.!*-VW0/**3-AF# B!,Q64P/)ZI5XC< ;Q,C_.2?[_V]'
MT>"8GBGR [;! ;?=(_-.N"/>0F*BDF; !7!V$#D^.4>V1D%EX2(Y1VGQ]J,.
M ^KG0U45@."SR%9Q@C^U]]CK2;AV>;$MIU?6D>[./#231;PPM25)*_(B\$LD
MF!8J^ER%XT-M[1G-II^56 =CPH$(/QMOL@B8M3(YD-%L+9@! VT S?NDI_D"
M0,NZP)> XW]O4-Y"<5V /W7WNB-T.^6ER*8(F#B&/^7%$ES%LA+N P"ITB%)
M ![0^0J9^OY%':3G#)TXT-N.V0"XL/2[*I_<1:L<VNTDMTV#ZN$0!S 0W-9?
MO1,R#S@T% 11R.IED-XN &9&:(;WT$L9>4^:ZMA\M1NF(G]%'H))M)9/;5,T
M."</_]2!2;X6H\*L9W)T6AI5%/:9J)L6$!,RK_'> @O(KE0W#&G?B#=^.YR>
M@0-<3J1+(8(8+3<M2;?10_B. +?8O,K3O6]D !.["+ T-66SKA0UH'Y\7JK4
MD([PVUL-0@?N<$ZY1NCYB#-ZRJK+XR! E;UDJ@'2,KV".ZY+< OJXH#[4 ,B
MBYDZ7NM/^=[,%Q#^YZ-ABOH L4[#&[_ LQ27\<7('@E>W.I]C7'=_V3]GQ40
MQ SUR1?R-Z7H&*2 2=35J1L&+I-Z=6P/F7F$*!3!+!X>09/8V;:.L3ZS]TB$
M2-:J71.H!1-&J5-BZIXD6X9;_^T*;O8K99WLG\6J'"8\QU8%8IA@!71+0V<L
M[SUP@MFO:'#$8^%WK+O $:=)>JSUBZ:?M[Z6^G22TA"R<#* SV*TLS'99$L^
M+:SP10,94\*?+NICHKW#BNZC@6* =]%/W6<S9-.5I +?/2,L_@)B?.)\R%3W
MN$>GY70)=5YZ:,E_:@D36E!CZRX:QXLL%GQUZ648HL(M?$.JXJX+5%$,D&IJ
M#"#J)W#IR/07%GP7OHT$M$\AM=;=H ,IIC+G$Y\G5QSV>'$UI*7+^87_:8,-
MTV^X81IX@41]O!N&!A_*\U^\_;;K1@+P:@P7NM=-];IX+AX>+B_<5G/$]_YC
MP3F_@L[$5.^1E99 )JN<):M#7G&YE82#>#\EYY*.XTQZ(D<LP7)U[+GO"6K/
M;M^8'M]DC$K:ALO4!&HMAY0'PL'M(3M Q<$1/(0C,E1][#/*BN6-AK"0K<)7
M#U[<<F-2J4(_4&;QTA#OGXA]LX@ [G#J9^*T &.)UM %GYS!]BA&LFL78R)^
M5BW ZY. XJ*=_X3X*'\5!W@B# P2&[X+M?!<U#=N?\HURFZ :.D_(%0K((^&
M*TYFA#_"R8!'[RG3U#4?B($?V1N8AJ/TQZQ286,"5[/1'\H:EF\^-ZD4D'U>
M<GS/C)C$^]K'2T]?@-_W;[D>']7U>Q[!]42*H:I:_Y>Y7ZPJT5) Y<6!PSO:
M J(8#O'Z\%>V_U7VB ('3L$>3JFM(@A2E2K5Q1%SM9CD=[,8WV_QU*.R2VB/
M FBEY.K/@4KW!3T#L2([/U#OO?^3%H G"#>#6D[O 9X"1QSV_48<<#X?>1I[
M_T&<\.=APH7^J\O/#(O5\8&O(*\<?,/M1M.3FO45(9XGF&5K;8]W\+SFB;S4
MM,=WRL;(671\&-40]]M,SKN3Q/? 1?O >\CF*-#O2=)1\:H^9H840"7')+*W
MM7KLV@$N&X$3*?M63I7^Z"NF(8X(TW1MJ6IK4MA<YFG%* )X7D".041.?CFO
M_ OX;"K7TD6L7F6-[Q]Q7L8#I>#;( ;L?R$TXT_!KG1R1Y;VB#L=2Q$TM"E4
M")66#O"^TM"]%Y1>BDDHSPQY>@G#]#KRXQI+P'F2F.?H F!OYU.MSZ&E^*+M
MYE>I\P*RW"0SL1'//%8LQY[SMG2/;:, B#M?WY]HAQ?WS?_G6=3__4$.ZTUH
M=$ZPV9V5^&TVEK5'U/?Z,O?NZLF^58A\NU?)96P/E8BNK"ZAE@")P_V>%B:T
MYN="C'RJ5$H6";(N4 H]=#R6TUQ0F7ZO$?O+=8.4-DW:C'>'#H=@EJ,<#,S\
M#URU1_Q6L[=QP;Z2N32C1J )>F;:&TN_<6K.O=RF$T"2ZO]S''^,P3]CX50G
M_"GS(/_'^/O)KQE=JV*V/H#-,'*PM922W<;14H4VFG&MM9I#G0/8E[!I/B3@
M>.DH(JEB+N?26N?M<6]@03KP3Y+9F2^3:^R9V2]!84B:SMRY,=C?#DQG'W\M
MBQ%L:.\<)F)X#'$/PYC#"!R2$?!U<0HQ<RQI(*)"43G190PAOK-YRL FO(0+
M9G'+QO"[OEC0*+1IH  9N],M*(NIFMA#<OWUCS29-./?Z'SOKS*%.NG/E"[I
M$&L! JU24,I5M,]R#^1F1P*:>LXETE8'<@]M^:W^ GJ]S/=8U0E= 3Z9DB3N
ME+YR0.0V6W^&AF2&B9-\PTBP$M80;?D!7N+EU87B,6CZ(%X8&H'X "Z@<.K
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M65J1V1BF,1(#IIO'"R6FQ&/)'Z:8=. T)RYL.?-<;RDW@<H_^;^U=-B(&(]
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M>D8K)D*Y3,5UJ+1\X3K('P5$-^J$-SP2-.X8#OQ)U]-;K.[*U]\K7%_0?/Z
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MD/:UU<<J2_%W6>&#92F8NQE#Z_9<HUH?[I2R$9Q^[>-,J7(!<;6@<_3C\Q&
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M$X'X]>GMO >+)!V5Z89-O\6>3YX#/G[FRX*S]C-UO\1\%41MQZAR@ZY IZ3
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MC&6WK6^GEMU]%;RVOGVRSO]V9!GZC]9]#@[/\6M[V.ZL0M4_DK ;3-1 *P?
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M:XVY'2U[^"Z#MT5B.DYB%0IJ6$"HT8RT%#<5+G"+0+RU_O=#JE5W2N!$67\
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M](#+]+9LY79L93WE!P:S*5=H/WX9PEJ)-^BV^FXK&-A.N]7QA><ZSJ#E.NY
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M"!XX8=.LPRNL/B(#C8-&+Y2%.PL@9P3CXP;B3TQL?TKN0F!%M. J^LAR?E(
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M IXD=!OYF,D/*CU-@$%3=HS%T=+[^LKN[I61&?=42FQ@P>:"X"QDZS03TJ%
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ME@MRI#^'_ @&<5$YAI<4R%' TF6O454,J:+@(GUJW<[UG$'0#83PAIU.T.D
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MNN0\0+D_L"TN@0Z,U8W0V"3J#L@KDLE"X$5JYL*,RC9)/-'%K4(4(Q0QT;R
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MW:&$0"%5<"IJQPG)2G]3+:2+7D6K0 @UK%>FM@@-0_\B9U.1L$*$B?X#!39
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M(8K46+SU\!,N.V=QS0WOE*B2S OG$Q==['^DH5-P&B,+2M2B,T9#Y)I7K.R
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M#X.,_&OF$UDKTPC6E@F*Z+*XAB*<X7Q*\-U+JNC5'K401_+Z4I/K!'Q3;%*
MA;GPDBI(,A,!&^NVXBG??@N-K]_$+Z6MKHD%N,4.!)/8:";E3G1>4<Q);,>9
MB>@<:X3GJ/80_N=$]3 (<"DW$G::X/X$PQ%6U(G(#1I+H0;K&EK//@K7V8E/
M8-$:;GZ/:7.,SMPQL)EG#]N491&G1SGPD$FT[H'$Y!VU)F=ZB=WMU+/*OIMF
MQ@B2[6JH$#4M;K:[!@(6!O(XW0F0^;CAX!6D.F+DH!R?%@ ^B.9#A1Y@3CV
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ML[0*,1)BD+"NRAS;IK-E41:-XBA@17 +-/$)3R> 7PS&ZDX$O@1!W/!1Q9T
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MT[&M0]1/=3T6X7YDDLQM9.:]ZV;3MBE]8%J0],EO<*^Q&"1#I/TL<B 2#N'
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MKXT BFAFTF17..5I:]:L?I\X0Z**_2Q%D2I>.<;\-F*?7\-1:] 4(<1O.]+
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MHQ\OHO^MKDILW_VO9 FR)O^"O?E[@473.+I(RFI>4)5]B5%_U7@H[,"7O>>
M25*41MA?PPN;0:3 M5M*<5XB*J9T=(F,S\0^OD/L$8'((KFI!!1 8QC(\61X
M2:J00R\?@0AGOP6SY!"=,U4FF$?16RHWJV^I%\ [4249TU],TP&+OL2,,&:B
MU,?D6)AQ62;K!"0DBIK%S5;^2+LTTVJSR 0?Q( L=V/KL]#6?FHD$_=6&6C^
MV*)DF,Y]#2>"T!<;D-MS1!K6WXAK_/=/$T!8\761?WR@T!\KEY2 H^KX.M?$
M*T.-1# KD$UP78@N3,/GF-))I9"?4,=V@+)P,;5E6C%\7"(0+.&FZX[0&A-[
M,RPV$J[?I4>;//\ _PUZ7V-)@LUSG<2"]<']O1J?E0A9.&,HMV!:8SB;M) *
M@4!I7C:.N0M;;?&(,G&2MT?29;.@B4M8Z4>\$_?C2+%44;., =?=@A#191LT
ME4F+QEC[\*KZ2!TGR!]&%] /DUHM2@A07=Q9E(>\7JHS$_I[@QA=?G7RB#@Z
M 93Y)3QV&0>=N/!RPK79^=,P=%[DBXS-QHZ0UR\0<4M]@CT$^!VWH!NS1;>\
M6>X<M_W%2^H>WW!)VC24""6M93['<J!1]'$#6_X)9*21J4&B6X+?27,I@6MR
MV'\#$U*C%UM_K3P]E6V/_]/+MIY@&BC$&[LD6"PI)R'Q&!X@[OXL2<C5/5A7
M?Q6+RWA*/8HJC,X["(ZED_=Y4*8*E6>G&@Y4BX_Q\L_><YS^ABI3]#S<!6LF
MZT;6U3SGXXT$=<3,@'B-C*EZQ.LAL@Q?"3[GAUDQ*::B.$"1H'.K250BXM,;
MXF$C9 AG[GG"G&T":W !/NW0R@ZQ9ON-"[]F$)WW+5;ORX3M!P%9:-;8@GZH
M,/U/F8%U1;\E-"WOM*Z\?4?G(3DAJ$J%M0JCB)!_,)A/'HB*Y[(1WNY3 "S6
M")62; NM)#0VI(%3)E*B+J2$!Z;1YKP&[PL<&A2QE,N+<GU5P?P564M[[;IC
M-[*2BC+%_VBE1RDI:H;32-W*F\/J8RD6UCRLE7A8D5ID/V,*H076G69(75T+
M)%GE05%LEW52$F-;5ZU7!'$56'_T:!=&#U_5W57BCH^:;9NA*5QPH!4 MDK.
M^++C'3-'=^@3AP_CK3'_5'!_ECX@D6W?V#_]F\LS\[&-@KJT[@O59IU:V#0Y
M0D-1LXCR$$H(3VV9R)(F K^HRNA\@:78($S*&Y20+.^U_^;4YW/+#>QX6I8H
M0N^(5Q<E]!7Z3OW>X=]",6*Q"[PYHB]6L<##C WC6?3K113HFPXA\  RG_NH
MH6__"5O79(5R/K^_4AIJ=4?90),:F!'9&B^GD'$]\O!!*U2L_6('CKT4^S3K
MA+J0!0=M?0+RW;_!\V;5\IG?929>]GN<+'-Z#>_F IL6FP]%]);&*"RBLYQ'
MH'PDNBY1#@21H]7:MLJ5;-]+AMBRHY4CSKYH)'L9G9)64 >3Q&R-< 3=$FSN
M=-NPW05F:@Q!V<@A0J\2=%F.>-CVCE<1-_)P5XL'YI?W1B^ $J8T -D[W/M[
MWFQ5N*DRZN"1XOD1Z\)(IXQ:$KLY!!_BU_ABY6 #[Q5\+_P%^"EKSKZV*7S"
MM@.JT=M0U"#VH"./T4_'-NF&R'.V7(>$".5R-MG>KK@P(T"@_-7@$0S]0!<K
M4!>QRP9%X0>\O6%"SDRI*ZCF)C,]C0@G-@5D SL*EYQJ+'65-^M87*>NSTM
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M3;6ID5(@X2CV1L"4/*X=WB!$AE4IPKQ8,-V=7X>CJ[LR4F)98C;D>4G+%:V
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MTHV4Z&RGMC2$YK,2)BPF+C3WF)Q,3%(X<J3:O*IU0/$DW$L..4%3>72+(#)
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M8S0 ^)H)NZ8OF&VZGP31R!UKC0%:1$5Z+69_72?AI#D>+-*H?"<;OB!12U,
M:7,NW(!23;\&%^_L]HP5[4X4I1XJH".1',!70:[F7#C3;%$2DMIHXJ@U$<:6
MI+D$!.=LZNL<I ]- XT2YKF>F,KC/IC@\?B*6V/O*$25\6<Z%4W/A*^Y@Y"7
MW*XFMY"8ME9#7=#F%.LF92)#4I9Y"@%7T2RU)RJ1EEOV$[',II.'$15%D0&O
MW?HT)6DM_N.\6//8P#8T*4A*49;_6J:TL*#IW@='S*$";&A]JV1 ,N"^HUD9
MRE.Y=V"C5>&LAZ\/XAXT(: EN(4%M^.2C7P@^B;>FG-@2!'EF /Q#DV>7"X6
M;\?TK,&D*+](PX?"<5NZ'2I56Z[3#GZ IS)A_ZE,N%TF_*5>86*%S!7'W [\
M([RAUW!F[]$2N0*3K(T'6OG5(78V>+$V'LF4)N4[I"12T24X7:F%D6(NV0D'
M@*H8*85MNWC<.OM&#IP_N,R3TL ,Q5K4'YB^_*-FJ@:]7@RO+FA\P-$W^ C!
M>++8*^"QP^J2*&M"]E TC#/@FXK'N#,D0#*2ZFRE%6?JW8A)\24_<![;WR-0
M*M:KWCGBCXH</G:,7)JN7='A=>AC7A.^G3+E.-JY:2GZ9^IM$\Z*IJ-8A8'?
MM)O"Y@110C1)PKD8S=!B>HVBX;*$CIHV1P_6G2YT&*<2T.G:/.P;[,HEX=QD
M%*&S9& WCU0:N]9HOBWLRS6F175P(-%+DU^.F9!ZG?-F9YNP0SF8\8>:FZO,
M[;%SU%FN^"6NGE)=,1ST3; X&OM'Z;7NX\U5+&Q3#&S4^<59'%U<I+0'K\]?
MW6OMT+?J/+Z8%T\S!1NF(+ 19I3:#BB6M##7)::<3;7,)&X1F6M_2ZI:<G--
MOD!;Z[=HL4?KI=9WJXG@1A^3QBFJ+ [S,4Z?>(<('I%9FP-A\S3QEB!Z?R/%
MY*5F5%>&N1WL/F5OUL5GC6U?DRS#*IS]TML0[4*3LOP-V+N&.N P.X]Z3$JT
MVN:2%G6Z66)VEZ8XTJM&F825U*'V=KLEBKRU$U[(:0*QW(*Z2*.TO^197269
M:F?*/(8OAS!<5.$*;QA,>)((2-!XI$D6;#^ZWI#_9BS'-DO"HF=2\LLPU<SN
MMK5E^SOG._?%7. :KIO=G1Q[9PGGZ^$+H)JITK7KE6+!^ I+P=1=O[^G0='B
MAJD0A#:_R_=5[QM<\8(4U"7U(=;>A!379\E@4S");):6R3_Y^+A(Q6';*$<;
MDY H',^&?#O]0/+C[[6DCQ7#2\!<"4:R'!S(S)"0H4NA1V0I?"8EI?R\L\#G
MEW9.[ATJ"54((%@++*[(_$X#UQH<H0"'H;8YL/[[@=/Q%FY?R>SRY0H$FX@F
M."E$$N\-)$6#;Q<+FD3)V(4GUJ$$6C*.^M#?0 P+R8)L:U=?/>SO8::=E:9;
MQ>^\Z4-SFH0.D%,I#^,$,WHO>"ET:J@TL37?&.N0&)%G^2*YV0)[U=ZAQ4PI
M!K.B77P+H''XV:F5>PBW>YT?HGX7/+%.W5@EE(GOW"??4(;;*@J$K#=)L9N1
M>QF(FT.H.<060?-L##IR/FF-LOL#?CH+A0UU F87$$6[L-.>H:]U(WD4HX:1
MDZKI:E^7+JN"%)D8>3[B@B8C7X"SWI1+IMY-/3I)4+&@VTCQ-@7W\@7E!5C#
M!*]=8-Q;]IQ+X7AQB_:CT]D,_T'F<^<LX%.J<-"VCGOC@]FS@\$SEEC<;ZMV
MP^F^,>ND>I?M*O\.D3<*]B%GBE*>%+($<"'G'J-YP8)O0D.+%_DE-A.@V.,U
MJ%I*[2M81\$$+</F$@X3J)P3YH9_JC[FI"=;]:HMY WGT9!2P_-7) [T<OMX
M*JQ8)!TSK-'@=F"PUC=DBE#\BW*.KTNZ-MX')]%.#SG8_AWADMT'1MP5>C$=
M[R0 N5&S('D7!6> "%$XYQ.@F<R \PAC3(>AF!651'^<C7/H66N5<;E/RDQ3
M8X";3&POEG-369XOP['%PL_3-!(^!6Z#*W<$GA7AW#XE6(J)MW-GW%#,V3OA
M#6]$1^@V<(PO"$W:>59;_C93B(I-0XL;\2:LE, \KEOX>_S4+1M+<9*)-SS>
M53'#MBC="8J%777QE! ZJ@\J$'VJ Z% +:N,VS:\4Z5J MP5T\+,C=3Y=.9B
MFAGP@3Y1U?([&4Q'D73'02K70<AM'XX^:D'?#J6'@O,<AXZ#S5BMA8?UVV86
M#(J_70/_MK[A&I\(W[*$UT)4D3OQG/<9U#I\8<M!526*^67>)$L!++=M?^=X
M[Z.H\^I4B;5,2))EX-@7G]K(8=,>WHVWS4XCYPDN<$C?]3_#Z"V0!+E9F(J_
MKA8;T*S; Q!\5"SWU&SWSO"4A$,JS&6:R_M'C=J\C-YQPD?3>>27"\\?DYL]
M-%WG3H+4>Q2\%]R!B?@9'5P6H#\D7.&H*R>D5+,15\Q/JS215W^@ XRT>!#H
M"0I,\%>>)%&P[=%$6LC:#3D+ZA=^=P9F%.OL0YZOZ+LLD" T#"C WU$!C?1.
M@X9#4YXA+0\UXJT+PU=C6V5E*6Z[& \:E9X]ZZ3U*(6L6M6J$U&?!83+7U<>
M<J#35@$H:I5_>'[=KAK/_MY[\K^D 5G>3"P-C-;%$6ZZDLJQWG%K=E3ZQA7
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M]7U2]KN<;K_%Q6'E;+%-W*6BW9_97M/OEJM%Q8:0K;L1#S*;#TE'XD5JH$%
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M.0P38F >@Q1>W$>]J]NFN58>8:1&AR;Y[!9"#6TR$X!X;]MD;Q"QL_4/R<5
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M<1=UGALSX;;?Y):W;] 5C0Q<9:]#;$7ZXH57QJ\12],3@8<HN7][A$O)SW;
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M\'CR_)9TD6[\KK7FY265%#FWK([(_GA .07L@/88N\])":IL[FUUK:UKT+>
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M+4Y$T3#E_^'9X&0521$L05HO!X^_]^5 ))TI7= *QBB4;H79WB'A:B-,,M:
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M BB>PA6P5%O#^ +B+" :D;,X@_< $'G8AH:,&C]&^45V=V%YP<0!:]&Z.^>
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M)V.*]G7),0B]\UL^NQ$Q[)S%\*X)L*;8+]0IC[?K'M?D*"5?Y\5!"(94@YM
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MZDD.4G,M08G8_8X2D[0>WK]/;ZZOON/.I;_F8E=D686.(_-QTX_6##:),'&
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MG,8!J;"/MH*$/TJO1KATNR+Y6%<HIJC$?*L"?YX&]8M4I>^2,+M/QL\2'1U
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MK6LN+F9"E\].K_%CY$$VR"Q+33L<AG !N&V:<8A(IU'@:C+DZA*ZT^1PXME
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M22"0"O!0]C)=G+*[=6/<\>NQ;+JZ'Y#OLDXC'75TZ6& ]B ISD<"NV>*\PE
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M/!A*1KZ4S@Z-'R(7GM/JEAAX=AX[C2"5*4#\S:C1Q4V/D!KVOE#@,7*?S1H
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MI&&,'SR439&D]OQV*QPCZ;-NF@SC'7]&"U/D[#AEZ;7LU,IZL6MW_-#1QI&
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MLV61KD>+;%0D\]DJ2S>+8IIDDSS93.;K\>3%6;K(3>C.F= Z6;>AUN?JLZ<
MSY$C1WC*J&\-&"X?)C#;V+U$ ,/!-J$2*4-H_B!W)#0F@FI!9CUKSU_6ZI_,
M\]$\2\:S:9'.)NDBV<R7B[S(YL4J'^79R^J_U-7_Z5X6(<TME(YP#"4 CGS
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MB>B[/(K'\<J]M;-4&A/ER[ "0=;%"[QYLS1GRBR,BQ:&'/V< ^\^.38/(9Y
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M+B!L\N-R*M-<2)G-$@C]XWA>'/S0O90\B49]5P;,S3=ILC.Z.K>4A]N7D'9
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M$;K+)=]$*E(D51-U"6.&H[&$* \OV4Z]U\)Y_Z:N_K5A?J15==60>]HLC(H
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MH!7:ZM<)%V/@*IN_H.,%3G/-_<2Q!WB%M[*JS@_;SW<3XQWC&E.;/ZP_:]6
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M,1MZ=]0J>"[<$:$C3$Z1N071)TGE)#GV'7A.=')42&%#[%-L;(M)V[Q:41A
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M(,[\+)R&TSB1J9C%82IB,?>C,( @Z2!^7V:W2A!#=(% <O ^84W_D#4H)0/
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M;N\--E%*5Y+E?@0#'8U75RN]>L(6-Y5+V*P)!*""6]#0;-(,Y#D><)+3_W^
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MI[^R:M(C='[#M&E4\BQR)1J+^&#3O>[4X&%P.*&SQ@=T4, ](XH'.NX?3LI
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M'*T'.+:V17%IV-F^R;]B<-L3'M"P_H#RL78/O0+W/)\)G4_OP9=@<Y;=[N^
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M1RMJ[(:]Z9SP6O>*?!TY,?5=?*-[P(G% O[E7PKLIJB[@?1FW/6M8U+KXW?
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M$?[S=^,VX8;T\P>P':9%.X976T>2#7W^\DD1/QXI41W< N#YV+46[NBHJ]\
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M(=K&/LDH^FK!@;D4-B:-6X6,[8V? &=6(3ER68/RKG!09K3FV+(B=3-=J)M
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ME.$/3NPNK3Y*NVX_G_Q[;[CWC9&CWC%.P8Y%PG,$[-%D:O<F0]J_;<7J*\3
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MULR,239'F\B5Z-I0;>.*BP$JR4>!WJNE"(B#.EMM0JE!"EP@<B(P(71#1:0
MQ4@EX<%M=S9H7(,"8B^6;JNDAITH?EU+X28[*N/E%3]$K7X3@0ZW*]RY7>9
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M,J>K:5]P;+Q"4%#<0E]1*L*,U3+'Q;%'N5IVP^$5Q;EY/.@W0WO,#S,*:D7
M7RG[BL\AB'A89Q'7^<]E;$L&EAQI+(.RG*/Y9BSO-UI?(/ZLSO-30_-DKFIV
M;^X<"*]BZZB\</P_=QZ1?9*+-U(HX5@S'K/%TH[";NR6RKF[J7(7G:1("OJ-
M<O1AQ2M9LIJ^58J>J5O(Q 9?H#TLP%QQ&$D%JX9>Y@NE<B5??1S%QBY:,H@"
MM#^(XBA2Y>*SUT2[H=17\Q:21LC8@)<=+RR)<SS!KU*V]SK6W]CQ@-A7_@/$
M#RE7$8U9#*YS U!*_ZI7E:.?G)0-Q('WP?![<SQ9N>) ]N!8,1V_RM]LVA^
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M-8PNF!R6(*3$PK[E6ERFA2WG38)V"=I>-327$%U3OY.X"!/[<7O9 (&V+#[
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MG+52=TRFS*SLHND3=3=?];0'O(C*=H.8*9+94N(LD?49^4ERR*0EZ)6/IM9
MW9__]'(!.[@[\CGT O/0!FL#MWRK?XWEB'!;2BXFV1:.*+'6HN+^ L\4,+^/
M#5ZH"-G^S +9VR>,Q1I%.%(D:\1MRHP'W*<M,<!%T0(<''27][+"6,[$7+G2
M;IESS?]T>7E]?7,C.#L'/4@IFS-C:?]DZ;33[_X@K%ONR8>X3>H0Y\+0"66#
M&T131XHSK^_90(UL(?F-[8_YD-=-R&FG"-I<;IQ\N*DW5Y#/0=34ECQQ>G]Y
M<?=1N[U*7-BW[OB+_7+N>NZ7: R FJQ_Y@TQPQ^-]'^,]@F;%@0@?T6"NO&]
M,9IS]0;^7^BQSWJS;N@GK,GO;R<6M<\O(LL./1])Y];"H5'M[E]^G7K9A[PP
MOINV)@[@W1R'E.@U&HF4F#+R/Q*'3:1]&%&*MET%)8&Q*W-!EHV/U:4\&[85
M\*O\QN/@UF:[TUO,KAE/W$NZ'\$%E63<EF)<Q;C2K7L5XQK-AIZ'<2]9(W<V
M>.#ZWY$=OE:2?]N*?Q7_2K?N5?S;,MJ=7/Q+@I%VXWC/U52\'<6XBG&E6_<J
MQFVWVD;"N%\\G$PBAJJ\>:1520[N+@K ,-)I-AK]]_7XPTV]J;1T&9E]61!3
MI6;L_\R1A59G0O$%'T.NGZ"Q($%9CL,?>_RH!;[YV\G/R?CQ[%^3QQ.-..%O
M)_88ME:;^-Z3;>'LJE=8*G9T/)F1-!U,PQ19DJT&4 S\"4022[25?'XXI"P_
MFUT_C4#&54B$ZM7T]^"-Z<\1&Q?R$]SO'271K0'0W^\__ZY]MAV'NJX=C;5O
M;/K?X>'2N]I?">,JO?^>^(/T,QA//J5A3;N_TSYZ+UJGT9< WF_4T2Z>0%-T
M0,!V:MIMX!/J2 #8__2[3<W0.KV6UL.:**E.)/7FYD>2&Q\W[S1_=9TE?N,^
MPL.(^'0$JZ(^'W'(A@>Q1#=14A74#D]'R[,:SV7 Y3RYL,_G=@C/,O&*NXGM
MXJA1,4!RL3.VU]SF-Y;T3ZJ-R!/5"!YX4XM!38"8QP C&V0Z$*>G 3L]Y9'=
MI:FGI]P=93>_6Y9(R<@//C1J8B2HPQS78"K\Y"7G/C7-3$/)E(62^5A9$R-4
M0XQ0L?&]F2FSVBN;32QF>X;/7AV_P)F@MF=IR,36/%ABT&X&(I<YV:>F!XK+
MQ"$=SBL'>9AL:PKTNS,0$9H7^0 ZHX'EEX(%2 .4(T-B^_A,G"+L.+!!(%/P
M4OAY F\,9A\Q\0*;3;(5RQ28SH'H=&E!Y' ,8\E&BF4MKN(H'*M\!B^.\X6=
MXV.+OY\]G&F/U(67XY!:H#<Z08235(I.^( (AP9GY>#\CR2P.<J$#)"+SX%7
M@R74"(HAIHT)4((]L!W<J6D:BRVC ![O@A>#MYYI=T#N,[?9+"Q%7Y#&D:IB
M=A B<1D0 Q)0-G<7.8@)(]AX$$X('-$F7,MFZ ,'*\.K$SV<3+$6"CEFC>Q
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M>T#L9BY.ED-? *<N/*J&FTX 64&(<M@&4"A&J) O0?@0MFV<E<<H3+G0L>S
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MT&GWT_YV-22T G2W@.Z[KD71J )4T>A!;(XU J0R6Q(+.E669B.4A:"$6MD
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MYGHA>E4^? WR#GCTT6>587X8+PV$'8M)L$SA1>L\V]7"_A4%H3U\72DDF!3
M_\Z(MP:ZO:9#B8]R;?1^IWKRY,,-\T,;_??U^(.QC]U>*#81)7\9^4FX@.M=
M1A@+(DPGOW[(HF]"'FE]X%/RLTZ&L+ASXCR3U^ ]/IWC>B^"=VIA3 ];.FVV
M.[T?0'XCSY_:?H"%:06-[?UO)[CYH*2IXXA.<JQ'UC0ZP- UL4-<(W[E.8E"
M3X10A*Y9''Y9%&3AY"9KR<CEB([A\0,-N-\G$PI2U0RT3Z%UQL(I=AAH030(
M;,LF/L98MCI!78F*0P4\BXQ)76;EX4,B!5%<WDT OVA[!6BN,>GY"A)(HZY%
MK47.U:HPGQQTM@;F;EWM^\,5K-J+ J"K0#NE+R;%'1YQ_6)I@)_XK[$7 =86
M9?H=R-9;JEWRB1>Q@Z @UQ(U(TJLM4A@[_'<ZCO@&&?-(9FD'2;XILCZ D:>
MBNWL"5#3<Q#3OYTT3^:!KC2999N&YJ[N$=?MQE@N=GT8LE5LI-AH_VRT*P^[
M</YHE)H_8OLS-LI6^H%'= PO_!KW4:,O$^H&-"CU-N<X9P>$R0;E G0J**L-
MY8+3-!G!5% >&Y2*,%5-"EM8Q:M6)2"7<A"U@E))6P7EL4&I"%-E^*^V#[[2
M@+(D&#S]L\#4<;P)'I<JBV&WL;K^N@B6@",4E 4D_T@@J/>?7C\S4.K&]\8L
MO;Z!_Q=ZJSK!<?%TX5I7J7"ZYD'.(O+L:X;1*BK-7CZR4C!6G3WS<-_,_*FK
MB.= _=!_\(SX']^\E0W5=LN"K5JG-\^"I>,]%352-F!9K!0%Y5&KE(IA4L&H
M*%(JU5_-2-'OU*58>H2!(F*-;=<.0C0DGZBR$W8;*]+7'NY^[$JY<"BEJ(LI
M0):7HJ%1(2&GSJ8A)R'GP-V]F))R10:=&D9AO1T.KOVJ!*-B<\E"5]VM0E>[
M9V6]UNSU5/!**D-5!:]DL9H4E))#J4(%A\:D@E%1I%2JOYK!JYR-3#U51W5X
M*)6>+BF4)93=^XA$]3:-1"55G<)?#8II16ATYN<]J^"3@K$D/)F'Y?I;A8UV
MP7?M6K^[?>_[@].)"A0ITZXLYHB"\JC52,4PJ6!4%"F5ZJ]FH.B&]T_.1("T
M4]LUO3%]5]-<JNKBJJKACA1*E?%0KG"2WFBL&TXRQ^/!.9=K]):)LMBO_4+#
M[5U;+0 \P.4G'W1=5X$E"6%4/+X_'C_-Q</Z1O&I'3/RA^8\^TK*MZOV8/HK
M8_(R^Q4C'(1R46]S%=I2QNH1FH%'#*4*)!P:DPI&19$JM'7X'"BP(C7'"Z9G
MXZ@$J&JKOR.%\D##3G?K$LLYL[60J%=STR0J$&K<5_X$DJW0:!<.=9VO_5$!
MK\/#J)A;HFPLO6%LE8VU,P9NU_KMTD2\5$J6,C:5&:>@5%$">3"I8%04*97J
MKV;<ZB,);)/W)[>="(<ZLR 5CBJ^\RW;)?ZK]H SBW]1=L..&U$9\EC'Y5#2
MY8"RA()['S&GC;N67Q/?M=W'X)[Z3# Q"8;]D[G\RCBQWQ^N)N*BK#-[^^4F
M\68;*W,V&F>-3D,%H12,9>74/(RX70/S_7)C2_4RE\M\5"&E2MLN"LJCUBX5
MPZ2"45&D5*J_FB&E?S)OD%H: 0#)(]7 CAM07_.&,R&E0/.B, B)"U\^UK0!
MFHZU;"Q*Q9Q4S$DR3B\'E 5*]IVRU/[#3AMW+H^EV@47:E^83+L;,D%VEXJQ
MY?[O%IYOL]&MM3J]6J==6#1J?\IB*Q918%:4F?/PZG;]R0_)L+K1J77;[5JK
M+U/_\N;F-MV\%?MK./"L5_:!#!R*'RS[:2^FI]Y9"N<O/""%Y#7TO-#U0LII
MZ\N/CMYH]KN&930'E Q;M&-9O79CV,:-Y%=^]1#H41A.SG_]]?GY^>QEX#MG
MGO_X:[/1,'[UX>=?XVM/M)>Q<^X0]_&W$^K6OS^<?/B2F+D!MVY')- &E+J:
M3T/?P^U_HLZK1JQ_10':QZ$'OPP=:H:L((#=!=_ _@?PU\2Q0XT.A_ S7 L\
M\IF-DM8[-0VUE'8*]\+KX"%?<)7Z.T9I,7R"S/:Q&_K2W?@&JR*FZ8U!0[UB
MVP^$+-!PF:#*;6#M1QQZ-"%^B&A#) ##LZIC@HL>\GXA< EP:TAQ-&9PMJN%
MX:;8P]>5#, H'/\[P[4-=,=,AQ(?1>SH_4Y-SY,/-T#E0)+]]_7X0VL?N[U0
M)"!*_C+R$S>6I]4RPEA00W[RZX<L^B8@F.L#GY*?=3*$Q9T3YYF\!N_QZ1S7
M>Q$J4PMC\L+2J=%LZ#^ _$:>/[7]  N3>!K;^]].</-!45''F1 +-0I3#M/H
M !,-V]Z<-^)7GI,H](1K+^3HXK# (N>?DYNLJOUR1,?P^($&W.^3"8T RD#[
M%%IGS+6WPT +HD%@6S;Q;8!GJ[.1E:B0HC7#ED[-958>/B12$,7EY0BT#X!H
MN]KUOR,[?%WD"JP*.<E!6VM@Z];5OC]<@9[PH@!H*=!.Z8M)<5>9ZB1C+P+<
M+.H\<"!K9:D.R2=$Q)Z!&EQ+H(PHL=;:]-:^7862>%[K!'M,ST'N^^VD<S(/
M= Y)=,!U;2FBXJ"N$#\[LD2*A9G'GV6,G1098)0&T(0YFL?&'!<@S='M!Q^F
M3/PQ(8!^VRT3R":9V"%Q%$\KGMXU3YMF-(X<-,G+Q"!7=&B;=J@81#'(CBF-
MSWLJ$V\P>W $?U _8#$UO?^^3/#3I0& TG#,VK$?Y;4J&;4YQ_#3FE)S3)D
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ME4I1Q]=\84@$K#XF[2 LTY947Q(I[T[10ND 542K:*%T@);>YEMO:.JA0A*
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MKWDC\8_GR[ ?[SBMQN1K%91$8[1JS98*VRA *\"[I32-JT\SI0&T[,9QJW'
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M!50#+-!0\ZGI@?+Y#[6T9SL<@3?L^S28>"[F4VL.IE=KCDT&MF.'K]770BI
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MOE%J3_LL/OI/L89[ZWAX":)+I(O(GN/S;=%$F<GRQ!]L34^?Q>PD.UW[@K+
MBX=+S>@T:DDIQE0^41+VB.LS,(69NCBX14,Q%K(D3IZNS&NTLM,JX L+."BD
M/&^49;T3WV<U4KQ0@4U%B@<[X4P,G+$PX".-X!TH0\ZTK_$?F/W.F%,D^8#R
M@VM90UL$EB7@V8$V!G<W\N.)$ZPNR[>#M$?[*AB$/N7U"3CEP0[B.50L4W"(
M&2ZBX('G00$$O+0R,]>;PW>FW0[Y,(!,4M+T +<!%=N#,R6$[QUO%O_93[IL
MS2XMK5/#O](RC07+RR1&86HZM41%3=+U?OJB,^TBBV"+B1E,SQH*ZA)%<6)/
M 25IK&'N[7[V-2P%+0#3%J_ I#1XUU7DQZGV0'BV!\#Q-*TYRX7M,LZ"JP&=
M9%'E> %FJ*6%L/%(K,T3+IL;E]1]I0'%X0$7KG4%/.)XC(%$;[.J) O_=4N!
M'".);6D&3;)+XBFXK11N3LQ+<R2#Z23)SYB.*1C&7_;$J<1+UK [&B!%^F),
M(U[_#+[M%EG%S8U+1&Y=G%WTC;Q4SM3XM&4:/,>,%I*7<A1?)V6<<<D4LQDR
MB\C,.A(#&#/%:*\B@3<N;4HJL3EI,]T5UW5;=$A]IOC(R[+"MF$<H(XUK-#$
M> NJ3G@\C6LFA0'";(M4]//II:M+ML^T[V)-3*?R!>0!#UDQ,[%*Y"L/XFX2
MK(J%%7AS(+,#JY:6CN/KDB<L>2^O$:,NX58'W#%;C!8C[I5BJ6>V;#,+$,*?
M-5[$!$,^-"LN:\-!E:("#7&8O SKVW+@R ZFC!8W)B:Q'US'\UT3>\6IA:V.
M23XL!)*WZ##+-,E" S9O:!%ZXO%^+R$SZF)#.!G42QV;/G$4!%/IZV//QZFC
M/W'B$)M<BK9Q;!3"8OZ#FN36Q2X'2!S<T$RH4Q0<9AHBQ)9GP(:@D2=B.RSL
MR >T/HG:4_I(V!_@05A(,[5T''#,BYQHB,.9\,4.^*0R\L(>!Z0-YB%ZT1G"
MJZ&W\J]9CF;7<^JHX=_UB4-<ERTF1))[M/%.7HO >RC "W' (=J5B6IE9G9F
MG0E_!O/8?F8]& "#1!2L"4RRJ.*BW8N%"(<9V0WLYR!F=K!K<=O3 :S,YIW"
M.G\CZT2!3H:%]!>;]V)"[,Q+F:DL$NLQH9ZP7>#\S)\&ET>BW&%*4 N+H72L
M$TX)GW1)V=G!.!C1'HJ6&>GW2QD%'C2@G"\"G*.(S/(U*Y86O(0]+/:P8N<&
MC3FPUH0[P\56H#T"X83Q2.%V Z4:(TL!1O+VE%,WMM$V+F=,&I-^YFM*B[XJ
M9[3];</2+]$N^6;*$4XUM>V"((K&9:CIQ3A.#SUCMA:V[5IFW[F:OK(#'.Z-
M:2\U($WL[(*2V\NZZ./,334^P!KMLO0"%FX*,+YK!R,V!WGH ]T]>_Y/9H7P
M!S!]D=S$#0P!8_9A(QO$.'@_J"V8'HGPH:GE-.:3JB<$8^'V!*.QV;X]PE_*
MCO83=X -031OP%F?M]L)O,@742DZH8SJ4B<,0QK<Q@IM$?Q:]$-FH/.S.P4*
M&7A1N &\S(!$"6.[/#6("?Y$.PL%-#T%-L'DHNT)XK8>IHB[)4I/S 865:IH
M!,1A+]@V-EH%E1)V)L 6121CY&/@T-78^0T*V4S'@^4;E=1U9RB*F78U(!\V
MWY1W(T.=:H<<X+-=U8Z5^N =DUC5R;LZ>5<G[](<%ZJ3=W7RKD[>93MYE\UQ
MD<!OV2^ZMO=C;C%(8MD\>C5_2+DDYAB,F(TKXHE)J"MI*8I=O\!%9P8V'GW[
M=O SCJG$D=/I_FZ!Z=L#M-/!7G^>#E3.G<2C*V#Z%*!F#Y8W_G(!F!.Q9EQU
MC*8T?)BZ*K7$QTA]/;R;-7"J Y+F/+@8GVPZ.J QCNS8[B0* W$ZS[V9-,+%
M@^^@=!YM'LY>Y#V>2XO03^C/:?JY]G\B#V.;S(D!GHM<'NFCUCN>=,%BJMQ'
MRG31PD[,0<":9RWQE=@^":+'=EDIC7*7>J$K_6B+@#+K7X2^I=B35[1:!,QB
M7^0E5@YG\UR[&\#KGGBLFN,W06#B10LBP\C?O_E6>+-HKVF#"*/@ON^QBD6>
M13$5+O"G;Q'?#K7 !FP0;+.IV6S6&;;I6[PKDJ/3.->^NUZ*4($W$O>OPNP>
M6$\8PF^P,M>;0@7(C20RD8O^,#5D(?D9TI/?M_ED%A;V-Y=U_<.P".B>"7E%
M] "4?$8M#[JPK^).T6S^8WJ\/YGXW@LKQQ%G"AFD6KR5:E+4PQOTB9YZS%QB
M@CNC\.?V)4YX8W?Z:>>SI'N9.&"9ZHA&G,#+0A8(T!*,L&?#3MBB\1*>9!'>
M8\EG\?)0G!IBP#%9P\2G2#_X $%7O,.H]L5SDR2D.?T*VOM-2ZJN"<LFM8(6
M,JC(8(H/;,(I3,4-0GULX<:4$%.6"%X2%TMCDPY2LL@Z\DR>VP$;-I?-E/3K
MW>(08/,1'"-8\$<4DXA6H#BF=^^8DK]PK5L7 T_ KUCH6)E6AG_?,CN)(:W.
ME8N909OLQO/2?(Y@R8)8I,*-9='*+O>)JD6[L*OWSK0+C" _$]\2>04@"D$D
M,5<;_#?1&QIE(,76SUQ0I6E2LP=MCSY);)[YO$1\#7O>(PI92\,6C4PPAR"V
M0*^SM:"X(ICUX*6GB]/+97WPDC+)^"&<4;G@7' \.?\$9I2Y BK>[A3/)U&K
M8M0=NZ';F<$"V#";S$(>B YQ7.I,-\43Z2 QG"RI!D0U3=X@DBB2;!E@85]@
MB1VUX^&]E<FZY2W_V"%_DA0ZOZQ,V@;:5]B*G+5D#5D%:8@[C*?^3+;AJ4B:
M4LLVK\ZN3O:->Q0,1?&IJ6BL2<0YJOQY'AE*C'$]IYV"T#-_:IXXX6&8X$<L
M=#QQO%>*\**G%3DAB0_B+-@NGL7W#+21K<9%TOCH$/-G_<$<>6@T\"?7T?1E
M>M.SP'Z:8YI:IF.U,.HL&H*NY5X7"[3T3B_?[0K?V_47S'(><DO:#=OA.>'L
M=,JR65**Q7&(UX%]FFTKC_DC+#(+1EAZ]19JM[U1\\??D7-9 _U@ AL/ %J+
MDX(K=PZ_;?)DBKEZ@KJE&;*R:^/D.(6;FT(V!.DQK!@"D_0*%L+T-O )L/BM
MZWI/7#I?1.&(.U"G>$%<JG%[>Y',S6":/#VQK6&RC!WRSL;>@*<[)=E0,6#/
M-JAP9K\RE8E<DTB5%$Z68,6?Q5AQ[GGB>O8T=LR,W%K3YM:?N99!R_*8V +9
MZ]_(@U["QNJL>/JL6%=GQ>JL6)T52W3 I<Z*U5FQ.BN6[:PXC_F_]M %WOL=
M\^/QF/&>O%8TW_;S1G9^ZZS1$0&V&$7HJ<ENQ]]'?A 1GK+_0+G!JK=B:SU=
M2C; JGTBSS5-[W<,[?3/>"+U/KV3__VNQNHPDB#!HK%Z+.?486$WAQV>L,$Y
MSFL2NZ^Q0 T?'0;WYVF5U^QL1-1IK[N[X6<.Q94  GN1%=, KW>VH'WP?Z?%
M%O'R ^*  , Z"XN*'%KX=4!'Q!GR>)SM!A'?%3Z7DQV8?@>7$M.>63NT>/P=
M8\VD2D?L!BLPCO,0B)/)A&7U+M.572SGE:*_]$A\*P["P!I%"[8@2^QBPEOV
MX?%T&(S2<@^*K4N4>,?T, ,A1BO1N7. _3 2PFK?1,Q7%/XS'XMG"%MLRY-(
M*=YUEJ%<$94=BYO#J:,?P'<NNLK=\F[NB"*&XQ+!T#.D% 56EI+J1D)(QNJN
MKWIGOI4B(C[70F8F?EQ%/(_DAP[_B]7G/[YY/_3F#X/_M?O5=!?TA0Q'7A3@
MBKX_7$W7_KU=.P^>-E8 @FOOO&X>&S,V;F%RZ;%#)X[5KW;P\Y+ESN"G\FO&
M+]L.E<LBAQ\XIYE%Y[*KRIN%*6@L4#3QPB3G'SS#?\6CEC/RS5RU=IZMQ),)
M<%0Y>]"J\WAY3Q:6#@YD7[)S?MZM,SVB9\6'Z5RR 7%_LG0I'BO$X4U)Q6&F
MHE3$YZ83 ^TPRIY-87_3A><:V;E_K 5!_!3<0'0 $=J::"@#RW90(=LNRJRI
M?1,:DZEE(7J$,@MH]B7R[M?TZ<031?WM#8=U,<"W'HPH#:>I=Y9X17H=.ZT
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M88FMAF+N%,QU9HR:GH/T_]M)\T0JH+>,GV1#C(+#UYU4*\T6E09014LRK+;
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M%6ITU3WCNF=<]XR7TS.>_X)B34^YOK HX\)BO\PMY0)#IK$B3$SI7%HLMGA
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M4U.HN4;WJ>D^-=VGMM\^-243B@?+LF8Q*0>P8+<PP/8]HLN%F%^/NZ%7'@W
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M5YRJT*FT@N?1W_1&T69,?YL5TM\T2,LJREG%HLML.?P;<;%SG8]JLF:V:],
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M.PD.7S2&G#3LC'S.ZE"QJ<&Y#SQ'BX^AANF^2LY3 XPK' +^J_C6D^P8%<=
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MH!59GW Q,B:.&6PN[L.-Q?V/^U]"SG]=@[S"GH^O^%M?&;JKNLK06E4&5N-
M VDI< 3,?.Z LP!F1E5I,.=V /O]:(+]2PK#./X66\\8+"&JGAQ\DV(8\:/P
MSBMBG^-?3$H)3L/Q"2;5K$-R89NC\5/!H_&BLS@:D164LNE .SX@M[>=(XHZ
MOS*]J,;V=,6HLMTG( JPT\'4]\+'Z?)W6WTF Z"F8'N)C]W'X '"'VAU0LL.
M0'+HG#!%HL;#*_LA?A[;Z%L9HS"8>KX=O()A9C]\]>'VYXC_]?K#.\,*"3Z+
M,I5G%LNQ9R"_S%CYH0.L)-)V+,YZ1;4R=G094S CKA> 2@7& R&ND"-@G>32
MSY%!;2RIPO^;XX*KJF976WJ@7SSD#9IM)I/S$.P3OC V?=\&CL$;SZ;/A&X2
M!F#\F:$Z#G5,G<\&TF/A(>1[+W!L,6_E?_.<Y.VE.J@1O9OD<E9!5:] N^W@
M"EC^*O@]FN'G,T+V?G3J]K-#]A3L-P-VQ\%UG!=99RMUG<T#KS/%N8B6::;*
M0O,=ONJ"C?#F!#,E<$J#@>6B+^FCQO/4'D^9)3:?3-MA\0\H ZPD!/LA=&(I
M,'JV@RE8H+@]]?@I#[]D>Q;^<$AWY^!4>VYG2\_M+'^ZF)[;J>=V%G(P]-Q.
M/;=S[U)9=&ZG^JJTF@$WSM&=DJ&A]>[PJ>!MXI'K+>.1:S(A/@:[P<KM0(Z;
MEDYAY(/%S%!) 6S.B*5B1J[UQ38?;,<.X!PXZ.C0C<-BD#1P55F: )S.R[T(
MU1H/1/YBW(IRRE68;]KOZV(C/38MW:0=R]BT*A&J94F%U9;H;&H#JX?O%-<;
M/8-/BYF>P;==SZ"VREI=]$@T+6]:W@Z_C3L<P7=8DYZ]P]_6W+;6H^O62N[F
MH0DMW%/151E3JXPNJ78[JRIC.0F\DOJ]D[**93+QNH5R9H+5.D/=N*WI/!:%
MS:./G65]_'4WR>AIVJ]&=FL7@V-%CU$\05=P!H_ C:GF%AV:T..T0J6X#=VM
MW 9LV!.OB>;+^-2/D6M](BZ9V %-'PMRY=&LDLC\W9JM[D"[%YK.(U'L/'K;
MV]*]4$-S>ZMJJY2^'@#"3F7OY >AQ/2Q2MRU8+N?B./-L3021)$&.J6A35BY
MODE_*]_DUOWN>V-"J91:,&K7"YDMQ>_H=C72KJ;S6)0VCTX.MO0[]J&5::.W
ME%+'T\QM< #<2N[#,>-?9I@D-=:R#U?C8KO;$Y3L,BY*5C&GM#>A%)UJ:,0)
M:7<>Y1UN>]52DOJV>T?J=AQG-N-O/I9E6+$^+ E)4\E-.S2AQQD3E>%==#(1
M,]XT3TQ.R_ N$*UV%6-;>QB:SFKJ9A[56P%QV= W*$OY^K5V4W%\^]/,2GPA
MX 34C7^83L@K+4S'\9[U&$(=S.S?F3C/!RF0T_1M5Q$:*<1(ZL-IN2"Y34CR
MI<[\9?DE@=:28__?J<@(G46IO.$YSV4OMJU8W8G%2/>;WBFE(3JODE@QQS2J
MY@X=FM"*!FKJ,K0B;;A58:>63U7.CDH'W=@>>8J)=R7F-^W"[ZWL**K.=@T0
M(,C+3NX+M2]=VY% >2N^:UTI*3_=\U$) =:Z&-?%;9L:*J>-RT/=-D.1*##5
M3<D1!K=R< 6;'S,EAD_@T?_E2*2OB"&?XBO4X%FN^4A$_P&?'8(H]H25&>+4
M$&K,/)\8COTG@OX'4]-ETS+@+YBBF1$#QY(PS'H?L_[X0_CK:8[)LPWOXY<?
M)'7$:B"@MA$Z 1LK((GF#TPE&2FRR)PP,%,CG NH_$<VSE!^+QUHWPI]R1R.
MK$]Q4 F'[ ^F'H4OD!D.W/%?#<N>P$\3=PP;^D#XUQ'$/[#9K*&1\91RUP&D
MS7WO"9AH(0_=-QFX&:>4'9^Q/$Z%4%0?FTYA568JIP(/MFE"UWBP\-$5@'#6
M+H,&3$ZB0=Z%\"P_,&V72SAG%>[Q0@" A;P'RYCXWHP!M;\YQ0%_RF,:D$(=
MEUA\QACV\C$:R11X.,PI;;%L7(H<VH2":Z5"H!O/B(WNHK3"0BB;L9,<N8&(
M-KG.@$%18./5]./R^7#%%GWKOCF+HY=W%D=C%=5"#N,0,I\#R[E;',LYG(%0
MO]Y-5M>N%G!S!M#VV_,T/V\Y8.N'!Q9)CO<!P4R1\WU"D:>Y?/M&C2X1A>FB
MHVZ:X9/I,"L&)NOOIAOBX2A&XB@5@U4T.[WE9??_YKKL5+H J91K^I76@WC0
M@V,S#W'MUJVUN\?5C+!Q_E1EPW85^NC@@T_NFRX5TL6\096VIJ)VK3*W&ONP
M3DN]%=<ACU1_M7[QG,ROGUY*AF8\FSU<2B']N9!1Q++:B;WJ7:Q._SLF:W6<
M_IF8#H0!JL:WTO9K!_:KVRQNOZ+)X (@9R>&JU7K](\+0^*H'*U8!+DR5E6I
MW3G>^O!#AYE'P85<MG+;7ID]%H >DX$\3M].AZC:Q=N/V6IO>GVR]^BT7>NF
M8 ,<DPVKM)/W<W%]:X[_$]KLTG0*5OAQ:LR(_W@"J$7:9NW79G4*V:S%I%XA
MIC^YE'YE0KH;T]6M]3K5L%T%IX<?I_MU@JDU-0*UT^DJ+,<2=@M9PKWDYMJU
MBT$U0L^"IJ_27EM&:JZEU.94U%\[=-Y-_27FLF\K->T:A6&#@O@-[(&BY?!K
MROV217^"N<TFL'?L$--'KDX_[-0<G7V\^?U_7MK-YO!#7?ZEW3Y4!23?GJF_
M5+C(RDE3O)^S]Q_C_)N;CZ3^X!/SS[HY@=5=FLZS^4H_G(E]%\\_4&EGWOK-
M+6HVTPYO+DY+V@H,5<"T7DW)#![_@/7HOCDG(9!(C2^!U6 %[%CI3L,':ENV
MZ=N$;N7#[)D-FUBLMPZ8;UX 5(B&@1O;!?MOFXYQ'Y@!ZWNA!I;=I_@_LF Z
M9]B[,=MBBCKE) N0&R&[_!$@N2**EC'+:GPMWXG_:(QY]5:CTXTQD)5%I[,<
M3$*%/&MUI9+#=\@3(6V6K[!$XF3=DVTM096,5LNH&R(S BX6D'6.OAE;:VOX
MP7JWSSZ C3LEWESC3:%&B8M&I\5_X <!;HQMQXZ:T<#N>#YA(BH[T>(9);!,
MX#N&J6\FO<FWNV!ZA1M_[L=38H4.N9M\GDP(^+)/)$H/_ !+F5S63Q1:M;IC
M,MK3C)'AI^V*[%F3HDNWV2IL](.#9.)AC$$O3Z8+1LXDSWTF'A920]W$P289
M#CCWT3#\]:Q]IA316YXO<1=,A4"ZLDDH+4O'(TL5PRPZ :7(<:]47;V)1;[5
MU)<J$7K28M:LM)AMF@K25EFK2W%U0>2/8.J%U'0M6FF]J1*A6MZJ+V\RWRKS
M%"6B=J@,#HIEV,8#F2#TU")9173C@#+5:0>_/]SO)(UNX=0TST.C0.-WKN 9
MMAO:[N/=7""^T4],SJ-\-:&?7P+?!/MLNZ;_>AN0&?WFN?CKON<X\-5;E#M"
M2YF4W*YU!]5 ^2CS*NA4IFRH1:?*YB37?(SN1:%6\FJ8@EYMV&NI/9YL Q.0
M' ]2L2QD]M*P]B,,//^57>#Y"#RJTB;INGY=U\^MY;"HSY1^B9]F,&-V[WOH
MD[CAN_UV$UF^>CN[RK\:R$&'F$?VFXJ,T//(JF]A<AB07C'D'H6LB%):LP/S
M\5NFEW6<N:F?L2JK&$*W4ENM4U.'C27+<)]ZK>U23FCO$G6#RPV3G[C@CH(;
M L>%Z41Q1<)>;A]9&A08"!^O;#>E3C95D$ZU#40>_6^7D&Q2T BDPQTJI1PZ
MS[3H E%J8[1?HPRANAZHRNS4\JE&DV#E0^1X$U,=OV/\Q<8I9('I!DMM9BOO
MKBW](/$A5C;>>J%G(6:=I8_DPNE3T?0R^*R,RMG8K)0A62K)CC[5*G_7T2N&
MYL:%?>1:P@VG-YX/+O?WT)][\ ;\ZU_$].&/?Z+HQZ!!"/TG\<DW+T#OW@>9
MUV'Z,>I-5>A46K_SJ&^W^(P -76X E'VL?:0Z:A:VZ>*&'Q]?JI!IY;/'?:S
M53*N3EWQ:"U\1R4WK7!Y3F?^8EA>B#@@5:_..=!22G"9>UM?3R>OH):]WQ=J
M7[JV(V%Y5GS9NE)"?[HGJ1+RK%4SKIK]<FZ.JZR?RRBRFS68JH$CNV.LN+\5
MPHKK-208UV@\!J<J@+=8=CYTQ["?INT&K^"A)-HV=XRIMXRWNV!5@O0,C+4;
MH!\AU5Z)Z1O$Q3N$%4#-6AQTS;!LRW"]P)B:3\3 %T(74=H>7:#0BM<%\JL,
MRX.UX>?181L'\"@S8,\S9\A#A'1;_X!GVW&,\=1T'PE+\-@3T!HW<%[AG6 *
MO,8'N< /H]4V9L"G*6T@K.HJ0IRYV+*YY]CC5\1]8[AP8U!BV#/>3<1(!MTW
MG< &NGWBF $2Y66M$OX+5F<V]US"%[3JIC8,KEE+FI,#&G!0N/_R!R?^N^D'
M\4%/]-JF8\>CH7]0),#A6I$T<N)9MHVZ(=9HX")QPP0N/A>]^*+CH+"5LU>C
M0O:JWVA?\!^(N():L\RSRP1>[ML"V=_8_67)X@5095PNOYNO>++0B@%3HHGA
MB)%H4.(,?85-X$LR3-["[X1H5(6M L:Q?@3V>3G$X7Y*2* >]"276 T]J6Y,
MH^$"CP<NL$J$:EE28;5'<VUX DIQU*!3&GI2BYF&GMSNJDY;9:TN&@I0RYN6
MM\-OXXE"3WZ>S1WOE1"6.Y69;Y&_UFT#RES5'OXBMI2V@6'6:-!?XY#"+_Z*
MIXJ_LMA\!>I$"*WXY!?;?+ =&_/:5Z'O@YR4,0JY(CB15:EM.WHZE=;>',K9
M;Z8J9U-)Y6QU=;&_>L[$B-VKGY#_H ;TV"ZJP12%42O#"^FWRO%"A+3OQ, -
MVMKY4)M.-=3EA%0_CV:WRW%A=JG9BJ,FZA:4Q(IU^Z):EDHM0C6=ITFG%M#3
MBGJ/@..ZPTG5#J=20MI..2'M=4A^>K&/E>OY]JJ!LE,5:ZN;&ZNN^GDTNUM.
M2+M3S6ZW!FI%M<?0#KG<YK>FB>-CHI5#L+?9! :/'6+ZR-?IAYWZ'F<?;UC+
M77/XH2[_@L,A#M/7PK=GZD>Y"&X'6+M/2F+K[/W'./_FYB.I/_C$_+-N3F!U
MEZ;S;+[2#V=BW\7S#]2PD[<K)[GTY4Z<S,J6-.>;B].2O@)#%3"A5U,R@\<_
M8'.6;\Y)""12XTM@-5A!"W9JTO"!VI9M^C9VYFX1@^R9#65B\F/O).M\Q7:T
M&]LUW;%M.@:BGY,9J#'O9PU6NX 3;8+%"EHSV193U"DG60Q;$;++'P&2*_*(
M\NQ>S3#*=^(_&F->O=7H=&,,9,UNZ2P'DZ .8FZ%I9+G3N6)D%9K)RR1.%GW
M9%M+4*4-VY"-<_3@?C?G'OU@O:MT4_*G@DW)%QW^ PFVE-&8/.@7[91/[TV.
M$UCI_N1@A=.RNG,NY/7-5N78\>!-C,7\,-VTK/.4NM%T4]/YKPAL1<6D5V5N
M%;4D'8LDZ4L@K1*ZBU_+DI8EW7I\&CIQU*V@&A!"BYD&A-!NKWH</VE].9X.
M_2H1JN6M^O)VHH@0]Z;#[LHU(H32]6T'+[THIW!UX^L[ABN\YL9.BN[(M<0G
M!*8_Q>?&K_;^:0?3^$-**()KU=J]GBYPU70>B7KGT=Y!\3F2*JIPO[FJP$II
M[K$&F6]X)%/3)_4'D[+BA5=>D5#);3DTH<=IJ4IQ1"Y*=4108IG ?A?RNA<'
M9##0#HBF\UC4.H_6#LMW0 ZANL/6D?H=QYDB^>Y[$T(I;!,6T1/_R1[KU(@V
M7>5Z)(-FF1Y)7&2EQ.[!L+6[JT!]VB/1=%93K?-H;:MTC^1 JMO5N1 %78\?
MA!+3'T_YF$U8BN/-T4NMYM9HO#UU\?9*\6':9?HP4O9'KG6]D'R1']Z#1>ST
MM2^C-IUJ*-8)&8D\-J!3ND>DH"%0R@+H=$UBQ1K$4RW+IA:AFL[3I%,+Z&G%
MU4? <8WDIRJ27RG!<K<HE$G<O;WR:$#+\'%KG9;&ZU2<3B54XW2T/(\2]PI%
MN[O4Y,'@U-$Y5] Z<P!+76Q<$!8-0#-]UW8?Z7?BLV*2@R)(==<RTL@)==8Q
MZD!+8'SQ*#5@309;E#$* M]^"#G<4N 9=[YENZ;_RM^>PB.(G^S_V3U$Z@(S
M*X$_E@%X]LFDL/\N+,_!Y<UA>90MSZ:P^[-YB,TO#Z\&2)5M,5BM*5E\W'PR
M;4<R #X^\Y"?L--B^?A-_ +G*['J)JB5^0A/"!G @#<Q/,DV]K/4\,* !J:+
MO]4PKFV'$? &?=0&/IJ^\XID/*Q;$7D9DWD ])@!(\HBKC>#WPX\'Y]FNV.?
ML!);>(B !>.KC6A%G@:\Z&69;/;49R]T+&,*BS0>"''C:S'L"7O8'$3*#>R4
M)TQ-BW_+IA1GR#'X3OZEC-\%JIX)+,Y"3ME/Y"V>X>,H:"OB7:[EU,JVU/#C
M^%4RF9!Q@!^(%N*\1C\.$CL.?38O"'_+A/<CNO+BV5T4=@(7>';+!H@).>9*
M.6OV#6NWO98N0]LQE:,DH'CL!5.!7(?:P,Y:W!^^N>R2=+U F$LV++GK4HGA
M-[CLPDH]"[X/@H<GEJ5Q\'2HK^%U3A2]K$J$:DDZ_%IU'E4=CA^O2L2PRRJM
M$U4B5(N2 HLM5N.@K:N&O]$H>%K,JBAF&@5/F^6B^M(_-7VY=8T$,%E-IL-%
M(M"U6%HPWW"3LX_\6Y89F$>@A">'</;VQ1<FZ/%BY++2VWMH0G5IGJ;S..G4
M GI:[E_V>?)-WBQ6<BMTN9FJY6:E%)46+F,"J;YUQ]Z,8.'/]F5H!H7UP\?/
M/K;:-2!+EY:J3:<2"G(ZNIY'E8N!7>U<GWNU84_C5U7)8=$-D6H9*+4(U72>
M)IU:0'50NU%]0%0_KM.D6F&/@:&:3BV@2IFFHPM'V =LUP(&7-;Q.\9?[-G<
M\P/3#9;Z05;>3>76/_.W5H78W&2[HE,$&TF*MH344MI+*BE?.A^D:CZHC-SO
MQ<8(PC)7)+5JQ)7J&].INPGK)KM;=/4M-9;%DDKLD_&TTNVWFRBOU,R&#&X.
M:MW^1:W?T_ #BM.IA"*=CDW(H_+%X(=5T/M6IU\;]'JU[G#U;D@IA3_-?(#.
M&:MEL-0B5--YFG1J =41_B854CK0UDZU6DYU*8'VQC#WTN%>5&3@=Z[@&;8;
M@H=]-R?<<4<0ER5W6_C8D<_]Q_WU7""]%/.\FXUF7\?:BM.IA"Z=CEG(H_7%
M@.U54_V4"5VGA0ZX#]>(K^K-P'KWX%MI&HQ,26!*B8UN-F&KQPXQ?=SAZ8>=
MNE!G'V^ $^UF<_BA+O_2[AX*8(L+RM2/7'%NLMA6IG1&GKW_&.??W'PD]0>?
MF'_6S0FL[M)TGLU7^N%,2*!X_H&0P_+"@R67O@P)EMDKF!:?<'%:LAS 4 6L
M_=64S.#Q#X@SYYMS$@*)U/@26 T.0QA0@X8/U+9L-IM^JQS?GME0:END%R#4
MH\?0\&X@6G/'B.1X'Y@!X4/93?AO8,200VI&#!!A&U2.3+;%%'7*269*&GD:
M_!$@N2*,EF[&:H MWXG_:(QY]5:C$T=491?5Z2P'DW"XIO0CDDI^/,H3(:U[
M65@B<<;OR;:6H$K;0>L:Y^A[_F[./?K!>I<,UG+ C ZVAQD=Q?!-[R/DT\\O
M##K6XDYMA,FYBDI:/032!7CMHLAD!=HW'1F7< !>QAEC JQ)PRS='5*I06UW
M3 2LKX QGJW@]2)@;3T"LV4_2P7L*M58IXK>VJF;!-$8:L>"4%DE0K4D'7ZM
M1U,2H55"894X%H#**A&J14F!Q1:K)M#658-0:JQ3+695%#.-=:K-<E%].3FL
MTV]1<I*G((] =TX.HC36;&%X<U8-@FG?>>B/IR9=S3)7<F\+5S^E*FQ%RY\.
MM99]E$7V\EXR_1*W2[\^S^:.]TK(/4Y1O&."_Y5%9LO74%M>/HUF8"6"DAH6
M![5FLU-KZQI*U>E40_-.R(KD,1+]5"/1C!F)YA$8B5:SUNWU:KV+52-Q6M66
M.ZB^7%Y#OB(X)0L>>['RPYP4KA8_-1N#TJN?LBN=5FGH[)> $O:ITVAVTA__
ML:32A[6_\%8A:O*/__M_#%F@FO+_3 6!UO?38.9\_/]02P$"% ,4    " #&
MA'Y4(SFL 402  #XOP  $0              @ $     8VUM8BTR,#(Q,3(S
M,2YX<V102P$"% ,4    " #&A'Y455%]TSP,    LP  %0
M@ %S$@  8VUM8BTR,#(Q,3(S,5]C86PN>&UL4$L! A0#%     @ QH1^5)_0
M1K[%'@  'LD! !4              ( !XAX  &-M;6(M,C R,3$R,S%?9&5F
M+GAM;%!+ 0(4 Q0    ( ,:$?E0TQ)F(>U$  )!7!  5              "
M =H]  !C;6UB+3(P,C$Q,C,Q7VQA8BYX;6Q02P$"% ,4    " #&A'Y4M\!:
MQJ4U  !%I , %0              @ &(CP  8VUM8BTR,#(Q,3(S,5]P<F4N
M>&UL4$L! A0#%     @ QH1^5.$M ,9=/P  (QX! !$              ( !
M8,4  &5X:&EB:71?,3 M,3 N:'1M4$L! A0#%     @ QH1^5-[J73,K0
MA"L! !$              ( ![ 0! &5X:&EB:71?,3 M,3$N:'1M4$L! A0#
M%     @ QH1^5)35IHU,.@  Y/<! !               ( !1D4! &5X:&EB
M:71?,3 M,BYH=&U02P$"% ,4    " #&A'Y44[MTQ+,#  #4%@  $
M        @ ' ?P$ 97AH:6)I=%\R,2TQ+FAT;5!+ 0(4 Q0    ( ,:$?E1C
M&;\UB0,  %4+   0              "  :&# 0!E>&AI8FET7S(S+3$N:'1M
M4$L! A0#%     @ QH1^5#R+.UD-"@  ?4   !               ( !6(<!
M &5X:&EB:71?,S$M,2YH=&U02P$"% ,4    " #&A'Y4VW."N?P)  #R/P
M$               @ &3D0$ 97AH:6)I=%\S,2TR+FAT;5!+ 0(4 Q0    (
M ,:$?E2O\!1MF00  )P5   0              "  ;V; 0!E>&AI8FET7S,R
M+3$N:'1M4$L! A0#%     @ QH1^5.3*)#B!!   *A4  !
M ( !A* ! &5X:&EB:71?,S(M,BYH=&U02P$"% ,4    " #&A'Y4&GWVE7E,
M  #_V@$ #P              @ $SI0$ 97AH:6)I=%\T+3$N:'1M4$L! A0#
M%     @ QH1^5-]>O+[SN@  $4<!  H              ( !V?$! &EM86=E
M,"YJ<&=02P$"% ,4    " #&A'Y4'(7,@WQZ  #-?   #@
M@ 'TK ( :6UA9V4P,# Q-RYJ<&=02P$"% ,4    " #&A'Y4UO_B6NXH 0#Q
M? $ "@              @ &<)P, :6UA9V4Q+FIP9U!+ 0(4 Q0    ( ,:$
M?E1![@%M/^@! /$J @ +              "  ;)0! !I;6%G93$P+FIP9U!+
M 0(4 Q0    ( ,:$?E3-AL#?IT@  #A:   +              "  1HY!@!I
M;6%G93$Q+FIP9U!+ 0(4 Q0    ( ,:$?E3']1]V1$\!  R. 0 +
M      "  >J!!@!I;6%G93$R+FIP9U!+ 0(4 Q0    ( ,:$?E2L=122L? !
M  D) @ +              "  5?1!P!I;6%G93$S+FIP9U!+ 0(4 Q0    (
M ,:$?E2CC$Y%5A4" .X^ @ +              "  3'""0!I;6%G93$T+FIP
M9U!+ 0(4 Q0    ( ,:$?E099$?/\30# )-& P +              "  ;#7
M"P!I;6%G93$U+FIP9U!+ 0(4 Q0    ( ,:$?E3Y=+WV:8$  'OL   +
M          "  <H,#P!I;6%G93$V+FIP9U!+ 0(4 Q0    ( ,:$?E2ON)\(
M$XD" $/L @ *              "  5R.#P!I;6%G93(N:G!G4$L! A0#%
M  @ QH1^5.C\.E\K@@$ TM$!  H              ( !EQ<2 &EM86=E-"YJ
M<&=02P$"% ,4    " #&A'Y49^0)FXXV @ 47@( "@              @ 'J
MF1, :6UA9V4U+FIP9U!+ 0(4 Q0    ( ,:$?E2MT#=!+:$! ,O8 0 *
M          "  :#0%0!I;6%G938N:G!G4$L! A0#%     @ QH1^5!Q:"R90
M%0$ Y64!  H              ( !]7$7 &EM86=E-RYJ<&=02P$"% ,4
M" #&A'Y4!P%I$ZVD  #3#0$ "@              @ %MAQ@ :6UA9V4X+FIP
M9U!+ 0(4 Q0    ( ,:$?E3KGR^SEZP! '/W 0 *              "  4(L
M&0!I;6%G93DN:G!G4$L! A0#%     @ QH1^5$^I4]#T#@  02D   @
M         ( ! =D: &MP;6<N:G!G4$L! A0#%     @ QH1^5.\.="+ZZ (
MY"D:  T              ( !&^@: 'IK,C(R-S4S-"YH=&U02P4&     "(
,(@#L!P  0-$=

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
